Citrus Sinensis ID: 046112

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500--
Protein Sequence
DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLLVLTLALSSLFCRLMCMKKRGNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEAP
Secondary Structure (PSIPRED)
ccccccccccccHHHcccccccEEEcccccccccccHHHHHcccccEEEcccccccccccHHHHccccccEEEcccccccccccHHHHccccccEEcccccccEEcccccccccccccccccccccccccccccccccccccccccccccccEEHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEEcccccEEEEEEEccccccccccHHHHHHHHHcccccccccEEEEEcccccccccccEEEEcccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccEEEccccccHHcccccccEEEEEccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHccc
Secondary Structure Prediction (SSPRO)
EccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEcccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHccccccHccccccEEcHHHHHHHHccccHccEEccccccEEEEEEcccccEEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHcccccccccccccEEEEEEccccccHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEccccHccEEccccccEEEccHHHHHHEccccccEEEEEEEcccccccHHHHHcccccccccHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHccccHEEEcHHHcccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHccccc
Coil and Loop (DISEMBL)
dlsnnnlsgtlspqlvglssLSIFNVSGNLLsgaisnnfgsctsleqldmhgnlfagpigsslsslrglrvldlsqnnlsdeIPEFLAGFKFLQNLNlsynnfesmlpiegifknasatsvfgnkklcggipefqlptcvskkskrnrstlplKLVIVIDIGLLVLTLALSSLFCRLMCmkkrgnptpsisfpyVSYRMLYnatkgfssenligagnfgsvykgiLFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTacsgvdfqgndFKALVYEFMANGsleewmhpiteedkrhkapgnlnslKRLNIAIDVACVLKYLhldcqppiahcdlkpsnillddemTAYVSDFGIARFLEAADEQTrsigvegttgyiapeygmghevssygdvYSFGILLLEMftglrpsddmfkdnlnlrncVKSALPERAEEIrassgstqRSIILECLISICEIgvacsaeqpgermkindvEPRLRLIKKKLLEAP
Flexible Loop (DISEMBL)
dlsnnnlsgtlspqLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIPEFqlptcvskkskrnrstlplklVIVIDIGLLVLTLALSSLFCRLMCMKKrgnptpsisFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEeirassgstqrsIILECLISICEIGVacsaeqpgermkindveprlRLIKKKLLEAP
Low Complexity Region (SEG)
DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIgsslsslrglrvldlsQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPlklvividigllvltlalsslFCRLMCMKKRGNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRsiileclisiceiGVACSAEQPGERMKINDVEPRLRLIKKKLLEAP
Disordered region (IsUnstruct)
**************LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIPEFQLPTCVSK*****RSTLPLKLVIVIDIGLLVLTLALSSLFCRLMCMKKRGNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPI************LNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV*********************IILECLISICEIGVACSA***************************
Disordered Region (DISOPRED)
DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIPE*********************LVIVIDIGLLVLTLALSSLFCR******************VSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITE*******P**LNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEA*****RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEA*
Disordered Region (DISEMBL)
DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLLVLTLALSSLFCRLMCMKKRGNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA**********QRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEAP
Disordered Region (DISPRO)
*LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIPEFQLPTCV*******RSTLPLKLVIVIDIGLLVLTLALSSLFCRLMCMKKRGNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE******PGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK*****
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLLVLTLALSSLFCRLMCMKKRGNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEAP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	502	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.988	0.491	0.478	1e-126
C0LGT6	1031	LRR receptor-like serine/	no	no	0.978	0.476	0.462	1e-117
Q9SD62	1025	Putative receptor-like pr	no	no	0.992	0.485	0.451	1e-110
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.966	0.494	0.358	2e-72
Q9FL28	1173	LRR receptor-like serine/	no	no	0.938	0.401	0.337	1e-59
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.932	0.373	0.339	2e-58
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.918	0.369	0.337	2e-57
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.926	0.459	0.318	4e-57
C0LGF4	591	LRR receptor-like serine/	no	no	0.932	0.791	0.320	2e-56
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.938	0.470	0.318	3e-55

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  452 bits (1164), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 250/523 (47%), Positives = 337/523 (64%), Gaps = 27/523 (5%)

Query: 1    DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            D+S N+L G+L   +  L +L   ++  N LSG +    G+C ++E L + GNLF G I 
Sbjct: 487  DMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDI- 545

Query: 61   SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
              L  L G++ +DLS N+LS  IPE+ A F  L+ LNLS+NN E  +P++GIF+NA+  S
Sbjct: 546  PDLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVS 605

Query: 121  VFGNKKLCGGIPEFQLPTCVSKKS---KRNRSTLPLKLVIVIDIGL-LVLTLALSSLFCR 176
            + GN  LCGGI  FQL  C+S+     K++ S L  K+VI + +G+ L+L L ++S+   
Sbjct: 606  IVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLK-KVVIGVSVGITLLLLLFMASV--T 662

Query: 177  LMCMKKR------GNPTPS---ISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILF 227
            L+ ++KR       NPTPS   +    +SY  L NAT GFSS N++G+G+FG+VYK +L 
Sbjct: 663  LIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLL 722

Query: 228  ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE 287
                 VAVKV N+    A KSF  ECE  ++IRHRNLVK+ TACS +DFQGN+F+AL+YE
Sbjct: 723  TEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYE 782

Query: 288  FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLK 347
            FM NGSL+ W+HP  E ++ H+    L  L+RLNIAIDVA VL YLH+ C  PIAHCDLK
Sbjct: 783  FMPNGSLDMWLHP-EEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLK 841

Query: 348  PSNILLDDEMTAYVSDFGIARFLEAADE-----QTRSIGVEGTTGYIAPEYGMGHEVSSY 402
            PSN+LLDD++TA+VSDFG+AR L   DE     Q  S GV GT GY APEYG+G + S  
Sbjct: 842  PSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSIN 901

Query: 403  GDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASS----GSTQRSI 458
            GDVYSFGILLLEMFTG RP++++F  N  L +  KSALPER  +I   S    G      
Sbjct: 902  GDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFP 961

Query: 459  ILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEA 501
            ++ECL  + E+G+ C  E P  R+  + V   L  I+++  +A
Sbjct: 962  VVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFKA 1004

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  421 bits (1082), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 240/519 (46%), Positives = 318/519 (61%), Gaps = 28/519 (5%)

Query: 1    DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            DLSNN L+G    ++  L  L     S N LSG +    G C S+E L M GN F G I 
Sbjct: 495  DLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAI- 553

Query: 61   SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
              +S L  L+ +D S NNLS  IP +LA    L+NLNLS N FE  +P  G+F+NA+A S
Sbjct: 554  PDISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVS 613

Query: 121  VFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIV----IDIGLLVLTLALSSLFCR 176
            VFGN  +CGG+ E QL  C+ + S R R  L ++  +V    I I  L+L + ++SL C 
Sbjct: 614  VFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASL-CW 672

Query: 177  LMCMKKR-----GNPTPSISF----PYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILF 227
             M  KK+     GNP+ S +       VSY  L++AT  FSS NLIG+GNFG+V+KG+L 
Sbjct: 673  FMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLG 732

Query: 228  ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE 287
                 VAVKV N+L H A+KSF  ECE  + IRHRNLVK+ T CS +D +GNDF+ALVYE
Sbjct: 733  PENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYE 792

Query: 288  FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLK 347
            FM  GSL+ W+  + + ++ +    +L   ++LNIAIDVA  L+YLH+ C  P+AHCD+K
Sbjct: 793  FMPKGSLDMWLQ-LEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIK 851

Query: 348  PSNILLDDEMTAYVSDFGIARFLEAADE-----QTRSIGVEGTTGYIAPEYGMGHEVSSY 402
            PSNILLDD++TA+VSDFG+A+ L   D      Q  S GV GT GY APEYGMG + S  
Sbjct: 852  PSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQ 911

Query: 403  GDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILEC 462
            GDVYSFGILLLEMF+G +P+D+ F  + NL +  KS L        +S GS     I E 
Sbjct: 912  GDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL----SGCTSSGGSNA---IDEG 964

Query: 463  LISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEA 501
            L  + ++G+ CS E P +RM+ ++    L  I+ K   +
Sbjct: 965  LRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSS 1003

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  398 bits (1022), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 246/545 (45%), Positives = 314/545 (57%), Gaps = 47/545 (8%)

Query: 1    DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLL------------------------SGAIS 36
            +L  N L+G++  +L+ L SL + NVS NLL                        SG I 
Sbjct: 479  NLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIP 538

Query: 37   NNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNL 96
                +C SLE L + GN F GPI   +  L GLR LDLS+NNLS  IPE++A F  LQNL
Sbjct: 539  QTLANCLSLEFLLLQGNSFVGPI-PDIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNL 597

Query: 97   NLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLV 156
            NLS NNF+  +P EG+F+N SA SVFGN  LCGGIP  QL  C  +  +R+ S   +  +
Sbjct: 598  NLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITI 657

Query: 157  IV---IDIGLLVLTLALSSLFCRLMCMKKRGNP-------TPSISF-PYVSYRMLYNATK 205
             V   +   LL+    +   + +L     R N        +P  SF   +SY  LY  T 
Sbjct: 658  CVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTG 717

Query: 206  GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV 265
            GFSS NLIG+GNFG+V+KG L     AVA+KV N+    A+KSF  ECE    IRHRNLV
Sbjct: 718  GFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLV 777

Query: 266  KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
            K+ T CS  DF+GNDF+ALVYEFM NG+L+ W+HP  E ++       L    RLNIAID
Sbjct: 778  KLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP-DEIEETGNPSRTLGLFARLNIAID 836

Query: 326  VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT-----RSI 380
            VA  L YLH  C  PIAHCD+KPSNILLD ++TA+VSDFG+A+ L   D  T      S 
Sbjct: 837  VASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSA 896

Query: 381  GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL 440
            GV GT GY APEYGMG   S  GDVYSFGI+LLE+FTG RP++ +F D L L +  KSAL
Sbjct: 897  GVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSAL 956

Query: 441  PER-----AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK 495
             +R      +E        Q   ++ECL  +  +GV+CS E P  R+ + +   +L  I+
Sbjct: 957  QKRQALDITDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIR 1016

Query: 496  KKLLE 500
            +    
Sbjct: 1017 ESFFR 1021

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  273 bits (698), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 191/533 (35%), Positives = 279/533 (52%), Gaps = 48/533 (9%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +LS+N+LSG +  +L  +  +   ++S N LSG I    GSC +LE L++  N F+  + 
Sbjct: 449 NLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLP 508

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
           SSL  L  L+ LD+S N L+  IP        L++LN S+N     +  +G F   +  S
Sbjct: 509 SSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIES 568

Query: 121 VFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLLVL--TLALSSLFCRLM 178
             G+  LCG I   Q      KK K     LP+ L ++    L V    L   S F + +
Sbjct: 569 FLGDSLLCGSIKGMQ---ACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNL 625

Query: 179 CM---------KKRGNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFES 229
            +         +K+    P   +P +SY+ L  AT GF++ +LIG+G FG VYKG+L  +
Sbjct: 626 TVYAKEEVEDEEKQNQNDP--KYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVL-RN 682

Query: 230 TTAVAVKVFN-VLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEF 288
            T VAVKV +     + S SF  EC++ +  RHRNL+++ T CS   F      ALV   
Sbjct: 683 NTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFN-----ALVLPL 737

Query: 289 MANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKP 348
           M NGSLE  ++P     K      NL+ ++ +NI  DVA  + YLH      + HCDLKP
Sbjct: 738 MPNGSLERHLYPGEYSSK------NLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKP 791

Query: 349 SNILLDDEMTAYVSDFGIARFLEAADE-----QTRSIGVE-----GTTGYIAPEYGMGHE 398
           SNILLDDEMTA V+DFGI+R ++  +E      + S G       G+ GYIAPEYGMG  
Sbjct: 792 SNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKR 851

Query: 399 VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQR-- 456
            S++GDVYSFG+LLLE+ +G RP+D +  +  +L   +KS  P+  E I   + S  +  
Sbjct: 852 ASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQ 911

Query: 457 -------SIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEAP 502
                   +  E ++ + E+G+ C+   P  R  + DV   +  +K+ L   P
Sbjct: 912 GKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKEYLFACP 964

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  231 bits (588), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 179/531 (33%), Positives = 274/531 (51%), Gaps = 60/531 (11%)

Query: 1    DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDMHGNLFAGPI 59
            DLSNN  SG++   L    ++   + S N LSG I +  F     +  L++  N F+G I
Sbjct: 655  DLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEI 714

Query: 60   GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASAT 119
              S  ++  L  LDLS NNL+ EIPE LA    L++L L+ NN +  +P  G+FKN +A+
Sbjct: 715  PQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINAS 774

Query: 120  SVFGNKKLCGGIPEFQLPTCVSKK----SKRNRSTLPLKLVIVIDIGLLVLTLALSSLFC 175
             + GN  LCG     + P  + +K    SKR R       VI+I +G     L +  L  
Sbjct: 775  DLMGNTDLCGSKKPLK-PCTIKQKSSHFSKRTR-------VILIILGSAAALLLVLLLVL 826

Query: 176  RLMCMKKRG----NPTPSISFPYVSYRM---------LYNATKGFSSENLIGAGNFGSVY 222
             L C KK+     N + S S P +   +         L  AT  F+S N+IG+ +  +VY
Sbjct: 827  ILTCCKKKEKKIENSSES-SLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVY 885

Query: 223  KGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND 280
            KG L E  T +AVKV N+     ++ K F  E +    ++HRNLVK+     G  ++   
Sbjct: 886  KGQL-EDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGK 940

Query: 281  FKALVYEFMANGSLEEWMHPITEEDKRHKAP-GNLNSLKRLNIAIDVACVLKYLHLDCQP 339
             KALV  FM NG+LE+ +H          AP G+L  L+++++ + +A  + YLH     
Sbjct: 941  TKALVLPFMENGNLEDTIH-------GSAAPIGSL--LEKIDLCVHIASGIDYLHSGYGF 991

Query: 340  PIAHCDLKPSNILLDDEMTAYVSDFGIAR---FLEAADEQTRSIGVEGTTGYIAPEYGMG 396
            PI HCDLKP+NILLD +  A+VSDFG AR   F E       +   EGT GY+APE+   
Sbjct: 992  PIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYM 1051

Query: 397  HEVSSYGDVYSFGILLLEMFTGLRPS--DDMFKDNLNLRNCVKSALPE-RAEEIRASSGS 453
             +V++  DV+SFGI+++E+ T  RP+  +D    ++ LR  V+ ++   R   +R     
Sbjct: 1052 RKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDME 1111

Query: 454  TQRSII-------LECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK 497
               SI+       +E  + +C   + C++ +P +R  +N++   L  ++ K
Sbjct: 1112 LGDSIVSLKQEEAIEDFLKLC---LFCTSSRPEDRPDMNEILTHLMKLRGK 1159

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  227 bits (578), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 173/510 (33%), Positives = 245/510 (48%), Gaps = 42/510 (8%)

Query: 1    DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQ-LDMHGNLFAGPI 59
            +L  N LSG L   +  LS L    +S N L+G I    G    L+  LD+  N F G I
Sbjct: 726  NLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRI 785

Query: 60   GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASAT 119
             S++S+L  L  LDLS N L  E+P  +   K L  LNLSYNN E  L  +  F    A 
Sbjct: 786  PSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQAD 843

Query: 120  SVFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIV------IDIGLLVLTLALSSL 173
            +  GN  LCG      L  C    SK  RS  P  +VI+        I L+VL + L   
Sbjct: 844  AFVGNAGLCGS----PLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFK 899

Query: 174  FCRLMCMKKRGNPTPSISFPY---------------VSYRMLYNATKGFSSENLIGAGNF 218
                +  K RG  +   S                  + +  +  AT   + E +IG+G  
Sbjct: 900  QNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGS 959

Query: 219  GSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG 278
            G VYK  L    T    K+       ++KSF  E +    IRHR+LVK+   CS    + 
Sbjct: 960  GKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSS---KA 1016

Query: 279  NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ 338
            +    L+YE+MANGS+ +W+H   E  K+ +    L    RL IA+ +A  ++YLH DC 
Sbjct: 1017 DGLNLLIYEYMANGSVWDWLHA-NENTKKKEV---LGWETRLKIALGLAQGVEYLHYDCV 1072

Query: 339  PPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEA-ADEQTRSIGV-EGTTGYIAPEYGMG 396
            PPI H D+K SN+LLD  + A++ DFG+A+ L    D  T S  +  G+ GYIAPEY   
Sbjct: 1073 PPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYS 1132

Query: 397  HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL--PERAEEIRASSGST 454
             + +   DVYS GI+L+E+ TG  P++ MF +  ++   V++ L  P  +E       S 
Sbjct: 1133 LKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSE 1192

Query: 455  QRSII---LECLISICEIGVACSAEQPGER 481
             +S++    E    + EI + C+   P ER
Sbjct: 1193 LKSLLPCEEEAAYQVLEIALQCTKSYPQER 1222

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  223 bits (569), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 176/521 (33%), Positives = 256/521 (49%), Gaps = 60/521 (11%)

Query: 1    DLSNNNLSGTLSPQLVG-LSSLSIFNVSGNLLSGAISNNFGSCTSLEQ-LDMHGNLFAGP 58
            +L  N  SG+L PQ +G LS L    +S N L+G I    G    L+  LD+  N F G 
Sbjct: 725  NLDKNQFSGSL-PQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGD 783

Query: 59   IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASA 118
            I S++ +L  L  LDLS N L+ E+P  +   K L  LN+S+NN    L  +  F    A
Sbjct: 784  IPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPA 841

Query: 119  TSVFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVID-------IGLLVLTLALS 171
             S  GN  LCG      L  C   +S   +  L  + V++I        IGL++L +AL 
Sbjct: 842  DSFLGNTGLCGS----PLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALF 897

Query: 172  SLFCRLMCMKKRGNPTPSISFPY-------------------VSYRMLYNATKGFSSENL 212
                R    KK G+ + + +                      + +  +  AT   S E +
Sbjct: 898  -FKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFM 956

Query: 213  IGAGNFGSVYKGILFESTTAVAVKVFNVLHHD---ASKSFAVECEVTRNIRHRNLVKVFT 269
            IG+G  G VYK  L E+   VAVK   +L  D   ++KSF+ E +    IRHR+LVK+  
Sbjct: 957  IGSGGSGKVYKAEL-ENGETVAVK--KILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMG 1013

Query: 270  ACSGVDFQGNDFKALVYEFMANGSLEEWMH---PITEEDKRHKAPGNLNSLKRLNIAIDV 326
             CS    +      L+YE+M NGS+ +W+H   P+ E+ K+      L+   RL IA+ +
Sbjct: 1014 YCSS---KSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKL-----LDWEARLRIAVGL 1065

Query: 327  ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL-EAADEQTRS-IGVEG 384
            A  ++YLH DC PPI H D+K SN+LLD  M A++ DFG+A+ L E  D  T S      
Sbjct: 1066 AQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFAC 1125

Query: 385  TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA 444
            + GYIAPEY    + +   DVYS GI+L+E+ TG  P+D +F   +++   V++ L E A
Sbjct: 1126 SYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHL-EVA 1184

Query: 445  EEIRASSGSTQRSIIL----ECLISICEIGVACSAEQPGER 481
               R      +   +L    +    + EI + C+   P ER
Sbjct: 1185 GSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQER 1225

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  222 bits (566), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 163/511 (31%), Positives = 269/511 (52%), Gaps = 46/511 (9%)

Query: 2   LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGS 61
           +++N +SG +  Q     SLS  ++S N L+G I ++  SC  L  L++  N   G I  
Sbjct: 483 VADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPR 542

Query: 62  SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSV 121
            ++++  L VLDLS N+L+  +PE +     L+ LN+SYN     +PI G  K  +   +
Sbjct: 543 QITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDL 602

Query: 122 FGNKKLCGGIPEFQLPTCVS-KKSKRNRSTLPLKLVI---VIDI----GLLVLTLALSSL 173
            GN  LCGG+    LP C   +++  + S+L  K ++   +I I     L +LT+   +L
Sbjct: 603 RGNSGLCGGV----LPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTL 658

Query: 174 FCRLMCMKKRGNPTPSI-SFPY---VSYRMLYNATKGFS---SENLIGAGNFGSVYKGIL 226
           + +       G+ T S   +P+     +R+ + A+   +     N+IG G  G VYK  +
Sbjct: 659 YKKWYSNGFCGDETASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEM 718

Query: 227 FESTTAVAVKVFNVLHHD----ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK 282
             S+T +AVK       D     +  F  E  +   +RHRN+V++      + F  ND  
Sbjct: 719 SRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRL------LGFLYNDKN 772

Query: 283 AL-VYEFMANGSLEEWMHPITEEDKRHKAPGNL--NSLKRLNIAIDVACVLKYLHLDCQP 339
            + VYEFM NG+L + +H          A G L  + + R NIA+ VA  L YLH DC P
Sbjct: 773 MMIVYEFMLNGNLGDAIH-------GKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHP 825

Query: 340 PIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEV 399
           P+ H D+K +NILLD  + A ++DFG+AR + A  ++T S+ V G+ GYIAPEYG   +V
Sbjct: 826 PVIHRDIKSNNILLDANLDARIADFGLARMM-ARKKETVSM-VAGSYGYIAPEYGYTLKV 883

Query: 400 SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER---AEEIRASSGSTQR 456
               D+YS+G++LLE+ TG RP +  F +++++   V+  + +     E +  + G+ + 
Sbjct: 884 DEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEEALDPNVGNCR- 942

Query: 457 SIILECLISICEIGVACSAEQPGERMKINDV 487
             + E ++ + +I + C+ + P +R  + DV
Sbjct: 943 -YVQEEMLLVLQIALLCTTKLPKDRPSMRDV 972

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1

 Score =  220 bits (560), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 163/509 (32%), Positives = 241/509 (47%), Gaps = 41/509 (8%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +L+ + + G L P +  L  L +  +  N L GAI    G+CT+LE++ +  N F GPI 
Sbjct: 80  NLTYHKIMGPLPPDIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIP 139

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
           + +  L GL+ LD+S N LS  IP  L   K L N N+S N     +P +G+    S  S
Sbjct: 140 AEMGDLPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIPSDGVLSGFSKNS 199

Query: 121 VFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKL---VIVIDIGLLVLTLALSSLFCRL 177
             GN  LCG   +          S  ++S    K     ++I     V  L L +L C  
Sbjct: 200 FIGNLNLCGKHVDVVCQDDSGNPSSHSQSGQNQKKNSGKLLISASATVGALLLVALMCFW 259

Query: 178 MCM--------------KKRGNPTPSISF----PYVSYRMLYNATKGFSSENLIGAGNFG 219
            C               K  G     + F    PY S + +    +  + E++IG G FG
Sbjct: 260 GCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSS-KDIIKKLEMLNEEHIIGCGGFG 318

Query: 220 SVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN 279
           +VYK +  +     A+K    L+    + F  E E+  +I+HR LV +   C+       
Sbjct: 319 TVYK-LAMDDGKVFALKRILKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN-----SP 372

Query: 280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQP 339
             K L+Y+++  GSL+E +H   E+         L+   R+NI I  A  L YLH DC P
Sbjct: 373 TSKLLLYDYLPGGSLDEALHERGEQ---------LDWDSRVNIIIGAAKGLSYLHHDCSP 423

Query: 340 PIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEV 399
            I H D+K SNILLD  + A VSDFG+A+ LE  +    +I V GT GY+APEY      
Sbjct: 424 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI-VAGTFGYLAPEYMQSGRA 482

Query: 400 SSYGDVYSFGILLLEMFTGLRPSDDMF-KDNLNLRNCVKSALPERAEEIRASSGSTQRSI 458
           +   DVYSFG+L+LE+ +G RP+D  F +  LN+   +K  + E+    R         +
Sbjct: 483 TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNVVGWLKFLISEKRP--RDIVDPNCEGM 540

Query: 459 ILECLISICEIGVACSAEQPGERMKINDV 487
            +E L ++  I   C +  P ER  ++ V
Sbjct: 541 QMESLDALLSIATQCVSPSPEERPTMHRV 569

Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  216 bits (550), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 170/533 (31%), Positives = 249/533 (46%), Gaps = 62/533 (11%)

Query: 2   LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGS 61
           LSNN LSG+L   +  LS +    + GN  SG+I    G    L +LD   NLF+G I  
Sbjct: 463 LSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAP 522

Query: 62  SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLS---------------------- 99
            +S  + L  +DLS+N LS +IP  L G K L  LNLS                      
Sbjct: 523 EISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVD 582

Query: 100 --YNNFESMLPIEGIFKNASATSVFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVI 157
             YNN   ++P  G F   + TS  GN  LCG      L  C   K        PL    
Sbjct: 583 FSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPY----LGPC--GKGTHQSHVKPLS--A 634

Query: 158 VIDIGLLVLTLALSSLFCRLMCMKKRG--NPTPSISFPYVSYRMLY----NATKGFSSEN 211
              + L++  L  S +F  +  +K R   N + + ++   +++ L     +       +N
Sbjct: 635 TTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQRLDFTCDDVLDSLKEDN 694

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS--FAVECEVTRNIRHRNLVKVFT 269
           +IG G  G VYKG + +    VAVK    + H +S    F  E +    IRHR++V++  
Sbjct: 695 IIGKGGAGIVYKGTMPKGD-LVAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLG 753

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            CS      ++   LVYE+M NGSL E +H         K  G+L+   R  IA++ A  
Sbjct: 754 FCSN-----HETNLLVYEYMPNGSLGEVLH--------GKKGGHLHWNTRYKIALEAAKG 800

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           L YLH DC P I H D+K +NILLD    A+V+DFG+A+FL+ +        + G+ GYI
Sbjct: 801 LCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 860

Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRA 449
           APEY    +V    DVYSFG++LLE+ TG +P  + F D +++   V+S      + +  
Sbjct: 861 APEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGE-FGDGVDIVQWVRSMTDSNKDCVLK 919

Query: 450 SSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEAP 502
                  S+ +  +  +  + + C  EQ  ER       P +R + + L E P
Sbjct: 920 VIDLRLSSVPVHEVTHVFYVALLCVEEQAVER-------PTMREVVQILTEIP 965

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	502
359486510	965	PREDICTED: probable LRR receptor-like se	0.990	0.515	0.564	1e-158
255581223	1015	receptor-kinase, putative [Ricinus commu	0.976	0.482	0.537	1e-148
255586722	936	serine-threonine protein kinase, plant-t	0.984	0.527	0.55	1e-147
224097752	1025	predicted protein [Populus trichocarpa]	0.988	0.483	0.552	1e-145
224121306	966	predicted protein [Populus trichocarpa]	0.948	0.492	0.523	1e-144
255570308	1033	receptor-kinase, putative [Ricinus commu	0.982	0.477	0.546	1e-143
224127492	1022	predicted protein [Populus trichocarpa]	0.982	0.482	0.524	1e-143
359482058	1040	PREDICTED: probable LRR receptor-like se	0.992	0.478	0.544	1e-142
224135241	985	predicted protein [Populus trichocarpa]	0.986	0.502	0.530	1e-141
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.992	0.261	0.542	1e-141

>gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera]

 Score =  564 bits (1453), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 309/547 (56%), Positives = 362/547 (66%), Gaps = 50/547 (9%)

Query: 1   DLSNNNLSGTLSPQLV-------------------------GLSSLSIFNVSGNLLSGAI 35
           DLS NNLSGT+ PQ+V                          L +L + +VS N+LSG I
Sbjct: 406 DLSLNNLSGTIPPQVVSLSSLSISLDISDNRLTGALPIEVGNLKNLGVLDVSNNMLSGGI 465

Query: 36  SNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQN 95
            ++ GSCTSLE L M GN F G I SS SSLRG+R+LDLS NNLS +IPEFL    F Q 
Sbjct: 466 PSSVGSCTSLEYLSMKGNFFQGSIPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIHF-QL 524

Query: 96  LNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKL 155
           +NLSYN+FE +LP EG+FKN SATS+ GN KLCGGIPEFQLP C  ++ K+   +L LK+
Sbjct: 525 VNLSYNDFEGILPTEGVFKNVSATSIMGNSKLCGGIPEFQLPKCNLQEPKKRGLSLALKI 584

Query: 156 VIVIDIGLLVLTLALSSLFCRLMCMKKRGNPTPSISFPY---VSYRMLYNATKGFSSENL 212
           +I    GLL +T  LS L   L   KK+G P  S S      VSY+ L  AT GFSS NL
Sbjct: 585 IIATVSGLLAITCVLSFLIF-LWLRKKKGEPASSSSEKSLLKVSYQSLLRATDGFSSSNL 643

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G+FGSVYKGIL    TA+AVKV N+L   ASKSF  ECE  RNIRHRNLVKV TACS
Sbjct: 644 IGVGSFGSVYKGILDHDGTAIAVKVLNLLRKGASKSFIAECEALRNIRHRNLVKVLTACS 703

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
           GVD+QGNDFKA+VYEFM NGSLE+W+HP     +    P  LN L+RLNIAIDVAC L Y
Sbjct: 704 GVDYQGNDFKAVVYEFMVNGSLEQWLHPTPTTAEASAPPRKLNFLQRLNIAIDVACALDY 763

Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL-EAADE----QTRSIGVEGTTG 387
           LH  CQ PI HCDLKPSN+LLD EMT +V DFGIA+FL EAA      Q+ SIG+ GT G
Sbjct: 764 LHHQCQTPIVHCDLKPSNVLLDTEMTGHVGDFGIAKFLPEAATRVPEIQSSSIGIRGTIG 823

Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEI 447
           Y APEYGMG EVS+ GDVYSFGILLLEMFTG RP++DMFKD+LN+ N VK+A+PER  EI
Sbjct: 824 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKRPTEDMFKDSLNIHNFVKTAVPERVAEI 883

Query: 448 ----------RASSGSTQRSI-----ILECLISICEIGVACSAEQPGERMKINDVEPRLR 492
                        + ++QR +       ECLISI  IG+ACSAE P ER  I D    L 
Sbjct: 884 ADPVLLQEGVEMDNTTSQRRMASSHDAQECLISIFGIGLACSAELPRERKNITDAAAELN 943

Query: 493 LIKKKLL 499
            ++   L
Sbjct: 944 SVRDIFL 950

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255581223|ref|XP_002531424.1| receptor-kinase, putative [Ricinus communis] gi|223528974|gb|EEF30966.1| receptor-kinase, putative [Ricinus communis]

 Score =  532 bits (1370), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 296/551 (53%), Positives = 355/551 (64%), Gaps = 61/551 (11%)

Query: 1    DLSNNNLSGTLSPQLVGLSSLSI-------------------------FNVSGNLLSGAI 35
            DL+ NNLSG++  Q+ GLSSLSI                           +S N+LSG I
Sbjct: 471  DLAKNNLSGSIPLQVFGLSSLSIALDLSANHFTGVIPMEVGNLKDLEQLGISDNMLSGRI 530

Query: 36   SNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQN 95
             ++ GSC  LE L + GN F G + SSLSSLRGLRVLD S NNLS EIPEFL  F  L++
Sbjct: 531  PDSLGSCIKLEVLALQGNFFDGLVPSSLSSLRGLRVLDFSSNNLSGEIPEFLQSFDLLES 590

Query: 96   LNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKL 155
            LNLSYNNFE  +P+EGIF+NAS T V GN KLCGGIPEF L  C +K  K  + TL LK+
Sbjct: 591  LNLSYNNFEGRVPVEGIFRNASTTLVMGNDKLCGGIPEFHLAKCNAKSPK--KLTLLLKI 648

Query: 156  VIVIDIGLLVLTLALSSLFCRLMCM-KKRGNPTPSISFPY------VSYRMLYNATKGFS 208
            VI     LL L+  L  +F     + KK+  PT   S PY      VS++ L  AT GFS
Sbjct: 649  VISTICSLLGLSFIL--IFALTFWLRKKKEEPT---SDPYGHLLLNVSFQSLLRATDGFS 703

Query: 209  SENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
            S NLIG G+FG VYKG L E    +AVKV N+LHH AS SF  ECE  RNIRHRNLVKV 
Sbjct: 704  SANLIGRGSFGHVYKGFLDEGNVTIAVKVLNLLHHGASTSFIAECEALRNIRHRNLVKVL 763

Query: 269  TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
            TACSG+D+QGNDFKALVYE+M NGSLEEW+HPI   ++  + P +LN L+RLNIAIDVA 
Sbjct: 764  TACSGIDYQGNDFKALVYEYMVNGSLEEWLHPIPRTEEV-EPPRSLNLLQRLNIAIDVAS 822

Query: 329  VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD-----EQTRSIGVE 383
             L YLH  C  PI HCDLKPSN+LLD EM  +VSDFG+A+ L  +       Q+ SIGV 
Sbjct: 823  ALDYLHNQCTTPIVHCDLKPSNVLLDSEMNGHVSDFGLAKILSESTNSFPVSQSSSIGVR 882

Query: 384  GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER 443
            GT G+  PEYG+G  VS+YGDVYS+GILLLE+FTG RP+DDMFK++LNL N  + A  ++
Sbjct: 883  GTVGFAPPEYGVGSNVSTYGDVYSYGILLLELFTGKRPTDDMFKEDLNLHNFAEIAFRDQ 942

Query: 444  AEEI--------------RASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP 489
              E+              R +S   QR  + ECL S+  IGVACS E P ERMKINDV  
Sbjct: 943  LAEVADPILLQETAVRETRLNSRKCQR--LEECLFSMLRIGVACSTEMPQERMKINDVVT 1000

Query: 490  RLRLIKKKLLE 500
             L  I+ KL+ 
Sbjct: 1001 GLHAIRDKLVR 1011

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255586722|ref|XP_002533985.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526036|gb|EEF28405.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  528 bits (1360), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 286/520 (55%), Positives = 354/520 (68%), Gaps = 26/520 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DLS+N L+GT+  ++  L SL   +VS N LSG I +  GSC SLE L M GN F G I 
Sbjct: 422 DLSDNQLTGTVPVEVGNLKSLGQLDVSNNKLSGWIPSTLGSCKSLESLHMKGNNFQGLIP 481

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
           SSL SL+ L+VLDLS NNLS +IPEFL+    LQ LNLS+NNFE  +P +G+F+N SATS
Sbjct: 482 SSLGSLKALQVLDLSHNNLSGQIPEFLSQIVLLQ-LNLSHNNFEGPVPAKGVFRNVSATS 540

Query: 121 VFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLLVLTLALSSLFCRLMCM 180
           + GN KLCGGIPEF L  C+S + K++  T  L++V+     L+ +TL L  +    +  
Sbjct: 541 LEGNNKLCGGIPEFHLAPCISTRHKKSGLTHNLRIVVATVCVLVGVTLLLWVIVVFFLKK 600

Query: 181 KKRGNPTPSISFPY---VSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKV 237
           K+R   + S S      +SY  LY AT GFSS N +GAG+FG+V+KG L    T++AVKV
Sbjct: 601 KRRKESSSSFSEKKALELSYHTLYKATDGFSSANTLGAGSFGTVFKGELGGGETSIAVKV 660

Query: 238 FNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW 297
           FN++ H A KSF  ECE  RNIRHRNLVKV TACS VD+QGN+FKALVYEFM NGSLEEW
Sbjct: 661 FNLMRHGAFKSFIAECEALRNIRHRNLVKVLTACSSVDYQGNEFKALVYEFMVNGSLEEW 720

Query: 298 MHPITEEDKRHKAP-GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE 356
           +HP    D+    P  NLN L+RLNIA+DVAC L YLH  C+ PI HCDLKPSNILLD+E
Sbjct: 721 LHP---PDEAKAIPRNNLNILQRLNIAVDVACALDYLHNHCETPIIHCDLKPSNILLDNE 777

Query: 357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMF 416
           MT +V DFG+A+F      Q+ SIG+ G+ GY   EYG G+EVS+ GDVYS+GILLLE+F
Sbjct: 778 MTGHVGDFGLAKFYRERSHQSSSIGIRGSLGYAPAEYGTGNEVSTSGDVYSYGILLLEIF 837

Query: 417 TGLRPSDDMFKDNLNLRNCVKSALPERAEE----------------IRASSGSTQRSIIL 460
           TG RP DD F ++++L N VK+ALPE+  E                IR S+ S  R+  +
Sbjct: 838 TGKRPMDDWFNEDVSLHNYVKNALPEQVVEILDPTLFQEGEGGISLIRRSNASINRT--M 895

Query: 461 ECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE 500
           ECLISICEIGVACSAE PGERM I DV  +L  I+ KLL 
Sbjct: 896 ECLISICEIGVACSAETPGERMNICDVAGQLVSIRNKLLR 935

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa]

 Score =  520 bits (1340), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 288/521 (55%), Positives = 354/521 (67%), Gaps = 25/521 (4%)

Query: 2    LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGS 61
            LS N L+G+L  ++  L++L  FN+S N LSG I    GSC SLE L M GNLF GPI  
Sbjct: 499  LSENQLTGSLPLEVGKLANLGYFNLSHNRLSGEIPRTLGSCVSLEFLYMEGNLFQGPIPE 558

Query: 62   SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSV 121
            SLSSLR L++L+LS NNLS EIP+FLA  K L +L+LS+NN E  +P++GIF  AS  S+
Sbjct: 559  SLSSLRALQILNLSHNNLSGEIPKFLAELKLLTSLDLSFNNLEGEVPVQGIFARASGFSM 618

Query: 122  FGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLLVLTLALSSLFCRLMCMK 181
             GNKKLCGG+P+  L  C SKKS++ +S+  LKL+I I  G + + L +S +    +  K
Sbjct: 619  LGNKKLCGGMPQLNLSRCTSKKSRKLKSSTKLKLIIAIPCGFVGIILVVSYMLFFFLKEK 678

Query: 182  K----RGNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKV 237
            K     G+P  S +F  V+Y  L  AT GFS  NLIGAG+FGSVYKGIL     AVAVKV
Sbjct: 679  KSRPASGSPWES-TFQRVAYEDLLQATNGFSPANLIGAGSFGSVYKGILRSDGAAVAVKV 737

Query: 238  FNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW 297
            FN+L   ASKSF  EC    NIRHRNLVKV TACSG+DFQGNDFKALVYEFM NGSLEEW
Sbjct: 738  FNLLREGASKSFMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEW 797

Query: 298  MHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM 357
            +HP    D+ H+   +L+ L+RLNIAIDVA  L YLH  CQ  I HCDLKPSN+LLD ++
Sbjct: 798  LHPAQISDEAHRRR-DLSLLQRLNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDL 856

Query: 358  TAYVSDFGIARFLEAAD-----EQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILL 412
            TA+V DFG+AR L  A      +QT SIG++GT GY APEYG+G EVS YGDVYS+GILL
Sbjct: 857  TAHVGDFGLARLLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILL 916

Query: 413  LEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEI---------RASSGSTQRSII---- 459
            LE+FTG RP+D +FKD LNL N  K+ALP    E+           +SG   R +     
Sbjct: 917  LEVFTGRRPTDGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEETSGDASRRMSHIGN 976

Query: 460  -LECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL 499
             +ECL +I ++GVACSAE P ERM+I+ V   LR I+  LL
Sbjct: 977  HMECLAAIVKVGVACSAEFPRERMEISSVAVELRRIRHILL 1017

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224121306|ref|XP_002330794.1| predicted protein [Populus trichocarpa] gi|222872596|gb|EEF09727.1| predicted protein [Populus trichocarpa]

 Score =  519 bits (1336), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 273/521 (52%), Positives = 347/521 (66%), Gaps = 45/521 (8%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DLS NNL G+L  ++  L++L I ++S N+LSG I    GSC  LE L M  N F G I 
Sbjct: 457 DLSRNNLIGSLPTEVGTLTNLGILDISHNMLSGEIPGTLGSCVRLESLFMQNNFFQGTIP 516

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
           SS  SLRGL+VL+LS NNL+  IP+F   F+ L  LNLS+NNFE ++P +G+F+N+SA S
Sbjct: 517 SSFISLRGLQVLNLSHNNLTGSIPDFFLDFRALATLNLSFNNFEGLVPTDGVFRNSSAVS 576

Query: 121 VFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLLVLTLALSSLFCRLMCM 180
           V GN KLCGGI EFQL  C  K +K+ R TL +KL                         
Sbjct: 577 VVGNSKLCGGIAEFQLLECNFKGTKKGRLTLAMKL------------------------- 611

Query: 181 KKRGNPTPSI---SFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKV 237
           +K+  PTP+    S   +SYR L  AT GFS  NL+G G FGSVYKGIL      VAVKV
Sbjct: 612 RKKVEPTPTSPENSVFQMSYRSLLKATDGFSLTNLLGVGGFGSVYKGILDNDEKLVAVKV 671

Query: 238 FNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW 297
            N+L+  ASKSF  ECEV RN+RHRNLVK+ TACSG D+QGNDFKALVYEFM NGSLEEW
Sbjct: 672 LNLLNPRASKSFKAECEVLRNVRHRNLVKLLTACSGSDYQGNDFKALVYEFMVNGSLEEW 731

Query: 298 MHPITEE-DKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE 356
           +HPIT   D+  ++  +LN ++RLNIAID++C L+YLH  C+ PI HCDLKPSN+LLDDE
Sbjct: 732 LHPITPGIDEARESSRSLNFVQRLNIAIDISCALEYLHRGCRTPIVHCDLKPSNVLLDDE 791

Query: 357 MTAYVSDFGIARFLEAAD-----EQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGIL 411
           M  +V DFG+ARF   A       ++ + GV GT GY APEYGMG+EVS+ GDV+S+GIL
Sbjct: 792 MIGHVGDFGLARFFPEATNNLSFNRSSTNGVRGTIGYTAPEYGMGNEVSTSGDVFSYGIL 851

Query: 412 LLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEI-----------RASSGSTQRSIIL 460
           LLEMF+G RP+D +F+D+LNL   +K+ALP + EEI             SS     S + 
Sbjct: 852 LLEMFSGKRPTDVIFEDSLNLHTYMKAALPGKVEEILDPILVQEIKGERSSSYMWNSKVQ 911

Query: 461 ECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEA 501
           +C++S+ E+G+ACSAE P ERM I++V   L+ IK+KLL +
Sbjct: 912 DCVVSVFEVGIACSAELPSERMDISEVTAELQAIKEKLLRS 952

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255570308|ref|XP_002526114.1| receptor-kinase, putative [Ricinus communis] gi|223534611|gb|EEF36308.1| receptor-kinase, putative [Ricinus communis]

 Score =  516 bits (1328), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 282/516 (54%), Positives = 354/516 (68%), Gaps = 23/516 (4%)

Query: 2    LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGS 61
            LS+N+L G LS ++  L++L +  V  N LSG I ++ GSC  LE+L+M  N F G I S
Sbjct: 500  LSHNHLVGALSEKVQNLNNLGVLYVDHNFLSGEIPSSLGSCIRLERLNMRDNSFKGSIPS 559

Query: 62   SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSV 121
            SLS+LRGL+V+DLS NNLS +IPEFL  F FLQ+LNLS+N+FE ++P EG+FKNAS+TSV
Sbjct: 560  SLSALRGLQVVDLSHNNLSGQIPEFLGSFPFLQSLNLSFNDFEGLVPTEGVFKNASSTSV 619

Query: 122  FGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLLVLTLALSSLFCRLMCMK 181
             GN KLCGG+ +F L  C  + S   R  L LK  I+  + +L+  L + S    L   K
Sbjct: 620  MGNNKLCGGVSDFHLLACNIRSSTNRR--LKLK-AIIASVAVLLGALLMLSFLLILRSRK 676

Query: 182  KRGNPTPSISFPY--VSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN 239
            K   P  S   P   VSY+ L++ATKGFSS NLI  G FGSVY+G+L ES   VAVKV N
Sbjct: 677  KSQAPALSSEIPLLRVSYQNLHDATKGFSSSNLINVGGFGSVYQGVLGESGQLVAVKVLN 736

Query: 240  VLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH 299
            V H  A+KSF VECEV ++IRHRNLVKV TACS +D+QGNDFKALVYEFM NGSLEEW+H
Sbjct: 737  VQHQTAAKSFMVECEVLKSIRHRNLVKVLTACSSIDYQGNDFKALVYEFMVNGSLEEWLH 796

Query: 300  PITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA 359
            P+   D   + P  L+ L+RLNIAID+A  L+YL   C+  I HCDLKPSN+LLD E+T 
Sbjct: 797  PVV-VDGSDEPPKKLDLLQRLNIAIDIASALEYLQNHCETTIVHCDLKPSNVLLDAELTG 855

Query: 360  YVSDFGIARFLEAADEQTR------SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLL 413
            +VSDFGIA+FL   D   R      S+ + GT GY  PEYGMG +VS +GD+YS+GILLL
Sbjct: 856  HVSDFGIAKFL-LKDNNNRSTNLSSSVQLRGTIGYAPPEYGMGGQVSIFGDIYSYGILLL 914

Query: 414  EMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEI------RASSGSTQRSI----ILECL 463
            EMFTG RP++DMFK+ LNL    KSALP+   EI      + S     RSI    I++CL
Sbjct: 915  EMFTGKRPTNDMFKEGLNLHKFAKSALPDGVAEILDPVLLQESGEIDSRSIRTKKIMDCL 974

Query: 464  ISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL 499
            ISI +IGV+CSAE PG+R+  +DV  +L  I+ KLL
Sbjct: 975  ISIVDIGVSCSAELPGDRVCTSDVALKLSSIRSKLL 1010

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa]

 Score =  514 bits (1324), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 274/522 (52%), Positives = 344/522 (65%), Gaps = 29/522 (5%)

Query: 2    LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGS 61
            LS N L+G+L  ++  L +L   +VS N  SG I  + GSC SLE L +  N   GPI  
Sbjct: 500  LSENELTGSLPIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCVSLESLHLEENFLQGPIPI 559

Query: 62   SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSV 121
            +LSSLR ++ L+LS NNL+ +IPEFL  FK L++LNLS+N+FE  +P++G F+N SA S+
Sbjct: 560  TLSSLRAIQELNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPVQGAFQNTSAISI 619

Query: 122  FGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVID--IGLLVLTLALSSLFCRLMC 179
            FGNKKLCGGIP+  L  C S +   ++S  P KL+ +I    G L + L +S  F    C
Sbjct: 620  FGNKKLCGGIPQLNLTRCPSSEPTNSKS--PTKLIWIIGSVCGFLGVILIIS--FLLFYC 675

Query: 180  MKKRGN------PTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAV 233
             +K+ +      P+   SFP V+Y  L  AT GFSS NLIG G+FGSV+KGIL      V
Sbjct: 676  FRKKKDKPAASQPSLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPDKIVV 735

Query: 234  AVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGS 293
            AVKV N+L   ASKSF  ECE  ++IRHRNLVK+ T CS +DFQGNDFKALVYEFM NG+
Sbjct: 736  AVKVLNLLRKGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFMVNGN 795

Query: 294  LEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL 353
            LEEW+HP+   D+ +  P  L+ + RLNIAI +A  L YLH DCQ PI HCDLKPSNILL
Sbjct: 796  LEEWLHPVQTSDEAN-GPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPSNILL 854

Query: 354  DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLL 413
            D  MTA+V DFG+ARF   A  QT S+G++GT GY APEYG+G +VS+YGDVYS+GILLL
Sbjct: 855  DTNMTAHVGDFGLARFHSEASNQTSSVGLKGTIGYAAPEYGIGGKVSTYGDVYSYGILLL 914

Query: 414  EMFTGLRPSDDMFKDNLNLRNCVKSALPER---------AEEIRASSGSTQRSI------ 458
            EMFTG RP D MFKD LNL +  K ALP+R           EIR+ + S +  +      
Sbjct: 915  EMFTGKRPVDGMFKDGLNLHSYAKMALPDRIVEVVDPLLVREIRSVNSSDEMGMYHIGPH 974

Query: 459  -ILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL 499
             I  CL++I ++GVACS E P ERM I DV   L  IK  LL
Sbjct: 975  EISACLMTIIKMGVACSVELPRERMDIGDVVTELNRIKDTLL 1016

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  511 bits (1315), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 287/527 (54%), Positives = 340/527 (64%), Gaps = 29/527 (5%)

Query: 1    DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            +L+ N L+G L  ++  L +L   +VS N LSG I +  GSC +LE L M GN F G I 
Sbjct: 504  NLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIP 563

Query: 61   SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
             S  SLRGL  LDLS+NNLS +IPEFL     L NLNLS+NNFE  LP +G+F NA++TS
Sbjct: 564  PSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATSTS 622

Query: 121  VFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLLVLTLALSSLFC-RLMC 179
            V GN KLCGGIPE  LP C   K K   S   LKL+I +  G L L L +S L   RL  
Sbjct: 623  VAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVINRLRR 682

Query: 180  MKKRGNPTPSIS---FPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVK 236
            +K+  + T + S      VSY  L+ AT GFSS NLIG G FGSVYKGIL +  T VAVK
Sbjct: 683  VKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVK 742

Query: 237  VFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEE 296
            V  +    A KSF  ECE  RNIRHRNLVKV T CS VD+QGNDFKALVYEFM NGSLE 
Sbjct: 743  VIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLEN 802

Query: 297  WMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE 356
            W+HP+   D+ +     L+  +RLNIAIDVA  L YLH  C  PI HCDLKPSNILLD++
Sbjct: 803  WLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDND 862

Query: 357  MTAYVSDFGIARFL-EAADE----QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGIL 411
            MTA+V DFG+ARF+ EAA      Q+ SIG++GT GY APEYGMG +VS+ GD YS+GIL
Sbjct: 863  MTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGIL 922

Query: 412  LLEMFTGLRPSDDMFKDNLNLRNCVKSALPER---------------AEEIRASSGST-- 454
            LLEMFTG RP++ MF D LNL N VK ALPER                EE  A+  S   
Sbjct: 923  LLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLA 982

Query: 455  --QRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL 499
              +R  + ECLISI  IGV+CS E P ERM I +    L+LI+K LL
Sbjct: 983  HMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILL 1029

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224135241|ref|XP_002327600.1| predicted protein [Populus trichocarpa] gi|222836154|gb|EEE74575.1| predicted protein [Populus trichocarpa]

 Score =  509 bits (1310), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 279/526 (53%), Positives = 343/526 (65%), Gaps = 31/526 (5%)

Query: 2   LSNNNLSGTLSPQLVGLSSLSIF-------------NVSGNLLSGAISNNFGSCTSLEQL 48
           LS NNLSG +  +++ +SSLS++             ++S N LSG I  + GSC SLE L
Sbjct: 445 LSQNNLSGPIPKEVLSISSLSMYLVLSENQLTLGYMDISKNRLSGEIPASLGSCESLEHL 504

Query: 49  DMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
            + GN F GPI  SL SLR L+ L+LS NNL+ +IP+FL  FK LQ+L+LS+N+ E  +P
Sbjct: 505 SLDGNFFQGPISESLRSLRALQDLNLSHNNLTGQIPKFLGDFKLLQSLDLSFNDLEGEVP 564

Query: 109 IEGIFKNASATSVFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLLVLTL 168
           + G+F+N SA S+ GNK LCGGI +  LPTC SK +K   ST  L L++ I  G + L  
Sbjct: 565 MNGVFENTSAISIAGNKNLCGGILQLNLPTCRSKSTKPKSST-KLALIVAIPCGFIGLIF 623

Query: 169 ALSSL-FCRLMCMKKRGNPTPS-----ISFPYVSYRMLYNATKGFSSENLIGAGNFGSVY 222
             S L FC   C+KK    T +     I F  V+Y+ L  AT GFSSENLIGAG+FGSVY
Sbjct: 624 ITSFLYFC---CLKKSLRKTKNDLAREIPFQGVAYKDLRQATNGFSSENLIGAGSFGSVY 680

Query: 223 KGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK 282
           KG+L      VAVKVFN+L   ASKSF  EC    NIRHRNLVKV  A +GVD QG DFK
Sbjct: 681 KGLLASDGVIVAVKVFNLLREGASKSFMRECAALTNIRHRNLVKVLCAYAGVDVQGKDFK 740

Query: 283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIA 342
           ALVYEFM NGSLEEW+HP     +    P NLN ++RLNIAIDVA  L YLH  C+ PIA
Sbjct: 741 ALVYEFMINGSLEEWLHPNQTLYQEVHEPRNLNLIQRLNIAIDVANALDYLHNHCKTPIA 800

Query: 343 HCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSY 402
           HCDLKPSN+LLD +MTA+V DFG+ +FL  A  QT S+G++GT GY APEYG+G EVS+ 
Sbjct: 801 HCDLKPSNVLLDGDMTAHVGDFGLLKFLSEASCQTSSVGLKGTVGYAAPEYGIGSEVSTL 860

Query: 403 GDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE-------IRASSGSTQ 455
           GDVYS+GILLLEM TG RP+D MFKD + L N VK ALP+R  +       I    G   
Sbjct: 861 GDVYSYGILLLEMITGKRPTDSMFKDGIELHNYVKMALPDRVVDVADPKLVIEVDQGKDA 920

Query: 456 RSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEA 501
              ILECLISI ++GV CS + P ERM I++V   L   +   LE 
Sbjct: 921 HQ-ILECLISISKVGVFCSEKFPRERMGISNVVAVLNRTRANFLEG 965

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  507 bits (1306), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 286/527 (54%), Positives = 339/527 (64%), Gaps = 29/527 (5%)

Query: 1    DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            +L+ N L+G L  ++  L +L   +VS N LSG I +  GSC +LE L M GN F G I 
Sbjct: 535  NLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIP 594

Query: 61   SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
             S  SLRGL  LDLS+NNLS +IPEFL     L NLNLS+NNFE  LP +G+F NA++TS
Sbjct: 595  PSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATSTS 653

Query: 121  VFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLLVLTLALSSLFC-RLMC 179
            V GN KLCGGIPE  LP C   K K   S   LKL+I +  G L L L +S L   RL  
Sbjct: 654  VAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVINRLRR 713

Query: 180  MKKRGNPTPSIS---FPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVK 236
            +K+  + T + S      VSY  L+ AT GFSS NLIG G FGSVYKG L +  T VAVK
Sbjct: 714  VKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQDETVVAVK 773

Query: 237  VFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEE 296
            V  +    A KSF  ECE  RNIRHRNLVKV T CS VD+QGNDFKALVYEFM NGSLE 
Sbjct: 774  VIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLEN 833

Query: 297  WMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE 356
            W+HP+   D+ +     L+  +RLNIAIDVA  L YLH  C  PI HCDLKPSNILLD++
Sbjct: 834  WLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDND 893

Query: 357  MTAYVSDFGIARFL-EAADE----QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGIL 411
            MTA+V DFG+ARF+ EAA      Q+ SIG++GT GY APEYGMG +VS+ GD YS+GIL
Sbjct: 894  MTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGIL 953

Query: 412  LLEMFTGLRPSDDMFKDNLNLRNCVKSALPER---------------AEEIRASSGST-- 454
            LLEMFTG RP++ MF D LNL N VK ALPER                EE  A+  S   
Sbjct: 954  LLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLA 1013

Query: 455  --QRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL 499
              +R  + ECLISI  IGV+CS E P ERM I +    L+LI+K LL
Sbjct: 1014 HMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILL 1060

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	502
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.988	0.491	0.449	1.9e-110
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.990	0.491	0.413	6.5e-106
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.978	0.476	0.435	4.4e-100
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.990	0.492	0.428	3.1e-99
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.878	0.430	0.474	1.5e-97
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.970	0.475	0.407	2.7e-91
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.794	0.794	0.444	8e-89
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.595	0.305	0.398	9.1e-63
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.605	0.373	0.391	5.3e-56
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.846	0.362	0.336	1.4e-52

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1048 (374.0 bits), Expect = 1.9e-110, Sum P(2) = 1.9e-110
 Identities = 235/523 (44%), Positives = 307/523 (58%)

Query:     1 DLSNNNLSGTLSPQLVG-LSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
             D+S N+L G+L PQ +G L +L   ++  N LSG +    G+C ++E L + GNLF G I
Sbjct:   487 DMSGNSLIGSL-PQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDI 545

Query:    60 XXXXXXXXXXXXXXXXQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASAT 119
                              N+LS  IPE+ A F  L+ LNLS+NN E  +P++GIF+NA+  
Sbjct:   546 PDLKGLVGVKEVDLS-NNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTV 604

Query:   120 SVFGNKKLCGGIPEFQLPTCVSKKS---KRNRSTLPXXXXXXXXXXXXXXXXXXXXXFCR 176
             S+ GN  LCGGI  FQL  C+S+     K++ S L                         
Sbjct:   605 SIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASV--T 662

Query:   177 LMCMKKR------GNPTPS---ISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILF 227
             L+ ++KR       NPTPS   +    +SY  L NAT GFSS N++G+G+FG+VYK +L 
Sbjct:   663 LIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLL 722

Query:   228 ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE 287
                  VAVKV N+    A KSF  ECE  ++IRHRNLVK+ TACS +DFQGN+F+AL+YE
Sbjct:   723 TEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYE 782

Query:   288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLK 347
             FM NGSL+ W+HP  E ++ H+    L  L+RLNIAIDVA VL YLH+ C  PIAHCDLK
Sbjct:   783 FMPNGSLDMWLHP-EEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLK 841

Query:   348 PSNILLDDEMTAYVSDFGIARFLEAADE-----QTRSIGVEGTTGYIAPEYGMGHEVSSY 402
             PSN+LLDD++TA+VSDFG+AR L   DE     Q  S GV GT GY APEYG+G + S  
Sbjct:   842 PSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSIN 901

Query:   403 GDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASS----GSTQRXX 458
             GDVYSFGILLLEMFTG RP++++F  N  L +  KSALPER  +I   S    G      
Sbjct:   902 GDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFP 961

Query:   459 XXXXXXXXXXXGVACSAEQPGERMKINDVEPRLRLIKKKLLEA 501
                        G+ C  E P  R+  + V   L  I+++  +A
Sbjct:   962 VVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFKA 1004

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 974 (347.9 bits), Expect = 6.5e-106, Sum P(2) = 6.5e-106
 Identities = 214/518 (41%), Positives = 293/518 (56%)

Query:     2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIXX 61
             +  N+LSG+L   +  L +L   ++  N  SG +    G+C ++EQL + GN F G I  
Sbjct:   489 MEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPN 548

Query:    62 XXXXXXXXXXXXXXQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSV 121
                            N+LS  IPE+ A F  L+ LNLS NNF   +P +G F+N++   V
Sbjct:   549 IRGLMGVRRVDLS-NNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFV 607

Query:   122 FGNKKLCGGIPEFQLPTCVSKK----SKRNRSTLPXXXXXXXXXXXXXXXXXXXXXFCRL 177
             FGNK LCGGI + +L  C++++    +K +                           C  
Sbjct:   608 FGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWF 667

Query:   178 MCMKKR---GNPTPS---ISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTT 231
                +K     N  PS   I    +SY  L NAT GFSS N++G+G+FG+V+K +L   + 
Sbjct:   668 RKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESK 727

Query:   232 AVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMAN 291
              VAVKV N+    A KSF  ECE  ++ RHRNLVK+ TAC+  DFQGN+F+AL+YE++ N
Sbjct:   728 IVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPN 787

Query:   292 GSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNI 351
             GS++ W+HP   E+ R + P  L  L+RLNI IDVA VL YLH+ C  PIAHCDLKPSN+
Sbjct:   788 GSVDMWLHPEEVEEIR-RPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNV 846

Query:   352 LLDDEMTAYVSDFGIARFLEAADE-----QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVY 406
             LL+D++TA+VSDFG+AR L   D+     Q  S GV GT GY APEYGMG + S +GDVY
Sbjct:   847 LLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVY 906

Query:   407 SFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASS----GSTQRXXXXXX 462
             SFG+LLLEMFTG RP+D++F  NL L +  K ALPE+  EI   +    G          
Sbjct:   907 SFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIGLRVGFRTAEC 966

Query:   463 XXXXXXXGVACSAEQPGERMKINDVEPRLRLIKKKLLE 500
                    G+ C  E P  R+  ++V   L  I+++  +
Sbjct:   967 LTLVLEVGLRCCEEYPTNRLATSEVAKELISIRERFFK 1004

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 993 (354.6 bits), Expect = 4.4e-100, P = 4.4e-100
 Identities = 226/519 (43%), Positives = 293/519 (56%)

Query:     1 DLSNNNLSGTLSPQLVGLSSLSI-FNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
             DLSNN L+G   P+ VG   L +    S N LSG +    G C S+E L M GN F G I
Sbjct:   495 DLSNNFLTGHF-PEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAI 553

Query:    60 XXXXXXXXXXXXXXXXQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASAT 119
                              NNLS  IP +LA    L+NLNLS N FE  +P  G+F+NA+A 
Sbjct:   554 PDISRLVSLKNVDFS-NNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAV 612

Query:   120 SVFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPXXXXXXXXX---XXXXXXXXXXXXFCR 176
             SVFGN  +CGG+ E QL  C+ + S R R  L                          C 
Sbjct:   613 SVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCW 672

Query:   177 LMCMKKR-----GNPTPSISFPY----VSYRMLYNATKGFSSENLIGAGNFGSVYKGILF 227
              M  KK+     GNP+ S +       VSY  L++AT  FSS NLIG+GNFG+V+KG+L 
Sbjct:   673 FMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLG 732

Query:   228 ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE 287
                  VAVKV N+L H A+KSF  ECE  + IRHRNLVK+ T CS +D +GNDF+ALVYE
Sbjct:   733 PENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYE 792

Query:   288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLK 347
             FM  GSL+ W+  + + ++ +    +L   ++LNIAIDVA  L+YLH+ C  P+AHCD+K
Sbjct:   793 FMPKGSLDMWLQ-LEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIK 851

Query:   348 PSNILLDDEMTAYVSDFGIARFLEAADEQT-----RSIGVEGTTGYIAPEYGMGHEVSSY 402
             PSNILLDD++TA+VSDFG+A+ L   D ++      S GV GT GY APEYGMG + S  
Sbjct:   852 PSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQ 911

Query:   403 GDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRXXXXXX 462
             GDVYSFGILLLEMF+G +P+D+ F  + NL +  KS L        +S GS         
Sbjct:   912 GDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL----SGCTSSGGSN---AIDEG 964

Query:   463 XXXXXXXGVACSAEQPGERMKINDVEPRLRLIKKKLLEA 501
                    G+ CS E P +RM+ ++    L  I+ K   +
Sbjct:   965 LRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSS 1003

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 985 (351.8 bits), Expect = 3.1e-99, P = 3.1e-99
 Identities = 222/518 (42%), Positives = 294/518 (56%)

Query:     1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIX 60
             ++ +N+LSG+L   +  L +L    +  N LSG +    G C S+E + +  N F G I 
Sbjct:   488 NMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIP 547

Query:    61 XXXXXXXXXXXXXXXQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
                             NNLS  I E+   F  L+ LNLS NNFE  +P EGIF+NA+  S
Sbjct:   548 DIKGLMGVKNVDLS-NNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVS 606

Query:   121 VFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPXXXXXXXXXXXXXXXXXXXXXFCRLMCM 180
             VFGNK LCG I E +L  C+++ +    +  P                        L   
Sbjct:   607 VFGNKNLCGSIKELKLKPCIAQ-APPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWF 665

Query:   181 KKRGN--------P-TPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTT 231
             KKR N        P T  I    +SY  L NAT GFSS N++G+G+FG+V+K +L     
Sbjct:   666 KKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENK 725

Query:   232 AVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMAN 291
              VAVKV N+    A KSF  ECE  ++IRHRNLVK+ TAC+ +DFQGN+F+AL+YEFM N
Sbjct:   726 IVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPN 785

Query:   292 GSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNI 351
             GSL++W+HP  E ++ H+    L  L+RLNIAIDVA VL YLH+ C  PIAHCDLKPSNI
Sbjct:   786 GSLDKWLHP-EEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNI 844

Query:   352 LLDDEMTAYVSDFGIARFLEAADE-----QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVY 406
             LLDD++TA+VSDFG+AR L   D+     Q  S GV GT GY APEYGMG + S +GDVY
Sbjct:   845 LLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVY 904

Query:   407 SFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASS----GSTQRXXXXXX 462
             SFG+L+LEMFTG RP++++F  N  L +  K+ALPER  +I   S    G          
Sbjct:   905 SFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSILHSGLRVGFPVLEC 964

Query:   463 XXXXXXXGVACSAEQPGERMKINDVEPRLRLIKKKLLE 500
                    G+ C  E P  R+  ++    L  I+++  +
Sbjct:   965 LKGILDVGLRCCEESPLNRLATSEAAKELISIRERFFK 1002

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 969 (346.2 bits), Expect = 1.5e-97, P = 1.5e-97
 Identities = 218/459 (47%), Positives = 267/459 (58%)

Query:     1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIX 60
             ++S N L G L   +  L  L   +VS N LSG I     +C SLE L + GN F GPI 
Sbjct:   503 NVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP 562

Query:    61 XXXXXXXXXXXXXXXQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
                            +NNLS  IPE++A F  LQNLNLS NNF+  +P EG+F+N SA S
Sbjct:   563 DIRGLTGLRFLDLS-KNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMS 621

Query:   121 VFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPXXXXXXXXXXXXXXXXXXXXXF-C---- 175
             VFGN  LCGGIP  QL  C  +  +R+ S                        + C    
Sbjct:   622 VFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKL 681

Query:   176 RLMCMKKRGNP-----TPSISF-PYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFES 229
             R+  ++   N      +P  SF   +SY  LY  T GFSS NLIG+GNFG+V+KG L   
Sbjct:   682 RVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSK 741

Query:   230 TTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFM 289
               AVA+KV N+    A+KSF  ECE    IRHRNLVK+ T CS  DF+GNDF+ALVYEFM
Sbjct:   742 NKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFM 801

Query:   290 ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPS 349
              NG+L+ W+HP  E ++       L    RLNIAIDVA  L YLH  C  PIAHCD+KPS
Sbjct:   802 PNGNLDMWLHP-DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPS 860

Query:   350 NILLDDEMTAYVSDFGIARFLEAADEQT-----RSIGVEGTTGYIAPEYGMGHEVSSYGD 404
             NILLD ++TA+VSDFG+A+ L   D  T      S GV GT GY APEYGMG   S  GD
Sbjct:   861 NILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGD 920

Query:   405 VYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER 443
             VYSFGI+LLE+FTG RP++ +F D L L +  KSAL +R
Sbjct:   921 VYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKR 959

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 910 (325.4 bits), Expect = 2.7e-91, P = 2.7e-91
 Identities = 212/520 (40%), Positives = 279/520 (53%)

Query:     1 DLSNNNLSGTLSPQLVG-LSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
             ++S NNL G++ PQ +G L +L  F+   N LSG I N  G C  L  L +  NL +G I
Sbjct:   503 NVSKNNLEGSI-PQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSI 561

Query:    60 XXXXXXXXXXXXXXXXQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASAT 119
                              NNLS +IP  LA    L +LNLS+N+F   +P  G F  AS  
Sbjct:   562 PSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGI 621

Query:   120 SVFGNKKLCGGIPEFQLPTCVSK-KSKRNRSTLPXXXXXXXXXXXXXXXXXXXXXFCRLM 178
             S+ GN KLCGGIP+  LP C    +++++   LP                       R  
Sbjct:   622 SIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLPISVSLAAALAILSSLYLLITWHKRT- 680

Query:   179 CMKKRGNP--TPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVK 236
                K+G P  T     P VSY  L  AT GF+  NL+G+G+FGSVYKG L      VAVK
Sbjct:   681 ---KKGAPSRTSMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKL-NIQDHVAVK 736

Query:   237 VFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEE 296
             V  + +  A KSF  ECE  RN+RHRNLVK+ T CS +D +GNDFKA+VY+FM NGSLE+
Sbjct:   737 VLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLED 796

Query:   297 WMHPITEE--DKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD 354
             W+HP T +  D+RH     LN  +R+ I +DVAC L YLH     P+ HCD+K SN+LLD
Sbjct:   797 WIHPETNDQADQRH-----LNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLD 851

Query:   355 DEMTAYVSDFGIARFL----EAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGI 410
              +M A+V DFG+AR L        + T S+G  GT GY APEYG+G   S++GD+YS+GI
Sbjct:   852 SDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGI 911

Query:   411 LLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASS---------GSTQRX---X 458
             L+LE+ TG RP+D  F+ +L LR  V+  L  R  ++  +           ST       
Sbjct:   912 LVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENWLNSTNNSPCRR 971

Query:   459 XXXXXXXXXXXGVACSAEQPGERMKINDVEPRLRLIKKKL 498
                        G++CS E P  R    D+   L  IK+ L
Sbjct:   972 ITECIVWLLRLGLSCSQELPSSRTPTGDIIDELNAIKQNL 1011

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 847 (303.2 bits), Expect = 8.0e-89, Sum P(2) = 8.0e-89
 Identities = 192/432 (44%), Positives = 245/432 (56%)

Query:    79 LSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE--------GIFKNASATSVFGNKKLCGG 130
             LS  I   +    FL++LNL  N+F+S +P E        G+F+N +  SVFGN+ LCGG
Sbjct:    85 LSGSISPSIGNLSFLRSLNLGDNSFQSNIPQEFEGSVPTKGVFQNGTTVSVFGNENLCGG 144

Query:   131 IPEFQLPTCVSKKSKRNRSTLPXXXXXXXXXXXXXXXXXXXXXFCRLMCMKKRGNPTPSI 190
             + E QL  C+  +S R +   P                        L   KK+ +     
Sbjct:   145 VIEMQLKPCI--ESPRQKK--PFSLGEKVAVGVGVALLFLFIIVASLSWFKKKNDK---- 196

Query:   191 SFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA 250
                 +SY  LYNAT GFSS NLIG+GNF  V+KG+L      VAVKV N+L H A+KSF 
Sbjct:   197 ----ISYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVLNLLKHGATKSFI 252

Query:   251 VECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKA 310
              ECE  + IRHRNL K+ T CS +D QGNDF+ALVYEFM  GSL+ W+ P   E   + +
Sbjct:   253 AECESFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANNHS 312

Query:   311 PGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL 370
               +L   +++NIAIDVA  L+YLH+ C  P+AHCD+KPSN+LLDD++TA+VSDFG+AR L
Sbjct:   313 R-SLTFAEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLLDDDLTAHVSDFGLARLL 371

Query:   371 EAADEQT-----RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
                DE+T      S GV GT GY APEYGMG + S  GDVYSFG+LLLEMFTG +P+D+ 
Sbjct:   372 YNFDEKTFLNQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVYSFGVLLLEMFTGKKPTDNS 431

Query:   426 FKDNLNLRNCVKSALPERAEEIRASSGSTQRXXXXXXXXXXXXXGVACSAEQPGERMKIN 485
             F    NL    KS L         S G   R             G+ CS E P +RM + 
Sbjct:   432 FGGGYNLHGYTKSVL-----SCSTSRGG--RTMVDEWLRLVLEVGIKCSEEYPRDRMGMA 484

Query:   486 DVEPRLRLIKKK 497
             +    L  IK K
Sbjct:   485 EAVRELVSIKSK 496

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 523 (189.2 bits), Expect = 9.1e-63, Sum P(2) = 9.1e-63
 Identities = 132/331 (39%), Positives = 183/331 (55%)

Query:   192 FPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFA 250
             +P +SY+ L  AT GF++ +LIG+G FG VYKG+L  + T VAVKV +     + S SF 
Sbjct:   646 YPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSFK 704

Query:   251 VECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKA 310
              EC++ +  RHRNL+++ T CS     G  F ALV   M NGSLE  ++P     K    
Sbjct:   705 RECQILKRTRHRNLIRIITTCSK---PG--FNALVLPLMPNGSLERHLYPGEYSSK---- 755

Query:   311 PGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL 370
               NL+ ++ +NI  DVA  + YLH      + HCDLKPSNILLDDEMTA V+DFGI+R +
Sbjct:   756 --NLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLV 813

Query:   371 EAADEQTR-----SIGVE-----GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +  +E        S G       G+ GYIAPEYGMG   S++GDVYSFG+LLLE+ +G R
Sbjct:   814 QGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRR 873

Query:   421 PSDDMFKDNLNLRNCVKSALPERAEEI--RASS-----GSTQRXXXX--XXXXXXXXXGV 471
             P+D +  +  +L   +KS  P+  E I  +A S     G  ++               G+
Sbjct:   874 PTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGL 933

Query:   472 ACSAEQPGERMKINDVEPRLRLIKKKLLEAP 502
              C+   P  R  + DV   +  +K+ L   P
Sbjct:   934 VCTQYNPSTRPDMLDVAHEMGRLKEYLFACP 964

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 577 (208.2 bits), Expect = 5.3e-56, P = 5.3e-56
 Identities = 125/319 (39%), Positives = 173/319 (54%)

Query:     1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIX 60
             D+S+NNL G++  ++  L ++  F+   N LSG   +  G C  L+ L +  N   G I 
Sbjct:   477 DVSHNNLEGSIPKEIGKLKNIVEFHADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIP 536

Query:    61 XXXXXXXXXXXXXXXQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
                             NNLS +IP  L     L +LNLS+N+F   +P  G+F NAS   
Sbjct:   537 IALTQLKGLDTLDLSGNNLSGQIPMSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIY 596

Query:   121 VFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPXXXXXXXXXXXXXXXXXXXXXFCRLMCM 180
             + GN  +CGGIPE  LPTC  K  K+ +  +                      +  L C 
Sbjct:   597 IQGNAHICGGIPELHLPTCSLKSRKKKKHQI---LLLVVVICLVSTLAVFSLLYMLLTCH 653

Query:   181 KKRGNPTPSIS----FPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFES-----TT 231
             K+R    P+ +     P ++Y+ L  AT GFSS +L+G+G+FGSVYKG  F+S     T+
Sbjct:   654 KRRKKEVPATTSMQGHPMITYKQLVKATDGFSSSHLLGSGSFGSVYKGE-FDSQDGEITS 712

Query:   232 AVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMAN 291
              VAV+V  +    A KSF  ECE  RN RHRNLVK+ T CS +D +GNDFKA+VY+FM N
Sbjct:   713 LVAVRVLKLETPKALKSFTAECETLRNTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPN 772

Query:   292 GSLEEWMHPITEE--DKRH 308
             GSLE+W+HP T +  ++RH
Sbjct:   773 GSLEDWLHPETNDQAEQRH 791

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 555 (200.4 bits), Expect = 1.4e-52, P = 1.4e-52
 Identities = 154/458 (33%), Positives = 227/458 (49%)

Query:     1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDMHGNLFAGPI 59
             DLSNN  SG++   L    ++   + S N LSG I +  F     +  L++  N F+G I
Sbjct:   655 DLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEI 714

Query:    60 XXXXXXXXXXXXXXXXQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASAT 119
                              NNL+ EIPE LA    L++L L+ NN +  +P  G+FKN +A+
Sbjct:   715 PQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINAS 774

Query:   120 SVFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPXXXXXXXXXXXXXXXXXXXXXFCRLMC 179
              + GN  LCG     +  T   K S  ++ T                        C    
Sbjct:   775 DLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKK 834

Query:   180 MKKRGNPTPSISFPYVSYRM---------LYNATKGFSSENLIGAGNFGSVYKGILFEST 230
              KK  N + S S P +   +         L  AT  F+S N+IG+ +  +VYKG L E  
Sbjct:   835 EKKIENSSES-SLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDG 892

Query:   231 TAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEF 288
             T +AVKV N+    A   K F  E +    ++HRNLVK+     G  ++    KALV  F
Sbjct:   893 TVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTKALVLPF 948

Query:   289 MANGSLEEWMHPITEEDKRHKAP-GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLK 347
             M NG+LE+ +H          AP G+L  L+++++ + +A  + YLH     PI HCDLK
Sbjct:   949 MENGNLEDTIHGSA-------APIGSL--LEKIDLCVHIASGIDYLHSGYGFPIVHCDLK 999

Query:   348 PSNILLDDEMTAYVSDFGIARFLEAADE--QTRSIGV-EGTTGYIAPEYGMGHEVSSYGD 404
             P+NILLD +  A+VSDFG AR L   ++   T S    EGT GY+APE+    +V++  D
Sbjct:  1000 PANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKAD 1059

Query:   405 VYSFGILLLEMFTGLRPS--DDMFKDNLNLRNCVKSAL 440
             V+SFGI+++E+ T  RP+  +D    ++ LR  V+ ++
Sbjct:  1060 VFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSI 1097

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00029263001 SubName- Full=Chromosome chr13 scaffold_48, whole genome shotgun sequence; (886 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	502
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-39
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-39
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-39
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-34
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-33
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-32
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-32
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-32
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-25
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-24
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-23
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-22
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-18
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-17
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-17
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-15
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-14
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-13
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-13
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-13
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-12
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-12
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-11
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-11
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-11
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-11
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-10
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-10
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	7e-10
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-09
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-09
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-08
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-08
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-08
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-08
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-06
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-06
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	6e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-05
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-05
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-05
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	8e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-05
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-04
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-04
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-04
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-04
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	9e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	0.002
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.002
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	0.002
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	0.003
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.004
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  153 bits (388), Expect = 1e-39
 Identities = 139/505 (27%), Positives = 219/505 (43%), Gaps = 59/505 (11%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DLS N  SG +  +L  LS L    +S N LSG I +   SC  L  LD+  N  +G I 
Sbjct: 481 DLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
           +S S +  L  LDLSQN LS EIP+ L   + L  +N+S+N+    LP  G F   +A++
Sbjct: 541 ASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASA 600

Query: 121 VFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLLVLTLALSSLFC----- 175
           V GN  LCGG     LP C     KR R T      I   +G  ++   ++  F      
Sbjct: 601 VAGNIDLCGGDTTSGLPPC-----KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGR 655

Query: 176 RLMCMKKRGNPTPSISFPYVSYRMLYNAT-----KGFSSENLIGAGNFGSVYKGILFEST 230
             + +K+  N   +    +   ++  + T          EN+I  G  G+ YKG   ++ 
Sbjct: 656 NNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNG 715

Query: 231 TAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMA 290
               VK  N ++   S   A        ++H N+VK+   C     +      L++E++ 
Sbjct: 716 MQFVVKEINDVNSIPSSEIA----DMGKLQHPNIVKLIGLC-----RSEKGAYLIHEYIE 766

Query: 291 NGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSN 350
             +L E +              NL+  +R  IAI +A  L++LH  C P +   +L P  
Sbjct: 767 GKNLSEVLR-------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEK 813

Query: 351 ILLD--DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSF 408
           I++D  DE    +S  G+        +    I    ++ Y+APE     +++   D+Y F
Sbjct: 814 IIIDGKDEPHLRLSLPGL-----LCTDTKCFI----SSAYVAPETRETKDITEKSDIYGF 864

Query: 409 GILLLEMFTGLRPSDDMFKDNLNL----RNCVKSALPER--AEEIRASSGSTQRSIILEC 462
           G++L+E+ TG  P+D  F  + ++    R C      +      IR      Q  I    
Sbjct: 865 GLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEI---- 920

Query: 463 LISICEIGVACSAEQPGERMKINDV 487
            + +  + + C+A  P  R   NDV
Sbjct: 921 -VEVMNLALHCTATDPTARPCANDV 944

Length = 968

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  143 bits (364), Expect = 1e-39
 Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 30/261 (11%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-KSFAVECEVTRNIRHRNLV 265
           +     +G G+FG VY     ++   VA+KV          +    E ++ + ++H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH---PITEEDKRHKAPGNLNSLKRLNI 322
           +++       F+  D   LV E+   G L + +     ++E++ R               
Sbjct: 61  RLYDV-----FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF-------------Y 102

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
              +   L+YLH      I H DLKP NILLD++    ++DFG+AR L+  ++ T  +  
Sbjct: 103 LRQILSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV-- 157

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE 442
            GT  Y+APE  +G       D++S G++L E+ TG  P     +     +   K   P 
Sbjct: 158 -GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF 216

Query: 443 RAEEIRASSGSTQRSIILECL 463
              E   S     + +I + L
Sbjct: 217 PPPEWDIS--PEAKDLIRKLL 235

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  141 bits (358), Expect = 3e-39
 Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 22/206 (10%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G FG+VY     ++   VA+K+          +    E E+ + + H N+VK++   
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY--- 57

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            GV F+  +   LV E+   GSL++ +          +  G L+  + L I + +   L+
Sbjct: 58  -GV-FEDENHLYLVMEYCEGGSLKDLLK---------ENEGKLSEDEILRILLQILEGLE 106

Query: 332 YLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           YLH      I H DLKP NILLD D     ++DFG+++ L +     ++I   GT  Y+A
Sbjct: 107 YLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMA 161

Query: 391 PEYGMG-HEVSSYGDVYSFGILLLEM 415
           PE  +G    S   D++S G++L E+
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  130 bits (329), Expect = 1e-34
 Identities = 72/271 (26%), Positives = 119/271 (43%), Gaps = 37/271 (13%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +G+G+FG+VYK     +   VAVK+           ++   E  + R + H N+V++  A
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMH---PITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                F+  D   LV E+   G L +++    P++E++ +              IA+ + 
Sbjct: 67  -----FEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKK-------------IALQIL 108

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             L+YLH +    I H DLKP NILLD+     ++DFG+A+ L  +     +    GT  
Sbjct: 109 RGLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTF--VGTPW 163

Query: 388 YIAPEYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC-VKSALPERAE 445
           Y+APE  +G        DV+S G++L E+ TG  P       +       +     E  E
Sbjct: 164 YMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDE 223

Query: 446 EIRASSGSTQRSIILECL-------ISICEI 469
              +S     + +I +CL        +  EI
Sbjct: 224 PKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  125 bits (316), Expect = 7e-33
 Identities = 69/241 (28%), Positives = 107/241 (44%), Gaps = 32/241 (13%)

Query: 211 NLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASKS----FAVECEVTRNIRHRN 263
             +G G FG VYKG L      TT VAVK    L  DAS+     F  E  V + + H N
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT---LKEDASEEERKDFLKEARVMKKLGHPN 57

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           +V++   C+    +   +  LV E+M  G L +++          +    L+    L+ A
Sbjct: 58  VVRLLGVCTE---EEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPE-KSTLSLKDLLSFA 111

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           I +A  ++YL         H DL   N L+ +++   +SDFG++R +   D        +
Sbjct: 112 IQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY-----YRK 163

Query: 384 GTTGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVK 437
            T G +     APE       +S  DV+SFG+LL E+FT G  P   +   N  +   ++
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--SNEEVLEYLR 221

Query: 438 S 438
            
Sbjct: 222 K 222

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  123 bits (312), Expect = 3e-32
 Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 33/224 (14%)

Query: 213 IGAGNFGSVYKGILF----ESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKV 267
           +G G FG VYKG L      + T VAVK        +  + F  E  + + + H N+V++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C+    QG     +V E+M  G L +++          K    L     L +A+ +A
Sbjct: 67  LGVCT----QGEPLY-IVTEYMPGGDLLDFLR---------KHGEKLTLKDLLQMALQIA 112

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             ++YL         H DL   N L+ + +   +SDFG++R +   D   +        G
Sbjct: 113 KGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRK-----RGGG 164

Query: 388 YI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +     APE     + +S  DV+SFG+LL E+FT G +P   M
Sbjct: 165 KLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 208

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  123 bits (311), Expect = 4e-32
 Identities = 69/235 (29%), Positives = 110/235 (46%), Gaps = 31/235 (13%)

Query: 213 IGAGNFGSVYKGIL----FESTTAVAVKVFNVLHHDAS----KSFAVECEVTRNIRHRNL 264
           +G G FG VYKG L          VAVK    L  DAS    + F  E  + R + H N+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKT---LKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+   C+    +      +V E+M  G L +++       ++++ P  L+    L+ A+
Sbjct: 64  VKLLGVCT----EEEPLM-IVMEYMPGGDLLDYL-------RKNR-PKELSLSDLLSFAL 110

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +A  ++YL         H DL   N L+ + +   +SDFG++R L   D+  +  G + 
Sbjct: 111 QIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKL 166

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS 438
              ++APE     + +S  DV+SFG+LL E+FT G  P   M   N  +   +K 
Sbjct: 167 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM--SNAEVLEYLKK 219

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  123 bits (311), Expect = 4e-32
 Identities = 70/235 (29%), Positives = 107/235 (45%), Gaps = 32/235 (13%)

Query: 213 IGAGNFGSVYKGILFESTTA----VAVKVFNVLHHDAS----KSFAVECEVTRNIRHRNL 264
           +G G FG VYKG L          VAVK    L  DAS    + F  E  + R + H N+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKT---LKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+   C+    +      +V E+M  G L  ++          K    L+    L+ A+
Sbjct: 64  VKLLGVCT----EEEPLY-IVMEYMEGGDLLSYLR---------KNRPKLSLSDLLSFAL 109

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +A  ++YL         H DL   N L+ + +   +SDFG++R L   D+  R  G + 
Sbjct: 110 QIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKL 165

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS 438
              ++APE     + +S  DV+SFG+LL E+FT G +P   M   N  +   +K+
Sbjct: 166 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM--SNEEVLEYLKN 218

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  116 bits (292), Expect = 2e-29
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 26/217 (11%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT--RNIRHRNLVKVF 268
            L+G G+FGSVY  +  ++   +AVK   +      +  A+E E+    +++H N+V+ +
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 269 TACSGVDFQ-GNDFKALVYEFMANGSLEEWMH---PITEEDKRHKAPGNLNSLKRLNIAI 324
               G +     +   +  E+++ GSL   +     + E   R                 
Sbjct: 66  ----GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK-------------YTR 108

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +   L YLH      I H D+K +NIL+D +    ++DFG A+ L   +    +  V G
Sbjct: 109 QILEGLAYLH-SNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           T  ++APE   G E     D++S G  ++EM TG  P
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  107 bits (266), Expect = 3e-25
 Identities = 68/231 (29%), Positives = 101/231 (43%), Gaps = 30/231 (12%)

Query: 206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV---LHHDASKSFAVECEVTRNIRH- 261
            +     +G G+FG VY          VA+KV            + F  E ++  ++ H 
Sbjct: 1   SYRILRKLGEGSFGEVYLA---RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            N+VK++       FQ      LV E++  GSLE+ +       K+    G L+  + L 
Sbjct: 58  PNIVKLYDF-----FQDEGSLYLVMEYVDGGSLEDLL-------KKIGRKGPLSESEALF 105

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADE----Q 376
           I   +   L+YLH      I H D+KP NILLD D     + DFG+A+ L          
Sbjct: 106 ILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIP 162

Query: 377 TRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDD 424
                  GT GY+APE  +G  ++      D++S GI L E+ TGL P + 
Sbjct: 163 ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 1e-24
 Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 30/209 (14%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
            IG G FG V  G        VAVK        A+++F  E  V   +RH NLV++    
Sbjct: 13  TIGKGEFGDVMLGDYRGQK--VAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLL--- 66

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            GV  QGN    +V E+MA GSL +++        R +    +   ++L  A+DV   ++
Sbjct: 67  -GVVLQGNPL-YIVTEYMAKGSLVDYL--------RSRGRAVITLAQQLGFALDVCEGME 116

Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG---VEGTTGY 388
           YL    +    H DL   N+L+ +++ A VSDFG+A+       Q +  G   V+ T   
Sbjct: 117 YLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWT--- 166

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            APE     + S+  DV+SFGILL E+++
Sbjct: 167 -APEALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 99.6 bits (249), Expect = 9e-24
 Identities = 68/229 (29%), Positives = 110/229 (48%), Gaps = 36/229 (15%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +LIG G FG VYKG+  E+   VA+K  ++  +  +A KS   E ++ +N++H N+VK  
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLN-SLKRLNIAIDVA 327
            +      + +D   ++ E+  NGSL           +  K  G    SL    +A+ V 
Sbjct: 66  GS-----IETSDSLYIILEYAENGSLR----------QIIKKFGPFPESL----VAVYVY 106

Query: 328 CV---LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            V   L YLH   +  + H D+K +NIL   +    ++DFG+A  L    +   S  V G
Sbjct: 107 QVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVG 161

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG------LRPSDDMFK 427
           T  ++APE       S+  D++S G  ++E+ TG      L P   +F+
Sbjct: 162 TPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR 210

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 34/219 (15%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     IG G FG VYK     +   VA+KV  +   +  +    E ++ +  +H N+VK
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEE----WMHPITEEDKRHKAPGNLNSLKRLNI 322
            + +     +   D   +V EF + GSL++        +TE                  I
Sbjct: 62  YYGS-----YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ----------------I 100

Query: 323 AIDVACVLK---YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
           A     +LK   YLH      I H D+K +NILL  +    + DFG++  L   D + R+
Sbjct: 101 AYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARN 155

Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
             V GT  ++APE   G       D++S GI  +E+  G
Sbjct: 156 TMV-GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG 193

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 99.0 bits (247), Expect = 3e-23
 Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 23/219 (10%)

Query: 211 NLIGAGNFGSVYKG---ILFESTTA-VAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLV 265
             +G G+FG V       L ++T   VAVK  N    +  +S F  E E+ R + H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           K    C      G     L+ E++ +GSL +++       +RH+    +N  + L  +  
Sbjct: 70  KYKGVCEK---PGGRSLRLIMEYLPSGSLRDYL-------QRHRD--QINLKRLLLFSSQ 117

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE--QTRSIGVE 383
           +   + YL         H DL   NIL++ E    +SDFG+A+ L    +    +  G E
Sbjct: 118 ICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG-E 173

Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
               + APE     + SS  DV+SFG+ L E+FT   PS
Sbjct: 174 SPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 98.7 bits (246), Expect = 3e-23
 Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 31/217 (14%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F+ E  +G+G FG V++G L+++   VA+K+    ++L       F  E +  + +RH++
Sbjct: 8   FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQ---DFQKEVQALKRLRHKH 63

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           L+ +F  CS       +   ++ E M  GSL  ++   + E +       L     +++A
Sbjct: 64  LISLFAVCSV-----GEPVYIITELMEKGSLLAFLR--SPEGQ------VLPVASLIDMA 110

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS--IG 381
             VA  + YL    +    H DL   NIL+ +++   V+DFG+AR ++     +    I 
Sbjct: 111 CQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP 167

Query: 382 VEGTTGYIAPEYGMGHEV-SSYGDVYSFGILLLEMFT 417
            + T    APE    H   S+  DV+SFGILL EMFT
Sbjct: 168 YKWT----APE-AASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 98.3 bits (245), Expect = 4e-23
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 19/205 (9%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +GAG FG V++G L+ +TT VAVK       D  K F  E ++ + +RH  L++++  C+
Sbjct: 14  LGAGQFGEVWEG-LWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E M  GSL E++           A   L   + +++A  VA  + Y
Sbjct: 72  L-----EEPIYIVTELMKYGSLLEYLQ--------GGAGRALKLPQLIDMAAQVASGMAY 118

Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           L    Q  I H DL   N+L+ +     V+DFG+AR ++  D      G +    + APE
Sbjct: 119 LEA--QNYI-HRDLAARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPE 174

Query: 393 YGMGHEVSSYGDVYSFGILLLEMFT 417
             + +  S   DV+SFGILL E+ T
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 69/224 (30%), Positives = 102/224 (45%), Gaps = 37/224 (16%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVF 268
           N IG G FG VY  +  ++   +AVK   +        K  A E +V   ++H NLVK +
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 269 TACSGVDFQGNDFKALVYEFM---ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
               GV+         VY FM   + G+LEE +         H    + + ++   + + 
Sbjct: 66  ----GVEVHREK----VYIFMEYCSGGTLEELLE--------HGRILDEHVIRVYTLQLL 109

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG---- 381
               L YLH      I H D+KP+NI LD      + DFG A  L+     T ++G    
Sbjct: 110 EG--LAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK---NNTTTMGEEVQ 161

Query: 382 -VEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
            + GT  Y+APE   G +   +G   D++S G ++LEM TG RP
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 24/212 (11%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-KSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G+ G VYK     +    A+K  +V   +   K    E +  R+     +VK    C
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKA--PGNLNSLKRLNIAIDVACV 329
            G  ++  +  ++V E+M  GSL + +       K+        L       IA  +   
Sbjct: 65  YGAFYKEGEI-SIVLEYMDGGSLADLL-------KKVGKIPEPVLAY-----IARQILKG 111

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           L YLH      I H D+KPSN+L++ +    ++DFGI++ LE   +Q  +    GT  Y+
Sbjct: 112 LDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYM 167

Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           +PE   G   S   D++S G+ LLE   G  P
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 94.1 bits (235), Expect = 7e-22
 Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 37/219 (16%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           +G G+FG V      ++    A+KV     ++     +    E  +   I H  +VK+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN------IA 323
           A     FQ  +   LV E+   G L  + H              L+   R +       A
Sbjct: 61  A-----FQTEEKLYLVLEYAPGGEL--FSH--------------LSKEGRFSEERARFYA 99

Query: 324 IDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
            ++   L+YLH L     I + DLKP NILLD +    ++DFG+A+ L +   +T +   
Sbjct: 100 AEIVLALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF-- 153

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            GT  Y+APE  +G       D +S G+LL EM TG  P
Sbjct: 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 94.3 bits (235), Expect = 9e-22
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 19/205 (9%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +GAG FG V+ G  +  TT VAVK          ++F  E ++ + +RH  LV+++  CS
Sbjct: 14  LGAGQFGEVWMG-TWNGTTKVAVKTLKPGTMSP-EAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
               +      +V E+M+ GSL +++   + E K+ + P      + +++A  +A  + Y
Sbjct: 72  ----EEEPI-YIVTEYMSKGSLLDFLK--SGEGKKLRLP------QLVDMAAQIAEGMAY 118

Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           L         H DL   NIL+ + +   ++DFG+AR +E  DE T   G +    + APE
Sbjct: 119 LE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIE-DDEYTAREGAKFPIKWTAPE 174

Query: 393 YGMGHEVSSYGDVYSFGILLLEMFT 417
                  +   DV+SFGILL E+ T
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 91.6 bits (228), Expect = 7e-21
 Identities = 67/224 (29%), Positives = 96/224 (42%), Gaps = 35/224 (15%)

Query: 213 IGAGNFGSVYKGILFE---STTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV KG+          VAVK     H  A K  F  E  V   + H  +V++ 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C G          LV E    G L +++     + +R     +L       +A  VA 
Sbjct: 63  GVCKGEPLM------LVMELAPLGPLLKYL-----KKRREIPVSDL-----KELAHQVAM 106

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG- 387
            + YL         H DL   N+LL +   A +SDFG++R L A  +  R+     TT  
Sbjct: 107 GMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA-----TTAG 158

Query: 388 -----YIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
                + APE     + SS  DV+S+G+ L E F+ G +P  +M
Sbjct: 159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 24/208 (11%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--VLHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +G+G FG V+ G  +     VA+K+     +  D    F  E +V   + H NLV+++  
Sbjct: 12  LGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGV 67

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    Q   F  +V E+MANG L  ++       +  K  G L +   L++  DV   +
Sbjct: 68  CTK---QRPIF--IVTEYMANGCLLNYL-------RERK--GKLGTEWLLDMCSDVCEAM 113

Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL  +      H DL   N L+ ++    VSDFG+AR++   D+ T S G +    +  
Sbjct: 114 EYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSSQGTKFPVKWAP 169

Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFTG 418
           PE       SS  DV+SFG+L+ E+F+ 
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 89.9 bits (224), Expect = 4e-20
 Identities = 60/242 (24%), Positives = 101/242 (41%), Gaps = 42/242 (17%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEV-TRNIRHR 262
           F    +IG G+F +V      E+    A+K+ +   ++     K   +E EV TR   H 
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
            ++K++       FQ  +    V E+  NG L +++             G+L+       
Sbjct: 63  GIIKLYYT-----FQDEENLYFVLEYAPNGELLQYIRKY----------GSLDEKCTRFY 107

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL------------ 370
           A ++   L+YLH      I H DLKP NILLD +M   ++DFG A+ L            
Sbjct: 108 AAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164

Query: 371 ------EAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
                 +    + R     GT  Y++PE  +  + +    D+++ G ++ +M TG  P  
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPEL-LNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223

Query: 424 DM 425
             
Sbjct: 224 GS 225

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 63/242 (26%), Positives = 87/242 (35%), Gaps = 70/242 (28%)

Query: 206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA---------VECEVT 256
            F    +IG G FG                KV  V   D  K FA         VE    
Sbjct: 1   HFELLRVIGKGAFG----------------KVCIVQKRDTKKMFAMKYMNKQKCVEKGSV 44

Query: 257 RNI----------RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLE---EWMHPITE 303
           RN+           H  LV ++ +     FQ  +   LV + +  G L          +E
Sbjct: 45  RNVLNERRILQELNHPFLVNLWYS-----FQDEENMYLVVDLLLGGDLRYHLSQKVKFSE 99

Query: 304 EDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD 363
           E  +                 ++   L+YLH      I H D+KP NILLD++   +++D
Sbjct: 100 EQVKF-------------WICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITD 143

Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPE----YGMGHEVSSYGDVYSFGILLLEMFTGL 419
           F IA  +      T +    GT GY+APE     G    V    D +S G+   E   G 
Sbjct: 144 FNIATKVTP---DTLTTSTSGTPGYMAPEVLCRQGYSVAV----DWWSLGVTAYECLRGK 196

Query: 420 RP 421
           RP
Sbjct: 197 RP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 87.1 bits (216), Expect = 3e-19
 Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 45/296 (15%)

Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G G FG V+ G  +          VAVK       +DA K F  E E+  N +H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGN----LNSLKRLNI 322
            +  C+    +G D   +V+E+M +G L +++     +    K+P +    L   + L I
Sbjct: 73  FYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           A+ +A  + YL         H DL   N L+  ++   + DFG++R +   D       V
Sbjct: 128 AVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR----V 180

Query: 383 EGTT----GYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVK 437
            G T     ++ PE  M  + ++  DV+SFG++L E+FT G +P   +   N  +  C+ 
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL--SNEEVIECIT 238

Query: 438 SA-LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR 492
              L +R                  C   + +I + C    P +R+ I D+  RL+
Sbjct: 239 QGRLLQRPR---------------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 79/313 (25%), Positives = 139/313 (44%), Gaps = 67/313 (21%)

Query: 207 FSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIR 260
           F  E  +G G FG VYKG L       S T+VA+K           + F  E E+  +++
Sbjct: 9   FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66

Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MH-PI-----TEEDKRHKAPG 312
           H N+V +   C+           +++E++A+G L E+   + P         D+  K+  
Sbjct: 67  HPNIVCLLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS- 120

Query: 313 NLNSLKRLNIAIDVACVLKYL---HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
            L+    L+IAI +A  ++YL   H        H DL   N L+ + +T  +SDFG++R 
Sbjct: 121 -LDCSDFLHIAIQIAAGMEYLSSHH------FVHRDLAARNCLVGEGLTVKISDFGLSRD 173

Query: 370 LEAAD---EQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP---- 421
           + +AD    Q++S+       ++ PE  +  + ++  D++SFG++L E+F+ GL+P    
Sbjct: 174 IYSADYYRVQSKSL---LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230

Query: 422 --SDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPG 479
              + +      +R+      PE                  +C   +  + + C  E P 
Sbjct: 231 SNQEVIEM----IRSRQLLPCPE------------------DCPARVYALMIECWNEIPA 268

Query: 480 ERMKINDVEPRLR 492
            R +  D+  RLR
Sbjct: 269 RRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 23/215 (10%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKV 267
           ++ +G G +G VY+G+  + +  VAVK    L  D    + F  E  V + I+H NLV++
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQL 67

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C+    +   F  ++ EFM  G+L +++     ++        +N++  L +A  ++
Sbjct: 68  LGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQIS 114

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             ++YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    
Sbjct: 115 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 170

Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           + APE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 205

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 66/229 (28%), Positives = 111/229 (48%), Gaps = 33/229 (14%)

Query: 208 SSENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRN 263
           + + +IGAG FG V++GIL        AVA+K     + +  +  F  E  +     H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++++     GV  +      ++ E+M NG+L++++    + D      G  +S + + + 
Sbjct: 68  IIRL----EGVVTKFKPA-MIITEYMENGALDKYLR---DHD------GEFSSYQLVGML 113

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
             +A  +KYL         H DL   NIL++  +   VSDFG++R LE   E T +    
Sbjct: 114 RGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT---- 166

Query: 384 GTTG------YIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            T+G      + APE     + +S  DV+SFGI++ E+ + G RP  DM
Sbjct: 167 -TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 84.1 bits (209), Expect = 3e-18
 Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 36/222 (16%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-KSFAV-ECEVTRNIRHRNLVKVF 268
             IG G+FG VY            +K  ++ +     +  A+ E ++ + + H N++K +
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMH-------PITEEDKRHKAPGNLNSLKRLN 321
                  F+      +V E+   G L + +        P  EE             + L+
Sbjct: 66  E-----SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE-------------QILD 107

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +   LKYLH      I H D+KP NI L       + DFGI++ L +  +  ++  
Sbjct: 108 WFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-- 162

Query: 382 VEGTTGYIAPEY--GMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           V GT  Y++PE      +   S  D++S G +L E+ T   P
Sbjct: 163 VVGTPYYLSPELCQNKPYNYKS--DIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 36/211 (17%)

Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDAS-KSFAVECEVTRNIRHRNLVKV 267
           IG G FG V    Y+G        VAVK    + +DA+ ++F  E  V   +RH NLV++
Sbjct: 14  IGKGEFGDVMLGDYRG------NKVAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQL 64

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                GV  +      +V E+MA GSL +++        R +    L     L  ++DV 
Sbjct: 65  L----GVIVEEKGGLYIVTEYMAKGSLVDYL--------RSRGRSVLGGDCLLKFSLDVC 112

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ-TRSIGVEGTT 386
             ++YL  +      H DL   N+L+ ++  A VSDFG+ +  EA+  Q T  + V+ T 
Sbjct: 113 EAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT- 166

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              APE     + S+  DV+SFGILL E+++
Sbjct: 167 ---APEALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 37/270 (13%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +   T VAVK        + +SF  E ++ + +RH  LV+++   S
Sbjct: 14  LGNGQFGEVWMG-TWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    + + R     NL     +++A  VA  + Y
Sbjct: 72  ------EEPIYIVTEYMSKGSLLDFL---KDGEGRALKLPNL-----VDMAAQVAAGMAY 117

Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ D +   ++DFG+AR +E  +E T   G +    + APE
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173

Query: 393 YGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAEEIRASS 451
             +    +   DV+SFGILL E+ T G  P   M     N R  ++    ER   +    
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-----NNREVLEQV--ERGYRMPCPQ 226

Query: 452 GSTQRSIILECLISICEIGVACSAEQPGER 481
                     C IS+ E+ + C  + P ER
Sbjct: 227 D---------CPISLHELMLQCWKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 14  LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    E  K  + P      + +++A  +A  + Y
Sbjct: 72  ------EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLP------QLVDMAAQIASGMAY 117

Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173

Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 27/215 (12%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS---FAVECEVTRNIRHRNLVKVFT 269
           +G G FG V  G  +     VA+K+      + S S   F  E +V   + H  LV+++ 
Sbjct: 12  LGTGQFGVVKYG-KWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C+    Q   +  +V E+M+NG L  ++     E  +   P  L     L +  DV   
Sbjct: 67  VCTK---QRPIY--IVTEYMSNGCLLNYL----REHGKRFQPSQL-----LEMCKDVCEG 112

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           + YL         H DL   N L+DD+    VSDFG++R++   DE T S+G +    + 
Sbjct: 113 MAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWS 168

Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            PE  +  + SS  DV++FG+L+ E+++ G  P +
Sbjct: 169 PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 69/215 (32%), Positives = 98/215 (45%), Gaps = 33/215 (15%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
            IG GNFG VYKG+L +  T VAVK     L  D  + F  E E+ +   H N+VK+   
Sbjct: 2   KIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C  V  Q      +V E +  GSL  ++          K    L   K L +++D A  +
Sbjct: 61  C--VQKQP---IYIVMELVPGGSLLTFLR---------KKKNRLTVKKLLQMSLDAAAGM 106

Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE----AADEQTRSIGVEGTT 386
           +YL         H DL   N L+ +     +SDFG++R  E       +  + I ++ T 
Sbjct: 107 EYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT- 162

Query: 387 GYIAPE---YGMGHEVSSYGDVYSFGILLLEMFTG 418
              APE   YG     +S  DV+S+GILL E F+ 
Sbjct: 163 ---APEALNYG---RYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 21/213 (9%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG+G FG V+ G   E    VA+K        + + F  E +V   + H  LV+++    
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLY---- 65

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
           GV  + +    LV+EFM +G L +++       +R    G  +    L + +DV   + Y
Sbjct: 66  GVCTERSPI-CLVFEFMEHGCLSDYL-----RAQR----GKFSQETLLGMCLDVCEGMAY 115

Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           L       + H DL   N L+ +     VSDFG+ RF+   D+ T S G +    + +PE
Sbjct: 116 LESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPE 171

Query: 393 YGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDD 424
                + SS  DV+SFG+L+ E+F+ G  P ++
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 26/208 (12%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +GAG FG V+ G  +   T VA+K           +F  E  + + ++H  LV+++   +
Sbjct: 14  LGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   ++ E+M NGSL +++   T E  +      L   K +++A  +A  + +
Sbjct: 72  ------QEPIYIITEYMENGSLVDFLK--TPEGIK------LTINKLIDMAAQIAEGMAF 117

Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   ++DFG+AR +E  +E T   G +    + APE
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPE 173

Query: 393 ---YGMGHEVSSYGDVYSFGILLLEMFT 417
              YG     +   DV+SFGILL E+ T
Sbjct: 174 AINYGT---FTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 65/225 (28%), Positives = 99/225 (44%), Gaps = 33/225 (14%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G++GSVYK I  E+   VA+KV  V   +  +    E  + +      +VK
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN---IA 323
            +    G  F+  D   +V E+   GS+ + M  IT               K L    IA
Sbjct: 63  YY----GSYFKNTDL-WIVMEYCGAGSVSDIMK-ITN--------------KTLTEEEIA 102

Query: 324 IDVACVLK---YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
             +   LK   YLH        H D+K  NILL++E  A ++DFG++  L     +  + 
Sbjct: 103 AILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT- 158

Query: 381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
            V GT  ++APE       ++  D++S GI  +EM  G  P  D+
Sbjct: 159 -VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 6e-17
 Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 24/218 (11%)

Query: 213 IGAGNFGSVYKGI---LFESTT-AVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVKV 267
           +G+G FG+VYKG+     E     VA+KV        A+K    E  V  ++ H ++V++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     Q      L+ + M  G L +++       + HK   N+ S   LN  + +A
Sbjct: 75  LGICLSSQVQ------LITQLMPLGCLLDYV-------RNHK--DNIGSQYLLNWCVQIA 119

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YL    +  + H DL   N+L+       ++DFG+A+ L+  +++  + G +    
Sbjct: 120 KGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176

Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDD 424
           ++A E  +    +   DV+S+G+ + E+ T G +P + 
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 8e-17
 Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 22/221 (9%)

Query: 210 ENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLV 265
           E +IG G FG V +G L    +    VA+K       D  +  F  E  +     H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           ++     GV  +      ++ E+M NGSL++++        R    G     + + +   
Sbjct: 69  RL----EGVVTKSRPV-MIITEYMENGSLDKFL--------REND-GKFTVGQLVGMLRG 114

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +A  +KYL         H DL   NIL++  +   VSDFG++R LE ++    + G +  
Sbjct: 115 IASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             + APE     + +S  DV+SFGI++ E+ + G RP  DM
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 27/214 (12%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G FG+V +G      T   V V N+     +++F  E  V   + H+NLV++     
Sbjct: 14  IGEGEFGAVLQG----EYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLL---- 65

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
           GV      +  +V E M+ G+L  ++        R +    ++ ++ L  ++DVA  ++Y
Sbjct: 66  GVILHNGLY--IVMELMSKGNLVNFL--------RTRGRALVSVIQLLQFSLDVAEGMEY 115

Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           L       + H DL   NIL+ ++  A VSDFG+AR      + ++ + V+ T    APE
Sbjct: 116 LE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSK-LPVKWT----APE 167

Query: 393 YGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
                + SS  DV+S+G+LL E+F+ G  P   M
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 32/218 (14%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRNIRHRNLVKVFT 269
           N IG+G  G+VYK I   +    A+KV    H D   +    E E+ R++ H N+VK   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK--- 136

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C  +     + + L+ EFM  GSLE     I +E         L  + R      +   
Sbjct: 137 -CHDMFDHNGEIQVLL-EFMDGGSLEG--THIADE-------QFLADVAR-----QILSG 180

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL-EAADEQTRSIGVEGTTGY 388
           + YLH   +  I H D+KPSN+L++      ++DFG++R L +  D    S+   GT  Y
Sbjct: 181 IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV---GTIAY 234

Query: 389 IAPE-----YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           ++PE        G      GD++S G+ +LE + G  P
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 78.6 bits (193), Expect = 2e-16
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 22/209 (10%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K          ++F  E ++ + +RH  LV ++   S
Sbjct: 14  LGQGCFGEVWMGT-WNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRH-KAPGNLNSLKRLNIAIDVACVLK 331
                  +   +V EFM  GSL +++    E D ++ K P      + +++A  +A  + 
Sbjct: 72  ------EEPIYIVTEFMGKGSLLDFL---KEGDGKYLKLP------QLVDMAAQIADGMA 116

Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           Y+    +    H DL+ +NIL+ D +   ++DFG+AR +E  +E T   G +    + AP
Sbjct: 117 YIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAP 172

Query: 392 EYGMGHEVSSYGDVYSFGILLLEMFTGLR 420
           E  +    +   DV+SFGILL E+ T  R
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 74/299 (24%), Positives = 123/299 (41%), Gaps = 51/299 (17%)

Query: 213 IGAGNFGSVY----KGILFES-TTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKV 267
           +G G FG V+      +L E     VAVK        A + F  E E+   ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHP------ITEEDKRHKAPGNLNSLKRLN 321
           +  C+           +V+E+M +G L  ++        I    +   APG L   + L 
Sbjct: 73  YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGE-DVAPGQLTLGQMLA 126

Query: 322 IAIDVACVLKYL---HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
           IA  +A  + YL   H        H DL   N L+   +   + DFG++R + + D    
Sbjct: 127 IASQIASGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR- 179

Query: 379 SIGVEGTT----GYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLR 433
              V G T     ++ PE  +  + ++  D++SFG++L E+FT G +P   +   N    
Sbjct: 180 ---VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL--SNTEAI 234

Query: 434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR 492
            C+        E  R             C   +  I   C   +P +RM I D+  RL+
Sbjct: 235 ECITQG--RELERPRT------------CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 79.9 bits (197), Expect = 1e-15
 Identities = 43/108 (39%), Positives = 68/108 (62%)

Query: 2   LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGS 61
           L  NNLSG +  ++ GL+SL+  ++  N L+G I ++ G+  +L+ L ++ N  +GPI  
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278

Query: 62  SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPI 109
           S+ SL+ L  LDLS N+LS EIPE +   + L+ L+L  NNF   +P+
Sbjct: 279 SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326

Length = 968

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 41/224 (18%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVKVFTAC 271
           IG G    VY  I   +   VA+K  ++     S      E +      H N+VK +T+ 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS- 67

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
               F   D   LV  +++ GSL + M        +   P        L+ AI +A VLK
Sbjct: 68  ----FVVGDELWLVMPYLSGGSLLDIM--------KSSYPRGG-----LDEAI-IATVLK 109

Query: 332 -------YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE- 383
                  YLH + Q    H D+K  NILL ++ +  ++DFG++  L  AD   R+  V  
Sbjct: 110 EVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASL--ADGGDRTRKVRK 164

Query: 384 ---GTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
              GT  ++APE  +  +V  Y    D++SFGI  +E+ TG  P
Sbjct: 165 TFVGTPCWMAPE--VMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)

Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDAS-KSFAVECEVTRNIRHRNLV 265
           E +IGAG FG V +G L    +    VA+K     + +   + F  E  +     H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 266 K---VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
               V T    V         ++ EFM NG+L+ ++          +  G    ++ + +
Sbjct: 69  HLEGVVTKSRPV--------MIITEFMENGALDSFLR---------QNDGQFTVIQLVGM 111

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE--AAD-EQTRS 379
              +A  +KYL    +    H DL   NIL++  +   VSDFG++RFLE   +D   T S
Sbjct: 112 LRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168

Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLE-MFTGLRPSDDM 425
           +G +    + APE     + +S  DV+S+GI++ E M  G RP  DM
Sbjct: 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 24/218 (11%)

Query: 212 LIGAGNFGSVYKGILF-ESTTA---VAVKVFN-VLHHDASKSFAVECEVTRNIRHRNLVK 266
           ++G+G FG+VYKGI   E  T    VA+K+ N      A+  F  E  +  ++ H +LV+
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +   C     Q      LV + M +G L +++H        HK   N+ S   LN  + +
Sbjct: 74  LLGVCLSPTIQ------LVTQLMPHGCLLDYVH-------EHK--DNIGSQLLLNWCVQI 118

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
           A  + YL    +  + H DL   N+L+       ++DFG+AR LE  +++  + G +   
Sbjct: 119 AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 175

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            ++A E     + +   DV+S+G+ + E+ T G +P D
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 66/248 (26%), Positives = 114/248 (45%), Gaps = 36/248 (14%)

Query: 212 LIGAGNFGSVYKGILFESTTA--VAVKVFNVLH-------HDASKSFA---VECEVTR-N 258
            +G+G FG VYK +  ++     +A+K  NV +        +  KS      E  + +  
Sbjct: 7   HLGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 259 IRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLK 318
           +RH N+V+ +       F  ND   +V + +    L E  H  + ++K+ +        +
Sbjct: 66  LRHPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTE-----E 113

Query: 319 RL-NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT 377
           R+ NI + +   L+YLH + +  I H DL P+NI+L ++    ++DFG+A+       ++
Sbjct: 114 RIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPES 168

Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP---SDDMFKDNLNLRN 434
           +   V GT  Y  PE           DV++FG +L +M T L+P   S +M      +  
Sbjct: 169 KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTNMLSLATKIVE 227

Query: 435 CVKSALPE 442
            V   LPE
Sbjct: 228 AVYEPLPE 235

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 32/220 (14%)

Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKS----FAVECEVTRNIRHRN 263
           +G G+FG VY+G+       E  T VA+K    ++ +AS      F  E  V +     +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKT---VNENASMRERIEFLNEASVMKEFNCHH 70

Query: 264 LVKVFTACSGVDFQGNDFKALV-YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           +V++     GV   G     LV  E MA G L+ ++     E + +   G     K + +
Sbjct: 71  VVRLL----GVVSTGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG- 381
           A ++A  + YL         H DL   N ++ +++T  + DFG+ R +   D   R  G 
Sbjct: 125 AAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD-YYRKGGK 180

Query: 382 ----VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               V     ++APE       ++  DV+SFG++L EM T
Sbjct: 181 GLLPVR----WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 78.4 bits (193), Expect = 3e-15
 Identities = 52/133 (39%), Positives = 71/133 (53%), Gaps = 2/133 (1%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DLSNN LSG +   +   SSL + ++ GN+L G I N+  + TSLE L +  N   G I 
Sbjct: 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIP 205

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASAT 119
             L  ++ L+ + L  NNLS EIP  + G   L +L+L YNN    +P   G  KN    
Sbjct: 206 RELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYL 265

Query: 120 SVFGNKKLCGGIP 132
            ++ N KL G IP
Sbjct: 266 FLYQN-KLSGPIP 277

Length = 968

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRNIRHRNLVKVFTAC 271
           +GAGN G V K +   +   +AVK   +  ++A  K    E ++        +V  + A 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
               +   D  ++  E+M  GSL++ +       K  +       L +  IA+ V   L 
Sbjct: 69  ----YNNGDI-SICMEYMDGGSLDKIL-------KEVQGRIPERILGK--IAVAVLKGLT 114

Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE--GTTGYI 389
           YLH   +  I H D+KPSNIL++      + DFG++  L        S+     GT+ Y+
Sbjct: 115 YLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQL------VNSLAKTFVGTSSYM 166

Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           APE   G++ S   D++S G+ L+E+ TG  P
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 36/223 (16%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG+G +G VYK     +   VA+KV  +   D  +    E  + +  RH N+V  F +  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-- 68

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK- 331
              +   D   +V E+   GSL++    +T              L  L IA      LK 
Sbjct: 69  ---YLRRDKLWIVMEYCGGGSLQDIYQ-VTRG-----------PLSELQIAYVCRETLKG 113

Query: 332 --YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE----GT 385
             YLH   +    H D+K +NILL ++    ++DFG++  L      T +I       GT
Sbjct: 114 LAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGT 164

Query: 386 TGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDM 425
             ++APE         Y    D+++ GI  +E+     P  D+
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 77/297 (25%), Positives = 124/297 (41%), Gaps = 58/297 (19%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-----ECEVTRNIRH---RN 263
           LIG G +G+VY+G    +   VA+K+ N+     +    V     E  +   +R     N
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINL----DTPDDDVSDIQREVALLSQLRQSQPPN 63

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH--PITEEDKRHKAPGNLNSLKRLN 321
           + K +    G   +G     ++ E+   GS+   M   PI E   ++ +           
Sbjct: 64  ITKYY----GSYLKGPRL-WIIMEYAEGGSVRTLMKAGPIAE---KYISV---------- 105

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           I  +V   LKY+H      + H D+K +NIL+ +     + DFG+A  L   +   RS  
Sbjct: 106 IIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL-NQNSSKRSTF 161

Query: 382 VEGTTGYIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS 438
           V GT  ++APE     E   Y    D++S GI + EM TG  P  D+  D       +  
Sbjct: 162 V-GTPYWMAPEVIT--EGKYYDTKADIWSLGITIYEMATGNPPYSDV--DAFRAMMLIPK 216

Query: 439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK 495
           + P R E+   +  S            + E   AC  E+P ER+   ++  + + IK
Sbjct: 217 SKPPRLED---NGYSK----------LLREFVAACLDEEPKERLSAEELL-KSKWIK 259

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 72/299 (24%), Positives = 127/299 (42%), Gaps = 42/299 (14%)

Query: 213 IGAGNFGSVYKGILFESTTA-----VAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKV 267
           +G G FG V+    +  +       VAVK        A K F  E E+  N++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHP------ITEEDKRHKAPGNLNSLKRLN 321
           +  C   D    D   +V+E+M +G L +++        I  + +  +A G L   + L+
Sbjct: 73  YGVC--GD---GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           IA  +A  + YL         H DL   N L+   +   + DFG++R + + D       
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184

Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSAL 440
                 ++ PE  M  + ++  DV+SFG++L E+FT G +P   +   N  +  C+    
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL--SNTEVIECI---- 238

Query: 441 PERAEEIRASSGSTQRSIILE---CLISICEIGVACSAEQPGERMKINDVEPRLRLIKK 496
                        TQ  ++     C   + +I + C   +P +R+ I ++   L  + K
Sbjct: 239 -------------TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 74.9 bits (184), Expect = 6e-15
 Identities = 64/235 (27%), Positives = 110/235 (46%), Gaps = 41/235 (17%)

Query: 213 IGAGNFGSVYK----GIL-FESTTAVAVKVFNVLHHDAS----KSFAVECEVTRNIRHRN 263
           IG G FG V++    G+L +E  T VAVK+   L  +AS      F  E  +     H N
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKM---LKEEASADMQADFQREAALMAEFDHPN 69

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEE--------WMHPITEEDKRHKAPG--- 312
           +VK+   C+     G     L++E+MA G L E            ++      +  G   
Sbjct: 70  IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 313 -NLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
             L+  ++L IA  VA  + YL    +    H DL   N L+ + M   ++DFG++R + 
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 372 AAD----EQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           +AD     +  +I +     ++ PE    +  ++  DV+++G++L E+F+ G++P
Sbjct: 182 SADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 74.6 bits (183), Expect = 7e-15
 Identities = 65/230 (28%), Positives = 101/230 (43%), Gaps = 39/230 (16%)

Query: 210 ENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLV 265
           E +IGAG FG V  G L    +    VA+K     + +  +  F  E  +     H N++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 266 K---VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
               V T    V         +V E+M NGSL+ ++       ++H   G    ++ + +
Sbjct: 69  HLEGVVTKSKPV--------MIVTEYMENGSLDAFL-------RKHD--GQFTVIQLVGM 111

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
              +A  +KYL         H DL   NIL++  +   VSDFG++R LE   E   +   
Sbjct: 112 LRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT--- 165

Query: 383 EGTTG------YIAPEYGMGHEVSSYGDVYSFGILLLE-MFTGLRPSDDM 425
             T G      + APE     + +S  DV+S+GI++ E M  G RP  +M
Sbjct: 166 --TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 74.1 bits (182), Expect = 7e-15
 Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 26/208 (12%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS---FAVECEVTRNIRHRNLVKVFT 269
           +G+G FG V+ G  + +   VA+K  N    + + S   F  E +V   + H  LV+++ 
Sbjct: 12  LGSGQFGVVHLG-KWRAQIKVAIKAIN----EGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C+    Q      +V EFM NG L  ++        R +  G L+    L++  DV   
Sbjct: 67  VCT----QQKPL-YIVTEFMENGCLLNYL--------RQRQ-GKLSKDMLLSMCQDVCEG 112

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           ++YL    +    H DL   N L+       VSDFG+ R++   DE T S G +    + 
Sbjct: 113 MEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWS 168

Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFT 417
            PE     + SS  DV+SFG+L+ E+FT
Sbjct: 169 PPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 55/205 (26%), Positives = 104/205 (50%), Gaps = 19/205 (9%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +GAG FG V+ G  + ++T VAVK        + ++F  E  + + ++H  LV+++   +
Sbjct: 14  LGAGQFGEVWMG-YYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   ++ E+MA GSL +++   ++E  +   P      K ++ +  +A  + Y
Sbjct: 72  K-----EEPIYIITEYMAKGSLLDFLK--SDEGGKVLLP------KLIDFSAQIAEGMAY 118

Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +N+L+ + +   ++DFG+AR +E  +E T   G +    + APE
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPE 174

Query: 393 YGMGHEVSSYGDVYSFGILLLEMFT 417
                  +   DV+SFGILL E+ T
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 43/287 (14%)

Query: 213 IGAGNFGSVYKGIL--FESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVF 268
           +G+GNFG+V KG+    +S   VAVK+    ++D +       E  V + + +  +V++ 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C    +       LV E    G L +++     +  +H    N+  L        V+ 
Sbjct: 63  GICEAESWM------LVMELAELGPLNKFL-----QKNKHVTEKNITELVH-----QVSM 106

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT--T 386
            +KYL    +    H DL   N+LL  +  A +SDFG+++ L  ADE        G    
Sbjct: 107 GMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKTHGKWPV 162

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAE 445
            + APE    ++ SS  DV+SFG+L+ E F+ G +P   M  + +       + + E  E
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV-------TQMIESGE 215

Query: 446 EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR 492
            +              C   + ++   C      ER     VE RLR
Sbjct: 216 RMECPQR---------CPPEMYDLMKLCWTYGVDERPGFAVVELRLR 253

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 46/239 (19%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNV----------LHHDASKSFAVECEVTRNIRH 261
           LIG G +G VY  +   +   +AVK   +             D  K+   E E  +++ H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEED-KRHKAPGNLNSLK 318
            N+V       G +    ++ ++  E++  GS+      +   EE   R      L  L 
Sbjct: 68  LNIV----QYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122

Query: 319 RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
                        YLH      I H DLK  N+L+D +    +SDFGI++  +   +  +
Sbjct: 123 -------------YLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ 166

Query: 379 SIGVEGTTGYIAPE----YGMGHEVSSYGDVYSFGILLLEMFTGLRP-SDD-----MFK 427
           ++ ++G+  ++APE    Y  G+  S+  D++S G ++LEMF G RP SD+     MFK
Sbjct: 167 NMSMQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 34/226 (15%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT--RNIRHRNL 264
           F+    IG G+FG VYK I   +   VA+KV + L     +   ++ E+      R   +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-LEEAEDEIEDIQQEIQFLSQCRSPYI 61

Query: 265 VKVFTACSGVDFQGNDFK-ALVYEFMANGSLEEWMHPIT-EEDKRHKAPGNLNSLKRLNI 322
            K +   S +       K  ++ E+   GS  + + P   +E                 I
Sbjct: 62  TKYYG--SFLK----GSKLWIIMEYCGGGSCLDLLKPGKLDETY---------------I 100

Query: 323 AI---DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
           A    +V   L+YLH   +  I H D+K +NILL +E    ++DFG++  L      ++ 
Sbjct: 101 AFILREVLLGLEYLH--EEGKI-HRDIKAANILLSEEGDVKLADFGVSGQLT--STMSKR 155

Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
               GT  ++APE           D++S GI  +E+  G  P  D+
Sbjct: 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 24/212 (11%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSF-AVECEVT--RNIRHRNLVK 266
           L+G G FG VY     ++   +AVK         +  K   A+ECE+   +N++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
            +        + ++  ++  E+M  GS+++ +          KA G L           +
Sbjct: 69  YYGC-----LRDDETLSIFMEYMPGGSVKDQL----------KAYGALTETVTRKYTRQI 113

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEA-ADEQTRSIGVEGT 385
              ++YLH +    I H D+K +NIL D      + DFG ++ L+      T    V GT
Sbjct: 114 LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             +++PE   G       DV+S G  ++EM T
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 17/218 (7%)

Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKV 267
           +G G FG V+    +     +    VAVK       +A K F  E E+  N++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMH---PITEEDKRHKAPGNLNSLKRLNIAI 324
           +  C     +G+    +V+E+M +G L +++    P          P  L   + L+IA 
Sbjct: 73  YGVC----VEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +A  + YL         H DL   N L+ + +   + DFG++R + + D          
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
              ++ PE  M  + ++  DV+S G++L E+FT G +P
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 72.2 bits (177), Expect = 5e-14
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 19/212 (8%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA---VECEVTRNIRHRNLVKVFT 269
           +G G FG V    +  +    A K  N       K +    VE  +   +  R +V +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
           A     FQ      LV   M  G L   ++ + EE+     PG     +       +   
Sbjct: 61  A-----FQTKTDLCLVMTIMNGGDLRYHIYNVDEEN-----PG-FPEPRACFYTAQIISG 109

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           L++LH   Q  I + DLKP N+LLD++    +SD G+A  +E  D Q+++ G  GT G++
Sbjct: 110 LEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFM 164

Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           APE   G E     D ++ G+ L EM     P
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 73.7 bits (181), Expect = 9e-14
 Identities = 43/110 (39%), Positives = 65/110 (59%), Gaps = 2/110 (1%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +LSNNN +G++      + +L   ++S N+LSG I N+ GS +SL+ LD+ GN+  G I 
Sbjct: 124 NLSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE 110
           +SL++L  L  L L+ N L  +IP  L   K L+ + L YNN    +P E
Sbjct: 182 NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE 231

Length = 968

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 9e-14
 Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 33/224 (14%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
            +G G FG V+      S    A+KV     V+     +    E  V + + H  ++++F
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
              +  D     F  ++ E++  G L  ++          +  G  ++   L  A ++ C
Sbjct: 68  --WTEHD---QRFLYMLMEYVPGGELFSYL----------RNSGRFSNSTGLFYASEIVC 112

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L+YLH      I + DLKP NILLD E    ++DFG A+  +  D   R+  + GT  Y
Sbjct: 113 ALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK--KLRD---RTWTLCGTPEY 164

Query: 389 IAPEY--GMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 430
           +APE     GH  +   D ++ GIL+ EM  G  P    F DN 
Sbjct: 165 LAPEVIQSKGHNKAV--DWWALGILIYEMLVGYPP---FFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 22/221 (9%)

Query: 212 LIGAGNFGSVYKGILFESTTA---VAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVK 266
           ++G G FGSV +G L +   +   VAVK   +  H  S  + F  E    ++  H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 267 VFTACSGVDFQGNDFKAL-----VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
           +     GV F+ +  + +     +  FM +G L  ++            P  L     L 
Sbjct: 66  LI----GVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGG----LPEKLPLQTLLK 117

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             +D+A  ++YL         H DL   N +L ++MT  V+DFG+++ + + D   +   
Sbjct: 118 FMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174

Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
            +    +IA E       +S  DV++FG+ + E+ T G  P
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.9 bits (179), Expect = 1e-13
 Identities = 57/185 (30%), Positives = 74/185 (40%), Gaps = 35/185 (18%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L N  L G +   +  L  L   N+SGN + G I  + GS TSLE LD+  N F G I 
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
            SL  L  LR+L+L+ N+LS  +P  L G                   +     N     
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAALGG-----------------RLLHRASFN----- 521

Query: 121 VFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLLVLTLALSSLFCRLMCM 180
              N  LC GIP   L  C           L +   I I  G+ V  L L  + C +   
Sbjct: 522 FTDNAGLC-GIP--GLRAC--------GPHLSVGAKIGIAFGVSVAFLFL--VICAMCWW 568

Query: 181 KKRGN 185
           K+R N
Sbjct: 569 KRRQN 573

Length = 623

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 65/217 (29%), Positives = 93/217 (42%), Gaps = 40/217 (18%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVK-VFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
           IG GNFG V+ G L    T VAVK     L  D    F  E  + +   H N+V++   C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
           +    Q      +V E +  G    ++        R + P  L   + + +  + A  ++
Sbjct: 63  T----QKQPI-YIVMELVQGGDFLTFL--------RTEGP-RLKVKELIQMVENAAAGME 108

Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG---- 387
           YL         H DL   N L+ ++    +SDFG++R  E  D      GV  +TG    
Sbjct: 109 YLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR--EEED------GVYASTGGMKQ 157

Query: 388 ----YIAPE---YGMGHEVSSYGDVYSFGILLLEMFT 417
               + APE   YG     SS  DV+SFGILL E F+
Sbjct: 158 IPVKWTAPEALNYG---RYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 71/232 (30%), Positives = 104/232 (44%), Gaps = 40/232 (17%)

Query: 207 FSSENL-----IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-KSFAVECEVTRNIR 260
           F++E+L     IG G FG+V K +   S T +AVK       +   K   ++ +V   +R
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MR 58

Query: 261 HRNLVKVFTACSGVDFQGNDFKA----LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNS 316
             +   +      V F G  F+     +  E M + SL++  +    E  +   P  +  
Sbjct: 59  SSDCPYI------VKFYGALFREGDCWICMELM-DISLDK-FYKYVYEVLKSVIPEEILG 110

Query: 317 LKRLNIAIDVACV--LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD 374
                  I VA V  L YL  + +  I H D+KPSNILLD      + DFGI+  L  + 
Sbjct: 111 ------KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162

Query: 375 EQTRSIGVEGTTGYIAPE-----YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            +TR  G      Y+APE        G++V S  DV+S GI L E+ TG  P
Sbjct: 163 AKTRDAGCR---PYMAPERIDPSARDGYDVRS--DVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 30/215 (13%)

Query: 212 LIGAGNFGSVYKGILFESTTA------VAVKVF--NVLHHDASKSFAVECEVTRNIRHRN 263
            +G G+FG V +G   E +T+      VAVK    + L  D    F  E  +  ++ H N
Sbjct: 2   KLGDGSFGVVRRG---EWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHEN 57

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           L++++    GV         +V E    GSL + +       K       +++L   + A
Sbjct: 58  LIRLY----GVVLT--HPLMMVTELAPLGSLLDRLR------KDALGHFLISTL--CDYA 103

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS-IGV 382
           + +A  ++YL         H DL   NILL  +    + DFG+ R L   ++       +
Sbjct: 104 VQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL 160

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
           +    + APE       S   DV+ FG+ L EMFT
Sbjct: 161 KVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 67/235 (28%), Positives = 105/235 (44%), Gaps = 47/235 (20%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS---------KSFAVECEVTRNIRHR 262
           LIG+G+FGSVY G+   S   +AVK   +    AS          + A E  + + ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 263 NLVKVFTACSGVDF--------QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNL 314
           N+V+   +    D          G    AL+  +   G+ EE                  
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY---GAFEE------------------ 105

Query: 315 NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD 374
            +L R N    +   L YLH      I H D+K +NIL+D++    +SDFGI++ LEA  
Sbjct: 106 -TLVR-NFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160

Query: 375 EQTRSIG----VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
             T++ G    ++G+  ++APE       +   D++S G L++EM TG  P  D 
Sbjct: 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 61/213 (28%), Positives = 91/213 (42%), Gaps = 19/213 (8%)

Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRNIRHRN 263
           +     + +G G  GSV K  L  +    A+K      +    K    E E+ ++ +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL-NI 322
           +VK + A   +D   +     + E+   GSL+          K+ K  G     K L  I
Sbjct: 61  IVKYYGAF--LDESSSSIGIAM-EYCEGGSLDSIY-------KKVKKRGGRIGEKVLGKI 110

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           A  V   L YLH      I H D+KPSNILL  +    + DFG++   E  +    +   
Sbjct: 111 AESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTF-- 163

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEM 415
            GT+ Y+APE   G   S   DV+S G+ LLE+
Sbjct: 164 TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 60/228 (26%), Positives = 95/228 (41%), Gaps = 46/228 (20%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           +G G+FG V       S    A+K+ +   ++     +    E  + ++IRH  LV ++ 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI------A 323
           +     FQ +    LV E++  G L                   L    R         A
Sbjct: 69  S-----FQDDSNLYLVMEYVPGGELFSH----------------LRKSGRFPEPVARFYA 107

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
             V   L+YLH      I + DLKP N+LLD +    ++DFG A+ ++      R+  + 
Sbjct: 108 AQVVLALEYLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVK-----GRTYTLC 159

Query: 384 GTTGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN 429
           GT  Y+APE     G+  +   D ++ GIL+ EM  G  P    F D+
Sbjct: 160 GTPEYLAPEIILSKGYGKAV--DWWALGILIYEMLAGYPP----FFDD 201

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 69.9 bits (172), Expect = 3e-13
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 51/233 (21%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV----ECEVTRNIRHRNLVK-- 266
           IG G +G VYK    ++   VA+K   +   +  + F +    E ++ + +RH N+V+  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRM--ENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 267 -VFTACSGVDFQGNDFKALVYEFMA---NGSLEEWMHPITEEDKRHKAPGNLNSL-KRLN 321
            + T+      +G+ +  +V+E+M     G L+      TE          +    K+L 
Sbjct: 65  EIVTSKG----KGSIY--MVFEYMDHDLTGLLDSPEVKFTE--------SQIKCYMKQLL 110

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE---AADEQTR 378
                   L+YLH      I H D+K SNIL++++    ++DFG+AR      +AD   R
Sbjct: 111 EG------LQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR 161

Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTG---LRPSDDM 425
            I    T  Y  PE  +G     YG   D++S G +L E+F G    + S ++
Sbjct: 162 VI----TLWYRPPELLLGAT--RYGPEVDMWSVGCILAELFLGKPIFQGSTEL 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 21/221 (9%)

Query: 211 NLIGAGNFGSVYKGIL-----FESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNL 264
             +G G FG VY+G+            VAVK       +  +S F +E  +     H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           V+      GV F+    + ++ E MA G L+ ++    E   R + P +L     L  A 
Sbjct: 72  VR----LIGVSFERLP-RFILLELMAGGDLKSFLR---ENRPRPERPSSLTMKDLLFCAR 123

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDE---MTAYVSDFGIARFLEAADEQTRSIG 381
           DVA   KYL    +    H D+   N LL  +     A ++DFG+AR +  A    +   
Sbjct: 124 DVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180

Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
                 ++ PE  +    +S  DV+SFG+LL E+F+ G  P
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 32/230 (13%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G GN G+VYK     +   +AVKV  + +  +  K    E E+        ++  + A 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA- 67

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
               F   +  ++  EFM  GSL          D   K P ++  L R  IA+ V   L 
Sbjct: 68  ----FFVENRISICTEFMDGGSL----------DVYRKIPEHV--LGR--IAVAVVKGLT 109

Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YL       I H D+KPSN+L++      + DFG++  L  +  +T      GT  Y+AP
Sbjct: 110 YL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV----GTNAYMAP 162

Query: 392 EYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN-----LNLRNCV 436
           E   G +   + DV+S GI  +E+  G  P   + K+      L L  C+
Sbjct: 163 ERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI 212

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 34/223 (15%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG VYK    E+    A K+  +   +  + F VE ++    +H N+V ++ A  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 273 GVDFQGNDFKALVY-EFMANGSLEEWM----HPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                  + K  +  EF   G+L+  M      +TE   R+             +   + 
Sbjct: 73  ------YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-------------VCRQML 113

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             L +LH      + H DLK  NILL  +    ++DFG++   ++   Q R   + GT  
Sbjct: 114 EALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-QKRDTFI-GTPY 168

Query: 388 YIAPEYGMGHEVSS--Y---GDVYSFGILLLEMFTGLRPSDDM 425
           ++APE           Y    D++S GI L+E+     P  ++
Sbjct: 169 WMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 67/221 (30%), Positives = 100/221 (45%), Gaps = 31/221 (14%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           L+G GNFG V+KG L +  T VAVK     L  +    F  E  + +   H N+VK+   
Sbjct: 2   LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    Q      +V E +  G    ++    +E         L + + +  A+D A  +
Sbjct: 61  CT----QRQPI-YIVMELVPGGDFLSFLRKKKDE---------LKTKQLVKFALDAAAGM 106

Query: 331 KYLHL-DCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT-TGY 388
            YL   +C     H DL   N L+ +     +SDFG++R  +  D    S G++     +
Sbjct: 107 AYLESKNC----IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKW 160

Query: 389 IAPE---YGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            APE   YG     SS  DV+S+GILL E F+ G+ P   M
Sbjct: 161 TAPEALNYG---RYSSESDVWSYGILLWETFSLGVCPYPGM 198

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 69/301 (22%), Positives = 113/301 (37%), Gaps = 61/301 (20%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-----ECEVTRNIRHRNLVK 266
           L+G+G+FGSVY+G+  +     AVK  ++     +   AV     E  +   ++H N+V+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 267 VF-TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI- 324
              T          D   +  E +  GSL              K      S     I + 
Sbjct: 67  YLGTEREE------DNLYIFLELVPGGSL-------------AKLLKKYGSFPEPVIRLY 107

Query: 325 --DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
              +   L+YLH        H D+K +NIL+D      ++DFG+A+ +       +S   
Sbjct: 108 TRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF-AKS--F 161

Query: 383 EGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP 441
           +G+  ++APE            D++S G  +LEM TG  P   +       +      LP
Sbjct: 162 KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP 221

Query: 442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEA 501
              + +   +    +  IL+CL                        +P LR    +LLE 
Sbjct: 222 PIPDHLSDEA----KDFILKCL----------------------QRDPSLRPTAAELLEH 255

Query: 502 P 502
           P
Sbjct: 256 P 256

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 71.4 bits (175), Expect = 5e-13
 Identities = 46/135 (34%), Positives = 66/135 (48%), Gaps = 7/135 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDMHGNLFAGPI 59
           DLS  N+SG +S  +  L  +   N+S N LSG I ++ F + +SL  L++  N F G I
Sbjct: 75  DLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSI 134

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASAT 119
                S+  L  LDLS N LS EIP  +  F  L+ L+L  N     +P      N ++ 
Sbjct: 135 PR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS--LTNLTSL 190

Query: 120 SVF--GNKKLCGGIP 132
                 + +L G IP
Sbjct: 191 EFLTLASNQLVGQIP 205

Length = 968

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 31/220 (14%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-KSFAV-ECEVTRNIRHRNLVKVFT 269
           L+G G++G V K    E+   VA+K F     D   K  A+ E  + + +RH NLV +  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
                 F+      LV+EF+ +  L          D   K P  L+  +       +   
Sbjct: 68  V-----FRRKKRLYLVFEFVDHTVL----------DDLEKYPNGLDESRVRKYLFQILRG 112

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ-TRSIGVEGTTGY 388
           +++ H      I H D+KP NIL+       + DFG AR L A  E  T  +    T  Y
Sbjct: 113 IEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV---ATRWY 166

Query: 389 IAPEYGMGHEVSSYG---DVYSFGILLLEMFTG--LRPSD 423
            APE  +G   + YG   D+++ G L+ EM TG  L P D
Sbjct: 167 RAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 61/223 (27%), Positives = 85/223 (38%), Gaps = 44/223 (19%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRN--------- 263
           +G G FG V          A  VK          K +A +    + ++ R          
Sbjct: 1   LGKGGFGEVC---------ACQVK-------ATGKMYACKKLDKKRLKKRKGEQMALNEK 44

Query: 264 --LVKV---FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLK 318
             L KV   F       F+  D   LV   M  G L+  ++           PG     +
Sbjct: 45  KILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIY-------NVGEPG-FPEAR 96

Query: 319 RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
            +  A  + C L++LH   Q  I + DLKP N+LLDD     +SD G+A  L+      +
Sbjct: 97  AIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK---GGKK 150

Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             G  GT GY+APE   G       D ++ G  L EM  G  P
Sbjct: 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 26/211 (12%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           E  +GAG FG V+    +   T VAVK           +F  E  V + ++H  LVK+  
Sbjct: 11  EKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA 68

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
             +       +   ++ EFMA GSL +++   ++E  +   P      K ++ +  +A  
Sbjct: 69  VVT------KEPIYIITEFMAKGSLLDFLK--SDEGSKQPLP------KLIDFSAQIAEG 114

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           + ++    Q    H DL+ +NIL+   +   ++DFG+AR +E  +E T   G +    + 
Sbjct: 115 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWT 170

Query: 390 APE---YGMGHEVSSYGDVYSFGILLLEMFT 417
           APE   +G     +   DV+SFGILL+E+ T
Sbjct: 171 APEAINFG---SFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 68.0 bits (167), Expect = 8e-13
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 33/221 (14%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           I  G +G V+      +    A+KV     ++  +       E ++    +   +VK++ 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLN-SLKRLNIAIDVAC 328
           +     FQG     LV E++  G L   +  +          G+L+  + R+ IA  V  
Sbjct: 61  S-----FQGKKNLYLVMEYLPGGDLASLLENV----------GSLDEDVARIYIAEIVLA 105

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF------LEAADEQTRSIGV 382
            L+YLH      I H DLKP NIL+D      ++DFG+++       +   D++     +
Sbjct: 106 -LEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161

Query: 383 EGTTGYIAPEY--GMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            GT  YIAPE   G GH  +   D +S G +L E   G+ P
Sbjct: 162 VGTPDYIAPEVILGQGHSKTV--DWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 55/227 (24%), Positives = 102/227 (44%), Gaps = 36/227 (15%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTR------NIRHRN 263
           L+G+G FG+V+KGI      ++ + V      D S  ++F    E+T       ++ H  
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ---EITDHMLAMGSLDHAY 70

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           +V++   C G   Q      LV +    GSL + +       ++H+   +L+  + LN  
Sbjct: 71  IVRLLGICPGASLQ------LVTQLSPLGSLLDHV-------RQHR--DSLDPQRLLNWC 115

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           + +A  + YL       + H +L   NILL  +    ++DFG+A  L   D++      +
Sbjct: 116 VQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172

Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-------GLRPSD 423
               ++A E  +    +   DV+S+G+ + EM +       G+RP +
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 33/224 (14%)

Query: 211 NLIGAGNFGSVYKG----ILFEST--TAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRN 263
           N +G+G FG VY+G    IL   +    VAVK       D  K  F  E  +  N  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL-NI 322
           +VK+   C  +    N+ + ++ E M  G L  ++     + +  +    L +LK L +I
Sbjct: 61  IVKLLGVC--LL---NEPQYIIMELMEGGDLLSYL----RDARVERFGPPLLTLKELLDI 111

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILL-----DDEMTAYVSDFGIARFLEAAD--- 374
            +DVA    YL    Q    H DL   N L+     D +    + DFG+AR +  +D   
Sbjct: 112 CLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168

Query: 375 -EQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            E    + V     ++APE  +  + ++  DV+SFG+L+ E+ T
Sbjct: 169 KEGEGLLPVR----WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 35/225 (15%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS----KSFAVECEVTRNI-RHRNL 264
           E++IG GNFG V + ++ +    +   +  +L   AS    + FA E EV   +  H N+
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAI-KMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHP--ITEED----KRHKAPGNLNSLK 318
           + +  AC     +   +  +  E+   G+L +++    + E D    K H     L S +
Sbjct: 66  INLLGAC-----ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 319 RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
            L  A DVA  ++YL    +    H DL   N+L+ + + + ++DFG++R  E       
Sbjct: 121 LLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEE------- 170

Query: 379 SIGVEGTTGYIAPEYGMGHEVSSY------GDVYSFGILLLEMFT 417
            + V+ T G + P   M  E  +Y       DV+SFG+LL E+ +
Sbjct: 171 -VYVKKTMGRL-PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 20/219 (9%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-KSFAV-ECEVTRNIRHRNL 264
           F   N IG G+FG V+K +        A+K  ++   +   +  A+ E  V   +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           ++ + +     F       +V E+  NG L + +        +   P   + + R  I I
Sbjct: 62  IRYYES-----FLDKGKLNIVMEYAENGDLHKLLK------MQRGRPLPEDQVWRFFIQI 110

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +   L +LH      I H D+K  N+ LD      + D G+A+ L        +I   G
Sbjct: 111 LLG--LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI--VG 163

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD 423
           T  Y++PE       +   DV++ G++L E  TG  P D
Sbjct: 164 TPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 59/228 (25%), Positives = 89/228 (39%), Gaps = 46/228 (20%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVK---V 267
           IG G  G V+K    E+   VA+K   +  L          E +  +  +H  +VK   V
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWM----HPITEEDKRHKAPGNLNSLKRLNIA 323
           F   SG          LV E+M    L E +     P+ E             +K     
Sbjct: 68  FPHGSGF--------VLVMEYMP-SDLSEVLRDEERPLPEA-----------QVKSYMRM 107

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           +       Y+H      I H DLKP+N+L+  +    ++DFG+AR     + +  S  V 
Sbjct: 108 LLKGV--AYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV- 161

Query: 384 GTTGYIAPE--YGMGHEVSSYG---DVYSFGILLLEMFTG--LRPSDD 424
            T  Y APE  YG       Y    D+++ G +  E+  G  L P ++
Sbjct: 162 ATRWYRAPELLYGARK----YDPGVDLWAVGCIFAELLNGSPLFPGEN 205

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 41/295 (13%)

Query: 213 IGAGNFGSVYKGILF----ESTTAVAVKVFNVLHHDAS-KSFAVECEVTRNIRHRNLVKV 267
           +G   FG +YKG L+    +    VA+K    +++      F  E  +   + H N+V +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITE----EDKRHKAPGNLNSLKRL 320
                GV  Q      +++E++  G L E++    P ++     D+      +L+    L
Sbjct: 73  L----GVVTQEQPV-CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 321 NIAIDVACVLKYL--HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
           +IAI +A  ++YL  H        H DL   NIL+ +++   +SD G++R + +AD    
Sbjct: 128 HIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182

Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVK 437
                    ++ PE  M  + SS  D++SFG++L E+F+ GL+P    F +   +    K
Sbjct: 183 QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVIEMVRK 241

Query: 438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR 492
             L   +E               +C   +  +   C  E P  R +  D+  RLR
Sbjct: 242 RQLLPCSE---------------DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 51/220 (23%), Positives = 98/220 (44%), Gaps = 20/220 (9%)

Query: 206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT-----RNIR 260
             +  +L+  G FG ++ GIL +       +VF     D +    V   +        + 
Sbjct: 7   RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66

Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR- 319
           H+N++ +   C     +  +   ++Y +M  G+L+ ++     +  R     N  +L   
Sbjct: 67  HQNILPILHVC----IEDGEPPFVLYPYMNWGNLKLFL-----QQCRLGEANNPQALSTQ 117

Query: 320 --LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT 377
             +++AI +AC + YLH   +  + H D+   N ++D+E+   ++D  ++R L   D   
Sbjct: 118 QLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174

Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                     ++A E  +  E SS  DV+SFG+LL E+ T
Sbjct: 175 LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 65/230 (28%), Positives = 98/230 (42%), Gaps = 31/230 (13%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEV-TRNIRHRNLVKV 267
           ++G G+FG V    L  +    A+K      VL  D  +   VE  V      H  L  +
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI-AIDV 326
           F  C+   FQ  +    V E++  G L   M  I    +            R    A ++
Sbjct: 62  F--CT---FQTKEHLFFVMEYLNGGDL---MFHIQSSGRF--------DEARARFYAAEI 105

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
            C L++LH   +  I + DLK  N+LLD +    ++DFG+ +     + +  +    GT 
Sbjct: 106 ICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC--GTP 160

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLN 431
            YIAPE   G + +   D +SFG+LL EM  G  P      D++F   LN
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 68/223 (30%), Positives = 108/223 (48%), Gaps = 41/223 (18%)

Query: 212 LIGAGNFGSVY---KGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRNLV 265
           ++G G+FG V+   K    ++    A+KV     +   D  ++  +E ++   + H  +V
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSL-----EEWMHPITEEDKRHKAPGNLNSLKRL 320
           K+  A     FQ      L+ +F+  G L     +E M   TEED +         L  L
Sbjct: 62  KLHYA-----FQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKF-------YLAEL 107

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            +A+D      +LH      I + DLKP NILLD+E    ++DFG+++  E+ D + ++ 
Sbjct: 108 ALALD------HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAY 156

Query: 381 GVEGTTGYIAPEY--GMGHEVSSYGDVYSFGILLLEMFTGLRP 421
              GT  Y+APE     GH  S+  D +SFG+L+ EM TG  P
Sbjct: 157 SFCGTVEYMAPEVVNRRGHTQSA--DWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 38/215 (17%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G  G VYK     +   VA+K    L     +    E  + ++ +H N+V  + +  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELIINEILIMKDCKHPNIVDYYDS-- 83

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN------IAIDV 326
              +   D   +V E+M  GSL +    I              +  R+N      +  +V
Sbjct: 84  ---YLVGDELWVVMEYMDGGSLTD----IIT-----------QNFVRMNEPQIAYVCREV 125

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
              L+YLH      + H D+K  NILL  + +  ++DFG A  L     +  S+ V GT 
Sbjct: 126 LQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-V-GTP 180

Query: 387 GYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTG 418
            ++APE     +   YG   D++S GI+ +EM  G
Sbjct: 181 YWMAPEVIKRKD---YGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 56/213 (26%), Positives = 85/213 (39%), Gaps = 28/213 (13%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA-VECEVTRNIRHRNLVKVFTAC 271
           I  G FGSVY      +    A+KV       A      V+ E  R I        + A 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE--RAIMMIQGESPYVAK 61

Query: 272 SGVDFQGNDFKALVYEFMANG---SLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
               FQ  D+  LV E++  G   SL + +  + E+  +                 +V  
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-------------QYIAEVVL 108

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            ++ LH   Q  I H D+KP N+L+D      ++DFG++R      E  + +G   T  Y
Sbjct: 109 GVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR---NGLENKKFVG---TPDY 159

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           +APE  +G       D +S G ++ E   G  P
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 66/239 (27%), Positives = 102/239 (42%), Gaps = 56/239 (23%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKV----FNVLHHDASKSFAVECEVTRNIRHR 262
           + + + +G+G +G V      ++   VA+K     F    H A +++  E  + +++ H 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH-AKRTYR-ELRLLKHMDHE 74

Query: 263 N---LVKVFTACSGV-DFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLK 318
           N   L+ VFT  S + DFQ  D   LV   M    L                  N+   +
Sbjct: 75  NVIGLLDVFTPASSLEDFQ--DV-YLVTHLMG-ADL-----------------NNIVKCQ 113

Query: 319 RLN------IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEA 372
           +L+      +   +   LKY+H      I H DLKPSNI ++++    + DFG+AR    
Sbjct: 114 KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR--HT 168

Query: 373 ADEQTRSIGVEGTTGYIAPE--YGMGHEVSSYG---DVYSFGILLLEMFTG--LRPSDD 424
            DE T   G   T  Y APE      H    Y    D++S G ++ E+ TG  L P  D
Sbjct: 169 DDEMT---GYVATRWYRAPEIMLNWMH----YNQTVDIWSVGCIMAELLTGKTLFPGSD 220

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 66.8 bits (164), Expect = 4e-12
 Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 47/229 (20%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVK-VFNVLHH--DASKSFAVECEVTRNIRHRNLVK- 266
             IG+G +G V   +   +   VA+K + NV     DA +    E ++ R++RH N++  
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGL 64

Query: 267 --VFTACSGVDFQGNDFKALVYEFMANGSLEEWMH---PITEEDKRHKAPGNLNSLKRLN 321
             +    S  DF  ND   +V E M    L + +    P+T++  ++             
Sbjct: 65  LDILRPPSPEDF--NDV-YIVTELMET-DLHKVIKSPQPLTDDHIQY------------- 107

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
               +   LKYLH      + H DLKPSNIL++      + DFG+AR ++  +++     
Sbjct: 108 FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK---- 160

Query: 382 VEGTTGYI------APEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
               T Y+      APE  +    S Y    D++S G +  E+ T  +P
Sbjct: 161 -GFLTEYVVTRWYRAPELLLS--SSRYTKAIDIWSVGCIFAELLTR-KP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 25/216 (11%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRN-LVKV---F 268
           IG G+FG V +    ++    A+K      H  S+S     EVT  +  R  L +V   F
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRK-AHIVSRS-----EVTHTLAERTVLAQVNCPF 54

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                  FQ  +   LV  F+  G L    H +  E       G  +  +      ++ C
Sbjct: 55  IVPLKFSFQSPEKLYLVLAFINGGEL---FHHLQRE-------GRFDLSRARFYTAELLC 104

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L+ LH   +  + + DLKP NILLD +    + DFG+ +     D++T +    GT  Y
Sbjct: 105 ALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC--GTPEY 159

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD 424
           +APE  +GH  +   D ++ G+LL EM TGL P  D
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 65.7 bits (161), Expect = 6e-12
 Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 34/217 (15%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFT 269
           +G G FG V    +       A+K     H       +    E E+     H  +VK++ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
                 F+   +  ++ E+   G L   +             G  +          +ACV
Sbjct: 61  T-----FKDKKYIYMLMEYCLGGELWTILRDR----------GLFDEYTARFY---IACV 102

Query: 330 ---LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
               +YLH      I + DLKP N+LLD      + DFG A+ L++  ++T +    GT 
Sbjct: 103 VLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG-QKTWTFC--GTP 156

Query: 387 GYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            Y+APE     G++ S   D +S GILL E+ TG  P
Sbjct: 157 EYVAPEIILNKGYDFSV--DYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 67.9 bits (166), Expect = 7e-12
 Identities = 55/202 (27%), Positives = 80/202 (39%), Gaps = 28/202 (13%)

Query: 228 ESTTAVAVKVFNVLHHDASKSFA---VECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL 284
            +   VA+K+      +     A    E  +   + H N+V +    SG           
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD--SGE--APPGLLFA 56

Query: 285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHC 344
           V+E++   +L E             A G L + +   + + V   L   H      I H 
Sbjct: 57  VFEYVPGRTLRE----------VLAADGALPAGETGRLMLQVLDALACAH---NQGIVHR 103

Query: 345 DLKPSNILL---DDEMTAYVSDFGIARFL---EAADEQ--TRSIGVEGTTGYIAPEYGMG 396
           DLKP NI++        A V DFGI   L     AD    TR+  V GT  Y APE   G
Sbjct: 104 DLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG 163

Query: 397 HEVSSYGDVYSFGILLLEMFTG 418
             V+   D+Y++G++ LE  TG
Sbjct: 164 EPVTPNSDLYAWGLIFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 65.3 bits (160), Expect = 7e-12
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 22/216 (10%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-ASKSFAV-ECEVTRNIRHRNLVKVFTA 270
           IG G+FG+V K         +  K  +  +     K   V E  + R ++H N+V+ +  
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY-- 65

Query: 271 CSGVDFQGNDFKALVY---EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
               D   +     +Y   E+   G L + +    +E K  +       L +L +A    
Sbjct: 66  ----DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA---- 117

Query: 328 CVLKYLH--LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
             L   H   D    + H DLKP+NI LD      + DFG+A+ L       ++    GT
Sbjct: 118 --LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY--VGT 173

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             Y++PE           D++S G L+ E+   L P
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA-LSP 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 65.6 bits (160), Expect = 8e-12
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 28/215 (13%)

Query: 212 LIGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKS---FAVECEVTRNIRHRNL 264
            +G GNFGSV    Y  +   +   VAVK    L H  ++    F  E E+ ++++H N+
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKK---LQHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK    C      G     LV E++  GSL +++     +  R +    L+  K L  A 
Sbjct: 68  VKYKGVCYSA---GRRNLRLVMEYLPYGSLRDYL-----QKHRER----LDHRKLLLYAS 115

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE--QTRSIGV 382
            +   ++YL         H DL   NIL++ E    + DFG+ + L    E  + R  G 
Sbjct: 116 QICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPG- 171

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
           E    + APE     + S   DV+SFG++L E+FT
Sbjct: 172 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 66/215 (30%), Positives = 98/215 (45%), Gaps = 26/215 (12%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEV-TRNIRHRNLVKV 267
           ++G G+FG V+   L  +    A+K      VL  D  +   VE  V +    H  L  +
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI-AIDV 326
           +  C+   FQ  +    V E++  G L   M  I      HK       L R    A ++
Sbjct: 62  Y--CT---FQTKENLFFVMEYLNGGDL---MFHI---QSCHKF-----DLPRATFYAAEI 105

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
            C L++LH      I + DLK  NILLD +    ++DFG+ +     D +T +    GT 
Sbjct: 106 ICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC--GTP 160

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            YIAPE  +G + ++  D +SFG+LL EM  G  P
Sbjct: 161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 67/251 (26%), Positives = 97/251 (38%), Gaps = 55/251 (21%)

Query: 200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI 259
           L + T  F    +IG G +G VYK    ++   VA+K+ +++  D  +    E  + R  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKY 59

Query: 260 -RHRNLVKVFTACSGVDFQGNDFKA----------LVYEFMANGSLEEWMHPITEEDKRH 308
             H N+           F G   K           LV E    GS       +T+  K  
Sbjct: 60  SNHPNI---------ATFYGAFIKKNPPGNDDQLWLVMELCGGGS-------VTDLVKGL 103

Query: 309 KAPGNLNSLKRLNIAI---DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG 365
           +  G    LK   IA    +    L YLH   +  + H D+K  NILL       + DFG
Sbjct: 104 RKKG--KRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG 158

Query: 366 IARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEV--------SSY---GDVYSFGILLLE 414
           ++  L        ++G   T  +I   Y M  EV        +SY    DV+S GI  +E
Sbjct: 159 VSAQL------DSTLGRRNT--FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210

Query: 415 MFTGLRPSDDM 425
           +  G  P  DM
Sbjct: 211 LADGKPPLCDM 221

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 68/233 (29%), Positives = 103/233 (44%), Gaps = 35/233 (15%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLV 265
           F    ++G G +G VYKG   ++    A+KV +V   D  +   +E  + +    HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIA 76

Query: 266 KVFTACSGVDFQGNDFKA-LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
             + A       G+D +  LV EF   GS       +T+  K  K     N+LK   IA 
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGS-------VTDLVKNTKG----NALKEDWIAY 125

Query: 325 DVACVLKYL-HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
               +L+ L HL     I H D+K  N+LL +     + DFG++  L+      R++G  
Sbjct: 126 ICREILRGLAHLHAHKVI-HRDIKGQNVLLTENAEVKLVDFGVSAQLD------RTVGRR 178

Query: 384 GTTGYIAPEYGMGHEV--------SSY---GDVYSFGILLLEMFTGLRPSDDM 425
            T  +I   Y M  EV        ++Y    D++S GI  +EM  G  P  DM
Sbjct: 179 NT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 64.4 bits (158), Expect = 2e-11
 Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 35/221 (15%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVEC--EVT--RNIRHR 262
           +     +G G +G VYK    ++   VA+K   +   +  +        E++  + ++H 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKK--IRLDNEEEGIPSTALREISLLKELKHP 58

Query: 263 NLVK---VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           N+VK   V                LV+E+     L++++        +   P + N +K 
Sbjct: 59  NIVKLLDVIH--------TERKLYLVFEYCDM-DLKKYL-------DKRPGPLSPNLIKS 102

Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ-TR 378
             I   +   L Y H      I H DLKP NIL++ +    ++DFG+AR         T 
Sbjct: 103 --IMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157

Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYG-DVYSFGILLLEMFTG 418
            + V  T  Y APE  +G +  S   D++S G +  EM TG
Sbjct: 158 EV-V--TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 50/167 (29%), Positives = 80/167 (47%), Gaps = 16/167 (9%)

Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAP 311
           E E+ RN+ H N+VK    C+  +  GN  K L+ EF+ +GSL+E++        R+K  
Sbjct: 56  EIEILRNLYHENIVKYKGICT--EDGGNGIK-LIMEFLPSGSLKEYL-------PRNKNK 105

Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
            NL     L  A+ +   + YL         H DL   N+L++ E    + DFG+ + +E
Sbjct: 106 INLKQQ--LKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160

Query: 372 AADE-QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              E  T    ++    + APE  +  +     DV+SFG+ L E+ T
Sbjct: 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 66.3 bits (162), Expect = 2e-11
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 42/233 (18%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKV-------FNVLHHDASKSFAVECEVTRNIRHRNL 264
           LIG G  G VY       +  VA+K          +L     K F  E ++  ++ H  +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLK----KRFLREAKIAADLIHPGI 64

Query: 265 VKVFTACSGVDFQGNDFKALVY---EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR-L 320
           V V++ CS  D         VY    ++   +L+  +  + +++   K      S+   L
Sbjct: 65  VPVYSICSDGD--------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
           +I   +   ++Y+H      + H DLKP NILL       + D+G A F +  +E    I
Sbjct: 117 SIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173

Query: 381 GVE----------------GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            V+                GT  Y+APE  +G   S   D+Y+ G++L +M T
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 38/230 (16%)

Query: 213 IGAGNFGSVYKGILFE-----STTAVAVKVFNVLHHDASKS----FAVECEVTRNIRHRN 263
           +G G FG V K   F        T VAVK+   L  +AS S       E  + + + H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKM---LKENASSSELRDLLSEFNLLKQVNHPH 64

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI- 322
           ++K++ ACS      +    L+ E+   GSL  ++      + R   P  L S    N  
Sbjct: 65  VIKLYGACSQ-----DGPLLLIVEYAKYGSLRSFL-----RESRKVGPSYLGSDGNRNSS 114

Query: 323 --------AIDVACVLKYLHLDCQP-------PIAHCDLKPSNILLDDEMTAYVSDFGIA 367
                   A+ +  ++ +     +         + H DL   N+L+ +     +SDFG++
Sbjct: 115 YLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174

Query: 368 RFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
           R +   D   +         ++A E    H  ++  DV+SFG+LL E+ T
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 33/224 (14%)

Query: 210 ENLIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLV 265
           +++IG GNFG V K  + +      A   ++      D  + FA E EV   +  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHP--ITEEDKR----HKAPGNLNSLKR 319
            +  AC     +   +  L  E+  +G+L +++    + E D      +     L+S + 
Sbjct: 72  NLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
           L+ A DVA  + YL    Q    H DL   NIL+ +   A ++DFG++R  E        
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------- 175

Query: 380 IGVEGTTGYIAPEYGMGHEVSSY------GDVYSFGILLLEMFT 417
           + V+ T G + P   M  E  +Y       DV+S+G+LL E+ +
Sbjct: 176 VYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 64/267 (23%), Positives = 105/267 (39%), Gaps = 49/267 (18%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
           ++G G +G VY      +   +A+K          +    E  +   ++HRN+V+   + 
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
           S      N F  +  E +  GSL   +       K ++      + + L         LK
Sbjct: 75  SE-----NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE-------GLK 122

Query: 332 YLHLDCQPPIAHCDLKPSNILLDD-EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           YLH      I H D+K  N+L++       +SDFG ++ L   +  T +    GT  Y+A
Sbjct: 123 YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF--TGTLQYMA 177

Query: 391 PEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDD------------MFKDNLNLRNC 435
           PE  +      YG   D++S G  ++EM TG  P  +            MFK +      
Sbjct: 178 PEV-IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH------ 230

Query: 436 VKSALPERAEEIRASSGSTQRSIILEC 462
                PE  E + A +    ++ IL C
Sbjct: 231 -----PEIPESLSAEA----KNFILRC 248

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 27/215 (12%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-ASKSFAV-ECEVTRNIRHRNLVKVFT 269
           ++G G +G V K     +   VA+K F     D   K  A+ E +V R +RH N+V +  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
           A     F+      LV+E++    LE              +PG L      +    +   
Sbjct: 68  A-----FRRKGRLYLVFEYVERTLLELL----------EASPGGLPPDAVRSYIWQLLQA 112

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           + Y H      I H D+KP NIL+ +     + DFG AR L A      +  V  T  Y 
Sbjct: 113 IAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYR 168

Query: 390 APEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
           APE  +G   ++YG   DV++ G ++ E+  G  P
Sbjct: 169 APELLVGD--TNYGKPVDVWAIGCIMAELLDG-EP 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 73/253 (28%), Positives = 106/253 (41%), Gaps = 43/253 (16%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG VYK    E+    A KV +    +  + + VE ++  +  H N+VK+  A  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 71

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWM----HPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
              +  N+   L+ EF A G+++  M     P+TE   R      L +            
Sbjct: 72  ---YYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA------------ 115

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI----GVEG 384
            L YLH   +  I H DLK  NIL   +    ++DFG++       + TR+I       G
Sbjct: 116 -LNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSA------KNTRTIQRRDSFIG 165

Query: 385 TTGYIAPEYGMGHEVSS------YGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS 438
           T  ++APE  M  E S         DV+S GI L+EM   + P          L    KS
Sbjct: 166 TPYWMAPEVVMC-ETSKDRPYDYKADVWSLGITLIEM-AQIEPPHHELNPMRVLLKIAKS 223

Query: 439 ALPERAEEIRASS 451
             P  A+  R SS
Sbjct: 224 EPPTLAQPSRWSS 236

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 34/226 (15%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F+    IG G+FG VYKGI   +   VA+K+ + L     +   ++ E+T          
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID-LEEAEDEIEDIQQEIT---------- 54

Query: 267 VFTACSG---VDFQGNDFKA----LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           V + C       + G+  K     ++ E++  GS  + +            PG L     
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-----------PGPLEETYI 103

Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             I  ++   L YLH + +    H D+K +N+LL ++    ++DFG+A  L   D Q + 
Sbjct: 104 ATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKR 158

Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
               GT  ++APE           D++S GI  +E+  G  P+ D+
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 34/226 (15%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F+    IG G+FG V+KGI   +   VA+K+ + L     +   ++ E+T          
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID-LEEAEDEIEDIQQEIT---------- 54

Query: 267 VFTACSG---VDFQGNDFKA----LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           V + C       + G+  K     ++ E++  GS  + +             G  +  + 
Sbjct: 55  VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-----------GPFDEFQI 103

Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             +  ++   L YLH + +    H D+K +N+LL ++    ++DFG+A  L   D Q + 
Sbjct: 104 ATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKR 158

Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
               GT  ++APE        S  D++S GI  +E+  G  P+ DM
Sbjct: 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 64/224 (28%), Positives = 96/224 (42%), Gaps = 27/224 (12%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           ++G G+FG V    L       AVK      VL  D  +   VE  V   +   N     
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVL-ALAWENPFLTH 60

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C+   FQ  +    V EF+  G L   M  I ++       G  +  +    A ++ C
Sbjct: 61  LYCT---FQTKEHLFFVMEFLNGGDL---MFHIQDK-------GRFDLYRATFYAAEIVC 107

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L++LH      I + DLK  N++LD +    ++DFG+ +  E      R+    GT  Y
Sbjct: 108 GLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDY 162

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP-----SDDMFK 427
           IAPE   G + +   D +SFG+LL EM  G  P      D++F+
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 63.2 bits (153), Expect = 5e-11
 Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 34/226 (15%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F+    IG G+FG V+KGI   +   VA+K+ + L     +   ++ E+T          
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEIT---------- 54

Query: 267 VFTACSG---VDFQGNDFKA----LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           V + C       + G+  K     ++ E++  GS  + +            PG L+  + 
Sbjct: 55  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----------PGPLDETQI 103

Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             I  ++   L YLH + +    H D+K +N+LL +     ++DFG+A  L   D Q + 
Sbjct: 104 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKR 158

Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
               GT  ++APE        S  D++S GI  +E+  G  P  ++
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 27/220 (12%)

Query: 213 IGAGNFGSVYKGI--LFESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVKVFT 269
           +G+GNFG V KG+  + +    VA+KV    +  + +     E E+   + +  +V++  
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAP-GNLNSLKRLNIAIDVAC 328
            C            LV E  + G L +++       K+ +    N+  L        V+ 
Sbjct: 63  VCEAEALM------LVMEMASGGPLNKFL-----SGKKDEITVSNVVELMH-----QVSM 106

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE--QTRSIGVEGTT 386
            +KYL         H DL   N+LL ++  A +SDFG+++ L A D   + RS G     
Sbjct: 107 GMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK 163

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            Y APE     + SS  DV+S+GI + E F+ G +P   M
Sbjct: 164 WY-APECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 36/214 (16%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           ++G G FG V+          V +K   V  +  D   +   EC+V + + H N+++ + 
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
                +F  +    +V E+   G+L E++                   KR N  +D   +
Sbjct: 67  -----NFLEDKALMIVMEYAPGGTLAEYIQ------------------KRCNSLLDEDTI 103

Query: 330 LKY-------LHLDCQPPIAHCDLKPSNILLDD-EMTAYVSDFGIARFLEAADEQTRSIG 381
           L +       LH      I H DLK  NILLD  +M   + DFGI++ L +   ++++  
Sbjct: 104 LHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYT 160

Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           V GT  YI+PE   G   +   D+++ G +L E+
Sbjct: 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 74/298 (24%), Positives = 131/298 (43%), Gaps = 47/298 (15%)

Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G   FG VYKG LF     E T AVA+K   +       + F  E  +   ++H N+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWM-----HP---ITEEDKRHKAPGNLNSLK 318
           +     GV  +     ++++ + ++  L E++     H     T++DK  K+   L    
Sbjct: 73  LL----GVVTKEQPL-SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS--TLEPAD 125

Query: 319 RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
            ++I   +A  +++L       + H DL   N+L+ D++   +SD G+ R + AAD    
Sbjct: 126 FVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182

Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVK 437
                    +++PE  M  + S   D++S+G++L E+F+ GL+P             C  
Sbjct: 183 MGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY------------CGY 230

Query: 438 SALPERAEEIRASSGSTQRSIIL---ECLISICEIGVACSAEQPGERMKINDVEPRLR 492
           S   +  E IR       R ++    +C   +  + + C  E P  R +  D+  RLR
Sbjct: 231 SN-QDVIEMIR------NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 63.4 bits (154), Expect = 6e-11
 Identities = 70/233 (30%), Positives = 114/233 (48%), Gaps = 41/233 (17%)

Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-ASKSFAV----E 252
           + ++   + ++S   +G+G +GSV   I   +   VA+K    L     S+ FA     E
Sbjct: 8   KTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKK---LSRPFQSEIFAKRAYRE 64

Query: 253 CEVTRNIRHRN---LVKVFT-ACSGVDFQGNDFKALVYEFMANGSLEEWM-HPITEEDKR 307
             + ++++H N   L+ VFT A SG +FQ  DF  LV  +M    L++ M HP++E+  +
Sbjct: 65  LTLLKHMQHENVIGLLDVFTSAVSGDEFQ--DF-YLVMPYMQT-DLQKIMGHPLSEDKVQ 120

Query: 308 HKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA 367
           +             +   + C LKY+H      I H DLKP N+ ++++    + DFG+A
Sbjct: 121 Y-------------LVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA 164

Query: 368 RFLEAADEQTRSIGVEGTTGYIAPEYGMG--HEVSSYGDVYSFGILLLEMFTG 418
           R  +A  E T   G   T  Y APE  +   H   +  D++S G ++ EM TG
Sbjct: 165 RHADA--EMT---GYVVTRWYRAPEVILNWMHYNQTV-DIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 27/222 (12%)

Query: 212 LIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDAS----KSFAVECEVTRNI-RH 261
            +G G FG V K           T+ VAVK+   L  DA+         E E+ + I +H
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKM---LKDDATEKDLSDLVSEMEMMKMIGKH 75

Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH---PITEE---DKRHKAPGNLN 315
           +N++ +   C+    +G  +  +V E+ A+G+L +++    P  E    D        L 
Sbjct: 76  KNIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 316 SLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE 375
               ++ A  VA  +++L         H DL   N+L+ ++    ++DFG+AR +   D 
Sbjct: 131 QKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187

Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             ++        ++APE       +   DV+SFG+LL E+FT
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 62.5 bits (152), Expect = 8e-11
 Identities = 71/244 (29%), Positives = 113/244 (46%), Gaps = 46/244 (18%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV----ECEVTRNIRHR 262
           F     IG G +G VYK    ++   VA+K   V   +  + F +    E ++ R + HR
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALK--KVRLDNEKEGFPITAIREIKILRQLNHR 66

Query: 263 NLVK----VFTACSGVDF---QGNDFKALVYEFMAN---GSLEEWMHPITEEDKRHKAPG 312
           N+V     V      +DF   +G  +  LV+E+M +   G LE  +   +E+        
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFY--LVFEYMDHDLMGLLESGLVHFSED-------- 116

Query: 313 NLNSL-KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
           ++ S  K+L         L Y H   +    H D+K SNILL+++    ++DFG+AR   
Sbjct: 117 HIKSFMKQLLEG------LNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167

Query: 372 AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKD 428
           + + +  +  V  T  Y  PE  +G E   YG   DV+S G +L E+FT  +P   +F+ 
Sbjct: 168 SEESRPYTNKVI-TLWYRPPELLLGEE--RYGPAIDVWSCGCILGELFTK-KP---IFQA 220

Query: 429 NLNL 432
           N  L
Sbjct: 221 NQEL 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 62.2 bits (152), Expect = 9e-11
 Identities = 64/227 (28%), Positives = 100/227 (44%), Gaps = 54/227 (23%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV--EC----EVTRNIR----HR 262
           +G G FGSVY     E+   VA+K          K F    EC    EV +++R    H 
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREV-KSLRKLNEHP 58

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM-----HPITEEDKRHKAPGNLNSL 317
           N+VK+        F+ ND    V+E+M  G+L + M      P +E   R          
Sbjct: 59  NIVKLKEV-----FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR---------- 102

Query: 318 KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT 377
              +I   +   L ++H   +    H DLKP N+L+       ++DFG+AR + +    T
Sbjct: 103 ---SIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156

Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
             +    T  Y APE  +    +SY    D+++ G ++ E++T LRP
Sbjct: 157 DYV---STRWYRAPEILLRS--TSYSSPVDIWALGCIMAELYT-LRP 197

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 9e-11
 Identities = 57/225 (25%), Positives = 90/225 (40%), Gaps = 41/225 (18%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR------HRNLVK 266
           IG G +G VYK     +   VA+K   +       S  +     R I+      H N++K
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFE----SEGIPKTALREIKLLKELNHPNIIK 62

Query: 267 ---VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
              VF     +         LV+EFM +  L + +        + +  G   SL + +  
Sbjct: 63  LLDVFRHKGDL--------YLVFEFM-DTDLYKLI--------KDRQRGLPESLIK-SYL 104

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
             +   L + H      I H DLKP N+L++ E    ++DFG+AR   +     R     
Sbjct: 105 YQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLAR---SFGSPVRPYTHY 158

Query: 384 -GTTGYIAPEYGMGHEVSSYG-DVYSFGILLLEMFTG--LRPSDD 424
             T  Y APE  +G +  S   D++S G +  E+ +   L P   
Sbjct: 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 64.1 bits (156), Expect = 1e-10
 Identities = 48/133 (36%), Positives = 66/133 (49%), Gaps = 2/133 (1%)

Query: 2   LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGS 61
           L++N L G +  +L  + SL    +  N LSG I    G  TSL  LD+  N   GPI S
Sbjct: 195 LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254

Query: 62  SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGI-FKNASATS 120
           SL +L+ L+ L L QN LS  IP  +   + L +L+LS N+    +P   I  +N     
Sbjct: 255 SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILH 314

Query: 121 VFGNKKLCGGIPE 133
           +F N    G IP 
Sbjct: 315 LFSN-NFTGKIPV 326

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 53/147 (36%), Positives = 71/147 (48%), Gaps = 5/147 (3%)

Query: 2   LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGS 61
           L  N LSG + P +  L  L   ++S N LSG I        +LE L +  N F G I  
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326

Query: 62  SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS- 120
           +L+SL  L+VL L  N  S EIP+ L     L  L+LS NN    +P EG+  + +    
Sbjct: 327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP-EGLCSSGNLFKL 385

Query: 121 -VFGNKKLCGGIPEFQLPTCVSKKSKR 146
            +F N  L G IP+  L  C S +  R
Sbjct: 386 ILFSN-SLEGEIPK-SLGACRSLRRVR 410

Length = 968

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 67/232 (28%), Positives = 101/232 (43%), Gaps = 33/232 (14%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLV 265
           F    L+G G +G VYKG   ++    A+KV +V   D  +    E  + +    HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIA 66

Query: 266 KVFTACSGVDFQGNDFKA-LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
             + A    +  G D +  LV EF   GS       +T+  K  K     N+LK   IA 
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGS-------VTDLIKNTKG----NTLKEEWIAY 115

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
               +L+ L    Q  + H D+K  N+LL +     + DFG++  L+      R++G   
Sbjct: 116 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD------RTVGRRN 169

Query: 385 TTGYIAPEYGMGHEV--------SSY---GDVYSFGILLLEMFTGLRPSDDM 425
           T  +I   Y M  EV        ++Y    D++S GI  +EM  G  P  DM
Sbjct: 170 T--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 63/243 (25%), Positives = 110/243 (45%), Gaps = 43/243 (17%)

Query: 213 IGAGNFGSVYKGILFES----------TTAVAVKVFNVLHHDASKS----FAVECEVTRN 258
           +G G FG V   ++ E+           T VAVK+   L  DA++        E E+ + 
Sbjct: 26  LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKM---LKSDATEKDLSDLISEMEMMKM 79

Query: 259 I-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH----PITEE--DKRHKAP 311
           I +H+N++ +  AC+    Q      +V E+ + G+L E++     P  E   +      
Sbjct: 80  IGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPE 134

Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
             L+    ++ A  VA  ++YL         H DL   N+L+ ++    ++DFG+AR + 
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191

Query: 372 AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-------GLRPSDD 424
             D   ++        ++APE       +   DV+SFG+LL E+FT       G+ P ++
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 250

Query: 425 MFK 427
           +FK
Sbjct: 251 LFK 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 71/250 (28%), Positives = 102/250 (40%), Gaps = 39/250 (15%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRN------IRHR 262
           ++G G+FG V    L ES    AVKV     +L  D      VEC +T          H 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDD-----VECTMTEKRILSLARNHP 56

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
            L +++       FQ  D    V EF+  G L   M  I ++ +R          +    
Sbjct: 57  FLTQLYCC-----FQTPDRLFFVMEFVNGGDL---MFHI-QKSRRFDEA------RARFY 101

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           A ++   L +LH      I + DLK  N+LLD E    ++DFG+ +  E       +   
Sbjct: 102 AAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTF 156

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLNLRNCVK 437
            GT  YIAPE           D ++ G+LL EM  G  P      DD+F+  LN      
Sbjct: 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 216

Query: 438 SALPERAEEI 447
           + L + A +I
Sbjct: 217 TWLSQDAVDI 226

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 34/219 (15%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS----KSFAVECEVTRNIRHRNLVKVF 268
           +GAGN GSV K     + T +A KV   +H  A     K    E ++    R   +V  +
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKV---VHIGAKSSVRKQILRELQIMHECRSPYIVSFY 69

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMH---PITEEDKRHKAPGNLNSLKRLNIAID 325
            A     F   +   +  EFM  GSL+       PI  E                 IA+ 
Sbjct: 70  GA-----FLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK-------------IAVA 111

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           V   L YL+   +  I H D+KPSNIL++      + DFG++  L  +   T      GT
Sbjct: 112 VVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT----FVGT 165

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD 424
           + Y++PE   G + +   DV+S GI ++E+  G  P   
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 20/209 (9%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT-----RNIRHRNLVKV 267
           IG G +G+VYK     S   VA+K   V  ++     +   EV          H N+V++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C+           LV+E + +  L  ++  +         PG L +    ++     
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKV-------PPPG-LPAETIKDLMRQFL 118

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             L +LH +C   I H DLKP NIL+       ++DFG+AR       Q     V  T  
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLW 172

Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMF 416
           Y APE  +    ++  D++S G +  EMF
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 34/234 (14%)

Query: 207 FSSENLI-----GAGNFGSVYKGILF-------ESTTAVAVKVFNVLHHDAS-KSFA--- 250
           F  + L+     G G FG V +   +       + T  VAVK+   L  +A+ K  A   
Sbjct: 9   FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM---LKDNATDKDLADLI 65

Query: 251 VECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH---PITEEDK 306
            E E+ + I +H+N++ +   C+    Q      +V E+ A G+L E++    P   +  
Sbjct: 66  SEMELMKLIGKHKNIINLLGVCT----QEGPLYVIV-EYAAKGNLREFLRARRPPGPDYT 120

Query: 307 RH--KAPGNLNSLKRL-NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD 363
               K P    S K L + A  VA  ++YL         H DL   N+L+ ++    ++D
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIAD 177

Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
           FG+AR +   D   ++        ++APE       +   DV+SFGIL+ E+FT
Sbjct: 178 FGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 40/218 (18%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVK----VFNVLHHDASKSFAVECEVTRNIRHRNLVKV- 267
           IG+G +G V   I   S   VA+K     F+V    A ++   E ++ R+ +H N++ + 
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLR-ELKILRHFKHDNIIAIR 70

Query: 268 --FTACSGVDFQGNDFKA--LVYEFMANGSLEEWMH---PITEEDKRHKAPGNLNSLKRL 320
                       G DFK   +V + M +  L   +H   P+TEE  R+     L  L R 
Sbjct: 71  DILRP------PGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRY----FLYQLLR- 118

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
                    LKY+H      + H DLKPSN+L++++    + DFG+AR L ++  + +  
Sbjct: 119 --------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF 167

Query: 381 GVE--GTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEM 415
             E   T  Y APE  +   E ++  D++S G +  EM
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 46/146 (31%), Positives = 65/146 (44%), Gaps = 14/146 (9%)

Query: 276 FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHL 335
           ++  D   LV   M  G L+  ++        H         + +  A ++ C L+ LH 
Sbjct: 69  YETKDALCLVLTLMNGGDLKFHIY--------HMGEAGFEEGRAVFYAAEICCGLEDLH- 119

Query: 336 DCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM 395
             Q  I + DLKP NILLDD     +SD G+A  +   + QT   G  GT GY+APE   
Sbjct: 120 --QERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIK-GRVGTVGYMAPEVVK 174

Query: 396 GHEVSSYGDVYSFGILLLEMFTGLRP 421
               +   D ++ G LL EM  G  P
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 31/237 (13%)

Query: 213 IGAGNFGSVYK----GILFEST---TAVAVKVFNVLHHDASKSFAV-ECEVTRNI-RHRN 263
           +G G FG V      GI  +       VAVK+      D   S  V E E+ + I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRH-----KAPGNLNSLK 318
           ++ +  AC+    Q      LV E+ + G+L E++         +     K P    + K
Sbjct: 80  IINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 319 RL-NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT 377
            L + A  VA  ++YL         H DL   N+L+ ++    ++DFG+AR +   D   
Sbjct: 135 DLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191

Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-------GLRPSDDMFK 427
           ++        ++APE       +   DV+SFG+LL E+FT       G+ P +++FK
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFK 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 24/214 (11%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVT-RNIRHRNLVKV 267
           +IG G+FG V         +  AVKV     +L          E  V  +N++H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
             +     FQ  +    V +++  G L  + H   + ++    P      +    A +VA
Sbjct: 62  HYS-----FQTAEKLYFVLDYVNGGEL--FFH--LQRERCFLEP------RARFYAAEVA 106

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YLH      I + DLKP NILLD +    ++DFG+ +  E  + +  +    GT  
Sbjct: 107 SAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPE 161

Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           Y+APE           D +  G +L EM  GL P
Sbjct: 162 YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 62.6 bits (152), Expect = 3e-10
 Identities = 41/108 (37%), Positives = 57/108 (52%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DLS+N+LSG +   ++ L +L I ++  N  +G I     S   L+ L +  N F+G I 
Sbjct: 290 DLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP 349

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
            +L     L VLDLS NNL+ EIPE L     L  L L  N+ E  +P
Sbjct: 350 KNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397

Length = 968

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 60/213 (28%), Positives = 88/213 (41%), Gaps = 24/213 (11%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEV-TRNIRHRNLVKVF 268
           IG G+FG V            AVKV     +L     K    E  V  +N++H  LV + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
            +     FQ  D    V +++  G L  + H   + ++    P      +    A ++A 
Sbjct: 63  YS-----FQTADKLYFVLDYVNGGEL--FFH--LQRERSFPEP------RARFYAAEIAS 107

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L YLH      I + DLKP NILLD +    ++DFG+ +      + T +    GT  Y
Sbjct: 108 ALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC--GTPEY 162

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           +APE           D +  G +L EM  GL P
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 36/214 (16%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG VYK    E+    A KV      +  + + VE E+     H  +VK+  A  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA-- 77

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC---- 328
              F  +    ++ EF   G+++  M    E D+    P            I V C    
Sbjct: 78  ---FYWDGKLWIMIEFCPGGAVDAIM---LELDRGLTEP-----------QIQVICRQML 120

Query: 329 -VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI-ARFLEAADEQTRSIGVEGTT 386
             L+YLH      I H DLK  N+LL  +    ++DFG+ A+ ++    +   I   GT 
Sbjct: 121 EALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI---GTP 174

Query: 387 GYIAPEYGMGHEV--SSY---GDVYSFGILLLEM 415
            ++APE  M   +  + Y    D++S GI L+EM
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 54/223 (24%), Positives = 101/223 (45%), Gaps = 24/223 (10%)

Query: 207 FSSENLIGAGNFGSVYKGILFES----TTAVAVKVF-NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+           VA+K         A+K    E  V  ++ +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 69  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHKD--NIGSQYLLN 113

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL    +  + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 114 WCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170

Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 60.2 bits (146), Expect = 4e-10
 Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 29/225 (12%)

Query: 211 NLIGAGNFGSVYKGILFEST---TAVAVKVFN-VLHHDASKSFAVECEVTRNIRHRNLVK 266
            +IG G+FG VY G L +S       AVK  N +   +  + F  E  + ++  H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL-NIAID 325
           +   C  +  +G+    +V  +M +G L  ++          ++  +  ++K L    + 
Sbjct: 61  LLGIC--LPSEGSPL--VVLPYMKHGDLRNFI----------RSETHNPTVKDLIGFGLQ 106

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI----G 381
           VA  ++YL         H DL   N +LD+  T  V+DFG+AR  +  D++  S+    G
Sbjct: 107 VAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHNHTG 161

Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 34/85 (40%), Positives = 44/85 (51%), Gaps = 7/85 (8%)

Query: 341 IAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE-YGMGHEV 399
           + H D+KPSNILLD      + DFGI+  L  +  +TRS    G   Y+APE        
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS---AGCAAYMAPERIDPPDPN 192

Query: 400 SSY---GDVYSFGILLLEMFTGLRP 421
             Y    DV+S GI L+E+ TG  P
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 39/234 (16%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVT-RNI-----RHR 262
           ++G G+FG V    L  +    AVKV     +L  D      VEC +T + +     +H 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD-----VECTMTEKRVLALAGKHP 56

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
            L ++  +C    FQ  D    V E++  G L   M  I +   R   P      +    
Sbjct: 57  FLTQLH-SC----FQTKDRLFFVMEYVNGGDL---MFHI-QRSGRFDEP------RARFY 101

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           A ++   L++LH   +  I + DLK  N+LLD E    ++DFG+ +        T +   
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC- 157

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLN 431
            GT  YIAPE           D ++ G+LL EM  G  P      D++F+  L 
Sbjct: 158 -GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 25/222 (11%)

Query: 210 ENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLV 265
           E ++G G FG + +G L    +    VA+        D  +  F  E        H N+V
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           ++     GV  +GN    +V E+M+NG+L+ ++       ++H+  G L + + + +   
Sbjct: 70  RL----EGVITRGNTM-MIVTEYMSNGALDSFL-------RKHE--GQLVAGQLMGMLPG 115

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS-IGVEG 384
           +A  +KYL    +    H  L    +L++ ++   +S F   R  E   E   + +  + 
Sbjct: 116 LASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKS 170

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLE-MFTGLRPSDDM 425
              + APE    H  SS  DV+SFGI++ E M  G RP  DM
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 60.1 bits (145), Expect = 4e-10
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 33/223 (14%)

Query: 211 NLIGAGNFGSVYKGILFESTTAV--AVKVFN-VLHHDASKSFAVECEVTRNI-RHRNLVK 266
           ++IG GNFG V K  + +    +  A+K        D  + FA E EV   +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHP--ITEED----KRHKAPGNLNSLKRL 320
           +  AC     +   +  L  E+  +G+L +++    + E D      +     L+S + L
Sbjct: 61  LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
           + A DVA  + YL    Q    H DL   NIL+ +   A ++DFG++R  E        +
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE--------V 164

Query: 381 GVEGTTGYIAPEYGMGHEVSSY------GDVYSFGILLLEMFT 417
            V+ T G + P   M  E  +Y       DV+S+G+LL E+ +
Sbjct: 165 YVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 31/220 (14%)

Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNIRHRNL 264
           +G G+FG V    Y      +   VAVK    L  +  +     +  E  + + + H N+
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKT---LKRECGQQNTSGWKKEINILKTLYHENI 68

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK    CS    QG     L+ E++  GSL +++            P +  +L +L +  
Sbjct: 69  VKYKGCCSE---QGGKGLQLIMEYVPLGSLRDYL------------PKHKLNLAQLLLFA 113

Query: 325 DVACV-LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR-SIGV 382
              C  + YLH   Q  I H DL   N+LLD++    + DFG+A+ +    E  R     
Sbjct: 114 QQICEGMAYLH--SQHYI-HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 170

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
           +    + A E    ++ S   DV+SFG+ L E+ T     
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK 210

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 60.0 bits (146), Expect = 6e-10
 Identities = 57/239 (23%), Positives = 93/239 (38%), Gaps = 59/239 (24%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV----ECEVTRNIRHRNLVK-- 266
           +G G FG VYK    ++   VA+K   +L H+    F +    E ++ + ++H N+V   
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALK--KILMHNEKDGFPITALREIKILKKLKHPNVVPLI 73

Query: 267 --VFTACSGVDFQGNDFKALVYEFMA---NGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
                       +      +V  +M    +G LE                   N   +L 
Sbjct: 74  DMAVERPDKSKRKRGSV-YMVTPYMDHDLSGLLE-------------------NPSVKLT 113

Query: 322 IAIDVACVLK-------YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD 374
            +  + C +        YLH   +  I H D+K +NIL+D++    ++DFG+AR  +   
Sbjct: 114 ES-QIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169

Query: 375 EQTRSIGVEGTTGYI---------APEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
              +  G  GT  Y           PE  +G     Y    D++  G +  EMFT  RP
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER--RYTTAVDIWGIGCVFAEMFTR-RP 225

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 24/218 (11%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKV-FNVLHHD----ASKSFAVECEVTRNIRHRNLVK 266
           ++G+G FG+VYKGI       V + V   VL  +    A+K    E  V   +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +   C     Q      LV + M  G L +++       + +K    + S   LN  + +
Sbjct: 74  LLGICLTSTVQ------LVTQLMPYGCLLDYV-------RENK--DRIGSQDLLNWCVQI 118

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
           A  + YL    +  + H DL   N+L+       ++DFG+AR L+  + +  + G +   
Sbjct: 119 AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 175

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 59.7 bits (144), Expect = 7e-10
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 28/218 (12%)

Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASK----SFAVECEVTRNIRHRN 263
           +G G+FG VY+GI       E  T VA+K  N     AS      F  E  V +     +
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 70

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPI--TEEDKRHKAPGNLNSLKRLN 321
           +V++     GV  QG     ++ E M  G L+ ++  +    E+   +AP +L   K + 
Sbjct: 71  VVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK--KMIQ 123

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           +A ++A  + YL+ +      H DL   N ++ ++ T  + DFG+ R +   D   +  G
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--G 178

Query: 382 VEG--TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            +G     +++PE       ++Y DV+SFG++L E+ T
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 60/221 (27%), Positives = 91/221 (41%), Gaps = 26/221 (11%)

Query: 206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIRHRN 263
            F     +G G++GSVYK          A+K  ++       +  AV E  +  ++ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL-NI 322
           ++    A     F   +   +V E+   G L + +        + K    L   + +  I
Sbjct: 61  IISYKEA-----FLDGNKLCIVMEYAPFGDLSKAI-------SKRKKKRKLIPEQEIWRI 108

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE--AADEQTRSI 380
            I +   L+ LH   +  I H DLK +NILL       + D GI++ L+   A  Q    
Sbjct: 109 FIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--- 162

Query: 381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
              GT  Y+APE   G   S   D++S G LL EM T   P
Sbjct: 163 ---GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 69/300 (23%), Positives = 120/300 (40%), Gaps = 40/300 (13%)

Query: 207 FSSENLIGAGNFGSVYKGILFE---STTAVAVKVF--NVLHHDASKSFAVECEVTRNIRH 261
           F+   ++G G FGSV +  L     S   VAVK+   ++      + F  E    +   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 262 RNLVKVFTACSGVDFQGNDFKAL-----VYEFMANGSLEEW--MHPITEEDKRHKAPGNL 314
            N++K+     GV  +      L     +  FM +G L  +  M  I EE      P  L
Sbjct: 61  PNVIKLI----GVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEE------PFTL 110

Query: 315 NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD 374
                +   ID+A  ++YL         H DL   N +L++ MT  V+DFG+++ + + D
Sbjct: 111 PLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167

Query: 375 EQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN 434
              +    +    ++A E    +  +++ DV++FG+ + E+ T               R 
Sbjct: 168 YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT---------------RG 212

Query: 435 CVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI 494
               A  E +E         +     +CL  + E+   C + +P  R     +  +L LI
Sbjct: 213 QTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 61.0 bits (148), Expect = 9e-10
 Identities = 37/108 (34%), Positives = 53/108 (49%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DLS NNL+G +   L    +L    +  N L G I  + G+C SL ++ +  N F+G + 
Sbjct: 362 DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
           S  + L  +  LD+S NNL   I         LQ L+L+ N F   LP
Sbjct: 422 SEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP 469

Length = 968

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 51/217 (23%), Positives = 98/217 (45%), Gaps = 36/217 (16%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVKVFTAC 271
           +G G + +VYKG    +   VA+K  ++   + + S A+ E  + + ++H N+V++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV- 66

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
                   +   LV+E+M +  L+++M     +    +   + N++K          +LK
Sbjct: 67  ----IHTENKLMLVFEYM-DKDLKKYM-----DTHGVRGALDPNTVKSF-----TYQLLK 111

Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT----- 386
            +    +  + H DLKP N+L++      ++DFG+A          R+ G+   T     
Sbjct: 112 GIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLA----------RAFGIPVNTFSNEV 161

Query: 387 ---GYIAPEYGMGHEVSSYG-DVYSFGILLLEMFTGL 419
               Y AP+  +G    S   D++S G ++ EM TG 
Sbjct: 162 VTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 22/216 (10%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKV--FNVLHHDASKSF-AVECEVT--RNIRHRNLVK 266
           L+G G FG VY     ++   +A K   F+    + SK   A+ECE+   +N++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
            +        +      +  E+M  GS+++ +          KA G L           +
Sbjct: 69  YYGCLRD---RAEKTLTIFMEYMPGGSVKDQL----------KAYGALTESVTRKYTRQI 115

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-GVEGT 385
              + YLH +    I H D+K +NIL D      + DFG ++ L+        I  V GT
Sbjct: 116 LEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             +++PE   G       DV+S G  ++EM T   P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 24/235 (10%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVK---VFNVLHHDASKSFAVECEVTRNIRHRN 263
           F  E  IG G F  VY+         VA+K   +F+++   A      E ++ + + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL-NI 322
           ++K + +     F  ++   +V E    G L   +       K  K    L   K +   
Sbjct: 64  VIKYYAS-----FIEDNELNIVLELADAGDLSRMI-------KHFKKQKRLIPEKTVWKY 111

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
            + +   L+++H      + H D+KP+N+ +       + D G+ RF  +      S+  
Sbjct: 112 FVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-- 166

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK 437
            GT  Y++PE    +  +   D++S G LL EM     P    + D +NL +  K
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCK 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 52/195 (26%), Positives = 95/195 (48%), Gaps = 25/195 (12%)

Query: 233 VAVKVFNVLHHDASKS----FAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEF 288
           VAVK+   L  D +K+    F  E ++   +++ N++++   C       +D   ++ E+
Sbjct: 47  VAVKM---LRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS-----DDPLCMITEY 98

Query: 289 MANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI---AIDVACVLKYLHLDCQPPIAHCD 345
           M NG L +++     E     A  N+ S+   N+   A+ +A  +KYL         H D
Sbjct: 99  MENGDLNQFLSQREIESTFTHA-NNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRD 154

Query: 346 LKPSNILLDDEMTAYVSDFGIARFLEAADE---QTRSIGVEGTTGYIAPEYGMGHEVSSY 402
           L   N L+ +  T  ++DFG++R L + D    Q R++       ++A E  +  + ++ 
Sbjct: 155 LATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAV---LPIRWMAWESILLGKFTTA 211

Query: 403 GDVYSFGILLLEMFT 417
            DV++FG+ L EMFT
Sbjct: 212 SDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 65/240 (27%), Positives = 94/240 (39%), Gaps = 31/240 (12%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +IG G+FG V            AVKV     VL+    K    E    RN+  +N+   F
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAE----RNVLLKNVKHPF 57

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                  FQ  +    V +F+  G L  + H   + ++    P       R   A ++A 
Sbjct: 58  LVGLHYSFQTTEKLYFVLDFVNGGEL--FFH--LQRERSFPEP-----RARFYAA-EIAS 107

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L YLH      I + DLKP NILLD +    ++DFG+ +  E   +   +    GT  Y
Sbjct: 108 ALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEY 162

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP---------SDDMFKDNLNLRNCVKSA 439
           +APE        +  D +  G +L EM  GL P          D++    L LR      
Sbjct: 163 LAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLT 222

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)

Query: 204 TKGFSSENLIGAGNFGSVYKGILFESTTAVA---VKVFNVLHHDASKSFAVECEVTRNIR 260
              F  E  IG G F  VYK I       VA   V++F ++   A +    E ++ + + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N++K   +     F  N+   +V E    G L   +       K  K    L   + +
Sbjct: 61  HPNVIKYLAS-----FIENNELNIVLELADAGDLSRMI-------KHFKKQKRLIPERTI 108

Query: 321 -NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
               + +   L+++H      I H D+KP+N+ +       + D G+ RF   + + T +
Sbjct: 109 WKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAA 163

Query: 380 IGVEGTTGYIAPE--YGMGHEVSSYGDVYSFGILLLEM 415
             + GT  Y++PE  +  G+   S  D++S G LL EM
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKS--DIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 47/226 (20%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G FG VY+    ++    A+KV       + K    + EV   I  RN++      +
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNIL----VRT 50

Query: 273 GVD-----------FQGNDFKALVYEFMANGSLEEWMHPITE---EDKRHKAPGNLNSLK 318
            +D           FQ +    LV ++M+ G L  + H   E    + R           
Sbjct: 51  LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDR----------A 98

Query: 319 RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
           +  IA ++   L++LH   +  I + DLKP NILLD      + DFG+++     ++ T 
Sbjct: 99  KFYIA-ELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154

Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
           +    GTT Y+APE  +  +   Y    D +S G+L+ EM  G  P
Sbjct: 155 TFC--GTTEYLAPEVLL--DEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 67/250 (26%), Positives = 95/250 (38%), Gaps = 66/250 (26%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKV---FNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           L+G G+ G V+   L  +    A+KV     ++  +  K    E E+   + H  L  ++
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI------ 322
                  FQ   +  LV ++   G L              + PG     K L+       
Sbjct: 68  A-----SFQTETYLCLVMDYCPGGELF---------RLLQRQPG-----KCLSEEVARFY 108

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA--------------- 367
           A +V   L+YLHL     I + DLKP NILL +     +SDF ++               
Sbjct: 109 AAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165

Query: 368 --------------RFLEAADEQTRSIGVEGTTGYIAPEY--GMGHEVSSYGDVYSFGIL 411
                          F E    ++ S  V GT  YIAPE   G GH   S  D ++ GIL
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSF-V-GTEEYIAPEVISGDGH--GSAVDWWTLGIL 221

Query: 412 LLEMFTGLRP 421
           L EM  G  P
Sbjct: 222 LYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 24/223 (10%)

Query: 202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRH 261
           +  K +   N+IG G+FG VY+ I  +++  VA+K   VL     K+   E  + +N+ H
Sbjct: 63  SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQYKN--RELLIMKNLNH 118

Query: 262 RNLVKV----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            N++ +    +T C   + + N F  +V EF+   ++ ++M      +  H  P  L  L
Sbjct: 119 INIIFLKDYYYTECFKKN-EKNIFLNVVMEFIPQ-TVHKYMKHYARNN--HALPLFLVKL 174

Query: 318 KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQ 376
                +  +   L Y+H      I H DLKP N+L+D +  T  + DFG A+ L A    
Sbjct: 175 ----YSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-- 225

Query: 377 TRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
            RS+    +  Y APE  +G    +++ D++S G ++ EM  G
Sbjct: 226 -RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 27/213 (12%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVKVFTAC 271
           +G G + +V+KG    +   VA+K   + H + +   A+ E  + +N++H N+V +    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH--- 69

Query: 272 SGVDFQGNDFK-ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
              D    +    LV+E++ +  L++++             GNL S+   N+ I +  +L
Sbjct: 70  ---DIIHTERCLTLVFEYLDS-DLKQYLDNC----------GNLMSMH--NVKIFMFQLL 113

Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT-GYI 389
           + L    +  I H DLKP N+L++++    ++DFG+AR   A    T++   E  T  Y 
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYR 170

Query: 390 APEYGMGH-EVSSYGDVYSFGILLLEMFTGLRP 421
            P+  +G  E S+  D++  G +L EM TG RP
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATG-RP 202

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 42/134 (31%), Positives = 68/134 (50%), Gaps = 19/134 (14%)

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           IA+ +   L+YLH   +  + H D+KPSN+L++      + DFGI+ +L  +  +T   G
Sbjct: 108 IAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAG 165

Query: 382 VEGTTGYIAPEY------GMGHEVSSYGDVYSFGILLLEMFTGLRPSD---DMFKDNLNL 432
            +    Y+APE         G++V S  DV+S GI ++E+ TG  P D     F+    L
Sbjct: 166 CK---PYMAPERINPELNQKGYDVKS--DVWSLGITMIELATGRFPYDSWKTPFQ---QL 217

Query: 433 RNCVKSALPERAEE 446
           +  V+   P+   E
Sbjct: 218 KQVVEEPSPQLPAE 231

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 64/234 (27%), Positives = 95/234 (40%), Gaps = 39/234 (16%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVT-RNI-----RHR 262
           ++G G+FG V    L  +    A+KV     +L  D      V+C +T + I     +H 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDD-----VDCTMTEKRILALAAKHP 56

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
            L  +        FQ  D    V E++  G L   M  I    K  +             
Sbjct: 57  FLTALHCC-----FQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRF-------Y 101

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           A +V   L +LH   +  + + DLK  NILLD E    ++DFG+ +  E       +   
Sbjct: 102 AAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTF 156

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLN 431
            GT  YIAPE     E     D ++ G+L+ EM  G  P      DD+F+  L+
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 35/220 (15%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV----ECEVTRNIRHRNLVKVF 268
           IG G FG V+K    ++   VA+K   VL  +  + F +    E ++ + ++H N+V + 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 269 TACSGVDFQGNDFKA---LVYEFMAN---GSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
             C       N +K    LV+EF  +   G L       T  + +      LN L     
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLY---- 133

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR--FLEAADEQTRSI 380
                    Y+H +    I H D+K +NIL+  +    ++DFG+AR   L    +  R  
Sbjct: 134 ---------YIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 381 GVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFT 417
               T  Y  PE  +G     YG   D++  G ++ EM+T
Sbjct: 182 NRVVTLWYRPPELLLGER--DYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 21/220 (9%)

Query: 202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRH 261
           +  K ++    IG G  G+VY  I   +   VA+K  N+      +    E  V R  +H
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKH 75

Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            N+V    +     +   D   +V E++A GSL + +     ++      G + ++ R  
Sbjct: 76  PNIVNYLDS-----YLVGDELWVVMEYLAGGSLTDVVTETCMDE------GQIAAVCR-- 122

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
              +    L++LH +    + H D+K  NILL  + +  ++DFG     +   EQ++   
Sbjct: 123 ---ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRST 174

Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  ++APE           D++S GI+ +EM  G  P
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 56/236 (23%), Positives = 95/236 (40%), Gaps = 36/236 (15%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVK---VFNVLHHDASKSFAVECEVTRNIRHRN 263
           F  E  IG G F  VY+         VA+K   +F ++   A +    E ++ + + H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++K   +     F  ++   +V E    G L + +    ++             KRL   
Sbjct: 64  VIKYLDS-----FIEDNELNIVLELADAGDLSQMIKYFKKQ-------------KRL--- 102

Query: 324 IDVACVLKYLHLDCQP-------PIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
           I    V KY    C          + H D+KP+N+ +       + D G+ RF  +  + 
Sbjct: 103 IPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KT 160

Query: 377 TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 432
           T +  + GT  Y++PE    +  +   D++S G LL EM     P    + D +NL
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 68/233 (29%), Positives = 104/233 (44%), Gaps = 60/233 (25%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVK-VFNVLHH--DASKSFAVECEVT--RNIR-HRNLVK 266
           +G G +G V+K I   +   VA+K +F+   +  DA ++F    E+   + +  H N+VK
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR---EIMFLQELGDHPNIVK 71

Query: 267 ---VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
              V  A +  D        LV+E+M             E D        L+++ R NI 
Sbjct: 72  LLNVIKAENDKDIY------LVFEYM-------------ETD--------LHAVIRANIL 104

Query: 324 IDV-----------ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR-FLE 371
            DV           A  LKY+H      + H DLKPSNILL+ +    ++DFG+AR   E
Sbjct: 105 EDVHKRYIMYQLLKA--LKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159

Query: 372 AADEQTRSIGVE--GTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRP 421
             +     +  +   T  Y APE  +G    +   D++S G +L EM  G +P
Sbjct: 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KP 211

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 57.6 bits (140), Expect = 3e-09
 Identities = 56/224 (25%), Positives = 89/224 (39%), Gaps = 37/224 (16%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV--ECEVTRNIR---HRNLV 265
             IG G +G+VYK     +   VA+K   V   +     +   E  + + +    H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEED-----KRHKAPGNLNSLKRL 320
           ++   C G          LV+E +             ++D      +   PG L      
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-------------DQDLATYLSKCPKPG-LPPETIK 110

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
           ++   +   + +LH      I H DLKP NIL+  +    ++DFG+AR       +    
Sbjct: 111 DLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALT 164

Query: 381 GVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
            V  T  Y APE  +    SSY    D++S G +  E+F   RP
Sbjct: 165 SVVVTLWYRAPEVLLQ---SSYATPVDMWSVGCIFAELFR-RRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 16/147 (10%)

Query: 276 FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHL 335
           ++  D   LV   M  G L+  ++        +      +  + +  A ++ C L+ LH 
Sbjct: 69  YETKDALCLVLTLMNGGDLKFHIY--------NMGNPGFDEERAVFYAAEITCGLEDLH- 119

Query: 336 DCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM 395
             +  I + DLKP NILLDD     +SD G+A  +E  + +T   G  GT GY+APE  +
Sbjct: 120 --RERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIR-GRVGTVGYMAPEV-V 173

Query: 396 GHEVSSYG-DVYSFGILLLEMFTGLRP 421
            +E  ++  D +  G L+ EM  G  P
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 55/180 (30%), Positives = 76/180 (42%), Gaps = 14/180 (7%)

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
           A ++ C L+ LH   +    + DLKP NILLDD     +SD G+A  +   +    SI G
Sbjct: 108 AAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRG 160

Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP 441
             GT GY+APE       +   D +  G L+ EM  G  P     K+ +  R  V   + 
Sbjct: 161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR-KEKVK-REEVDRRVL 218

Query: 442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEA 501
           E  E   A      +SI    L    +  + C  E  GE  +     P  R +  K LEA
Sbjct: 219 ETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR----HPFFRNMNFKRLEA 274

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 55/235 (23%), Positives = 101/235 (42%), Gaps = 27/235 (11%)

Query: 213 IGAGNFGSVYK----GILFESTTAVAVKVFNVLHHDASKS----FAVECEVTRNI-RHRN 263
           +G G FG V      GI  +           +L  DA++        E E+ + I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++ +  AC+    Q      +V E+ + G+L E++         +         +++   
Sbjct: 83  IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 324 IDVACVLKYL----HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             V+C  +      +L  Q  I H DL   N+L+ +     ++DFG+AR +   D   ++
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196

Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-------GLRPSDDMFK 427
                   ++APE       +   DV+SFG+L+ E+FT       G+ P +++FK
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)

Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRNLV 265
           +G G+FG V    YK    E    VA+K F    ++          E ++   I H   V
Sbjct: 38  LGTGSFGRVILATYKN---EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV 94

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
            ++ +     F+   +  LV EF+  G    ++       +  + P ++        A  
Sbjct: 95  NLYGS-----FKDESYLYLVLEFVIGGEFFTFLR------RNKRFPNDVGCF----YAAQ 139

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +  + +YL       I + DLKP N+LLD +    ++DFG A+ ++     TR+  + GT
Sbjct: 140 IVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-----TRTYTLCGT 191

Query: 386 TGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             YIAPE    +GH      D ++ GI + E+  G  P
Sbjct: 192 PEYIAPEILLNVGH--GKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 34/222 (15%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           F     +G G+FG V       +    A+K      +L     +  A E  +   + H  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           +V +   CS   FQ  +    + EF+  G L       T   K  + P   N + +   A
Sbjct: 80  IVNMM--CS---FQDENRVYFLLEFVVGGEL------FTHLRKAGRFP---NDVAKFYHA 125

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++    +YLH      I + DLKP N+LLD++    V+DFG A+ +       R+  + 
Sbjct: 126 -ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-----PDRTFTLC 176

Query: 384 GTTGYIAPEY----GMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y+APE     G G  V    D ++ G+LL E   G  P
Sbjct: 177 GTPEYLAPEVIQSKGHGKAV----DWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 67/224 (29%), Positives = 95/224 (42%), Gaps = 45/224 (20%)

Query: 213 IGAGNFGSVYKGILFESTTA---VAVKVF---NVLHHDASKSFAVE---CEVTRNIRHRN 263
           +G G+FG V   +L E        A+K     +++  D  +S   E    E   + RH  
Sbjct: 7   LGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           LV +F AC    FQ  D    V E+ A G L   M  I  +         + S  R    
Sbjct: 64  LVNLF-AC----FQTEDHVCFVMEYAAGGDL---MMHIHTD---------VFSEPRAVFY 106

Query: 324 IDVACV---LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
              ACV   L+YLH   +  I + DLK  N+LLD E    ++DFG+ +  E      R+ 
Sbjct: 107 --AACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTS 159

Query: 381 GVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
              GT  ++APE       +SY    D +  G+L+ EM  G  P
Sbjct: 160 TFCGTPEFLAPEVLTE---TSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 57.0 bits (137), Expect = 6e-09
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 12/210 (5%)

Query: 213 IGAGNFGSVYKGILF--ESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G G FGSV +G L   +S   VAVK   +        + F  E    +   H N++++ 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 269 TAC-SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
             C   V+ +G     ++  FM +G L    H      +    P  L +   +    D+A
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDL----HSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             ++YL         H DL   N +L++ M   V+DFG+++ +   D   +    +    
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
           +IA E       ++  DV+SFG+ + E+ T
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 38/103 (36%), Positives = 55/103 (53%), Gaps = 15/103 (14%)

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR-FLEAADEQTRSIGVE 383
           ++   L++LH   +  I + D+K  NILLD E    ++DFG+++ FL    E+T S    
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-- 167

Query: 384 GTTGYIAPEY-----GMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y+APE      G G  V    D +S GIL+ E+ TG  P
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAV----DWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)

Query: 202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV---ECEVTRN 258
           N  + F     IG+G +G VYK     +    A+KV  +   +  + FAV   E  + ++
Sbjct: 6   NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL---EPGEDFAVVQQEIIMMKD 62

Query: 259 IRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLK 318
            +H N+V  F +     +   D   +  EF   GSL++  H            G L+  +
Sbjct: 63  CKHSNIVAYFGS-----YLRRDKLWICMEFCGGGSLQDIYH----------VTGPLSESQ 107

Query: 319 RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
              ++ +    L YLH   +    H D+K +NILL D     ++DFG++  + A   + +
Sbjct: 108 IAYVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164

Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEM 415
           S    GT  ++APE         Y    D+++ GI  +E+
Sbjct: 165 SF--IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 8e-09
 Identities = 59/249 (23%), Positives = 91/249 (36%), Gaps = 66/249 (26%)

Query: 212 LIGAGNFGSVYKGILFESTTA--VAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           +IG G FG V+  ++ +  T    A+KV         KS  ++     ++R    +    
Sbjct: 8   VIGRGAFGEVW--LVRDKDTGQVYAMKV-------LRKSDMIKRNQIAHVRAERDILADA 58

Query: 270 ACSGV-----DFQGNDFKALVYEFMANGSLEEWM--HPITEEDKRHKAPGNLNSLKRLNI 322
               +      FQ  +   LV E+M  G L   +    +  E+             R  I
Sbjct: 59  DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-----------TARFYI 107

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA-RFLEAADEQTRSIG 381
           A ++   L  +H      I H D+KP NIL+D +    ++DFG+  +  +A D +     
Sbjct: 108 A-ELVLALDSVHK--LGFI-HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLND 163

Query: 382 --------------------------VEGTTGYIAPEYGMGHEVSSYG---DVYSFGILL 412
                                       GT  YIAPE   G     YG   D +S G++L
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP---YGLECDWWSLGVIL 220

Query: 413 LEMFTGLRP 421
            EM  G  P
Sbjct: 221 YEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 23/206 (11%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G+G +G VYK     +    AVK+  +   D       E  + +  +H N+V  F +  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS-- 74

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
              +   +   +  E+   GSL++  H            G L+ L+   +  +    L Y
Sbjct: 75  ---YLSREKLWICMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRETLQGLAY 121

Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           LH   +    H D+K +NILL D     ++DFG+A  + A   + +S    GT  ++APE
Sbjct: 122 LHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF--IGTPYWMAPE 176

Query: 393 YGMGHEVSSYG---DVYSFGILLLEM 415
                +   Y    D+++ GI  +E+
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 23/219 (10%)

Query: 202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIR 260
            AT   + E L G G++ +VYKGI   +   VA+KV ++   +     A+ E  + + ++
Sbjct: 3   AATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK 61

Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+V +            +    V+E+M +  L ++M        +H  PG L+     
Sbjct: 62  HANIVLLHDI-----IHTKETLTFVFEYM-HTDLAQYM-------IQH--PGGLHPYNVR 106

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
                +   L Y+H      I H DLKP N+L+       ++DFG+AR  ++   QT S 
Sbjct: 107 LFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSS 162

Query: 381 GVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
            V  T  Y  P+  +G  + SS  D++  G + +EM  G
Sbjct: 163 EVV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 22/216 (10%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKV--FNVLHHDASKSF-AVECEVT--RNIRHRNLVK 266
           L+G G FG VY     ++   +AVK   F+    + SK   A+ECE+   +N+RH  +V+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
            +      D +       V E+M  GS+++ +          KA G L           +
Sbjct: 69  YYGCLR--DPEEKKLSIFV-EYMPGGSIKDQL----------KAYGALTENVTRRYTRQI 115

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-GVEGT 385
              + YLH +    I H D+K +NIL D      + DFG ++ ++        I  V GT
Sbjct: 116 LQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             +++PE   G       DV+S    ++EM T   P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 64/240 (26%), Positives = 104/240 (43%), Gaps = 41/240 (17%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G+ G V    +  S   VAVK  ++      +    E  + R+ +H N+V+++ +  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 85

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWM-HPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
              +   D   +V EF+  G+L + + H    E++               IA     VLK
Sbjct: 86  ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ---------------IAAVCLAVLK 127

Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
            L +     + H D+K  +ILL  +    +SDFG     + + E  R   + GT  ++AP
Sbjct: 128 ALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAP 185

Query: 392 EY----GMGHEVSSYGDVYSFGILLLEMFTGLRP--------SDDMFKDNL--NLRNCVK 437
           E       G EV    D++S GI+++EM  G  P        +  M +DNL   L+N  K
Sbjct: 186 ELISRLPYGPEV----DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHK 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 33/220 (15%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G GN+GSVYK  +    T V + +  + L  D SK   +  E+  +I H+ +       
Sbjct: 9   LGKGNYGSVYK--VLHRPTGVTMAMKEIRLELDESKFNQIIMEL--DILHKAVSPYI--- 61

Query: 272 SGVDFQGNDF-KALVY---EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
             VDF G  F +  VY   E+M  GSL++        +   +     + L+R  I   V 
Sbjct: 62  --VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-----DVLRR--ITYAVV 112

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             LK+L  +    I H D+KP+N+L++      + DFG++  L A+  +T +IG +    
Sbjct: 113 KGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-NIGCQ---S 166

Query: 388 YIAPEY---GMGHEVSSY---GDVYSFGILLLEMFTGLRP 421
           Y+APE    G  ++  +Y    DV+S G+ +LEM  G  P
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 62/263 (23%), Positives = 110/263 (41%), Gaps = 29/263 (11%)

Query: 207 FSSENL-----IGAGNFGSVY----KGILFEST-TAVAVKVFNVLHHDASKS-FAVECEV 255
           F   NL     +G G FG V+    KGI  E   T V VK       +  +S F  E ++
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 256 TRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLN 315
            R + H+N+V++   C     +  +   ++ E+   G L++++   T+       P  L+
Sbjct: 62  FRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLR-ATKSKDEKLKPPPLS 115

Query: 316 SLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE 375
           + +++ +   +A  + +L         H DL   N L+  +    VS   +++      E
Sbjct: 116 TKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSE 171

Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP----SDDMFKDNL 430
             +         ++APE     + S+  DV+SFG+L+ E+FT G  P    SD+   + L
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231

Query: 431 ---NLRNCVKSALPERAEEIRAS 450
               L   V    P R  ++   
Sbjct: 232 QAGKLELPVPEGCPSRLYKLMTR 254

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 55.5 bits (133), Expect = 2e-08
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 21/217 (9%)

Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNL 264
           K ++    IG G  G+VY  I   +   VA+K  N+      +    E  V R  ++ N+
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           V    +     +   D   +V E++A GSL + +     ++      G + ++ R     
Sbjct: 79  VNYLDS-----YLVGDELWVVMEYLAGGSLTDVVTETCMDE------GQIAAVCR----- 122

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           +    L +LH +    + H D+K  NILL  + +  ++DFG     +   EQ++   + G
Sbjct: 123 ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVG 177

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           T  ++APE           D++S GI+ +EM  G  P
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 40/267 (14%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR------HRNLV 265
            +G G F S Y+    ++ T +AVK    + + +S+   V   + + IR      H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           +      G   + + F   V E+MA GS+   +             G       +N    
Sbjct: 67  R----MLGATCEDSHFNLFV-EWMAGGSVSHLLSKY----------GAFKEAVIINYTEQ 111

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDE-MTAYVSDFGIARFLEA----ADE-QTRS 379
           +   L YLH + Q  I H D+K +N+L+D       ++DFG A  L A    A E Q + 
Sbjct: 112 LLRGLSYLH-ENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168

Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP-SDDMFKDNLNLRNCVKS 438
           +G   T  ++APE   G +     DV+S G +++EM T   P + +   ++L L   + S
Sbjct: 169 LG---TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS 225

Query: 439 AL--PERAEEIRASSGSTQRSIILECL 463
           A   P   E +        R + L CL
Sbjct: 226 ATTAPSIPEHLSPGL----RDVTLRCL 248

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 28/218 (12%)

Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASK----SFAVECEVTRNIRHRN 263
           +G G+FG VY+G        E+ T VAVK  N     AS      F  E  V +     +
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN---ESASLRERIEFLNEASVMKGFTCHH 70

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPI--TEEDKRHKAPGNLNSLKRLN 321
           +V++     GV  +G     +V E MA+G L+ ++  +    E+   + P  L  +  + 
Sbjct: 71  VVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM--IQ 123

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           +A ++A  + YL+        H DL   N ++  + T  + DFG+ R +   D   +  G
Sbjct: 124 MAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK--G 178

Query: 382 VEG--TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            +G     ++APE       ++  D++SFG++L E+ +
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 66/233 (28%), Positives = 108/233 (46%), Gaps = 46/233 (19%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-ASKSFAV----ECEVTRNIRHRN---L 264
           +G+G +G+V   +   +   VA+K    L+    S+ FA     E  + ++++H N   L
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKK---LYRPFQSELFAKRAYRELRLLKHMKHENVIGL 79

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMAN--GSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           + VFT    +D + +DF  LV  FM    G L +    ++E+  +      L  LK    
Sbjct: 80  LDVFTPDLSLD-RFHDF-YLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLK---- 132

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
                    Y+H      I H DLKP N+ ++++    + DFG+AR  +   E T   G 
Sbjct: 133 ---------YIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMT---GY 175

Query: 383 EGTTGYIAPEYGMG--HEVSSYGDVYSFGILLLEMFTGLRPSDDMFK--DNLN 431
             T  Y APE  +   H   +  D++S G ++ EM TG +P   +FK  D+L+
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTV-DIWSVGCIMAEMLTG-KP---LFKGHDHLD 223

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 21/217 (9%)

Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNL 264
           K ++    IG G  G+VY  +   +   VA++  N+      +    E  V R  ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           V    +     +   D   +V E++A GSL + +     ++      G + ++ R     
Sbjct: 80  VNYLDS-----YLVGDELWVVMEYLAGGSLTDVVTETCMDE------GQIAAVCR----- 123

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           +    L++LH +    + H D+K  NILL  + +  ++DFG     +   EQ++   + G
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVG 178

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           T  ++APE           D++S GI+ +EM  G  P
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 69/233 (29%), Positives = 106/233 (45%), Gaps = 48/233 (20%)

Query: 210 ENL--IGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRHR 262
           +NL  IG+G  G V       +   VA+K       NV H  A +++  E  + + + H+
Sbjct: 19  QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH--AKRAYR-ELVLMKLVNHK 75

Query: 263 N---LVKVFTACSGVDFQGNDFKA--LVYEFM-ANGSLEEWMHPITEEDKRHKAPGNLNS 316
           N   L+ VFT    ++    +F+   LV E M AN      +  + + D  H+       
Sbjct: 76  NIIGLLNVFTPQKSLE----EFQDVYLVMELMDAN------LCQVIQMDLDHE------- 118

Query: 317 LKRLNIAI-DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE 375
             R++  +  + C +K+LH      I H DLKPSNI++  + T  + DFG+AR   A   
Sbjct: 119 --RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTS 171

Query: 376 QTRSIGVEGTTGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTG--LRPSDD 424
              +  V  T  Y APE   GMG+      D++S G ++ EM  G  L P  D
Sbjct: 172 FMMTPYVV-TRYYRAPEVILGMGY--KENVDIWSVGCIMGEMIRGTVLFPGTD 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 27/213 (12%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVKVFTAC 271
           +G G + +V+KG    +   VA+K   + H + +   A+ E  + ++++H N+V +    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH--- 70

Query: 272 SGVDFQGNDFK-ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
              D    D    LV+E++ +  L+++M             GN+ S+   N+ I +  +L
Sbjct: 71  ---DIVHTDKSLTLVFEYL-DKDLKQYMDDC----------GNIMSMH--NVKIFLYQIL 114

Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT-GYI 389
           + L    +  + H DLKP N+L+++     ++DFG+AR   A    T++   E  T  Y 
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYR 171

Query: 390 APEYGMG-HEVSSYGDVYSFGILLLEMFTGLRP 421
            P+  +G  E S+  D++  G +  EM +G RP
Sbjct: 172 PPDVLLGSSEYSTQIDMWGVGCIFFEMASG-RP 203

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 22/216 (10%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKV--FNVLHHDASKSF-AVECEVT--RNIRHRNLVK 266
           L+G G FG VY     ++   +AVK   F+    + SK   A+ECE+   +N+ H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
            +      D       ++  E M  GS+++ +          K+ G L           +
Sbjct: 69  YYGCLR--DPMERTL-SIFMEHMPGGSIKDQL----------KSYGALTENVTRKYTRQI 115

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEA-ADEQTRSIGVEGT 385
              + YLH +    I H D+K +NIL D      + DFG ++ L+      T    V GT
Sbjct: 116 LEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             +++PE   G       D++S G  ++EM T   P
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 24/219 (10%)

Query: 205 KGFSSENL--IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRH 261
           K  S E L  +G G++ +VYKG    +   VA+KV  +   + +   A+ E  + + ++H
Sbjct: 3   KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH 62

Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            N+V +            +   LV+E++ +  L ++M          K PG L+      
Sbjct: 63  ANIVLLHDI-----IHTKETLTLVFEYV-HTDLCQYMD---------KHPGGLHPENVKL 107

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
               +   L Y+H   Q  I H DLKP N+L+ D     ++DFG+AR  ++    T S  
Sbjct: 108 FLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNE 163

Query: 382 VEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGL 419
           V  T  Y  P+  +G  E S+  D++  G + +EM  G+
Sbjct: 164 VV-TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGV 201

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 38/107 (35%), Positives = 56/107 (52%), Gaps = 11/107 (10%)

Query: 319 RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
           R+ IA ++   L +LH   Q  I + D+K  NILLD E    ++DFG+++    A+E+ R
Sbjct: 108 RVYIA-EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEER 162

Query: 379 SIGVEGTTGYIAPEY----GMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           +    GT  Y+APE       GH      D +S G+L  E+ TG  P
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGH--DKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 24/215 (11%)

Query: 212 LIGAGNFGSVYKGI---LFESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVKV 267
            IG G FG VY+G+         AVAVK   N       + F  E  + R   H ++VK+
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
               +       +   +V E    G L  ++       + +K   +L+    +  +  ++
Sbjct: 73  IGVIT------ENPVWIVMELAPLGELRSYL-------QVNKY--SLDLASLILYSYQLS 117

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             L YL         H D+   N+L+       + DFG++R+LE       S G +    
Sbjct: 118 TALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG-KLPIK 173

Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           ++APE       +S  DV+ FG+ + E+   G++P
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 22/227 (9%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           F+   ++G G+FG V       +    A+K+     V+  D  +   VE  V        
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            +    +C    FQ  D    V E++  G L   M+ I +  K  K P      + +  A
Sbjct: 62  FLTQLHSC----FQTVDRLYFVMEYVNGGDL---MYHIQQVGK-FKEP------QAVFYA 107

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +++  L +LH   +  I + DLK  N++LD E    ++DFG+ +        TR+    
Sbjct: 108 AEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-- 162

Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 430
           GT  YIAPE           D +++G+LL EM  G  P D   +D L
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 54.1 bits (131), Expect = 5e-08
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 56/226 (24%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNV---------LHHDASKSFAVECEVTRNIR 260
              +G G +  VYK    E+   VA+K   +         ++  A +    E ++ + ++
Sbjct: 5   GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR----EIKLLQELK 60

Query: 261 HRN---LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHK-APGNLNS 316
           H N   L+ VF   S ++        LV+EFM    LE+ +      DK     P ++ S
Sbjct: 61  HPNIIGLLDVFGHKSNIN--------LVFEFME-TDLEKVIK-----DKSIVLTPADIKS 106

Query: 317 -----LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
                L+ L           YLH      I H DLKP+N+L+  +    ++DFG+AR   
Sbjct: 107 YMLMTLRGLE----------YLH-SNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153

Query: 372 AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLE 414
           + + +     V  T  Y APE   G     YG   D++S G +  E
Sbjct: 154 SPNRKMTHQVV--TRWYRAPELLFG--ARHYGVGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 31/213 (14%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-ASKSFAV-ECEVTRNIRHRNLVKVFTA 270
           IG G++G V+K    E+   VA+K F     D   K  A+ E  + + ++H NLV +   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                F+      LV+E+          H +  E +++  P  +       I       +
Sbjct: 69  -----FRRKRKLHLVFEYCD--------HTVLNELEKN--PRGVPEHLIKKIIWQTLQAV 113

Query: 331 KYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA-DEQTRSIGVEGTTGY 388
            + H  +C     H D+KP NIL+  +    + DFG AR L    D+ T  +    T  Y
Sbjct: 114 NFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV---ATRWY 166

Query: 389 IAPEYGMGHEVSSYG---DVYSFGILLLEMFTG 418
            APE  +G   + YG   DV++ G +  E+ TG
Sbjct: 167 RAPELLVGD--TQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 53.6 bits (129), Expect = 6e-08
 Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 33/215 (15%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G+ G V       +   VAVK  ++      +    E  + R+ +H N+V+++++  
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS-- 84

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
              +   D   +V EF+  G+L +    +T           +N  +   + + V   L +
Sbjct: 85  ---YLVGDELWVVMEFLEGGALTDI---VTH--------TRMNEEQIATVCLAVLKALSF 130

Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           LH      + H D+K  +ILL  +    +SDFG     + + E  R   + GT  ++APE
Sbjct: 131 LH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPE 185

Query: 393 ------YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
                 YG   EV    D++S GI+++EM  G  P
Sbjct: 186 VISRLPYGT--EV----DIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 56/239 (23%), Positives = 100/239 (41%), Gaps = 23/239 (9%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G+ G V       +   VAVK  ++      +    E  + R+  H N+V ++ +  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS-- 87

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
              +   D   +V EF+  G+L +    I    +       +N  +   + + V   L Y
Sbjct: 88  ---YLVGDELWVVMEFLEGGALTD----IVTHTR-------MNEEQIATVCLSVLRALSY 133

Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           LH      + H D+K  +ILL  +    +SDFG     + + E  +   + GT  ++APE
Sbjct: 134 LH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPE 188

Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASS 451
                   +  D++S GI+++EM  G  P  +  +  L     ++  LP R ++    S
Sbjct: 189 VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN--EPPLQAMRRIRDNLPPRVKDSHKVS 245

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 8e-08
 Identities = 30/86 (34%), Positives = 43/86 (50%), Gaps = 6/86 (6%)

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           L+YLH      I H D+K  NI ++D     + D G A+F   A      +G+ GT    
Sbjct: 170 LRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---FLGLAGTVETN 223

Query: 390 APEYGMGHEVSSYGDVYSFGILLLEM 415
           APE     + +S  D++S GI+L EM
Sbjct: 224 APEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 53.6 bits (129), Expect = 8e-08
 Identities = 68/280 (24%), Positives = 111/280 (39%), Gaps = 47/280 (16%)

Query: 191 SFPYVSYRML-YNATKGFSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVFN 239
            + Y+    L Y+    F   NL     +GAG FG V +   +     ++   VAVK+  
Sbjct: 15  EYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK 74

Query: 240 -VLHHDASKSFAVECEVTRNI-RHRNLVKVFTAC--SGVDFQGNDFKALVYEFMANGSLE 295
              H    ++   E ++  ++  H N+V +  AC   G          ++ E+   G L 
Sbjct: 75  PTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL-------VITEYCCYGDLL 127

Query: 296 EWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHL-DCQPPIAHCDLKPSNILLD 354
            ++       KR      L     L+ +  VA  + +L   +C     H DL   N+LL 
Sbjct: 128 NFLR-----RKRESF---LTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLT 175

Query: 355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTT----GYIAPEYGMGHEVSSYGDVYSFGI 410
                 + DFG+AR +           V+G       ++APE       +   DV+S+GI
Sbjct: 176 HGKIVKICDFGLARDIMNDSNYV----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 231

Query: 411 LLLEMFT-GLRPSDDMFKDNL---NLRNCVKSALPERAEE 446
           LL E+F+ G  P   M  D+     ++   + A PE A  
Sbjct: 232 LLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPA 271

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 23/227 (10%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT--RNIRHRNLVKVFTA 270
           IG G+FG +Y       +    +K  ++      +  A + EV     ++H N+V  F +
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR-LNIAIDVACV 329
                FQ N    +V E+   G L   M  I  +       G L S  + L+  + ++  
Sbjct: 68  -----FQENGRLFIVMEYCDGGDL---MKRINRQR------GVLFSEDQILSWFVQISLG 113

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDE-MTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
           LK++H      I H D+K  NI L    M A + DFGIAR L  + E   +    GT  Y
Sbjct: 114 LKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYY 168

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC 435
           ++PE       ++  D++S G +L E+ T   P +      L L+ C
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 53.6 bits (128), Expect = 8e-08
 Identities = 51/217 (23%), Positives = 95/217 (43%), Gaps = 21/217 (9%)

Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNL 264
           K ++    IG G  G+V+  I   +   VA+K  N+      +    E  V + +++ N+
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           V    +     F   D   +V E++A GSL + +     ++ +  A           +  
Sbjct: 79  VNFLDS-----FLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA-----------VCR 122

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           +    L++LH +    + H D+K  N+LL  + +  ++DFG     +   EQ++   + G
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVG 177

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           T  ++APE           D++S GI+ +EM  G  P
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 35/99 (35%), Positives = 48/99 (48%), Gaps = 6/99 (6%)

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           A ++ C L+ L    +  I + DLKP NILLDD     +SD G+A  +    E     G 
Sbjct: 108 AAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIP---EGETVRGR 161

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            GT GY+APE     + +   D +  G L+ EM  G  P
Sbjct: 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 52/212 (24%), Positives = 99/212 (46%), Gaps = 25/212 (11%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVKVFTAC 271
           +G G + +VYKG    +   VA+K   + H + +   A+ E  + ++++H N+V +    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI- 72

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
                       LV+E++             ++D +       NS+   N+ + +  +L+
Sbjct: 73  ----IHTEKSLTLVFEYL-------------DKDLKQYLDDCGNSINMHNVKLFLFQLLR 115

Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT-GYIA 390
            L+   +  + H DLKP N+L+++     ++DFG+AR   A    T++   E  T  Y  
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRP 172

Query: 391 PEYGMGH-EVSSYGDVYSFGILLLEMFTGLRP 421
           P+  +G  + S+  D++  G +  EM TG RP
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTG-RP 203

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 53.6 bits (129), Expect = 9e-08
 Identities = 49/155 (31%), Positives = 70/155 (45%), Gaps = 15/155 (9%)

Query: 276 FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHL 335
           FQ  D    V E++  G L   M+ I +  K  K P        +  A ++A  L +LH 
Sbjct: 70  FQTMDRLYFVMEYVNGGDL---MYHIQQVGK-FKEP------HAVFYAAEIAIGLFFLH- 118

Query: 336 DCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM 395
                I + DLK  N++LD E    ++DFG+ +      + TR+    GT  YIAPE   
Sbjct: 119 --SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC--GTPDYIAPEIIA 174

Query: 396 GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 430
                   D ++FG+LL EM  G  P D   +D L
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 9e-08
 Identities = 51/237 (21%), Positives = 94/237 (39%), Gaps = 39/237 (16%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--VLHH-DASKSFAVECEVTRNIRHRNLVKVFT 269
           +G G +G V+     ++   VA+K     +L   +  +    E ++    +   LVK+  
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLK----RLNIAID 325
           A     FQ +++  L  E++  G     ++             NL  L     R  +A +
Sbjct: 69  A-----FQDDEYLYLAMEYVPGGDFRTLLN-------------NLGVLSEDHARFYMA-E 109

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +   +  LH   +    H DLKP N L+D      ++DFG+     +    T +  V G+
Sbjct: 110 MFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGL-----SKGIVTYANSVVGS 161

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLNLRNCVK 437
             Y+APE   G       D +S G +L E   G  P      ++ +++    +  ++
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ 218

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 62/228 (27%), Positives = 93/228 (40%), Gaps = 27/228 (11%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +IG G+FG V            AVKV     +L     K    E    RN+  +N+   F
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSE----RNVLLKNVKHPF 57

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                  FQ  D    V +++  G L  + H   + ++    P      +    A ++A 
Sbjct: 58  LVGLHFSFQTADKLYFVLDYINGGEL--FYH--LQRERCFLEP------RARFYAAEIAS 107

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L YLH      I + DLKP NILLD +    ++DFG+ +  E  +    +    GT  Y
Sbjct: 108 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEY 162

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLN 431
           +APE           D +  G +L EM  GL P     + +M+ + LN
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 48/228 (21%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIRHRNLVKVFTA 270
           IG G +G VYK     +   VA+K   +    +   S A+ E  + + + H N+VK+   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL--- 64

Query: 271 CSGVDFQGNDFKA-LVYEFMANGSLEEWMH--PITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              +D    + K  LV+EF+ +  L+++M   P++                     I + 
Sbjct: 65  ---LDVIHTENKLYLVFEFL-HQDLKKFMDASPLSG--------------------IPLP 100

Query: 328 CVLKYLHLDCQPPIAHC--------DLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
            +  YL    Q  +A C        DLKP N+L++ E    ++DFG+AR   A     R+
Sbjct: 101 LIKSYLFQLLQ-GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRT 156

Query: 380 IGVEGTT-GYIAPEYGMGHEVSSYG-DVYSFGILLLEMFT--GLRPSD 423
              E  T  Y APE  +G +  S   D++S G +  EM T   L P D
Sbjct: 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 63/255 (24%), Positives = 103/255 (40%), Gaps = 57/255 (22%)

Query: 201 YNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV----ECEVT 256
           ++    + + + IG G +G V       +   VA+K  +   H   ++F      E ++ 
Sbjct: 1   FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH---QTFCQRTLREIKIL 57

Query: 257 RNIRHRNLVKVFTACSGVDFQGNDFKA--LVYEFMANGSLEEWMHPITEEDKRHKAPGNL 314
           R  +H N++ +        F+   F    +V E M              E   +K     
Sbjct: 58  RRFKHENIIGILDIIRPPSFE--SFNDVYIVQELM--------------ETDLYKL---- 97

Query: 315 NSLKRLNIAIDVACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI 366
             +K  +++ D            LKY+H      + H DLKPSN+LL+      + DFG+
Sbjct: 98  --IKTQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGL 152

Query: 367 ARFLEAADEQTRSIGVE--GTTGYIAPEYGMGHEVSSYG-----DVYSFGILLLEMFTG- 418
           AR  +   + T  +  E   T  Y APE  M   ++S G     D++S G +L EM +  
Sbjct: 153 ARIADPEHDHTGFL-TEYVATRWYRAPEI-M---LNSKGYTKAIDIWSVGCILAEMLSNR 207

Query: 419 -LRPSDDMFKDNLNL 432
            L P  D +   LNL
Sbjct: 208 PLFPGKD-YLHQLNL 221

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 37/216 (17%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-KSFAV-ECEVTRNIRHRNLVKVFTA 270
           IG G +G VYKG   ++   VA+K   +   +    S A+ E  + + ++H N+V +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCL--- 64

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
              V  Q +    L++EF+            + + K++     L+SL +    +D   V 
Sbjct: 65  -QDVLMQESRL-YLIFEFL------------SMDLKKY-----LDSLPK-GQYMDAELVK 104

Query: 331 KYLH------LDC-QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            YL+      L C    + H DLKP N+L+D++    ++DFG+AR   A     R    E
Sbjct: 105 SYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR---AFGIPVRVYTHE 161

Query: 384 GTT-GYIAPEYGMGHEVSSYG-DVYSFGILLLEMFT 417
             T  Y APE  +G    S   D++S G +  EM T
Sbjct: 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 65/256 (25%), Positives = 111/256 (43%), Gaps = 59/256 (23%)

Query: 194 YVSYRMLYNAT-----KGFSSENLIGAGNFGSVYKGILFESTTAVAVKV------FNVLH 242
              YR   N T     + + + + +G+G +GSV     F++ T + V V      F  + 
Sbjct: 1   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSII 58

Query: 243 HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHP 300
           H A +++  E  + ++++H N++                  L+  F    SLEE+  ++ 
Sbjct: 59  H-AKRTYR-ELRLLKHMKHENVI-----------------GLLDVFTPARSLEEFNDVYL 99

Query: 301 ITEEDKRHKAPGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNI 351
           +T     H    +LN++ +     D         +   LKY+H      I H DLKPSN+
Sbjct: 100 VT-----HLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNL 151

Query: 352 LLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGI 410
            ++++    + DFG+AR     DE T   G   T  Y APE  +     +   D++S G 
Sbjct: 152 AVNEDCELKILDFGLAR--HTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 206

Query: 411 LLLEMFTG--LRPSDD 424
           ++ E+ TG  L P  D
Sbjct: 207 IMAELLTGRTLFPGTD 222

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 61/225 (27%), Positives = 91/225 (40%), Gaps = 30/225 (13%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           F    +IG G FG V    +  +    A+K+ N   +L    +  F  E +V  N   R 
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNS--LKRLN 321
           +  +  A     FQ  +   LV ++   G L   +    +     + P ++    L  + 
Sbjct: 63  ITNLHYA-----FQDENNLYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMV 112

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           +AID    L Y+H D         +KP N+LLD      ++DFG    L  AD   +S  
Sbjct: 113 LAIDSVHQLGYVHRD---------IKPDNVLLDKNGHIRLADFGSCLRLL-ADGTVQSNV 162

Query: 382 VEGTTGYIAPEY--GMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
             GT  YI+PE    M      YG   D +S G+ + EM  G  P
Sbjct: 163 AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 35/103 (33%), Positives = 50/103 (48%), Gaps = 10/103 (9%)

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           + C + +LH      I + D+KP N+LLDD+    +SD G+A  L+     T+     GT
Sbjct: 104 ITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGT 157

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD 428
            GY+APE       S   D ++ G  + EM  G  P    FKD
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP----FKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 24/217 (11%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLV 265
           F   + +GAGN G V+K     S   +A K+ ++    A ++  + E +V        +V
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             + A     F  +   ++  E M  GSL++ +       K  + P  +  L +++IA  
Sbjct: 67  GFYGA-----FYSDGEISICMEHMDGGSLDQVL------KKAGRIPEQI--LGKVSIA-- 111

Query: 326 VACVLKYL-HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
              V+K L +L  +  I H D+KPSNIL++      + DFG++  L   D    S    G
Sbjct: 112 ---VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VG 164

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           T  Y++PE   G   S   D++S G+ L+EM  G  P
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 64/233 (27%), Positives = 97/233 (41%), Gaps = 46/233 (19%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-KSFAV-ECEVTRNIRHRNLVKVFTA 270
           IG G +G VYK     +   VA+K   +   D    S A+ E  + + + H N+V++   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD- 65

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
              V    N    LV+EF+ +  L+++M                         +D   + 
Sbjct: 66  ---VVHSENKL-YLVFEFL-DLDLKKYMDSSPL------------------TGLDPPLIK 102

Query: 331 KYLHLDCQPPIAHC--------DLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
            YL+   Q  IA+C        DLKP N+L+D E    ++DFG+AR   A     R+   
Sbjct: 103 SYLYQLLQG-IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR---AFGVPVRTYTH 158

Query: 383 EGTT-GYIAPEYGMGHEVSSYG-DVYSFGILLLEM------FTGLRPSDDMFK 427
           E  T  Y APE  +G    S   D++S G +  EM      F G    D +F+
Sbjct: 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 18/219 (8%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRNLVKVFTAC 271
           IG G +G V+K +  ++ +  AVK+ + + HD  +    E  + + +  H N+VK +   
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
              D +  D   LV E    GS+ + +    +  +R      +       I  +    L+
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER------MEEPIIAYILHEALMGLQ 138

Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           +LH++      H D+K +NILL  E    + DFG++  L +     R+  V GT  ++AP
Sbjct: 139 HLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST-RLRRNTSV-GTPFWMAP 193

Query: 392 EYGMGHEV--SSYG---DVYSFGILLLEMFTGLRPSDDM 425
           E     +   S+Y    DV+S GI  +E+  G  P  D+
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 51/230 (22%), Positives = 83/230 (36%), Gaps = 36/230 (15%)

Query: 213 IGAGNFGSVYKGILFE--STTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFT 269
           IG G FG V  G      S   V VK        D    F  E +  R + H N+++   
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C            LV EF   G L+ ++        R              +A +VA  
Sbjct: 63  QCIESIPY-----LLVLEFCPLGDLKNYL-----RSNRGMVAQMAQKDVLQRMACEVASG 112

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR------FLEAADEQTRSIGVE 383
           L +LH   Q    H DL   N  L  +++  + D+G+A       +    D     +   
Sbjct: 113 LLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR-- 167

Query: 384 GTTGYIAPEYG-------MGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
               ++APE         +  + +   +++S G+ + E+FT   +P  D+
Sbjct: 168 ----WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 64/224 (28%), Positives = 100/224 (44%), Gaps = 38/224 (16%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNL-- 264
           F     +GAGN G V K +   S   +A K+             +  E+   IR++ +  
Sbjct: 3   FEKLGELGAGNGGVVTKVLHRPSGLIMARKL-------------IHLEIKPAIRNQIIRE 49

Query: 265 VKVFTACSG---VDFQGNDFK----ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
           +KV   C+    V F G  +     ++  E M  GSL++ +       K  + P N+  L
Sbjct: 50  LKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK------KAGRIPENI--L 101

Query: 318 KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT 377
            +++IA  V   L YL    +  I H D+KPSNIL++      + DFG++  L   D   
Sbjct: 102 GKISIA--VLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMA 155

Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            S    GT  Y++PE   G   +   D++S G+ L+EM  G  P
Sbjct: 156 NSF--VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 33/219 (15%)

Query: 213 IGAGNFGSVYKGILFE--STTAVAVKVFNVLHHDAS----KSFAVECEVTRNIRHRNLVK 266
           IG G FG V  G +    +   V VK   V    AS      F  E +  R+++H NL++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRV---SASVQEQMKFLEEAQPYRSLQHSNLLQ 59

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C+ V         LV EF   G L+ ++    + +     P +  +L+R+  A ++
Sbjct: 60  CLGQCTEVTPY-----LLVMEFCPLGDLKGYLRSCRKAELM--TP-DPTTLQRM--ACEI 109

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
           A  L +LH   +    H DL   N LL  ++T  + D+G++      D       +    
Sbjct: 110 ALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166

Query: 387 GYIAPEYGMGHEV---------SSYGDVYSFGILLLEMF 416
            +IAPE  +  EV         +   +V+S G+ + E+F
Sbjct: 167 RWIAPE--LVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 22/210 (10%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVKVFTAC 271
           +GAGN G V K     S   +A K+ ++    A ++  + E +V        +V  + A 
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA- 71

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
               F  +   ++  E M  GSL++    + +E KR   P  +  L +++IA+     L 
Sbjct: 72  ----FYSDGEISICMEHMDGGSLDQ----VLKEAKR--IPEEI--LGKVSIAVLRG--LA 117

Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YL    Q  I H D+KPSNIL++      + DFG++  L   D    S    GT  Y++P
Sbjct: 118 YLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGTRSYMSP 171

Query: 392 EYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           E   G   S   D++S G+ L+E+  G  P
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 5/99 (5%)

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           +++  L YLH   +  I + DLK  N+LLD E    ++D+G+ +  E       +    G
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCG 158

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD 423
           T  YIAPE   G +     D ++ G+L+ EM  G  P D
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 64/226 (28%), Positives = 96/226 (42%), Gaps = 32/226 (14%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           F    +IG G FG V    L  +    A+K+ N   +L    +  F  E +V  N  ++ 
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNS--LKRLN 321
           +  +  A     FQ  +   LV ++   G L   +     ED+    P ++    L  + 
Sbjct: 63  ITTLHYA-----FQDENNLYLVMDYYVGGDLLTLLSKF--EDR---LPEDMARFYLAEMV 112

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG-IARFLEAADEQTRSI 380
           IAID    L Y+H D         +KP NIL+D      ++DFG   + +E    Q+ S+
Sbjct: 113 IAIDSVHQLHYVHRD---------IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS-SV 162

Query: 381 GVEGTTGYIAPEY--GMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
            V GT  YI+PE    M      YG   D +S G+ + EM  G  P
Sbjct: 163 AV-GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 63/276 (22%), Positives = 102/276 (36%), Gaps = 63/276 (22%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHR--------- 262
           +IG G FG VY                     D  K +A++C   + I+ +         
Sbjct: 1   IIGRGGFGEVY----------------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNE 44

Query: 263 ----NLVKV----FTACSGVDFQGNDFKALVYEFMANGSLEEWM--HPI-TEEDKRHKAP 311
               +LV      F  C    F   D  + + + M  G L   +  H + +E + R  A 
Sbjct: 45  RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAA 104

Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
                        ++   L+++H      + + DLKP+NILLD+     +SD G+A    
Sbjct: 105 -------------EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA---- 144

Query: 372 AADEQTRSIGVEGTTGYIAPE-YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM-FKDN 429
               + +     GT GY+APE    G    S  D +S G +L ++  G  P      KD 
Sbjct: 145 CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Query: 430 LNLRNCVKSALPERAEEIRASSGSTQRSIILECLIS 465
             +     +   E  +     S S +   +LE L+ 
Sbjct: 205 HEIDRMTLTMAVELPD-----SFSPELRSLLEGLLQ 235

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 50.7 bits (121), Expect = 7e-07
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 34/202 (16%)

Query: 233 VAVKVFNVLHHDASKS----FAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEF 288
           VAVK+   L  DA+K+    F  E ++   ++  N++++   C  VD    D   ++ E+
Sbjct: 49  VAVKI---LRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVC--VD---EDPLCMITEY 100

Query: 289 MANGSLEEWMHPITEEDKRHKAPGNLNSLKR-----------LNIAIDVACVLKYLHLDC 337
           M NG L +++     +DK  +  GN                 L++A+ +A  +KYL    
Sbjct: 101 MENGDLNQFLSSHHLDDK--EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---S 155

Query: 338 QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE---QTRSIGVEGTTGYIAPEYG 394
                H DL   N L+ + +T  ++DFG++R L A D    Q R++       ++A E  
Sbjct: 156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAV---LPIRWMAWECI 212

Query: 395 MGHEVSSYGDVYSFGILLLEMF 416
           +  + ++  DV++FG+ L E+ 
Sbjct: 213 LMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 50.2 bits (120), Expect = 7e-07
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 28/211 (13%)

Query: 213 IGAGNFGSVYKGILFESTT---AVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKV 267
           IG G+FG   K IL +S        +K  N+  +     +    E  V  N++H N+V+ 
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR-LNIAIDV 326
             +     F+ N    +V ++   G L +         K +   G L    + L+  + +
Sbjct: 65  QES-----FEENGNLYIVMDYCEGGDLYK---------KINAQRGVLFPEDQILDWFVQI 110

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
              LK++H      I H D+K  NI L  + T  + DFGIAR L +  E  R+    GT 
Sbjct: 111 CLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTP 165

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            Y++PE       ++  D+++ G +L EM T
Sbjct: 166 YYLSPEICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 8/100 (8%)

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR-FLEAADEQTRSIGVE 383
           ++   L++LH   +  I + D+K  NILLD      ++DFG+++ F E  DE  R+    
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE--DEVERAYSFC 167

Query: 384 GTTGYIAPEYGMGHEV--SSYGDVYSFGILLLEMFTGLRP 421
           GT  Y+AP+   G +       D +S G+L+ E+ TG  P
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.8 bits (121), Expect = 8e-07
 Identities = 72/266 (27%), Positives = 114/266 (42%), Gaps = 56/266 (21%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKV----FNVLHHDASKSFAVECEVTRNIRHRN---LV 265
           +G+G +GSV           VAVK     F  L H A +++  E  + ++++H N   L+
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH-ARRTYR-ELRLLKHMKHENVIGLL 80

Query: 266 KVFT-ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
            VFT A S  +F  N+   LV   M                       +LN++ +     
Sbjct: 81  DVFTPATSIENF--NEV-YLVTNLMG---------------------ADLNNIVKCQKLS 116

Query: 325 D---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE 375
           D         +   LKY+H      I H DLKPSN+ ++++    + DFG+AR  +A DE
Sbjct: 117 DEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDE 171

Query: 376 QTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG--LRPSDDMFKDNLNL 432
            T   G   T  Y APE  +     +   D++S G ++ E+  G  L P +D       +
Sbjct: 172 MT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228

Query: 433 RNCVKSALPERAEEIRASSGSTQRSI 458
              V +  PE  ++I  SS   ++ I
Sbjct: 229 MEVVGTPSPEVLKKI--SSEHARKYI 252

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 22/222 (9%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           ++G G+FG V       +    A+K+     V+  D  +   VE  V         +   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
            +C    FQ  D    V E++  G L   M+ I ++  R K P        +  A ++A 
Sbjct: 67  HSC----FQTMDRLYFVMEYVNGGDL---MYQI-QQVGRFKEP------HAVFYAAEIAI 112

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L +LH      I + DLK  N++LD E    ++DFG+ +  E   +   +    GT  Y
Sbjct: 113 GLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDY 167

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 430
           IAPE           D ++FG+LL EM  G  P +   +D L
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 28/200 (14%)

Query: 229 STTAVAVKVFNVLHHDASKS----FAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL 284
           +   VAVKV   L  DAS +    F  E ++   +   N+ ++   C+      +    +
Sbjct: 45  APVLVAVKV---LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV-----DPPLCM 96

Query: 285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR---LNIAIDVACVLKYLHLDCQPPI 341
           + E+M NG L +++       +      N  SL     L +A  +A  ++YL        
Sbjct: 97  IMEYMENGDLNQFLQ--KHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNF 151

Query: 342 AHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT----GYIAPEYGMGH 397
            H DL   N L+    T  ++DFG++R L ++D       V+G       ++A E  +  
Sbjct: 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR----VQGRAPLPIRWMAWESVLLG 207

Query: 398 EVSSYGDVYSFGILLLEMFT 417
           + ++  DV++FG+ L E+ T
Sbjct: 208 KFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 6/110 (5%)

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           A ++   L +LH   +  I + DLK  N+LLD +    ++D+G+ +      + T +   
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC- 157

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 432
            GT  YIAPE   G E     D ++ G+L+ EM  G  P  D+  DN ++
Sbjct: 158 -GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF-DIITDNPDM 205

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 35/104 (33%), Positives = 48/104 (46%), Gaps = 23/104 (22%)

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           LKY+H      + H DLKPSNIL+++     + DFG+AR     D Q         TGY+
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQ--------MTGYV 166

Query: 390 APEYGMGHEV----SSYG---DVYSFGILLLEMFTG--LRPSDD 424
           +  Y    E+      Y    D++S G +  EM  G  L P  D
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 27/218 (12%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G+ G V+  +  +    VAVK   +    + K    E ++ R + H N+VKV+    
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV--- 329
                  +    + E  +   ++E+M    E D         N L++  ++ + A +   
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYM----ETDLA-------NVLEQGPLSEEHARLFMY 121

Query: 330 -----LKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQT--RSIG 381
                LKY+H      + H DLKP+N+ ++ +++   + DFG+AR ++         S G
Sbjct: 122 QLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178

Query: 382 VEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
           +  T  Y +P   +  +  +   D+++ G +  EM TG
Sbjct: 179 LV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 62/250 (24%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVF--NVLHHDASKS----------FAV--ECEVT 256
             +G G +G V K     +   VA+K      + +D +K           F    E ++ 
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 257 RNIRHRN---LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGN 313
             I+H N   LV V+    G      DF  LV + MA   L++                 
Sbjct: 75  NEIKHENIMGLVDVY--VEG------DFINLVMDIMA-SDLKKV---------------- 109

Query: 314 LNSLKRLNIAIDVACVLKY----LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR- 368
           ++   RL  +  V C+L      L++  +    H DL P+NI ++ +    ++DFG+AR 
Sbjct: 110 VDRKIRLTES-QVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARR 168

Query: 369 ------FLEAADEQTRSIGVEGTTG-----YIAPEYGMGHEVSSYG-DVYSFGILLLEMF 416
                     + ++T     E T+      Y APE  MG E   +  D++S G +  E+ 
Sbjct: 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228

Query: 417 TG--LRPSDD 424
           TG  L P ++
Sbjct: 229 TGKPLFPGEN 238

Length = 335

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 76/273 (27%), Positives = 110/273 (40%), Gaps = 87/273 (31%)

Query: 236 KVFNVLH---HDASKSFAVE----CEVTRNIR-------HRNLVKVFTACSGVD----FQ 277
           KVF V      D  K FA++      + RN +        RN+++       VD    FQ
Sbjct: 11  KVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ 70

Query: 278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI-DVAC-------- 328
                 L+ E+++ G L  +MH                 L+R  I + D AC        
Sbjct: 71  TGGKLYLILEYLSGGEL--FMH-----------------LEREGIFMEDTACFYLSEISL 111

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L++LH   Q  I + DLKP NILLD +    ++DFG+ +  E+  E T +    GT  Y
Sbjct: 112 ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEY 166

Query: 389 IAPEY----GMGHEVSSYGDVYSFGILLLEMFTGLRP---------SDDMFKDNLNL--- 432
           +APE     G G  V    D +S G L+ +M TG  P          D + K  LNL   
Sbjct: 167 MAPEILMRSGHGKAV----DWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPY 222

Query: 433 -----RNCVKSAL-----------PERAEEIRA 449
                R+ +K  L           P  A E+++
Sbjct: 223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 18/219 (8%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTAC 271
           IG G +G VYK    +  +  AVK+ + +  D  +    E  + +++  H N+VK +   
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
              D        LV E    GS+ E +  +    +R      L+      I       L+
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR------LDEAMISYILYGALLGLQ 142

Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           +LH      I H D+K +NILL  E    + DFG++  L +     R+  V GT  ++AP
Sbjct: 143 HLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST-RLRRNTSV-GTPFWMAP 197

Query: 392 EYGMGHEVSSYG-----DVYSFGILLLEMFTGLRPSDDM 425
           E     +   Y      DV+S GI  +E+  G  P  DM
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 57/232 (24%)

Query: 212 LIGAGNFGSVYKGILFESTTAV-AVKV---FNVLHHDASKSFAVECEVTRNIR-HRN--- 263
           +IG G FG V + +  +S+  V A+K+   F ++    S  F  E    R+I  H N   
Sbjct: 50  VIGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE----RDIMAHANSEW 104

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSL----------EEWMHPITEEDKRHKAPGN 313
           +V++  A     FQ + +  +V E+M  G L          E+W    T E         
Sbjct: 105 IVQLHYA-----FQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAE--------- 150

Query: 314 LNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA 373
                 + +A+D    + ++H D         +KP N+LLD      ++DFG    ++ A
Sbjct: 151 ------VVLALDAIHSMGFIHRD---------VKPDNMLLDKSGHLKLADFGTCMKMD-A 194

Query: 374 DEQTRSIGVEGTTGYIAPEYGMGHEVSS-YG---DVYSFGILLLEMFTGLRP 421
           +   R     GT  YI+PE          YG   D +S G+ L EM  G  P
Sbjct: 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 21/209 (10%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G+ G V       S   VAVK+ ++      +    E  + R+ +H+N+V+++ +  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY- 87

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                G +   L+ EF+  G+L + +               LN  +   +   V   L Y
Sbjct: 88  ---LVGEELWVLM-EFLQGGALTDIVSQT-----------RLNEEQIATVCESVLQALCY 132

Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           LH      + H D+K  +ILL  +    +SDFG    +     + +S+   GT  ++APE
Sbjct: 133 LH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAPE 187

Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
                   +  D++S GI+++EM  G  P
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 69/272 (25%), Positives = 113/272 (41%), Gaps = 39/272 (14%)

Query: 210 ENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           + LIG G FG VY+               K+ N+     +++  +E  V  NI   + + 
Sbjct: 17  DKLIGCGGFGCVYETQCASDHCINNQAVAKIENL----ENETIVMETLVYNNIYDIDKIA 72

Query: 267 VFTACSGVDFQG-------NDFK--ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
           ++     +D  G         FK   + Y F+    LE+ +    E  KR K        
Sbjct: 73  LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFIL---LEKLVENTKEIFKRIKCKN----- 124

Query: 318 KRL--NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA-------R 368
           K+L  NI  D+   L+Y+H   +  I+H D+KP NI++D     Y+ D+GIA       +
Sbjct: 125 KKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGK 181

Query: 369 FLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD 428
            +E + EQ       GT  Y   +   G  V+  GD+ S G  +L+ + G++     F  
Sbjct: 182 HIEYSKEQKDL--HRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK-WAGIKLPWKGFGH 238

Query: 429 NLNLRNCVKSALPERAEEIRASSGSTQRSIIL 460
           N NL +  K    +R  E +    +  + I  
Sbjct: 239 NGNLIHAAKCDFIKRLHEGKIKIKNANKFIYD 270

Length = 294

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 33/218 (15%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           L+G G FG V       S    A+K+     ++  D       E  V +N RH      F
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP-----F 56

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE---DKRHKAPGNLNSLKRLNIAID 325
                  FQ  D    V E++  G L  + H   E    + R +  G            +
Sbjct: 57  LTSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYG-----------AE 103

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR--FLEAADEQTRSIGVE 383
           +   L YLH      I + DLK  N++LD +    ++DFG+ +    +AA  +T      
Sbjct: 104 IVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC---- 156

Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y+APE    ++     D +  G+++ EM  G  P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 39/118 (33%), Positives = 55/118 (46%), Gaps = 25/118 (21%)

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR-FLEAADEQTRSIGVEGTT 386
           C LKY+H      + H DLKP N+L++ +    + DFG+AR F E   E    +     T
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-----T 167

Query: 387 GYIAPEYGMGHEV----SSYG---DVYSFGILLLEMFTGLRPSDDMFK-----DNLNL 432
            Y+A  +    E+     SY    DV+S G +L E   G +P   +FK     D LN 
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGKDYVDQLNQ 221

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 31/94 (32%), Positives = 45/94 (47%), Gaps = 5/94 (5%)

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           + +A  L+YLH   +  I H DLK  N+ L       V D GIAR LE   +   ++   
Sbjct: 109 VQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL--I 163

Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
           GT  Y++PE       +   DV++ G  + EM T
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 55/231 (23%), Positives = 88/231 (38%), Gaps = 57/231 (24%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHR--------- 262
           +IG G FG VY                     D  K +A++C   + I+ +         
Sbjct: 1   IIGRGGFGEVY----------------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNE 44

Query: 263 ----NLVKV----FTACSGVDFQGNDFKALVYEFMANGSLEEWM--HPI-TEEDKRHKAP 311
               +LV      F  C    F   D    + + M  G L   +  H + +E++ R    
Sbjct: 45  RIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF--- 101

Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
                      A ++   L+++H      + + DLKP+NILLD+     +SD G+A    
Sbjct: 102 ----------YATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA---- 144

Query: 372 AADEQTRSIGVEGTTGYIAPE-YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
               + +     GT GY+APE    G    S  D +S G +L ++  G  P
Sbjct: 145 CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 35/222 (15%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTRNIRH 261
           F   N IG G +G VY+     S   VA+K   +   D  +     S   E  +  N+RH
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM---DNERDGIPISSLREITLLLNLRH 65

Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEF----MANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            N+V++     G   +  D   LV E+    +A+  L+    P +E   +          
Sbjct: 66  PNIVELKEVVVG---KHLDSIFLVMEYCEQDLAS-LLDNMPTPFSESQVK---------- 111

Query: 318 KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT 377
               + + +   L+YLH +    I H DLK SN+LL D+    ++DFG+AR      +  
Sbjct: 112 ---CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165

Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYG-DVYSFGILLLEMFTG 418
               V  T  Y APE  +G    +   D+++ G +L E+   
Sbjct: 166 TPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 3e-06
 Identities = 61/244 (25%), Positives = 90/244 (36%), Gaps = 58/244 (23%)

Query: 206 GFSSENLIGAGNFGSVYKGILFES--TTAVAVKVFNVLHHDA---SKSFAVECEVTRNIR 260
            +  E  IG G +G VYK            A+K F          S+S   E  + R ++
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM----------HPIT--EEDKRH 308
           H N+V                  LV  F+ +     ++            I    + KR 
Sbjct: 61  HENVVS-----------------LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRV 103

Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL--DDEMTAYV--SDF 364
             P ++  +K L   I     + YLH      + H DLKP+NIL+  +      V   D 
Sbjct: 104 SIPPSM--VKSLLWQI--LNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156

Query: 365 GIARFLEA-----ADEQTRSIGVEGTTGYIAPEYGMG--HEVSSYGDVYSFGILLLEMFT 417
           G+AR   A     AD       V  T  Y APE  +G  H   +  D+++ G +  E+ T
Sbjct: 157 GLARLFNAPLKPLADLD----PVVVTIWYRAPELLLGARHYTKAI-DIWAIGCIFAELLT 211

Query: 418 GLRP 421
            L P
Sbjct: 212 -LEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 37/220 (16%)

Query: 212 LIGAGNFGSVYKGILFESTTAV--AVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVK 266
           L+G G FG V   ++ E  T    A+K+     ++  D       E  V +N RH  L  
Sbjct: 2   LLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMH-----PITEEDKRHKAPGNLNSLKRLN 321
           +  A     FQ +D    V E+ ANG  E + H       TEE  R              
Sbjct: 60  LKYA-----FQTHDRLCFVMEY-ANGG-ELFFHLSRERVFTEERARFYGA---------- 102

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
              ++   L+YLH      + + D+K  N++LD +    ++DFG+ +  E   +      
Sbjct: 103 ---EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT 154

Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             GT  Y+APE    ++     D +  G+++ EM  G  P
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 21/214 (9%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF--NVLHHDASKSFAVECEVTRNIRHRNL 264
           F    ++G G +G V K    E+   VA+K F  +  + +  ++   E ++ R ++  N+
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           V++  A     F+      LV+E++    LE     + EE      P  + S        
Sbjct: 63  VELKEA-----FRRRGKLYLVFEYVEKNMLE-----LLEEMPNGVPPEKVRSY------- 105

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +  ++K +H   +  I H D+KP N+L+       + DFG AR L        +  V  
Sbjct: 106 -IYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-A 163

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
           T  Y +PE  +G       D++S G +L E+  G
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 28/211 (13%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH--------DASKSFAVECEVTRNIRHRNL 264
           +G G+FG+VY   L +   AVA +   VL          + +     E ++   + H  +
Sbjct: 8   LGKGSFGTVY---LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK   +     F   D   ++ E+     L+  +  +    K            +L + +
Sbjct: 65  VKFHAS-----FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
                  Y+H   Q  I H DLK  NI L + +   + DFG++R L  + +   +    G
Sbjct: 120 H------YMH---QRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTF--TG 167

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           T  Y++PE        S  D++S G +L EM
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 65/231 (28%), Positives = 103/231 (44%), Gaps = 37/231 (16%)

Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTA--VAVKVF--NVLHHDASKSFAVECEVTRNIR 260
           K F  ++L+G G+FG V   ++ E  T    A+KV   +VL    + SF  E    R+I 
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEE---ERDIL 55

Query: 261 HRN----LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNS 316
             +    + ++  A     FQ  D   LV E+   G L   ++       R++   +   
Sbjct: 56  SISNSPWIPQLQYA-----FQDKDNLYLVMEYQPGGDLLSLLN-------RYEDQFD-ED 102

Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
           + +  +A ++   +  +H   Q    H D+KP N+L+D      ++DFG A  L  A++ 
Sbjct: 103 MAQFYLA-ELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT-ANKM 157

Query: 377 TRSIGVEGTTGYIAPEY--GM-GHEVSSYG---DVYSFGILLLEMFTGLRP 421
             S    GT  YIAPE    M G    +YG   D +S G++  EM  G  P
Sbjct: 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 47.8 bits (114), Expect = 5e-06
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 25/213 (11%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-KSFAV-ECEVTRNIRHRNLVKVFTA 270
           IG G +G+V+K    E+   VA+K   +   D    S A+ E  + + ++H+N+V+++  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                   +    LV+E+  +  L+++      +         +  L +          L
Sbjct: 68  -----LHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLK---------GL 112

Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT-GYI 389
            + H      + H DLKP N+L++      ++DFG+AR   A     R    E  T  Y 
Sbjct: 113 AFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVRCYSAEVVTLWYR 166

Query: 390 APEYGMGHEVSSYG-DVYSFGILLLEMFTGLRP 421
            P+   G ++ S   D++S G +  E+    RP
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 47.9 bits (114), Expect = 5e-06
 Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 40/225 (17%)

Query: 210 ENLIGAGNFGSVYKGILFE-------STTAVAVKVFNVLHHDASKSFAVECEVTRNIRHR 262
           E+L G G F  ++KGI  E         T V +KV +  H + S+SF     +   + H+
Sbjct: 1   ESL-GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           +LV  +  C        D   +V E++  GSL+ ++       K       +N   +L +
Sbjct: 60  HLVLNYGVC-----VCGDESIMVQEYVKFGSLDTYLK------KNKNL---INISWKLEV 105

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY--------VSDFGIARFLEAAD 374
           A  +A  L +L       + H ++   N+LL  E            +SD GI+  +   +
Sbjct: 106 AKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE 162

Query: 375 EQTRSIGVEGTTGYIAPE-YGMGHEVSSYGDVYSFGILLLEMFTG 418
                I       ++ PE       +S   D +SFG  L E+F+G
Sbjct: 163 ILLERI------PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 9/92 (9%)

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           LKYLH      I H D+KP N+L++      + DFG+AR +E  DE ++ +  E  T Y 
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDE-SKHMTQEVVTQYY 170

Query: 390 -APEYGMG--HEVSSYGDVYSFGILLLEMFTG 418
            APE  MG  H  S+  D++S G +  E+   
Sbjct: 171 RAPEILMGSRHYTSAV-DIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 53/222 (23%), Positives = 95/222 (42%), Gaps = 40/222 (18%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS----KSFAVECEVTRNIRHRNLVKVF 268
           IG G FG V    ++ + T VA  V   L  +AS      F  + +  R ++H N+++  
Sbjct: 3   IGNGWFGKVLLSEIY-TDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 269 TAC-SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
             C   + +       LV+E+   G L+ ++    E+  R     N   L    +A ++A
Sbjct: 62  GQCVEAIPY------LLVFEYCELGDLKSYLS--QEQWHR----RNSQLLLLQRMACEIA 109

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA------RFLEAADEQTRSIG 381
             + ++H   +    H DL   N  L  ++T  V D+GI        ++E  D++   + 
Sbjct: 110 AGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPL- 165

Query: 382 VEGTTGYIAPEY-GMGH------EVSSYGDVYSFGILLLEMF 416
                 ++APE  G  H      E +   +V++ G+ L E+F
Sbjct: 166 -----RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 62/222 (27%), Positives = 92/222 (41%), Gaps = 37/222 (16%)

Query: 212 LIGAGNFGSVYKGILFESTTAV-AVKV---FNVLHHDASKSFAVECEVTRNIRHRNLVKV 267
           +IG G FG V + +  +ST  V A+K+   F ++    S  F  E ++        +V++
Sbjct: 50  VIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           F A     FQ + +  +V E+M  G L   M         +  P       R   A +V 
Sbjct: 109 FYA-----FQDDRYLYMVMEYMPGGDLVNLM-------SNYDVPEKW---ARFYTA-EVV 152

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             L  +H        H D+KP N+LLD      ++DFG    +   +   R     GT  
Sbjct: 153 LALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTPD 208

Query: 388 YIAPEY-----GMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
           YI+PE      G G+    YG   D +S G+ L EM  G  P
Sbjct: 209 YISPEVLKSQGGDGY----YGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 47.9 bits (114), Expect = 6e-06
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 5/101 (4%)

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           + +++  L +LH   +  I + DLK  N+LLD E    ++D+G+ +  E       +   
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTF 156

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD 423
            GT  YIAPE   G +     D ++ G+L+ EM  G  P D
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 47/198 (23%), Positives = 91/198 (45%), Gaps = 32/198 (16%)

Query: 233 VAVKVFNVLHHDASKS----FAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEF 288
           VAVK+   L  DA+K+    F  E ++   ++  N++++   C  +    +D   ++ E+
Sbjct: 49  VAVKM---LREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVC--IT---SDPLCMITEY 100

Query: 289 MANGSLEEWM------HPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIA 342
           M NG L +++          + D    +   L     + +A  +A  +KYL         
Sbjct: 101 MENGDLNQFLSRHEPQEAAEKADVVTISYSTL-----IFMATQIASGMKYLS---SLNFV 152

Query: 343 HCDLKPSNILLDDEMTAYVSDFGIARFLEAADE---QTRSIGVEGTTGYIAPEYGMGHEV 399
           H DL   N L+    T  ++DFG++R L + D    Q R++       +++ E  +  + 
Sbjct: 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAV---LPIRWMSWESILLGKF 209

Query: 400 SSYGDVYSFGILLLEMFT 417
           ++  DV++FG+ L E+ T
Sbjct: 210 TTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 47.7 bits (114), Expect = 6e-06
 Identities = 36/152 (23%), Positives = 56/152 (36%), Gaps = 33/152 (21%)

Query: 1   DLSNNNLSGTLSPQLVGL----SSLSIFNVSGNLLSGA----ISNNFGSCTSLEQLDMHG 52
            L  N L G     L         L   N++ N +  A    ++    +  +LE LD++ 
Sbjct: 143 VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNN 202

Query: 53  NLF----AGPIGSSLSSLRGLRVLDLSQNNLSDEI-----PEFLAGFKFLQNLNLSYNNF 103
           N      A  +  +L+SL+ L VL+L  NNL+D          L+    L  L+LS N+ 
Sbjct: 203 NGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262

Query: 104 ESMLPIEGIFKNASATSVFGNKKLCGGIPEFQ 135
                              G K L   + E +
Sbjct: 263 TDD----------------GAKDLAEVLAEKE 278

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 58/225 (25%), Positives = 91/225 (40%), Gaps = 30/225 (13%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           F    +IG G FG V    +  +    A+K+ N   +L    +  F  E  V  N   + 
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNS--LKRLN 321
           +  +  A     FQ  ++  LV ++   G L   +     ED+    P ++    +  + 
Sbjct: 63  ITTLHYA-----FQDENYLYLVMDYYVGGDLLTLLSKF--EDR---LPEDMARFYIAEMV 112

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           +AI     L Y+H D         +KP N+LLD      ++DFG    +        S+ 
Sbjct: 113 LAIHSIHQLHYVHRD---------IKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA 163

Query: 382 VEGTTGYIAPEY--GMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
           V GT  YI+PE    M   +  YG   D +S G+ + EM  G  P
Sbjct: 164 V-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 48.3 bits (115), Expect = 7e-06
 Identities = 31/102 (30%), Positives = 50/102 (49%)

Query: 2   LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGS 61
           L +N  SG +   L   ++L++ ++S N L+G I     S  +L +L +  N   G I  
Sbjct: 339 LWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398

Query: 62  SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNF 103
           SL + R LR + L  N+ S E+P        +  L++S NN 
Sbjct: 399 SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL 440

Length = 968

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 33/227 (14%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-KSFAV-ECEVTRNIRHRNLVKVFTA 270
           IG G +G VYK     +   +A+K   +   D    S A+ E  + + ++H N+V++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ-- 67

Query: 271 CSGVDFQGNDFKA-LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
               D   ++ +  LV+E++ +  L++ M    +  K  +    L       I   +A  
Sbjct: 68  ----DVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPR----LIKTYLYQILRGIA-- 116

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAY-VSDFGIARFLEAADEQTRSIGVEGTT-G 387
             Y H      + H DLKP N+L+D    A  ++DFG+AR   A     R+   E  T  
Sbjct: 117 --YCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR---AFGIPVRTFTHEVVTLW 168

Query: 388 YIAPEYGMG-HEVSSYGDVYSFGILLLEM------FTGLRPSDDMFK 427
           Y APE  +G    S+  D++S G +  EM      F G    D++FK
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215

Length = 294

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 43/221 (19%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVK----V 267
           +G G++ +VYKG    +   VA+K   + H + +   A+ E  + ++++H N+V     +
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWM--HPITEEDKRHKAPGNLNSLKRLNIAID 325
            T  +           LV+E++ +  L+++M                    L   N+ + 
Sbjct: 73  HTKKTLT---------LVFEYL-DTDLKQYMDDCG--------------GGLSMHNVRLF 108

Query: 326 VACVLK---YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           +  +L+   Y H   Q  + H DLKP N+L+ +     ++DFG+AR   A    +++   
Sbjct: 109 LFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSN 162

Query: 383 EGTT-GYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRP 421
           E  T  Y  P+  +G  E S+  D++  G +  EM TG RP
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG-RP 202

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 36/104 (34%), Positives = 49/104 (47%), Gaps = 18/104 (17%)

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR-----FLEAADEQTRSIGV 382
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR     F+      TR    
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 190

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG--LRPSDD 424
                Y APE  +G       D++S G ++ EM  G  L P  D
Sbjct: 191 -----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 37/132 (28%), Positives = 57/132 (43%), Gaps = 10/132 (7%)

Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           Y+H   +  I H D+K  NI L       + DFGI++ L    E + +  V GT  Y++P
Sbjct: 116 YIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSP 170

Query: 392 EYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASS 451
           E   G + +   D+++ G +L E+ T  R  D     N  L   VK         +   S
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFD---ATNP-LNLVVKIVQGNYTPVVSVYS 226

Query: 452 GSTQRSIILECL 463
            S   S++   L
Sbjct: 227 -SELISLVHSLL 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 6/93 (6%)

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           + C +K+LH      I H DLKPSNI++  + T  + DFG+AR        T  +    T
Sbjct: 132 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYV---VT 185

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
             Y APE  +G       D++S G ++ E+  G
Sbjct: 186 RYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 47/239 (19%)

Query: 204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVK--VFNVLHHDAS----KSFAVECEVTR 257
           TKG     ++G G +G+VY G L      +AVK    +  +  A+    +    E ++ +
Sbjct: 3   TKG----EVLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLK 57

Query: 258 NIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH---PITEEDKRHKAPGNL 314
           +++H N+V+    C       N   ++  EF+  GS+   ++   P+ E          L
Sbjct: 58  SLKHVNIVQYLGTC----LDDNTI-SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL 112

Query: 315 NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA- 373
           + +              YLH +C   + H D+K +N++L       + DFG AR L    
Sbjct: 113 DGVA-------------YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156

Query: 374 -----DEQTRSIGVEGTTGYIAPEY--GMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
                    +S  + GT  ++APE     G+   S  D++S G  + EM TG  P   M
Sbjct: 157 LHGTHSNMLKS--MHGTPYWMAPEVINESGYGRKS--DIWSIGCTVFEMATGKPPLASM 211

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 29/219 (13%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVK-VFNVLHH--DASKSFAVECEVTRNIRHRNLVK 266
           + +IG G++G V   I   +   VA+K + +V  H  DA++    E ++ R +RH ++V+
Sbjct: 5   QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVE 63

Query: 267 VFTACSGVDFQGNDFKAL--VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +            +FK +  V+E M     E  +H +       KA  +L          
Sbjct: 64  IKHIMLPPS--RREFKDIYVVFELM-----ESDLHQVI------KANDDLTPEHHQFFLY 110

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR--FLEAADEQTRSIGV 382
            +   LKY+H      + H DLKP NIL + +    + DFG+AR  F +       +  V
Sbjct: 111 QLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167

Query: 383 EGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTG 418
             T  Y APE   G   S Y    D++S G +  E+ TG
Sbjct: 168 -ATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 36/212 (16%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV---LHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           IG G+FG+VY      +   VAVK  +      ++  +    E +  + ++H N ++ + 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE-YK 87

Query: 270 ACSGVDFQGNDFKALVYEFM---ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
            C    +       LV E+    A+  LE    P+ E +      G L  L         
Sbjct: 88  GC----YLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA-------- 135

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
                YLH      + H D+K  NILL +     ++DFG A     A+         GT 
Sbjct: 136 -----YLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTP 181

Query: 387 GYIAPEYGMGHEVSSYG---DVYSFGILLLEM 415
            ++APE  +  +   Y    DV+S GI  +E+
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 4/83 (4%)

Query: 343 HCDLKPSNILLDDEMTAYVSDFGIARFLEA--ADEQTRSIGVEGTTGYIAPEYGMGHEVS 400
           H D+K +NILL       + DFG ++   A  +D+  R+    GT  Y+APE       S
Sbjct: 166 HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC--GTPYYVAPEIWRRKPYS 223

Query: 401 SYGDVYSFGILLLEMFTGLRPSD 423
              D++S G+LL E+ T  RP D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 55/238 (23%), Positives = 88/238 (36%), Gaps = 37/238 (15%)

Query: 199 MLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV---ECEV 255
           +L    K F             + K     + T VAVK  N L   + +   +   E   
Sbjct: 2   LLTLIGKCFED------LMIVHLAKHK--PTNTLVAVKKIN-LDSCSKEDLKLLQQEIIT 52

Query: 256 TRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLN 315
           +R ++H N++   T+     F  +    +V   MA GS E+ +       K H   G L 
Sbjct: 53  SRQLQHPNILPYVTS-----FIVDSELYVVSPLMAYGSCEDLL-------KTHFPEG-LP 99

Query: 316 SLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE 375
            L    I  DV   L Y+H        H  +K S+ILL  +    +S    +  +    +
Sbjct: 100 ELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK 156

Query: 376 QTRSI-----GVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDM 425
           + R +            +++PE  +   +  Y    D+YS GI   E+  G  P  DM
Sbjct: 157 RQRVVHDFPKSSVKNLPWLSPEV-LQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 23/211 (10%)

Query: 213 IGAGNFGSVYKGI-LFESTTAVAVKVFNVLHHDASKSFAV--ECEVTRNIR---HRNLVK 266
           IG G +G V+K   L      VA+K   V   +     +   E  V R++    H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG-NLNSLKRLNIAID 325
           +F  C+           LV+E + +  L  ++  + E       PG    ++K  ++   
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-------PGVPTETIK--DMMFQ 118

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +   L +LH      + H DLKP NIL+       ++DFG+AR       Q     V  T
Sbjct: 119 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVT 172

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMF 416
             Y APE  +    ++  D++S G +  EMF
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 25/75 (33%), Positives = 38/75 (50%)

Query: 343 HCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSY 402
           H DL   NILL +     + DFG+AR +    +  R         ++APE       ++ 
Sbjct: 196 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQ 255

Query: 403 GDVYSFGILLLEMFT 417
            DV+SFG+LL E+F+
Sbjct: 256 SDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 61/235 (25%), Positives = 91/235 (38%), Gaps = 35/235 (14%)

Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKV---FNVLHHDASKSFAVECE 254
           R L    + +    +IG G FG V       S    A+K+   F ++    S  F  E +
Sbjct: 36  RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 255 VTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNL 314
           +        +V++F A     FQ + +  +V E+M  G L   M      +K  K     
Sbjct: 96  IMAFANSPWVVQLFCA-----FQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF---- 146

Query: 315 NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD 374
                     +V   L  +H      + H D+KP N+LLD      ++DFG    ++   
Sbjct: 147 -------YTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196

Query: 375 EQTRSIGVEGTTGYIAPEY-----GMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
              R     GT  YI+PE      G G+    YG   D +S G+ L EM  G  P
Sbjct: 197 -MVRCDTAVGTPDYISPEVLKSQGGDGY----YGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 25/75 (33%), Positives = 38/75 (50%)

Query: 343 HCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSY 402
           H DL   NILL +     + DFG+AR +    +  R         ++APE       ++ 
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQ 256

Query: 403 GDVYSFGILLLEMFT 417
            DV+SFG+LL E+F+
Sbjct: 257 SDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 183

Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           Y APE  +G       D++S G ++ EM
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 62/269 (23%), Positives = 98/269 (36%), Gaps = 79/269 (29%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRNL- 264
           F S  +IG G FG V      ++    A+K          KS  +E E   ++R  R++ 
Sbjct: 3   FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR-------KSEMLEKEQVAHVRAERDIL 55

Query: 265 --------VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGN 313
                   VK++   S   FQ  ++  L+ E++  G +   +      TEE+ R      
Sbjct: 56  AEADNPWVVKLY--YS---FQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRF----- 105

Query: 314 LNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA 373
              +    +AID    L Y+H D         +KP N+LLD +    +SDFG+   L+ +
Sbjct: 106 --YIAETILAIDSIHKLGYIHRD---------IKPDNLLLDAKGHIKLSDFGLCTGLKKS 154

Query: 374 DEQT---RSIGVE---------------------------------GTTGYIAPEYGMGH 397
                                                         GT  YIAPE  +  
Sbjct: 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT 214

Query: 398 EVSSYGDVYSFGILLLEMFTGLRP--SDD 424
             +   D +S G+++ EM  G  P  SD+
Sbjct: 215 GYNKECDWWSLGVIMYEMLVGYPPFCSDN 243

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 71/305 (23%), Positives = 120/305 (39%), Gaps = 81/305 (26%)

Query: 198 RMLYNATKGFSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVFNV-LHHDAS 246
           ++ YN    F  +NL     +GAG FG V +   F     ++   VAVK+     H D  
Sbjct: 26  QLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDER 85

Query: 247 KSFAVECEVTRNI-RHRNLVKVFTACSG----------------VDFQGNDFKALVYEFM 289
           ++   E ++  ++ +H+N+V +  AC+                 ++F     +  +   M
Sbjct: 86  EALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVM 145

Query: 290 A------------NGSLEEW------------------MHPIT-----------EEDKRH 308
           A            N +LE+                   M P++           EED   
Sbjct: 146 ALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTED 205

Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHL-DCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA 367
             P +L+ L  L  +  VA  + +L   +C     H D+   N+LL D   A + DFG+A
Sbjct: 206 SWPLDLDDL--LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLA 259

Query: 368 RFLEAADEQTRSIGVEGTTGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDD 424
           R +                 ++APE  +   + V S  DV+S+GILL E+F+ G  P   
Sbjct: 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQS--DVWSYGILLWEIFSLGKSPYPG 317

Query: 425 MFKDN 429
           +  ++
Sbjct: 318 ILVNS 322

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)

Query: 212 LIGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVK 266
           L+G G FG V   ++ E  T    A+K+     ++  D       E  V +N RH     
Sbjct: 2   LLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP---- 55

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE---DKRHKAPGNLNSLKRLNIA 323
            F       FQ +D    V E+ ANG  E + H   E    + R +  G           
Sbjct: 56  -FLTALKYSFQTHDRLCFVMEY-ANGG-ELFFHLSRERVFSEDRARFYG----------- 101

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L YLH   +  + + DLK  N++LD +    ++DFG+ +  E   +        
Sbjct: 102 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFC 157

Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y+APE    ++     D +  G+++ EM  G  P
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 30/209 (14%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA---VECEVTRNIRHRNLVKVFT 269
           IG G+FG+VY      +   VA+K  +     +++ +     E    + +RH N ++ + 
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C    +       LV E+   GS  + +       + HK P  L  ++   I       
Sbjct: 82  GC----YLREHTAWLVMEYCL-GSASDIL-------EVHKKP--LQEVEIAAICHGALQG 127

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           L YLH   +    H D+K  NILL +  T  ++DFG A  +  A+         GT  ++
Sbjct: 128 LAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWM 178

Query: 390 APEYGMGHEVSSYG---DVYSFGILLLEM 415
           APE  +  +   Y    DV+S GI  +E+
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 25/75 (33%), Positives = 37/75 (49%)

Query: 343 HCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSY 402
           H DL   NILL +     + DFG+AR +    +  R         ++APE       +  
Sbjct: 202 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 261

Query: 403 GDVYSFGILLLEMFT 417
            DV+SFG+LL E+F+
Sbjct: 262 SDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 60/233 (25%), Positives = 95/233 (40%), Gaps = 44/233 (18%)

Query: 213 IGAGNFGSVYKGIL------------FESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR 260
           +G G    +Y GIL            +E    V +KV +  H D S +F     + R + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H+++V ++  C  V    N    +V EF+  G L+ +MH  ++          L +  + 
Sbjct: 63  HKHIVLLYGVC--VRDVEN---IMVEEFVEFGPLDLFMHRKSDV---------LTTPWKF 108

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL-----DDEMTAYV--SDFGIARFLEAA 373
            +A  +A  L YL       + H ++   NILL     D E   ++  SD GI   + + 
Sbjct: 109 KVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165

Query: 374 DEQTRSIGVEGTTGYIAPE-YGMGHEVSSYGDVYSFGILLLEM-FTGLRPSDD 424
            E    I       +IAPE       +S   D +SFG  L E+ + G  P  D
Sbjct: 166 QECVERI------PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 44.6 bits (105), Expect = 9e-05
 Identities = 49/191 (25%), Positives = 77/191 (40%), Gaps = 40/191 (20%)

Query: 250 AVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALV--------YEFMANGSLEEWMHPI 301
           A E  + R I H +++++        F  N F  L+        Y ++A           
Sbjct: 131 ATEAHILRAINHPSIIQLKGT-----FTYNKFTCLILPRYKTDLYCYLA----------- 174

Query: 302 TEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
               KR+ A  ++ +++R      V   ++YLH   +  I H D+K  NI ++      +
Sbjct: 175 ---AKRNIAICDILAIER-----SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCL 223

Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            DFG A F        +  G  GT    APE           D++S GI+L EM T    
Sbjct: 224 GDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC--- 279

Query: 422 SDDMF-KDNLN 431
            D +F KD L+
Sbjct: 280 HDSLFEKDGLD 290

Length = 391

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 44.3 bits (104), Expect = 9e-05
 Identities = 57/254 (22%), Positives = 95/254 (37%), Gaps = 60/254 (23%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F S  +IG G FG V      ++    A+K+    ++L  +       E ++        
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRL 320
           +VK+F +     FQ      L+ EF+  G +   +     +TEE+ +         +   
Sbjct: 63  VVKMFYS-----FQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQF-------YIAET 110

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA------- 373
            +AID    L ++H D         +KP N+LLD +    +SDFG+   L+ A       
Sbjct: 111 VLAIDSIHQLGFIHRD---------IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYR 161

Query: 374 --------------------------DEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYS 407
                                     + +  +    GT  YIAPE  M    +   D +S
Sbjct: 162 NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS 221

Query: 408 FGILLLEMFTGLRP 421
            G+++ EM  G  P
Sbjct: 222 LGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 36/220 (16%)

Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA---VECEVTRNIRH 261
           K F+    IG G+FG+VY      +   VA+K  +     +++ +     E +  + I+H
Sbjct: 25  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            N          ++++G      + E  A   +E  +   ++  + HK P     L+ + 
Sbjct: 85  PN---------SIEYKG----CYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVE 126

Query: 322 IAIDVACVLK---YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
           IA      L+   YLH      + H D+K  NILL +     ++DFG A     A+    
Sbjct: 127 IAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV- 182

Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEM 415
                GT  ++APE  +  +   Y    DV+S GI  +E+
Sbjct: 183 -----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 59/249 (23%), Positives = 95/249 (38%), Gaps = 70/249 (28%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV- 265
           F +  LI  G +G+VY                 V H +  + FA++    +N+  RN + 
Sbjct: 3   FETIKLISNGAYGAVYL----------------VRHKETRQRFAMKKINKQNLILRNQIQ 46

Query: 266 KVFTACSGVDFQGNDFKA-------------LVYEFMANG---SLEEWMHPITEEDKRHK 309
           +VF     + F  N F               +V E++  G   +L + +  +  +     
Sbjct: 47  QVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD----- 101

Query: 310 APGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR- 368
                  + R+  A +    L+YLH      I H DLKP N+L+       ++DFG+++ 
Sbjct: 102 -------MARMYFA-ETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150

Query: 369 ------------FLEAADEQTRSIGVEGTTGYIAPEY----GMGHEVSSYGDVYSFGILL 412
                        +E    +     V GT  YIAPE     G G  V    D ++ GI+L
Sbjct: 151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPV----DWWAMGIIL 206

Query: 413 LEMFTGLRP 421
            E   G  P
Sbjct: 207 YEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 36/220 (16%)

Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA---VECEVTRNIRH 261
           K FS    IG G+FG+VY      ++  VA+K  +     +++ +     E    + +RH
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            N ++ +  C    +       LV E+   GS  + +       + HK P     L+ + 
Sbjct: 75  PNTIQ-YRGC----YLREHTAWLVMEYCL-GSASDLL-------EVHKKP-----LQEVE 116

Query: 322 IAIDVACVLK---YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
           IA      L+   YLH      + H D+K  NILL +     + DFG A  +  A+    
Sbjct: 117 IAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV- 172

Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEM 415
                GT  ++APE  +  +   Y    DV+S GI  +E+
Sbjct: 173 -----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 31/91 (34%), Positives = 42/91 (46%), Gaps = 10/91 (10%)

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           LKY+H      + H DLKPSN+LL+      + DFG+AR      +      V  T  Y 
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV--TRWYR 175

Query: 390 APEYGMGHEVSSYG---DVYSFGILLLEMFT 417
           APE  +    S Y    DV+S G +  E+  
Sbjct: 176 APELLL--NCSEYTTAIDVWSVGCIFAELLG 204

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 19/190 (10%)

Query: 235 VKVFNVLHHDASKSFA-VECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGS 293
           V  F +L+ +   ++A  E        H  +VK F      DF+ +D   L+ E+ + G 
Sbjct: 97  VAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFD-----DFKSDDKLLLIMEYGSGGD 151

Query: 294 LEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL 353
           L +    I +  K H  P     +  L   I +A  L  +H      + H DLK +NI L
Sbjct: 152 LNK---QIKQRLKEH-LPFQEYEVGLLFYQIVLA--LDEVHSRK---MMHRDLKSANIFL 202

Query: 354 DDEMTAYVSDFGIARFLEAADEQTRSIGVE--GTTGYIAPEYGMGHEVSSYGDVYSFGIL 411
                  + DFG ++  + +D  +  +     GT  Y+APE       S   D++S G++
Sbjct: 203 MPTGIIKLGDFGFSK--QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVI 260

Query: 412 LLEMFTGLRP 421
           L E+ T  RP
Sbjct: 261 LYELLTLHRP 270

Length = 478

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 59/260 (22%), Positives = 94/260 (36%), Gaps = 72/260 (27%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---------NVLHHDASKSFAVECEVTR 257
           F S  +IG G FG V      ++    A+K+           V H  A +   VE +   
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 258 NIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGNL 314
                 +VK+F +     FQ      L+ EF+  G +   +     ++EE  +       
Sbjct: 63  ------VVKMFYS-----FQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF------ 105

Query: 315 NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA- 373
             +    +AID    L ++H D         +KP N+LLD +    +SDFG+   L+ A 
Sbjct: 106 -YIAETVLAIDAIHQLGFIHRD---------IKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155

Query: 374 --------------------------------DEQTRSIGVEGTTGYIAPEYGMGHEVSS 401
                                           + +  +    GT  YIAPE  M    + 
Sbjct: 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK 215

Query: 402 YGDVYSFGILLLEMFTGLRP 421
             D +S G+++ EM  G  P
Sbjct: 216 LCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 39/221 (17%)

Query: 212 LIGAGNFGSVYKGILF-ESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLV 265
           L+G G FG V   IL  E  T    A+K+     ++  D       E  V +N RH  L 
Sbjct: 2   LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH-----PITEEDKRHKAPGNLNSLKRL 320
            +  +     FQ +D    V E+ ANG  E + H       +E+  R             
Sbjct: 59  ALKYS-----FQTHDRLCFVMEY-ANGG-ELFFHLSRERVFSEDRARFYGA--------- 102

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
               ++   L YLH  C   + + DLK  N++LD +    ++DFG+ +    +D  T   
Sbjct: 103 ----EIVSALGYLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKT 154

Query: 381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
              GT  Y+APE    ++     D +  G+++ EM  G  P
Sbjct: 155 FC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.7 bits (91), Expect = 3e-04
 Identities = 23/60 (38%), Positives = 33/60 (55%)

Query: 44  SLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNF 103
           +L+ LD+  N        +   L  L+VLDLS NNL+   PE  +G   L++L+LS NN 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 30/86 (34%), Positives = 42/86 (48%), Gaps = 3/86 (3%)

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           L YLH      I H D+K  NI LD+   A + DFG A  L+A  +  +  G  GT    
Sbjct: 198 LAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN 254

Query: 390 APEYGMGHEVSSYGDVYSFGILLLEM 415
           +PE        +  D++S G++L EM
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 39/153 (25%), Positives = 65/153 (42%), Gaps = 33/153 (21%)

Query: 284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAH 343
           LV+E++ +  L+++M      D   + PG           +    +  +++   +  +AH
Sbjct: 83  LVFEYL-DSDLKKFM------DSNGRGPGR---------PLPAKTIKSFMYQLLKG-VAH 125

Query: 344 C--------DLKPSNILLDDE-MTAYVSDFGIAR-FLEAADEQTRSIGVEGTTGYIAPEY 393
           C        DLKP N+L+D +     ++D G+ R F       T  I    T  Y APE 
Sbjct: 126 CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI---VTLWYRAPEV 182

Query: 394 GMG-HEVSSYGDVYSFGILLLEMFTG--LRPSD 423
            +G    S+  D++S G +  EM     L P D
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 38/118 (32%), Positives = 52/118 (44%), Gaps = 8/118 (6%)

Query: 18  LSSLSIFNVSGN--LLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLS 75
           L  LS +N S +  L  G   NN     S+   D+ G   +G I S++  L  ++ ++LS
Sbjct: 45  LKYLSNWNSSADVCLWQGITCNNSSRVVSI---DLSGKNISGKISSAIFRLPYIQTINLS 101

Query: 76  QNNLSDEIPEFLAGFKF-LQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIP 132
            N LS  IP+ +      L+ LNLS NNF     I         T    N  L G IP
Sbjct: 102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTG--SIPRGSIPNLETLDLSNNMLSGEIP 157

Length = 968

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.9 bits (89), Expect = 4e-04
 Identities = 21/60 (35%), Positives = 29/60 (48%)

Query: 20 SLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL 79
          +L   ++S N L+      F    +L+ LD+ GN        + S L  LR LDLS NNL
Sbjct: 1  NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 37/126 (29%), Positives = 61/126 (48%), Gaps = 5/126 (3%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN-LFAGPI 59
           DL NNN++       +  S+L   ++S N +  ++ +   +  +L+ LD+  N L    +
Sbjct: 122 DLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD--L 178

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASAT 119
              LS+L  L  LDLS N +SD +P  +     L+ L+LS N+   +L      KN S  
Sbjct: 179 PKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGL 237

Query: 120 SVFGNK 125
            +  NK
Sbjct: 238 ELSNNK 243

Length = 394

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 42.4 bits (99), Expect = 4e-04
 Identities = 32/133 (24%), Positives = 56/133 (42%), Gaps = 18/133 (13%)

Query: 285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHC 344
           +Y FM + + +    P+ ++ +               I   + C ++Y+H      + H 
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTRA--------------IMKQLLCAVEYIH---DKKLIHR 291

Query: 345 DLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGD 404
           D+K  NI L+ +    + DFG A   E   E     G  GT    +PE   G       D
Sbjct: 292 DIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITD 350

Query: 405 VYSFGILLLEMFT 417
           ++S G++LL+M +
Sbjct: 351 IWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 41.0 bits (96), Expect = 6e-04
 Identities = 33/97 (34%), Positives = 42/97 (43%), Gaps = 10/97 (10%)

Query: 345 DLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGD 404
           DL P+NILLDD     ++ F   R+ E  D       VE    Y APE G   E +   D
Sbjct: 110 DLNPNNILLDDRGHIQLTYFS--RWSEVED-SCDGEAVENM--YCAPEVGGISEETEACD 164

Query: 405 VYSFGILLLEMFTGL-----RPSDDMFKDNLNLRNCV 436
            +S G +L E+ TG       PS       LN+   V
Sbjct: 165 WWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWV 201

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 36.7 bits (86), Expect = 9e-04
 Identities = 15/43 (34%), Positives = 23/43 (53%), Gaps = 2/43 (4%)

Query: 69  LRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
           L  LDLS N ++D +P  L+    L+ L+LS N    + P+  
Sbjct: 3   LETLDLSNNQITD-LPP-LSNLPNLETLDLSGNKITDLSPLSN 43

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.8 bits (86), Expect = 0.001
 Identities = 20/55 (36%), Positives = 27/55 (49%)

Query: 1  DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLF 55
          DLSNN L+        GL +L + ++SGN L+      F    SL  LD+ GN  
Sbjct: 6  DLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 33/107 (30%), Positives = 49/107 (45%), Gaps = 6/107 (5%)

Query: 343 HCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSY 402
           H DL   N+LL       + DFG+AR +                 ++APE    +  ++ 
Sbjct: 260 HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL 319

Query: 403 GDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS----ALPERA 444
            DV+S+GILL E+F+ G  P   M  D+    N +KS    A P+ A
Sbjct: 320 SDVWSYGILLWEIFSLGGTPYPGMIVDS-TFYNKIKSGYRMAKPDHA 365

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 37/114 (32%), Positives = 58/114 (50%), Gaps = 8/114 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DLS N+LS  L   L  LS+L+  ++SGN +S  +       ++LE+LD+  N     I 
Sbjct: 169 DLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNN----SII 222

Query: 61  SSLSSLRGLRVLDLS--QNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGI 112
             LSSL  L+ L      NN  +++PE +     L+ L+LS N   S+  +  +
Sbjct: 223 ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISSLGSL 276

Length = 394

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.9 bits (95), Expect = 0.002
 Identities = 57/245 (23%), Positives = 94/245 (38%), Gaps = 59/245 (24%)

Query: 213 IGAGNFGSVY-----KGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKV 267
           IG G FG V+     +   F    A++   +  L         +E  V R ++H+N+V+ 
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAIS---YRGLKEREKSQLVIEVNVMRELKHKNIVRY 77

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                    + N    ++ EF   G L   +       K +K  G +     ++I   + 
Sbjct: 78  IDRFLN---KANQKLYILMEFCDAGDLSRNIQ------KCYKMFGKIEEHAIVDITRQLL 128

Query: 328 CVLKYLHLDCQPP----IAHCDLKPSNILLDDEM-----------------TAYVSDFGI 366
             L Y H     P    + H DLKP NI L   +                  A + DFG+
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188

Query: 367 ARFLEAADEQTRSIGVE-------GTTGYIAPEYGMGHEVSSY---GDVYSFGILLLEMF 416
                     +++IG+E       GT  Y +PE  + HE  SY    D+++ G ++ E+ 
Sbjct: 189 ----------SKNIGIESMAHSCVGTPYYWSPEL-LLHETKSYDDKSDMWALGCIIYELC 237

Query: 417 TGLRP 421
           +G  P
Sbjct: 238 SGKTP 242

Length = 1021

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 39.9 bits (94), Expect = 0.002
 Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 33/217 (15%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV----ECEVTRNIRHRNLVK 266
           N I  G +G VY+    ++   VA+K   +      + F +    E  +   ++H N+V 
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILLKLQHPNIVT 68

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL-KRLNIAID 325
           V     G +    D   +V E++     E  +  + E  K+      +  L  +L   + 
Sbjct: 69  VKEVVVGSNL---DKIYMVMEYV-----EHDLKSLMETMKQPFLQSEVKCLMLQLLSGV- 119

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR-FLEAADEQTRSIGVEG 384
                 +LH      I H DLK SN+LL++     + DFG+AR +       T+ + V  
Sbjct: 120 -----AHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLV-V-- 168

Query: 385 TTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTG 418
           T  Y APE  +G     Y    D++S G +  E+ T 
Sbjct: 169 TLWYRAPELLLG--AKEYSTAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 8/79 (10%)

Query: 343 HCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT----GYIAPEYGMGHE 398
           H DL   N+L+ +     + DFG+AR +   D    S   +G+T     ++APE    + 
Sbjct: 262 HRDLAARNVLICEGKLVKICDFGLARDI-MRDSNYIS---KGSTFLPLKWMAPESIFNNL 317

Query: 399 VSSYGDVYSFGILLLEMFT 417
            ++  DV+SFGILL E+FT
Sbjct: 318 YTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 30/101 (29%), Positives = 42/101 (41%), Gaps = 2/101 (1%)

Query: 341 IAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVS 400
           + H D+K  NI L       + DFG AR L        +    GT  Y+ PE       +
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLL--TSPGAYACTYVGTPYYVPPEIWENMPYN 178

Query: 401 SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP 441
           +  D++S G +L E+ T   P       NL L+ C  S  P
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 38.7 bits (91), Expect = 0.004
 Identities = 32/117 (27%), Positives = 47/117 (40%), Gaps = 18/117 (15%)

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT-AYVSDFGIARFLEAADEQTRS 379
            I   +   L  LH      I H D+K  N+L D      Y+ D+G+ +           
Sbjct: 113 KIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK----------I 159

Query: 380 IGVE----GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 432
           IG      GT  Y +PE   GH      D ++ G+L  E+ TG  P  +   + L+L
Sbjct: 160 IGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216

Length = 267

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 38.8 bits (91), Expect = 0.004
 Identities = 53/224 (23%), Positives = 88/224 (39%), Gaps = 48/224 (21%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIR-HRNLVK---- 266
           IG G F  V K    ++    A+K          +   + E +  R +  H N+++    
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +F   +G         ALV+E M + +L E +       K  K P  L   +  +    +
Sbjct: 67  LFDRKTGR-------LALVFELM-DMNLYELI-------KGRKRP--LPEKRVKSYMYQL 109

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
              L ++H   +  I H D+KP NIL+ D+    ++DFG  R + +    T  I    T 
Sbjct: 110 LKSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYI---STR 162

Query: 387 GYIAPE---------YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            Y APE           M        D+++ G +  E+ + L P
Sbjct: 163 WYRAPECLLTDGYYGPKM--------DIWAVGCVFFEILS-LFP 197

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	502
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.8
PRK10345	210	hypothetical protein; Provisional	99.79
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.78
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.78
smart00090	237	RIO RIO-like kinase.	99.77
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.69
PLN03150	623	hypothetical protein; Provisional	99.67
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.6
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.6
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.59
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.59
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.57
PLN03150	623	hypothetical protein; Provisional	99.53
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.53
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.43
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.32
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.3
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.28
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.27
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.27
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.26
KOG1243	690	consensus Protein kinase [General function predict	99.26
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.24
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.23
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.23
COG4248	637	Uncharacterized protein with protein kinase and he	99.21
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.18
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.12
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.11
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.1
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.08
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.07
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.07
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.02
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.97
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.97
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.96
KOG3087	229	consensus Serine/threonine protein kinase [General	98.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.94
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.91
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.88
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.87
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.86
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.85
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.85
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.81
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.8
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.8
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.77
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.76
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.76
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.69
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.65
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.63
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.63
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.62
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.61
PRK09902	216	hypothetical protein; Provisional	98.59
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.57
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.52
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.51
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.51
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.45
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.35
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.33
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.33
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.33
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.31
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.3
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.24
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.21
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.16
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.07

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.3e-64  Score=562.00  Aligned_cols=460  Identities=27%  Similarity=0.419  Sum_probs=359.9

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|++++.+|..+.++++|+.|+|++|++++.+|..+.++++|++|+|++|.+++.+|..|..+++|+.|||++|+++
T Consensus       481 ~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  560 (968)
T PLN00113        481 DLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS  560 (968)
T ss_pred             ECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCccc
Confidence            68899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCccccCCCCCcCCccccccCccCCCCCCCceeeeehh
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVID  160 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~i~i~  160 (502)
                      |.+|..+.++++|+.|++++|++++.+|..+.+..+....+.+|+.+||+.+....++|....    +... +.++++++
T Consensus       561 ~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~----~~~~-~~~~~~~~  635 (968)
T PLN00113        561 GEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR----KTPS-WWFYITCT  635 (968)
T ss_pred             ccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc----ccce-eeeehhHH
Confidence            999999999999999999999999999988888888888899999999987666677774321    1111 22222222


Q ss_pred             hHHHHHHHHHHHHHHHHHHHHhhCC-CC---C--CCCC--------CccCHHHHHHhccCCCCCCcccccCCceEEEEEE
Q 046112          161 IGLLVLTLALSSLFCRLMCMKKRGN-PT---P--SISF--------PYVSYRMLYNATKGFSSENLIGAGNFGSVYKGIL  226 (502)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~--~~~~--------~~~~~~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~  226 (502)
                      ++++++++++++ ++.+.+++++.. +.   .  ....        ..+++++   ....|...++||+|+||.||+|..
T Consensus       636 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~  711 (968)
T PLN00113        636 LGAFLVLALVAF-GFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKGASYKGKS  711 (968)
T ss_pred             HHHHHHHHHHHH-HHHHHHhhhcccccccccccccccccccccccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEE
Confidence            222222222221 111112221110 10   0  0000        1122222   335677888999999999999988


Q ss_pred             cCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhh
Q 046112          227 FESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK  306 (502)
Q Consensus       227 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~  306 (502)
                      ..++..||||+++....    ....|++.+++++|||||+++++|..     .+..++||||+++|+|.++++.      
T Consensus       712 ~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey~~~g~L~~~l~~------  776 (968)
T PLN00113        712 IKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRS-----EKGAYLIHEYIEGKNLSEVLRN------  776 (968)
T ss_pred             CCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEc-----CCCCEEEEeCCCCCcHHHHHhc------
Confidence            88999999999864322    12346889999999999999999743     3478999999999999999842      


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecccccccceeccccccc
Q 046112          307 RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT  386 (502)
Q Consensus       307 ~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~  386 (502)
                             ++|.++.+++.|+|+|++|||..++++|+||||||+||+++.++.+++. ||.+.....      .....+|+
T Consensus       777 -------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~  842 (968)
T PLN00113        777 -------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISS  842 (968)
T ss_pred             -------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccc
Confidence                   7899999999999999999998778899999999999999999998876 665543221      11235789


Q ss_pred             ccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc-chhhhcccCCCCcchhhHHHHHH
Q 046112          387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE-RAEEIRASSGSTQRSIILECLIS  465 (502)
Q Consensus       387 ~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~  465 (502)
                      .|+|||++.+..++.++|||||||++|||+||+.||+..........+|++..... ....+.|+..........++..+
T Consensus       843 ~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (968)
T PLN00113        843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE  922 (968)
T ss_pred             cccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHH
Confidence            99999999999999999999999999999999999976555556677777655433 34445565554443444567778


Q ss_pred             HHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          466 ICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       466 l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      +.+++.+||+.||++||||+||++.|+++.+..
T Consensus       923 ~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        923 VMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             HHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            999999999999999999999999999887643

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-58  Score=452.58  Aligned_cols=290  Identities=38%  Similarity=0.590  Sum_probs=246.2

Q ss_pred             CCCccCHHHHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeec
Q 046112          191 SFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTA  270 (502)
Q Consensus       191 ~~~~~~~~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  270 (502)
                      ....|++.++..||++|+..++||+|+||.||+| ...+|+.||||+++....+..++|..|++++.+++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG-~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKG-VLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEE-EECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            5677999999999999999999999999999999 556779999998875443215669999999999999999999999


Q ss_pred             ccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCC
Q 046112          271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSN  350 (502)
Q Consensus       271 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~N  350 (502)
                      |.+..    .+.+||||||++|||.++|+.        .....++|.+|++||.++|+||+|||..+.++|+||||||+|
T Consensus       140 C~e~~----~~~~LVYEym~nGsL~d~L~~--------~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN  207 (361)
T KOG1187|consen  140 CLEGG----EHRLLVYEYMPNGSLEDHLHG--------KKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN  207 (361)
T ss_pred             EecCC----ceEEEEEEccCCCCHHHHhCC--------CCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence            96432    258999999999999999975        111178999999999999999999999999999999999999


Q ss_pred             eeeCCCCcEEEeeeccceecccccccceeccc-ccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccc-cc
Q 046112          351 ILLDDEMTAYVSDFGIARFLEAADEQTRSIGV-EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMF-KD  428 (502)
Q Consensus       351 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~-~~  428 (502)
                      ||||+++++||+|||+|+..+......  ... .||.+|+|||+...+..+.|+|||||||+|+|++||+.|.+... ..
T Consensus       208 ILLD~~~~aKlsDFGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~  285 (361)
T KOG1187|consen  208 ILLDEDFNAKLSDFGLAKLGPEGDTSV--STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRG  285 (361)
T ss_pred             eeECCCCCEEccCccCcccCCccccce--eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcc
Confidence            999999999999999997654311111  111 79999999999999999999999999999999999999988643 34


Q ss_pred             ccchHHHHHhhccc-chhhhcccCCCC-cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          429 NLNLRNCVKSALPE-RAEEIRASSGST-QRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       429 ~~~~~~~~~~~~~~-~~~~~~d~~~~~-~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                      ...+.+|+...+.+ ...+++|+.+.. ... ..++...+..++.+|++.+|++||+|.||+++|+.+..
T Consensus       286 ~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~-~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  286 ELSLVEWAKPLLEEGKLREIVDPRLKEGEYP-DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             cccHHHHHHHHHHCcchhheeCCCccCCCCC-hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            45588998777766 789999999763 222 12678889999999999999999999999999966543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-50  Score=392.47  Aligned_cols=259  Identities=33%  Similarity=0.494  Sum_probs=210.6

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeE-EEEEEecccCcch--hHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          208 SSENLIGAGNFGSVYKGILFESTTA-VAVKVFNVLHHDA--SKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       208 ~~~~~lG~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ...+.+|+|+||+||+|.+  .|+. ||||++.......  .++|.+|+.++.+++|||||+++|+|....    ...++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~~i  117 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSLCI  117 (362)
T ss_pred             hhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----CceEE
Confidence            3445699999999999987  5555 9999997543222  458999999999999999999999985421    26899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceeecCCCCCeeeCCCC-cEEEe
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPP-IAHCDLKPSNILLDDEM-TAYVS  362 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-i~H~dlk~~NIll~~~~-~~kl~  362 (502)
                      |||||++|+|.++++.        .....+++..++.|+.+||+||.|||   +.+ ||||||||+|||++.++ ++||+
T Consensus       118 VtEy~~~GsL~~~l~~--------~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~  186 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHK--------KRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIA  186 (362)
T ss_pred             EEEeCCCCcHHHHHhh--------cccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEEC
Confidence            9999999999999964        24677999999999999999999999   777 99999999999999997 99999


Q ss_pred             eeccceecccccccceecccccccccccCcccC--CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM--GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |||+++......  .......||+.|||||.+.  ...|+.|+|||||||++|||+||+.||.+.....  ....   ..
T Consensus       187 DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~--~~~~---v~  259 (362)
T KOG0192|consen  187 DFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ--VASA---VV  259 (362)
T ss_pred             CCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH--HHHH---HH
Confidence            999998765332  2233467999999999999  5699999999999999999999999998853311  1111   10


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE  500 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~  500 (502)
                      ..          ...+.+..+|...+..++.+||..||.+||++.+++..|+.+.+....
T Consensus       260 ~~----------~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  260 VG----------GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             hc----------CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            00          011122234788899999999999999999999999999999886653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-49  Score=368.62  Aligned_cols=252  Identities=25%  Similarity=0.316  Sum_probs=208.7

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc-ceeEE
Q 046112          208 SSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND-FKALV  285 (502)
Q Consensus       208 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~-~~~lv  285 (502)
                      ...+.||+|..|+||++++..+++.+|+|++.... ....+++.+|+++++..+||+||.++|.+.     .+. ...|+
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~-----~~~~~isI~  156 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY-----SNGEEISIC  156 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE-----eCCceEEee
Confidence            55689999999999999999999999999995432 334578999999999999999999999953     333 59999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeec
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG  365 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg  365 (502)
                      ||||.+|||++++..          .+.+++...-+|+.++++||.|||+  +++|+||||||+|||++..|+|||||||
T Consensus       157 mEYMDgGSLd~~~k~----------~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFG  224 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKR----------VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFG  224 (364)
T ss_pred             hhhcCCCCHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEecccc
Confidence            999999999999843          3669999999999999999999994  3899999999999999999999999999


Q ss_pred             cceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchh
Q 046112          366 IARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAE  445 (502)
Q Consensus       366 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  445 (502)
                      .++.+...    .....+||..|||||.+.+..|+.++||||||++++|+.+|+.||........++.+        .+.
T Consensus       225 VS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~--------Ll~  292 (364)
T KOG0581|consen  225 VSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE--------LLC  292 (364)
T ss_pred             ccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH--------HHH
Confidence            99877654    334678999999999999999999999999999999999999999764222222222        222


Q ss_pred             hhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          446 EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       446 ~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      .+.+...+..++  ..+..++..++..|+++||.+||+++|+++.
T Consensus       293 ~Iv~~ppP~lP~--~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  293 AIVDEPPPRLPE--GEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             HHhcCCCCCCCc--ccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            233322222222  1478889999999999999999999999763

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-49  Score=383.49  Aligned_cols=255  Identities=30%  Similarity=0.455  Sum_probs=211.2

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEee
Q 046112          208 SSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE  287 (502)
Q Consensus       208 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  287 (502)
                      ...+.||+|-||.||.|.+ .....||+|.++.. ....++|.+|+++|++++|+|||+++|+|...+     ..+||||
T Consensus       209 ~l~~~LG~G~FG~V~~g~~-~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVtE  281 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKW-NGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVTE  281 (468)
T ss_pred             HHHHHhcCCccceEEEEEE-cCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEEE
Confidence            3457899999999999977 45558999998864 344678999999999999999999999986433     7899999


Q ss_pred             eccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccc
Q 046112          288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA  367 (502)
Q Consensus       288 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a  367 (502)
                      ||+.|+|.++|..        .....+...+.+.++.|||+||+||+   ++++|||||.++|||++++..+||+|||+|
T Consensus       282 ~m~~GsLl~yLr~--------~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLA  350 (468)
T KOG0197|consen  282 YMPKGSLLDYLRT--------REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLA  350 (468)
T ss_pred             ecccCcHHHHhhh--------cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccc
Confidence            9999999999964        45667899999999999999999999   999999999999999999999999999999


Q ss_pred             eecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccchhh
Q 046112          368 RFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       368 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      +... .+.+....+..-+..|.|||.+..+++|.|||||||||+|||++| |+.||..+...+  ..+.+....      
T Consensus       351 r~~~-d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--v~~~le~Gy------  421 (468)
T KOG0197|consen  351 RLIG-DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--VLELLERGY------  421 (468)
T ss_pred             cccC-CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--HHHHHhccC------
Confidence            9443 333444445556788999999999999999999999999999999 999988753221  111111111      


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                              ..+-+..|+..+.++|..||+.+|++|||++.+...|+.+...
T Consensus       422 --------Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  422 --------RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             --------cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence                    1111347899999999999999999999999999999887654

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.4e-49  Score=398.45  Aligned_cols=268  Identities=25%  Similarity=0.429  Sum_probs=221.9

Q ss_pred             CCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          206 GFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      +....+.||+|+||.||+|+-.     .....||||.++..... ..++|++|+++++.++|||||+++|.|...+    
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~----  562 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD----  562 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC----
Confidence            3445678999999999999653     24468999999876655 6789999999999999999999999996544    


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKA----PGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD  355 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~  355 (502)
                       ..++|+|||..|+|.+||............    +.+++..+.++||.|||.||.||-   ++.+|||||..+|+|+.+
T Consensus       563 -P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  563 -PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGE  638 (774)
T ss_pred             -eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceecc
Confidence             899999999999999999654332222212    455999999999999999999999   999999999999999999


Q ss_pred             CCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHH
Q 046112          356 EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRN  434 (502)
Q Consensus       356 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~  434 (502)
                      +..|||+|||+++.+-..+++.......-..+|||||.++.+++|++||||||||+|||+++ |+.||.+...++     
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-----  713 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-----  713 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----
Confidence            99999999999998877777655445556889999999999999999999999999999999 999998743322     


Q ss_pred             HHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          435 CVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       435 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                              .++.+.+...-..   ++.|+.++..||..||+.+|++||+++|+...|+...+.
T Consensus       714 --------VIe~i~~g~lL~~---Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  714 --------VIECIRAGQLLSC---PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             --------HHHHHHcCCcccC---CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                    1122222222122   358999999999999999999999999999999887554

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-47  Score=373.67  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=209.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ..|...+.||+|||+.+|++++..+|..||+|++...   .....+...+|+++.+.++|||||+++++     |++.+.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence            4688999999999999999999999999999998642   23345678899999999999999999999     778889


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .|+|.|+|++|+|..++          ....++++.++..+..||+.||.|||   +.+|+|||||..|+||+++++|||
T Consensus        93 VYivLELC~~~sL~el~----------Krrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKI  159 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELL----------KRRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKI  159 (592)
T ss_pred             eEEEEEecCCccHHHHH----------HhcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEe
Confidence            99999999999999998          45678999999999999999999999   999999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+|..+...++.  ....+|||.|+|||++.....+..+||||+||+||.|+.|++||+...     +.+-.+. +.
T Consensus       160 gDFGLAt~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----vkety~~-Ik  231 (592)
T KOG0575|consen  160 GDFGLATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----VKETYNK-IK  231 (592)
T ss_pred             cccceeeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----HHHHHHH-HH
Confidence            999999988755433  345789999999999999999999999999999999999999998721     1111111 10


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                                 ...+.++.....+..+|+.++++.||.+|||+++|+.
T Consensus       232 -----------~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  232 -----------LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -----------hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                       0111112233445668999999999999999999975

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5e-47  Score=354.48  Aligned_cols=200  Identities=31%  Similarity=0.522  Sum_probs=177.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc--CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL--HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ..+|...+.||+|+||+||+|++..++..||||.+...  .....+.+..|+++|+.++|||||++++++.     .+++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-----~~~~   83 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE-----DDDF   83 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-----cCCe
Confidence            45788888999999999999999999999999998654  3444566889999999999999999999954     4459


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC-----
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE-----  356 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~-----  356 (502)
                      .++|||||.+|+|.+|++.          .+.+++.+...+..|+|.||++||   +++||||||||.||||+..     
T Consensus        84 i~lVMEyC~gGDLs~yi~~----------~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~  150 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRR----------RGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDT  150 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCC
Confidence            9999999999999999953          457999999999999999999999   9999999999999999765     


Q ss_pred             -CcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          357 -MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       357 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                       -.+||+|||+|+.+.+...   ....+|++.|||||+++..+|+.|+|+||.|+++|++++|+.||+.
T Consensus       151 ~~~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  151 SPVLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             CceEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence             4689999999998864332   2357899999999999999999999999999999999999999985

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-48  Score=343.15  Aligned_cols=258  Identities=23%  Similarity=0.296  Sum_probs=206.1

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc-e
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF-K  282 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~-~  282 (502)
                      +|.+.++||+|.||+||++....+|..||.|.++-..  ..+.+....|+.+|++++|||||+++++.    +..+.+ .
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~----f~~~~evl   95 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHS----FIEDNEVL   95 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHh----hhccchhh
Confidence            4677889999999999999999999999999987433  33456788999999999999999998853    333444 8


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeecCCCCCeeeCCCCcEE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPP--IAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--i~H~dlk~~NIll~~~~~~k  360 (502)
                      +||||||..|+|...++.++      .....+++...++++.|++.||..+|.-- +.  |+||||||.||+++.+|.||
T Consensus        96 nivmE~c~~GDLsqmIk~~K------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvK  168 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFK------KQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVK  168 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHH------hccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCcee
Confidence            89999999999999997644      44567899999999999999999999211 45  99999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||+++++....+  ...+.+|||.||+||.+....|+.||||||+||++|||..-++||.+.     ++.+..+..-
T Consensus       169 LGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~  241 (375)
T KOG0591|consen  169 LGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIE  241 (375)
T ss_pred             eccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHH
Confidence            999999998865432  335688999999999999999999999999999999999999999762     2332221111


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                      ..        ..+..+  ..-....+..|+..|+..||+.||+...++..+
T Consensus       242 qg--------d~~~~p--~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  242 QG--------DYPPLP--DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             cC--------CCCCCc--HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            11        111111  124466788999999999999999865554444

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-47  Score=353.82  Aligned_cols=252  Identities=23%  Similarity=0.301  Sum_probs=203.8

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-------chhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-------DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      +.|...+.||+|+||.|-+|....+|+.||||++++...       ......++|+++|++++|||||++.++     +.
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~-----f~  246 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF-----FE  246 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----ee
Confidence            456778999999999999999999999999999974321       122345799999999999999999999     55


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC-
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE-  356 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~-  356 (502)
                      ..+..|+||||++||.|.+.+          ...+.+.+.....++.|++.|+.|||   +.||+||||||+|||+..+ 
T Consensus       247 ~~ds~YmVlE~v~GGeLfd~v----------v~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~  313 (475)
T KOG0615|consen  247 VPDSSYMVLEYVEGGELFDKV----------VANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDA  313 (475)
T ss_pred             cCCceEEEEEEecCccHHHHH----------HhccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCC
Confidence            566889999999999999998          33455666777889999999999999   9999999999999999766 


Q ss_pred             --CcEEEeeeccceecccccccceecccccccccccCcccCCCccC---ccccchhHHHHHHHHHhCCCCCccccccccc
Q 046112          357 --MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVS---SYGDVYSFGILLLEMFTGLRPSDDMFKDNLN  431 (502)
Q Consensus       357 --~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s---~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~  431 (502)
                        ..+||+|||+|+...   +...+...+||+.|.|||++.+..++   .+.|+||+||+||-+++|.+||.+...+..-
T Consensus       314 e~~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl  390 (475)
T KOG0615|consen  314 EDCLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL  390 (475)
T ss_pred             cceEEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH
Confidence              789999999999765   33455678899999999999876533   3679999999999999999999874333211


Q ss_pred             hHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          432 LRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       432 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..+..+.            .....+....+...+..+++.+++..||++|||+.|+++
T Consensus       391 ~eQI~~G------------~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  391 KEQILKG------------RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHHHhcC------------cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            1222222            222223334577788889999999999999999999875

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-45  Score=357.24  Aligned_cols=263  Identities=25%  Similarity=0.362  Sum_probs=207.1

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ..+.+...+.||+|+||+||+|+|..   .||||+++....  +..+.|..|+..+++-+|.||+-++|||...      
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p------  460 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP------  460 (678)
T ss_pred             CHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC------
Confidence            34455678899999999999998854   499999986543  3457899999999999999999999998532      


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..+||+.+|++.||+.++|.         ....++..+.+.||+|+|+||.|||   .++|||||||..||++.+++.||
T Consensus       461 ~~AIiTqwCeGsSLY~hlHv---------~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVk  528 (678)
T KOG0193|consen  461 PLAIITQWCEGSSLYTHLHV---------QETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVK  528 (678)
T ss_pred             ceeeeehhccCchhhhhccc---------hhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEE
Confidence            34999999999999999984         3456888999999999999999999   99999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCC---CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHH
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG---HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  437 (502)
                      |+|||++..-..-.......-..|...|||||++..   .+|+..+||||||+|+|||+||..||... ..+..+...-+
T Consensus       529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIifmVGr  607 (678)
T KOG0193|consen  529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQIIFMVGR  607 (678)
T ss_pred             EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheEEEecc
Confidence            999999964322111111122346788999999875   46999999999999999999999999842 11111111101


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      ....           +........|++++.+|+..||..++++||++.+++..|+.+....
T Consensus       608 G~l~-----------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  608 GYLM-----------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             cccC-----------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            1000           1111223478899999999999999999999999999988886643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.2e-44  Score=325.32  Aligned_cols=262  Identities=21%  Similarity=0.327  Sum_probs=203.1

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc--hhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD--ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .|+...++|+|+||+||++++.++|+.||||++....++  -.+-..+|++++++++|+|+|.++++     +......+
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrklh   77 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKLH   77 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhcceeE
Confidence            466778999999999999999999999999998754332  23457899999999999999999999     55566899


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||++.--|.+. .         .....++.....+++.|++.|+.|+|   +++++||||||+|||++.++.+||||
T Consensus        78 LVFE~~dhTvL~eL-e---------~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCD  144 (396)
T KOG0593|consen   78 LVFEYCDHTVLHEL-E---------RYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCD  144 (396)
T ss_pred             EEeeecchHHHHHH-H---------hccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEecc
Confidence            99999976544443 2         34566888999999999999999999   99999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+|+.+..+..  ..+.++.|.+|+|||.+.+ .+|....||||.||++.||++|.+.|.+.  .+.+....+...+.+
T Consensus       145 FGFAR~L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~--SDiDQLy~I~ktLG~  220 (396)
T KOG0593|consen  145 FGFARTLSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR--SDIDQLYLIRKTLGN  220 (396)
T ss_pred             chhhHhhcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc--chHHHHHHHHHHHcc
Confidence            999998874322  2346778999999999888 68999999999999999999999988762  222322222222221


Q ss_pred             ---chhhhcc----------cCCCCcchh---hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 ---RAEEIRA----------SSGSTQRSI---ILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ---~~~~~~d----------~~~~~~~~~---~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                         .-..++.          +..+...+.   .......+++++..|++.||.+|++-+|++.
T Consensus       221 L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  221 LIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence               1111111          111111111   1233447789999999999999999998863

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-45  Score=382.42  Aligned_cols=266  Identities=24%  Similarity=0.368  Sum_probs=216.3

Q ss_pred             CCCCCCcccccCCceEEEEEEcCC-C----eEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          206 GFSSENLIGAGNFGSVYKGILFES-T----TAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      +.+....||+|.||.||+|..... |    ..||||.++... .+...+|.+|..+|++++|||||+++|.|..     .
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-----~  767 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-----S  767 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----C
Confidence            344567899999999999976543 2    348999887543 4456789999999999999999999999854     3


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...+|++|||++|+|..||++.+...   .+...++..+.+.++.|||+|+.||+   +.++|||||.++|+||+....|
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~---~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~V  841 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAP---FQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVV  841 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhccccc---CCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcE
Confidence            47899999999999999997643322   23677899999999999999999999   9999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHH-HHH
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRN-CVK  437 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~-~~~  437 (502)
                      ||+|||+|+.+...+++.......-...|||||.+.++.++.|+|||||||++||++| |..||.+..+.  +... +.+
T Consensus       842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--~v~~~~~~  919 (1025)
T KOG1095|consen  842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--EVLLDVLE  919 (1025)
T ss_pred             EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH--HHHHHHHh
Confidence            9999999996665555444333344578999999999999999999999999999999 99999873221  1111 111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                                     ...-+.+..|+..+.++|..||+.+|++||++..+++.+..+.....
T Consensus       920 ---------------ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  920 ---------------GGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             ---------------CCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence                           11223345889999999999999999999999999999988876553

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-44  Score=337.55  Aligned_cols=263  Identities=25%  Similarity=0.334  Sum_probs=210.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcch-hHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .+.|...+.||.|..++||+|+..+.+..||||+++...-+. .+.+++|+..++.++||||++++..     |..+..+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~s-----Fvv~~~L   99 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCS-----FVVDSEL   99 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEE-----EEeccee
Confidence            457888899999999999999999999999999998654333 4889999999999999999999876     4556689


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      |+||.||.+||+.+.++.        .....+++.....|..++++||.|||   .+|.||||||+.|||+|++|.|||+
T Consensus       100 WvVmpfMa~GS~ldIik~--------~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLa  168 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKT--------YYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLA  168 (516)
T ss_pred             EEeehhhcCCcHHHHHHH--------HccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEc
Confidence            999999999999999965        45566999999999999999999999   9999999999999999999999999


Q ss_pred             eeccceecccccccc--eecccccccccccCcccCC--CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          363 DFGIARFLEAADEQT--RSIGVEGTTGYIAPEYGMG--HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      |||.+..+.......  +.....||+.|||||.++.  ..|+.|+||||||++..|+.+|+.||....... .+..-+..
T Consensus       169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-vLl~tLqn  247 (516)
T KOG0582|consen  169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-VLLLTLQN  247 (516)
T ss_pred             CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-HHHHHhcC
Confidence            999987766544321  1255689999999999554  469999999999999999999999998742211 11111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..+...      .....++........+.+++..|+.+||++|||++++++
T Consensus       248 ~pp~~~------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  248 DPPTLL------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CCCCcc------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111100      000111112344558899999999999999999999875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-45  Score=368.55  Aligned_cols=258  Identities=25%  Similarity=0.437  Sum_probs=214.4

Q ss_pred             CCCCCcccccCCceEEEEEEcCCC---eEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          207 FSSENLIGAGNFGSVYKGILFEST---TAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ..+.++||.|.||.||+|+.+..|   ..||||.++....+ ...+|..|+.+|.++.||||+++.|.     .......
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGV-----VTks~Pv  705 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGV-----VTKSKPV  705 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEE-----EecCcee
Confidence            356789999999999999877555   56999999976544 34679999999999999999999999     5556689


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      +||.|||+||+|+.||+.         ..+.+++.+...+..+||.||.||.   +.++|||||.++|||++.+..+|++
T Consensus       706 MIiTEyMENGsLDsFLR~---------~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVs  773 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQ---------NDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVS  773 (996)
T ss_pred             EEEhhhhhCCcHHHHHhh---------cCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEec
Confidence            999999999999999963         4466999999999999999999999   9999999999999999999999999


Q ss_pred             eeccceecccccc-cceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhc
Q 046112          363 DFGIARFLEAADE-QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       363 Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |||++|.+.+... .....+-.-...|.|||.+...+++.+||||||||||||.++ |.+||=++.+.+  ....+....
T Consensus       774 DFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--VIkaIe~gy  851 (996)
T KOG0196|consen  774 DFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VIKAIEQGY  851 (996)
T ss_pred             cccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH--HHHHHHhcc
Confidence            9999998865442 222233334689999999999999999999999999999988 999986643321  111111111


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                                    ..+.+.+|+..|.+||+.||++|-.+||++.+++..|.++.+.
T Consensus       852 --------------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  852 --------------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             --------------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence                          1122468999999999999999999999999999999988653

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=335.40  Aligned_cols=243  Identities=25%  Similarity=0.348  Sum_probs=199.5

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .++|...++||+|+||.||.++..++++.+|+|++++..   ....+....|..++.+++||.||++.-.     |+..+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~~   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTEE   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccCC
Confidence            467899999999999999999999999999999997542   2345668889999999999999999876     77888


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      .+|+|+||+.||.|..+|          +..+.+++..+.-++.+|+.||.|||   +.+|+||||||+|||||.+|.++
T Consensus        99 kLylVld~~~GGeLf~hL----------~~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~  165 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHL----------QREGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIK  165 (357)
T ss_pred             eEEEEEeccCCccHHHHH----------HhcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEE
Confidence            999999999999999999          44567889988899999999999999   99999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||+++......  ..+...+||+.|||||++.+..|+..+|.||+||++|||++|.+||...     +...+.+...
T Consensus       166 LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~~~~I~  238 (357)
T KOG0598|consen  166 LTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKMYDKIL  238 (357)
T ss_pred             EeccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHHHHHHh
Confidence            99999998543332  2334578999999999999999999999999999999999999999762     1222222222


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM  482 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP  482 (502)
                      ...        ....+.   -......+++.+.++.||++|.
T Consensus       239 ~~k--------~~~~p~---~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  239 KGK--------LPLPPG---YLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             cCc--------CCCCCc---cCCHHHHHHHHHHhccCHHHhc
Confidence            211        011111   1233455788888899999996

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=339.87  Aligned_cols=259  Identities=26%  Similarity=0.386  Sum_probs=203.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ..++...+.||+|+||+||++....+|...|||..........+.+.+|+.+|.+++|||||+++|......  . ..++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-eeeE
Confidence            345677899999999999999988889999999987553333567899999999999999999999632211  1 3688


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC-CCcEEEe
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD-EMTAYVS  362 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~-~~~~kl~  362 (502)
                      +.|||+++|||.+++..        ... .+++......+.|+++||+|||   +++|+||||||+|||++. ++.+||+
T Consensus        93 i~mEy~~~GsL~~~~~~--------~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~Kla  160 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKR--------YGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLA  160 (313)
T ss_pred             eeeeccCCCcHHHHHHH--------cCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEec
Confidence            99999999999999953        222 6999999999999999999999   999999999999999999 7999999


Q ss_pred             eeccceecccc-cccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          363 DFGIARFLEAA-DEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       363 Dfg~a~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |||+++..... ..........||+.|||||++..+ ....++||||+||++.||+||+.||....    ...++.-...
T Consensus       161 DFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~----~~~~~~~~ig  236 (313)
T KOG0198|consen  161 DFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF----EEAEALLLIG  236 (313)
T ss_pred             cCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc----chHHHHHHHh
Confidence            99999876541 112334467899999999999964 33458999999999999999999998631    1111111110


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                      .+       .   ..+.++........+++.+|+..||++|||++++++.-
T Consensus       237 ~~-------~---~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  237 RE-------D---SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             cc-------C---CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            00       0   11122234455677899999999999999999998764

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-44  Score=345.90  Aligned_cols=261  Identities=23%  Similarity=0.339  Sum_probs=214.3

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEE
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      ....++||+|-||.|.++. .+.+..||||.++..... ...+|.+|+++|.+++||||++++|+|...+     ..++|
T Consensus       540 L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----PicmI  613 (807)
T KOG1094|consen  540 LRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PLCMI  613 (807)
T ss_pred             eehhhhhcCcccceeEEEE-ecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----chHHH
Confidence            3456899999999999995 466799999999866544 3488999999999999999999999996544     78999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeec
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG  365 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg  365 (502)
                      +|||++|+|.+++..        .....+.......|+.|||.||+||.   +-++|||||.++|+|+|.++++||+|||
T Consensus       614 ~EYmEnGDLnqFl~a--------heapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfg  682 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSA--------HELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFG  682 (807)
T ss_pred             HHHHhcCcHHHHHHh--------ccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcc
Confidence            999999999999964        22233566677889999999999999   8999999999999999999999999999


Q ss_pred             cceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh--CCCCCccccccccchHHHHHhhcccc
Q 046112          366 IARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT--GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       366 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ++|.+-..+++......+-+..|||||.+..++++++||||+|||++||+++  ...||.+..++.          +.+.
T Consensus       683 msR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~----------vven  752 (807)
T KOG1094|consen  683 MSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ----------VVEN  752 (807)
T ss_pred             cccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH----------HHHh
Confidence            9998777776665555667899999999999999999999999999999876  778887643321          1122


Q ss_pred             hhhhc-ccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          444 AEEIR-ASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       444 ~~~~~-d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      ..++. ++........+.-|+..+.+++.+||+.|-++||+++++...|.+.
T Consensus       753 ~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  753 AGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            22222 2222222333457889999999999999999999999999888764

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=9e-44  Score=352.27  Aligned_cols=272  Identities=24%  Similarity=0.334  Sum_probs=206.7

Q ss_pred             ccCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccCc-chhHHHHHHHHHHhcC-CCCccceeeeccccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNI-RHRNLVKVFTACSGVDF  276 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  276 (502)
                      .++|...++||+|+||.||+|.+.     .+++.||||+++.... ...+.+.+|+.++..+ +||||++++++|..   
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---   82 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK---   82 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC---
Confidence            457888999999999999999642     3457899999874332 2346788999999999 89999999998742   


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhh--------------------------------------------------
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDK--------------------------------------------------  306 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------------------------------------------  306 (502)
                       .+...++||||+++|+|.+++........                                                  
T Consensus        83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence             23468899999999999999864211000                                                  


Q ss_pred             --ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecccccccceeccccc
Q 046112          307 --RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG  384 (502)
Q Consensus       307 --~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  384 (502)
                        .......+++.+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.............+
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence              0001245888899999999999999999   89999999999999999999999999999986543332222233456


Q ss_pred             ccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHH
Q 046112          385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECL  463 (502)
Q Consensus       385 t~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  463 (502)
                      +..|+|||++.+..++.++|||||||++|||++ |+.||....... .+......           .....   ....+.
T Consensus       239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~~-----------~~~~~---~~~~~~  303 (338)
T cd05102         239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLKD-----------GTRMR---APENAT  303 (338)
T ss_pred             CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHhc-----------CCCCC---CCCCCC
Confidence            788999999999999999999999999999997 999997632111 11111110           00000   012345


Q ss_pred             HHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          464 ISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       464 ~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ..+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            5688999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=345.84  Aligned_cols=253  Identities=23%  Similarity=0.369  Sum_probs=207.3

Q ss_pred             HhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcC-CCCccceeeecccccccC
Q 046112          202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       202 ~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  277 (502)
                      ....+|..++.||+|+|++|++|+...+++.+|||++.+.   .....+-+..|-++|.+| .||.|++++..     |+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----FQ  144 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----FQ  144 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----ee
Confidence            3456889999999999999999999999999999998643   223345577889999999 89999999876     67


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                      +...+|+|+||+++|+|.++++.          .+.+++.....++.+|..||+|||   +.|||||||||+|||||.++
T Consensus       145 D~~sLYFvLe~A~nGdll~~i~K----------~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dm  211 (604)
T KOG0592|consen  145 DEESLYFVLEYAPNGDLLDLIKK----------YGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDG  211 (604)
T ss_pred             cccceEEEEEecCCCcHHHHHHH----------hCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCC
Confidence            77799999999999999999953          467899999999999999999999   99999999999999999999


Q ss_pred             cEEEeeeccceeccccccc---------ce--ecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccc
Q 046112          358 TAYVSDFGIARFLEAADEQ---------TR--SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMF  426 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~  426 (502)
                      ++||+|||-|+.+.+....         ..  ....+||..|.+||++.++..+..+|+|+|||++|.|+.|++||.+..
T Consensus       212 hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N  291 (604)
T KOG0592|consen  212 HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN  291 (604)
T ss_pred             cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence            9999999999988654322         11  245889999999999999999999999999999999999999997621


Q ss_pred             ccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          427 KDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                       +..-+            ..+++-    .+++....++...+|+.+.+..||.+|+|.+++.+
T Consensus       292 -eyliF------------qkI~~l----~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  292 -EYLIF------------QKIQAL----DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             -HHHHH------------HHHHHh----cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence             11111            111111    12222233456668888999999999999987754

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4e-43  Score=310.29  Aligned_cols=264  Identities=20%  Similarity=0.282  Sum_probs=205.3

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .+|...+++|+|.||.||+|++.++|+.||||+++...  ..-.....+|++.|+.++|+||+.++++     +...+..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence            46777899999999999999999999999999987542  2234567899999999999999999999     5666689


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      .+|+|||+ -+|...++         .....++..+...++.++.+|++|||   .+.|+||||||+|+|++++|.+||+
T Consensus        77 ~lVfEfm~-tdLe~vIk---------d~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiA  143 (318)
T KOG0659|consen   77 SLVFEFMP-TDLEVVIK---------DKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIA  143 (318)
T ss_pred             EEEEEecc-ccHHHHhc---------ccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEee
Confidence            99999995 48888885         34566889999999999999999999   9999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||+|+.+.+......  ..+.|.+|+|||.+.+. .|+...||||.||++.||+-|.+-|.+. + +.+....+-..+.
T Consensus       144 DFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-s-DidQL~~If~~LG  219 (318)
T KOG0659|consen  144 DFGLARFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-S-DIDQLSKIFRALG  219 (318)
T ss_pred             cccchhccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-c-hHHHHHHHHHHcC
Confidence            9999999876654332  23679999999998874 6999999999999999999998666542 2 2222222212211


Q ss_pred             c-chhhhcccC----------C--CCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          442 E-RAEEIRASS----------G--STQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       442 ~-~~~~~~d~~----------~--~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      . ...++.+-.          .  .........+....++++..++..||.+|+|++|++++
T Consensus       220 TP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  220 TPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1 111111100          0  00111223455566899999999999999999998753

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=342.95  Aligned_cols=250  Identities=23%  Similarity=0.310  Sum_probs=208.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ..|....+||+|+.|.||.|....++..||||++........+-+.+|+.+|+..+|+|||++++.+.     ..++.++
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl-----v~deLWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL-----VGDELWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc-----ccceeEE
Confidence            45777889999999999999999999999999998776666677899999999999999999998853     3468999


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      |||||++|+|.|.+..           ..+++.+...|+.++++||+|||   ..+|+|||||.+|||++.++.+||+||
T Consensus       348 VMEym~ggsLTDvVt~-----------~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDF  413 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTK-----------TRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDF  413 (550)
T ss_pred             EEeecCCCchhhhhhc-----------ccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeee
Confidence            9999999999999853           33889999999999999999999   999999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      |++..+.....  .....+||+.|||||......|.+|.||||||++++||+-|.+||-.   +. .++.         +
T Consensus       414 GFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln---E~-PlrA---------l  478 (550)
T KOG0578|consen  414 GFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN---EN-PLRA---------L  478 (550)
T ss_pred             eeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC---CC-hHHH---------H
Confidence            99987765433  33467899999999999999999999999999999999999999864   11 1111         1


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      +.+.+..-.. ..........+.+++.+|++.||++||++.|+++
T Consensus       479 yLIa~ng~P~-lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  479 YLIATNGTPK-LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             HHHhhcCCCC-cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            1111111111 1112345667889999999999999999999986

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=348.77  Aligned_cols=261  Identities=26%  Similarity=0.385  Sum_probs=208.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCe---E-EEEEEecc---cCcchhHHHHHHHHHHhcCCCCccceeeeccccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTT---A-VAVKVFNV---LHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF  276 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~---~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  276 (502)
                      .++....++||+|+||.||+|.....+.   . ||||..+.   ......++|..|++++++++|||||+++|++...  
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~--  233 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE--  233 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--
Confidence            3445566899999999999998765422   3 89999874   2345568899999999999999999999997543  


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE  356 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~  356 (502)
                         ...++|||+|+||+|.++|..         ....++..+++.++.++|.||+|||   +.+++||||.++|+|++.+
T Consensus       234 ---~Pl~ivmEl~~gGsL~~~L~k---------~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~  298 (474)
T KOG0194|consen  234 ---EPLMLVMELCNGGSLDDYLKK---------NKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKK  298 (474)
T ss_pred             ---CccEEEEEecCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCC
Confidence               389999999999999999963         2336999999999999999999999   9999999999999999999


Q ss_pred             CcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHH
Q 046112          357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~  435 (502)
                      +.+||+|||+++.-..  .........-+..|+|||.+..+.+++++|||||||++||+++ |..||.+....  ....+
T Consensus       299 ~~vKISDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~k  374 (474)
T KOG0194|consen  299 GVVKISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAK  374 (474)
T ss_pred             CeEEeCccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHH
Confidence            9999999999875431  1111112245688999999999999999999999999999999 89899874221  22222


Q ss_pred             H-HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          436 V-KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       436 ~-~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      + ....+-              ......+..+..++.+||..+|++||||.++.+.|+.+.....
T Consensus       375 I~~~~~r~--------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  375 IVKNGYRM--------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             HHhcCccC--------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            2 111111              1112456778889999999999999999999999999876643

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-43  Score=335.74  Aligned_cols=265  Identities=21%  Similarity=0.257  Sum_probs=203.3

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .|...++||+|.||.||+|++..+|+.||+|++....  .....-..+||.+|++++||||+++.+.....   .....|
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~siY  194 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGSIY  194 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCceEE
Confidence            4566789999999999999999999999999987544  33456678999999999999999999985432   245799


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+|||++ +|.-++.         ...-.+++.+...+..|++.||+|+|   .++|+|||||.+|||+|.+|.+||+|
T Consensus       195 lVFeYMdh-DL~GLl~---------~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaD  261 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLS---------SPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIAD  261 (560)
T ss_pred             EEEecccc-hhhhhhc---------CCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEecc
Confidence            99999965 7777764         34456899999999999999999999   99999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+|+++....... .++.+.|.+|+|||.+.+. .|+.+.|+||.||+|.||++|++.|....  +....+.+-.....
T Consensus       262 FGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t--EveQl~kIfklcGS  338 (560)
T KOG0600|consen  262 FGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT--EVEQLHKIFKLCGS  338 (560)
T ss_pred             ccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc--HHHHHHHHHHHhCC
Confidence            99999887655433 4567789999999998875 69999999999999999999999987621  11111111111110


Q ss_pred             -----ch-h-----hhcccCCCCcc---hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 -----RA-E-----EIRASSGSTQR---SIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 -----~~-~-----~~~d~~~~~~~---~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                           |. .     ..+.+.-....   +.........++|+..++..||.+|.|+.++++
T Consensus       339 P~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  339 PTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                 10 0     00001100000   011123446678899999999999999998874

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-44  Score=338.34  Aligned_cols=266  Identities=20%  Similarity=0.218  Sum_probs=204.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcch-hHHHHHHHHHHhcCC-CCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|...++||.|.||+||+|+...++..||||.++..-... .-.-.+|++.|++++ |||||++.+...    +.+..+
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~----d~~~~L   85 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIR----DNDRIL   85 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh----ccCceE
Confidence            45677789999999999999999999999999997543222 223468999999999 999999999842    223389


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||| ..+|.+.+++         ....+++.+...|+.||++||+|+|   ++|+.|||+||+|||+.....+||+
T Consensus        86 ~fVfE~M-d~NLYqLmK~---------R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKia  152 (538)
T KOG0661|consen   86 YFVFEFM-DCNLYQLMKD---------RNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIA  152 (538)
T ss_pred             eeeHHhh-hhhHHHHHhh---------cCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEec
Confidence            9999999 5699999863         3678999999999999999999999   9999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccC-CCccCccccchhHHHHHHHHHhCCCCCcccccccc--chHHHHHhh
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM-GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL--NLRNCVKSA  439 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~--~~~~~~~~~  439 (502)
                      |||+||.+....   ..+.++.|.+|+|||++. .+-|+.+.||||+||+++|+.+-++.|.+..+-+.  .+.+.+...
T Consensus       153 DFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP  229 (538)
T KOG0661|consen  153 DFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTP  229 (538)
T ss_pred             ccccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCC
Confidence            999999776543   334677899999999865 56799999999999999999999988876322111  011111110


Q ss_pred             ccc-chh-----hhcccCCC-----CcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          440 LPE-RAE-----EIRASSGS-----TQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       440 ~~~-~~~-----~~~d~~~~-----~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ..+ +.+     ..+.-.++     ...+....+..+..+++.+|+.+||.+|||++|.++.
T Consensus       230 ~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  230 DKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             ccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            000 110     11111111     1122233567788899999999999999999998763

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.6e-42  Score=332.76  Aligned_cols=251  Identities=22%  Similarity=0.323  Sum_probs=199.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccCcch---hHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA---SKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      ...||+|++|.||+|.+  +|+.||||+++......   .+.|.+|+.++.+++||||++++|++... .......++||
T Consensus        25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~  101 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLIL  101 (283)
T ss_pred             CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEE
Confidence            46899999999999977  78999999987543332   46688999999999999999999987431 12334688999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceeecCCCCCeeeCCCCcEEEeeec
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ-PPIAHCDLKPSNILLDDEMTAYVSDFG  365 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~i~H~dlk~~NIll~~~~~~kl~Dfg  365 (502)
                      ||+++|+|.++++.          ...+++...+.++.+++.|+.|||   + .+++||||||+||++++++.+||+|||
T Consensus       102 Ey~~~g~L~~~l~~----------~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg  168 (283)
T PHA02988        102 EYCTRGYLREVLDK----------EKDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHG  168 (283)
T ss_pred             EeCCCCcHHHHHhh----------CCCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccc
Confidence            99999999999853          345889999999999999999999   5 478899999999999999999999999


Q ss_pred             cceecccccccceecccccccccccCcccCC--CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          366 IARFLEAADEQTRSIGVEGTTGYIAPEYGMG--HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       366 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      +++......     ....++..|+|||++.+  ..++.++|||||||++|||++|+.||.....     .+.........
T Consensus       169 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~~~~i~~~~  238 (283)
T PHA02988        169 LEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEIYDLIINKN  238 (283)
T ss_pred             hHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcC
Confidence            997653322     12457889999999876  6899999999999999999999999976321     11111111000


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                      .          .......++..+.+++.+||+.||++|||++|+++.|+.++.
T Consensus       239 ~----------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        239 N----------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             C----------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            0          001112456678899999999999999999999999988763

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=341.73  Aligned_cols=249  Identities=23%  Similarity=0.344  Sum_probs=202.6

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc----Cc-chhHHHHHHHHHHhcCC-CCccceeeeccccccc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL----HH-DASKSFAVECEVTRNIR-HRNLVKVFTACSGVDF  276 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  276 (502)
                      ...+|...+.||+|+||.|+.|.+..++..||+|+++..    .. ...+.+.+|+.++++++ ||||++++.+.     
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~-----   89 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF-----   89 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE-----
Confidence            456889999999999999999999999999999987643    11 23456678999999999 99999999994     


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE  356 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~  356 (502)
                      ......++||||+.+|+|.+++.          ..+.+.+.....++.|++.|++|||   +++|+||||||+|||+|.+
T Consensus        90 ~t~~~~~ivmEy~~gGdL~~~i~----------~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~  156 (370)
T KOG0583|consen   90 ATPTKIYIVMEYCSGGDLFDYIV----------NKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGN  156 (370)
T ss_pred             ecCCeEEEEEEecCCccHHHHHH----------HcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCC
Confidence            44457999999999999999994          3567888999999999999999999   9999999999999999999


Q ss_pred             -CcEEEeeeccceecccccccceecccccccccccCcccCCCc-cC-ccccchhHHHHHHHHHhCCCCCccccccccchH
Q 046112          357 -MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE-VS-SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR  433 (502)
Q Consensus       357 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~  433 (502)
                       +++||+|||++....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.  .   ..
T Consensus       157 ~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~--~---~~  229 (370)
T KOG0583|consen  157 EGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS--N---VP  229 (370)
T ss_pred             CCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc--c---HH
Confidence             999999999998774  1222334578999999999999977 86 6699999999999999999999872  1   11


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHH-HHHHHHHHhhcccCCCCCCCCHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILEC-LISICEIGVACSAEQPGERMKINDVE  488 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~-~~~l~~l~~~c~~~dP~~RPt~~ev~  488 (502)
                      ...+. +       ...    ...++... ...+..++.+|+..||.+|+|+.++.
T Consensus       230 ~l~~k-i-------~~~----~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  230 NLYRK-I-------RKG----EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             HHHHH-H-------hcC----CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            11111 1       111    11111122 55677999999999999999999998

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-43  Score=331.09  Aligned_cols=249  Identities=23%  Similarity=0.321  Sum_probs=205.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ..|+..+.||+|+||.||+|.+..+++.||+|+++... .+...+++.|+.++..++++||.+++|.+     -.+..++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsy-----l~g~~Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSY-----LKGTKLW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhe-----eecccHH
Confidence            35777799999999999999999999999999998653 34567899999999999999999999984     3455899


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      ++||||.+|++.+.+.          ....+++....-|..++..|+.|||   ..+.+|||||+.|||+..+|.||++|
T Consensus        88 iiMey~~gGsv~~lL~----------~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~D  154 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLK----------SGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLAD  154 (467)
T ss_pred             HHHHHhcCcchhhhhc----------cCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEe
Confidence            9999999999999984          3334467777788999999999999   99999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||.+..+.....  +....+||+.|||||++....|+.|+||||+|++.+||.+|.+|+.+....             ..
T Consensus       155 fgVa~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-------------rv  219 (467)
T KOG0201|consen  155 FGVAGQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-------------RV  219 (467)
T ss_pred             cceeeeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-------------eE
Confidence            999976654433  225688999999999999989999999999999999999999999874221             00


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      +. ++-...+..  ....+...+.+++..|+.+||+.||++.++++
T Consensus       220 lf-lIpk~~PP~--L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  220 LF-LIPKSAPPR--LDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             EE-eccCCCCCc--cccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            11 111111111  11255677889999999999999999999875

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6e-43  Score=337.37  Aligned_cols=247  Identities=26%  Similarity=0.394  Sum_probs=203.6

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEee
Q 046112          208 SSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE  287 (502)
Q Consensus       208 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  287 (502)
                      +..+-||.|+.|.||+|+.  .++.||||+++..       =..+++.|++|+||||+.+.|+|....     .++||||
T Consensus       127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsP-----cyCIiME  192 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSP-----CYCIIME  192 (904)
T ss_pred             hhhhhhccCcccceeeeec--cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCc-----eeEEeee
Confidence            4567899999999999976  6688999987532       134788899999999999999996544     8999999


Q ss_pred             eccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccc
Q 046112          288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA  367 (502)
Q Consensus       288 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a  367 (502)
                      ||+.|-|...|+          ....+.......|..+||.||.|||   .+.|||||||.-|||++.+..|||+|||-+
T Consensus       193 fCa~GqL~~VLk----------a~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS  259 (904)
T KOG4721|consen  193 FCAQGQLYEVLK----------AGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTS  259 (904)
T ss_pred             ccccccHHHHHh----------ccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccch
Confidence            999999999994          4566788889999999999999999   899999999999999999999999999999


Q ss_pred             eecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhh
Q 046112          368 RFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEI  447 (502)
Q Consensus       368 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  447 (502)
                      +.....   .....+.||..|||||++.....++|.||||||||||||+||..||.+.....+.+-      +...    
T Consensus       260 ~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG------VGsN----  326 (904)
T KOG4721|consen  260 KELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG------VGSN----  326 (904)
T ss_pred             Hhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe------ccCC----
Confidence            865433   334567899999999999999999999999999999999999999987432211000      0000    


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          448 RASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       448 ~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                           ......+.+|+.-+.-|++.||+..|..||++.+++..|.-...++.
T Consensus       327 -----sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell  373 (904)
T KOG4721|consen  327 -----SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL  373 (904)
T ss_pred             -----cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence                 01112245888999999999999999999999999999876554443

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=323.34  Aligned_cols=268  Identities=28%  Similarity=0.394  Sum_probs=203.6

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHh--cCCCCccceeeecccccccCCCcceeE
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTR--NIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ....++||+|+||.||+|+.  .++.||||++..   +..+.|+.|-++.+  .++|+||++++++-...+.. ..+++|
T Consensus       212 l~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~eywL  285 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEYWL  285 (534)
T ss_pred             hhhHHHhhcCccceeehhhc--cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccceeE
Confidence            34567899999999999976  558999999874   34677888888876  45899999999883322211 348899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCceeecCCCCCeeeCCCCc
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLD------CQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      |+||.++|||.+||..           ..++|....+|+..+++||+|||++      .+++|+|||||++|||+.+|++
T Consensus       286 Vt~fh~kGsL~dyL~~-----------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT  354 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKA-----------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT  354 (534)
T ss_pred             EeeeccCCcHHHHHHh-----------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc
Confidence            9999999999999964           5589999999999999999999964      4678999999999999999999


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCc-cC-----ccccchhHHHHHHHHHhCCCCCc--------c
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE-VS-----SYGDVYSFGILLLEMFTGLRPSD--------D  424 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~~sDvws~Gv~l~el~tg~~p~~--------~  424 (502)
                      +.|+|||+|..+.+........+.+||.+|||||++.+.. +.     .+.||||+|.||||+++...-++        -
T Consensus       355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql  434 (534)
T KOG3653|consen  355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL  434 (534)
T ss_pred             EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence            9999999999998777666667789999999999987642 21     34899999999999998653332        1


Q ss_pred             ccccc----cchHHHHHhhcccchhhhcccCCCCcchhh--HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          425 MFKDN----LNLRNCVKSALPERAEEIRASSGSTQRSII--LECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       425 ~~~~~----~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~--~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      .|..+    ..+.+.-       ...+.++..+..++..  -..+..+.+.+..||..||+.|.|+.-|.+++..+..-.
T Consensus       435 pfe~evG~hPt~e~mq-------~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  435 PFEAEVGNHPTLEEMQ-------ELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             chhHHhcCCCCHHHHH-------HHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            11111    1111100       0011111111111111  134677889999999999999999999999998886544

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-43  Score=305.19  Aligned_cols=272  Identities=21%  Similarity=0.256  Sum_probs=218.1

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ..++|.+.+.+|+|||+-||.++...+++.+|+|++.....+..+..++|++..++++|||++++++++....-.+..+.
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            45689999999999999999999899999999999987666677889999999999999999999999866544566689


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      |++++|+..|||.+.+....      .....+++.+.+.|+.++++||.+||.. .++++||||||.|||+++.+.+++.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k------~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLK------IKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             EEEeehhccccHHHHHHHHh------hcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEE
Confidence            99999999999999986422      3445689999999999999999999932 3459999999999999999999999


Q ss_pred             eeccceeccccccc-------ceecccccccccccCcccCC---CccCccccchhHHHHHHHHHhCCCCCccccccccch
Q 046112          363 DFGIARFLEAADEQ-------TRSIGVEGTTGYIAPEYGMG---HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL  432 (502)
Q Consensus       363 Dfg~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~  432 (502)
                      |||.++...-.-..       .....-..|..|+|||.+.-   ...++++|||||||++|+|+.|..||+.....+.++
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl  251 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL  251 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence            99998755322111       11223456899999998764   468999999999999999999999999866655443


Q ss_pred             HHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          433 RNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       433 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      .-.+...      .+.-+.   ..    ...+.+.+++.+|++.||.+||++.+++..+..+
T Consensus       252 aLAv~n~------q~s~P~---~~----~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  252 ALAVQNA------QISIPN---SS----RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             EEeeecc------ccccCC---CC----CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            3221110      000010   11    1456788999999999999999999999988765

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.6e-42  Score=331.07  Aligned_cols=253  Identities=24%  Similarity=0.297  Sum_probs=198.8

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .|...+.||+|+||.||+|....+++.||+|.+....   ......+.+|++++++++|+|++++.+++.     .++..
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-----TKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeE
Confidence            3667789999999999999988899999999986432   122345788999999999999999998853     34578


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++|+||+++|+|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+
T Consensus        76 ~lv~e~~~~g~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~  144 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYN--------MGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRIS  144 (285)
T ss_pred             EEEEEecCCCcHHHHHHh--------hCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEe
Confidence            999999999999888742        22345889999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      |||++.......   ......||..|+|||++.+..++.++|||||||++|||++|+.||......  ...+.+......
T Consensus       145 Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~  219 (285)
T cd05631         145 DLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER--VKREEVDRRVKE  219 (285)
T ss_pred             eCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc--hhHHHHHHHhhc
Confidence            999998653322   123456899999999999999999999999999999999999999763211  111111111111


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK-----INDVEPR  490 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt-----~~ev~~~  490 (502)
                      ..           ..+.......+.+++.+|++.||++||+     ++++.+.
T Consensus       220 ~~-----------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         220 DQ-----------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             cc-----------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            00           0111223456779999999999999997     7887763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1e-41  Score=332.47  Aligned_cols=271  Identities=21%  Similarity=0.337  Sum_probs=202.3

Q ss_pred             cCCCCCCcccccCCceEEEEEEcC----------------CCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCcccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFE----------------STTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKV  267 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l  267 (502)
                      ++|...++||+|+||.||+|.+..                ++..||+|++..... ....+|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467888999999999999996532                345799999875432 234679999999999999999999


Q ss_pred             eecccccccCCCcceeEEeeeccCCChhhhccCCchhhhc---------cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 046112          268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKR---------HKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ  338 (502)
Q Consensus       268 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~  338 (502)
                      ++++..     .+..++||||+++|+|.+++.........         ......+++...+.++.|++.||+|||   +
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~  156 (304)
T cd05096          85 LGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---S  156 (304)
T ss_pred             EEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---H
Confidence            998643     34789999999999999998532111000         112345788999999999999999999   8


Q ss_pred             CCceeecCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-
Q 046112          339 PPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-  417 (502)
Q Consensus       339 ~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-  417 (502)
                      .+|+||||||+|||++.++.+||+|||+++.+.............++..|+|||++..+.++.++||||||+++|||++ 
T Consensus       157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence            9999999999999999999999999999986644333222233456788999999988899999999999999999987 


Q ss_pred             -CCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          418 -GLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       418 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                       +..||.....  ......+............       ......++..+.+++.+||+.||++|||+.||.+.|+
T Consensus       237 ~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         237 CKEQPYGELTD--EQVIENAGEFFRDQGRQVY-------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             cCCCCCCcCCH--HHHHHHHHHHhhhcccccc-------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence             5567765321  1112222111111000000       0001244567889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.2e-42  Score=333.59  Aligned_cols=247  Identities=27%  Similarity=0.412  Sum_probs=206.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|.+.+.||+|+||+||||+.+.+.+.||+|.+.+...  .+.+.+.+|++++++++|||||.++++     ++...+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence            467778899999999999999999999999999875433  234678999999999999999999999     6667799


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++|.||+.+ +|..++          ...+.+++.....++.++..||.|||   +.+|.|||+||.|||++.++.+|+|
T Consensus        77 ~vVte~a~g-~L~~il----------~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~Klc  142 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTIL----------EQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLC  142 (808)
T ss_pred             EEEehhhhh-hHHHHH----------HhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeec
Confidence            999999976 999999          45677999999999999999999999   9999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      |||+|+.+...  ......+.||+-|||||...+..|+..+|.||+||++||+++|++||...     ++.+.++....+
T Consensus       143 dFg~Ar~m~~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d  215 (808)
T KOG0597|consen  143 DFGLARAMSTN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKD  215 (808)
T ss_pred             hhhhhhhcccC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcC
Confidence            99999976532  33445688999999999999999999999999999999999999999651     333444333322


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .            ...+.+....+..++...+.+||.+|.|-.+++.
T Consensus       216 ~------------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  216 P------------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             C------------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            1            0111244455667788888999999999888764

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-41  Score=338.78  Aligned_cols=268  Identities=24%  Similarity=0.357  Sum_probs=203.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcC-----CCeEEEEEEecccCc-chhHHHHHHHHHHhcC-CCCccceeeecccccccC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFE-----STTAVAVKVFNVLHH-DASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  277 (502)
                      ++|...+.||+|+||.||+|.+..     ++..||+|+++.... +....+.+|+++++.+ +|+||++++++|..    
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~----  113 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH----  113 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC----
Confidence            468889999999999999997543     345799999875432 3345688999999999 89999999998643    


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchh-----------------------------------------------------
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEE-----------------------------------------------------  304 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------------------------  304 (502)
                       ....++||||+++|+|.++++.....                                                     
T Consensus       114 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         114 -GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             -CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence             34789999999999999998532110                                                     


Q ss_pred             -------hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecccccccc
Q 046112          305 -------DKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT  377 (502)
Q Consensus       305 -------~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  377 (502)
                             .........+++.+..+++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.+.......
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                   000011235788999999999999999999   8999999999999999999999999999998654332222


Q ss_pred             eecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccchhhhcccCCCCcc
Q 046112          378 RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQR  456 (502)
Q Consensus       378 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  456 (502)
                      ......++..|+|||++.+..++.++|||||||++|||++ |+.||....... .+.........        ..   .+
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~--------~~---~~  337 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQ--------MS---RP  337 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccC--------cc---CC
Confidence            2223345678999999999999999999999999999997 999997632211 11111111100        00   00


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          457 SIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       457 ~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                         ...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       338 ---~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         338 ---DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence               112456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=336.23  Aligned_cols=258  Identities=24%  Similarity=0.403  Sum_probs=216.9

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ..+.+..++||-|.||.||.|.|+.-.-.||||.++.. .....+|..|+.+|+.++|||+|+++|+|....     ..|
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-----PFY  339 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-----PFY  339 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-----CeE
Confidence            34556778999999999999999988899999999753 345689999999999999999999999996533     789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      ||+|||.+|+|.+||.+        ..+..++....+.++.||+.||+||.   .+.+|||||.++|+|+.++..|||+|
T Consensus       340 IiTEfM~yGNLLdYLRe--------cnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvAD  408 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRE--------CNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVAD  408 (1157)
T ss_pred             EEEecccCccHHHHHHH--------hchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeec
Confidence            99999999999999975        34455777788999999999999999   99999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+++++.. +++..+.+..-.+-|.|||.+....++.|+|||+|||+||||.| |..||...     ++-+.       
T Consensus       409 FGLsRlMtg-DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSqV-------  475 (1157)
T KOG4278|consen  409 FGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQV-------  475 (1157)
T ss_pred             cchhhhhcC-CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHH-------
Confidence            999998754 44455556666889999999999999999999999999999999 99999763     22221       


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                        +++......  .+.++.|+..+.+||..||++.|.+||+++|+.+.++.|-
T Consensus       476 --Y~LLEkgyR--M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  476 --YGLLEKGYR--MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             --HHHHhcccc--ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence              111111111  1123478999999999999999999999999999998764

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.2e-41  Score=339.10  Aligned_cols=267  Identities=22%  Similarity=0.301  Sum_probs=203.2

Q ss_pred             cCCCCCCcccccCCceEEEEEE-----cCCCeEEEEEEecccC-cchhHHHHHHHHHHhcC-CCCccceeeecccccccC
Q 046112          205 KGFSSENLIGAGNFGSVYKGIL-----FESTTAVAVKVFNVLH-HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  277 (502)
                      ++|...+.||+|+||.||+|.+     ..++..||||+++... ....+.+.+|++++..+ +||||++++++|..    
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~----  110 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV----  110 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc----
Confidence            4678889999999999999964     2456789999987432 23346788999999999 89999999999643    


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhh----------------------------------------------------
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEED----------------------------------------------------  305 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------------------------------------------------  305 (502)
                       .+..++||||+++|+|.++++......                                                    
T Consensus       111 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         111 -GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             -CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence             447899999999999999985421000                                                    


Q ss_pred             -------------hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceeccc
Q 046112          306 -------------KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEA  372 (502)
Q Consensus       306 -------------~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~  372 (502)
                                   ........+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                         00011235889999999999999999999   89999999999999999999999999999986643


Q ss_pred             ccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccchhhhcccC
Q 046112          373 ADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAEEIRASS  451 (502)
Q Consensus       373 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  451 (502)
                      ...........++..|+|||.+.+..++.++|||||||++|||++ |..||.....+ ......+.....          
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~----------  335 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYR----------  335 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCcc----------
Confidence            332222223345678999999999999999999999999999998 89998753221 112222221110          


Q ss_pred             CCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          452 GSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       452 ~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                       ...+   ...+.++.+++.+|++.||++|||+.|+++.|++.
T Consensus       336 -~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 -MLSP---ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -CCCC---CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence             0000   12245678999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2e-41  Score=332.23  Aligned_cols=259  Identities=22%  Similarity=0.386  Sum_probs=204.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeE----EEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTA----VAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .+|+..+.||+|+||.||+|.+..++..    ||+|+++... ....+++..|+.+++.++||||++++|+|..      
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------   80 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   80 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence            4688899999999999999987665554    8999987433 2345678899999999999999999999743      


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++++||+++|+|.+++..         ....+++...+.++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~---------~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~  148 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHV  148 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHh---------ccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcE
Confidence            246799999999999999853         2345888999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  438 (502)
                      ||+|||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||++....  .+.+....
T Consensus       149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~  226 (316)
T cd05108         149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEK  226 (316)
T ss_pred             EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhC
Confidence            9999999987654333222223345678999999999999999999999999999998 99998753111  11111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ..          ....    ...+...+.+++.+||+.+|.+||++.+++..+..+.++
T Consensus       227 ~~----------~~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         227 GE----------RLPQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             CC----------CCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            00          0000    113445678999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-42  Score=331.30  Aligned_cols=246  Identities=24%  Similarity=0.349  Sum_probs=197.2

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||+|....+++.||+|+++...   ....+.+.+|++++++++||||+++++++     .....
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence            36888899999999999999988889999999986432   12345688999999999999999999874     34558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl  142 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRN----------SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKL  142 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEE
Confidence            8999999999999999842          345888999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+++.....     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  ....+   ....
T Consensus       143 ~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--~~~~~---~i~~  212 (291)
T cd05612         143 TDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--FGIYE---KILA  212 (291)
T ss_pred             EecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH---HHHh
Confidence            999999765321     1234689999999999998999999999999999999999999975211  11111   1110


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK-----INDVEPR  490 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt-----~~ev~~~  490 (502)
                      ..            ..+.......+.+++.+|++.||.+||+     ++|+++.
T Consensus       213 ~~------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         213 GK------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CC------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            00            0011122446779999999999999995     7777643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.1e-41  Score=334.96  Aligned_cols=242  Identities=21%  Similarity=0.243  Sum_probs=192.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEee
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE  287 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  287 (502)
                      +.||+|+||.||++....+|+.||+|+++...   ......+..|++++++++||||+++.+++     ..++..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            46999999999999998899999999987432   22345678899999999999999999884     44558999999


Q ss_pred             eccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccc
Q 046112          288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA  367 (502)
Q Consensus       288 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a  367 (502)
                      |+++|+|.+++..          ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a  142 (323)
T cd05571          76 YANGGELFFHLSR----------ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLC  142 (323)
T ss_pred             CCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCC
Confidence            9999999988842          346889999999999999999999   899999999999999999999999999998


Q ss_pred             eecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhh
Q 046112          368 RFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEI  447 (502)
Q Consensus       368 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  447 (502)
                      +......  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     ...........    
T Consensus       143 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~~~~~~----  211 (323)
T cd05571         143 KEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEE----  211 (323)
T ss_pred             cccccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCC----
Confidence            7532211  112345689999999999999999999999999999999999999965211     11111111000    


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 046112          448 RASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEP  489 (502)
Q Consensus       448 ~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~  489 (502)
                              ..+.......+.+++.+|++.||++||     ++.++++
T Consensus       212 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         212 --------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                    001112345677999999999999999     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.3e-42  Score=325.89  Aligned_cols=250  Identities=32%  Similarity=0.502  Sum_probs=193.4

Q ss_pred             CCcccccCCceEEEEEEc----CCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          210 ENLIGAGNFGSVYKGILF----ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      .+.||.|.||.||+|.+.    ..+..|+||.++.... ...+.|.+|++.+++++||||++++|+|..     .+..++
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~~~l   78 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEPLFL   78 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSSEEE
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-----cccccc
Confidence            468999999999999887    4578899999965433 336789999999999999999999999852     335899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      |+||+++|+|.++++.        .....+++.+++.|+.|++.||+|||   +.+++|+||+++||+++.++.+||+||
T Consensus        79 v~e~~~~g~L~~~L~~--------~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f  147 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKS--------KNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDF  147 (259)
T ss_dssp             EEE--TTEBHHHHHHH--------TCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEEST
T ss_pred             cccccccccccccccc--------cccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence            9999999999999964        33566899999999999999999999   889999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |++....................|+|||.+.+..++.++||||||+++||+++ |+.||.+...  .++.+.+.....  
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~~~~~~--  223 (259)
T PF07714_consen  148 GLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKLKQGQR--  223 (259)
T ss_dssp             TTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHHHTTEE--
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccc--
Confidence            99987633333223334556789999999999999999999999999999999 7899876311  111111111100  


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                                  ......++..+.+++.+||..||++|||++++++.|
T Consensus       224 ------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 ------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                        011123466788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6e-41  Score=323.60  Aligned_cols=265  Identities=26%  Similarity=0.453  Sum_probs=206.2

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCC-----eEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFEST-----TAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      ++|...+.||+|+||.||+|.....+     ..||+|.++.... .....|.+|++++++++||||+++++++.     .
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence            36788899999999999999765544     6899999874332 23456899999999999999999999853     3


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhh------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCee
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDK------RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNIL  352 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIl  352 (502)
                      ....+++|||+++|+|.+++........      .......+++...+.++.|++.||+|||   +.+++||||||+||+
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil  156 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCL  156 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEE
Confidence            4478999999999999999854211100      0011256889999999999999999999   899999999999999


Q ss_pred             eCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccc
Q 046112          353 LDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLN  431 (502)
Q Consensus       353 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~  431 (502)
                      +++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......  .
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~  234 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--E  234 (283)
T ss_pred             EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence            99999999999999986544333222333456788999999998899999999999999999998 99998753211  1


Q ss_pred             hHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 046112          432 LRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL  493 (502)
Q Consensus       432 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~  493 (502)
                      ..+.+...           ...   .....++..+.+++.+||+.||.+||+++||.+.|++
T Consensus       235 ~~~~i~~~-----------~~~---~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 VIEMIRSR-----------QLL---PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcC-----------CcC---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            12111111           000   1123567788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-41  Score=331.73  Aligned_cols=238  Identities=25%  Similarity=0.336  Sum_probs=189.4

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeec
Q 046112          213 IGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFM  289 (502)
Q Consensus       213 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  289 (502)
                      ||+|+||.||+|.+..+++.||+|+++..   .......+..|++++++++||||+++++++     ...+..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            69999999999999889999999998642   223345678899999999999999999885     3445889999999


Q ss_pred             cCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          290 ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       290 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                      ++|+|.+++..          ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~  142 (312)
T cd05585          76 NGGELFHHLQR----------EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL  142 (312)
T ss_pred             CCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence            99999999842          345889999999999999999999   89999999999999999999999999999975


Q ss_pred             cccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcc
Q 046112          370 LEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRA  449 (502)
Q Consensus       370 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  449 (502)
                      .....  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....     ..+.........      
T Consensus       143 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~~------  209 (312)
T cd05585         143 NMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQEP------  209 (312)
T ss_pred             CccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcCC------
Confidence            43221  12234568999999999999999999999999999999999999997521     111111111110      


Q ss_pred             cCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 046112          450 SSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV  487 (502)
Q Consensus       450 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev  487 (502)
                            ..+.......+.+++.+|++.||++||++.++
T Consensus       210 ------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~  241 (312)
T cd05585         210 ------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGA  241 (312)
T ss_pred             ------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence                  01111334567799999999999999864333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.2e-41  Score=321.03  Aligned_cols=256  Identities=22%  Similarity=0.363  Sum_probs=201.2

Q ss_pred             cCCCCCCcccccCCceEEEEEEc---CCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ++|...+.||+|+||.||+|.+.   ..+..||+|.++.... .....+.+|+..+++++||||+++++++.     .++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RGN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cCC
Confidence            46788899999999999999764   3467899999875432 23457889999999999999999999853     345


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.+++..         ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~  147 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRK---------HEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCK  147 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEE
Confidence            78999999999999999852         2346889999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ++|||.+........ .......++..|+|||.+.+..++.++|||||||++||+++ |+.||......  ...+.+...
T Consensus       148 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~  224 (266)
T cd05064         148 ISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVEDG  224 (266)
T ss_pred             ECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCC
Confidence            999998764322111 11112335678999999999999999999999999999875 99999753211  111111110


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                                 ..   ......++..+.+++.+||+.+|++||+++++.+.|+++
T Consensus       225 -----------~~---~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 -----------FR---LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -----------CC---CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                       00   011224566788999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.3e-41  Score=331.02  Aligned_cols=270  Identities=23%  Similarity=0.319  Sum_probs=205.8

Q ss_pred             cCCCCCCcccccCCceEEEEEEcC-----CCeEEEEEEecccCc-chhHHHHHHHHHHhcC-CCCccceeeecccccccC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFE-----STTAVAVKVFNVLHH-DASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  277 (502)
                      ++|.+.+.||+|+||.||+|....     +++.||+|+++.... ...+.+..|++++.++ +|+||++++++|..    
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~----   82 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK----   82 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec----
Confidence            468889999999999999996433     357899999874332 2345678899999999 89999999998742    


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhh---------------------------------------------------h
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEED---------------------------------------------------K  306 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------------------------------------------~  306 (502)
                      .+...++++||+++|+|.+++.......                                                   .
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence            3457889999999999999885321100                                                   0


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecccccccceeccccccc
Q 046112          307 RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT  386 (502)
Q Consensus       307 ~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~  386 (502)
                      .......+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.+.............++.
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence            0001236899999999999999999999   8999999999999999999999999999998764433322333445678


Q ss_pred             ccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHH
Q 046112          387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLIS  465 (502)
Q Consensus       387 ~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  465 (502)
                      .|+|||++.+..++.++|||||||++||+++ |+.||......+ .+.........           ...   .......
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~-----------~~~---~~~~~~~  304 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGTR-----------MRA---PEYATPE  304 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccCC-----------CCC---CccCCHH
Confidence            8999999999999999999999999999998 999987532111 11111111000           000   1123456


Q ss_pred             HHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          466 ICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       466 l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                      +.+++.+|++.+|++||++.|+++.|+++.+
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            8899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.9e-41  Score=334.33  Aligned_cols=269  Identities=20%  Similarity=0.233  Sum_probs=198.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|+..+.||+|+||.||+|.+..++..||||+++...  ......+.+|++++++++||||+++++++...........+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4777899999999999999988899999999986422  22345688999999999999999999987543323334689


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+. ++|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        81 lv~e~~~-~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~D  146 (338)
T cd07859          81 VVFELME-SDLHQVIK----------ANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICD  146 (338)
T ss_pred             EEEecCC-CCHHHHHH----------hcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEcc
Confidence            9999995 78988873          2345889999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccc-cceecccccccccccCcccCC--CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          364 FGIARFLEAADE-QTRSIGVEGTTGYIAPEYGMG--HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       364 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      ||+++....... ........||..|+|||++.+  ..++.++|||||||++|||+||+.||.....  ......+....
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~  224 (338)
T cd07859         147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLL  224 (338)
T ss_pred             CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHh
Confidence            999975433221 112234568999999999876  6789999999999999999999999965211  01111111100


Q ss_pred             cc----c------------hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          441 PE----R------------AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       441 ~~----~------------~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ..    .            ...+..................+.+++.+|++.||++|||++|+++.
T Consensus       225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00    0            00000000000000001224567799999999999999999999853

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-41  Score=320.20  Aligned_cols=258  Identities=22%  Similarity=0.281  Sum_probs=200.1

Q ss_pred             HhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--------------chhHHHHHHHHHHhcCCCCcccee
Q 046112          202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--------------DASKSFAVECEVTRNIRHRNLVKV  267 (502)
Q Consensus       202 ~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l  267 (502)
                      ...++|+....||+|.||.|-+|.+..+++.||||++.+...              ...+...+|+.+|++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            345789999999999999999999999999999999864211              122478899999999999999999


Q ss_pred             eecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCC
Q 046112          268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLK  347 (502)
Q Consensus       268 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk  347 (502)
                      +++..   -+..+..|+|+|||..|.+...-          .....++..++.+++.++..||+|||   .++|+|||||
T Consensus       174 iEvLD---DP~s~~~YlVley~s~G~v~w~p----------~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIK  237 (576)
T KOG0585|consen  174 IEVLD---DPESDKLYLVLEYCSKGEVKWCP----------PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIK  237 (576)
T ss_pred             EEeec---CcccCceEEEEEeccCCccccCC----------CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccc
Confidence            99853   35567899999999999876542          12223899999999999999999999   9999999999


Q ss_pred             CCCeeeCCCCcEEEeeeccceecccccc---cceecccccccccccCcccCCCc----cCccccchhHHHHHHHHHhCCC
Q 046112          348 PSNILLDDEMTAYVSDFGIARFLEAADE---QTRSIGVEGTTGYIAPEYGMGHE----VSSYGDVYSFGILLLEMFTGLR  420 (502)
Q Consensus       348 ~~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvws~Gv~l~el~tg~~  420 (502)
                      |+|+|++++++|||+|||.+........   ........||+.|+|||...++.    .+.+.||||+||+||.++.|+.
T Consensus       238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~  317 (576)
T KOG0585|consen  238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL  317 (576)
T ss_pred             hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence            9999999999999999999986633211   11123378999999999987733    3566899999999999999999


Q ss_pred             CCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          421 PSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       421 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ||.+.+      ......++-+....+     +.    ..+....+.+|+++++++||++|.+..+|...
T Consensus       318 PF~~~~------~~~l~~KIvn~pL~f-----P~----~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  318 PFFDDF------ELELFDKIVNDPLEF-----PE----NPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             Ccccch------HHHHHHHHhcCcccC-----CC----cccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            997621      111111111111111     11    12445667799999999999999999998654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-41  Score=333.72  Aligned_cols=248  Identities=22%  Similarity=0.312  Sum_probs=205.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .-|..++.||+|+.|.|-.|++..+|+.+|||++.+..   ......+.+|+-+|+.+.|||++++++.     +..+.+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~~   86 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQH   86 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCce
Confidence            35677899999999999999999999999999987542   2223568899999999999999999998     667779


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      +|+|.||+++|-|.+++          ...+++++.+..+++.||..|+.|+|   ..+|+|||+||+|+|||..+++||
T Consensus        87 lylvlEyv~gGELFdyl----------v~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKI  153 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYL----------VRKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKI  153 (786)
T ss_pred             EEEEEEecCCchhHHHH----------HhhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEee
Confidence            99999999999999999          45678999999999999999999999   999999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccC-ccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVS-SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      +|||+|..-.+ +.  .....+|.+.|.|||++++.+|+ .++||||.||+||.|+||+.||++     ++++..+...-
T Consensus       154 ADFGMAsLe~~-gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLlKV~  225 (786)
T KOG0588|consen  154 ADFGMASLEVP-GK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLLKVQ  225 (786)
T ss_pred             eccceeecccC-Cc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHHHHH
Confidence            99999974322 22  22356799999999999999985 569999999999999999999986     23333322211


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      .            +.++.+.+...+..+|+.+|+..||+.|.|++||.+.
T Consensus       226 ~------------G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  226 R------------GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             c------------CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            1            1111222445566789999999999999999999864

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.7e-40  Score=319.70  Aligned_cols=259  Identities=22%  Similarity=0.339  Sum_probs=201.8

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCe----EEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTT----AVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .+|...+.||+|+||.||+|.+..++.    .+++|.+..... ....++..|+..+++++||||+++++++..      
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence            367788999999999999998876665    467777653222 234567788889999999999999998632      


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++++||+++|+|.++++.         ....+++.....++.|++.||+|||   +.+++||||||+||++++++.+
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~  148 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQ---------HRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIV  148 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcE
Confidence            246789999999999999852         2345899999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  438 (502)
                      ||+|||+++...............++..|+|||...++.++.++|||||||++||+++ |+.||.+...  ....+.+..
T Consensus       149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~  226 (279)
T cd05111         149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEK  226 (279)
T ss_pred             EEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHC
Confidence            9999999987644332222234557788999999998899999999999999999998 9999876321  111111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ...           ....   ..+...+.+++.+|+..+|++|||+.|+++.|..+.++
T Consensus       227 ~~~-----------~~~~---~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         227 GER-----------LAQP---QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             CCc-----------CCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            100           0000   12345667899999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-41  Score=334.31  Aligned_cols=245  Identities=22%  Similarity=0.271  Sum_probs=196.2

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|++++++++||||+++++++     ..++.
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   92 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDENR   92 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCCE
Confidence            46788899999999999999998899999999986431   22345688999999999999999999984     44558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        93 ~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl  159 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRK----------AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKV  159 (329)
T ss_pred             EEEEEcCCCCChHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEE
Confidence            9999999999999998842          345788888999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+++......     ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.+...     .+.......
T Consensus       160 ~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i~~  229 (329)
T PTZ00263        160 TDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRIYEKILA  229 (329)
T ss_pred             eeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHHHHHHhc
Confidence            9999998654321     234689999999999999999999999999999999999999965211     111111110


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK-----INDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt-----~~ev~~  489 (502)
                      .        ...    +.......+.+++.+|++.||.+||+     ++++++
T Consensus       230 ~--------~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        230 G--------RLK----FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             C--------CcC----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            0        000    00112345679999999999999997     566653

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.8e-41  Score=330.82  Aligned_cols=243  Identities=21%  Similarity=0.257  Sum_probs=193.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEee
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE  287 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  287 (502)
                      +.||+|+||.||++....+++.||+|+++..   .......+.+|+++++.++||||+++.+++     ...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            4689999999999999889999999998743   223346688899999999999999999874     44558999999


Q ss_pred             eccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccc
Q 046112          288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA  367 (502)
Q Consensus       288 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a  367 (502)
                      |+++|+|.+++..          ...+++.+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        76 y~~~g~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~  142 (328)
T cd05593          76 YVNGGELFFHLSR----------ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLC  142 (328)
T ss_pred             CCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCC
Confidence            9999999988742          345889999999999999999999   899999999999999999999999999998


Q ss_pred             eecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhh
Q 046112          368 RFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEI  447 (502)
Q Consensus       368 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  447 (502)
                      +......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+.........    
T Consensus       143 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~----  211 (328)
T cd05593         143 KEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMED----  211 (328)
T ss_pred             ccCCCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhccCC----
Confidence            7532211  112345689999999999999999999999999999999999999965211     11111111000    


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 046112          448 RASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEPR  490 (502)
Q Consensus       448 ~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~~  490 (502)
                              ..+.......+.+++.+|++.||++||     ++.|+++.
T Consensus       212 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         212 --------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             --------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                    001112345677899999999999997     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.7e-41  Score=331.04  Aligned_cols=242  Identities=21%  Similarity=0.251  Sum_probs=192.3

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEee
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE  287 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  287 (502)
                      +.||+|+||.||++....+|..||+|+++...   ......+..|+++++.++||||+++++++     ..++..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            46899999999999988899999999987432   22345677899999999999999999884     34458999999


Q ss_pred             eccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccc
Q 046112          288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA  367 (502)
Q Consensus       288 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a  367 (502)
                      |+++|+|..++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~  142 (323)
T cd05595          76 YANGGELFFHLSR----------ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC  142 (323)
T ss_pred             CCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHh
Confidence            9999999988742          345889999999999999999999   899999999999999999999999999998


Q ss_pred             eecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhh
Q 046112          368 RFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEI  447 (502)
Q Consensus       368 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  447 (502)
                      +......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......     ..........    
T Consensus       143 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~~~~~~----  211 (323)
T cd05595         143 KEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILMEE----  211 (323)
T ss_pred             ccccCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCC----
Confidence            7532221  1123456899999999999999999999999999999999999999652111     1111111000    


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 046112          448 RASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEP  489 (502)
Q Consensus       448 ~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~  489 (502)
                          .    .+.......+.+++.+|++.||++||     ++.++++
T Consensus       212 ----~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         212 ----I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             ----C----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                0    01113345677999999999999998     7887765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-40  Score=318.36  Aligned_cols=256  Identities=24%  Similarity=0.395  Sum_probs=204.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      .+|...+.||+|+||.||+|.+...++.||+|.++.. .....++.+|++++++++|+|+++++++|..     ++..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYI   79 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCCcEE
Confidence            3567788999999999999998888999999998743 2335678999999999999999999998643     347899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      +|||+++++|.+++..        .....+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        80 v~e~~~~~~L~~~~~~--------~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df  148 (263)
T cd05052          80 ITEFMTYGNLLDYLRE--------CNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADF  148 (263)
T ss_pred             EEEeCCCCcHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCC
Confidence            9999999999999853        23456899999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....     .+.........
T Consensus       149 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~~~~  222 (263)
T cd05052         149 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKGY  222 (263)
T ss_pred             cccccccccee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCCC
Confidence            99986543221 11122334678999999999999999999999999999998 9999865211     11111110000


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                           .      .+....++..+.+++.+|++.+|++|||+.++.+.|+.+
T Consensus       223 -----~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         223 -----R------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -----C------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                 0      011123456788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.9e-40  Score=321.25  Aligned_cols=269  Identities=21%  Similarity=0.276  Sum_probs=197.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcC-CCeEEEEEEecccCc--chhHHHHHHHHHHhcC---CCCccceeeecccccccCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFE-STTAVAVKVFNVLHH--DASKSFAVECEVTRNI---RHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~  278 (502)
                      .+|...+.||+|+||.||+|++.. ++..||+|+++....  .....+.+|+.+++.+   +||||++++++|.......
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            368888999999999999998754 578899999874322  2234566777776655   6999999999875433344


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      ....++|+||++ ++|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~  148 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDK--------VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQ  148 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCC
Confidence            557899999996 689988853        23345889999999999999999999   899999999999999999999


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +||+|||+++.....   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .+......
T Consensus       149 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~  224 (290)
T cd07862         149 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDV  224 (290)
T ss_pred             EEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHH
Confidence            999999999865432   12234568999999999988899999999999999999999999997632211 11111111


Q ss_pred             hc---cc-chhh------hcccCC-CCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 AL---PE-RAEE------IRASSG-STQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~---~~-~~~~------~~d~~~-~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..   +. +...      ...... ........+....+.+++.+|++.||++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         225 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00   00 0000      000000 0001111233456779999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-41  Score=330.89  Aligned_cols=254  Identities=20%  Similarity=0.281  Sum_probs=200.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||+|.+..+++.||+|+++...   ......+..|++++..++||||+++++++     ...+.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence            36888899999999999999998889999999987432   22345688899999999999999999885     34558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL  142 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNN----------LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKL  142 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEE
Confidence            9999999999999999842          345788899999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+++....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+...  
T Consensus       143 ~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~--  213 (333)
T cd05600         143 TDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--ETWENLKYW--  213 (333)
T ss_pred             EeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH--HHHHHHHhc--
Confidence            99999975533     223456899999999999999999999999999999999999999752111  111111100  


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                        ...+..+.....   .......+.+++.+|+..+|.+||+++++++.
T Consensus       214 --~~~~~~~~~~~~---~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         214 --KETLQRPVYDDP---RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             --cccccCCCCCcc---ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence              000000100000   01335567789999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8e-41  Score=321.71  Aligned_cols=266  Identities=22%  Similarity=0.337  Sum_probs=202.7

Q ss_pred             hccCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeeccccccc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF  276 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  276 (502)
                      ++++|+..+.||+|+||.||+|.+.     ..+..||+|+++... .....++.+|+.+++.++||||+++++++.    
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~----   79 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----   79 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence            4668999999999999999999753     245789999886432 223456889999999999999999999853    


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE  356 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~  356 (502)
                       .+...++||||+++|+|.+++...............+++..+..++.+++.|++|||   +.+++||||||+||+++++
T Consensus        80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          80 -QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED  155 (277)
T ss_pred             -CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCC
Confidence             345789999999999999998542211111112345688899999999999999999   8999999999999999999


Q ss_pred             CcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHH
Q 046112          357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~  435 (502)
                      +.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....     .+.
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~~~  230 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQV  230 (277)
T ss_pred             CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHH
Confidence            9999999999976543332222222345788999999999899999999999999999999 7888865321     111


Q ss_pred             HHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                      ........        ..   .....++..+.+++.+|++.+|++|||+.|+++.|+
T Consensus       231 ~~~~~~~~--------~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         231 LRFVMEGG--------LL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHHcCC--------cC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            11110000        00   011234567889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=317.10  Aligned_cols=258  Identities=25%  Similarity=0.420  Sum_probs=204.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCC---CeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFES---TTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .++|+..+.||+|+||.||+|.+...   ...||||.++.... .....|..|+.++++++||||+++++++     ..+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   77 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKS   77 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecC
Confidence            35788899999999999999987543   46899999875433 2346788999999999999999999985     344


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +..++||||+++++|.+++..         ....+++..+..++.+++.|++|||   +.+|+||||||+||++++++.+
T Consensus        78 ~~~~iv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~  145 (266)
T cd05033          78 RPVMIITEYMENGSLDKFLRE---------NDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVC  145 (266)
T ss_pred             CceEEEEEcCCCCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCE
Confidence            578999999999999999853         2246889999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +|+|||+++...............++..|+|||...+..++.++||||||+++||+++ |..||......  ........
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~  223 (266)
T cd05033         146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVED  223 (266)
T ss_pred             EECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHc
Confidence            9999999987652222222223345678999999999999999999999999999998 99998653211  11111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      ..       ..+       ....++..+.+++.+|++.+|++||++.|+++.|.++
T Consensus       224 ~~-------~~~-------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         224 GY-------RLP-------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CC-------CCC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            00       000       0123456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=343.90  Aligned_cols=264  Identities=22%  Similarity=0.261  Sum_probs=209.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-CCccceeeeccccccc-CC-Ccce
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDF-QG-NDFK  282 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-~~-~~~~  282 (502)
                      ++++.+.|.+|||+.||.|++...|..+|+|++-..+..+.+...+|+++|++|+ |+|||.+++....... .+ .-+.
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            5567889999999999999998888999999987666667788999999999997 9999999994322221 22 3578


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      +|.||||++|+|-|++..        .....|++.++++|+.++++|+++|| .+.++|||||||.+||||+.++..|||
T Consensus       118 llLmEyC~gg~Lvd~mn~--------Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNT--------RLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             EeehhhccCCcHHHHHHH--------HHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeC
Confidence            899999999999999953        22334999999999999999999999 557889999999999999999999999


Q ss_pred             eeccceecccccccc-------eecccccccccccCcccC---CCccCccccchhHHHHHHHHHhCCCCCccccccccch
Q 046112          363 DFGIARFLEAADEQT-------RSIGVEGTTGYIAPEYGM---GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL  432 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~  432 (502)
                      |||.|..........       .......|+.|+|||++.   +..+++|+||||+||+||.|+....||++...     
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----  263 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----  263 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----
Confidence            999986433222110       112345799999999754   56899999999999999999999999987211     


Q ss_pred             HHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          433 RNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       433 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                                  ..+.+.... .++ .......|..||..||+.||.+||++-+|++.+.+|...
T Consensus       264 ------------laIlng~Y~-~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  264 ------------LAILNGNYS-FPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ------------eeEEecccc-CCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                        011111111 011 135677888999999999999999999999999888654

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.8e-40  Score=327.39  Aligned_cols=262  Identities=23%  Similarity=0.259  Sum_probs=202.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .++|+..+.||+|+||.||++++..++..+|+|+++.... .....+.+|++++++++||||+++++++.     .++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence            3578899999999999999999988999999999875432 23467899999999999999999999853     34578


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceeecCCCCCeeeCCCCcEEE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQP-PIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      ++||||+++|+|.+++..          ...+++..+..++.+++.||.|||   +. +|+||||||+|||++.++.+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl  145 (331)
T cd06649          79 SICMEHMDGGSLDQVLKE----------AKRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKL  145 (331)
T ss_pred             EEEeecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEE
Confidence            999999999999999842          245788999999999999999999   54 6999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||++.......    .....||..|+|||++.+..++.++|||||||++|||+||+.||......  .+...+.....
T Consensus       146 ~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~  219 (331)
T cd06649         146 CDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVV  219 (331)
T ss_pred             ccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhccccc
Confidence            9999997553321    12346899999999999999999999999999999999999999653211  11111111000


Q ss_pred             cc-------------------------------hhh----hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 046112          442 ER-------------------------------AEE----IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKIND  486 (502)
Q Consensus       442 ~~-------------------------------~~~----~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~e  486 (502)
                      ..                               ..+    +.....+...  .......+.+++.+||+.||++|||+.|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~~P~~Rpt~~e  297 (331)
T cd06649         220 DGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP--NGVFTPDFQEFVNKCLIKNPAERADLKM  297 (331)
T ss_pred             ccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCC--CccccHHHHHHHHHHccCCcccCCCHHH
Confidence            00                               000    0000000000  0123457889999999999999999999


Q ss_pred             HHHHH
Q 046112          487 VEPRL  491 (502)
Q Consensus       487 v~~~L  491 (502)
                      +++.-
T Consensus       298 ll~h~  302 (331)
T cd06649         298 LMNHT  302 (331)
T ss_pred             HhcCh
Confidence            98753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.2e-40  Score=332.90  Aligned_cols=269  Identities=23%  Similarity=0.370  Sum_probs=206.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcC-----CCeEEEEEEecccCc-chhHHHHHHHHHHhcCC-CCccceeeeccccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFE-----STTAVAVKVFNVLHH-DASKSFAVECEVTRNIR-HRNLVKVFTACSGVDF  276 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  276 (502)
                      .++|.+.++||+|+||.||+|.+..     .+..||||+++.... ...+.+.+|+++++++. ||||++++++|..   
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~---  112 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK---  112 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc---
Confidence            4578888999999999999997643     235799999875432 23457899999999996 9999999999643   


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhh--------------------------------------------------
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDK--------------------------------------------------  306 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------------------------------------------  306 (502)
                        ....++||||+++|+|.++++.......                                                  
T Consensus       113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         113 --SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             --CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence              4478999999999999999864211000                                                  


Q ss_pred             ------------------------------------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCC
Q 046112          307 ------------------------------------RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSN  350 (502)
Q Consensus       307 ------------------------------------~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~N  350 (502)
                                                          .......+++..+..++.|++.||+|||   +.+|+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHh
Confidence                                                0001235888999999999999999999   8999999999999


Q ss_pred             eeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccc
Q 046112          351 ILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDN  429 (502)
Q Consensus       351 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~  429 (502)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....+.
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            9999999999999999986644332222233456788999999999999999999999999999997 999987632211


Q ss_pred             cchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          430 LNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                       .....+.....              ......++..+.+++.+||+.||++|||+.+|.+.|+++.
T Consensus       348 -~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 -TFYNKIKSGYR--------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             -HHHHHHhcCCC--------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence             11111111100              0011244567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-41  Score=296.21  Aligned_cols=251  Identities=22%  Similarity=0.355  Sum_probs=206.9

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      +.++|.+++.||+|.||.||.|+...++-.||+|++.+.   ..+...++.+|+++-+.++||||+++++|     +-+.
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~   94 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDS   94 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eecc
Confidence            346789999999999999999999999999999998643   23345789999999999999999999999     4455


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...|+++||.++|++...|.+        .....+++.....+..|+|.|+.|+|   .++|+||||||+|+|++.++..
T Consensus        95 ~riyLilEya~~gel~k~L~~--------~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~l  163 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQE--------GRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGEL  163 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHh--------cccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCe
Confidence            689999999999999999964        45566888889999999999999999   9999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||.+..-+    ..+....+||+.|.+||+..+...+...|+|++|++.||++.|.+||+....++ -+....+  
T Consensus       164 kiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-tYkrI~k--  236 (281)
T KOG0580|consen  164 KIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-TYKRIRK--  236 (281)
T ss_pred             eccCCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-HHHHHHH--
Confidence            999999986432    122234679999999999999999999999999999999999999998743111 1111111  


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                           .++.++         ........+++.+|+.++|.+|.+..|+++.
T Consensus       237 -----~~~~~p---------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  237 -----VDLKFP---------STISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             -----ccccCC---------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                 111111         2334556799999999999999999998764

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-41  Score=326.86  Aligned_cols=254  Identities=24%  Similarity=0.419  Sum_probs=211.7

Q ss_pred             CCCCcccccCCceEEEEEEcCC----CeEEEEEEecc-cCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          208 SSENLIGAGNFGSVYKGILFES----TTAVAVKVFNV-LHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       208 ~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      +..++||.|-||.||+|.+...    .-.||||.-+. ...+..+.|..|..+|++++||||++++|.|...      ..
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P~  465 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------PM  465 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------ce
Confidence            3457899999999999986532    34688888775 3345567899999999999999999999999653      58


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      +||||.++.|.|..||.         .....++......++.|++.||+|||   +..+|||||.++|||+....-||++
T Consensus       466 WivmEL~~~GELr~yLq---------~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLa  533 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQ---------QNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLA  533 (974)
T ss_pred             eEEEecccchhHHHHHH---------hccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeec
Confidence            99999999999999996         34566888899999999999999999   9999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||++|.+.....+... ...-+.-|||||.+.-.+++.+||||.|||.+||++. |..||....+.+.           
T Consensus       534 DFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----------  601 (974)
T KOG4257|consen  534 DFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----------  601 (974)
T ss_pred             ccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------
Confidence            99999988776654433 3345678999999999999999999999999999987 9999987433221           


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                        +..+.   -....+.++.|+..+..|+.+||.+||.+||++.++...|+++..
T Consensus       602 --I~~iE---nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  602 --IGHIE---NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             --EEEec---CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence              11111   112233356899999999999999999999999999999998866

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.7e-40  Score=321.31  Aligned_cols=270  Identities=24%  Similarity=0.441  Sum_probs=208.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .+|...+.||+|+||.||++...     .++..+|+|.++.......+.+.+|++++++++|||+++++++|.     ..
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence            46788899999999999999642     345678999987655455677999999999999999999999864     34


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhh---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDK---RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE  356 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~---~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~  356 (502)
                      +..++|+||+++++|.+++........   .......+++.+++.++.|++.||+|||   +.+++||||||+||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccC
Confidence            578999999999999999853221100   1122345899999999999999999999   8999999999999999999


Q ss_pred             CcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHH
Q 046112          357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~  435 (502)
                      +.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||+| |+.||......  .....
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~~~~~  234 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIEC  234 (288)
T ss_pred             CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH
Confidence            9999999999986543322222223345778999999999899999999999999999998 99998653211  11111


Q ss_pred             HHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      +..   ...        ...   ...++..+.+++.+|++.+|.+|||+.|+.+.|+.+.+..
T Consensus       235 i~~---~~~--------~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         235 ITQ---GRV--------LQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             HHc---CCc--------CCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence            111   000        000   0123456889999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.6e-41  Score=305.48  Aligned_cols=267  Identities=23%  Similarity=0.232  Sum_probs=201.9

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.|++|+||.||+|++..+++.||+|+++....  .-.-...+|+.++.+.+|||||.+-.+..+..   -+.
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d~  151 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MDK  151 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---cce
Confidence            3467778999999999999999999999999999975432  22234678999999999999999998866543   336


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .|+|||||+. +|...++         ....++...+...+..|+++|++|||   ..-|+|||||++|+|+...|.+||
T Consensus       152 iy~VMe~~Eh-DLksl~d---------~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKi  218 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLME---------TMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKI  218 (419)
T ss_pred             eeeeHHHHHh-hHHHHHH---------hccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEe
Confidence            9999999965 8888886         44567899999999999999999999   999999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      +|||+||.+..+..  ..+..+.|.+|+|||.+.+. .|++..|+||+||++.|++++++.|.+. .+..++...++..-
T Consensus       219 aDFGLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~-sE~dQl~~If~llG  295 (419)
T KOG0663|consen  219 ADFGLAREYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK-SEIDQLDKIFKLLG  295 (419)
T ss_pred             cccchhhhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC-chHHHHHHHHHHhC
Confidence            99999998876533  23456789999999998874 6999999999999999999999888762 11222222221110


Q ss_pred             -cc---chh--hhcc---cCCCC------cchhhHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 -PE---RAE--EIRA---SSGST------QRSIILE-CLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 -~~---~~~--~~~d---~~~~~------~~~~~~~-~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                       +.   |..  ++..   -....      ...+... ....-.+++...+..||.+|.|++|.++
T Consensus       296 tPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  296 TPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence             10   110  0000   00000      0111000 2244567888889999999999998764

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.4e-40  Score=320.79  Aligned_cols=270  Identities=25%  Similarity=0.433  Sum_probs=209.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .+|...+.||+|+||.||+|...     .++..+++|.++.......+.+.+|++++++++|+||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence            35677889999999999999753     345678999987655445577999999999999999999999864     34


Q ss_pred             cceeEEeeeccCCChhhhccCCchhh------hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEED------KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL  353 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll  353 (502)
                      +..++||||+++++|.+++.......      ........+++..++.++.+++.|++|||   +.+|+||||||+||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEE
Confidence            57899999999999999986422100      00012345899999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccch
Q 046112          354 DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNL  432 (502)
Q Consensus       354 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~  432 (502)
                      +.++.++|+|||++................++..|+|||++.+..++.++|||||||++|||+| |+.||......  ..
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~  234 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EV  234 (291)
T ss_pred             ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence            9999999999999976544332222234456788999999999999999999999999999999 99998653211  11


Q ss_pred             HHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          433 RNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       433 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      .+....           ......   ...++..+.+++.+|++.+|++|||+.+|++.|+++.+..
T Consensus       235 ~~~~~~-----------~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~  286 (291)
T cd05094         235 IECITQ-----------GRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT  286 (291)
T ss_pred             HHHHhC-----------CCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence            111100           000001   1134567889999999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-40  Score=315.54  Aligned_cols=265  Identities=23%  Similarity=0.370  Sum_probs=203.9

Q ss_pred             CCCCCcccccCCceEEEEEEcCC---CeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeeccccccc-CCCc
Q 046112          207 FSSENLIGAGNFGSVYKGILFES---TTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-QGND  280 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~  280 (502)
                      |...+.||+|+||.||+|....+   +..||+|+++....  .....+..|++.++.++|||++++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            45678999999999999976543   37899999875322  234578999999999999999999998754332 2234


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++++||+++|+|..++.....    ......+++.....++.|++.||+|||   +.+++||||||+||++++++.+|
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~k  153 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRL----GGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVC  153 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhc----cCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEE
Confidence            57899999999999999853111    122346899999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||.+...  ....+.+...
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~~~~  231 (273)
T cd05035         154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYLRHG  231 (273)
T ss_pred             ECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcC
Confidence            999999987654433222222335678999999988899999999999999999999 8999865221  1111211111


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                                 ....   ....+...+.+++.+|++.||++|||+.|+++.|+.+
T Consensus       232 -----------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 -----------NRLK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -----------CCCC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                       0000   1123456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.9e-40  Score=320.82  Aligned_cols=265  Identities=21%  Similarity=0.273  Sum_probs=199.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|.+.+.||+|+||.||+|++..+++.||+|+++...  ....+.+.+|+++++.++||||+++++++     ..++..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence            36888999999999999999998899999999987532  22345688999999999999999999885     345588


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||++++++..+.          .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+
T Consensus        76 ~lv~e~~~~~~l~~~~----------~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~  142 (287)
T cd07848          76 YLVFEYVEKNMLELLE----------EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLC  142 (287)
T ss_pred             EEEEecCCCCHHHHHH----------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEe
Confidence            9999999988776553          22345888999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHH--HHhhc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC--VKSAL  440 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~  440 (502)
                      |||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....  .....
T Consensus       143 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~  220 (287)
T cd07848         143 DFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPL  220 (287)
T ss_pred             eccCccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCC
Confidence            9999986543221 11234568999999999999899999999999999999999999997532111 11100  00000


Q ss_pred             cc-chh---------hhcccCCCCc----chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PE-RAE---------EIRASSGSTQ----RSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~-~~~---------~~~d~~~~~~----~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      +. ...         ....+.....    ..........+.+++.+|++.||++|||++|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         221 PAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00 000         0000000000    0011124567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.7e-40  Score=320.54  Aligned_cols=270  Identities=25%  Similarity=0.347  Sum_probs=203.5

Q ss_pred             cCCCCCCcccccCCceEEEEEE----cCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGIL----FESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .+|...+.||+|+||.||++..    ..++..||+|.++.......+.+.+|++++++++||||+++++++..   .+..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence            4677889999999999999963    34688999999876555556788999999999999999999998642   2344


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++|+||+++|+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+|
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~  148 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQK---------HRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVK  148 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHh---------cCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEE
Confidence            68899999999999999852         2345889999999999999999999   89999999999999999999999


Q ss_pred             Eeeeccceecccccccce-ecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTR-SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++.......... .....++..|+|||+..+..++.++|||||||++|||++|..|+......   +.......
T Consensus       149 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~  225 (284)
T cd05081         149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGND  225 (284)
T ss_pred             ECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccc
Confidence            999999987654332111 11223445699999999889999999999999999999988775432110   00000000


Q ss_pred             cc-----cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          440 LP-----ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       440 ~~-----~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      ..     ..+.+......  .......++..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         226 KQGQMIVYHLIELLKNNG--RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cccccchHHHHHHHhcCC--cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00     00011111100  0011123456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-41  Score=309.64  Aligned_cols=274  Identities=23%  Similarity=0.287  Sum_probs=209.5

Q ss_pred             HHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEec--ccCcchhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN--VLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       200 l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      .......|...+.||+|+||.|+.+.+..+|+.||||++.  ....-..++..+|+++++.++|+||+.+.+........
T Consensus        17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence            3344556666789999999999999999999999999986  23344567888999999999999999999986553334


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                      .-...|+|+|+| .-+|...++          ....++......+..|+++||.|+|   +.+|+|||+||+|++++.+.
T Consensus        97 ~f~DvYiV~elM-etDL~~iik----------~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c  162 (359)
T KOG0660|consen   97 KFNDVYLVFELM-ETDLHQIIK----------SQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADC  162 (359)
T ss_pred             ccceeEEehhHH-hhHHHHHHH----------cCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCC
Confidence            456899999999 668988884          3445888999999999999999999   99999999999999999999


Q ss_pred             cEEEeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          358 TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                      ..||+|||+|+...........+..+.|.+|+|||.+.. ..|+...||||.||++.||++|++-|.+.  +.....+.+
T Consensus       163 ~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~--d~v~Ql~lI  240 (359)
T KOG0660|consen  163 DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK--DYVHQLQLI  240 (359)
T ss_pred             CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC--chHHHHHHH
Confidence            999999999998865533444567888999999998654 67999999999999999999999998762  111111111


Q ss_pred             Hhhccc----chhhhc--------ccCCC----CcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          437 KSALPE----RAEEIR--------ASSGS----TQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       437 ~~~~~~----~~~~~~--------d~~~~----~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      -..++.    .+..+.        .....    ..............+|+.+|+..||.+|+|++|.++
T Consensus       241 ~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  241 LELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            111111    001110        00000    001111233456678999999999999999999875

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.5e-40  Score=316.83  Aligned_cols=259  Identities=22%  Similarity=0.380  Sum_probs=204.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCe----EEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTT----AVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .+|...++||+|+||+||+|.+..++.    .||+|+++... ......+..|+.++..++||||++++++|..      
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------   80 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT------   80 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC------
Confidence            467888999999999999998776665    48999986433 2335678899999999999999999998742      


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++++||+++|+|.++++.         ....+++..++.++.|++.||+|||   +.+|+||||||+|||+++++.+
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~---------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~  148 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVRE---------NKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHV  148 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcE
Confidence            246799999999999999853         2345889999999999999999999   9999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  438 (502)
                      ||+|||+++...............++..|+|||...+..++.++|||||||++||+++ |..||+....  .....++..
T Consensus       149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~  226 (279)
T cd05109         149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEK  226 (279)
T ss_pred             EECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHC
Confidence            9999999987653332222223345678999999999899999999999999999998 9999875321  112222211


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ...              ......+...+.+++.+|++.||++||++.++++.|+++.++
T Consensus       227 ~~~--------------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         227 GER--------------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             CCc--------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            100              000113455678999999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.1e-40  Score=315.82  Aligned_cols=265  Identities=22%  Similarity=0.363  Sum_probs=201.1

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCe--EEEEEEeccc--CcchhHHHHHHHHHHhcCCCCccceeeeccccccc-CCCcc
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTT--AVAVKVFNVL--HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-QGNDF  281 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~  281 (502)
                      |.+.+.||+|+||.||+|++...+.  .||+|.++..  .....+.+..|++++++++|+||++++++|..... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999998766654  6899988643  23335678899999999999999999998743211 12235


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++++||+++|+|.+++....    .......+++.....++.|++.||+|||   +++|+||||||+|||+++++.+||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl  153 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSR----LGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCV  153 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhc----ccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEE
Confidence            789999999999998873211    1122345899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      +|||+++.+.............+++.|+|||+..+..++.++||||||+++||+++ |+.||.....  ..+...+... 
T Consensus       154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~-  230 (272)
T cd05075         154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLRQG-  230 (272)
T ss_pred             CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcC-
Confidence            99999987644332111122345678999999999999999999999999999999 8899865211  1111111110 


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                       ..        .    .....++..+.+++.+||+.||++|||+.++++.|+++
T Consensus       231 -~~--------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         231 -NR--------L----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             -CC--------C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             00        0    00113455678999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-40  Score=343.28  Aligned_cols=254  Identities=18%  Similarity=0.193  Sum_probs=201.0

Q ss_pred             CCCCCCcccccCCceEEEEEEcCC-CeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          206 GFSSENLIGAGNFGSVYKGILFES-TTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      .|...+.||+|+||.||+|....+ +..||+|.+..........+..|+.+++.++||||+++++++.     ..+..++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence            377889999999999999987666 7888999775544444556788999999999999999999853     3458999


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++|+|.++++..      ......+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus       143 v~E~~~gg~L~~~l~~~------~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DF  213 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQR------LKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDF  213 (478)
T ss_pred             EEECCCCCCHHHHHHHH------HhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeC
Confidence            99999999999987531      123456888999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      |+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||....     ..+......... 
T Consensus       214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----~~~~~~~~~~~~-  287 (478)
T PTZ00267        214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----QREIMQQVLYGK-  287 (478)
T ss_pred             cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCC-
Confidence            99987654332222344568999999999999999999999999999999999999997521     111111111100 


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                             ..   .....+...+.+++.+|+..||++||++.+++.
T Consensus       288 -------~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        288 -------YD---PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -------CC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                   00   001123456789999999999999999999864

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.9e-41  Score=330.80  Aligned_cols=247  Identities=21%  Similarity=0.285  Sum_probs=195.5

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCC-eEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFEST-TAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .++|...+.||+|+||.||+|.+...+ ..||+|++...   .....+.+.+|+++++.++||||+++++++     ...
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence            346888899999999999999765544 78999998642   223345688899999999999999999985     344


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +..++||||+++|+|.+++..          ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~i  170 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRR----------NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFI  170 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCE
Confidence            589999999999999999842          345888999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ....+   ..
T Consensus       171 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~---~i  240 (340)
T PTZ00426        171 KMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--LLIYQ---KI  240 (340)
T ss_pred             EEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--HHHHH---HH
Confidence            99999999865422     1235689999999999998899999999999999999999999975211  11111   11


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEPR  490 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~~  490 (502)
                      . .       .... .   .......+.+++.+|++.||++|+     +++++.+.
T Consensus       241 ~-~-------~~~~-~---p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        241 L-E-------GIIY-F---PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             h-c-------CCCC-C---CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            0 0       0000 0   011234466899999999999995     78887653

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-40  Score=343.13  Aligned_cols=266  Identities=22%  Similarity=0.260  Sum_probs=207.6

Q ss_pred             HHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       200 l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      .....++|...+.||+|+||+||+|.+..+++.||||+++...  ......+.+|+..+..++|+|++++.+.+...+..
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            3345578999999999999999999998899999999986532  23345688899999999999999988764322211


Q ss_pred             ---CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          278 ---GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       278 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                         .....++||||+++|+|.++++..      ......+++..+..++.|++.||.|||   +.+|+||||||+|||++
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~------~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~  177 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSR------AKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLC  177 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHh------hccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEe
Confidence               112467999999999999998531      123456889999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHH
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN  434 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~  434 (502)
                      .++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...     ...+
T Consensus       178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~~  252 (496)
T PTZ00283        178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NMEE  252 (496)
T ss_pred             CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHHH
Confidence            99999999999998765433222233467899999999999999999999999999999999999999752     1222


Q ss_pred             HHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          435 CVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       435 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      .+.........           .....+...+.+++.+||+.||.+||++.++++.
T Consensus       253 ~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        253 VMHKTLAGRYD-----------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHHHhcCCCC-----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            22221111100           0112345668899999999999999999998763

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-40  Score=317.40  Aligned_cols=255  Identities=27%  Similarity=0.447  Sum_probs=205.7

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ..+|+..++||.|+||.||+|.+.. +..+|+|+++.........+..|+.+++.++|+|++++++++.     ..+..+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCeE
Confidence            4568888999999999999997765 8899999988665545678999999999999999999999854     344789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++|+|.+++..        .....+++.++..++.+++.|+.|||   +.+|+||||+|+||++++++.+||+|
T Consensus        79 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d  147 (261)
T cd05148          79 IITELMEKGSLLAFLRS--------PEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVAD  147 (261)
T ss_pred             EEEeecccCCHHHHHhc--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEcc
Confidence            99999999999999864        33456899999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||.+.........  .....++..|+|||......++.++||||||+++|++++ |+.||.....  ......+....  
T Consensus       148 ~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~--  221 (261)
T cd05148         148 FGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQITAGY--  221 (261)
T ss_pred             ccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHHhCC--
Confidence            9999765432211  123446778999999988899999999999999999998 8999965321  11111111100  


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL  493 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~  493 (502)
                                  .......++..+.+++.+|++.||++|||++++++.|+.
T Consensus       222 ------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         222 ------------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence                        001112445678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.9e-40  Score=313.82  Aligned_cols=262  Identities=19%  Similarity=0.308  Sum_probs=206.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||+|....+++.||||.++...   ......+.+|+++++.++|||++++++++.     ..+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence            57888999999999999999988899999999876422   223456889999999999999999999853     3447


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++++||+++|+|.+++....      .....+++.....++.+++.||+|||   +.+++|+||||+||+++.++.++|
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l  147 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFK------KQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhh------hccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEE
Confidence            899999999999998884311      22345788899999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||++........  ......++..|+|||.+.+..++.++||||||+++|||++|+.||.........+.+.+...  
T Consensus       148 ~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--  223 (267)
T cd08228         148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC--  223 (267)
T ss_pred             CccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC--
Confidence            99999986643221  11234578899999999988899999999999999999999999865221111111111100  


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                               .....  ........+.+++.+||+.+|++||++.+|++.+++++
T Consensus       224 ---------~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         224 ---------DYPPL--PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ---------CCCCC--ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                     00000  01234567889999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-41  Score=299.82  Aligned_cols=197  Identities=28%  Similarity=0.408  Sum_probs=175.8

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc---hhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD---ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|.....||.|+||.|.+++...+|..+|+|++++...-   ..+...+|..+|+.+.||.++++.+.+     .+.+.
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~~  118 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNSN  118 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCCe
Confidence            4567788999999999999999999999999999754322   234467899999999999999999874     45568


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||.+||-|..+++          ..++++++.+.-+|.+|+.|++|||   +..|++||+||+|||+|.+|.+||
T Consensus       119 lymvmeyv~GGElFS~Lr----------k~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKi  185 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLR----------KSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKI  185 (355)
T ss_pred             EEEEEeccCCccHHHHHH----------hcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEE
Confidence            999999999999999994          3466899999999999999999999   999999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      .|||+|+...     .++...+||+.|+|||.+....+..++|-|||||++|||+.|.+||.+
T Consensus       186 tDFGFAK~v~-----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~  243 (355)
T KOG0616|consen  186 TDFGFAKRVS-----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD  243 (355)
T ss_pred             EeccceEEec-----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence            9999998654     235668899999999999999999999999999999999999999976

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.1e-41  Score=328.72  Aligned_cols=242  Identities=21%  Similarity=0.252  Sum_probs=191.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEee
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE  287 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  287 (502)
                      +.||+|+||.||++....+++.||+|+++...   ......+..|++++..++||||+++.+++     ..++..++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            46899999999999988899999999987432   22345677899999999999999999874     44558999999


Q ss_pred             eccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ-PPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       288 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      |+++|+|.+++.          ....+++..+..++.|++.||+|||   + .+|+||||||+|||++.++.+||+|||+
T Consensus        76 ~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~  142 (325)
T cd05594          76 YANGGELFFHLS----------RERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGL  142 (325)
T ss_pred             CCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCC
Confidence            999999998874          2345889999999999999999999   6 7999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....+  .....+   ...    
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~~~i---~~~----  211 (325)
T cd05594         143 CKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELI---LME----  211 (325)
T ss_pred             CeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHHHHH---hcC----
Confidence            875432211  122356899999999999999999999999999999999999999652111  111111   000    


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEP  489 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~  489 (502)
                          .    ..+.......+.+++.+|++.||++|+     ++.++++
T Consensus       212 ----~----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         212 ----E----IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             ----C----CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence                0    001112345677899999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.5e-40  Score=317.64  Aligned_cols=264  Identities=26%  Similarity=0.470  Sum_probs=204.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcC-----CCeEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccccccCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFE-----STTAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      .+|...+.||+|+||.||+|....     ++..||||.++..... ..+.+.+|++++++++|+|++++++++.     .
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~   79 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT-----E   79 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe-----c
Confidence            457778999999999999997643     3578999998765443 4578999999999999999999999854     3


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhh----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDK----RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                      ....++||||+++|+|.+++........    .......+++.+...++.+++.|+.|||   +.+++||||||+||+++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~  156 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVG  156 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEc
Confidence            4578999999999999999964221100    0123456889999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchH
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLR  433 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~  433 (502)
                      .++.+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|||++ |+.||.....+  ...
T Consensus       157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~  234 (280)
T cd05049         157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVI  234 (280)
T ss_pred             CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHH
Confidence            999999999999976543332222223345788999999999999999999999999999999 99998653211  111


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                      ..+...           .....   ...++..+.+++.+||+.||++||++.||++.|+
T Consensus       235 ~~~~~~-----------~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         235 ECITQG-----------RLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHcC-----------CcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            111110           00000   1134567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.5e-40  Score=310.36  Aligned_cols=249  Identities=26%  Similarity=0.376  Sum_probs=195.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeec
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFM  289 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  289 (502)
                      +.||+|+||.||+|.+..+++.+|+|.+.... .+....+.+|++++++++||||++++++|..     ....++|+||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence            46999999999999988899999999876432 2334678999999999999999999998643     34789999999


Q ss_pred             cCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          290 ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       290 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                      ++++|.+++..         ....+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus        76 ~~~~L~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  143 (252)
T cd05084          76 QGGDFLTFLRT---------EGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSRE  143 (252)
T ss_pred             cCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcc
Confidence            99999999842         2345789999999999999999999   89999999999999999999999999999875


Q ss_pred             cccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccchhhhc
Q 046112          370 LEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAEEIR  448 (502)
Q Consensus       370 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  448 (502)
                      ...............+..|+|||.+.++.++.++|||||||++||+++ |..||......  ..........+       
T Consensus       144 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~~~~-------  214 (252)
T cd05084         144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQGVR-------  214 (252)
T ss_pred             cccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCC-------
Confidence            432211111111223467999999999899999999999999999998 88888653211  11111111000       


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          449 ASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       449 d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                             ......++..+.+++.+|++.+|++|||+.++.+.|.
T Consensus       215 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 -------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             -------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence                   0011234567889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.3e-40  Score=316.79  Aligned_cols=267  Identities=23%  Similarity=0.363  Sum_probs=204.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcC-----CCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          206 GFSSENLIGAGNFGSVYKGILFE-----STTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      +|...+.||+|+||.||+|....     ....+++|.+..... .....+..|+++++.++||||+++++.|.     ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            46778899999999999997642     336789998764432 23467889999999999999999999864     34


Q ss_pred             cceeEEeeeccCCChhhhccCCchhh--------------hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeec
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEED--------------KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCD  345 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~d  345 (502)
                      +..++++||+.+|+|.+++.......              ........+++...+.++.|++.|++|||   +.+|+|||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~d  152 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRD  152 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhh
Confidence            47899999999999999985422110              00112345889999999999999999999   89999999


Q ss_pred             CCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCcc
Q 046112          346 LKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDD  424 (502)
Q Consensus       346 lk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~  424 (502)
                      |||+||++++++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||+| |+.||..
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            999999999999999999999976543332222223345678999999988899999999999999999999 9999865


Q ss_pred             ccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          425 MFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                      ..  ...+.+.+.....        .      +....+...+.+++.+|++.+|++||+++|+++.|+++..
T Consensus       233 ~~--~~~~~~~~~~~~~--------~------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         233 IA--PERLFNLLKTGYR--------M------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CC--HHHHHHHHhCCCC--------C------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            32  1112222211110        0      0012345678899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5e-40  Score=317.94  Aligned_cols=263  Identities=20%  Similarity=0.245  Sum_probs=196.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|...+.||+|+||.||+|....++..||+|+++.... .....+.+|++++++++||||+++++++     ......+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence            568889999999999999999888999999999875432 2345678999999999999999999984     3445789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||++ |+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        80 lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~D  146 (288)
T cd07871          80 LVFEYLD-SDLKQYLDN---------CGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLAD  146 (288)
T ss_pred             EEEeCCC-cCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECc
Confidence            9999997 589888742         2234788899999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+++.......  ......+++.|+|||.+.+ ..++.++||||+||++|||+||+.||.......  ...........
T Consensus       147 fG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~  222 (288)
T cd07871         147 FGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE--ELHLIFRLLGT  222 (288)
T ss_pred             CcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCC
Confidence            999975432221  1223457899999998865 568999999999999999999999996522111  11111111100


Q ss_pred             ----ch------hhh---cccCCCCcc--hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 ----RA------EEI---RASSGSTQR--SIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ----~~------~~~---~d~~~~~~~--~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                          ..      .++   ..+......  ...........+++.+|++.||.+|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         223 PTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                00      000   000000000  000112345679999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.1e-40  Score=315.21  Aligned_cols=269  Identities=22%  Similarity=0.383  Sum_probs=210.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcC----CCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFE----STTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      .++|...+.||+|+||.||+|.+..    .+..|++|+++... ......+.+|+.++++++|+|++++++++.    ..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~~   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI----ED   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----cC
Confidence            4678888999999999999997754    26889999886432 233466889999999999999999999873    33


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      +...++++||+++|+|.+++.......  ......+++.++..++.+++.||+|||   +.+++||||||+||++++++.
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~  155 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGE--ANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQ  155 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccc--cccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCc
Confidence            457899999999999999985422110  012356899999999999999999999   899999999999999999999


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHH
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  437 (502)
                      +||+|||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||....  ...+..++.
T Consensus       156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~  233 (280)
T cd05043         156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYLK  233 (280)
T ss_pred             EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHHH
Confidence            99999999986644332222223345778999999998889999999999999999999 999997521  112222222


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ....          ..    ....++..+.+++.+||+.||++|||+.++++.|+.+.++
T Consensus       234 ~~~~----------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         234 DGYR----------LA----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             cCCC----------CC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            1110          00    0113456788999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.6e-40  Score=324.03  Aligned_cols=241  Identities=25%  Similarity=0.355  Sum_probs=187.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhc-CCCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRN-IRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.||+|+||.||+|....+++.||+|+++...   ....+.+..|..++.. .+||||+++++++     ..++..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            46999999999999988899999999987431   2233445566676664 4899999999884     4455899999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.+++..          ...+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~gg~L~~~~~~----------~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~  142 (316)
T cd05592          76 EYLNGGDLMFHIQS----------SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGM  142 (316)
T ss_pred             cCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcC
Confidence            99999999988842          345888899999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+........    
T Consensus       143 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~----  211 (316)
T cd05592         143 CKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILND----  211 (316)
T ss_pred             CeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcC----
Confidence            97543222  122345689999999999999999999999999999999999999975321     1111111000    


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKIN-DVE  488 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~-ev~  488 (502)
                              ...+...+...+.+++.+|++.||++||++. ++.
T Consensus       212 --------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         212 --------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                    0001112344567899999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=328.39  Aligned_cols=244  Identities=25%  Similarity=0.317  Sum_probs=206.1

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcC-CCCccceeeecccccccCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  278 (502)
                      ..++|....+||+|+||.|+++....+++.+|||++++.   ..++.+....|..++... +||.++.++..     ++.
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT  440 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT  440 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence            345788889999999999999999999999999999864   345567788888887766 59999999987     677


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      .+++++||||..||++..+           ...+.+++....-++..++.||.|||   +++||+||||.+|||||.+|.
T Consensus       441 ~~~l~fvmey~~Ggdm~~~-----------~~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh  506 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGDLMHH-----------IHTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGH  506 (694)
T ss_pred             CCeEEEEEEecCCCcEEEE-----------EecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCc
Confidence            7799999999999994433           34467999999999999999999999   999999999999999999999


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +||+|||+++..-.  ...++...+||+.|||||.+.+..|+.+.|-|||||+||||+.|..||.+              
T Consensus       507 ~kiADFGlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g--------------  570 (694)
T KOG0694|consen  507 VKIADFGLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG--------------  570 (694)
T ss_pred             EEecccccccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC--------------
Confidence            99999999985432  22345568999999999999999999999999999999999999999986              


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKI  484 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~  484 (502)
                         +..++++|........++.-+..+...++.+.+.++|++|.-+
T Consensus       571 ---ddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  571 ---DDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---CCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence               2233444444444444555677788899999999999999866

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-40  Score=317.79  Aligned_cols=253  Identities=25%  Similarity=0.314  Sum_probs=198.6

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      +|+..++||+|+||.||++....+++.||+|++....   ......+.+|+.++++++||||+++++++.     ..+..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeE
Confidence            4677889999999999999888889999999986432   122345778999999999999999998853     34589


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++|+|.+++..        .....+++..+..++.|++.|+.|||   +.+|+||||||+||++++++.++|+
T Consensus        76 ~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~  144 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYN--------MGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRIS  144 (285)
T ss_pred             EEEEeccCCCcHHHHHHh--------cCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEe
Confidence            999999999999988743        22345899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      |||+++.......   .....|+..|+|||++.+..++.++|||||||++||+++|+.||......  ...+.+...+..
T Consensus       145 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~--~~~~~~~~~~~~  219 (285)
T cd05605         145 DLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK--VKREEVERRVKE  219 (285)
T ss_pred             eCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh--hHHHHHHHHhhh
Confidence            9999986542221   12346899999999999889999999999999999999999999752211  111111111110


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEPR  490 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~~  490 (502)
                      .           ...+.......+.+++.+|+..||++||     +++++.+.
T Consensus       220 ~-----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         220 D-----------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             c-----------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            0           0111123455678999999999999999     78888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.5e-40  Score=316.39  Aligned_cols=269  Identities=23%  Similarity=0.297  Sum_probs=202.2

Q ss_pred             CCCCcccccCCceEEEEE----EcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          208 SSENLIGAGNFGSVYKGI----LFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       208 ~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ...+.||+|+||+||++.    ...++..||+|.++.... .....+.+|++++++++||||++++++|..   ......
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~~   83 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKGL   83 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCceE
Confidence            778899999999998764    335678899999875432 235678899999999999999999998643   223467


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++|+|.+++..           ..+++.++..++.|++.|+.|||   +.+|+||||||+||++++++.+||+
T Consensus        84 ~lv~e~~~~~~l~~~~~~-----------~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~  149 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPK-----------HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIG  149 (283)
T ss_pred             EEEecCCCCCCHHHHHHH-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEe
Confidence            899999999999999842           24899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccce-ecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTR-SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||+++.+........ .....++..|+|||......++.++||||||+++|||+||+.|+...................
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05080         150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT  229 (283)
T ss_pred             ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccc
Confidence            9999986654322111 122335667999999998899999999999999999999999986532111111110000000


Q ss_pred             -cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          442 -ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       442 -~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                       ....+..+....  ......++..+.+++.+|++.+|++|||++++++.|+.+.
T Consensus       230 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         230 VVRLIELLERGMR--LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhhhhcCCC--CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence             011111111110  1112245678899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-40  Score=311.61  Aligned_cols=255  Identities=28%  Similarity=0.432  Sum_probs=202.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|++|.||+|.+ .+++.||+|.++... ...+++.+|++++++++|||++++++++.     .....+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   77 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLW-NNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIY   77 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEe-cCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCee
Confidence            45688889999999999999965 566789999987543 23567899999999999999999999853     344789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++++|.+++..        .....+++..+..++.+++.|+.|||   +.+|+||||||+||+++.++.+||+|
T Consensus        78 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d  146 (261)
T cd05068          78 IVTELMKYGSLLEYLQG--------GAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVAD  146 (261)
T ss_pred             eeeecccCCcHHHHHhc--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECC
Confidence            99999999999999853        22356899999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+++....... ....+...+..|+|||+..+..++.++||||||+++||++| |+.||......  .....+..... 
T Consensus       147 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~-  222 (261)
T cd05068         147 FGLARVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVDQGYR-  222 (261)
T ss_pred             cceEEEccCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC-
Confidence            999987653221 11122233468999999999999999999999999999999 99998653111  11111111000 


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL  493 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~  493 (502)
                                   ......++..+.+++.+|++.+|++||++.++++.|+.
T Consensus       223 -------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 -------------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             -------------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                         00112345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8e-41  Score=323.60  Aligned_cols=252  Identities=20%  Similarity=0.269  Sum_probs=210.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc-
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF-  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~-  281 (502)
                      ++|...+++|+|+||.++..+...+++.+++|.+....  ....+....|+.++++++|||||.+.+.     +..++. 
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds-----~~~~~~~   78 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDS-----FEEDGQL   78 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccc-----hhcCCce
Confidence            46788899999999999999999999999999987543  2334567899999999999999999998     444456 


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .+|||+|++||++.+.+..        .....+++.+...++.|++.|+.|||   +..|+|||||+.||+++.+..|||
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~--------~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkL  147 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKE--------QKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKL  147 (426)
T ss_pred             EEEEEeecCCCCHHHHHHH--------HhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceee
Confidence            9999999999999999864        33566899999999999999999999   999999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+|+.+.+...  ....+.||+.||+||.+.+.+|..|+||||+||++|||.+-+++|...     ++...+....+
T Consensus       148 gDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~Li~ki~~  220 (426)
T KOG0589|consen  148 GDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSELILKINR  220 (426)
T ss_pred             cchhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHHHHHHhh
Confidence            99999998876652  234578999999999999999999999999999999999999999862     22222222221


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ..    .       .+.......++..++..|++.+|+.||++.+++.+
T Consensus       221 ~~----~-------~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 GL----Y-------SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             cc----C-------CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            11    1       11123446678899999999999999999999876

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.5e-40  Score=312.51  Aligned_cols=254  Identities=25%  Similarity=0.419  Sum_probs=201.3

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|...++||+|+||.||+|.. .++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.     ..+..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   78 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIYI   78 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcEE
Confidence            4678889999999999999965 567789999876432 23567899999999999999999998853     4457899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ++||+++|+|.++++.        .....+++.++..++.+++.||+|||   +.+++||||||+||+++.++.++|+||
T Consensus        79 v~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df  147 (261)
T cd05072          79 ITEYMAKGSLLDFLKS--------DEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADF  147 (261)
T ss_pred             EEecCCCCcHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCC
Confidence            9999999999999853        23456788899999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |+++....... .......++..|+|||+.....++.++|||||||++|||+| |+.||......  .....+.....  
T Consensus       148 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~--  222 (261)
T cd05072         148 GLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYR--  222 (261)
T ss_pred             ccceecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCC--
Confidence            99986643221 11223345778999999998889999999999999999998 99998652111  11111111100  


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL  493 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~  493 (502)
                              ...    ...++..+.+++.+|+..+|++||+++++.+.|++
T Consensus       223 --------~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         223 --------MPR----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             --------CCC----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                    000    11234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.3e-40  Score=310.86  Aligned_cols=251  Identities=25%  Similarity=0.391  Sum_probs=197.2

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|+..+.||+|+||.||++.+ .++..+|+|.++... .....+..|++++++++||||+++++++.     .....++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~-~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKW-RAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEe-ccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEE
Confidence            4577788999999999999965 456689999876432 23467889999999999999999999864     3447899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++|+|.++++.         ....+++..+..++.+++.||+|||   +.+|+||||||+||++++++.+||+||
T Consensus        77 v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~  144 (256)
T cd05114          77 VTEFMENGCLLNYLRQ---------RQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDF  144 (256)
T ss_pred             EEEcCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCC
Confidence            9999999999998853         1235889999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |.++........ ......++..|+|||.+.+..++.++||||||+++||+++ |+.||.....  ......+.....  
T Consensus       145 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~--  219 (256)
T cd05114         145 GMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFR--  219 (256)
T ss_pred             CCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCC--
Confidence            999765432221 1123345678999999998889999999999999999999 8999865311  111111111100  


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                               ...+   ......+.+++.+||+.+|++||+++++++.|
T Consensus       220 ---------~~~~---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 ---------LYRP---KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---------CCCC---CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                     0000   11245678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5e-40  Score=327.19  Aligned_cols=248  Identities=25%  Similarity=0.331  Sum_probs=191.0

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      +|...+.||+|+||.||+|.+..+++.||||++..... .....+.+|+++++.++|+||+++++++     ..++..++
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~l  149 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEIQV  149 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeEEE
Confidence            44567899999999999999888999999999864432 2346789999999999999999999984     44558899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++|+|.+..              ..++.....++.|++.||+|||   +.+|+||||||+|||+++++.+||+||
T Consensus       150 v~e~~~~~~L~~~~--------------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~Df  212 (353)
T PLN00034        150 LLEFMDGGSLEGTH--------------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADF  212 (353)
T ss_pred             EEecCCCCcccccc--------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccc
Confidence            99999999986542              2345677889999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCC-----CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-----HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+++.+.....  ......||..|+|||++..     ...+.++|||||||++|||++|+.||.....  ..+.......
T Consensus       213 G~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~~~  288 (353)
T PLN00034        213 GVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMCAI  288 (353)
T ss_pred             ccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHHHH
Confidence            99986643221  1234568999999998743     2345689999999999999999999973211  1111111111


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ....           .......+...+.+++.+||+.||++|||+.|+++.
T Consensus       289 ~~~~-----------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        289 CMSQ-----------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             hccC-----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000           000112345568899999999999999999999864

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-40  Score=315.96  Aligned_cols=265  Identities=23%  Similarity=0.331  Sum_probs=204.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcC-----CCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFE-----STTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      .++|...+.||+|+||.||+|....     .+..||+|.+..... .....+.+|+.+++.++|||++++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence            3467888999999999999997754     347899999864332 33457889999999999999999999853     


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                      .....++||||+++|+|.+++...............+++..++.++.|++.||.|||   +.+|+||||||+||+++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~  156 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCC
Confidence            345789999999999999998642221111122345789999999999999999999   89999999999999999999


Q ss_pred             cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHH
Q 046112          358 TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~  436 (502)
                      .+||+|||+++.+.............++..|+|||.+.++.++.++|||||||++||++| |+.||.....  .......
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~  234 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFV  234 (277)
T ss_pred             CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHHH
Confidence            999999999986654332222223446788999999988889999999999999999998 9999865211  1111111


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                      ..           ...   ......++..+.+++.+|++.+|++|||+.++++.|+
T Consensus       235 ~~-----------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 ID-----------GGH---LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             hc-----------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            10           000   0111234667889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.1e-40  Score=324.33  Aligned_cols=242  Identities=24%  Similarity=0.293  Sum_probs=189.8

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      ++||+|+||.||+|+...+++.||+|+++...   ......+..|.+++..+ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence            46999999999999988889999999987431   23345577888888865 799999999984     4455889999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        76 E~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~  142 (321)
T cd05591          76 EYVNGGDLMFQIQR----------SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGM  142 (321)
T ss_pred             eCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeeccc
Confidence            99999999988742          345888999999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  ...+   .....    
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~---~i~~~----  211 (321)
T cd05591         143 CKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLFE---SILHD----  211 (321)
T ss_pred             ceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--HHHH---HHHcC----
Confidence            875432221  123456899999999999999999999999999999999999999753211  1111   11100    


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-------CHHHHHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERM-------KINDVEP  489 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-------t~~ev~~  489 (502)
                          ..    .........+.+++.+|++.||++||       +++++++
T Consensus       212 ----~~----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         212 ----DV----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             ----CC----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                00    00011234677899999999999999       6776654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.9e-40  Score=315.29  Aligned_cols=264  Identities=25%  Similarity=0.421  Sum_probs=203.0

Q ss_pred             cCCCCCCcccccCCceEEEEEE-----cCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGIL-----FESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .+|...++||+|+||.||++..     ..++..+|+|.++.........+.+|++++++++|+||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----EG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----cC
Confidence            3567789999999999999963     2356789999887655555678999999999999999999999853     34


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhh-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDK-----RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                      ...++++||+++|+|.++++.......     .......+++..++.++.|++.|++|||   +.+++||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~  156 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVG  156 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEc
Confidence            478999999999999999864321100     0112245899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchH
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLR  433 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~  433 (502)
                      +++.+||+|||+++...............+++.|+|||+..+..++.++|||||||++|||++ |+.||.......  ..
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~  234 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AI  234 (280)
T ss_pred             CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HH
Confidence            999999999999976543322222222345678999999999999999999999999999998 999986532111  11


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                      .......           ..   .....++..+.+++.+||+.||++||++.||.+.|+
T Consensus       235 ~~~~~~~-----------~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 ECITQGR-----------EL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHcCc-----------cC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            1111000           00   001134566889999999999999999999998885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.6e-40  Score=324.32  Aligned_cols=239  Identities=25%  Similarity=0.305  Sum_probs=187.4

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHH---hcCCCCccceeeecccccccCCCc
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVT---RNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      |.+.+.||+|+||.||+|.+..+++.||||+++...   ....+.+..|++++   +.++||||+++++++     ...+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence            556789999999999999998899999999987432   22334566666554   567899999999984     4455


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|..+++.           ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~k  141 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT-----------DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVK  141 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEE
Confidence            89999999999999888742           35899999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||+++......  .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.....     .+......
T Consensus       142 L~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-----~~~~~~i~  214 (324)
T cd05589         142 IADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-----EEVFDSIV  214 (324)
T ss_pred             eCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH
Confidence            99999987432221  122345689999999999999999999999999999999999999975311     11111110


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK  483 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt  483 (502)
                      ..        ..    .........+.+++.+|++.||.+||+
T Consensus       215 ~~--------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~  245 (324)
T cd05589         215 ND--------EV----RYPRFLSREAISIMRRLLRRNPERRLG  245 (324)
T ss_pred             hC--------CC----CCCCCCCHHHHHHHHHHhhcCHhHcCC
Confidence            00        00    011123456778999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7e-40  Score=316.15  Aligned_cols=265  Identities=25%  Similarity=0.408  Sum_probs=201.8

Q ss_pred             cCCCCCCcccccCCceEEEEEEc----CCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILF----ESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      ++|+..+.||+|+||.||+|...    ..+..|++|.++... ......+.+|++++++++||||+++++++     ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ecC
Confidence            35677889999999999999753    456789999987433 23346788999999999999999999984     334


Q ss_pred             cceeEEeeeccCCChhhhccCCchh-------hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCee
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEE-------DKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNIL  352 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIl  352 (502)
                      ...++||||+++|+|.+++......       .........+++.+.+.++.+++.||+|||   +.+|+||||||+|||
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nil  156 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNIL  156 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEE
Confidence            5789999999999999998421100       000111345889999999999999999999   899999999999999


Q ss_pred             eCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccc
Q 046112          353 LDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLN  431 (502)
Q Consensus       353 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~  431 (502)
                      +++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....  ..
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~  234 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QE  234 (283)
T ss_pred             EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HH
Confidence            99999999999999986644332222233445778999999988889999999999999999998 9999865211  11


Q ss_pred             hHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 046112          432 LRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL  493 (502)
Q Consensus       432 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~  493 (502)
                      ..+.+....   .       .    .....++..+.+++.+|++.||++||++.++.+.|..
T Consensus       235 ~~~~~~~~~---~-------~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 VIEMVRKRQ---L-------L----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcCC---c-------C----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            111111110   0       0    0111345667899999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=331.96  Aligned_cols=256  Identities=24%  Similarity=0.405  Sum_probs=212.8

Q ss_pred             CCCCcccccCCceEEEEEEcCCCe----EEEEEEeccc-CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          208 SSENLIGAGNFGSVYKGILFESTT----AVAVKVFNVL-HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       208 ~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ...++||+|+||+||+|.+.+.|+    +||+|++... ...+..++.+|+-+|.+++|||+++++|+|...      ..
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~~  772 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------TL  772 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------hH
Confidence            456899999999999999988775    4688887643 344578899999999999999999999999653      37


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      .||++||+.|+|.++++.         .+..+.....+.|..|||+||.|||   +++++||||.++|||+..-..+||.
T Consensus       773 qlvtq~mP~G~LlDyvr~---------hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkit  840 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVRE---------HRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKIT  840 (1177)
T ss_pred             HHHHHhcccchHHHHHHH---------hhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEE
Confidence            899999999999999963         4456788899999999999999999   9999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||+|+.+.+...........-.+-|||=|.+....++.++|||||||++||++| |..|++.+..++            
T Consensus       841 dfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------------  908 (1177)
T KOG1025|consen  841 DFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------------  908 (1177)
T ss_pred             ecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------------
Confidence            9999998877665554444556788999999999999999999999999999999 999998742221            


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                        +.+++...  ..-+.+.-|...+..++.+||..|+..||+++++..++.++.++
T Consensus       909 --I~dlle~g--eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  909 --IPDLLEKG--ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             --hhHHHhcc--ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence              11111110  11222347888999999999999999999999999999887654

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.5e-40  Score=315.37  Aligned_cols=248  Identities=23%  Similarity=0.284  Sum_probs=192.8

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeec
Q 046112          213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFM  289 (502)
Q Consensus       213 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  289 (502)
                      ||+|+||+||++.+..+++.||+|.+.....   ...+.+..|++++++++|+||+++.+++     ......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            6999999999999888999999999864322   1235677899999999999999998874     3445789999999


Q ss_pred             cCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          290 ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       290 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                      ++|+|.+++....      .....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus        76 ~~g~L~~~~~~~~------~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  146 (280)
T cd05608          76 NGGDLRYHIYNVD------EENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVE  146 (280)
T ss_pred             CCCCHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence            9999998874311      23456899999999999999999999   89999999999999999999999999999976


Q ss_pred             cccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcc
Q 046112          370 LEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRA  449 (502)
Q Consensus       370 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  449 (502)
                      +......  .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ...........        
T Consensus       147 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~--------  215 (280)
T cd05608         147 LKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILN--------  215 (280)
T ss_pred             cCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhcc--------
Confidence            5433221  234568999999999999999999999999999999999999997522111 11111111100        


Q ss_pred             cCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 046112          450 SSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEP  489 (502)
Q Consensus       450 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~  489 (502)
                      .    ...+....+..+.+++.+|++.||++||     +++++++
T Consensus       216 ~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         216 D----SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             c----CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            0    0011123455678999999999999999     6666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.8e-40  Score=323.43  Aligned_cols=238  Identities=25%  Similarity=0.287  Sum_probs=187.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.||+|+||.||+|....+++.||+|+++..   .......+..|..++..+ +||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            4689999999999999889999999998642   223345677788888766 699999999884     4455889999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        76 Ey~~~g~L~~~i~~----------~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~  142 (320)
T cd05590          76 EFVNGGDLMFHIQK----------SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGM  142 (320)
T ss_pred             cCCCCchHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCC
Confidence            99999999988842          345889999999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      ++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     .+.........   
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~---  212 (320)
T cd05590         143 CKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILNDE---  212 (320)
T ss_pred             CeecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcCC---
Confidence            875322211  12345689999999999999999999999999999999999999975311     11111111100   


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKIN  485 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~  485 (502)
                           .    .........+.+++.+|++.||++||++.
T Consensus       213 -----~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~  242 (320)
T cd05590         213 -----V----VYPTWLSQDAVDILKAFMTKNPTMRLGSL  242 (320)
T ss_pred             -----C----CCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence                 0    00112344567899999999999999983

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.4e-40  Score=322.88  Aligned_cols=242  Identities=22%  Similarity=0.303  Sum_probs=189.6

Q ss_pred             CcccccCCceEEEEEEc---CCCeEEEEEEecccC----cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          211 NLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLH----HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +.||+|+||.||+++..   ..++.||+|+++...    ......+..|+++++.++||||+++++++     ..++..+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence            67999999999999753   468899999987421    12234577899999999999999999885     3445789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++|+|.+++..          ...+.+..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        77 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D  143 (323)
T cd05584          77 LILEYLSGGELFMHLER----------EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTD  143 (323)
T ss_pred             EEEeCCCCchHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEee
Confidence            99999999999998842          345778888899999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .........  
T Consensus       144 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~~~~~--  214 (323)
T cd05584         144 FGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTIDKILK--  214 (323)
T ss_pred             CcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHHHHHc--
Confidence            999875432221  12235689999999999998899999999999999999999999975211     111111111  


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEP  489 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~  489 (502)
                            ....    ........+.+++.+|++.||++||     +++++.+
T Consensus       215 ------~~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         215 ------GKLN----LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ------CCCC----CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                  1100    1112345677999999999999999     7777765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9e-41  Score=309.30  Aligned_cols=266  Identities=23%  Similarity=0.296  Sum_probs=199.9

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEE
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      .|...+++|.|+||.||+|...+++..||||+.-...    +--.+|+++|++++|||||++.-++......+.-...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4566789999999999999999999999999864322    222569999999999999999988765432223356689


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC-CcEEEeee
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE-MTAYVSDF  364 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~-~~~kl~Df  364 (502)
                      |||||. +|.++++.+.      .....++.....-+..|+.+||+|||   +.+|+||||||.|+|+|.+ +.+|||||
T Consensus       101 leymP~-tL~~~~r~~~------~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYT------RANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             HHhchH-HHHHHHHHHh------hcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccC
Confidence            999965 8988886432      23455777778889999999999999   8999999999999999976 89999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |.|+.+......   .++..|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+ .+...++++.++-.-...
T Consensus       171 GSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik~lG~Pt  246 (364)
T KOG0658|consen  171 GSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIKVLGTPT  246 (364)
T ss_pred             CcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHHHhCCCC
Confidence            999987654432   345568899999998874 699999999999999999999998876 222233444433221111


Q ss_pred             hhhh----------cccCCCCcc---hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AEEI----------RASSGSTQR---SIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~~~----------~d~~~~~~~---~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .+++          ..+......   -+......+.++++.++++.+|.+|.++.|++.
T Consensus       247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            1111          111111111   022355667889999999999999999998874

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-39  Score=327.03  Aligned_cols=259  Identities=22%  Similarity=0.252  Sum_probs=195.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      .+|...+.||+|+||.||++.+..+++.||+|...      .+.+.+|++++++++||||+++++++     ..+...++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~l  160 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTF-----TYNKFTCL  160 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeEE
Confidence            57999999999999999999999999999999753      24578899999999999999999984     34457899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      |+|++. ++|.+++.          ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus       161 v~e~~~-~~L~~~l~----------~~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DF  226 (391)
T PHA03212        161 ILPRYK-TDLYCYLA----------AKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDF  226 (391)
T ss_pred             EEecCC-CCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeC
Confidence            999984 78888873          2345889999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccc------cccchHHHHHh
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFK------DNLNLRNCVKS  438 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~------~~~~~~~~~~~  438 (502)
                      |+|+...... ........||+.|+|||++.+..++.++|||||||++|||+||+.|+.....      ....+...+..
T Consensus       227 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~  305 (391)
T PHA03212        227 GAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR  305 (391)
T ss_pred             Cccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence            9997543221 1122345799999999999999999999999999999999999988643211      01111111111


Q ss_pred             hc--cc--------chhhhc---------ccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 AL--PE--------RAEEIR---------ASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~--~~--------~~~~~~---------d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .-  +.        ......         .+..........+.+..+.+++.+|++.||++|||++|+++
T Consensus       306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00  00        000000         00000000111234567889999999999999999999985

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.6e-40  Score=314.91  Aligned_cols=262  Identities=24%  Similarity=0.345  Sum_probs=201.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcC-----CCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFE-----STTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      +++|...+.||+|++|.||+|.+..     .+..||+|.++.... .....|..|+.++++++|+||+++++++..    
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE----   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence            4678889999999999999998876     678899998864432 234568999999999999999999998543    


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                       ....++||||+++|+|.++++.....   ......+++..++.++.+++.|++|||   +.+++||||||+||+++.++
T Consensus        81 -~~~~~lv~e~~~g~~L~~~i~~~~~~---~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~  153 (277)
T cd05036          81 -RLPRFILLELMAGGDLKSFLRENRPR---PERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKG  153 (277)
T ss_pred             -CCCcEEEEecCCCCCHHHHHHHhCCC---CCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccC
Confidence             34678999999999999998642211   112346899999999999999999999   88999999999999998654


Q ss_pred             ---cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchH
Q 046112          358 ---TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLR  433 (502)
Q Consensus       358 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~  433 (502)
                         .+||+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||+.....  ...
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~  231 (277)
T cd05036         154 PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVM  231 (277)
T ss_pred             CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH
Confidence               699999999986633222111112233568999999999999999999999999999997 99998753211  111


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                      ..+...   .         .  ......++..+.+++.+|++.+|++||++.+|++.|.
T Consensus       232 ~~~~~~---~---------~--~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         232 EFVTGG---G---------R--LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHcC---C---------c--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111100   0         0  0011234567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.2e-40  Score=315.66  Aligned_cols=264  Identities=23%  Similarity=0.372  Sum_probs=201.6

Q ss_pred             CCCCCCcccccCCceEEEEEEcC-----CCeEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          206 GFSSENLIGAGNFGSVYKGILFE-----STTAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      +|...+.||+|+||.||+|....     .+..||+|+++..... ....+..|+.++..++||||+++++++..     .
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~   80 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-----E   80 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----C
Confidence            35567889999999999997653     3578999998754332 23568899999999999999999998643     3


Q ss_pred             cceeEEeeeccCCChhhhccCCchh------hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEE------DKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL  353 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll  353 (502)
                      ...++++||+++++|.+++......      .........+++..+..++.|++.||.|||   +.+|+||||||+||++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~  157 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLV  157 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEe
Confidence            4789999999999999998421100      000112345889999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccch
Q 046112          354 DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNL  432 (502)
Q Consensus       354 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~  432 (502)
                      ++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....     
T Consensus       158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----  232 (283)
T cd05091         158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----  232 (283)
T ss_pred             cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence            9999999999999886544332222233456789999999988889999999999999999998 8888865211     


Q ss_pred             HHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 046112          433 RNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL  493 (502)
Q Consensus       433 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~  493 (502)
                      .++......        ....   ....+++..+.+++..|++.+|++||+++++++.|+.
T Consensus       233 ~~~~~~i~~--------~~~~---~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 QDVIEMIRN--------RQVL---PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHHHc--------CCcC---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            111111111        1100   1112456678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.5e-40  Score=323.68  Aligned_cols=242  Identities=24%  Similarity=0.283  Sum_probs=189.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCC-ccceeeecccccccCCCcc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHR-NLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~~  281 (502)
                      +|+..+.||+|+||.||+|....+++.||+|+++..   .....+.+..|.+++..++|+ +|+++.+++     ...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence            477889999999999999998888999999998743   223345678899999999765 577777763     34458


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----------~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL  142 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQ----------VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKI  142 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEE
Confidence            9999999999999988842          345788999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||+||+.||......  .....+...  
T Consensus       143 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~~--  216 (324)
T cd05587         143 ADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIMEH--  216 (324)
T ss_pred             eecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHcC--
Confidence            99999874322211  123456899999999999999999999999999999999999999753211  111111100  


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKI  484 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~  484 (502)
                               ..    .+.......+.+++.+|+..||.+|++.
T Consensus       217 ---------~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         217 ---------NV----SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ---------CC----CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                     00    0011234456789999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-39  Score=322.05  Aligned_cols=270  Identities=21%  Similarity=0.301  Sum_probs=203.2

Q ss_pred             cCCCCCCcccccCCceEEEEEE-----cCCCeEEEEEEecccCc-chhHHHHHHHHHHhcC-CCCccceeeecccccccC
Q 046112          205 KGFSSENLIGAGNFGSVYKGIL-----FESTTAVAVKVFNVLHH-DASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  277 (502)
                      ++|...+.||+|+||.||+|.+     ..+++.||||+++.... .....+.+|+.++.++ +||||++++++|..    
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----   82 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK----   82 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec----
Confidence            4788899999999999999974     24678999999875332 2345688999999999 68999999998742    


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhh----------------------------------------------------
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEED----------------------------------------------------  305 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------------------------------------------------  305 (502)
                      .+...+++|||+++|+|.++++......                                                    
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            2346789999999999999985321000                                                    


Q ss_pred             -----hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecccccccceec
Q 046112          306 -----KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI  380 (502)
Q Consensus       306 -----~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  380 (502)
                           ........+++.++..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||++.............
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                 00001234788899999999999999999   8999999999999999999999999999997654332222222


Q ss_pred             ccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhh
Q 046112          381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSII  459 (502)
Q Consensus       381 ~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  459 (502)
                      ...++..|+|||...+..++.++||||||+++||+++ |..||....... .....+.....           ...+   
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~-----------~~~~---  304 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTR-----------MRAP---  304 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccCC-----------CCCC---
Confidence            3445678999999988899999999999999999997 999986532111 11111110000           0000   


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          460 LECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       460 ~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                      ......+.+++..||+.||++|||+.|+++.|+.+.+
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            0123457899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-39  Score=317.31  Aligned_cols=266  Identities=21%  Similarity=0.312  Sum_probs=196.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .++|...+.||+|+||.||+|....+++.||||+++.... .....+.+|+.+++.++||||+++++++     ......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence            4689999999999999999999888999999999875432 2234678899999999999999999985     344588


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||++ ++|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+
T Consensus        79 ~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~  145 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDK---------HPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLA  145 (303)
T ss_pred             EEEEECCC-cCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEC
Confidence            99999995 688777742         2345788899999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc-
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL-  440 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-  440 (502)
                      |||+++......  .......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||....+....+........ 
T Consensus       146 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  223 (303)
T cd07869         146 DFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGT  223 (303)
T ss_pred             CCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCC
Confidence            999997543221  11233567899999998765 45888999999999999999999999763221111111111000 


Q ss_pred             cc---ch--hhh--cccC-CC--Ccchhh-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PE---RA--EEI--RASS-GS--TQRSII-----LECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~---~~--~~~--~d~~-~~--~~~~~~-----~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      +.   +.  ...  .++. ..  ......     ......+.+++.+|++.||++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         224 PNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             CChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00   00  000  0000 00  000000     011245678999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.6e-40  Score=317.17  Aligned_cols=269  Identities=23%  Similarity=0.367  Sum_probs=206.5

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcC-----CCeEEEEEEecccCc-chhHHHHHHHHHHhcC-CCCccceeeecccccc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFE-----STTAVAVKVFNVLHH-DASKSFAVECEVTRNI-RHRNLVKVFTACSGVD  275 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  275 (502)
                      ..++|+..+.||+|+||.||++....     ....+|+|.+..... .....+.+|++++.++ +|+||++++++|.   
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~---   86 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT---   86 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc---
Confidence            44578888999999999999997653     347899999875322 2345688999999999 7999999999864   


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhhh------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCC
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEEDK------RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPS  349 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~  349 (502)
                        .+...+++|||+++|+|.++++.......      .......+++..++.++.|++.|++|||   +.+|+||||||+
T Consensus        87 --~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~  161 (293)
T cd05053          87 --QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAAR  161 (293)
T ss_pred             --CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCcccccccee
Confidence              34478999999999999999864211000      0023456899999999999999999999   899999999999


Q ss_pred             CeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCcccccc
Q 046112          350 NILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKD  428 (502)
Q Consensus       350 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~  428 (502)
                      ||++++++.+||+|||+++.+.............++..|+|||...+..++.++|||||||++||+++ |..||......
T Consensus       162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  241 (293)
T cd05053         162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  241 (293)
T ss_pred             eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence            99999999999999999987654433222233345678999999998899999999999999999998 99998652111


Q ss_pred             ccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          429 NLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                        ..........              .......+...+.+++.+|+..+|++|||+.|+++.|+.+.
T Consensus       242 --~~~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         242 --ELFKLLKEGY--------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --HHHHHHHcCC--------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence              1111111100              00111234567889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.5e-39  Score=314.70  Aligned_cols=268  Identities=21%  Similarity=0.300  Sum_probs=203.4

Q ss_pred             hccCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeeccccccc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDF  276 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  276 (502)
                      .+++|++.+.||+|+||.||+|...     ..+..||+|.++.... .....+.+|+.++++++||||+++++++.    
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----   79 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS----   79 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence            4568899999999999999999654     2356899998764332 22346788999999999999999999853    


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE  356 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~  356 (502)
                       .+...++||||+++|+|.+++................++.....++.|++.||.|||   +++|+||||||+||+++++
T Consensus        80 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~  155 (288)
T cd05061          80 -KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHD  155 (288)
T ss_pred             -CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCC
Confidence             344789999999999999999642211111122345677888999999999999999   9999999999999999999


Q ss_pred             CcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHH
Q 046112          357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~  435 (502)
                      +.++|+|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |..||.....+     +.
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~  230 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QV  230 (288)
T ss_pred             CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HH
Confidence            9999999999986544332222222345678999999999899999999999999999998 78888653211     11


Q ss_pred             HHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      .+..        .+....   .....+...+.+++.+|++.||++|||+.++++.|++.
T Consensus       231 ~~~~--------~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         231 LKFV--------MDGGYL---DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHHH--------HcCCCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            1111        111000   01123456788999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.6e-39  Score=319.24  Aligned_cols=199  Identities=27%  Similarity=0.360  Sum_probs=171.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .++|+..+.||+|+||.||++.+..++..+|+|+++.... .....+.+|++++++++||||++++++|.     .++..
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence            3688999999999999999999988999999998875422 23467899999999999999999999864     34589


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceeecCCCCCeeeCCCCcEEE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ-PPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      ++||||+++|+|.+++..          ...+++.....++.+++.||.|||   + .+|+||||||+|||++.++.+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL  145 (333)
T cd06650          79 SICMEHMDGGSLDQVLKK----------AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKL  145 (333)
T ss_pred             EEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEE
Confidence            999999999999999842          235788889999999999999999   5 47999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      +|||++..+....    .....|+..|+|||++.+..++.++|||||||++||+++|+.||..
T Consensus       146 ~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         146 CDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             eeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9999987553221    1234689999999999988899999999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-40  Score=328.98  Aligned_cols=254  Identities=22%  Similarity=0.327  Sum_probs=200.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||+||+|.+..+++.||+|+++...   ......+..|++++..++||||+++++++     ..++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence            46888899999999999999998899999999987432   23456788999999999999999999874     44568


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL  142 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIR----------KDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKL  142 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEe
Confidence            9999999999999999853          256889999999999999999999   899999999999999999999999


Q ss_pred             eeeccceeccccc---------------------------ccceecccccccccccCcccCCCccCccccchhHHHHHHH
Q 046112          362 SDFGIARFLEAAD---------------------------EQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLE  414 (502)
Q Consensus       362 ~Dfg~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~e  414 (502)
                      +|||++.......                           .........||+.|+|||.+.+..++.++|||||||++||
T Consensus       143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e  222 (350)
T cd05573         143 ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE  222 (350)
T ss_pred             ecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhh
Confidence            9999997654332                           0011234568999999999999999999999999999999


Q ss_pred             HHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHH
Q 046112          415 MFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK-INDVEPR  490 (502)
Q Consensus       415 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt-~~ev~~~  490 (502)
                      |++|+.||......     ....... .......   .+...    .....+.+++.+|+. ||.+||+ ++|+++.
T Consensus       223 ll~g~~Pf~~~~~~-----~~~~~i~-~~~~~~~---~p~~~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         223 MLYGFPPFYSDTLQ-----ETYNKII-NWKESLR---FPPDP----PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             hccCCCCCCCCCHH-----HHHHHHh-ccCCccc---CCCCC----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            99999999763211     1111100 1000000   00011    134567788999997 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.3e-40  Score=323.03  Aligned_cols=243  Identities=24%  Similarity=0.297  Sum_probs=188.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.||+|+||.||+|....+++.||+|+++...   ....+.+..|+.++.++ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence            46999999999999998899999999987532   22345577888888776 799999999984     3455899999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|..++.          ....+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        76 E~~~~~~L~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~  142 (329)
T cd05618          76 EYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM  142 (329)
T ss_pred             eCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCc
Confidence            9999999998873          2345889999999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccccc---ccchHHHHHhhcccc
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD---NLNLRNCVKSALPER  443 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~  443 (502)
                      ++.......  ......||..|+|||++.+..++.++|||||||++|||++|+.||+.....   ......++...+...
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~  220 (329)
T cd05618         143 CKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK  220 (329)
T ss_pred             cccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC
Confidence            875322211  123456899999999999999999999999999999999999999642111   111112211111110


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKI  484 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~  484 (502)
                                 ...++......+.+++.+|++.||++||++
T Consensus       221 -----------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         221 -----------QIRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                       001112334567799999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.1e-39  Score=314.90  Aligned_cols=247  Identities=21%  Similarity=0.323  Sum_probs=197.7

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      ..++|....+||+|+||.||+|+...+|..+|+|++++..-   ...+-+..|-.+|...++|.||+++..     |++.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence            45789999999999999999999999999999999986432   334557789999999999999999877     7788


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +.+||||||++||++..+|          ...+.|++......+.+.+.|+..+|   +.|+|||||||+|+|||..|++
T Consensus       214 ~~LYLiMEylPGGD~mTLL----------~~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHi  280 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLL----------MRKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHI  280 (550)
T ss_pred             CeeEEEEEecCCccHHHHH----------HhcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCE
Confidence            8999999999999999998          44567888888899999999999999   9999999999999999999999


Q ss_pred             EEeeeccceecccc----------------------ccc----ce-------------------ecccccccccccCccc
Q 046112          360 YVSDFGIARFLEAA----------------------DEQ----TR-------------------SIGVEGTTGYIAPEYG  394 (502)
Q Consensus       360 kl~Dfg~a~~~~~~----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~  394 (502)
                      ||+|||++.-+...                      +..    ..                   ..+.+|||.|||||++
T Consensus       281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl  360 (550)
T KOG0605|consen  281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL  360 (550)
T ss_pred             eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence            99999998432110                      000    00                   1235699999999999


Q ss_pred             CCCccCccccchhHHHHHHHHHhCCCCCccccccc--cchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhh
Q 046112          395 MGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN--LNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVA  472 (502)
Q Consensus       395 ~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~  472 (502)
                      .+..|+..+|.||+||++|||+.|.+||.......  ..+..|-...        .-+.       ...+..+..+|+.+
T Consensus       361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l--------~fP~-------~~~~s~eA~DLI~r  425 (550)
T KOG0605|consen  361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL--------KFPE-------EVDLSDEAKDLITR  425 (550)
T ss_pred             hcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc--------cCCC-------cCcccHHHHHHHHH
Confidence            99999999999999999999999999997632111  1222222111        1111       01223566789999


Q ss_pred             cccCCCCCCCC
Q 046112          473 CSAEQPGERMK  483 (502)
Q Consensus       473 c~~~dP~~RPt  483 (502)
                      |+. ||++|.-
T Consensus       426 ll~-d~~~RLG  435 (550)
T KOG0605|consen  426 LLC-DPENRLG  435 (550)
T ss_pred             Hhc-CHHHhcC
Confidence            999 9999986

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2e-39  Score=310.37  Aligned_cols=258  Identities=26%  Similarity=0.454  Sum_probs=201.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCe---EEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTT---AVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      +++|+..+.||+|+||.||+|....++.   .+|+|.++... ....+.+..|++++++++|||++++.+++.     ..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   78 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KF   78 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cC
Confidence            3467888999999999999998765443   79999886542 233467889999999999999999999853     34


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +..++||||+++++|.+++..         ....+++.++..++.+++.|++|||   +.+++||||||+||++++++.+
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~  146 (268)
T cd05063          79 KPAMIITEYMENGALDKYLRD---------HDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLEC  146 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcE
Confidence            478999999999999999842         2345889999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccce-ecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHH
Q 046112          360 YVSDFGIARFLEAADEQTR-SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  437 (502)
                      ||+|||++........... ......+..|+|||++....++.++|||||||++||+++ |+.||......  .....+.
T Consensus       147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~i~  224 (268)
T cd05063         147 KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKAIN  224 (268)
T ss_pred             EECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHh
Confidence            9999999976643322111 112223567999999998889999999999999999998 99998652211  1111111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      ..       .       ..+...+++..+.+++.+|++.+|++||++++|++.|+++
T Consensus       225 ~~-------~-------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         225 DG-------F-------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             cC-------C-------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            00       0       0001123456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.6e-39  Score=307.61  Aligned_cols=249  Identities=25%  Similarity=0.391  Sum_probs=194.7

Q ss_pred             cccccCCceEEEEEEc--CCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeee
Q 046112          212 LIGAGNFGSVYKGILF--ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEF  288 (502)
Q Consensus       212 ~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  288 (502)
                      .||+|+||.||+|.+.  ..+..||+|++..... ...+.+.+|+.++++++||||++++++|.      .+..++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence            3899999999999664  4566799999875432 23466899999999999999999999863      2357899999


Q ss_pred             ccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccce
Q 046112          289 MANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR  368 (502)
Q Consensus       289 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~  368 (502)
                      +++|+|.+++..         ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus        76 ~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  143 (257)
T cd05115          76 ASGGPLNKFLSG---------KKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSK  143 (257)
T ss_pred             CCCCCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccc
Confidence            999999999842         2346899999999999999999999   8999999999999999999999999999997


Q ss_pred             ecccccccce-ecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccchhh
Q 046112          369 FLEAADEQTR-SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       369 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      .......... .....++..|+|||......++.++|||||||++||+++ |+.||......  .....+....      
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~------  215 (257)
T cd05115         144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIEQGK------  215 (257)
T ss_pred             cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCC------
Confidence            6543322111 122233578999999988889999999999999999996 99999763221  1111111110      


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                              .......+..++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       216 --------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         216 --------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                    0011123466788999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.3e-40  Score=320.34  Aligned_cols=241  Identities=25%  Similarity=0.356  Sum_probs=188.2

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhc-CCCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRN-IRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.||+|+||.||+|.+..+++.||+|+++...   ......+..|..++.. ++||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence            46899999999999988889999999987431   2234556677777775 5899999999985     3445889999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.+++..          ...+++.+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        76 ey~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  142 (316)
T cd05619          76 EYLNGGDLMFHIQS----------CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGM  142 (316)
T ss_pred             eCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCc
Confidence            99999999998842          245788899999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ....+.+...       
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i~~~-------  211 (316)
T cd05619         143 CKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSIRMD-------  211 (316)
T ss_pred             ceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC-------
Confidence            875322211  12345689999999999999999999999999999999999999975211  1111111110       


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKIN-DVE  488 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~-ev~  488 (502)
                        .+..+      ......+.+++.+|++.||++||++. ++.
T Consensus       212 --~~~~~------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         212 --NPCYP------RWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             --CCCCC------ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence              00000      11234567899999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.2e-40  Score=328.85  Aligned_cols=254  Identities=19%  Similarity=0.284  Sum_probs=192.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .|...+.||+|+||+||+|.+..+++.||+|+++...   ......+..|++++++++||||+++++++     ...+..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence            5778899999999999999999999999999986432   22345688999999999999999999985     345589


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++|+|.+++..          ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~----------~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~  143 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIR----------MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLT  143 (381)
T ss_pred             EEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEe
Confidence            999999999999999842          245788888999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccc---------------------------------------------cceecccccccccccCcccCCC
Q 046112          363 DFGIARFLEAADE---------------------------------------------QTRSIGVEGTTGYIAPEYGMGH  397 (502)
Q Consensus       363 Dfg~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~  397 (502)
                      |||+++.......                                             ........||+.|+|||.+.+.
T Consensus       144 DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~  223 (381)
T cd05626         144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK  223 (381)
T ss_pred             eCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC
Confidence            9999764321000                                             0001235699999999999998


Q ss_pred             ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhh--ccc
Q 046112          398 EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVA--CSA  475 (502)
Q Consensus       398 ~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~--c~~  475 (502)
                      .++.++|||||||++|||+||+.||........ ...    .. ......   ..+...    .....+.+++.+  |+.
T Consensus       224 ~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~----i~-~~~~~~---~~~~~~----~~s~~~~dli~~ll~~~  290 (381)
T cd05626         224 GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTET-QLK----VI-NWENTL---HIPPQV----KLSPEAVDLITKLCCSA  290 (381)
T ss_pred             CCCCccceeehhhHHHHHHhCCCCCcCCCHHHH-HHH----HH-cccccc---CCCCCC----CCCHHHHHHHHHHccCc
Confidence            999999999999999999999999975321110 000    00 000000   001111    122344456655  666


Q ss_pred             CCCCCCCCHHHHHHH
Q 046112          476 EQPGERMKINDVEPR  490 (502)
Q Consensus       476 ~dP~~RPt~~ev~~~  490 (502)
                      .+|..||+++|++..
T Consensus       291 ~~~~~R~~~~~~l~h  305 (381)
T cd05626         291 EERLGRNGADDIKAH  305 (381)
T ss_pred             ccccCCCCHHHHhcC
Confidence            777779999999763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.7e-39  Score=311.02  Aligned_cols=247  Identities=22%  Similarity=0.300  Sum_probs=192.1

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeec
Q 046112          213 IGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFM  289 (502)
Q Consensus       213 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  289 (502)
                      ||+|+||.||++....+|+.+|+|.+....   ....+.+..|++++++++||||+++.+++     ..+...++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            699999999999988899999999986321   12234556799999999999999998874     4455899999999


Q ss_pred             cCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          290 ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       290 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                      ++|+|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++..
T Consensus        76 ~g~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~  144 (277)
T cd05607          76 NGGDLKYHIYN--------VGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVE  144 (277)
T ss_pred             CCCCHHHHHHh--------ccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeee
Confidence            99999988753        23345889999999999999999999   89999999999999999999999999999976


Q ss_pred             cccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcc
Q 046112          370 LEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRA  449 (502)
Q Consensus       370 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  449 (502)
                      .....   ......|+..|+|||++.+..++.++||||+||++|||++|+.||...... ....+..........     
T Consensus       145 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~-----  215 (277)
T cd05607         145 LKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLEDEV-----  215 (277)
T ss_pred             cCCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhcccc-----
Confidence            54322   122346899999999999988999999999999999999999998752211 111111111111100     


Q ss_pred             cCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          450 SSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       450 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                         ...   .......+.+++.+|++.||++||+++|+++.
T Consensus       216 ---~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         216 ---KFE---HQNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             ---ccc---cccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence               000   01234567899999999999999999776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-40  Score=329.12  Aligned_cols=253  Identities=19%  Similarity=0.295  Sum_probs=195.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|+..+.||+|+||.||+|++..+++.||||+++...   ......+.+|++++..++||||+++++++     ..++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence            47888999999999999999998899999999987432   22345678899999999999999999884     44558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~~g~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl  142 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMK----------KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKL  142 (364)
T ss_pred             EEEEECCCCCcHHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEE
Confidence            9999999999999999842          345889999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccc------------------------------------eecccccccccccCcccCCCccCccccc
Q 046112          362 SDFGIARFLEAADEQT------------------------------------RSIGVEGTTGYIAPEYGMGHEVSSYGDV  405 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDv  405 (502)
                      +|||++..+.......                                    ......||+.|+|||++....++.++||
T Consensus       143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  222 (364)
T cd05599         143 SDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW  222 (364)
T ss_pred             eecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeee
Confidence            9999987543211100                                    0112468999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC--
Q 046112          406 YSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK--  483 (502)
Q Consensus       406 ws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt--  483 (502)
                      |||||++|||++|+.||.....     .+...... .....+.   .+...    .....+.+++.+|+. +|.+|++  
T Consensus       223 wSlG~il~el~~G~~Pf~~~~~-----~~~~~~i~-~~~~~~~---~~~~~----~~s~~~~~li~~ll~-~p~~R~~~~  288 (364)
T cd05599         223 WSLGVIMYEMLVGYPPFCSDNP-----QETYRKII-NWKETLQ---FPDEV----PLSPEAKDLIKRLCC-EAERRLGNN  288 (364)
T ss_pred             ecchhHHHHhhcCCCCCCCCCH-----HHHHHHHH-cCCCccC---CCCCC----CCCHHHHHHHHHHcc-CHhhcCCCC
Confidence            9999999999999999975311     11111111 0000000   00000    123455678888886 9999998  


Q ss_pred             -HHHHHH
Q 046112          484 -INDVEP  489 (502)
Q Consensus       484 -~~ev~~  489 (502)
                       +.|+++
T Consensus       289 ~~~~ll~  295 (364)
T cd05599         289 GVNEIKS  295 (364)
T ss_pred             CHHHHhc
Confidence             888765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7.3e-40  Score=321.22  Aligned_cols=242  Identities=24%  Similarity=0.294  Sum_probs=191.0

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.||+|+||.||+|.+..++..||+|+++..   .......+..|.+++..+ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            4699999999999998888999999998743   123345677888888877 799999999984     3445899999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  142 (318)
T cd05570          76 EYVNGGDLMFHIQR----------SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGM  142 (318)
T ss_pred             cCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCC
Confidence            99999999988742          345899999999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+........    
T Consensus       143 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~i~~~----  211 (318)
T cd05570         143 CKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQSILED----  211 (318)
T ss_pred             CeecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHHHHcC----
Confidence            875322211  12234689999999999999999999999999999999999999975211     1111111100    


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKI-----NDVEP  489 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~-----~ev~~  489 (502)
                          .    ..+.......+.+++.+|++.||.+||++     .++++
T Consensus       212 ----~----~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         212 ----E----VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             ----C----CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence                0    00111234567899999999999999999     76654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.7e-39  Score=324.94  Aligned_cols=269  Identities=22%  Similarity=0.311  Sum_probs=204.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccCc-chhHHHHHHHHHHhcCC-CCccceeeeccccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIR-HRNLVKVFTACSGVDF  276 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  276 (502)
                      .++|...+.||+|+||.||+|.+.     ..++.||+|+++.... ...+.+..|++++.++. ||||++++++|..   
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~---  112 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK---  112 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc---
Confidence            345777899999999999999753     3457899999975432 22357889999999997 9999999999643   


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhh---------------------------------------------------
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEED---------------------------------------------------  305 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------------------------------------------  305 (502)
                        ....++|+||+++|+|.++++......                                                   
T Consensus       113 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         113 --GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             --CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence              347899999999999999996432100                                                   


Q ss_pred             -------------------------------------hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCC
Q 046112          306 -------------------------------------KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKP  348 (502)
Q Consensus       306 -------------------------------------~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~  348 (502)
                                                           ........+++...+.++.|++.||+|||   +.+|+||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCc
Confidence                                                 00011235788889999999999999999   89999999999


Q ss_pred             CCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccc
Q 046112          349 SNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFK  427 (502)
Q Consensus       349 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~  427 (502)
                      +|||+++++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999986543322122223456788999999998889999999999999999998 8999865321


Q ss_pred             cccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          428 DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                      .+ .....+....          ..    .....+...+.+++.+||..+|.+||+++|+++.|+.+.
T Consensus       348 ~~-~~~~~~~~~~----------~~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 NE-QFYNAIKRGY----------RM----AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             hH-HHHHHHHcCC----------CC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            11 0111111000          00    001123567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.8e-39  Score=314.17  Aligned_cols=267  Identities=23%  Similarity=0.363  Sum_probs=202.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCe--EEEEEEecccC-cchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTT--AVAVKVFNVLH-HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ++|++.+.||+|+||.||+|....++.  .+++|.++... ....+.+..|++++.++ +||||+++++++.     ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence            478889999999999999998766654  46888877432 23346788999999999 7999999999853     344


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhh------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDK------RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                      ..++++||+++|+|.++++.......      .......+++..+..++.|++.|++|||   +.+|+||||||+|||++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEEC
Confidence            78999999999999999864221100      0112345889999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchH
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLR  433 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~  433 (502)
                      +++.+||+|||++......   ........+..|+|||+..+..++.++|||||||++|||++ |..||.....     .
T Consensus       154 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----~  225 (297)
T cd05089         154 ENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----A  225 (297)
T ss_pred             CCCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----H
Confidence            9999999999998643211   11111223567999999998899999999999999999997 9999975321     1


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      +.........        .   ......+...+.+++.+|++.+|.+|||++++++.|+.+.+..
T Consensus       226 ~~~~~~~~~~--------~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         226 ELYEKLPQGY--------R---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HHHHHHhcCC--------C---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            1111110000        0   0001134566789999999999999999999999999887754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6e-39  Score=306.73  Aligned_cols=262  Identities=22%  Similarity=0.310  Sum_probs=207.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|+..+.||+|+||.||+|....+++.||+|.++...   ....+.+.+|++++++++|+|++++++++.     ..+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence            57888999999999999999888899999999886422   223567889999999999999999999853     3457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++....      .....+++.++..++.+++.|++|||   +.+|+||||+|+||+++.++.++|
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l  147 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFK------KQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhc------ccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEE
Confidence            899999999999999885311      23345889999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||++.........  .....++..|+|||.+.+..++.++|||||||++||+++|+.||....   .+..........
T Consensus       148 ~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~  222 (267)
T cd08224         148 GDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEK  222 (267)
T ss_pred             eccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhhc
Confidence            999998765432211  123457889999999998889999999999999999999999986422   122221111110


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                      .        .....+  .......+.+++.+|+..+|++|||+.++++.|+++.
T Consensus       223 ~--------~~~~~~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         223 C--------DYPPLP--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             C--------CCCCCC--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            0        000000  1134557789999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.7e-39  Score=314.91  Aligned_cols=259  Identities=23%  Similarity=0.341  Sum_probs=201.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccC-cchhHHHHHHHHHHhcC-CCCccceeeecccccccC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLH-HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  277 (502)
                      ++|...+.||+|+||.||+|...     ..+..||||.++... ....+.+.+|+++++++ +||||++++++|..    
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----  110 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI----  110 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec----
Confidence            46888899999999999999642     345689999987543 23346788999999999 79999999998643    


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                       .+..++||||+++|+|.++++.        .....+++.+...++.+++.|++|||   +.+|+|+||||+||+++.++
T Consensus       111 -~~~~~lv~e~~~~~~L~~~i~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~  178 (302)
T cd05055         111 -GGPILVITEYCCYGDLLNFLRR--------KRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGK  178 (302)
T ss_pred             -CCceEEEEEcCCCCcHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCC
Confidence             3478999999999999999853        22234899999999999999999999   89999999999999999999


Q ss_pred             cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHH
Q 046112          358 TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~  436 (502)
                      .++++|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |+.||....... .+....
T Consensus       179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~  257 (302)
T cd05055         179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLI  257 (302)
T ss_pred             eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHH
Confidence            999999999986543322112223345778999999999999999999999999999998 999987532211 111111


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      .....           ...   .......+.+++.+|+..+|++|||+.|+++.|+++
T Consensus       258 ~~~~~-----------~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         258 KEGYR-----------MAQ---PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HcCCc-----------CCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            11100           000   011235688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.3e-39  Score=309.69  Aligned_cols=262  Identities=20%  Similarity=0.307  Sum_probs=206.3

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||+|....+++.+|||.+....   .....++.+|+++++.++|||++++++++.     .++.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence            46778899999999999999888899999999876432   223457889999999999999999999853     3447


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .+++|||+++++|.+++....      .....+++.....++.+++.|++|||   +.+++|+||||+||+++.++.++|
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l  147 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFK------KQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhh------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEE
Confidence            899999999999999885311      23456899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||++........  ......++..|+|||+..+..++.++||||||+++|||++|..||.....+   .....+..  
T Consensus       148 ~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~--  220 (267)
T cd08229         148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI--  220 (267)
T ss_pred             CcchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhh--
Confidence            99999876543221  112345888999999999989999999999999999999999998652211   11111111  


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                         .....+...     .......+.+++.+|+..||++||||.+|.+.++++.
T Consensus       221 ---~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         221 ---EQCDYPPLP-----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ---hcCCCCCCC-----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence               010001000     1134567889999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.6e-40  Score=322.86  Aligned_cols=238  Identities=24%  Similarity=0.285  Sum_probs=185.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHH-HHhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECE-VTRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.||+|+||+||+|.+..+|+.||+|++....   ......+..|.. +++.++||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence            46899999999999998899999999986432   122344455544 56789999999999884     3455889999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.+++..          ...+++.....++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        76 e~~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~  142 (323)
T cd05575          76 DYVNGGELFFHLQR----------ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGL  142 (323)
T ss_pred             cCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCC
Confidence            99999999998842          345788899999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||....     ..+........    
T Consensus       143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~----  211 (323)
T cd05575         143 CKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDNILNK----  211 (323)
T ss_pred             CcccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcC----
Confidence            87532221  12234568999999999999999999999999999999999999997521     11111111110    


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKIN  485 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~  485 (502)
                          .....    ......+.+++.+|++.||.+||++.
T Consensus       212 ----~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         212 ----PLRLK----PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ----CCCCC----CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                01111    12245677999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.3e-39  Score=313.55  Aligned_cols=272  Identities=20%  Similarity=0.296  Sum_probs=203.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCC----------------CeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFES----------------TTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVK  266 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~  266 (502)
                      ..+|...+.||+|+||.||+|.....                +..||+|.+..... ...+.+.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            35788899999999999999876543                35689999875432 34567899999999999999999


Q ss_pred             eeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeec
Q 046112          267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKR-HKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCD  345 (502)
Q Consensus       267 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~d  345 (502)
                      ++++|.     .+...++++||+++++|.+++......... ......+++...+.++.|++.||+|||   +.+|+|||
T Consensus        84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~d  155 (296)
T cd05051          84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRD  155 (296)
T ss_pred             EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccc
Confidence            999864     335789999999999999998642211000 112346899999999999999999999   89999999


Q ss_pred             CCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh--CCCCCc
Q 046112          346 LKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT--GLRPSD  423 (502)
Q Consensus       346 lk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t--g~~p~~  423 (502)
                      |||+||+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++||+++  |..||.
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            999999999999999999999986544433233334556789999999998899999999999999999998  677776


Q ss_pred             cccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          424 DMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                      .....  .............       ...........++..+.+++.+|++.||++|||+.|+++.|+
T Consensus       236 ~~~~~--~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         236 HLTDQ--QVIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             CcChH--HHHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            42211  1111111110000       000000001133467889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.1e-39  Score=309.27  Aligned_cols=256  Identities=25%  Similarity=0.421  Sum_probs=201.2

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCe---EEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTT---AVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      +|...+.||+|+||.||+|....+++   .||||.++... ....+.|..|+.++++++||||+++++++     ..+..
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~   79 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSRP   79 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCCc
Confidence            46778999999999999998766554   69999987542 33456799999999999999999999985     34457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..         ....+++.+++.++.|++.|++|||   +.+++||||||+||+++.++.+||
T Consensus        80 ~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl  147 (269)
T cd05065          80 VMIITEFMENGALDSFLRQ---------NDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKV  147 (269)
T ss_pred             eEEEEecCCCCcHHHHHhh---------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEE
Confidence            8999999999999999852         2345889999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecc---cccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHH
Q 046112          362 SDFGIARFLEAADEQTRSIG---VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  437 (502)
                      +|||++..+...........   ...+..|+|||++.+..++.++|||||||++||+++ |+.||.....  .....++.
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~  225 (269)
T cd05065         148 SDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIE  225 (269)
T ss_pred             CCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHH
Confidence            99999876543322111111   112457999999999999999999999999999987 9999875321  11222221


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      ...          .    .+...+++..+.+++.+|++.+|.+||++.+++..|+.+
T Consensus       226 ~~~----------~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         226 QDY----------R----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             cCC----------c----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110          0    001124556788999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.2e-40  Score=321.68  Aligned_cols=242  Identities=24%  Similarity=0.281  Sum_probs=189.6

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      +|...+.||+|+||.||+|....++..||+|+++...   ......+..|..++..+ +|++|+++.+++     ...+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            4777899999999999999998889999999987432   22234566677887776 588899888874     34458


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL  142 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQ----------VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKI  142 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEE
Confidence            8999999999999988842          345888999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||+||+.||......  .+.+.+...  
T Consensus       143 ~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~~~--  216 (323)
T cd05616         143 ADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIMEH--  216 (323)
T ss_pred             ccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHHHhC--
Confidence            99999975432211  123456899999999999999999999999999999999999999763211  111111110  


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKI  484 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~  484 (502)
                               ..    .+.......+.+++.+|++.||.+|++.
T Consensus       217 ---------~~----~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         217 ---------NV----AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---------CC----CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                     00    0011234566789999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.2e-39  Score=309.89  Aligned_cols=255  Identities=22%  Similarity=0.291  Sum_probs=199.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|...+.||+|+||.||+|....+++.||+|+++.........+.+|+.++++++||||+++++++.     ..+..++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEEE
Confidence            47888999999999999999988899999999987554444567889999999999999999999853     3457899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      |+||+++++|.++++.          ...+++..+..++.|++.|+.|||   +.+|+||||+|+||+++.++.+||+||
T Consensus        84 v~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~df  150 (267)
T cd06646          84 CMEYCGGGSLQDIYHV----------TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADF  150 (267)
T ss_pred             EEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcC
Confidence            9999999999998842          245789999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccC---CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGM---GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |++........  ......++..|+|||.+.   ...++.++|||||||++|||++|+.||........ .....     
T Consensus       151 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~-----  222 (267)
T cd06646         151 GVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMS-----  222 (267)
T ss_pred             ccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeee-----
Confidence            99986543221  122345788999999874   34578899999999999999999999865321110 00000     


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                        ......+....    .......+.+++.+|++.+|++|||++++++.|
T Consensus       223 --~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         223 --KSNFQPPKLKD----KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --cCCCCCCCCcc----ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              00000000000    112345788999999999999999999998653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3e-39  Score=322.79  Aligned_cols=202  Identities=25%  Similarity=0.363  Sum_probs=172.8

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|+..+.||+|+||+||++....+++.||+|+++...   ......+..|+.++.+++|+||+++++.+     .....
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence            47888999999999999999988899999999986432   22335678899999999999999999884     44558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL  142 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMK----------KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKL  142 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEE
Confidence            9999999999999999842          346889999999999999999999   899999999999999999999999


Q ss_pred             eeeccceeccccccc---------------------------------ceecccccccccccCcccCCCccCccccchhH
Q 046112          362 SDFGIARFLEAADEQ---------------------------------TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSF  408 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~  408 (502)
                      +|||+++.+......                                 .......||+.|+|||++.+..++.++|||||
T Consensus       143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSl  222 (363)
T cd05628         143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL  222 (363)
T ss_pred             eeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhh
Confidence            999998754321100                                 00123579999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCcc
Q 046112          409 GILLLEMFTGLRPSDD  424 (502)
Q Consensus       409 Gv~l~el~tg~~p~~~  424 (502)
                      ||++|||++|+.||..
T Consensus       223 Gvil~ell~G~~Pf~~  238 (363)
T cd05628         223 GVIMYEMLIGYPPFCS  238 (363)
T ss_pred             HHHHHHHHhCCCCCCC
Confidence            9999999999999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.5e-39  Score=306.80  Aligned_cols=247  Identities=26%  Similarity=0.387  Sum_probs=194.4

Q ss_pred             cccccCCceEEEEEE--cCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEee
Q 046112          212 LIGAGNFGSVYKGIL--FESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE  287 (502)
Q Consensus       212 ~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  287 (502)
                      .||+|+||.||+|.+  ..++..+|+|+++....  ...+++..|+.++++++||||+++++++.      .+..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence            689999999999964  35678999999874432  23467899999999999999999999863      235689999


Q ss_pred             eccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccc
Q 046112          288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA  367 (502)
Q Consensus       288 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a  367 (502)
                      |+++|+|.+++..          ...+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~  142 (257)
T cd05116          76 LAELGPLNKFLQK----------NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLS  142 (257)
T ss_pred             cCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccc
Confidence            9999999999842          235889999999999999999999   899999999999999999999999999999


Q ss_pred             eecccccccce-ecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccchh
Q 046112          368 RFLEAADEQTR-SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAE  445 (502)
Q Consensus       368 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  445 (502)
                      +.+........ .....++..|+|||......++.++|||||||++||+++ |+.||.....  ....+.+....     
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~~~-----  215 (257)
T cd05116         143 KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESGE-----  215 (257)
T ss_pred             cccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCC-----
Confidence            87644332111 122234578999999988889999999999999999998 9999976321  11111111100     


Q ss_pred             hhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 046112          446 EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL  493 (502)
Q Consensus       446 ~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~  493 (502)
                               ..+....++..+.+++.+|++.||++||++++|++.|++
T Consensus       216 ---------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         216 ---------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence                     001112345667899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.2e-39  Score=306.62  Aligned_cols=250  Identities=20%  Similarity=0.283  Sum_probs=201.6

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc--CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL--HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|+..+.||+|++|.||+|....+++.|++|.+...  .......+..|++++++++|||++++++++.     ..+..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence            467778999999999999998889999999998643  2334567889999999999999999999853     345889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||+++++|.++++.        .....+++.....++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|
T Consensus        76 lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~d  144 (256)
T cd08529          76 IVMEYAENGDLHKLLKM--------QRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGD  144 (256)
T ss_pred             EEEEeCCCCcHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcc
Confidence            99999999999999853        22356889999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||+++.+......  .....++..|+|||+..+..++.++|||||||++|||++|+.||.....     .......... 
T Consensus       145 f~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~-  216 (256)
T cd08529         145 LGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALILKIIRG-  216 (256)
T ss_pred             cccceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcC-
Confidence            9999866543221  1234578899999999999999999999999999999999999975321     1111111100 


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                             ..   ..........+.+++.+|++.+|++||++.++++
T Consensus       217 -------~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         217 -------VF---PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             -------CC---CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence                   00   1111234567889999999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-39  Score=319.67  Aligned_cols=241  Identities=25%  Similarity=0.320  Sum_probs=188.0

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhc-CCCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRN-IRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.||+|+||.||+|.+..+++.||+|+++...   ......+..|..++.. .+||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            46999999999999998899999999987431   2234456677777765 4899999999884     4456899999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.+++..          ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        76 E~~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~  142 (316)
T cd05620          76 EFLNGGDLMFHIQD----------KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGM  142 (316)
T ss_pred             CCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCC
Confidence            99999999988742          345788899999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ....+.+....      
T Consensus       143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~~------  212 (316)
T cd05620         143 CKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVDT------  212 (316)
T ss_pred             CeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC------
Confidence            87432211  122345689999999999999999999999999999999999999975211  11111111000      


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKIN-DVE  488 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~-ev~  488 (502)
                         +..+      ......+.+++.+|++.||++||++. ++.
T Consensus       213 ---~~~~------~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         213 ---PHYP------RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ---CCCC------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence               0001      11234567899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.7e-39  Score=306.21  Aligned_cols=254  Identities=27%  Similarity=0.420  Sum_probs=200.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|...++||+|+||.||+|.+.. +..||+|+++... ...+.+.+|++++++++|||++++++++.      ....++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~l   77 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYI   77 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecC-CceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcEE
Confidence            468889999999999999997644 4569999987533 23467899999999999999999998742      235789


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++|+|.+++..        .....+++..+..++.+++.||+|||   +.+++||||||+||++++++.++|+||
T Consensus        78 v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~df  146 (262)
T cd05071          78 VTEYMSKGSLLDFLKG--------EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF  146 (262)
T ss_pred             EEEcCCCCcHHHHHhh--------ccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccC
Confidence            9999999999999853        22345789999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |.++.+...... ......++..|+|||+..+..++.++||||||+++||++| |+.||.......  ..   ...... 
T Consensus       147 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~---~~~~~~-  219 (262)
T cd05071         147 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VL---DQVERG-  219 (262)
T ss_pred             Cceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HH---HHHhcC-
Confidence            999866433321 1123446778999999988899999999999999999999 888886532111  11   000000 


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                             .   ......+++..+.+++.+|++.+|++||+++++++.|+..
T Consensus       220 -------~---~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         220 -------Y---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -------C---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                   0   0011224567788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.1e-40  Score=324.91  Aligned_cols=253  Identities=21%  Similarity=0.218  Sum_probs=197.3

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||+||++....+++.||+|+++...   ....+.+.+|+.+++.++|+||+++++++     ...+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence            46888899999999999999998999999999987432   22345688999999999999999999874     34457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..         ....+++.....++.|++.||.|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL  143 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNR---------YEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKL  143 (330)
T ss_pred             EEEEECCCCCCCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEe
Confidence            8999999999999999853         2346889999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccC------CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHH
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM------GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  435 (502)
                      +|||++..+...... ......||+.|+|||++.      ...++.++|||||||++|||++|+.||.....     ...
T Consensus       144 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~  217 (330)
T cd05601         144 ADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----AKT  217 (330)
T ss_pred             ccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----HHH
Confidence            999999866433221 223356899999999986      45678999999999999999999999975211     111


Q ss_pred             HHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .......  ....  ..+..    ......+.+++..|++ +|.+|||++++++
T Consensus       218 ~~~i~~~--~~~~--~~~~~----~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         218 YNNIMNF--QRFL--KFPED----PKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHHHcC--CCcc--CCCCC----CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            1111100  0000  00111    1234456788889997 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3e-39  Score=314.83  Aligned_cols=268  Identities=25%  Similarity=0.362  Sum_probs=201.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCe--EEEEEEecccC-cchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTT--AVAVKVFNVLH-HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ++|+..+.||+|+||.||+|.+..++.  .+|+|.++... ......+.+|++++.++ +||||+++++++.     .++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CCC
Confidence            467888999999999999998776665  45777765322 23346788999999999 8999999999853     345


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhc------cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKR------HKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                      ..++|+||+++|+|.++++........      ......+++.+++.++.|++.|++|||   +.+|+||||||+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~  158 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG  158 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEec
Confidence            789999999999999998642211000      012346889999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchH
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLR  433 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~  433 (502)
                      .++.+||+|||++......   .......++..|+|||++.+..++.++|||||||++||++| |..||.....     .
T Consensus       159 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~  230 (303)
T cd05088         159 ENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----A  230 (303)
T ss_pred             CCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-----H
Confidence            9999999999998632211   11111234667999999988889999999999999999998 9999865211     1


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      +..... +..   .   ...    ........+.+++.+|++.+|++||+++++++.|..+.+...
T Consensus       231 ~~~~~~-~~~---~---~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         231 ELYEKL-PQG---Y---RLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             HHHHHH-hcC---C---cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            111111 000   0   000    011234567899999999999999999999999998866543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.4e-39  Score=320.63  Aligned_cols=247  Identities=23%  Similarity=0.295  Sum_probs=191.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      ++||+|+||.||+|.+..+++.||+|+++...   ....+.+..|..++..+ +||||+++++++     ......++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            46899999999999998899999999987432   22335578899999888 799999999984     3445889999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~g~L~~~~~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~  142 (329)
T cd05588          76 EFVSGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGM  142 (329)
T ss_pred             eCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcc
Confidence            9999999998873          2346899999999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccccc---ccchHHHHHhhcccc
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD---NLNLRNCVKSALPER  443 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~  443 (502)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|||+||+.||+.....   ......+....+...
T Consensus       143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  220 (329)
T cd05588         143 CKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK  220 (329)
T ss_pred             ccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC
Confidence            87432211  1123456899999999999999999999999999999999999999742111   111112221111110


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC------HHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK------INDVE  488 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt------~~ev~  488 (502)
                             ..    .+.......+.+++.+|++.||.+||+      +++++
T Consensus       221 -------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         221 -------QI----RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             -------CC----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence                   00    011123456779999999999999998      55664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-39  Score=322.20  Aligned_cols=252  Identities=21%  Similarity=0.281  Sum_probs=192.8

Q ss_pred             CCCCCCcccccCCceEEEEEEc---CCCeEEEEEEecccC----cchhHHHHHHHHHHhcC-CCCccceeeecccccccC
Q 046112          206 GFSSENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLH----HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  277 (502)
                      +|+..+.||+|+||.||+++..   .+++.||+|+++...    ....+.+..|++++..+ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            4778899999999999998653   468899999986421    12235678899999999 599999998873     4


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                      .+...++||||+++|+|.+++..          ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~  142 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQ----------RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEG  142 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCC
Confidence            45578999999999999998842          345888999999999999999999   89999999999999999999


Q ss_pred             cEEEeeeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          358 TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                      .+||+|||+++....... .......||+.|+|||.+.+. .++.++|||||||++|||+||+.||....... ......
T Consensus       143 ~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~  220 (332)
T cd05614         143 HVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVS  220 (332)
T ss_pred             CEEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHH
Confidence            999999999976533222 122345689999999998865 47889999999999999999999996422111 111111


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEP  489 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~  489 (502)
                      .... .     .++.      +.......+.+++.+|++.||++||     +++++++
T Consensus       221 ~~~~-~-----~~~~------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         221 RRIL-K-----CDPP------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHHh-c-----CCCC------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            1111 0     0011      1112345677899999999999999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.1e-39  Score=306.81  Aligned_cols=253  Identities=28%  Similarity=0.447  Sum_probs=199.8

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|.+.+.||+|+||.||+|.. .++..+|+|.++.... ..+.+.+|+.++++++|+|++++++++.      ....++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~-~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~l   77 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTW-NGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIYI   77 (260)
T ss_pred             HHhhhhheeccccCceEEEEEe-cCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcEE
Confidence            4678889999999999999955 5667799999875333 3467999999999999999999998742      235789


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      +|||+++++|.++++.        .....+++.++..++.+++.||+|||   +.+|+||||||+||++++++.++|+||
T Consensus        78 v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~df  146 (260)
T cd05070          78 VTEYMSKGSLLDFLKD--------GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADF  146 (260)
T ss_pred             EEEecCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCc
Confidence            9999999999999853        23345889999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |++..+...... ......++..|+|||+..+..++.++||||||+++||+++ |+.||.+...  ...........+  
T Consensus       147 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~--  221 (260)
T cd05070         147 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQVERGYR--  221 (260)
T ss_pred             eeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCC--
Confidence            999865432211 1123345678999999988899999999999999999999 8999865321  111111111000  


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL  493 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~  493 (502)
                                  .+.....+..+.+++.+|+..+|++|||+.++.+.|+.
T Consensus       222 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 ------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                        00112345678899999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-39  Score=325.92  Aligned_cols=255  Identities=22%  Similarity=0.276  Sum_probs=197.2

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      ..++|...+.||+|+||.||+++...+++.||+|+++..   .......+..|+.+++.++||||+++++++     ..+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            346788899999999999999999889999999998642   122334578899999999999999999874     445


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++||||+++|+|.+++..           ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-----------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~  181 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSN-----------YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL  181 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCE
Confidence            589999999999999998842           23677788889999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCC----ccCccccchhHHHHHHHHHhCCCCCccccccccchHHH
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH----EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  435 (502)
                      ||+|||+++....... .......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||.....     ...
T Consensus       182 kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~  255 (370)
T cd05596         182 KLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGT  255 (370)
T ss_pred             EEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----HHH
Confidence            9999999986543221 122345689999999987653    478999999999999999999999975211     111


Q ss_pred             HHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 046112          436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGE--RMKINDVEPR  490 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~--RPt~~ev~~~  490 (502)
                      ....... ...+.   .+..    ......+.+++.+|++.+|.+  ||++.|+++.
T Consensus       256 ~~~i~~~-~~~~~---~~~~----~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         256 YSKIMDH-KNSLT---FPDD----IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HHHHHcC-CCcCC---CCCc----CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            1111100 00000   0111    123456678999999999988  9999999653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.3e-39  Score=316.25  Aligned_cols=271  Identities=23%  Similarity=0.329  Sum_probs=205.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcC-------CCeEEEEEEecccC-cchhHHHHHHHHHHhcC-CCCccceeeecccccc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFE-------STTAVAVKVFNVLH-HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVD  275 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  275 (502)
                      ++|.+.+.||+|+||.||++.+..       .+..+|+|.++... ......+..|++++.++ +||||++++++|..  
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--   95 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ--   95 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--
Confidence            568889999999999999997543       23579999987542 23345688899999999 79999999998643  


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhhh------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCC
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEEDK------RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPS  349 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~  349 (502)
                         .+..++||||+++|+|.+++........      .......+++.+++.++.|++.||+|||   +.+++||||||+
T Consensus        96 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~  169 (307)
T cd05098          96 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR  169 (307)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHH
Confidence               3478999999999999999964211100      0012245899999999999999999999   899999999999


Q ss_pred             CeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCcccccc
Q 046112          350 NILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKD  428 (502)
Q Consensus       350 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~  428 (502)
                      ||+++.++.+||+|||.++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||..... 
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-  248 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-  248 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-
Confidence            99999999999999999976543222121222234568999999998889999999999999999998 8888864211 


Q ss_pred             ccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          429 NLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                       ......+...   .           ..+....+...+.+++.+|+..+|++|||+.++++.|.++.+...
T Consensus       249 -~~~~~~~~~~---~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         249 -EELFKLLKEG---H-----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             -HHHHHHHHcC---C-----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence             1111111110   0           001112345678899999999999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-39  Score=304.49  Aligned_cols=249  Identities=28%  Similarity=0.405  Sum_probs=197.0

Q ss_pred             CcccccCCceEEEEEEcCCC---eEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFEST---TAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      ++||+|+||.||+|.+...+   ..+|+|.++.... ...+++..|++++++++|||++++++++.      .+..++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence            47999999999999765544   7899999875433 24567899999999999999999999753      23579999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.+++..          ...+++..+..++.|++.|++|||   ..+++||||||+||+++.++.+||+|||+
T Consensus        75 e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~  141 (257)
T cd05060          75 ELAPLGPLLKYLKK----------RREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGM  141 (257)
T ss_pred             EeCCCCcHHHHHHh----------CCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccc
Confidence            99999999999853          236889999999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccc-eecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccch
Q 046112          367 ARFLEAADEQT-RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       367 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      ++......... ......++..|+|||...+..++.++|||||||++||+++ |+.||.....  .....++.....   
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~---  216 (257)
T cd05060         142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER---  216 (257)
T ss_pred             cceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc---
Confidence            98664433211 1112223567999999999999999999999999999998 9999976321  122222211110   


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      .           .....++..+.+++.+|++.+|++||++.++++.|+.+
T Consensus       217 ~-----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         217 L-----------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             C-----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            0           01123456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.3e-39  Score=310.57  Aligned_cols=259  Identities=24%  Similarity=0.321  Sum_probs=201.2

Q ss_pred             HhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeecccccccCC-C
Q 046112          202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQG-N  279 (502)
Q Consensus       202 ~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~-~  279 (502)
                      .+++.|+..+.||+|+||.||+|....+++.||+|++.... .....+..|+.++.++ +|+|++++++++......+ .
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35677888899999999999999988899999999987543 3346788899999998 6999999999875432221 3


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...+++|||+++|+|.+++..        .....+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~--------~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~  150 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKN--------TKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV  150 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCE
Confidence            468899999999999999853        23346889999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccC-----CCccCccccchhHHHHHHHHHhCCCCCccccccccchHH
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM-----GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN  434 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~  434 (502)
                      +|+|||++.......  .......|+..|+|||++.     ...++.++|||||||++|||++|+.||.+....    ..
T Consensus       151 ~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~  224 (272)
T cd06637         151 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RA  224 (272)
T ss_pred             EEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HH
Confidence            999999997654322  1223456889999999876     346888999999999999999999999653211    11


Q ss_pred             HHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          435 CVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       435 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..... ...     ....  .   ...++..+.+++.+|+..+|.+|||+.|+++
T Consensus       225 ~~~~~-~~~-----~~~~--~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         225 LFLIP-RNP-----APRL--K---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHHHh-cCC-----CCCC--C---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            10000 000     0000  0   0123456789999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.8e-39  Score=311.12  Aligned_cols=268  Identities=23%  Similarity=0.278  Sum_probs=197.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcC---CCCccceeeecccccccCCCc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNI---RHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~  280 (502)
                      +|...+.||+|+||+||+|.+..+++.||+|.++....  .....+.+|+++++++   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            47788999999999999999999999999999874322  2234566777776655   799999999987543333455


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++|+||++ ++|.+++..        .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+|
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~k  148 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDK--------VPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVK  148 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEE
Confidence            7899999997 588888753        23345899999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||+++.......   .....+|..|+|||++.+..++.++|||||||++|||++|++||...... ..+........
T Consensus       149 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~  224 (288)
T cd07863         149 LADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIG  224 (288)
T ss_pred             ECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhC
Confidence            999999986543221   12345789999999999989999999999999999999999998653211 11111111000


Q ss_pred             -c---cchhhh------cccCC-CCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 -P---ERAEEI------RASSG-STQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 -~---~~~~~~------~d~~~-~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                       +   .+....      ..+.. ........+....+.+++.+|++.||++|||+.|++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             0   000000      00000 0001111234556789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.8e-40  Score=323.37  Aligned_cols=239  Identities=23%  Similarity=0.297  Sum_probs=188.7

Q ss_pred             CcccccCCceEEEEEEc---CCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEE
Q 046112          211 NLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      +.||+|+||.||+++..   .+|+.+|+|+++...  ......+..|++++++++||||+++++++     ..+...++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence            57999999999998653   578999999987432  12234577899999999999999999885     345588999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeec
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG  365 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg  365 (502)
                      |||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        77 ~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg  143 (318)
T cd05582          77 LDFLRGGDLFTRLSK----------EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFG  143 (318)
T ss_pred             EcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeecc
Confidence            999999999998842          345889999999999999999999   8999999999999999999999999999


Q ss_pred             cceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchh
Q 046112          366 IARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAE  445 (502)
Q Consensus       366 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  445 (502)
                      +++......  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     .+........   
T Consensus       144 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~i~~~---  213 (318)
T cd05582         144 LSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTMILKA---  213 (318)
T ss_pred             CCcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHHHHcC---
Confidence            997653321  122345689999999999988899999999999999999999999975311     1111111100   


Q ss_pred             hhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 046112          446 EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKIND  486 (502)
Q Consensus       446 ~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~e  486 (502)
                           ..    .+.......+.+++.+|++.||++||++.+
T Consensus       214 -----~~----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         214 -----KL----GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -----CC----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                 00    011123456778999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.8e-39  Score=305.58  Aligned_cols=254  Identities=24%  Similarity=0.405  Sum_probs=193.1

Q ss_pred             CcccccCCceEEEEEEcC---CCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFE---STTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.||+|+||.||+|.+..   ....||+|.+.... ....+.+..|+.+++.++|||+++++++|.    ..+...++|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICL----PSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEee----cCCCCcEEEE
Confidence            468999999999997643   34679999875432 233567889999999999999999999763    2334578999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.+++..         .....++..+..++.+++.|++|||   +.+++||||||+|||+++++.+||+|||+
T Consensus        77 e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~  144 (262)
T cd05058          77 PYMKHGDLRNFIRS---------ETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGL  144 (262)
T ss_pred             ecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccc
Confidence            99999999999853         2234677788999999999999999   89999999999999999999999999999


Q ss_pred             ceeccccccc--ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhC-CCCCccccccccchHHHHHhhcccc
Q 046112          367 ARFLEAADEQ--TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG-LRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       367 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ++.+......  .......++..|+|||+..+..++.++|||||||++|||++| .+||....  ...+...+...    
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~----  218 (262)
T cd05058         145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYLLQG----  218 (262)
T ss_pred             cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcC----
Confidence            9765432211  111234457789999999888999999999999999999995 55665421  11111111110    


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                             ...   .....++..+.+++.+||..+|++||++.|+++.|+++..
T Consensus       219 -------~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         219 -------RRL---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             -------CCC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                   000   0011234568899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.3e-39  Score=314.00  Aligned_cols=270  Identities=21%  Similarity=0.325  Sum_probs=206.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEc-------CCCeEEEEEEecccC-cchhHHHHHHHHHHhcC-CCCccceeeeccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILF-------ESTTAVAVKVFNVLH-HDASKSFAVECEVTRNI-RHRNLVKVFTACSGV  274 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  274 (502)
                      ..+|...+.||+|+||.||+|+..       .++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++.  
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe--
Confidence            356788899999999999999642       234579999886432 23346788999999999 8999999999854  


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhhhc------cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEEDKR------HKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKP  348 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~  348 (502)
                         .....++||||+++|+|.+++.........      ......+++.++..++.|++.||+|||   +.+|+||||||
T Consensus        92 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp  165 (304)
T cd05101          92 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAA  165 (304)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeeccccc
Confidence               344789999999999999998642111000      012345889999999999999999999   89999999999


Q ss_pred             CCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccc
Q 046112          349 SNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFK  427 (502)
Q Consensus       349 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~  427 (502)
                      +||++++++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |..||.... 
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-  244 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-  244 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-
Confidence            999999999999999999987654333222233445678999999999899999999999999999998 788886521 


Q ss_pred             cccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          428 DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                          ..+..........           ......++..+.+++.+||..+|.+|||+.|+++.|+++...
T Consensus       245 ----~~~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         245 ----VEELFKLLKEGHR-----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             ----HHHHHHHHHcCCc-----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                1111111100000           001124566788999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.3e-39  Score=313.53  Aligned_cols=271  Identities=20%  Similarity=0.315  Sum_probs=200.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEc----------------CCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCcccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILF----------------ESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKV  267 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  267 (502)
                      ++|+..+.||+|+||.||++...                .++..||+|+++... ......+..|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888999999999999998532                234578999987543 2334678999999999999999999


Q ss_pred             eecccccccCCCcceeEEeeeccCCChhhhccCCchhhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecC
Q 046112          268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK-RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDL  346 (502)
Q Consensus       268 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dl  346 (502)
                      ++++.     ..+..++||||+++|+|.+++........ .......+++.+...++.|++.|++|||   +.+++||||
T Consensus        85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl  156 (296)
T cd05095          85 LAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDL  156 (296)
T ss_pred             EEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccC
Confidence            99853     34478999999999999999864221110 0122345788999999999999999999   899999999


Q ss_pred             CCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh--CCCCCcc
Q 046112          347 KPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT--GLRPSDD  424 (502)
Q Consensus       347 k~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t--g~~p~~~  424 (502)
                      ||+||+++.++.++|+|||+++.+.............++..|+|||...++.++.++|||||||++|||++  |..||..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            99999999999999999999976543322221222334678999999888889999999999999999998  7788764


Q ss_pred             ccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          425 MFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                      ....  ..................       .+....++..+.+++.+|++.||.+||+++||++.|+
T Consensus       237 ~~~~--~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         237 LSDE--QVIENTGEFFRDQGRQVY-------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             cChH--HHHHHHHHHHhhcccccc-------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            2111  111111110000000000       0001234567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.6e-39  Score=304.67  Aligned_cols=250  Identities=26%  Similarity=0.382  Sum_probs=198.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      .+|...+.||+|+||.||++..  .+..||+|.++..  ...+.+.+|+.++++++|+|++++++++.    ..+...++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceEE
Confidence            3678889999999999999965  5788999988643  23567899999999999999999998752    33456899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ++||+++|+|.+++..        .....+++..++.++.+++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        78 v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df  146 (256)
T cd05082          78 VTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDF  146 (256)
T ss_pred             EEECCCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCC
Confidence            9999999999999853        23345889999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |++.......     ....++..|+|||+..+..++.++|||||||++|||++ |+.||...     ...+.........
T Consensus       147 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~~~~  216 (256)
T cd05082         147 GLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVEKGY  216 (256)
T ss_pred             ccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhcCC
Confidence            9987543221     12334678999999998899999999999999999998 99998652     1111111110000


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      .           ......++..+.+++.+|++.+|++|||++++++.|+++
T Consensus       217 ~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         217 K-----------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             C-----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            0           001123466788999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-40  Score=306.04  Aligned_cols=248  Identities=21%  Similarity=0.340  Sum_probs=203.8

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcch---hHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA---SKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      -+|.+.+.||+|.||.|-+|.....|+.||||.+++.....   .-.+.+|+++|+.++||||+.++.+     |++.+.
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkdK  127 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKDK  127 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCce
Confidence            35677789999999999999888899999999987544333   3457889999999999999999998     778889


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      ..|||||..+|.|++|+          ...+.+++.+..+++.||..|+.|+|   +++++|||||.+|||||+++++||
T Consensus       128 IvivMEYaS~GeLYDYi----------Ser~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKI  194 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYI----------SERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKI  194 (668)
T ss_pred             EEEEEEecCCccHHHHH----------HHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeee
Confidence            99999999999999999          44677999999999999999999999   999999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccC-ccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVS-SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      +|||++-.+....   ....++|.+-|.+||...+..|. +..|-||+||+||.|+.|..||++.     +....+++.-
T Consensus       195 ADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQIs  266 (668)
T KOG0611|consen  195 ADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQIS  266 (668)
T ss_pred             eccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHHhh
Confidence            9999997665432   23457899999999999998885 5689999999999999999999872     1111222111


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                      ..   ..+          ..+.+....-|+.+|+..+|++|.|+.|+....
T Consensus       267 ~G---aYr----------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  267 RG---AYR----------EPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             cc---ccc----------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            11   000          112244456789999999999999999997653

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-39  Score=305.39  Aligned_cols=253  Identities=21%  Similarity=0.303  Sum_probs=199.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-----chhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-----DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      ++|...+.||+|++|.||+|....++..||+|.+.....     ...+.+.+|++++++++||||+++++++.     .+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence            578899999999999999998888899999999864321     12356888999999999999999999853     44


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +..++|+||+++++|.+++..          ...+++.....++.+++.|++|||   +.+|+||||+|+||++++++.+
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~  143 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKA----------YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNV  143 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHH----------hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence            589999999999999998842          245788889999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccce-ecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADEQTR-SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +|+|||+++.......... .....++..|+|||.+.+..++.++||||||+++||+++|+.||.....    .......
T Consensus       144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~  219 (263)
T cd06625         144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKI  219 (263)
T ss_pred             EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHHHH
Confidence            9999999976543221111 1234578899999999999999999999999999999999999865211    1110000


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      .....           .......+...+.+++.+|+..+|.+|||+.|+++.
T Consensus       220 ~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         220 ATQPT-----------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             hccCC-----------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            00000           011112345567899999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-39  Score=309.45  Aligned_cols=260  Identities=22%  Similarity=0.395  Sum_probs=204.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCe----EEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTT----AVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .+|...+.||+|+||.||+|....+|.    .+|+|.++.... ....++.+|+.++++++|||+++++++|..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            457778999999999999998765554    589998765432 234678899999999999999999998753      


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++|+||+++|+|.++++.         ....+++...+.++.|++.|++|||   +.+++||||||+||++++++.+
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~  148 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRN---------HKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHV  148 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeE
Confidence            478999999999999999853         2345899999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  438 (502)
                      ||+|||+++...............++..|+|||......++.++||||||+++||+++ |+.||+....  .++.+.+..
T Consensus       149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~  226 (279)
T cd05057         149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLEK  226 (279)
T ss_pred             EECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhC
Confidence            9999999987653332222222334578999999988899999999999999999999 9999976321  111221111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      ..           ....   ...+...+.+++.+||..+|.+||++.++++.|.++.++.
T Consensus       227 ~~-----------~~~~---~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         227 GE-----------RLPQ---PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             CC-----------CCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence            00           0000   1123456789999999999999999999999999986643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-39  Score=311.21  Aligned_cols=271  Identities=22%  Similarity=0.330  Sum_probs=198.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCC--------------CeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFES--------------TTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFT  269 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~  269 (502)
                      ++|...+.||+|+||.||++.....              ...||+|.++... ......|.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            4688889999999999999865322              2358999986432 223457899999999999999999999


Q ss_pred             cccccccCCCcceeEEeeeccCCChhhhccCCchhh--hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCC
Q 046112          270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEED--KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLK  347 (502)
Q Consensus       270 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk  347 (502)
                      ++.     .....++||||+++++|.+++.......  ........+++..++.++.+++.|++|||   +.+++|||||
T Consensus        85 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlk  156 (295)
T cd05097          85 VCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLA  156 (295)
T ss_pred             EEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccC
Confidence            964     3447899999999999999985321000  00012234789999999999999999999   8999999999


Q ss_pred             CCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh--CCCCCccc
Q 046112          348 PSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT--GLRPSDDM  425 (502)
Q Consensus       348 ~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t--g~~p~~~~  425 (502)
                      |+||++++++.+||+|||+++...............++..|+|||+...+.++.++|||||||+++||++  |..||...
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            9999999999999999999976543322222223445778999999998899999999999999999998  56677652


Q ss_pred             cccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          426 FKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                      ..+  ..................    ....   ..++..+.+++.+|++.||++||++.+|++.|+
T Consensus       237 ~~~--~~~~~~~~~~~~~~~~~~----~~~~---~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         237 SDE--QVIENTGEFFRNQGRQIY----LSQT---PLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ChH--HHHHHHHHhhhhcccccc----CCCC---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            111  111111111100000000    0001   123467889999999999999999999998885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=327.09  Aligned_cols=254  Identities=19%  Similarity=0.258  Sum_probs=193.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||++....+++.||||++....   ....+.+.+|++++++++||||+++++++     .....
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence            46888999999999999999999999999999986421   22345688899999999999999999984     44558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl  142 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIK----------YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKL  142 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEE
Confidence            9999999999999999842          345788888899999999999999   999999999999999999999999


Q ss_pred             eeeccceeccccccc---------------------------------------------ceecccccccccccCcccCC
Q 046112          362 SDFGIARFLEAADEQ---------------------------------------------TRSIGVEGTTGYIAPEYGMG  396 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~  396 (502)
                      +|||+++.+......                                             .......||+.|+|||++.+
T Consensus       143 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  222 (377)
T cd05629         143 SDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ  222 (377)
T ss_pred             eecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc
Confidence            999999643211000                                             00012468999999999999


Q ss_pred             CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccC
Q 046112          397 HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAE  476 (502)
Q Consensus       397 ~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~  476 (502)
                      ..++.++|||||||++|||+||+.||......     +...... .+...+.   .+..    ......+.+++.+|+. 
T Consensus       223 ~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-----~~~~~i~-~~~~~~~---~p~~----~~~s~~~~dli~~lL~-  288 (377)
T cd05629         223 QGYGQECDWWSLGAIMFECLIGWPPFCSENSH-----ETYRKII-NWRETLY---FPDD----IHLSVEAEDLIRRLIT-  288 (377)
T ss_pred             CCCCCceeeEecchhhhhhhcCCCCCCCCCHH-----HHHHHHH-ccCCccC---CCCC----CCCCHHHHHHHHHHhc-
Confidence            99999999999999999999999999752211     1111110 0000000   0000    0123456688888987 


Q ss_pred             CCCCC---CCHHHHHHH
Q 046112          477 QPGER---MKINDVEPR  490 (502)
Q Consensus       477 dP~~R---Pt~~ev~~~  490 (502)
                      +|.+|   +++.|+++.
T Consensus       289 ~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         289 NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             CHhhcCCCCCHHHHhcC
Confidence            66665   599888764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.6e-39  Score=312.42  Aligned_cols=259  Identities=24%  Similarity=0.422  Sum_probs=202.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCe----EEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTT----AVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      ++|...+.||+|+||.||+|.+..++.    .||+|.+..... ....++.+|+.++++++||||++++++|..      
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~------   80 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS------   80 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC------
Confidence            467788999999999999998776665    578888764332 223468899999999999999999998743      


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++++||+++|+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+
T Consensus        81 ~~~~~v~e~~~~g~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~  148 (303)
T cd05110          81 PTIQLVTQLMPHGCLLDYVHE---------HKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHV  148 (303)
T ss_pred             CCceeeehhcCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCce
Confidence            235799999999999999852         2345788999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  438 (502)
                      ||+|||+++...............++..|+|||++.+..++.++|||||||++||+++ |+.||.....  .....++..
T Consensus       149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~  226 (303)
T cd05110         149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEK  226 (303)
T ss_pred             EEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHC
Confidence            9999999986643322222223445778999999998899999999999999999998 8999865321  112222111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ..          ....    ...+...+.+++.+||..+|++||++.++++.|+.+.+.
T Consensus       227 ~~----------~~~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         227 GE----------RLPQ----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CC----------CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            10          0000    112345678999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4e-39  Score=341.55  Aligned_cols=270  Identities=23%  Similarity=0.338  Sum_probs=205.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|.+.++||+|+||.||+|.+..+++.||+|+++....   ...+.+.+|++++++++||||+++++++.     .++.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence            478889999999999999999888999999999874322   22457899999999999999999999864     3447


Q ss_pred             eeEEeeeccCCChhhhccCCchhh-hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEED-KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      .++||||+++|+|.+++....... ........+++...+.++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEE
Confidence            899999999999999985421111 00112345677888999999999999999   89999999999999999999999


Q ss_pred             Eeeeccceecccccc----------------cceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          361 VSDFGIARFLEAADE----------------QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      |+|||+++.......                ........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999986621110                0011124689999999999999999999999999999999999999975


Q ss_pred             ccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHHHHHHH
Q 046112          425 MFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-KINDVEPRLRLIKK  496 (502)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-t~~ev~~~L~~i~~  496 (502)
                      .........    .... .....      ..   ..+.+..+.+++.+|++.||++|| +++++.+.|+...+
T Consensus       234 ~~~~ki~~~----~~i~-~P~~~------~p---~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        234 KKGRKISYR----DVIL-SPIEV------AP---YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             cchhhhhhh----hhcc-Chhhc------cc---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            211111000    0000 00000      00   123456678999999999999996 67778888877654

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=8.5e-40  Score=321.82  Aligned_cols=241  Identities=24%  Similarity=0.287  Sum_probs=186.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHH-HHhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECE-VTRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.||+|+||.||+|....+|+.+|+|++...   .......+..|.. +++.++||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            4689999999999999889999999998643   1223345555555 46789999999999884     3455899999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|..++.          ....+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~  142 (325)
T cd05604          76 DFVNGGELFFHLQ----------RERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGL  142 (325)
T ss_pred             cCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCC
Confidence            9999999998873          2345889999999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||....     ..+..+.....    
T Consensus       143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~~~~~----  211 (325)
T cd05604         143 CKEGIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----VAEMYDNILHK----  211 (325)
T ss_pred             cccCCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----HHHHHHHHHcC----
Confidence            87432211  12234568999999999999999999999999999999999999997521     11111111110    


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVE  488 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~  488 (502)
                          .....+    .....+.+++.+|++.+|.+||++.+.+
T Consensus       212 ----~~~~~~----~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         212 ----PLVLRP----GASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             ----CccCCC----CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence                000011    1234566899999999999999986433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.8e-39  Score=306.37  Aligned_cols=252  Identities=25%  Similarity=0.384  Sum_probs=197.2

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|...+.||+|+||.||+|.+. ++..+|+|.++... ....++.+|+.++.+++||||++++++|..     ....++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   76 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYI   76 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEE
Confidence            35677889999999999999653 45679999887432 234678999999999999999999998643     346799


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++|+|.+++..         ....+++..++.++.+++.|++|||   +.+++|+||||+||++++++.+||+||
T Consensus        77 v~e~~~~~~l~~~i~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~  144 (256)
T cd05113          77 VTEYMSNGCLLNYLRE---------HGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDF  144 (256)
T ss_pred             EEEcCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCC
Confidence            9999999999999852         1235899999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |.++....... .......++..|+|||+..+..++.++|||||||++|||++ |+.||......  .....+.....  
T Consensus       145 g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~--  219 (256)
T cd05113         145 GLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQGLR--  219 (256)
T ss_pred             ccceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhcCCC--
Confidence            99986543321 12223345678999999998889999999999999999999 99998652211  11111111000  


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                               ....   ......+.+++.+||+.+|++||++.++++.|+
T Consensus       220 ---------~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 ---------LYRP---HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---------CCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                     0000   122467789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-39  Score=301.87  Aligned_cols=270  Identities=24%  Similarity=0.365  Sum_probs=203.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhc--CCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRN--IRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .+....+.||+|.||.||+|++  .|+.||||++...   +++++.+|.++++.  ++|+||+.+++.-... -..-.++
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~TQL  284 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWTQL  284 (513)
T ss_pred             heeEEEEEecCccccceeeccc--cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccC-CCceEEE
Confidence            3455678999999999999998  7889999999743   35678888888775  5999999999873221 1223478


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceeecCCCCCeeeCCCC
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLD-----CQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~i~H~dlk~~NIll~~~~  357 (502)
                      +||++|.++|||.|||..           ..++....++++..+|.||++||.+     .++.|.|||||+.|||+..++
T Consensus       285 wLvTdYHe~GSL~DyL~r-----------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~  353 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR-----------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  353 (513)
T ss_pred             EEeeecccCCcHHHHHhh-----------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence            999999999999999953           5588889999999999999999953     478899999999999999999


Q ss_pred             cEEEeeeccceecccccc--cceecccccccccccCcccCCC------ccCccccchhHHHHHHHHHhC----------C
Q 046112          358 TAYVSDFGIARFLEAADE--QTRSIGVEGTTGYIAPEYGMGH------EVSSYGDVYSFGILLLEMFTG----------L  419 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDvws~Gv~l~el~tg----------~  419 (502)
                      .+.|+|+|+|........  .......+||.+|||||++...      ..-..+||||||.|+||+.-.          +
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            999999999976654422  2223457899999999987652      122348999999999999852          4


Q ss_pred             CCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          420 RPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       420 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                      .||.+.-..+.++.+.-+-.--++...-+.....     ..+++..+.++|+.||..+|..|-|+=-+-+.|.++.+
T Consensus       434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~-----s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWK-----SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCcccCCCCCCCHHHHhcceeecccCCCCCcccc-----cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            6776654444433332111110111111111111     24778899999999999999999999999888888764

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-39  Score=320.71  Aligned_cols=241  Identities=24%  Similarity=0.265  Sum_probs=185.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHH-HHHhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVEC-EVTRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.||+|+||.||+|++..+++.||+|++....   ......+..|. .+++.++||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence            46999999999999998899999999986432   12223344444 356788999999999884     3455889999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.+++..          ...+.+.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~  142 (325)
T cd05602          76 DYINGGELFYHLQR----------ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGL  142 (325)
T ss_pred             eCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCC
Confidence            99999999998842          344777888889999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+........    
T Consensus       143 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~----  211 (325)
T cd05602         143 CKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNILNK----  211 (325)
T ss_pred             CcccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHHHHhC----
Confidence            97543221  122345689999999999999999999999999999999999999975211     1111111100    


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVE  488 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~  488 (502)
                          ....    .......+.+++.+|++.||.+||++.+..
T Consensus       212 ----~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         212 ----PLQL----KPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             ----CcCC----CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence                0000    112345677899999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-39  Score=305.90  Aligned_cols=250  Identities=27%  Similarity=0.398  Sum_probs=196.2

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEE
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      +|+..+.||+|+||.||+|.+. ++..+|+|+++... .....+.+|++++++++||||+++++++.     .....++|
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv   77 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFIV   77 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEEE
Confidence            5778899999999999999764 56789999886432 23457888999999999999999999853     34478999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeec
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG  365 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg  365 (502)
                      +||+++++|.+++..         ....+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||
T Consensus        78 ~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg  145 (256)
T cd05059          78 TEYMANGCLLNYLRE---------RKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFG  145 (256)
T ss_pred             EecCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcc
Confidence            999999999999852         2236889999999999999999999   8999999999999999999999999999


Q ss_pred             cceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccch
Q 046112          366 IARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       366 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      +++....... .......++..|+|||...+..++.++||||||+++||+++ |+.||+....  ......+....    
T Consensus       146 ~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~----  218 (256)
T cd05059         146 LARYVLDDQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--SEVVESVSAGY----  218 (256)
T ss_pred             cceecccccc-cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--HHHHHHHHcCC----
Confidence            9986543221 11122234567999999999999999999999999999999 8999865211  11111111110    


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                          ...   .   ...++..+.+++.+|++.+|++|||+.|+++.|
T Consensus       219 ----~~~---~---~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         219 ----RLY---R---PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ----cCC---C---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                000   0   113456788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.4e-39  Score=310.84  Aligned_cols=252  Identities=24%  Similarity=0.300  Sum_probs=197.0

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      |+..+.||+|+||+||+|.+..+++.+|+|.+....   ......+.+|++++++++|+|++++.+++     ..++..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence            566788999999999999998899999999986432   12234577899999999999999998874     3445889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++++|.+++..        .....+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|
T Consensus        77 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~D  145 (285)
T cd05632          77 LVLTIMNGGDLKFHIYN--------MGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISD  145 (285)
T ss_pred             EEEEeccCccHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEec
Confidence            99999999999988753        22346899999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||++.......   ......|+..|+|||++.+..++.++|||||||++||+++|+.||.......  ..+.+.......
T Consensus       146 fg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~~~~~~~~~  220 (285)
T cd05632         146 LGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREEVDRRVLET  220 (285)
T ss_pred             CCcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhhhcc
Confidence            99997653221   1234568999999999998899999999999999999999999997531111  111111111110


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK-----INDVEPR  490 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt-----~~ev~~~  490 (502)
                      ..           .+.......+.+++.+|++.||++||+     +.+++..
T Consensus       221 ~~-----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         221 EE-----------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             cc-----------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            00           011123456779999999999999999     5666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.9e-39  Score=306.98  Aligned_cols=257  Identities=25%  Similarity=0.425  Sum_probs=201.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCC---CeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFES---TTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .+|...+.||+|+||.||+|....+   +..+|+|.++... ....+.+..|+.++.+++||||+++++++.     .++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence            4678889999999999999976543   3479999886533 223467899999999999999999999853     345


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++++|.+++..         ....+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~  146 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRK---------HDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCK  146 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEE
Confidence            78999999999999999852         2345889999999999999999999   89999999999999999999999


Q ss_pred             Eeeeccceecccccccce-ecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHh
Q 046112          361 VSDFGIARFLEAADEQTR-SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  438 (502)
                      ++|||++..+........ .....++..|+|||++.+..++.++||||||+++||+++ |+.||......  .....+..
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~  224 (267)
T cd05066         147 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEE  224 (267)
T ss_pred             eCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhC
Confidence            999999987654322111 112223568999999998899999999999999999887 99998753211  11111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      ...              .+....++..+.+++.+|++.+|.+||+|.++++.|.++
T Consensus       225 ~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 GYR--------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCc--------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            100              000113456678999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2e-39  Score=324.03  Aligned_cols=255  Identities=21%  Similarity=0.268  Sum_probs=194.8

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      ..++|+..+.||+|+||.||++....+++.+|+|+++..   .......+.+|+.+++.++||||+++++++     ..+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~  115 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD  115 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence            456789999999999999999999889999999998642   122345688899999999999999999884     445


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++||||+++|+|.+++..           ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-----------~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~  181 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHL  181 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCE
Confidence            689999999999999998842           23678888999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCC----ccCccccchhHHHHHHHHHhCCCCCccccccccchHHH
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH----EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  435 (502)
                      ||+|||++........ .......||+.|+|||.+.+.    .++.++||||+||++|||++|+.||.....     ...
T Consensus       182 kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----~~~  255 (370)
T cd05621         182 KLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----VGT  255 (370)
T ss_pred             EEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----HHH
Confidence            9999999987643221 122345699999999998754    378899999999999999999999975211     111


Q ss_pred             HHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 046112          436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGE--RMKINDVEPR  490 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~--RPt~~ev~~~  490 (502)
                      ....... ...+   ..+.    ..+....+.+++.+|+..++.+  ||++.|+++.
T Consensus       256 ~~~i~~~-~~~~---~~p~----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         256 YSKIMDH-KNSL---NFPE----DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHHHhC-Cccc---CCCC----cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            1111000 0000   0000    0122445567788888755543  8899998764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.8e-39  Score=309.01  Aligned_cols=263  Identities=23%  Similarity=0.354  Sum_probs=201.8

Q ss_pred             CCCCCCcccccCCceEEEEEE----cCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          206 GFSSENLIGAGNFGSVYKGIL----FESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .|.+.+.||+|+||.||.+..    ..++..||+|.++... ......+.+|++++++++|||++++.+++..   .+..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCCC
Confidence            467788999999999999964    3568899999987443 2334678999999999999999999998643   2234


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++++|.+++..         ....+++..+..++.+++.||+|||   +++++||||||+||+++.++.++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~  149 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPR---------NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVK  149 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEE
Confidence            67899999999999999842         2235899999999999999999999   99999999999999999999999


Q ss_pred             Eeeeccceeccccccc-ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccccc----------c
Q 046112          361 VSDFGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD----------N  429 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~----------~  429 (502)
                      |+|||+++.+...... .......++..|+|||+..+..++.++|||||||++||++|++.|.......          .
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd05079         150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ  229 (284)
T ss_pred             ECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccc
Confidence            9999999866543321 1112345677899999998888999999999999999999988765332110          0


Q ss_pred             cchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          430 LNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      ......+..        +.+...   .+....++..+.+++.+|++.+|++|||++++++.|+.+
T Consensus       230 ~~~~~~~~~--------~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         230 MTVTRLVRV--------LEEGKR---LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ccHHHHHHH--------HHcCcc---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000111000        000000   011123466788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.3e-39  Score=309.89  Aligned_cols=265  Identities=25%  Similarity=0.393  Sum_probs=202.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      .++|...+.||+|+||.||+|...     .++..||+|++..... ...+.+.+|++++++++|||+++++++|..    
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~----   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV----   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence            457888999999999999999763     2578899999875432 234678999999999999999999998643    


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhh------------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeec
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDK------------RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCD  345 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~d  345 (502)
                       +...++|+||+++|+|.+++........            .......+++..++.++.+++.||+|||   ..+++|||
T Consensus        80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~d  155 (288)
T cd05050          80 -GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRD  155 (288)
T ss_pred             -CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeeccc
Confidence             3478999999999999999864221100            0112245789999999999999999999   89999999


Q ss_pred             CCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCcc
Q 046112          346 LKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDD  424 (502)
Q Consensus       346 lk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~  424 (502)
                      |||+||++++++.++|+|||++..+..............+..|+|||...+..++.++|||||||++|||++ |..||..
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999876543322222222334678999999998899999999999999999998 8888865


Q ss_pred             ccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          425 MFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                      ...     .+......        +......   ...++..+.+++.+|++.+|++|||+.|+++.|+
T Consensus       236 ~~~-----~~~~~~~~--------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         236 MAH-----EEVIYYVR--------DGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             CCH-----HHHHHHHh--------cCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            321     11111111        0100000   1134567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.9e-39  Score=309.66  Aligned_cols=272  Identities=25%  Similarity=0.336  Sum_probs=204.9

Q ss_pred             CCCCCCcccccCCceEEEEEEcC----CCeEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFE----STTAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .|...+.||+|+||.||+|....    ++..+|||+++..... ..+.|..|+++++.++|||++++++++..   .+..
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~~   81 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGGR   81 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCCC
Confidence            46667899999999999997643    4789999998755443 45789999999999999999999998642   2345


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..+++|||+++++|.+++..         ....+++..+..++.+++.||+|||   +.+++||||||+||+++.++.++
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~---------~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~  149 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQR---------HRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVK  149 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHh---------CccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEE
Confidence            78999999999999999853         2235899999999999999999999   89999999999999999999999


Q ss_pred             Eeeeccceeccccccc-ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh-
Q 046112          361 VSDFGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS-  438 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-  438 (502)
                      |+|||++......... .......++..|+|||+..+..++.++||||||++++||+||+.|+................ 
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  229 (284)
T cd05038         150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ  229 (284)
T ss_pred             EcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence            9999999876533221 11122345667999999998899999999999999999999999986532211110000000 


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      .......+......  .......++.++.+++.+|++.+|++|||+.|++++|+.+
T Consensus       230 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         230 MIVTRLLELLKEGE--RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             ccHHHHHHHHHcCC--cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            00000111111100  0011124557788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.5e-39  Score=303.54  Aligned_cols=249  Identities=27%  Similarity=0.426  Sum_probs=200.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|...+.||.|+||.||+|..  .++.||+|.++.... ..+.+.+|+.++++++|+|++++++++..     ....++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~   77 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYI   77 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEE
Confidence            4678889999999999999965  578899999875443 45788999999999999999999998542     457899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++++|.+++..        .....+++.....++.|++.|+.|||   +.+++||||||+||++++++.+||+||
T Consensus        78 v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~  146 (256)
T cd05039          78 VTEYMAKGSLVDYLRS--------RGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDF  146 (256)
T ss_pred             EEEecCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccc
Confidence            9999999999999853        22346899999999999999999999   999999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |.++.......     ....+..|+|||++....++.++||||||+++||+++ |+.||......  .+...+.....  
T Consensus       147 g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~--  217 (256)
T cd05039         147 GLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEKGYR--  217 (256)
T ss_pred             ccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhcCCC--
Confidence            99976532211     2334678999999998899999999999999999997 99998653111  11111111100  


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL  493 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~  493 (502)
                                  ......++..+.+++.+|+..+|++|||+.|++++|+.
T Consensus       218 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         218 ------------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ------------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence                        00012345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-41  Score=293.45  Aligned_cols=252  Identities=22%  Similarity=0.330  Sum_probs=199.6

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecc--cCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      +++|+..+.||+|.|+.||+....++|+.+|+|+++.  ......+++.+|+.+.+.++||||+++...     +.....
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~~   84 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEESF   84 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccce
Confidence            4567778899999999999999999999999998863  333456789999999999999999999987     445568


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC---CCCc
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMT  358 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~---~~~~  358 (502)
                      .++|+|+|.|++|..-+-          .+...++...-+..+||+++|.|+|   .++|||||+||+|++|.   ....
T Consensus        85 ~ylvFe~m~G~dl~~eIV----------~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~  151 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAA  151 (355)
T ss_pred             eEEEEecccchHHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCc
Confidence            999999999999976552          2244677788899999999999999   99999999999999994   4457


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +|++|||+|..+.   ......+..|||+|||||++...+|+..+|||+.||+||-|+.|.+||-+....  .+.+   +
T Consensus       152 vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--rlye---~  223 (355)
T KOG0033|consen  152 VKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYE---Q  223 (355)
T ss_pred             eeecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--HHHH---H
Confidence            9999999998776   233446788999999999999999999999999999999999999999762111  1111   1


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                              ++........+......++..+|+.+|+..||.+|.|+.|.++
T Consensus       224 --------I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  224 --------IKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             --------HhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                    1111111111112233445568999999999999999988764

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.9e-39  Score=317.55  Aligned_cols=243  Identities=24%  Similarity=0.288  Sum_probs=189.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCC-CCccceeeecccccccCCCcc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  281 (502)
                      +|...+.||+|+||.||+|....+++.||+|+++..   .....+.+..|..++..+. |++|+++.+++     ...+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence            366778999999999999999889999999998743   1233456778888888886 56777777763     44457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++.          ....+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~Ey~~~g~L~~~i~----------~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL  142 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQ----------QVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKI  142 (323)
T ss_pred             EEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEE
Confidence            899999999999999884          2345889999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  ...+   ....
T Consensus       143 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~---~i~~  215 (323)
T cd05615         143 ADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQ---SIME  215 (323)
T ss_pred             eccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHH---HHHh
Confidence            99999875432211  123456899999999999989999999999999999999999999763211  1111   1110


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKIN  485 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~  485 (502)
                      .        ..    .........+.+++.+|++.+|.+|++..
T Consensus       216 ~--------~~----~~p~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         216 H--------NV----SYPKSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             C--------CC----CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence            0        00    00112344567899999999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.4e-39  Score=326.99  Aligned_cols=254  Identities=19%  Similarity=0.296  Sum_probs=192.3

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|++.+.||+|+||.||+|+...+++.||||++....   ......+.+|++++++++|+||+++++.+     ..++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence            36888999999999999999998999999999986421   22345688899999999999999999884     45568


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL  142 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIR----------LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKL  142 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEE
Confidence            9999999999999999842          345788888899999999999999   899999999999999999999999


Q ss_pred             eeeccceeccccc-----------------------------------------ccceecccccccccccCcccCCCccC
Q 046112          362 SDFGIARFLEAAD-----------------------------------------EQTRSIGVEGTTGYIAPEYGMGHEVS  400 (502)
Q Consensus       362 ~Dfg~a~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s  400 (502)
                      +|||+|..+....                                         .........||+.|+|||++.+..++
T Consensus       143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  222 (376)
T cd05598         143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT  222 (376)
T ss_pred             EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence            9999975321000                                         00001235699999999999999999


Q ss_pred             ccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCC
Q 046112          401 SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGE  480 (502)
Q Consensus       401 ~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~  480 (502)
                      .++|||||||++|||++|+.||.......     ...... .+......   ....    .....+.+++.+|+ .+|.+
T Consensus       223 ~~~DiwSlGvilyell~G~~Pf~~~~~~~-----~~~~i~-~~~~~~~~---~~~~----~~s~~~~~li~~l~-~~p~~  288 (376)
T cd05598         223 QLCDWWSVGVILYEMLVGQPPFLADTPAE-----TQLKVI-NWETTLHI---PSQA----KLSREASDLILRLC-CGAED  288 (376)
T ss_pred             cceeeeeccceeeehhhCCCCCCCCCHHH-----HHHHHh-ccCccccC---CCCC----CCCHHHHHHHHHHh-cCHhh
Confidence            99999999999999999999997632111     111000 00000000   0011    12334456666655 49999


Q ss_pred             CC---CHHHHHHH
Q 046112          481 RM---KINDVEPR  490 (502)
Q Consensus       481 RP---t~~ev~~~  490 (502)
                      |+   ++.|+++.
T Consensus       289 R~~~~t~~ell~h  301 (376)
T cd05598         289 RLGKNGADEIKAH  301 (376)
T ss_pred             cCCCCCHHHHhCC
Confidence            99   88888753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.2e-39  Score=321.19  Aligned_cols=268  Identities=21%  Similarity=0.224  Sum_probs=197.3

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|+..+.||+|+||.||++.+..+++.||+|++....  ....+.+.+|+++++.++||||+++++++...........+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999888899999999986432  22346788999999999999999999986543222223689


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||+. ++|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        81 lv~e~~~-~~l~~~~~----------~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~D  146 (372)
T cd07853          81 VVTELMQ-SDLHKIIV----------SPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICD  146 (372)
T ss_pred             EEeeccc-cCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEecc
Confidence            9999996 67877763          2346889999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+++....... .......+|..|+|||.+.+. .++.++|||||||++|||++|+.||......  .....+......
T Consensus       147 fg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~g~  223 (372)
T cd07853         147 FGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLDLITDLLGT  223 (372)
T ss_pred             ccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCC
Confidence            999986543222 122334578999999998774 4789999999999999999999999753111  111111110000


Q ss_pred             -chh-----------hhcc-cC----CCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          443 -RAE-----------EIRA-SS----GSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       443 -~~~-----------~~~d-~~----~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                       ...           .+.. +.    .........+....+.+++.+|++.||++|||+.|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence             000           0000 00    000000111234567899999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=303.25  Aligned_cols=257  Identities=28%  Similarity=0.434  Sum_probs=202.8

Q ss_pred             CcccccCCceEEEEEEcCC---CeEEEEEEecccCcch-hHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDA-SKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.||+|+||.||+|.....   +..|++|.++...... .+.+.+|++.++.++|+|++++++++..     ....++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            4799999999999988765   8899999987654333 5788999999999999999999998643     55889999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++++|.+++....... .......+++..+..++.+++.|++|||   +.+++||||+|+||++++++.+||+|||.
T Consensus        76 e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~  151 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGL  151 (262)
T ss_pred             EeccCCcHHHHHhhccccc-cccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccc
Confidence            9999999999986411000 0011366899999999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccchh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAE  445 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  445 (502)
                      +................++..|+|||.+....++.++||||+|+++||+++ |+.||....  ...+.+.+..       
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~-------  222 (262)
T cd00192         152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--NEEVLEYLRK-------  222 (262)
T ss_pred             ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHc-------
Confidence            987654432222334567889999999988899999999999999999999 699997641  1111111111       


Q ss_pred             hhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          446 EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       446 ~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                          ..   .......++..+.+++.+|++.+|++|||+.|+++.|+
T Consensus       223 ----~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 ----GY---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----CC---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                00   00111234667889999999999999999999998763

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1e-38  Score=305.43  Aligned_cols=256  Identities=22%  Similarity=0.296  Sum_probs=199.0

Q ss_pred             HHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          201 YNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       201 ~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      +-+++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|++++++++|+||+++++++..     ++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~   78 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-----NG   78 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-----CC
Confidence            4466777777899999999999998888899999999876555556789999999999999999999998643     45


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC-CC
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNL--NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD-EM  357 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~-~~  357 (502)
                      ..++|+||+++++|.+++..         ....+  ++..+..++.|++.|++|||   +.+|+||||||+||+++. ++
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~  146 (268)
T cd06624          79 FFKIFMEQVPGGSLSALLRS---------KWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSG  146 (268)
T ss_pred             EEEEEEecCCCCCHHHHHHH---------hcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCC
Confidence            78999999999999999853         11223  77888899999999999999   899999999999999986 67


Q ss_pred             cEEEeeeccceecccccccceecccccccccccCcccCCCc--cCccccchhHHHHHHHHHhCCCCCccccccccchHHH
Q 046112          358 TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE--VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  435 (502)
                      .++|+|||++........  ......++..|+|||++....  ++.++||||||+++||+++|+.||........  ..+
T Consensus       147 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~  222 (268)
T cd06624         147 VVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMF  222 (268)
T ss_pred             eEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHh
Confidence            999999999876543221  112345789999999986643  78999999999999999999999865221110  000


Q ss_pred             HHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      . ....           .....+.......+.+++.+|++.+|++|||+.|+++
T Consensus       223 ~-~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         223 K-VGMF-----------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             h-hhhh-----------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            0 0000           0011111234556779999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-38  Score=312.23  Aligned_cols=271  Identities=22%  Similarity=0.345  Sum_probs=205.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEc-------CCCeEEEEEEecccC-cchhHHHHHHHHHHhcC-CCCccceeeecccccc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILF-------ESTTAVAVKVFNVLH-HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVD  275 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  275 (502)
                      ++|...+.||+|+||.||+|...       .....+|+|.++... ......+..|+++++++ +||||++++++|..  
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--   89 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ--   89 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc--
Confidence            46778899999999999999653       235679999887432 23345688999999999 69999999998643  


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhhh------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCC
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEEDK------RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPS  349 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~  349 (502)
                         ....++++||+++|+|.+++........      .......+++.+...++.|++.||.|||   +.+|+||||||+
T Consensus        90 ---~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~  163 (314)
T cd05099          90 ---EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAAR  163 (314)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccce
Confidence               3478999999999999999864211000      0012345899999999999999999999   899999999999


Q ss_pred             CeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCcccccc
Q 046112          350 NILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKD  428 (502)
Q Consensus       350 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~  428 (502)
                      ||++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |+.||......
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999986643322221122234567999999998899999999999999999999 89998652111


Q ss_pred             ccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          429 NLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                        ........   ...           .+....++..+.+++.+|+..+|++|||+.|+++.|.++.....
T Consensus       244 --~~~~~~~~---~~~-----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~  298 (314)
T cd05099         244 --ELFKLLRE---GHR-----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS  298 (314)
T ss_pred             --HHHHHHHc---CCC-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence              11111110   000           00112345577799999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.3e-39  Score=318.29  Aligned_cols=238  Identities=24%  Similarity=0.308  Sum_probs=184.4

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHH-HHhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECE-VTRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      ++||+|+||.||+|++..+++.||+|++....   ......+..|.. +++.++||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            47999999999999998899999999986422   122334555554 57889999999999874     3455899999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.+++.          ....+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  142 (321)
T cd05603          76 DYVNGGELFFHLQ----------RERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGL  142 (321)
T ss_pred             cCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCC
Confidence            9999999988873          2345788888999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      ++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....     ..+........    
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~----  211 (321)
T cd05603         143 CKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNILHK----  211 (321)
T ss_pred             CccCCCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHHhcC----
Confidence            875322211  1234568999999999999899999999999999999999999997521     11111111110    


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKIN  485 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~  485 (502)
                          ..    .........+.+++.+|++.||.+||++.
T Consensus       212 ----~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         212 ----PL----QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ----CC----CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                00    00112244677999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.8e-39  Score=304.38  Aligned_cols=251  Identities=18%  Similarity=0.246  Sum_probs=200.3

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      +|...+.||+|+||.||++.+..++..+|+|.++... ....+.+..|+.++++++|+|++++.+.+     ...+..++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            4677889999999999999998899999999986432 23456788899999999999999999984     44558999


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ++||+++|+|.+++..        .....+++.....++.+++.||.|||   +.+|+|+||||+||++++++.++++||
T Consensus        76 v~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~df  144 (255)
T cd08219          76 VMEYCDGGDLMQKIKL--------QRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDF  144 (255)
T ss_pred             EEeeCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEccc
Confidence            9999999999998743        23345788899999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      |.++.......  ......++..|+|||+..+..++.++||||||+++|+|++|+.||....     .............
T Consensus       145 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~  217 (255)
T cd08219         145 GSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKVCQGSY  217 (255)
T ss_pred             Ccceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHHhcCCC
Confidence            99976543222  1223568889999999998889999999999999999999999997521     1111111110000


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                              ..   ........+.+++.+||+.||++|||+.+++.+
T Consensus       218 --------~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 --------KP---LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --------CC---CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                    00   011234567799999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.5e-39  Score=310.55  Aligned_cols=251  Identities=20%  Similarity=0.272  Sum_probs=200.8

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      .+|+..+.||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++|+|++++++++.     .....++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEEE
Confidence            47888899999999999999888899999999987655555677899999999999999999999853     3458899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++++|.+++..           ..+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        95 v~e~~~~~~L~~~~~~-----------~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~df  160 (296)
T cd06654          95 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF  160 (296)
T ss_pred             eecccCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECcc
Confidence            9999999999998842           23788899999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      |++........  ......+++.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..    ...
T Consensus       161 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-~~~~~~~----~~~  233 (296)
T cd06654         161 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIAT----NGT  233 (296)
T ss_pred             ccchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-hHHHHhc----CCC
Confidence            99875543221  1123457889999999998889999999999999999999999996532111 1111100    000


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                           +....    .......+.+++.+|+..+|++|||+.|+++.
T Consensus       234 -----~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         234 -----PELQN----PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             -----CCCCC----ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence                 00000    11334567789999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-38  Score=304.41  Aligned_cols=258  Identities=26%  Similarity=0.363  Sum_probs=195.1

Q ss_pred             CcccccCCceEEEEEEcCCCe--EEEEEEecccC-cchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFESTT--AVAVKVFNVLH-HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.||+|+||.||+|....++.  .+++|.++... ....+.+..|++++.++ +||||++++++|..     ....++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEE
Confidence            468999999999998877665  46888876432 23446788999999999 79999999998643     34789999


Q ss_pred             eeccCCChhhhccCCchhhh------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          287 EFMANGSLEEWMHPITEEDK------RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ||+++|+|.+++........      .......+++.++..++.+++.|++|||   +.+++||||||+||++++++.+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEE
Confidence            99999999999864221100      0112345889999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||++......   ........+..|+|||+.....++.++|||||||++|||++ |..||.....     .+.....
T Consensus       153 l~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~~  224 (270)
T cd05047         153 IADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEKL  224 (270)
T ss_pred             ECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----HHHHHHH
Confidence            9999998632211   11112234567999999988889999999999999999997 9999965311     1111111


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                      .....           .+....+...+.+++.+|++.+|.+|||+.++++.|.++.
T Consensus       225 ~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         225 PQGYR-----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             hCCCC-----------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            00000           0001123456789999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=320.26  Aligned_cols=252  Identities=23%  Similarity=0.348  Sum_probs=205.6

Q ss_pred             CCCCcccccCCceEEEEEEcCC-C--eEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          208 SSENLIGAGNFGSVYKGILFES-T--TAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       208 ~~~~~lG~G~~g~Vy~~~~~~~-~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ...++||+|.||.|++|.|... |  ..||||.++..... ...+|.+|+.+|.+++|+|+++++|...+      ....
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~m  186 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPAM  186 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chhh
Confidence            4457899999999999988642 3  46899999855433 56899999999999999999999998532      3678


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+|.++.|||.+.|+.        .....+-......++.|||.||.||.   .+++|||||.++|+||-....|||+|
T Consensus       187 MV~ELaplGSLldrLrk--------a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~D  255 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRK--------AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICD  255 (1039)
T ss_pred             HHhhhcccchHHHHHhh--------ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeec
Confidence            99999999999999974        44566888888999999999999999   99999999999999999999999999


Q ss_pred             eccceeccccccccee-cccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcc
Q 046112          364 FGIARFLEAADEQTRS-IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      ||+.+.+...+....+ ....-.+.|+|||.+...+++.+||||+|||++|||+| |..||-+.  .+.++.+.++    
T Consensus       256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~--~g~qIL~~iD----  329 (1039)
T KOG0199|consen  256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--RGIQILKNID----  329 (1039)
T ss_pred             ccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC--CHHHHHHhcc----
Confidence            9999988766543333 34556789999999999999999999999999999999 88998762  1112222111    


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                             +...-..   ...|++.++++++.||..+|++|||+..+.+.+-
T Consensus       330 -------~~erLpR---Pk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  330 -------AGERLPR---PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             -------ccccCCC---CCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence                   1111111   3478999999999999999999999999986553

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.6e-38  Score=304.52  Aligned_cols=258  Identities=22%  Similarity=0.387  Sum_probs=202.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCC---CeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFES---TTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ++|...+.||+|+||.||+|.+...   ...|+||...... ....+.+.+|+.++++++|||+++++++|..      .
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence            4577889999999999999976543   3568999876543 3345678999999999999999999998632      3


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.+++..         ....+++..+..++.+++.|++|||   +.+++||||||+||+++.++.+|
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~  147 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQV---------NKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVK  147 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeE
Confidence            56899999999999999852         2335899999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++......... .....++..|+|||.+....++.++||||||+++||+++ |+.||.......  ........
T Consensus       148 l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~  224 (270)
T cd05056         148 LGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIENG  224 (270)
T ss_pred             EccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcC
Confidence            99999998664432211 122334568999999988889999999999999999986 999997632211  11111100


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                        ..            ......++..+.+++.+|+..+|++|||+.++++.|+.++.+
T Consensus       225 --~~------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         225 --ER------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             --Cc------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              00            001124456788999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.7e-38  Score=302.75  Aligned_cols=257  Identities=23%  Similarity=0.307  Sum_probs=188.7

Q ss_pred             CcccccCCceEEEEEEcC--CCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEee
Q 046112          211 NLIGAGNFGSVYKGILFE--STTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE  287 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  287 (502)
                      +.||+|+||.||+|....  .+..+|+|.++.... .....+.+|+.++++++||||+++++++..     ....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEEE
Confidence            368999999999997543  446789998875432 234578899999999999999999998643     346899999


Q ss_pred             eccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccc
Q 046112          288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA  367 (502)
Q Consensus       288 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a  367 (502)
                      |+++|+|.++++...     .......++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~  147 (269)
T cd05087          76 FCPLGDLKGYLRSCR-----KAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLS  147 (269)
T ss_pred             CCCCCcHHHHHHHhh-----hcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCcccc
Confidence            999999999985311     112234677788899999999999999   899999999999999999999999999999


Q ss_pred             eecccccccceecccccccccccCcccCCC-------ccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhh
Q 046112          368 RFLEAADEQTRSIGVEGTTGYIAPEYGMGH-------EVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       368 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      +...............++..|+|||++...       .++.++||||||+++|||++ |+.||.......  ....   .
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~---~  222 (269)
T cd05087         148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTY---T  222 (269)
T ss_pred             ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHH---H
Confidence            754333222222234567889999987642       35789999999999999996 999997532211  1111   0


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                      .........++...      ......+.+++..|+ .+|++|||++||++.|+
T Consensus       223 ~~~~~~~~~~~~~~------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         223 VREQQLKLPKPRLK------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             hhcccCCCCCCccC------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            10101111111111      112345678899998 58999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-38  Score=304.17  Aligned_cols=250  Identities=25%  Similarity=0.351  Sum_probs=196.9

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc---------hhHHHHHHHHHHhcCCCCccceeeeccccccc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD---------ASKSFAVECEVTRNIRHRNLVKVFTACSGVDF  276 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  276 (502)
                      +|.....||+|++|.||+|....+++.+|+|.+......         ..+.+.+|++++++++||||+++++++.    
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   76 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL----   76 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence            367788999999999999988888999999988643222         1256888999999999999999999853    


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE  356 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~  356 (502)
                       .....++|+||+++++|.+++..          ...+++.....++.+++.|++|||   +.+++||||+|+||+++++
T Consensus        77 -~~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~  142 (267)
T cd06628          77 -DADHLNIFLEYVPGGSVAALLNN----------YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNK  142 (267)
T ss_pred             -eCCccEEEEEecCCCCHHHHHHh----------ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCC
Confidence             34578999999999999999842          245788889999999999999999   8999999999999999999


Q ss_pred             CcEEEeeeccceeccccccc----ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccch
Q 046112          357 MTAYVSDFGIARFLEAADEQ----TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL  432 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~  432 (502)
                      +.++|+|||+++........    .......++..|+|||.+.+..++.++|||||||++|||++|+.||....... ..
T Consensus       143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~  221 (267)
T cd06628         143 GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AI  221 (267)
T ss_pred             CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HH
Confidence            99999999999866432111    11122457889999999998889999999999999999999999997631110 00


Q ss_pred             HHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          433 RNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       433 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..            +......   .........+.+++.+|++.||.+||++.|+++
T Consensus       222 ~~------------~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         222 FK------------IGENASP---EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HH------------HhccCCC---cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            00            0000000   111234566789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-38  Score=302.97  Aligned_cols=253  Identities=25%  Similarity=0.406  Sum_probs=200.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|...++||+|+||.||+|. ..+++.||+|.+..... ....+.+|+.++++++|+|+++++++.      ..+..++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~-~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~------~~~~~~~   77 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV------TQEPIYI   77 (260)
T ss_pred             HHceeeeeeccCccceEEeee-cCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE------ccCCcEE
Confidence            467888999999999999995 46778899999875432 346789999999999999999999873      2236899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ++||+++|+|.+++..        .....+++.++..++.+++.||+|||   +.+++||||||+||++++++.++|+||
T Consensus        78 v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~df  146 (260)
T cd05067          78 ITEYMENGSLVDFLKT--------PEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADF  146 (260)
T ss_pred             EEEcCCCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccC
Confidence            9999999999998853        33456889999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |++........ .......++..|+|||+.....++.++||||||+++||+++ |+.||.....  ............  
T Consensus       147 g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~--  221 (260)
T cd05067         147 GLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQNLERGYR--  221 (260)
T ss_pred             cceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHHcCCC--
Confidence            99976542221 11223446778999999998889999999999999999999 9999975321  111111111100  


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL  493 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~  493 (502)
                              .    ......+..+.+++.+|++.+|++|||++++...|+.
T Consensus       222 --------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 --------M----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             --------C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                    0    0011234568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.6e-38  Score=302.05  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=197.4

Q ss_pred             CcccccCCceEEEEEEcC-CC--eEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFE-ST--TAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.||+|++|.||+|.+.. ++  ..||+|.++.... ...+.+..|++++++++||||+++++++..      ...++|+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            468999999999998754 33  3689999876544 456789999999999999999999998532      5789999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.+++..        .....+++.....++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||+
T Consensus        75 e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~  143 (257)
T cd05040          75 ELAPLGSLLDRLRK--------DALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGL  143 (257)
T ss_pred             EecCCCcHHHHHHh--------cccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccc
Confidence            99999999999853        11146899999999999999999999   89999999999999999999999999999


Q ss_pred             ceeccccccc-ceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccch
Q 046112          367 ARFLEAADEQ-TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       367 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      ++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |+.||......  .....+....    
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~----  217 (257)
T cd05040         144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDKEG----  217 (257)
T ss_pred             cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHhcC----
Confidence            9876543221 11123456789999999999899999999999999999999 99998652111  1111111100    


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                           ....    .....+..+.+++.+|++.+|++||++.++++.|.
T Consensus       218 -----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 -----ERLE----RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -----CcCC----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                 0000    01234567889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.9e-39  Score=324.25  Aligned_cols=201  Identities=21%  Similarity=0.354  Sum_probs=169.9

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .|...++||+|+||.||+|+...+++.||+|++....   ......+.+|++++++++||||+++++.+     ..++..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence            5788899999999999999998999999999986432   22345688899999999999999999985     345589


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++|+|.+++..          ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~----------~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~  143 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIR----------MGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLT  143 (382)
T ss_pred             EEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEe
Confidence            999999999999998842          245788888899999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccc---------------------------------------------cceecccccccccccCcccCCC
Q 046112          363 DFGIARFLEAADE---------------------------------------------QTRSIGVEGTTGYIAPEYGMGH  397 (502)
Q Consensus       363 Dfg~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~  397 (502)
                      |||+++.+.....                                             ........||+.|+|||++.+.
T Consensus       144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~  223 (382)
T cd05625         144 DFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT  223 (382)
T ss_pred             ECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC
Confidence            9999753211000                                             0001234689999999999999


Q ss_pred             ccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          398 EVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       398 ~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      .++.++|||||||++|||++|+.||..
T Consensus       224 ~~~~~~DiwSlGvil~elltG~~Pf~~  250 (382)
T cd05625         224 GYTQLCDWWSVGVILYEMLVGQPPFLA  250 (382)
T ss_pred             CCCCeeeEEechHHHHHHHhCCCCCCC
Confidence            999999999999999999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-38  Score=307.75  Aligned_cols=269  Identities=22%  Similarity=0.295  Sum_probs=207.1

Q ss_pred             CHHHHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeeccccc
Q 046112          196 SYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGV  274 (502)
Q Consensus       196 ~~~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  274 (502)
                      .+..+..++++|...+.||+|+||.||++....+++.+|+|+++... .....+..|+.+++++ +|||++++++++...
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34555667889999999999999999999998899999999876432 2346688899999999 699999999987554


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                      ....++..++||||+++++|.++++..      ......+++..+..++.|++.|+.|||   +.+|+||||||+||+++
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~  158 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGF------LKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLT  158 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHh------hccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEEC
Confidence            444556789999999999999987531      122345788999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCC-----CccCccccchhHHHHHHHHHhCCCCCccccccc
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-----HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN  429 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~  429 (502)
                      +++.+||+|||+++.+.....  ......|++.|+|||++..     ..++.++|||||||++|||++|+.||.....  
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~--  234 (286)
T cd06638         159 TEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP--  234 (286)
T ss_pred             CCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch--
Confidence            999999999999986543221  1223468999999998753     4578899999999999999999999875311  


Q ss_pred             cchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          430 LNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                        ...... ..........+      .   ..+...+.+++.+|++.||++|||+.|+++.
T Consensus       235 --~~~~~~-~~~~~~~~~~~------~---~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         235 --MRALFK-IPRNPPPTLHQ------P---ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             --hHHHhh-ccccCCCcccC------C---CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence              111100 00000000000      0   1123467899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.5e-38  Score=301.43  Aligned_cols=253  Identities=27%  Similarity=0.426  Sum_probs=198.8

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|...+.||+|++|.||+|.+. .+..+|+|.+.... ...+.+.+|++++++++|+|++++++++.      .+..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~   77 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWN-GTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI   77 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEc-CCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence            45778889999999999999664 44569999876432 23467889999999999999999998742      235789


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      +|||+++|+|.++++.        .....+++..+..++.+++.||+|||   +.+++|+||||+||++++++.++|+||
T Consensus        78 v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~df  146 (260)
T cd05069          78 VTEFMGKGSLLDFLKE--------GDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADF  146 (260)
T ss_pred             EEEcCCCCCHHHHHhh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCC
Confidence            9999999999999853        23345789999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |+++....... .......++..|+|||+..+..++.++|||||||++||++| |+.||.+....  ....+......  
T Consensus       147 g~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~--  221 (260)
T cd05069         147 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERGYR--  221 (260)
T ss_pred             ccceEccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC--
Confidence            99986643221 11123346778999999998899999999999999999999 99998763221  11111111100  


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL  493 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~  493 (502)
                                  .......+..+.+++.+|+..||++||+++++++.|+.
T Consensus       222 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 ------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                        00112345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.5e-39  Score=327.07  Aligned_cols=268  Identities=22%  Similarity=0.281  Sum_probs=193.7

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeeccccccc---CCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF---QGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~~  280 (502)
                      ..+|...+.||+|+||.||+|....+++.||||++...    .....+|+.+++.++||||+++.+++....+   ....
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            45789999999999999999998889999999987532    2334579999999999999999887543222   1223


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC-cE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM-TA  359 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~-~~  359 (502)
                      ..++||||++ ++|.+++....      .....+++.....++.|++.||+|||   +.+|+||||||+|||++.++ .+
T Consensus       141 ~l~lvmE~~~-~~l~~~~~~~~------~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~v  210 (440)
T PTZ00036        141 FLNVVMEFIP-QTVHKYMKHYA------RNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTL  210 (440)
T ss_pred             EEEEEEecCC-ccHHHHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCce
Confidence            5679999997 47777664211      23456889999999999999999999   89999999999999999664 79


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      ||+|||+|+.+....   ......||+.|+|||++.+. .++.++|||||||++|||++|++||...... ..+......
T Consensus       211 kL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~  286 (440)
T PTZ00036        211 KLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQV  286 (440)
T ss_pred             eeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHH
Confidence            999999998654322   12345679999999987764 6899999999999999999999999753211 111111111


Q ss_pred             hcccchhhh--ccc-----CCCCc------chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 ALPERAEEI--RAS-----SGSTQ------RSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~~~~~~~~--~d~-----~~~~~------~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .-......+  ..+     ..+..      ..+....+..+.+++.+|++.||.+|||+.|+++
T Consensus       287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            000000000  000     00000      0011123456889999999999999999999884

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.5e-38  Score=302.55  Aligned_cols=248  Identities=23%  Similarity=0.355  Sum_probs=201.0

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      .|+..+.||+|+||.||+|.+..++..||+|+++... ......+.+|++++++++|||++++++++.     .+...++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence            4667789999999999999888889999999987543 234567889999999999999999999853     3458999


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++|+|.+++..           ..+++.+...++.+++.|++|||   +.+++|+||+|+||+++.++.++|+||
T Consensus        80 v~e~~~~~~L~~~i~~-----------~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~df  145 (277)
T cd06640          80 IMEYLGGGSALDLLRA-----------GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADF  145 (277)
T ss_pred             EEecCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEccc
Confidence            9999999999998742           34788889999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      |++........  ......++..|+|||++.+..++.++|||||||++|||+||+.||.......  .....    .   
T Consensus       146 g~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~----~---  214 (277)
T cd06640         146 GVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--VLFLI----P---  214 (277)
T ss_pred             ccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--Hhhhh----h---
Confidence            99976543321  1223457889999999998889999999999999999999999987532111  00000    0   


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                           ..  ........++..+.+++.+||+.+|++||++.++++.
T Consensus       215 -----~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         215 -----KN--NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -----cC--CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                 00  0112233567778899999999999999999999766

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=8e-39  Score=306.04  Aligned_cols=253  Identities=23%  Similarity=0.304  Sum_probs=197.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|...+.||+|+||.||+|....+++.||+|+++.........+.+|+.+++.++|||++++++++     ...+..++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEEEE
Confidence            4677778999999999999998889999999998765444456688899999999999999999984     34458899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      |+||+++++|.+++..          ...+++.+...++.+++.|+.|||   +.+++|+||||+||+++.++.++|+||
T Consensus        84 v~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~df  150 (267)
T cd06645          84 CMEFCGGGSLQDIYHV----------TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADF  150 (267)
T ss_pred             EEeccCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcc
Confidence            9999999999998842          345889999999999999999999   889999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccC---CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGM---GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |++.......  .......|+..|+|||++.   ...++.++|||||||++|||++|+.||....... .......... 
T Consensus       151 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~~~~~~-  226 (267)
T cd06645         151 GVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMTKSNF-  226 (267)
T ss_pred             eeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhhhccCC-
Confidence            9987654321  1123456889999999874   4568899999999999999999999986532111 0000000000 


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                       .     .+.....    ......+.+++.+|++.+|++||+++++++
T Consensus       227 -~-----~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         227 -Q-----PPKLKDK----MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             -C-----CCccccc----CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence             0     0000000    122345779999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.4e-38  Score=304.76  Aligned_cols=249  Identities=24%  Similarity=0.315  Sum_probs=195.4

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      +|...++||+|+||.||+|.+..++..||+|++.... ....+.+.+|++++++++|||++++++++..     .+..++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence            5777889999999999999988899999999986542 2334678899999999999999999998643     347889


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      |+||+++|+|..+.              .+++.....++.|++.||.|||   +.+|+|+||||+||+++.++.++|+||
T Consensus        77 v~e~~~~~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~df  139 (279)
T cd06619          77 CTEFMDGGSLDVYR--------------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDF  139 (279)
T ss_pred             EEecCCCCChHHhh--------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeC
Confidence            99999999996542              2567788899999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccc--hHHHHHhhccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN--LRNCVKSALPE  442 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~  442 (502)
                      |++.......    .....+|..|+|||++.+..++.++||||||+++|||++|+.||.........  ........   
T Consensus       140 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---  212 (279)
T cd06619         140 GVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI---  212 (279)
T ss_pred             Ccceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH---
Confidence            9997653321    22346889999999999999999999999999999999999999753322111  11111110   


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                           .+.......  .......+.+++.+|++.+|++||+++|+++.
T Consensus       213 -----~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         213 -----VDEDPPVLP--VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -----hccCCCCCC--CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                 000000000  01123457799999999999999999999764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.8e-38  Score=299.20  Aligned_cols=247  Identities=28%  Similarity=0.408  Sum_probs=193.2

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeec
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFM  289 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  289 (502)
                      ++||+|+||.||+|.. .++..+|+|.++.... .....+.+|++++++++|||+++++++|..     ....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence            4789999999999964 5788999999875432 234568899999999999999999998643     34789999999


Q ss_pred             cCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          290 ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       290 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                      ++++|.+++..         ....+++..+..++.+++.||.|+|   +.+++||||||+||++++++.+||+|||++..
T Consensus        75 ~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~  142 (250)
T cd05085          75 PGGDFLSFLRK---------KKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ  142 (250)
T ss_pred             CCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCcccee
Confidence            99999998842         2345789999999999999999999   89999999999999999999999999999875


Q ss_pred             cccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccchhhhc
Q 046112          370 LEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAEEIR  448 (502)
Q Consensus       370 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  448 (502)
                      ...... .......+++.|+|||+..+..++.++||||||+++||+++ |..||......  .....+.....       
T Consensus       143 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~~~~~-------  212 (250)
T cd05085         143 EDDGIY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVEKGYR-------  212 (250)
T ss_pred             cccccc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCC-------
Confidence            432211 11112234678999999998899999999999999999998 99998753211  11111111000       


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          449 ASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       449 d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                             ......++..+.+++.+|++.+|++||++.|+.+.|.
T Consensus       213 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 -------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                   0001134567889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.2e-38  Score=313.03  Aligned_cols=268  Identities=22%  Similarity=0.331  Sum_probs=204.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcC-------CCeEEEEEEecccC-cchhHHHHHHHHHHhcC-CCCccceeeecccccc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFE-------STTAVAVKVFNVLH-HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVD  275 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  275 (502)
                      .+|.+.+.||+|+||.||+|.+..       .+..||+|.++... ....+++.+|+++++++ +||||++++++|..  
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence            367888999999999999997543       23478999887432 22346789999999999 79999999998643  


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhhh------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCC
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEEDK------RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPS  349 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~  349 (502)
                         .+..++++||+++|+|.+++........      .......+++.+++.++.|++.||+|||   +.+|+||||||+
T Consensus        90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~  163 (334)
T cd05100          90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAAR  163 (334)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccc
Confidence               3478999999999999999864211000      0112345889999999999999999999   899999999999


Q ss_pred             CeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCcccccc
Q 046112          350 NILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKD  428 (502)
Q Consensus       350 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~  428 (502)
                      ||++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....  
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--  241 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--  241 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC--
Confidence            99999999999999999986644322222223334578999999999999999999999999999998 888886521  


Q ss_pred             ccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          429 NLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                         ..+..........           .+....+...+.+++.+|++.+|++|||+.|+++.|+.+..
T Consensus       242 ---~~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         242 ---VEELFKLLKEGHR-----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             ---HHHHHHHHHcCCC-----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence               1111111110000           00112345678899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.9e-38  Score=310.11  Aligned_cols=263  Identities=19%  Similarity=0.255  Sum_probs=195.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|...+.||+|+||.||+|.+..++..||+|+++.... .....+.+|++++++++||||+++++++.     .++..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence            568888999999999999999888899999999875432 23456788999999999999999999853     345789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++ +|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        81 lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~D  147 (309)
T cd07872          81 LVFEYLDK-DLKQYMDD---------CGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLAD  147 (309)
T ss_pred             EEEeCCCC-CHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECc
Confidence            99999974 88877742         2345788899999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+++.......  ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||......+  ....+......
T Consensus       148 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~  223 (309)
T cd07872         148 FGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED--ELHLIFRLLGT  223 (309)
T ss_pred             cccceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCC
Confidence            999975433221  1123457899999998765 568999999999999999999999997532111  11111111100


Q ss_pred             ch----------hhhcccCCCCc-----chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 RA----------EEIRASSGSTQ-----RSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ~~----------~~~~d~~~~~~-----~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..          ....+......     ..........+.+++.+|++.||.+|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         224 PTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00          00000000000     0001123456779999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-38  Score=305.26  Aligned_cols=239  Identities=22%  Similarity=0.305  Sum_probs=183.8

Q ss_pred             cccccCCceEEEEEEcC------------------------CCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCcccee
Q 046112          212 LIGAGNFGSVYKGILFE------------------------STTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKV  267 (502)
Q Consensus       212 ~lG~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  267 (502)
                      .||+|+||.||+|....                        ....|++|+++........++.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            68999999999996432                        124688998875444445678899999999999999999


Q ss_pred             eecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCC
Q 046112          268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLK  347 (502)
Q Consensus       268 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk  347 (502)
                      +++|..     +...++||||+++|+|..++..         ....+++..++.++.|+++||+|||   +.+|+|||||
T Consensus        82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlk  144 (274)
T cd05076          82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRK---------EKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVC  144 (274)
T ss_pred             EEEEEe-----CCceEEEEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCC
Confidence            999753     3478999999999999998842         2345789999999999999999999   8999999999


Q ss_pred             CCCeeeCCCC-------cEEEeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHH-hC
Q 046112          348 PSNILLDDEM-------TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMF-TG  418 (502)
Q Consensus       348 ~~NIll~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~-tg  418 (502)
                      |+||+++..+       .+|++|||++......      ....++..|+|||.+.+ ..++.++|||||||++||++ +|
T Consensus       145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g  218 (274)
T cd05076         145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG  218 (274)
T ss_pred             cccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999997543       4899999988643221      12346788999998865 56899999999999999985 69


Q ss_pred             CCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          419 LRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       419 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                      +.||.......  .........          ...      ......+.+++.+||+.+|++|||+.++++.|
T Consensus       219 ~~p~~~~~~~~--~~~~~~~~~----------~~~------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         219 EVPLKERTPSE--KERFYEKKH----------RLP------EPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             CCCccccChHH--HHHHHHhcc----------CCC------CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            99987532111  111111100          000      01123578999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.9e-38  Score=316.73  Aligned_cols=268  Identities=20%  Similarity=0.197  Sum_probs=196.6

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccc-cCCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVD-FQGN  279 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~  279 (502)
                      ..++|...+.||+|+||.||++.+..++..||+|+++...  ......+.+|+.+++.++||||+++++++.... ....
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3568899999999999999999988899999999986432  233467889999999999999999999864322 1122


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++||||+++ +|.+.++            ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~  162 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL  162 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh------------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCE
Confidence            357999999965 5665552            23677888899999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||+++.....   .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+....+..
T Consensus       163 kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~  238 (359)
T cd07876         163 KILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQL  238 (359)
T ss_pred             EEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc
Confidence            99999999754321   1123456899999999999999999999999999999999999999753211 0011100000


Q ss_pred             cc----------cchhhhccc----------------CCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          440 LP----------ERAEEIRAS----------------SGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       440 ~~----------~~~~~~~d~----------------~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      -.          .........                ...............+.+++.+|++.||++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         239 GTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             CCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00          000000000                0000000011224567899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.1e-38  Score=303.49  Aligned_cols=255  Identities=27%  Similarity=0.417  Sum_probs=196.2

Q ss_pred             CcccccCCceEEEEEEcCCC------eEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          211 NLIGAGNFGSVYKGILFEST------TAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +.||+|+||.||+|......      ..+|+|.+.... ......+.+|+++++.++||||++++++|.     ..+..+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence            46899999999999775433      689999876432 234567889999999999999999999864     334789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC-----c
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM-----T  358 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~-----~  358 (502)
                      +||||+++|+|.+++......   ......+++.+++.++.+++.|++|||   +.+++|+||||+||+++.+.     .
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~  149 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVE---RFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRV  149 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhc---ccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcc
Confidence            999999999999998642111   013345789999999999999999999   89999999999999999877     8


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHH
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  437 (502)
                      ++++|||+++...............++..|+|||++.++.++.++|||||||++|||+| |+.||.....  ......+.
T Consensus       150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~~  227 (269)
T cd05044         150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHVT  227 (269)
T ss_pred             eEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHHh
Confidence            99999999976543332222223345678999999999999999999999999999998 9999865211  11111111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                      ..              .........+..+.+++.+|++.+|.+||++.++.+.|+
T Consensus       228 ~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         228 AG--------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             cC--------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            00              000111234567889999999999999999999998885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.5e-38  Score=295.14  Aligned_cols=272  Identities=21%  Similarity=0.262  Sum_probs=202.6

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCc-cceeeecccccc-cCCCcc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRN-LVKVFTACSGVD-FQGNDF  281 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-~~~~~~  281 (502)
                      .|...++||+|+||+||+|+...+|+.||+|+++....  .......+|+.++++++|+| ||++++++.... +.....
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            45566889999999999999999999999999876543  24556789999999999999 999999975433 122347


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++|+||+ .-+|..++.....      ....++......+..|++.||+|||   +++|+||||||.|||++++|.+||
T Consensus        92 l~lvfe~~-d~DL~~ymd~~~~------~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKl  161 (323)
T KOG0594|consen   92 LYLVFEFL-DRDLKKYMDSLPK------KPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKL  161 (323)
T ss_pred             EEEEEEee-cccHHHHHHhccc------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEee
Confidence            88999999 5689999864221      1145677888999999999999999   999999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh-
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA-  439 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-  439 (502)
                      +|||+|+...-+...  ....++|.+|+|||.+.+. .|++..||||+||++.||++++.-|.+..+ ..++....+.. 
T Consensus       162 aDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lG  238 (323)
T KOG0594|consen  162 ADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLG  238 (323)
T ss_pred             eccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcC
Confidence            999999966533221  3456789999999998886 799999999999999999999988876322 11121111111 


Q ss_pred             cc---cchhhhcccCC-------CCcchhhHHHH---HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          440 LP---ERAEEIRASSG-------STQRSIILECL---ISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       440 ~~---~~~~~~~d~~~-------~~~~~~~~~~~---~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      .+   .|.....-+..       ..........+   ....+++.+|++.+|.+|.|++.+++.
T Consensus       239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            01   01111111110       00111111111   367789999999999999999998875

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-38  Score=302.66  Aligned_cols=240  Identities=24%  Similarity=0.341  Sum_probs=185.3

Q ss_pred             CcccccCCceEEEEEEcC------------CCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCC
Q 046112          211 NLIGAGNFGSVYKGILFE------------STTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      +.||+|+||.||+|....            ....|++|+++....+....+.+|+.+++.++||||++++++|..     
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-----   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-----   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            468999999999996432            233689998876555555678899999999999999999999643     


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      +...++||||+++|+|..+++.         ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~  143 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHR---------KSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGI  143 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCc
Confidence            3467899999999999988742         2345889999999999999999999   999999999999999987654


Q ss_pred             -------EEEeeeccceecccccccceecccccccccccCcccC-CCccCccccchhHHHHHHHHH-hCCCCCccccccc
Q 046112          359 -------AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM-GHEVSSYGDVYSFGILLLEMF-TGLRPSDDMFKDN  429 (502)
Q Consensus       359 -------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvws~Gv~l~el~-tg~~p~~~~~~~~  429 (502)
                             ++++|||++......      ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+.......
T Consensus       144 ~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~  217 (262)
T cd05077         144 DGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE  217 (262)
T ss_pred             cCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence                   899999998654321      2345788899999887 466899999999999999997 5888876521110


Q ss_pred             cchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          430 LNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                        .....            ........    .....+.+++.+||+.||++||++.++++.|
T Consensus       218 --~~~~~------------~~~~~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         218 --KERFY------------EGQCMLVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             --HHHHH------------hcCccCCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence              00000            00000001    1234678999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.5e-38  Score=307.07  Aligned_cols=251  Identities=25%  Similarity=0.325  Sum_probs=196.9

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      |...+.||+|+||.||++.+..+++.||+|.+.....   .....+..|+.++++++|++++++.+.+.     ..+..+
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEEE
Confidence            6677899999999999999999999999999864321   12345778999999999999999998853     345889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++|+|.+++..        .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|
T Consensus        77 lv~e~~~g~~L~~~l~~--------~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~D  145 (285)
T cd05630          77 LVLTLMNGGDLKFHIYH--------MGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISD  145 (285)
T ss_pred             EEEEecCCCcHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEee
Confidence            99999999999998843        22345889999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||++........   .....|+..|+|||++.+..++.++|||||||++|||++|+.||....... .... ....... 
T Consensus       146 fg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~-~~~~~~~-  219 (285)
T cd05630         146 LGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREE-VERLVKE-  219 (285)
T ss_pred             ccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHH-HHhhhhh-
Confidence            999875432221   123468999999999999999999999999999999999999997532111 0010 1111000 


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK-----INDVEP  489 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt-----~~ev~~  489 (502)
                         ...       .........+.+++.+|++.||++|||     ++|+++
T Consensus       220 ---~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         220 ---VQE-------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ---hhh-------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence               000       001123456779999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.2e-38  Score=303.63  Aligned_cols=250  Identities=24%  Similarity=0.298  Sum_probs=195.8

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      |+..+.||+|+||.||+|....++..+++|.+........+.+..|+++++.++|||++++++++.     ..+..++|+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEEE
Confidence            456688999999999999998889999999987554445667889999999999999999999864     345789999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|..++..         ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+
T Consensus        82 e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~  149 (282)
T cd06643          82 EFCAGGAVDAVMLE---------LERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGV  149 (282)
T ss_pred             EecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccc
Confidence            99999999988742         2346899999999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccC-----CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGM-----GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +.......  .......++..|+|||++.     +..++.++|||||||++|||++|+.||..... ...........  
T Consensus       150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~~--  224 (282)
T cd06643         150 SAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSE--  224 (282)
T ss_pred             cccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-HHHHHHHhhcC--
Confidence            87543221  1123346889999999874     34578899999999999999999999875211 10111111000  


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                        ....     . .   .......+.+++.+||+.+|.+||++.++++
T Consensus       225 --~~~~-----~-~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         225 --PPTL-----A-Q---PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             --CCCC-----C-C---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0000     0 0   1123456789999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.1e-39  Score=319.54  Aligned_cols=259  Identities=20%  Similarity=0.248  Sum_probs=196.5

Q ss_pred             HHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccc
Q 046112          199 MLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVD  275 (502)
Q Consensus       199 ~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  275 (502)
                      ++....++|...+.||+|+||.||++.+..+++.+|+|+++..   .......+.+|+.+++.++||||+++++++    
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~----  112 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF----  112 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE----
Confidence            3444567899999999999999999999999999999998642   122345578899999999999999999884    


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD  355 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~  355 (502)
                       ..+...++||||+++|+|.+++..           ..++...+..++.|++.||+|||   +.+|+||||||+|||++.
T Consensus       113 -~~~~~~~lv~Ey~~gg~L~~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~  177 (371)
T cd05622         113 -QDDRYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDK  177 (371)
T ss_pred             -EcCCEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECC
Confidence             445589999999999999998842           23677888899999999999999   999999999999999999


Q ss_pred             CCcEEEeeeccceecccccccceecccccccccccCcccCCC----ccCccccchhHHHHHHHHHhCCCCCccccccccc
Q 046112          356 EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH----EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN  431 (502)
Q Consensus       356 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~  431 (502)
                      ++.+||+|||+++....... .......||+.|+|||++...    .++.++|||||||++|||++|+.||.....    
T Consensus       178 ~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----  252 (371)
T cd05622         178 SGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----  252 (371)
T ss_pred             CCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----
Confidence            99999999999986643221 122345699999999998753    378999999999999999999999975211    


Q ss_pred             hHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 046112          432 LRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGE--RMKINDVEPR  490 (502)
Q Consensus       432 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~--RPt~~ev~~~  490 (502)
                       ........ .....+   ..+..    ......+.+++.+|+..++.+  ||+++|+.+.
T Consensus       253 -~~~~~~i~-~~~~~~---~~~~~----~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         253 -VGTYSKIM-NHKNSL---TFPDD----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             -HHHHHHHH-cCCCcc---cCCCc----CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence             11111110 000000   00111    123445668888999844433  7788888764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.1e-38  Score=305.97  Aligned_cols=269  Identities=23%  Similarity=0.263  Sum_probs=206.8

Q ss_pred             cCHHHHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeecccc
Q 046112          195 VSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSG  273 (502)
Q Consensus       195 ~~~~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  273 (502)
                      +.+.++..++++|...+.||+|+||.||++....+++.+|+|++.... .....+..|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344556667889999999999999999999988899999999986432 2346678899999998 79999999999765


Q ss_pred             cccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee
Q 046112          274 VDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL  353 (502)
Q Consensus       274 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll  353 (502)
                      .+.......++|+||+++|+|.++++...      .....+++..+..++.|++.||.|||   +.+++||||||+||++
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili  161 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLL------ICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILL  161 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhh------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEE
Confidence            43333457899999999999999885311      22345889999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeeeccceecccccccceecccccccccccCcccCCC-----ccCccccchhHHHHHHHHHhCCCCCcccccc
Q 046112          354 DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-----EVSSYGDVYSFGILLLEMFTGLRPSDDMFKD  428 (502)
Q Consensus       354 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~  428 (502)
                      +.++.+||+|||++........  ......++..|+|||.+...     .++.++|||||||++|||++|+.||......
T Consensus       162 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~  239 (291)
T cd06639         162 TTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV  239 (291)
T ss_pred             cCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence            9999999999999876543221  11234578899999987643     3689999999999999999999998753211


Q ss_pred             ccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          429 NLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      . ....+.+    .....+.+         ..+....+.+++.+|++.+|++||++.|+++
T Consensus       240 ~-~~~~~~~----~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         240 K-TLFKIPR----NPPPTLLH---------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             H-HHHHHhc----CCCCCCCc---------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            0 1111100    00000100         1123456889999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1e-38  Score=314.28  Aligned_cols=244  Identities=23%  Similarity=0.290  Sum_probs=189.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.||+|+||.||+|....+++.||+|+++...   ....+.+..|+.++.++ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            46999999999999998999999999987532   22345678899998888 699999999884     3445899999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~  142 (327)
T cd05617          76 EYVNGGDLMFHMQ----------RQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGM  142 (327)
T ss_pred             eCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEecccc
Confidence            9999999998873          2345899999999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccccc-ccchHHHHHhhcccchh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD-NLNLRNCVKSALPERAE  445 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~  445 (502)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||+..... .....++..........
T Consensus       143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  220 (327)
T cd05617         143 CKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI  220 (327)
T ss_pred             ceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC
Confidence            87532211  1123456899999999999999999999999999999999999999643221 11112222111111100


Q ss_pred             hhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 046112          446 EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKIN  485 (502)
Q Consensus       446 ~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~  485 (502)
                                 .+.......+.+++.+|++.||++||+++
T Consensus       221 -----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         221 -----------RIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             -----------CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence                       01112234567899999999999999854

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.2e-38  Score=307.57  Aligned_cols=250  Identities=20%  Similarity=0.279  Sum_probs=200.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      .+|+..+.||.|++|.||+|.+..+++.|++|.+........+.+.+|+++++.++|||++++++++.     ..+..++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence            46888899999999999999988899999999987655555677899999999999999999999853     3458999


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      |+||+++++|.+++..           ..+++.++..++.+++.|++|||   +.+++||||+|+||+++.++.+||+||
T Consensus        94 v~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~df  159 (296)
T cd06655          94 VMEYLAGGSLTDVVTE-----------TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDF  159 (296)
T ss_pred             EEEecCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccC
Confidence            9999999999998742           34789999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      |++.........  .....++..|+|||.+.+..++.++|||||||++||+++|+.||....... .. ......   ..
T Consensus       160 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-~~-~~~~~~---~~  232 (296)
T cd06655         160 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-AL-YLIATN---GT  232 (296)
T ss_pred             ccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH-HHHHhc---CC
Confidence            998765433221  123457889999999999889999999999999999999999997632111 00 000000   00


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .     ...    ........+.+++.+||..||++|||+.+++.
T Consensus       233 ~-----~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         233 P-----ELQ----NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             c-----ccC----CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            0     000    01233456778999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.6e-38  Score=299.38  Aligned_cols=250  Identities=26%  Similarity=0.323  Sum_probs=200.8

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|+..+.||+|+||.||+|....++..+++|.++....  .+++.+|++++++++|||++++++++.     .....++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEEE
Confidence            578889999999999999998888889999999875422  678999999999999999999999854     3458899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ++||+++++|.+++..         ....+++.....++.+++.|+.|||   +.+++||||+|+||+++.++.++|+||
T Consensus        76 ~~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~df  143 (256)
T cd06612          76 VMEYCGAGSVSDIMKI---------TNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADF  143 (256)
T ss_pred             EEecCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEccc
Confidence            9999999999999842         2356899999999999999999999   889999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      |++........  ......++..|+|||++.+..++.++||||||+++|||++|+.||........ ...     .... 
T Consensus       144 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-~~~-----~~~~-  214 (256)
T cd06612         144 GVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-IFM-----IPNK-  214 (256)
T ss_pred             ccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-hhh-----hccC-
Confidence            99976543321  11234478899999999998999999999999999999999999875321110 000     0000 


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                             ..............+.+++.+|++.+|++|||+.|+++
T Consensus       215 -------~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         215 -------PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -------CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence                   00000111233456789999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.1e-37  Score=298.64  Aligned_cols=257  Identities=23%  Similarity=0.302  Sum_probs=186.5

Q ss_pred             CcccccCCceEEEEEEcC--CCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEee
Q 046112          211 NLIGAGNFGSVYKGILFE--STTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE  287 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  287 (502)
                      +.||+|+||.||+|....  ....+++|.+..... .....+.+|++.++.++||||++++++|..     ....++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEEE
Confidence            368999999999996432  345788887754322 234568899999999999999999998643     347899999


Q ss_pred             eccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccc
Q 046112          288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA  367 (502)
Q Consensus       288 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a  367 (502)
                      |+++|+|.+++.....     ......++.....++.|++.|++|||   +.+|+||||||+||++++++.+||+|||++
T Consensus        76 ~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~  147 (269)
T cd05042          76 FCPLGDLKNYLRSNRG-----MVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA  147 (269)
T ss_pred             eCCCCcHHHHHHhccc-----cccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccc
Confidence            9999999999854211     11233567788899999999999999   899999999999999999999999999998


Q ss_pred             eecccccccceecccccccccccCcccC-------CCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhh
Q 046112          368 RFLEAADEQTRSIGVEGTTGYIAPEYGM-------GHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       368 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      +...............++..|+|||+..       ...++.++|||||||++|||++ |..||....... .+...+.  
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~--  224 (269)
T cd05042         148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVR--  224 (269)
T ss_pred             cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhh--
Confidence            7543322222222344577899999864       3457889999999999999999 788886532111 1111111  


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                        +....+..+..      .......+.+++..|+ .||++|||++||++.|.
T Consensus       225 --~~~~~~~~~~~------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         225 --EQDIKLPKPQL------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             --ccCccCCCCcc------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence              11111111111      1233455667888898 49999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.9e-38  Score=299.42  Aligned_cols=251  Identities=20%  Similarity=0.278  Sum_probs=199.4

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|+..+.||+|++|.||++.+..+++.||+|.++...  ....+.+..|++++++++|+|++++.+.+.    ..+...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            4778899999999999999988889999999986432  233456888999999999999999988642    1234678


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      ++|||+++++|.+++..        .....+++.++..++.+++.|++|||   +.+++||||+|+||+++.++.++|+|
T Consensus        77 lv~e~~~~~~l~~~l~~--------~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~d  145 (257)
T cd08223          77 IVMGFCEGGDLYHKLKE--------QKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGD  145 (257)
T ss_pred             EEecccCCCcHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEec
Confidence            99999999999999853        23345899999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||++..+.....  ......+++.|+|||...+..++.++||||||++++|+++|+.||+...     ............
T Consensus       146 f~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~~~~~  218 (257)
T cd08223         146 LGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRIIEGK  218 (257)
T ss_pred             ccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhcC
Confidence            999986643221  1223457889999999999999999999999999999999999987521     111111111111


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .        .   .........+.+++.+|++.+|++|||+.++++
T Consensus       219 ~--------~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         219 L--------P---PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             C--------C---CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0        0   011234557889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-38  Score=301.17  Aligned_cols=255  Identities=27%  Similarity=0.439  Sum_probs=201.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|.+.+.||+|+||.||+|.. .++..||||.++... ...+++.+|++++++++|+|++++++++.     .....+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~-~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   77 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTW-NGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIY   77 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEE-cCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceE
Confidence            45788899999999999999965 566789999987433 33567999999999999999999998853     344789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++++|.+++..        .....+++.++..++.+++.|+.|||   +.+++|+||||+||++++++.+||+|
T Consensus        78 ~v~e~~~~~~L~~~i~~--------~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d  146 (261)
T cd05034          78 IVTEYMSKGSLLDFLKS--------GEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIAD  146 (261)
T ss_pred             EEEeccCCCCHHHHHhc--------cccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECc
Confidence            99999999999999854        23356899999999999999999999   88999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+++....... ........+..|+|||.+.+..++.++||||||+++||+++ |+.||.....  ....+....... 
T Consensus       147 ~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~~~~~-  222 (261)
T cd05034         147 FGLARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQVERGYR-  222 (261)
T ss_pred             cccceeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC-
Confidence            999986643211 11122334678999999998889999999999999999999 9999865311  111111111100 


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL  493 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~  493 (502)
                               ..    ...+++..+.+++.+|++.+|++||+++++.+.|+.
T Consensus       223 ---------~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 ---------MP----RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ---------CC----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                     00    011235568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-38  Score=299.65  Aligned_cols=254  Identities=24%  Similarity=0.310  Sum_probs=202.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|...+.||.|+||.||+|....+++.+++|++........+.+.+|++++++++|||++++++++     ......++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence            5788889999999999999998888899999998865555567899999999999999999999884     34557899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      +|||+++++|.+++..         ....+++..+..++.|++.|++|||   +.+|+|+||+|+||++++++.+||+||
T Consensus        78 ~~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~  145 (262)
T cd06613          78 VMEYCGGGSLQDIYQV---------TRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADF  145 (262)
T ss_pred             EEeCCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECcc
Confidence            9999999999998842         2245889999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCC---ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH---EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |++.......  .......++..|+|||.....   .++.++||||||+++|||+||+.||........ .......   
T Consensus       146 g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~---  219 (262)
T cd06613         146 GVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKS---  219 (262)
T ss_pred             ccchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhc---
Confidence            9987654322  112335678899999998776   889999999999999999999999875321110 0000000   


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                          ......    ..........+.+++.+|++.+|.+|||+++++.
T Consensus       220 ----~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         220 ----NFPPPK----LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ----cCCCcc----ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                000000    0111234567889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-38  Score=320.45  Aligned_cols=263  Identities=17%  Similarity=0.212  Sum_probs=194.9

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ..+|.+.+.||+|+||.||+|.+...++.||||...      ...+.+|++++++++|+|||++++++.     .+...+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRV-----VGGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEEE
Confidence            457889999999999999999998889999999632      234678999999999999999999853     334789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|||++ .++|.+++..         ....+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus       237 lv~e~~-~~~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~D  303 (461)
T PHA03211        237 LVLPKY-RSDLYTYLGA---------RLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGD  303 (461)
T ss_pred             EEEEcc-CCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcc
Confidence            999999 5788888742         2346899999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccc------cchHHHHH
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN------LNLRNCVK  437 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~------~~~~~~~~  437 (502)
                      ||+++...............||..|+|||++.+..++.++|||||||++|||++|..|+.......      ..+...+.
T Consensus       304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~  383 (461)
T PHA03211        304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR  383 (461)
T ss_pred             cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence            999986643322222334679999999999999999999999999999999999887653311110      11111111


Q ss_pred             hhc---ccc--------hhhhccc----CCCC-cchhh---HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          438 SAL---PER--------AEEIRAS----SGST-QRSII---LECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       438 ~~~---~~~--------~~~~~d~----~~~~-~~~~~---~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ...   .+.        .......    .... .....   ......+.+++.+|++.||.+|||+.|+++.
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            110   000        0000000    0000 00000   0112356789999999999999999999863

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8e-38  Score=303.22  Aligned_cols=252  Identities=23%  Similarity=0.267  Sum_probs=198.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      +.|.+.+.||+|+||.||+|+...++..+++|++........+.+..|+++++.++|||++++++++.     .+...++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence            46788899999999999999998889999999987655555677899999999999999999999853     3447899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++++|..++..         ....+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+||
T Consensus        87 v~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~df  154 (292)
T cd06644          87 MIEFCPGGAVDAIMLE---------LDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADF  154 (292)
T ss_pred             EEecCCCCcHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccC
Confidence            9999999999888742         2345889999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccC-----CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGM-----GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |++.......  .......++..|+|||++.     ...++.++|||||||++|||++|+.||.....     .......
T Consensus       155 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~  227 (292)
T cd06644         155 GVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKI  227 (292)
T ss_pred             ccceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHHHH
Confidence            9987543221  1122345788999999875     34578899999999999999999999865211     1111111


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .....     +...    ........+.+++.+|++.+|++||++.|+++
T Consensus       228 ~~~~~-----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         228 AKSEP-----PTLS----QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             hcCCC-----ccCC----CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000     0000    01133456778999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.4e-38  Score=297.83  Aligned_cols=251  Identities=19%  Similarity=0.257  Sum_probs=202.0

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|+..+.||+|+||.||.++...++..+++|.+....  ....+++.+|++++++++|+||+++++++.     ..+..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence            4778899999999999999988999999999876432  334567889999999999999999999953     345889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      ++|||+++|+|.+++..        .....+++..+..++.+++.|++|||   +.+++|+||+|+||++++++.+||+|
T Consensus        76 ~~~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d  144 (256)
T cd08221          76 IEMEYANGGTLYDKIVR--------QKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGD  144 (256)
T ss_pred             EEEEecCCCcHHHHHHh--------ccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECc
Confidence            99999999999999853        22456889999999999999999999   88999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||++........  ......+++.|+|||+..+..++.++||||||+++|||++|+.||+...     ..+.+...... 
T Consensus       145 ~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~-  216 (256)
T cd08221         145 FGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLVVKIVQG-  216 (256)
T ss_pred             CcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcC-
Confidence            999986644332  1234568899999999988889999999999999999999999986521     11111111111 


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                             .....   .......+.+++.+|++.+|.+||++.|+++.
T Consensus       217 -------~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         217 -------NYTPV---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             -------CCCCC---ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                   00000   12335567899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.3e-38  Score=310.88  Aligned_cols=263  Identities=20%  Similarity=0.207  Sum_probs=193.2

Q ss_pred             CCccccc--CCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEE
Q 046112          210 ENLIGAG--NFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       210 ~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      .++||+|  +|++||++....+|+.||+|+++...  ....+.+.+|+++++.++||||+++++++.     .++..++|
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~lv   77 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWVV   77 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEEE
Confidence            5689999  78899999999999999999987542  223456788999999999999999999853     34578999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeec
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG  365 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg  365 (502)
                      +||+++|+|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++++||+
T Consensus        78 ~e~~~~~~l~~~~~~--------~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~  146 (327)
T cd08227          78 TSFMAYGSAKDLICT--------HFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLR  146 (327)
T ss_pred             EeccCCCcHHHHHHh--------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccc
Confidence            999999999999843        22345889999999999999999999   8999999999999999999999999998


Q ss_pred             cceecccccccc-----eecccccccccccCcccCC--CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          366 IARFLEAADEQT-----RSIGVEGTTGYIAPEYGMG--HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       366 ~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      .+..........     ......++..|+|||++.+  ..++.++|||||||++|||++|+.||....... ........
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~  225 (327)
T cd08227         147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKLNG  225 (327)
T ss_pred             hhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-HHHHHhcC
Confidence            654332111100     0112346778999999876  458999999999999999999999997532211 11111111


Q ss_pred             hcccch-------hhh--------cccCC---------------CCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 046112          439 ALPERA-------EEI--------RASSG---------------STQRSIILECLISICEIGVACSAEQPGERMKINDVE  488 (502)
Q Consensus       439 ~~~~~~-------~~~--------~d~~~---------------~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~  488 (502)
                      ..+...       +++        .+...               ........+....+.+++.+|++.||++|||++|++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell  305 (327)
T cd08227         226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL  305 (327)
T ss_pred             CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence            111000       000        00000               000011123456788999999999999999999998


Q ss_pred             H
Q 046112          489 P  489 (502)
Q Consensus       489 ~  489 (502)
                      +
T Consensus       306 ~  306 (327)
T cd08227         306 N  306 (327)
T ss_pred             c
Confidence            6

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.5e-38  Score=308.08  Aligned_cols=276  Identities=18%  Similarity=0.254  Sum_probs=203.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|...+.||+|+||.||+|.+..++..||+|.++... ......+.+|+.++++++||||+++++++.     .....+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~~   80 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT   80 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeEE
Confidence            46888899999999999999988889999999987433 233456788999999999999999999853     445789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||++ ++|.+++..         ....+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        81 lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~d  147 (301)
T cd07873          81 LVFEYLD-KDLKQYLDD---------CGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLAD  147 (301)
T ss_pred             EEEeccc-cCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECc
Confidence            9999996 689888742         2345788899999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||++........  ......+++.|+|||.+.+. .++.++|||||||++|||+||+.||......  ............
T Consensus       148 fg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~  223 (301)
T cd07873         148 FGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGT  223 (301)
T ss_pred             CcchhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCC
Confidence            999975432221  11234568899999987654 5788999999999999999999999753211  111111111110


Q ss_pred             ----chhhhccc------CCCCc-----chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HHHHHHHHHhhCC
Q 046112          443 ----RAEEIRAS------SGSTQ-----RSIILECLISICEIGVACSAEQPGERMKINDVEP--RLRLIKKKLLEAP  502 (502)
Q Consensus       443 ----~~~~~~d~------~~~~~-----~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~--~L~~i~~~~~~~~  502 (502)
                          ....+...      ..+..     ..........+.+++.+|++.||.+|||++|+++  .++.+.++..+.|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~~~~  300 (301)
T cd07873         224 PTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKLP  300 (301)
T ss_pred             CChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhhcCC
Confidence                00000000      00000     0001123456779999999999999999999987  5566665555443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.2e-38  Score=303.62  Aligned_cols=247  Identities=24%  Similarity=0.358  Sum_probs=197.6

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEE
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      |+..+.||+|+||.||+|.+..++..||+|.++... ....+.+.+|++++++++||||+++++++.     .+...++|
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   80 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWII   80 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEEE
Confidence            445678999999999999888889999999987433 234467899999999999999999999853     44578999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeec
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG  365 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg  365 (502)
                      +||+++++|.+++..           ..+++..+..++.+++.|+.|||   +.+++|+||+|+||++++++.++++|||
T Consensus        81 ~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06642          81 MEYLGGGSALDLLKP-----------GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             EEccCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEcccc
Confidence            999999999998742           35788899999999999999999   8999999999999999999999999999


Q ss_pred             cceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchh
Q 046112          366 IARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAE  445 (502)
Q Consensus       366 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  445 (502)
                      ++..+.....  ......++..|+|||++.+..++.++|||||||++||++||+.|+.......  .....    ..   
T Consensus       147 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~----~~---  215 (277)
T cd06642         147 VAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLI----PK---  215 (277)
T ss_pred             ccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhh----hc---
Confidence            9976543221  1123457889999999999899999999999999999999999987532111  11110    00   


Q ss_pred             hhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          446 EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       446 ~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                          ...   ......++..+.+++.+|++.+|++||++.++++.
T Consensus       216 ----~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         216 ----NSP---PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ----CCC---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                000   01112345668899999999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.1e-38  Score=305.86  Aligned_cols=261  Identities=24%  Similarity=0.288  Sum_probs=199.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|...+.||+|+||.||++.+..++..+|+|.++.... ....++.+|++++.+++||||+++++++.     .++..+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence            368889999999999999999988999999999875422 23456889999999999999999999853     345899


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceeecCCCCCeeeCCCCcEEEe
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ-PPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      +|+||+++++|.++++.          ...+++..+..++.|++.||+|||   + .+++||||||+||+++.++.+||+
T Consensus        76 lv~ey~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~  142 (308)
T cd06615          76 ICMEHMDGGSLDQVLKK----------AGRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLC  142 (308)
T ss_pred             EEeeccCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEc
Confidence            99999999999999843          245788899999999999999999   5 589999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      |||++.......    .....++..|+|||...+..++.++|||||||++||+++|+.||.....  .....+.......
T Consensus       143 dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~  216 (308)
T cd06615         143 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSE  216 (308)
T ss_pred             cCCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCcccc
Confidence            999987553221    1234678999999999888899999999999999999999999864211  1111111111000


Q ss_pred             c-------------------------hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          443 R-------------------------AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       443 ~-------------------------~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                      .                         ...+.....+..+.  ......+.+++.+|+..+|++|||+.|+++.-
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         217 GEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPS--GAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             ccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcC--cccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            0                         00000000000000  01345688999999999999999999998763

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-38  Score=312.26  Aligned_cols=269  Identities=19%  Similarity=0.241  Sum_probs=197.9

Q ss_pred             HHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeeccccccc-C
Q 046112          201 YNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-Q  277 (502)
Q Consensus       201 ~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~  277 (502)
                      ....++|...+.||+|+||.||+|.+..++..||||+++....  ...+.+.+|++++++++||||+++++++..... .
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            3456789999999999999999999888999999999864321  234567789999999999999999987643211 1


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                      .....++++|++ +++|.+++..           ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~  155 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC-----------QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDC  155 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCC
Confidence            224578999988 8899887632           34889999999999999999999   89999999999999999999


Q ss_pred             cEEEeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          358 TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                      .+||+|||+++.....     .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+..+.
T Consensus       156 ~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~  229 (343)
T cd07878         156 ELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIM  229 (343)
T ss_pred             CEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHH
Confidence            9999999999865432     224568999999999877 56899999999999999999999999652110 0111111


Q ss_pred             Hhhc---ccchhhhc-------ccCCCCcch-----hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          437 KSAL---PERAEEIR-------ASSGSTQRS-----IILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       437 ~~~~---~~~~~~~~-------d~~~~~~~~-----~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ....   .+....+.       .........     ........+.+++.+|++.||.+|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         230 EVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000   00000000       000000000     001123356799999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.8e-38  Score=299.48  Aligned_cols=253  Identities=20%  Similarity=0.294  Sum_probs=193.8

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-----chhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-----DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .+|...+.||+|+||.||+|....++..|++|+++....     .....+.+|+.++++++||||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence            478889999999999999998888899999998864321     223568889999999999999999987532   123


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++++||+++++|.+++..          ...+++.....++.|++.||+|||   +.+|+||||+|+||+++.++.+
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~  145 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKA----------YGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNV  145 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCE
Confidence            467899999999999999842          234788899999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccc-cceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADE-QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      ||+|||+++....... ........++..|+|||++.+..++.++|||||||++||+++|+.||.....     ...+..
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----~~~~~~  220 (266)
T cd06651         146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----MAAIFK  220 (266)
T ss_pred             EEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-----HHHHHH
Confidence            9999999976543211 1111234578899999999998899999999999999999999999975311     111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .....    ..      ..+.......+..++ +|+..+|++||+++|+++
T Consensus       221 ~~~~~----~~------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         221 IATQP----TN------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HhcCC----CC------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            10000    00      111112233444555 688899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.5e-38  Score=326.31  Aligned_cols=265  Identities=20%  Similarity=0.283  Sum_probs=192.1

Q ss_pred             HHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCC------Cccceeeeccc
Q 046112          199 MLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRH------RNLVKVFTACS  272 (502)
Q Consensus       199 ~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~  272 (502)
                      ++...+++|.+.++||+|+||+||+|.+...++.||||+++... ....++..|+++++.++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34445678999999999999999999988889999999986432 223455667777776654      45788887753


Q ss_pred             ccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceeecCCCCCe
Q 046112          273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ-PPIAHCDLKPSNI  351 (502)
Q Consensus       273 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~i~H~dlk~~NI  351 (502)
                          ......++|||++ +++|.+++..          ...+++..+..++.|++.||+|||   . .+|+||||||+||
T Consensus       202 ----~~~~~~~iv~~~~-g~~l~~~l~~----------~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NI  263 (467)
T PTZ00284        202 ----NETGHMCIVMPKY-GPCLLDWIMK----------HGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENI  263 (467)
T ss_pred             ----cCCceEEEEEecc-CCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHE
Confidence                2334788999988 7888888742          246889999999999999999999   6 5999999999999


Q ss_pred             eeCCCC----------------cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHH
Q 046112          352 LLDDEM----------------TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEM  415 (502)
Q Consensus       352 ll~~~~----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el  415 (502)
                      |++.++                .+||+|||.+.....     ......||+.|+|||++.+..++.++|||||||++|||
T Consensus       264 Ll~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~el  338 (467)
T PTZ00284        264 LMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL  338 (467)
T ss_pred             EEecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHH
Confidence            998765                499999998753221     12346789999999999999999999999999999999


Q ss_pred             HhCCCCCccccccccchHHHHHhhc---cc-c--------hhhhcccCCC---------------CcchhhHHHHHHHHH
Q 046112          416 FTGLRPSDDMFKDNLNLRNCVKSAL---PE-R--------AEEIRASSGS---------------TQRSIILECLISICE  468 (502)
Q Consensus       416 ~tg~~p~~~~~~~~~~~~~~~~~~~---~~-~--------~~~~~d~~~~---------------~~~~~~~~~~~~l~~  468 (502)
                      ++|+.||+....  ......+...+   +. +        ..++.+....               ............+.+
T Consensus       339 ltG~~pf~~~~~--~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  416 (467)
T PTZ00284        339 YTGKLLYDTHDN--LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCD  416 (467)
T ss_pred             HhCCCCCCCCCh--HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHH
Confidence            999999975321  11111111111   00 0        0001100000               000000011345779


Q ss_pred             HHhhcccCCCCCCCCHHHHHH
Q 046112          469 IGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       469 l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      |+.+|++.||++|||++|+++
T Consensus       417 li~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        417 LIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHHhCCcChhhCCCHHHHhc
Confidence            999999999999999999986

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.8e-38  Score=305.41  Aligned_cols=251  Identities=22%  Similarity=0.278  Sum_probs=200.7

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ..+|+..+.||+|+||.||+|....++..||+|.+........+.+..|+.+++.++|+|++++++++.     .++..+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEE
Confidence            357888999999999999999888899999999987655555577889999999999999999999853     345889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++++|.+++..           ..+++.++..++.+++.||.|||   +.+++||||||+||+++.++.++|+|
T Consensus        93 lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~D  158 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTD  158 (297)
T ss_pred             EeecccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECc
Confidence            99999999999998742           34788899999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||++.........  .....+++.|+|||...+..++.++|||||||++|++++|+.||........ ...         
T Consensus       159 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-~~~---------  226 (297)
T cd06656         159 FGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL---------  226 (297)
T ss_pred             CccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-eee---------
Confidence            9999765433221  1234578899999999998899999999999999999999999965211110 000         


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                         +...... ...........+.+++.+|+..+|++||++.++++
T Consensus       227 ---~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         227 ---IATNGTP-ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ---eccCCCC-CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0000000 00001233455778999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-38  Score=296.04  Aligned_cols=248  Identities=29%  Similarity=0.403  Sum_probs=194.4

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeec
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFM  289 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  289 (502)
                      ++||+|+||.||++.+.. ++.||+|.++..... ....+..|++++++++|+||+++++++.     .....++|+||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence            478999999999997766 999999998754333 4567899999999999999999999853     344789999999


Q ss_pred             cCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          290 ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       290 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                      ++++|.+++..         ....+++..+..++.+++.|++|||   +.+++||||+|+||+++.++.+||+|||++..
T Consensus        75 ~~~~l~~~l~~---------~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~  142 (251)
T cd05041          75 PGGSLLTFLRK---------KKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRE  142 (251)
T ss_pred             CCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeecccccc
Confidence            99999999842         2235788899999999999999999   89999999999999999999999999999975


Q ss_pred             cccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccchhhhc
Q 046112          370 LEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAEEIR  448 (502)
Q Consensus       370 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  448 (502)
                      ...............+..|+|||.+.+..++.++|||||||++||++| |..||.....  ......+....        
T Consensus       143 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~~~~~~--------  212 (251)
T cd05041         143 EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRERIESGY--------  212 (251)
T ss_pred             ccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHHHHhcCC--------
Confidence            432111111112234567999999998899999999999999999999 8888865321  11111111100        


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          449 ASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       449 d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                            .......++..+.+++.+|++.+|++|||+.|+++.|+
T Consensus       213 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         213 ------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence                  00011234567889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-38  Score=301.56  Aligned_cols=249  Identities=24%  Similarity=0.346  Sum_probs=199.8

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|...+.||.|++|.||+|.+..++..||+|++.... ......+.+|+++++.++|+|++++++++.     .+...+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence            35777889999999999999998899999999987543 333467889999999999999999999853     345889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||+++++|.+++..           ..+++.....++.|++.|+.|||   +.+++||||+|+||++++++.++|+|
T Consensus        76 ~v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d  141 (274)
T cd06609          76 IIMEYCGGGSCLDLLKP-----------GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLAD  141 (274)
T ss_pred             EEEEeeCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcc
Confidence            99999999999999853           26889999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||+++.+.....  ......++..|+|||++.+..++.++|||||||++||++||+.||.....  ......+..   ..
T Consensus       142 ~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~---~~  214 (274)
T cd06609         142 FGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--MRVLFLIPK---NN  214 (274)
T ss_pred             cccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--HHHHHHhhh---cC
Confidence            999987654321  12234578899999999998899999999999999999999999975321  111100000   00


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..     .....     .....+.+++.+|+..+|++|||++++++
T Consensus       215 ~~-----~~~~~-----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         215 PP-----SLEGN-----KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CC-----CCccc-----ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            00     00000     13456788999999999999999999965

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.5e-37  Score=295.94  Aligned_cols=256  Identities=20%  Similarity=0.286  Sum_probs=185.2

Q ss_pred             CcccccCCceEEEEEEcCC--CeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEee
Q 046112          211 NLIGAGNFGSVYKGILFES--TTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE  287 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  287 (502)
                      +.||+|+||.||+|....+  ...+++|.++... ....+.+.+|+..++.++||||++++++|..     ....++|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEe
Confidence            3699999999999965433  2356677665433 2345679999999999999999999998643     347899999


Q ss_pred             eccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccc
Q 046112          288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA  367 (502)
Q Consensus       288 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a  367 (502)
                      |+++|+|.++++...      ......++.....++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~  146 (268)
T cd05086          76 YCELGDLKSYLSQEQ------WHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIG  146 (268)
T ss_pred             cCCCCcHHHHHHhhh------cccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccc
Confidence            999999999986411      12234667778899999999999999   899999999999999999999999999998


Q ss_pred             eecccccccceecccccccccccCcccCC-------CccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhh
Q 046112          368 RFLEAADEQTRSIGVEGTTGYIAPEYGMG-------HEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       368 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ................++..|+|||+...       ..++.++|||||||++|||++ |..||.....     .+.....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~  221 (268)
T cd05086         147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHV  221 (268)
T ss_pred             cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH
Confidence            64322221122234557889999998753       345789999999999999997 5778764211     1111111


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                      ..+....+.++....      .....+.+++..|| .+|++||++++|++.|.
T Consensus       222 ~~~~~~~~~~~~~~~------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         222 IKDQQVKLFKPQLEL------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HhhcccccCCCccCC------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            111111222222211      12345667888999 57999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.2e-38  Score=314.63  Aligned_cols=268  Identities=20%  Similarity=0.199  Sum_probs=197.7

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccc-cCCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVD-FQGN  279 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~  279 (502)
                      ..++|...+.||+|+||.||++.+...++.||||+++...  ......+.+|+.+++.++||||+++++++.... ....
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4568999999999999999999888889999999987432  223466788999999999999999999864322 1223


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++||||+++ +|.+.+.            ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~  158 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL  158 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCE
Confidence            457999999964 6666552            23778888999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||+++......   ......+|..|+|||++.+..++.++|||||||++|||++|+.||....... .+...+...
T Consensus       159 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~  234 (355)
T cd07874         159 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQL  234 (355)
T ss_pred             EEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence            999999997543221   1233568999999999999999999999999999999999999997521100 011000000


Q ss_pred             ----------cccchhhh----------------cccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          440 ----------LPERAEEI----------------RASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       440 ----------~~~~~~~~----------------~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                                .......+                .+................+.+++.+|++.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                      00000000                0000000000011224567899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.8e-38  Score=304.23  Aligned_cols=256  Identities=25%  Similarity=0.293  Sum_probs=201.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|+..+.||+|+||+||++.+..+++.||+|++.... ....+.+.+|+++++.++||||+++++++.     .....+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence            45677889999999999999988889999999876443 233567899999999999999999999954     335889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++++|.+++..          .+.+++.....++.+++.|+.|||+  ..+++||||+|+||++++++.++|+|
T Consensus        80 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d  147 (284)
T cd06620          80 MCMEFMDCGSLDRIYKK----------GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCD  147 (284)
T ss_pred             EEEecCCCCCHHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEcc
Confidence            99999999999998742          3458899999999999999999993  25899999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccc------cchHHHHH
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN------LNLRNCVK  437 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~------~~~~~~~~  437 (502)
                      ||++.......    .....|+..|+|||++.+..++.++|||||||++||++||+.||+......      .....+..
T Consensus       148 ~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  223 (284)
T cd06620         148 FGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ  223 (284)
T ss_pred             CCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH
Confidence            99986543221    123468899999999988899999999999999999999999997633211      11112222


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                      .....        ......  ..+++..+.+++.+|++.||++|||+.|+++..
T Consensus       224 ~~~~~--------~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         224 QIVQE--------PPPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             HHhhc--------cCCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            21111        000000  113556788999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.7e-38  Score=298.76  Aligned_cols=250  Identities=22%  Similarity=0.296  Sum_probs=200.8

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|+..+.||+|+||.+|++....+++.||+|.++...  ....+++.+|+.++++++||||+++++++     ...+..+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            4778899999999999999988899999999986432  23346789999999999999999999984     4455899


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||+++++|.+++..        .....+++.+...++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|
T Consensus        76 lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d  144 (256)
T cd08218          76 IVMDYCEGGDLYKKINA--------QRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGD  144 (256)
T ss_pred             EEEecCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEee
Confidence            99999999999998853        22345788999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||++.........  .....++..|+|||+..+..++.++|||||||+++|+++|+.||...     ...+.+.......
T Consensus       145 ~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~~~  217 (256)
T cd08218         145 FGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NMKNLVLKIIRGS  217 (256)
T ss_pred             ccceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----CHHHHHHHHhcCC
Confidence            9999765432221  12345788999999999989999999999999999999999998642     1112221111111


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .        .   .........+.+++.+|++.+|.+||++.||++
T Consensus       218 ~--------~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 Y--------P---PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             C--------C---CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            0        0   011234566889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-39  Score=315.94  Aligned_cols=245  Identities=24%  Similarity=0.342  Sum_probs=202.1

Q ss_pred             cccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeeccC
Q 046112          212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMAN  291 (502)
Q Consensus       212 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~  291 (502)
                      +||+|.||+||.|++..+...+|||-+........+-+.+|+.+-++++|.|||+++|.|.     .+.+.-|.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s-----enGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS-----ENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC-----CCCeEEEEeecCCC
Confidence            6999999999999999999999999998766666778999999999999999999999964     34478899999999


Q ss_pred             CChhhhccCCchhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC-CCCcEEEeeeccce
Q 046112          292 GSLEEWMHPITEEDKRHKAPGNL--NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIAR  368 (502)
Q Consensus       292 gsL~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~-~~~~~kl~Dfg~a~  368 (502)
                      |||.+.+..         .-+++  .+.+.-.+.+||++||.|||   +..|||||||-.|||++ -.|.+||+|||-++
T Consensus       657 GSLSsLLrs---------kWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsK  724 (1226)
T KOG4279|consen  657 GSLSSLLRS---------KWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSK  724 (1226)
T ss_pred             CcHHHHHHh---------ccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccch
Confidence            999999953         33445  67788889999999999999   99999999999999995 67899999999887


Q ss_pred             ecccccccceecccccccccccCcccCCC--ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhh
Q 046112          369 FLEAADEQTRSIGVEGTTGYIAPEYGMGH--EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       369 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      .+..-  ...+....||..|||||++-.+  .|..++|||||||++.||.||++||-...+....+.             
T Consensus       725 RLAgi--nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF-------------  789 (1226)
T KOG4279|consen  725 RLAGI--NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF-------------  789 (1226)
T ss_pred             hhccC--CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh-------------
Confidence            65322  2333456799999999998865  488999999999999999999999976432211111             


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                       .-...+..++++++...+...++++|+.+||.+||+++++++
T Consensus       790 -kVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  790 -KVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             -hhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence             112223345556677778889999999999999999999875

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.4e-39  Score=304.33  Aligned_cols=240  Identities=23%  Similarity=0.337  Sum_probs=185.0

Q ss_pred             CcccccCCceEEEEEEcCCCe-------EEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          211 NLIGAGNFGSVYKGILFESTT-------AVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +.||+|+||.||+|.....+.       .|++|.+........+.+.+|+.+++.++|||++++++++..     +...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence            469999999999997754433       488888765444445678899999999999999999998643     34789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc-----
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT-----  358 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~-----  358 (502)
                      +||||+++|+|.++++.         ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.     
T Consensus        76 lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~  143 (258)
T cd05078          76 MVQEYVKFGSLDTYLKK---------NKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGN  143 (258)
T ss_pred             EEEecCCCCcHHHHHhc---------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCC
Confidence            99999999999999853         2235789999999999999999999   899999999999999987765     


Q ss_pred             ---EEEeeeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCC-CCCccccccccchH
Q 046112          359 ---AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGL-RPSDDMFKDNLNLR  433 (502)
Q Consensus       359 ---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~-~p~~~~~~~~~~~~  433 (502)
                         ++++|||++......      ....++..|+|||++.+. .++.++|||||||++||+++|. .|+......  ...
T Consensus       144 ~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~~~  215 (258)
T cd05078         144 PPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKL  215 (258)
T ss_pred             CceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--HHH
Confidence               699999988654322      124578889999998874 5799999999999999999985 555431110  001


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                      .....            ...    ........+.+++.+|++.||++|||++++++.|
T Consensus       216 ~~~~~------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         216 QFYED------------RHQ----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             HHHHc------------ccc----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            10000            000    0011234578999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.3e-38  Score=314.08  Aligned_cols=268  Identities=19%  Similarity=0.178  Sum_probs=197.6

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccc-cCCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVD-FQGN  279 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~  279 (502)
                      ..++|...+.||+|+||.||++.+...++.||||++....  ....+.+.+|+.+++.++||||+++++++.... ....
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3568999999999999999999988899999999987432  233467888999999999999999998764322 1233


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++||||+++ +|.+.+.            ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  165 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL  165 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH------------hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcE
Confidence            467999999964 6766652            23678888999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||+++......   ......+|..|+|||++.+..++.++|||||||++|||++|+.||...... ..+...+...
T Consensus       166 kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~  241 (364)
T cd07875         166 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQL  241 (364)
T ss_pred             EEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc
Confidence            999999997653321   123356899999999999999999999999999999999999999753111 0111111000


Q ss_pred             c----------ccchhhhccc----------------CCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          440 L----------PERAEEIRAS----------------SGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       440 ~----------~~~~~~~~d~----------------~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      -          ..........                ..+............+.+++.+|++.||.+|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0          0000000000                0000000001123467899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.4e-38  Score=307.57  Aligned_cols=205  Identities=22%  Similarity=0.279  Sum_probs=162.0

Q ss_pred             CCcccccCCceEEEEEEc--CCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEee
Q 046112          210 ENLIGAGNFGSVYKGILF--ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE  287 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  287 (502)
                      +++||+|+||+||+|...  .+++.+|+|.++...  ....+.+|++++++++||||+++++++..   ..+...++++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence            468999999999999764  366889999986432  23567889999999999999999987532   23446889999


Q ss_pred             eccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee----CCCCcEEEee
Q 046112          288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL----DDEMTAYVSD  363 (502)
Q Consensus       288 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll----~~~~~~kl~D  363 (502)
                      |+. ++|.+++....... .......+++.....++.|++.||.|||   +.+|+||||||+|||+    +.++.+||+|
T Consensus        81 ~~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07868          81 YAE-HDLWHIIKFHRASK-ANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             ccC-CCHHHHHHhccccc-ccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence            985 58888764311110 1122345889999999999999999999   8999999999999999    4567999999


Q ss_pred             eccceecccccc-cceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          364 FGIARFLEAADE-QTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       364 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      ||+++....... ........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            999987643322 112234668999999999877 4589999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-38  Score=303.89  Aligned_cols=254  Identities=22%  Similarity=0.302  Sum_probs=200.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|.+.+.||+|+||.||+|.+..++..+|+|+++.......+.+..|++++++++|||++++++++.     .+...+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence            456888899999999999999888889999999987655555677999999999999999999999853     345789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++++|.+++..         ....+++.....++.|++.|+.|||   +.+|+|+||+|+||+++.++.++|+|
T Consensus        79 lv~e~~~~~~L~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d  146 (280)
T cd06611          79 ILIEFCDGGALDSIMLE---------LERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLAD  146 (280)
T ss_pred             EEeeccCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEcc
Confidence            99999999999999842         2345889999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccC-----CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGM-----GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      ||++........  ......+++.|+|||.+.     ...++.++||||||+++|||++|+.||...... ..+..+...
T Consensus       147 ~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~  223 (280)
T cd06611         147 FGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILKS  223 (280)
T ss_pred             Cccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhcC
Confidence            999865432211  122345789999999875     345788999999999999999999998753111 011111000


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      .    .     +.    ..........+.+++.+|++.+|.+||++.++++.
T Consensus       224 ~----~-----~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         224 E----P-----PT----LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             C----C-----CC----cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0    0     00    00011234567789999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.9e-38  Score=299.77  Aligned_cols=265  Identities=23%  Similarity=0.368  Sum_probs=199.6

Q ss_pred             CCCCCcccccCCceEEEEEEcC---CCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCC-Cc
Q 046112          207 FSSENLIGAGNFGSVYKGILFE---STTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG-ND  280 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-~~  280 (502)
                      |...+.||+|+||.||+|.+..   ++..||||+++...  ....+++.+|++++++++|||++++++++......+ ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            5567899999999999997543   46899999987532  223467889999999999999999999864322111 12


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++++||+++|+|.+++.....    ......+++.....++.|++.|++|||   +.+|+||||||+||+++.++.+|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~----~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~k  153 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRI----GEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVC  153 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcc----cCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEE
Confidence            34789999999999988742110    122335788999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++...............+++.|++||.+....++.++|||||||++||+++ |+.||.....  .....++...
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~  231 (273)
T cd05074         154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKG  231 (273)
T ss_pred             ECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcC
Confidence            999999986543322222223345678999999998889999999999999999999 8899865321  1111111110


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      .          ....    ...+...+.+++.+|++.+|++||++.++++.|+.+
T Consensus       232 ~----------~~~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 N----------RLKQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             C----------cCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0          0000    113346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8.2e-39  Score=319.33  Aligned_cols=202  Identities=25%  Similarity=0.362  Sum_probs=172.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|+..+.||+|+||.||++....+++.||+|+++..   .......+..|++++..++||||+++++.+     ...+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            3678889999999999999999889999999998642   223345678899999999999999999884     45568


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL  142 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMK----------KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKL  142 (360)
T ss_pred             EEEEEeCCCCccHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEE
Confidence            9999999999999999842          345888999999999999999999   999999999999999999999999


Q ss_pred             eeeccceeccccccc---------------------------------ceecccccccccccCcccCCCccCccccchhH
Q 046112          362 SDFGIARFLEAADEQ---------------------------------TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSF  408 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~  408 (502)
                      +|||++..+......                                 .......||+.|+|||++.+..++.++|||||
T Consensus       143 ~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl  222 (360)
T cd05627         143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL  222 (360)
T ss_pred             eeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccc
Confidence            999998754321100                                 00123568999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCcc
Q 046112          409 GILLLEMFTGLRPSDD  424 (502)
Q Consensus       409 Gv~l~el~tg~~p~~~  424 (502)
                      ||++|||+||+.||..
T Consensus       223 Gvilyel~tG~~Pf~~  238 (360)
T cd05627         223 GVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cceeeecccCCCCCCC
Confidence            9999999999999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.7e-38  Score=296.96  Aligned_cols=238  Identities=24%  Similarity=0.361  Sum_probs=187.7

Q ss_pred             CcccccCCceEEEEEEcCCC----------eEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          211 NLIGAGNFGSVYKGILFEST----------TAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      +.||+|+||.||+|.....+          ..|++|+++..... ...+.+|+.++++++|||+++++++|..      .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence            46899999999999887665          35788887654333 6788999999999999999999998743      3


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC---
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM---  357 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~---  357 (502)
                      ..++|+||+++|+|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++   
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~  141 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHR---------EKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNE  141 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCcccc
Confidence            57899999999999999853         1226889999999999999999999   89999999999999999887   


Q ss_pred             ----cEEEeeeccceecccccccceecccccccccccCcccCCC--ccCccccchhHHHHHHHHHh-CCCCCcccccccc
Q 046112          358 ----TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH--EVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNL  430 (502)
Q Consensus       358 ----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~  430 (502)
                          .+||+|||++......      ....++..|+|||++.+.  .++.++|||||||++||+++ |..|+.....  .
T Consensus       142 ~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~  213 (259)
T cd05037         142 GYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--S  213 (259)
T ss_pred             CCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--h
Confidence                7999999999765431      123466789999998876  78999999999999999999 5777765321  1


Q ss_pred             chHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          431 NLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                      ....+..           ........     ....+.+++.+|+..+|.+|||+.|+++.|
T Consensus       214 ~~~~~~~-----------~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         214 EKERFYQ-----------DQHRLPMP-----DCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             hHHHHHh-----------cCCCCCCC-----CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            1111111           00000001     115778999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-40  Score=295.75  Aligned_cols=249  Identities=24%  Similarity=0.292  Sum_probs=205.6

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      |.+.++||+|+||+||+|.+.++|..||+|.+...  ...+++..|+.++++.+.|++|+++|.+     ..+..+++||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSY-----FK~sDLWIVM  107 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSY-----FKHSDLWIVM  107 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhh-----ccCCceEeeh
Confidence            55678999999999999999999999999987653  3467899999999999999999999985     3445899999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      |||-.||..+.++         ....++.+.+...++...++||+|||   ...-+|||||+.||||+-+|.+||+|||.
T Consensus       108 EYCGAGSiSDI~R---------~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGV  175 (502)
T KOG0574|consen  108 EYCGAGSISDIMR---------ARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGV  175 (502)
T ss_pred             hhcCCCcHHHHHH---------HhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccc
Confidence            9999999999985         45678999999999999999999999   77789999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      |..+..  +......+.||+.|||||++..-.|+.++||||+|++..||..|++||.+.....              ...
T Consensus       176 AGQLTD--TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR--------------AIF  239 (502)
T KOG0574|consen  176 AGQLTD--TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR--------------AIF  239 (502)
T ss_pred             cchhhh--hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc--------------eeE
Confidence            975532  3333456889999999999999899999999999999999999999998742211              001


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ++....+.-..-+++-..++-+++++|+-+.|++|-|+.++++.
T Consensus       240 MIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  240 MIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             eccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            11111111111134567788899999999999999999988763

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-38  Score=312.68  Aligned_cols=193  Identities=24%  Similarity=0.344  Sum_probs=163.1

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ...+|.+.+.||+|+||.||+|....++..||+|+...      .....|+.++++++||||+++++++.     .....
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~  132 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLV-----SGAIT  132 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEE-----eCCee
Confidence            34579999999999999999999888889999997542      22356899999999999999999854     34478


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++|+||+ .++|.+++.         .....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus       133 ~lv~e~~-~~~l~~~l~---------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~  199 (357)
T PHA03209        133 CMVLPHY-SSDLYTYLT---------KRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIG  199 (357)
T ss_pred             EEEEEcc-CCcHHHHHH---------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEe
Confidence            9999999 568888874         23356899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCC
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS  422 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~  422 (502)
                      |||+++.....   .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       200 DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        200 DLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cCccccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            99999753221   1223456899999999999999999999999999999999865554

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=9.5e-38  Score=297.44  Aligned_cols=253  Identities=26%  Similarity=0.397  Sum_probs=199.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|...+.||+|+||.||+|.. ..+..+|+|.++.. ......+.+|++++++++|+|++++.+++..      ...++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~   77 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI   77 (260)
T ss_pred             cceeEEeEecCccceEEEEEEe-cCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence            5678889999999999999964 56677999987643 2234678899999999999999999988532      46799


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      +|||+++|+|.+++..        .....+++.++..++.+++.||.|||   +.+++||||+|+||+++.++.+||+||
T Consensus        78 v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~  146 (260)
T cd05073          78 ITEFMAKGSLLDFLKS--------DEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADF  146 (260)
T ss_pred             EEEeCCCCcHHHHHHh--------CCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCC
Confidence            9999999999999853        23445788899999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |.+........ .......++..|+|||++....++.++|||||||++||++| |+.||.....  .....+......  
T Consensus       147 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~--  221 (260)
T cd05073         147 GLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYR--  221 (260)
T ss_pred             cceeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCC--
Confidence            99976543221 11223345678999999998889999999999999999999 9999875311  112222111100  


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL  493 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~  493 (502)
                              ..    .....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus       222 --------~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 --------MP----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             --------CC----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                    00    011334568899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.7e-39  Score=283.74  Aligned_cols=252  Identities=23%  Similarity=0.354  Sum_probs=201.3

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcch----h----HHHHHHHHHHhcC-CCCccceeeeccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA----S----KSFAVECEVTRNI-RHRNLVKVFTACSGV  274 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~----~~~~~E~~~l~~l-~h~niv~l~~~~~~~  274 (502)
                      ...|...+.+|.|..++|-++...++|...|+|++.......    .    +.-..|+.+++++ .||+|+.+.++    
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~----   91 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV----   91 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee----
Confidence            356777889999999999999899999999999987433211    1    3456799999998 59999999998    


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                       ++.+.+.++|+|.|+.|.|.|+|          ...-.+++....+|..|+..|++|||   ...||||||||+|||+|
T Consensus        92 -yes~sF~FlVFdl~prGELFDyL----------ts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILld  157 (411)
T KOG0599|consen   92 -YESDAFVFLVFDLMPRGELFDYL----------TSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLD  157 (411)
T ss_pred             -ccCcchhhhhhhhcccchHHHHh----------hhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeec
Confidence             55666999999999999999999          44567899999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCC------CccCccccchhHHHHHHHHHhCCCCCcccccc
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG------HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD  428 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~  428 (502)
                      ++.++||+|||+|+.+.+....   ...+||++|+|||.+..      ..|+...|+||.||+||.|+.|.+||-...  
T Consensus       158 dn~~i~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--  232 (411)
T KOG0599|consen  158 DNMNIKISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--  232 (411)
T ss_pred             cccceEEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--
Confidence            9999999999999987765432   35789999999998653      357888999999999999999999984310  


Q ss_pred             ccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          429 NLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                        ++.  .-.++.+-..++       ..+...+......+|+.+|++.||++|.|++|+++
T Consensus       233 --Qml--MLR~ImeGkyqF-------~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  233 --QML--MLRMIMEGKYQF-------RSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             --HHH--HHHHHHhccccc-------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence              000  001111111111       11223455666779999999999999999999875

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.6e-38  Score=299.75  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=196.4

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc----------hhHHHHHHHHHHhcCCCCccceeeecccccc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD----------ASKSFAVECEVTRNIRHRNLVKVFTACSGVD  275 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  275 (502)
                      +|...+.||+|+||.||+|....+++.+|+|.++.....          ..+.+..|+++++.++|||++++++++.   
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---   78 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET---   78 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence            466788999999999999988888999999987532110          1245788999999999999999999854   


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD  355 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~  355 (502)
                        ..+..++|+||+++|+|.+++..          ...+++..+..++.+++.|+.|||   +.+++||||+|+||+++.
T Consensus        79 --~~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~  143 (272)
T cd06629          79 --TEEYLSIFLEYVPGGSIGSCLRT----------YGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDA  143 (272)
T ss_pred             --cCCceEEEEecCCCCcHHHHHhh----------ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcC
Confidence              34578999999999999999853          245888899999999999999999   899999999999999999


Q ss_pred             CCcEEEeeeccceecccccccceecccccccccccCcccCCCc--cCccccchhHHHHHHHHHhCCCCCccccccccchH
Q 046112          356 EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE--VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR  433 (502)
Q Consensus       356 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~  433 (502)
                      ++.++++|||+++...............++..|+|||......  ++.++||||||+++||+++|+.||.....    ..
T Consensus       144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~  219 (272)
T cd06629         144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IA  219 (272)
T ss_pred             CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HH
Confidence            9999999999997654322222223455789999999987654  88999999999999999999999864211    11


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .............+       ......+....+.+++.+|+..+|++|||+.+|++
T Consensus       220 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         220 AMFKLGNKRSAPPI-------PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             HHHHhhccccCCcC-------CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            11110000000000       01111234567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-37  Score=298.80  Aligned_cols=261  Identities=25%  Similarity=0.286  Sum_probs=201.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|...+.||.|++|.||++....+++.+|+|.+..... .....+.+|++++++++||||++++++|..   ......+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence            357778899999999999999888899999999875432 345678999999999999999999998643   2344689


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++++|.+++....      .....+++.....++.+++.||+|||   +.+++|+||+|+||++++++.++|+|
T Consensus        78 lv~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d  148 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVK------KRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCD  148 (287)
T ss_pred             EEEEecCCCCHHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEee
Confidence            9999999999998874311      23455788899999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccccc---ccchHHHHHhhc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD---NLNLRNCVKSAL  440 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~  440 (502)
                      ||++........    ....++..|+|||.+.+..++.++|||||||++|||++|+.||+.....   ......+.....
T Consensus       149 fg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  224 (287)
T cd06621         149 FGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP  224 (287)
T ss_pred             cccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence            999865432211    1234688899999999999999999999999999999999999764221   112222211110


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                         ...+.+     ...........+.+++.+|++.+|.+|||+.|+++
T Consensus       225 ---~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         225 ---NPELKD-----EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             ---chhhcc-----CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence               001100     00000123456889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-38  Score=336.21  Aligned_cols=260  Identities=19%  Similarity=0.259  Sum_probs=199.1

Q ss_pred             HhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       202 ~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      ...++|.+.+.||+|+||+||+|.+..++..||+|++....  ......+..|+.++++++|||||++++++..   ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KAN   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cCC
Confidence            34568999999999999999999999999999999987432  2334678899999999999999999997532   233


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----CCCceeecCCCCCeeeCC
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDC----QPPIAHCDLKPSNILLDD  355 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----~~~i~H~dlk~~NIll~~  355 (502)
                      ...++||||+++|+|.+++....      .....+++..++.|+.||+.||+|||...    ..+|+||||||+|||++.
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s  160 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCY------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST  160 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence            46899999999999999985311      22356899999999999999999999422    156999999999999964


Q ss_pred             -----------------CCcEEEeeeccceecccccccceecccccccccccCcccCC--CccCccccchhHHHHHHHHH
Q 046112          356 -----------------EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG--HEVSSYGDVYSFGILLLEMF  416 (502)
Q Consensus       356 -----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvws~Gv~l~el~  416 (502)
                                       ...+||+|||++..+....   ......||+.|+|||++.+  ..++.++|||||||++|||+
T Consensus       161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL  237 (1021)
T PTZ00266        161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC  237 (1021)
T ss_pred             CccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence                             2358999999997653321   1234568999999999864  45889999999999999999


Q ss_pred             hCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          417 TGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       417 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ||+.||....    .....+......       +...     .......+.+|+..||..+|.+||++.|++.
T Consensus       238 TGk~PF~~~~----~~~qli~~lk~~-------p~lp-----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        238 SGKTPFHKAN----NFSQLISELKRG-------PDLP-----IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HCCCCCCcCC----cHHHHHHHHhcC-------CCCC-----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            9999996521    112211111000       0000     0122456789999999999999999999984

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.5e-37  Score=295.38  Aligned_cols=252  Identities=29%  Similarity=0.477  Sum_probs=199.2

Q ss_pred             CCCCCcccccCCceEEEEEEcCCC----eEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          207 FSSENLIGAGNFGSVYKGILFEST----TAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++..+.||.|+||.||++.+...+    ..||+|+++..... ..+.+..|++.+..++|+|++++++++..     .+.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCe
Confidence            356789999999999999887665    89999998755433 46789999999999999999999998643     357


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .+++|||+++++|.+++..        .....+++.++..++.|++.|++|||   +.+++||||+|+||++++++.++|
T Consensus        76 ~~~i~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l  144 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRK--------NRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKI  144 (258)
T ss_pred             eEEEEeccCCCCHHHHHHh--------hhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEE
Confidence            8999999999999999853        11222899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      +|||+++........... ...+++.|+|||...+..++.++||||+|++++||++ |+.||...  ......+.+....
T Consensus       145 ~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~~~~~  221 (258)
T smart00219      145 SDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--SNEEVLEYLKKGY  221 (258)
T ss_pred             cccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCC
Confidence            999999876544222211 2336789999999988889999999999999999998 88888652  1111121111110


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                      .           ..   ....++..+.+++.+|++.+|++|||+.|+++.|
T Consensus       222 ~-----------~~---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 R-----------LP---KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             C-----------CC---CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0           00   0112456788999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.6e-37  Score=300.05  Aligned_cols=263  Identities=22%  Similarity=0.307  Sum_probs=198.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|+..+.||+|++|.||+|.+..+++.||+|++....  ....+.+.+|++++++++|||++++++++     ......
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence            36788899999999999999988889999999986432  22345688999999999999999999985     344578


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++++|..+..          ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+
T Consensus        76 ~~v~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~  142 (286)
T cd07847          76 HLVFEYCDHTVLNELEK----------NPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLC  142 (286)
T ss_pred             EEEEeccCccHHHHHHh----------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEEC
Confidence            99999999998888763          2345899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||++........  ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ .. ........
T Consensus       143 dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~-~~~~~~~~  218 (286)
T cd07847         143 DFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QL-YLIRKTLG  218 (286)
T ss_pred             ccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HH-HHHHHHhC
Confidence            9999987644322  1123457889999999876 557899999999999999999999997532211 11 11111110


Q ss_pred             c---chhhhc----------ccCCCCcch---hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 E---RAEEIR----------ASSGSTQRS---IILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~---~~~~~~----------d~~~~~~~~---~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .   ......          .+......+   ........+.+++.+|++.+|++||++.|++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         219 DLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0   000000          000000000   01123466789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-39  Score=311.04  Aligned_cols=245  Identities=24%  Similarity=0.286  Sum_probs=196.8

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcch---hHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA---SKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      |+..+.||.|+||.||-|.+..+...||||.++-...++   -.++..|+..|.+++|||.+.+.|++     -.+...+
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCy-----Lre~TaW  102 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCY-----LREHTAW  102 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCccccccee-----eccchHH
Confidence            344578999999999999999999999999997544333   35688999999999999999999985     3444789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||| -||-.|++.         ....++-+.....|+.+.+.||+|||   +.+.||||||+.||||++.|.|||+|
T Consensus       103 LVMEYC-lGSAsDlle---------VhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaD  169 (948)
T KOG0577|consen  103 LVMEYC-LGSASDLLE---------VHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLAD  169 (948)
T ss_pred             HHHHHH-hccHHHHHH---------HHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeecc
Confidence            999999 667777774         33466888899999999999999999   99999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCC---CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG---HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      ||.|.+..+.      .+++|||.|||||++..   +.|+-|.||||+|++-.||...++|+..+...     ..     
T Consensus       170 FGSAsi~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-----SA-----  233 (948)
T KOG0577|consen  170 FGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SA-----  233 (948)
T ss_pred             ccchhhcCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-----HH-----
Confidence            9999776543      35789999999998764   68999999999999999999999997764211     11     


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                         ++-+.-...+...  ..+-...+..++..|+++-|.+|||.++++..
T Consensus       234 ---LYHIAQNesPtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  234 ---LYHIAQNESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             ---HHHHHhcCCCCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence               1111111111111  12456678899999999999999999988753

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.1e-37  Score=300.66  Aligned_cols=265  Identities=23%  Similarity=0.297  Sum_probs=204.0

Q ss_pred             CHHHHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeeccccc
Q 046112          196 SYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGV  274 (502)
Q Consensus       196 ~~~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  274 (502)
                      ++.++..+.+.|+..+.||+|+||.||+|.+..+++.+|+|++.... .....+..|+.++.++ +|+|++++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            45556667788999999999999999999998899999999986532 2345688899999988 699999999987532


Q ss_pred             cc-CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee
Q 046112          275 DF-QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL  353 (502)
Q Consensus       275 ~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll  353 (502)
                      .. ......+++|||+++|+|.+++..        .....+++..+..++.|++.|++|||   +.+|+|+||+|+||++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili  154 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKN--------TKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLL  154 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHH--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEE
Confidence            21 234578999999999999998853        22345778888999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeeeccceecccccccceecccccccccccCcccC-----CCccCccccchhHHHHHHHHHhCCCCCcccccc
Q 046112          354 DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM-----GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD  428 (502)
Q Consensus       354 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~  428 (502)
                      ++++.++|+|||++........  ......++..|+|||.+.     ...++.++|||||||++|||++|+.||......
T Consensus       155 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~  232 (282)
T cd06636         155 TENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM  232 (282)
T ss_pred             CCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH
Confidence            9999999999999875532211  122356889999999875     346888999999999999999999999653111


Q ss_pred             ccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          429 NLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                          .....         +........  ....+...+.+++.+||+.||.+|||+.|+++
T Consensus       233 ----~~~~~---------~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         233 ----RALFL---------IPRNPPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ----hhhhh---------HhhCCCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                00000         000000000  01134567889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.4e-38  Score=301.22  Aligned_cols=253  Identities=26%  Similarity=0.413  Sum_probs=197.2

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchh--HHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      |...+.||+|+||+||++....++..+|+|++........  .....|+.++++++||||+++++++.     .....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-----DDNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-----ESSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-----ccccccc
Confidence            4456899999999999999999999999999986543322  23355999999999999999999853     3558899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++++|.+++.          ....+++..+..++.|+++||++||   +.+|+|+||||+||+++.++.++|+||
T Consensus        76 v~~~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Df  142 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQ----------KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDF  142 (260)
T ss_dssp             EEEEETTEBHHHHHH----------HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSG
T ss_pred             ccccccccccccccc----------ccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence            999999999999984          2345789999999999999999999   889999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccC-CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGM-GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |.+....  ..........++..|+|||... +..++.++||||+|+++|+|++|..||.....  .+............
T Consensus       143 g~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~  218 (260)
T PF00069_consen  143 GSSVKLS--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKILKRP  218 (260)
T ss_dssp             TTTEEST--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHHHTH
T ss_pred             ccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhccccc
Confidence            9997641  1222334566899999999998 88899999999999999999999999987411  11111111111000


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...   .. ..    .......+.+++.+|++.||++||++.++++
T Consensus       219 ~~~---~~-~~----~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  219 LPS---SS-QQ----SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHH---HT-TS----HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccc---cc-cc----cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000   00 00    0011367889999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.3e-37  Score=297.89  Aligned_cols=256  Identities=22%  Similarity=0.352  Sum_probs=197.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcC-CCeEEEEEEecccC----------cchhHHHHHHHHHHhc-CCCCccceeeecccc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFE-STTAVAVKVFNVLH----------HDASKSFAVECEVTRN-IRHRNLVKVFTACSG  273 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  273 (502)
                      +|+..+.||+|+||.||+|.... +++.+|+|.+....          .....++..|+.++.+ ++|||++++++++. 
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence            47788999999999999998776 67899999875321          1223456778887764 79999999999853 


Q ss_pred             cccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee
Q 046112          274 VDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL  353 (502)
Q Consensus       274 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll  353 (502)
                          .++..+++|||+++++|.+++....      .....+++..++.++.|++.|+.|||.  ..+++|+||+|+||++
T Consensus        80 ----~~~~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~  147 (269)
T cd08528          80 ----ENDRLYIVMDLIEGAPLGEHFNSLK------EKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIML  147 (269)
T ss_pred             ----cCCeEEEEEecCCCCcHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEE
Confidence                3458899999999999999874211      223568899999999999999999992  2679999999999999


Q ss_pred             CCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchH
Q 046112          354 DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR  433 (502)
Q Consensus       354 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~  433 (502)
                      +.++.+||+|||.+.......   ......++..|+|||+..+..++.++||||||+++||+++|+.||....     ..
T Consensus       148 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----~~  219 (269)
T cd08528         148 GEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----ML  219 (269)
T ss_pred             CCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----HH
Confidence            999999999999998654432   2234568899999999999889999999999999999999999986521     11


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                      ...........    .+...      ......+.+++.+|++.||++||++.|+.++++
T Consensus       220 ~~~~~~~~~~~----~~~~~------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         220 SLATKIVEAVY----EPLPE------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHHHHhhccC----CcCCc------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11111100000    00000      123456789999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=306.87  Aligned_cols=202  Identities=25%  Similarity=0.309  Sum_probs=170.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||++....+++.||+|+++..   .....+.+.+|..++..++|+||+++++++     ..++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence            4688899999999999999998889999999998642   122345688899999999999999999884     34558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl  143 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRL  143 (331)
T ss_pred             EEEEEecCCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEE
Confidence            9999999999999999842         2345788899999999999999999   999999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCC-----CccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-----HEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      +|||++..+...... ......||+.|+|||++..     ..++.++|||||||++|||++|+.||..
T Consensus       144 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         144 ADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             EECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            999998765432221 1122458999999999863     4578899999999999999999999965

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.3e-38  Score=315.25  Aligned_cols=263  Identities=20%  Similarity=0.211  Sum_probs=195.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEc--CCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILF--ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ..+|...+.||+|+||.||++...  ..+..||+|.+...     +...+|++++++++||||+++++++     .....
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKST  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCCE
Confidence            347888999999999999999653  34678999987532     3456899999999999999999884     34457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++|||++. ++|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.++|
T Consensus       161 ~~lv~e~~~-~~l~~~l~----------~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l  226 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVD----------RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVL  226 (392)
T ss_pred             EEEEehhcC-CCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEE
Confidence            899999985 68888772          2356899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccc--cchHHHHHhh
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN--LNLRNCVKSA  439 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~--~~~~~~~~~~  439 (502)
                      +|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..+...++..
T Consensus       227 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~  306 (392)
T PHA03207        227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM  306 (392)
T ss_pred             ccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh
Confidence            99999976654433333345679999999999999999999999999999999999999986532211  1111111110


Q ss_pred             cccch-----------hhhcccCCCCc--chhh-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          440 LPERA-----------EEIRASSGSTQ--RSII-----LECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       440 ~~~~~-----------~~~~d~~~~~~--~~~~-----~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      -....           ..+........  ....     ......+.+++.+|+..||++|||+.|++..
T Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        307 QVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000           00000000000  0000     0123456788999999999999999998764

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-37  Score=297.64  Aligned_cols=253  Identities=25%  Similarity=0.316  Sum_probs=201.2

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      +|+..+.||+|++|.||++.+..+++.||+|++.... ....+++.+|++++++++||||+++++.+..     ....++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEEE
Confidence            5677889999999999999998889999999987543 2345678899999999999999999988533     358899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceeecCCCCCeeeCCCCcEEEee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ-PPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      ++||+++++|.+++..         ....+++.....++.+++.|++|||   + .+++|+||+|+||++++++.++|+|
T Consensus        77 v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d  144 (265)
T cd06605          77 CMEYMDGGSLDKILKE---------VQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCD  144 (265)
T ss_pred             EEEecCCCcHHHHHHH---------ccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEee
Confidence            9999999999999853         1256888899999999999999999   7 8999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||.+.........    ...++..|+|||+..+..++.++||||||+++|++++|+.||...........+..+..... 
T Consensus       145 ~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-  219 (265)
T cd06605         145 FGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-  219 (265)
T ss_pred             cccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC-
Confidence            9998755332211    15678899999999999999999999999999999999999976432222222222221111 


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                             .......  ......+.+++.+|+..+|++|||+.+++.
T Consensus       220 -------~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         220 -------PPPRLPS--GKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             -------CCCCCCh--hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence                   0001111  114566889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.6e-38  Score=301.49  Aligned_cols=265  Identities=20%  Similarity=0.232  Sum_probs=195.3

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|+..+.||+|++|.||+|....++..||+|+++....  ...+.+.+|+.++++++|||++++++++.     .+...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence            47778899999999999999888999999999864322  23467889999999999999999999853     445889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||++ ++|.+++...       .....+++..+..++.|++.||+|||   +.+|+||||+|+||+++.++.+||+|
T Consensus        76 ~v~e~~~-~~l~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d  144 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSL-------PKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLAD  144 (285)
T ss_pred             EEEecCC-CCHHHHHhcC-------CCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECc
Confidence            9999997 6898887531       22356889999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc-
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP-  441 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-  441 (502)
                      ||++........  ......+++.|+|||.+.+. .++.++|||||||++|||+||+.||....... ........... 
T Consensus       145 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~  221 (285)
T cd07861         145 FGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTP  221 (285)
T ss_pred             ccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence            999975533211  11233568899999987654 57899999999999999999999997521110 01110000000 


Q ss_pred             -c-------chhhh---cccCC-CCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 -E-------RAEEI---RASSG-STQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 -~-------~~~~~---~d~~~-~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                       +       .....   ..... ............++.+++.+|++.||++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         222 TEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             ChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence             0       00000   00000 0000001123456779999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1e-37  Score=296.48  Aligned_cols=251  Identities=27%  Similarity=0.435  Sum_probs=196.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      .+|+..+.||+|+||.||+|.+. .+..+|+|.++... .....+..|++++++++|||++++++++.     .....++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~   76 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICL   76 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEE
Confidence            46777899999999999999764 46789999886432 23467899999999999999999999853     3447899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      |+||+++++|.+++..         ....+++..+..++.+++.|++|||   +.+++||||||+||+++.++.+||+||
T Consensus        77 v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~  144 (256)
T cd05112          77 VFEFMEHGCLSDYLRA---------QRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDF  144 (256)
T ss_pred             EEEcCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCC
Confidence            9999999999998842         2345788999999999999999999   889999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |+++....... .......++.+|+|||+..++.++.++||||||+++||+++ |+.||.....     ...+...... 
T Consensus       145 g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~-  217 (256)
T cd05112         145 GMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVETINAG-  217 (256)
T ss_pred             cceeecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHHhCC-
Confidence            99976543221 11122335678999999998899999999999999999998 9999875221     1111111000 


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                       ....      .+.   ..+..+.+++.+|++.+|++|||+.|+++.|
T Consensus       218 -~~~~------~~~---~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         218 -FRLY------KPR---LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -CCCC------CCC---CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence             0000      001   1245688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.7e-38  Score=310.06  Aligned_cols=255  Identities=21%  Similarity=0.247  Sum_probs=193.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||+++...+++.||+|+++..   .......+..|..++..++|+||+++++++     ...+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            4688899999999999999999889999999998642   122345578899999999999999999884     44568


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~---------~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl  143 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRL  143 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEE
Confidence            9999999999999999852         2345788899999999999999999   999999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCC-----CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-----HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                      +|||+++.+...... ......||+.|+|||++.+     +.++.++|||||||++|||++|+.||....     ..+..
T Consensus       144 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~~~~  217 (331)
T cd05624         144 ADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETY  217 (331)
T ss_pred             EeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-----HHHHH
Confidence            999999766433221 1223568999999998875     568899999999999999999999996521     11111


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGE--RMKINDVEP  489 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~--RPt~~ev~~  489 (502)
                      ....... ...      ..+....+....+.+++.+|++.++++  |++++++.+
T Consensus       218 ~~i~~~~-~~~------~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         218 GKIMNHE-ERF------QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             HHHHcCC-Ccc------cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            1111000 000      000101123455667888888765544  567877764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-37  Score=305.36  Aligned_cols=205  Identities=22%  Similarity=0.291  Sum_probs=161.7

Q ss_pred             CCcccccCCceEEEEEEcC--CCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEee
Q 046112          210 ENLIGAGNFGSVYKGILFE--STTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE  287 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  287 (502)
                      +.+||+|+||.||+|....  .+..||+|.++...  ....+.+|++++++++||||+++++++..   ..+...++|+|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEe
Confidence            4689999999999997543  55789999886432  23567889999999999999999998642   23457789999


Q ss_pred             eccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee----CCCCcEEEee
Q 046112          288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL----DDEMTAYVSD  363 (502)
Q Consensus       288 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll----~~~~~~kl~D  363 (502)
                      |+. ++|.+++...... ........+++..+..++.|++.||.|||   +.+|+||||||+|||+    +.++.+||+|
T Consensus        81 ~~~-~~l~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07867          81 YAE-HDLWHIIKFHRAS-KANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             eeC-CcHHHHHHhhhcc-ccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence            986 5777776421111 01122345889999999999999999999   8999999999999999    5667999999


Q ss_pred             eccceeccccccc-ceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          364 FGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       364 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      ||+++........ .......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            9999876543221 12234568999999999876 4589999999999999999999999964

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.4e-38  Score=303.26  Aligned_cols=249  Identities=22%  Similarity=0.294  Sum_probs=196.3

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      |.....||+|+||.||++....++..||||.++.......+.+.+|+..++.++|+|++++++.+.     ..+..++||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv~   98 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVVM   98 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEEE
Confidence            344567999999999999888889999999987655455667899999999999999999998853     345889999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++++|.+++..           ..+++.....++.+++.|++|||   +.+|+||||||+||++++++.++|+|||+
T Consensus        99 e~~~~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~  164 (292)
T cd06658          99 EFLEGGALTDIVTH-----------TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGF  164 (292)
T ss_pred             eCCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcc
Confidence            99999999998742           24788899999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      +........  ......++..|+|||+..+..++.++|||||||++||+++|+.||.....  ......+....      
T Consensus       165 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~~------  234 (292)
T cd06658         165 CAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQAMRRIRDNL------  234 (292)
T ss_pred             hhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcC------
Confidence            875432221  12234578999999999888899999999999999999999999865211  01111111111      


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                        .+.....    ......+.+++.+|+..||.+|||++|+++.
T Consensus       235 --~~~~~~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         235 --PPRVKDS----HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             --CCccccc----cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              1111111    1223456788999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.1e-37  Score=295.46  Aligned_cols=257  Identities=21%  Similarity=0.281  Sum_probs=203.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|...+.||.|+||.||++....++..||+|+++...  ....+.+..|++++++++|||++++++++..   ......+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            4677889999999999999988899999999986432  2334568889999999999999999987532   2344678


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceeecCCCCCeeeCCCCcEEE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDC--QPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      ++|||+++++|.+++....      .....+++...+.++.+++.||+|||..+  +.+++|+||+|+||++++++.+||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl  151 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCK------KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL  151 (265)
T ss_pred             EEehhccCCCHHHHHHHHh------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence            9999999999999985311      23456899999999999999999999554  678999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||++.........  .....+++.|+|||.+.+..++.++||||||++++++++|+.||....  ...+.+.+..   
T Consensus       152 ~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~---  224 (265)
T cd08217         152 GDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKE---  224 (265)
T ss_pred             ecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhc---
Confidence            999999866543221  223468899999999999889999999999999999999999997632  1111111111   


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                              ....   .........+.+++.+|++.+|++||++.+|++
T Consensus       225 --------~~~~---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         225 --------GKFR---RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             --------CCCC---CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                    1111   112244567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8.2e-38  Score=308.60  Aligned_cols=256  Identities=21%  Similarity=0.248  Sum_probs=192.8

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...++||+|+||.||++....+++.+|+|++...   .......+..|+.++..++|++|+++++++     ...+.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence            4688889999999999999999888999999998632   122234588899999999999999999884     34558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.++++.         ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~ey~~~g~L~~~l~~---------~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL  143 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRL  143 (332)
T ss_pred             EEEEEeccCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEE
Confidence            9999999999999999852         2345888899999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccC-----CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM-----GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                      +|||++........ .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...     +..+..
T Consensus       144 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-----~~~~~~  217 (332)
T cd05623         144 ADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETY  217 (332)
T ss_pred             eecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-----CHHHHH
Confidence            99999975533222 1222356899999999876     346889999999999999999999999752     111111


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCC--CCCCHHHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPG--ERMKINDVEPR  490 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~--~RPt~~ev~~~  490 (502)
                      ....... ....   .+   .....+...+.+++.+|+..++.  .|++++|+++.
T Consensus       218 ~~i~~~~-~~~~---~p---~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         218 GKIMNHK-ERFQ---FP---AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHhCCC-cccc---CC---CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            1111100 0000   00   00112345566777777755444  47889888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.2e-38  Score=301.77  Aligned_cols=264  Identities=24%  Similarity=0.311  Sum_probs=197.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|+..+.||+|+||.||+|.+..+++.||+|++.....  ...+.+.+|+++++.++||||+++++++     ..+...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence            367888999999999999998888899999998764322  2346788999999999999999999985     345588


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++|+||+++++|.++..          ....+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+
T Consensus        76 ~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~  142 (286)
T cd07846          76 YLVFEFVDHTVLDDLEK----------YPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLC  142 (286)
T ss_pred             EEEEecCCccHHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEE
Confidence            99999999999988763          2234899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHH--hh
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK--SA  439 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~--~~  439 (502)
                      |||++..+.....  ......++..|+|||+..+ ..++.++||||||+++|||++|+.||...... ..+.....  ..
T Consensus       143 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~  219 (286)
T cd07846         143 DFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGN  219 (286)
T ss_pred             eeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCC
Confidence            9999976543321  1223457889999999875 45788999999999999999999998642110 00000000  00


Q ss_pred             cccchhhhcc----------cCCCCcch---hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAEEIRA----------SSGSTQRS---IILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~~~~d----------~~~~~~~~---~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .........+          +.......   ........+.+++.+|++.+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         220 LIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             CchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0000000000          00000000   01133567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.8e-37  Score=294.86  Aligned_cols=248  Identities=23%  Similarity=0.325  Sum_probs=196.6

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-----cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-----HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      +|...+.||+|++|.||+|....++..|++|.+....     .+..+.+..|+++++.++|+|++++++++.     ...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence            4677889999999999999887789999999986533     123467889999999999999999999853     345


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++++||+++++|.+++..          ...+++..+..++.+++.|++|||   +.+|+|+||+|+||+++.++.+|
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~k  142 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKK----------YGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVK  142 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence            78999999999999999842          235788999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCc-cCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||++.......   ......++..|+|||...... ++.++|+|||||++|++++|+.||.....    . ......
T Consensus       143 l~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~-~~~~~~  214 (258)
T cd06632         143 LADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----V-AAVFKI  214 (258)
T ss_pred             EccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----H-HHHHHH
Confidence            99999987654322   123456889999999987766 89999999999999999999999876321    0 100000


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...       ..   ...+.......+.+++.+|++.+|.+||++.++++
T Consensus       215 ~~~-------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         215 GRS-------KE---LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             Hhc-------cc---CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            000       00   00111123456778999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.6e-37  Score=295.30  Aligned_cols=253  Identities=20%  Similarity=0.255  Sum_probs=194.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-----cchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-----HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .+|+..+.||+|+||.||+|....++..||+|.+....     ....+.+.+|++++++++||||+++++++..   ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence            47888999999999999999988889999999875321     1123568889999999999999999997532   123


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...+++|||+++++|.+++..          ...+++.....++.+++.||+|||   +.+++|+||||+||+++.++.+
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~  145 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKS----------YGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNV  145 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCE
Confidence            467899999999999998842          234778888999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccc-cceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADE-QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +|+|||+++....... ........++..|+|||...+..++.++|||||||++||+++|+.||.....    .... ..
T Consensus       146 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~-~~  220 (265)
T cd06652         146 KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAAI-FK  220 (265)
T ss_pred             EECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHHH-HH
Confidence            9999999976532211 1112234588899999999888899999999999999999999999865211    1111 00


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ....       +..   ..........+.+++.+|+. +|++||+++|+++
T Consensus       221 ~~~~-------~~~---~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         221 IATQ-------PTN---PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HhcC-------CCC---CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            0000       000   01112334556678888885 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-37  Score=295.21  Aligned_cols=246  Identities=27%  Similarity=0.443  Sum_probs=194.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|+..+.||+|+||.||++..  .++.||+|.++..  .....+.+|+.++++++|||++++++++..      +..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~   75 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI   75 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence            4578889999999999999954  7788999998643  234678999999999999999999998532      24689


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++|+|.+++..        .....+++..++.++.|++.|+.|||   +.+++||||||+||+++.++.+||+||
T Consensus        76 v~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Df  144 (254)
T cd05083          76 VMELMSKGNLVNFLRT--------RGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDF  144 (254)
T ss_pred             EEECCCCCCHHHHHHh--------cCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCC
Confidence            9999999999999853        22345789999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |++.......     .....+..|+|||++.+..++.++|||||||++|||++ |+.||......  ...+......   
T Consensus       145 g~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~---  214 (254)
T cd05083         145 GLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVKECVEKGY---  214 (254)
T ss_pred             ccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhCCC---
Confidence            9987543211     12234568999999998899999999999999999998 99998753111  1111111100   


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                               .  .+....++..+.+++.+|++.+|++||+++++++.|+
T Consensus       215 ---------~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         215 ---------R--MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             ---------C--CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence                     0  0001234567789999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=304.82  Aligned_cols=253  Identities=23%  Similarity=0.315  Sum_probs=206.4

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc---hhHHHHHHHHHHhcCC-CCccceeeecccccccCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD---ASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  278 (502)
                      ....|...+.||+|.||.||+++...+|+.+|+|++++....   ....+.+|+++|+++. |||||.+.+.     ++.
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e~  107 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FED  107 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EEc
Confidence            345688889999999999999999999999999999754332   3468899999999998 9999999999     455


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC--
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE--  356 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~--  356 (502)
                      ....++|||++.||.|.+.+-.        .   .+++.....++.+++.++.|||   +.+|+||||||+|+|+...  
T Consensus       108 ~~~~~lvmEL~~GGeLfd~i~~--------~---~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~  173 (382)
T KOG0032|consen  108 PDSVYLVMELCEGGELFDRIVK--------K---HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDE  173 (382)
T ss_pred             CCeEEEEEEecCCchHHHHHHH--------c---cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccC
Confidence            5689999999999999999853        1   3899999999999999999999   8999999999999999633  


Q ss_pred             --CcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHH
Q 046112          357 --MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN  434 (502)
Q Consensus       357 --~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~  434 (502)
                        +.+|++|||++.....   .......+||+.|+|||.+....|+..+||||.||++|.|++|.+||....+.. ....
T Consensus       174 ~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~-~~~~  249 (382)
T KOG0032|consen  174 GSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE-IFLA  249 (382)
T ss_pred             CCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH-HHHH
Confidence              5799999999998765   334456889999999999999999999999999999999999999998732221 1111


Q ss_pred             HHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          435 CVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       435 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ......     ++.       .+.........-+++..|+..||..|+|+.++++.
T Consensus       250 i~~~~~-----~f~-------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  250 ILRGDF-----DFT-------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             HHcCCC-----CCC-------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            111111     111       11123445566789999999999999999999873

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-37  Score=299.41  Aligned_cols=255  Identities=22%  Similarity=0.259  Sum_probs=197.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|+..+.||+|+||.||++.+..++..||+|.++... ......+.+|++++++++|+||+++++++.     .++..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEE
Confidence            35778899999999999999988899999999887532 233467889999999999999999999853     345889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||+++++|..+++..       .....+++..+..++.+++.|+.|||.  +.+|+||||||+||+++.++.+||+|
T Consensus        76 lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d  146 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGG-------VATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCD  146 (286)
T ss_pred             EEEeecCCCCHHHHHHhc-------cccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEee
Confidence            999999999999988531       113468999999999999999999993  25899999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCC------ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHH
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH------EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  437 (502)
                      ||++..+....    .....++..|+|||.+.+.      .++.++|||||||++||+++|+.||......  ...... 
T Consensus       147 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~-  219 (286)
T cd06622         147 FGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQL-  219 (286)
T ss_pred             cCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHHH-
Confidence            99987553221    1223578899999987554      3588999999999999999999999652111  111111 


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                             ..+.+....   ....++...+.+++.+|++.+|++||+++++++.
T Consensus       220 -------~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         220 -------SAIVDGDPP---TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -------HHHhhcCCC---CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence                   111111111   1122456677899999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.4e-37  Score=295.54  Aligned_cols=259  Identities=24%  Similarity=0.312  Sum_probs=202.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|+..+.||.|+||+||+|....++..+++|+++... ....+.+.+|++.++.++|+|++++++.+     ...+..+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEE
Confidence            46888999999999999999888889999999986433 22457789999999999999999999874     3345889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||+++++|.+++...       .....+++.....++.|++.|++|||   +.+++||||+|+||++++++.++|+|
T Consensus        76 iv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~d  145 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSS-------YPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIAD  145 (267)
T ss_pred             EEEeccCCCcHHHHHHHh-------cccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcc
Confidence            999999999999998531       11246889999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccc--eecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          364 FGIARFLEAADEQT--RSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       364 fg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      ||++..+.......  ......++..|+|||++... .++.++|||||||++|||++|+.||...... ..+........
T Consensus       146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~  224 (267)
T cd06610         146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQNDP  224 (267)
T ss_pred             cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCCC
Confidence            99987665433221  12334688999999998876 7899999999999999999999999753211 11111111100


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                               +...... ........+.+++.+|++.||++||++.++++
T Consensus       225 ---------~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         225 ---------PSLETGA-DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ---------CCcCCcc-ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                     0000000 01134567789999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=297.72  Aligned_cols=262  Identities=23%  Similarity=0.300  Sum_probs=203.5

Q ss_pred             HhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeeccccccc-CCC
Q 046112          202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDF-QGN  279 (502)
Q Consensus       202 ~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-~~~  279 (502)
                      .++++|+..+.||+|++|.||+|....+++.+++|++..... ..+.+..|+.+++++ +|+||+++++++..... ...
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            356889999999999999999999888889999999875432 346789999999999 69999999998754332 234


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++||||+++++|.+++....      .....+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~  152 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLR------KKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEV  152 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeE
Confidence            56899999999999999885311      22456889999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCC-----CccCccccchhHHHHHHHHHhCCCCCccccccccchHH
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-----HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN  434 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~  434 (502)
                      ||+|||++.......  .......++..|+|||.+..     ..++.++|||||||+++|+++|+.||...... ....+
T Consensus       153 ~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~  229 (275)
T cd06608         153 KLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFK  229 (275)
T ss_pred             EECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHH
Confidence            999999987654322  11233558899999998753     34788999999999999999999999652111 11111


Q ss_pred             HHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          435 CVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       435 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .....    ...         ..........+.+++.+|+..||++|||+.|+++
T Consensus       230 ~~~~~----~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 IPRNP----PPT---------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hhccC----CCC---------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11000    000         0001234567889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=312.64  Aligned_cols=236  Identities=22%  Similarity=0.237  Sum_probs=179.5

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHHHHhcC---CCCccceeeecccccccCCCcceeEEe
Q 046112          213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECEVTRNI---RHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       213 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      ||+|+||+||+|++..+++.||||++.....   .....+..|..++...   +||||+++++++     ...+..++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            6999999999999988999999999864221   1223345566666655   699999999874     4455899999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        76 e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~  142 (330)
T cd05586          76 DYMSGGELFWHLQ----------KEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGL  142 (330)
T ss_pred             cCCCCChHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCc
Confidence            9999999998874          2345889999999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAE  445 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  445 (502)
                      ++.......  ......||..|+|||.+.+. .++.++|||||||++|||+||+.||....     ..+..+....... 
T Consensus       143 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~~-  214 (330)
T cd05586         143 SKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-----TQQMYRNIAFGKV-  214 (330)
T ss_pred             CcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-----HHHHHHHHHcCCC-
Confidence            875332221  12345689999999998764 48999999999999999999999996521     1111111110000 


Q ss_pred             hhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 046112          446 EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKI  484 (502)
Q Consensus       446 ~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~  484 (502)
                           ....     ......+.+++.+|++.||.+||++
T Consensus       215 -----~~~~-----~~~~~~~~~li~~~L~~~P~~R~~~  243 (330)
T cd05586         215 -----RFPK-----NVLSDEGRQFVKGLLNRNPQHRLGA  243 (330)
T ss_pred             -----CCCC-----ccCCHHHHHHHHHHcCCCHHHCCCC
Confidence                 0000     0123456689999999999999954

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=308.54  Aligned_cols=271  Identities=20%  Similarity=0.257  Sum_probs=201.4

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .+++|...+.||+|+||.||+|.+..++..||+|+++... ......+..|+.++++++||||+++++++....+.....
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            3568999999999999999999988899999999986432 233466888999999999999999999876554445557


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++|+||+. ++|.+++..           ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||
T Consensus        83 ~~lv~e~~~-~~l~~~~~~-----------~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl  147 (336)
T cd07849          83 VYIVQELME-TDLYKLIKT-----------QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKI  147 (336)
T ss_pred             EEEEehhcc-cCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEE
Confidence            899999996 577776632           35889999999999999999999   899999999999999999999999


Q ss_pred             eeeccceeccccccc-ceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          362 SDFGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      +|||++......... .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.....  ..........
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~  225 (336)
T cd07849         148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGV  225 (336)
T ss_pred             CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHH
Confidence            999999765433221 11233567899999998654 5689999999999999999999999965211  0111111110


Q ss_pred             cc----cchhhhcccC-------CCCc-----chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          440 LP----ERAEEIRASS-------GSTQ-----RSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       440 ~~----~~~~~~~d~~-------~~~~-----~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ..    +....+.+..       ....     ..........+.+++.+|++.+|++|||+.|+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             cCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            10    0111000000       0000     00011234568899999999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2e-37  Score=299.08  Aligned_cols=264  Identities=20%  Similarity=0.230  Sum_probs=195.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|+..+.||+|++|.||+|+...++..||||+++....  .....+..|++++++++||||+++++++     ..++..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence            47788999999999999999888999999998864322  2235788999999999999999999985     3455889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+. ++|.+++..        .....+++..+..++.+++.||+|||   +.+++||||+|+||+++.++.+||+|
T Consensus        76 ~v~e~~~-~~l~~~~~~--------~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~d  143 (284)
T cd07860          76 LVFEFLH-QDLKKFMDA--------SPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLAD  143 (284)
T ss_pred             EEeeccc-cCHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEee
Confidence            9999995 689888753        33456899999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCc-cCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||++........  ......++..|+|||...+.. ++.++|||||||++||++||+.||..... ...........-..
T Consensus       144 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~  220 (284)
T cd07860         144 FGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTP  220 (284)
T ss_pred             ccchhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCC
Confidence            999876543221  112334678999999877644 68899999999999999999999865211 11111111111000


Q ss_pred             --ch-----------hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 --RA-----------EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 --~~-----------~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                        ..           ..+..................+.+++.+|++.||++|||++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         221 DEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             ChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence              00           000000000000001123345678999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.3e-37  Score=301.52  Aligned_cols=244  Identities=25%  Similarity=0.322  Sum_probs=196.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|+..+.||+|+||.||++.+..+++.||+|+++...   ....+.+.+|++++++++||||+++++++     .....
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence            46788899999999999999998899999999986432   22346688999999999999999999984     34558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++++|.+++..          ...+++..+..++.|++.||.|||   +.+|+||||+|+||++++++.+||
T Consensus        76 ~~~v~e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl  142 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRK----------SGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKI  142 (290)
T ss_pred             EEEEEecCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEE
Confidence            8999999999999999842          356889999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||++......     .....+++.|+|||.+.+...+.++||||||+++|||++|+.||.....  ....+   ... 
T Consensus       143 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~---~~~-  211 (290)
T cd05580         143 TDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQIYE---KIL-  211 (290)
T ss_pred             eeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHH---HHh-
Confidence            999999865433     2234578999999999888899999999999999999999999865221  01111   000 


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVE  488 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~  488 (502)
                             ....    .+.......+.+++.+|+..||.+||     +++|++
T Consensus       212 -------~~~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         212 -------EGKV----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             -------cCCc----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence                   0000    01112245677999999999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.3e-37  Score=303.60  Aligned_cols=256  Identities=21%  Similarity=0.262  Sum_probs=196.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||++.....++.|++|.++...   ....+.+.+|+++++.++||||+++++.+     ..++.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence            36788899999999999999998899999999987542   22345688999999999999999999884     34457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++++|.+++..          ...+++.....++.+++.|++|||   +.+++||||||+||+++.++.+||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l  142 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKN----------IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKL  142 (305)
T ss_pred             EEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEE
Confidence            8999999999999999842          245788999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccc-------------cceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccccc
Q 046112          362 SDFGIARFLEAADE-------------QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD  428 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~  428 (502)
                      +|||+++.......             ........++..|+|||++....++.++|||||||++||+++|+.||....  
T Consensus       143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--  220 (305)
T cd05609         143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--  220 (305)
T ss_pred             eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--
Confidence            99999864211100             001112457889999999998899999999999999999999999986421  


Q ss_pred             ccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          429 NLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                         ..++........   ...+..      ....+..+.+++.+|++.+|++||++.++.+.|+
T Consensus       221 ---~~~~~~~~~~~~---~~~~~~------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         221 ---PEELFGQVISDD---IEWPEG------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             ---HHHHHHHHHhcc---cCCCCc------cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence               111111111000   000000      0123456789999999999999999765555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.4e-37  Score=293.71  Aligned_cols=249  Identities=22%  Similarity=0.352  Sum_probs=198.0

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|...+.||+|++|.||++....++..+|+|.+....  ......+..|++++++++|||++++++.+     ..++..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence            4777889999999999999988899999999986432  23356788999999999999999999873     4456889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC-CcEEEe
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE-MTAYVS  362 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~-~~~kl~  362 (502)
                      +|+||+++++|.+++..        .....+++..+..++.+++.|++|||   +.+++|+||+|+||+++++ +.+||+
T Consensus        76 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~  144 (256)
T cd08220          76 IVMEYAPGGTLAEYIQK--------RCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIG  144 (256)
T ss_pred             EEEecCCCCCHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEc
Confidence            99999999999999853        22345889999999999999999999   8999999999999999855 468999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      |||++........   .....++..|+|||...+..++.++||||||+++|++++|+.||+....     ...+......
T Consensus       145 d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~  216 (256)
T cd08220         145 DFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLKIMSG  216 (256)
T ss_pred             cCCCceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHHHHhc
Confidence            9999986643221   1234578899999999988899999999999999999999999865211     1111111111


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ....           ........+.+++.+||+.+|.+|||+.|+++
T Consensus       217 ~~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         217 TFAP-----------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCC-----------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            0000           11123556789999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.7e-37  Score=298.07  Aligned_cols=253  Identities=22%  Similarity=0.276  Sum_probs=192.2

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHH-HhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEV-TRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|+..+.||+|+||.||+|.+..+|+.||+|+++... ......+..|+.. ++..+|||++++++++.     .+...
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence            46888899999999999999998899999999987542 2233455556665 66678999999999863     34478


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceeecCCCCCeeeCCCCcEEE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQP-PIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      +++|||++ |+|.+++....      .....+++..+..++.|++.||+|||   +. +++||||||+||+++.++.+||
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl  145 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVY------DKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKL  145 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhc------cCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEE
Confidence            99999996 78888774311      22356899999999999999999999   76 8999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCC----CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHH
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG----HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  437 (502)
                      +|||+++.+.....   .....++..|+|||.+.+    ..++.++|||||||++|||++|+.||.........+.....
T Consensus       146 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  222 (283)
T cd06617         146 CDFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE  222 (283)
T ss_pred             eecccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh
Confidence            99999976532211   122457889999998765    45688999999999999999999998652211111111111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..            .....  ....+..+.+++.+|+..+|++||++.++++
T Consensus       223 ~~------------~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         223 EP------------SPQLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             cC------------CCCCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00            00000  0123556889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.2e-37  Score=295.04  Aligned_cols=254  Identities=23%  Similarity=0.326  Sum_probs=198.7

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc------chhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH------DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      +|+..+.||+|++|.||+|....++..||+|+++....      ...+.+..|++++++++|+|++++++++     ...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            47788999999999999999888999999999864321      1246788999999999999999999985     344


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC-c
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM-T  358 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~-~  358 (502)
                      +..++|+||+++++|.+++..          ...+++.....++.|++.||.|||   +.+++|+||+|+||+++.++ .
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~  142 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSK----------YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQR  142 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHH----------hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence            588999999999999999842          245788999999999999999999   89999999999999998775 6


Q ss_pred             EEEeeeccceeccccccc--ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          359 AYVSDFGIARFLEAADEQ--TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                      +||+|||.+..+......  .......++..|+|||.+.+..++.++||||+|++++|+++|+.||.....  .......
T Consensus       143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~  220 (268)
T cd06630         143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH--SNHLALI  220 (268)
T ss_pred             EEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--cchHHHH
Confidence            999999999766543211  111234578899999999888899999999999999999999999864211  1111111


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .....          .....+........+.+++.+|+..+|++||++.|+++
T Consensus       221 ~~~~~----------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         221 FKIAS----------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHhc----------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            10000          00011122244567889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-37  Score=300.12  Aligned_cols=264  Identities=18%  Similarity=0.248  Sum_probs=193.9

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|+..+.||+|+||.||+|.+..+|+.||+|+++....  .....+.+|++++++++|||++++++++     ......+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence            46778899999999999999988999999999864322  2235678899999999999999999984     4455889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||++ ++|.+++..         ....+++.....++.|+++||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus        76 lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d  142 (284)
T cd07839          76 LVFEYCD-QDLKKYFDS---------CNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLAD  142 (284)
T ss_pred             EEEecCC-CCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECc
Confidence            9999996 578877642         2345899999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+++.......  ......++..|+|||++.+. .++.++|||||||++|||+||+.|+.........+....+.....
T Consensus       143 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  220 (284)
T cd07839         143 FGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  220 (284)
T ss_pred             cchhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            999975533221  11234568899999988764 478999999999999999999998644222111111110000000


Q ss_pred             ------chhhhccc----CCCCc---chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 ------RAEEIRAS----SGSTQ---RSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ------~~~~~~d~----~~~~~---~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                            ......+.    .....   ..........+.+++.+|++.||.+|||++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         221 TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                  00000000    00000   0001123467789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.6e-37  Score=301.62  Aligned_cols=246  Identities=22%  Similarity=0.280  Sum_probs=194.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeec
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFM  289 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  289 (502)
                      ...||+|+||.||+|....++..||+|+++.......+.+.+|+.+++.++|||++++++++.     .++..++|+||+
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv~e~~  100 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVLMEFL  100 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEEEecC
Confidence            457999999999999888889999999987554445567889999999999999999999853     345889999999


Q ss_pred             cCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          290 ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       290 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                      ++++|.+++..           ..+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||++..
T Consensus       101 ~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~  166 (297)
T cd06659         101 QGGALTDIVSQ-----------TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ  166 (297)
T ss_pred             CCCCHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhh
Confidence            99999987632           34788999999999999999999   89999999999999999999999999999875


Q ss_pred             cccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcc
Q 046112          370 LEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRA  449 (502)
Q Consensus       370 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  449 (502)
                      +.....  ......++..|+|||++.+..++.++|||||||++|||++|+.||.....  ......+......       
T Consensus       167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~-------  235 (297)
T cd06659         167 ISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPP-------  235 (297)
T ss_pred             cccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhccCCC-------
Confidence            433221  12235688999999999988999999999999999999999999864211  1111111110000       


Q ss_pred             cCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          450 SSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       450 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                       ....    .......+.+++.+|++.+|++||+++++++.
T Consensus       236 -~~~~----~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         236 -KLKN----AHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             -Cccc----cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             0000    01223457789999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.2e-37  Score=298.04  Aligned_cols=267  Identities=22%  Similarity=0.302  Sum_probs=195.5

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++.+|...+.||+|+||.||+|....++..||+|+++.... .....+.+|+++++.++|+||+++.+++.     .++.
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~   77 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKET   77 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCe
Confidence            56789999999999999999998888899999999865432 22346788999999999999999999853     4457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++|+||+. ++|.+++..         ....+.+.....++.|++.||+|||   +.+|+|+||||+||+++.++.+||
T Consensus        78 ~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l  144 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQ---------HPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKL  144 (291)
T ss_pred             EEEEEeccc-CCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEE
Confidence            899999995 777776632         2345778888899999999999999   889999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh--
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS--  438 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~--  438 (502)
                      +|||+++........  .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||+........+.+....  
T Consensus       145 ~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~  222 (291)
T cd07870         145 ADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLG  222 (291)
T ss_pred             eccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcC
Confidence            999999754332211  1234468899999998754 57889999999999999999999997532211111111000  


Q ss_pred             -----------hcccchhhhcccCCCCcchh---hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 -----------ALPERAEEIRASSGSTQRSI---ILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 -----------~~~~~~~~~~d~~~~~~~~~---~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                                 ..+....+............   .......+.+++.+|+..||.+|||+.|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         223 VPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             CCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                       00000001000000000000   0012456778999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.5e-37  Score=296.93  Aligned_cols=263  Identities=19%  Similarity=0.232  Sum_probs=198.6

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|...+.||+|++|.||+|.+..+++.||+|++....  ....+.+.+|+.++++++|||++++++++     ......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence            4777889999999999999988899999999987543  23356789999999999999999999985     3355889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||+ +++|.+++..         ....+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|
T Consensus        76 ~v~e~~-~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~d  142 (286)
T cd07832          76 LVMEYM-PSDLSEVLRD---------EERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIAD  142 (286)
T ss_pred             EEeccc-CCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEee
Confidence            999999 9999998853         2256899999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||++........ .......++..|+|||.+.+. .++.++||||+|++++|++||++||.....  ......+......
T Consensus       143 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~  219 (286)
T cd07832         143 FGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGT  219 (286)
T ss_pred             eeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCC
Confidence            999986643321 112234688999999988654 468999999999999999999887754211  1111111111100


Q ss_pred             -ch------hhhcc------cCCCC--cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 -RA------EEIRA------SSGST--QRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 -~~------~~~~d------~~~~~--~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                       ..      .++.+      +....  ......+....+.+++.+|++.+|++|||++++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         220 PNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence             00      00000      00000  00011133578889999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.6e-37  Score=296.94  Aligned_cols=263  Identities=21%  Similarity=0.354  Sum_probs=200.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcC-----CCeEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccccccCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFE-----STTAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      ++|.....||+|+||.||+|....     ....|++|.+...... ..+.+..|++++++++|+|++++++++..     
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-----   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-----
Confidence            467888999999999999997543     3567999987653333 35679999999999999999999998643     


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      ....++||||+++|+|.++++...... .......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~-~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~  155 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKD-EKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQRE  155 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhccccc-ccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCc
Confidence            347899999999999999985421100 0011236899999999999999999999   899999999999999999999


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHH
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  437 (502)
                      ++++|||++....... ........++..|+|||.+.+..++.++||||||+++||+++ |..||.....  ........
T Consensus       156 ~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~~~~~  232 (275)
T cd05046         156 VKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLNRLQ  232 (275)
T ss_pred             EEEcccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHHHHHHH
Confidence            9999999987543222 112223456778999999988889999999999999999999 8888865321  11111111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                      .....    +.         ....++..+.+++.+|++.+|++|||+.|++..|.
T Consensus       233 ~~~~~----~~---------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         233 AGKLE----LP---------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             cCCcC----CC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            10000    00         01134567889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.8e-37  Score=294.11  Aligned_cols=251  Identities=20%  Similarity=0.294  Sum_probs=194.9

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc------chhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH------DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      +|...+.||+|+||.||+|.. .++..+|+|.++....      .....+.+|++++++++|+||++++++|..     .
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----D   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----C
Confidence            477889999999999999965 6788999998864321      123568889999999999999999999643     3


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +..++++||+++++|.+++..          ...+++..+..++.|++.|++|||   +.+|+|+||+|+||++++++.+
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~  141 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNR----------FGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGII  141 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeE
Confidence            588999999999999999842          235788889999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccc----cceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHH
Q 046112          360 YVSDFGIARFLEAADE----QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  435 (502)
                      +|+|||++........    ........++..|+|||+..+..++.++|||||||++||+++|+.||....... .....
T Consensus       142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~  220 (265)
T cd06631         142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYI  220 (265)
T ss_pred             EeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHh
Confidence            9999999875532111    111223568899999999999889999999999999999999999997531111 01000


Q ss_pred             HHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      . .. ...     .+.      ........+.+++.+|++.+|++||++.|+++
T Consensus       221 ~-~~-~~~-----~~~------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         221 G-AH-RGL-----MPR------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             h-hc-cCC-----CCC------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0 00 000     000      11123456789999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.2e-37  Score=292.27  Aligned_cols=253  Identities=26%  Similarity=0.373  Sum_probs=198.9

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc--hhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD--ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|...+.||+|+||.||+|....++..|++|.++.....  ..+.+..|++++++++|+||+++++++     ...+..+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            477789999999999999988888999999998755432  467889999999999999999999984     3445889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||+++++|.+++..          ...+++..+..++.+++.|++|||   +.+|+|+||+|+||++++++.+||+|
T Consensus        76 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d  142 (264)
T cd06626          76 IFMEYCSGGTLEELLEH----------GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGD  142 (264)
T ss_pred             EEEecCCCCcHHHHHhh----------cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcc
Confidence            99999999999999842          234788889999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccce--ecccccccccccCcccCCCc---cCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          364 FGIARFLEAADEQTR--SIGVEGTTGYIAPEYGMGHE---VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       364 fg~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      ||++...........  .....++..|+|||++.+..   ++.++||||||+++||+++|+.||....... ........
T Consensus       143 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~  221 (264)
T cd06626         143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGA  221 (264)
T ss_pred             cccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhc
Confidence            999986644322111  12356788999999988766   8899999999999999999999997532111 11111110


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .        ..+..+.    .......+.+++.+|++.+|++|||+.|++.
T Consensus       222 ~--------~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 G--------HKPPIPD----SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             C--------CCCCCCc----ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0        0000110    1123556778999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.2e-37  Score=297.42  Aligned_cols=262  Identities=21%  Similarity=0.256  Sum_probs=196.1

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc-----hhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-----ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      +|...+.||+|++|.||+|.+..+++.||+|.++.....     ....+..|++++++++|+||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence            467788999999999999988888999999998754322     23457789999999999999999998543     45


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+ +|+|.+++..        . ...+++..+..++.|+++||+|||   +.+|+|+||+|+||+++.++.++
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~--------~-~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~  142 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKD--------K-SIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLK  142 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhc--------c-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEE
Confidence            889999999 9999999853        1 136899999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++........  .....+++.|+|||.+.+ ..++.++|||||||++||+++|..||..... ...+...... 
T Consensus       143 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~-  218 (298)
T cd07841         143 LADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEA-  218 (298)
T ss_pred             EccceeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHH-
Confidence            9999999876543221  122346788999998865 4678999999999999999999877764211 1111111110 


Q ss_pred             cccchh----------hhcccCC---CCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAE----------EIRASSG---STQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~----------~~~d~~~---~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ......          .......   .............+.+++.+|++.||++|||++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         219 LGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            000000          0000000   0001111234567889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.1e-37  Score=294.67  Aligned_cols=248  Identities=23%  Similarity=0.318  Sum_probs=198.7

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      +|...+.||.|+||.||+|.+..++..||+|++....   ....+.+.+|++++++++||||+++++.+     ..+...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            4778899999999999999988889999999987432   23457789999999999999999999884     455689


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++|+||+++++|.+++..          ...+++.....++.+++.||.|||   +.+++|+||+|+||++++++.++|+
T Consensus        76 ~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~  142 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQ----------KVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHIT  142 (258)
T ss_pred             EEEEeCCCCCCHHHHHHh----------cCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEe
Confidence            999999999999999842          256889999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      |||++.......   ......++..|+|||...+..++.++||||||+++|++++|+.||......   ...........
T Consensus       143 d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~  216 (258)
T cd05578         143 DFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQET  216 (258)
T ss_pred             ecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhcc
Confidence            999987654332   123455788999999999888999999999999999999999999763221   11111111100


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCH--HHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKI--NDVE  488 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~--~ev~  488 (502)
                                 .........+..+.+++.+|++.||.+||++  +|+.
T Consensus       217 -----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 -----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                       0011112345678899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-37  Score=294.49  Aligned_cols=248  Identities=25%  Similarity=0.380  Sum_probs=196.1

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCC---CCccceeeecccccccCCCcc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIR---HRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .|+..+.||+|+||.||+|.+..+++.||+|.++... .....++.+|++++++++   |||++++++++.     .+..
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence            4667789999999999999988899999999987532 234567889999999986   999999999853     3457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++++|.+++..           ..+++...+.++.+++.|+.|||   +.+|+|+||+|+||++++++.++|
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l  142 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKA-----------GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKL  142 (277)
T ss_pred             EEEEEecCCCCcHHHHHHc-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEE
Confidence            8999999999999998742           25889999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      +|||++........  ......|+..|+|||++.++ .++.++|||||||++|+|++|+.||.....     ....... 
T Consensus       143 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~~-  214 (277)
T cd06917         143 CDFGVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMMLI-  214 (277)
T ss_pred             ccCCceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhcc-
Confidence            99999987654332  12334688899999988754 478999999999999999999999975211     1111100 


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...    ..+....     ......+.+++.+|++.||++||++.|+++
T Consensus       215 ~~~----~~~~~~~-----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         215 PKS----KPPRLED-----NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ccC----CCCCCCc-----ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            000    0000000     013456789999999999999999999965

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.4e-37  Score=291.67  Aligned_cols=253  Identities=25%  Similarity=0.325  Sum_probs=204.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|...+.||+|++|.||+|....+++.|++|++..... ...+.+..|++.+.+++|+|++++++++.     .....+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS   75 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence            367888999999999999999888899999999875433 34578999999999999999999999853     345899


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceeecCCCCCeeeCCCCcEEEe
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ-PPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      +|+||+++++|.+++..          ...+++..+..++.|+++|++|||   + .+++||||+|+||+++.++.++|+
T Consensus        76 lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~  142 (264)
T cd06623          76 IVLEYMDGGSLADLLKK----------VGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIA  142 (264)
T ss_pred             EEEEecCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEc
Confidence            99999999999999842          256889999999999999999999   8 999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      |||.+..........  ....++..|+|||...+..++.++||||||+++||++||+.||.....  ....+........
T Consensus       143 df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~  218 (264)
T cd06623         143 DFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDG  218 (264)
T ss_pred             cCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcC
Confidence            999998664333221  234578899999999999999999999999999999999999976432  0111111111110


Q ss_pred             chhhhcccCCCCcchhhHH-HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILE-CLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~-~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                              ....   .... .+..+.+++.+|+..+|++||++.++++.
T Consensus       219 --------~~~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         219 --------PPPS---LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             --------CCCC---CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                    0000   1112 45678899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.2e-37  Score=294.20  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=198.1

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      -|...+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|++.+++++|||++++++++.     .+...++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEE
Confidence            3667789999999999999888889999999876432 233467889999999999999999999853     4458899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      |+||+++++|.+++..           ..+++.....++.+++.|+.|||   +.+++|+||+|+||+++.++.++|+||
T Consensus        80 v~e~~~~~~l~~~i~~-----------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~df  145 (277)
T cd06641          80 IMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADF  145 (277)
T ss_pred             EEEeCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeec
Confidence            9999999999998842           34789999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      |++..+.....  ......++..|+|||+..+..++.++|||||||++||+++|+.||......  .....+    ..  
T Consensus       146 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~----~~--  215 (277)
T cd06641         146 GVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFLI----PK--  215 (277)
T ss_pred             ccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHHH----hc--
Confidence            99876543221  112345788999999998888999999999999999999999998652110  111111    00  


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                           ..   .......+...+.+++.+|++.+|.+||++.++++.
T Consensus       216 -----~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         216 -----NN---PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             -----CC---CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                 00   001112345667899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=301.63  Aligned_cols=254  Identities=26%  Similarity=0.328  Sum_probs=198.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc---hhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD---ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|++|.||+|....+++.+|+|.+......   ..+.+..|+++++.++|+||+++++.+     .....
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence            3678889999999999999988888999999998754322   346688999999999999999999884     34558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++++|.+++..        .....+++.....++.|++.||+|||   +.+++||||||+||+++.++.++|
T Consensus        76 ~~lv~e~~~~~~L~~~~~~--------~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l  144 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQR--------QPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIML  144 (316)
T ss_pred             EEEEEEecCCCCHHHHHHh--------CCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEE
Confidence            8999999999999999853        23356899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceeccccccc---------------------------ceecccccccccccCcccCCCccCccccchhHHHHHHH
Q 046112          362 SDFGIARFLEAADEQ---------------------------TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLE  414 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~e  414 (502)
                      +|||++.........                           .......||..|+|||+..+..++.++||||||+++|+
T Consensus       145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~  224 (316)
T cd05574         145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE  224 (316)
T ss_pred             eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence            999998754322110                           01112457889999999999889999999999999999


Q ss_pred             HHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC----HHHHHH
Q 046112          415 MFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK----INDVEP  489 (502)
Q Consensus       415 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt----~~ev~~  489 (502)
                      |++|+.||...... ..+..            +.+..... .. .......+.+++.+|+..||++|||    ++|++.
T Consensus       225 l~~g~~pf~~~~~~-~~~~~------------~~~~~~~~-~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         225 MLYGTTPFKGSNRD-ETFSN------------ILKKEVTF-PG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HhhCCCCCCCCchH-HHHHH------------HhcCCccC-CC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            99999999753211 11111            11100000 00 0114567889999999999999999    666554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.4e-37  Score=294.91  Aligned_cols=249  Identities=21%  Similarity=0.269  Sum_probs=197.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEE
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      .|...+.||+|++|.||++....++..+++|+++.......+.+.+|+.+++.++|||++++++++.     ..+..+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEE
Confidence            3555679999999999999888889999999987554445567889999999999999999999843     34578999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeec
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG  365 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg  365 (502)
                      +||+++++|.+++..           ..+++..+..++.+++.|++|||   +.+++||||+|+||+++.++.++|+|||
T Consensus        95 ~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g  160 (285)
T cd06648          95 MEFLEGGALTDIVTH-----------TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFG  160 (285)
T ss_pred             EeccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccc
Confidence            999999999998742           34788899999999999999999   8999999999999999999999999999


Q ss_pred             cceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchh
Q 046112          366 IARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAE  445 (502)
Q Consensus       366 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  445 (502)
                      ++........  ......|++.|+|||...+..++.++|||||||++|||++|+.||....     ............  
T Consensus       161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-----~~~~~~~~~~~~--  231 (285)
T cd06648         161 FCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-----PLQAMKRIRDNL--  231 (285)
T ss_pred             cchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-----HHHHHHHHHhcC--
Confidence            8875432211  1223458899999999988889999999999999999999999986521     111111111000  


Q ss_pred             hhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          446 EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       446 ~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                         .+....    .......+.+++.+|++.+|++|||+.++++
T Consensus       232 ---~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         232 ---PPKLKN----LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ---CCCCcc----cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence               000000    1123457889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.5e-37  Score=306.58  Aligned_cols=196  Identities=27%  Similarity=0.383  Sum_probs=168.6

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-C-----CccceeeecccccccCCC
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-H-----RNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~~  279 (502)
                      +|.+.+.||+|+||.|-+|.+..+++.||||+++.... -..+-..|+.+|..++ |     -|+|+++++     +...
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~fr  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FYFR  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cccc
Confidence            67889999999999999999999999999999985432 2355677999999987 4     389999999     5556


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC--C
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE--M  357 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~--~  357 (502)
                      ++.|||+|.+ .-+|.++++.        +...+++......|+.||+.||.+||   +.+|||+||||+||||.+.  .
T Consensus       261 ~HlciVfELL-~~NLYellK~--------n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~  328 (586)
T KOG0667|consen  261 NHLCIVFELL-STNLYELLKN--------NKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRS  328 (586)
T ss_pred             cceeeeehhh-hhhHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcC
Confidence            6999999998 5699999975        56677999999999999999999999   9999999999999999643  3


Q ss_pred             cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          358 TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      .+||+|||.|+.......     .+.-+..|+|||++.+.+|+.+.|||||||++.||++|.+.|.+
T Consensus       329 ~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  329 RIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             ceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            899999999986544322     33456789999999999999999999999999999999877754

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8.4e-37  Score=290.17  Aligned_cols=250  Identities=22%  Similarity=0.291  Sum_probs=198.4

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|...+.||+|+||.||+|....+|..+|+|.+....  ....+.+.+|++++++++|+|++++++.+.     .+...+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-----~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ-----ENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec-----cCCeEE
Confidence            4677889999999999999998899999999986432  233457889999999999999999999853     445889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC-cEEEe
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM-TAYVS  362 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~-~~kl~  362 (502)
                      +|+||+++++|.+++..        .....+++..+..++.+++.|++|||   +.+++|+||+|+||++++++ .+||+
T Consensus        76 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~  144 (257)
T cd08225          76 IVMEYCDGGDLMKRINR--------QRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLG  144 (257)
T ss_pred             EEEecCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEec
Confidence            99999999999999853        22345789999999999999999999   89999999999999999885 56999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      |||.+.........  .....|++.|+|||+..+..++.++||||||+++||+++|+.||...     ...+.+......
T Consensus       145 d~~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~  217 (257)
T cd08225         145 DFGIARQLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-----NLHQLVLKICQG  217 (257)
T ss_pred             ccccchhccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcc
Confidence            99999766433221  12345889999999998888999999999999999999999998642     122222222111


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ....    .       .......+.+++.+|+..+|++|||+.|+++
T Consensus       218 ~~~~----~-------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         218 YFAP----I-------SPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             cCCC----C-------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            1110    0       1123446789999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-37  Score=296.39  Aligned_cols=263  Identities=24%  Similarity=0.304  Sum_probs=198.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|+..+.||+|++|.||+|.+.++++.||+|+++...  ....+.+.+|++++++++|+||+++++++.     ..+..+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEEE
Confidence            6788899999999999999988889999999987432  223467899999999999999999999864     345789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||++++.+..+..          ....+++.....++.+++.|++|||   ..+++|+||+|+||++++++.+||+|
T Consensus        77 iv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d  143 (288)
T cd07833          77 LVFEYVERTLLELLEA----------SPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCD  143 (288)
T ss_pred             EEEecCCCCHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEe
Confidence            9999999877766542          2345889999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||++........ .......++..|+|||++.+. .++.++||||||+++||+++|+.||......+ .+.. .......
T Consensus       144 ~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~-~~~~~~~  220 (288)
T cd07833         144 FGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYL-IQKCLGP  220 (288)
T ss_pred             eecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHHhCC
Confidence            999986654332 122335678899999999888 88999999999999999999999987521110 0100 0000000


Q ss_pred             ---chhhhc--ccC-----CCC--cc-----hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 ---RAEEIR--ASS-----GST--QR-----SIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ---~~~~~~--d~~-----~~~--~~-----~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                         ......  +..     ...  ..     .+...+...+.+++.+|+..+|++|||++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         221 LPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence               000000  000     000  00     001123677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.7e-37  Score=296.35  Aligned_cols=251  Identities=22%  Similarity=0.279  Sum_probs=199.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      .+|...+.||+|+||.||+|....++..||+|.+........+.+.+|+.++++++|||++++++++.     ..+..++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~l   93 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELWV   93 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEEE
Confidence            57888899999999999999888889999999987554455677899999999999999999999853     3457899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      |+||+++++|.+++..           ..+++..+..++.+++.|+.|||   +.+++||||+|+||+++.++.++|+||
T Consensus        94 v~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~df  159 (293)
T cd06647          94 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF  159 (293)
T ss_pred             EEecCCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccC
Confidence            9999999999999842           24678899999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      |++........  ......+++.|+|||......++.++|||||||++||+++|+.||........ .....        
T Consensus       160 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~--------  228 (293)
T cd06647         160 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIA--------  228 (293)
T ss_pred             cceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeehh--------
Confidence            99875543322  11234578899999999888899999999999999999999999975211110 00000        


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                         .... .. ..........+.+++.+||..+|++||++.+++..
T Consensus       229 ---~~~~-~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         229 ---TNGT-PE-LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ---cCCC-CC-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0000 00 00011234567799999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=333.54  Aligned_cols=257  Identities=25%  Similarity=0.336  Sum_probs=203.3

Q ss_pred             HHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCC
Q 046112          201 YNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       201 ~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      .+.+-++.....||.|.||.||-|...++|...|+|-++...  ....+...+|+.++..++|||+|+++|+     .-.
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV-----EvH 1305 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV-----EVH 1305 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce-----eec
Confidence            344567788899999999999999999999999999887433  3345678899999999999999999998     344


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      .+..+|.||||++|+|.+.+..          ....++.....+..|++.|++|||   +.+||||||||+||+|+.+|.
T Consensus      1306 Rekv~IFMEyC~~GsLa~ll~~----------gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~ 1372 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEH----------GRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGL 1372 (1509)
T ss_pred             HHHHHHHHHHhccCcHHHHHHh----------cchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCc
Confidence            5588999999999999999843          233455555667899999999999   999999999999999999999


Q ss_pred             EEEeeeccceecccccc--cceecccccccccccCcccCCCc---cCccccchhHHHHHHHHHhCCCCCccccccccchH
Q 046112          359 AYVSDFGIARFLEAADE--QTRSIGVEGTTGYIAPEYGMGHE---VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR  433 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~  433 (502)
                      +|++|||.|..+.....  .....+..||+.|||||.+.+..   ...+.||||+|||++||+||++||.....+-.-+.
T Consensus      1373 iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy 1452 (1509)
T KOG4645|consen 1373 IKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY 1452 (1509)
T ss_pred             EEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh
Confidence            99999999988765431  22334678999999999988743   45678999999999999999999987543322222


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      +..-.               ..+.+++....+=.+++..|+..||+.|.++.|+++.
T Consensus      1453 ~V~~g---------------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1453 HVAAG---------------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             HHhcc---------------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            21111               1122233344555689999999999999999877653

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-37  Score=299.62  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=196.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc--CcchhHHHHHHHHHHhcCC-CCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL--HHDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ..|++.++||+||.+.||++. ..+...+|+|++...  +......|..|++.|.+++ |.+||++++|     .-.+..
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~-~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY-----Ev~d~~  434 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVL-NSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY-----EVTDGY  434 (677)
T ss_pred             chhhHHHhhcCCCcceeeeee-cCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee-----eccCce
Confidence            457888999999999999994 455667777765532  3344577999999999995 8999999999     344668


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .|+||||= ..+|..+|..        ......+| .+..++.|++.|+.++|   ..+|||.||||.|+|+- .|.+||
T Consensus       435 lYmvmE~G-d~DL~kiL~k--------~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKL  500 (677)
T KOG0596|consen  435 LYMVMECG-DIDLNKILKK--------KKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKL  500 (677)
T ss_pred             EEEEeecc-cccHHHHHHh--------ccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEe
Confidence            99999975 5689999864        22222334 67789999999999999   99999999999999995 469999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCC-----------ccCccccchhHHHHHHHHHhCCCCCcccccccc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-----------EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL  430 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~  430 (502)
                      +|||+|..+.+..+.......+||+.||+||.+...           +++.+|||||+||+||+|+.|+.||.....   
T Consensus       501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---  577 (677)
T KOG0596|consen  501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---  577 (677)
T ss_pred             eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---
Confidence            999999988877776667788999999999987653           267889999999999999999999976211   


Q ss_pred             chHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          431 NLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                         .|      .++..+.|+.....++... ...++.++|+.|+.+||.+|||+.|+++
T Consensus       578 ---~~------aKl~aI~~P~~~Iefp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  578 ---QI------AKLHAITDPNHEIEFPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ---HH------HHHHhhcCCCccccccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence               11      2344455553321111111 1223889999999999999999999975

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.3e-37  Score=286.42  Aligned_cols=251  Identities=26%  Similarity=0.360  Sum_probs=201.3

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      |...+.||+|.-|+||+++...++..+|+|++.+..   .....+.+.|-++|+.++||.+..+++.     ++.++..+
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~~~c  153 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDKYSC  153 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccceeE
Confidence            445678999999999999998888999999997542   3344667889999999999999999998     66677999


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      ++||||+||+|....+.        +....+++..+.-++.++.-||+|||   -.|||.|||||+|||+.++|++-|+|
T Consensus       154 l~meyCpGGdL~~Lrqk--------Qp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsD  222 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQK--------QPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSD  222 (459)
T ss_pred             EEEecCCCccHHHHHhh--------CCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeee
Confidence            99999999999999865        66677999999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccc----------------------------------c--------------------ccceecccccccccc
Q 046112          364 FGIARFLEAA----------------------------------D--------------------EQTRSIGVEGTTGYI  389 (502)
Q Consensus       364 fg~a~~~~~~----------------------------------~--------------------~~~~~~~~~gt~~y~  389 (502)
                      |.++......                                  .                    ...+..+.+||-.|+
T Consensus       223 FDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYl  302 (459)
T KOG0610|consen  223 FDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYL  302 (459)
T ss_pred             ccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccc
Confidence            9987432110                                  0                    011234567999999


Q ss_pred             cCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHH
Q 046112          390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEI  469 (502)
Q Consensus       390 aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l  469 (502)
                      |||++.+...+.+.|.|+|||++|||+.|+.||.+...+. -+...+....          ..+..    .+......+|
T Consensus       303 APEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~NIv~~~l----------~Fp~~----~~vs~~akDL  367 (459)
T KOG0610|consen  303 APEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRNIVGQPL----------KFPEE----PEVSSAAKDL  367 (459)
T ss_pred             cceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHHHhcCCC----------cCCCC----CcchhHHHHH
Confidence            9999999999999999999999999999999998743221 2222222111          11111    1445667799


Q ss_pred             HhhcccCCCCCCCC----HHHHH
Q 046112          470 GVACSAEQPGERMK----INDVE  488 (502)
Q Consensus       470 ~~~c~~~dP~~RPt----~~ev~  488 (502)
                      +.+.+.+||++|.-    ++||-
T Consensus       368 Ir~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  368 IRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             HHHHhccChhhhhccccchHHhh
Confidence            99999999999987    66553

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=294.12  Aligned_cols=263  Identities=20%  Similarity=0.248  Sum_probs=194.8

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      |+..+.||.|++|.||+|.+..+|..||+|++....  ......+.+|++++++++|||++++++++.     ..+..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence            566789999999999999988899999999987543  223356888999999999999999999864     3458899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      +|||+ +++|.+++..        .....+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+||
T Consensus        76 v~e~~-~~~l~~~~~~--------~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df  143 (283)
T cd07835          76 VFEFL-DLDLKKYMDS--------SPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADF  143 (283)
T ss_pred             EEecc-CcCHHHHHhh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeec
Confidence            99999 4789998853        22246899999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc-c
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP-E  442 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~  442 (502)
                      |+++.......  ......++..|+|||++.+. .++.++||||||+++|||++|+.||...... ..+....+.... .
T Consensus       144 ~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~  220 (283)
T cd07835         144 GLARAFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPD  220 (283)
T ss_pred             ccccccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCC
Confidence            99975532211  11223468899999987664 5789999999999999999999998653211 111111111000 0


Q ss_pred             --------chhhhcc----cCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 --------RAEEIRA----SSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 --------~~~~~~d----~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                              ...+...    ................+.+++.+|++.||++|||++|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         221 EDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                    0000000    0000000111122356779999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=294.62  Aligned_cols=265  Identities=22%  Similarity=0.302  Sum_probs=193.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|...+.||+|++|.||+|....+++.||+|.+..... .....+.+|++++++++|+||+++++++     ..++..+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence            578888999999999999998888899999999864332 2234577899999999999999999985     3445899


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||++ ++|.+++..         ....+++.....++.|++.||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus        80 lv~e~~~-~~L~~~~~~---------~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d  146 (291)
T cd07844          80 LVFEYLD-TDLKQYMDD---------CGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLAD  146 (291)
T ss_pred             EEEecCC-CCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECc
Confidence            9999997 599988742         2236788999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc--
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL--  440 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--  440 (502)
                      ||+++.......  ......++..|+|||...+ ..++.++||||+||++|||++|+.||.........+....+..-  
T Consensus       147 fg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  224 (291)
T cd07844         147 FGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTP  224 (291)
T ss_pred             cccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCC
Confidence            999875432111  1122346788999998875 45889999999999999999999999653211111111110000  


Q ss_pred             -ccchhhh------cccCCC--Ccchh-----hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 -PERAEEI------RASSGS--TQRSI-----ILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 -~~~~~~~------~d~~~~--~~~~~-----~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                       +......      ......  .....     .......+.+++.+|++.+|++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         225 TEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence             0000000      000000  00000     0011256678999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.6e-36  Score=294.21  Aligned_cols=264  Identities=21%  Similarity=0.238  Sum_probs=185.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCC---CeEEEEEEecccCcchh-----------HHHHHHHHHHhcCCCCccceeee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDAS-----------KSFAVECEVTRNIRHRNLVKVFT  269 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~  269 (502)
                      .++|.+.++||+|+||.||+|....+   +..+|+|+.........           .....+...+..++|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            35788999999999999999987766   66777776443221110           11222334556778999999998


Q ss_pred             cccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCC
Q 046112          270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPS  349 (502)
Q Consensus       270 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~  349 (502)
                      ++.... ......++++|++. .++.+.+..          ....++.....++.|++.||+|||   +.+|+||||||+
T Consensus        91 ~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~  155 (294)
T PHA02882         91 CGSFKR-CRMYYRFILLEKLV-ENTKEIFKR----------IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPE  155 (294)
T ss_pred             eeeEec-CCceEEEEEEehhc-cCHHHHHHh----------hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHH
Confidence            653221 11123467777663 355555421          123467788899999999999999   899999999999


Q ss_pred             CeeeCCCCcEEEeeeccceeccccccc-----ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          350 NILLDDEMTAYVSDFGIARFLEAADEQ-----TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       350 NIll~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      |||++.++.++|+|||+|+.+......     .......||+.|+|||+..+..++.++|||||||++|||++|+.||..
T Consensus       156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~  235 (294)
T PHA02882        156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG  235 (294)
T ss_pred             HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence            999999999999999999876432211     111234689999999999999999999999999999999999999976


Q ss_pred             ccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          425 MFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                      ..... ..........   ...+.....    . ...++..+.+++..|++.+|++||+++++.+.+
T Consensus       236 ~~~~~-~~~~~~~~~~---~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        236 FGHNG-NLIHAAKCDF---IKRLHEGKI----K-IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             cccch-HHHHHhHHHH---HHHhhhhhh----c-cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            42211 1111111110   000100000    0 123467788999999999999999999998875

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.4e-36  Score=295.06  Aligned_cols=248  Identities=23%  Similarity=0.272  Sum_probs=194.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ...|...+.||+|+||.||+|....+++.||+|++.....   ...+++.+|+++++.++|||++++.++|..     .+
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~   88 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EH   88 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CC
Confidence            3457788999999999999998888899999999864322   233568899999999999999999999643     34


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++|+||++ |++.+++..         ....+++..+..++.|++.||.|||   +.+|+||||+|+||++++++.++
T Consensus        89 ~~~lv~e~~~-g~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~k  155 (307)
T cd06607          89 TAWLVMEYCL-GSASDILEV---------HKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVK  155 (307)
T ss_pred             eEEEEHHhhC-CCHHHHHHH---------cccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEE
Confidence            7899999996 677776631         2345899999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccC---CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHH
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM---GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  437 (502)
                      |+|||++......      ....++..|+|||.+.   ...++.++||||||+++||++||+.||......     ....
T Consensus       156 L~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~~~  224 (307)
T cd06607         156 LADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALY  224 (307)
T ss_pred             EeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HHHH
Confidence            9999998755322      1245788999999874   456889999999999999999999998653111     0000


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      .....        ......  ...+...+.+++.+||+.+|++||++.+++..
T Consensus       225 ~~~~~--------~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         225 HIAQN--------DSPTLS--SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHhcC--------CCCCCC--chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00000        000000  12345678899999999999999999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.7e-37  Score=302.81  Aligned_cols=275  Identities=20%  Similarity=0.223  Sum_probs=202.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc--CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL--HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||+||+|.+..+++.||||.++..  .......+..|+.+++.++|+||+++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45788899999999999999999889999999998643  2233456778999999999999999999865433233346


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++|+||+. ++|.+++.          ....+++.....++.|++.||.|||   +.+++||||||+||+++.++.+||
T Consensus        84 ~~lv~e~~~-~~L~~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL  149 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR----------SSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKI  149 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEE
Confidence            899999995 78888873          2345889999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccc-c-chHHHHHh
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN-L-NLRNCVKS  438 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~-~-~~~~~~~~  438 (502)
                      +|||+++......  .......++..|+|||.+.. ..++.++|||||||++|||++|+.||....... . ........
T Consensus       150 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  227 (337)
T cd07858         150 CDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS  227 (337)
T ss_pred             CcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999998654322  11223457889999998765 468999999999999999999999996531100 0 00000000


Q ss_pred             hcccch--------hhhcccCC----CCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHH
Q 046112          439 ALPERA--------EEIRASSG----STQRSIILECLISICEIGVACSAEQPGERMKINDVEPR--LRLI  494 (502)
Q Consensus       439 ~~~~~~--------~~~~d~~~----~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~--L~~i  494 (502)
                      ...+..        ........    ........++...+.+++.+|++.+|++|||++|+++.  ++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             CChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            000000        00000000    00001112345678899999999999999999999876  5544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.1e-36  Score=300.87  Aligned_cols=270  Identities=21%  Similarity=0.247  Sum_probs=201.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|+..+.||+|+||.||+|....++..||+|++....  ....+.+.+|+.++++++||||+++++++.... .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence            368888999999999999999988899999999987532  233466788999999999999999998764322 23457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++|+||+. |+|.+++..          ...+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||
T Consensus        83 ~~lv~e~~~-~~l~~~~~~----------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl  148 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHS----------DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRI  148 (334)
T ss_pred             EEEEEehhh-hhHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEe
Confidence            899999995 689888742          344899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceeccccccc--ceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          362 SDFGIARFLEAADEQ--TRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +|||++.........  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....  ......+..
T Consensus       149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~--~~~~~~~~~  226 (334)
T cd07855         149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY--VHQLKLILS  226 (334)
T ss_pred             cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh--HHHHHHHHH
Confidence            999999765432211  11123468899999998765 5689999999999999999999999965311  111111111


Q ss_pred             hccc------------chhhhcccCCC-Cc---chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          439 ALPE------------RAEEIRASSGS-TQ---RSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       439 ~~~~------------~~~~~~d~~~~-~~---~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ....            ......+.... ..   ..........+.+++.+|++.+|++|||+++++..
T Consensus       227 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         227 VLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             HhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1110            00001100000 00   01112346678899999999999999999998763

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.3e-37  Score=292.14  Aligned_cols=246  Identities=23%  Similarity=0.352  Sum_probs=192.0

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeec
Q 046112          213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFM  289 (502)
Q Consensus       213 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  289 (502)
                      ||+|+||.||++.+..+++.+++|+++....   ...+.+.+|++++++++|||++++++.+     ......++++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            6899999999998888899999999865432   3456788999999999999999998874     4455889999999


Q ss_pred             cCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          290 ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       290 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                      ++++|.++++.          ...+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++..
T Consensus        76 ~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~  142 (265)
T cd05579          76 PGGDLASLLEN----------VGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKV  142 (265)
T ss_pred             CCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence            99999999842          236899999999999999999999   89999999999999999999999999999875


Q ss_pred             cccccc------cceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          370 LEAADE------QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       370 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ......      ........++..|+|||.......+.++||||||+++||+++|+.||.....     .+.........
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~  217 (265)
T cd05579         143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQNILNGK  217 (265)
T ss_pred             cccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCC
Confidence            433211      1122335578899999999888899999999999999999999999975321     11111111000


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                      .      .....    ......+.+++.+|++.+|++|||+.++.+.|
T Consensus       218 ~------~~~~~----~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         218 I------EWPED----VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             c------CCCcc----ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            0      00000    01256778999999999999999996665544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.8e-36  Score=284.32  Aligned_cols=250  Identities=24%  Similarity=0.341  Sum_probs=200.8

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEE
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      +|+..+.||+|++|.||++....++..+++|++........+.+.+|++++++++|+|++++++++.     .+...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence            4677889999999999999888889999999987655445678999999999999999999999853     34578999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeec
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG  365 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg  365 (502)
                      +||+++++|.+++..         ....+++..+..++.+++.|++|||   ..+++||||+|+||++++++.++|+|||
T Consensus        76 ~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~  143 (253)
T cd05122          76 MEFCSGGSLKDLLKS---------TNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFG  143 (253)
T ss_pred             EecCCCCcHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecc
Confidence            999999999999853         1256899999999999999999999   8999999999999999999999999999


Q ss_pred             cceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchh
Q 046112          366 IARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAE  445 (502)
Q Consensus       366 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  445 (502)
                      .+........   .....++..|+|||+..+..++.++||||||++++++++|+.||......  ........   ....
T Consensus       144 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~---~~~~  215 (253)
T cd05122         144 LSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFKIAT---NGPP  215 (253)
T ss_pred             cccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHh---cCCC
Confidence            9976654322   23456788999999999888999999999999999999999998752110  00000000   0000


Q ss_pred             hhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          446 EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       446 ~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..        .. .......+.+++.+|++.||++|||+.|+++
T Consensus       216 ~~--------~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         216 GL--------RN-PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             Cc--------Cc-ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00        00 1122456889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.2e-36  Score=290.30  Aligned_cols=261  Identities=19%  Similarity=0.194  Sum_probs=192.4

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCC-CCccceeeecccccccCCCcceeE
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      |...+.||+|+||.||+|....++..||+|+++... .........|+..+.++. |+|++++++++...   ..+..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            456788999999999999988899999999987532 222334457888888885 99999999986432   2257899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      |+||++ |+|.+++..         ....+++.++..++.|++.||+|||   +.+++||||+|+||+++. +.+||+||
T Consensus        78 v~e~~~-~~l~~~l~~---------~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~df  143 (282)
T cd07831          78 VFELMD-MNLYELIKG---------RKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADF  143 (282)
T ss_pred             EEecCC-ccHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEec
Confidence            999996 688887742         2346899999999999999999999   899999999999999999 99999999


Q ss_pred             ccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |+++........   ....++..|+|||+... ..++.++|||||||++|||++|+.||.....  .+...+........
T Consensus       144 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~  218 (282)
T cd07831         144 GSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTP  218 (282)
T ss_pred             ccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCC
Confidence            999765432211   22457889999997654 5678899999999999999999999975321  11111111111110


Q ss_pred             hh---hhccc------CC-----CCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AE---EIRAS------SG-----STQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~---~~~d~------~~-----~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..   .....      ..     ..........+..+.+++.+|++++|++||+++++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         219 DAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00   00000      00     0011112244678899999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.5e-36  Score=300.33  Aligned_cols=268  Identities=22%  Similarity=0.285  Sum_probs=198.2

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc--CcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL--HHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  279 (502)
                      ..++|+..+.||+|+||.||+|.+..+++.+|+|++...  .......+..|+.+++++ +||||++++++|..   ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence            346788889999999999999988888999999987532  222345677899999999 99999999998642   223


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++||||++ ++|.+++..           ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~  146 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRA-----------NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRV  146 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcE
Confidence            46799999996 599888742           25788899999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceeccccccc---ceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHH
Q 046112          360 YVSDFGIARFLEAADEQ---TRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  435 (502)
                      ||+|||++.........   .......++..|+|||.+.+ ..++.++||||||+++|||+||+.||.......  ....
T Consensus       147 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~--~~~~  224 (337)
T cd07852         147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN--QLEK  224 (337)
T ss_pred             EEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--HHHH
Confidence            99999999866443221   12233568899999998765 567899999999999999999999986521110  0000


Q ss_pred             HHhhcc------------cchhhhcccCC----CCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          436 VKSALP------------ERAEEIRASSG----STQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       436 ~~~~~~------------~~~~~~~d~~~----~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      +.....            .....+.+...    ........+....+.+++.+|++.||++|||+.++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         225 IIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000000            00001111000    00011111245678899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.5e-36  Score=292.04  Aligned_cols=245  Identities=24%  Similarity=0.307  Sum_probs=190.0

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeec
Q 046112          213 IGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFM  289 (502)
Q Consensus       213 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  289 (502)
                      ||+|+||+||++....+|+.+|+|.+....   ......+..|++++++++|||++++.+.+     ...+..++|+||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            699999999999888899999999986422   22344567899999999999999999874     3445889999999


Q ss_pred             cCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          290 ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       290 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                      ++++|.+++..        .....+++..+..++.|++.|+.|||   +.+++||||+|+||++++++.++|+|||.+..
T Consensus        76 ~~~~L~~~l~~--------~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~  144 (277)
T cd05577          76 NGGDLKYHIYN--------VGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVE  144 (277)
T ss_pred             CCCcHHHHHHH--------cCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhh
Confidence            99999999853        22346899999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcc
Q 046112          370 LEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRA  449 (502)
Q Consensus       370 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  449 (502)
                      ....   .......++..|+|||+..+..++.++|||||||++++|++|+.||....... ..... .......      
T Consensus       145 ~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~-~~~~~~~------  213 (277)
T cd05577         145 LKGG---KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEEL-KRRTLEM------  213 (277)
T ss_pred             hccC---CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHH-Hhccccc------
Confidence            5431   11223457889999999988889999999999999999999999996532211 11111 1111000      


Q ss_pred             cCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 046112          450 SSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEP  489 (502)
Q Consensus       450 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~  489 (502)
                           ...........+.+++.+|++.||.+||     ++.++++
T Consensus       214 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         214 -----AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             -----cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence                 0011112355677999999999999999     5555653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=318.01  Aligned_cols=270  Identities=25%  Similarity=0.376  Sum_probs=209.4

Q ss_pred             hccCCCCCCcccccCCceEEEEEEc---C----CCeEEEEEEecccCc-chhHHHHHHHHHHhcC-CCCccceeeecccc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILF---E----STTAVAVKVFNVLHH-DASKSFAVECEVTRNI-RHRNLVKVFTACSG  273 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~---~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  273 (502)
                      ..++....+.+|+|.||.|++|...   .    ....||||.++.... ...+.+..|+++|+.+ +|+|++.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3344456679999999999999643   1    256899999985543 3457899999999988 69999999999865


Q ss_pred             cccCCCcceeEEeeeccCCChhhhccCCchhhhccCC----C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCC
Q 046112          274 VDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKA----P--GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLK  347 (502)
Q Consensus       274 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~----~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk  347 (502)
                           ....++|+||+..|+|.++++..+........    .  ..++..+.+.++.|||.|++||+   +.+++||||.
T Consensus       374 -----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLA  445 (609)
T KOG0200|consen  374 -----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLA  445 (609)
T ss_pred             -----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhh
Confidence                 45789999999999999999764400000011    1  34899999999999999999999   9999999999


Q ss_pred             CCCeeeCCCCcEEEeeeccceecccccccceeccc-ccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccc
Q 046112          348 PSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV-EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM  425 (502)
Q Consensus       348 ~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~  425 (502)
                      ++|||+..+..+||+|||+|+.....+......+. .-...|||||.+....|+.|||||||||+||||+| |..||.+.
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            99999999999999999999976555443322111 13556999999999999999999999999999999 99999762


Q ss_pred             cccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          426 FKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                      .. ..++.++++...           ....   +..|..++.++|+.||+.+|++||++.++++.+....
T Consensus       526 ~~-~~~l~~~l~~G~-----------r~~~---P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  526 PP-TEELLEFLKEGN-----------RMEQ---PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             Cc-HHHHHHHHhcCC-----------CCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            11 111222222221           1112   2367888999999999999999999999999998853

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.4e-36  Score=290.85  Aligned_cols=253  Identities=23%  Similarity=0.284  Sum_probs=201.3

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .++.|+..+.||+|++|.||+|.+..++..+++|+++.... ....+..|++.+++++|+|++++++++..     ....
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-----GDEL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCEE
Confidence            46678888999999999999998887899999999875443 45678899999999999999999998543     3588


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++|+||+++++|.+++..         ....+++..+..++.+++.||+|||   +.+++|+||+|+||+++.++.++|+
T Consensus        91 ~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~  158 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQ---------NFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLA  158 (286)
T ss_pred             EEEEeccCCCcHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEEC
Confidence            999999999999999853         1136899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      |||++........  ......++..|+|||.+.+..++.++|||||||++|++++|+.||...... .........    
T Consensus       159 d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~~----  231 (286)
T cd06614         159 DFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITTK----  231 (286)
T ss_pred             ccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhc----
Confidence            9999865433221  112344788999999998888999999999999999999999998652111 011111000    


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                              ....... ...+...+.+++.+|++.+|.+|||+.++++
T Consensus       232 --------~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         232 --------GIPPLKN-PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             --------CCCCCcc-hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                    0000000 1124567889999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.2e-36  Score=286.08  Aligned_cols=254  Identities=23%  Similarity=0.336  Sum_probs=202.7

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|...+.||+|++|.||+|....+++.|++|+++....  ...+.+.+|++++++++|+|++++++.+...   .....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEE
Confidence            46778899999999999998888899999999875432  3457789999999999999999999986432   125789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +++||+++++|.+++..          ...+++..+..++.+++.|++|||   +.+++|+||+|+||+++.++.++|+|
T Consensus        78 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d  144 (260)
T cd06606          78 IFLEYVSGGSLSSLLKK----------FGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLAD  144 (260)
T ss_pred             EEEEecCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcc
Confidence            99999999999999842          227899999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||.+................++..|+|||...+...+.++||||||++++++++|+.||.....    .........   
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~---  217 (260)
T cd06606         145 FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALYKIG---  217 (260)
T ss_pred             cccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHhcc---
Confidence            9999876544321112345678899999999988899999999999999999999999976321    111111100   


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                           .  ..............+.+++.+|++.+|++||++.|+++
T Consensus       218 -----~--~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         218 -----S--SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -----c--cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                 0  00111112233567889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=302.82  Aligned_cols=205  Identities=30%  Similarity=0.426  Sum_probs=173.6

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccc-cCCCcceeE
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVD-FQGNDFKAL  284 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~~l  284 (502)
                      +...+.||+|+||.||+|+...+|+.||||.++... ....+...+|++++++++|+|||++++.-.+.. ..-.....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            345689999999999999999999999999998643 334567889999999999999999998732211 011346789


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC--CCC--cEE
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD--DEM--TAY  360 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~--~~~--~~k  360 (502)
                      |||||++|||+..|..       ......|++.+.+.+..+++.||.|||   +++|+||||||.||++-  .++  .-|
T Consensus        95 vmEyC~gGsL~~~L~~-------PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyK  164 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNS-------PENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYK  164 (732)
T ss_pred             EEeecCCCcHHHHhcC-------cccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEe
Confidence            9999999999999964       345677999999999999999999999   99999999999999993  223  579


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      |+|||.|+.++...   ...+.+||..|.+||.... +.|+...|.|||||++||++||..||..
T Consensus       165 LtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  165 LTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             eecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            99999999876543   5567899999999999884 7889999999999999999999999975

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.6e-36  Score=287.79  Aligned_cols=243  Identities=23%  Similarity=0.319  Sum_probs=192.4

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeec
Q 046112          213 IGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFM  289 (502)
Q Consensus       213 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  289 (502)
                      ||.|++|.||++....+++.+|+|++....   ....+.+..|++++++++||||+++++++     ..+...++++||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence            699999999999988889999999986432   23346789999999999999999999984     3455789999999


Q ss_pred             cCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          290 ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       290 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                      ++++|.+++..          ...+++..+..++.+++.||+|||   +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~~L~~~l~~----------~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~  142 (262)
T cd05572          76 LGGELWTILRD----------RGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKK  142 (262)
T ss_pred             CCCcHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence            99999999843          234788999999999999999999   89999999999999999999999999999986


Q ss_pred             cccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcc
Q 046112          370 LEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRA  449 (502)
Q Consensus       370 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  449 (502)
                      .....   ......++..|+|||.+.+..++.++|+||||+++||+++|+.||.....+.   .......        .+
T Consensus       143 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~--------~~  208 (262)
T cd05572         143 LKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDI--------LK  208 (262)
T ss_pred             cCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHHH--------hc
Confidence            64332   1223467889999999988889999999999999999999999997632211   1111111        10


Q ss_pred             cCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 046112          450 SSGSTQRSIILECLISICEIGVACSAEQPGERMK-----INDVEP  489 (502)
Q Consensus       450 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt-----~~ev~~  489 (502)
                      ..  ....+.......+.+++.+||+.+|++||+     ++|+++
T Consensus       209 ~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         209 GN--GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cC--CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            00  001111223567889999999999999999     566554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=7e-37  Score=283.77  Aligned_cols=275  Identities=20%  Similarity=0.284  Sum_probs=219.3

Q ss_pred             HHHhccCCCCCCcccccCCceEEEEEEcCC-----CeEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccc
Q 046112          200 LYNATKGFSSENLIGAGNFGSVYKGILFES-----TTAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSG  273 (502)
Q Consensus       200 l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~  273 (502)
                      +.....+++....+-+|.||.||+|.+.+.     .+.|-||.++....+ ....+..|.-++....|||+..+.+.|.+
T Consensus       279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            334445677777899999999999977643     344556665533222 23457778888888999999999999853


Q ss_pred             cccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee
Q 046112          274 VDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL  353 (502)
Q Consensus       274 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll  353 (502)
                          ..+..+++|.++.-|+|..++...+.  ........++..+...++.|++.|++|||   +++|+|.||.++|.++
T Consensus       359 ----~~~~P~V~y~~~~~gNLK~FL~~Cr~--~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvI  429 (563)
T KOG1024|consen  359 ----DYATPFVLYPATGVGNLKSFLQICRG--DDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVI  429 (563)
T ss_pred             ----ccCcceEEEeccCcchHHHHHHHhcc--CCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhccee
Confidence                45678999999999999999974432  22355677889999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccch
Q 046112          354 DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNL  432 (502)
Q Consensus       354 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~  432 (502)
                      |+..+|||+|=.++|.+.+.++.....+-..+..||+||.+....|+.++|||||||+||||+| |+.|+.+..  +..+
T Consensus       430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID--PfEm  507 (563)
T KOG1024|consen  430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID--PFEM  507 (563)
T ss_pred             hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC--HHHH
Confidence            9999999999999999998887665555566789999999999999999999999999999999 999987632  1122


Q ss_pred             HHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          433 RNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       433 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      ..+++...+              ...+.+|+.++..+|.-||..+|++||++++++..|++...++.
T Consensus       508 ~~ylkdGyR--------------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt  560 (563)
T KOG1024|consen  508 EHYLKDGYR--------------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT  560 (563)
T ss_pred             HHHHhccce--------------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence            222222211              11134899999999999999999999999999999998877654

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.7e-36  Score=293.64  Aligned_cols=246  Identities=24%  Similarity=0.291  Sum_probs=192.5

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      |...+.||+|+||.||+|....++..||+|.+.....   .....+..|++++++++|||+++++++|..     +...+
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~  101 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTAW  101 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeEE
Confidence            5667899999999999999888999999999864322   233568889999999999999999998643     34789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||++ |+|.+.+..         ....+++.++..++.+++.|+.|||   +.+|+||||+|+||+++.++.++|+|
T Consensus       102 lv~e~~~-g~l~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~d  168 (317)
T cd06635         102 LVMEYCL-GSASDLLEV---------HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLAD  168 (317)
T ss_pred             EEEeCCC-CCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEec
Confidence            9999996 578777632         2345899999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccC---CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGM---GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      ||++......      ....+++.|+|||++.   .+.++.++|||||||++|||++|+.||...... .....+.....
T Consensus       169 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~  241 (317)
T cd06635         169 FGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNES  241 (317)
T ss_pred             CCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccC
Confidence            9998754322      2345788999999874   456899999999999999999999998652111 01111111100


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                      +           ...   .......+.+++.+|++.+|.+||++.++++..
T Consensus       242 ~-----------~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         242 P-----------TLQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             C-----------CCC---CccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            0           000   113445678999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=302.14  Aligned_cols=250  Identities=25%  Similarity=0.318  Sum_probs=200.0

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      |.+...||.|+||.||+|...+++-..|-|++.........+|.-|+++|+..+||+||++++.|+     .++.+++..
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-----~enkLwili  108 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-----FENKLWILI  108 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-----ccCceEEEE
Confidence            455678999999999999888888888899988766677788999999999999999999999853     345799999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      |||.||-.+..+-         .....+.+.+..-++++++.||.|||   +..|||||||+.|||++-+|.++|+|||.
T Consensus       109 EFC~GGAVDaiml---------EL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGV  176 (1187)
T KOG0579|consen  109 EFCGGGAVDAIML---------ELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGV  176 (1187)
T ss_pred             eecCCchHhHHHH---------HhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccc
Confidence            9999999988874         34567999999999999999999999   99999999999999999999999999998


Q ss_pred             ceecccccccceecccccccccccCcccC-----CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGM-----GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +....  .+......+.||+.|||||+.+     +.+|+.++||||||++|.||..+.+|..+... -..+....++..|
T Consensus       177 SAKn~--~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-MRVllKiaKSePP  253 (1187)
T KOG0579|consen  177 SAKNK--STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEPP  253 (1187)
T ss_pred             cccch--hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-HHHHHHHhhcCCC
Confidence            85332  1222334678999999999855     46899999999999999999999999765211 0011111111111


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .    +.      .   +..-...+.+++.+|+.+||..||+++++++
T Consensus       254 T----Ll------q---PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  254 T----LL------Q---PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             c----cc------C---cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            1    11      0   1233556789999999999999999999875

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.3e-36  Score=298.32  Aligned_cols=267  Identities=21%  Similarity=0.218  Sum_probs=197.8

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc--CcchhHHHHHHHHHHhcCCCCccceeeecccccc-cCCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL--HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVD-FQGN  279 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~  279 (502)
                      ..++|...+.||+|+||.||+|....+++.||+|++...  .....+.+.+|++++++++||||+++++++.... +...
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            456899999999999999999999889999999998643  2233456778999999999999999999864321 1223


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++||||+. ++|.+.+..            .++......++.|++.||+|||   ..+|+||||||+||+++.++.+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~------------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~  157 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM------------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL  157 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCE
Confidence            46799999995 588877632            1788889999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||+++.......   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+..... .
T Consensus       158 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~-~  232 (353)
T cd07850         158 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIE-Q  232 (353)
T ss_pred             EEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH-h
Confidence            9999999986543221   22345788999999999999999999999999999999999999642110 00111000 0


Q ss_pred             ccc-----------chhhhcccCC----------------CCc-chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          440 LPE-----------RAEEIRASSG----------------STQ-RSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       440 ~~~-----------~~~~~~d~~~----------------~~~-~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      +..           ......+...                ... ..........+.+++.+|++.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         233 LGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             cCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000           0000000000                000 00011235567899999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.5e-36  Score=288.87  Aligned_cols=243  Identities=20%  Similarity=0.238  Sum_probs=183.7

Q ss_pred             cccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHHH---HhcCCCCccceeeecccccccCCCcceeEE
Q 046112          212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECEV---TRNIRHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       212 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      +||+|+||.||++....+++.+|+|.+.....   .....+..|..+   +...+|||++.+.+++.     .++..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence            48999999999999888899999998864321   112334444443   33447999999988743     34578999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeec
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG  365 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg  365 (502)
                      |||+++|+|.+++..          ...+++.....++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||
T Consensus        76 ~e~~~~~~L~~~i~~----------~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg  142 (279)
T cd05633          76 LDLMNGGDLHYHLSQ----------HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG  142 (279)
T ss_pred             EecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCC
Confidence            999999999988742          345899999999999999999999   8999999999999999999999999999


Q ss_pred             cceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch
Q 046112          366 IARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       366 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      ++........    ....|+..|+|||.... ..++.++|||||||++|||++|+.||........   .......... 
T Consensus       143 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~-  214 (279)
T cd05633         143 LACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLTV-  214 (279)
T ss_pred             cceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH---HHHHHHhhcC-
Confidence            9875432211    23458999999998864 5689999999999999999999999975322111   1111111000 


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEPR  490 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~~  490 (502)
                          .      ..........+.+++.+|++.||++||     |++|+++.
T Consensus       215 ----~------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         215 ----N------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ----C------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                0      011123455678999999999999999     58888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=296.65  Aligned_cols=271  Identities=20%  Similarity=0.227  Sum_probs=196.4

Q ss_pred             CCCCCCcccccCCceEEEEEEcC--CCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFE--STTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      +|...+.||+|+||.||+|....  .+..||+|.+....   ......+.+|++++++++||||+++++++...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            36777899999999999998877  78999999987632   33346678899999999999999999997532   235


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC----C
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD----E  356 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~----~  356 (502)
                      ..++||||+++ +|.+++....     ......+++.....++.|++.||+|||   +.+|+||||||+||+++.    +
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~  148 (316)
T cd07842          78 SVYLLFDYAEH-DLWQIIKFHR-----QAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPER  148 (316)
T ss_pred             eEEEEEeCCCc-CHHHHHHhhc-----cCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCcc
Confidence            78999999964 6766653211     112246889999999999999999999   899999999999999999    9


Q ss_pred             CcEEEeeeccceecccccc-cceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccc-----
Q 046112          357 MTAYVSDFGIARFLEAADE-QTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN-----  429 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~-----  429 (502)
                      +.+||+|||+++....... ........+++.|+|||.+.+ ..++.++|||||||+++||++|+.||.....+.     
T Consensus       149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~  228 (316)
T cd07842         149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP  228 (316)
T ss_pred             ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccch
Confidence            9999999999986643322 112234567899999998766 457899999999999999999999997532221     


Q ss_pred             ---cchHHHHHhhc-------------ccchh---hhcccCCCCcchhhH------HHHHHHHHHHhhcccCCCCCCCCH
Q 046112          430 ---LNLRNCVKSAL-------------PERAE---EIRASSGSTQRSIIL------ECLISICEIGVACSAEQPGERMKI  484 (502)
Q Consensus       430 ---~~~~~~~~~~~-------------~~~~~---~~~d~~~~~~~~~~~------~~~~~l~~l~~~c~~~dP~~RPt~  484 (502)
                         ..+...+...-             ++...   ......... .....      .....+.+++.+|++.||++|||+
T Consensus       229 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~  307 (316)
T cd07842         229 FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPS-NSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA  307 (316)
T ss_pred             hHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCC-ccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH
Confidence               01111111000             00000   000000000 00000      234568899999999999999999


Q ss_pred             HHHHH
Q 046112          485 NDVEP  489 (502)
Q Consensus       485 ~ev~~  489 (502)
                      .|+++
T Consensus       308 ~eil~  312 (316)
T cd07842         308 EEALE  312 (316)
T ss_pred             HHHhc
Confidence            99875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-36  Score=287.30  Aligned_cols=261  Identities=21%  Similarity=0.250  Sum_probs=198.7

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc--hhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD--ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      |...+.||+|++|.||+|....+++.+++|.++.....  ....+..|++++++++|+|++++++++.     .++..++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence            45678899999999999988889999999998754322  3467888999999999999999999854     3458899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      |+||+++ +|.+++..         ....+++..+..++.+++.||.|||   +.+|+|+||+|+||+++.++.++|+||
T Consensus        76 v~e~~~~-~l~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df  142 (283)
T cd05118          76 VFEFMDT-DLYKLIKD---------RQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADF  142 (283)
T ss_pred             EEeccCC-CHHHHHHh---------hcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeee
Confidence            9999975 88887742         2256899999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc--
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP--  441 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--  441 (502)
                      |.+.......  .......++..|+|||.+.+. .++.++||||||+++|+++||+.||......+ .+... .....  
T Consensus       143 ~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~-~~~~~~~  218 (283)
T cd05118         143 GLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKI-FRTLGTP  218 (283)
T ss_pred             eeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-HHHcCCC
Confidence            9998765433  112234578899999998876 78999999999999999999999986532111 11111 11100  


Q ss_pred             --cchhh-----------hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 --ERAEE-----------IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 --~~~~~-----------~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                        .....           ..+...........+....+.+++.+|++.||.+||++.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         219 DPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             chHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence              00000           0000111111222356778899999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-36  Score=284.17  Aligned_cols=248  Identities=26%  Similarity=0.392  Sum_probs=199.3

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|+..+.||+|++|.||+|....+++.+++|.+.....  ...+.+.+|++++++++|+|++++++++.     .....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence            46778999999999999998888899999999875443  34567899999999999999999999853     345789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +++||+++++|.+++..          ...+++..+..++.+++.|+.|||   +.+|+||||+|+||+++.++.++|+|
T Consensus        76 ~v~e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d  142 (254)
T cd06627          76 IILEYAENGSLRQIIKK----------FGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLAD  142 (254)
T ss_pred             EEEecCCCCcHHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEec
Confidence            99999999999999842          256899999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||.+.........  .....++..|+|||...+..++.++||||+|+++|++++|+.||.....    ....... ....
T Consensus       143 ~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~-~~~~  215 (254)
T cd06627         143 FGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRI-VQDD  215 (254)
T ss_pred             cccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHH-hccC
Confidence            9999876543321  2234578899999998888889999999999999999999999875211    1111000 0000


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                                 ...+.......+.+++.+|+..+|++|||+.+++.
T Consensus       216 -----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         216 -----------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                       00111123456779999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.7e-36  Score=292.67  Aligned_cols=271  Identities=18%  Similarity=0.212  Sum_probs=195.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeeccccccc---CC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDF---QG  278 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~  278 (502)
                      .++|...+.||+|+||.||+|....+++.||||.+.....  .....+.+|++++++++||||++++++|.....   ..
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            3578889999999999999999888999999998864322  223456789999999999999999998754321   12


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      ....++||||+. ++|.+++..         ....+++.+...++.|++.||+|||   +.+++|+||||+||+++.++.
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~  157 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSN---------KNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGI  157 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCc
Confidence            345699999996 578777642         2345899999999999999999999   889999999999999999999


Q ss_pred             EEEeeeccceeccccccc--ceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHH
Q 046112          359 AYVSDFGIARFLEAADEQ--TRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  435 (502)
                      +||+|||++.........  .......++..|+|||.+.+. .++.++||||||+++|||+||+.||.....  ......
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--~~~~~~  235 (310)
T cd07865         158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--QHQLTL  235 (310)
T ss_pred             EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence            999999999765433221  111234578899999987664 478899999999999999999999865211  111111


Q ss_pred             HHhhcccchhhh---------ccc-CCCC-cchhhH------HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          436 VKSALPERAEEI---------RAS-SGST-QRSIIL------ECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       436 ~~~~~~~~~~~~---------~d~-~~~~-~~~~~~------~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      +.........++         .+. .... ......      .....+.+++.+|+..||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            111110000000         000 0000 000000      01245678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.2e-36  Score=290.92  Aligned_cols=244  Identities=23%  Similarity=0.310  Sum_probs=194.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeecc
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMA  290 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~  290 (502)
                      .+||+|+||.||++....++..||+|++..........+.+|+.+++.++|+|++++++++.     .++..++||||++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~  100 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVMEFLE  100 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEEecCC
Confidence            57999999999999888899999999986544445567899999999999999999999853     4458999999999


Q ss_pred             CCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceec
Q 046112          291 NGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL  370 (502)
Q Consensus       291 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~  370 (502)
                      +++|.+++..           ..+++.....++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++...
T Consensus       101 ~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~  166 (292)
T cd06657         101 GGALTDIVTH-----------TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  166 (292)
T ss_pred             CCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence            9999988632           24788899999999999999999   889999999999999999999999999998755


Q ss_pred             ccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhccc
Q 046112          371 EAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRAS  450 (502)
Q Consensus       371 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  450 (502)
                      .....  ......+++.|+|||+..+..++.++|||||||++||+++|+.||....  ............+..       
T Consensus       167 ~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~--~~~~~~~~~~~~~~~-------  235 (292)
T cd06657         167 SKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPK-------  235 (292)
T ss_pred             ccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhhCCcc-------
Confidence            43221  1223457899999999988889999999999999999999999986521  111111111111110       


Q ss_pred             CCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          451 SGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       451 ~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                       ...    .......+.+++.+|++.+|.+||++.++++
T Consensus       236 -~~~----~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         236 -LKN----LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             -cCC----cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence             001    1123445778999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.7e-36  Score=290.11  Aligned_cols=273  Identities=18%  Similarity=0.185  Sum_probs=196.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCC-CCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|+..+.||+|+||.||+|.+..+++.||+|+++....  .....+.+|+.+++.++ |||++++++++...+......
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            368888999999999999999888999999998764322  23467888999999995 699999998865433222334


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC-CCcEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD-EMTAY  360 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~-~~~~k  360 (502)
                      .++||||+++ +|.+++....     ......+++.....++.|++.||.|||   +.+|+||||+|+||+++. ++.+|
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~k  151 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNG-----RGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLK  151 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhc-----ccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEE
Confidence            7999999985 8888875311     111346899999999999999999999   899999999999999998 89999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++.+......  .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||...... ..+.......
T Consensus       152 l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~  228 (295)
T cd07837         152 IADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-QQLLHIFKLL  228 (295)
T ss_pred             EeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHh
Confidence            9999999765332211  122346888999998765 45789999999999999999999998652111 0111111100


Q ss_pred             c-cc--c---hhhhcc----cCCC--CcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 L-PE--R---AEEIRA----SSGS--TQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~-~~--~---~~~~~d----~~~~--~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      . +.  .   .....+    +...  ............+.+++.+|+..||.+||++.|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0 00  0   000000    0000  000001134566789999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.5e-36  Score=291.84  Aligned_cols=265  Identities=20%  Similarity=0.204  Sum_probs=195.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|+..+.||+|+||.||+|.+..+++.+|+|.++....  .....+.+|++++++++||||+++++++...   .....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence            468888999999999999999888899999999874332  2234567899999999999999999986432   12589


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++|+||+. ++|.+++..         ....+++.....++.|++.||+|||   +.+++|+||||+||+++.++.+||+
T Consensus        82 ~lv~e~~~-~~L~~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~  148 (293)
T cd07843          82 YMVMEYVE-HDLKSLMET---------MKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKIC  148 (293)
T ss_pred             EEEehhcC-cCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEe
Confidence            99999997 599888742         1235899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||+++.......  ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...... ..+.. +.....
T Consensus       149 d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~-~~~~~~  224 (293)
T cd07843         149 DFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNK-IFKLLG  224 (293)
T ss_pred             ecCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHH-HHHHhC
Confidence            9999986654321  11234568899999988764 4689999999999999999999998752111 00100 000000


Q ss_pred             --------------cch-hhhcccCCCC-cchhhHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 --------------ERA-EEIRASSGST-QRSIILE-CLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 --------------~~~-~~~~d~~~~~-~~~~~~~-~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                                    ... .......... ...+... ....+.+++.+|++.+|++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         225 TPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             CCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                          000 0000000000 0000001 2556789999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.5e-36  Score=284.91  Aligned_cols=250  Identities=24%  Similarity=0.274  Sum_probs=200.4

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|+..+.||+|++|.||++....++..+++|.+....  .....++..|++++++++|+||+++.+++.     .....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence            4777899999999999999888899999999987432  233456788999999999999999998853     345899


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||+++++|.+++...      ......+++..+..++.+++.||+|||   +.+++|+||+|+||++++++.+||+|
T Consensus        76 ~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d  146 (256)
T cd08530          76 IVMEYAPFGDLSKAISKR------KKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGD  146 (256)
T ss_pred             EEehhcCCCCHHHHHHHH------HhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEee
Confidence            999999999999998531      122356889999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||++......    ......++..|+|||...+..++.++|+||||+++||+++|+.||......  .+...+..     
T Consensus       147 ~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~-----  215 (256)
T cd08530         147 LGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQR-----  215 (256)
T ss_pred             ccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc-----
Confidence            9999766543    112345788999999999999999999999999999999999999753211  11111100     


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                            ...   ..........+.+++.+|++.+|++||++.|+++
T Consensus       216 ------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         216 ------GKY---PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ------CCC---CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                  000   1111244566889999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.4e-36  Score=292.31  Aligned_cols=266  Identities=23%  Similarity=0.229  Sum_probs=196.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||.||+|.+..+|+.||+|+++....  .....+.+|+.++++++|+|++++++++...   ..+.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence            4678899999999999999999888999999999874322  2234567899999999999999999985421   2246


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+. ++|.+++..         ....+++.++..++.|++.|++|||   +.+++||||||+||++++++.+||
T Consensus        83 ~~lv~e~~~-~~l~~~l~~---------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL  149 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDN---------MPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKI  149 (309)
T ss_pred             EEEEEecCC-CCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence            799999996 588888742         2256899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      +|||++........  ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.....  ......+....
T Consensus       150 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~~~~~  225 (309)
T cd07845         150 ADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLIIQLL  225 (309)
T ss_pred             CccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhc
Confidence            99999986653321  1122345788999998865 4578999999999999999999999975211  11111111111


Q ss_pred             ccchhhhc---------------ccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PERAEEIR---------------ASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~---------------d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ......++               .................+.+++.+|++.||++|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         226 GTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             CCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            10000000               00000000000113556778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-36  Score=294.72  Aligned_cols=276  Identities=20%  Similarity=0.241  Sum_probs=205.3

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|.+.+.||.|++|.||+|....++..||+|++....  ....+.+.+|+++++.++|+||+++.+++...........+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999988889999999987543  33456789999999999999999999986543222234689


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      ++|||++ ++|.+++..          ...+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.++|+|
T Consensus        81 lv~e~~~-~~l~~~l~~----------~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~d  146 (330)
T cd07834          81 IVTELME-TDLHKVIKS----------PQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICD  146 (330)
T ss_pred             EEecchh-hhHHHHHhC----------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcc
Confidence            9999997 588888742          236899999999999999999999   89999999999999999999999999


Q ss_pred             eccceeccccccc-ceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          364 FGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       364 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      ||++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......  .....+.....
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~  224 (330)
T cd07834         147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLG  224 (330)
T ss_pred             cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcC
Confidence            9999876543211 112334578899999999887 8999999999999999999999999753211  11111111110


Q ss_pred             cc------------hhhhccc-CCC---CcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHHHHH
Q 046112          442 ER------------AEEIRAS-SGS---TQRSIILECLISICEIGVACSAEQPGERMKINDVEPR--LRLIKKK  497 (502)
Q Consensus       442 ~~------------~~~~~d~-~~~---~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~--L~~i~~~  497 (502)
                      ..            ....... ...   .......+....+.+++.+||+++|.+|||++++++.  ++.++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence            00            0000000 000   0000111245678899999999999999999999874  5555443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4e-37  Score=302.35  Aligned_cols=246  Identities=25%  Similarity=0.408  Sum_probs=194.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEE---EEEeccc-CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEE
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVA---VKVFNVL-HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~va---vK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      ..+||+|+|-+||+|.+..+|..||   ||.-+.. .....+.|..|+.+|+.|+||||++++.++...+   +...-+|
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in~i  121 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTINFI  121 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceeeee
Confidence            4689999999999999988898887   3322222 1223478999999999999999999999865432   3567899


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC-CCcEEEeee
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD-EMTAYVSDF  364 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~-~~~~kl~Df  364 (502)
                      +|.|..|+|..|...          .+.++......|+.||++||.|||.. .++|+|||||-.||+++. .|.|||+|+
T Consensus       122 TEL~TSGtLr~Y~kk----------~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDL  190 (632)
T KOG0584|consen  122 TELFTSGTLREYRKK----------HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDL  190 (632)
T ss_pred             eecccCCcHHHHHHH----------hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecch
Confidence            999999999999853          34466778899999999999999954 789999999999999975 589999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      |+|.......    ...+.|||.|||||+.. ..|++..||||||+.++||+|+..||........-+...+.+..|..+
T Consensus       191 GLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl  265 (632)
T KOG0584|consen  191 GLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL  265 (632)
T ss_pred             hHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh
Confidence            9998765432    23478999999999866 789999999999999999999999998643322223333333334444


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..+.|              +++.+++.+|+.. ..+|||+.|+++
T Consensus       266 ~kV~d--------------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  266 SKVKD--------------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             hccCC--------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence            44333              3466899999998 999999999875

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.8e-36  Score=293.16  Aligned_cols=258  Identities=25%  Similarity=0.245  Sum_probs=192.6

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCC-CCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|...+.||+|+||.||++.+..++..||+|.+.... ......+..|+.++.++. |+||+++++++.     .+...+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcEE
Confidence            4556678999999999999998899999999986432 234567889999999996 999999999853     345788


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      ++|||+. +++.++.....     ......+++.....++.+++.||+|||+  ..+++||||||+||+++.++.+||+|
T Consensus        80 ~~~e~~~-~~l~~l~~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~d  151 (288)
T cd06616          80 ICMELMD-ISLDKFYKYVY-----EVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCD  151 (288)
T ss_pred             EEEeccc-CCHHHHHHHHH-----HhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEee
Confidence            9999985 46555432100     0223568999999999999999999993  35899999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCC---ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH---EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      ||+++........   ....++..|+|||.+.+.   .++.++|||||||++||+++|+.||....    ...+.+....
T Consensus       152 fg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~  224 (288)
T cd06616         152 FGISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVV  224 (288)
T ss_pred             cchhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhc
Confidence            9999755432211   223578899999998776   68999999999999999999999987521    1111111111


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ....     +...  ......+...+.+++.+|++.+|++|||+.++++.
T Consensus       225 ~~~~-----~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         225 KGDP-----PILS--NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCCC-----CcCC--CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1100     0000  01112345678899999999999999999998864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.4e-36  Score=283.46  Aligned_cols=252  Identities=22%  Similarity=0.313  Sum_probs=201.8

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|...+.||.|++|.||++.+..++..+++|++.....  ...+.+..|+++++.++|||++++.+.+     ......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~-----~~~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF-----EEKGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEE-----ecCCEEE
Confidence            46778899999999999999988899999999875433  4456788999999999999999999884     3346889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||+++++|.+++....      .....+++.....++.+++.|++|||   +.+++|+||+|+||++++++.++|+|
T Consensus        76 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d  146 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQK------KEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGD  146 (258)
T ss_pred             EEEEecCCCcHHHHHHHhh------ccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECC
Confidence            9999999999999985311      12467899999999999999999999   88999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||.+.......  .......+++.|+|||...+..++.++||||+|++++++++|+.||+...     ..+.........
T Consensus       147 ~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~  219 (258)
T cd08215         147 FGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQ  219 (258)
T ss_pred             ccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCC
Confidence            99997654432  12223467889999999988889999999999999999999999986521     111111111111


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                              ....   .......+.+++.+|+..+|++|||+.|+++
T Consensus       220 --------~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 --------YPPI---PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             --------CCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                    0001   1133456789999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-35  Score=285.69  Aligned_cols=267  Identities=21%  Similarity=0.261  Sum_probs=196.0

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc--hhHHHHHHHHHHhcC---CCCccceeeecccccccCCCcc
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD--ASKSFAVECEVTRNI---RHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      |++.+.||+|+||.||+|.+..+++.+|+|+++.....  ....+..|++++.++   +|+|++++++++...+......
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            55678999999999999998878999999998743222  234566777776655   6999999999976544333345


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .+++|||+. ++|.+++..        .....+++..+..++.+++.||.|||   +.+++|+||+|+||+++.++.+||
T Consensus        81 ~~l~~e~~~-~~l~~~l~~--------~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l  148 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSK--------CPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKI  148 (287)
T ss_pred             eEEEehhcc-cCHHHHHHH--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEE
Confidence            899999996 589888743        22235899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||++..+......   ....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+.........
T Consensus       149 ~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~  224 (287)
T cd07838         149 ADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGL  224 (287)
T ss_pred             eccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCC
Confidence            999999776433221   233478899999999999999999999999999999999999875221 1112222111100


Q ss_pred             cchhh-----------hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEE-----------IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~-----------~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .....           ..............+....+.+++.+|++.||.+||++.|++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         225 PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00000           0000000111112244567789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.3e-35  Score=283.79  Aligned_cols=247  Identities=20%  Similarity=0.302  Sum_probs=189.9

Q ss_pred             HHhccCCCCCCcc--cccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeecccccccC
Q 046112          201 YNATKGFSSENLI--GAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       201 ~~~t~~~~~~~~l--G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  277 (502)
                      ....++|...+.+  |+|+||.||++....++..+|+|.+.......   .  |+.....+ +|||++++++++.     
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~-----   79 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVT-----   79 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEe-----
Confidence            3344566666666  99999999999988899999999986432211   1  22222222 7999999999853     


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                      ..+..++||||+++|+|.+++..          ...+++.....++.|+++|+.|||   +.+++||||||+||+++.++
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~  146 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKK----------EGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAK  146 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCC
Confidence            34489999999999999999842          236899999999999999999999   89999999999999999988


Q ss_pred             -cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          358 -TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       358 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                       .++|+|||+++.....      ....++..|+|||++.+..++.++|||||||++||+++|+.||.....+......+.
T Consensus       147 ~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~  220 (267)
T PHA03390        147 DRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL  220 (267)
T ss_pred             CeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH
Confidence             9999999998765422      123578999999999998999999999999999999999999986443333333332


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC-HHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK-INDVEP  489 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt-~~ev~~  489 (502)
                      ... ..        .    ..........+.+++.+|++.+|.+||+ ++|+++
T Consensus       221 ~~~-~~--------~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        221 KRQ-QK--------K----LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             Hhh-cc--------c----CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            221 10        0    0011134556789999999999999996 688764

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.3e-36  Score=290.24  Aligned_cols=264  Identities=20%  Similarity=0.235  Sum_probs=193.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|...+.||+|++|.||+|.+..+++.||+|.+.....  ...+.+..|++++++++|||++++++++.     .....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence            468888999999999999999888999999999864322  23456889999999999999999999853     44589


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC-CCcEEE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD-EMTAYV  361 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~-~~~~kl  361 (502)
                      ++||||++ ++|.+++..        .....+++.....++.|++.||+|||   +.+++||||+|+||+++. ++.+||
T Consensus        77 ~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl  144 (294)
T PLN00009         77 YLVFEYLD-LDLKKHMDS--------SPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKL  144 (294)
T ss_pred             EEEEeccc-ccHHHHHHh--------CCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEE
Confidence            99999995 578777632        22334577888899999999999999   899999999999999985 567999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      +|||++........  ......+++.|+|||++.+ ..++.++|||||||++|+|+||+.||......+ .+.+... ..
T Consensus       145 ~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~-~~  220 (294)
T PLN00009        145 ADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFR-IL  220 (294)
T ss_pred             cccccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-Hh
Confidence            99999975533211  1123456889999998766 457899999999999999999999997532111 1111110 00


Q ss_pred             ccchhhhcc------------cCC--CCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PERAEEIRA------------SSG--STQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~d------------~~~--~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .......+.            +..  .............+.+++.+|++.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        221 GTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             CCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000000000            000  0000001123456789999999999999999999986

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.1e-36  Score=287.88  Aligned_cols=265  Identities=20%  Similarity=0.274  Sum_probs=196.4

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      +|+..+.||+|++|.||+|.+..+|..||||+++.... .....+..|++++++++|+|++++++++.     ..+..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence            47788999999999999999888999999999875432 23456778999999999999999999854     3447899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||++ ++|.+++...       .....+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+||
T Consensus        76 v~e~~~-~~l~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~  144 (284)
T cd07836          76 VFEYMD-KDLKKYMDTH-------GVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADF  144 (284)
T ss_pred             EEecCC-ccHHHHHHhc-------CCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeec
Confidence            999997 4888887431       12345899999999999999999999   889999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh---c
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA---L  440 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~---~  440 (502)
                      |+++.......  ......++..|++||++.+. .++.++|||||||++||+++|+.||......+ ......+..   .
T Consensus       145 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~  221 (284)
T cd07836         145 GLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPT  221 (284)
T ss_pred             chhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCC
Confidence            99975433211  11234568899999987664 57889999999999999999999997532111 111111100   0


Q ss_pred             ccchhhhcc-----cCCCC-----cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PERAEEIRA-----SSGST-----QRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~d-----~~~~~-----~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ......+.+     .....     ...........+.+++.+|++.||.+||++.|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         222 ESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000000     00000     00111233566789999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-36  Score=287.93  Aligned_cols=264  Identities=20%  Similarity=0.251  Sum_probs=196.3

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      |...+.||+|++|.||+|....+++.+|+|++....  ......+.+|++++++++|+|++++++++...   ..+..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence            556789999999999999988889999999997653  23346688999999999999999999986432   1357899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      |+||++ ++|.+++..         ....+++..+..++.+++.|++|||   +.+++|+||+|+||++++++.+||+||
T Consensus        78 v~e~~~-~~l~~~~~~---------~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~  144 (287)
T cd07840          78 VFEYMD-HDLTGLLDS---------PEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADF  144 (287)
T ss_pred             Eecccc-ccHHHHHhc---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccc
Confidence            999997 488888742         2246899999999999999999999   889999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc-
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE-  442 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-  442 (502)
                      |++........ .......++..|+|||.+.+ ..++.++||||||+++|||+||+.||+....  ......+...... 
T Consensus       145 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~--~~~~~~~~~~~~~~  221 (287)
T cd07840         145 GLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE--LEQLEKIFELCGSP  221 (287)
T ss_pred             cceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCC
Confidence            99986654332 11223456788999997765 4578999999999999999999999975321  1111111111000 


Q ss_pred             ---chhhhcc--------cCCC---CcchhhHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 ---RAEEIRA--------SSGS---TQRSIILE-CLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ---~~~~~~d--------~~~~---~~~~~~~~-~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                         ....+.+        ....   ...+.... +...+.+++.+|++.+|++||++.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             chhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               0000000        0000   00000111 2667889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-36  Score=284.45  Aligned_cols=253  Identities=20%  Similarity=0.251  Sum_probs=195.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc-----CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL-----HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .+|...+.||+|+||.||+|.+..++..||+|.+...     .......+.+|++++++++|+||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence            4788899999999999999998889999999987532     12234578899999999999999999998532   123


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++++||+++++|.+++..          ...+++.....++.+++.|+.|||   +.+++|+||||+||+++.++.+
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~  145 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKA----------YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNV  145 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCE
Confidence            467899999999999998842          234788889999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccc-cceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADE-QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +|+|||+++....... ........++..|+|||+..+..++.++|||||||++||+++|+.||.+...    .... ..
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~-~~  220 (264)
T cd06653         146 KLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAI-FK  220 (264)
T ss_pred             EECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHH-HH
Confidence            9999999976532111 1111234588999999999988899999999999999999999999975211    1111 11


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .....          ....++......+.+++.+|+. +|..||++.+++.
T Consensus       221 ~~~~~----------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         221 IATQP----------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHcCC----------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            11000          0011112344567799999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-36  Score=284.72  Aligned_cols=244  Identities=23%  Similarity=0.304  Sum_probs=185.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHHH-HhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECEV-TRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.||+|+||.||+|....+++.||+|+++....   .....+..|..+ ....+|+|++++++++     ..++..++|+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence            578999999999998888899999999864321   112234445444 4456899999999985     3445899999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++++|.+++..          ...+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||+
T Consensus        77 e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~  143 (260)
T cd05611          77 EYLNGGDCASLIKT----------LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGL  143 (260)
T ss_pred             eccCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeeccc
Confidence            99999999999842          235788899999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      ++....      .....++..|+|||...+..++.++||||||+++||+++|..||.....     ............  
T Consensus       144 ~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~--  210 (260)
T cd05611         144 SRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILSRRI--  210 (260)
T ss_pred             ceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhccc--
Confidence            875432      1234578899999999888899999999999999999999999975321     111111100000  


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                            .........+...+.+++.+|++.+|++||++.++.+.|
T Consensus       211 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         211 ------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ------CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence                  000011123456788999999999999999876655433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.4e-35  Score=288.86  Aligned_cols=271  Identities=20%  Similarity=0.223  Sum_probs=197.6

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccc-----
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVD-----  275 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  275 (502)
                      +.++|+..+.||+|+||.||+|....+++.||+|+++...  ......+..|++++++++|||++++++++....     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4568899999999999999999988889999999987532  223356788999999999999999999864422     


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD  355 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~  355 (502)
                      .......++|+||+++ ++.+.+..         ....+++..+..++.|++.||+|||   +.+|+||||||+||++++
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~  151 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLES---------GLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNN  151 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhc---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence            1123478999999975 67666632         2346899999999999999999999   899999999999999999


Q ss_pred             CCcEEEeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHH
Q 046112          356 EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN  434 (502)
Q Consensus       356 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~  434 (502)
                      ++.+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+..
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~  229 (302)
T cd07864         152 KGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLEL  229 (302)
T ss_pred             CCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH
Confidence            99999999999986643322 11122345778999998765 4578999999999999999999999975211 111111


Q ss_pred             HHHhhccc----chhhhc--------ccCCC---CcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          435 CVKSALPE----RAEEIR--------ASSGS---TQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       435 ~~~~~~~~----~~~~~~--------d~~~~---~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                       +......    ....+.        +....   .........+..+.+++.+|++.+|.+||++.+++.
T Consensus       230 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         230 -ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             -HHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             1111100    000000        00000   000001123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.4e-35  Score=285.27  Aligned_cols=242  Identities=21%  Similarity=0.245  Sum_probs=183.5

Q ss_pred             cccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHH---HHhcCCCCccceeeecccccccCCCcceeEE
Q 046112          212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECE---VTRNIRHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       212 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      .||+|+||.||+|....+++.||+|.+.....   .....+..|..   .++...||+++++.+++     ...+..++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            48999999999998888899999998864321   11222334433   44556899999998874     344588999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeec
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG  365 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg  365 (502)
                      +||+++|+|.+++.          ....+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        76 ~e~~~g~~L~~~l~----------~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg  142 (278)
T cd05606          76 LDLMNGGDLHYHLS----------QHGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG  142 (278)
T ss_pred             EecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCc
Confidence            99999999998873          2346899999999999999999999   8999999999999999999999999999


Q ss_pred             cceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch
Q 046112          366 IARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       366 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      ++.......    .....|+..|+|||.+.++ .++.++||||+||++|||++|+.||........  ... ......  
T Consensus       143 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~-~~~~~~--  213 (278)
T cd05606         143 LACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEI-DRMTLT--  213 (278)
T ss_pred             CccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHH-HHHhhc--
Confidence            987543221    1234689999999998754 689999999999999999999999976321111  110 000000  


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEP  489 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~  489 (502)
                         ....      ........+.+++.+|+..+|.+||     ++.++++
T Consensus       214 ---~~~~------~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         214 ---MAVE------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ---cCCC------CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence               0000      1112345678999999999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.3e-35  Score=292.45  Aligned_cols=268  Identities=21%  Similarity=0.274  Sum_probs=193.6

Q ss_pred             Cccccc--CCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAG--NFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      ..||+|  +||+||++.+..+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++.     .++..++|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence            356666  89999999988899999999987432  223467889999999999999999999853     445789999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+.+|+|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++||+.
T Consensus        79 e~~~~~~l~~~l~~--------~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~  147 (328)
T cd08226          79 PFMAYGSANSLLKT--------YFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSH  147 (328)
T ss_pred             ecccCCCHHHHHHh--------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHH
Confidence            99999999999854        22345888999999999999999999   89999999999999999999999999986


Q ss_pred             ceecccccccce-----ecccccccccccCcccCCC--ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          367 ARFLEAADEQTR-----SIGVEGTTGYIAPEYGMGH--EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       367 a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~--~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      +...........     .....++..|+|||++.+.  .++.++|||||||++||+++|+.||....... .........
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~  226 (328)
T cd08226         148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-MLLQKLKGP  226 (328)
T ss_pred             HhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-HHHHHhcCC
Confidence            543322111100     0012245679999998763  47899999999999999999999997632211 011100000


Q ss_pred             c---------ccchh------------------------hhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 046112          440 L---------PERAE------------------------EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKIND  486 (502)
Q Consensus       440 ~---------~~~~~------------------------~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~e  486 (502)
                      .         +....                        .+.+..  ........+...+.+++.+|++.||++|||+.|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e  304 (328)
T cd08226         227 PYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSER--LRTPSSKTFSPAFQNLVELCLQQDPEKRPSASS  304 (328)
T ss_pred             CCCCccccccchhhhhhccchhhhhcccccchhcccccccccccc--ccchhhhhhhHHHHHHHHHHccCCcccCCCHHH
Confidence            0         00000                        000000  011112346678899999999999999999999


Q ss_pred             HHH--HHHHHHHH
Q 046112          487 VEP--RLRLIKKK  497 (502)
Q Consensus       487 v~~--~L~~i~~~  497 (502)
                      +++  .++.++++
T Consensus       305 ~l~~~~~~~~~~~  317 (328)
T cd08226         305 LLSHAFFKQVKEQ  317 (328)
T ss_pred             HhhCHHHHHHHHh
Confidence            964  44555443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.5e-35  Score=288.82  Aligned_cols=257  Identities=21%  Similarity=0.226  Sum_probs=186.0

Q ss_pred             CCceEEEEEEcCCCeEEEEEEeccc--CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeeccCCCh
Q 046112          217 NFGSVYKGILFESTTAVAVKVFNVL--HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSL  294 (502)
Q Consensus       217 ~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL  294 (502)
                      ++|.||.++...+++.||||+++..  .....+.+..|+++++.++|+||+++++++     ...+..+++|||+++|+|
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEEEeccCCCCH
Confidence            3445555555568999999998754  233456799999999999999999999984     345578999999999999


Q ss_pred             hhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceeccccc
Q 046112          295 EEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD  374 (502)
Q Consensus       295 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  374 (502)
                      .+++..        .....+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.+..+....
T Consensus        87 ~~~l~~--------~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~  155 (314)
T cd08216          87 EDLLKT--------HFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG  155 (314)
T ss_pred             HHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence            999853        22345788899999999999999999   8999999999999999999999999999987554322


Q ss_pred             cc-----ceecccccccccccCcccCC--CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch---
Q 046112          375 EQ-----TRSIGVEGTTGYIAPEYGMG--HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA---  444 (502)
Q Consensus       375 ~~-----~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---  444 (502)
                      ..     .......++..|+|||++..  ..++.++|||||||++|||++|+.||....... ...+......+...   
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  234 (314)
T cd08216         156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLDKS  234 (314)
T ss_pred             ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCccccccC
Confidence            11     11123456788999999876  358899999999999999999999997532111 11111111111000   


Q ss_pred             ------hhh-------cccCCC--CcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          445 ------EEI-------RASSGS--TQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       445 ------~~~-------~d~~~~--~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                            ..+       .++...  ............+.+++.+||+.||++|||++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                  000       000000  0011112334567889999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.4e-36  Score=288.92  Aligned_cols=250  Identities=24%  Similarity=0.392  Sum_probs=198.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCC-CCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~  280 (502)
                      ++|...+.||+|+||.||+|....++..||+|++...   .....+.+..|++++++++ ||||+++++++     ...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence            4678889999999999999998889999999998642   2233467888999999998 99999999884     4455


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++++|.+++..          ...+++.....++.|++.||.|||   +.+++|+||+|+||+++.++.++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~  142 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRK----------YGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIK  142 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEE
Confidence            88999999999999999842          236899999999999999999999   89999999999999999999999


Q ss_pred             Eeeeccceeccccccc------------------ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCC
Q 046112          361 VSDFGIARFLEAADEQ------------------TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS  422 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~  422 (502)
                      ++|||++.........                  .......++..|+|||......++.++||||||++++++++|+.||
T Consensus       143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  222 (280)
T cd05581         143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF  222 (280)
T ss_pred             ecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence            9999998765433211                  1222345788999999998888999999999999999999999998


Q ss_pred             ccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCH----HHHHH
Q 046112          423 DDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKI----NDVEP  489 (502)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~----~ev~~  489 (502)
                      .....    . .......        ...    ..........+.+++.+|++.+|.+||++    +++++
T Consensus       223 ~~~~~----~-~~~~~~~--------~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         223 RGSNE----Y-LTFQKIL--------KLE----YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             CCccH----H-HHHHHHH--------hcC----CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            76321    0 0001100        000    00111235567899999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.1e-35  Score=288.79  Aligned_cols=253  Identities=23%  Similarity=0.308  Sum_probs=191.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCC-CCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||+++... .....++..|+.++.+.. ||||++++++|..     ...
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DSD   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CCe
Confidence            356788899999999999999887779999999987543 233455677887776665 9999999999643     447


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceeecCCCCCeeeCCCCcEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ-PPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      .+++|||+. +++.+++..         ....+++..+..++.+++.|++|||   + .+|+||||+|+||++++++.+|
T Consensus        89 ~~~v~e~~~-~~l~~l~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~k  155 (296)
T cd06618          89 VFICMELMS-TCLDKLLKR---------IQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVK  155 (296)
T ss_pred             EEEEeeccC-cCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEE
Confidence            899999984 577776532         2246889999999999999999999   5 5899999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCc----cCccccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE----VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                      |+|||++..+......   ....++..|+|||++.+..    ++.++||||||+++|||++|+.||.....+.    +..
T Consensus       156 L~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~  228 (296)
T cd06618         156 LCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF----EVL  228 (296)
T ss_pred             ECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH----HHH
Confidence            9999998765432211   2234678999999987654    8899999999999999999999986521111    111


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ..........     ...    ...+...+.+++.+|+..||++||++.++++.
T Consensus       229 ~~~~~~~~~~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         229 TKILQEEPPS-----LPP----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHHhcCCCCC-----CCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1111110000     000    01234568899999999999999999999765

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1e-35  Score=294.86  Aligned_cols=268  Identities=20%  Similarity=0.290  Sum_probs=195.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccc---------
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVD---------  275 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---------  275 (502)
                      .+|...+.||.|+||.||+|....++..||+|.+........+.+.+|++++++++||||+++++++....         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57888999999999999999998999999999987655555677889999999999999999998754321         


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC-
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD-  354 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~-  354 (502)
                      .......++|+||++ ++|.+++..           ..+++.....++.|++.||.|||   +.+|+||||||+||+++ 
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~  149 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ-----------GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINT  149 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcC
Confidence            111235789999996 588887632           34788999999999999999999   89999999999999997 


Q ss_pred             CCCcEEEeeeccceeccccccc-ceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccch
Q 046112          355 DEMTAYVSDFGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL  432 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~  432 (502)
                      +++.+|++|||+++.+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||....... ..
T Consensus       150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~  228 (342)
T cd07854         150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QM  228 (342)
T ss_pred             CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence            4567899999999765432211 11122357889999997654 568889999999999999999999996532110 11


Q ss_pred             HHHHHhhccc----ch--------hhhcccCCCC---cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          433 RNCVKSALPE----RA--------EEIRASSGST---QRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       433 ~~~~~~~~~~----~~--------~~~~d~~~~~---~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...... .+.    ..        ..+.......   ...........+.+++.+|++.||++|||+.|++.
T Consensus       229 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         229 QLILES-VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHHh-cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            111100 000    00        0000000000   00001123456779999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=286.68  Aligned_cols=201  Identities=27%  Similarity=0.373  Sum_probs=177.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      +.|+.-++||+|+||.||-++...+|+.+|.|.+.+..   .........|-.++.+++.+.||.+--+     ++..+.
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd~  259 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKDA  259 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCCc
Confidence            45777889999999999999999999999999886432   2334556789999999999999998766     455669


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      +++|+..|.||+|.-++.+        ...+.+++....-.+.+|+.||++||   ...||.||+||+|||||+.|+++|
T Consensus       260 LClVLtlMNGGDLkfHiyn--------~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRI  328 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYN--------HGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRI  328 (591)
T ss_pred             eEEEEEeecCCceeEEeec--------cCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEe
Confidence            9999999999999999865        44578999999999999999999999   999999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      +|+|+|..+.....   ..+.+||.+|||||++..+.|+...|-||+||++|||+.|+.||..
T Consensus       329 SDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~  388 (591)
T KOG0986|consen  329 SDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ  388 (591)
T ss_pred             eccceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence            99999987764432   3355899999999999999999999999999999999999999976

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=7.5e-36  Score=288.78  Aligned_cols=255  Identities=23%  Similarity=0.288  Sum_probs=194.6

Q ss_pred             CCCCCCcccccCCceEEEEEEc---CCCeEEEEEEecccC----cchhHHHHHHHHHHhcC-CCCccceeeecccccccC
Q 046112          206 GFSSENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLH----HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  277 (502)
                      +|...+.||+|++|.||++...   .+++.||||+++...    ....+.+..|++++.++ +|||++++.+.     +.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-----FQ   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-----ee
Confidence            3677889999999999999753   467889999986421    22345688999999999 59999999887     44


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                      .+...++||||+++|+|.+++..          ...+++.....++.|+++||.|||   +.+++||||+|+||+++.++
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~  142 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQ----------REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEG  142 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhh----------cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCC
Confidence            45678999999999999998842          245788899999999999999999   89999999999999999999


Q ss_pred             cEEEeeeccceecccccccceecccccccccccCcccCCCc--cCccccchhHHHHHHHHHhCCCCCccccccccchHHH
Q 046112          358 TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE--VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  435 (502)
                      .++|+|||+++....... .......++..|+|||...+..  .+.++||||||+++|||++|+.||...... ....+.
T Consensus       143 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~  220 (288)
T cd05583         143 HVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEI  220 (288)
T ss_pred             CEEEEECccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHH
Confidence            999999999876543322 1122345789999999987765  788999999999999999999998642111 111111


Q ss_pred             HHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                      .+....        ..    ..........+.+++.+|++.||++|||+.++.+.|+
T Consensus       221 ~~~~~~--------~~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         221 SRRILK--------SK----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             HHHHHc--------cC----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            111110        00    0111123456778999999999999999988876654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.3e-36  Score=294.82  Aligned_cols=250  Identities=23%  Similarity=0.350  Sum_probs=200.4

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcch--hHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA--SKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      -+..|.+...||+|.|+.|..|.+..++..||+|.+++..-+.  ...+.+|+++|..++|||||+++.+.     ....
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~~  128 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETEA  128 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eecc
Confidence            4567888999999999999999999999999999998654332  24588999999999999999999984     4455


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      .+++||||+.+|.+++++..          .+...+.....++.|+.+|++|||   ++.|+|||||++||||+.+.++|
T Consensus       129 ~lylV~eya~~ge~~~yl~~----------~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnik  195 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVK----------HGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIK  195 (596)
T ss_pred             eeEEEEEeccCchhHHHHHh----------cccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhccccccccee
Confidence            89999999999999999943          334555778889999999999999   99999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCcc-CccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEV-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||++.++....   .....+|++.|.|||++.+.++ .+.+|+||+|+++|-|+.|..||++.              
T Consensus       196 IaDfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~--------------  258 (596)
T KOG0586|consen  196 IADFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ--------------  258 (596)
T ss_pred             eeccccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc--------------
Confidence            99999998876432   3345779999999999999876 56799999999999999999999872              


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                         .+.++..........+..-...++-+++.+.+-.+|.+|++++++.+.
T Consensus       259 ---~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  259 ---NLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ---ccccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence               111111111111111111122234477888889999999999998753

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.8e-35  Score=288.88  Aligned_cols=247  Identities=23%  Similarity=0.269  Sum_probs=192.0

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .|+..+.||+|+||.||+|....++..+|+|.+....   ....+++.+|+++++.++|+|++++.+++..     ....
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCee
Confidence            4666788999999999999988889999999886422   2234567889999999999999999998643     3478


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++|+||+. |++.+.+..         ....+++.++..++.+++.|+.|||   +.+++||||+|+||+++.++.++|+
T Consensus        91 ~lv~e~~~-~~l~~~~~~---------~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~  157 (308)
T cd06634          91 WLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLG  157 (308)
T ss_pred             EEEEEccC-CCHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEEC
Confidence            99999996 688777632         2345788999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccC---CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM---GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |||++......      ....++..|+|||.+.   ...++.++|||||||++|||++|+.||....... ....+....
T Consensus       158 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~  230 (308)
T cd06634         158 DFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNE  230 (308)
T ss_pred             CcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhcC
Confidence            99998765432      2245788999999874   3568899999999999999999999986521110 011111100


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                      .+            ...  .......+.+++.+||+.+|++||+++++++.-
T Consensus       231 ~~------------~~~--~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         231 SP------------ALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             CC------------CcC--cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            00            000  113455678999999999999999999988653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-35  Score=283.44  Aligned_cols=261  Identities=22%  Similarity=0.241  Sum_probs=193.2

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc-hhHHHHHHHHHHhcCC-CCccceeeecccccccCCCcceeE
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-ASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      |...+.||+|++|+||+|....+++.|++|++...... ......+|+..+++++ |+|++++++++.     .++..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence            56678999999999999988888999999998654322 2234557899999999 999999999854     3558899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+ +|+|.+++..        .....+++..+..++.|++.+|.|||   +.+++|+||+|+||++++++.++|+||
T Consensus        76 v~e~~-~~~l~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~  143 (283)
T cd07830          76 VFEYM-EGNLYQLMKD--------RKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADF  143 (283)
T ss_pred             EEecC-CCCHHHHHHh--------cccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeec
Confidence            99999 8899988853        22356899999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccC-CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc-
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGM-GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE-  442 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-  442 (502)
                      |++........   .....++..|+|||.+. ...++.++||||||++++|+++|+.||....... .... ....... 
T Consensus       144 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~-~~~~~~~~  218 (283)
T cd07830         144 GLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYK-ICSVLGTP  218 (283)
T ss_pred             ccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHH-HHHhcCCC
Confidence            99976543222   12345788999999875 4568999999999999999999999986531110 0100 0000000 


Q ss_pred             ---------chhhhcccCCCCc-----chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 ---------RAEEIRASSGSTQ-----RSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ---------~~~~~~d~~~~~~-----~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                               ......+......     ..........+.+++.+|++.+|++|||+.|++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         219 TKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                     0000000000000     0001112456889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-36  Score=285.25  Aligned_cols=247  Identities=20%  Similarity=0.315  Sum_probs=202.6

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc--hhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD--ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      =|...+.||+|.|+.|-+|++.-+|..||||++.+..-+  ....+..|+..|+.++|||||+++++     ......+|
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTKly   93 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTKLY   93 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccceEE
Confidence            466778999999999999999999999999999865433  34567889999999999999999998     44556899


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee-CCCCcEEEe
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL-DDEMTAYVS  362 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll-~~~~~~kl~  362 (502)
                      +|.|.=.+|+|++|+-         .....+.+.-..+++.||+.|+.|+|   +..+|||||||+||.+ ..-|-|||.
T Consensus        94 LiLELGD~GDl~DyIm---------KHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLT  161 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIM---------KHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLT  161 (864)
T ss_pred             EEEEecCCchHHHHHH---------hhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEee
Confidence            9999999999999983         33456888899999999999999999   8899999999999877 456899999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCc-cccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~-~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||++-.+.+....   ...+|...|-|||.+.+..|+. +.||||+||+||.|++|+.||+...+.+            
T Consensus       162 DFGFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE------------  226 (864)
T KOG4717|consen  162 DFGFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE------------  226 (864)
T ss_pred             eccccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh------------
Confidence            99999877665443   3467999999999999998875 5799999999999999999998743221            


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                       .+-.++|    ..+..+.-...++.+|+..|+..||++|.+.+|++.
T Consensus       227 -TLTmImD----CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  227 -TLTMIMD----CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -hhhhhhc----ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence             1122222    223333455666779999999999999999999864

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=268.58  Aligned_cols=249  Identities=23%  Similarity=0.293  Sum_probs=190.0

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccc-CcchhHHHHHHHHHHhcCC-CCccceeeecccccccCCCcceeEE
Q 046112          208 SSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL-HHDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       208 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      .....||.|+.|.||+++...+|..+|||.+... +.++.+++...++++.+-+ +|.||+-+||+     -.+...++.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF-----i~n~dV~Ic  169 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYF-----ITNTDVFIC  169 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE-----eeCchHHHH
Confidence            3456799999999999999999999999998754 3344567777888776664 89999999994     445578899


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeec
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG  365 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg  365 (502)
                      ||.|. ..+...+.         ....++++...-++...+.+||.||.+  +++|+|||+||+|||+|+.|++|+||||
T Consensus       170 MelMs-~C~ekLlk---------rik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  170 MELMS-TCAEKLLK---------RIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             HHHHH-HHHHHHHH---------HhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeeccc
Confidence            99883 34455543         233457777788999999999999985  7899999999999999999999999999


Q ss_pred             cceecccccccceecccccccccccCcccCC---CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          366 IARFLEAADEQTRSIGVEGTTGYIAPEYGMG---HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       366 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ++..+.......   ...|.+.|||||.+..   ..|+-++||||||+.++||.||+.||.....+-..+-.... ..+ 
T Consensus       238 IsGrlvdSkAht---rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~eP-  312 (391)
T KOG0983|consen  238 ISGRLVDSKAHT---RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEP-  312 (391)
T ss_pred             ccceeecccccc---cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCC-
Confidence            998775544333   3468899999998775   36899999999999999999999999863222111111111 111 


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                             +.++...    .....+.++...|+++|+.+||...++++
T Consensus       313 -------P~L~~~~----gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  313 -------PLLPGHM----GFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             -------CCCCccc----CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                   1111111    24567889999999999999999988875

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.2e-35  Score=281.10  Aligned_cols=251  Identities=20%  Similarity=0.282  Sum_probs=193.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-----cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-----HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      +|...+.||+|+||.||++.+...+..+++|+++...     ......+..|+.++++++|||++++++++.     ..+
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence            4677899999999999999887766667777765321     223345778999999999999999999853     344


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++|+||+++++|.+++....      .....+++..+..++.|++.|+.|||   +.+++|+||+|+||++++ +.++
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~  145 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELK------HTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLK  145 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHh------hcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEe
Confidence            7899999999999999885311      23456899999999999999999999   899999999999999976 5699


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||++........  ......++..|+|||...+..++.++||||||+++|++++|..||...     ..........
T Consensus       146 l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~~~~~~~~~~  218 (260)
T cd08222         146 IGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----NFLSVVLRIV  218 (260)
T ss_pred             ecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHH
Confidence            999999976543222  112345788999999998888999999999999999999999998642     1111111111


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                              ......   ....+...+.+++.+|++.+|++||++.|+++
T Consensus       219 --------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         219 --------EGPTPS---LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             --------cCCCCC---CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                    001111   11244567889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.3e-35  Score=285.64  Aligned_cols=252  Identities=21%  Similarity=0.288  Sum_probs=191.3

Q ss_pred             CCCCCCcccccCCceEEEEEEc---CCCeEEEEEEecccC----cchhHHHHHHHHHHhcC-CCCccceeeecccccccC
Q 046112          206 GFSSENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLH----HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  277 (502)
                      +|+..+.||+|+||.||++...   .+|..||+|+++...    ....+.+..|++++.++ +|+||+++.+++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            4677889999999999999764   478999999986432    12346678899999999 599999998773     4


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                      .+...++|+||+++++|.+++..          ...+++.....++.|++.||.|||   +.+++||||+|+||+++.++
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~  142 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQ----------RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNG  142 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCC
Confidence            44578999999999999999842          245788888999999999999999   89999999999999999999


Q ss_pred             cEEEeeeccceecccccccceecccccccccccCcccCCC--ccCccccchhHHHHHHHHHhCCCCCccccccccchHHH
Q 046112          358 TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH--EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  435 (502)
                      .+||+|||++........ .......|+..|+|||.....  .++.++||||||+++||+++|+.||..... .......
T Consensus       143 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~  220 (290)
T cd05613         143 HVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEI  220 (290)
T ss_pred             CEEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHH
Confidence            999999999976543221 112235588999999998753  467899999999999999999999864211 1111221


Q ss_pred             HHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 046112          436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEP  489 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~  489 (502)
                      .......            ...........+.+++.+|++.||++||     ++.++.+
T Consensus       221 ~~~~~~~------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         221 SRRILKS------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHHhhcc------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            1111100            0011123455678999999999999997     5666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.5e-35  Score=291.73  Aligned_cols=268  Identities=20%  Similarity=0.233  Sum_probs=198.3

Q ss_pred             HHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeeccccccc
Q 046112          199 MLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF  276 (502)
Q Consensus       199 ~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  276 (502)
                      ++...+++|+..+.||.|+||.||+|....+++.||+|++....  ....+.+..|+++++.++|||++++.+++..   
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---   80 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS---   80 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec---
Confidence            34557889999999999999999999988899999999875422  2234678889999999999999999998632   


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE  356 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~  356 (502)
                       .....++++||+ +++|.++++.           ..+++.....++.|++.||+|||   +.+|+||||+|+||+++++
T Consensus        81 -~~~~~~lv~e~~-~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~  144 (328)
T cd07856          81 -PLEDIYFVTELL-GTDLHRLLTS-----------RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINEN  144 (328)
T ss_pred             -CCCcEEEEeehh-ccCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCC
Confidence             234678999998 5688887742           34677788899999999999999   8999999999999999999


Q ss_pred             CcEEEeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccc--cch-
Q 046112          357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN--LNL-  432 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~--~~~-  432 (502)
                      +.++|+|||.+......     .....++..|+|||.+.+ ..++.++|||||||++||++||+.||.......  ..+ 
T Consensus       145 ~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~  219 (328)
T cd07856         145 CDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIIT  219 (328)
T ss_pred             CCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999998754321     123456888999998766 568999999999999999999999996532110  000 


Q ss_pred             -------HHHHHhhcccchhhhc-ccCCCCcch---hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          433 -------RNCVKSALPERAEEIR-ASSGSTQRS---IILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       433 -------~~~~~~~~~~~~~~~~-d~~~~~~~~---~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                             .++..........++. .........   ........+.+++.+|++.+|++|||+++++..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         220 DLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                   0111111000000000 000000001   011234678899999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.4e-35  Score=291.13  Aligned_cols=268  Identities=20%  Similarity=0.227  Sum_probs=192.8

Q ss_pred             CCCCCCcccccCCceEEEEEEcCC--CeEEEEEEecccCc--chhHHHHHHHHHHhcC-CCCccceeeecccccccCCCc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFES--TTAVAVKVFNVLHH--DASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  280 (502)
                      +|...+.||+|+||.||++.....  +..||+|++.....  ...+.+.+|+++++++ +||||+++++.+... .....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence            467778999999999999988777  88999999864322  2245678899999999 599999999875321 12234


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++++||+. ++|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+|
T Consensus        80 ~~~~~~e~~~-~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~k  145 (332)
T cd07857          80 ELYLYEELME-ADLHQIIR----------SGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELK  145 (332)
T ss_pred             cEEEEEeccc-CCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEE
Confidence            5788888885 68988873          2345889999999999999999999   89999999999999999999999


Q ss_pred             Eeeeccceeccccccc--ceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHH---
Q 046112          361 VSDFGIARFLEAADEQ--TRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN---  434 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~---  434 (502)
                      |+|||+++........  .......||..|+|||+..+ ..++.++|||||||++|++++|+.||....... .+..   
T Consensus       146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~  224 (332)
T cd07857         146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQ  224 (332)
T ss_pred             eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHH
Confidence            9999999865432211  11233568999999998765 468999999999999999999999986521100 0000   


Q ss_pred             --------HHHhhcccchhhhcc---cCC-CCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          435 --------CVKSALPERAEEIRA---SSG-STQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       435 --------~~~~~~~~~~~~~~d---~~~-~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                              ...............   ... .........+...+.+++.+|++.||++|||+.|++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                    000000000000000   000 0000001122457889999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.6e-35  Score=291.31  Aligned_cols=265  Identities=20%  Similarity=0.238  Sum_probs=193.1

Q ss_pred             ccCCC-CCCcccccCCceEEEEEEcCCCeEEEEEEecccCcch--------------hHHHHHHHHHHhcCCCCccceee
Q 046112          204 TKGFS-SENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA--------------SKSFAVECEVTRNIRHRNLVKVF  268 (502)
Q Consensus       204 t~~~~-~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~  268 (502)
                      .++|. ..+.||+|+||+||+|.+..+++.||||.++......              ...+.+|+++++.++|+|+++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            34555 3577999999999999988899999999986432211              12477899999999999999999


Q ss_pred             ecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCC
Q 046112          269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKP  348 (502)
Q Consensus       269 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~  348 (502)
                      +++.     ..+..++||||+. |+|.+++.          ....+++.....++.|++.||.|||   +.+|+||||+|
T Consensus        87 ~~~~-----~~~~~~lv~e~~~-~~l~~~l~----------~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~  147 (335)
T PTZ00024         87 DVYV-----EGDFINLVMDIMA-SDLKKVVD----------RKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSP  147 (335)
T ss_pred             EEEe-----cCCcEEEEEeccc-cCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccH
Confidence            9853     3458899999996 68988873          2345888999999999999999999   89999999999


Q ss_pred             CCeeeCCCCcEEEeeeccceeccccc------------ccceecccccccccccCcccCCC-ccCccccchhHHHHHHHH
Q 046112          349 SNILLDDEMTAYVSDFGIARFLEAAD------------EQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEM  415 (502)
Q Consensus       349 ~NIll~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el  415 (502)
                      +||+++.++.++|+|||+++......            .........++..|+|||++.+. .++.++|||||||++|||
T Consensus       148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el  227 (335)
T PTZ00024        148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL  227 (335)
T ss_pred             HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence            99999999999999999997654111            01111223467889999998764 478999999999999999


Q ss_pred             HhCCCCCccccccccchHHHHHhhccc-----chhhhc----ccC----CCCcchhhHHHHHHHHHHHhhcccCCCCCCC
Q 046112          416 FTGLRPSDDMFKDNLNLRNCVKSALPE-----RAEEIR----ASS----GSTQRSIILECLISICEIGVACSAEQPGERM  482 (502)
Q Consensus       416 ~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~----d~~----~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP  482 (502)
                      ++|+.||......+  ....+......     +.....    .+.    ..........+...+.+++.+|++.+|++||
T Consensus       228 ~tg~~p~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~  305 (335)
T PTZ00024        228 LTGKPLFPGENEID--QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI  305 (335)
T ss_pred             HhCCCCCCCCCHHH--HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhcc
Confidence            99999997532111  11111111100     000000    000    0000011112355678999999999999999


Q ss_pred             CHHHHHH
Q 046112          483 KINDVEP  489 (502)
Q Consensus       483 t~~ev~~  489 (502)
                      |++|++.
T Consensus       306 s~~~~l~  312 (335)
T PTZ00024        306 SAKEALK  312 (335)
T ss_pred             CHHHHhc
Confidence            9999975

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.3e-36  Score=313.35  Aligned_cols=258  Identities=22%  Similarity=0.277  Sum_probs=190.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccC------
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ------  277 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------  277 (502)
                      .+|.+.+.||+||||.||+++.+-+|+.+|||++.... ......+.+|++.+++++|||||+++..+.+....      
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            46778899999999999999999999999999987543 33346688899999999999999998542211100      


Q ss_pred             -------------------------------------------------------------------------------C
Q 046112          278 -------------------------------------------------------------------------------G  278 (502)
Q Consensus       278 -------------------------------------------------------------------------------~  278 (502)
                                                                                                     +
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                           0


Q ss_pred             ---------------------C--------cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHH
Q 046112          279 ---------------------N--------DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV  329 (502)
Q Consensus       279 ---------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~  329 (502)
                                           +        ...||=||||+.-+++++++.        +... -.....++++.+|++|
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~--------N~~~-~~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR--------NHFN-SQRDEAWRLFREILEG  709 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh--------cccc-hhhHHHHHHHHHHHHH
Confidence                                 0        234567788877777777643        1110 0355678999999999


Q ss_pred             HHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecc----cc------------cccceecccccccccccCcc
Q 046112          330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE----AA------------DEQTRSIGVEGTTGYIAPEY  393 (502)
Q Consensus       330 l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~----~~------------~~~~~~~~~~gt~~y~aPE~  393 (502)
                      |+|+|   +.+||||||||.||+||++..|||+|||+|+...    ..            ......++.+||.-|+|||.
T Consensus       710 LaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  710 LAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            99999   9999999999999999999999999999998721    00            01113456789999999999


Q ss_pred             cCCC---ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHH
Q 046112          394 GMGH---EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIG  470 (502)
Q Consensus       394 ~~~~---~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~  470 (502)
                      +.+.   .|+.|+|+||+|||++||+.   ||....+.-            ..+..+++...+...++.......=.+++
T Consensus       787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa------------~iL~~LR~g~iP~~~~f~~~~~~~e~slI  851 (1351)
T KOG1035|consen  787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA------------SILTNLRKGSIPEPADFFDPEHPEEASLI  851 (1351)
T ss_pred             hcccccccccchhhhHHHHHHHHHHhc---cCCchHHHH------------HHHHhcccCCCCCCcccccccchHHHHHH
Confidence            8874   49999999999999999996   665421111            11222233333333333334444456899


Q ss_pred             hhcccCCCCCCCCHHHHHH
Q 046112          471 VACSAEQPGERMKINDVEP  489 (502)
Q Consensus       471 ~~c~~~dP~~RPt~~ev~~  489 (502)
                      .++++.||.+|||+.|++.
T Consensus       852 ~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  852 RWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHhcCCCccCCCHHHHhh
Confidence            9999999999999999875

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-35  Score=290.60  Aligned_cols=269  Identities=20%  Similarity=0.271  Sum_probs=195.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeeccccccc-CCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-QGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~  280 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||+++...  ......+.+|+++++.++||||+++++++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478888999999999999999888889999999986432  2223568899999999999999999998643221 1223


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++|+||+. .+|..+..            ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus        94 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~k  157 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG------------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELK  157 (342)
T ss_pred             eEEEEecccc-cCHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence            5689999986 46665541            24788899999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++.....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+.... ..
T Consensus       158 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~-~~  230 (342)
T cd07879         158 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQIL-KV  230 (342)
T ss_pred             EeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-Hh
Confidence            9999998754321     123456889999999876 468899999999999999999999997521100 011100 00


Q ss_pred             ccc----chhhhccc-------CCC--Ccch---hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHHH
Q 046112          440 LPE----RAEEIRAS-------SGS--TQRS---IILECLISICEIGVACSAEQPGERMKINDVEPR--LRLIK  495 (502)
Q Consensus       440 ~~~----~~~~~~d~-------~~~--~~~~---~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~--L~~i~  495 (502)
                      .+.    ....+.+.       ...  ...+   ........+.+++.+|++.||++||++++++..  ++.++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            000    00000000       000  0000   001234467799999999999999999999843  55554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-35  Score=289.54  Aligned_cols=273  Identities=19%  Similarity=0.252  Sum_probs=199.7

Q ss_pred             HHHHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeeccccc
Q 046112          197 YRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGV  274 (502)
Q Consensus       197 ~~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  274 (502)
                      ..++...+++|...+.||+|+||.||+|....++..||+|+++...  ....+.+.+|++++++++||||+++.+++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            4566778899999999999999999999888899999999987432  22245678899999999999999999876432


Q ss_pred             c-cCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee
Q 046112          275 D-FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL  353 (502)
Q Consensus       275 ~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll  353 (502)
                      . +......+++++++ +++|.+++..           ..+++..+..++.|++.|++|||   +.+|+||||||+||++
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll  153 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAV  153 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEE
Confidence            2 12223567888876 8899887632           34889999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccch
Q 046112          354 DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL  432 (502)
Q Consensus       354 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~  432 (502)
                      ++++.+||+|||+++.....     .....++..|+|||...+ ..++.++|||||||++||+++|+.||...... ..+
T Consensus       154 ~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~  227 (345)
T cd07877         154 NEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQL  227 (345)
T ss_pred             cCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH
Confidence            99999999999998754321     123457889999998766 56889999999999999999999998642111 111


Q ss_pred             HHHHHhhcc---cchhhhccc-------CCCCcc-----hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          433 RNCVKSALP---ERAEEIRAS-------SGSTQR-----SIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       433 ~~~~~~~~~---~~~~~~~d~-------~~~~~~-----~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      .........   .....+.+.       ......     +........+.+++.+|++.||.+||++.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         228 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            111110000   000000000       000000     0000124457799999999999999999998753

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.9e-35  Score=287.79  Aligned_cols=272  Identities=19%  Similarity=0.229  Sum_probs=195.6

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeeccccccc---CC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDF---QG  278 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~  278 (502)
                      .++|+..+.||+|+||.||+|.+..+++.+|+|++.....  .....+.+|++++++++||||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            5689999999999999999999888999999998864322  223467889999999999999999987543221   12


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      ....++|+||+.+ +|...+..         ....+++..+..++.|+++||+|||   +.+|+||||||+||++++++.
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~---------~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~  153 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN---------PSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGI  153 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCC
Confidence            3457899999864 67666642         2346899999999999999999999   899999999999999999999


Q ss_pred             EEEeeeccceeccccccc---------ceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCcccccc
Q 046112          359 AYVSDFGIARFLEAADEQ---------TRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD  428 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~  428 (502)
                      ++|+|||+++........         .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus       154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~  233 (311)
T cd07866         154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI  233 (311)
T ss_pred             EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999999765432211         11223457888999998765 45889999999999999999999998752211


Q ss_pred             ccchHHHHHhhc--ccc-------hhhhc----ccCCCC-cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          429 NLNLRNCVKSAL--PER-------AEEIR----ASSGST-QRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       429 ~~~~~~~~~~~~--~~~-------~~~~~----d~~~~~-~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      . ..........  ...       .....    ....+. ...........+.+++.+|++.||++|||+.|++.
T Consensus       234 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         234 D-QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             H-HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            0 1111110000  000       00000    000000 00001122356789999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.5e-34  Score=283.05  Aligned_cols=245  Identities=23%  Similarity=0.262  Sum_probs=189.6

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      |...+.||+|+||+||+|....++..|++|++.....   .....+..|++++++++|||++++++++..     ....+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEE
Confidence            4556789999999999999888999999999864322   223567889999999999999999998643     44789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+. |++.+++.         .....+++.++..++.|++.|++|||   +.+++||||+|+||++++++.+||+|
T Consensus        98 lv~e~~~-~~l~~~l~---------~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~d  164 (313)
T cd06633          98 LVMEYCL-GSASDLLE---------VHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLAD  164 (313)
T ss_pred             EEEecCC-CCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEee
Confidence            9999995 67777763         22345889999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccC---CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGM---GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      ||++.....      .....++..|+|||++.   ...++.++|||||||++|||++|+.||.....     ........
T Consensus       165 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~  233 (313)
T cd06633         165 FGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIA  233 (313)
T ss_pred             cCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHH
Confidence            999864321      12345788999999974   45688999999999999999999999865311     11111110


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      .....     ..  .   .......+.+++.+|++.+|.+||++.+++..
T Consensus       234 ~~~~~-----~~--~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         234 QNDSP-----TL--Q---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             hcCCC-----CC--C---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000     00  0   01223457789999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-35  Score=305.72  Aligned_cols=270  Identities=20%  Similarity=0.175  Sum_probs=183.5

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCC-eEEEEE------------------EecccCcchhHHHHHHHHHHhcCCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFEST-TAVAVK------------------VFNVLHHDASKSFAVECEVTRNIRHRNL  264 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~ni  264 (502)
                      .++|.+.+.||+|+||+||++...... ..+++|                  .++ ........+.+|++++++++||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence            468999999999999999998653322 111222                  111 111234568899999999999999


Q ss_pred             ceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceee
Q 046112          265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHC  344 (502)
Q Consensus       265 v~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~  344 (502)
                      +++++++.     ..+..++|+|++ .++|.+++.....     .........+...++.|++.||.|||   +.+|+||
T Consensus       226 v~l~~~~~-----~~~~~~lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHr  291 (501)
T PHA03210        226 LKIEEILR-----SEANTYMITQKY-DFDLYSFMYDEAF-----DWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHR  291 (501)
T ss_pred             CcEeEEEE-----ECCeeEEEEecc-ccCHHHHHhhccc-----cccccccHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence            99999853     344789999998 4677777643111     11122345567789999999999999   8999999


Q ss_pred             cCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCC-Cc
Q 046112          345 DLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP-SD  423 (502)
Q Consensus       345 dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p-~~  423 (502)
                      ||||+|||++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ +.
T Consensus       292 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~  370 (501)
T PHA03210        292 DIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG  370 (501)
T ss_pred             CCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence            9999999999999999999999987643322 222345789999999999999999999999999999999998754 43


Q ss_pred             ccccc-ccchHHHHHhh------cccc---hhhhcccC-C----CCcchhhH--HHHHHHHHHHhhcccCCCCCCCCHHH
Q 046112          424 DMFKD-NLNLRNCVKSA------LPER---AEEIRASS-G----STQRSIIL--ECLISICEIGVACSAEQPGERMKIND  486 (502)
Q Consensus       424 ~~~~~-~~~~~~~~~~~------~~~~---~~~~~d~~-~----~~~~~~~~--~~~~~l~~l~~~c~~~dP~~RPt~~e  486 (502)
                      ..... ...+.+.....      ++..   ....++.. .    ........  .....+.+++.+|++.||.+|||+.|
T Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~e  450 (501)
T PHA03210        371 DGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAE  450 (501)
T ss_pred             CCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHH
Confidence            32111 11122211111      0000   00000000 0    00000000  12234667889999999999999999


Q ss_pred             HHH
Q 046112          487 VEP  489 (502)
Q Consensus       487 v~~  489 (502)
                      +++
T Consensus       451 lL~  453 (501)
T PHA03210        451 LLA  453 (501)
T ss_pred             Hhh
Confidence            986

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-35  Score=276.65  Aligned_cols=237  Identities=26%  Similarity=0.335  Sum_probs=189.6

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeec
Q 046112          213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFM  289 (502)
Q Consensus       213 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  289 (502)
                      ||+|+||.||++....+++.+|+|+++....   .....+..|++++++++|+|++++++.+     ..+...++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            6999999999998888899999999875322   2345788999999999999999999874     4556899999999


Q ss_pred             cCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          290 ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       290 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                      ++++|.+++..          ...+++.....++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~  142 (250)
T cd05123          76 PGGELFSHLSK----------EGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKE  142 (250)
T ss_pred             CCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCccee
Confidence            99999999842          235889999999999999999999   89999999999999999999999999999976


Q ss_pred             cccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcc
Q 046112          370 LEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRA  449 (502)
Q Consensus       370 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  449 (502)
                      .....  .......++..|+|||...+...+.++|+||||+++||+++|+.||.....     ..........       
T Consensus       143 ~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~-------  208 (250)
T cd05123         143 LSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKD-------  208 (250)
T ss_pred             cccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcC-------
Confidence            54322  112345578899999999988899999999999999999999999965311     1111111100       


Q ss_pred             cCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 046112          450 SSGSTQRSIILECLISICEIGVACSAEQPGERMKIND  486 (502)
Q Consensus       450 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~e  486 (502)
                       .    ..+.......+.+++.+|+..||++||++.+
T Consensus       209 -~----~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         209 -P----LRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             -C----CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence             0    0011122456779999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-35  Score=280.34  Aligned_cols=261  Identities=21%  Similarity=0.264  Sum_probs=195.8

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      |+..+.||+|++|.||+|....+++.+|+|++....  ....+.+..|++++++++|+|++++++++.     .....++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence            456688999999999999998889999999987543  233467888999999999999999999854     3358999


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      |+||++ ++|.+++..         ....+++..+..++.+++.||+|||   +.+|+||||+|+||++++++.++|+||
T Consensus        76 v~e~~~-~~l~~~i~~---------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~  142 (282)
T cd07829          76 VFEYCD-MDLKKYLDK---------RPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADF  142 (282)
T ss_pred             EecCcC-cCHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecC
Confidence            999997 599999853         1146899999999999999999999   889999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |.++.......  ......++..|+|||.+.+. .++.++|||||||++||+++|+.||......  .....+.......
T Consensus       143 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~  218 (282)
T cd07829         143 GLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--DQLFKIFQILGTP  218 (282)
T ss_pred             CcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHHHhCCC
Confidence            99976543322  11233457789999998776 8899999999999999999999998652211  1111111111000


Q ss_pred             h-------hhh--cccCCCC-----cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 A-------EEI--RASSGST-----QRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~-------~~~--~d~~~~~-----~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .       ..+  .+...+.     ...........+.+++.+|+..+|++||++.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         219 TEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0       000  0000000     00001122457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.1e-35  Score=289.94  Aligned_cols=269  Identities=20%  Similarity=0.239  Sum_probs=197.6

Q ss_pred             HHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeeccccccc-
Q 046112          200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-  276 (502)
Q Consensus       200 l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  276 (502)
                      +....++|+..+.||+|+||.||+|....++..||||+++....  .....+.+|++++++++||||+++++++..... 
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            44456789999999999999999999888999999999864322  224568899999999999999999988643211 


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE  356 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~  356 (502)
                      ......++||||+ +++|.+++..           ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.+
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~-----------~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~  154 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKH-----------EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNED  154 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCC
Confidence            1113468999998 7799887632           35889999999999999999999   8999999999999999999


Q ss_pred             CcEEEeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHH
Q 046112          357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  435 (502)
                      +.++|+|||++......     .....+++.|+|||.+.+ ..++.++|||||||++|++++|+.||...... ..+...
T Consensus       155 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~  228 (343)
T cd07880         155 CELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEI  228 (343)
T ss_pred             CCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence            99999999999754321     123456889999998876 45889999999999999999999999753111 011111


Q ss_pred             HH-----------hhcccchhhhccc----CCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          436 VK-----------SALPERAEEIRAS----SGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       436 ~~-----------~~~~~~~~~~~d~----~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..           .............    ...........+...+.+++.+|++.||++|||+.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         229 MKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            10           0000000000000    000000111233456789999999999999999999883

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.5e-35  Score=288.42  Aligned_cols=265  Identities=19%  Similarity=0.248  Sum_probs=196.3

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeeccccccc-CCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-QGN  279 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~  279 (502)
                      ..++|...+.||+|++|.||+|....++..||+|++....  ....+.+.+|+.++++++|||++++++++...+. ...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678899999999999999999998889999999986432  2233567789999999999999999987533221 122


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++|+||+ +++|.+++..           ..+++..+..++.|++.|++|||   +.+|+||||+|+||++++++.+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~  157 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-----------QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCEL  157 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCE
Confidence            3489999998 6799888742           35899999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +|+|||++......     .....++..|+|||...+ ..++.++|||||||++||+++|+.||.....  ......+..
T Consensus       158 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~  230 (343)
T cd07851         158 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMN  230 (343)
T ss_pred             EEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHH
Confidence            99999999765322     223457889999998765 4678999999999999999999999965211  111111111


Q ss_pred             hccc------------chhhhcccCC-CCcc---hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 ALPE------------RAEEIRASSG-STQR---SIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~~~------------~~~~~~d~~~-~~~~---~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ....            ....+..... ....   .........+.+++.+|++.+|++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         231 LVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0100            0000000000 0000   001123567889999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=265.75  Aligned_cols=259  Identities=22%  Similarity=0.279  Sum_probs=202.6

Q ss_pred             HhccCCCCC-CcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCC
Q 046112          202 NATKGFSSE-NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       202 ~~t~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  279 (502)
                      ..|++|++. ++||-|-.|.|-.+..+.+|+.+|+|++..     ....++|+++--+. .|||||.+++.+.. .+.+.
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~r  131 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYEN-SYQGR  131 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhh-hccCc
Confidence            346666654 689999999999999999999999999852     34567788875444 69999999998743 35677


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC---CC
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD---DE  356 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~---~~  356 (502)
                      ..+.+|||.|+||.|...+.+        .....+++.++..|..||+.|+.|||   +..|.||||||+|+|..   .+
T Consensus       132 kcLLiVmE~meGGeLfsriq~--------~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~n  200 (400)
T KOG0604|consen  132 KCLLIVMECMEGGELFSRIQD--------RGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPN  200 (400)
T ss_pred             eeeEeeeecccchHHHHHHHH--------cccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCC
Confidence            789999999999999999864        45567999999999999999999999   99999999999999996   45


Q ss_pred             CcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                      ..+||+|||+|+.-..   .......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||-.......  .--.
T Consensus       201 a~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--spgM  275 (400)
T KOG0604|consen  201 APLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGM  275 (400)
T ss_pred             cceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC--ChhH
Confidence            6899999999985432   2223345679999999999999999999999999999999999999976433211  1111


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      +..+...-+++.++       ...+..+..-++++..++.+|++|.|+.|+++
T Consensus       276 k~rI~~gqy~FP~p-------EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  276 KRRIRTGQYEFPEP-------EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HhHhhccCccCCCh-------hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            12222212222221       23456667778999999999999999999875

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=7e-37  Score=270.46  Aligned_cols=254  Identities=25%  Similarity=0.257  Sum_probs=191.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHH-hcCCCCccceeeecccccccCCCcceeEEee
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVT-RNIRHRNLVKVFTACSGVDFQGNDFKALVYE  287 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  287 (502)
                      ...||.|+||+|++-.+.++|+..|||+++.... .+.+++..|.+.. +.-+.||||+++|++..     +...++.||
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-----EGdcWiCME  143 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-----EGDCWICME  143 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-----CCceeeeHH
Confidence            4689999999999999999999999999986544 4567888888864 44579999999999732     336799999


Q ss_pred             eccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccc
Q 046112          288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA  367 (502)
Q Consensus       288 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a  367 (502)
                      .| .-||+.+.....     ..+...+++...-+|+....+||.||-.  +..|+|||+||+|||+|..|.+||||||++
T Consensus       144 LM-d~SlDklYk~vy-----~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIc  215 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVY-----SVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGIC  215 (361)
T ss_pred             HH-hhhHHHHHHHHH-----HHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccch
Confidence            99 557766553211     1345668888888999999999999985  668999999999999999999999999998


Q ss_pred             eecccccccceecccccccccccCcccCC--CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchh
Q 046112          368 RFLEAADEQTRSIGVEGTTGYIAPEYGMG--HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAE  445 (502)
Q Consensus       368 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  445 (502)
                      ..+..+-.   .+.-.|...|||||.+..  ..|+-+|||||+|++|+|+.||+.|+..-.+--.++.+.+....+... 
T Consensus       216 GqLv~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~-  291 (361)
T KOG1006|consen  216 GQLVDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL-  291 (361)
T ss_pred             HhHHHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec-
Confidence            75543221   223457788999998775  348999999999999999999999987521111122222222221100 


Q ss_pred             hhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          446 EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       446 ~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                               ...-..+....+..++..|+.+|-..||...++.+
T Consensus       292 ---------~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  292 ---------FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             ---------CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence                     00001234567889999999999999999998865

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=8.2e-36  Score=269.12  Aligned_cols=208  Identities=23%  Similarity=0.291  Sum_probs=170.9

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCC----CeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFES----TTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      -..|.....||+|.||.||+|...++    .+.+|+|.++...  ..-.....+|+.+++.++|||++.+..++.    .
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl----~   98 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL----S   98 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh----c
Confidence            34678889999999999999954433    2368999987542  234577899999999999999999998853    3


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC-
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE-  356 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~-  356 (502)
                      .+...++++||.+. +|...++-.+.     .....++......|..||+.|+.|||   ++=|+||||||.|||+..+ 
T Consensus        99 ~d~~v~l~fdYAEh-DL~~II~fHr~-----~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdg  169 (438)
T KOG0666|consen   99 HDKKVWLLFDYAEH-DLWHIIKFHRA-----SKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDG  169 (438)
T ss_pred             cCceEEEEehhhhh-hHHHHHHHhcc-----chhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccC
Confidence            36689999999965 78777754222     23357899999999999999999999   8999999999999999877 


Q ss_pred             ---CcEEEeeeccceecccccccc-eecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          357 ---MTAYVSDFGIARFLEAADEQT-RSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       357 ---~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                         |.|||+|||++|.+..+-... ....++.|++|+|||.+.+. .|+.+.||||.||++.||+|-++-|..
T Consensus       170 perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  170 PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence               899999999999987665422 33457789999999998885 588889999999999999998877754

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=262.89  Aligned_cols=269  Identities=21%  Similarity=0.303  Sum_probs=204.4

Q ss_pred             CCCccCHHHHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-CCccceeee
Q 046112          191 SFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRNLVKVFT  269 (502)
Q Consensus       191 ~~~~~~~~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~  269 (502)
                      +...-.+++++..|     .+.||+|+++.|--+....+|..+|||++.+..........+|++++...+ |+||+.+++
T Consensus        69 ss~~g~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLie  143 (463)
T KOG0607|consen   69 SSLSGKFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIE  143 (463)
T ss_pred             ccccchHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHH
Confidence            33444578888887     479999999999999999999999999998877777788999999998885 999999999


Q ss_pred             cccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCC
Q 046112          270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPS  349 (502)
Q Consensus       270 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~  349 (502)
                      +     |++++..|+|||-|.||+|..+++          ...-+++.++-++.++||.||.|||   .++|.|||+||+
T Consensus       144 f-----FEdd~~FYLVfEKm~GGplLshI~----------~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPE  205 (463)
T KOG0607|consen  144 F-----FEDDTRFYLVFEKMRGGPLLSHIQ----------KRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPE  205 (463)
T ss_pred             H-----hcccceEEEEEecccCchHHHHHH----------HhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCcc
Confidence            9     777889999999999999999984          3455888899999999999999999   999999999999


Q ss_pred             CeeeCCC---CcEEEeeeccceecccc-----cccceecccccccccccCcccC-----CCccCccccchhHHHHHHHHH
Q 046112          350 NILLDDE---MTAYVSDFGIARFLEAA-----DEQTRSIGVEGTTGYIAPEYGM-----GHEVSSYGDVYSFGILLLEMF  416 (502)
Q Consensus       350 NIll~~~---~~~kl~Dfg~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvws~Gv~l~el~  416 (502)
                      |||....   -.+|||||.+..-+...     .........+|+..|||||+..     ...|+.++|.||+||++|-|+
T Consensus       206 NiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImL  285 (463)
T KOG0607|consen  206 NILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIML  285 (463)
T ss_pred             ceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHH
Confidence            9999654   36899999987432111     1122334567899999999643     235889999999999999999


Q ss_pred             hCCCCCccccccc------cchHHHHH---hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 046112          417 TGLRPSDDMFKDN------LNLRNCVK---SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV  487 (502)
Q Consensus       417 tg~~p~~~~~~~~------~~~~~~~~---~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev  487 (502)
                      +|.+||.+...++      ...+.+-+   ..+.+-.+++.|...       .....+..+++...+..|+.+|.++.++
T Consensus       286 sGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdW-------ahIS~eakdlisnLlvrda~~rlsa~~v  358 (463)
T KOG0607|consen  286 SGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDW-------AHISSEAKDLISNLLVRDAKQRLSAAQV  358 (463)
T ss_pred             hCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhh-------HHhhHHHHHHHHHHHhccHHhhhhhhhc
Confidence            9999997754322      11111111   111122222222221       1223344466677777999999999888


Q ss_pred             HH
Q 046112          488 EP  489 (502)
Q Consensus       488 ~~  489 (502)
                      ++
T Consensus       359 ln  360 (463)
T KOG0607|consen  359 LN  360 (463)
T ss_pred             cC
Confidence            75

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-35  Score=265.71  Aligned_cols=200  Identities=25%  Similarity=0.305  Sum_probs=172.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhH---HHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK---SFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...++||+|.||.|-+++.+.+++.+|+|++++...-+.+   --..|-.+++..+||.+..+--.     ++.++.
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~dr  242 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQDR  242 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCce
Confidence            5788889999999999999999999999999999865433333   34568889999999998877644     667779


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      +|+||||..||.|.-+|.          ....+++....-...+|..||.|||   +++||.||+|.+|.|||.+|.+||
T Consensus       243 lCFVMeyanGGeLf~HLs----------rer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKi  309 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLS----------RERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKI  309 (516)
T ss_pred             EEEEEEEccCceEeeehh----------hhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEe
Confidence            999999999999998884          3456777777888899999999999   999999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      +|||+++.--  .....+...+||+.|+|||++....|..+.|.|.+|||+|||++|+.||..
T Consensus       310 tDFGLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn  370 (516)
T KOG0690|consen  310 TDFGLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN  370 (516)
T ss_pred             eecccchhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence            9999997422  223345568899999999999999999999999999999999999999965

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-34  Score=288.71  Aligned_cols=266  Identities=22%  Similarity=0.291  Sum_probs=215.5

Q ss_pred             CHHHHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeeccccc
Q 046112          196 SYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGV  274 (502)
Q Consensus       196 ~~~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  274 (502)
                      .+..+...++.|.+.+.||+|.+|.||+++...+++.+|+|++.... +...+...|.++++.. +|||++.++|++.-.
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            34445556778889999999999999999999999999999986543 3456788899999887 699999999998877


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                      +...++.+++|||||.+||..|+++.        .....+.|.-...|+++++.|+.+||   ...++|||||-.|||++
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn--------~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT  157 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKN--------TKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLT  157 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhh--------hcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEe
Confidence            77888899999999999999999975        33677899999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCCC-----ccCccccchhHHHHHHHHHhCCCCCccccccc
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-----EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN  429 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~  429 (502)
                      .++.||++|||.+..+..  +..+.....||+.|||||++...     .|+.++|+||+|++..||.-|.+|+.++...-
T Consensus       158 ~e~~VKLvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr  235 (953)
T KOG0587|consen  158 ENAEVKLVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR  235 (953)
T ss_pred             ccCcEEEeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence            999999999999975543  23344567899999999987753     47888999999999999999999998753211


Q ss_pred             cchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          430 LNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                              ..     . .+.+..+....-+..-..++.+++..|+.+|-++||++.++++
T Consensus       236 --------aL-----F-~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  236 --------AL-----F-LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             --------hh-----c-cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                    00     0 0001111000112345677889999999999999999998875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.4e-34  Score=304.90  Aligned_cols=146  Identities=27%  Similarity=0.420  Sum_probs=127.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|.+.++||+|+||.||+|.+..+++.||||+++...   ......+..|+.++..++||||+++++++     .....
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence            57888999999999999999998889999999986432   12236788899999999999999999874     34458


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++++|.+++..          ...+++.....++.|++.||.|||   ..+|+||||||+|||++.++.+||
T Consensus        79 ~~lVmEy~~g~~L~~li~~----------~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL  145 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHI----------YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKL  145 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEE
Confidence            9999999999999999842          234788889999999999999999   889999999999999999999999


Q ss_pred             eeeccce
Q 046112          362 SDFGIAR  368 (502)
Q Consensus       362 ~Dfg~a~  368 (502)
                      +|||+++
T Consensus       146 ~DFGls~  152 (669)
T cd05610         146 TDFGLSK  152 (669)
T ss_pred             EeCCCCc
Confidence            9999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-35  Score=258.99  Aligned_cols=270  Identities=19%  Similarity=0.238  Sum_probs=199.7

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecc--cCcchhHHHHHHHHHHhcCCCCccceeeecccccccCC---Cc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG---ND  280 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~---~~  280 (502)
                      .|....+||+|.||.||+|+..++++.||+|+.-.  ....-.....+|++++..++|+|++.+++.|....-+.   ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            45556789999999999999999999999987532  22222345678999999999999999999996643222   23


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++|+.+|+. +|...+.         .....++..+..++..++..||.|+|   ...|+|||+||.|+|++.++.+|
T Consensus        98 t~ylVf~~ceh-DLaGlLs---------n~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilk  164 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLS---------NRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILK  164 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhc---------CccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEE
Confidence            47899999965 7777774         33456888999999999999999999   99999999999999999999999


Q ss_pred             Eeeeccceecccccc--cceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHH
Q 046112          361 VSDFGIARFLEAADE--QTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  437 (502)
                      |+|||+++.+...+.  ..+.++.+.|.+|++||.+.+ ..|+++.|||+-||++.||+||.+-+....  +....+.+.
T Consensus       165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt--eqqql~~Is  242 (376)
T KOG0669|consen  165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT--EQQQLHLIS  242 (376)
T ss_pred             eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh--HHHHHHHHH
Confidence            999999986654433  334566778999999998876 569999999999999999999987776521  112222222


Q ss_pred             hhcccchhh------------hc--ccCCCCcchhhHHHHH------HHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          438 SALPERAEE------------IR--ASSGSTQRSIILECLI------SICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       438 ~~~~~~~~~------------~~--d~~~~~~~~~~~~~~~------~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      .....-..+            -+  .+..+.......+...      ..++|+..++..||.+|+++.+++..
T Consensus       243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            222110000            01  1111112222223333      56789999999999999999988753

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.3e-34  Score=266.02  Aligned_cols=222  Identities=21%  Similarity=0.125  Sum_probs=174.7

Q ss_pred             cCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeeccCCChh
Q 046112          216 GNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLE  295 (502)
Q Consensus       216 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~  295 (502)
                      |.+|.||++++..+++.+|+|+++...     .+..|...+....|||++++++++     ...+..++||||+++|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHH
Confidence            899999999999999999999986432     334455555566799999999984     3445889999999999999


Q ss_pred             hhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecccccc
Q 046112          296 EWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE  375 (502)
Q Consensus       296 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  375 (502)
                      +++..          ...+++.....++.|++.||+|||   +.+|+||||||+||+++.++.++++|||.+....... 
T Consensus        74 ~~l~~----------~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-  139 (237)
T cd05576          74 SHISK----------FLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-  139 (237)
T ss_pred             HHHHH----------hcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-
Confidence            98842          234889999999999999999999   8999999999999999999999999999886543321 


Q ss_pred             cceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCc
Q 046112          376 QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQ  455 (502)
Q Consensus       376 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  455 (502)
                          ....++..|+|||...+..++.++||||+|+++||+++|+.|+.......           ..    ....     
T Consensus       140 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~----~~~~-----  195 (237)
T cd05576         140 ----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NT----HTTL-----  195 (237)
T ss_pred             ----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------cc----cccc-----
Confidence                22345678999999988889999999999999999999998875421100           00    0000     


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 046112          456 RSIILECLISICEIGVACSAEQPGERMKIND  486 (502)
Q Consensus       456 ~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~e  486 (502)
                       .........+.+++.+|++.||++||++.+
T Consensus       196 -~~~~~~~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         196 -NIPEWVSEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             -CCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence             001123456778999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=267.48  Aligned_cols=263  Identities=21%  Similarity=0.272  Sum_probs=201.5

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCC--C----ccceeeecccccccC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRH--R----NLVKVFTACSGVDFQ  277 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~~~  277 (502)
                      +++|.+...+|+|.||.|-.+.+.+.+..||||+++..... .+...-|+++++++.+  |    -+|.+.+|     ++
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd  161 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD  161 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence            67899999999999999999988888999999999854322 2445679999999942  2    36777777     66


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC--
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD--  355 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~--  355 (502)
                      ..++.+||+|.+ |-|+.+++..        +...+++......|+.|++++++|||   +.+++|-||||+|||+.+  
T Consensus       162 yrghiCivfell-G~S~~dFlk~--------N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~  229 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKE--------NNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSE  229 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhcc--------CCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccc
Confidence            677999999988 7799999965        56677889999999999999999999   999999999999999932  


Q ss_pred             ------------------CCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh
Q 046112          356 ------------------EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT  417 (502)
Q Consensus       356 ------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t  417 (502)
                                        +..++|.|||.|++-.+..     ..++.|..|+|||++.+-.++.++||||+||+|+|+.|
T Consensus       230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt  304 (415)
T KOG0671|consen  230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT  304 (415)
T ss_pred             eEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence                              3468999999998654333     34567999999999999999999999999999999999


Q ss_pred             CCCCCccccc-cccchHHHHHhhcccchhhh-----------cc---------------cCCC--CcchhhHHHHHHHHH
Q 046112          418 GLRPSDDMFK-DNLNLRNCVKSALPERAEEI-----------RA---------------SSGS--TQRSIILECLISICE  468 (502)
Q Consensus       418 g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~-----------~d---------------~~~~--~~~~~~~~~~~~l~~  468 (502)
                      |...|....+ +...+.+-+-+.+|..+..-           .|               +.-+  ........+...+.+
T Consensus       305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD  384 (415)
T KOG0671|consen  305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD  384 (415)
T ss_pred             cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence            9998865321 11223333333333211100           00               0000  000112355667999


Q ss_pred             HHhhcccCCCCCCCCHHHHHH
Q 046112          469 IGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       469 l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      |+.+++..||.+|+|+.|++.
T Consensus       385 Ll~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  385 LLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHHccCccccccHHHHhc
Confidence            999999999999999999875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.8e-33  Score=289.81  Aligned_cols=274  Identities=18%  Similarity=0.143  Sum_probs=171.6

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCC----CeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccc-cccC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFES----TTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSG-VDFQ  277 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  277 (502)
                      ..++|...+.||+|+||.||+|.+..+    +..||||+++....  .+.+..|  .+....+.++..+...+.. ....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            567899999999999999999988888    89999998763221  1111111  1222223333332222111 1113


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchh----hhc------cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEE----DKR------HKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLK  347 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk  347 (502)
                      .+...++|+||+++++|.++++.....    ...      ..............++.|++.||+|||   +++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            455789999999999999998532100    000      000111223345679999999999999   8999999999


Q ss_pred             CCCeeeCC-CCcEEEeeeccceecccccccceecccccccccccCcccCCC----------------------ccCcccc
Q 046112          348 PSNILLDD-EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH----------------------EVSSYGD  404 (502)
Q Consensus       348 ~~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~sD  404 (502)
                      |+|||+++ ++.+||+|||+|+.+...... ......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 579999999999865432221 12345688999999954321                      2345679


Q ss_pred             chhHHHHHHHHHhCCCCCccccc--------cccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccC
Q 046112          405 VYSFGILLLEMFTGLRPSDDMFK--------DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAE  476 (502)
Q Consensus       405 vws~Gv~l~el~tg~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~  476 (502)
                      ||||||++|||+++..|++....        .+.+...|.....+...     +......+..........+|+.+|++.
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRAS-----PDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccc-----hhhhhhhhhccccchHHHHHHHHHccC
Confidence            99999999999998777654110        01111122111110000     000000000111123455899999999


Q ss_pred             CCCCCCCHHHHHH
Q 046112          477 QPGERMKINDVEP  489 (502)
Q Consensus       477 dP~~RPt~~ev~~  489 (502)
                      ||++|||+.|+++
T Consensus       437 dP~kR~ta~e~L~  449 (566)
T PLN03225        437 KGRQRISAKAALA  449 (566)
T ss_pred             CcccCCCHHHHhC
Confidence            9999999999986

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=8.8e-33  Score=259.49  Aligned_cols=239  Identities=26%  Similarity=0.374  Sum_probs=190.2

Q ss_pred             CCceEEEEEEcCCCeEEEEEEecccCcch-hHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeeccCCChh
Q 046112          217 NFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLE  295 (502)
Q Consensus       217 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~  295 (502)
                      +||.||+|....++..+++|++....... .+.+.+|++.+++++|+|++++++++..     ....++++||+++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence            58999999888889999999987654433 6789999999999999999999998643     34789999999999999


Q ss_pred             hhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecccccc
Q 046112          296 EWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE  375 (502)
Q Consensus       296 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  375 (502)
                      +++..          ...+++..+..++.+++.++.|||   +.+++|+||+|+||++++++.++|+|||.+....... 
T Consensus        76 ~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-  141 (244)
T smart00220       76 DLLKK----------RGRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-  141 (244)
T ss_pred             HHHHh----------ccCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-
Confidence            99843          122888999999999999999999   8899999999999999999999999999998765432 


Q ss_pred             cceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCc
Q 046112          376 QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQ  455 (502)
Q Consensus       376 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  455 (502)
                        ......++..|++||......++.++||||||++++++++|..||..... .....+........            .
T Consensus       142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-~~~~~~~~~~~~~~------------~  206 (244)
T smart00220      142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-LLELFKKIGKPKPP------------F  206 (244)
T ss_pred             --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHhccCCC------------C
Confidence              22345578899999999888899999999999999999999999865211 11111111111000            0


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          456 RSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       456 ~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..........+.+++.+|+..+|++||++.++++
T Consensus       207 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      207 PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            0000014567889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=276.87  Aligned_cols=240  Identities=22%  Similarity=0.245  Sum_probs=190.3

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++.|.....+|.|+|+.|-.+....++...+||++...    ..+..+|+.++... +|||++++.+.|     .++.+.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~  391 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEI  391 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeeccee-----cCCcee
Confidence            56778888899999999999999999999999998754    23345677666655 699999999984     455689


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee-CCCCcEEE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL-DDEMTAYV  361 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll-~~~~~~kl  361 (502)
                      ++|||.+.+|-+.+.+..          .. .....+..|+.+++.|+.|||   +++|+||||||+|||+ ++.++++|
T Consensus       392 ~~v~e~l~g~ell~ri~~----------~~-~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrl  457 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRS----------KP-EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRL  457 (612)
T ss_pred             eeeehhccccHHHHHHHh----------cc-hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEE
Confidence            999999999988777632          11 222677789999999999999   8999999999999999 68999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||.++.....     ....+-|..|.|||.+....+++++|+||||++||+|++|+.||.....+ .++...+..   
T Consensus       458 tyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~---  528 (612)
T KOG0603|consen  458 TYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQM---  528 (612)
T ss_pred             EEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcC---
Confidence            999999876544     22334588999999999999999999999999999999999999763322 122211100   


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                                    .++.........+|+..|++.||.+||+|.++..
T Consensus       529 --------------~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  529 --------------PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --------------CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                          0111244555668999999999999999999864

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7e-33  Score=231.45  Aligned_cols=199  Identities=23%  Similarity=0.353  Sum_probs=167.6

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +|...++||+|.+|+||+|+..++++.||+|+++....  .-.....+|+-+++.++|+|||++++..     ..++..-
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence            45567899999999999999999999999999875433  3346788999999999999999999983     4455888


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||| ..+|..+..         .-.+.++......+..|+++|+.++|   ++.+.|||+||.|.|++.+|+.|++|
T Consensus        78 lvfe~c-dqdlkkyfd---------slng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelklad  144 (292)
T KOG0662|consen   78 LVFEFC-DQDLKKYFD---------SLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLAD  144 (292)
T ss_pred             EeHHHh-hHHHHHHHH---------hcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecc
Confidence            999999 457887774         44567888999999999999999999   99999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCc-cCccccchhHHHHHHHHHh-CCCCCcc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFT-GLRPSDD  424 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvws~Gv~l~el~t-g~~p~~~  424 (502)
                      ||+++.+.-+..  -....+.|.+|.+|.++.+.+ |++..|+||-||++.|+.. |++.|.+
T Consensus       145 fglarafgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg  205 (292)
T KOG0662|consen  145 FGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG  205 (292)
T ss_pred             cchhhhcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence            999987654332  112345699999999988865 8999999999999999988 6655654

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=292.13  Aligned_cols=208  Identities=26%  Similarity=0.336  Sum_probs=180.0

Q ss_pred             HHHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeeccccc
Q 046112          198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGV  274 (502)
Q Consensus       198 ~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  274 (502)
                      ..++-..++|.+.++||+|+||.|..++...+++.+|.|++++.   ......-|..|-++|..-+.+=|+.+.-+    
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA----  143 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA----  143 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH----
Confidence            34555678999999999999999999999999999999999862   33445679999999999999999998766    


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                       |+++..+|+|||||+||+|-..+..          ...+++.-+..++..|.-||.-+|   +.|+|||||||+|||+|
T Consensus       144 -FQD~~~LYlVMdY~pGGDlltLlSk----------~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld  209 (1317)
T KOG0612|consen  144 -FQDERYLYLVMDYMPGGDLLTLLSK----------FDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLD  209 (1317)
T ss_pred             -hcCccceEEEEecccCchHHHHHhh----------cCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEec
Confidence             7888899999999999999999853          236777777888899999999999   99999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCC-----CccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-----HEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      ..|++||+|||.+-.+...+. ......+|||-|++||++..     +.|...+|.||+||++|||+.|..||..
T Consensus       210 ~~GHikLADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  210 KSGHIKLADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             ccCcEeeccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            999999999999877664433 33456789999999998663     5788999999999999999999999865

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-33  Score=263.38  Aligned_cols=257  Identities=23%  Similarity=0.371  Sum_probs=192.0

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecc--cCcchh-----HHHHHHHHHHhcCCCCccceeeecccccccCC
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDAS-----KSFAVECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      +|-..++||+|||+.||+|.+....+.||||+-..  .-.+..     +-..+|..+-+.+.||.||++++|+.    -+
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs----lD  539 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS----LD  539 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee----ec
Confidence            35556789999999999999999999999998532  211211     34667999999999999999999963    23


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC---C
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD---D  355 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~---~  355 (502)
                      .+..|-|.|||+|.+|+-||+          ....+++.++..|+.||+.||.||. +.+++|+|-||||.||||-   .
T Consensus       540 tdsFCTVLEYceGNDLDFYLK----------QhklmSEKEARSIiMQiVnAL~YLN-EikpPIIHYDLKPgNILLv~Gta  608 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLK----------QHKLMSEKEARSIIMQIVNALKYLN-EIKPPIIHYDLKPGNILLVNGTA  608 (775)
T ss_pred             cccceeeeeecCCCchhHHHH----------hhhhhhHHHHHHHHHHHHHHHHHHh-ccCCCeeeeccCCccEEEecCcc
Confidence            446789999999999999984          3456788999999999999999997 4478999999999999995   4


Q ss_pred             CCcEEEeeeccceecccccccc-----eecccccccccccCcccCCC----ccCccccchhHHHHHHHHHhCCCCCcccc
Q 046112          356 EMTAYVSDFGIARFLEAADEQT-----RSIGVEGTTGYIAPEYGMGH----EVSSYGDVYSFGILLLEMFTGLRPSDDMF  426 (502)
Q Consensus       356 ~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~s~~sDvws~Gv~l~el~tg~~p~~~~~  426 (502)
                      .|.+||.|||+++++.......     .+.-..||.+|++||++.-+    +++.|.||||.||++|.++.|+.||....
T Consensus       609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq  688 (775)
T KOG1151|consen  609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ  688 (775)
T ss_pred             cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence            5789999999999887554321     12335699999999987643    58899999999999999999999997532


Q ss_pred             ccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 046112          427 KDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVE  488 (502)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~  488 (502)
                      ...    ..+....--...++   .++..+    ....+...++.+|+.+.-++|....++.
T Consensus       689 sQQ----dILqeNTIlkAtEV---qFP~KP----vVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  689 SQQ----DILQENTILKATEV---QFPPKP----VVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hHH----HHHhhhchhcceec---cCCCCC----ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            211    11111100011111   111111    2233445788999999999998877765

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=262.00  Aligned_cols=200  Identities=27%  Similarity=0.331  Sum_probs=167.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .+|....+||+|+||.|.+|....+.+.+|||++++..   .+..+--..|-++|+.- +-|.++.+..++     +.-+
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QTmD  423 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QTMD  423 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hhhh
Confidence            46788899999999999999888888999999998532   22223334566666655 567888888774     4445


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      .+|+||||+.+|+|-..+          ++-+.+.++.+.-+|.+||-||-+||   +++|+.||||..|||||.+|.+|
T Consensus       424 RLyFVMEyvnGGDLMyhi----------QQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiK  490 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHI----------QQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIK  490 (683)
T ss_pred             heeeEEEEecCchhhhHH----------HHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceE
Confidence            899999999999998877          34566788889999999999999999   99999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      |+|||+++.---..  ..+....||+.|+|||.+...+|....|.|||||+||||+.|++||+.
T Consensus       491 i~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG  552 (683)
T KOG0696|consen  491 IADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG  552 (683)
T ss_pred             eeecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence            99999997432222  233457899999999999999999999999999999999999999987

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.9e-32  Score=274.70  Aligned_cols=272  Identities=17%  Similarity=0.199  Sum_probs=181.8

Q ss_pred             hccCCCCCCcccccCCceEEEEEEc----------------CCCeEEEEEEecccCcchhHH--------------HHHH
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILF----------------ESTTAVAVKVFNVLHHDASKS--------------FAVE  252 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E  252 (502)
                      ..++|.+.++||+|+||+||+|...                ..++.||||+++.......++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4678999999999999999999642                345689999987543222223              3346


Q ss_pred             HHHHhcCCCCcc-----ceeeeccccccc---CCCcceeEEeeeccCCChhhhccCCchh--------------hhccCC
Q 046112          253 CEVTRNIRHRNL-----VKVFTACSGVDF---QGNDFKALVYEFMANGSLEEWMHPITEE--------------DKRHKA  310 (502)
Q Consensus       253 ~~~l~~l~h~ni-----v~l~~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~~~  310 (502)
                      +.++.+++|.++     ++++++|.....   ......++||||+++|+|.++++.....              ......
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            667777766544     677777643211   1234689999999999999999742100              000011


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecccccccceeccccccccccc
Q 046112          311 PGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA  390 (502)
Q Consensus       311 ~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  390 (502)
                      ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+....... .....+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeC
Confidence            234678889999999999999999   8899999999999999999999999999997554322111 112234789999


Q ss_pred             CcccCCCcc----------------------CccccchhHHHHHHHHHhCCC-CCcccc--ccc-----cchHHHHHhhc
Q 046112          391 PEYGMGHEV----------------------SSYGDVYSFGILLLEMFTGLR-PSDDMF--KDN-----LNLRNCVKSAL  440 (502)
Q Consensus       391 PE~~~~~~~----------------------s~~sDvws~Gv~l~el~tg~~-p~~~~~--~~~-----~~~~~~~~~~~  440 (502)
                      ||.+.....                      ..+.||||+||+++||++|.. |+....  ...     .+...|...  
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--  456 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--  456 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--
Confidence            998754321                      134699999999999999875 665321  110     011111100  


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCC---CCCCCHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQP---GERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP---~~RPt~~ev~~  489 (502)
                      ...         ....+..........+++.+++..+|   .+|+|++|+++
T Consensus       457 ~~~---------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        457 KGQ---------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ccc---------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            000         00011112334556688888888765   68999999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=7.7e-33  Score=236.31  Aligned_cols=216  Identities=25%  Similarity=0.331  Sum_probs=171.3

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc-CcchhHHHHHHHHHHh-cCCCCccceeeecccccccCCCcceeE
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL-HHDASKSFAVECEVTR-NIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ......||+|++|.|-+-++..+|...|+|++... ..+..+...+|+++.. ...+|.+|.++|..     ......++
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~regdvwI  122 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----FREGDVWI  122 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh-----hccccEEE
Confidence            34457899999999988889999999999999754 3455677888888755 45799999999974     44557999


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      .||.| .-||+.+..+.      ......+++...-+|+..+..||.|||.  +..++|||+||+|||++.+|+||+|||
T Consensus       123 cME~M-~tSldkfy~~v------~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  123 CMELM-DTSLDKFYRKV------LKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             eHHHh-hhhHHHHHHHH------HhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEccc
Confidence            99999 45887776431      1345678888899999999999999995  568999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCC----CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMG----HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |++..+.++-...   -..|...|||||.+..    ..|+-||||||+|++++||.+++.||+.-+..-.++.+.++..
T Consensus       194 GIsG~L~dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  194 GISGYLVDSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP  269 (282)
T ss_pred             ccceeehhhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence            9998775432221   2347788999998664    4799999999999999999999999987444333444444443

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=4.4e-33  Score=267.09  Aligned_cols=243  Identities=23%  Similarity=0.358  Sum_probs=186.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEee
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYE  287 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  287 (502)
                      .++||.|-||+||-|++..+|+.||||++.+..  .....++++|+.+|++++||.||.+..-     ++..+..++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence            589999999999999999999999999997543  3345778999999999999999999876     445568999999


Q ss_pred             eccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC---CcEEEeee
Q 046112          288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE---MTAYVSDF  364 (502)
Q Consensus       288 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~---~~~kl~Df  364 (502)
                      -+.| +..+.+-.        ...+.+++-.-.-++.||+.||.|||   ..+|+|.||||+||||.+.   -++|||||
T Consensus       644 Kl~G-DMLEMILS--------sEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDF  711 (888)
T KOG4236|consen  644 KLHG-DMLEMILS--------SEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDF  711 (888)
T ss_pred             hhcc-hHHHHHHH--------hhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccc
Confidence            9954 54444422        45677888888889999999999999   8999999999999999643   48999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      |+||++....   ....++||+.|+|||++..+.|...-|+||.||++|--++|..||....+    +.+    ++.+  
T Consensus       712 GfARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----Ind----QIQN--  778 (888)
T KOG4236|consen  712 GFARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED----IND----QIQN--  778 (888)
T ss_pred             cceeecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc----hhH----Hhhc--
Confidence            9999986532   33468899999999999999999999999999999999999999976211    111    1111  


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV  487 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev  487 (502)
                           ..+.-.+.-..+......+++...++..=.+|-|...-
T Consensus       779 -----AaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~  816 (888)
T KOG4236|consen  779 -----AAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKS  816 (888)
T ss_pred             -----cccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence                 11111111123444455566666666666667666543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.8e-33  Score=246.95  Aligned_cols=268  Identities=20%  Similarity=0.245  Sum_probs=195.2

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +....+.||.|+||.||...+..+|+.||.|++....  -.+.+.+-+|++++..++|.|++..++...-.....-.+.|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            3456789999999999999999999999999876322  22457788999999999999999998874322222223677


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +++|.| ..+|...+          ..+..++.....-+.+||++||.|||   +.+|.||||||.|.|++.+...||||
T Consensus       134 V~TELm-QSDLHKII----------VSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICD  199 (449)
T KOG0664|consen  134 VLTELM-QSDLHKII----------VSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICD  199 (449)
T ss_pred             HHHHHH-Hhhhhhee----------ccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecc
Confidence            889988 55777776          55677888888899999999999999   99999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+|+.-+..+. ..++.-+.|..|+|||.+++. .|+.+.||||.||++.|++..+..|..  ..+.+..+.+...+..
T Consensus       200 FGLARvee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA--q~PiqQL~lItdLLGT  276 (449)
T KOG0664|consen  200 FGLARTWDQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA--AGPIEQLQMIIDLLGT  276 (449)
T ss_pred             cccccccchhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc--cChHHHHHHHHHHhCC
Confidence            999986544333 223344568899999999985 599999999999999999998887764  1223333333333322


Q ss_pred             -chhhhcc----------------cCCCCcchhhH--HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          443 -RAEEIRA----------------SSGSTQRSIIL--ECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       443 -~~~~~~d----------------~~~~~~~~~~~--~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                       ..+.+..                +..+..+....  .--.+-..+...++..||..|.+..+.+..
T Consensus       277 Ps~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  277 PSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             CcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence             1111111                11111111111  112233456667788999999998887654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=275.74  Aligned_cols=247  Identities=24%  Similarity=0.382  Sum_probs=186.9

Q ss_pred             CCCCCcccccCCce-EEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcceeE
Q 046112          207 FSSENLIGAGNFGS-VYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       207 ~~~~~~lG~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      |...+++|.|+.|+ ||+|..  .|+.||||++-.   +-.+-.++|++.++.- +|||||++++.     ..+..+.||
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YI  580 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYI  580 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEE
Confidence            34456789999886 799976  788999998753   2234568899999887 59999999876     455679999


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC---C--CcE
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD---E--MTA  359 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~---~--~~~  359 (502)
                      ..|.| .-||++++..... +.  ...   .....+.+..|++.||++||   +-+||||||||.|||++.   +  .++
T Consensus       581 alELC-~~sL~dlie~~~~-d~--~~~---~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra  650 (903)
T KOG1027|consen  581 ALELC-ACSLQDLIESSGL-DV--EMQ---SDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRA  650 (903)
T ss_pred             EehHh-hhhHHHHHhcccc-ch--hhc---ccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeE
Confidence            99999 6799999965210 00  011   11345678889999999999   899999999999999975   2  589


Q ss_pred             EEeeeccceecccccc-cceecccccccccccCcccCCCccCccccchhHHHHHHHHHhC-CCCCccccccccchHHHHH
Q 046112          360 YVSDFGIARFLEAADE-QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG-LRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg-~~p~~~~~~~~~~~~~~~~  437 (502)
                      +|+|||+++.+..... ..+..+..||-+|+|||++....-+.+.||+|+||++|..++| +.||.+....+.++..-..
T Consensus       651 ~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~  730 (903)
T KOG1027|consen  651 KISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNY  730 (903)
T ss_pred             EecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcc
Confidence            9999999998876554 3345678899999999999998888899999999999999985 9999885444333221110


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...     .        ..+ ..+|  +..+|+.+|+.++|..||++.+|+.
T Consensus       731 ~L~-----~--------L~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  731 TLV-----H--------LEP-LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             cee-----e--------ecc-CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            000     0        000 1122  5669999999999999999999963

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9e-31  Score=238.69  Aligned_cols=247  Identities=24%  Similarity=0.315  Sum_probs=191.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .+|....+||+|+|+.|..++...+.+.+|+|++++.   ..+..+..+.|-.+..+- +||.+|.+..+     ++.+.
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqtes  324 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTES  324 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hcccc
Confidence            4678889999999999999999999999999998854   223345667777776655 79999999887     66667


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      .+++|.||+++|+|--++          .....+++..+.-...+|.-||.|||   +++|+.||||..|||+|..|.+|
T Consensus       325 rlffvieyv~ggdlmfhm----------qrqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghik  391 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHM----------QRQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIK  391 (593)
T ss_pred             eEEEEEEEecCcceeeeh----------hhhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCcee
Confidence            999999999999997666          34456888888889999999999999   99999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccc--cccccchHHHHHh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM--FKDNLNLRNCVKS  438 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~--~~~~~~~~~~~~~  438 (502)
                      +.|+|+++.--.+.  ..+...+||+.|+|||.+.+..|....|.|++||+++||+.|+.||+-.  .+.+.+...+.-.
T Consensus       392 ltdygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq  469 (593)
T KOG0695|consen  392 LTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ  469 (593)
T ss_pred             ecccchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH
Confidence            99999997533222  2234578999999999999999999999999999999999999999842  2222233332222


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM  482 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP  482 (502)
                      .+-++  .+         .++.........+++.-+++||.+|.
T Consensus       470 vilek--qi---------riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  470 VILEK--QI---------RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             HHhhh--cc---------cccceeehhhHHHHHHhhcCCcHHhc
Confidence            22111  11         11112233344667777899999885

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=256.07  Aligned_cols=241  Identities=22%  Similarity=0.354  Sum_probs=189.7

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +.....||-|+||.|=++........+|+|++++..   ....+-...|-.+|...+.|.||+++-.     +.+++..|
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~kyvY  496 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKYVY  496 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchhhh
Confidence            344557999999999998765555558999887543   3334456789999999999999999877     66777999


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +.||-|-||.|...|.          .++.++..+..-++..+.+|++|||   .++||.|||||+|.+||.+|-+||.|
T Consensus       497 mLmEaClGGElWTiLr----------dRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVD  563 (732)
T KOG0614|consen  497 MLMEACLGGELWTILR----------DRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVD  563 (732)
T ss_pred             hhHHhhcCchhhhhhh----------hcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEee
Confidence            9999999999999984          4567888888899999999999999   99999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||+|+.+...   ..++..+||+.|.|||.+.+...+.+.|.||+|++++||+||++||...  ++....+.+-..+   
T Consensus       564 FGFAKki~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~--dpmktYn~ILkGi---  635 (732)
T KOG0614|consen  564 FGFAKKIGSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV--DPMKTYNLILKGI---  635 (732)
T ss_pred             hhhHHHhccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC--chHHHHHHHHhhh---
Confidence            9999977543   4456788999999999999999999999999999999999999999863  1211111111111   


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK  483 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt  483 (502)
                       +.+         .++........+++++..+.+|.+|.-
T Consensus       636 -d~i---------~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  636 -DKI---------EFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -hhh---------hcccccchhHHHHHHHHHhcCcHhhhc
Confidence             000         011223344456777767889999875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.4e-30  Score=225.89  Aligned_cols=262  Identities=18%  Similarity=0.274  Sum_probs=196.1

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-CCccceeeecccccccCCCcc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ..++|++.+++|+|.++.||.|....+.+.++||+++..   ..+.+.+|+++++.++ ||||+++++....   +....
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~D---p~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKD---PESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcC---ccccC
Confidence            456788899999999999999988889999999999843   3577899999999998 9999999998543   33456


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC-CcEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE-MTAY  360 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~-~~~k  360 (502)
                      ..+|+||+.+.+.....             +.++.........+++.||.|+|   +.||.|||+||.|+++|.. ...+
T Consensus       110 paLiFE~v~n~Dfk~ly-------------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLr  173 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY-------------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLR  173 (338)
T ss_pred             chhHhhhhccccHHHHh-------------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceee
Confidence            78999999998776655             33666677889999999999999   9999999999999999954 5799


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|+|+|.++-+..+...   .+.+..|--||.+.+- .|+..-|+|||||++..|+..+.||....+...+++..++-.
T Consensus       174 lIDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL  250 (338)
T KOG0668|consen  174 LIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL  250 (338)
T ss_pred             eeecchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence            999999998877655433   2345567889998874 578889999999999999999999876444444444332211


Q ss_pred             ccc---------------chhhhcccCCCCc-chhh-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPE---------------RAEEIRASSGSTQ-RSII-----LECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~---------------~~~~~~d~~~~~~-~~~~-----~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      -.+               ....++..-.... ..+.     --...+..+++.+.+..|.++|||++|...
T Consensus       251 Gt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  251 GTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             ChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            111               1111111110000 0000     001245668888889999999999999865

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=9.4e-29  Score=226.54  Aligned_cols=211  Identities=28%  Similarity=0.478  Sum_probs=179.4

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeeccC
Q 046112          213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMAN  291 (502)
Q Consensus       213 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~  291 (502)
                      ||+|++|.||++....+++.+++|++...... ..+.+.+|++.++.++|++++++++++..     ....++++||+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence            68999999999988777999999998754322 34679999999999999999999998543     3578999999999


Q ss_pred             CChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC-CCcEEEeeeccceec
Q 046112          292 GSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD-EMTAYVSDFGIARFL  370 (502)
Q Consensus       292 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~-~~~~kl~Dfg~a~~~  370 (502)
                      ++|.+++..         ....+++..+..++.++++++.+||   +.+++|+||+|.||+++. ++.++|+|||.+...
T Consensus        76 ~~l~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~  143 (215)
T cd00180          76 GSLKDLLKE---------NEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL  143 (215)
T ss_pred             CcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence            999999853         1145889999999999999999999   889999999999999999 899999999999866


Q ss_pred             ccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcc
Q 046112          371 EAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRA  449 (502)
Q Consensus       371 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  449 (502)
                      .....  ......+...|++||..... ..+.++|+|++|++++++                                  
T Consensus       144 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------  187 (215)
T cd00180         144 TSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------  187 (215)
T ss_pred             cCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence            44321  12234567889999998887 888999999999999999                                  


Q ss_pred             cCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          450 SSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       450 ~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                                    ..+.+++..|++.+|.+||++.++++.
T Consensus       188 --------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                          346689999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=225.24  Aligned_cols=250  Identities=20%  Similarity=0.279  Sum_probs=188.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      +.|++.+.+|+|.||.+-++++..+.+.+++|.+.... ...++|.+|...--.+ .|.||+..++..    ++..+...
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Yv   98 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAYV   98 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceEE
Confidence            46788899999999999999999999999999887543 2367899988765555 589999988764    56667889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC--CCCcEEE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD--DEMTAYV  361 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~--~~~~~kl  361 (502)
                      +++||++.|+|.+-+.           ...+.+....+++.|++.|+.|+|   +..+||||||.+|||+-  +..++|+
T Consensus        99 F~qE~aP~gdL~snv~-----------~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKl  164 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVE-----------AAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKL  164 (378)
T ss_pred             EeeccCccchhhhhcC-----------cccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEe
Confidence            9999999999998763           245777888999999999999999   99999999999999993  4459999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCC-----CccCccccchhHHHHHHHHHhCCCCCccccccccchH---
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-----HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR---  433 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~---  433 (502)
                      ||||..+..+...     .....+..|.+||....     -...+.+|||.||++++.++||+.||......+..+.   
T Consensus       165 cDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~  239 (378)
T KOG1345|consen  165 CDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE  239 (378)
T ss_pred             eecccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence            9999987543221     12234667999997543     2356779999999999999999999986544444444   


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      +|..+..+..+..        ..    .......++.++-+..+|++|-...++.++
T Consensus       240 ~w~~rk~~~~P~~--------F~----~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  240 QWLKRKNPALPKK--------FN----PFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             HHhcccCccCchh--------hc----ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            4444333321111        11    223456678888889999999554444433

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-30  Score=256.33  Aligned_cols=254  Identities=24%  Similarity=0.325  Sum_probs=202.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|....++|.|.+|.|||+++..+++..|+|+++....+..+-.+.|+-+++..+||||+.++|.+     ...+..+
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-----lr~dklw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-----LRRDKLW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-----hhhcCcE
Confidence            45677889999999999999999999999999999988888888889999999999999999999984     4455899


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      ++||||.+|+|++..|          ..+++++.+...++....+|++|||   +.+-+|||||-.||++++.+.+|++|
T Consensus        89 icMEycgggslQdiy~----------~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaD  155 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLAD  155 (829)
T ss_pred             EEEEecCCCcccceee----------ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecc
Confidence            9999999999999875          3567999999999999999999999   99999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccC---CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGM---GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      ||.+..+..  ......+..||+.|||||+..   .+.|..++|||+.|+...|+-.-++|..+..... .+.-..++..
T Consensus       156 fgvsaqita--ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-~l~LmTkS~~  232 (829)
T KOG0576|consen  156 FGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-ALFLMTKSGF  232 (829)
T ss_pred             cCchhhhhh--hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-HHHHhhccCC
Confidence            999865432  223345678999999999754   4678999999999999999998888854421100 0000001110


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                        ....+.|      .   ..-...+-++++.|+.++|++|||++.+++
T Consensus       233 --qpp~lkD------k---~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  233 --QPPTLKD------K---TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             --CCCcccC------C---ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence              0000111      1   123456778999999999999999987764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=2.7e-28  Score=226.46  Aligned_cols=200  Identities=30%  Similarity=0.449  Sum_probs=168.9

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEE
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      |...+.||.|++|.||++....+++.+++|.+...... ..+.+.+|++.+++++|+|++++++++..     ....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence            45678899999999999988777899999998765443 56788999999999999999999998543     3478999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeec
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG  365 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg  365 (502)
                      +||+++++|.+++..         ....+++.....++.+++.++.+||   +.+++|+|++|+||+++.++.++|+|||
T Consensus        76 ~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g  143 (225)
T smart00221       76 MEYCEGGDLFDYLRK---------KGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFG  143 (225)
T ss_pred             EeccCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCc
Confidence            999999999999853         1111788999999999999999999   8899999999999999999999999999


Q ss_pred             cceecccccccceecccccccccccCccc-CCCccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          366 IARFLEAADEQTRSIGVEGTTGYIAPEYG-MGHEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       366 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      .+......... ......++..|++||.. ....++.++|||+||++++|+++|+.||+.
T Consensus       144 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      144 LARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            99876543211 12234567889999998 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=7e-29  Score=243.01  Aligned_cols=203  Identities=23%  Similarity=0.354  Sum_probs=168.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .-|...+.||-|+||.|.++...++...+|.|.+++.+   .....-...|-++|+.-+.+=||+++-.     |++.+.
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn  703 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN  703 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence            34667788999999999999888888889999886432   2223446779999999999999999866     777889


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      +|+||+|++||++-.+|          ...+.+.+.-+..++.++..|+++.|   +.|+|||||||+|||+|.+|.+||
T Consensus       704 LYFVMdYIPGGDmMSLL----------IrmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKL  770 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLL----------IRMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKL  770 (1034)
T ss_pred             eEEEEeccCCccHHHHH----------HHhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceee
Confidence            99999999999998887          33455777777778889999999999   999999999999999999999999


Q ss_pred             eeeccceecccc---------cc-----------cc--------------------eecccccccccccCcccCCCccCc
Q 046112          362 SDFGIARFLEAA---------DE-----------QT--------------------RSIGVEGTTGYIAPEYGMGHEVSS  401 (502)
Q Consensus       362 ~Dfg~a~~~~~~---------~~-----------~~--------------------~~~~~~gt~~y~aPE~~~~~~~s~  401 (502)
                      .|||+++-+...         +.           +.                    .....+||+.|+|||++....++.
T Consensus       771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q  850 (1034)
T KOG0608|consen  771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ  850 (1034)
T ss_pred             eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence            999998533110         00           00                    011246999999999999999999


Q ss_pred             cccchhHHHHHHHHHhCCCCCccc
Q 046112          402 YGDVYSFGILLLEMFTGLRPSDDM  425 (502)
Q Consensus       402 ~sDvws~Gv~l~el~tg~~p~~~~  425 (502)
                      .+|.||.||+||||+.|+.||-+.
T Consensus       851 ~cdwws~gvil~em~~g~~pf~~~  874 (1034)
T KOG0608|consen  851 LCDWWSVGVILYEMLVGQPPFLAD  874 (1034)
T ss_pred             cchhhHhhHHHHHHhhCCCCccCC
Confidence            999999999999999999999764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-28  Score=234.47  Aligned_cols=136  Identities=23%  Similarity=0.327  Sum_probs=114.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-----C---Cccceeeeccccccc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-----H---RNLVKVFTACSGVDF  276 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~~~  276 (502)
                      .+|-+.++||=|.|++||++.+....+.||+|+.+.... -.+....|+++|++++     |   .+||++++++.... 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG-  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG-  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC-
Confidence            467888999999999999999999999999999875322 2355678999999884     2   47999999875443 


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL  353 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll  353 (502)
                      +++.+.++|+|++ |.+|..++..        .....++...+.+|+.|++.||.|||..  -+|||-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~--------s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKY--------SNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHH--------hCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence            5667999999999 8889888854        5567799999999999999999999974  489999999999999

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-29  Score=243.64  Aligned_cols=198  Identities=23%  Similarity=0.323  Sum_probs=169.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--------chhHHHHHHHHHHhcCC---CCccceeeeccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--------DASKSFAVECEVTRNIR---HRNLVKVFTACS  272 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  272 (502)
                      ..+|+..+.+|+|+||.|+.|.++++...|+||.+.+...        ......-.|+++|..++   |+||++++++  
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf--  637 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF--  637 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe--
Confidence            3468888999999999999999999999999998865321        12234567999999997   9999999999  


Q ss_pred             ccccCCCcceeEEeeec-cCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCe
Q 046112          273 GVDFQGNDFKALVYEFM-ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNI  351 (502)
Q Consensus       273 ~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NI  351 (502)
                         |++++..+|+||-. ++-+|.+++          .....+++.....|+.|++.|+++||   +.+|||||||-+||
T Consensus       638 ---FEddd~yyl~te~hg~gIDLFd~I----------E~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenv  701 (772)
T KOG1152|consen  638 ---FEDDDYYYLETEVHGEGIDLFDFI----------EFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENV  701 (772)
T ss_pred             ---eecCCeeEEEecCCCCCcchhhhh----------hccCccchHHHHHHHHHHHhcccccc---ccCceecccccccE
Confidence               77888999999975 556899998          44567899999999999999999999   99999999999999


Q ss_pred             eeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCcc-ccchhHHHHHHHHHhCCCCCc
Q 046112          352 LLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSY-GDVYSFGILLLEMFTGLRPSD  423 (502)
Q Consensus       352 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDvws~Gv~l~el~tg~~p~~  423 (502)
                      .++.+|-+||.|||.|......    .....+||..|.|||++.+.+|--| -|||++|++||.++...-||-
T Consensus       702 ivd~~g~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  702 IVDSNGFVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEecCCeEEEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999999999998654332    2234679999999999999988655 799999999999998888874

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=224.34  Aligned_cols=261  Identities=22%  Similarity=0.206  Sum_probs=192.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc--CcchhHHHHHHHHHHhcCCCCccceeeeccccccc-CCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL--HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-QGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~  281 (502)
                      .+|.....+|.|.- .|..+-+.-.+++||+|.+...  .....++..+|...+..++|+|+++++.++.-... ..-..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666778888888 7777777778999999987533  23446778899999999999999999998643221 12236


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .|+|||+| .++|...++            -.++-.+...|..|++.|+.|||   +.+|+||||||+||++..+..+||
T Consensus        96 ~y~v~e~m-~~nl~~vi~------------~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi  159 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL------------MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKI  159 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH------------HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheee
Confidence            78999999 668888774            22556678899999999999999   999999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh--h
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS--A  439 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~--~  439 (502)
                      .|||+|+.-...   -..+.++.|..|.|||.+.+..+.+..||||.||++.||++|+.-|.+.    ..+.+|.+.  .
T Consensus       160 ~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~  232 (369)
T KOG0665|consen  160 LDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQ  232 (369)
T ss_pred             ccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHH
Confidence            999999854322   3456788899999999999988999999999999999999999887641    112222110  0


Q ss_pred             cc-------------------cc-------h-hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LP-------------------ER-------A-EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~-------------------~~-------~-~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      +.                   ..       . .-+.|.......+...-......+++.+|+..+|++|.+++++++
T Consensus       233 lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  233 LGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             hcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            00                   00       0 011111111111111112335668899999999999999999875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=5.8e-28  Score=227.71  Aligned_cols=264  Identities=23%  Similarity=0.312  Sum_probs=196.0

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcC---CCeEEEEEEecccCcchhHHHHHHHHHHhcCC-CCccceeeecccccccCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFE---STTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  278 (502)
                      ..+.|...++||+|.|++||++....   ..+.||+|.+....  ....+..|+++|..+. +.||+++.++     +..
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~-----~rn  106 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGC-----FRN  106 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhh-----hcc
Confidence            44667889999999999999998777   78899999987543  3466899999999985 8999999988     677


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC-C
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE-M  357 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~-~  357 (502)
                      ++...+|+||++.-...+++..             ++........+.+..||+++|   ..|||||||||+|+|.+.. +
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~-------------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~  170 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS-------------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQ  170 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc-------------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccC
Confidence            7899999999999998888743             567788889999999999999   9999999999999999854 5


Q ss_pred             cEEEeeeccceeccccc------------------------------------------ccceecccccccccccCcccC
Q 046112          358 TAYVSDFGIARFLEAAD------------------------------------------EQTRSIGVEGTTGYIAPEYGM  395 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~  395 (502)
                      .-.|.|||+|...+...                                          .........||+||.|||++.
T Consensus       171 rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~  250 (418)
T KOG1167|consen  171 RGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLF  250 (418)
T ss_pred             CceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHh
Confidence            77899999996211000                                          000122356999999999877


Q ss_pred             C-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc----------cc-----------hhhhc----c
Q 046112          396 G-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP----------ER-----------AEEIR----A  449 (502)
Q Consensus       396 ~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------~~-----------~~~~~----d  449 (502)
                      . ..-++++||||-||+++-+++++.||....++-..+.+.+...-.          ..           ..+..    .
T Consensus       251 k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s  330 (418)
T KOG1167|consen  251 RCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFET  330 (418)
T ss_pred             hccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhc
Confidence            5 567899999999999999999999987644443333333211100          00           00000    0


Q ss_pred             c---CCCC------cchhhHHH-HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          450 S---SGST------QRSIILEC-LISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       450 ~---~~~~------~~~~~~~~-~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .   ....      ......++ +..++++..+|+..||.+|.|++|.+.
T Consensus       331 ~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  331 LHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            0   0000      00111122 337889999999999999999999874

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=1.3e-28  Score=236.22  Aligned_cols=274  Identities=20%  Similarity=0.219  Sum_probs=204.6

Q ss_pred             cCHHHHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC------CCccceee
Q 046112          195 VSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR------HRNLVKVF  268 (502)
Q Consensus       195 ~~~~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~  268 (502)
                      +.+..-+....+|.+....|+|-|++|.+|.+...|..||||++..... -.+.=..|+++|.+|+      --|+++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            3333334456678888899999999999999999999999999975322 2355678999999995      34888888


Q ss_pred             ecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCC
Q 046112          269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKP  348 (502)
Q Consensus       269 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~  348 (502)
                      -.     |....++|+|+|-+ ..+|.+.|..+       .....|....+..++.|+.-||..|-   .-+|+|.||||
T Consensus       501 r~-----F~hknHLClVFE~L-slNLRevLKKy-------G~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKP  564 (752)
T KOG0670|consen  501 RH-----FKHKNHLCLVFEPL-SLNLREVLKKY-------GRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKP  564 (752)
T ss_pred             HH-----hhhcceeEEEehhh-hchHHHHHHHh-------CcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCc
Confidence            76     55667999999987 66899999653       33455777888899999999999999   88999999999


Q ss_pred             CCeeeCCC-CcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccc
Q 046112          349 SNILLDDE-MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFK  427 (502)
Q Consensus       349 ~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~  427 (502)
                      .|||+.+. ..+||||||.|.......-    +.+.....|.|||++.+..|+...|+||.||+||||.||+..|.+..+
T Consensus       565 DNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN  640 (752)
T KOG0670|consen  565 DNILVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN  640 (752)
T ss_pred             cceEeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence            99999866 4679999999976654332    223345679999999999999999999999999999999998876332


Q ss_pred             cc-cchHHHHHhhcccch---hhh----cccCC-----------------------------------CCcchhhHHHHH
Q 046112          428 DN-LNLRNCVKSALPERA---EEI----RASSG-----------------------------------STQRSIILECLI  464 (502)
Q Consensus       428 ~~-~~~~~~~~~~~~~~~---~~~----~d~~~-----------------------------------~~~~~~~~~~~~  464 (502)
                      .. ..+..-++..++..+   ..+    +|..+                                   +..++-......
T Consensus       641 N~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~  720 (752)
T KOG0670|consen  641 NQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQ  720 (752)
T ss_pred             HHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHH
Confidence            21 123333334433311   111    11111                                   001111234566


Q ss_pred             HHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          465 SICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       465 ~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .+.+|+..|+..||++|.|..+.+.
T Consensus       721 ~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  721 QLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHHHHHHHHhccChhhcCCHHHHhc
Confidence            7889999999999999999998764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=7.5e-27  Score=208.61  Aligned_cols=170  Identities=21%  Similarity=0.223  Sum_probs=127.9

Q ss_pred             CChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecc
Q 046112          292 GSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE  371 (502)
Q Consensus       292 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~  371 (502)
                      |||.++++.         ....+++.++..++.|++.||+|||   +.+      ||+|||++.++.+|+  ||+++...
T Consensus         1 GsL~~~l~~---------~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~   60 (176)
T smart00750        1 VSLADILEV---------RGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKT   60 (176)
T ss_pred             CcHHHHHHH---------hCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeec
Confidence            688888842         2356999999999999999999999   555      999999999999999  99998654


Q ss_pred             cccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccC
Q 046112          372 AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASS  451 (502)
Q Consensus       372 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  451 (502)
                      ...       ..||+.|||||++.+..++.++|||||||++|||+||+.||.........+..+.........       
T Consensus        61 ~~~-------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------  126 (176)
T smart00750       61 PEQ-------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP-------  126 (176)
T ss_pred             ccc-------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc-------
Confidence            321       257899999999999999999999999999999999999987532222222222211111100       


Q ss_pred             CCCcchhhHHHH--HHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          452 GSTQRSIILECL--ISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       452 ~~~~~~~~~~~~--~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                        ..........  ..+.+++.+|+..+|++||++.|+++.+..+..+
T Consensus       127 --~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      127 --RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             --cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence              0000011222  2688999999999999999999999999877554

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.8e-27  Score=260.35  Aligned_cols=201  Identities=17%  Similarity=0.290  Sum_probs=139.7

Q ss_pred             cCCC-Cccceeeeccccccc--CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046112          258 NIRH-RNLVKVFTACSGVDF--QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLH  334 (502)
Q Consensus       258 ~l~h-~niv~l~~~~~~~~~--~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH  334 (502)
                      .++| .||+++++++.....  ..+...+.++||+ +++|.++++.         ....+++.+++.++.||++||+|||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH   97 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---------PDRSVDAFECFHVFRQIVEIVNAAH   97 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---------ccccccHHHHHHHHHHHHHHHHHHH
Confidence            4455 588888887522211  2233567788887 6799999952         2355899999999999999999999


Q ss_pred             hCCCCCceeecCCCCCeeeCC-------------------CCcEEEeeeccceecccccc--------------cceecc
Q 046112          335 LDCQPPIAHCDLKPSNILLDD-------------------EMTAYVSDFGIARFLEAADE--------------QTRSIG  381 (502)
Q Consensus       335 ~~~~~~i~H~dlk~~NIll~~-------------------~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~  381 (502)
                         +.+|+||||||+|||++.                   ++.+|++|||+++.......              ......
T Consensus        98 ---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (793)
T PLN00181         98 ---SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL  174 (793)
T ss_pred             ---hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence               999999999999999954                   44566677776654221000              000112


Q ss_pred             cccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHH
Q 046112          382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILE  461 (502)
Q Consensus       382 ~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  461 (502)
                      ..||+.|||||++.+..++.++|||||||+||||++|..|+.....   .+........+        +.       ...
T Consensus       175 ~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~~~--------~~-------~~~  236 (793)
T PLN00181        175 AMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRVLP--------PQ-------ILL  236 (793)
T ss_pred             cCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhhcC--------hh-------hhh
Confidence            4578899999999999999999999999999999999988654110   01111111000        00       011


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          462 CLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       462 ~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .......++.+|++++|.+||+|.|+++
T Consensus       237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        237 NWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             cCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            1233457788999999999999999975

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-27  Score=211.39  Aligned_cols=245  Identities=22%  Similarity=0.358  Sum_probs=187.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccc--CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeee
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVL--HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEF  288 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  288 (502)
                      -+|.+...|..|+|++  .|..+++|+++..  .....++|..|.-.++.+.||||++++|.|...     ....++..|
T Consensus       196 tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~isq~  268 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVIISQY  268 (448)
T ss_pred             hhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEeeee
Confidence            3678899999999998  4556777887643  233457899999999999999999999998654     378899999


Q ss_pred             ccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe--eecc
Q 046112          289 MANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS--DFGI  366 (502)
Q Consensus       289 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~--Dfg~  366 (502)
                      |+.|||+..+|+        ...-..+..+..+++.++|+|++|||.- ++-|..-.+.+..|++|++.+++|+  |--+
T Consensus       269 mp~gslynvlhe--------~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kf  339 (448)
T KOG0195|consen  269 MPFGSLYNVLHE--------QTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKF  339 (448)
T ss_pred             ccchHHHHHHhc--------CccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheeccccee
Confidence            999999999986        4455678889999999999999999943 4445556799999999999998874  3222


Q ss_pred             ceecccccccceecccccccccccCcccCCCcc---CccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEV---SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      +.   +      ..+..-.+.||+||.++..+-   -.++|+|||++++||+.|...||.+....+..+.-..       
T Consensus       340 sf---q------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-------  403 (448)
T KOG0195|consen  340 SF---Q------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-------  403 (448)
T ss_pred             ee---e------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-------
Confidence            21   1      122334688999999987653   3568999999999999999999987432221111111       


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                       +.+       ...++......+.+++.-|+..||.+||.+..++-.|+++.
T Consensus       404 -egl-------rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  404 -EGL-------RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -ccc-------cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence             101       11222345667889999999999999999999999998874

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=8.6e-25  Score=213.35  Aligned_cols=168  Identities=22%  Similarity=0.179  Sum_probs=130.3

Q ss_pred             HhccCCCCCCcccccCCceEEEEEEcC-CCeEEEEEEeccc-----CcchhHHHHHHHHHHhcCCCCccceeeecccccc
Q 046112          202 NATKGFSSENLIGAGNFGSVYKGILFE-STTAVAVKVFNVL-----HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVD  275 (502)
Q Consensus       202 ~~t~~~~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  275 (502)
                      ....+|...+.||+|+||+||+|.+.. ++..||||++...     .......|.+|++++++++|+|+++.+..+    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            345689999999999999999997765 6788899986532     112345689999999999999998643221    


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecC-CCCCeeeC
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDL-KPSNILLD  354 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dl-k~~NIll~  354 (502)
                          ...++||||+++++|... .         .. .      ...++.++++||+|||   +.+|+|||| ||+|||++
T Consensus        91 ----~~~~LVmE~~~G~~L~~~-~---------~~-~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~  146 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHLA-R---------PH-G------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMG  146 (365)
T ss_pred             ----CCcEEEEEccCCCCHHHh-C---------cc-c------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEc
Confidence                246999999999999632 1         00 0      1357889999999999   899999999 99999999


Q ss_pred             CCCcEEEeeeccceecccccccce------ecccccccccccCcccCCC
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTR------SIGVEGTTGYIAPEYGMGH  397 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  397 (502)
                      .++.+||+|||+|+.+........      -....+++.|+|||++...
T Consensus       147 ~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        147 PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999999999999987755432111      1356688999999987653

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=5.2e-23  Score=201.46  Aligned_cols=264  Identities=21%  Similarity=0.258  Sum_probs=193.1

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCC-eEEEEEEecccCcchhHHHHHHHHHHhcCCC----CccceeeecccccccCCCc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFEST-TAVAVKVFNVLHHDASKSFAVECEVTRNIRH----RNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~~~~~~~~~~  280 (502)
                      +|.+.+.||+|+||.||.+.+...+ ..+|+|............+..|..++..+..    +++..+++...    ..+.
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7999999999999999999876654 6788888765433322367888888888863    57777777631    3455


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC----
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE----  356 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~----  356 (502)
                      ..++||+.+ +.||.++...        .....++..+.+.|+.|+..+|.++|   +.+++||||||.|++++..    
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~--------~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~  162 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKR--------NPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSE  162 (322)
T ss_pred             eeEEEEecc-CccHHHHHHh--------CCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcc
Confidence            789999987 8899997643        22567999999999999999999999   9999999999999999865    


Q ss_pred             -CcEEEeeeccce--ecccccc----cce--ecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccc
Q 046112          357 -MTAYVSDFGIAR--FLEAADE----QTR--SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFK  427 (502)
Q Consensus       357 -~~~kl~Dfg~a~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~  427 (502)
                       ..+.|.|||+++  .+.....    ..+  .....||..|+++....+...+.+.|+||++.++.|++.|..||.....
T Consensus       163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~  242 (322)
T KOG1164|consen  163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM  242 (322)
T ss_pred             cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence             469999999998  3322211    111  1345699999999999999999999999999999999999999965322


Q ss_pred             cccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          428 DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ...  ...+......   .....       .....+..+.++...+-..+..++|....+...++.....
T Consensus       243 ~~~--~~~~~~~~~~---~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  243 TDL--KSKFEKDPRK---LLTDR-------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             cch--HHHHHHHhhh---hcccc-------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            111  1111111000   00000       0112344555666666668999999999999988776554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=1.5e-23  Score=217.88  Aligned_cols=254  Identities=22%  Similarity=0.261  Sum_probs=189.6

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccc--Ccch----hHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          209 SENLIGAGNFGSVYKGILFESTTAVAVKVFNVL--HHDA----SKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       209 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ..+++|.|++|.|+........+..+.|.+...  ....    ...+..|+-+-..++|||++..+..+...+     ..
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-----~~  396 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-----GI  396 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-----cc
Confidence            467899999998888876666666666654311  1111    122566777788899999988877754322     33


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      .-+|||+++ +|...+..          ...+...++-.+..|+..|+.|+|   ..+|.|||+|++|++++.++.+||+
T Consensus       397 ~~~mE~~~~-Dlf~~~~~----------~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~  462 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMS----------NGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKII  462 (601)
T ss_pred             hhhhhcccH-HHHHHHhc----------ccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEe
Confidence            344999999 99998842          245777888999999999999999   9999999999999999999999999


Q ss_pred             eeccceeccccccc--ceecccccccccccCcccCCCccCcc-ccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          363 DFGIARFLEAADEQ--TRSIGVEGTTGYIAPEYGMGHEVSSY-GDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       363 Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~-sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |||.+.......+.  ....+..|.-.|+|||.+.+..|++. .||||.|+++..|.+|+.||......+..+.+.    
T Consensus       463 Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~----  538 (601)
T KOG0590|consen  463 DFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN----  538 (601)
T ss_pred             ecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh----
Confidence            99999766544443  45567889999999999999999877 799999999999999999997654443332110    


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                          ..........+...+....+.+...++.++++.||.+|.|++++++
T Consensus       539 ----~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  539 ----NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ----ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence                0000011112223334456667778999999999999999999975

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=1.8e-21  Score=191.20  Aligned_cols=260  Identities=28%  Similarity=0.393  Sum_probs=191.5

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc---hhHHHHHHHHHHhcCCCC-ccceeeecccccccCCCcce
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD---ASKSFAVECEVTRNIRHR-NLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~~~  282 (502)
                      |...+.||.|+||.||++.+.   ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+..     ......
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence            556778999999999999775   78899998754332   367799999999999988 799999884     233347


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC-cEEE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM-TAYV  361 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~-~~kl  361 (502)
                      +++++|+.++++.+++....      .. ..+.......+..+++.++.|+|   ..+++|||+||+||+++... .+++
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~------~~-~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l  143 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIG------RK-GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKL  143 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcc------cc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEE
Confidence            99999999999997764210      00 36888899999999999999999   88999999999999999988 7999


Q ss_pred             eeeccceecccccccc----eecccccccccccCcccCC---CccCccccchhHHHHHHHHHhCCCCCcccccc--ccch
Q 046112          362 SDFGIARFLEAADEQT----RSIGVEGTTGYIAPEYGMG---HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD--NLNL  432 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~--~~~~  432 (502)
                      +|||.++.........    ......|+..|+|||...+   ..++...|+||+|++++++++|..||......  ....
T Consensus       144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~  223 (384)
T COG0515         144 IDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT  223 (384)
T ss_pred             eccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHH
Confidence            9999998655443221    2356779999999999987   57889999999999999999999997653221  0111


Q ss_pred             HHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          433 RNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       433 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ...+......    ..........  .......+.+++..|+..+|..|.++.+....
T Consensus       224 ~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         224 LKIILELPTP----SLASPLSPSN--PELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHHhcCCc----ccccccCccc--cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1111111100    0000000000  01223567788889999999999998877654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=2.4e-21  Score=177.47  Aligned_cols=262  Identities=16%  Similarity=0.226  Sum_probs=193.3

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-CCccceeeecccccccCCCcceeE
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      .|.++++||+|+||.++.|...-++..||||.-..  .....++..|....+.|. .+.|-.++-+     -+.+.+..+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~NiL  101 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNIL  101 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeee-----ccccchhhh
Confidence            68899999999999999999999999999997432  233567888998888875 5777766644     234456789


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC-----CcE
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE-----MTA  359 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~-----~~~  359 (502)
                      |+|.+ |-||.|++.         --...++..+.+.+|.|+..-++|+|   ++.+|.|||||+|+|+...     ..+
T Consensus       102 VidLL-GPSLEDLFD---------~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~I  168 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFD---------LCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVI  168 (449)
T ss_pred             hhhhh-CcCHHHHHH---------HhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceE
Confidence            99988 889998874         22456899999999999999999999   9999999999999999643     468


Q ss_pred             EEeeeccceecccccc-----cceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHH
Q 046112          360 YVSDFGIARFLEAADE-----QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN  434 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~  434 (502)
                      .|.|||+|+.+..+.+     .....+..||..||+-....+.+-|.+-|+=|+|-+++..+-|..||.+...+..  .+
T Consensus       169 hiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn--K~  246 (449)
T KOG1165|consen  169 HIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN--KE  246 (449)
T ss_pred             EEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch--HH
Confidence            9999999998876654     2334567799999999999999999999999999999999999999987432211  11


Q ss_pred             HHHhhcccchhhhcccCC-CCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          435 CVKSALPERAEEIRASSG-STQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       435 ~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      -. .++.+       ..- -.....++..+.++...+.-.-..+-.+-|..+-+..-+.++.+.
T Consensus       247 kY-eKIGe-------~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr  302 (449)
T KOG1165|consen  247 KY-EKIGE-------TKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR  302 (449)
T ss_pred             HH-HHhcc-------ccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence            00 11111       000 011112223344555555544467777888877666666555443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=2.1e-21  Score=170.29  Aligned_cols=263  Identities=20%  Similarity=0.270  Sum_probs=193.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCC-ccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHR-NLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~~~  282 (502)
                      ...|...++||.|+||.+|.|....+|..||||+-+....  ...+..|.++...+++- .|..+..|     ..+....
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~yn   86 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHY-----GTEKDYN   86 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhh-----ccccccc
Confidence            3578889999999999999999999999999998654332  34577889999888763 44444444     3445577


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC---CcE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE---MTA  359 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~---~~~  359 (502)
                      .+||+.. +-||.+.+.-         -...++..+.+-++-|+..-++|+|   .++++||||||+|+|..-+   ..+
T Consensus        87 vlVMdLL-GPsLEdLfnf---------C~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl  153 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNF---------CSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKL  153 (341)
T ss_pred             eeeeecc-CccHHHHHHH---------HhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceE
Confidence            8999988 8899988742         2345788899999999999999999   8999999999999999744   478


Q ss_pred             EEeeeccceecccccc-----cceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccc--cch
Q 046112          360 YVSDFGIARFLEAADE-----QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN--LNL  432 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~--~~~  432 (502)
                      .++|||+|+.+....+     .....+..||..|.+-....+.+-+.+-|+=|+|.+|..+--|..||.+.....  ..+
T Consensus       154 ~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy  233 (341)
T KOG1163|consen  154 YLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY  233 (341)
T ss_pred             EEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH
Confidence            9999999987754433     223445679999999888888888899999999999999999999998743211  111


Q ss_pred             HHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          433 RNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       433 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ....+.+....++           ..+...+.++.-.+.-|-..--++-|...-+.+.++-+...
T Consensus       234 EkI~EkK~s~~ie-----------~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~  287 (341)
T KOG1163|consen  234 EKISEKKMSTPIE-----------VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT  287 (341)
T ss_pred             HHHHHhhcCCCHH-----------HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence            1111111111111           11122355667777788888888888887776666555443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1e-21  Score=178.28  Aligned_cols=177  Identities=11%  Similarity=0.103  Sum_probs=133.0

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHH---------HHHHHHHHhcCCCCccceeeecccc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS---------FAVECEVTRNIRHRNLVKVFTACSG  273 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~  273 (502)
                      ..++|...+++|.|+||.||....  ++..+|||++..........         +.+|+..+.+++|++|..+..+...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            357899999999999999999744  46689999997543332222         6789999999999999999877432


Q ss_pred             cc---cCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCC
Q 046112          274 VD---FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSN  350 (502)
Q Consensus       274 ~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~N  350 (502)
                      ..   +......++||||++|.+|.++..              ++.    ....+++.++..+|   ..+++|||++|+|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~N  165 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGN  165 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh--------------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHH
Confidence            11   112346889999999999987631              111    24568999999999   9999999999999


Q ss_pred             eeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh
Q 046112          351 ILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT  417 (502)
Q Consensus       351 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t  417 (502)
                      |++++++ ++|+|||............              .+.....+..++|+|+|||++.-+..
T Consensus       166 ili~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        166 FIVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHHH
Confidence            9999988 9999999886543211110              13334456678999999999887653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=3.1e-21  Score=173.33  Aligned_cols=140  Identities=16%  Similarity=0.180  Sum_probs=106.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccCcc--h-------hHH-----------------HHHHHHHHhcCCCCc
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD--A-------SKS-----------------FAVECEVTRNIRHRN  263 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~n  263 (502)
                      .+.||+|+||.||+|... +|+.||||+++.....  .       ...                 ...|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999764 8999999998753211  1       112                 234899999998877


Q ss_pred             cceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCce
Q 046112          264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYL-HLDCQPPIA  342 (502)
Q Consensus       264 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~i~  342 (502)
                      +.....+.    .   ...++||||++++++.....          ....+++.+...++.|++.+|.|+ |   +.+|+
T Consensus        81 v~~p~~~~----~---~~~~iVmE~i~g~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~L~~l~H---~~gii  140 (190)
T cd05147          81 IPCPEPIL----L---KSHVLVMEFIGDDGWAAPRL----------KDAPLSESKARELYLQVIQIMRILYQ---DCRLV  140 (190)
T ss_pred             CCCCcEEE----e---cCCEEEEEEeCCCCCcchhh----------hcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            64332221    1   13489999999887654421          124578889999999999999999 6   78999


Q ss_pred             eecCCCCCeeeCCCCcEEEeeeccceecc
Q 046112          343 HCDLKPSNILLDDEMTAYVSDFGIARFLE  371 (502)
Q Consensus       343 H~dlk~~NIll~~~~~~kl~Dfg~a~~~~  371 (502)
                      ||||||+|||++ ++.++|+|||+|....
T Consensus       141 HrDlkP~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         141 HADLSEYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             cCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence            999999999998 4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=4.8e-21  Score=190.27  Aligned_cols=215  Identities=28%  Similarity=0.358  Sum_probs=161.5

Q ss_pred             HhcCCCCccceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 046112          256 TRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHL  335 (502)
Q Consensus       256 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~  335 (502)
                      |+.+.|.|+.+++|.|...     ...++|.+|+..|+|.|.+.         .....++|.....+..+++.||+|+| 
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~---------~~~~~~d~~F~~s~~rdi~~Gl~ylh-   65 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILS---------NEDIKLDYFFILSFIRDISKGLAYLH-   65 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHh---------ccccCccHHHHHHHHHHHHHHHHHHh-
Confidence            4568899999999997543     58899999999999999985         34566899999999999999999999 


Q ss_pred             CCCCCc-eeecCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCc-------cCccccchh
Q 046112          336 DCQPPI-AHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE-------VSSYGDVYS  407 (502)
Q Consensus       336 ~~~~~i-~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~~sDvws  407 (502)
                        ..+| +|+.++++|.++|..+.+||+|||+.................-..-|.|||.+....       .+.++||||
T Consensus        66 --~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs  143 (484)
T KOG1023|consen   66 --NSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYS  143 (484)
T ss_pred             --cCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeeh
Confidence              5555 999999999999999999999999987764311111111222356799999887631       467799999


Q ss_pred             HHHHHHHHHhCCCCCcccccccc--chHHHHHhhcccchhhhcccCCCCcchhh--HHHHHHHHHHHhhcccCCCCCCCC
Q 046112          408 FGILLLEMFTGLRPSDDMFKDNL--NLRNCVKSALPERAEEIRASSGSTQRSII--LECLISICEIGVACSAEQPGERMK  483 (502)
Q Consensus       408 ~Gv~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~~~--~~~~~~l~~l~~~c~~~dP~~RPt  483 (502)
                      ||++++|+++.+.||+.......  .+...++..          ......+.+.  .+....+..++..||..+|++||+
T Consensus       144 ~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~----------~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs  213 (484)
T KOG1023|consen  144 FGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKG----------GSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPS  213 (484)
T ss_pred             HHHHHHHHHhccCccccccccCChHHHHHHHHhc----------CCCCcCcchhhhhhcchHHHHHHHHhcccChhhCcc
Confidence            99999999999999987433322  222222220          1100111111  144457889999999999999999


Q ss_pred             HHHHHHHHHHHHHH
Q 046112          484 INDVEPRLRLIKKK  497 (502)
Q Consensus       484 ~~ev~~~L~~i~~~  497 (502)
                      ++++...++.+...
T Consensus       214 ~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  214 IEQIRSKLLTINKG  227 (484)
T ss_pred             HHHHHhhhhhhccc
Confidence            99999888877553

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=3.4e-20  Score=167.31  Aligned_cols=140  Identities=19%  Similarity=0.159  Sum_probs=108.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccCcch--------------------------hHHHHHHHHHHhcCCCCc
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA--------------------------SKSFAVECEVTRNIRHRN  263 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~n  263 (502)
                      ...||+|++|.||+|... +|+.||||+++......                          ...+..|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999765 89999999987542110                          112357889999999988


Q ss_pred             cceeeecccccccCCCcceeEEeeeccCCChhhh-ccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCc
Q 046112          264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW-MHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ-PPI  341 (502)
Q Consensus       264 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~i  341 (502)
                      +.....+..       ...++||||++++++... +.           ...++......++.+++.++.++|   . .+|
T Consensus        81 i~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l~-----------~~~~~~~~~~~i~~~l~~~l~~lH---~~~gi  139 (190)
T cd05145          81 VPVPEPILL-------KKNVLVMEFIGDDGSPAPRLK-----------DVPLEEEEAEELYEQVVEQMRRLY---QEAGL  139 (190)
T ss_pred             CCCceEEEe-------cCCEEEEEEecCCCchhhhhh-----------hccCCHHHHHHHHHHHHHHHHHHH---HhCCE
Confidence            754333311       124899999998865433 21           134667788999999999999999   7 899


Q ss_pred             eeecCCCCCeeeCCCCcEEEeeeccceeccc
Q 046112          342 AHCDLKPSNILLDDEMTAYVSDFGIARFLEA  372 (502)
Q Consensus       342 ~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~  372 (502)
                      +||||||+||+++ ++.++|+|||++..+..
T Consensus       140 vHrDlkP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         140 VHGDLSEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             ecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence            9999999999999 88999999999986643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2e-19  Score=159.71  Aligned_cols=185  Identities=14%  Similarity=0.046  Sum_probs=135.3

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc---c-hhHHHHHHHHHHhcCC-CCccceeeecccccccCCCcce
Q 046112          208 SSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH---D-ASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       208 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .+...|+.|+||+||.+..  .+.+++.+.++....   . ....+.+|+++++++. |+++.+++++.         ..
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence            4567899999999998743  677788777764322   1 1225889999999995 57888888761         46


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecC-CCCCeeeCCCCcEEE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDL-KPSNILLDDEMTAYV  361 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dl-k~~NIll~~~~~~kl  361 (502)
                      +++|||+++.+|......                 ....+..+++.++.++|   ..+|+|||| ||+|||++.++.++|
T Consensus        74 ~lvmeyI~G~~L~~~~~~-----------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~L  133 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR-----------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAV  133 (218)
T ss_pred             EEEEeeecCccHHhhhhh-----------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEE
Confidence            899999999998654310                 11346788999999999   999999999 799999999999999


Q ss_pred             eeeccceeccccccc----c-e------ecccccccccccCcccCC-CccC-ccccchhHHHHHHHHHhCCCCCc
Q 046112          362 SDFGIARFLEAADEQ----T-R------SIGVEGTTGYIAPEYGMG-HEVS-SYGDVYSFGILLLEMFTGLRPSD  423 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~----~-~------~~~~~gt~~y~aPE~~~~-~~~s-~~sDvws~Gv~l~el~tg~~p~~  423 (502)
                      +|||+|.........    . +      ..-...++.|++|+...- ...+ .+.+.++-|.-+|.++|+..|+-
T Consensus       134 IDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        134 IDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             EECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            999999855433211    0 0      011225667777764322 1223 45688899999999999998854

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.80  E-value=6.6e-20  Score=171.52  Aligned_cols=242  Identities=19%  Similarity=0.226  Sum_probs=148.9

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHHHHhcCCC----------Cccceeeeccc-
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECEVTRNIRH----------RNLVKVFTACS-  272 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~-  272 (502)
                      +...+.||.|+++.||.+.+.++++.+|||++-....   ...+++.+|.-....+.+          -.++--++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            3456789999999999999999999999999764332   234556666655444322          11111111100 


Q ss_pred             c--ccc----CCCc-----ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 046112          273 G--VDF----QGND-----FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPI  341 (502)
Q Consensus       273 ~--~~~----~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i  341 (502)
                      .  ..+    .+..     ..+++|+-+ .++|.+++.......   .....+....++.+..|+.+.+++||   ..++
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~---~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~Gl  166 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA---QTHSPLAFAARLSLTVQMIRLVANLH---SYGL  166 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT---TTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc---cccchhHHHHHHHHHHHHHHHHHHHh---hcce
Confidence            0  000    0001     235566666 678888764322111   11233556667888899999999999   9999


Q ss_pred             eeecCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCC--------CccCccccchhHHHHHH
Q 046112          342 AHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG--------HEVSSYGDVYSFGILLL  413 (502)
Q Consensus       342 ~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDvws~Gv~l~  413 (502)
                      +|+||+|+|++++.+|.++|+||+.........   . . ...+..|.+||....        -.++.+.|.|++|+++|
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~-~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly  241 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---R-C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY  241 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEEE---E-G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCcee---e-c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence            999999999999999999999998876443211   1 1 334577999997543        35788999999999999


Q ss_pred             HHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCC
Q 046112          414 EMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGER  481 (502)
Q Consensus       414 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~R  481 (502)
                      .|++|+.||+....+.....                 ....    +.+.++.+..|+...++++|++|
T Consensus       242 ~lWC~~lPf~~~~~~~~~~~-----------------~f~~----C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  242 SLWCGRLPFGLSSPEADPEW-----------------DFSR----CRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHSS-STCCCGGGSTSGG-----------------GGTT----SS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHccCCCCCCCccccccc-----------------cchh----cCCcCHHHHHHHHHHccCCcccC
Confidence            99999999986432221100                 0010    11456778899999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.80  E-value=4.5e-20  Score=192.21  Aligned_cols=250  Identities=20%  Similarity=0.194  Sum_probs=171.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHH--HhcCCCCccceeeecccccccCCCcce
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEV--TRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++...+.||.+.|=.|.+|++. .|. |+||++-+.. .-.-+.|.++++-  ...++|||++++.-+     ...+...
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~-----~~t~kAA   96 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKV-----LVTDKAA   96 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHH-----HHhhHHH
Confidence            5566789999999999999664 454 8899975433 2233444443332  555689999998765     3334466


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      |+|-+|. ..+|+|.+          ..++-+...+..-|+.|++.|+..+|   +.+|+|||||.+|||++.=.-+.|+
T Consensus        97 ylvRqyv-khnLyDRl----------STRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~Lt  162 (1431)
T KOG1240|consen   97 YLVRQYV-KHNLYDRL----------STRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLT  162 (1431)
T ss_pred             HHHHHHH-hhhhhhhh----------ccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhh
Confidence            7788887 55888887          34555777788889999999999999   9999999999999999999999999


Q ss_pred             eeccceec-ccccc----cceecccccccccccCcccCCC----------c-cCccccchhHHHHHHHHHh-CCCCCccc
Q 046112          363 DFGIARFL-EAADE----QTRSIGVEGTTGYIAPEYGMGH----------E-VSSYGDVYSFGILLLEMFT-GLRPSDDM  425 (502)
Q Consensus       363 Dfg~a~~~-~~~~~----~~~~~~~~gt~~y~aPE~~~~~----------~-~s~~sDvws~Gv~l~el~t-g~~p~~~~  425 (502)
                      ||..-+-. -+.+.    .........-.+|+|||.+...          . .+++-||||.||+++||++ |++||+-.
T Consensus       163 DFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS  242 (1431)
T KOG1240|consen  163 DFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS  242 (1431)
T ss_pred             cccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH
Confidence            99765321 11111    1111112234589999976542          1 5677899999999999988 88888641


Q ss_pred             cccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          426 FKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                           ++..+- ..-....+..+....          -..+..++..|++.||++|.++++.++.-+
T Consensus       243 -----QL~aYr-~~~~~~~e~~Le~Ie----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  243 -----QLLAYR-SGNADDPEQLLEKIE----------DVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             -----HHHhHh-ccCccCHHHHHHhCc----------CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence                 111111 110111111111100          014568889999999999999999988644

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=1e-18  Score=158.44  Aligned_cols=140  Identities=18%  Similarity=0.244  Sum_probs=105.0

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-----CCCccceeeecccccccCCCcc
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-----RHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .+..+.||+|+||.||.  +..++.. +||++........+.+.+|+++++.+     .||||++++|+..+.  .+...
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~--~g~g~   78 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD--CGTGY   78 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC--CCCeE
Confidence            34568999999999996  5455554 69988755444567899999999999     579999999986432  11123


Q ss_pred             -eeEEeee--ccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCceeecCCCCCeeeCC--
Q 046112          282 -KALVYEF--MANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL-KYLHLDCQPPIAHCDLKPSNILLDD--  355 (502)
Q Consensus       282 -~~lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~i~H~dlk~~NIll~~--  355 (502)
                       ..+|+||  +++|+|.+++..           ..+++.  ..++.+++.++ +|||   +.+|+||||||+|||++.  
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~-----------~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~  142 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQ-----------CRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRIS  142 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHc-----------ccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccC
Confidence             3378999  668999999943           124444  35567777777 9999   999999999999999973  


Q ss_pred             --CCcEEEeeeccc
Q 046112          356 --EMTAYVSDFGIA  367 (502)
Q Consensus       356 --~~~~kl~Dfg~a  367 (502)
                        +..++|+||+.+
T Consensus       143 ~~~~~~~LiDg~G~  156 (210)
T PRK10345        143 ESEVIPVVCDNIGE  156 (210)
T ss_pred             CCCCcEEEEECCCC
Confidence              348999995444

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.78  E-value=3.4e-20  Score=184.18  Aligned_cols=187  Identities=27%  Similarity=0.301  Sum_probs=151.1

Q ss_pred             cccccCCceEEEEEE---cCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCC-CCccceeeecccccccCCCcceeEE
Q 046112          212 LIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       212 ~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      .+|+|.||.|+.+..   .+.+..+|.|+++....  ........|..++...+ ||.+|++...     ++.+...+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence            378999999987532   24567778888764321  11124556888888887 9999998766     5666789999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeec
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG  365 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg  365 (502)
                      .+|..+|.|...+.          ....++..........++-+++++|   +.+|+|||+|++||+++.+|.+++.|||
T Consensus        76 ld~~rgg~lft~l~----------~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfg  142 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLS----------KEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFG  142 (612)
T ss_pred             hhhcccchhhhccc----------cCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCch
Confidence            99999999988873          3445666777778888999999999   9999999999999999999999999999


Q ss_pred             cceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          366 IARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       366 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      +++..-.....      +||..|||||.+.  ......|-||||++++|++||..||..
T Consensus       143 lske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  143 LSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             hhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            99866443322      7899999999988  567889999999999999999999876

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=1.3e-18  Score=184.75  Aligned_cols=195  Identities=22%  Similarity=0.272  Sum_probs=154.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC---CCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR---HRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ..|.+.+.+|+|+||+||+|...+ |+.||+|+=+...   .-+|---.+++.+|+   -+.|+.+..+     ....+.
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a-----~~~~~~  768 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSA-----HVFQNA  768 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHH-----HccCCc
Confidence            456777899999999999996654 9999999865322   122333344455555   2333333333     223346


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC-------
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD-------  354 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~-------  354 (502)
                      .++|+||.+.|||.+++.          ..+.++|.-.+.++.++++-++.||   ..+|||+||||+|.||.       
T Consensus       769 S~lv~ey~~~Gtlld~~N----------~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~  835 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN----------TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADS  835 (974)
T ss_pred             ceeeeeccccccHHHhhc----------cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCC
Confidence            789999999999999984          4566889999999999999999999   99999999999999993       


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCC
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP  421 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p  421 (502)
                      +..-++|+|||.+..+..-.......+.++|-.+-.+|+..+..++...|-|.++-+++-|+.|+..
T Consensus       836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            3456899999999776655555666788899999999999999999999999999999999999744

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=3e-18  Score=159.28  Aligned_cols=143  Identities=17%  Similarity=0.147  Sum_probs=109.4

Q ss_pred             CCCCCCcccccCCceEEEEE-EcCCCeEEEEEEecccCcc------------------------hhHHHHHHHHHHhcCC
Q 046112          206 GFSSENLIGAGNFGSVYKGI-LFESTTAVAVKVFNVLHHD------------------------ASKSFAVECEVTRNIR  260 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  260 (502)
                      .|.+.+.||+|+||.||+|. ...+|+.||+|+++.....                        ....+..|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            35667899999999999997 5678999999998743210                        0123567999999997


Q ss_pred             CC--ccceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 046112          261 HR--NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ  338 (502)
Q Consensus       261 h~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~  338 (502)
                      +.  .+.+++++         ...++||||+++++|.....          ....+...+...++.+++.++++||   .
T Consensus       109 ~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~LH---~  166 (237)
T smart00090      109 EAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRL----------KDVEPEEEEEFELYDDILEEMRKLY---K  166 (237)
T ss_pred             hcCCCCCeeeEe---------cCceEEEEEecCCccccccc----------ccCCcchHHHHHHHHHHHHHHHHHH---h
Confidence            53  23344432         13479999999988876541          1123455567889999999999999   8


Q ss_pred             CC-ceeecCCCCCeeeCCCCcEEEeeeccceecc
Q 046112          339 PP-IAHCDLKPSNILLDDEMTAYVSDFGIARFLE  371 (502)
Q Consensus       339 ~~-i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~  371 (502)
                      .+ |+||||||+||+++ ++.++|+|||.+....
T Consensus       167 ~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      167 EGELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             cCCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            88 99999999999999 8899999999987543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=7.5e-18  Score=158.10  Aligned_cols=202  Identities=23%  Similarity=0.247  Sum_probs=141.7

Q ss_pred             CCCccceeeecccccc----------------------cCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHH
Q 046112          260 RHRNLVKVFTACSGVD----------------------FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL  317 (502)
Q Consensus       260 ~h~niv~l~~~~~~~~----------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~  317 (502)
                      +|||||++.+++...-                      ...+...|+||..+ ..+|++++..           ...+..
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-----------~~~s~r  341 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-----------RHRSYR  341 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-----------CCCchH
Confidence            5999999987643211                      12245678888877 4588888742           224555


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee--CCCC--cEEEeeeccceecccc----cccceecccccccccc
Q 046112          318 KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL--DDEM--TAYVSDFGIARFLEAA----DEQTRSIGVEGTTGYI  389 (502)
Q Consensus       318 ~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll--~~~~--~~kl~Dfg~a~~~~~~----~~~~~~~~~~gt~~y~  389 (502)
                      .+.-|..|+++|+.|||   +++|.|||+|++|||+  |+|.  ...|+|||++-.-...    +......+.-|...-|
T Consensus       342 ~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm  418 (598)
T KOG4158|consen  342 TGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM  418 (598)
T ss_pred             HHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence            67788999999999999   9999999999999999  4444  5678999987432221    1122233455788899


Q ss_pred             cCcccCCCc------cCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHH
Q 046112          390 APEYGMGHE------VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECL  463 (502)
Q Consensus       390 aPE~~~~~~------~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  463 (502)
                      |||.....+      .-.|+|.|+.|.+.||+++..-||-...+.-.+.+.+-+..++               ..+..++
T Consensus       419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP---------------alp~~vp  483 (598)
T KOG4158|consen  419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP---------------ALPSRVP  483 (598)
T ss_pred             chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC---------------CCcccCC
Confidence            999876532      3468999999999999999999987632222333332222222               1233566


Q ss_pred             HHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          464 ISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       464 ~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                      ..+.+++...++.||.+|++..-....|
T Consensus       484 p~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  484 PVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             hHHHHHHHHHhcCCccccCCccHHHhHH
Confidence            7778888899999999999976655554

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.74  E-value=6.9e-19  Score=171.64  Aligned_cols=175  Identities=21%  Similarity=0.331  Sum_probs=130.7

Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..+|.|++|...+|.+|+..       .......++...+.++.|++.|+.|      ++.+|+|+||.||+...+..+|
T Consensus       330 ~lyI~Mn~c~~~tledWl~r-------r~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~k  396 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRR-------RRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLK  396 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhC-------CCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhh
Confidence            57799999999999999953       1334556788899999999999988      6889999999999999999999


Q ss_pred             Eeeeccceeccccc----ccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHH
Q 046112          361 VSDFGIARFLEAAD----EQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       361 l~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~  435 (502)
                      |.|||+........    ....++...||..||+||.+.+..|+.|+||||+|++|+|+++ -..+++..          
T Consensus       397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------  466 (516)
T KOG1033|consen  397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------  466 (516)
T ss_pred             hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------
Confidence            99999998765544    2334556789999999999999999999999999999999998 22232221          


Q ss_pred             HHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 046112          436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV  487 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev  487 (502)
                            ....++.|...+.  .+..+.+. =..+..+++...|.+||++.++
T Consensus       467 ------~t~~d~r~g~ip~--~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  467 ------ATLTDIRDGIIPP--EFLQDYPE-EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             ------HhhhhhhcCCCCh--HHhhcCcH-HHHHHHHhcCCCcccCchHHHH
Confidence                  1122233332221  11112221 2357778899999999955444

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=3.2e-17  Score=149.09  Aligned_cols=143  Identities=20%  Similarity=0.162  Sum_probs=108.7

Q ss_pred             HHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc----------------------hhHHHHHHHHHHh
Q 046112          200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD----------------------ASKSFAVECEVTR  257 (502)
Q Consensus       200 l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~  257 (502)
                      +...-..|...+.||+|+||.||++.. .+|+.||||+++.....                      ....+..|..++.
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            333333477789999999999999965 57999999987542210                      0123567888888


Q ss_pred             cCCCCc--cceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 046112          258 NIRHRN--LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHL  335 (502)
Q Consensus       258 ~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~  335 (502)
                      .+.|++  +...++.         ...++||||+++++|.+....                .....++.+++.++.++| 
T Consensus        89 ~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~----------------~~~~~~~~~i~~~l~~lh-  142 (198)
T cd05144          89 ALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL----------------EDPEEVLDEILEEIVKAY-  142 (198)
T ss_pred             HHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc----------------ccHHHHHHHHHHHHHHHH-
Confidence            887774  4444332         245899999999998765320                234578899999999999 


Q ss_pred             CCCCCceeecCCCCCeeeCCCCcEEEeeeccceecc
Q 046112          336 DCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE  371 (502)
Q Consensus       336 ~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~  371 (502)
                        ..+|+||||+|+||++++++.++|+|||++....
T Consensus       143 --~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         143 --KHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             --HCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence              8999999999999999999999999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=4.2e-17  Score=150.07  Aligned_cols=134  Identities=20%  Similarity=0.286  Sum_probs=108.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccCcc--------hhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD--------ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      +.||+|++|.||+|.+  .|..|++|+.......        ....+..|++++..++|+++.....++.     ..+..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCC
Confidence            5799999999999976  6778899986532211        1245778999999999998876665532     23367


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      +++|||+++++|.+++..             ..+ .+..++.+++.++.++|   ..+++|||++|.||+++ ++.++|+
T Consensus        75 ~lv~e~~~G~~L~~~~~~-------------~~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~li  136 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINS-------------NGM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLI  136 (211)
T ss_pred             EEEEEEeCCcCHHHHHHh-------------ccH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEE
Confidence            899999999999998742             111 78899999999999999   89999999999999999 7899999


Q ss_pred             eecccee
Q 046112          363 DFGIARF  369 (502)
Q Consensus       363 Dfg~a~~  369 (502)
                      |||.+..
T Consensus       137 Df~~a~~  143 (211)
T PRK14879        137 DFGLAEF  143 (211)
T ss_pred             ECCcccC
Confidence            9999864

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=6.6e-17  Score=169.08  Aligned_cols=139  Identities=19%  Similarity=0.324  Sum_probs=108.0

Q ss_pred             HhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEe--cccCc------chhHHHHHHHHHHhcCCCCccceeeecccc
Q 046112          202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF--NVLHH------DASKSFAVECEVTRNIRHRNLVKVFTACSG  273 (502)
Q Consensus       202 ~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~--~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  273 (502)
                      .....|...+.||+|+||+||+|.+...  .+++|+.  +....      .....+.+|++++..++|++++....++..
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~  407 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD  407 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence            3344556789999999999999976433  3444432  21111      113468899999999999998877666432


Q ss_pred             cccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee
Q 046112          274 VDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL  353 (502)
Q Consensus       274 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll  353 (502)
                           ....++||||+++++|.+++.                  ....++.+++.++.|||   +.+++||||||+|||+
T Consensus       408 -----~~~~~lv~E~~~g~~L~~~l~------------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl  461 (535)
T PRK09605        408 -----PEEKTIVMEYIGGKDLKDVLE------------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV  461 (535)
T ss_pred             -----CCCCEEEEEecCCCcHHHHHH------------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE
Confidence                 235689999999999998873                  35678999999999999   8999999999999999


Q ss_pred             CCCCcEEEeeecccee
Q 046112          354 DDEMTAYVSDFGIARF  369 (502)
Q Consensus       354 ~~~~~~kl~Dfg~a~~  369 (502)
                       +++.++|+|||+++.
T Consensus       462 -~~~~~~liDFGla~~  476 (535)
T PRK09605        462 -RDDRLYLIDFGLGKY  476 (535)
T ss_pred             -ECCcEEEEeCccccc
Confidence             678999999999974

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.69  E-value=1.2e-16  Score=145.52  Aligned_cols=130  Identities=20%  Similarity=0.291  Sum_probs=101.2

Q ss_pred             cccccCCceEEEEEEcCCCeEEEEEEecccCc--c------hhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--D------ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       212 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .||+|+||.||+|.+  .+..|++|+......  .      ....+.+|++++..++|+++.....++.     ..+..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence            489999999999964  667899998643211  1      1255778999999998876544433322     223568


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++++|.+++..        .  .       ..++.+++.+|.+||   +.+++|||++|.||+++ ++.+++.|
T Consensus        74 lv~e~~~g~~l~~~~~~--------~--~-------~~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liD  132 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEE--------G--N-------DELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLID  132 (199)
T ss_pred             EEEEEECCccHHHHHhh--------c--H-------HHHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEE
Confidence            99999999999988742        0  0       078999999999999   99999999999999999 88999999


Q ss_pred             ecccee
Q 046112          364 FGIARF  369 (502)
Q Consensus       364 fg~a~~  369 (502)
                      ||++..
T Consensus       133 fg~a~~  138 (199)
T TIGR03724       133 FGLGKY  138 (199)
T ss_pred             CCCCcC
Confidence            999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PLN03150 hypothetical protein; Provisional

Probab=99.67  E-value=1.8e-16  Score=167.53  Aligned_cols=118  Identities=30%  Similarity=0.415  Sum_probs=105.7

Q ss_pred             CCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCceeeCC
Q 046112           20 SLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLS   99 (502)
Q Consensus        20 ~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l~   99 (502)
                      .++.|+|++|.|+|.+|..|+.|++|+.|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|..++++++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            47889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCcchhh--cccccceeecCCccccCCCCCcCCcccc
Q 046112          100 YNNFESMLPIEGI--FKNASATSVFGNKKLCGGIPEFQLPTCV  140 (502)
Q Consensus       100 ~N~l~~~~~~~~~--~~~~~~~~~~~n~~l~g~~p~~~~~~~~  140 (502)
                      +|+|+|.+|....  ...+..+.+.+|+.+||.+   ..+.|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p---~l~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP---GLRACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC---CCCCCc
Confidence            9999998886532  2355678899999999843   256674

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=1.1e-16  Score=166.98  Aligned_cols=211  Identities=26%  Similarity=0.310  Sum_probs=140.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ..+|...+.|..|++|.||..++..+.+++|.|+ ++.     ..      +++     ||..+.+           ..+
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq-----~l------ilR-----nilt~a~-----------npf  133 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQ-----NL------ILR-----NILTFAG-----------NPF  133 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-ccc-----ch------hhh-----ccccccC-----------Ccc
Confidence            3578888999999999999999988888999853 211     11      111     1222222           112


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|      |+=...+.          ..+.++.        +++.+++|||   +.+|+|||+||+|.+++.-|.+|+.|
T Consensus       134 vv------gDc~tllk----------~~g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTD  186 (1205)
T KOG0606|consen  134 VV------GDCATLLK----------NIGPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTD  186 (1205)
T ss_pred             ee------chhhhhcc----------cCCCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccc
Confidence            22      33223332          1222222        2277899999   99999999999999999999999999


Q ss_pred             eccceecccccc-------------cceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccccccc
Q 046112          364 FGIARFLEAADE-------------QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL  430 (502)
Q Consensus       364 fg~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~  430 (502)
                      ||+++.......             +.....++||+.|+|||++....|....|.|++|+++||.+-|+.||+....+  
T Consensus       187 fgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe--  264 (1205)
T KOG0606|consen  187 FGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--  264 (1205)
T ss_pred             hhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH--
Confidence            999865422111             11123467999999999999999999999999999999999999999873211  


Q ss_pred             chHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC
Q 046112          431 NLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK  483 (502)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt  483 (502)
                      .+...+-...-++.++  |.          ....+..+++.+.++.+|..|--
T Consensus       265 elfg~visd~i~wpE~--de----------a~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  265 ELFGQVISDDIEWPEE--DE----------ALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             HHHhhhhhhhcccccc--Cc----------CCCHHHHHHHHHHHHhChHhhcc
Confidence            1221111111122222  11          22344557777777888888863

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.62  E-value=2.3e-15  Score=135.71  Aligned_cols=136  Identities=21%  Similarity=0.261  Sum_probs=94.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccCcch--hHHH----------------------HHHHHHHhcCCCCc--
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA--SKSF----------------------AVECEVTRNIRHRN--  263 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~----------------------~~E~~~l~~l~h~n--  263 (502)
                      .+.||+|+||.||+|... +++.||||+++......  ...+                      ..|.+.+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            468999999999999654 78999999986432111  1111                      23444444443322  


Q ss_pred             cceeeecccccccCCCcceeEEeeeccCCChhhh-ccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCc
Q 046112          264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW-MHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ-PPI  341 (502)
Q Consensus       264 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~i  341 (502)
                      +.+.+++         ...++||||++++++... +..         ..  .. .....++.+++.++.++|   . .+|
T Consensus        81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~---------~~--~~-~~~~~~~~~~~~~l~~lh---~~~~i  136 (187)
T cd05119          81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKD---------VR--LL-EDPEELYDQILELMRKLY---REAGL  136 (187)
T ss_pred             CCceEec---------CCCEEEEEEeCCCCccChhhhh---------hh--hc-ccHHHHHHHHHHHHHHHh---hccCc
Confidence            2333322         145899999999654321 110         00  00 456789999999999999   7 899


Q ss_pred             eeecCCCCCeeeCCCCcEEEeeeccceecc
Q 046112          342 AHCDLKPSNILLDDEMTAYVSDFGIARFLE  371 (502)
Q Consensus       342 ~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~  371 (502)
                      +||||||+||+++ ++.++++|||.+....
T Consensus       137 vH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         137 VHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CcCCCChhhEEEE-CCcEEEEECccccccc
Confidence            9999999999999 8999999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=7.8e-15  Score=126.98  Aligned_cols=135  Identities=22%  Similarity=0.262  Sum_probs=108.7

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCC--CccceeeecccccccCCCcceeEEe
Q 046112          209 SENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRH--RNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       209 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.+.||+|.++.||++..  .+..+++|..+....  ...+..|+.++..++|  .++.+++++.     ...+..++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~--~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEe--cCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEE
Confidence            356899999999999976  337899998765332  4578899999999976  4888888774     2335789999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||++++++..+                 +......++.+++.+++++|.....+++|+|++|+||+++..+.+++.|||.
T Consensus        73 e~~~g~~~~~~-----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~  135 (155)
T cd05120          73 EWIEGETLDEV-----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY  135 (155)
T ss_pred             EecCCeecccC-----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence            99988766532                 4456678899999999999954446899999999999999989999999999


Q ss_pred             cee
Q 046112          367 ARF  369 (502)
Q Consensus       367 a~~  369 (502)
                      ++.
T Consensus       136 ~~~  138 (155)
T cd05120         136 AGY  138 (155)
T ss_pred             ccC
Confidence            864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.60  E-value=1.5e-16  Score=165.88  Aligned_cols=257  Identities=22%  Similarity=0.253  Sum_probs=185.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEc-CCCeEEEEEEecccC--cchhHHHHHHHHHHhcCC-CCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILF-ESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~  280 (502)
                      ..|...+.||+|+|+.|-..... .....+|+|.+....  .........|..+-..+. |+|++.+++.     .....
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~~   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSPR   94 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCCc
Confidence            35566677999999999877442 334456677665443  222344455777777776 9999999987     45556


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC-cE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM-TA  359 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~-~~  359 (502)
                      ..+++.+|..+|++.+.+..        ......+....-....|+..++.|+|.  ..++.|||+||+|.+++..+ ..
T Consensus        95 ~~~~~~~~s~g~~~f~~i~~--------~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l  164 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKISH--------PDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSAL  164 (601)
T ss_pred             ccccccCccccccccccccc--------CCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcc
Confidence            88999999999999887721        222234555667788999999999995  67899999999999999999 99


Q ss_pred             EEeeeccceeccc-ccccceeccccc-ccccccCcccCCCc-cCccccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          360 YVSDFGIARFLEA-ADEQTRSIGVEG-TTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       360 kl~Dfg~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~-~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                      +++|||+|..+.. ...........| ++.|+|||...+.. .....|+||.|+++.-+++|..|++........+..|.
T Consensus       165 ~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~  244 (601)
T KOG0590|consen  165 KIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK  244 (601)
T ss_pred             cCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec
Confidence            9999999988776 444444556677 99999999988854 45668999999999999999999987655444444443


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVE  488 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~  488 (502)
                      .......            ............++..+++..+|..|.+.+++.
T Consensus       245 ~~~~~~~------------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  245 SNKGRFT------------QLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ccccccc------------cCccccCChhhhhcccccccCCchhcccccccc
Confidence            3321100            000011223345777788889999999988764

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.60  E-value=5.4e-17  Score=135.55  Aligned_cols=123  Identities=29%  Similarity=0.421  Sum_probs=73.4

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      ||+|+|+ .+|+.+..|.+|+.|++++|+++ .+|..+++|++|+.|+++-|++.. +|..|+.++.|+.|||+.|+++.
T Consensus        40 LSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~-lprgfgs~p~levldltynnl~e  116 (264)
T KOG0617|consen   40 LSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNI-LPRGFGSFPALEVLDLTYNNLNE  116 (264)
T ss_pred             cccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhc-CccccCCCchhhhhhcccccccc
Confidence            4566666 55566666666666666666666 556666666666666666666653 56666666666666666665553


Q ss_pred             -CChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCccc
Q 046112           82 -EIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKL  127 (502)
Q Consensus        82 -~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l  127 (502)
                       .+|..|..+..|+-|+|++|.++-+|+..+.+++++.+.+.+|+.+
T Consensus       117 ~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll  163 (264)
T KOG0617|consen  117 NSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL  163 (264)
T ss_pred             ccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh
Confidence             3455555555555666666666655555555555555555555433

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.59  E-value=1e-14  Score=135.85  Aligned_cols=140  Identities=14%  Similarity=0.128  Sum_probs=103.3

Q ss_pred             CCccc-ccCCceEEEEEEcCCCeEEEEEEecccC-------------cchhHHHHHHHHHHhcCCCCcc--ceeeecccc
Q 046112          210 ENLIG-AGNFGSVYKGILFESTTAVAVKVFNVLH-------------HDASKSFAVECEVTRNIRHRNL--VKVFTACSG  273 (502)
Q Consensus       210 ~~~lG-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~  273 (502)
                      ...|| .|+.|+||.+..  .+..++||++....             ......+.+|++++..++|+++  .+.++++..
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            46788 899999999955  46788999874311             0123567889999999998774  566665322


Q ss_pred             cccCCCcceeEEeeeccC-CChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCee
Q 046112          274 VDFQGNDFKALVYEFMAN-GSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNIL  352 (502)
Q Consensus       274 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIl  352 (502)
                      .. ......++|+||+++ .+|.+++..           ..++..    .+.+++.++.+||   +.+|+||||||.|||
T Consensus       114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~-----------~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NIL  174 (239)
T PRK01723        114 RH-GLFYRADILIERIEGARDLVALLQE-----------APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNIL  174 (239)
T ss_pred             ec-CcceeeeEEEEecCCCCCHHHHHhc-----------CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEE
Confidence            11 011123599999997 689888742           123332    3568999999999   999999999999999


Q ss_pred             eCCCCcEEEeeeccceec
Q 046112          353 LDDEMTAYVSDFGIARFL  370 (502)
Q Consensus       353 l~~~~~~kl~Dfg~a~~~  370 (502)
                      ++.++.++|+|||.++..
T Consensus       175 v~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        175 LDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             EcCCCCEEEEECCCcccC
Confidence            999899999999998753

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.59  E-value=9.5e-17  Score=134.08  Aligned_cols=122  Identities=29%  Similarity=0.388  Sum_probs=84.7

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCC-CCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG-PIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      ++++|+|+ .+|.+++++++|+.|+++-|+|. .+|..|+.++.|+.|||++|++.. .+|+.|..+..|+.|+|++|.|
T Consensus        62 n~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndf  139 (264)
T KOG0617|consen   62 NLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDF  139 (264)
T ss_pred             hcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCc
Confidence            35667776 66777777777777777777776 667777777777777777776654 4667776677777777777777


Q ss_pred             CCCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      . .+|+.++++.+|+.|.+.+|.+-+.|...+.+..+..+..+||.
T Consensus       140 e-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnr  184 (264)
T KOG0617|consen  140 E-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNR  184 (264)
T ss_pred             c-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccce
Confidence            6 66777777777777777777777766666666666666666663

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.57  E-value=1.3e-14  Score=163.57  Aligned_cols=130  Identities=33%  Similarity=0.508  Sum_probs=106.5

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      |++|++.|.+|..+ .+++|+.|+|++|++++.+|..|.++++|+.|+|++|++++.+|..+..+++|+.|+|++|.++|
T Consensus       459 L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  537 (968)
T PLN00113        459 LARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSG  537 (968)
T ss_pred             CcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccc
Confidence            45555555555433 44678888888888888888889999999999999999999999999999999999999999999


Q ss_pred             CChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCccccCCCCC
Q 046112           82 EIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNKKLCGGIPE  133 (502)
Q Consensus        82 ~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~l~g~~p~  133 (502)
                      .+|..|.++++|+.|+|++|++++..|.. ..+..+..+.+++|+ +.|..|.
T Consensus       538 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~-l~~~~p~  589 (968)
T PLN00113        538 QIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH-LHGSLPS  589 (968)
T ss_pred             cCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCc-ceeeCCC
Confidence            99999999999999999999999876654 556778888888885 5554543

>PLN03150 hypothetical protein; Provisional

Probab=99.53  E-value=1.8e-14  Score=152.45  Aligned_cols=104  Identities=38%  Similarity=0.522  Sum_probs=97.4

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +|++|.|+|.+|+.++++++|+.|+|++|+|+|.+|..++.|++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+
T Consensus       424 ~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~  503 (623)
T PLN03150        424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS  503 (623)
T ss_pred             ECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCccc
Confidence            58899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCChhhhcCc-CCCceeeCCCCccc
Q 046112           81 DEIPEFLAGF-KFLQNLNLSYNNFE  104 (502)
Q Consensus        81 ~~~p~~~~~~-~~L~~l~l~~N~l~  104 (502)
                      |.+|..+..+ .++..+++.+|...
T Consensus       504 g~iP~~l~~~~~~~~~l~~~~N~~l  528 (623)
T PLN03150        504 GRVPAALGGRLLHRASFNFTDNAGL  528 (623)
T ss_pred             ccCChHHhhccccCceEEecCCccc
Confidence            9999998764 46778999998743

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=1.6e-14  Score=132.87  Aligned_cols=208  Identities=19%  Similarity=0.254  Sum_probs=143.6

Q ss_pred             HHhcCCCCccceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046112          255 VTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLH  334 (502)
Q Consensus       255 ~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH  334 (502)
                      -+-.+-|.|+|++..|+....+.+.....++.|||+.|++..+|++..      .....+......+|+-||..||.|||
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~------~~~~a~~~~~wkkw~tqIlsal~yLh  193 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK------KNQKALFQKAWKKWCTQILSALSYLH  193 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH------HhhhhhhHHHHHHHHHHHHhhhhhhh
Confidence            355567999999999987766666778889999999999999997533      22345667778899999999999999


Q ss_pred             hCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecccccc---cceecccccccccccCcccCCCccCccccchhHHHH
Q 046112          335 LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE---QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGIL  411 (502)
Q Consensus       335 ~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~  411 (502)
                       .|.++|+|+++.-+-|++..++-+|++--.-.. ..+.-.   ......-.+.++|.|||+......+.++|||+||..
T Consensus       194 -s~~PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc  271 (458)
T KOG1266|consen  194 -SCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC  271 (458)
T ss_pred             -ccCCccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence             678999999999999999999999985221110 100000   001111235688999999888888999999999999


Q ss_pred             HHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          412 LLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       412 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .+||..|..--........     +...+......    ....          .=...+.+|++.+|..||+|.+++.
T Consensus       272 AlemailEiq~tnseS~~~-----~ee~ia~~i~~----len~----------lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  272 ALEMAILEIQSTNSESKVE-----VEENIANVIIG----LENG----------LQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHHHHheeccCCCcceee-----hhhhhhhheee----ccCc----------cccCcCcccccCCCCCCcchhhhhc
Confidence            9999887543111000000     00000010000    0000          0125678999999999999998764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.43  E-value=5.2e-13  Score=135.23  Aligned_cols=143  Identities=22%  Similarity=0.238  Sum_probs=98.0

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccCcch----------------------------------------hHHH
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA----------------------------------------SKSF  249 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~  249 (502)
                      .+.||.|++|.||+|+. .+|+.||||+.+......                                        .-+|
T Consensus       122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            47899999999999954 688999999975321000                                        0024


Q ss_pred             HHHHHHHhcC----CCCccceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHH
Q 046112          250 AVECEVTRNI----RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID  325 (502)
Q Consensus       250 ~~E~~~l~~l----~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  325 (502)
                      ..|+..+.++    +|.+-+.+-..+.    ...+..++||||++|++|.++...        . ....   .+..++..
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~----~~~~~~vLvmE~i~G~~L~~~~~~--------~-~~~~---~~~~ia~~  264 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYW----DRTSERVLTMEWIDGIPLSDIAAL--------D-EAGL---DRKALAEN  264 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEeh----hhcCCceEEEEeECCcccccHHHH--------H-hcCC---CHHHHHHH
Confidence            4455544444    2333333333331    223357899999999999887531        0 0111   23456666


Q ss_pred             HHH-HHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceeccc
Q 046112          326 VAC-VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEA  372 (502)
Q Consensus       326 ia~-~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~  372 (502)
                      ++. .+..+|   ..+++|+|++|.||+++.++.+++.|||++..+.+
T Consensus       265 ~~~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       265 LARSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            665 467788   89999999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.32  E-value=1.3e-13  Score=136.56  Aligned_cols=126  Identities=24%  Similarity=0.249  Sum_probs=94.4

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCC-CCCCCcCCCCCCCEEEccCcccC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG-PIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||+|+|+ .+.-..+.+.+|++|+||+|+|+ .+|..++.|++|+.|++.+|+|+- -+|+.++.|.+|+.+.+++|++.
T Consensus       252 LS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE  329 (1255)
T KOG0444|consen  252 LSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE  329 (1255)
T ss_pred             cCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc
Confidence            4444444 34334444455566666666666 677777888888888888887542 27888888888888888888887


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCccccCC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGG  130 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~g~  130 (502)
                       .+|.+++.|..|+.|.|+.|.|..+|..+-.++.+..+++..|+.+.-+
T Consensus       330 -lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMP  378 (1255)
T KOG0444|consen  330 -LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMP  378 (1255)
T ss_pred             -cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCC
Confidence             7888888888888888888888888888888888888999999887654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=3.6e-12  Score=127.38  Aligned_cols=246  Identities=25%  Similarity=0.268  Sum_probs=169.9

Q ss_pred             CCCCCcccc--cCCceEEEEEE--cCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCC-CCccceeeecccccccCCC
Q 046112          207 FSSENLIGA--GNFGSVYKGIL--FESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       207 ~~~~~~lG~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~  279 (502)
                      |...+.+|.  |.+|.+|.+.-  ..++..+|+|.=+....  .....=.+|+....+++ |+|.++....     +.+.
T Consensus       116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~~  190 (524)
T KOG0601|consen  116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEGS  190 (524)
T ss_pred             cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----cccC
Confidence            445678899  99999999977  77889999998443322  22222344566566664 8999885554     5666


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCceeecCCCCCeeeCC
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC----VLKYLHLDCQPPIAHCDLKPSNILLDD  355 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~i~H~dlk~~NIll~~  355 (502)
                      +..++=+|++ +.+|..+-+.         ....++....+....+...    |+.++|   ...++|-|+||.||+...
T Consensus       191 ~~lfiqtE~~-~~sl~~~~~~---------~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~  257 (524)
T KOG0601|consen  191 GILFIQTELC-GESLQSYCHT---------PCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTS  257 (524)
T ss_pred             Ccceeeeccc-cchhHHhhhc---------ccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheeccc
Confidence            6888888887 5788887753         2233555566667777777    999999   999999999999999999


Q ss_pred             C-CcEEEeeeccceecccccccc---eecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccc-c
Q 046112          356 E-MTAYVSDFGIARFLEAADEQT---RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN-L  430 (502)
Q Consensus       356 ~-~~~kl~Dfg~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~-~  430 (502)
                      + ...++.|||+...+....-..   ......|..-|++||...+ .++..+|+|++|.+.+|..+|..+........ .
T Consensus       258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~  336 (524)
T KOG0601|consen  258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWS  336 (524)
T ss_pred             ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcc
Confidence            9 899999999998776554211   1122357778999998765 57788999999999999999876654321111 1


Q ss_pred             chHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 046112          431 NLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVE  488 (502)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~  488 (502)
                      .++++.   ++              .++...-..++......+++.+|..|++.+.+.
T Consensus       337 ~~r~~~---ip--------------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  337 QLRQGY---IP--------------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             cccccc---Cc--------------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            111110   10              011111122344477788999999999888664

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.30  E-value=1.7e-13  Score=134.81  Aligned_cols=124  Identities=23%  Similarity=0.230  Sum_probs=63.4

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      |||+|.|+...+++++...+|++|+||+|+|+...++.|..|..|+.|+|++|+++..-...|..+++|+.|||++|.|+
T Consensus       299 ~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls  378 (873)
T KOG4194|consen  299 DLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELS  378 (873)
T ss_pred             ccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEE
Confidence            34555555444555555555555555555555444445555555555555555555544445555555555555555555


Q ss_pred             CCChh---hhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCC
Q 046112           81 DEIPE---FLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGN  124 (502)
Q Consensus        81 ~~~p~---~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n  124 (502)
                      +.+.+   .|..+++|+.|.+.+|+|..++... ..+..++.+.+.+|
T Consensus       379 ~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~N  426 (873)
T KOG4194|consen  379 WCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDN  426 (873)
T ss_pred             EEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCC
Confidence            44432   3444555555555555555544433 23344444544444

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.28  E-value=1.8e-11  Score=108.24  Aligned_cols=127  Identities=20%  Similarity=0.203  Sum_probs=92.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccce-eeecccccccCCCcceeEEeee
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK-VFTACSGVDFQGNDFKALVYEF  288 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~~~~~~lv~e~  288 (502)
                      .+.++.|.++.||++..  .+..+++|+...... ....+..|+++++.+.+.++++ ++.+.       ....++||||
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEe
Confidence            35788999999999965  478899998754321 2335678999998886655443 33331       1235799999


Q ss_pred             ccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----ceeecCCCCCeeeCCCCcEEEee
Q 046112          289 MANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPP-----IAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       289 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-----i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +++.++.+.-               .   ....++.+++++++.||   ..+     ++|+|++|.||+++ ++.+++.|
T Consensus        73 i~G~~l~~~~---------------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liD  130 (170)
T cd05151          73 IEGSELLTED---------------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLID  130 (170)
T ss_pred             cCCCcccccc---------------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEe
Confidence            9998775420               0   11235678999999999   555     59999999999999 66899999


Q ss_pred             eccce
Q 046112          364 FGIAR  368 (502)
Q Consensus       364 fg~a~  368 (502)
                      ||.+.
T Consensus       131 f~~a~  135 (170)
T cd05151         131 WEYAG  135 (170)
T ss_pred             ccccc
Confidence            99885

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.27  E-value=3e-11  Score=123.84  Aligned_cols=150  Identities=17%  Similarity=0.156  Sum_probs=93.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc----------------------------------hhH---
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD----------------------------------ASK---  247 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------------------~~~---  247 (502)
                      ..|+. +.||.|++|.||+|+...+|+.||||+.+..-..                                  -.+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 7899999999999987666999999998632100                                  011   


Q ss_pred             ---HHHHHHHHHhcCC----CCccceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHH
Q 046112          248 ---SFAVECEVTRNIR----HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL  320 (502)
Q Consensus       248 ---~~~~E~~~l~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~  320 (502)
                         +|..|+..+.+++    +.+.+.+-..+    .......++||||++|+.+.++-.-         .....+.   .
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~----~d~st~~VLvmE~i~G~~l~d~~~l---------~~~g~d~---~  262 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVY----WDYCSETVMVMERMYGIPVSDVAAL---------RAAGTDM---K  262 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceee----cccCCCceEEEeeecCccHHhHHHH---------HhcCCCH---H
Confidence               1333444433332    33333332222    1223467899999999999874210         0011121   1


Q ss_pred             HHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC----cEEEeeeccceecccc
Q 046112          321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM----TAYVSDFGIARFLEAA  373 (502)
Q Consensus       321 ~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~----~~kl~Dfg~a~~~~~~  373 (502)
                      .++...+.  .|+++-...+++|+|++|.||+++.++    .+++.|||++..+.+.
T Consensus       263 ~la~~~v~--~~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        263 LLAERGVE--VFFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             HHHHHHHH--HHHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            22222222  122222278999999999999999888    9999999999877544

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.27  E-value=3e-13  Score=127.58  Aligned_cols=116  Identities=30%  Similarity=0.437  Sum_probs=71.1

Q ss_pred             CCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcC-CCCCCCEEEccCcccCCC
Q 046112            4 NNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLS-SLRGLRVLDLSQNNLSDE   82 (502)
Q Consensus         4 ~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~~~   82 (502)
                      .|-++ .+|+.++.+.+|..|+|.+|+|. .+| +|.++..|.+|+++.|+|.- +|.... .|.+|..|||.+|++. .
T Consensus       192 ~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~-lpae~~~~L~~l~vLDLRdNklk-e  266 (565)
T KOG0472|consen  192 SNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEM-LPAEHLKHLNSLLVLDLRDNKLK-E  266 (565)
T ss_pred             hhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHh-hHHHHhcccccceeeeccccccc-c
Confidence            44444 56666666666666666666666 555 56666666666666666664 444433 5666666666666666 5


Q ss_pred             ChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           83 IPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        83 ~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      .|..+.-+++|..||+|+|.|++.|+..+.+ .+..+.+.||+
T Consensus       267 ~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNP  308 (565)
T KOG0472|consen  267 VPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNP  308 (565)
T ss_pred             CchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCc
Confidence            6666666666666666666666666665555 55555555654

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.26  E-value=7.1e-13  Score=125.08  Aligned_cols=122  Identities=30%  Similarity=0.403  Sum_probs=109.4

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      +++|.++ .+|..+..+++|+.|+|++|-|. .+|.+++.+..|+.||+|.|+|.- +|..+-.+..|+.+-.++|++..
T Consensus       419 lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~-lP~~~y~lq~lEtllas~nqi~~  495 (565)
T KOG0472|consen  419 LSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRM-LPECLYELQTLETLLASNNQIGS  495 (565)
T ss_pred             hhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccccccccc-chHHHhhHHHHHHHHhccccccc
Confidence            5677777 88888899999999999999999 899999999999999999999986 88888888888888888999985


Q ss_pred             CChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCcc
Q 046112           82 EIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKK  126 (502)
Q Consensus        82 ~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~  126 (502)
                      .-|+.+.++.+|..|||.+|.|..+||..+.+.++..+.+.||+.
T Consensus       496 vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf  540 (565)
T KOG0472|consen  496 VDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF  540 (565)
T ss_pred             cChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence            556669999999999999999999999999999999999999975

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.26  E-value=1.2e-10  Score=117.83  Aligned_cols=171  Identities=15%  Similarity=0.160  Sum_probs=124.3

Q ss_pred             EEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeeccCCChhhhccCCc
Q 046112          223 KGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPIT  302 (502)
Q Consensus       223 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  302 (502)
                      .|..+.++.+|.|...+...........+-++.++.+|||||++++..     ....+..|+|+|.+.  .|..++..  
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk~--  100 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLKE--  100 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHHH--
Confidence            455667888999998876544334556777889999999999999987     445558999999873  35555532  


Q ss_pred             hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecccccccceeccc
Q 046112          303 EEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV  382 (502)
Q Consensus       303 ~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  382 (502)
                                 +........+.||+.||.|||+  +.+++|++|.-..|+++..|..||++|.++........  .....
T Consensus       101 -----------l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~  165 (690)
T KOG1243|consen  101 -----------LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSL  165 (690)
T ss_pred             -----------hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccc
Confidence                       2244556678899999999985  56899999999999999999999999998864432221  11111


Q ss_pred             ccccccccCcccCCCccCccccchhHHHHHHHHHhCC
Q 046112          383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGL  419 (502)
Q Consensus       383 ~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~  419 (502)
                      ..-..|..|+.+....  -..|.|.||++++|++.|.
T Consensus       166 ~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  166 YLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             hhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence            2223466666544333  2369999999999999993

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.24  E-value=1.4e-12  Score=129.45  Aligned_cols=122  Identities=25%  Similarity=0.293  Sum_probs=84.6

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCC-CcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLS-GAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +++|+|. .+-.+++.|+.|+++.+.+|+|. .-+|..+-.|..|+.||||+|+|.. .|..+..-+++-.|+||+|+|.
T Consensus        62 ~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~E-vP~~LE~AKn~iVLNLS~N~Ie  139 (1255)
T KOG0444|consen   62 MAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLRE-VPTNLEYAKNSIVLNLSYNNIE  139 (1255)
T ss_pred             hhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhhh-cchhhhhhcCcEEEEcccCccc
Confidence            4566666 45566666777777777777766 4466667777777777777777775 6777777777777777777776


Q ss_pred             CCChh-hhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCcc
Q 046112           81 DEIPE-FLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKK  126 (502)
Q Consensus        81 ~~~p~-~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~  126 (502)
                       +||. -|.++..|-.|+||+|.|..+||...++..+..+.+++|+.
T Consensus       140 -tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL  185 (1255)
T KOG0444|consen  140 -TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPL  185 (1255)
T ss_pred             -cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChh
Confidence             5554 44567777777777777777777777777777777777753

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.23  E-value=8e-13  Score=130.19  Aligned_cols=125  Identities=22%  Similarity=0.280  Sum_probs=94.7

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||+.|+++..--..+.+|++|+.|+||.|.|..+-++.....++|++|+|++|+|+...+.+|..|.+|+.|+|++|.+.
T Consensus       275 ~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~  354 (873)
T KOG4194|consen  275 NLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID  354 (873)
T ss_pred             ecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH
Confidence            46777777555556778888888888888888777777777888888888888888777777888888888888888887


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch----hhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE----GIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~----~~~~~~~~~~~~~n~  125 (502)
                      -.-...|..+++|+.|||++|.|+..+...    ..++.+..+.+.||+
T Consensus       355 ~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq  403 (873)
T KOG4194|consen  355 HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ  403 (873)
T ss_pred             HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence            444557778888888888888888776543    234566777788875

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.23  E-value=1.7e-10  Score=102.75  Aligned_cols=138  Identities=19%  Similarity=0.202  Sum_probs=96.2

Q ss_pred             CCcccccCCceEEEEEEcC------CCeEEEEEEecccCc----------------------chhHHHH----HHHHHHh
Q 046112          210 ENLIGAGNFGSVYKGILFE------STTAVAVKVFNVLHH----------------------DASKSFA----VECEVTR  257 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~----------------------~~~~~~~----~E~~~l~  257 (502)
                      ...||.|--+.||.|....      .+..+|||+.+....                      ...+.+.    +|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999996433      357999998753110                      0112233    7888888


Q ss_pred             cCCC--CccceeeecccccccCCCcceeEEeeeccCCChhh-hccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-
Q 046112          258 NIRH--RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEE-WMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYL-  333 (502)
Q Consensus       258 ~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-  333 (502)
                      ++..  -++-.++++         ...++||||+.++.+.. .+.           ...++..+...+..++..+|..+ 
T Consensus        82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lk-----------d~~~~~~~~~~i~~~i~~~l~~l~  141 (197)
T cd05146          82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLK-----------DAKLNDEEMKNAYYQVLSMMKQLY  141 (197)
T ss_pred             HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhh-----------ccccCHHHHHHHHHHHHHHHHHHH
Confidence            8753  344455543         25689999997654321 121           11234445667789999999998 


Q ss_pred             HhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecc
Q 046112          334 HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE  371 (502)
Q Consensus       334 H~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~  371 (502)
                      |   ..+|+||||++.||+++ ++.+.|+|||.+....
T Consensus       142 H---~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         142 K---ECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             H---hCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            7   88999999999999997 4689999999987554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.21  E-value=1.2e-09  Score=104.60  Aligned_cols=279  Identities=14%  Similarity=0.120  Sum_probs=168.5

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeecccccc--cCCCcceeE
Q 046112          208 SSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVD--FQGNDFKAL  284 (502)
Q Consensus       208 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--~~~~~~~~l  284 (502)
                      ..+..||+|+.+.+|-.-.   -...+-|+..........+   .+..|... .||-+-.-+.|-...-  -.+.....+
T Consensus        14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecch---hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            3467899999999996522   2223456665443222222   23333333 4554433222211110  112223567


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      .|..+++.   +-++.....+.+...-...+|...++.+..+|.+.+.||   ..|.+-+|+.++|+|+++++.|.+.|-
T Consensus        88 lmP~v~g~---~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          88 LMPKVSGK---EPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             ecccCCCc---cchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcc
Confidence            77776654   222222223334455667899999999999999999999   899999999999999999999999875


Q ss_pred             ccceecccccccceecccccccccccCcccC-----CCccCccccchhHHHHHHHHHhC-CCCCccccc---cccchHHH
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGM-----GHEVSSYGDVYSFGILLLEMFTG-LRPSDDMFK---DNLNLRNC  435 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvws~Gv~l~el~tg-~~p~~~~~~---~~~~~~~~  435 (502)
                      ..-..   ..........+|...|.+||.-.     +..-+..+|-|.+||++++++.| +.||.+..-   .+.-+...
T Consensus       162 Dsfqi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~  238 (637)
T COG4248         162 DSFQI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD  238 (637)
T ss_pred             cceee---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence            43322   12333445667899999999643     45567789999999999999875 999986421   11112211


Q ss_pred             HHhhcccchhhhcccCCCCcchh-hHHHHHHHHHHHhhcccCC--CCCCCCHHHHHHHHHHHHHHHhhC
Q 046112          436 VKSALPERAEEIRASSGSTQRSI-ILECLISICEIGVACSAEQ--PGERMKINDVEPRLRLIKKKLLEA  501 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~-~~~~~~~l~~l~~~c~~~d--P~~RPt~~ev~~~L~~i~~~~~~~  501 (502)
                      +.........+-.-......... ..-.+..+.-+..+|+...  +.-|||++..+..|..+..++..+
T Consensus       239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C  307 (637)
T COG4248         239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC  307 (637)
T ss_pred             hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence            11111000000000000000000 1223445666777888754  568999999999999998877554

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.18  E-value=2.7e-11  Score=105.77  Aligned_cols=117  Identities=32%  Similarity=0.402  Sum_probs=39.8

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCC-CCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFG-SCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      |..+.|. .+| .+.+..++++|+|++|+|+ .+. .++ .+.+|+.|||++|+|+. ++ .+..+++|+.|+|++|+|+
T Consensus         4 lt~~~i~-~~~-~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~   77 (175)
T PF14580_consen    4 LTANMIE-QIA-QYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS   77 (175)
T ss_dssp             ------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred             ccccccc-ccc-ccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC
Confidence            3445555 443 4667778999999999999 554 466 68999999999999997 43 5888999999999999999


Q ss_pred             CCChhhh-cCcCCCceeeCCCCccccCCc--chhhcccccceeecCCc
Q 046112           81 DEIPEFL-AGFKFLQNLNLSYNNFESMLP--IEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~-~~~~~L~~l~l~~N~l~~~~~--~~~~~~~~~~~~~~~n~  125 (502)
                       .++..+ ..+++|+.|++++|+|...-.  ....++.+..+.+.+||
T Consensus        78 -~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NP  124 (175)
T PF14580_consen   78 -SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNP  124 (175)
T ss_dssp             -S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-G
T ss_pred             -ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCc
Confidence             565555 468999999999999987543  23457788888888885

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.12  E-value=9e-12  Score=113.49  Aligned_cols=119  Identities=26%  Similarity=0.324  Sum_probs=95.4

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      |||+|.|+ .+.++..-++.++.|+||+|.|. .+.. +..|++|+.||||+|.++. +.++-..|.+++.|.|+.|.|.
T Consensus       290 DLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~La~N~iE  365 (490)
T KOG1259|consen  290 DLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKLAQNKIE  365 (490)
T ss_pred             cccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhHh-hhhhHhhhcCEeeeehhhhhHh
Confidence            78888888 88888878888999999999888 4443 8888899999999998886 6666677888889999999886


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccC--CcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESM--LPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~--~~~~~~~~~~~~~~~~~n~  125 (502)
                       .+ .++.++-+|..||+++|+|...  ...++.++++..+.+.+|+
T Consensus       366 -~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP  410 (490)
T KOG1259|consen  366 -TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP  410 (490)
T ss_pred             -hh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence             22 4577778888999999998764  3455778888888888885

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.11  E-value=4.8e-11  Score=104.25  Aligned_cols=102  Identities=28%  Similarity=0.371  Sum_probs=45.7

Q ss_pred             CCCCCccccccccccC-CCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCc-CCCCCCCEEEccCcc
Q 046112            1 DLSNNNLSGTLSPQLV-GLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSL-SSLRGLRVLDLSQNN   78 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~-~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~ls~N~   78 (502)
                      +|++|+|+ .+ +.++ .+.+|+.|+|++|.|+ .++ .+..|++|+.|++++|+|+. ++..+ ..+++|+.|+|++|+
T Consensus        25 ~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~   99 (175)
T PF14580_consen   25 NLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNK   99 (175)
T ss_dssp             -------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS-
T ss_pred             cccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCc
Confidence            58899999 56 4576 5899999999999999 454 48889999999999999997 55445 468999999999999


Q ss_pred             cCCCCh-hhhcCcCCCceeeCCCCccccCC
Q 046112           79 LSDEIP-EFLAGFKFLQNLNLSYNNFESML  107 (502)
Q Consensus        79 l~~~~p-~~~~~~~~L~~l~l~~N~l~~~~  107 (502)
                      |...-- ..+..+++|+.|+|.+|.++...
T Consensus       100 I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~  129 (175)
T PF14580_consen  100 ISDLNELEPLSSLPKLRVLSLEGNPVCEKK  129 (175)
T ss_dssp             --SCCCCGGGGG-TT--EEE-TT-GGGGST
T ss_pred             CCChHHhHHHHcCCCcceeeccCCcccchh
Confidence            984221 46778999999999999998654

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.10  E-value=5.4e-11  Score=85.51  Aligned_cols=61  Identities=34%  Similarity=0.481  Sum_probs=41.7

Q ss_pred             CCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112           19 SSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus        19 ~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      ++|+.|+|++|+|+...+..|.++++|++|++++|+++...|..|..+++|+.|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3567777777777755555667777777777777777766666677777777777777764

...

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.08  E-value=1.7e-09  Score=100.10  Aligned_cols=145  Identities=19%  Similarity=0.189  Sum_probs=104.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCC--ccceeeecccccccCCCcceeEEee
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHR--NLVKVFTACSGVDFQGNDFKALVYE  287 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~~~~~~lv~e  287 (502)
                      +.|+.|..+.+|++.. .+|..+++|....... .....+..|+++++.+++.  ++.+++.++....  ..+..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEe-cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence            5789999999999965 4467899998764322 1345788999999998763  4566666643211  1124689999


Q ss_pred             eccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------
Q 046112          288 FMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLD-------------------------------  336 (502)
Q Consensus       288 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-------------------------------  336 (502)
                      |++++++.+.+..           ..++..++..++.+++++++.||..                               
T Consensus        81 ~i~G~~l~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (223)
T cd05154          81 RVDGRVLRDRLLR-----------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDAS  149 (223)
T ss_pred             EeCCEecCCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhh
Confidence            9999888775420           2356666777777777777777731                               


Q ss_pred             ----------------------CCCCceeecCCCCCeeeCC--CCcEEEeeecccee
Q 046112          337 ----------------------CQPPIAHCDLKPSNILLDD--EMTAYVSDFGIARF  369 (502)
Q Consensus       337 ----------------------~~~~i~H~dlk~~NIll~~--~~~~kl~Dfg~a~~  369 (502)
                                            ....++|+|+.+.||+++.  ++.+.|.||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         150 RTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                  1246799999999999998  66789999998863

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.07  E-value=1.7e-10  Score=115.55  Aligned_cols=247  Identities=21%  Similarity=0.175  Sum_probs=165.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEc-CCCeEEEEEEecccCcch-hHHH-HHHHHHHhcC-CCCccceeeecccccccCCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILF-ESTTAVAVKVFNVLHHDA-SKSF-AVECEVTRNI-RHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~-~~~~-~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  279 (502)
                      +.+|.....||.|.|+.|+..... .++..+++|.+....... .+.+ ..|+-+...+ .|.+++++...     +...
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~~~  338 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WSQL  338 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----cccc
Confidence            456788889999999999998655 677888888765332221 2222 3455555555 47787776554     3334


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC-Cc
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE-MT  358 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~-~~  358 (502)
                      ...++=-||++++++....          .....++...++.+..+++.++.++|   ++.++|+|+||+||++..+ +.
T Consensus       339 r~~~ip~e~~~~~s~~l~~----------~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~  405 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRS----------VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFF  405 (524)
T ss_pred             ccccCchhhhcCcchhhhh----------HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhh
Confidence            4667888999999887655          22344677788999999999999999   9999999999999999876 78


Q ss_pred             EEEeeeccceecccccccceeccccccccc-ccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHH
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGY-IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  437 (502)
                      -+++|||.+..+.-..    ......+..| .+|+......+-.+.|++|||..+.|..+|..--..       ..+|. 
T Consensus       406 ~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-------~~~~~-  473 (524)
T KOG0601|consen  406 SKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-------GVQSL-  473 (524)
T ss_pred             hhccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcc-------cccce-
Confidence            8999999986422111    0111123333 356666667788999999999999999998744222       01110 


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                              .++........    .....+..+...+...++..||.+.++....+
T Consensus       474 --------~i~~~~~p~~~----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  474 --------TIRSGDTPNLP----GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             --------eeecccccCCC----chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                    01111111111    11234456667777899999999888765544

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.07  E-value=1.5e-11  Score=127.52  Aligned_cols=124  Identities=28%  Similarity=0.385  Sum_probs=106.4

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      |.+|+|+...-+.+.+..+|+.|+|++|+|.......+.+|..|+.|+||+|+|+. +|..+..++.|++|...+|++. 
T Consensus       366 lanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ahsN~l~-  443 (1081)
T KOG0618|consen  366 LANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHTLRAHSNQLL-  443 (1081)
T ss_pred             HhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHHHhhcCCcee-
Confidence            57899986665678999999999999999994444458999999999999999997 8999999999999999999999 


Q ss_pred             CChhhhcCcCCCceeeCCCCccccCC-cchhhcccccceeecCCcccc
Q 046112           82 EIPEFLAGFKFLQNLNLSYNNFESML-PIEGIFKNASATSVFGNKKLC  128 (502)
Q Consensus        82 ~~p~~~~~~~~L~~l~l~~N~l~~~~-~~~~~~~~~~~~~~~~n~~l~  128 (502)
                      .+| .+..++.|+.+|+|.|+|+... +.....+++..+++.||.++.
T Consensus       444 ~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~  490 (1081)
T KOG0618|consen  444 SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLV  490 (1081)
T ss_pred             ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccc
Confidence            789 8999999999999999997654 333333789999999998643

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.02  E-value=1.7e-10  Score=82.93  Aligned_cols=61  Identities=38%  Similarity=0.500  Sum_probs=56.5

Q ss_pred             CCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCceeeCCCCcc
Q 046112           43 TSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNF  103 (502)
Q Consensus        43 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l~~N~l  103 (502)
                      ++|++|++++|+|+...+..|..+++|+.|+|++|.++...|..|.++++|+.|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5799999999999997778999999999999999999976677999999999999999986

...

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.97  E-value=2.3e-10  Score=120.65  Aligned_cols=205  Identities=24%  Similarity=0.333  Sum_probs=137.5

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      ..+++.+.+-+-.|.++.++.+.-...|...+.|+....   .....+....+-.+.-..++|-+++..--     +.-.
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~r  876 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCR  876 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCC
Confidence            345566667788899999988765555655555544321   11112222223223323344555443322     3344


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...+++++|..+++|...+|...          ..+..-.......+..+.+|||   ...+.|+|++|.|.+...++..
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~----------~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~  943 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSG----------CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHR  943 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCC----------CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCc
Confidence            57889999999999999987532          1221112223445667899999   7779999999999999999999


Q ss_pred             EEeeeccceeccc---------------------cc--------ccceecccccccccccCcccCCCccCccccchhHHH
Q 046112          360 YVSDFGIARFLEA---------------------AD--------EQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGI  410 (502)
Q Consensus       360 kl~Dfg~a~~~~~---------------------~~--------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv  410 (502)
                      +++|||.......                     ..        .........+|+.|.+||...+......+|.|+.|+
T Consensus       944 ~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~ 1023 (1205)
T KOG0606|consen  944 PLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGV 1023 (1205)
T ss_pred             ccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhh
Confidence            9999983321110                     00        001133467899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCccc
Q 046112          411 LLLEMFTGLRPSDDM  425 (502)
Q Consensus       411 ~l~el~tg~~p~~~~  425 (502)
                      +++|.++|..||.+.
T Consensus      1024 ~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 1024 CLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             hhhhhhcCCCCCCCc
Confidence            999999999999863

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.97  E-value=6.6e-09  Score=102.12  Aligned_cols=180  Identities=17%  Similarity=0.137  Sum_probs=135.4

Q ss_pred             CCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeeeccC-CChh
Q 046112          217 NFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMAN-GSLE  295 (502)
Q Consensus       217 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-gsL~  295 (502)
                      ...+.|++...-+|..+++|++.............-+++.+++.|+|+|++.+++.... .++...++||+|+++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHH
Confidence            34578999888899999999995443333333455678899999999999998866433 345578999999987 5787


Q ss_pred             hhccCCchhh-----hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceec
Q 046112          296 EWMHPITEED-----KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL  370 (502)
Q Consensus       296 ~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~  370 (502)
                      +.........     .........++...+.++.|+..||.++|   +.|..-+-|.+++|+++.+.+++|+..|+...+
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeee
Confidence            7765433322     11223455778899999999999999999   899999999999999999999999988887766


Q ss_pred             ccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCC
Q 046112          371 EAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGL  419 (502)
Q Consensus       371 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~  419 (502)
                      ...+..                -+.   --.+-|.=.||.+++.|.||.
T Consensus       444 ~~d~~~----------------~le---~~Qq~D~~~lG~ll~aLAt~~  473 (655)
T KOG3741|consen  444 QEDPTE----------------PLE---SQQQNDLRDLGLLLLALATGT  473 (655)
T ss_pred             cCCCCc----------------chh---HHhhhhHHHHHHHHHHHhhcc
Confidence            543311                011   113468888999999999995

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=5.9e-09  Score=89.79  Aligned_cols=129  Identities=23%  Similarity=0.334  Sum_probs=90.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEE-ecccCcc-------hhHHHHHHHHHHhcCCCCcc--ceeeecccccccCCCc
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKV-FNVLHHD-------ASKSFAVECEVTRNIRHRNL--VKVFTACSGVDFQGND  280 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~-~~~~~~~-------~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~~~  280 (502)
                      ..+++|+-+.+|.+.+  -|..+.+|. +++....       ....-.+|+.++.+++--.|  .-++.+       +.+
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD   72 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence            3678999999999965  333466664 3222111       12345678888887753322  222322       233


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ...|+|||+++-.|.+.+..        .         +..++..+-.-+.-||   ..+|+|+||.++||.+..+. +.
T Consensus        73 ~~~I~me~I~G~~lkd~l~~--------~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~  131 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEE--------A---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IY  131 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHh--------c---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EE
Confidence            56799999999999988853        1         2456677777788999   99999999999999998775 99


Q ss_pred             Eeeecccee
Q 046112          361 VSDFGIARF  369 (502)
Q Consensus       361 l~Dfg~a~~  369 (502)
                      ++|||++.+
T Consensus       132 ~IDfGLg~~  140 (204)
T COG3642         132 FIDFGLGEF  140 (204)
T ss_pred             EEECCcccc
Confidence            999999974

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.94  E-value=7.4e-09  Score=88.73  Aligned_cols=143  Identities=22%  Similarity=0.272  Sum_probs=96.2

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEE-ecccCcc-------hhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          209 SENLIGAGNFGSVYKGILFESTTAVAVKV-FNVLHHD-------ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       209 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~-~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ....+-+|+-+.|+++.+  .|+...||. +.+....       ..+....|++.+.+++--.|.-..-+     +.+..
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~-----~~D~~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI-----FIDTY   83 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-----EEecC
Confidence            467899999999999966  777777774 3222111       23456778998888752222111111     11122


Q ss_pred             ceeEEeeeccC-CChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC--
Q 046112          281 FKALVYEFMAN-GSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM--  357 (502)
Q Consensus       281 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~--  357 (502)
                      .-.|+|||+++ .++.+++..        .............++..+-+.+.-||   ...|+|+||..+||++..++  
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~--------~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~  152 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILS--------TMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQ  152 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHH--------HccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCc
Confidence            45699999976 477887743        22222233333678888999999999   99999999999999996544  


Q ss_pred             -cEEEeeecccee
Q 046112          358 -TAYVSDFGIARF  369 (502)
Q Consensus       358 -~~kl~Dfg~a~~  369 (502)
                       .+.+.|||++..
T Consensus       153 ~~~~lIdfgls~~  165 (229)
T KOG3087|consen  153 ITPILIDFGLSSV  165 (229)
T ss_pred             CceEEEeecchhc
Confidence             568999999853

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.94  E-value=3.7e-11  Score=113.45  Aligned_cols=128  Identities=21%  Similarity=0.198  Sum_probs=93.0

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcC-CccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHG-NLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      |..|+|+...|.+|+.+.+|+.||||+|+|+-+-|+.|.+|.+|..|-+.+ |+|+...-..|..|.+|+.|.+..|++.
T Consensus        74 LdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~  153 (498)
T KOG4237|consen   74 LDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHIN  153 (498)
T ss_pred             eccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhc
Confidence            567788744445677788888888888888877778888888887774444 7888755566888888888888888887


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCc-chhhcccccceeecCCccccC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLP-IEGIFKNASATSVFGNKKLCG  129 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~-~~~~~~~~~~~~~~~n~~l~g  129 (502)
                      -.....|..+++|..|.+-+|.+..+.. .......++.+.+..|+..|-
T Consensus       154 Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icd  203 (498)
T KOG4237|consen  154 CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICD  203 (498)
T ss_pred             chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccc
Confidence            6667788888888888888888877665 334455566666777765543

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.91  E-value=1.8e-10  Score=113.71  Aligned_cols=93  Identities=30%  Similarity=0.383  Sum_probs=36.8

Q ss_pred             cccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCc
Q 046112           11 LSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGF   90 (502)
Q Consensus        11 ~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~   90 (502)
                      +|+.++.+..|..||.+.|.+. .+|..+++|.+|+.|++..|++.. +|..+..| .|..||+|+|+++ .+|-.|.+|
T Consensus       158 lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~El~~L-pLi~lDfScNkis-~iPv~fr~m  233 (722)
T KOG0532|consen  158 LPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPEELCSL-PLIRLDFSCNKIS-YLPVDFRKM  233 (722)
T ss_pred             CCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCHHHhCC-ceeeeecccCcee-ecchhhhhh
Confidence            3333333333333333333333 333333333333333333333333 33333321 3444444444444 344444444


Q ss_pred             CCCceeeCCCCccccCC
Q 046112           91 KFLQNLNLSYNNFESML  107 (502)
Q Consensus        91 ~~L~~l~l~~N~l~~~~  107 (502)
                      +.|++|-|.+|.|++.|
T Consensus       234 ~~Lq~l~LenNPLqSPP  250 (722)
T KOG0532|consen  234 RHLQVLQLENNPLQSPP  250 (722)
T ss_pred             hhheeeeeccCCCCCCh
Confidence            44444444444444433

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.88  E-value=2.3e-09  Score=114.70  Aligned_cols=94  Identities=24%  Similarity=0.404  Sum_probs=49.1

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      |++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.  .+|+.|+|++|+++. +|..+.  ++|+.|+|++|+|+ 
T Consensus       206 Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~~-LP~~l~--s~L~~L~Ls~N~L~-  275 (754)
T PRK15370        206 LDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRITE-LPERLP--SALQSLDLFHNKIS-  275 (754)
T ss_pred             ecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccCc-CChhHh--CCCCEEECcCCccC-
Confidence            4555555 4454432  35566666666655 3444332  345555555555553 444443  35666666666665 


Q ss_pred             CChhhhcCcCCCceeeCCCCccccCC
Q 046112           82 EIPEFLAGFKFLQNLNLSYNNFESML  107 (502)
Q Consensus        82 ~~p~~~~~~~~L~~l~l~~N~l~~~~  107 (502)
                      .+|..+.  ++|+.|++++|+|++++
T Consensus       276 ~LP~~l~--~sL~~L~Ls~N~Lt~LP  299 (754)
T PRK15370        276 CLPENLP--EELRYLSVYDNSIRTLP  299 (754)
T ss_pred             ccccccC--CCCcEEECCCCccccCc
Confidence            4554432  35566666666665544

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.87  E-value=2.7e-09  Score=113.61  Aligned_cols=102  Identities=22%  Similarity=0.238  Sum_probs=57.0

Q ss_pred             CCCCEEeccCCcCCCcCCccCCCC-----------------CCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112           19 SSLSIFNVSGNLLSGAISNNFGSC-----------------TSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus        19 ~~L~~l~l~~N~l~~~~~~~~~~l-----------------~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      .+|+.|+|++|+|+ .+|....++                 ++|+.|+|++|+|++ +|...   ++|+.|+|++|+|+ 
T Consensus       342 ~~Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Ls-  415 (788)
T PRK15387        342 SGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLT-  415 (788)
T ss_pred             cccceEecCCCccC-CCCCCCcccceehhhccccccCcccccccceEEecCCcccC-CCCcc---cCCCEEEccCCcCC-
Confidence            36788888888888 455422111                 244555555555554 33322   35556666666665 


Q ss_pred             CChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCccccCC
Q 046112           82 EIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGG  130 (502)
Q Consensus        82 ~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~g~  130 (502)
                      .+|...   .+|+.|++++|+|+.+|.....+..+..+.+.+|+ +++.
T Consensus       416 sIP~l~---~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~-Ls~~  460 (788)
T PRK15387        416 SLPMLP---SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNP-LSER  460 (788)
T ss_pred             CCCcch---hhhhhhhhccCcccccChHHhhccCCCeEECCCCC-CCch
Confidence            355432   34556666666666665555556666666666664 4443

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.86  E-value=2.1e-08  Score=89.13  Aligned_cols=126  Identities=22%  Similarity=0.290  Sum_probs=79.7

Q ss_pred             eEEEEEEcCCCeEEEEEEecccCc-------------c-------------hhHHHHHHHHHHhcCCCC--ccceeeecc
Q 046112          220 SVYKGILFESTTAVAVKVFNVLHH-------------D-------------ASKSFAVECEVTRNIRHR--NLVKVFTAC  271 (502)
Q Consensus       220 ~Vy~~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~E~~~l~~l~h~--niv~l~~~~  271 (502)
                      .||.| ...+|..+|||+.+....             .             ......+|.+.|.++...  ++-+++.+ 
T Consensus         1 ~Vy~~-~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHA-IDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEE-EECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEE-ECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            38999 447888999998743210             0             113466799999999755  45555544 


Q ss_pred             cccccCCCcceeEEeeecc--CCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCceeecCCC
Q 046112          272 SGVDFQGNDFKALVYEFMA--NGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY-LHLDCQPPIAHCDLKP  348 (502)
Q Consensus       272 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~-LH~~~~~~i~H~dlk~  348 (502)
                              ....+||||++  +..+..+...            .++......++.++...+.. +|   ..+|+|+|+.+
T Consensus        79 --------~~~~ivME~I~~~G~~~~~l~~~------------~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~  135 (188)
T PF01163_consen   79 --------NRNVIVMEYIGEDGVPLPRLKDV------------DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSE  135 (188)
T ss_dssp             --------ETTEEEEE--EETTEEGGCHHHC------------GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-ST
T ss_pred             --------eCCEEEEEecCCCccchhhHHhc------------cccchhHHHHHHHHHHHHHHHHH---hcCceecCCCh
Confidence                    14579999998  5444433211            01122345677777775555 57   89999999999


Q ss_pred             CCeeeCCCCcEEEeeeccceecc
Q 046112          349 SNILLDDEMTAYVSDFGIARFLE  371 (502)
Q Consensus       349 ~NIll~~~~~~kl~Dfg~a~~~~  371 (502)
                      .||+++++ .+.|+|||.+....
T Consensus       136 ~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  136 YNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             TSEEEETT-CEEE--GTTEEETT
T ss_pred             hhEEeecc-eEEEEecCcceecC
Confidence            99999988 99999999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.85  E-value=3.3e-08  Score=93.27  Aligned_cols=146  Identities=14%  Similarity=0.049  Sum_probs=97.3

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccCc-----------chhHHHHHHHHHHhcCCCC--ccceeeecccccccC
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-----------DASKSFAVECEVTRNIRHR--NLVKVFTACSGVDFQ  277 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~  277 (502)
                      +.+-.-....|++...  +|+.+.||+......           .....+.+|...+.++...  .+..++++.......
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            4455445555777644  677899997643221           1112477888888777422  223333332110001


Q ss_pred             CCcceeEEeeeccCC-ChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC-
Q 046112          278 GNDFKALVYEFMANG-SLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD-  355 (502)
Q Consensus       278 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~-  355 (502)
                      .....++|+|++++- +|.+++...        .....+...+..++.+++..+.-||   ..+|+|+|++++|||++. 
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~--------~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~  174 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADW--------ATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLP  174 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhh--------cccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEecc
Confidence            123578999999886 898887421        1123445667789999999999999   999999999999999975 


Q ss_pred             ------CCcEEEeeecccee
Q 046112          356 ------EMTAYVSDFGIARF  369 (502)
Q Consensus       356 ------~~~~kl~Dfg~a~~  369 (502)
                            +..+.++||+.++.
T Consensus       175 ~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        175 FPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             ccCCCCCceEEEEECCcccc
Confidence                  57899999998853

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.85  E-value=2.6e-10  Score=118.56  Aligned_cols=98  Identities=37%  Similarity=0.466  Sum_probs=86.2

Q ss_pred             CCCCCccccccccc-cCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~-~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      +|++|+|. .+|.. +.+|..|+.|+||+|+|+ .+|..+.++..|++|...+|++.. +| .+..+++|+.+|||.|+|
T Consensus       389 hLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~-fP-e~~~l~qL~~lDlS~N~L  464 (1081)
T KOG0618|consen  389 HLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLS-FP-ELAQLPQLKVLDLSCNNL  464 (1081)
T ss_pred             eecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceee-ch-hhhhcCcceEEecccchh
Confidence            58999999 77764 778999999999999999 999999999999999999999996 88 899999999999999999


Q ss_pred             CCC-ChhhhcCcCCCceeeCCCCcc
Q 046112           80 SDE-IPEFLAGFKFLQNLNLSYNNF  103 (502)
Q Consensus        80 ~~~-~p~~~~~~~~L~~l~l~~N~l  103 (502)
                      +.. +|... .-++|++|||++|.-
T Consensus       465 ~~~~l~~~~-p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  465 SEVTLPEAL-PSPNLKYLDLSGNTR  488 (1081)
T ss_pred             hhhhhhhhC-CCcccceeeccCCcc
Confidence            853 34333 338999999999973

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.81  E-value=9.5e-09  Score=109.97  Aligned_cols=111  Identities=23%  Similarity=0.323  Sum_probs=90.8

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +|+++.|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|++ +|..+.  .+|+.|+|++|.+.
T Consensus       184 ~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L~  254 (754)
T PRK15370        184 RLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMELSINRIT  254 (754)
T ss_pred             EeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEECcCCccC
Confidence            46778888 6787664  58999999999999 6777664  699999999999996 787664  58999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                       .+|..+.  ++|+.|++++|+|+.+|...  ..++..+.+++|+
T Consensus       255 -~LP~~l~--s~L~~L~Ls~N~L~~LP~~l--~~sL~~L~Ls~N~  294 (754)
T PRK15370        255 -ELPERLP--SALQSLDLFHNKISCLPENL--PEELRYLSVYDNS  294 (754)
T ss_pred             -cCChhHh--CCCCEEECcCCccCcccccc--CCCCcEEECCCCc
Confidence             7888775  57999999999999876543  3467788887774

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.80  E-value=2.5e-10  Score=92.43  Aligned_cols=125  Identities=21%  Similarity=0.235  Sum_probs=98.6

Q ss_pred             CCCCCccccccccccC---CCCCCCEEeccCCcCCCcCCccCCC-CCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccC
Q 046112            1 DLSNNNLSGTLSPQLV---GLSSLSIFNVSGNLLSGAISNNFGS-CTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQ   76 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~---~l~~L~~l~l~~N~l~~~~~~~~~~-l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~   76 (502)
                      ||++++|- .+++...   ....|+.++|++|.|. ..|..|.. .+.++.|+|++|+|+. +|..++.++.|+.|+++.
T Consensus        33 dLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisd-vPeE~Aam~aLr~lNl~~  109 (177)
T KOG4579|consen   33 DLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISD-VPEELAAMPALRSLNLRF  109 (177)
T ss_pred             ccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhh-chHHHhhhHHhhhccccc
Confidence            56777776 6666544   4566777899999999 55655554 5699999999999997 899999999999999999


Q ss_pred             cccCCCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCccccCC
Q 046112           77 NNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGG  130 (502)
Q Consensus        77 N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~g~  130 (502)
                      |.|. ..|..+..+.+|-.|+..+|.+..++-. ...+....+.-.||+.+.++
T Consensus       110 N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~d-l~~s~~~al~~lgnepl~~~  161 (177)
T KOG4579|consen  110 NPLN-AEPRVIAPLIKLDMLDSPENARAEIDVD-LFYSSLPALIKLGNEPLGDE  161 (177)
T ss_pred             Cccc-cchHHHHHHHhHHHhcCCCCccccCcHH-HhccccHHHHHhcCCccccc
Confidence            9999 7899888899999999999999887765 33444555555577666554

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.80  E-value=3.9e-10  Score=111.33  Aligned_cols=119  Identities=29%  Similarity=0.395  Sum_probs=110.3

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|..++.+..|..||.+.|++.. +|..++.|.+|+.|++..|++.
T Consensus       127 ~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~s-lpsql~~l~slr~l~vrRn~l~  202 (722)
T KOG0532|consen  127 DLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQS-LPSQLGYLTSLRDLNVRRNHLE  202 (722)
T ss_pred             hhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhh-chHHhhhHHHHHHHHHhhhhhh
Confidence            68999999 8999998887 899999999999 999999999999999999999997 8999999999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                       .+|..+..| .|..||+|.|+++.+|-.+..++.+..+.+.+|+
T Consensus       203 -~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNP  245 (722)
T KOG0532|consen  203 -DLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNP  245 (722)
T ss_pred             -hCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCC
Confidence             789989866 4789999999999999988888999998888885

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.77  E-value=1.4e-09  Score=99.45  Aligned_cols=108  Identities=22%  Similarity=0.279  Sum_probs=90.4

Q ss_pred             cccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCC
Q 046112           13 PQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKF   92 (502)
Q Consensus        13 ~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~   92 (502)
                      ..+..+..|++||||+|.++ .+..+..-+|.++.|++|+|.|.. + .+++.|++|+.||||+|.++ .+-.+-.++-+
T Consensus       278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN  353 (490)
T KOG1259|consen  278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGN  353 (490)
T ss_pred             EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcC
Confidence            34455678999999999999 888899999999999999999986 3 44999999999999999999 68888888999


Q ss_pred             CceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           93 LQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        93 L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      ++.|.|+.|.|..... ...+-.+..+++.+|+
T Consensus       354 IKtL~La~N~iE~LSG-L~KLYSLvnLDl~~N~  385 (490)
T KOG1259|consen  354 IKTLKLAQNKIETLSG-LRKLYSLVNLDLSSNQ  385 (490)
T ss_pred             EeeeehhhhhHhhhhh-hHhhhhheeccccccc
Confidence            9999999999976543 2344556677777775

>PLN03210 Resistant to P

Probab=98.76  E-value=2.5e-08  Score=113.66  Aligned_cols=121  Identities=19%  Similarity=0.224  Sum_probs=64.5

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      |++|...+.+|..++++++|+.|+|++|...+.+|..+ ++++|+.|+|++|..-..+|..   .++|+.|+|++|.|+ 
T Consensus       785 Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-  859 (1153)
T PLN03210        785 LSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-  859 (1153)
T ss_pred             CCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-
Confidence            34444444555555555555555555543333455444 4555555555554333334332   245566666666665 


Q ss_pred             CChhhhcCcCCCceeeCCC-CccccCCcchhhcccccceeecCCccc
Q 046112           82 EIPEFLAGFKFLQNLNLSY-NNFESMLPIEGIFKNASATSVFGNKKL  127 (502)
Q Consensus        82 ~~p~~~~~~~~L~~l~l~~-N~l~~~~~~~~~~~~~~~~~~~~n~~l  127 (502)
                      .+|.++..+++|+.|+|++ |+|++++.....++.+..+.+.+...+
T Consensus       860 ~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~~L  906 (1153)
T PLN03210        860 EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCGAL  906 (1153)
T ss_pred             cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCccc
Confidence            4666666666666666655 455555555455555555555554433

syringae 6; Provisional

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.76  E-value=1.6e-08  Score=107.73  Aligned_cols=73  Identities=22%  Similarity=0.367  Sum_probs=52.6

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|+ .+|+.+.  ++|+.|+|++|+|+ .+|..   +++|++|+|++|+|+. +|..   .++|+.|+|++|.|+
T Consensus       207 dLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~  275 (788)
T PRK15387        207 NVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLT  275 (788)
T ss_pred             EcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc---ccccceeeccCCchh
Confidence            57889998 7888775  37888999999988 56642   5788889999888886 5543   245666666666665


Q ss_pred             CCChh
Q 046112           81 DEIPE   85 (502)
Q Consensus        81 ~~~p~   85 (502)
                       .+|.
T Consensus       276 -~Lp~  279 (788)
T PRK15387        276 -HLPA  279 (788)
T ss_pred             -hhhh
Confidence             3443

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.69  E-value=1.7e-07  Score=85.73  Aligned_cols=133  Identities=22%  Similarity=0.171  Sum_probs=92.6

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccCc----------------------chhHHHHHHHHHHhcCCCC--cc
Q 046112          209 SENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH----------------------DASKSFAVECEVTRNIRHR--NL  264 (502)
Q Consensus       209 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--ni  264 (502)
                      +++.||-|--+.||.|. .+.|..+|||.=+...+                      -+....++|.++|.++...  .+
T Consensus        95 iG~~IGvGKEsdVY~~~-~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          95 IGTKIGVGKESDVYVAI-DPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hccccccCccceEEEEE-CCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            46899999999999994 46889999995321100                      0123467799999998654  55


Q ss_pred             ceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceee
Q 046112          265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHC  344 (502)
Q Consensus       265 v~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~  344 (502)
                      -+.+++         +...+||||+++--|...-               ++....-.++..|..-+.-.-   ..||||+
T Consensus       174 P~P~~~---------nRHaVvMe~ieG~eL~~~r---------------~~~en~~~il~~il~~~~~~~---~~GiVHG  226 (304)
T COG0478         174 PKPIAW---------NRHAVVMEYIEGVELYRLR---------------LDVENPDEILDKILEEVRKAY---RRGIVHG  226 (304)
T ss_pred             CCcccc---------ccceeeeehcccceeeccc---------------CcccCHHHHHHHHHHHHHHHH---HcCcccc
Confidence            555554         3568999999885554321               112223344444544444444   6789999


Q ss_pred             cCCCCCeeeCCCCcEEEeeecccee
Q 046112          345 DLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       345 dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                      |+++-||+++++|.+.+.||-.+..
T Consensus       227 DlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         227 DLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             CCchheEEEecCCCEEEEeCccccc
Confidence            9999999999999999999977653

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.65  E-value=1e-08  Score=103.67  Aligned_cols=109  Identities=28%  Similarity=0.455  Sum_probs=68.1

Q ss_pred             ccCCCCCCCEEeccCCcCCCcCCccCCCCC-CCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCC
Q 046112           14 QLVGLSSLSIFNVSGNLLSGAISNNFGSCT-SLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKF   92 (502)
Q Consensus        14 ~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~   92 (502)
                      .+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++.. +|..+..+++|+.|++++|+++ .+|.....++.
T Consensus       111 ~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~  187 (394)
T COG4886         111 ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSN  187 (394)
T ss_pred             hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchhh-hhhhhhccccccccccCCchhh-hhhhhhhhhhh
Confidence            3445566666777777666 5555555553 66777777776665 5556666666777777777766 56655556666


Q ss_pred             CceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           93 LQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        93 L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      |+.|++++|+++.+++.......+..+...+|+
T Consensus       188 L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~  220 (394)
T COG4886         188 LNNLDLSGNKISDLPPEIELLSALEELDLSNNS  220 (394)
T ss_pred             hhheeccCCccccCchhhhhhhhhhhhhhcCCc
Confidence            666677777766666654444445555555553

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.63  E-value=8.8e-09  Score=104.89  Aligned_cols=150  Identities=17%  Similarity=0.222  Sum_probs=99.3

Q ss_pred             HHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecccccccce-------ecccccccccccCcccCC
Q 046112          324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR-------SIGVEGTTGYIAPEYGMG  396 (502)
Q Consensus       324 ~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~  396 (502)
                      .+++.|+.|+|.  +.++||++|.|++|.++.++..||+.|+++...........       ..-......|.|||++..
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345589999995  67899999999999999999999999998865544221110       011224568999999999


Q ss_pred             CccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhccc
Q 046112          397 HEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSA  475 (502)
Q Consensus       397 ~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~  475 (502)
                      ...+.++|+||+||++|.+.. |+.-++. ...... ........ + ..         ...+..+.+.++.+=+.+.+.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a-~~~~~~-~~~~~~~~-~-~~---------~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAA-NGGLLS-YSFSRNLL-N-AG---------AFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhc-cCCcch-hhhhhccc-c-cc---------cccccccCcHHHHHHHHHHhc
Confidence            888999999999999999995 5544433 111111 11000000 0 00         000112445556666677788


Q ss_pred             CCCCCCCCHHHHH
Q 046112          476 EQPGERMKINDVE  488 (502)
Q Consensus       476 ~dP~~RPt~~ev~  488 (502)
                      .++..||++.++.
T Consensus       251 ~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  251 GDSAVRPTLDLLL  263 (700)
T ss_pred             CCcccCcchhhhh
Confidence            9999999777664

>PLN03210 Resistant to P

Probab=98.63  E-value=1e-07  Score=108.67  Aligned_cols=120  Identities=22%  Similarity=0.251  Sum_probs=85.6

Q ss_pred             CCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCC
Q 046112            3 SNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDE   82 (502)
Q Consensus         3 ~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~   82 (502)
                      .+|.++ .+|..+ .+.+|+.|+|++|+|. .+|..+..+++|+.|+|++|.....+| .++.+++|+.|+|++|.....
T Consensus       597 ~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~  672 (1153)
T PLN03210        597 DKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVE  672 (1153)
T ss_pred             cCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccc
Confidence            344444 566555 5678888888888887 677778888888888888776444566 477888888888888765557


Q ss_pred             ChhhhcCcCCCceeeCCCC-ccccCCcchhhcccccceeecCCccc
Q 046112           83 IPEFLAGFKFLQNLNLSYN-NFESMLPIEGIFKNASATSVFGNKKL  127 (502)
Q Consensus        83 ~p~~~~~~~~L~~l~l~~N-~l~~~~~~~~~~~~~~~~~~~~n~~l  127 (502)
                      +|..+.++++|+.|++++| +++.+|.. ..++++..+.+.++..+
T Consensus       673 lp~si~~L~~L~~L~L~~c~~L~~Lp~~-i~l~sL~~L~Lsgc~~L  717 (1153)
T PLN03210        673 LPSSIQYLNKLEDLDMSRCENLEILPTG-INLKSLYRLNLSGCSRL  717 (1153)
T ss_pred             cchhhhccCCCCEEeCCCCCCcCccCCc-CCCCCCCEEeCCCCCCc
Confidence            8888888888888888875 45554443 35667777777776543

syringae 6; Provisional

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.62  E-value=1.5e-09  Score=110.09  Aligned_cols=123  Identities=24%  Similarity=0.266  Sum_probs=98.5

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +.+.|+|. ....++.-++.|+.|||++|+++...  .+..|+.|+.|||++|+|....--....+. |..|.|.||.++
T Consensus       170 ~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~  245 (1096)
T KOG1859|consen  170 SFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALT  245 (1096)
T ss_pred             hcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHH
Confidence            35678888 77778888899999999999999543  788999999999999999974333344444 999999999998


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCc--chhhcccccceeecCCccccC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLP--IEGIFKNASATSVFGNKKLCG  129 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~--~~~~~~~~~~~~~~~n~~l~g  129 (502)
                       .+ ..+.++.+|+.||+++|-|.+-..  ..+.+..+..+.+.|||.-|.
T Consensus       246 -tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  246 -TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             -hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence             33 357899999999999999987443  346677788899999976664

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.61  E-value=8e-09  Score=97.98  Aligned_cols=91  Identities=20%  Similarity=0.246  Sum_probs=44.3

Q ss_pred             CCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCceeeCCCCccccCCcchh-hccccc
Q 046112           39 FGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG-IFKNAS  117 (502)
Q Consensus        39 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~-~~~~~~  117 (502)
                      |..|++|+.|+|++|+|+.+-+.+|..+..|+.|.|..|+|.-.-...|.++..|+.|+|.+|+|+.+.|..+ .+..+.
T Consensus       270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~  349 (498)
T KOG4237|consen  270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS  349 (498)
T ss_pred             HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence            4455555555555555555445555555555555555555543333444455555555555555554444331 223344


Q ss_pred             ceeecCCccccC
Q 046112          118 ATSVFGNKKLCG  129 (502)
Q Consensus       118 ~~~~~~n~~l~g  129 (502)
                      .+.+.+|+..|.
T Consensus       350 ~l~l~~Np~~Cn  361 (498)
T KOG4237|consen  350 TLNLLSNPFNCN  361 (498)
T ss_pred             eeehccCcccCc
Confidence            445555554443

>PRK09902 hypothetical protein; Provisional

Probab=98.59  E-value=9.9e-07  Score=78.95  Aligned_cols=142  Identities=20%  Similarity=0.138  Sum_probs=100.8

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEecc-c----C-cchhHHHHHHHHHHhcCCC--CccceeeecccccccCCCcceeE
Q 046112          213 IGAGNFGSVYKGILFESTTAVAVKVFNV-L----H-HDASKSFAVECEVTRNIRH--RNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       213 lG~G~~g~Vy~~~~~~~~~~vavK~~~~-~----~-~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      -|.||-+.|++-..  .|..+-+|+-.. .    . .-....|.+|...+.++..  -.+.+++ ++........-..+|
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            46688888998744  444688887531 0    1 2245789999999988853  2344444 332111222335779


Q ss_pred             EeeeccC-CChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc--EEE
Q 046112          285 VYEFMAN-GSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT--AYV  361 (502)
Q Consensus       285 v~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~--~kl  361 (502)
                      |+|-+++ -+|.+++.+        ....+.+...+..+..+++..++-||   ..++.|+|+.+.||+++.++.  +++
T Consensus       103 VTe~L~g~~~L~~~l~~--------~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~l  171 (216)
T PRK09902        103 VTEDMAGFISIADWYAQ--------HAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGF  171 (216)
T ss_pred             EEEeCCCCccHHHHHhc--------CCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEE
Confidence            9998754 588888743        22335677788899999999999999   999999999999999986666  999


Q ss_pred             eeeccce
Q 046112          362 SDFGIAR  368 (502)
Q Consensus       362 ~Dfg~a~  368 (502)
                      .||.-++
T Consensus       172 IDlEk~r  178 (216)
T PRK09902        172 LDLEKSR  178 (216)
T ss_pred             EEhhccc
Confidence            9998765

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.57  E-value=6.6e-09  Score=101.83  Aligned_cols=115  Identities=22%  Similarity=0.181  Sum_probs=83.3

Q ss_pred             cccccCCCCCCCEEeccCCcCCCcCCccCCCCCC---CCEEECcCCccCC----CCCCCcCCC-CCCCEEEccCcccCCC
Q 046112           11 LSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTS---LEQLDMHGNLFAG----PIGSSLSSL-RGLRVLDLSQNNLSDE   82 (502)
Q Consensus        11 ~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~---L~~L~l~~N~l~~----~~p~~~~~l-~~L~~L~ls~N~l~~~   82 (502)
                      ++..+..+++|+.|+|++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|+.|+|++|.+++.
T Consensus        73 ~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~  152 (319)
T cd00116          73 LLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGA  152 (319)
T ss_pred             HHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCch
Confidence            4456777889999999999998766666666666   9999999998873    233455666 8899999999998843


Q ss_pred             ----ChhhhcCcCCCceeeCCCCccccCC-----cchhhcccccceeecCCc
Q 046112           83 ----IPEFLAGFKFLQNLNLSYNNFESML-----PIEGIFKNASATSVFGNK  125 (502)
Q Consensus        83 ----~p~~~~~~~~L~~l~l~~N~l~~~~-----~~~~~~~~~~~~~~~~n~  125 (502)
                          ++..+..++.|+.|++++|.+++..     .....+.++..+.+.+|.
T Consensus       153 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~  204 (319)
T cd00116         153 SCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNG  204 (319)
T ss_pred             HHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCc
Confidence                3445667778999999999887521     111223477788887774

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.52  E-value=7.1e-07  Score=81.38  Aligned_cols=110  Identities=23%  Similarity=0.270  Sum_probs=80.3

Q ss_pred             HHHHHHHHHHhcCCC--CccceeeecccccccCCCcceeEEeeeccCC-ChhhhccCCchhhhccCCCCCCCHHHHHHHH
Q 046112          247 KSFAVECEVTRNIRH--RNLVKVFTACSGVDFQGNDFKALVYEFMANG-SLEEWMHPITEEDKRHKAPGNLNSLKRLNIA  323 (502)
Q Consensus       247 ~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  323 (502)
                      ....+|...+..+..  -.+.+.+++..... ......++|+|++++. +|.+++..          ....+...+..++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~----------~~~~~~~~~~~ll  124 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQ----------WEQLDPSQRRELL  124 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHh----------hcccchhhHHHHH
Confidence            456778887776642  23344444432211 1123568999999884 79988842          1115566778999


Q ss_pred             HHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC---cEEEeeeccceec
Q 046112          324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM---TAYVSDFGIARFL  370 (502)
Q Consensus       324 ~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~---~~kl~Dfg~a~~~  370 (502)
                      .+++..++-||   ..+|+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       125 ~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  125 RALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999999   99999999999999999887   8999999988653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.51  E-value=5.5e-08  Score=98.36  Aligned_cols=120  Identities=29%  Similarity=0.402  Sum_probs=81.3

Q ss_pred             CCCCccccccccccCCCC-CCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            2 LSNNNLSGTLSPQLVGLS-SLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~-~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +.+|+++ .+|+....+. +|+.|++++|++. .+|..++.+++|+.|++++|+++. +|...+.++.|+.|++++|+++
T Consensus       123 l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~-l~~~~~~~~~L~~L~ls~N~i~  199 (394)
T COG4886         123 LDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS  199 (394)
T ss_pred             cCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhhh-hhhhhhhhhhhhheeccCCccc
Confidence            5566776 6666666664 7777777777777 666667777777777777777776 5665556677777777777777


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                       .+|........|+.|++++|.+...+.....+.++..+...+|.
T Consensus       200 -~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~  243 (394)
T COG4886         200 -DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNK  243 (394)
T ss_pred             -cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCce
Confidence             67766655666777777777655555555555555555545553

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.51  E-value=1.3e-08  Score=99.65  Aligned_cols=125  Identities=23%  Similarity=0.215  Sum_probs=94.2

Q ss_pred             CCCCCcccc----ccccccCCCCCCCEEeccCCcCCC------cCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCC--
Q 046112            1 DLSNNNLSG----TLSPQLVGLSSLSIFNVSGNLLSG------AISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRG--   68 (502)
Q Consensus         1 dl~~n~l~~----~~p~~~~~l~~L~~l~l~~N~l~~------~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~--   68 (502)
                      +|+++.++.    .++..+...++|+.|++++|.+.+      .++..+..+++|+.|++++|.+.+..+..+..+.+  
T Consensus        29 ~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~  108 (319)
T cd00116          29 RLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSS  108 (319)
T ss_pred             eecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccC
Confidence            467777753    366677788899999999999873      34456778999999999999998766666766666  


Q ss_pred             -CCEEEccCcccCC----CChhhhcCc-CCCceeeCCCCccccCCcc-----hhhcccccceeecCCc
Q 046112           69 -LRVLDLSQNNLSD----EIPEFLAGF-KFLQNLNLSYNNFESMLPI-----EGIFKNASATSVFGNK  125 (502)
Q Consensus        69 -L~~L~ls~N~l~~----~~p~~~~~~-~~L~~l~l~~N~l~~~~~~-----~~~~~~~~~~~~~~n~  125 (502)
                       |+.|++++|.+++    .+...+..+ ++|+.|++++|++++....     ......+..+.+.+|+
T Consensus       109 ~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~  176 (319)
T cd00116         109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNG  176 (319)
T ss_pred             cccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCC
Confidence             9999999999984    233456667 8999999999999853221     1233467888888774

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.45  E-value=7.8e-09  Score=83.88  Aligned_cols=103  Identities=17%  Similarity=0.225  Sum_probs=85.3

Q ss_pred             CCCCCccccccccccCC-CCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSPQLVG-LSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~-l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      +|++|.+. .+|+.|.. ++.+++|+|++|.|+ .+|.++..++.|+.|+++.|.|.. .|.-+..|.+|.+||..+|.+
T Consensus        59 ~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~-~p~vi~~L~~l~~Lds~~na~  135 (177)
T KOG4579|consen   59 SLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNA-EPRVIAPLIKLDMLDSPENAR  135 (177)
T ss_pred             ecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCcccc-chHHHHHHHhHHHhcCCCCcc
Confidence            58999999 88888875 569999999999999 899999999999999999999996 788888899999999999999


Q ss_pred             CCCChhhhcCcCCCceeeCCCCccccCC
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYNNFESML  107 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N~l~~~~  107 (502)
                      . .+|..+..-......++.+|.+.+--
T Consensus       136 ~-eid~dl~~s~~~al~~lgnepl~~~~  162 (177)
T KOG4579|consen  136 A-EIDVDLFYSSLPALIKLGNEPLGDET  162 (177)
T ss_pred             c-cCcHHHhccccHHHHHhcCCcccccC
Confidence            8 67766443333444566677665543

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.35  E-value=2.7e-07  Score=60.78  Aligned_cols=35  Identities=40%  Similarity=0.598  Sum_probs=13.9

Q ss_pred             CCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112           45 LEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus        45 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      |++|++++|+|+. +|+.|++|++|+.|++++|+|+
T Consensus         3 L~~L~l~~N~i~~-l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    3 LEELDLSNNQITD-LPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             -SEEEETSSS-SS-HGGHGTTCTTSSEEEETSSCCS
T ss_pred             ceEEEccCCCCcc-cCchHhCCCCCCEEEecCCCCC
Confidence            4444444444443 3333444444444444444443

...

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.33  E-value=8.3e-06  Score=74.12  Aligned_cols=155  Identities=18%  Similarity=0.150  Sum_probs=96.0

Q ss_pred             ccCHHHHHHhccCCCCCCc---ccccCCceEEEEEEcCCCeEEEEEEecccCcch------------------------h
Q 046112          194 YVSYRMLYNATKGFSSENL---IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA------------------------S  246 (502)
Q Consensus       194 ~~~~~~l~~~t~~~~~~~~---lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------------------------~  246 (502)
                      ..++..+....++..+.+.   |.+|--+.||+| ...++..+|||+++.....-                        .
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a-~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLA-ETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEee-ccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            3445555555555555444   455666789999 44678999999986432110                        0


Q ss_pred             HHHHHHHHHHhcCCCC--ccceeeecccccccCCCcceeEEeeeccCC-ChhhhccCCchhhhccCCCCCCCHHHHHHHH
Q 046112          247 KSFAVECEVTRNIRHR--NLVKVFTACSGVDFQGNDFKALVYEFMANG-SLEEWMHPITEEDKRHKAPGNLNSLKRLNIA  323 (502)
Q Consensus       247 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  323 (502)
                      ....+|..-|.++...  .+-+-+++         ....+||||+... .-.-.|.           ..++.......+.
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~---------~~nVLvMEfIg~~g~pAP~Lk-----------Dv~~e~~e~~~~~  172 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAF---------RNNVLVMEFIGDDGLPAPRLK-----------DVPLELEEAEGLY  172 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceee---------cCCeEEEEeccCCCCCCCCcc-----------cCCcCchhHHHHH
Confidence            1133455556555322  22222322         1457999999543 1111111           1122222566677


Q ss_pred             HHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceeccc
Q 046112          324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEA  372 (502)
Q Consensus       324 ~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~  372 (502)
                      .++.+.+.-|-.  ..++||+||+.-|||+. ++.+.|+|||.|....+
T Consensus       173 ~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         173 EDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             HHHHHHHHHHHH--hcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence            788888877761  48999999999999999 88999999999875543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.33  E-value=5.9e-06  Score=74.29  Aligned_cols=141  Identities=16%  Similarity=0.165  Sum_probs=87.6

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHH---------HHHHHHHhcCCC---Cccceeeecc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSF---------AVECEVTRNIRH---RNLVKVFTAC  271 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---~niv~l~~~~  271 (502)
                      ..+|...+++-......|.+-..  +|....+|..+.......+.|         .+++..+.+++.   .....++.++
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            45677777777766666666543  678888998765433222222         223333333322   2222222211


Q ss_pred             cccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCe
Q 046112          272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNI  351 (502)
Q Consensus       272 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NI  351 (502)
                      .-..+......+++|||++|..|.+...              ++.    .++..+++++.-+|   +.|++|+|..|.|+
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNF  166 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNF  166 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh--------------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcE
Confidence            1111222335678999999988876531              111    24556778899999   99999999999999


Q ss_pred             eeCCCCcEEEeeeccce
Q 046112          352 LLDDEMTAYVSDFGIAR  368 (502)
Q Consensus       352 ll~~~~~~kl~Dfg~a~  368 (502)
                      ++++++ +++.||+..+
T Consensus       167 lv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  167 LVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             EEECCc-EEEEECcccc
Confidence            998654 9999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.33  E-value=2.2e-07  Score=93.82  Aligned_cols=183  Identities=19%  Similarity=0.158  Sum_probs=130.0

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCc-cceeeecccccccCCCcceeEEeee
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRN-LVKVFTACSGVDFQGNDFKALVYEF  288 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~~~~lv~e~  288 (502)
                      .+-+++|+.+.+||.+.......+ .+.+..     ..+..-++++|.+++||| .++.++-     .+.++..++++++
T Consensus       247 fh~fvK~altknpKkRptaeklL~-h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d-----~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLED-----YDGEDYLWIPMRI  315 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhhee-ceeecc-----chhhHHHHHHHHHccCCCCccccccc-----CCcccccchhhhh
Confidence            345789999999998654443333 444432     244566899999999999 5554443     4556688899999


Q ss_pred             ccCC-ChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccc
Q 046112          289 MANG-SLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA  367 (502)
Q Consensus       289 ~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a  367 (502)
                      +..| +-.....         .....+...+...+...-.++++++|   +-.=+|+|    ||+..+ ...+..||+..
T Consensus       316 ~s~~rs~~~~~~---------~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~  378 (829)
T KOG0576|consen  316 CSTGRSSALEMT---------VSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVP  378 (829)
T ss_pred             hcCCccccccCC---------hhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCC
Confidence            9877 3222221         11223444455566777788999999   55457888    777665 68899999988


Q ss_pred             eecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCc
Q 046112          368 RFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD  423 (502)
Q Consensus       368 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~  423 (502)
                      ..+....   ......+|+.|+|||......+..+.|+|+.|+-..++.-|-+|-.
T Consensus       379 ~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  379 PQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            7665433   2234568999999999999999999999999998888888877743

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.31  E-value=1.9e-05  Score=70.49  Aligned_cols=105  Identities=19%  Similarity=0.196  Sum_probs=83.2

Q ss_pred             HHHHHHHhcCCC-CccceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHH
Q 046112          250 AVECEVTRNIRH-RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC  328 (502)
Q Consensus       250 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~  328 (502)
                      ..|.-+++.+++ +++.+++|+|.         .++|.||...+++......       ...-..-+|..|.+||.++++
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~-------l~~~~~~~w~~R~~iA~~lL~   70 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRP-------LSQFLQSPWEQRAKIALQLLE   70 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCccccccccc-------cccccccCHHHHHHHHHHHHH
Confidence            457788888876 69999999993         4689999987766432100       011233689999999999999


Q ss_pred             HHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceec
Q 046112          329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL  370 (502)
Q Consensus       329 ~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~  370 (502)
                      .+.++++.....+.-.|++++|+-+++++++|+.|...+...
T Consensus        71 ~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   71 LLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             HHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            999999765566899999999999999999999999877544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.30  E-value=5.9e-07  Score=59.14  Aligned_cols=41  Identities=37%  Similarity=0.601  Sum_probs=35.4

Q ss_pred             CCCCEEEccCcccCCCChhhhcCcCCCceeeCCCCccccCCc
Q 046112           67 RGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP  108 (502)
Q Consensus        67 ~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~  108 (502)
                      ++|+.|+|++|+|+ .+|+.+.+|++|+.|++++|+|+.+++
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~i~~   41 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISDISP   41 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSBEGG
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCCCcC
Confidence            57999999999999 688889999999999999999987654

...

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.24  E-value=1.5e-05  Score=73.75  Aligned_cols=146  Identities=16%  Similarity=0.199  Sum_probs=79.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCc--cceeeecccccccCCCcceeEEeee
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRN--LVKVFTACSGVDFQGNDFKALVYEF  288 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~  288 (502)
                      ..||+|..+.||+.    .+..+++|......  ......+|.++++.+..-.  +.+.++++     ...+...+|||+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~   75 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYEL   75 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeee
Confidence            57899999999984    24456788865422  2345788999988875332  34445442     122346789999


Q ss_pred             ccCCC-hhhhccCC-----------ch-hhhccC-CCCCCCHHHHHH-HHH----------HHHH-HHHHHHh-CCCCCc
Q 046112          289 MANGS-LEEWMHPI-----------TE-EDKRHK-APGNLNSLKRLN-IAI----------DVAC-VLKYLHL-DCQPPI  341 (502)
Q Consensus       289 ~~~gs-L~~~l~~~-----------~~-~~~~~~-~~~~l~~~~~~~-i~~----------~ia~-~l~~LH~-~~~~~i  341 (502)
                      ++|.+ +...+...           .. ....+. ............ +..          .+.. ...+|.. .....+
T Consensus        76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~  155 (226)
T TIGR02172        76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC  155 (226)
T ss_pred             cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence            98863 22222110           00 000000 000111111100 000          0011 1222221 123457


Q ss_pred             eeecCCCCCeeeCCCCcEEEeeeccce
Q 046112          342 AHCDLKPSNILLDDEMTAYVSDFGIAR  368 (502)
Q Consensus       342 ~H~dlk~~NIll~~~~~~kl~Dfg~a~  368 (502)
                      +|+|+.|.||++++++ +.|.||+.+.
T Consensus       156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       156 LHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             EecCCCCCcEEEcCCC-cEEEechhcC
Confidence            8999999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.21  E-value=6e-06  Score=84.58  Aligned_cols=144  Identities=19%  Similarity=0.239  Sum_probs=91.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccCc----------------------c--------h----------hHHHH
Q 046112          211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH----------------------D--------A----------SKSFA  250 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~--------~----------~~~~~  250 (502)
                      +.|+.++-|-||+|+. .+|+.||||+....-.                      .        .          +-++.
T Consensus       131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            6899999999999955 6699999999742110                      0        0          01133


Q ss_pred             HHHHHHhcC----CCCccceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHH
Q 046112          251 VECEVTRNI----RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV  326 (502)
Q Consensus       251 ~E~~~l~~l----~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  326 (502)
                      .|...+.++    +...-+.+-..|    ++......++|||++|-.+.+...-         .....+   +..++..+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~----we~t~~~VLtmE~i~Gi~i~d~~~l---------~~~g~d---~k~ia~~~  273 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVY----WEYTTRRVLTMEWIDGIKISDIAAL---------KSAGID---RKELAELL  273 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceee----hhccCCcEEEEEeeCCEecccHHHH---------HhcCCC---HHHHHHHH
Confidence            344444443    222222232222    3344578899999999888877421         113344   33444444


Q ss_pred             HHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecccc
Q 046112          327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA  373 (502)
Q Consensus       327 a~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  373 (502)
                      +++  |+-+-...+++|.|..|.||+++.++++.+.|||+...+.+.
T Consensus       274 ~~~--f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         274 VRA--FLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHH--HHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            433  222222578999999999999999999999999998876543

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.16  E-value=6.7e-07  Score=90.85  Aligned_cols=118  Identities=29%  Similarity=0.313  Sum_probs=82.1

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      |..|.|. .+-..+..+++|+.|+|.+|+|. .+...+..+++|++|+|++|+|+..  ..+..++.|+.|++++|.|+ 
T Consensus        79 l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~-  153 (414)
T KOG0531|consen   79 LRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLIS-  153 (414)
T ss_pred             cchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhhheeccCcch-
Confidence            3445555 33344677788888888888888 4444477788888888888888874  44667777888888888887 


Q ss_pred             CChhhhcCcCCCceeeCCCCccccCCcc-hhhcccccceeecCCc
Q 046112           82 EIPEFLAGFKFLQNLNLSYNNFESMLPI-EGIFKNASATSVFGNK  125 (502)
Q Consensus        82 ~~p~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~  125 (502)
                      .++ .+..+..|+.+++++|.++.+.+. ...+..+..+.+.+|.
T Consensus       154 ~~~-~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~  197 (414)
T KOG0531|consen  154 DIS-GLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNS  197 (414)
T ss_pred             hcc-CCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCc
Confidence            333 455578888888888888776663 2334455555555554

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.07  E-value=3.7e-07  Score=88.00  Aligned_cols=116  Identities=22%  Similarity=0.147  Sum_probs=78.7

Q ss_pred             ccCCCCCCCEEeccCCcCCCcCC--ccCCCCCCCCEEECcCCccCCCCCCCc-CCCCCCCEEEccCcccCCC-ChhhhcC
Q 046112           14 QLVGLSSLSIFNVSGNLLSGAIS--NNFGSCTSLEQLDMHGNLFAGPIGSSL-SSLRGLRVLDLSQNNLSDE-IPEFLAG   89 (502)
Q Consensus        14 ~~~~l~~L~~l~l~~N~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~-~p~~~~~   89 (502)
                      -...|++++.||||+|-|....|  .-...|++|+.|+|+.|++.....+.. ..+++|+.|.|+.+.|+.. +-..+..
T Consensus       141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~  220 (505)
T KOG3207|consen  141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLT  220 (505)
T ss_pred             hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHh
Confidence            35568889999999998885443  235678999999999998875332222 2457888888888888732 2234456


Q ss_pred             cCCCceeeCCCCc-cccCCcchhhcccccceeecCCccccC
Q 046112           90 FKFLQNLNLSYNN-FESMLPIEGIFKNASATSVFGNKKLCG  129 (502)
Q Consensus        90 ~~~L~~l~l~~N~-l~~~~~~~~~~~~~~~~~~~~n~~l~g  129 (502)
                      +|+|+.|+|..|. +.-.......+..+..|++++|+.+..
T Consensus       221 fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~  261 (505)
T KOG3207|consen  221 FPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDF  261 (505)
T ss_pred             CCcHHHhhhhcccccceecchhhhhhHHhhccccCCccccc
Confidence            7888888888884 322233345566777888888876543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	502
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-33
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-31
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-24
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-23
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-22
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-22
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-21
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		8e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		9e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-09
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		7e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		9e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-07
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-07
3soa_A	444	Full-Length Human Camkii Length = 444		8e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		9e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-06
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-06
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-06
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-06
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		8e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-05
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-05
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-05
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-05
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-05
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-05
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-05
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-05
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-05
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-05
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-05
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-05
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-05
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-05
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-05
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-05
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-05
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-05
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-05
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		5e-05
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-05
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-04
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-04
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-04
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-04
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-04
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-04
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-04
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-04
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		5e-04
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		5e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 97/295 (32%), Positives = 141/295 (47%), Gaps = 16/295 (5%)
Query: 196 SYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV 255
           S R L  A+  FS++N++G G FG VYKG L + T     ++           F  E E+
Sbjct: 29  SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEM 88
Query: 256 TRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLN 315
                HRNL+++   C          + LVY +MANGS+   +       +R ++   L+
Sbjct: 89  ISMAVHRNLLRLRGFC-----MTPTERLLVYPYMANGSVASCLR------ERPESQPPLD 137
Query: 316 SLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE 375
             KR  IA+  A  L YLH  C P I H D+K +NILLD+E  A V DFG+A+ ++  D 
Sbjct: 138 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX 197
Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMF---KDNLNL 432
                 V GT G+IAPEY    + S   DV+ +G++LLE+ TG R  D       D++ L
Sbjct: 198 HV-XXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 256
Query: 433 RNCVKSALPERAEEIRASSGSTQRXXXXXXXXXXXXXGVACSAEQPGERMKINDV 487
            + VK  L E+  E        Q               + C+   P ER K+++V
Sbjct: 257 LDWVKGLLKEKKLEALVDV-DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 310

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  132 bits (331), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 94/295 (31%), Positives = 138/295 (46%), Gaps = 16/295 (5%)
Query: 196 SYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV 255
           S R L  A+  F ++N++G G FG VYKG L +       ++           F  E E+
Sbjct: 21  SLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 256 TRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLN 315
                HRNL+++   C          + LVY +MANGS+   +       +R ++   L+
Sbjct: 81  ISMAVHRNLLRLRGFC-----MTPTERLLVYPYMANGSVASCLR------ERPESQPPLD 129
Query: 316 SLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE 375
             KR  IA+  A  L YLH  C P I H D+K +NILLD+E  A V DFG+A+ ++  D 
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX 189
Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMF---KDNLNL 432
                 V G  G+IAPEY    + S   DV+ +G++LLE+ TG R  D       D++ L
Sbjct: 190 HV-XXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 433 RNCVKSALPERAEEIRASSGSTQRXXXXXXXXXXXXXGVACSAEQPGERMKINDV 487
            + VK  L E+  E        Q               + C+   P ER K+++V
Sbjct: 249 LDWVKGLLKEKKLEALVDV-DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 81/241 (33%), Positives = 118/241 (48%), Gaps = 24/241 (9%)
Query: 192 FPYVSYRMLYNATKGFSSE------NLIGAGNFGSVYKGILFESTTAVA--VKVFNVLHH 243
           F   S+  L N T  F         N +G G FG VYKG +  +T AV     + ++   
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 71
Query: 244 DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITE 303
           +  + F  E +V    +H NLV++     G    G+D   LVY +M NGSL + +  +  
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVYVYMPNGSLLDRLSCL-- 124
Query: 304 EDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD 363
                     L+   R  IA   A  + +LH +      H D+K +NILLD+  TA +SD
Sbjct: 125 -----DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISD 176
Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD 423
           FG+AR  E   +      + GTT Y+APE   G E++   D+YSFG++LLE+ TGL   D
Sbjct: 177 FGLARASEKFAQTVMXXRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 424 D 424
           +
Sbjct: 236 E 236

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/241 (33%), Positives = 118/241 (48%), Gaps = 24/241 (9%)
Query: 192 FPYVSYRMLYNATKGFSSE------NLIGAGNFGSVYKGILFESTTAVA--VKVFNVLHH 243
           F   S+  L N T  F         N +G G FG VYKG +  +T AV     + ++   
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 65
Query: 244 DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITE 303
           +  + F  E +V    +H NLV++     G    G+D   LVY +M NGSL + +  +  
Sbjct: 66  ELKQQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVYVYMPNGSLLDRLSCL-- 118
Query: 304 EDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD 363
                     L+   R  IA   A  + +LH +      H D+K +NILLD+  TA +SD
Sbjct: 119 -----DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISD 170
Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD 423
           FG+AR  E   +      + GTT Y+APE   G E++   D+YSFG++LLE+ TGL   D
Sbjct: 171 FGLARASEKFAQXVMXXRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD 229
Query: 424 D 424
           +
Sbjct: 230 E 230

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/241 (33%), Positives = 118/241 (48%), Gaps = 24/241 (9%)
Query: 192 FPYVSYRMLYNATKGFSSE------NLIGAGNFGSVYKGILFESTTAVA--VKVFNVLHH 243
           F   S+  L N T  F         N +G G FG VYKG +  +T AV     + ++   
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 71
Query: 244 DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITE 303
           +  + F  E +V    +H NLV++     G    G+D   LVY +M NGSL + +  +  
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVYVYMPNGSLLDRLSCL-- 124
Query: 304 EDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD 363
                     L+   R  IA   A  + +LH +      H D+K +NILLD+  TA +SD
Sbjct: 125 -----DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISD 176
Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD 423
           FG+AR  E   +      + GTT Y+APE   G E++   D+YSFG++LLE+ TGL   D
Sbjct: 177 FGLARASEKFAQTVMXSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 424 D 424
           +
Sbjct: 236 E 236

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 15/209 (7%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IGAG+FG+V++     S  AV + +    H +    F  E  + + +RH N+V    A +
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
               Q  +  ++V E+++ GSL   +H       +  A   L+  +RL++A DVA  + Y
Sbjct: 105 ----QPPNL-SIVTEYLSRGSLYRLLH-------KSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           LH +  PPI H DLK  N+L+D + T  V DFG++R    A     S    GT  ++APE
Sbjct: 153 LH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPE 209
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
                  +   DVYSFG++L E+ T  +P
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/241 (33%), Positives = 115/241 (47%), Gaps = 24/241 (9%)
Query: 192 FPYVSYRMLYNATKGFSSE------NLIGAGNFGSVYKGILFESTTAVA--VKVFNVLHH 243
           F   S+  L N T  F         N  G G FG VYKG +  +T AV     + ++   
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 62
Query: 244 DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITE 303
           +  + F  E +V    +H NLV++     G    G+D   LVY +  NGSL + +  +  
Sbjct: 63  ELKQQFDQEIKVXAKCQHENLVELL----GFSSDGDDL-CLVYVYXPNGSLLDRLSCL-- 115
Query: 304 EDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD 363
                     L+   R  IA   A  + +LH +      H D+K +NILLD+  TA +SD
Sbjct: 116 -----DGTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISD 167
Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD 423
           FG+AR  E   +      + GTT Y APE   G E++   D+YSFG++LLE+ TGL   D
Sbjct: 168 FGLARASEKFAQXVXXSRIVGTTAYXAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD 226
Query: 424 D 424
           +
Sbjct: 227 E 227

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 15/209 (7%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IGAG+FG+V++     S  AV + +    H +    F  E  + + +RH N+V    A +
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
               Q  +  ++V E+++ GSL   +H       +  A   L+  +RL++A DVA  + Y
Sbjct: 105 ----QPPNL-SIVTEYLSRGSLYRLLH-------KSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           LH +  PPI H +LK  N+L+D + T  V DFG++R   +    ++S    GT  ++APE
Sbjct: 153 LH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEWMAPE 209
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
                  +   DVYSFG++L E+ T  +P
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/233 (34%), Positives = 114/233 (48%), Gaps = 29/233 (12%)
Query: 193 PYVSYRM----LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS 248
           P+ SYR+    L  AT  F  + LIG G FG VYKG+L +    VA+K          + 
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK-VALKRRTPESSQGIEE 81
Query: 249 FAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRH 308
           F  E E     RH +LV +   C     + N+   L+Y++M NG+L           KRH
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCD----ERNEM-ILIYKYMENGNL-----------KRH 125
Query: 309 KAPGNLNSL-----KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD 363
               +L ++     +RL I I  A  L YLH      I H D+K  NILLD+     ++D
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITD 182
Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMF 416
           FGI++     D+      V+GT GYI PEY +   ++   DVYSFG++L E+ 
Sbjct: 183 FGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/233 (34%), Positives = 113/233 (48%), Gaps = 29/233 (12%)
Query: 193 PYVSYRM----LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS 248
           P+ SYR+    L  AT  F  + LIG G FG VYKG+L +    VA+K          + 
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK-VALKRRTPESSQGIEE 81
Query: 249 FAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRH 308
           F  E E     RH +LV +   C     + N+   L+Y++M NG+L           KRH
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCD----ERNEM-ILIYKYMENGNL-----------KRH 125
Query: 309 KAPGNLNSL-----KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD 363
               +L ++     +RL I I  A  L YLH      I H D+K  NILLD+     ++D
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITD 182
Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMF 416
           FGI++      +      V+GT GYI PEY +   ++   DVYSFG++L E+ 
Sbjct: 183 FGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 28/223 (12%)
Query: 208 SSENLIGAGNFGSVYKGILFEST----TAVAVKVFNVLHHDASK-SFAVECEVTRNIRHR 262
           + + +IGAG FG VYKG+L  S+      VA+K     + +  +  F  E  +     H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 263 NLVKVFTACSGVDFQGNDFKAL--VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           N++++    S        +K +  + E+M NG+L++++    E+D      G  + L+ +
Sbjct: 107 NIIRLEGVIS-------KYKPMMIITEYMENGALDKFLR---EKD------GEFSVLQLV 150
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            +   +A  +KYL         H DL   NIL++  +   VSDFG++R LE   E T + 
Sbjct: 151 GMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 381 -GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
            G +    + APE     + +S  DV+SFGI++ E+ T G RP
Sbjct: 208 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 16  LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    E  K  + P      + +++A  +A  + Y
Sbjct: 74  ------EEPIXIVTEYMSKGSLLDFLK--GETGKYLRLP------QLVDMAAQIASGMAY 119
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 120 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPE 175
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 176 AALYGRFTIKSDVWSFGILLTELTTKGR 203

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 115/243 (47%), Gaps = 25/243 (10%)
Query: 187 TPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILF-ESTTA---VAVKVFN-VL 241
           TPS + P  +   +   T+      ++G+G FG+VYKGI   E  T    VA+K+ N   
Sbjct: 21  TPSGTAPNQAQLRILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT 79
Query: 242 HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPI 301
              A+  F  E  +  ++ H +LV++   C     Q      LV + M +G L E++H  
Sbjct: 80  GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVH-- 131
Query: 302 TEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
                 HK   N+ S   LN  + +A  + YL    +  + H DL   N+L+       +
Sbjct: 132 -----EHK--DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKI 181
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLR 420
           +DFG+AR LE  +++  + G +    ++A E     + +   DV+S+G+ + E+ T G +
Sbjct: 182 TDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGK 241
Query: 421 PSD 423
           P D
Sbjct: 242 PYD 244

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + IRH  LV+++   S
Sbjct: 26  LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    E  K  + P      + +++A  +A  + Y
Sbjct: 84  ------EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLP------QLVDMAAQIASGMAY 129
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 185
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 275 LGQGCFGEVWMGT-WNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    E  K  + P      + +++A  +A  + Y
Sbjct: 333 ------EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLP------QLVDMAAQIASGMAY 378
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 379 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 434
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGR 462

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 26  LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    E  K  + P      + +++A  +A  + Y
Sbjct: 84  ------EEPIYIVIEYMSKGSLLDFLK--GEMGKYLRLP------QLVDMAAQIASGMAY 129
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPE 185
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 101/217 (46%), Gaps = 32/217 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           IG+G+FG+VYKG   +    VAVK+ NV      +  +F  E  V R  RH N++     
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL---- 73
Query: 271 CSGVDFQGNDFK---ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                F G   K   A+V ++    SL   +H I  +            +K ++IA   A
Sbjct: 74  -----FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTA 119
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YLH      I H DLK +NI L +++T  + DFG+A          +   + G+  
Sbjct: 120 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 388 YIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRP 421
           ++APE     + + Y    DVY+FGI+L E+ TG  P
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 101/217 (46%), Gaps = 32/217 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           IG+G+FG+VYKG   +    VAVK+ NV      +  +F  E  V R  RH N++     
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL---- 96
Query: 271 CSGVDFQGNDFK---ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                F G   K   A+V ++    SL   +H I  +            +K ++IA   A
Sbjct: 97  -----FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTA 142
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YLH      I H DLK +NI L +++T  + DFG+A          +   + G+  
Sbjct: 143 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 199
Query: 388 YIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRP 421
           ++APE     + + Y    DVY+FGI+L E+ TG  P
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 19  LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    E  K  + P      + +++A  +A  + Y
Sbjct: 77  ------EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLP------QLVDMAAQIASGMAY 122
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 123 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 178
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGR 206

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 192 LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    E  K  + P      + +++A  +A  + Y
Sbjct: 250 ------EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLP------QLVDMAAQIASGMAY 295
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 296 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 351
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 101/217 (46%), Gaps = 32/217 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           IG+G+FG+VYKG   +    VAVK+ NV      +  +F  E  V R  RH N++     
Sbjct: 43  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL---- 95
Query: 271 CSGVDFQGNDFK---ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                F G   K   A+V ++    SL   +H I  +            +K ++IA   A
Sbjct: 96  -----FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTA 141
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YLH      I H DLK +NI L +++T  + DFG+A          +   + G+  
Sbjct: 142 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 198
Query: 388 YIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRP 421
           ++APE     + + Y    DVY+FGI+L E+ TG  P
Sbjct: 199 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 101/217 (46%), Gaps = 32/217 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           IG+G+FG+VYKG   +    VAVK+ NV      +  +F  E  V R  RH N++     
Sbjct: 18  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL---- 70
Query: 271 CSGVDFQGNDFK---ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                F G   K   A+V ++    SL   +H I  +            +K ++IA   A
Sbjct: 71  -----FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTA 116
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YLH      I H DLK +NI L +++T  + DFG+A          +   + G+  
Sbjct: 117 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 173
Query: 388 YIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRP 421
           ++APE     + + Y    DVY+FGI+L E+ TG  P
Sbjct: 174 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 26  LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    E  K  + P      + +++A  +A  + Y
Sbjct: 84  ------EEPIYIVIEYMSKGSLLDFLK--GEMGKYLRLP------QLVDMAAQIASGMAY 129
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 185
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 192 LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    E  K  + P      + +++A  +A  + Y
Sbjct: 250 ------EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLP------QLVDMAAQIASGMAY 295
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 296 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 351
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           IG+G+FG+VYKG   +    VAVK+ NV      +  +F  E  V R  RH N++     
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
            +          A+V ++    SL   +H I  +            +K ++IA   A  +
Sbjct: 73  STAPQL------AIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTAQGM 117
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
            YLH      I H DLK +NI L +++T  + DFG+A          +   + G+  ++A
Sbjct: 118 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 391 PEYGMGHEVSSY---GDVYSFGILLLEMFTGLRP 421
           PE     + + Y    DVY+FGI+L E+ TG  P
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 101/217 (46%), Gaps = 32/217 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           IG+G+FG+VYKG   +    VAVK+ NV      +  +F  E  V R  RH N++     
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL---- 73
Query: 271 CSGVDFQGNDFK---ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                F G   K   A+V ++    SL   +H I  +            +K ++IA   A
Sbjct: 74  -----FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTA 119
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YLH      I H DLK +NI L +++T  + DFG+A          +   + G+  
Sbjct: 120 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 388 YIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRP 421
           ++APE     + + Y    DVY+FGI+L E+ TG  P
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 101/217 (46%), Gaps = 32/217 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           IG+G+FG+VYKG   +    VAVK+ NV      +  +F  E  V R  RH N++     
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL---- 68
Query: 271 CSGVDFQGNDFK---ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                F G   K   A+V ++    SL   +H I  +            +K ++IA   A
Sbjct: 69  -----FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTA 114
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YLH      I H DLK +NI L +++T  + DFG+A          +   + G+  
Sbjct: 115 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 388 YIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRP 421
           ++APE     + + Y    DVY+FGI+L E+ TG  P
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 105/223 (47%), Gaps = 44/223 (19%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           IG+G+FG+VYKG   +    VAVK+ NV      +  +F  E  V R  RH N++     
Sbjct: 36  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL---- 88
Query: 271 CSGVDFQGNDFK---ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                F G   K   A+V ++    SL   +H I  +            +K ++IA   A
Sbjct: 89  -----FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTA 134
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG------ 381
             + YLH      I H DLK +NI L +++T  + DFG+      A E++R  G      
Sbjct: 135 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGL------ATEKSRWSGSHQFEQ 185
Query: 382 VEGTTGYIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRP 421
           + G+  ++APE     + + Y    DVY+FGI+L E+ TG  P
Sbjct: 186 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 15  LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    E  K  + P      + +++A  +A  + Y
Sbjct: 73  ------EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLP------QLVDMAAQIASGMAY 118
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 119 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 174
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 175 AALYGRFTIKSDVWSFGILLTELTTKGR 202

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 105/223 (47%), Gaps = 44/223 (19%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           IG+G+FG+VYKG   +    VAVK+ NV      +  +F  E  V R  RH N++     
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL---- 96
Query: 271 CSGVDFQGNDFK---ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                F G   K   A+V ++    SL   +H I  +            +K ++IA   A
Sbjct: 97  -----FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTA 142
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG------ 381
             + YLH      I H DLK +NI L +++T  + DFG+      A E++R  G      
Sbjct: 143 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGL------ATEKSRWSGSHQFEQ 193
Query: 382 VEGTTGYIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRP 421
           + G+  ++APE     + + Y    DVY+FGI+L E+ TG  P
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 26  LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    E  K  + P      + +++A  +A  + Y
Sbjct: 84  ------EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLP------QLVDMAAQIASGMAY 129
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 185
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 17  LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    E  K  + P      + +++A  +A  + Y
Sbjct: 75  ------EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLP------QLVDMAAQIASGMAY 120
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 121 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 176
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGR 204

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 105/223 (47%), Gaps = 44/223 (19%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           IG+G+FG+VYKG   +    VAVK+ NV      +  +F  E  V R  RH N++     
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL---- 68
Query: 271 CSGVDFQGNDFK---ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                F G   K   A+V ++    SL   +H I  +            +K ++IA   A
Sbjct: 69  -----FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTA 114
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG------ 381
             + YLH      I H DLK +NI L +++T  + DFG+      A E++R  G      
Sbjct: 115 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGL------ATEKSRWSGSHQFEQ 165
Query: 382 VEGTTGYIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRP 421
           + G+  ++APE     + + Y    DVY+FGI+L E+ TG  P
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 26/208 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS---FAVECEVTRNIRHRNLVKVFT 269
           +G G FG V  G  +     VA+K+      + S S   F  E +V  N+ H  LV+++ 
Sbjct: 32  LGTGQFGVVKYG-KWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C+    Q   F  ++ E+MANG L  ++  +     RH+      + + L +  DV   
Sbjct: 87  VCTK---QRPIF--IITEYMANGCLLNYLREM-----RHR----FQTQQLLEMCKDVCEA 132
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           ++YL         H DL   N L++D+    VSDFG++R++   DE+T S+G +    + 
Sbjct: 133 MEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEETSSVGSKFPVRWS 188
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFT 417
            PE  M  + SS  D+++FG+L+ E+++
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 211 NLIGAGNFGSVYKGILF-ESTTA---VAVKVFN-VLHHDASKSFAVECEVTRNIRHRNLV 265
            ++G+G FG+VYKGI   E  T    VA+K+ N      A+  F  E  +  ++ H +LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           ++   C     Q      LV + M +G L E++H        HK   N+ S   LN  + 
Sbjct: 81  RLLGVCLSPTIQ------LVTQLMPHGCLLEYVH-------EHK--DNIGSQLLLNWCVQ 125
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +A  + YL    +  + H DL   N+L+       ++DFG+AR LE  +++  + G +  
Sbjct: 126 IAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 182
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
             ++A E     + +   DV+S+G+ + E+ T G +P D
Sbjct: 183 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 192 LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    E  K  + P      + +++A  +A  + Y
Sbjct: 250 ------EEPIYIVGEYMSKGSLLDFLK--GETGKYLRLP------QLVDMAAQIASGMAY 295
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 296 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 351
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 26  LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    E  K  + P      + +++A  +A  + Y
Sbjct: 84  ------EEPIYIVCEYMSKGSLLDFLK--GEMGKYLRLP------QLVDMAAQIASGMAY 129
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 185
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K      + + ++F  E +V + +RH  LV+++   S
Sbjct: 193 LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    E  K  + P      + +++A  +A  + Y
Sbjct: 251 ------EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLP------QLVDMAAQIASGMAY 296
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+ R +E  +E T   G +    + APE
Sbjct: 297 VE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIE-DNEYTARQGAKFPIKWTAPE 352
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 353 AALYGRFTIKSDVWSFGILLTELTTKGR 380

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 23  LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M  GSL +++    E  K  + P      + ++++  +A  + Y
Sbjct: 81  ------EEPIYIVTEYMNKGSLLDFLK--GETGKYLRLP------QLVDMSAQIASGMAY 126
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 127 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEWTARQGAKFPIKWTAPE 182
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 26  LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ GSL +++    E  K  + P      + +++A  +A  + Y
Sbjct: 84  ------EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLP------QLVDMAAQIASGMAY 129
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL  +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 130 VE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 185
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS---FAVECEVTRNIRHRNLVKVFT 269
           +G G FG V  G  +     VA+K+      + S S   F  E +V  N+ H  LV+++ 
Sbjct: 32  LGTGQFGVVKYG-KWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C+    Q   F  ++ E+MANG L  ++  +     RH+      + + L +  DV   
Sbjct: 87  VCTK---QRPIF--IITEYMANGCLLNYLREM-----RHR----FQTQQLLEMCKDVCEA 132
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           ++YL         H DL   N L++D+    VSDFG++R++   DE T S+G +    + 
Sbjct: 133 MEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWS 188
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFT 417
            PE  M  + SS  D+++FG+L+ E+++
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS---FAVECEVTRNIRHRNLVKVFT 269
           +G G FG V  G  +     VA+K+      + S S   F  E +V  N+ H  LV+++ 
Sbjct: 12  LGTGQFGVVKYG-KWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C+    Q   F  ++ E+MANG L  ++  +     RH+      + + L +  DV   
Sbjct: 67  VCTK---QRPIF--IITEYMANGCLLNYLREM-----RHR----FQTQQLLEMCKDVCEA 112
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           ++YL         H DL   N L++D+    VSDFG++R++   DE T S+G +    + 
Sbjct: 113 MEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWS 168
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFT 417
            PE  M  + SS  D+++FG+L+ E+++
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS---FAVECEVTRNIRHRNLVKVFT 269
           +G G FG V  G  +     VA+K+      + S S   F  E +V  N+ H  LV+++ 
Sbjct: 16  LGTGQFGVVKYG-KWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C+    Q   F  ++ E+MANG L  ++  +     RH+      + + L +  DV   
Sbjct: 71  VCTK---QRPIF--IITEYMANGCLLNYLREM-----RHR----FQTQQLLEMCKDVCEA 116
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           ++YL         H DL   N L++D+    VSDFG++R++   DE T S+G +    + 
Sbjct: 117 MEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWS 172
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFT 417
            PE  M  + SS  D+++FG+L+ E+++
Sbjct: 173 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 26  LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ G L +++    E  K  + P      + +++A  +A  + Y
Sbjct: 84  ------EEPIYIVMEYMSKGCLLDFLK--GEMGKYLRLP------QLVDMAAQIASGMAY 129
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 185
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       +  + F  E E+ ++++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C      G     L+ EF+  GSL E++       ++HK    ++ +K L     +  
Sbjct: 81  GVCYSA---GRRNLKLIMEFLPYGSLREYL-------QKHKE--RIDHIKLLQYTSQICK 128
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG- 387
            ++YL         H DL   NIL+++E    + DFG+ + L   D++   +   G +  
Sbjct: 129 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPI 184
Query: 388 -YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
            + APE     + S   DV+SFG++L E+FT +  S
Sbjct: 185 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 220

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS---FAVECEVTRNIRHRNLVKVFT 269
           +G G FG V  G  +     VA+K+      + S S   F  E +V  N+ H  LV+++ 
Sbjct: 17  LGTGQFGVVKYG-KWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C+    Q   F  ++ E+MANG L  ++  +     RH+      + + L +  DV   
Sbjct: 72  VCTK---QRPIF--IITEYMANGCLLNYLREM-----RHR----FQTQQLLEMCKDVCEA 117
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           ++YL         H DL   N L++D+    VSDFG++R++   DE T S+G +    + 
Sbjct: 118 MEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWS 173
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFT 417
            PE  M  + SS  D+++FG+L+ E+++
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS---FAVECEVTRNIRHRNLVKVFT 269
           +G G FG V  G  +     VA+K+      + S S   F  E +V  N+ H  LV+++ 
Sbjct: 23  LGTGQFGVVKYG-KWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 77
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C+    Q   F  ++ E+MANG L  ++  +     RH+      + + L +  DV   
Sbjct: 78  VCTK---QRPIF--IITEYMANGCLLNYLREM-----RHR----FQTQQLLEMCKDVCEA 123
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           ++YL         H DL   N L++D+    VSDFG++R++   DE T S+G +    + 
Sbjct: 124 MEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWS 179
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFT 417
            PE  M  + SS  D+++FG+L+ E+++
Sbjct: 180 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        +N++  L +A  ++  +
Sbjct: 79  CT----REPPFYIII-EFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAM 125
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 126 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 181
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 182 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 213

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 26  LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M+ G L +++    E  K  + P      + +++A  +A  + Y
Sbjct: 84  ------EEPIYIVTEYMSKGCLLDFLK--GEMGKYLRLP------QLVDMAAQIASGMAY 129
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 185
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +  TT VA+K        + ++F  E +V + +RH  LV+++   S
Sbjct: 23  LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M  GSL +++    E  K  + P      + ++++  +A  + Y
Sbjct: 81  ------EEPIYIVTEYMNKGSLLDFLK--GETGKYLRLP------QLVDMSAQIASGMAY 126
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    + APE
Sbjct: 127 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 182
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        +N++  L +A  ++  +
Sbjct: 83  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAM 129
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 130 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 185
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        +N++  L +A  ++  +
Sbjct: 83  CT----REPPFYIII-EFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAM 129
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 130 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 185
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        +N++  L +A  ++  +
Sbjct: 79  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAM 125
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 126 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTA 181
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 182 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 213

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        +N++  L +A  ++  +
Sbjct: 91  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAM 137
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 138 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 193
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 194 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 225

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 33/227 (14%)
Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLV 265
           E +IGAG FG V  G L    +   AVA+K   V + +  +  F  E  +     H N+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
            +     GV  +G     +V EFM NG+L+ ++          K  G    ++ + +   
Sbjct: 108 HL----EGVVTRGKPV-MIVIEFMENGALDAFLR---------KHDGQFTVIQLVGMLRG 153
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +A  ++YL         H DL   NIL++  +   VSDFG++R +E   E      V  T
Sbjct: 154 IAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPE-----AVYTT 205
Query: 386 TG------YIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
           TG      + APE     + +S  DV+S+GI++ E+ + G RP  DM
Sbjct: 206 TGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 252

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        +N++  L +A  ++  +
Sbjct: 83  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAM 129
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 130 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 185
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        +N++  L +A  ++  +
Sbjct: 83  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAM 129
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 130 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 185
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        +N++  L +A  ++  +
Sbjct: 80  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAM 126
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 127 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTA 182
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        +N++  L +A  ++  +
Sbjct: 80  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAM 126
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 127 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 182
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        +N++  L +A  ++  +
Sbjct: 78  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAM 124
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 180
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        +N++  L +A  ++  +
Sbjct: 78  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAM 124
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 180
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        +N++  L +A  ++  +
Sbjct: 82  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAM 128
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 129 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 184
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        +N++  L +A  ++  +
Sbjct: 80  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAM 126
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 127 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 182
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G FG VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        ++++  L +A  ++  +
Sbjct: 76  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAM 122
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 123 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 178
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +GAG FG V+ G  +   T VAVK      +  DA   F  E  + + ++H+ LV+++  
Sbjct: 27  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAV 82
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG--NLNSLKRLNIAIDVAC 328
            +       +   ++ E+M NGSL +++          K P    L   K L++A  +A 
Sbjct: 83  VT------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAE 126
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            + ++    +    H DL+ +NIL+ D ++  ++DFG+AR +E  +E T   G +    +
Sbjct: 127 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKW 182
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            APE       +   DV+SFGILL E+ T
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +GAG FG V+ G  +   T VAVK      +  DA   F  E  + + ++H+ LV+++  
Sbjct: 29  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAV 84
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG--NLNSLKRLNIAIDVAC 328
            +       +   ++ E+M NGSL +++          K P    L   K L++A  +A 
Sbjct: 85  VT------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAE 128
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            + ++    +    H DL+ +NIL+ D ++  ++DFG+AR +E  +E T   G +    +
Sbjct: 129 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKW 184
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            APE       +   DV+SFGILL E+ T
Sbjct: 185 TAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +GAG FG V+ G  +   T VAVK      +  DA   F  E  + + ++H+ LV+++  
Sbjct: 30  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAV 85
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG--NLNSLKRLNIAIDVAC 328
            +       +   ++ E+M NGSL +++          K P    L   K L++A  +A 
Sbjct: 86  VT------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAE 129
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            + ++    +    H DL+ +NIL+ D ++  ++DFG+AR +E  +E T   G +    +
Sbjct: 130 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKW 185
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            APE       +   DV+SFGILL E+ T
Sbjct: 186 TAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +GAG FG V+ G  +   T VAVK      +  DA   F  E  + + ++H+ LV+++  
Sbjct: 21  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAV 76
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG--NLNSLKRLNIAIDVAC 328
            +       +   ++ E+M NGSL +++          K P    L   K L++A  +A 
Sbjct: 77  VT------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAE 120
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            + ++    +    H DL+ +NIL+ D ++  ++DFG+AR +E  +E T   G +    +
Sbjct: 121 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKW 176
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            APE       +   DV+SFGILL E+ T
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V+ G  +   T VA+K        + +SF  E ++ + ++H  LV+++   S
Sbjct: 17  LGNGQFGEVWMGT-WNGNTKVAIKTLKP-GTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   +V E+M  GSL +++     E +  K P NL     +++A  VA  + Y
Sbjct: 75  ------EEPIYIVTEYMNKGSLLDFLK--DGEGRALKLP-NL-----VDMAAQVAAGMAY 120
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +NIL+ + +   ++DFG+AR +E  +E T   G +    + APE
Sbjct: 121 IE---RMNYIHRDLRSANILVGNGLICKIADFGLARLIE-DNEXTARQGAKFPIKWTAPE 176
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLR 420
             +    +   DV+SFGILL E+ T  R
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELVTKGR 204

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +GAG FG V+ G  +   T VAVK      +  DA   F  E  + + ++H+ LV+++  
Sbjct: 23  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAV 78
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG--NLNSLKRLNIAIDVAC 328
            +       +   ++ E+M NGSL +++          K P    L   K L++A  +A 
Sbjct: 79  VT------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAE 122
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            + ++    +    H DL+ +NIL+ D ++  ++DFG+AR +E  +E T   G +    +
Sbjct: 123 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKW 178
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            APE       +   DV+SFGILL E+ T
Sbjct: 179 TAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +GAG FG V+ G  +   T VAVK      +  DA   F  E  + + ++H+ LV+++  
Sbjct: 22  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAV 77
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG--NLNSLKRLNIAIDVAC 328
            +       +   ++ E+M NGSL +++          K P    L   K L++A  +A 
Sbjct: 78  VT------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAE 121
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            + ++    +    H DL+ +NIL+ D ++  ++DFG+AR +E  +E T   G +    +
Sbjct: 122 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKW 177
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            APE       +   DV+SFGILL E+ T
Sbjct: 178 TAPEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +GAG FG V+ G  +   T VAVK      +  DA   F  E  + + ++H+ LV+++  
Sbjct: 27  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAV 82
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG--NLNSLKRLNIAIDVAC 328
            +       +   ++ E+M NGSL +++          K P    L   K L++A  +A 
Sbjct: 83  VT------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAE 126
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            + ++    +    H DL+ +NIL+ D ++  ++DFG+AR +E  +E T   G +    +
Sbjct: 127 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 182
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            APE       +   DV+SFGILL E+ T
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +GAG FG V+ G  +   T VAVK      +  DA   F  E  + + ++H+ LV+++  
Sbjct: 31  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAV 86
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG--NLNSLKRLNIAIDVAC 328
            +       +   ++ E+M NGSL +++          K P    L   K L++A  +A 
Sbjct: 87  VT------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAE 130
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            + ++    +    H DL+ +NIL+ D ++  ++DFG+AR +E  +E T   G +    +
Sbjct: 131 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 186
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLR 420
            APE       +   DV+SFGILL E+ T  R
Sbjct: 187 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +GAG FG V+ G  +   T VAVK      +  DA   F  E  + + ++H+ LV+++  
Sbjct: 21  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAV 76
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG--NLNSLKRLNIAIDVAC 328
            +       +   ++ E+M NGSL +++          K P    L   K L++A  +A 
Sbjct: 77  VT------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAE 120
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            + ++    +    H DL+ +NIL+ D ++  ++DFG+AR +E  +E T   G +    +
Sbjct: 121 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKW 176
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            APE       +   DV+SFGILL E+ T
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 116/244 (47%), Gaps = 27/244 (11%)
Query: 182 KRGNPTP-SISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV 240
           KR  PT   +S  Y  + M        + ++ +G G +G VY+G+  + +  VAVK    
Sbjct: 238 KRNKPTVYGVSPNYDKWEM---ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--- 291
Query: 241 LHHDA--SKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM 298
           L  D    + F  E  V + I+H NLV++   C+    +   F  ++ EFM  G+L +++
Sbjct: 292 LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYL 346
Query: 299 HPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT 358
                ++        +N++  L +A  ++  ++YL    +    H +L   N L+ +   
Sbjct: 347 RECNRQE--------VNAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHL 395
Query: 359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT- 417
             V+DFG++R +   D  T   G +    + APE    ++ S   DV++FG+LL E+ T 
Sbjct: 396 VKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 454
Query: 418 GLRP 421
           G+ P
Sbjct: 455 GMSP 458

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +GAG FG V+ G  +   T VAVK      +  DA   F  E  + + ++H+ LV+++  
Sbjct: 26  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAV 81
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG--NLNSLKRLNIAIDVAC 328
            +       +   ++ E+M NGSL +++          K P    L   K L++A  +A 
Sbjct: 82  VT------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAE 125
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            + ++    +    H DL+ +NIL+ D ++  ++DFG+AR +E  +E T   G +    +
Sbjct: 126 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 181
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            APE       +   DV+SFGILL E+ T
Sbjct: 182 TAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 115/244 (47%), Gaps = 40/244 (16%)
Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-------KSFAVECEVTRNIRHR 262
           E  IG G FG V+KG L +  + VA+K   +   +         + F  E  +  N+ H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N+VK++          ++   +V EF+  G L    H +   DK H    ++    +L +
Sbjct: 84  NIVKLYGLM-------HNPPRMVMEFVPCGDL---YHRLL--DKAHPIKWSV----KLRL 127
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLD--DE---MTAYVSDFGIARFLEAADEQT 377
            +D+A  ++Y+  +  PPI H DL+  NI L   DE   + A V+DFG+++      +  
Sbjct: 128 MLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------QSV 180
Query: 378 RSI-GVEGTTGYIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRPSDDMFKDNLNLR 433
            S+ G+ G   ++APE  +G E  SY    D YSF ++L  + TG  P D+     +   
Sbjct: 181 HSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 434 NCVK 437
           N ++
Sbjct: 240 NMIR 243

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS---FAVECEVTRNIRHRNLVKVFT 269
           +G G FG V  G  +     VA+K+      + S S   F  E +V  N+ H  LV+++ 
Sbjct: 17  LGTGQFGVVKYG-KWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C+    Q   F  ++ E+MANG L  ++  +     RH+      + + L +  DV   
Sbjct: 72  VCTK---QRPIF--IITEYMANGCLLNYLREM-----RHR----FQTQQLLEMCKDVCEA 117
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           ++YL         H DL   N L++D+    VSDFG++R++   DE T S G +    + 
Sbjct: 118 MEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSRGSKFPVRWS 173
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFT 417
            PE  M  + SS  D+++FG+L+ E+++
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       +  + F  E E+ ++++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C      G     L+ E++  GSL +++       ++HK    ++ +K L     +  
Sbjct: 78  GVCYSA---GRRNLKLIMEYLPYGSLRDYL-------QKHKE--RIDHIKLLQYTSQICK 125
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG- 387
            ++YL         H DL   NIL+++E    + DFG+ + L   D++   +   G +  
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPI 181
Query: 388 -YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
            + APE     + S   DV+SFG++L E+FT +  S
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       +  + F  E E+ ++++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C      G     L+ E++  GSL +++       ++HK    ++ +K L     +  
Sbjct: 81  GVCYSA---GRRNLKLIMEYLPYGSLRDYL-------QKHKE--RIDHIKLLQYTSQICK 128
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG- 387
            ++YL         H DL   NIL+++E    + DFG+ + L   D++   +   G +  
Sbjct: 129 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPI 184
Query: 388 -YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
            + APE     + S   DV+SFG++L E+FT +  S
Sbjct: 185 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 220

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       +  + F  E E+ ++++H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C      G     L+ E++  GSL +++       ++HK    ++ +K L     +  
Sbjct: 96  GVCYSA---GRRNLKLIMEYLPYGSLRDYL-------QKHKE--RIDHIKLLQYTSQICK 143
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG- 387
            ++YL         H DL   NIL+++E    + DFG+ + L   D++   +   G +  
Sbjct: 144 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPI 199
Query: 388 -YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
            + APE     + S   DV+SFG++L E+FT +  S
Sbjct: 200 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 235

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       +  + F  E E+ ++++H N+VK  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C      G     L+ E++  GSL +++       ++HK    ++ +K L     +  
Sbjct: 77  GVCYSA---GRRNLKLIMEYLPYGSLRDYL-------QKHKE--RIDHIKLLQYTSQICK 124
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG- 387
            ++YL         H DL   NIL+++E    + DFG+ + L   D++   +   G +  
Sbjct: 125 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPI 180
Query: 388 -YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
            + APE     + S   DV+SFG++L E+FT +  S
Sbjct: 181 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 216

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       +  + F  E E+ ++++H N+VK  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C      G     L+ E++  GSL +++       ++HK    ++ +K L     +  
Sbjct: 85  GVCYSA---GRRNLKLIMEYLPYGSLRDYL-------QKHKE--RIDHIKLLQYTSQICK 132
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG- 387
            ++YL         H DL   NIL+++E    + DFG+ + L   D++   +   G +  
Sbjct: 133 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPI 188
Query: 388 -YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
            + APE     + S   DV+SFG++L E+FT +  S
Sbjct: 189 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 224

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       +  + F  E E+ ++++H N+VK  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C      G     L+ E++  GSL +++       ++HK    ++ +K L     +  
Sbjct: 82  GVCYSA---GRRNLKLIMEYLPYGSLRDYL-------QKHKE--RIDHIKLLQYTSQICK 129
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG- 387
            ++YL         H DL   NIL+++E    + DFG+ + L   D++   +   G +  
Sbjct: 130 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPI 185
Query: 388 -YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
            + APE     + S   DV+SFG++L E+FT +  S
Sbjct: 186 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 221

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       +  + F  E E+ ++++H N+VK  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C      G     L+ E++  GSL +++       ++HK    ++ +K L     +  
Sbjct: 83  GVCYSA---GRRNLKLIMEYLPYGSLRDYL-------QKHKE--RIDHIKLLQYTSQICK 130
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG- 387
            ++YL         H DL   NIL+++E    + DFG+ + L   D++   +   G +  
Sbjct: 131 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPI 186
Query: 388 -YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
            + APE     + S   DV+SFG++L E+FT +  S
Sbjct: 187 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 222

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +GAG FG V+ G  +   T VAVK      +  DA   F  E  + + ++H+ LV+++  
Sbjct: 21  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAV 76
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG--NLNSLKRLNIAIDVAC 328
            +       +   ++ E+M NGSL +++          K P    L   K L++A  +A 
Sbjct: 77  VT------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAE 120
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            + ++    +    H DL+ +NIL+ D ++  ++DFG+AR +E  +E T   G +    +
Sbjct: 121 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 176
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            APE       +   DV+SFGILL E+ T
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       +  + F  E E+ ++++H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C      G     L+ E++  GSL +++       ++HK    ++ +K L     +  
Sbjct: 109 GVCYSA---GRRNLKLIMEYLPYGSLRDYL-------QKHKE--RIDHIKLLQYTSQICK 156
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG- 387
            ++YL         H DL   NIL+++E    + DFG+ + L   D++   +   G +  
Sbjct: 157 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPI 212
Query: 388 -YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
            + APE     + S   DV+SFG++L E+FT +  S
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 248

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        ++++  L +A  ++  +
Sbjct: 76  CT----REPPFYIII-EFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAM 122
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 123 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 178
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +GAG FG V+ G  +   T VAVK      +  DA   F  E  + + ++H+ LV+++  
Sbjct: 16  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAV 71
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG--NLNSLKRLNIAIDVAC 328
            +       +   ++ E+M NGSL +++          K P    L   K L++A  +A 
Sbjct: 72  VT------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAE 115
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            + ++    +    H DL+ +NIL+ D ++  ++DFG+AR +E  +E T   G +    +
Sbjct: 116 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 171
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            APE       +   DV+SFGILL E+ T
Sbjct: 172 TAPEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       +  + F  E E+ ++++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C      G     L+ E++  GSL +++       ++HK    ++ +K L     +  
Sbjct: 78  GVCYSA---GRRNLKLIMEYLPYGSLRDYL-------QKHKE--RIDHIKLLQYTSQICK 125
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG- 387
            ++YL         H DL   NIL+++E    + DFG+ + L   D++   +   G +  
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPI 181
Query: 388 -YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
            + APE     + S   DV+SFG++L E+FT +  S
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 217

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       +  + F  E E+ ++++H N+VK  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C      G     L+ E++  GSL +++       ++HK    ++ +K L     +  
Sbjct: 76  GVCYSA---GRRNLKLIMEYLPYGSLRDYL-------QKHKE--RIDHIKLLQYTSQICK 123
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG- 387
            ++YL         H DL   NIL+++E    + DFG+ + L   D++   +   G +  
Sbjct: 124 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPI 179
Query: 388 -YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
            + APE     + S   DV+SFG++L E+FT +  S
Sbjct: 180 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       +  + F  E E+ ++++H N+VK  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C      G     L+ E++  GSL +++       ++HK    ++ +K L     +  
Sbjct: 84  GVCYSA---GRRNLKLIMEYLPYGSLRDYL-------QKHKE--RIDHIKLLQYTSQICK 131
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG- 387
            ++YL         H DL   NIL+++E    + DFG+ + L   D++   +   G +  
Sbjct: 132 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPI 187
Query: 388 -YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
            + APE     + S   DV+SFG++L E+FT +  S
Sbjct: 188 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 223

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        ++++  L +A  ++  +
Sbjct: 78  CT----REPPFYIII-EFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAM 124
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 180
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        ++++  L +A  ++  +
Sbjct: 78  CT----REPPFYIII-EFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAM 124
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 180
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        ++++  L +A  ++  +
Sbjct: 83  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAM 129
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 130 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 185
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 32/217 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTA 270
           IG+G+FG+VYKG   +    VAVK+  V+    +  ++F  E  V R  RH N++ +F  
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL-LFMG 99
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                +   D  A+V ++    SL + +H   +E K           + ++IA   A  +
Sbjct: 100 -----YMTKDNLAIVTQWCEGSSLYKHLH--VQETK-------FQMFQLIDIARQTAQGM 145
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG--- 387
            YLH      I H D+K +NI L + +T  + DFG+A         + S  VE  TG   
Sbjct: 146 DYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLA---TVKSRWSGSQQVEQPTGSVL 199
Query: 388 YIAPEYGMGHE---VSSYGDVYSFGILLLEMFTGLRP 421
           ++APE     +    S   DVYS+GI+L E+ TG  P
Sbjct: 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       +  + F  E E+ ++++H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C      G     L+ E++  GSL +++       ++HK    ++ +K L     +  
Sbjct: 96  GVCYSA---GRRNLKLIMEYLPYGSLRDYL-------QKHKE--RIDHIKLLQYTSQICK 143
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG- 387
            ++YL         H DL   NIL+++E    + DFG+ + L   D++   +   G +  
Sbjct: 144 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPI 199
Query: 388 -YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
            + APE     + S   DV+SFG++L E+FT +  S
Sbjct: 200 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 235

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 102/223 (45%), Gaps = 44/223 (19%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           IG+G+FG+VYKG   +    VAVK+ NV      +  +F  E  V R  RH N++     
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL---- 84
Query: 271 CSGVDFQGNDFK---ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                F G   K   A+V ++    SL   +H          +       K ++IA   A
Sbjct: 85  -----FMGYSTKPQLAIVTQWCEGSSLYHHLHA---------SETKFEMKKLIDIARQTA 130
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG------ 381
             + YLH      I H DLK +NI L ++ T  + DFG+      A E++R  G      
Sbjct: 131 RGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGL------ATEKSRWSGSHQFEQ 181
Query: 382 VEGTTGYIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRP 421
           + G+  ++APE     + + Y    DVY+FGI+L E+ TG  P
Sbjct: 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 40/230 (17%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRN-------I 259
            + E +IG G FG VY+   F     VAVK      HD  +  +   E  R        +
Sbjct: 9   LTLEEIIGIGGFGKVYRA--FWIGDEVAVKA---ARHDPDEDISQTIENVRQEAKLFAML 63
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           +H N++    A  GV  +  +   LV EF   G       P+       + P ++     
Sbjct: 64  KHPNII----ALRGVCLKEPNL-CLVMEFARGG-------PLNRVLSGKRIPPDI----L 107
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM--------TAYVSDFGIARFLE 371
           +N A+ +A  + YLH +   PI H DLK SNIL+  ++           ++DFG+AR   
Sbjct: 108 VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW- 166
Query: 372 AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
               +T  +   G   ++APE       S   DV+S+G+LL E+ TG  P
Sbjct: 167 ---HRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 22/216 (10%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       +  + F  E E+ ++++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C      G     L+ E++  GSL +++       ++HK    ++ +K L     +  
Sbjct: 78  GVCYSA---GRRNLKLIMEYLPYGSLRDYL-------QKHKE--RIDHIKLLQYTSQICK 125
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE--QTRSIGVEGTT 386
            ++YL         H DL   NIL+++E    + DFG+ + L    E  + +  G E   
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG-ESPI 181
Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
            + APE     + S   DV+SFG++L E+FT +  S
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 217

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           IG+G+FG+VYKG   +    VAVK+ NV      +  +F  E  V R  RH N++     
Sbjct: 20  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL---- 72
Query: 271 CSGVDFQGNDFK---ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                F G   K   A+V ++    SL   +H          +       K ++IA   A
Sbjct: 73  -----FMGYSTKPQLAIVTQWCEGSSLYHHLHA---------SETKFEMKKLIDIARQTA 118
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YLH      I H DLK +NI L ++ T  + DFG+A          +   + G+  
Sbjct: 119 RGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 175
Query: 388 YIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRP 421
           ++APE     + + Y    DVY+FGI+L E+ TG  P
Sbjct: 176 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 38/220 (17%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           IG+G+FG+VYKG   +    VAVK+ NV      +  +F  E  V R  RH N++     
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
            +          A+V ++    SL   +H          +       K ++IA   A  +
Sbjct: 89  STAPQL------AIVTQWCEGSSLYHHLHA---------SETKFEMKKLIDIARQTARGM 133
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG------VEG 384
            YLH      I H DLK +NI L ++ T  + DFG+      A E++R  G      + G
Sbjct: 134 DYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGL------ATEKSRWSGSHQFEQLSG 184
Query: 385 TTGYIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRP 421
           +  ++APE     + + Y    DVY+FGI+L E+ TG  P
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        ++++  L +A  ++  +
Sbjct: 78  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAM 124
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 180
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        ++++  L +A  ++  +
Sbjct: 78  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAM 124
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 180
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +GAG  G V+ G  +   T VAVK      +  DA   F  E  + + ++H+ LV+++  
Sbjct: 21  LGAGQAGEVWMG-YYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAV 76
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG--NLNSLKRLNIAIDVAC 328
            +       +   ++ E+M NGSL +++          K P    L   K L++A  +A 
Sbjct: 77  VT------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAE 120
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            + ++    +    H DL+ +NIL+ D ++  ++DFG+AR +E A+   R  G +    +
Sbjct: 121 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTARE-GAKFPIKW 176
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            APE       +   DV+SFGILL E+ T
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG+G FG V+ G    +   VA+K        + + F  E EV   + H  LV+++  C 
Sbjct: 18  IGSGQFGLVHLGYWL-NKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 74
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                      LV+EFM +G L +++             G   +   L + +DV   + Y
Sbjct: 75  ----LEQAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAY 121
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           L   C   + H DL   N L+ +     VSDFG+ RF+   D+ T S G +    + +PE
Sbjct: 122 LEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPE 177
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFT 417
                  SS  DV+SFG+L+ E+F+
Sbjct: 178 VFSFSRYSSKSDVWSFGVLMWEVFS 202

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 114/244 (46%), Gaps = 40/244 (16%)
Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-------KSFAVECEVTRNIRHR 262
           E  IG G FG V+KG L +  + VA+K   +   +         + F  E  +  N+ H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N+VK++          ++   +V EF+  G L    H +   DK H    ++    +L +
Sbjct: 84  NIVKLYGLM-------HNPPRMVMEFVPCGDL---YHRLL--DKAHPIKWSV----KLRL 127
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLD--DE---MTAYVSDFGIARFLEAADEQT 377
            +D+A  ++Y+  +  PPI H DL+  NI L   DE   + A V+DFG ++      +  
Sbjct: 128 MLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ------QSV 180
Query: 378 RSI-GVEGTTGYIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRPSDDMFKDNLNLR 433
            S+ G+ G   ++APE  +G E  SY    D YSF ++L  + TG  P D+     +   
Sbjct: 181 HSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 434 NCVK 437
           N ++
Sbjct: 240 NMIR 243

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G FG VY+G +       S   VAVK    ++ +  +  F +E  +     H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C GV  Q    + ++ E MA G L+ ++    E   R   P +L  L  L++A D+
Sbjct: 113 ----CIGVSLQSLP-RFILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 164
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           AC  +YL  +      H D+   N LL        A + DFG+AR +  A    +     
Sbjct: 165 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               ++ PE  M    +S  D +SFG+LL E+F+
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG+G FG V+ G    +   VA+K        + + F  E EV   + H  LV+++  C 
Sbjct: 13  IGSGQFGLVHLGYWL-NKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 69
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                      LV+EFM +G L +++             G   +   L + +DV   + Y
Sbjct: 70  ----LEQAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAY 116
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           L   C   + H DL   N L+ +     VSDFG+ RF+   D+ T S G +    + +PE
Sbjct: 117 LEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPE 172
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFT 417
                  SS  DV+SFG+L+ E+F+
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFS 197

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 27/225 (12%)
Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLV 265
           E +IGAG FG V +G L    +  + VA+K     + +  +  F  E  +     H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 266 KVFTACSGVDFQGNDFKALVY-EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           ++    +      N    ++  EFM NG+L+ ++             G    ++ + +  
Sbjct: 81  RLEGVVT------NSMPVMILTEFMENGALDSFLR---------LNDGQFTVIQLVGMLR 125
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE---AADEQTRSIG 381
            +A  ++YL    +    H DL   NIL++  +   VSDFG++RFLE   +   +T S+G
Sbjct: 126 GIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG 182
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + APE     + +S  D +S+GI++ E+ + G RP  DM
Sbjct: 183 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDM 227

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS---FAVECEVTRNIRHRNLVKVFT 269
           IG+G FG V+ G    +   VA+K       + S S   F  E EV   + H  LV+++ 
Sbjct: 35  IGSGQFGLVHLGYWL-NKDKVAIKTIK----EGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C            LV+EFM +G L +++             G   +   L + +DV   
Sbjct: 90  VC-----LEQAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEG 135
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           + YL   C   + H DL   N L+ +     VSDFG+ RF+   D+ T S G +    + 
Sbjct: 136 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWA 191
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFT 417
           +PE       SS  DV+SFG+L+ E+F+
Sbjct: 192 SPEVFSFSRYSSKSDVWSFGVLMWEVFS 219

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G G FG VY+G +       S   VAVK    V        F +E  +   + H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C GV  Q    + ++ E MA G L+ ++    E   R   P +L  L  L++A D+
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 150
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           AC  +YL  +      H D+   N LL        A + DFG+AR +  A    +     
Sbjct: 151 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               ++ PE  M    +S  D +SFG+LL E+F+
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG+G FG V+ G    +   VA+K        + + F  E EV   + H  LV+++  C 
Sbjct: 15  IGSGQFGLVHLGYWL-NKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 71
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                      LV+EFM +G L +++             G   +   L + +DV   + Y
Sbjct: 72  ----LEQAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAY 118
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           L   C   + H DL   N L+ +     VSDFG+ RF+   D+ T S G +    + +PE
Sbjct: 119 LEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPE 174
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFT 417
                  SS  DV+SFG+L+ E+F+
Sbjct: 175 VFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G G FG VY+G +       S   VAVK    V        F +E  +   + H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C GV  Q    + ++ E MA G L+ ++    E   R   P +L  L  L++A D+
Sbjct: 113 ----CIGVSLQSLP-RFILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 164
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           AC  +YL  +      H D+   N LL        A + DFG+AR +  A    +     
Sbjct: 165 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               ++ PE  M    +S  D +SFG+LL E+F+
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           E  +GAG FG V+    +   T VAVK          ++F  E  V + ++H  LVK+  
Sbjct: 20  EKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 77
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
             +           ++ EFMA GSL +++   ++E  +   P      K ++ +  +A  
Sbjct: 78  VVTKEPIY------IITEFMAKGSLLDFLK--SDEGSKQPLP------KLIDFSAQIAEG 123
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           + ++    Q    H DL+ +NIL+   +   ++DFG+AR +E  +E T   G +    + 
Sbjct: 124 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWT 179
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFT 417
           APE       +   DV+SFGILL+E+ T
Sbjct: 180 APEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY+G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   F  ++ EFM  G+L +++     ++        ++++  L +A  ++  +
Sbjct: 76  CT----REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAM 122
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 123 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTA 178
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    ++ S   DV++FG+LL E+ T G+ P
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRN--IRHRNLVKVFT 269
           LIG G +G+VYKG L E    VAVKVF+  +    ++F  E  + R   + H N+ +   
Sbjct: 20  LIGRGRYGAVYKGSLDER--PVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIV 74
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
               V   G     LV E+  NGSL +++   T            + +    +A  V   
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----------DWVSSCRLAHSVTRG 123
Query: 330 LKYLHLDC------QPPIAHCDLKPSNILLDDEMTAYVSDFGIA------RFLEAADEQT 377
           L YLH +       +P I+H DL   N+L+ ++ T  +SDFG++      R +   +E  
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 378 RSIGVEGTTGYIAPEYGMG-------HEVSSYGDVYSFGILLLEMF 416
            +I   GT  Y+APE   G              D+Y+ G++  E+F
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       +  + F  E E+ ++++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C      G     L+ E++  GSL +++    E          ++ +K L     +  
Sbjct: 81  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQAHAE---------RIDHIKLLQYTSQICK 128
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG- 387
            ++YL         H DL   NIL+++E    + DFG+ + L   D++   +   G +  
Sbjct: 129 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPI 184
Query: 388 -YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
            + APE     + S   DV+SFG++L E+FT +  S
Sbjct: 185 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 220

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G G FG VY+G +       S   VAVK    V        F +E  +     H+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C GV  Q    + ++ E MA G L+ ++    E   R   P +L  L  L++A D+
Sbjct: 115 ----CIGVSLQSLP-RFILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 166
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           AC  +YL  +      H D+   N LL        A + DFG+AR +  A    +     
Sbjct: 167 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 223
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               ++ PE  M    +S  D +SFG+LL E+F+
Sbjct: 224 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G G FG VY+G +       S   VAVK    V        F +E  +     H+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C GV  Q    + ++ E MA G L+ ++    E   R   P +L  L  L++A D+
Sbjct: 105 ----CIGVSLQSLP-RFILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 156
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           AC  +YL  +      H D+   N LL        A + DFG+AR +  A    +     
Sbjct: 157 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 213
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               ++ PE  M    +S  D +SFG+LL E+F+
Sbjct: 214 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G G FG VY+G +       S   VAVK    V        F +E  +     H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C GV  Q    + ++ E MA G L+ ++    E   R   P +L  L  L++A D+
Sbjct: 98  ----CIGVSLQSLP-RFILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 149
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           AC  +YL  +      H D+   N LL        A + DFG+AR +  A    +     
Sbjct: 150 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               ++ PE  M    +S  D +SFG+LL E+F+
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           E  +GAG FG V+    +   T VAVK          ++F  E  V + ++H  LVK+  
Sbjct: 193 EKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 250
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
             +       +   ++ EFMA GSL +++   ++E  +   P      K ++ +  +A  
Sbjct: 251 VVT------KEPIYIITEFMAKGSLLDFLK--SDEGSKQPLP------KLIDFSAQIAEG 296
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           + ++    Q    H DL+ +NIL+   +   ++DFG+AR +E  +E T   G +    + 
Sbjct: 297 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWT 352
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFT 417
           APE       +   DV+SFGILL+E+ T
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKV 267
           +G G FG V+    +     +    VAVK        A K F  E E+  N++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHP------ITEEDKRHKAPGNLNSLKRLN 321
           +  C        D   +V+E+M +G L +++        I  + +  +A G L   + L+
Sbjct: 83  YGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           IA  +A  + YL         H DL   N L+   +   + DFG++R + + D       
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                 ++ PE  M  + ++  DV+SFG++L E+FT
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G G FG VY+G +       S   VAVK    V        F +E  +     H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C GV  Q    + ++ E MA G L+ ++    E   R   P +L  L  L++A D+
Sbjct: 98  ----CIGVSLQSLP-RFILMELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 149
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           AC  +YL  +      H D+   N LL        A + DFG+AR +  A    +     
Sbjct: 150 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               ++ PE  M    +S  D +SFG+LL E+F+
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G G FG VY+G +       S   VAVK    V        F +E  +     H+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C GV  Q    + ++ E MA G L+ ++    E   R   P +L  L  L++A D+
Sbjct: 90  ----CIGVSLQSLP-RFILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 141
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           AC  +YL  +      H D+   N LL        A + DFG+AR +  A    +     
Sbjct: 142 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 198
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               ++ PE  M    +S  D +SFG+LL E+F+
Sbjct: 199 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G G FG VY+G +       S   VAVK    V        F +E  +     H+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C GV  Q    + ++ E MA G L+ ++    E   R   P +L  L  L++A D+
Sbjct: 125 ----CIGVSLQSLP-RFILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 176
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           AC  +YL  +      H D+   N LL        A + DFG+AR +  A    +     
Sbjct: 177 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 233
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               ++ PE  M    +S  D +SFG+LL E+F+
Sbjct: 234 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G G FG VY+G +       S   VAVK    V        F +E  +     H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C GV  Q    + ++ E MA G L+ ++    E   R   P +L  L  L++A D+
Sbjct: 139 ----CIGVSLQSLP-RFILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 190
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           AC  +YL  +      H D+   N LL        A + DFG+AR +  A    +     
Sbjct: 191 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               ++ PE  M    +S  D +SFG+LL E+F+
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G G FG VY+G +       S   VAVK    V        F +E  +     H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C GV  Q    + ++ E MA G L+ ++    E   R   P +L  L  L++A D+
Sbjct: 113 ----CIGVSLQSLP-RFILMELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 164
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           AC  +YL  +      H D+   N LL        A + DFG+AR +  A    +     
Sbjct: 165 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               ++ PE  M    +S  D +SFG+LL E+F+
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G G FG VY+G +       S   VAVK    V        F +E  +     H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C GV  Q    + ++ E MA G L+ ++    E   R   P +L  L  L++A D+
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 150
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           AC  +YL  +      H D+   N LL        A + DFG+AR +  A    +     
Sbjct: 151 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               ++ PE  M    +S  D +SFG+LL E+F+
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 94  FVKLY-----FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDE---------TCTRFYTA 139
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 140 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 195
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE       S   D+++ G ++ ++  GL P
Sbjct: 196 GTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLV 265
           E +IGAG FG V  G L    +    VA+K     + +  +  F  E  +     H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 266 K---VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
               V T  + V         ++ EFM NGSL+ ++          +  G    ++ + +
Sbjct: 98  HLEGVVTKSTPV--------MIITEFMENGSLDSFLR---------QNDGQFTVIQLVGM 140
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE---AADEQTRS 379
              +A  +KYL         H DL   NIL++  +   VSDFG++RFLE   +    T +
Sbjct: 141 LRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 197
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
           +G +    + APE     + +S  DV+S+GI++ E+ + G RP  DM
Sbjct: 198 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 244

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 116/244 (47%), Gaps = 27/244 (11%)
Query: 182 KRGNPT-PSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV 240
           KR  PT   +S  Y  + M        + ++ +G G +G VY+G+  + +  VAVK    
Sbjct: 199 KRNKPTIYGVSPNYDKWEM---ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--- 252
Query: 241 LHHDASK--SFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM 298
           L  D  +   F  E  V + I+H NLV++   C+    +   F  ++ EFM  G+L +++
Sbjct: 253 LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYL 307
Query: 299 HPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT 358
                ++        ++++  L +A  ++  ++YL    +    H +L   N L+ +   
Sbjct: 308 RECNRQE--------VSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHL 356
Query: 359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT- 417
             V+DFG++R +   D  T   G +    + APE    ++ S   DV++FG+LL E+ T 
Sbjct: 357 VKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 415
Query: 418 GLRP 421
           G+ P
Sbjct: 416 GMSP 419

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +GAG FG V+ G  +   T VAVK      +  DA   F  E  + + ++H+ LV+++  
Sbjct: 17  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAV 72
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG--NLNSLKRLNIAIDVAC 328
            +       +   ++ E+M NGSL +++          K P    L   K L++A  +A 
Sbjct: 73  VT------QEPIYIITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAE 116
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            + ++    +    H +L+ +NIL+ D ++  ++DFG+AR +E  +E T   G +    +
Sbjct: 117 GMAFIE---ERNYIHRNLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 172
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            APE       +   DV+SFGILL E+ T
Sbjct: 173 TAPEAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 103/237 (43%), Gaps = 18/237 (7%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDAS--KSFAVECEVTRNIRHRNLVKVF 268
           ++G G    V+          VAVKV    L  D S    F  E +    + H  +V V+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                 +        +V E++   +L + +H  TE        G +   + + +  D   
Sbjct: 79  DTGEA-ETPAGPLPYIVMEYVDGVTLRDIVH--TE--------GPMTPKRAIEVIADACQ 127
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL-EAADEQTRSIGVEGTTG 387
            L + H   Q  I H D+KP+NI++       V DFGIAR + ++ +  T++  V GT  
Sbjct: 128 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA 444
           Y++PE   G  V +  DVYS G +L E+ TG  P      D++  ++  +  +P  A
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSA 241

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 114/244 (46%), Gaps = 40/244 (16%)
Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-------KSFAVECEVTRNIRHR 262
           E  IG G FG V+KG L +  + VA+K   +   +         + F  E  +  N+ H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N+VK++          ++   +V EF+  G L    H +   DK H    ++    +L +
Sbjct: 84  NIVKLYGLM-------HNPPRMVMEFVPCGDL---YHRLL--DKAHPIKWSV----KLRL 127
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLD--DE---MTAYVSDFGIARFLEAADEQT 377
            +D+A  ++Y+  +  PPI H DL+  NI L   DE   + A V+DF +++      +  
Sbjct: 128 MLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ------QSV 180
Query: 378 RSI-GVEGTTGYIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRPSDDMFKDNLNLR 433
            S+ G+ G   ++APE  +G E  SY    D YSF ++L  + TG  P D+     +   
Sbjct: 181 HSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 434 NCVK 437
           N ++
Sbjct: 240 NMIR 243

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G G FG VY+G +       S   VAVK    V        F +E  +     H+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C GV  Q    + ++ E MA G L+ ++    E   R   P +L  L  L++A D+
Sbjct: 116 ----CIGVSLQSLP-RFILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 167
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           AC  +YL  +      H D+   N LL        A + DFG+AR +  A    +     
Sbjct: 168 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 224
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               ++ PE  M    +S  D +SFG+LL E+F+
Sbjct: 225 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 96/225 (42%), Gaps = 30/225 (13%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNL 264
           K    E ++G G FG V K        A  V +  +      K+F VE      + H N+
Sbjct: 9   KEIEVEEVVGRGAFGVVCKA----KWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNI 64
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH---PITEEDKRHKAPGNLNSLKRLN 321
           VK++ AC        +   LV E+   GSL   +H   P+      H           ++
Sbjct: 65  VKLYGACL-------NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHA----------MS 107
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY-VSDFGIARFLEAADEQTRSI 380
             +  +  + YLH      + H DLKP N+LL    T   + DFG A      D QT   
Sbjct: 108 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMT 162
Query: 381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
             +G+  ++APE   G   S   DV+S+GI+L E+ T  +P D++
Sbjct: 163 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 207

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLV 265
           E +IG G FG V  G L    +    VA+K     + D  +  F  E  +     H N++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 266 K---VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
               V T C  V         ++ E+M NGSL+ ++          K  G    ++ + +
Sbjct: 94  HLEGVVTKCKPV--------MIITEYMENGSLDAFLR---------KNDGRFTVIQLVGM 136
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
              +   +KYL         H DL   NIL++  +   VSDFG++R LE   E   +  G
Sbjct: 137 LRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 193
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + APE     + +S  DV+S+GI++ E+ + G RP  DM
Sbjct: 194 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 238

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 96/225 (42%), Gaps = 30/225 (13%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNL 264
           K    E ++G G FG V K        A  V +  +      K+F VE      + H N+
Sbjct: 8   KEIEVEEVVGRGAFGVVCKA----KWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNI 63
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH---PITEEDKRHKAPGNLNSLKRLN 321
           VK++ AC        +   LV E+   GSL   +H   P+      H           ++
Sbjct: 64  VKLYGACL-------NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHA----------MS 106
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY-VSDFGIARFLEAADEQTRSI 380
             +  +  + YLH      + H DLKP N+LL    T   + DFG A      D QT   
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMT 161
Query: 381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
             +G+  ++APE   G   S   DV+S+GI+L E+ T  +P D++
Sbjct: 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLV 265
           E +IG G FG V  G L    +    VA+K     + D  +  F  E  +     H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 266 K---VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
               V T C  V         ++ E+M NGSL+ ++          K  G    ++ + +
Sbjct: 73  HLEGVVTKCKPV--------MIITEYMENGSLDAFLR---------KNDGRFTVIQLVGM 115
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
              +   +KYL         H DL   NIL++  +   VSDFG++R LE   E   +  G
Sbjct: 116 LRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 172
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + APE     + +S  DV+S+GI++ E+ + G RP  DM
Sbjct: 173 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 217

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLV 265
           E +IG G FG V  G L    +    VA+K     + D  +  F  E  +     H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 266 K---VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
               V T C  V         ++ E+M NGSL+ ++          K  G    ++ + +
Sbjct: 79  HLEGVVTKCKPV--------MIITEYMENGSLDAFLR---------KNDGRFTVIQLVGM 121
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
              +   +KYL         H DL   NIL++  +   VSDFG++R LE   E   +  G
Sbjct: 122 LRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 178
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + APE     + +S  DV+S+GI++ E+ + G RP  DM
Sbjct: 179 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 223

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLV 265
           E +IGAG FG V +G L    +  + VA+K     + +  +  F  E  +     H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 266 KVFTACSGVDFQGNDFKALVY-EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           ++    +      N    ++  EFM NG+L+ ++             G    ++ + +  
Sbjct: 79  RLEGVVT------NSMPVMILTEFMENGALDSFLR---------LNDGQFTVIQLVGMLR 123
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ---TRSIG 381
            +A  ++YL    +    H DL   NIL++  +   VSDFG++RFLE        T S+G
Sbjct: 124 GIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + APE     + +S  D +S+GI++ E+ + G RP  DM
Sbjct: 181 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDM 225

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVK-VFNVLHHDASKSFAVECEVTRNIRHRNLV 265
           +  +  +G G FG V + I  ++   VA+K     L     + + +E ++ + + H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 266 KVFTACSGVD-FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
                  G+     ND   L  E+   G L ++++             N   LK   I  
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE----------NCCGLKEGPIRT 126
Query: 325 ---DVACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTR 378
              D++  L+YLH   +  I H DLKP NI+L      +   + D G A+ L+  +  T 
Sbjct: 127 LLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 183
Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            +G   T  Y+APE     + +   D +SFG L  E  TG RP
Sbjct: 184 FVG---TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDAS--KSFAVECEVTRNIRHRNLVKVF 268
           ++G G    V+          VAVKV    L  D S    F  E +    + H  +V V+
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
            A    +        +V E++   +L + +H  TE        G +   + + +  D   
Sbjct: 79  -ATGEAETPAGPLPYIVMEYVDGVTLRDIVH--TE--------GPMTPKRAIEVIADACQ 127
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL-EAADEQTRSIGVEGTTG 387
            L + H   Q  I H D+KP+NI++       V DFGIAR + ++ +  T++  V GT  
Sbjct: 128 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           Y++PE   G  V +  DVYS G +L E+ TG  P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG+G FG V+ G    +   VA+K        + + F  E EV   + H  LV+++  C 
Sbjct: 15  IGSGQFGLVHLGYWL-NKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 71
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                      LV+EFM +G L +++             G   +   L + +DV   + Y
Sbjct: 72  ----LEQAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAY 118
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           L    +  + H DL   N L+ +     VSDFG+ RF+   D+ T S G +    + +PE
Sbjct: 119 LE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPE 174
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFT 417
                  SS  DV+SFG+L+ E+F+
Sbjct: 175 VFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVK-VFNVLHHDASKSFAVECEVTRNIRHRNLV 265
           +  +  +G G FG V + I  ++   VA+K     L     + + +E ++ + + H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 266 KVFTACSGVD-FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
                  G+     ND   L  E+   G L ++++             N   LK   I  
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE----------NCCGLKEGPIRT 125
Query: 325 ---DVACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTR 378
              D++  L+YLH   +  I H DLKP NI+L      +   + D G A+ L+  +  T 
Sbjct: 126 LLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 182
Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            +G   T  Y+APE     + +   D +SFG L  E  TG RP
Sbjct: 183 FVG---TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 22/216 (10%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       +  + F  E E+ ++++H N+VK  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C      G     L+ E++  GSL +++       ++HK    ++ +K L     +  
Sbjct: 79  GVCYSA---GRRNLKLIMEYLPYGSLRDYL-------QKHKE--RIDHIKLLQYTSQICK 126
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE--QTRSIGVEGTT 386
            ++YL         H +L   NIL+++E    + DFG+ + L    E  + +  G E   
Sbjct: 127 GMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG-ESPI 182
Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
            + APE     + S   DV+SFG++L E+FT +  S
Sbjct: 183 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 218

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 16/213 (7%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKV 267
           +G G FG V+    +     +    VAVK       +A K F  E E+  N++H ++VK 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMH---PITEEDKRHKAPGNLNSLKRLNIAI 324
           +  C     +G+    +V+E+M +G L +++    P          P  L   + L+IA 
Sbjct: 81  YGVC----VEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +A  + YL         H DL   N L+ + +   + DFG++R + + D          
Sbjct: 136 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 192
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              ++ PE  M  + ++  DV+S G++L E+FT
Sbjct: 193 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG+G FG V+ G    +   VA+K        + + F  E EV   + H  LV+++  C 
Sbjct: 16  IGSGQFGLVHLGYWL-NKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 72
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                      LV EFM +G L +++             G   +   L + +DV   + Y
Sbjct: 73  ----LEQAPICLVTEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAY 119
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           L   C   + H DL   N L+ +     VSDFG+ RF+   D+ T S G +    + +PE
Sbjct: 120 LEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPE 175
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFT 417
                  SS  DV+SFG+L+ E+F+
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 36/211 (17%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDAS-KSFAVECEVTRNIRHRNLVKV 267
           IG G FG V    Y+G        VAVK    + +DA+ ++F  E  V   +RH NLV++
Sbjct: 29  IGKGEFGDVMLGDYRG------NKVAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                GV  +      +V E+MA GSL +++        R +    L     L  ++DV 
Sbjct: 80  L----GVIVEEKGGLYIVTEYMAKGSLVDYL--------RSRGRSVLGGDCLLKFSLDVC 127
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ-TRSIGVEGTT 386
             ++YL  +      H DL   N+L+ ++  A VSDFG+ +  EA+  Q T  + V+ T 
Sbjct: 128 EAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT- 181
Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              APE     + S+  DV+SFGILL E+++
Sbjct: 182 ---APEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 36/211 (17%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDAS-KSFAVECEVTRNIRHRNLVKV 267
           IG G FG V    Y+G        VAVK    + +DA+ ++F  E  V   +RH NLV++
Sbjct: 14  IGKGEFGDVMLGDYRG------NKVAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                GV  +      +V E+MA GSL +++        R +    L     L  ++DV 
Sbjct: 65  L----GVIVEEKGGLYIVTEYMAKGSLVDYL--------RSRGRSVLGGDCLLKFSLDVC 112
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ-TRSIGVEGTT 386
             ++YL  +      H DL   N+L+ ++  A VSDFG+ +  EA+  Q T  + V+ T 
Sbjct: 113 EAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT- 166
Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              APE     + S+  DV+SFGILL E+++
Sbjct: 167 ---APEALREKKFSTKSDVWSFGILLWEIYS 194

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 36/211 (17%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDAS-KSFAVECEVTRNIRHRNLVKV 267
           IG G FG V    Y+G        VAVK    + +DA+ ++F  E  V   +RH NLV++
Sbjct: 201 IGKGEFGDVMLGDYRG------NKVAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                GV  +      +V E+MA GSL +++        R +    L     L  ++DV 
Sbjct: 252 L----GVIVEEKGGLYIVTEYMAKGSLVDYL--------RSRGRSVLGGDCLLKFSLDVC 299
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ-TRSIGVEGTT 386
             ++YL  +      H DL   N+L+ ++  A VSDFG+ +  EA+  Q T  + V+ T 
Sbjct: 300 EAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT- 353
Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              APE     + S+  DV+SFGILL E+++
Sbjct: 354 ---APEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VY G+  + +  VAVK    L  D  +   F  E  V + I+H NLV++   
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
           C+    +   +  +V E+M  G+L +++     E+        + ++  L +A  ++  +
Sbjct: 97  CT---LEPPFY--IVTEYMPYGNLLDYLRECNREE--------VTAVVLLYMATQISSAM 143
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +    + A
Sbjct: 144 EYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 199
Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           PE    +  S   DV++FG+LL E+ T G+ P
Sbjct: 200 PESLAYNTFSIKSDVWAFGVLLWEIATYGMSP 231

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 18/214 (8%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDAS--KSFAVECEVTRNIRHRNLVKVF 268
           ++G G    V+          VAVKV    L  D S    F  E +    + H  +V V+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                 +        +V E++   +L + +H  TE        G +   + + +  D   
Sbjct: 79  DTGEA-ETPAGPLPYIVMEYVDGVTLRDIVH--TE--------GPMTPKRAIEVIADACQ 127
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL-EAADEQTRSIGVEGTTG 387
            L + H   Q  I H D+KP+NI++       V DFGIAR + ++ +  T++  V GT  
Sbjct: 128 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           Y++PE   G  V +  DVYS G +L E+ TG  P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 213 IGAGNFGSVYKGILFESTT---AVAVKVFNV---LHHDASKSFAVECEVTRNIRHRNLVK 266
           +G G   +VY   L E T     VA+K   +      +  K F  E   +  + H+N+V 
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +      VD + +D   LV E++   +L E++          ++ G L+    +N    +
Sbjct: 76  MI----DVD-EEDDCYYLVMEYIEGPTLSEYI----------ESHGPLSVDTAINFTNQI 120
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
              +K+ H D +  I H D+KP NIL+D   T  + DFGIA+ L +    T++  V GT 
Sbjct: 121 LDGIKHAH-DMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTV 176
Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            Y +PE   G       D+YS GI+L EM  G  P
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 92  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 137
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 138 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV 193
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G G FG VY+G +       S   VAVK    V        F +E  +     H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C GV  Q    + ++ E MA G L+ ++    E   R   P +L  L  L++A D+
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 150
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           AC  +YL  +      H D+   N LL        A + DFG+A+ +  A    +     
Sbjct: 151 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAM 207
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               ++ PE  M    +S  D +SFG+LL E+F+
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 95  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 140
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 141 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 196
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 197 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 72  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 117
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 118 -EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 173
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 174 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 122/301 (40%), Gaps = 39/301 (12%)
Query: 213 IGAGNFGSVYKG-----ILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKV 267
           +G G FG V+       +  +    VAVK        A + F  E E+   ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK-----RHKAPGNLNSLKRLNI 322
           F  C+    +G     +V+E+M +G L  ++     + K        APG L   + L +
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           A  VA  + YL         H DL   N L+   +   + DFG++R + + D        
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALP 441
                ++ PE  +  + ++  DV+SFG++L E+FT G +P   +   N    +C+     
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--SNTEAIDCITQG-- 276
Query: 442 ERAEEIRASSGSTQRXXXXXXXXXXXXXGVACSAEQPGERMKINDVEPRLRLIKKKLLEA 501
              E  RA                       C   +P +R  I DV  RL    + L +A
Sbjct: 277 RELERPRACPPEVYAIMR------------GCWQREPQQRHSIKDVHARL----QALAQA 320
Query: 502 P 502
           P
Sbjct: 321 P 321

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 23/225 (10%)
Query: 207 FSSENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHR 262
            S + ++GAG FG V  G L    +   +VA+K   V + +  +  F  E  +     H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N++++     GV  +      +V E+M NGSL+ ++       ++H A      ++ + +
Sbjct: 107 NIIRL----EGVVTKSKPV-MIVTEYMENGSLDSFL-------RKHDA--QFTVIQLVGM 152
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
              +A  +KYL         H DL   NIL++  +   VSDFG+AR LE   E   +  G
Sbjct: 153 LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRG 209
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + +PE     + +S  DV+S+GI+L E+ + G RP  +M
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 71  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 116
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 117 -EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 172
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 173 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 94  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 139
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 140 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 97  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 142
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 143 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 198
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 199 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 94  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 139
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 140 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 196 GTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 122/301 (40%), Gaps = 39/301 (12%)
Query: 213 IGAGNFGSVYKG-----ILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKV 267
           +G G FG V+       +  +    VAVK        A + F  E E+   ++H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK-----RHKAPGNLNSLKRLNI 322
           F  C+    +G     +V+E+M +G L  ++     + K        APG L   + L +
Sbjct: 80  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           A  VA  + YL         H DL   N L+   +   + DFG++R + + D        
Sbjct: 135 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 191
Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALP 441
                ++ PE  +  + ++  DV+SFG++L E+FT G +P   +   N    +C+     
Sbjct: 192 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--SNTEAIDCITQG-- 247
Query: 442 ERAEEIRASSGSTQRXXXXXXXXXXXXXGVACSAEQPGERMKINDVEPRLRLIKKKLLEA 501
              E  RA                       C   +P +R  I DV  RL    + L +A
Sbjct: 248 RELERPRACPPEVYAIMR------------GCWQREPQQRHSIKDVHARL----QALAQA 291
Query: 502 P 502
           P
Sbjct: 292 P 292

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 94  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 139
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 140 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 95  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 140
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 141 -EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 196
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 197 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 69  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 114
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 115 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 170
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 171 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 70  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 115
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 116 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 171
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 36/211 (17%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDAS-KSFAVECEVTRNIRHRNLVKV 267
           IG G FG V    Y+G        VAVK    + +DA+ ++F  E  V   +RH NLV++
Sbjct: 20  IGKGEFGDVMLGDYRG------NKVAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQL 70
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                GV  +      +V E+MA GSL +++        R +    L     L  ++DV 
Sbjct: 71  L----GVIVEEKGGLYIVTEYMAKGSLVDYL--------RSRGRSVLGGDCLLKFSLDVC 118
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ-TRSIGVEGTT 386
             ++YL  +      H DL   N+L+ ++  A VSDFG+ +  EA+  Q T  + V+ T 
Sbjct: 119 EAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT- 172
Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              APE       S+  DV+SFGILL E+++
Sbjct: 173 ---APEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 94  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 139
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 140 -EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 92  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 137
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 138 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 122/301 (40%), Gaps = 39/301 (12%)
Query: 213 IGAGNFGSVYKG-----ILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKV 267
           +G G FG V+       +  +    VAVK        A + F  E E+   ++H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK-----RHKAPGNLNSLKRLNI 322
           F  C+    +G     +V+E+M +G L  ++     + K        APG L   + L +
Sbjct: 86  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           A  VA  + YL         H DL   N L+   +   + DFG++R + + D        
Sbjct: 141 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 197
Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALP 441
                ++ PE  +  + ++  DV+SFG++L E+FT G +P   +   N    +C+     
Sbjct: 198 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--SNTEAIDCITQG-- 253
Query: 442 ERAEEIRASSGSTQRXXXXXXXXXXXXXGVACSAEQPGERMKINDVEPRLRLIKKKLLEA 501
              E  RA                       C   +P +R  I DV  RL    + L +A
Sbjct: 254 RELERPRACPPEVYAIMR------------GCWQREPQQRHSIKDVHARL----QALAQA 297
Query: 502 P 502
           P
Sbjct: 298 P 298

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 94  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 139
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 140 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 91  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 136
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 137 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 192
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 193 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 92  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 137
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 138 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 18/214 (8%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDAS--KSFAVECEVTRNIRHRNLVKVF 268
           ++G G    V+          VAVKV    L  D S    F  E +    + H  +V V+
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                 +        +V E++   +L + +H  TE        G +   + + +  D   
Sbjct: 79  DTGEA-ETPAGPLPYIVMEYVDGVTLRDIVH--TE--------GPMTPKRAIEVIADACQ 127
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL-EAADEQTRSIGVEGTTG 387
            L + H   Q  I H D+KP+NI++       V DFGIAR + ++ +  T++  V GT  
Sbjct: 128 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           Y++PE   G  V +  DVYS G +L E+ TG  P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 99  FVKLYFC-----FQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 144
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 145 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 200
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 201 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 23/225 (10%)
Query: 207 FSSENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHR 262
            S + ++GAG FG V  G L    +   +VA+K   V + +  +  F  E  +     H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N++++     GV  +      +V E+M NGSL+ ++       ++H A      ++ + +
Sbjct: 107 NIIRL----EGVVTKSKPV-MIVTEYMENGSLDSFL-------RKHDA--QFTVIQLVGM 152
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
              +A  +KYL         H DL   NIL++  +   VSDFG++R LE   E   +  G
Sbjct: 153 LRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + +PE     + +S  DV+S+GI+L E+ + G RP  +M
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 76  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 121
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 122 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 177
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 178 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 23/225 (10%)
Query: 207 FSSENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHR 262
            S + ++GAG FG V  G L    +   +VA+K   V + +  +  F  E  +     H 
Sbjct: 35  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 94
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N++++     GV  +      +V E+M NGSL+ ++       ++H A      ++ + +
Sbjct: 95  NIIRL----EGVVTKSKPV-MIVTEYMENGSLDSFL-------RKHDA--QFTVIQLVGM 140
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
              +A  +KYL         H DL   NIL++  +   VSDFG++R LE   E   +  G
Sbjct: 141 LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + +PE     + +S  DV+S+GI+L E+ + G RP  +M
Sbjct: 198 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 242

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 18/214 (8%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDAS--KSFAVECEVTRNIRHRNLVKVF 268
           ++G G    V+          VAVKV    L  D S    F  E +    + H  +V V+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                 +        +V E++   +L + +H  TE        G +   + + +  D   
Sbjct: 79  DTGEA-ETPAGPLPYIVMEYVDGVTLRDIVH--TE--------GPMTPKRAIEVIADACQ 127
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL-EAADEQTRSIGVEGTTG 387
            L + H   Q  I H D+KP+NIL+       V DFGIAR + ++ +   ++  V GT  
Sbjct: 128 ALNFSH---QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQ 184
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           Y++PE   G  V +  DVYS G +L E+ TG  P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+    +++  +       E +V   + H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 91  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 136
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 137 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 192
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 193 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 23/225 (10%)
Query: 207 FSSENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHR 262
            S + ++GAG FG V  G L    +   +VA+K   V + +  +  F  E  +     H 
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N++++     GV  +      +V E+M NGSL+ ++       ++H A      ++ + +
Sbjct: 78  NIIRL----EGVVTKSKPV-MIVTEYMENGSLDSFL-------RKHDA--QFTVIQLVGM 123
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
              +A  +KYL         H DL   NIL++  +   VSDFG++R LE   E   +  G
Sbjct: 124 LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 180
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + +PE     + +S  DV+S+GI+L E+ + G RP  +M
Sbjct: 181 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 225

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 40/227 (17%)
Query: 216 GNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV--TRNIRHRNLVKVFTACSG 273
           G FG V+K  L      VAVK+F +      +S+  E E+  T  ++H NL++   A   
Sbjct: 26  GRFGCVWKAQLMNDF--VAVKIFPL---QDKQSWQSEREIFSTPGMKHENLLQFIAA--- 77
Query: 274 VDFQGNDFKA---LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL-NIAIDVACV 329
            + +G++ +    L+  F   GSL +++             GN+ +   L ++A  ++  
Sbjct: 78  -EKRGSNLEVELWLITAFHDKGSLTDYL------------KGNIITWNELCHVAETMSRG 124
Query: 330 LKYLHLDC--------QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           L YLH D         +P IAH D K  N+LL  ++TA ++DFG+A   E       + G
Sbjct: 125 LSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHG 184
Query: 382 VEGTTGYIAPEYGMG-----HEVSSYGDVYSFGILLLEMFTGLRPSD 423
             GT  Y+APE   G      +     D+Y+ G++L E+ +  + +D
Sbjct: 185 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 23/225 (10%)
Query: 207 FSSENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHR 262
            S + ++GAG FG V  G L    +   +VA+K   V + +  +  F  E  +     H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N++++     GV  +      +V E+M NGSL+ ++       ++H A      ++ + +
Sbjct: 107 NIIRL----EGVVTKSKPV-MIVTEYMENGSLDSFL-------RKHDA--QFTVIQLVGM 152
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
              +A  +KYL         H DL   NIL++  +   VSDFG++R LE   E   +  G
Sbjct: 153 LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + +PE     + +S  DV+S+GI+L E+ + G RP  +M
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 23/225 (10%)
Query: 207 FSSENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHR 262
            S + ++GAG FG V  G L    +   +VA+K   V + +  +  F  E  +     H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N++++     GV  +      +V E+M NGSL+ ++       ++H A      ++ + +
Sbjct: 107 NIIRL----EGVVTKSKPV-MIVTEYMENGSLDSFL-------RKHDA--QFTVIQLVGM 152
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
              +A  +KYL         H DL   NIL++  +   VSDFG++R LE   E   +  G
Sbjct: 153 LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + +PE     + +S  DV+S+GI+L E+ + G RP  +M
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 23/225 (10%)
Query: 207 FSSENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHR 262
            S + ++GAG FG V  G L    +   +VA+K   V + +  +  F  E  +     H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N++++     GV  +      +V E+M NGSL+ ++       ++H A      ++ + +
Sbjct: 107 NIIRL----EGVVTKSKPV-MIVTEYMENGSLDSFL-------RKHDA--QFTVIQLVGM 152
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
              +A  +KYL         H DL   NIL++  +   VSDFG++R LE   E   +  G
Sbjct: 153 LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + +PE     + +S  DV+S+GI+L E+ + G RP  +M
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 13/217 (5%)
Query: 211 NLIGAGNFGSVYKGILFE---STTAVAVKVFNVLHHDASK--SFAVECEVTRNIRHRNLV 265
            ++G G FGSV +G L +   ++  VAVK   + +    +   F  E    ++  H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           ++   C  +  QG     ++  FM  G L    H      +    P ++     L   +D
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDL----HTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +A  ++YL         H DL   N +L D+MT  V+DFG+++ + + D   +    +  
Sbjct: 156 IALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
             +IA E       +S  DV++FG+ + E+ T G+ P
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 31/227 (13%)
Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLV 265
           E +IGAG FG V  G L    +    VA+K     + +  +  F  E  +     H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 266 K---VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
               V T  + V         ++ EFM NGSL+ ++          +  G    ++ + +
Sbjct: 72  HLEGVVTKSTPV--------MIITEFMENGSLDSFLR---------QNDGQFTVIQLVGM 114
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE---AADEQTRS 379
              +A  +KYL         H  L   NIL++  +   VSDFG++RFLE   +    T +
Sbjct: 115 LRGIAAGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 171
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
           +G +    + APE     + +S  DV+S+GI++ E+ + G RP  DM
Sbjct: 172 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 218

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 23/225 (10%)
Query: 207 FSSENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHR 262
            S + ++GAG FG V  G L    +   +VA+K   V + +  +  F  E  +     H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N++++     GV  +      +V E+M NGSL+ ++       ++H A      ++ + +
Sbjct: 107 NIIRL----EGVVTKSKPV-MIVTEYMENGSLDSFL-------RKHDA--QFTVIQLVGM 152
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
              +A  +KYL         H DL   NIL++  +   VSDFG++R LE   E   +  G
Sbjct: 153 LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + +PE     + +S  DV+S+GI+L E+ + G RP  +M
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 23/225 (10%)
Query: 207 FSSENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHR 262
            S + ++GAG FG V  G L    +   +VA+K   V + +  +  F  E  +     H 
Sbjct: 45  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 104
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N++++     GV  +      +V E+M NGSL+ ++       ++H A      ++ + +
Sbjct: 105 NIIRL----EGVVTKSKPV-MIVTEYMENGSLDSFL-------RKHDA--QFTVIQLVGM 150
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
              +A  +KYL         H DL   NIL++  +   VSDFG++R LE   E   +  G
Sbjct: 151 LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 207
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + +PE     + +S  DV+S+GI+L E+ + G RP  +M
Sbjct: 208 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 252

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 207 FSSENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHR 262
            S + ++GAG FG V  G L    +   +VA+K   V + +  +  F  E  +     H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N++++     GV  +      +V E+M NGSL+ ++       ++H A      ++ + +
Sbjct: 107 NIIRL----EGVVTKSKPV-MIVTEYMENGSLDSFL-------RKHDA--QFTVIQLVGM 152
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
              +A  +KYL         H DL   NIL++  +   VSDFG+ R LE   E   +  G
Sbjct: 153 LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG 209
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + +PE     + +S  DV+S+GI+L E+ + G RP  +M
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 18/214 (8%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDAS--KSFAVECEVTRNIRHRNLVKVF 268
           ++G G    V+          VAVKV    L  D S    F  E +    + H  +V V+
Sbjct: 36  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 95
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                 +        +V E++   +L + +H  TE        G +   + + +  D   
Sbjct: 96  DTGEA-ETPAGPLPYIVMEYVDGVTLRDIVH--TE--------GPMTPKRAIEVIADACQ 144
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL-EAADEQTRSIGVEGTTG 387
            L + H   Q  I H D+KP+NI++       V DFGIAR + ++ +  T++  V GT  
Sbjct: 145 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 201
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           Y++PE   G  V +  DVYS G +L E+ TG  P
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +        ++   A+K+    +++  +       E +V   + H  
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I   D+         +  R   A
Sbjct: 92  FVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---------TCTRFYTA 137
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L+YLH      I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 138 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y++PE           D+++ G ++ ++  GL P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 109/239 (45%), Gaps = 29/239 (12%)
Query: 213 IGAGNFGSVYK----GIL-FESTTAVAVKVFNV-LHHDASKSFAVECEVTRNIRHRNLVK 266
           IG G FG V++    G+L +E  T VAVK+       D    F  E  +     + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWM------------HPITEEDKRHKAPGN- 313
           +   C+     G     L++E+MA G L E++            H       R  +PG  
Sbjct: 115 LLGVCA----VGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 314 -LNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEA 372
            L+  ++L IA  VA  + YL    +    H DL   N L+ + M   ++DFG++R + +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 373 ADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNL 430
           AD             ++ PE    +  ++  DV+++G++L E+F+ GL+P   M  + +
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 90/214 (42%), Gaps = 34/214 (15%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVK-VFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
           IG GNFG V+ G L    T VAVK     L  D    F  E  + +   H N+V++   C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
           +         K  +Y  M      +++  +  E  R      L     L +  D A  ++
Sbjct: 182 TQ--------KQPIYIVMELVQGGDFLTFLRTEGAR------LRVKTLLQMVGDAAAGME 227
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG---- 387
           YL   C     H DL   N L+ ++    +SDFG++R  E AD      GV   +G    
Sbjct: 228 YLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR--EEAD------GVXAASGGLRQ 276
Query: 388 ----YIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               + APE       SS  DV+SFGILL E F+
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 104/227 (45%), Gaps = 39/227 (17%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTRNIRH 261
           F    ++G G+FG V+       + A  +    VL     K        +E ++   + H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSL-----EEWMHPITEEDKRHKAPGNLNS 316
             +VK+  A     FQ      L+ +F+  G L     +E M   TEED +         
Sbjct: 86  PFIVKLHYA-----FQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKF-------Y 131
Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
           L  L +A+D      +LH      I + DLKP NILLD+E    ++DFG+++  E+ D +
Sbjct: 132 LAELALALD------HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHE 180
Query: 377 TRSIGVEGTTGYIAPEY--GMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            ++    GT  Y+APE     GH  S+  D +SFG+L+ EM TG  P
Sbjct: 181 KKAYSFCGTVEYMAPEVVNRRGHTQSA--DWWSFGVLMFEMLTGTLP 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 104/227 (45%), Gaps = 39/227 (17%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTRNIRH 261
           F    ++G G+FG V+       + A  +    VL     K        +E ++   + H
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 86
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSL-----EEWMHPITEEDKRHKAPGNLNS 316
             +VK+  A     FQ      L+ +F+  G L     +E M   TEED +         
Sbjct: 87  PFIVKLHYA-----FQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKF-------Y 132
Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
           L  L +A+D      +LH      I + DLKP NILLD+E    ++DFG+++  E+ D +
Sbjct: 133 LAELALALD------HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHE 181
Query: 377 TRSIGVEGTTGYIAPEY--GMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            ++    GT  Y+APE     GH  S+  D +SFG+L+ EM TG  P
Sbjct: 182 KKAYSFCGTVEYMAPEVVNRRGHTQSA--DWWSFGVLMFEMLTGTLP 226

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 23/222 (10%)
Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLV 265
           E +IG+G+ G V  G L    +    VA+K     + +  +  F  E  +     H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           ++     GV  +G     +V E+M NGSL+ ++       + H   G    ++ + +   
Sbjct: 114 RL----EGVVTRGR-LAMIVTEYMENGSLDTFL-------RTHD--GQFTIMQLVGMLRG 159
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE-AADEQTRSIGVEG 384
           V   ++YL         H DL   N+L+D  +   VSDFG++R LE   D    + G + 
Sbjct: 160 VGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI 216
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
              + APE       SS  DV+SFG+++ E+   G RP  +M
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 104/227 (45%), Gaps = 39/227 (17%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTRNIRH 261
           F    ++G G+FG V+       + A  +    VL     K        +E ++   + H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSL-----EEWMHPITEEDKRHKAPGNLNS 316
             +VK+  A     FQ      L+ +F+  G L     +E M   TEED +         
Sbjct: 86  PFIVKLHYA-----FQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKF-------Y 131
Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
           L  L +A+D      +LH      I + DLKP NILLD+E    ++DFG+++  E+ D +
Sbjct: 132 LAELALALD------HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHE 180
Query: 377 TRSIGVEGTTGYIAPEY--GMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            ++    GT  Y+APE     GH  S+  D +SFG+L+ EM TG  P
Sbjct: 181 KKAYSFCGTVEYMAPEVVNRRGHTQSA--DWWSFGVLMFEMLTGTLP 225

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 207 FSSENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHR 262
            S + ++GAG FG V  G L    +   +VA+K   V + +  +  F  E  +     H 
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N++++     GV  +      +V E M NGSL+ ++       ++H A      ++ + +
Sbjct: 78  NIIRL----EGVVTKSKPV-MIVTEXMENGSLDSFL-------RKHDA--QFTVIQLVGM 123
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
              +A  +KYL         H DL   NIL++  +   VSDFG++R LE   E   +  G
Sbjct: 124 LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 180
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + +PE     + +S  DV+S+GI+L E+ + G RP  +M
Sbjct: 181 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 225

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +GAG FG V+ G  + ++T VAVK        + ++F  E  + + ++H  LV+++   +
Sbjct: 21  LGAGQFGEVWMG-YYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   ++ E+MA GSL +++        +    G +   K ++ +  +A  + Y
Sbjct: 79  R-----EEPIYIITEYMAKGSLLDFL--------KSDEGGKVLLPKLIDFSAQIAEGMAY 125
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +N+L+ + +   ++DFG+AR +E  +E T   G +    + APE
Sbjct: 126 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPE 181
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFT 417
                  +   DV+SFGILL E+ T
Sbjct: 182 AINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 207 FSSENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHR 262
            S + ++GAG FG V  G L    +   +VA+K   V + +  +  F  E  +     H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N++++     GV  +      +V E M NGSL+ ++       ++H A      ++ + +
Sbjct: 107 NIIRL----EGVVTKSKPV-MIVTEXMENGSLDSFL-------RKHDA--QFTVIQLVGM 152
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
              +A  +KYL         H DL   NIL++  +   VSDFG++R LE   E   +  G
Sbjct: 153 LRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + +PE     + +S  DV+S+GI+L E+ + G RP  +M
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 90/214 (42%), Gaps = 34/214 (15%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVK-VFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
           IG GNFG V+ G L    T VAVK     L  D    F  E  + +   H N+V++   C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
           +         K  +Y  M      +++  +  E  R      L     L +  D A  ++
Sbjct: 182 TQ--------KQPIYIVMELVQGGDFLTFLRTEGAR------LRVKTLLQMVGDAAAGME 227
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG---- 387
           YL   C     H DL   N L+ ++    +SDFG++R  E AD      GV   +G    
Sbjct: 228 YLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR--EEAD------GVYAASGGLRQ 276
Query: 388 ----YIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               + APE       SS  DV+SFGILL E F+
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 207 FSSENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHR 262
            S + ++GAG FG V  G L    +   +VA+K   V + +  +  F  E  +     H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N++++     GV  +      +V E M NGSL+ ++       ++H A      ++ + +
Sbjct: 107 NIIRL----EGVVTKSKPV-MIVTEXMENGSLDSFL-------RKHDA--QFTVIQLVGM 152
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-G 381
              +A  +KYL         H DL   NIL++  +   VSDFG++R LE   E   +  G
Sbjct: 153 LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +    + +PE     + +S  DV+S+GI+L E+ + G RP  +M
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 23/222 (10%)
Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLV 265
           E +IGAG FG V  G L    +    VA+K   V + +  +  F  E  +     H N++
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
            +     GV  +      +V E+M NGSL+ ++          K  G    ++ + +   
Sbjct: 87  HL----EGVVTKSKPV-MIVTEYMENGSLDTFLK---------KNDGQFTVIQLVGMLRG 132
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI-GVEG 384
           ++  +KYL         H DL   NIL++  +   VSDFG++R LE   E   +  G + 
Sbjct: 133 ISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 189
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
              + APE     + +S  DV+S+GI++ E+ + G RP  +M
Sbjct: 190 PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEM 231

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +GAG FG V+ G  + ++T VAVK        + ++F  E  + + ++H  LV+++   +
Sbjct: 20  LGAGQFGEVWMG-YYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                  +   ++ EFMA GSL +++   ++E  +   P      K ++ +  +A  + Y
Sbjct: 78  K-----EEPIYIITEFMAKGSLLDFLK--SDEGGKVLLP------KLIDFSAQIAEGMAY 124
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           +    +    H DL+ +N+L+ + +   ++DFG+AR +E  +E T   G +    + APE
Sbjct: 125 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPE 180
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFT 417
                  +   +V+SFGILL E+ T
Sbjct: 181 AINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 31/233 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           F   NL+G G+F  VY+     +   VA+K+ +   +      +    E ++   ++H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH----PITEEDKRHKAPGNLNSLKR 319
           +++++       F+ +++  LV E   NG +  ++     P +E + RH           
Sbjct: 73  ILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH----------- 116
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                 +   + YLH      I H DL  SN+LL   M   ++DFG+A  L+   E+  +
Sbjct: 117 --FMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT 171
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD-DMFKDNLN 431
           +   GT  YI+PE           DV+S G +   +  G  P D D  K+ LN
Sbjct: 172 LC--GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN 222

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 30/208 (14%)
Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           E  +GAG FG V+    +   T VAVK          ++F  E  V + ++H  LVK+  
Sbjct: 187 EKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 244
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
             +       +   ++ EFMA GSL +++   ++E  +   P      K ++ +  +A  
Sbjct: 245 VVT------KEPIYIITEFMAKGSLLDFLK--SDEGSKQPLP------KLIDFSAQIAEG 290
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           + ++    Q    H DL+ +NIL+   +   ++DFG+AR           +G +    + 
Sbjct: 291 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLAR-----------VGAKFPIKWT 336
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFT 417
           APE       +   DV+SFGILL+E+ T
Sbjct: 337 APEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 23/222 (10%)
Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLV 265
           E +IG+G+ G V  G L    +    VA+K     + +  +  F  E  +     H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           ++     GV  +G     +V E+M NGSL+ ++       + H   G    ++ + +   
Sbjct: 114 RL----EGVVTRGR-LAMIVTEYMENGSLDTFL-------RTHD--GQFTIMQLVGMLRG 159
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE-AADEQTRSIGVEG 384
           V   ++YL         H DL   N+L+D  +   VSDFG++R LE   D    + G + 
Sbjct: 160 VGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
              + APE       SS  DV+SFG+++ E+   G RP  +M
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 39/226 (17%)
Query: 216 GNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTR--NIRHRNLVKVFTACSG 273
           G FG V+K  L      VAVK+F +      +S+  E EV     ++H N+++      G
Sbjct: 35  GRFGCVWKAQLLNEY--VAVKIFPI---QDKQSWQNEYEVYSLPGMKHENILQFI----G 85
Query: 274 VDFQGNDFKA---LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL-NIAIDVACV 329
            + +G        L+  F   GSL +++              N+ S   L +IA  +A  
Sbjct: 86  AEKRGTSVDVDLWLITAFHEKGSLSDFL------------KANVVSWNELCHIAETMARG 133
Query: 330 LKYLHLDC-------QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           L YLH D        +P I+H D+K  N+LL + +TA ++DFG+A   EA      + G 
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193
Query: 383 EGTTGYIAPEYGMG-----HEVSSYGDVYSFGILLLEMFTGLRPSD 423
            GT  Y+APE   G      +     D+Y+ G++L E+ +    +D
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 19/218 (8%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA---VECEVTRNIRHRN 263
           F    ++G G FG V+   +  +    A K  N       K +    VE ++   +  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           +V +  A     F+      LV   M  G +   ++ + E++   + P      + +   
Sbjct: 247 IVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP------RAIFYT 295
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
             +   L++LH   Q  I + DLKP N+LLDD+    +SD G+A  L+A   QT++ G  
Sbjct: 296 AQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYA 350
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT G++APE  +G E     D ++ G+ L EM     P
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 28/230 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVK-VFNVLHHDASKSFAVECEVT--RNIRHRNLVKVFT 269
           +G G+FG V     +++   VA+K +   L   +     VE E++  + +RH +++K++ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
             +       D   +V E+ A G L ++   I E+ +  +  G             + C 
Sbjct: 77  VIT----TPTDI-VMVIEY-AGGELFDY---IVEKKRMTEDEGR-------RFFQQIICA 120
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           ++Y H   +  I H DLKP N+LLDD +   ++DFG++  +   +    S    G+  Y 
Sbjct: 121 IEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYA 174
Query: 390 APEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSDDMFKDNL--NLRNCV 436
           APE   G   +    DV+S GI+L  M  G  P DD F  NL   + +CV
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV 224

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA---VECEVTRNIRHRNLVKV 267
            ++G G FG V+   +  +    A K  N       K +    VE ++   +  R +V +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
             A     F+      LV   M  G +   ++ + E++   + P      + +     + 
Sbjct: 251 AYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP------RAIFYTAQIV 299
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             L++LH   Q  I + DLKP N+LLDD+    +SD G+A  L+A   QT++ G  GT G
Sbjct: 300 SGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPG 354
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           ++APE  +G E     D ++ G+ L EM     P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA---VECEVTRNIRHRNLVKV 267
            ++G G FG V+   +  +    A K  N       K +    VE ++   +  R +V +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
             A     F+      LV   M  G +   ++ + E++   + P      + +     + 
Sbjct: 251 AYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP------RAIFYTAQIV 299
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             L++LH   Q  I + DLKP N+LLDD+    +SD G+A  L+A   QT++ G  GT G
Sbjct: 300 SGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPG 354
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           ++APE  +G E     D ++ G+ L EM     P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA---VECEVTRNIRHRNLVKV 267
            ++G G FG V+   +  +    A K  N       K +    VE ++   +  R +V +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
             A     F+      LV   M  G +   ++ + E++   + P      + +     + 
Sbjct: 251 AYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP------RAIFYTAQIV 299
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             L++LH   Q  I + DLKP N+LLDD+    +SD G+A  L+A   QT++ G  GT G
Sbjct: 300 SGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPG 354
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           ++APE  +G E     D ++ G+ L EM     P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 108/252 (42%), Gaps = 33/252 (13%)
Query: 187 TPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS 246
           +P+ S   +    L +    F    L+G G +G VYKG   ++    A+KV +V   D  
Sbjct: 6   SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEE 64
Query: 247 KSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFK-ALVYEFMANGSLEEWMHPITEE 304
           +    E  + +    HRN+   + A    +  G D +  LV EF   GS       +T+ 
Sbjct: 65  EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGS-------VTDL 117
Query: 305 DKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF 364
            K  K     N+LK   IA     +L+ L    Q  + H D+K  N+LL +     + DF
Sbjct: 118 IKNTKG----NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEV--------SSY---GDVYSFGILLL 413
           G++  L+      R++G   T  +I   Y M  EV        ++Y    D++S GI  +
Sbjct: 174 GVSAQLD------RTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAI 225
Query: 414 EMFTGLRPSDDM 425
           EM  G  P  DM
Sbjct: 226 EMAEGAPPLCDM 237

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS---FAVECEVTRNIRHRNLVKVFT 269
           +G+G FG V  G  ++    VAVK+      + S S   F  E +    + H  LVK + 
Sbjct: 16  LGSGQFGVVKLGK-WKGQYDVAVKMIK----EGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 270 ACSGVDFQGNDFKA-LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
            CS       ++   +V E+++NG L  ++        R    G L   + L +  DV  
Sbjct: 71  VCS------KEYPIYIVTEYISNGCLLNYL--------RSHGKG-LEPSQLLEMCYDVCE 115
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            + +L         H DL   N L+D ++   VSDFG+ R++   D+   S+G +    +
Sbjct: 116 GMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKW 171
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            APE     + SS  DV++FGIL+ E+F+ G  P D
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-KSFAVECEVTRNIRHRNLV 265
           +  + +IG+G    V           VA+K  N+     S      E +      H N+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             +T+     F   D   LV + ++ GS+ + +  I  + + HK+ G L+      I  +
Sbjct: 77  SYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGE-HKS-GVLDESTIATILRE 129
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE-- 383
           V   L+YLH + Q    H D+K  NILL ++ +  ++DFG++ FL    + TR+   +  
Sbjct: 130 VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 384 -GTTGYIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRP 421
            GT  ++APE  +  +V  Y    D++SFGI  +E+ TG  P
Sbjct: 187 VGTPCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 207 FSSENLIGAGNFGSVY---KGILFESTTAVAVKVFN--VLHHDASKSFAVECEVTRNIRH 261
           F    ++G G+FG V+   K    +S    A+KV     L         +E ++  ++ H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSL-----EEWMHPITEEDKRHKAPGNLNS 316
             +VK+  A     FQ      L+ +F+  G L     +E M   TEED +         
Sbjct: 90  PFVVKLHYA-----FQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKF-------- 134
Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
                   ++A  L +LH      I + DLKP NILLD+E    ++DFG+++  EA D +
Sbjct: 135 -----YLAELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHE 184
Query: 377 TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            ++    GT  Y+APE       S   D +S+G+L+ EM TG  P
Sbjct: 185 KKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 96  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 142
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI----GVE 383
             +KYL         H DL   N +LD++ T  V+DFG+AR  +  D++  S+    G +
Sbjct: 143 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEXXSVHNKTGAK 197
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
               ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 240

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 34/226 (15%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F+    IG G+FG V+KGI   +   VA+K+ + L     +   ++ E+T          
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEIT---------- 72
Query: 267 VFTACSG---VDFQGNDFK----ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           V + C       + G+  K     ++ E++  GS  + +            PG L+  + 
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----------PGPLDETQI 121
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             I  ++   L YLH + +    H D+K +N+LL +     ++DFG+A  L   D Q + 
Sbjct: 122 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKR 176
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
               GT  ++APE        S  D++S GI  +E+  G  P  ++
Sbjct: 177 NXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-KSFAVECEVTRNIRHRNLV 265
           +  + +IG+G    V           VA+K  N+     S      E +      H N+V
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             +T+     F   D   LV + ++ GS+ + +  I  + + HK+ G L+      I  +
Sbjct: 72  SYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGE-HKS-GVLDESTIATILRE 124
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE-- 383
           V   L+YLH + Q    H D+K  NILL ++ +  ++DFG++ FL    + TR+   +  
Sbjct: 125 VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 181
Query: 384 -GTTGYIAPEYGMGHEVSSY---GDVYSFGILLLEMFTGLRP 421
            GT  ++APE  +  +V  Y    D++SFGI  +E+ TG  P
Sbjct: 182 VGTPCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 34/226 (15%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F+    IG G+FG V+KGI   +   VA+K+ + L     +   ++ E+T          
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEIT---------- 57
Query: 267 VFTACSG---VDFQGNDFK----ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           V + C       + G+  K     ++ E++  GS  + +            PG L+  + 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----------PGPLDETQI 106
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             I  ++   L YLH + +    H D+K +N+LL +     ++DFG+A  L   D Q + 
Sbjct: 107 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKR 161
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
               GT  ++APE        S  D++S GI  +E+  G  P  ++
Sbjct: 162 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 34/226 (15%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F+    IG G+FG V+KGI   +   VA+K+ + L     +   ++ E+T          
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEIT---------- 57
Query: 267 VFTACSG---VDFQGNDFK----ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           V + C       + G+  K     ++ E++  GS  + +            PG L+  + 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----------PGPLDETQI 106
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             I  ++   L YLH + +    H D+K +N+LL +     ++DFG+A  L   D Q + 
Sbjct: 107 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKR 161
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
               GT  ++APE        S  D++S GI  +E+  G  P  ++
Sbjct: 162 NXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 34/226 (15%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F+  + IG G+FG VYKGI   +   VA+K+ + L     +   ++ E+T          
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIID-LEEAEDEIEDIQQEIT---------- 69
Query: 267 VFTACSG---VDFQGNDFKA----LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           V + C       + G+  K+    ++ E++  GS  + +            PG L     
Sbjct: 70  VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL-----------KPGPLEETYI 118
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             I  ++   L YLH + +    H D+K +N+LL ++    ++DFG+A  L   D Q + 
Sbjct: 119 ATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKR 173
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
               GT  ++APE           D++S GI  +E+  G  P+ D+
Sbjct: 174 NXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 219

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 116 LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 162
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI----GVE 383
             +KYL         H DL   N +LD++ T  V+DFG+AR  +  D++  S+    G +
Sbjct: 163 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAK 217
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
               ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 218 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 260

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 115 LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 161
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI----GVE 383
             +KYL         H DL   N +LD++ T  V+DFG+AR  +  D++  S+    G +
Sbjct: 162 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAK 216
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
               ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 217 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 259

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/260 (22%), Positives = 108/260 (41%), Gaps = 25/260 (9%)
Query: 183 RGNPTPSISFPYVSYR--MLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVA---VKV 237
           +G P P    P  + R  M YN    F  E  IG G F  VY+         VA   V++
Sbjct: 9   QGPPVPQFQ-PQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI 67
Query: 238 FNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW 297
           F+++   A      E ++ + + H N++K + +     F  ++   +V E    G L   
Sbjct: 68  FDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS-----FIEDNELNIVLELADAGDLSRM 122
Query: 298 MHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM 357
           +    ++ +       +         + +   L+++H      + H D+KP+N+ +    
Sbjct: 123 IKHFKKQKRL------IPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATG 173
Query: 358 TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              + D G+ RF  +  + T +  + GT  Y++PE    +  +   D++S G LL EM  
Sbjct: 174 VVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231
Query: 418 GLRPSDDMFKDNLNLRNCVK 437
              P    + D +NL +  K
Sbjct: 232 LQSP---FYGDKMNLYSLCK 248

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 213 IGAGNFGSVYKGILFES----------TTAVAVKVFNVLHHDASK----SFAVECEVTRN 258
           +G G FG V   +L E+           T VAVK+   L  DA++        E E+ + 
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKM---LKSDATEKDLSDLISEMEMMKM 89
Query: 259 I-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH---PITEE---DKRHKAP 311
           I +H+N++ +  AC+    Q      +V E+ + G+L E++    P   E   +  H   
Sbjct: 90  IGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEFSFNPSHNPE 144
Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
             L+S   ++ A  VA  ++YL         H DL   N+L+ ++    ++DFG+AR + 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 372 AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             D   ++        ++APE       +   DV+SFG+LL E+FT
Sbjct: 202 HIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 89  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 135
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI----GVE 383
             +KYL         H DL   N +LD++ T  V+DFG+AR  +  D++  S+    G +
Sbjct: 136 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAK 190
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
               ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 191 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 233

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 34/226 (15%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F+    IG G+FG V+KGI   +   VA+K+ + L     +   ++ E+T          
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEIT---------- 77
Query: 267 VFTACSG---VDFQGNDFK----ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           V + C       + G+  K     ++ E++  GS  + +            PG L+  + 
Sbjct: 78  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----------PGPLDETQI 126
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             I  ++   L YLH + +    H D+K +N+LL +     ++DFG+A  L   D Q + 
Sbjct: 127 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKR 181
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
               GT  ++APE        S  D++S GI  +E+  G  P  ++
Sbjct: 182 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 97  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 143
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI----GVE 383
             +KYL         H DL   N +LD++ T  V+DFG+AR  +  D++  S+    G +
Sbjct: 144 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAK 198
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
               ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 241

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY--- 70
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L     +A V+ 
Sbjct: 71  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL-----MAGVV- 118
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 34/226 (15%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F+    IG G+FG V+KGI   +   VA+K+ + L     +   ++ E+T          
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID-LEEAEDEIEDIQQEIT---------- 73
Query: 267 VFTACSG---VDFQGNDFKA----LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           V + C       + G+  K     ++ E++  GS  + +             G  +  + 
Sbjct: 74  VLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA-----------GPFDEFQI 122
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             +  ++   L YLH + +    H D+K +N+LL ++    ++DFG+A  L   D Q + 
Sbjct: 123 ATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKR 177
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
               GT  ++APE        S  D++S GI  +E+  G  P+ DM
Sbjct: 178 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY--- 71
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L     +A V+ 
Sbjct: 72  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL-----MAGVV- 119
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 94  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 140
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI----GVE 383
             +KYL         H DL   N +LD++ T  V+DFG+AR  +  D++  S+    G +
Sbjct: 141 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAK 195
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
               ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 95  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 141
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI----GVE 383
             +KYL         H DL   N +LD++ T  V+DFG+AR  +  D++  S+    G +
Sbjct: 142 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAK 196
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
               ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 239

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 97  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 143
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI----GVE 383
             +KYL         H DL   N +LD++ T  V+DFG+AR  +  D++  S+    G +
Sbjct: 144 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAK 198
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
               ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 241

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 96  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 142
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI----GVE 383
             +KYL         H DL   N +LD++ T  V+DFG+AR  +  D++  S+    G +
Sbjct: 143 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAK 197
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
               ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 240

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 16/167 (9%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAP 311
           E E+ RN+ H N+VK    C+  +  GN  K L+ EF+ +GSL+E++          K  
Sbjct: 61  EIEILRNLYHENIVKYKGICT--EDGGNGIK-LIMEFLPSGSLKEYLP---------KNK 108
Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
             +N  ++L  A+ +   + YL         H DL   N+L++ E    + DFG+ + +E
Sbjct: 109 NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 165
Query: 372 AADE-QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              E  T     +    + APE  M  +     DV+SFG+ L E+ T
Sbjct: 166 TDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 16/167 (9%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAP 311
           E E+ RN+ H N+VK    C+  +  GN  K L+ EF+ +GSL+E++          K  
Sbjct: 73  EIEILRNLYHENIVKYKGICT--EDGGNGIK-LIMEFLPSGSLKEYLP---------KNK 120
Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
             +N  ++L  A+ +   + YL         H DL   N+L++ E    + DFG+ + +E
Sbjct: 121 NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177
Query: 372 AADE-QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              E  T     +    + APE  M  +     DV+SFG+ L E+ T
Sbjct: 178 TDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 92  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 138
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI----GVE 383
             +KYL         H DL   N +LD++ T  V+DFG+AR  +  D++  S+    G +
Sbjct: 139 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAK 193
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
               ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 213 IGAGNFGSVYKGILFES----------TTAVAVKVFNVLHHDASK----SFAVECEVTRN 258
           +G G FG V   +L E+           T VAVK+   L  DA++        E E+ + 
Sbjct: 77  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKM---LKSDATEKDLSDLISEMEMMKM 130
Query: 259 I-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH----PITEE--DKRHKAP 311
           I +H+N++ +  AC+    Q      +V E+ + G+L E++     P  E   +  H   
Sbjct: 131 IGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
             L+S   ++ A  VA  ++YL         H DL   N+L+ ++    ++DFG+AR + 
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 372 AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             D   ++        ++APE       +   DV+SFG+LL E+FT
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 213 IGAGNFGSVYKGILFES----------TTAVAVKVFNVLHHDASK----SFAVECEVTRN 258
           +G G FG V   +L E+           T VAVK+   L  DA++        E E+ + 
Sbjct: 25  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKM---LKSDATEKDLSDLISEMEMMKM 78
Query: 259 I-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH----PITEE--DKRHKAP 311
           I +H+N++ +  AC+    Q      +V E+ + G+L E++     P  E   +  H   
Sbjct: 79  IGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPE 133
Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
             L+S   ++ A  VA  ++YL         H DL   N+L+ ++    ++DFG+AR + 
Sbjct: 134 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 190
Query: 372 AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             D   ++        ++APE       +   DV+SFG+LL E+FT
Sbjct: 191 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 117/262 (44%), Gaps = 53/262 (20%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV--TRNIRHRNLVKVFTA 270
           +G G +G V++G+    +  VAVK+F+       +S+  E E+  T  +RH N++  F A
Sbjct: 16  VGKGRYGEVWRGLWHGES--VAVKIFS---SRDEQSWFRETEIYNTVLLRHDNILG-FIA 69
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                   +    L+  +  +GSL +++   T E   H A         L +A+  AC L
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEP--HLA---------LRLAVSAACGL 118
Query: 331 KYLHLDC-----QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE-- 383
            +LH++      +P IAH D K  N+L+   +   ++D G+A  + +       IG    
Sbjct: 119 AHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPR 177
Query: 384 -GTTGYIAPEYGMGHEVSS-------YGDVYSFGILLLEM----------------FTGL 419
            GT  Y+APE  +  ++ +       + D+++FG++L E+                F  +
Sbjct: 178 VGTKRYMAPEV-LDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDV 236
Query: 420 RPSDDMFKDNLNLRNCVKSALP 441
            P+D  F+D +    CV    P
Sbjct: 237 VPNDPSFED-MKKVVCVDQQTP 257

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 96/221 (43%), Gaps = 24/221 (10%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEV-TRNIR 260
           + F    ++G G+FG V+     ++    A+K      VL  D  +   VE  V +    
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 77
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H  L  +F  C+   FQ  +    V E++  G L   M+ I    K   +          
Sbjct: 78  HPFLTHMF--CT---FQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATF------ 123
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
             A ++   L++LH      I + DLK  NILLD +    ++DFG+ +     D +T   
Sbjct: 124 -YAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEF 179
Query: 381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
              GT  YIAPE  +G + +   D +SFG+LL EM  G  P
Sbjct: 180 C--GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 19/220 (8%)
Query: 202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIR 260
           +++  F     +G G + +VYKG+   +   VA+K   +   + + S A+ E  + + ++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+V+++           +   LV+EFM N  L+++M      D R    GN      L
Sbjct: 62  HENIVRLYDV-----IHTENKLTLVFEFMDN-DLKKYM------DSR--TVGNTPRGLEL 107
Query: 321 NIAIDVAC-VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
           N+       +L+ L    +  I H DLKP N+L++      + DFG+AR          S
Sbjct: 108 NLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYG-DVYSFGILLLEMFTG 418
             V  T  Y AP+  MG    S   D++S G +L EM TG
Sbjct: 168 EVV--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG 205

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 213 IGAGNFGSVYKGILFES----------TTAVAVKVFNVLHHDASK----SFAVECEVTRN 258
           +G G FG V   +L E+           T VAVK+   L  DA++        E E+ + 
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKM---LKSDATEKDLSDLISEMEMMKM 89
Query: 259 I-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH----PITEE--DKRHKAP 311
           I +H+N++ +  AC+    Q      +V E+ + G+L E++     P  E   +  H   
Sbjct: 90  IGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPE 144
Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
             L+S   ++ A  VA  ++YL         H DL   N+L+ ++    ++DFG+AR + 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 372 AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             D   ++        ++APE       +   DV+SFG+LL E+FT
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 213 IGAGNFGSVYKGILFES----------TTAVAVKVFNVLHHDASK----SFAVECEVTRN 258
           +G G FG V   +L E+           T VAVK+   L  DA++        E E+ + 
Sbjct: 28  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKM---LKSDATEKDLSDLISEMEMMKM 81
Query: 259 I-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH----PITEE--DKRHKAP 311
           I +H+N++ +  AC+    Q      +V E+ + G+L E++     P  E   +  H   
Sbjct: 82  IGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPE 136
Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
             L+S   ++ A  VA  ++YL         H DL   N+L+ ++    ++DFG+AR + 
Sbjct: 137 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 193
Query: 372 AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             D   ++        ++APE       +   DV+SFG+LL E+FT
Sbjct: 194 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 213 IGAGNFGSVYKGILFES----------TTAVAVKVFNVLHHDASK----SFAVECEVTRN 258
           +G G FG V   +L E+           T VAVK+   L  DA++        E E+ + 
Sbjct: 21  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKM---LKSDATEKDLSDLISEMEMMKM 74
Query: 259 I-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH----PITEE--DKRHKAP 311
           I +H+N++ +  AC+    Q      +V E+ + G+L E++     P  E   +  H   
Sbjct: 75  IGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPE 129
Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
             L+S   ++ A  VA  ++YL         H DL   N+L+ ++    ++DFG+AR + 
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 372 AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             D   ++        ++APE       +   DV+SFG+LL E+FT
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       D  + F  E ++ + +    +VK  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY- 73
Query: 269 TACSGVDF-QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
               GV +  G     LV E++ +G L +++       +RH+A   L++ + L  +  + 
Sbjct: 74  ---RGVSYGPGRPELRLVMEYLPSGCLRDFL-------QRHRA--RLDASRLLLYSSQIC 121
Query: 328 CVLKYL-HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
             ++YL    C     H DL   NIL++ E    ++DFG+A+ L   D+    +   G +
Sbjct: 122 KGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDXXVVREPGQS 176
Query: 387 G--YIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              + APE    +  S   DV+SFG++L E+FT
Sbjct: 177 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 213 IGAGNFGSVYKGILFES----------TTAVAVKVFNVLHHDASK----SFAVECEVTRN 258
           +G G FG V   +L E+           T VAVK+   L  DA++        E E+ + 
Sbjct: 29  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKM---LKSDATEKDLSDLISEMEMMKM 82
Query: 259 I-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH----PITEE--DKRHKAP 311
           I +H+N++ +  AC+    Q      +V E+ + G+L E++     P  E   +  H   
Sbjct: 83  IGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPE 137
Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
             L+S   ++ A  VA  ++YL         H DL   N+L+ ++    ++DFG+AR + 
Sbjct: 138 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 194
Query: 372 AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             D   ++        ++APE       +   DV+SFG+LL E+FT
Sbjct: 195 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 213 IGAGNFGSVYKGILFES----------TTAVAVKVFNVLHHDASK----SFAVECEVTRN 258
           +G G FG V   +L E+           T VAVK+   L  DA++        E E+ + 
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKM---LKSDATEKDLSDLISEMEMMKM 89
Query: 259 I-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH----PITEE--DKRHKAP 311
           I +H+N++ +  AC+    Q      +V E+ + G+L E++     P  E   +  H   
Sbjct: 90  IGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPE 144
Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
             L+S   ++ A  VA  ++YL         H DL   N+L+ ++    ++DFG+AR + 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 372 AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             D   ++        ++APE       +   DV+SFG+LL E+FT
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 112/251 (44%), Gaps = 41/251 (16%)
Query: 183 RGNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFES---TTAVAVKVFN 239
           + NP P+I +P + +            +++IG GNFG V K  + +      A   ++  
Sbjct: 1   KNNPDPTI-YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE 52
Query: 240 VLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM 298
               D  + FA E EV   +  H N++ +  AC     +   +  L  E+  +G+L +++
Sbjct: 53  YASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFL 107
Query: 299 HP--ITEEDKR----HKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNIL 352
               + E D      +     L+S + L+ A DVA  + YL    Q    H DL   NIL
Sbjct: 108 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNIL 164
Query: 353 LDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSY------GDVY 406
           + +   A ++DFG++R  E        + V+ T G + P   M  E  +Y       DV+
Sbjct: 165 VGENYVAKIADFGLSRGQE--------VYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVW 215
Query: 407 SFGILLLEMFT 417
           S+G+LL E+ +
Sbjct: 216 SYGVLLWEIVS 226

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 213 IGAGNFGSVYKGILFES----------TTAVAVKVFNVLHHDASK----SFAVECEVTRN 258
           +G G FG V   +L E+           T VAVK+   L  DA++        E E+ + 
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKM---LKSDATEKDLSDLISEMEMMKM 89
Query: 259 I-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH----PITEE--DKRHKAP 311
           I +H+N++ +  AC+    Q      +V E+ + G+L E++     P  E   +  H   
Sbjct: 90  IGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQAREPPGLEYSYNPSHNPE 144
Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
             L+S   ++ A  VA  ++YL         H DL   N+L+ ++    ++DFG+AR + 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 372 AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             D   ++        ++APE       +   DV+SFG+LL E+FT
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 112/251 (44%), Gaps = 41/251 (16%)
Query: 183 RGNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFES---TTAVAVKVFN 239
           + NP P+I +P + +            +++IG GNFG V K  + +      A   ++  
Sbjct: 11  KNNPDPTI-YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE 62
Query: 240 VLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM 298
               D  + FA E EV   +  H N++ +  AC     +   +  L  E+  +G+L +++
Sbjct: 63  YASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFL 117
Query: 299 HP--ITEEDKR----HKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNIL 352
               + E D      +     L+S + L+ A DVA  + YL    Q    H DL   NIL
Sbjct: 118 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNIL 174
Query: 353 LDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSY------GDVY 406
           + +   A ++DFG++R  E        + V+ T G + P   M  E  +Y       DV+
Sbjct: 175 VGENYVAKIADFGLSRGQE--------VYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVW 225
Query: 407 SFGILLLEMFT 417
           S+G+LL E+ +
Sbjct: 226 SYGVLLWEIVS 236

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 115/255 (45%), Gaps = 26/255 (10%)
Query: 176 RLMCMKKRGNP-TPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVA 234
           RL+  ++   P TPS   P  +   +   T+ F    ++G+G FG+VYKG+       V 
Sbjct: 20  RLLQERELVEPLTPSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVK 78
Query: 235 VKVFNVLHHDAS-----KSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFM 289
           + V  +   +A+     K    E  V  ++ + ++ ++   C     Q      L+ + M
Sbjct: 79  IPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLM 132
Query: 290 ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPS 349
             G L +++       + HK   N+ S   LN  + +A  + YL       + H DL   
Sbjct: 133 PFGCLLDYV-------REHK--DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAAR 180
Query: 350 NILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFG 409
           N+L+       ++DFG+A+ L A +++  + G +    ++A E  +    +   DV+S+G
Sbjct: 181 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 240
Query: 410 ILLLEMFT-GLRPSD 423
           + + E+ T G +P D
Sbjct: 241 VTVWELMTFGSKPYD 255

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 33/235 (14%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
           ++G G FG   K    E+   + +K       +  ++F  E +V R + H N++K     
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI--- 73
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            GV ++       + E++  G+L   +  +  +      P +    +R++ A D+A  + 
Sbjct: 74  -GVLYKDKRLN-FITEYIKGGTLRGIIKSMDSQ-----YPWS----QRVSFAKDIASGMA 122
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG---------- 381
           YLH      I H DL   N L+ +     V+DFG+AR +   DE+T+  G          
Sbjct: 123 YLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLM--VDEKTQPEGLRSLKKPDRK 177
Query: 382 ----VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 432
               V G   ++APE   G       DV+SFGI+L E+   +    D     ++ 
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 105/252 (41%), Gaps = 41/252 (16%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG VYK    E++   A KV +    +  + + VE ++  +  H N+VK+  A  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 103
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWM----HPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
              +  N+   L+ EF A G+++  M     P+TE   +      L++            
Sbjct: 104 ---YYENNLWILI-EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA------------ 147
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE----G 384
            L YLH      I H DLK  NIL   +    ++DFG++       + TR+I       G
Sbjct: 148 -LNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSA------KNTRTIQRRDSFIG 197
Query: 385 TTGYIAPEYGM-----GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA 439
           T  ++APE  M             DV+S GI L+EM   + P          L    KS 
Sbjct: 198 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM-AEIEPPHHELNPMRVLLKIAKSE 256
Query: 440 LPERAEEIRASS 451
            P  A+  R SS
Sbjct: 257 PPTLAQPSRWSS 268

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       D  + F  E ++ + +    +VK  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY- 77
Query: 269 TACSGVDF-QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
               GV +  G     LV E++ +G L +++       +RH+A   L++ + L  +  + 
Sbjct: 78  ---RGVSYGPGRQSLRLVMEYLPSGCLRDFL-------QRHRA--RLDASRLLLYSSQIC 125
Query: 328 CVLKYL-HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
             ++YL    C     H DL   NIL++ E    ++DFG+A+ L   D+    +   G +
Sbjct: 126 KGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQS 180
Query: 387 G--YIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              + APE    +  S   DV+SFG++L E+FT
Sbjct: 181 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G++GSVYK I  E+   VA+K              VE ++   I+  ++++   +  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIK-----------QVPVESDLQEIIKEISIMQQCDSPH 85
Query: 273 GVDFQGNDFK----ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
            V + G+ FK     +V E+   GS+ + +        R+K      +L    IA  +  
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR------LRNK------TLTEDEIATILQS 133
Query: 329 VLK---YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
            LK   YLH   +    H D+K  NILL+ E  A ++DFG+A  L   D   +   V GT
Sbjct: 134 TLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGT 188
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
             ++APE       +   D++S GI  +EM  G  P  D+
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 111/261 (42%), Gaps = 49/261 (18%)
Query: 190 ISFPYVSYRMLYNATKGFSSENLI-----GAGNFGSVYKGILFE-----STTAVAVKVFN 239
           +S    ++++L +    F  +NL+     G G FG V K   F        T VAVK+  
Sbjct: 3   LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM-- 60
Query: 240 VLHHDASKS----FAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLE 295
            L  +AS S       E  V + + H +++K++ ACS    Q      L+ E+   GSL 
Sbjct: 61  -LKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS----QDGPL-LLIVEYAKYGSLR 114
Query: 296 EWMHP-------------------ITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLD 336
            ++                     +   D+R    G+L     ++ A  ++  ++YL   
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDL-----ISFAWQISQGMQYL--- 166
Query: 337 CQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG 396
            +  + H DL   NIL+ +     +SDFG++R +   D   +         ++A E    
Sbjct: 167 AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFD 226
Query: 397 HEVSSYGDVYSFGILLLEMFT 417
           H  ++  DV+SFG+LL E+ T
Sbjct: 227 HIYTTQSDVWSFGVLLWEIVT 247

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY--- 70
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L     +A V+ 
Sbjct: 71  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL-----MAGVV- 118
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L     +A V+ 
Sbjct: 71  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL-----MAGVV- 118
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L     +A V+ 
Sbjct: 71  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL-----MAGVV- 118
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 38/221 (17%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI--RHRNLVKVFTA 270
           IG G FG V++G        VAVK+F+       +S+  E E+ + +  RH N++  F A
Sbjct: 50  IGKGRFGEVWRGKW--RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILG-FIA 103
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
               D        LV ++  +GSL ++++  T           +     + +A+  A  L
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----------VTVEGMIKLALSTASGL 152
Query: 331 KYLHLDC-----QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE-- 383
            +LH++      +P IAH DLK  NIL+    T  ++D G+A      D  T +I +   
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPN 209
Query: 384 ---GTTGYIAPEY-----GMGH-EVSSYGDVYSFGILLLEM 415
              GT  Y+APE       M H E     D+Y+ G++  E+
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 111/261 (42%), Gaps = 49/261 (18%)
Query: 190 ISFPYVSYRMLYNATKGFSSENLI-----GAGNFGSVYKGILFE-----STTAVAVKVFN 239
           +S    ++++L +    F  +NL+     G G FG V K   F        T VAVK+  
Sbjct: 3   LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM-- 60
Query: 240 VLHHDASKS----FAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLE 295
            L  +AS S       E  V + + H +++K++ ACS    Q      L+ E+   GSL 
Sbjct: 61  -LKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS----QDGPL-LLIVEYAKYGSLR 114
Query: 296 EWMHP-------------------ITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLD 336
            ++                     +   D+R    G+L     ++ A  ++  ++YL   
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDL-----ISFAWQISQGMQYL--- 166
Query: 337 CQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG 396
            +  + H DL   NIL+ +     +SDFG++R +   D   +         ++A E    
Sbjct: 167 AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFD 226
Query: 397 HEVSSYGDVYSFGILLLEMFT 417
           H  ++  DV+SFG+LL E+ T
Sbjct: 227 HIYTTQSDVWSFGVLLWEIVT 247

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       D  + F  E ++ + +    +VK  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY- 76
Query: 269 TACSGVDF-QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
               GV +  G     LV E++ +G L +++       +RH+A   L++ + L  +  + 
Sbjct: 77  ---RGVSYGPGRQSLRLVMEYLPSGCLRDFL-------QRHRA--RLDASRLLLYSSQIC 124
Query: 328 CVLKYL-HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
             ++YL    C     H DL   NIL++ E    ++DFG+A+ L   D+    +   G +
Sbjct: 125 KGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQS 179
Query: 387 G--YIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              + APE    +  S   DV+SFG++L E+FT
Sbjct: 180 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 106/261 (40%), Gaps = 43/261 (16%)
Query: 199 MLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD--ASKSFAVECEVT 256
           + + + + + +  L+G G++G V K    ++   VA+K F     D    K    E ++ 
Sbjct: 19  LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLL 78
Query: 257 RNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNS 316
           + +RH NLV +   C     +      LV+EF+         H I            L+ 
Sbjct: 79  KQLRHENLVNLLEVC-----KKKKRWYLVFEFVD--------HTI------------LDD 113
Query: 317 LKRLNIAIDVACVLKYLHLD------CQPP-IAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           L+     +D   V KYL         C    I H D+KP NIL+       + DFG AR 
Sbjct: 114 LELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART 173
Query: 370 LEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTG--LRPSDD 424
           L A  E         T  Y APE  +G     YG   DV++ G L+ EMF G  L P D 
Sbjct: 174 LAAPGEVYDD--EVATRWYRAPELLVGD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229
Query: 425 MFKDNLNLRNCVKSALPERAE 445
                 ++  C+ + +P   E
Sbjct: 230 DIDQLYHIMMCLGNLIPRHQE 250

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 156 LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 202
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR--FLEAADEQTRSIGVEGT 385
             +K+L         H DL   N +LD++ T  V+DFG+AR  + +  D      G +  
Sbjct: 203 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L     +A V+ 
Sbjct: 71  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL-----MAGVV- 118
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 21/222 (9%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G   FG VYKG LF     E T AVA+K   +       + F  E  +   ++H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWM------HPITEEDKRHKAPGNLNSLKRL 320
           +    +      +   ++++ + ++G L E++        +   D        L     +
Sbjct: 94  LLGVVTK-----DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
           ++   +A  ++YL       + H DL   N+L+ D++   +SD G+ R + AAD      
Sbjct: 149 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 205
Query: 381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
                  ++APE  M  + S   D++S+G++L E+F+ GL+P
Sbjct: 206 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI------RHRNL 264
           + +G G FG V  G    +   VAVK+ N       +S  V  ++ R I      RH ++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILN---RQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +K++   S       DF  +V E+++ G L +++        +H   G +  ++   +  
Sbjct: 74  IKLYQVIS----TPTDF-FMVMEYVSGGELFDYI-------CKH---GRVEEMEARRLFQ 118
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +   + Y H   +  + H DLKP N+LLD  M A ++DFG++  +   +    S    G
Sbjct: 119 QILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---G 172
Query: 385 TTGYIAPEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSDD 424
           +  Y APE   G   +    D++S G++L  +  G  P DD
Sbjct: 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G GNFGSV    Y  +   +   VAVK       D  + F  E ++ + +    +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY- 89
Query: 269 TACSGVDF-QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
               GV +  G     LV E++ +G L +++       +RH+A   L++ + L  +  + 
Sbjct: 90  ---RGVSYGPGRQSLRLVMEYLPSGCLRDFL-------QRHRA--RLDASRLLLYSSQIC 137
Query: 328 CVLKYL-HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
             ++YL    C     H DL   NIL++ E    ++DFG+A+ L   D+    +   G +
Sbjct: 138 KGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQS 192
Query: 387 G--YIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              + APE    +  S   DV+SFG++L E+FT
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 38/221 (17%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI--RHRNLVKVFTA 270
           IG G FG V++G        VAVK+F+       +S+  E E+ + +  RH N++  F A
Sbjct: 11  IGKGRFGEVWRGKW--RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILG-FIA 64
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
               D        LV ++  +GSL ++++  T           +     + +A+  A  L
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----------VTVEGMIKLALSTASGL 113
Query: 331 KYLHLDC-----QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE-- 383
            +LH++      +P IAH DLK  NIL+    T  ++D G+A      D  T +I +   
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPN 170
Query: 384 ---GTTGYIAPEY-----GMGH-EVSSYGDVYSFGILLLEM 415
              GT  Y+APE       M H E     D+Y+ G++  E+
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 38/221 (17%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI--RHRNLVKVFTA 270
           IG G FG V++G        VAVK+F+       +S+  E E+ + +  RH N++  F A
Sbjct: 17  IGKGRFGEVWRGKW--RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILG-FIA 70
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
               D        LV ++  +GSL ++++  T           +     + +A+  A  L
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----------VTVEGMIKLALSTASGL 119
Query: 331 KYLHLDC-----QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE-- 383
            +LH++      +P IAH DLK  NIL+    T  ++D G+A      D  T +I +   
Sbjct: 120 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPN 176
Query: 384 ---GTTGYIAPEY-----GMGH-EVSSYGDVYSFGILLLEM 415
              GT  Y+APE       M H E     D+Y+ G++  E+
Sbjct: 177 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 38/221 (17%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI--RHRNLVKVFTA 270
           IG G FG V++G        VAVK+F+       +S+  E E+ + +  RH N++  F A
Sbjct: 37  IGKGRFGEVWRGKW--RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILG-FIA 90
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
               D        LV ++  +GSL ++++  T           +     + +A+  A  L
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----------VTVEGMIKLALSTASGL 139
Query: 331 KYLHLDC-----QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE-- 383
            +LH++      +P IAH DLK  NIL+    T  ++D G+A      D  T +I +   
Sbjct: 140 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPN 196
Query: 384 ---GTTGYIAPEY-----GMGH-EVSSYGDVYSFGILLLEM 415
              GT  Y+APE       M H E     D+Y+ G++  E+
Sbjct: 197 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 81  PHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYV-------REHK--DNIGSQYLLN 125
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 126 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 182
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 38/221 (17%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI--RHRNLVKVFTA 270
           IG G FG V++G        VAVK+F+       +S+  E E+ + +  RH N++  F A
Sbjct: 12  IGKGRFGEVWRGKW--RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILG-FIA 65
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
               D        LV ++  +GSL ++++  T           +     + +A+  A  L
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----------VTVEGMIKLALSTASGL 114
Query: 331 KYLHLDC-----QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE-- 383
            +LH++      +P IAH DLK  NIL+    T  ++D G+A      D  T +I +   
Sbjct: 115 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPN 171
Query: 384 ---GTTGYIAPEY-----GMGH-EVSSYGDVYSFGILLLEM 415
              GT  Y+APE       M H E     D+Y+ G++  E+
Sbjct: 172 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 78  PHVCRLLGICLTSTVQ------LIMQLMPFGXLLDYV-------REHK--DNIGSQYLLN 122
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 123 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 179
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 180 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 80  PHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYV-------REHK--DNIGSQYLLN 124
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 125 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEV-TRNIRHR 262
           F    ++G G+FG V+     ++    A+K      VL  D  +   VE  V +    H 
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
            L  +F  C+   FQ  +    V E++  G L   M+ I    K   +            
Sbjct: 79  FLTHMF--CT---FQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATF-------Y 123
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           A ++   L++LH      I + DLK  NILLD +    ++DFG+ +     D +T     
Sbjct: 124 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC- 179
Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            GT  YIAPE  +G + +   D +SFG+LL EM  G  P
Sbjct: 180 -GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 111/261 (42%), Gaps = 49/261 (18%)
Query: 190 ISFPYVSYRMLYNATKGFSSENLI-----GAGNFGSVYKGILFE-----STTAVAVKVFN 239
           +S    ++++L +    F  +NL+     G G FG V K   F        T VAVK+  
Sbjct: 3   LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM-- 60
Query: 240 VLHHDASKS----FAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLE 295
            L  +AS S       E  V + + H +++K++ ACS    Q      L+ E+   GSL 
Sbjct: 61  -LKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS----QDGPL-LLIVEYAKYGSLR 114
Query: 296 EWMHP-------------------ITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLD 336
            ++                     +   D+R    G+L     ++ A  ++  ++YL   
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDL-----ISFAWQISQGMQYL--- 166
Query: 337 CQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG 396
            +  + H DL   NIL+ +     +SDFG++R +   D   +         ++A E    
Sbjct: 167 AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD 226
Query: 397 HEVSSYGDVYSFGILLLEMFT 417
           H  ++  DV+SFG+LL E+ T
Sbjct: 227 HIYTTQSDVWSFGVLLWEIVT 247

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI------RHRNL 264
           + +G G FG V  G    +   VAVK+ N       +S  V  ++ R I      RH ++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILN---RQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +K++   S       DF  +V E+++ G L +++        +H   G +  ++   +  
Sbjct: 74  IKLYQVIS----TPTDF-FMVMEYVSGGELFDYI-------CKH---GRVEEMEARRLFQ 118
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +   + Y H   +  + H DLKP N+LLD  M A ++DFG++  +   +    S    G
Sbjct: 119 QILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---G 172
Query: 385 TTGYIAPEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSDD 424
           +  Y APE   G   +    D++S G++L  +  G  P DD
Sbjct: 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 38/221 (17%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI--RHRNLVKVFTA 270
           IG G FG V++G        VAVK+F+       +S+  E E+ + +  RH N++  F A
Sbjct: 14  IGKGRFGEVWRGKW--RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILG-FIA 67
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
               D        LV ++  +GSL ++++  T           +     + +A+  A  L
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----------VTVEGMIKLALSTASGL 116
Query: 331 KYLHLDC-----QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE-- 383
            +LH++      +P IAH DLK  NIL+    T  ++D G+A      D  T +I +   
Sbjct: 117 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPN 173
Query: 384 ---GTTGYIAPEY-----GMGH-EVSSYGDVYSFGILLLEM 415
              GT  Y+APE       M H E     D+Y+ G++  E+
Sbjct: 174 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 97  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 143
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR--FLEAADEQTRSIGVEGT 385
             +K+L         H DL   N +LD++ T  V+DFG+AR  + +  D      G +  
Sbjct: 144 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 200
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 241

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 102 LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 148
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR--FLEAADEQTRSIGVEGT 385
             +K+L         H DL   N +LD++ T  V+DFG+AR  + +  D      G +  
Sbjct: 149 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 205
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 206 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 246

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 98  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 144
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR--FLEAADEQTRSIGVEGT 385
             +K+L         H DL   N +LD++ T  V+DFG+AR  + +  D      G +  
Sbjct: 145 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 201
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 202 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 242

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 79  PHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYV-------REHK--DNIGSQYLLN 123
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 124 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 180
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 78  PHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYV-------REHK--DNIGSQYLLN 122
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 123 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 179
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 180 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 77  PHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYV-------REHK--DNIGSQYLLN 121
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 122 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 77  PHVCRLLGICLTSTVQ------LITQLMPFGXLLDYV-------REHK--DNIGSQYLLN 121
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 122 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 13/219 (5%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFE---STTAVAVKVF--NVLHHDASKSFAVECEVTRNI 259
           + F+   ++G G FGSV +  L +   S   VAVK+   +++     + F  E    +  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 260 RHRNLVKVFTACSGVDFQGN-DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLK 318
            H ++ K+         +G      ++  FM +G L    H      +  + P NL    
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDL----HAFLLASRIGENPFNLPLQT 138
Query: 319 RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
            +   +D+AC ++YL         H DL   N +L ++MT  V+DFG++R + + D   +
Sbjct: 139 LVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195
Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               +    ++A E    +  + + DV++FG+ + E+ T
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 104/252 (41%), Gaps = 41/252 (16%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG VYK    E++   A KV +    +  + + VE ++  +  H N+VK+  A  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 103
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWM----HPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
              +  N+   L+ EF A G+++  M     P+TE   +      L++            
Sbjct: 104 ---YYENNLWILI-EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA------------ 147
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE----G 384
            L YLH      I H DLK  NIL   +    ++DFG++       + TR I       G
Sbjct: 148 -LNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSA------KNTRXIQRRDSFIG 197
Query: 385 TTGYIAPEYGM-----GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA 439
           T  ++APE  M             DV+S GI L+EM   + P          L    KS 
Sbjct: 198 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM-AEIEPPHHELNPMRVLLKIAKSE 256
Query: 440 LPERAEEIRASS 451
            P  A+  R SS
Sbjct: 257 PPTLAQPSRWSS 268

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 104/252 (41%), Gaps = 41/252 (16%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG VYK    E++   A KV +    +  + + VE ++  +  H N+VK+  A  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 103
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWM----HPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
              +  N+   L+ EF A G+++  M     P+TE   +      L++            
Sbjct: 104 ---YYENNLWILI-EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA------------ 147
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE----G 384
            L YLH      I H DLK  NIL   +    ++DFG++       + TR I       G
Sbjct: 148 -LNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSA------KNTRXIQRRDXFIG 197
Query: 385 TTGYIAPEYGM-----GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA 439
           T  ++APE  M             DV+S GI L+EM   + P          L    KS 
Sbjct: 198 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM-AEIEPPHHELNPMRVLLKIAKSE 256
Query: 440 LPERAEEIRASS 451
            P  A+  R SS
Sbjct: 257 PPTLAQPSRWSS 268

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G+       E  T VA+K  N       +  F  E  V +     ++V+
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHK--APGNLNSLKRLNIAI 324
           +     GV  QG     ++ E M  G L+ ++  +  E + +   AP +L+  K + +A 
Sbjct: 78  LL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAG 130
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+ +      H DL   N ++ ++ T  + DFG+ R +   D   +      
Sbjct: 131 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLL 187
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              +++PE       ++Y DV+SFG++L E+ T
Sbjct: 188 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 98  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 144
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI----GVE 383
             +K+L         H DL   N +LD++ T  V+DFG+AR  +  D++  S+    G +
Sbjct: 145 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMLDKEFDSVHNKTGAK 199
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
               ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 242

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L     +A V+ 
Sbjct: 72  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL-----MAGVV- 119
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 21/222 (9%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G   FG VYKG LF     E T AVA+K   +       + F  E  +   ++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWM------HPITEEDKRHKAPGNLNSLKRL 320
           +    +      +   ++++ + ++G L E++        +   D        L     +
Sbjct: 77  LLGVVTK-----DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
           ++   +A  ++YL       + H DL   N+L+ D++   +SD G+ R + AAD      
Sbjct: 132 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
                  ++APE  M  + S   D++S+G++L E+F+ GL+P
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 80  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 124
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 125 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 97  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 143
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR--FLEAADEQTRSIGVEGT 385
             +K+L         H DL   N +LD++ T  V+DFG+AR  + +  D      G +  
Sbjct: 144 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 200
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 241

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 102 PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 146
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 147 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 203
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 204 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 87  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 131
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 132 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 188
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 189 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 80  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 124
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 125 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L     +A V+ 
Sbjct: 71  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL-----MAGVV- 118
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L     +A V+ 
Sbjct: 72  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL-----MAGVV- 119
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L     +A V+ 
Sbjct: 72  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL-----MAGVV- 119
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L     +A V+ 
Sbjct: 72  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL-----MAGVV- 119
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 84  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 128
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 129 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 212 LIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +IG G+FG VY G L ++       AVK  N +      S F  E  + ++  H N++ +
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     +      +V  +M +G L  ++   T          N      +   + VA
Sbjct: 95  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVA 141
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR--FLEAADEQTRSIGVEGT 385
             +K+L         H DL   N +LD++ T  V+DFG+AR  + +  D      G +  
Sbjct: 142 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 198
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             ++A E     + ++  DV+SFG+LL E+ T G  P  D+
Sbjct: 199 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 239

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 111/245 (45%), Gaps = 51/245 (20%)
Query: 202 NATKGF----SSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---------HDASKS 248
           ++T GF      + ++G G    V + I   +    AVK+ +V            +  ++
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 249 FAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM-HPITEEDK 306
              E ++ R +  H N++++        ++ N F  LV++ M  G L +++   +T  +K
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYLTEKVTLSEK 124
Query: 307 RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI 366
             +        K +   ++V C L  L+      I H DLKP NILLDD+M   ++DFG 
Sbjct: 125 ETR--------KIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 367 ARFLEAADEQTRSIGVEGTTGYIAPEY----------GMGHEVSSYGDVYSFGILLLEMF 416
           +  L+   E+ RS+   GT  Y+APE           G G EV    D++S G+++  + 
Sbjct: 171 SCQLDPG-EKLRSVC--GTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLL 223
Query: 417 TGLRP 421
            G  P
Sbjct: 224 AGSPP 228

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 79  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 123
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 124 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 180
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 113/253 (44%), Gaps = 41/253 (16%)
Query: 181 KKRGNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFES---TTAVAVKV 237
           K + NP P+I +P + +            +++IG GNFG V K  + +      A   ++
Sbjct: 6   KVKNNPDPTI-YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 57
Query: 238 FNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEE 296
                 D  + FA E EV   +  H N++ +  AC     +   +  L  E+  +G+L +
Sbjct: 58  KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLD 112
Query: 297 WMHP--ITEEDKR----HKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSN 350
           ++    + E D      +     L+S + L+ A DVA  + YL    Q    H +L   N
Sbjct: 113 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAARN 169
Query: 351 ILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSY------GD 404
           IL+ +   A ++DFG++R  E        + V+ T G + P   M  E  +Y       D
Sbjct: 170 ILVGENYVAKIADFGLSRGQE--------VYVKKTMGRL-PVRWMAIESLNYSVYTTNSD 220
Query: 405 VYSFGILLLEMFT 417
           V+S+G+LL E+ +
Sbjct: 221 VWSYGVLLWEIVS 233

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G+       E  T VA+K  N       +  F  E  V +     ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHK--APGNLNSLKRLNIAI 324
           +     GV  QG     ++ E M  G L+ ++  +  E + +   AP +L+  K + +A 
Sbjct: 87  LL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAG 139
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+ +      H DL   N ++ ++ T  + DFG+ R +   D   +      
Sbjct: 140 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLL 196
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              +++PE       ++Y DV+SFG++L E+ T
Sbjct: 197 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 69
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L     +A V+ 
Sbjct: 70  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL-----MAGVV- 117
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 118 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 77  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 121
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 122 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 80  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 124
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 125 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 83  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 127
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 128 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 184
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 185 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L   +       
Sbjct: 71  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGV------V 118
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L     +A V+ 
Sbjct: 72  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL-----MAGVV- 119
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKV-FNVLHHD----ASKSFAVECEVTRNIRHRNLV 265
            ++G+G FG+VYKGI       V + V   VL  +    A+K    E  V   +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           ++   C     Q      LV + M  G L          D   +  G L S   LN  + 
Sbjct: 83  RLLGICLTSTVQ------LVTQLMPYGCLL---------DHVRENRGRLGSQDLLNWCMQ 127
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +A  + YL  D +  + H DL   N+L+       ++DFG+AR L+  + +  + G +  
Sbjct: 128 IAKGMSYLE-DVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 184
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
             ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 185 IKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 26/227 (11%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVEC-EVTRNIRH-- 261
           + +  +++IG G    V + +   +    AVK+  V     S     E  E TR   H  
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 262 RNLVKVFTACSGVD-FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           R +       + +D ++ + F  LV++ M  G L +++   TE+         L+  +  
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEK-------VALSEKETR 203
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
           +I   +   + +LH +    I H DLKP NILLDD M   +SDFG +  LE   E+ R +
Sbjct: 204 SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLREL 259
Query: 381 GVEGTTGYIAPEY---GMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
              GT GY+APE     M      YG   D+++ G++L  +  G  P
Sbjct: 260 C--GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L   +       
Sbjct: 71  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGV------V 118
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L     +A V+ 
Sbjct: 71  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL-----MAGVV- 118
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L   +       
Sbjct: 71  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGV------V 118
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L   +       
Sbjct: 72  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGV------V 119
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 77  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 121
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 122 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L   +       
Sbjct: 71  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGV------V 118
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/264 (22%), Positives = 107/264 (40%), Gaps = 42/264 (15%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F    LIG+G FG V+K           ++     +  A +    E +    + H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIVH 69
Query: 267 VFTACSGVDF---------QGNDFKA---------------LVYEFMANGSLEEWMHPIT 302
                 G D+         + +D+                 +  EF   G+LE+W+    
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 303 EEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS 362
            E         L+ +  L +   +   + Y+H      + H DLKPSNI L D     + 
Sbjct: 130 GE--------KLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIG 178
Query: 363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS 422
           DFG+   L+   ++TRS   +GT  Y++PE     +     D+Y+ G++L E+      +
Sbjct: 179 DFGLVTSLKNDGKRTRS---KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 235
Query: 423 DDMFKDNLNLRNCVKSALPERAEE 446
            +  K   +LR+ + S + ++ E+
Sbjct: 236 FETSKFFTDLRDGIISDIFDKKEK 259

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 71  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 115
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 116 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 74  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 118
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 119 WCVQIAEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 175
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 176 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 29/221 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTRNIRHRNLVKV 267
           +G+GNFG+V KG  ++    V      +L ++A+          E  V + + +  +V++
Sbjct: 19  LGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C    +       LV E    G L +++     +  RH    N+     + +   V+
Sbjct: 78  IGICEAESWM------LVMEMAELGPLNKYL-----QQNRHVKDKNI-----IELVHQVS 121
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT-- 385
             +KYL    +    H DL   N+LL  +  A +SDFG+++ L  ADE        G   
Sbjct: 122 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR-ADENXYKAQTHGKWP 177
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             + APE    ++ SS  DV+SFG+L+ E F+ G +P   M
Sbjct: 178 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 218

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 29/221 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTRNIRHRNLVKV 267
           +G+GNFG+V KG  ++    V      +L ++A+          E  V + + +  +V++
Sbjct: 378 LGSGNFGTVKKG-YYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C    +       LV E    G L +++     +  RH    N+     + +   V+
Sbjct: 437 IGICEAESWM------LVMEMAELGPLNKYL-----QQNRHVKDKNI-----IELVHQVS 480
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT-- 385
             +KYL    +    H DL   N+LL  +  A +SDFG+++ L  ADE        G   
Sbjct: 481 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR-ADENYYKAQTHGKWP 536
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             + APE    ++ SS  DV+SFG+L+ E F+ G +P   M
Sbjct: 537 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 577

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 29/221 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTRNIRHRNLVKV 267
           +G+GNFG+V KG  ++    V      +L ++A+          E  V + + +  +V++
Sbjct: 377 LGSGNFGTVKKG-YYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C    +       LV E    G L +++     +  RH    N+     + +   V+
Sbjct: 436 IGICEAESWM------LVMEMAELGPLNKYL-----QQNRHVKDKNI-----IELVHQVS 479
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT-- 385
             +KYL    +    H DL   N+LL  +  A +SDFG+++ L  ADE        G   
Sbjct: 480 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR-ADENYYKAQTHGKWP 535
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             + APE    ++ SS  DV+SFG+L+ E F+ G +P   M
Sbjct: 536 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 29/221 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTRNIRHRNLVKV 267
           +G+GNFG+V KG  ++    V      +L ++A+          E  V + + +  +V++
Sbjct: 19  LGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C    +       LV E    G L +++     +  RH    N+     + +   V+
Sbjct: 78  IGICEAESWM------LVMEMAELGPLNKYL-----QQNRHVKDKNI-----IELVHQVS 121
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT-- 385
             +KYL    +    H DL   N+LL  +  A +SDFG+++ L  ADE        G   
Sbjct: 122 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR-ADENYYKAQTHGKWP 177
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             + APE    ++ SS  DV+SFG+L+ E F+ G +P   M
Sbjct: 178 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 218

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 47/238 (19%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---------HDASKSFAVECEV 255
           + +  + ++G G    V + I   +    AVK+ +V            +  ++   E ++
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 256 TRNIR-HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM-HPITEEDKRHKAPGN 313
            R +  H N++++        ++ N F  LV++ M  G L +++   +T  +K  +    
Sbjct: 64  LRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR---- 114
Query: 314 LNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA 373
               K +   ++V C L  L+      I H DLKP NILLDD+M   ++DFG +  L+  
Sbjct: 115 ----KIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 164
Query: 374 DEQTRSIGVEGTTGYIAPEY----------GMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            E+ R +   GT  Y+APE           G G EV    D++S G+++  +  G  P
Sbjct: 165 -EKLREVC--GTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 215

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 29/221 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTRNIRHRNLVKV 267
           +G+GNFG+V KG  ++    V      +L ++A+          E  V + + +  +V++
Sbjct: 13  LGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C    +       LV E    G L +++     +  RH    N+     + +   V+
Sbjct: 72  IGICEAESWM------LVMEMAELGPLNKYL-----QQNRHVKDKNI-----IELVHQVS 115
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT-- 385
             +KYL    +    H DL   N+LL  +  A +SDFG+++ L  ADE        G   
Sbjct: 116 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR-ADENYYKAQTHGKWP 171
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             + APE    ++ SS  DV+SFG+L+ E F+ G +P   M
Sbjct: 172 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 212

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 29/221 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTRNIRHRNLVKV 267
           +G+GNFG+V KG  ++    V      +L ++A+          E  V + + +  +V++
Sbjct: 33  LGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C    +       LV E    G L +++     +  RH    N+     + +   V+
Sbjct: 92  IGICEAESWM------LVMEMAELGPLNKYL-----QQNRHVKDKNI-----IELVHQVS 135
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT-- 385
             +KYL    +    H DL   N+LL  +  A +SDFG+++ L  ADE        G   
Sbjct: 136 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR-ADENYYKAQTHGKWP 191
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             + APE    ++ SS  DV+SFG+L+ E F+ G +P   M
Sbjct: 192 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 232

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 29/221 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTRNIRHRNLVKV 267
           +G+GNFG+V KG  ++    V      +L ++A+          E  V + + +  +V++
Sbjct: 25  LGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C    +       LV E    G L +++     +  RH    N+     + +   V+
Sbjct: 84  IGICEAESWM------LVMEMAELGPLNKYL-----QQNRHVKDKNI-----IELVHQVS 127
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT-- 385
             +KYL    +    H DL   N+LL  +  A +SDFG+++ L  ADE        G   
Sbjct: 128 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR-ADENYYKAQTHGKWP 183
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             + APE    ++ SS  DV+SFG+L+ E F+ G +P   M
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 29/221 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTRNIRHRNLVKV 267
           +G+GNFG+V KG  ++    V      +L ++A+          E  V + + +  +V++
Sbjct: 15  LGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C    +       LV E    G L +++     +  RH    N+     + +   V+
Sbjct: 74  IGICEAESWM------LVMEMAELGPLNKYL-----QQNRHVKDKNI-----IELVHQVS 117
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT-- 385
             +KYL    +    H DL   N+LL  +  A +SDFG+++ L  ADE        G   
Sbjct: 118 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR-ADENYYKAQTHGKWP 173
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             + APE    ++ SS  DV+SFG+L+ E F+ G +P   M
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G+       E  T VA+K  N       +  F  E  V +     ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHK--APGNLNSLKRLNIAI 324
           +     GV  QG     ++ E M  G L+ ++  +  E + +   AP +L+  K + +A 
Sbjct: 80  LL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAG 132
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+ +      H DL   N ++ ++ T  + DFG+ R +   D   +      
Sbjct: 133 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 189
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              +++PE       ++Y DV+SFG++L E+ T
Sbjct: 190 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 111/266 (41%), Gaps = 61/266 (22%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G +G V+ G        VAVKVF     +AS     E   T  +RH N++    A  
Sbjct: 45  IGKGRYGEVWMGKW--RGEKVAVKVF-FTTEEASWFRETEIYQTVLMRHENILGFIAA-- 99
Query: 273 GVDFQGNDFKALVY---EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
             D +G      +Y   ++  NGSL +++   T           L++   L +A      
Sbjct: 100 --DIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----------LDAKSMLKLAYSSVSG 146
Query: 330 LKYLHLDC-----QPPIAHCDLKPSNILLDDEMTAYVSDFGIA-RFLEAADE-----QTR 378
           L +LH +      +P IAH DLK  NIL+    T  ++D G+A +F+   +E      TR
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 379 SIGVEGTTGYIAPEY-----GMGHEVSSY--GDVYSFGILLLEM---------------- 415
                GT  Y+ PE         H   SY   D+YSFG++L E+                
Sbjct: 207 V----GTKRYMPPEVLDESLNRNH-FQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261
Query: 416 FTGLRPSDDMFKDNLNLRNCVKSALP 441
           +  L PSD  ++D   +  C+K   P
Sbjct: 262 YHDLVPSDPSYEDMREI-VCIKKLRP 286

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 79  PHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYV-------REHK--DNIGSQYLLN 123
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG A+ L A +++  + G
Sbjct: 124 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 110/245 (44%), Gaps = 51/245 (20%)
Query: 202 NATKGF----SSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---------HDASKS 248
           ++T GF      + ++G G    V + I   +    AVK+ +V            +  ++
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 249 FAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM-HPITEEDK 306
              E ++ R +  H N++++        ++ N F  LV++ M  G L +++   +T  +K
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYLTEKVTLSEK 124
Query: 307 RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI 366
             +        K +   ++V C L  L+      I H DLKP NILLDD+M   ++DFG 
Sbjct: 125 ETR--------KIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 367 ARFLEAADEQTRSIGVEGTTGYIAPEY----------GMGHEVSSYGDVYSFGILLLEMF 416
           +  L+   E+ R +   GT  Y+APE           G G EV    D++S G+++  + 
Sbjct: 171 SCQLDPG-EKLREVC--GTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLL 223
Query: 417 TGLRP 421
            G  P
Sbjct: 224 AGSPP 228

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 81  PHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYV-------REHK--DNIGSQYLLN 125
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG A+ L A +++  + G
Sbjct: 126 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 182
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 29/221 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTRNIRHRNLVKV 267
           +G+GNFG+V KG  ++    V      +L ++A+          E  V + + +  +V++
Sbjct: 35  LGSGNFGTVKKG-YYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C    +       LV E    G L +++     +  RH    N+     + +   V+
Sbjct: 94  IGICEAESWM------LVMEMAELGPLNKYL-----QQNRHVKDKNI-----IELVHQVS 137
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT-- 385
             +KYL    +    H DL   N+LL  +  A +SDFG+++ L  ADE        G   
Sbjct: 138 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR-ADENYYKAQTHGKWP 193
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             + APE    ++ SS  DV+SFG+L+ E F+ G +P   M
Sbjct: 194 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 234

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 29/221 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTRNIRHRNLVKV 267
           +G+GNFG+V KG  ++    V      +L ++A+          E  V + + +  +V++
Sbjct: 35  LGSGNFGTVKKG-YYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C    +       LV E    G L +++     +  RH    N+     + +   V+
Sbjct: 94  IGICEAESWM------LVMEMAELGPLNKYL-----QQNRHVKDKNI-----IELVHQVS 137
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT-- 385
             +KYL    +    H DL   N+LL  +  A +SDFG+++ L  ADE        G   
Sbjct: 138 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR-ADENYYKAQTHGKWP 193
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             + APE    ++ SS  DV+SFG+L+ E F+ G +P   M
Sbjct: 194 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 234

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 79  PHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYV-------REHK--DNIGSQYLLN 123
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG A+ L A +++  + G
Sbjct: 124 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 105/251 (41%), Gaps = 29/251 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F    LIG+G FG V+K           +K     +  A +    E +    + H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 267 VFTACSGVDFQ-----GNDFKA------LVYEFMANGSLEEWMHPITEEDKRHKAPGNLN 315
                 G D+       N  ++      +  EF   G+LE+W+     E         L+
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--------KLD 120
Query: 316 SLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE 375
            +  L +   +   + Y+H      + + DLKPSNI L D     + DFG+   L+   +
Sbjct: 121 KVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC 435
           + RS   +GT  Y++PE     +     D+Y+ G++L E+      + +  K   +LR+ 
Sbjct: 178 RXRS---KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 234
Query: 436 VKSALPERAEE 446
           + S + ++ E+
Sbjct: 235 IISDIFDKKEK 245

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 26/229 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V++     +    A K     H    ++   E +    +RH  LV +  A  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-- 222
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
              F+ ++   ++YEFM+ G L E    + +E  +      +  +++      V   L +
Sbjct: 223 ---FEDDNEMVMIYEFMSGGELFE---KVADEHNKMSEDEAVEYMRQ------VCKGLCH 270
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVS--DFGIARFLEAADEQTRSIGVE-GTTGYI 389
           +H +      H DLKP NI+   + +  +   DFG+   L+      +S+ V  GT  + 
Sbjct: 271 MHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK----QSVKVTTGTAEFA 323
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS 438
           APE   G  V  Y D++S G+L   + +GL P      D+  LRN VKS
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-NDDETLRN-VKS 370

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V++     +    A K     H    ++   E +    +RH  LV +  A  
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-- 116
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
              F+ ++   ++YEFM+ G L E    + +E  +      +  +++      V   L +
Sbjct: 117 ---FEDDNEMVMIYEFMSGGELFE---KVADEHNKMSEDEAVEYMRQ------VCKGLCH 164
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVS--DFGIARFLEAADEQTRSIGVE-GTTGYI 389
           +H +      H DLKP NI+   + +  +   DFG+   L+      +S+ V  GT  + 
Sbjct: 165 MHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK----QSVKVTTGTAEFA 217
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           APE   G  V  Y D++S G+L   + +GL P
Sbjct: 218 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--VLHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           IG G+F +VYKG+  E+T  VA        L     + F  E E  + ++H N+V+ + +
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL-NIAIDVACV 329
                 +G     LV E   +G+L+ ++       KR K    +  +K L +    +   
Sbjct: 94  WEST-VKGKKCIVLVTELXTSGTLKTYL-------KRFK----VXKIKVLRSWCRQILKG 141
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEM-TAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
           L++LH    PPI H DLK  NI +     +  + D G+A    A+  +     V GT  +
Sbjct: 142 LQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEF 196
Query: 389 IAPE-YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            APE Y   ++ S   DVY+FG   LE  T   P
Sbjct: 197 XAPEXYEEKYDESV--DVYAFGXCXLEXATSEYP 228

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 79  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 123
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG A+ L A +++  + G
Sbjct: 124 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 84  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 128
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG A+ L A +++  + G
Sbjct: 129 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 185
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G+       E  T VA+K  N       +  F  E  V +     ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHK--APGNLNSLKRLNIAI 324
           +     GV  QG     ++ E M  G L+ ++  +  E + +   AP +L+  K + +A 
Sbjct: 93  LL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAG 145
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+ +      H DL   N ++ ++ T  + DFG+ R +   D   +      
Sbjct: 146 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              +++PE       ++Y DV+SFG++L E+ T
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G+       E  T VA+K  N       +  F  E  V +     ++V+
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHK--APGNLNSLKRLNIAI 324
           +     GV  QG     ++ E M  G L+ ++  +  E + +   AP +L+  K + +A 
Sbjct: 84  LL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAG 136
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+ +      H DL   N ++ ++ T  + DFG+ R +   D   +      
Sbjct: 137 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 193
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              +++PE       ++Y DV+SFG++L E+ T
Sbjct: 194 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V   +   +  AVAVK+ ++    D  ++   E  +   + H N+VK +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFY--- 71
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L   +       
Sbjct: 72  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGV------V 119
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G+       E  T VA+K  N       +  F  E  V +     ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHK--APGNLNSLKRLNIAI 324
           +     GV  QG     ++ E M  G L+ ++  +  E + +   AP +L+  K + +A 
Sbjct: 87  LL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAG 139
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+ +      H DL   N ++ ++ T  + DFG+ R +   D   +      
Sbjct: 140 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 196
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              +++PE       ++Y DV+SFG++L E+ T
Sbjct: 197 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G+       E  T VA+K  N       +  F  E  V +     ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHK--APGNLNSLKRLNIAI 324
           +     GV  QG     ++ E M  G L+ ++  +  E + +   AP +L+  K + +A 
Sbjct: 86  LL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAG 138
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+ +      H DL   N ++ ++ T  + DFG+ R +   D   +      
Sbjct: 139 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 195
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              +++PE       ++Y DV+SFG++L E+ T
Sbjct: 196 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 77  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 121
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG A+ L A +++  + G
Sbjct: 122 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 178
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G+       E  T VA+K  N       +  F  E  V +     ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHK--APGNLNSLKRLNIAI 324
           +     GV  QG     ++ E M  G L+ ++  +  E + +   AP +L+  K + +A 
Sbjct: 86  LL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAG 138
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+ +      H DL   N ++ ++ T  + DFG+ R +   D   +      
Sbjct: 139 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 195
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              +++PE       ++Y DV+SFG++L E+ T
Sbjct: 196 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 99/241 (41%), Gaps = 25/241 (10%)
Query: 186 PTPSISFPYVSYRMLYNATKGF---SSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH 242
           P P   F +        A   F   S   ++G G FG V+K     +   +A K+     
Sbjct: 67  PAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG 126
Query: 243 HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPIT 302
               +    E  V   + H NL++++ A     F+  +   LV E++  G L      I 
Sbjct: 127 MKDKEEVKNEISVMNQLDHANLIQLYDA-----FESKNDIVLVMEYVDGGEL---FDRII 178
Query: 303 EEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL--DDEMTAY 360
           +E        NL  L  +     +   ++++H   Q  I H DLKP NIL    D     
Sbjct: 179 DESY------NLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIK 229
Query: 361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLR 420
           + DFG+AR  +  ++   +    GT  ++APE      VS   D++S G++   + +GL 
Sbjct: 230 IIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286
Query: 421 P 421
           P
Sbjct: 287 P 287

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G+       E  T VA+K  N       +  F  E  V +     ++V+
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHK--APGNLNSLKRLNIAI 324
           +     GV  QG     ++ E M  G L+ ++  +  E + +   AP +L+  K + +A 
Sbjct: 115 LL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAG 167
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+ +      H DL   N ++ ++ T  + DFG+ R +   D   +      
Sbjct: 168 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 224
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              +++PE       ++Y DV+SFG++L E+ T
Sbjct: 225 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECE---VTRNIRHRNLV 265
            ++G+G FG+V+KG+      ++ + V   +  D S  +SF    +      ++ H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           ++   C G   Q      LV +++  GSL        +  ++H+  G L     LN  + 
Sbjct: 97  RLLGLCPGSSLQ------LVTQYLPLGSL-------LDHVRQHR--GALGPQLLLNWGVQ 141
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +A  + YL    +  + H +L   N+LL       V+DFG+A  L   D+Q      +  
Sbjct: 142 IAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 198
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             ++A E     + +   DV+S+G+ + E+ T
Sbjct: 199 IKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 20/213 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G  G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +   
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +GN  + L  E+ + G L + + P    D     P       +L   +       
Sbjct: 71  -GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGV------V 118
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 392 EYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           E     E  +   DV+S GI+L  M  G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++ +G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 84  PHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYV-------REHK--DNIGSQYLLN 128
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 129 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 89/218 (40%), Gaps = 22/218 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV---ECEVTRNIRHRN 263
           F    ++G G FG V    +  +    A K          K  A+   E ++   +  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           +V +  A     ++  D   LV   M  G L+  ++        H         + +  A
Sbjct: 246 VVSLAYA-----YETKDALCLVLTLMNGGDLKFHIY--------HMGQAGFPEARAVFYA 292
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++ C L+ LH +    I + DLKP NILLDD     +SD G+A  +   + QT   G  
Sbjct: 293 AEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIK-GRV 346
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT GY+APE       +   D ++ G LL EM  G  P
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 104/239 (43%), Gaps = 25/239 (10%)
Query: 198 RMLYNATKGFSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDAS 246
           ++ YN    F   NL     +GAG FG V +   F     ++   VAVK+  +  H D  
Sbjct: 26  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK 85
Query: 247 KSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEED 305
           ++   E ++  ++ +H N+V +  AC+     G     ++ E+   G L  ++    E D
Sbjct: 86  EALMSELKIMSHLGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEAD 140
Query: 306 --KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD 363
             K    P  L  L  L+ +  VA  + +L         H D+   N+LL +   A + D
Sbjct: 141 LDKEDGRPLELRDL--LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGD 195
Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           FG+AR +                 ++APE       +   DV+S+GILL E+F+ GL P
Sbjct: 196 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 254

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECE---VTRNIRHRNLV 265
            ++G+G FG+V+KG+      ++ + V   +  D S  +SF    +      ++ H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           ++   C G   Q      LV +++  GSL        +  ++H+  G L     LN  + 
Sbjct: 79  RLLGLCPGSSLQ------LVTQYLPLGSL-------LDHVRQHR--GALGPQLLLNWGVQ 123
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +A  + YL    +  + H +L   N+LL       V+DFG+A  L   D+Q      +  
Sbjct: 124 IAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             ++A E     + +   DV+S+G+ + E+ T
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++ +G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 84  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 128
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 129 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 89/218 (40%), Gaps = 22/218 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV---ECEVTRNIRHRN 263
           F    ++G G FG V    +  +    A K          K  A+   E ++   +  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           +V +  A     ++  D   LV   M  G L+  ++        H         + +  A
Sbjct: 246 VVSLAYA-----YETKDALCLVLTLMNGGDLKFHIY--------HMGQAGFPEARAVFYA 292
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++ C L+ LH +    I + DLKP NILLDD     +SD G+A  +   + QT   G  
Sbjct: 293 AEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIK-GRV 346
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT GY+APE       +   D ++ G LL EM  G  P
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 104/239 (43%), Gaps = 25/239 (10%)
Query: 198 RMLYNATKGFSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDAS 246
           ++ YN    F   NL     +GAG FG V +   F     ++   VAVK+  +  H D  
Sbjct: 34  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK 93
Query: 247 KSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEED 305
           ++   E ++  ++ +H N+V +  AC+     G     ++ E+   G L  ++    E D
Sbjct: 94  EALMSELKIMSHLGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEAD 148
Query: 306 --KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD 363
             K    P  L  L  L+ +  VA  + +L         H D+   N+LL +   A + D
Sbjct: 149 LDKEDGRPLELRDL--LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGD 203
Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           FG+AR +                 ++APE       +   DV+S+GILL E+F+ GL P
Sbjct: 204 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 262

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI------RHRNL 264
           + +G G FG V  G    +   VAVK+ N       +S  V  ++ R I      RH ++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILN---RQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +K++   S      + F  +V E+++ G L +++             G L+  +   +  
Sbjct: 79  IKLYQVIST---PSDIF--MVMEYVSGGELFDYI----------CKNGRLDEKESRRLFQ 123
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +   + Y H      + H DLKP N+LLD  M A ++DFG++  +   +    S    G
Sbjct: 124 QILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---G 177
Query: 385 TTGYIAPEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSDD 424
           +  Y APE   G   +    D++S G++L  +  G  P DD
Sbjct: 178 SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVF-----NVLHHDASKSFAVECEVTRNIRH 261
           F    ++ +G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN
Sbjct: 77  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 121
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 122 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD 423
            +    ++A E  +    +   DV+S+G+ + E+ T G +P D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 33/234 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +G G F  V + +    T   A K+ N   L     +    E  + R ++H N+V++  +
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
            S        F  LV++ +  G L E +      +E D  H     L S+  ++      
Sbjct: 99  ISE-----EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIH------ 147
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDE---MTAYVSDFGIARFLEAADEQTRSIGVEG 384
                     Q  I H DLKP N+LL  +       ++DFG+A  +E   EQ    G  G
Sbjct: 148 ----------QHDIVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAG 195
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS 438
           T GY++PE           D+++ G++L  +  G  P  D  +D   L   +K+
Sbjct: 196 TPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWD--EDQHKLYQQIKA 247

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 99/252 (39%), Gaps = 27/252 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+FG V    + E+    AVKV     +L  D  +    E  +    R+  
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            +     C    FQ  D    V EF+  G L   M  I +  +  +A            A
Sbjct: 85  FLTQLFCC----FQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARF-------YA 130
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   L +LH      I + DLK  N+LLD E    ++DFG+ +  E       +    
Sbjct: 131 AEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFC 185
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLNLRNCVKS 438
           GT  YIAPE           D ++ G+LL EM  G  P      DD+F+  LN      +
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 245
Query: 439 ALPERAEEIRAS 450
            L E A  I  S
Sbjct: 246 WLHEDATGILKS 257

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 26/218 (11%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTRNI 259
           K +   + +G G F +VYK     +   VA+K   + H   +K     +   E ++ + +
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
            H N++ +  A     F      +LV++FM     E  +  I +++     P ++ +   
Sbjct: 70  SHPNIIGLLDA-----FGHKSNISLVFDFM-----ETDLEVIIKDNSLVLTPSHIKAYML 119
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
           + +       L+YLH   Q  I H DLKP+N+LLD+     ++DFG+A+   + +     
Sbjct: 120 MTLQ-----GLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXH 171
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYG-DVYSFGILLLEMF 416
             V  T  Y APE   G  +   G D+++ G +L E+ 
Sbjct: 172 QVV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/246 (22%), Positives = 104/246 (42%), Gaps = 28/246 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLV 265
           F     +G G FG V++          A+K   + + + A +    E +    + H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 266 KVFTAC----SGVDFQGNDFKALVY---EFMANGSLEEWMHPITEEDKRHKAPGNLNSLK 318
           + F A     +    Q +  K  +Y   +     +L++WM+     ++R ++        
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC------ 120
Query: 319 RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ-- 376
            L+I + +A  +++LH      + H DLKPSNI    +    V DFG+   ++  +E+  
Sbjct: 121 -LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 377 --------TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD 428
                    R  G  GT  Y++PE   G+  S   D++S G++L E+        +  + 
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRT 236
Query: 429 NLNLRN 434
             ++RN
Sbjct: 237 LTDVRN 242

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G+       E  T VA+K  N       +  F  E  V +     ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHK--APGNLNSLKRLNIAI 324
           +     GV  QG     ++ E M  G L+ ++  +  E + +   AP +L+  K + +A 
Sbjct: 80  LL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAG 132
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+ +      H DL   N  + ++ T  + DFG+ R +   D   +      
Sbjct: 133 EIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 189
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              +++PE       ++Y DV+SFG++L E+ T
Sbjct: 190 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 99/232 (42%), Gaps = 31/232 (13%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV----EC 253
           R++YN +  F  ++L+G G +G V       +   VA+K            FA+    E 
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREI 60
Query: 254 EVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGN 313
           ++ ++ +H N++ +F       F+  +   ++ E M        +H +           +
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVI----------S 105
Query: 314 LNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE-- 371
              L   +I   +   L+ + +     + H DLKPSN+L++      V DFG+AR ++  
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 372 AADEQTRSIGVEGTTGYIAPEYGMGHEV-------SSYGDVYSFGILLLEMF 416
           AAD    +    G T Y+A  +    EV       S   DV+S G +L E+F
Sbjct: 166 AADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 106/277 (38%), Gaps = 49/277 (17%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT-----R 257
           AT  +     IG G +G+VYK     S   VA+K   V + +     +   EV       
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 258 NIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
              H N+V++   C+           LV+E + +  L  ++      DK    P  L + 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL------DK--APPPGLPAE 112
Query: 318 KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT 377
              ++       L +LH +C   I H DLKP NIL+    T  ++DFG+AR       Q 
Sbjct: 113 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QM 166
Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMF--------------------- 416
               V  T  Y APE  +    ++  D++S G +  EMF                     
Sbjct: 167 ALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226
Query: 417 TGLRPSDDMFKDNLNLRNC--------VKSALPERAE 445
            GL P DD  +D    R          V+S +PE  E
Sbjct: 227 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEE 263

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G+ G V    +  S   VAVK  ++      +    E  + R+ +H N+V+++ +  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 216
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
              +   D   +V EF+  G+L +    I    +       +N  +   + + V   L  
Sbjct: 217 ---YLVGDELWVVMEFLEGGALTD----IVTHTR-------MNEEQIAAVCLAVLQALSV 262
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           LH      + H D+K  +ILL  +    +SDFG     + + E  R   + GT  ++APE
Sbjct: 263 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPE 317
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLRP--------SDDMFKDNLNLR 433
                      D++S GI+++EM  G  P        +  M +DNL  R
Sbjct: 318 LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR 366

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 36/220 (16%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV--TRNIRHRNLVKVFTA 270
           +G G +G V++G        VAVK+F+       KS+  E E+  T  +RH N++  F A
Sbjct: 16  VGKGRYGEVWRGSW--QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILG-FIA 69
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                   +    L+  +   GSL +++   T           L+++  L I + +A  L
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----------LDTVSCLRIVLSIASGL 118
Query: 331 KYLHLDC-----QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE-- 383
            +LH++      +P IAH DLK  NIL+       ++D G+A     +  Q   +G    
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL-DVGNNPR 177
Query: 384 -GTTGYIAPEYGMGHEVS-----SYG--DVYSFGILLLEM 415
            GT  Y+APE  +   +      SY   D+++FG++L E+
Sbjct: 178 VGTKRYMAPEV-LDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 36/220 (16%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV--TRNIRHRNLVKVFTA 270
           +G G +G V++G        VAVK+F+       KS+  E E+  T  +RH N++  F A
Sbjct: 45  VGKGRYGEVWRGSW--QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILG-FIA 98
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                   +    L+  +   GSL +++   T           L+++  L I + +A  L
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----------LDTVSCLRIVLSIASGL 147
Query: 331 KYLHLDC-----QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE-- 383
            +LH++      +P IAH DLK  NIL+       ++D G+A     +  Q   +G    
Sbjct: 148 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL-DVGNNPR 206
Query: 384 -GTTGYIAPEYGMGHEVS-----SYG--DVYSFGILLLEM 415
            GT  Y+APE  +   +      SY   D+++FG++L E+
Sbjct: 207 VGTKRYMAPEV-LDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 25/238 (10%)
Query: 198 RMLYNATKG-FSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVFNV-LHHDA 245
           R+ Y+A+K  F  + L     +G G FG V +   F      +   VAVK+      H  
Sbjct: 15  RLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 74
Query: 246 SKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE 304
            ++   E ++  +I  H N+V +  AC+     G     +V EF   G+L  ++     E
Sbjct: 75  HRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNE 130
Query: 305 DKRHKAPGNLN----SLKRL-NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA 359
              +K P +L     +L+ L   +  VA  +++L         H DL   NILL ++   
Sbjct: 131 FVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVV 187
Query: 360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            + DFG+AR +    +  R         ++APE       +   DV+SFG+LL E+F+
Sbjct: 188 KICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 36/220 (16%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV--TRNIRHRNLVKVFTA 270
           +G G +G V++G        VAVK+F+       KS+  E E+  T  +RH N++  F A
Sbjct: 16  VGKGRYGEVWRGSW--QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILG-FIA 69
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                   +    L+  +   GSL +++   T           L+++  L I + +A  L
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----------LDTVSCLRIVLSIASGL 118
Query: 331 KYLHLDC-----QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE-- 383
            +LH++      +P IAH DLK  NIL+       ++D G+A     +  Q   +G    
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL-DVGNNPR 177
Query: 384 -GTTGYIAPEYGMGHEVS-----SYG--DVYSFGILLLEM 415
            GT  Y+APE  +   +      SY   D+++FG++L E+
Sbjct: 178 VGTKRYMAPEV-LDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 106/277 (38%), Gaps = 49/277 (17%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT-----R 257
           AT  +     IG G +G+VYK     S   VA+K   V + +     +   EV       
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 258 NIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
              H N+V++   C+           LV+E + +  L  ++      DK    P  L + 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL------DK--APPPGLPAE 112
Query: 318 KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT 377
              ++       L +LH +C   I H DLKP NIL+    T  ++DFG+AR       Q 
Sbjct: 113 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QM 166
Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMF--------------------- 416
               V  T  Y APE  +    ++  D++S G +  EMF                     
Sbjct: 167 ALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226
Query: 417 TGLRPSDDMFKDNLNLRNC--------VKSALPERAE 445
            GL P DD  +D    R          V+S +PE  E
Sbjct: 227 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEE 263

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           A +V   L+YLH      I + DLKP NILLD      ++DFG A+++        +  +
Sbjct: 112 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYXL 163
Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD 424
            GT  YIAPE       +   D +SFGIL+ EM  G  P  D
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G+ G V    +  S   VAVK  ++      +    E  + R+ +H N+V+++ +  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 139
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
              +   D   +V EF+  G+L +    I    +       +N  +   + + V   L  
Sbjct: 140 ---YLVGDELWVVMEFLEGGALTD----IVTHTR-------MNEEQIAAVCLAVLQALSV 185
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           LH      + H D+K  +ILL  +    +SDFG     + + E  R   + GT  ++APE
Sbjct: 186 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPE 240
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLRP--------SDDMFKDNLNLR 433
                      D++S GI+++EM  G  P        +  M +DNL  R
Sbjct: 241 LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR 289

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 209 SENLIGAGNFGSVYKGILFEST---TAVAVKVFN-VLHHDASKSFAVECEVTRNIRHRNL 264
           S+ +IG G+FG VY G   +        A+K  + +      ++F  E  + R + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL-NIA 323
           +    A  G+         ++  +M +G L +++          ++P    ++K L +  
Sbjct: 85  L----ALIGIMLPPEGLPHVLLPYMCHGDLLQFI----------RSPQRNPTVKDLISFG 130
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG-- 381
           + VA  ++YL    +    H DL   N +LD+  T  V+DFG+AR  +  D +  S+   
Sbjct: 131 LQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR--DILDREYYSVQQH 185
Query: 382 --VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                   + A E    +  ++  DV+SFG+LL E+ T
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNL 264
           K ++    IG G  G+VY  +   +   VA++  N+      +    E  V R  ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           V    +     +   D   +V E++A GSL + +     ++      G + ++ R     
Sbjct: 80  VNYLDS-----YLVGDELWVVMEYLAGGSLTDVVTETCMDE------GQIAAVCR----- 123
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           +    L++LH +    + H D+K  NILL  + +  ++DFG     +   EQ++   + G
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSXMVG 178
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           T  ++APE           D++S GI+ +EM  G  P
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNL 264
           K ++    IG G  G+VY  +   +   VA++  N+      +    E  V R  ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           V    +     +   D   +V E++A GSL + +     ++      G + ++ R     
Sbjct: 80  VNYLDS-----YLVGDELWVVMEYLAGGSLTDVVTETCMDE------GQIAAVCR----- 123
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           +    L++LH +    + H D+K  NILL  + +  ++DFG     +   EQ++   + G
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVG 178
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           T  ++APE           D++S GI+ +EM  G  P
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNL 264
           K ++    IG G  G+VY  +   +   VA++  N+      +    E  V R  ++ N+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           V    +     +   D   +V E++A GSL + +     ++      G + ++ R     
Sbjct: 81  VNYLDS-----YLVGDELWVVMEYLAGGSLTDVVTETCMDE------GQIAAVCR----- 124
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           +    L++LH +    + H D+K  NILL  + +  ++DFG     +   EQ++   + G
Sbjct: 125 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSXMVG 179
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           T  ++APE           D++S GI+ +EM  G  P
Sbjct: 180 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 213 IGAGNFGSVYK----GILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNI-RHRN 263
           +G G FG V      GI  +           +L  DA++        E E+ + I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++ +  AC+    Q      +V E+ + G+L E++         +    N    +++   
Sbjct: 103 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 324 IDVACVLKYL----HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             V+C  +      +L  Q  I H DL   N+L+ +     ++DFG+AR +   D   ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                   ++APE       +   DV+SFG+L+ E+FT
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 33/225 (14%)
Query: 213 IGAGNFGSVYK----GILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNI-RHRN 263
           +G G FG V      GI  +           +L  DA++        E E+ + I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG-----NLNSLK 318
           ++ +  AC+    Q      +V E+ + G+L E++       +  + PG     ++N + 
Sbjct: 103 IINLLGACT----QDGPLYVIV-EYASKGNLREYL-------RARRPPGMEXSYDINRVP 150
Query: 319 RLNIAID--VACVLKYL----HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEA 372
              +     V+C  +      +L  Q  I H DL   N+L+ +     ++DFG+AR +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 373 ADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            D   ++        ++APE       +   DV+SFG+L+ E+FT
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNL 264
           K ++    IG G  G+VY  +   +   VA++  N+      +    E  V R  ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           V    +     +   D   +V E++A GSL + +     ++      G + ++ R     
Sbjct: 80  VNYLDS-----YLVGDELWVVMEYLAGGSLTDVVTETCMDE------GQIAAVCR----- 123
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           +    L++LH +    + H D+K  NILL  + +  ++DFG     +   EQ++   + G
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSEMVG 178
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           T  ++APE           D++S GI+ +EM  G  P
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           +G G FG+VY     ++   +A+KV     +           E E+  ++RH N+++++ 
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
                 F       L+ EF   G L        +E ++H   G  +  +      ++A  
Sbjct: 83  Y-----FHDRKRIYLMLEFAPRGEL-------YKELQKH---GRFDEQRSATFMEELADA 127
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           L Y H   +  + H D+KP N+L+  +    ++DFG +  + A   + R +   GT  Y+
Sbjct: 128 LHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMC--GTLDYL 180
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD 423
            PE   G       D++  G+L  E   G+ P D
Sbjct: 181 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G + + +  +++ D++  A         
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTA--------- 116
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 117 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 168
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 169 XXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 106/277 (38%), Gaps = 49/277 (17%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT-----R 257
           AT  +     IG G +G+VYK     S   VA+K   V + +     +   EV       
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 258 NIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
              H N+V++   C+           LV+E + +  L  ++      DK    P  L + 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL------DK--APPPGLPAE 112
Query: 318 KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT 377
              ++       L +LH +C   I H DLKP NIL+    T  ++DFG+AR       Q 
Sbjct: 113 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QM 166
Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMF--------------------- 416
               V  T  Y APE  +    ++  D++S G +  EMF                     
Sbjct: 167 ALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226
Query: 417 TGLRPSDDMFKDNLNLRNC--------VKSALPERAE 445
            GL P DD  +D    R          V+S +PE  E
Sbjct: 227 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEE 263

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 213 IGAGNFGSVYKG-----ILFESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G     I  E+ T VAVK  N       +  F  E  V +     ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRH--KAPGNLNSLKRLNIAI 324
           +     GV  +G     +V E MA+G L+ ++  +  E + +  + P  L  +  + +A 
Sbjct: 82  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM--IQMAA 134
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+        H DL   N ++  + T  + DFG+ R +   D   +      
Sbjct: 135 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL 191
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEM 415
              ++APE       ++  D++SFG++L E+
Sbjct: 192 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G+       E  T VA+K  N       +  F  E  V +     ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHK--APGNLNSLKRLNIAI 324
           +     GV  QG     ++ E M  G L+ ++  +      +   AP +L+  K + +A 
Sbjct: 93  LL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS--KMIQMAG 145
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+ +      H DL   N ++ ++ T  + DFG+ R +   D   +      
Sbjct: 146 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              +++PE       ++Y DV+SFG++L E+ T
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 213 IGAGNFGSVYKG-----ILFESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G     I  E+ T VAVK  N       +  F  E  V +     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRH--KAPGNLNSLKRLNIAI 324
           +     GV  +G     +V E MA+G L+ ++  +  E + +  + P  L  +  + +A 
Sbjct: 85  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM--IQMAA 137
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+        H DL   N ++  + T  + DFG+ R +   D   +      
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL 194
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEM 415
              ++APE       ++  D++SFG++L E+
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           +G G FG+VY     ++   +A+KV     +           E E+  ++RH N+++++ 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
                 F       L+ EF   G L        +E ++H   G  +  +      ++A  
Sbjct: 82  Y-----FHDRKRIYLMLEFAPRGEL-------YKELQKH---GRFDEQRSATFMEELADA 126
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           L Y H   +  + H D+KP N+L+  +    ++DFG +  + A   + R +   GT  Y+
Sbjct: 127 LHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMC--GTLDYL 179
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD 423
            PE   G       D++  G+L  E   G+ P D
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G+ G V    +  S   VAVK  ++      +    E  + R+ +H N+V+++ +  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 96
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
              +   D   +V EF+  G+L +    I    +       +N  +   + + V   L  
Sbjct: 97  ---YLVGDELWVVMEFLEGGALTD----IVTHTR-------MNEEQIAAVCLAVLQALSV 142
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           LH      + H D+K  +ILL  +    +SDFG     + + E  R   + GT  ++APE
Sbjct: 143 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPE 197
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLRP--------SDDMFKDNLNLR 433
                      D++S GI+++EM  G  P        +  M +DNL  R
Sbjct: 198 LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR 246

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 213 IGAGNFGSVYKG-----ILFESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G     I  E+ T VAVK  N       +  F  E  V +     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRH--KAPGNLNSLKRLNIAI 324
           +     GV  +G     +V E MA+G L+ ++  +  E + +  + P  L  +  + +A 
Sbjct: 85  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM--IQMAA 137
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+        H DL   N ++  + T  + DFG+ R +   D   +      
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL 194
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEM 415
              ++APE       ++  D++SFG++L E+
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNIRHRNLVKVF 268
           +G+G FG V+   L E  ++   +V   ++ D S+        E EV +++ H N++K+F
Sbjct: 30  LGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKA--PGNLNSLKRLNIAIDV 326
                  F+      +V E    G L   +  I     R KA   G +  L +      +
Sbjct: 87  EV-----FEDYHNMYIVMETCEGGEL---LERIVSAQARGKALSEGYVAELMK-----QM 133
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDD---EMTAYVSDFGIARFLEAADEQTRSIGVE 383
              L Y H      + H DLKP NIL  D        + DFG+A   ++ +  T +    
Sbjct: 134 MNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--- 187
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GT  Y+APE     +V+   D++S G+++  + TG  P
Sbjct: 188 GTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 213 IGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKV 267
           +G G+FG V   + + +TT   VA+K+ N   +   D       E    R +RH +++K+
Sbjct: 21  LGEGSFGKV--KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           +        +  D   +V E+  N    E    I + DK       ++  +       + 
Sbjct: 79  YDV-----IKSKDEIIMVIEYAGN----ELFDYIVQRDK-------MSEQEARRFFQQII 122
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             ++Y H   +  I H DLKP N+LLD+ +   ++DFG++  +   +    S    G+  
Sbjct: 123 SAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPN 176
Query: 388 YIAPEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSDD 424
           Y APE   G   +    DV+S G++L  M     P DD
Sbjct: 177 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G+       E  T VA+K  N       +  F  E  V +     ++V+
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHK--APGNLNSLKRLNIAI 324
           +     GV  QG     ++ E M  G L+ ++  +      +   AP +L+  K + +A 
Sbjct: 83  LL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS--KMIQMAG 135
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+ +      H DL   N ++ ++ T  + DFG+ R +   D   +      
Sbjct: 136 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 192
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              +++PE       ++Y DV+SFG++L E+ T
Sbjct: 193 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 101/232 (43%), Gaps = 31/232 (13%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV----EC 253
           R++YN +  F  ++L+G G +G V       +   VA+K            FA+    E 
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREI 60
Query: 254 EVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGN 313
           ++ ++ +H N++ +F       F+  +   ++ E M        +H +           +
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVI----------S 105
Query: 314 LNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE-- 371
              L   +I   +   L+ + +     + H DLKPSN+L++      V DFG+AR ++  
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 372 AAD------EQTRSIGVEGTTGYIAPEYGM-GHEVSSYGDVYSFGILLLEMF 416
           AAD      +Q+  +    T  Y APE  +   + S   DV+S G +L E+F
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 106/250 (42%), Gaps = 41/250 (16%)
Query: 198 RMLYNATKGFSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDAS 246
           ++ YN    F   NL     +GAG FG V +   F     ++   VAVK+  +  H D  
Sbjct: 34  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK 93
Query: 247 KSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEED 305
           ++   E ++  ++ +H N+V +  AC+     G     ++ E+   G L  ++       
Sbjct: 94  EALMSELKIMSHLGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFL------- 141
Query: 306 KRHKAPG-------------NLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNIL 352
           +R + PG              L+S   L+ +  VA  + +L         H D+   N+L
Sbjct: 142 RRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVL 198
Query: 353 LDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILL 412
           L +   A + DFG+AR +                 ++APE       +   DV+S+GILL
Sbjct: 199 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 258
Query: 413 LEMFT-GLRP 421
            E+F+ GL P
Sbjct: 259 WEIFSLGLNP 268

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G+ G V    +  S   VAVK  ++      +    E  + R+ +H N+V+++ +  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 94
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
              +   D   +V EF+  G+L +    I    +       +N  +   + + V   L  
Sbjct: 95  ---YLVGDELWVVMEFLEGGALTD----IVTHTR-------MNEEQIAAVCLAVLQALSV 140
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           LH      + H D+K  +ILL  +    +SDFG     + + E  R   + GT  ++APE
Sbjct: 141 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPE 195
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLRP--------SDDMFKDNLNLR 433
                      D++S GI+++EM  G  P        +  M +DNL  R
Sbjct: 196 LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR 244

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 43/230 (18%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVK-VFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFT 269
           +G G +G V+K I   +   VAVK +F+   +  DA ++F     +T    H N+V +  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 270 ACSGVDFQGNDFKA-LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                    ND    LV+++M     E  +H +   +        L  + +  +   +  
Sbjct: 77  VLRA----DNDRDVYLVFDYM-----ETDLHAVIRANI-------LEPVHKQYVVYQLIK 120
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR-FLEAA-------------- 373
           V+KYLH      + H D+KPSNILL+ E    V+DFG++R F+                 
Sbjct: 121 VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 374 ----DEQTRSIGVEGTTGYIAPEYGMGHEVSSYG-DVYSFGILLLEMFTG 418
               D+Q        T  Y APE  +G    + G D++S G +L E+  G
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 213 IGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKV 267
           +G G+FG V   + + +TT   VA+K+ N   +   D       E    R +RH +++K+
Sbjct: 22  LGEGSFGKV--KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           +        +  D   +V E+  N    E    I + DK       ++  +       + 
Sbjct: 80  YDV-----IKSKDEIIMVIEYAGN----ELFDYIVQRDK-------MSEQEARRFFQQII 123
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             ++Y H   +  I H DLKP N+LLD+ +   ++DFG++  +   +    S    G+  
Sbjct: 124 SAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPN 177
Query: 388 YIAPEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSDD 424
           Y APE   G   +    DV+S G++L  M     P DD
Sbjct: 178 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 22/214 (10%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
           ++G G +G VY G    +   +A+K         S+    E  + ++++H+N+V+   + 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 87
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
               F  N F  +  E +  GSL   +       +    P   N          +   LK
Sbjct: 88  ----FSENGFIKIFMEQVPGGSLSALL-------RSKWGPLKDNEQTIGFYTKQILEGLK 136
Query: 332 YLHLDCQPPIAHCDLKPSNILLDD-EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           YLH D Q  I H D+K  N+L++       +SDFG ++ L   +  T +    GT  Y+A
Sbjct: 137 YLH-DNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQYMA 191
Query: 391 PEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
           PE  +      YG   D++S G  ++EM TG  P
Sbjct: 192 PEI-IDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 27/215 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           IG G+FG V      ++    A+K  N    +  +  ++   E ++ + + H  LV ++ 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
           +     FQ  +   +V + +  G L            R+    N++  K   + + +  +
Sbjct: 83  S-----FQDEEDMFMVVDLLLGGDL------------RYHLQQNVH-FKEETVKLFICEL 124
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           +  L       I H D+KP NILLD+    +++DF IA  L     +T+   + GT  Y+
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPYM 181
Query: 390 APEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
           APE     + + Y    D +S G+   E+  G RP
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 94/229 (41%), Gaps = 29/229 (12%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +IG G+FG V            AVKV     +L     K    E    RN+  +N+   F
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE----RNVLLKNVKHPF 100
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                  FQ  D    V +++  G L  + H   E          L    R   A ++A 
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRER-------CFLEPRARF-YAAEIAS 150
Query: 329 VLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
            L YLH L+    I + DLKP NILLD +    ++DFG+ +  E  +  + +    GT  
Sbjct: 151 ALGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPE 204
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLN 431
           Y+APE           D +  G +L EM  GL P     + +M+ + LN
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 253

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 213 IGAGNFGSVYKGI--LFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRNIRHRNLVKVFT 269
           +G GNFGSV +G+  + +    VA+KV       A ++    E ++   + +  +V++  
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAP-GNLNSLKRLNIAIDVAC 328
            C            LV E    G L +++       KR + P  N+  L        V+ 
Sbjct: 78  VCQAEALM------LVMEMAGGGPLHKFL-----VGKREEIPVSNVAELLH-----QVSM 121
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE--QTRSIGVEGTT 386
            +KYL    +    H DL   N+LL +   A +SDFG+++ L A D     RS G +   
Sbjct: 122 GMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-KWPL 177
Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            + APE     + SS  DV+S+G+ + E  + G +P   M
Sbjct: 178 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 213 IGAGNFGSVYK----GILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNI-RHRN 263
           +G G FG V      GI  +           +L  DA++        E E+ + I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++ +  AC+    Q      +V E+ + G+L E++         +    N    +++   
Sbjct: 103 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 324 IDVACVLKYL----HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             V+C  +      +L  Q  I H DL   N+L+ +     ++DFG+AR +   D   ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKT 216
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                   ++APE       +   DV+SFG+L+ E+FT
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 213 IGAGNFGSVYK----GILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNI-RHRN 263
           +G G FG V      GI  +           +L  DA++        E E+ + I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++ +  AC+    Q      +V E+ + G+L E++         +    N    +++   
Sbjct: 103 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 324 IDVACVLKYL----HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             V+C  +      +L  Q  I H DL   N+L+ +     ++DFG+AR +   D   ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                   ++APE       +   DV+SFG+L+ E+FT
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 213 IGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKV 267
           +G G+FG V   + + +TT   VA+K+ N   +   D       E    R +RH +++K+
Sbjct: 12  LGEGSFGKV--KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           +        +  D   +V E+  N    E    I + DK       ++  +       + 
Sbjct: 70  YDV-----IKSKDEIIMVIEYAGN----ELFDYIVQRDK-------MSEQEARRFFQQII 113
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             ++Y H   +  I H DLKP N+LLD+ +   ++DFG++  +   +    S    G+  
Sbjct: 114 SAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPN 167
Query: 388 YIAPEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSDD 424
           Y APE   G   +    DV+S G++L  M     P DD
Sbjct: 168 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 107/280 (38%), Gaps = 52/280 (18%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTR 257
           AT  +     IG G +G+VYK     S   VA+K   V +          S   E  + R
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 258 NIR---HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNL 314
            +    H N+V++   C+           LV+E + +  L  ++      DK    P  L
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL------DK--APPPGL 117
Query: 315 NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD 374
            +    ++       L +LH +C   I H DLKP NIL+    T  ++DFG+AR      
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY-- 172
Query: 375 EQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMF------------------ 416
            Q     V  T  Y APE  +    ++  D++S G +  EMF                  
Sbjct: 173 -QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231
Query: 417 ---TGLRPSDDMFKDNLNLRNC--------VKSALPERAE 445
               GL P DD  +D    R          V+S +PE  E
Sbjct: 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEE 271

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 213 IGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKV 267
           +G G+FG V   + + +TT   VA+K+ N   +   D       E    R +RH +++K+
Sbjct: 16  LGEGSFGKV--KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           +        +  D   +V E+  N    E    I + DK       ++  +       + 
Sbjct: 74  YDV-----IKSKDEIIMVIEYAGN----ELFDYIVQRDK-------MSEQEARRFFQQII 117
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             ++Y H   +  I H DLKP N+LLD+ +   ++DFG++  +   +    S    G+  
Sbjct: 118 SAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPN 171
Query: 388 YIAPEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSDD 424
           Y APE   G   +    DV+S G++L  M     P DD
Sbjct: 172 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 213 IGAGNFGSVYK----GILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNI-RHRN 263
           +G G FG V      GI  +           +L  DA++        E E+ + I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++ +  AC+    Q      +V E+ + G+L E++         +    N    +++   
Sbjct: 103 IITLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 324 IDVACVLKYL----HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             V+C  +      +L  Q  I H DL   N+L+ +     ++DFG+AR +   D   ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                   ++APE       +   DV+SFG+L+ E+FT
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 213 IGAGNFGSVYK----GILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNI-RHRN 263
           +G G FG V      GI  +           +L  DA++        E E+ + I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++ +  AC+    Q      +V E+ + G+L E++         +    N    +++   
Sbjct: 103 IIHLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 324 IDVACVLKYL----HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             V+C  +      +L  Q  I H DL   N+L+ +     ++DFG+AR +   D   ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                   ++APE       +   DV+SFG+L+ E+FT
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 112
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 113 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----CHAPSSRR 164
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 165 TTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 213 IGAGNFGSVYK----GILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNI-RHRN 263
           +G G FG V      GI  +           +L  DA++        E E+ + I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++ +  AC+    Q      +V E+ + G+L E++         +    N    +++   
Sbjct: 149 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 324 IDVACVLKYL----HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             V+C  +      +L  Q  I H DL   N+L+ +     ++DFG+AR +   D   ++
Sbjct: 204 DLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                   ++APE       +   DV+SFG+L+ E+FT
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 213 IGAGNFGSVYK----GILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNI-RHRN 263
           +G G FG V      GI  +           +L  DA++        E E+ + I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++ +  AC+    Q      +V E+ + G+L E++         +    N    +++   
Sbjct: 90  IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 144
Query: 324 IDVACVLKYL----HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             V+C  +      +L  Q  I H DL   N+L+ +     ++DFG+AR +   D   ++
Sbjct: 145 DLVSCTYQLARGMEYLASQKCI-HRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKT 203
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                   ++APE       +   DV+SFG+L+ E+FT
Sbjct: 204 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G + + +  +++ D++  A         
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTA--------- 116
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 117 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 168
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 169 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/244 (22%), Positives = 100/244 (40%), Gaps = 26/244 (10%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY      S   +A+KV     +           E E+  ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F  +    L+ E+   G++   +  +++ D++  A         
Sbjct: 66  RHPNILRLYGY-----FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 111
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 112 -TYITELANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 163
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD-DMFKDNLNLRNCVKS 438
             + GT  Y+ PE   G       D++S G+L  E   G  P + + ++D     + V+ 
Sbjct: 164 AALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEF 223
Query: 439 ALPE 442
             P+
Sbjct: 224 TFPD 227

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G+ G V    +  S   VAVK  ++      +    E  + R+ +H N+V+++ +  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 89
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
              +   D   +V EF+  G+L +    I    +       +N  +   + + V   L  
Sbjct: 90  ---YLVGDELWVVMEFLEGGALTD----IVTHTR-------MNEEQIAAVCLAVLQALSV 135
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           LH      + H D+K  +ILL  +    +SDFG     + + E  R   + GT  ++APE
Sbjct: 136 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPE 190
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLRP--------SDDMFKDNLNLR 433
                      D++S GI+++EM  G  P        +  M +DNL  R
Sbjct: 191 LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR 239

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G+ G V    +  S   VAVK  ++      +    E  + R+ +H N+V+++ +  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 85
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
              +   D   +V EF+  G+L +    I    +       +N  +   + + V   L  
Sbjct: 86  ---YLVGDELWVVMEFLEGGALTD----IVTHTR-------MNEEQIAAVCLAVLQALSV 131
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           LH      + H D+K  +ILL  +    +SDFG     + + E  R   + GT  ++APE
Sbjct: 132 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPE 186
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLRP--------SDDMFKDNLNLR 433
                      D++S GI+++EM  G  P        +  M +DNL  R
Sbjct: 187 LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR 235

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 213 IGAGNFGSVYK----GILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNI-RHRN 263
           +G G FG V      GI  +           +L  DA++        E E+ + I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++ +  AC+    Q      +V E+ + G+L E++         +    N    +++   
Sbjct: 95  IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 149
Query: 324 IDVACVLKYL----HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             V+C  +      +L  Q  I H DL   N+L+ +     ++DFG+AR +   D   ++
Sbjct: 150 DLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 208
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                   ++APE       +   DV+SFG+L+ E+FT
Sbjct: 209 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 213 IGAGNFGSVYKG-----ILFESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G     I  E+ T VAVK  N       +  F  E  V +     ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRH--KAPGNLNSLKRLNIAI 324
           +     GV  +G     +V E MA+G L+ ++  +  E + +  + P  L  +  + +A 
Sbjct: 84  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM--IQMAA 136
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+        H DL   N ++  + T  + DFG+ R +   D   +      
Sbjct: 137 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 193
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEM 415
              ++APE       ++  D++SFG++L E+
Sbjct: 194 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 213 IGAGNFGSVYK----GILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNI-RHRN 263
           +G G FG V      GI  +           +L  DA++        E E+ + I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++ +  AC+    Q      +V E+ + G+L E++         +    N    +++   
Sbjct: 92  IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 146
Query: 324 IDVACVLKYL----HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             V+C  +      +L  Q  I H DL   N+L+ +     ++DFG+AR +   D   ++
Sbjct: 147 DLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 205
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                   ++APE       +   DV+SFG+L+ E+FT
Sbjct: 206 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 34/228 (14%)
Query: 199 MLYNATKGFSSENLIGAGNFGSVYKGILFESTT---AVAVKVFNV--LHHDASKSFAVEC 253
           + + + + +     IG G+FG   K IL +ST       +K  N+  +     +    E 
Sbjct: 18  LYFQSMEKYVRLQKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREV 74
Query: 254 EVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHP----ITEEDKRHK 309
            V  N++H N+V+   +     F+ N    +V ++   G L + ++     + +ED+   
Sbjct: 75  AVLANMKHPNIVQYRES-----FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-- 127
Query: 310 APGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
                     L+  + +   LK++H      I H D+K  NI L  + T  + DFGIAR 
Sbjct: 128 ----------LDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
Query: 370 LEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
           L +  E  R+    GT  Y++PE       ++  D+++ G +L E+ T
Sbjct: 175 LNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 87/212 (41%), Gaps = 25/212 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           +G G FG+VY     +S   +A+KV     +           E E+  ++RH N+++++ 
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
                 F       L+ E+   G++   +  ++  D++  A              ++A  
Sbjct: 80  Y-----FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTA----------TYITELANA 124
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           L Y H      + H D+KP N+LL       ++DFG +         +R   + GT  Y+
Sbjct: 125 LSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWS----VHAPSSRRTTLCGTLDYL 177
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            PE   G       D++S G+L  E   G+ P
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 22/214 (10%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
           ++G G +G VY G    +   +A+K         S+    E  + ++++H+N+V+   + 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 73
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
               F  N F  +  E +  GSL   +       +    P   N          +   LK
Sbjct: 74  ----FSENGFIKIFMEQVPGGSLSALL-------RSKWGPLKDNEQTIGFYTKQILEGLK 122
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAY-VSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           YLH D Q  I H D+K  N+L++       +SDFG ++ L   +  T +    GT  Y+A
Sbjct: 123 YLH-DNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQYMA 177
Query: 391 PEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
           PE  +      YG   D++S G  ++EM TG  P
Sbjct: 178 PEI-IDKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 92  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 137
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 138 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 189
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 190 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/239 (23%), Positives = 102/239 (42%), Gaps = 23/239 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G+ G V       +   VAVK  ++      +    E  + R+  H N+V ++++  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSS-- 110
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
              +   D   +V EF+  G+L + +               +N  +   + + V   L Y
Sbjct: 111 ---YLVGDELWVVMEFLEGGALTDIV-----------THTRMNEEQIATVCLSVLRALSY 156
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           LH      + H D+K  +ILL  +    +SDFG     + + E  +   + GT  ++APE
Sbjct: 157 LH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKXLVGTPYWMAPE 211
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASS 451
                   +  D++S GI+++EM  G  P  +  +  L     ++ +LP R +++   S
Sbjct: 212 VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN--EPPLQAMRRIRDSLPPRVKDLHKVS 268

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 116
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 117 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 168
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 169 TTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 33/234 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           IG G F  V + +   +    A K+ N   L     +    E  + R ++H N+V++  +
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
            S        F  LV++ +  G L E                ++ + +  + A    C+ 
Sbjct: 72  ISE-----EGFHYLVFDLVTGGELFE----------------DIVAREYYSEADASHCIQ 110
Query: 331 KYLH--LDC-QPPIAHCDLKPSNILLDDE---MTAYVSDFGIARFLEAADEQTRSIGVEG 384
           + L   L C Q  + H DLKP N+LL  +       ++DFG+A  +E   +Q    G  G
Sbjct: 111 QILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAG 168
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS 438
           T GY++PE           D+++ G++L  +  G  P  D  +D   L   +K+
Sbjct: 169 TPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWD--EDQHKLYQQIKA 220

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 111
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 112 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 163
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 164 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 111
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 112 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 163
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 164 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNL 264
           K ++    IG G  G+VY  +   +   VA++  N+      +    E  V R  ++ N+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           V    +     +   D   +V E++A GSL + +     ++      G + ++ R     
Sbjct: 81  VNYLDS-----YLVGDELWVVMEYLAGGSLTDVVTETCMDE------GQIAAVCR----- 124
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           +    L++LH +    + H ++K  NILL  + +  ++DFG     +   EQ++   + G
Sbjct: 125 ECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVG 179
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           T  ++APE           D++S GI+ +EM  G  P
Sbjct: 180 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 112
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 113 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 164
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 213 IGAGNFGSVYKG-----ILFESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G     I  E+ T VAVK  N       +  F  E  V +     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRH--KAPGNLNSLKRLNIAI 324
           +     GV  +G     +V E MA+G L+ ++  +  E + +  + P  L  +  + +A 
Sbjct: 85  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM--IQMAA 137
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+        H DL   N ++  + T  + DFG+ R +   D   +      
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 194
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEM 415
              ++APE       ++  D++SFG++L E+
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 114
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 115 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 166
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 167 AALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 83  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 128
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 129 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 180
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 181 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 100/232 (43%), Gaps = 31/232 (13%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV----EC 253
           R++YN +  F  ++L+G G +G V       +   VA+K            FA+    E 
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREI 60
Query: 254 EVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGN 313
           ++ ++ +H N++ +F       F+  +   ++ E M        +H +           +
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVI----------S 105
Query: 314 LNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE-- 371
              L   +I   +   L+ + +     + H DLKPSN+L++      V DFG+AR ++  
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 372 AAD------EQTRSIGVEGTTGYIAPEYGM-GHEVSSYGDVYSFGILLLEMF 416
           AAD      +Q+       T  Y APE  +   + S   DV+S G +L E+F
Sbjct: 166 AADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 105/241 (43%), Gaps = 25/241 (10%)
Query: 198 RMLYNATKGFSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDAS 246
           ++ YN    F   NL     +GAG FG V +   F     ++   VAVK+  +  H D  
Sbjct: 34  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK 93
Query: 247 KSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHP---IT 302
           ++   E ++  ++ +H N+V +  AC+     G     ++ E+   G L  ++     + 
Sbjct: 94  EALMSELKIMSHLGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVL 148
Query: 303 EEDKRHK-APGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
           E D     A   L++   L+ +  VA  + +L         H D+   N+LL +   A +
Sbjct: 149 ETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKI 205
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLR 420
            DFG+AR +                 ++APE       +   DV+S+GILL E+F+ GL 
Sbjct: 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 265
Query: 421 P 421
           P
Sbjct: 266 P 266

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 19/218 (8%)
Query: 213 IGAGNFGSVYK----GILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNI-RHRN 263
           +G G FG V      GI  +           +L  DA++        E E+ + I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++ +  AC+    Q      +V E+ + G+L E++         +    N    +++   
Sbjct: 103 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 324 IDVACVLKYL----HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             V+C  +      +L  Q  I H DL   N+L+ +     ++DFG+AR +   D    +
Sbjct: 158 DLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNT 216
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                   ++APE       +   DV+SFG+L+ E+FT
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 111
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 112 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 163
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 164 TELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 114
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 115 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 166
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 167 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 18/234 (7%)
Query: 198 RMLYNATKG-FSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVFNV-LHHDA 245
           R+ Y+A+K  F  + L     +G G FG V +   F      +   VAVK+      H  
Sbjct: 16  RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSE 75
Query: 246 SKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE 304
            ++   E ++  +I  H N+V +  AC+     G     +V EF   G+L  ++     E
Sbjct: 76  HRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNE 131
Query: 305 DKRHKAPGNLNSLKRLNIAIDVAC-VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD 363
              +K          L   I  +  V K +         H DL   NILL ++    + D
Sbjct: 132 FVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICD 191
Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
           FG+AR +    +  R         ++APE       +   DV+SFG+LL E+F+
Sbjct: 192 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 116
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 117 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 168
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 169 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 20/236 (8%)
Query: 198 RMLYNATKG-FSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVFNV-LHHDA 245
           R+ Y+A+K  F  + L     +G G FG V +   F      +   VAVK+      H  
Sbjct: 14  RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 73
Query: 246 SKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE 304
            ++   E ++  +I  H N+V +  AC+     G     +V EF   G+L  ++     E
Sbjct: 74  HRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNE 129
Query: 305 DKRHK-APGNL--NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
              +K AP +L  + L   ++      V K +         H DL   NILL ++    +
Sbjct: 130 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 189
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            DFG+AR +    +  R         ++APE       +   DV+SFG+LL E+F+
Sbjct: 190 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 116
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 117 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 168
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 169 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 111
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 112 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 163
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 164 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 25/212 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           +G G FG+VY     +S   +A+KV     +           E E+  ++RH N+++++ 
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
                 F       L+ E+   G++   +  ++  D++  A              ++A  
Sbjct: 80  Y-----FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTA----------TYITELANA 124
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           L Y H      + H D+KP N+LL       ++DFG +    ++   T    + GT  Y+
Sbjct: 125 LSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT----LCGTLDYL 177
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            PE   G       D++S G+L  E   G+ P
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 92  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 137
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 138 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 189
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 190 DDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
            +G G F   ++    ++    A K+     +L     +  ++E  + R++ H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                  F+ NDF  +V E     SL E +H      KR KA     +   L   I + C
Sbjct: 84  GF-----FEDNDFVFVVLELCRRRSLLE-LH------KRRKALTEPEARYYLR-QIVLGC 130
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
             +YLH +    + H DLK  N+ L++++   + DFG+A  +E   E+ +++   GT  Y
Sbjct: 131 --QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNY 183
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           IAPE       S   DV+S G ++  +  G  P
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
            +G G F   ++    ++    A K+     +L     +  ++E  + R++ H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                  F+ NDF  +V E     SL E +H      KR KA     +   L   I + C
Sbjct: 84  GF-----FEDNDFVFVVLELCRRRSLLE-LH------KRRKALTEPEARYYLR-QIVLGC 130
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
             +YLH +    + H DLK  N+ L++++   + DFG+A  +E   E+ +++   GT  Y
Sbjct: 131 --QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNY 183
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           IAPE       S   DV+S G ++  +  G  P
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 68  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 113
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 114 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 165
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 166 XXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 20/236 (8%)
Query: 198 RMLYNATKG-FSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVFNV-LHHDA 245
           R+ Y+A+K  F  + L     +G G FG V +   F      +   VAVK+      H  
Sbjct: 5   RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 64
Query: 246 SKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE 304
            ++   E ++  +I  H N+V +  AC+     G     +V EF   G+L  ++     E
Sbjct: 65  HRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNE 120
Query: 305 DKRHK-APGNL--NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
              +K AP +L  + L   ++      V K +         H DL   NILL ++    +
Sbjct: 121 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 180
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            DFG+AR +    +  R         ++APE       +   DV+SFG+LL E+F+
Sbjct: 181 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 111
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 112 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 163
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 164 AALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 106/253 (41%), Gaps = 40/253 (15%)
Query: 198 RMLYNATKGFSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDAS 246
           ++ YN    F   NL     +GAG FG V +   F     ++   VAVK+  +  H D  
Sbjct: 19  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK 78
Query: 247 KSFAVECEVTRNI-RHRNLVKVFTACSG----------------VDFQGNDFKALVYEFM 289
           ++   E ++  ++ +H N+V +  AC+                 ++F     +A++   +
Sbjct: 79  EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSL 138
Query: 290 ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPS 349
           A G   E +      DK    P  L  L  L+ +  VA  + +L         H D+   
Sbjct: 139 APGQDPEGL------DKEDGRPLELRDL--LHFSSQVAQGMAFL---ASKNCIHRDVAAR 187
Query: 350 NILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFG 409
           N+LL +   A + DFG+AR +                 ++APE       +   DV+S+G
Sbjct: 188 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 247
Query: 410 ILLLEMFT-GLRP 421
           ILL E+F+ GL P
Sbjct: 248 ILLWEIFSLGLNP 260

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 102/234 (43%), Gaps = 33/234 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +G G F  V + +   +    A K+ N   L     +    E  + R ++H N+V++  +
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
            S    +G+ +  L+++ +  G L E                ++ + +  + A    C+ 
Sbjct: 90  ISE---EGHHY--LIFDLVTGGELFE----------------DIVAREYYSEADASHCIQ 128
Query: 331 KYLH--LDC-QPPIAHCDLKPSNILLDDEM---TAYVSDFGIARFLEAADEQTRSIGVEG 384
           + L   L C Q  + H DLKP N+LL  ++      ++DFG+A  +E   EQ    G  G
Sbjct: 129 QILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAG 186
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS 438
           T GY++PE           D+++ G++L  +  G  P  D  +D   L   +K+
Sbjct: 187 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD--EDQHRLYQQIKA 238

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
            +G G F   ++    ++    A K+     +L     +  ++E  + R++ H+++V   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                  F+ NDF  +V E     SL E +H      KR KA     +   L   I + C
Sbjct: 88  GF-----FEDNDFVFVVLELCRRRSLLE-LH------KRRKALTEPEARYYLR-QIVLGC 134
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
             +YLH +    + H DLK  N+ L++++   + DFG+A  +E   E+ +++   GT  Y
Sbjct: 135 --QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNY 187
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           IAPE       S   DV+S G ++  +  G  P
Sbjct: 188 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 220

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 70  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 115
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 116 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 167
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 168 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 106/239 (44%), Gaps = 26/239 (10%)
Query: 198 RMLYNATKG-FSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVFNV-LHHDA 245
           R+ Y+A+K  F  + L     +G G FG V +   F      +   VAVK+      H  
Sbjct: 14  RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 73
Query: 246 SKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE 304
            ++   E ++  +I  H N+V +  AC+     G     +V EF   G+L  ++     E
Sbjct: 74  HRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNE 129
Query: 305 DKRHK-APGNLN----SLKRL-NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT 358
              +K AP +L     +L+ L   +  VA  +++L         H DL   NILL ++  
Sbjct: 130 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNV 186
Query: 359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             + DFG+AR +    +  R         ++APE       +   DV+SFG+LL E+F+
Sbjct: 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 65  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 110
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 111 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 162
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 163 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 111
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 112 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 163
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 164 TXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 106/239 (44%), Gaps = 26/239 (10%)
Query: 198 RMLYNATKG-FSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVFNV-LHHDA 245
           R+ Y+A+K  F  + L     +G G FG V +   F      +   VAVK+      H  
Sbjct: 14  RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 73
Query: 246 SKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE 304
            ++   E ++  +I  H N+V +  AC+     G     +V EF   G+L  ++     E
Sbjct: 74  HRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNE 129
Query: 305 DKRHK-APGNLN----SLKRL-NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT 358
              +K AP +L     +L+ L   +  VA  +++L         H DL   NILL ++  
Sbjct: 130 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNV 186
Query: 359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             + DFG+AR +    +  R         ++APE       +   DV+SFG+LL E+F+
Sbjct: 187 VKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH----DASKSFAV-ECEVTRNIRHRNLVKV 267
           IG G++G   K       +   + V+  L +    +A K   V E  + R ++H N+V+ 
Sbjct: 14  IGTGSYGRCQK---IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           +     +D + N    +V E+   G L   +   T+E +       L  + +L +A    
Sbjct: 71  YDRI--ID-RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA---- 123
Query: 328 CVLKYLHL--DCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
             LK  H   D    + H DLKP+N+ LD +    + DFG+AR L   ++  +     GT
Sbjct: 124 --LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV--GT 179
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             Y++PE       +   D++S G LL E+   + P
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 92/222 (41%), Gaps = 22/222 (9%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           ++G G+FG V       +    A+K+     V+  D  +   VE  V   +     +   
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
            +C    FQ  D    V E++  G L   M+ I +        G     + +  A +++ 
Sbjct: 86  HSC----FQTVDRLYFVMEYVNGGDL---MYHIQQV-------GKFKEPQAVFYAAEISI 131
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L +LH   +  I + DLK  N++LD E    ++DFG+ +        TR     GT  Y
Sbjct: 132 GLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFC--GTPDY 186
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 430
           IAPE           D +++G+LL EM  G  P D   +D L
Sbjct: 187 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 228

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 20/236 (8%)
Query: 198 RMLYNATKG-FSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVFNV-LHHDA 245
           R+ Y+A+K  F  + L     +G G FG V +   F      +   VAVK+      H  
Sbjct: 51  RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 110
Query: 246 SKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE 304
            ++   E ++  +I  H N+V +  AC+     G     +V EF   G+L  ++     E
Sbjct: 111 HRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNE 166
Query: 305 DKRHK-APGNL--NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
              +K AP +L  + L   ++      V K +         H DL   NILL ++    +
Sbjct: 167 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 226
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            DFG+AR +    +  R         ++APE       +   DV+SFG+LL E+F+
Sbjct: 227 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 112
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +    ++   T  
Sbjct: 113 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT-- 166
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 167 --LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 24/220 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN--VLHHDASKSFAVECEVTRNIRHRNL 264
           +  +  IG GNF  V       +   VAVK+ +   L+  + +    E  + + + H N+
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+F        +      LV E+ + G + +++           A G +   +      
Sbjct: 77  VKLFEVI-----ETEKTLYLVMEYASGGEVFDYL----------VAHGRMKEKEARAKFR 121
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +   ++Y H   Q  I H DLK  N+LLD +M   ++DFG +      ++        G
Sbjct: 122 QIVSAVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC---G 175
Query: 385 TTGYIAPEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSD 423
           +  Y APE   G +      DV+S G++L  + +G  P D
Sbjct: 176 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 111
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 112 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 163
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 164 XXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 30/217 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVFTA 270
           IG GNF  V       +   VAV++ +    ++S  +    E  + + + H N+VK+F  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                 +      LV E+ + G + +++           A G +   +       +   +
Sbjct: 82  I-----ETEKTLYLVMEYASGGEVFDYL----------VAHGRMKEKEARAKFRQIVSAV 126
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR---FLEAADEQTRSIGVEGTTG 387
           +Y H   Q  I H DLK  N+LLD +M   ++DFG +    F    DE        G+  
Sbjct: 127 QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC------GSPP 177
Query: 388 YIAPEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSD 423
           Y APE   G +      DV+S G++L  + +G  P D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVFTA 270
           IG GNF  V       +   VAVK+ +    ++S  +    E  + + + H N+VK+F  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                 +      LV E+ + G + +++           A G +   +       +   +
Sbjct: 82  I-----ETEKTLYLVMEYASGGEVFDYL----------VAHGRMKEKEARAKFRQIVSAV 126
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +Y H   Q  I H DLK  N+LLD +M   ++DFG +      ++        G+  Y A
Sbjct: 127 QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GSPPYAA 180
Query: 391 PEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSD 423
           PE   G +      DV+S G++L  + +G  P D
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 20/236 (8%)
Query: 198 RMLYNATKG-FSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVFNV-LHHDA 245
           R+ Y+A+K  F  + L     +G G FG V +   F      +   VAVK+      H  
Sbjct: 16  RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 75
Query: 246 SKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE 304
            ++   E ++  +I  H N+V +  AC+     G     +V EF   G+L  ++     E
Sbjct: 76  HRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNE 131
Query: 305 DKRHK-APGNL--NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
              +K AP +L  + L   ++      V K +         H DL   NILL ++    +
Sbjct: 132 FVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 191
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            DFG+AR +    +  R         ++APE       +   DV+SFG+LL E+F+
Sbjct: 192 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 213 IGAGNFGSVYKGI--LFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRNIRHRNLVKVFT 269
           +G GNFGSV +G+  + +    VA+KV       A ++    E ++   + +  +V++  
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAP-GNLNSLKRLNIAIDVAC 328
            C            LV E    G L +++       KR + P  N+  L        V+ 
Sbjct: 404 VCQAEALM------LVMEMAGGGPLHKFL-----VGKREEIPVSNVAELLH-----QVSM 447
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE--QTRSIGVEGTT 386
            +KYL    +    H +L   N+LL +   A +SDFG+++ L A D     RS G +   
Sbjct: 448 GMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-KWPL 503
Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            + APE     + SS  DV+S+G+ + E  + G +P   M
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVFTA 270
           IG GNF  V       +   VAVK+ +    ++S  +    E  + + + H N+VK+F  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                 +      LV E+ + G + +++           A G +   +       +   +
Sbjct: 82  I-----ETEKTLYLVMEYASGGEVFDYL----------VAHGRMKEKEARAKFRQIVSAV 126
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +Y H   Q  I H DLK  N+LLD +M   ++DFG +      ++        G+  Y A
Sbjct: 127 QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GSPPYAA 180
Query: 391 PEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSD 423
           PE   G +      DV+S G++L  + +G  P D
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 114
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 115 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 166
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 167 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVKVFTAC 271
           +G G +G VYK    +       ++      +   S A+ E  + + + H N+V +    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV- 87
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
                       LV+EFM             E+D +     N   L+   I I +  +L+
Sbjct: 88  ----IHSERCLTLVFEFM-------------EKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT-GYIA 390
            +    Q  I H DLKP N+L++ +    ++DFG+AR   A     RS   E  T  Y A
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR---AFGIPVRSYTHEVVTLWYRA 187
Query: 391 PEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
           P+  MG  + S+  D++S G +  EM TG
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVKVFTAC 271
           +G G +G VYK    +       ++      +   S A+ E  + + + H N+V +    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV- 87
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
                       LV+EFM             E+D +     N   L+   I I +  +L+
Sbjct: 88  ----IHSERCLTLVFEFM-------------EKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT-GYIA 390
            +    Q  I H DLKP N+L++ +    ++DFG+AR   A     RS   E  T  Y A
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR---AFGIPVRSYTHEVVTLWYRA 187
Query: 391 PEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
           P+  MG  + S+  D++S G +  EM TG
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 114
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 115 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 166
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 167 XXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 97/234 (41%), Gaps = 33/234 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +G G F  V + +   +    A K+ N   L     +    E  + R ++H N+V++  +
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
            S        F  LV++ +  G L E +      +E D  H     L S+          
Sbjct: 72  ISE-----EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN--------- 117
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDE---MTAYVSDFGIARFLEAADEQTRSIGVEG 384
               + HL+    I H DLKP N+LL  +       ++DFG+A  +E   +Q    G  G
Sbjct: 118 ----HCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAG 168
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS 438
           T GY++PE           D+++ G++L  +  G  P  D  +D   L   +K+
Sbjct: 169 TPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWD--EDQHRLYQQIKA 220

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 97/234 (41%), Gaps = 33/234 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +G G F  V + +   +    A K+ N   L     +    E  + R ++H N+V++  +
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
            S        F  LV++ +  G L E +      +E D  H     L S+          
Sbjct: 72  ISE-----EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN--------- 117
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDE---MTAYVSDFGIARFLEAADEQTRSIGVEG 384
               + HL+    I H DLKP N+LL  +       ++DFG+A  +E   +Q    G  G
Sbjct: 118 ----HCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAG 168
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS 438
           T GY++PE           D+++ G++L  +  G  P  D  +D   L   +K+
Sbjct: 169 TPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWD--EDQHRLYQQIKA 220

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVFTA 270
           IG GNF  V       +   VAVK+ +    ++S  +    E  + + + H N+VK+F  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                 +      LV E+ + G + +++           A G +   +       +   +
Sbjct: 82  I-----ETEKTLYLVMEYASGGEVFDYL----------VAHGRMKEKEARAKFRQIVSAV 126
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +Y H   Q  I H DLK  N+LLD +M   ++DFG +      ++        G   Y A
Sbjct: 127 QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD---AFCGAPPYAA 180
Query: 391 PEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSD 423
           PE   G +      DV+S G++L  + +G  P D
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 114
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 115 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 166
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 167 DDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 26/215 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--VLHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           IG GNF  V       +   VA+K+ +   L+  + +    E  + + + H N+VK+F  
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                 +      L+ E+ + G + +++           A G +   +  +    +   +
Sbjct: 80  I-----ETEKTLYLIMEYASGGEVFDYL----------VAHGRMKEKEARSKFRQIVSAV 124
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA-RFLEAADEQTRSIGVEGTTGYI 389
           +Y H   Q  I H DLK  N+LLD +M   ++DFG +  F       T      G+  Y 
Sbjct: 125 QYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC----GSPPYA 177
Query: 390 APEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSD 423
           APE   G +      DV+S G++L  + +G  P D
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV 265
            ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 76
Query: 266 KV--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++  F   SG      + K +VY  +    + E ++ +     R K      +L  + + 
Sbjct: 77  RLRYFFYSSG------EKKDVVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVK 125
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGV 382
           + +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I  
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI-- 183
Query: 383 EGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
             +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 184 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 19/218 (8%)
Query: 213 IGAGNFGSVYK----GILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNI-RHRN 263
           +G G FG V      GI  +           +L  DA++        E E+ + I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++ +  AC+    Q      +V  + + G+L E++         +    N    +++   
Sbjct: 103 IINLLGACT----QDGPLYVIV-AYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 324 IDVACVLKYL----HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             V+C  +      +L  Q  I H DL   N+L+ +     ++DFG+AR +   D   ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                   ++APE       +   DV+SFG+L+ E+FT
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     IG G+FG V      E+    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E+M  G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     IG G+FG V      E+    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E+M  G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 26/228 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G+G FG V++ +   +      K  N  +     +   E  +   + H  L+ +  A  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV-LK 331
              F+      L+ EF++ G L      I  ED +      +N +++       AC  LK
Sbjct: 117 ---FEDKYEMVLILEFLSGGEL---FDRIAAEDYKMSEAEVINYMRQ-------ACEGLK 163
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVS--DFGIARFLEAADEQTRSIGVEGTTGYI 389
           ++H   +  I H D+KP NI+ + +  + V   DFG+A  L   DE  +      T  + 
Sbjct: 164 HMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-DEIVKV--TTATAEFA 217
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRP--SDDMFKDNLNLRNC 435
           APE      V  Y D+++ G+L   + +GL P   +D  +   N++ C
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 265

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
            +G G F   ++    ++    A K+     +L     +  ++E  + R++ H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                  F+ NDF  +V E     SL E +H      KR KA     +   L   I + C
Sbjct: 108 GF-----FEDNDFVFVVLELCRRRSLLE-LH------KRRKALTEPEARYYLR-QIVLGC 154
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
             +YLH +    + H DLK  N+ L++++   + DFG+A  +E   E+ + +   GT  Y
Sbjct: 155 --QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNY 207
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           IAPE       S   DV+S G ++  +  G  P
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 26/222 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLV 265
           F   + +GAGN G V+K     S   +A K+ ++    A ++  + E +V        +V
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             + A     F  +   ++  E M  GSL++ +          K  G +       ++I 
Sbjct: 71  GFYGA-----FYSDGEISICMEHMDGGSLDQVL----------KKAGRIPEQILGKVSIA 115
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL--EAADEQTRSIGVE 383
           V   L YL    +  I H D+KPSNIL++      + DFG++  L  E A+E        
Sbjct: 116 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV------ 167
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
           GT  Y++PE   G   S   D++S G+ L+EM  G  P   M
Sbjct: 168 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPM 209

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 20/236 (8%)
Query: 198 RMLYNATKG-FSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVFNV-LHHDA 245
           R+ Y+A+K  F  + L     +G G FG V +   F      +   VAVK+      H  
Sbjct: 5   RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 64
Query: 246 SKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE 304
            ++   E ++  +I  H N+V +  AC+     G     ++ EF   G+L  ++     E
Sbjct: 65  HRALMSELKILIHIGHHLNVVNLLGACTK---PGGPL-MVITEFCKFGNLSTYLRSKRNE 120
Query: 305 DKRHK-APGNL--NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
              +K AP +L  + L   ++      V K +         H DL   NILL ++    +
Sbjct: 121 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 180
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            DFG+AR +    +  R         ++APE       +   DV+SFG+LL E+F+
Sbjct: 181 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
            +G G F   ++    ++    A K+     +L     +  ++E  + R++ H+++V   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                  F+ NDF  +V E     SL E +H      KR KA     +   L   I + C
Sbjct: 106 GF-----FEDNDFVFVVLELCRRRSLLE-LH------KRRKALTEPEARYYLR-QIVLGC 152
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
             +YLH +    + H DLK  N+ L++++   + DFG+A  +E   E+ + +   GT  Y
Sbjct: 153 --QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNY 205
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           IAPE       S   DV+S G ++  +  G  P
Sbjct: 206 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG VYK    E+    A KV      +  + + VE E+     H  +VK+  A  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA-- 76
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC--VL 330
              +  +    ++ EF   G+++  M    E D+    P            I V C  +L
Sbjct: 77  ---YYHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEP-----------QIQVVCRQML 119
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI-ARFLEAADEQTRSIGVEGTTGYI 389
           + L+      I H DLK  N+L+  E    ++DFG+ A+ L+   ++   I   GT  ++
Sbjct: 120 EALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI---GTPYWM 176
Query: 390 APEYGMGHEVSSY-----GDVYSFGILLLEM 415
           APE  M   +         D++S GI L+EM
Sbjct: 177 APEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 213 IGAGNFGSVYKG-----ILFESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G     I  E+ T VAVK  N       +  F  E  V +     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRH--KAPGNLNSLKRLNIAI 324
           +     GV  +G     +V E MA+G L+ ++  +  E + +  + P  L  +  + +A 
Sbjct: 85  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM--IQMAA 137
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR-FLEAADEQTRSIGVE 383
           ++A  + YL+        H DL   N ++  + T  + DFG+ R   E A  +    G+ 
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLL 194
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEM 415
               ++APE       ++  D++SFG++L E+
Sbjct: 195 PVR-WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 19/218 (8%)
Query: 213 IGAGNFGSVYK----GILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNI-RHRN 263
           +G G FG V      GI  +           +L  DA++        E E+ + I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++ +  AC+    Q      +V  + + G+L E++         +    N    +++   
Sbjct: 103 IINLLGACT----QDGPLYVIV-GYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 324 IDVACVLKYL----HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             V+C  +      +L  Q  I H DL   N+L+ +     ++DFG+AR +   D   ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                   ++APE       +   DV+SFG+L+ E+FT
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 213 IGAGNFGSVYKG-----ILFESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G     I  E+ T VAVK  N       +  F  E  V +     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRH--KAPGNLNSLKRLNIAI 324
           +     GV  +G     +V E MA+G L+ ++  +  E + +  + P  L  +  + +A 
Sbjct: 85  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM--IQMAA 137
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+        H +L   N ++  + T  + DFG+ R +   D   +      
Sbjct: 138 EIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 194
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEM 415
              ++APE       ++  D++SFG++L E+
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG VYK    E+    A KV      +  + + VE E+     H  +VK+  A  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA-- 84
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC--VL 330
              +  +    ++ EF   G+++  M    E D+    P            I V C  +L
Sbjct: 85  ---YYHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEP-----------QIQVVCRQML 127
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI-ARFLEAADEQTRSIGVEGTTGYI 389
           + L+      I H DLK  N+L+  E    ++DFG+ A+ L+   ++   I   GT  ++
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI---GTPYWM 184
Query: 390 APEYGMGHEVSSY-----GDVYSFGILLLEM 415
           APE  M   +         D++S GI L+EM
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--VLHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           IG GNF  V       +   VA+K+ +   L+  + +    E  + + + H N+VK+F  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                 +      L+ E+ + G + +++           A G +   +  +    +   +
Sbjct: 83  -----IETEKTLYLIMEYASGGEVFDYL----------VAHGRMKEKEARSKFRQIVSAV 127
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +Y H   Q  I H DLK  N+LLD +M   ++DFG +       +        G   Y A
Sbjct: 128 QYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD---AFCGAPPYAA 181
Query: 391 PEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSD 423
           PE   G +      DV+S G++L  + +G  P D
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 85/184 (46%), Gaps = 31/184 (16%)
Query: 248 SFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKR 307
            F  E ++  +I++   +     C G+     D   ++YE+M N S+ ++       DK 
Sbjct: 89  DFKNELQIITDIKNEYCL----TCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 308 HKAPGNLNSLKRLNIAIDVACVLK-------YLHLDCQPPIAHCDLKPSNILLDDEMTAY 360
           +     +  +K         C++K       Y+H   +  I H D+KPSNIL+D      
Sbjct: 144 YTCFIPIQVIK---------CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVK 192
Query: 361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFT 417
           +SDFG + ++   D++ +  G  GT  ++ PE+   +E S  G   D++S GI L  MF 
Sbjct: 193 LSDFGESEYM--VDKKIK--GSRGTYEFMPPEF-FSNESSYNGAKVDIWSLGICLYVMFY 247
Query: 418 GLRP 421
            + P
Sbjct: 248 NVVP 251

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           ++   +IG G+FG VY+  L +S   VA+K   VL   A K+   E ++ R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 267 V--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +  F   SG      + K  VY  +    + E ++ +     R K      +L  + + +
Sbjct: 78  LRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVKL 126
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I   
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--- 183
Query: 384 GTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
            +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 213 IGAGNFGSVYKG-----ILFESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G     I  E+ T VAVK  N       +  F  E  V +     ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRH--KAPGNLNSLKRLNIAI 324
           +     GV  +G     +V E MA+G L+ ++  +  E + +  + P  L  +  + +A 
Sbjct: 86  LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM--IQMAA 138
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  + YL+        H +L   N ++  + T  + DFG+ R +   D   +      
Sbjct: 139 EIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 195
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEM 415
              ++APE       ++  D++SFG++L E+
Sbjct: 196 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 30  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 83
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G  +       
Sbjct: 84  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFY 133
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D++    V+DFG A+ ++      R+  
Sbjct: 134 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG-----RTWX 184
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 185 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVFTA 270
           IG GNF  V       +   VAV++ +    ++S  +    E  + + + H N+VK+F  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                 +      LV E+ + G + +++           A G +   +       +   +
Sbjct: 82  I-----ETEKTLYLVMEYASGGEVFDYL----------VAHGRMKEKEARAKFRQIVSAV 126
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +Y H   Q  I H DLK  N+LLD +M   ++DFG +      ++        G+  Y A
Sbjct: 127 QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GSPPYAA 180
Query: 391 PEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSD 423
           PE   G +      DV+S G++L  + +G  P D
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           ++   +IG G+FG VY+  L +S   VA+K   VL   A K+   E ++ R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 267 V--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +  F   SG      + K  VY  +    + E ++ +     R K      +L  + + +
Sbjct: 78  LRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVKL 126
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I   
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--- 183
Query: 384 GTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
            +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 25/241 (10%)
Query: 198 RMLYNATKGFSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVF-NVLHHDAS 246
           ++ YN    F   NL     +GAG FG V +   F     ++   VAVK+  +  H D  
Sbjct: 34  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK 93
Query: 247 KSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHP---IT 302
           ++   E ++  ++ +H N+V +  AC+     G     ++ E+   G L  ++     + 
Sbjct: 94  EALMSELKIMSHLGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVL 148
Query: 303 EEDKRHKAPGNLNSLKRL-NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
           E D       +  S + L + +  VA  + +L         H D+   N+LL +   A +
Sbjct: 149 ETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKI 205
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLR 420
            DFG+AR +                 ++APE       +   DV+S+GILL E+F+ GL 
Sbjct: 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 265
Query: 421 P 421
           P
Sbjct: 266 P 266

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 30/217 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVFTA 270
           IG GNF  V       +   VAVK+ +    ++S  +    E  + + + H N+VK+F  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHP---ITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                 +      LV E+ + G + +++     + E++ R K                + 
Sbjct: 75  I-----ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-------------QIV 116
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             ++Y H   Q  I H DLK  N+LLD +M   ++DFG +      ++        G+  
Sbjct: 117 SAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GSPP 170
Query: 388 YIAPEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSD 423
           Y APE   G +      DV+S G++L  + +G  P D
Sbjct: 171 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +G G+FG V    Y      +   VAVK          +S +  E ++ R + H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     QG     LV E++  GSL +++        RH    ++   + L  A  + 
Sbjct: 82  KGCCED---QGEKSLQLVMEYVPLGSLRDYL-------PRH----SIGLAQLLLFAQQIC 127
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YLH        H +L   N+LLD++    + DFG+A+ +    E  R +  +G + 
Sbjct: 128 EGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VREDGDSP 183
Query: 388 --YIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             + APE    ++     DV+SFG+ L E+ T
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 22/235 (9%)
Query: 198 RMLYNATKG-FSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVFNV-LHHDA 245
           R+ Y+A+K  F  + L     +G G FG V +   F      +   VAVK+      H  
Sbjct: 14  RLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSE 73
Query: 246 SKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE 304
            ++   E ++  +I  H N+V +  AC+     G     +V EF   G+L  ++     E
Sbjct: 74  HRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNE 129
Query: 305 DKRHK-APGNLNSLKRL-NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS 362
              +K    +  +L+ L   +  VA  +++L         H DL   NILL ++    + 
Sbjct: 130 FVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIX 186
Query: 363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
           DFG+AR +    +  R         ++APE       +   DV+SFG+LL E+F+
Sbjct: 187 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +G G+FG V    Y      +   VAVK          +S +  E ++ R + H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     QG     LV E++  GSL +++        RH    ++   + L  A  + 
Sbjct: 82  KGCCED---QGEKSLQLVMEYVPLGSLRDYL-------PRH----SIGLAQLLLFAQQIC 127
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YLH        H +L   N+LLD++    + DFG+A+ +    E  R +  +G + 
Sbjct: 128 EGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VREDGDSP 183
Query: 388 --YIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             + APE    ++     DV+SFG+ L E+ T
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLV 265
           F   + +GAGN G V+K     S   +A K+ ++    A ++  + E +V        +V
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 129
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             + A     F  +   ++  E M  GSL++ +          K  G +       ++I 
Sbjct: 130 GFYGA-----FYSDGEISICMEHMDGGSLDQVL----------KKAGRIPEQILGKVSIA 174
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           V   L YL    +  I H D+KPSNIL++      + DFG++  L   D    S    GT
Sbjct: 175 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGT 228
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             Y++PE   G   S   D++S G+ L+EM  G  P
Sbjct: 229 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
            +G G F   ++    ++    A K+     +L     +  ++E  + R++ H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                  F+ NDF  +V E     SL E +H      KR KA     +   L   I + C
Sbjct: 82  GF-----FEDNDFVFVVLELCRRRSLLE-LH------KRRKALTEPEARYYLR-QIVLGC 128
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
             +YLH +    + H DLK  N+ L++++   + DFG+A  +E   E+ + +   GT  Y
Sbjct: 129 --QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNY 181
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           IAPE       S   DV+S G ++  +  G  P
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH----DASKSFAV-ECEVTRNIRHRNLVKV 267
           IG G++G   K       +   + V+  L +    +A K   V E  + R ++H N+V+ 
Sbjct: 14  IGTGSYGRCQK---IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           +     +D + N    +V E+   G L   +   T+E +       L  + +L +A    
Sbjct: 71  YDRI--ID-RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA---- 123
Query: 328 CVLKYLHL--DCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
             LK  H   D    + H DLKP+N+ LD +    + DFG+AR L       ++    GT
Sbjct: 124 --LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--GT 179
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             Y++PE       +   D++S G LL E+   + P
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH----DASKSFAV-ECEVTRNIRHRNLVKV 267
           IG G++G   K       +   + V+  L +    +A K   V E  + R ++H N+V+ 
Sbjct: 14  IGTGSYGRCQK---IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           +     +D + N    +V E+   G L   +   T+E +       L  + +L +A    
Sbjct: 71  YDRI--ID-RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA---- 123
Query: 328 CVLKYLHL--DCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
             LK  H   D    + H DLKP+N+ LD +    + DFG+AR L    + + +    GT
Sbjct: 124 --LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGT 179
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             Y++PE       +   D++S G LL E+   + P
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 68  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 113
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       +++FG +         +R 
Sbjct: 114 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS----VHAPSSRR 165
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 166 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 25/212 (11%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +G G+FG V    Y      +   VAVK          +S +  E ++ R + H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C      G     LV E++  GSL +++        RH    ++   + L  A  + 
Sbjct: 99  KGCCEDA---GAASLQLVMEYVPLGSLRDYL-------PRH----SIGLAQLLLFAQQIC 144
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YLH        H DL   N+LLD++    + DFG+A+ +    E  R +  +G + 
Sbjct: 145 EGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYR-VREDGDSP 200
Query: 388 --YIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             + APE    ++     DV+SFG+ L E+ T
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      E+    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 26/239 (10%)
Query: 198 RMLYNATKG-FSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVFNV-LHHDA 245
           R+ Y+A+K  F  + L     +G G FG V +   F      +   VAVK+      H  
Sbjct: 5   RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 64
Query: 246 SKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE 304
            ++   E ++  +I  H N+V +  AC+     G     ++ EF   G+L  ++     E
Sbjct: 65  HRALMSELKILIHIGHHLNVVNLLGACTK---PGGPL-MVITEFCKFGNLSTYLRSKRNE 120
Query: 305 DKRHK-APGNLN----SLKRL-NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT 358
              +K AP +L     +L+ L   +  VA  +++L         H DL   NILL ++  
Sbjct: 121 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNV 177
Query: 359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             + DFG+AR +    +  R         ++APE       +   DV+SFG+LL E+F+
Sbjct: 178 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 26/239 (10%)
Query: 198 RMLYNATKG-FSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVFNV-LHHDA 245
           R+ Y+A+K  F  + L     +G G FG V +   F      +   VAVK+      H  
Sbjct: 5   RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 64
Query: 246 SKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE 304
            ++   E ++  +I  H N+V +  AC+     G     ++ EF   G+L  ++     E
Sbjct: 65  HRALMSELKILIHIGHHLNVVNLLGACTK---PGGPL-MVITEFCKFGNLSTYLRSKRNE 120
Query: 305 DKRHK-APGNLN----SLKRL-NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT 358
              +K AP +L     +L+ L   +  VA  +++L         H DL   NILL ++  
Sbjct: 121 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNV 177
Query: 359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
             + DFG+AR +    +  R         ++APE       +   DV+SFG+LL E+F+
Sbjct: 178 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 44  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 97
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G  +       
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFY 147
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 148 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 198
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 81/173 (46%), Gaps = 25/173 (14%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAP 311
           E  + +++ H N++K+F       F+   +  LV EF   G L E +        RHK  
Sbjct: 96  EISLLKSLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQIIN------RHK-- 142
Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE---MTAYVSDFGIAR 368
              +     NI   +   + YLH   +  I H D+KP NILL+++   +   + DFG++ 
Sbjct: 143 --FDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 369 FLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           F  + D + R     GT  YIAPE  +  + +   DV+S G+++  +  G  P
Sbjct: 198 FF-SKDYKLRD--RLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 33/216 (15%)
Query: 213 IGAGNFGSVYKGILFE---STTAVAVKVF--NVLHH-DASKSFAVECEVTRNIRHRNLVK 266
           +G G+FG V +G        T +VAVK    +VL   +A   F  E     ++ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           ++        +      +V E    GSL        +  ++H+    L +L R   A+ V
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSL-------LDRLRKHQGHFLLGTLSR--YAVQV 130
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD-----EQTRSIG 381
           A  + YL         H DL   N+LL       + DFG+ R L   D     ++ R + 
Sbjct: 131 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVP 187
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                 + APE       S   D + FG+ L EMFT
Sbjct: 188 F----AWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +S   +A+KV     +           E E+  ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 114
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       +++FG +         +R 
Sbjct: 115 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS----VHAPSSRR 166
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 167 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 33/216 (15%)
Query: 213 IGAGNFGSVYKGILFE---STTAVAVKVF--NVLHH-DASKSFAVECEVTRNIRHRNLVK 266
           +G G+FG V +G        T +VAVK    +VL   +A   F  E     ++ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           ++        +      +V E    GSL        +  ++H+    L +L R   A+ V
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSL-------LDRLRKHQGHFLLGTLSR--YAVQV 124
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD-----EQTRSIG 381
           A  + YL         H DL   N+LL       + DFG+ R L   D     ++ R + 
Sbjct: 125 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 181
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                 + APE       S   D + FG+ L EMFT
Sbjct: 182 F----AWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 89/222 (40%), Gaps = 25/222 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI 259
           A + F     +G G FG+VY     +    +A+KV     +           E E+  ++
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           RH N+++++       F       L+ E+   G++   +  +++ D++  A         
Sbjct: 63  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------- 108
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
                ++A  L Y H      + H D+KP N+LL       ++DFG +         +R 
Sbjct: 109 -TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRR 160
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             + GT  Y+ PE   G       D++S G+L  E   G  P
Sbjct: 161 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 33/216 (15%)
Query: 213 IGAGNFGSVYKGILFE---STTAVAVKVF--NVLHH-DASKSFAVECEVTRNIRHRNLVK 266
           +G G+FG V +G        T +VAVK    +VL   +A   F  E     ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           ++        +      +V E    GSL        +  ++H+    L +L R   A+ V
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSL-------LDRLRKHQGHFLLGTLSR--YAVQV 120
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD-----EQTRSIG 381
           A  + YL         H DL   N+LL       + DFG+ R L   D     ++ R + 
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVP 177
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                 + APE       S   D + FG+ L EMFT
Sbjct: 178 F----AWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 26/237 (10%)
Query: 198 RMLYNATKG-FSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVFNV-LHHDA 245
           R+ Y+A+K  F  + L     +G G FG V +   F      +   VAVK+      H  
Sbjct: 14  RLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSE 73
Query: 246 SKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE 304
            ++   E ++  +I  H N+V +  AC+     G     +V EF   G+L  ++      
Sbjct: 74  HRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYL-----R 124
Query: 305 DKRHKAPGNLNSLKRLNIAIDVAC----VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY 360
            KR++     +  K       + C    V K +         H DL   NILL ++    
Sbjct: 125 SKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVK 184
Query: 361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
           + DFG+AR +    +  R         ++APE       +   DV+SFG+LL E+F+
Sbjct: 185 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 117
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G          
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFXEPHARFY 167
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 168 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 218
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 219 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 33/216 (15%)
Query: 213 IGAGNFGSVYKGILFE---STTAVAVKVF--NVLHH-DASKSFAVECEVTRNIRHRNLVK 266
           +G G+FG V +G        T +VAVK    +VL   +A   F  E     ++ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           ++        +      +V E    GSL        +  ++H+    L +L R   A+ V
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSL-------LDRLRKHQGHFLLGTLSR--YAVQV 124
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD-----EQTRSIG 381
           A  + YL         H DL   N+LL       + DFG+ R L   D     ++ R + 
Sbjct: 125 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 181
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                 + APE       S   D + FG+ L EMFT
Sbjct: 182 F----AWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G          
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFXEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 33/216 (15%)
Query: 213 IGAGNFGSVYKGILFE---STTAVAVKVF--NVLHH-DASKSFAVECEVTRNIRHRNLVK 266
           +G G+FG V +G        T +VAVK    +VL   +A   F  E     ++ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           ++        +      +V E    GSL        +  ++H+    L +L R   A+ V
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSL-------LDRLRKHQGHFLLGTLSR--YAVQV 130
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD-----EQTRSIG 381
           A  + YL         H DL   N+LL       + DFG+ R L   D     ++ R + 
Sbjct: 131 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                 + APE       S   D + FG+ L EMFT
Sbjct: 188 F----AWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 102/242 (42%), Gaps = 59/242 (24%)
Query: 207 FSSENL-----IGAGNFGSVYKGILFESTTAVAVK-VFNVLHHDASKSFAVECEVT-RNI 259
           F++E+L     IG G +GSV K +   S   +AVK + + +     K   ++ +V  R+ 
Sbjct: 19  FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS 78
Query: 260 RHRNLVKVFTACSGVDFQGND--------------FKALVYEFMANGSLEEWMHPITEED 305
               +V+ +    G  F+  D              F   VY  + +   EE +  IT   
Sbjct: 79  DCPYIVQFY----GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT--- 131
Query: 306 KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG 365
                   L ++K LN            HL     I H D+KPSNILLD      + DFG
Sbjct: 132 --------LATVKALN------------HLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171
Query: 366 IARFLEAADEQTRSIGVEGTTGYIAPEY------GMGHEVSSYGDVYSFGILLLEMFTGL 419
           I+  L  +  +TR  G      Y+APE         G++V S  DV+S GI L E+ TG 
Sbjct: 172 ISGQLVDSIAKTRDAGCR---PYMAPERIDPSASRQGYDVRS--DVWSLGITLYELATGR 226
Query: 420 RP 421
            P
Sbjct: 227 FP 228

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 89
Query: 267 V--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +  F   SG      + K  VY  +    + E ++ +     R K      +L  + + +
Sbjct: 90  LRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVKL 138
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I   
Sbjct: 139 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--- 195
Query: 384 GTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
            +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 196 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLV 265
           F   + +GAGN G V+K     S   +A K+ ++    A ++  + E +V        +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             + A     F  +   ++  E M  GSL++ +          K  G +       ++I 
Sbjct: 95  GFYGA-----FYSDGEISICMEHMDGGSLDQVL----------KKAGRIPEQILGKVSIA 139
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           V   L YL    +  I H D+KPSNIL++      + DFG++  L   D    S    GT
Sbjct: 140 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGT 193
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             Y++PE   G   S   D++S G+ L+EM  G  P
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G          
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFXEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 38  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 91
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G          
Sbjct: 92  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFXEPHARFY 141
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 142 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 192
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 193 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 23/220 (10%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           K +     +G G F   Y+    ++    A KV     +L     +  + E  + +++ +
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN 101
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++V          F+ +DF  +V E     SL E +H      KR KA     +   + 
Sbjct: 102 PHVVGFHGF-----FEDDDFVYVVLEICRRRSLLE-LH------KRRKAVTEPEARYFMR 149
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             I     ++YLH +    + H DLK  N+ L+D+M   + DFG+A  +E   E+ +++ 
Sbjct: 150 QTIQG---VQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLC 203
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             GT  YIAPE       S   D++S G +L  +  G  P
Sbjct: 204 --GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 78
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 79  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 116
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 117 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 173
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR    ADE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 174 LDFGLAR--HTADEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 229 LFPGTDHI-DQLKL 241

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 33/216 (15%)
Query: 213 IGAGNFGSVYKGILFE---STTAVAVKVF--NVLHH-DASKSFAVECEVTRNIRHRNLVK 266
           +G G+FG V +G        T +VAVK    +VL   +A   F  E     ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           ++        +      +V E    GSL        +  ++H+    L +L R   A+ V
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSL-------LDRLRKHQGHFLLGTLSR--YAVQV 120
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD-----EQTRSIG 381
           A  + YL         H DL   N+LL       + DFG+ R L   D     ++ R + 
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                 + APE       S   D + FG+ L EMFT
Sbjct: 178 F----AWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV 265
            ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 84
Query: 266 KV--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++  F   SG      + K  VY  +    + E ++ +     R K      +L  + + 
Sbjct: 85  RLRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVK 133
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGV 382
           + +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I  
Sbjct: 134 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI-- 191
Query: 383 EGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
             +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 192 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 227

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 117
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G  +       
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFY 167
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++ A     +  
Sbjct: 168 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA-----TWT 218
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 219 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLV 265
           F   + +GAGN G V+K     S   +A K+ ++    A ++  + E +V        +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             + A     F  +   ++  E M  GSL++ +          K  G +       ++I 
Sbjct: 68  GFYGA-----FYSDGEISICMEHMDGGSLDQVL----------KKAGRIPEQILGKVSIA 112
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           V   L YL    +  I H D+KPSNIL++      + DFG++  L   D    S    GT
Sbjct: 113 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGT 166
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             Y++PE   G   S   D++S G+ L+EM  G  P
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G          
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFXEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 78
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 79  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 116
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 117 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 173
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR    ADE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 174 LDFGLAR--HTADEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 229 LFPGTDHI-DQLKL 241

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 78
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 79  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 116
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 117 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 173
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR    ADE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 174 LDFGLAR--HTADEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 229 LFPGTDHI-DQLKL 241

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V+
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 81
Query: 267 V--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +  F   SG      + K  VY  +    + E ++ +     R K      +L  + + +
Sbjct: 82  LRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVKL 130
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I   
Sbjct: 131 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--- 187
Query: 384 GTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
            +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 188 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 223

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 111
Query: 267 V--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +  F   SG      + K  VY  +    + E ++ +     R K      +L  + + +
Sbjct: 112 LRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVKL 160
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I   
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--- 217
Query: 384 GTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
            +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 48/231 (20%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTA---VAVKVFN---VLHHDASKSFAVECEVTRNIR 260
           +  + ++G G+FG V   IL +        AVKV +   V      +S   E ++ + + 
Sbjct: 34  YKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N++K++       F+   +  LV E    G L +                 + S KR 
Sbjct: 91  HPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFD----------------EIISRKRF 129
Query: 321 NIAIDVACVLK-------YLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFL 370
           +  +D A +++       Y+H   +  I H DLKP N+LL+    +    + DFG++   
Sbjct: 130 S-EVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 185
Query: 371 EAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           EA+ +    I   GT  YIAPE   G       DV+S G++L  + +G  P
Sbjct: 186 EASKKMKDKI---GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 232

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV 265
            ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 77
Query: 266 KV--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++  F   SG      + K  VY  +    + E ++ +     R K      +L  + + 
Sbjct: 78  RLRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVK 126
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGV 382
           + +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I  
Sbjct: 127 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI-- 184
Query: 383 EGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
             +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 185 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 220

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV 265
            ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 76
Query: 266 KV--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++  F   SG      + K  VY  +    + E ++ +     R K      +L  + + 
Sbjct: 77  RLRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVK 125
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGV 382
           + +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I  
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI-- 183
Query: 383 EGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
             +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 184 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV 265
            ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 76
Query: 266 KV--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++  F   SG      + K  VY  +    + E ++ +     R K      +L  + + 
Sbjct: 77  RLRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVK 125
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGV 382
           + +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I  
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI-- 183
Query: 383 EGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
             +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 184 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV 265
            ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 95
Query: 266 KV--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++  F   SG      + K  VY  +    + E ++ +     R K      +L  + + 
Sbjct: 96  RLRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVK 144
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGV 382
           + +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I  
Sbjct: 145 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI-- 202
Query: 383 EGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
             +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 203 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 238

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 89
Query: 267 V--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +  F   SG      + K  VY  +    + E ++ +     R K      +L  + + +
Sbjct: 90  LRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVKL 138
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I   
Sbjct: 139 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--- 195
Query: 384 GTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
            +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 196 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 33/216 (15%)
Query: 213 IGAGNFGSVYKGILFE---STTAVAVKVF--NVLHH-DASKSFAVECEVTRNIRHRNLVK 266
           +G G+FG V +G        T +VAVK    +VL   +A   F  E     ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           ++        +      +V E    GSL        +  ++H+    L +L R   A+ V
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSL-------LDRLRKHQGHFLLGTLSR--YAVQV 120
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD-----EQTRSIG 381
           A  + YL         H DL   N+LL       + DFG+ R L   D     ++ R + 
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
                 + APE       S   D + FG+ L EMFT
Sbjct: 178 F----AWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLV 265
           F   + +GAGN G V+K     S   +A K+ ++    A ++  + E +V        +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             + A     F  +   ++  E M  GSL++ +          K  G +       ++I 
Sbjct: 68  GFYGA-----FYSDGEISICMEHMDGGSLDQVL----------KKAGRIPEQILGKVSIA 112
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           V   L YL    +  I H D+KPSNIL++      + DFG++  L   D    S    GT
Sbjct: 113 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGT 166
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             Y++PE   G   S   D++S G+ L+EM  G  P
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLV 265
           F   + +GAGN G V+K     S   +A K+ ++    A ++  + E +V        +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             + A     F  +   ++  E M  GSL++ +          K  G +       ++I 
Sbjct: 68  GFYGA-----FYSDGEISICMEHMDGGSLDQVL----------KKAGRIPEQILGKVSIA 112
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           V   L YL    +  I H D+KPSNIL++      + DFG++  L   D    S    GT
Sbjct: 113 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGT 166
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             Y++PE   G   S   D++S G+ L+EM  G  P
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLV 265
           F   + +GAGN G V+K     S   +A K+ ++    A ++  + E +V        +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             + A     F  +   ++  E M  GSL++ +       K  + P  +  L +++IA+ 
Sbjct: 68  GFYGA-----FYSDGEISICMEHMDGGSLDQVLK------KAGRIPEQI--LGKVSIAV- 113
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
              +    +L  +  I H D+KPSNIL++      + DFG++  L   D    S    GT
Sbjct: 114 ---IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGT 166
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             Y++PE   G   S   D++S G+ L+EM  G  P
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLV 265
           F   + +GAGN G V+K     S   +A K+ ++    A ++  + E +V        +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             + A     F  +   ++  E M  GSL++ +       K  + P  +  L +++IA+ 
Sbjct: 68  GFYGA-----FYSDGEISICMEHMDGGSLDQVLK------KAGRIPEQI--LGKVSIAV- 113
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
              +    +L  +  I H D+KPSNIL++      + DFG++  L   D    S    GT
Sbjct: 114 ---IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGT 166
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             Y++PE   G   S   D++S G+ L+EM  G  P
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 98/237 (41%), Gaps = 36/237 (15%)
Query: 200 LYNATKGFSS----ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVEC 253
           + NA+  FS     +  +G G F  V + +   +    A K+ N     A   +    E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 254 EVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHP---ITEEDKRHKA 310
            + R ++H N+V++  +      Q   F  LV++ +  G L E +      +E D  H  
Sbjct: 80  RICRKLQHPNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI 134
Query: 311 PGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM---TAYVSDFGIA 367
              L S+              Y H +    I H +LKP N+LL  +       ++DFG+A
Sbjct: 135 QQILESIA-------------YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 178
Query: 368 RFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD 424
             +E  D +    G  GT GY++PE       S   D+++ G++L  +  G  P  D
Sbjct: 179 --IEVNDSEAWH-GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     IG G+FG V      E+    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++  G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G          
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFAEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVKVFTAC 271
           +G G + +VYKG    +   VA+K   + H + +   A+ E  + ++++H N+V +    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI- 68
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
                       LV+E++ +  L++++             GN+ ++   N+ + +  +L+
Sbjct: 69  ----IHTEKSLTLVFEYL-DKDLKQYLDDC----------GNIINMH--NVKLFLFQLLR 111
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT-GYIA 390
            L    +  + H DLKP N+L+++     ++DFG+AR   A    T++   E  T  Y  
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYRP 168
Query: 391 PEYGMGH-EVSSYGDVYSFGILLLEMFTGLRP 421
           P+  +G  + S+  D++  G +  EM TG RP
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATG-RP 199

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 23/220 (10%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           K +     +G G F   Y+    ++    A KV     +L     +  + E  + +++ +
Sbjct: 26  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN 85
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++V          F+ +DF  +V E     SL E +H      KR KA     +   + 
Sbjct: 86  PHVVGFHGF-----FEDDDFVYVVLEICRRRSLLE-LH------KRRKAVTEPEARYFMR 133
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             I     ++YLH +    + H DLK  N+ L+D+M   + DFG+A  +E   E+ + + 
Sbjct: 134 QTIQG---VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC 187
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             GT  YIAPE       S   D++S G +L  +  G  P
Sbjct: 188 --GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ +M  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV 265
            ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 89
Query: 266 KV--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++  F   SG      + K  VY  +    + E ++ +     R K      +L  + + 
Sbjct: 90  RLRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVK 138
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGV 382
           + +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I  
Sbjct: 139 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI-- 196
Query: 383 EGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
             +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 197 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 232

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 23/220 (10%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           K +     +G G F   Y+    ++    A KV     +L     +  + E  + +++ +
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN 101
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++V          F+ +DF  +V E     SL E +H      KR KA     +   + 
Sbjct: 102 PHVVGFHGF-----FEDDDFVYVVLEICRRRSLLE-LH------KRRKAVTEPEARYFMR 149
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             I     ++YLH +    + H DLK  N+ L+D+M   + DFG+A  +E   E+ + + 
Sbjct: 150 QTIQG---VQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC 203
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             GT  YIAPE       S   D++S G +L  +  G  P
Sbjct: 204 --GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      E+    A+K+      D  K   ++ E+   +  + +++
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-----DKQKVVKLK-EIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E+   G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+++D +    V+DFG+A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V+
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 156
Query: 267 V--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +  F   SG      + K  VY  +    + E ++ +     R K      +L  + + +
Sbjct: 157 LRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVKL 205
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I   
Sbjct: 206 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--- 262
Query: 384 GTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
            +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 263 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 298

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV 265
            ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 76
Query: 266 KV--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++  F   SG      + K  VY  +    + E ++ +     R K      +L  + + 
Sbjct: 77  RLRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVK 125
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGV 382
           + +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I  
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI-- 183
Query: 383 EGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
             +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 184 -CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V+
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 115
Query: 267 V--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +  F   SG      + K  VY  +    + E ++ +     R K      +L  + + +
Sbjct: 116 LRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVKL 164
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I   
Sbjct: 165 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--- 221
Query: 384 GTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
            +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 222 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 257

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V+
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 113
Query: 267 V--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +  F   SG      + K  VY  +    + E ++ +     R K      +L  + + +
Sbjct: 114 LRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVKL 162
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I   
Sbjct: 163 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--- 219
Query: 384 GTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
            +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 220 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 255

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 111
Query: 267 V--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +  F   SG      + K  VY  +    + E ++ +     R K      +L  + + +
Sbjct: 112 LRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVKL 160
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I   
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--- 217
Query: 384 GTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
            +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLV 265
           F   + +GAGN G V+K     S   +A K+ ++    A ++  + E +V        +V
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             + A     F  +   ++  E M  GSL++ +       K  + P  +  L +++IA+ 
Sbjct: 87  GFYGA-----FYSDGEISICMEHMDGGSLDQVL------KKAGRIPEQI--LGKVSIAV- 132
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
              +    +L  +  I H D+KPSNIL++      + DFG++  L   D    S    GT
Sbjct: 133 ---IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGT 185
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             Y++PE   G   S   D++S G+ L+EM  G  P
Sbjct: 186 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V+
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 82
Query: 267 V--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +  F   SG      + K  VY  +    + E ++ +     R K      +L  + + +
Sbjct: 83  LRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVKL 131
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I   
Sbjct: 132 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--- 188
Query: 384 GTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
            +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 189 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 224

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 42/228 (18%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           +  + ++G G+FG V       +    AVKV +   V      +S   E ++ + + H N
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++K++       F+   +  LV E    G L +                 + S KR +  
Sbjct: 112 IMKLYEF-----FEDKGYFYLVGEVYTGGELFD----------------EIISRKRFS-E 149
Query: 324 IDVACVLK-------YLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAA 373
           +D A +++       Y+H   +  I H DLKP N+LL+    +    + DFG++   EA+
Sbjct: 150 VDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 206
Query: 374 DEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            +    I   GT  YIAPE   G       DV+S G++L  + +G  P
Sbjct: 207 KKMKDKI---GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 250

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 42/228 (18%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           +  + ++G G+FG V       +    AVKV +   V      +S   E ++ + + H N
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++K++       F+   +  LV E    G L +                 + S KR +  
Sbjct: 111 IMKLYEF-----FEDKGYFYLVGEVYTGGELFD----------------EIISRKRFS-E 148
Query: 324 IDVACVLK-------YLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAA 373
           +D A +++       Y+H   +  I H DLKP N+LL+    +    + DFG++   EA+
Sbjct: 149 VDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 205
Query: 374 DEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            +    I   GT  YIAPE   G       DV+S G++L  + +G  P
Sbjct: 206 KKMKDKI---GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 249

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           ++   +IG G+FG VY+  L +S   VA+K   VL     K+   E ++ R + H N+V+
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 105
Query: 267 V--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +  F   SG      + K  VY  +    + E ++ +     R K      +L  + + +
Sbjct: 106 LRYFFYSSG------EKKDEVYLNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVKL 154
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I   
Sbjct: 155 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--- 211
Query: 384 GTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
            +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 212 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 247

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+++D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 148 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 198
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      E+    A+K+      D  K   ++ E+   +  + +++
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-----DKQKVVKLK-EIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E+   G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+++D +    V+DFG+A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 23/220 (10%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           K +     +G G F   Y+    ++    A KV     +L     +  + E  + +++ +
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN 101
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++V          F+ +DF  +V E     SL E +H      KR KA     +   + 
Sbjct: 102 PHVVGFHGF-----FEDDDFVYVVLEICRRRSLLE-LH------KRRKAVTEPEARYFMR 149
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             I     ++YLH +    + H DLK  N+ L+D+M   + DFG+A  +E   E+ + + 
Sbjct: 150 QTIQG---VQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC 203
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             GT  YIAPE       S   D++S G +L  +  G  P
Sbjct: 204 --GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 148 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 198
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 42/228 (18%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           +  + ++G G+FG V       +    AVKV +   V      +S   E ++ + + H N
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++K++       F+   +  LV E    G L +                 + S KR +  
Sbjct: 88  IMKLYEF-----FEDKGYFYLVGEVYTGGELFD----------------EIISRKRFS-E 125
Query: 324 IDVACVLK-------YLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAA 373
           +D A +++       Y+H   +  I H DLKP N+LL+    +    + DFG++   EA+
Sbjct: 126 VDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 374 DEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            +    I   GT  YIAPE   G       DV+S G++L  + +G  P
Sbjct: 183 KKMKDKI---GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 226

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 148 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 198
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           ++   +IG G+FG VY+  L +S   VA+K   VL   A K+   E ++ R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 267 V--FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +  F   SG      + K  VY  +    +   ++ +     R K      +L  + + +
Sbjct: 78  LRYFFYSSG------EKKDEVYLNLVLDYVPATVYRVARHYSRAK-----QTLPVIYVKL 126
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +  + + L       I H D+KP N+LLD D     + DFG A+ L   +     I   
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI--- 183
Query: 384 GTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
            +  Y APE   G  + +S  DV+S G +L E+  G
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 148 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 198
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 148 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWT 198
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVKVFTAC 271
           +GAGN G V K     S   +A K+ ++    A ++  + E +V        +V  + A 
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA- 82
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
               F  +   ++  E M  GSL++    + +E KR   P  +  L +++IA+     L 
Sbjct: 83  ----FYSDGEISICMEHMDGGSLDQ----VLKEAKR--IPEEI--LGKVSIAVLRG--LA 128
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAP 391
           YL    Q  I H D+KPSNIL++      + DFG++  L   D    S    GT  Y+AP
Sbjct: 129 YLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGTRSYMAP 182
Query: 392 EYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           E   G   S   D++S G+ L+E+  G  P
Sbjct: 183 ERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 107/239 (44%), Gaps = 52/239 (21%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      +S   +AVK  +     ++H  A +++  E
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIH--AKRTYR-E 100
Query: 253 CEVTRNIRHRN---LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHK 309
             + ++++H N   L+ VFT  + ++ + ND   LV   M                    
Sbjct: 101 LRLLKHMKHENVIGLLDVFTPATSLE-EFNDV-YLVTHLMG------------------- 139
Query: 310 APGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY 360
              +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    
Sbjct: 140 --ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 194
Query: 361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
           + DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG
Sbjct: 195 ILDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 148 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 198
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 140 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 190
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 191 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 168 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 218
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 219 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 148 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWX 198
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 140 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 190
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 191 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G+ G V       S   VAVK+ ++      +    E  + R+ +H N+V+++ +  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY- 111
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
                G +   L+ EF+  G+L + +  +            LN  +   +   V   L Y
Sbjct: 112 ---LVGEELWVLM-EFLQGGALTDIVSQV-----------RLNEEQIATVCEAVLQALAY 156
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE 392
           LH      + H D+K  +ILL  +    +SDFG    + + D   R   V GT  ++APE
Sbjct: 157 LHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI-SKDVPKRKXLV-GTPYWMAPE 211
Query: 393 YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
                  ++  D++S GI+++EM  G  P
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 107/238 (44%), Gaps = 50/238 (21%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + IG+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 76
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 77  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 114
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 115 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKI 171
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG
Sbjct: 172 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 111/255 (43%), Gaps = 35/255 (13%)
Query: 194 YVSYRML-YNATKGFSSENL-----IGAGNFGSVYKGILFE-STTAVAVKV-FNVLHH-- 243
           YV +R   Y+    F  ENL     +G+G FG V     +  S T V+++V   +L    
Sbjct: 28  YVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA 87
Query: 244 DASKSFAVECEV---TRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHP 300
           D+S+  A+  E+   T+   H N+V +  AC+     G  +  L++E+   G L  ++  
Sbjct: 88  DSSEREALMSELKMMTQLGSHENIVNLLGACT---LSGPIY--LIFEYCCYGDLLNYLRS 142
Query: 301 ITEE----------DKRHKAPGNLNSL---KRLNIAIDVACVLKYLHLDCQPPIAHCDLK 347
             E+           KR +   +LN L     L  A  VA  +++L         H DL 
Sbjct: 143 KREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199
Query: 348 PSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYS 407
             N+L+       + DFG+AR + +               ++APE       +   DV+S
Sbjct: 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWS 259
Query: 408 FGILLLEMFT-GLRP 421
           +GILL E+F+ G+ P
Sbjct: 260 YGILLWEIFSLGVNP 274

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 133 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWT 183
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 184 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVKVFT 269
           +++G G   +V++G   ++    A+KVFN +         + E EV + + H+N+VK+F 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
                  +    K L+ EF   GSL    + + EE      P N   L      I +  V
Sbjct: 75  IEEETTTR---HKVLIMEFCPCGSL----YTVLEE------PSNAYGLPESEFLIVLRDV 121
Query: 330 LKYLHLDCQPPIAHCDLKPSNILL---DDEMTAY-VSDFGIARFLEAADEQTRSIGVEGT 385
           +  ++   +  I H ++KP NI+    +D  + Y ++DFG AR LE  DEQ   + + GT
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQF--VXLYGT 178
Query: 386 TGYIAPEY------GMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
             Y+ P+          H+   YG   D++S G+      TG  P
Sbjct: 179 EEYLHPDMYERAVLRKDHQ-KKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 106/261 (40%), Gaps = 40/261 (15%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           F    +IG G F  V    + ++    A+K+ N   +L       F  E +V  N   R 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           + ++  A     FQ  ++  LV E+   G L   +  +++  +R  A      L  + +A
Sbjct: 123 ITQLHFA-----FQDENYLYLVMEYYVGGDL---LTLLSKFGERIPAEMARFYLAEIVMA 174
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           ID    L Y+H D         +KP NILLD      ++DFG    L  AD   RS+   
Sbjct: 175 IDSVHRLGYVHRD---------IKPDNILLDRCGHIRLADFGSCLKLR-ADGTVRSLVAV 224
Query: 384 GTTGYIAPEYGMGHEVSSYG-------DVYSFGILLLEMFTGLRP--SDDM--------- 425
           GT  Y++PE                  D ++ G+   EMF G  P  +D           
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284
Query: 426 FKDNLNLRNCVKSALPERAEE 446
           +K++L+L   V   +PE A +
Sbjct: 285 YKEHLSL-PLVDEGVPEEARD 304

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           + F    +IG G FG V    L  +    A+K+ N   +L    +  F  E +V  N   
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
           + +  +  A     FQ ++   LV ++   G L   +  +++ + R         L  + 
Sbjct: 134 KWITTLHYA-----FQDDNNLYLVMDYYVGGDL---LTLLSKFEDRLPEEMARFYLAEMV 185
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG-IARFLEAADEQTRSI 380
           IAID    L Y+H D         +KP NIL+D      ++DFG   + +E    Q+ S+
Sbjct: 186 IAIDSVHQLHYVHRD---------IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS-SV 235
Query: 381 GVEGTTGYIAPEYGMGHE--VSSYG---DVYSFGILLLEMFTGLRP 421
            V GT  YI+PE     E     YG   D +S G+ + EM  G  P
Sbjct: 236 AV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 167 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 222 LFPGTDHI-DQLKL 234

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 31/225 (13%)
Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVKVFT 269
           +++G G   +V++G   ++    A+KVFN +         + E EV + + H+N+VK+F 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
                       K L+ EF   GSL    + + EE      P N   L      I +  V
Sbjct: 75  IEEETT---TRHKVLIMEFCPCGSL----YTVLEE------PSNAYGLPESEFLIVLRDV 121
Query: 330 LKYLHLDCQPPIAHCDLKPSNILL---DDEMTAY-VSDFGIARFLEAADEQTRSIGVEGT 385
           +  ++   +  I H ++KP NI+    +D  + Y ++DFG AR LE  DEQ   + + GT
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQF--VSLYGT 178
Query: 386 TGYIAPEY------GMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
             Y+ P+          H+   YG   D++S G+      TG  P
Sbjct: 179 EEYLHPDMYERAVLRKDHQ-KKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 114/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 82
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++                  L+  F    SLEE+  ++ +T     H  
Sbjct: 83  LRLLKHMKHENVI-----------------GLLDVFTPARSLEEFNDVYLVT-----HLM 120
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 121 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKI 177
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 178 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 232
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 233 LFPGTDHI-DQLKL 245

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+++D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 108/249 (43%), Gaps = 43/249 (17%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTR 257
           + ++   + + + + +G+G +GSV     F++ T + V V  +     SK F       R
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKL-----SKPFQSIIHAKR 79
Query: 258 NIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKAPGNLN 315
             R   L+K          +  +   L+  F    SLEE+  ++ +T     H    +LN
Sbjct: 80  TYRELRLLK--------HMKHENVIGLLDVFTPARSLEEFNDVYLVT-----HLMGADLN 126
Query: 316 SLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI 366
           ++ +     D         +   LKY+H      I H DLKPSN+ ++++    + DFG+
Sbjct: 127 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 183
Query: 367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG--LRPSD 423
           AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  L P  
Sbjct: 184 ARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 238
Query: 424 DMFKDNLNL 432
           D   D L L
Sbjct: 239 DHI-DQLKL 246

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 37/226 (16%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           FS   +IG G FG VY     ++    A+K  +       K   ++   T  +  R ++ 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD------KKRIKMKQGETLALNERIMLS 244
Query: 267 V-------FTACSGVDFQGNDFKALVYEFMANGSLEEWM--HPI-TEEDKRHKAPGNLNS 316
           +       F  C    F   D  + + + M  G L   +  H + +E D R         
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-------- 296
Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
                 A ++   L+++H      + + DLKP+NILLD+     +SD G+A        +
Sbjct: 297 -----YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSK 344
Query: 377 TRSIGVEGTTGYIAPE-YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            +     GT GY+APE    G    S  D +S G +L ++  G  P
Sbjct: 345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 76
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 77  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 114
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 115 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKI 171
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 172 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 227 LFPGTDHI-DQLKL 239

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 37/226 (16%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           FS   +IG G FG VY     ++    A+K  +       K   ++   T  +  R ++ 
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD------KKRIKMKQGETLALNERIMLS 243
Query: 267 V-------FTACSGVDFQGNDFKALVYEFMANGSLEEWM--HPI-TEEDKRHKAPGNLNS 316
           +       F  C    F   D  + + + M  G L   +  H + +E D R         
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-------- 295
Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
                 A ++   L+++H      + + DLKP+NILLD+     +SD G+A        +
Sbjct: 296 -----YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSK 343
Query: 377 TRSIGVEGTTGYIAPE-YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            +     GT GY+APE    G    S  D +S G +L ++  G  P
Sbjct: 344 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+++D +    V+DFG A+ ++      R+  
Sbjct: 148 AAQIVLTFEYLHSLD----LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWX 198
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 37/232 (15%)
Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH----DASKSFAVECEVTRNIRHRNLVK 266
           +L+G G++G V + +  E+    AVK+          +   +   E ++ R +RH+N+++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 267 VFTACSGVDFQGNDFKALVYEFMANG--SLEEWMHPITEEDKRH---KAPGNLNSLKRLN 321
           +      VD   N+ K  +Y  M      ++E +  + E  KR    +A G    L    
Sbjct: 71  L------VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQL---- 118
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE--AADEQTRS 379
             ID    L+YLH      I H D+KP N+LL    T  +S  G+A  L   AAD+  R+
Sbjct: 119 --IDG---LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 380 IGVEGTTGYIAPEYGMGHEVSS--YGDVYSFGILLLEMFTGLRP--SDDMFK 427
              +G+  +  PE   G +  S    D++S G+ L  + TGL P   D+++K
Sbjct: 171 --SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK 220

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+++D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+++D +    V+DFG A+ ++      R+  
Sbjct: 148 AAQIVLTFEYLHSLD----LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWX 198
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+++D +    V+DFG A+ ++      R+  
Sbjct: 148 AAQIVLTFEYLHSLD----LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWX 198
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+++D +    V+DFG A+ ++      R+  
Sbjct: 148 AAQIVLTFEYLHSLD----LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWX 198
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 37/226 (16%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           FS   +IG G FG VY     ++    A+K  +       K   ++   T  +  R ++ 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD------KKRIKMKQGETLALNERIMLS 244
Query: 267 V-------FTACSGVDFQGNDFKALVYEFMANGSLEEWM--HPI-TEEDKRHKAPGNLNS 316
           +       F  C    F   D  + + + M  G L   +  H + +E D R         
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-------- 296
Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
                 A ++   L+++H      + + DLKP+NILLD+     +SD G+A        +
Sbjct: 297 -----YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSK 344
Query: 377 TRSIGVEGTTGYIAPE-YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            +     GT GY+APE    G    S  D +S G +L ++  G  P
Sbjct: 345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 37/226 (16%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           FS   +IG G FG VY     ++    A+K  +       K   ++   T  +  R ++ 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD------KKRIKMKQGETLALNERIMLS 244
Query: 267 V-------FTACSGVDFQGNDFKALVYEFMANGSLEEWM--HPI-TEEDKRHKAPGNLNS 316
           +       F  C    F   D  + + + M  G L   +  H + +E D R         
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-------- 296
Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
                 A ++   L+++H      + + DLKP+NILLD+     +SD G+A        +
Sbjct: 297 -----YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSK 344
Query: 377 TRSIGVEGTTGYIAPE-YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            +     GT GY+APE    G    S  D +S G +L ++  G  P
Sbjct: 345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 27/222 (12%)
Query: 204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRN 263
           T G+  +  IG G++    + I   +    AVK+ +    D ++   +   + R  +H N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQHPN 77
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++ +        +    +  +V E M  G L        ++  R K     +  +   + 
Sbjct: 78  IITLKDV-----YDDGKYVYVVTELMKGGEL-------LDKILRQKF---FSEREASAVL 122
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM----TAYVSDFGIARFLEAADEQTRS 379
             +   ++YLH      + H DLKPSNIL  DE     +  + DFG A+ L A  E    
Sbjct: 123 FTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA--ENGLL 177
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           +    T  ++APE        +  D++S G+LL  M TG  P
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 50/238 (21%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG
Sbjct: 167 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+++D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM-GHEVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 167 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRT 221
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 222 LFPGTDHI-DQLKL 234

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+AP   +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 50/238 (21%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG
Sbjct: 167 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 82
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 83  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 120
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 121 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 177
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 178 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 232
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 233 LFPGTDHI-DQLKL 245

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 114/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++                  L+  F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVI-----------------GLLDVFTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 167 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 222 LFPGTDHI-DQLKL 234

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 50/238 (21%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG
Sbjct: 167 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 83
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 84  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 121
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 122 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 178
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 179 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 234 LFPGTDHI-DQLKL 246

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 27/213 (12%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +G G+FG V    Y      +   VAVK          +S +  E E+ R + H ++VK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     QG     LV E++  GSL +++            P +   L +L +     
Sbjct: 77  KGCCED---QGEKSVQLVMEYVPLGSLRDYL------------PRHCVGLAQLLLFAQQI 121
Query: 328 CV-LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
           C  + YLH        H  L   N+LLD++    + DFG+A+ +    E  R +  +G +
Sbjct: 122 CEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VREDGDS 177
Query: 387 G--YIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              + APE     +     DV+SFG+ L E+ T
Sbjct: 178 PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 83
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 84  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 121
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 122 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 178
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 179 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 234 LFPGTDHI-DQLKL 246

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 29/224 (12%)
Query: 201 YNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA--SKSFAVECEVTRN 258
           +   K + S   +G+G +GSV   I   S   VA+K  +        +K    E  + ++
Sbjct: 38  WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH 97
Query: 259 IRHRN---LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLN 315
           ++H N   L+ VFT  S +     +F    Y+F         + P  + D +       +
Sbjct: 98  MQHENVIGLLDVFTPASSL----RNF----YDFYL-------VMPFMQTDLQKIMGMEFS 142
Query: 316 SLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE 375
             K   +   +   LKY+H      + H DLKP N+ ++++    + DFG+AR  +A  E
Sbjct: 143 EEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--E 197
Query: 376 QTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
            T   G   T  Y APE  +     +   D++S G ++ EM TG
Sbjct: 198 MT---GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 238

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 27/213 (12%)
Query: 213 IGAGNFGSV----YKGILFESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +G G+FG V    Y      +   VAVK          +S +  E E+ R + H ++VK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     QG     LV E++  GSL +++            P +   L +L +     
Sbjct: 76  KGCCED---QGEKSVQLVMEYVPLGSLRDYL------------PRHCVGLAQLLLFAQQI 120
Query: 328 CV-LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
           C  + YLH        H  L   N+LLD++    + DFG+A+ +    E  R +  +G +
Sbjct: 121 CEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VREDGDS 176
Query: 387 G--YIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
              + APE     +     DV+SFG+ L E+ T
Sbjct: 177 PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 73
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 74  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 111
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 112 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 168
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 169 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 224 LFPGTDHI-DQLKL 236

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 94
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 95  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 132
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 133 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 189
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 190 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 244
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 245 LFPGTDHI-DQLKL 257

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 114/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++                  L+  F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVI-----------------GLLDVFTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 167 LDFGLARHTD--DEMT---GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 222 LFPGTDHI-DQLKL 234

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 73
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 74  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 111
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 112 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKI 168
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 169 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 224 LFPGTDHI-DQLKL 236

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 73
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 74  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 111
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 112 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 168
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 169 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 224 LFPGTDHI-DQLKL 236

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 167 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 222 LFPGTDHI-DQLKL 234

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 167 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 222 LFPGTDHI-DQLKL 234

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 91
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 92  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 129
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 130 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 186
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 187 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 242 LFPGTDHI-DQLKL 254

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH--AKRTYR-E 91
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 92  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 129
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 130 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 186
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 187 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 242 LFPGTDHI-DQLKL 254

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 101/234 (43%), Gaps = 33/234 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +G G F  V + +   +    A  + N   L     +    E  + R ++H N+V++  +
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
            S    +G+ +  L+++ +  G L E                ++ + +  + A    C+ 
Sbjct: 79  ISE---EGHHY--LIFDLVTGGELFE----------------DIVAREYYSEADASHCIQ 117
Query: 331 KYLH--LDC-QPPIAHCDLKPSNILLDDEM---TAYVSDFGIARFLEAADEQTRSIGVEG 384
           + L   L C Q  + H +LKP N+LL  ++      ++DFG+A  +E   EQ    G  G
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAG 175
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS 438
           T GY++PE           D+++ G++L  +  G  P  D  +D   L   +K+
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD--EDQHRLYQQIKA 227

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 108/238 (45%), Gaps = 50/238 (21%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++                  L+  F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVI-----------------GLLDVFTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG
Sbjct: 167 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 114/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++                  L+  F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVI-----------------GLLDVFTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 167 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 222 LFPGTDHI-DQLKL 234

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 50/238 (21%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 78
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 79  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 116
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 117 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 173
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG
Sbjct: 174 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFES---TTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           IG G FG V++GI         AVA+K   N       + F  E    R   H ++VK+ 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
               GV  +   +  ++ E    G L  ++       +  K   +L SL  +  A  ++ 
Sbjct: 78  ----GVITENPVW--IIMELCTLGELRSFL-------QVRKFSLDLASL--ILYAYQLST 122
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L YL         H D+   N+L+       + DFG++R++E +     S G +    +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKG-KLPIKW 178
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           +APE       +S  DV+ FG+ + E+   G++P
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 90
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 91  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 128
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 129 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 185
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 186 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 240
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 241 LFPGTDHI-DQLKL 253

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 77
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 78  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 115
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 116 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 172
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 173 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 228 LFPGTDHI-DQLKL 240

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 76
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 77  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 114
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 115 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 171
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 172 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 227 LFPGTDHI-DQLKL 239

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 73
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 74  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 111
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 112 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 168
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 169 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 224 LFPGTDHI-DQLKL 236

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 70
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 71  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 108
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 109 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 165
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 166 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 220
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 221 LFPGTDHI-DQLKL 233

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH--AKRTYR-E 90
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 91  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 128
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 129 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 185
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 186 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 240
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 241 LFPGTDHI-DQLKL 253

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 114/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 69
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++                  L+  F    SLEE+  ++ +T     H  
Sbjct: 70  LRLLKHMKHENVI-----------------GLLDVFTPARSLEEFNDVYLVT-----HLM 107
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 108 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 164
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 165 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 219
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 220 LFPGTDHI-DQLKL 232

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 68
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 69  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 106
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 107 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 163
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 164 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 218
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 219 LFPGTDHI-DQLKL 231

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 114/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 67
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++                  L+  F    SLEE+  ++ +T     H  
Sbjct: 68  LRLLKHMKHENVI-----------------GLLDVFTPARSLEEFNDVYLVT-----HLM 105
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 106 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 162
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 163 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 218 LFPGTDHI-DQLKL 230

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 167 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 222 LFPGTDHI-DQLKL 234

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 76
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 77  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 114
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 115 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 171
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 172 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 227 LFPGTDHI-DQLKL 239

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 32/220 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVFTA 270
           +G G F  V + +   +    A K+ N     A   +    E  + R ++H N+V++  +
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHP---ITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                 Q   F  LV++ +  G L E +      +E D  H     L S+          
Sbjct: 74  -----IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA--------- 119
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEM---TAYVSDFGIARFLEAADEQTRSIGVEG 384
               Y H +    I H +LKP N+LL  +       ++DFG+A  +E  D +    G  G
Sbjct: 120 ----YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH-GFAG 169
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD 424
           T GY++PE       S   D+++ G++L  +  G  P  D
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 68
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 69  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 106
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 107 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 163
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 164 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 218
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 219 LFPGTDHI-DQLKL 231

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVFTA 270
           IG GNF  V       +   VAVK+ +    ++S  +    E  + + + H N+VK+F  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                 +      LV E+ + G + +++           A G     +       +   +
Sbjct: 82  I-----ETEKTLYLVXEYASGGEVFDYL----------VAHGRXKEKEARAKFRQIVSAV 126
Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +Y H   Q  I H DLK  N+LLD +    ++DFG +      ++        G   Y A
Sbjct: 127 QYCH---QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLD---AFCGAPPYAA 180
Query: 391 PEYGMGHEVSS-YGDVYSFGILLLEMFTGLRPSD 423
           PE   G +      DV+S G++L  + +G  P D
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 49/233 (21%)
Query: 207 FSSENLIGAGNFGSVYK---------GILFESTTAVAVKVFNVLHHDASKSFAVECEVTR 257
           F    ++G G +G V++         G +F     V  K   V +   +     E  +  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIF--AMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 258 NIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            ++H  +V +  A     FQ      L+ E+++ G L                      L
Sbjct: 77  EVKHPFIVDLIYA-----FQTGGKLYLILEYLSGGEL-------------------FMQL 112
Query: 318 KRLNIAI-DVAC--------VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR 368
           +R  I + D AC         L +LH   Q  I + DLKP NI+L+ +    ++DFG+ +
Sbjct: 113 EREGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 369 FLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             E+  + T +    GT  Y+APE  M    +   D +S G L+ +M TG  P
Sbjct: 170 --ESIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 114/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH--AKRTYR-E 67
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++                  L+  F    SLEE+  ++ +T     H  
Sbjct: 68  LRLLKHMKHENVI-----------------GLLDVFTPARSLEEFNDVYLVT-----HLM 105
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 106 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 162
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 163 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 218 LFPGTDHI-DQLKL 230

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 59/125 (47%), Gaps = 13/125 (10%)
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
           L+I I +A  +++LH      + H DLKPSNI    +    V DFG+   ++  +E+   
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 380 I----------GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN 429
           +          G  GT  Y++PE   G+  S   D++S G++L E+        +  +  
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRII 283
Query: 430 LNLRN 434
            ++RN
Sbjct: 284 TDVRN 288

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 32/220 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVFTA 270
           +G G F  V + +   +    A K+ N     A   +    E  + R ++H N+V++  +
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHP---ITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                 Q   F  LV++ +  G L E +      +E D  H     L S+          
Sbjct: 74  -----IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA--------- 119
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEM---TAYVSDFGIARFLEAADEQTRSIGVEG 384
               Y H +    I H +LKP N+LL  +       ++DFG+A  +E  D +    G  G
Sbjct: 120 ----YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH-GFAG 169
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD 424
           T GY++PE       S   D+++ G++L  +  G  P  D
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 32/220 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVFTA 270
           +G G F  V + +   +    A K+ N     A   +    E  + R ++H N+V++  +
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 72
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHP---ITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                 Q   F  LV++ +  G L E +      +E D  H     L S+          
Sbjct: 73  -----IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA--------- 118
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEM---TAYVSDFGIARFLEAADEQTRSIGVEG 384
               Y H +    I H +LKP N+LL  +       ++DFG+A  +E  D +    G  G
Sbjct: 119 ----YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH-GFAG 168
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD 424
           T GY++PE       S   D+++ G++L  +  G  P  D
Sbjct: 169 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 208

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 29/224 (12%)
Query: 201 YNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA--SKSFAVECEVTRN 258
           +   K + S   +G+G +GSV   I   S   VA+K  +        +K    E  + ++
Sbjct: 20  WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH 79
Query: 259 IRHRN---LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLN 315
           ++H N   L+ VFT  S +     +F    Y+F         + P  + D +       +
Sbjct: 80  MQHENVIGLLDVFTPASSL----RNF----YDFYL-------VMPFMQTDLQKIMGLKFS 124
Query: 316 SLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE 375
             K   +   +   LKY+H      + H DLKP N+ ++++    + DFG+AR  +A  E
Sbjct: 125 EEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--E 179
Query: 376 QTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
            T   G   T  Y APE  +     +   D++S G ++ EM TG
Sbjct: 180 MT---GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 77
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 78  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 115
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 116 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKI 172
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 173 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 228 LFPGTDHI-DQLKL 240

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 77
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 78  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 115
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 116 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 172
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 173 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 228 LFPGTDHI-DQLKL 240

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 49/233 (21%)
Query: 207 FSSENLIGAGNFGSVYK---------GILFESTTAVAVKVFNVLHHDASKSFAVECEVTR 257
           F    ++G G +G V++         G +F     V  K   V +   +     E  +  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIF--AMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 258 NIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            ++H  +V +  A     FQ      L+ E+++ G L                      L
Sbjct: 77  EVKHPFIVDLIYA-----FQTGGKLYLILEYLSGGEL-------------------FMQL 112
Query: 318 KRLNIAI-DVAC--------VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR 368
           +R  I + D AC         L +LH   Q  I + DLKP NI+L+ +    ++DFG+ +
Sbjct: 113 EREGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 369 FLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             E+  + T +    GT  Y+APE  M    +   D +S G L+ +M TG  P
Sbjct: 170 --ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 35/220 (15%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV----ECEVTRNIRHRNLVKVF 268
           IG G FG V+K    ++   VA+K   VL  +  + F +    E ++ + ++H N+V + 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 269 TACSGVDFQGNDFKA---LVYEFMAN---GSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
             C       N  KA   LV++F  +   G L   +   T           L+ +KR+  
Sbjct: 84  EICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFT-----------LSEIKRV-- 130
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD--EQTRSI 380
              +  +L  L+   +  I H D+K +N+L+  +    ++DFG+AR    A   +  R  
Sbjct: 131 ---MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 381 GVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFT 417
               T  Y  PE  +G     YG   D++  G ++ EM+T
Sbjct: 188 NRVVTLWYRPPELLLGER--DYGPPIDLWGAGCIMAEMWT 225

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 106/263 (40%), Gaps = 56/263 (21%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKV----FNVLHHDASKSFAVECEVTRNIRHRN---LV 265
           +G+G +GSV           VAVK     F  L H A +++  E  + ++++H N   L+
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIH-ARRTYR-ELRLLKHLKHENVIGLL 93
Query: 266 KVFTACSGVDFQGNDFKA--LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VFT  + ++    DF    LV   M                       +LN++ +    
Sbjct: 94  DVFTPATSIE----DFSEVYLVTTLMG---------------------ADLNNIVKCQAL 128
Query: 324 IDVACV---------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD 374
            D             LKY+H      I H DLKPSN+ ++++    + DFG+AR    AD
Sbjct: 129 SDEHVQFLVYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QAD 182
Query: 375 EQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG--LRPSDDMFKDNLN 431
           E+    G   T  Y APE  +     +   D++S G ++ E+  G  L P  D       
Sbjct: 183 EEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKR 240
Query: 432 LRNCVKSALPERAEEIRASSGST 454
           +   V +  PE   +I +    T
Sbjct: 241 IMEVVGTPSPEVLAKISSEHART 263

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 112/255 (43%), Gaps = 55/255 (21%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH--AKRTYR-E 77
Query: 253 CEVTRNIRHRN---LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHK 309
             + ++++H N   L+ VFT    ++ + ND   LV   M                    
Sbjct: 78  LRLLKHMKHENVIGLLDVFTPARSLE-EFNDV-YLVTHLMG------------------- 116
Query: 310 APGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY 360
              +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    
Sbjct: 117 --ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 171
Query: 361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG- 418
           + DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG 
Sbjct: 172 ILDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
Query: 419 -LRPSDDMFKDNLNL 432
            L P  D   D L L
Sbjct: 227 TLFPGTDHI-DQLKL 240

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 106/263 (40%), Gaps = 56/263 (21%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKV----FNVLHHDASKSFAVECEVTRNIRHRN---LV 265
           +G+G +GSV           VAVK     F  L H A +++  E  + ++++H N   L+
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIH-ARRTYR-ELRLLKHLKHENVIGLL 85
Query: 266 KVFTACSGVDFQGNDFKA--LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VFT  + ++    DF    LV   M                       +LN++ +    
Sbjct: 86  DVFTPATSIE----DFSEVYLVTTLMG---------------------ADLNNIVKCQAL 120
Query: 324 IDVACV---------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD 374
            D             LKY+H      I H DLKPSN+ ++++    + DFG+AR    AD
Sbjct: 121 SDEHVQFLVYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QAD 174
Query: 375 EQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG--LRPSDDMFKDNLN 431
           E+    G   T  Y APE  +     +   D++S G ++ E+  G  L P  D       
Sbjct: 175 EEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKR 232
Query: 432 LRNCVKSALPERAEEIRASSGST 454
           +   V +  PE   +I +    T
Sbjct: 233 IMEVVGTPSPEVLAKISSEHART 255

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFES---TTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           IG G FG V++GI         AVA+K   N       + F  E    R   H ++VK+ 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
               GV  +   +  ++ E    G L  ++       +  K   +L SL  +  A  ++ 
Sbjct: 78  ----GVITENPVW--IIMELCTLGELRSFL-------QVRKYSLDLASL--ILYAYQLST 122
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L YL         H D+   N+L+       + DFG++R++E +     S G +    +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 178
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           +APE       +S  DV+ FG+ + E+   G++P
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 210 ENL--IGAGNFGSVYKGILFESTTAVAVKVFNVL-HHDASKSFAVECEVTRNIRHRNLVK 266
           ENL  +G+G  G V+K    ++   +AVK      + + +K   ++ +V   +   +   
Sbjct: 28  ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV---VLKSHDCP 84
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C G  F  N    +  E M  G+  E +       KR + P     L ++ +AI  
Sbjct: 85  YIVQCFGT-FITNTDVFIAMELM--GTCAEKLK------KRMQGPIPERILGKMTVAI-- 133
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
             V    +L  +  + H D+KPSNILLD+     + DFGI+  L     + RS G     
Sbjct: 134 --VKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGC---A 188
Query: 387 GYIAPEY-----GMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            Y+APE          +     DV+S GI L+E+ TG  P
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 112/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + +   +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH--AKRTYR-E 81
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 82  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 119
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 120 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 176
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 177 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 231
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 232 LFPGTDHI-DQLKL 244

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFES---TTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           IG G FG V++GI         AVA+K   N       + F  E    R   H ++VK+ 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
               GV  +   +  ++ E    G L  ++       +  K   +L SL  +  A  ++ 
Sbjct: 78  ----GVITENPVW--IIMELCTLGELRSFL-------QVRKYSLDLASL--ILYAYQLST 122
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L YL         H D+   N+L+       + DFG++R++E +     S G +    +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 178
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           +APE       +S  DV+ FG+ + E+   G++P
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 89/222 (40%), Gaps = 22/222 (9%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           ++G G+FG V       +    AVK+     V+  D  +   VE  V         +   
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
            +C    FQ  D    V E++  G L   M+ I +        G       +  A ++A 
Sbjct: 408 HSC----FQTMDRLYFVMEYVNGGDL---MYHIQQV-------GRFKEPHAVFYAAEIAI 453
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L +L       I + DLK  N++LD E    ++DFG+ +  E   +   +    GT  Y
Sbjct: 454 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDY 508
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 430
           IAPE           D ++FG+LL EM  G  P +   +D L
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 550

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 98/231 (42%), Gaps = 48/231 (20%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTA---VAVKVFN---VLHHDASKSFAVECEVTRNIR 260
           +  + ++G G+FG V   IL +        AVKV +   V      +S   E ++ + + 
Sbjct: 28  YKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+ K++       F+   +  LV E    G L +                 + S KR 
Sbjct: 85  HPNIXKLYEF-----FEDKGYFYLVGEVYTGGELFD----------------EIISRKRF 123
Query: 321 NIAIDVACVLK-------YLHLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFL 370
           +  +D A +++       Y H   +  I H DLKP N+LL+    +    + DFG++   
Sbjct: 124 S-EVDAARIIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179
Query: 371 EAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           EA+ +    I   GT  YIAPE   G       DV+S G++L  + +G  P
Sbjct: 180 EASKKXKDKI---GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 226

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFES---TTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           IG G FG V++GI         AVA+K   N       + F  E    R   H ++VK+ 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
               GV  +   +  ++ E    G L  ++       +  K   +L SL  +  A  ++ 
Sbjct: 106 ----GVITENPVW--IIMELCTLGELRSFL-------QVRKYSLDLASL--ILYAYQLST 150
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L YL         H D+   N+L+       + DFG++R++E +     S G +    +
Sbjct: 151 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 206
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           +APE       +S  DV+ FG+ + E+   G++P
Sbjct: 207 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 240

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFES---TTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           IG G FG V++GI         AVA+K   N       + F  E    R   H ++VK+ 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
               GV  +   +  ++ E    G L  ++       +  K   +L SL  +  A  ++ 
Sbjct: 81  ----GVITENPVW--IIMELCTLGELRSFL-------QVRKYSLDLASL--ILYAYQLST 125
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L YL         H D+   N+L+       + DFG++R++E +     S G +    +
Sbjct: 126 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 181
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           +APE       +S  DV+ FG+ + E+   G++P
Sbjct: 182 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 215

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 106/263 (40%), Gaps = 56/263 (21%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKV----FNVLHHDASKSFAVECEVTRNIRHRN---LV 265
           +G+G +GSV           VAVK     F  L H A +++  E  + ++++H N   L+
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIH-ARRTYR-ELRLLKHLKHENVIGLL 93
Query: 266 KVFTACSGVDFQGNDFKA--LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VFT  + ++    DF    LV   M                       +LN++ +    
Sbjct: 94  DVFTPATSIE----DFSEVYLVTTLMG---------------------ADLNNIVKSQAL 128
Query: 324 IDVACV---------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD 374
            D             LKY+H      I H DLKPSN+ ++++    + DFG+AR    AD
Sbjct: 129 SDEHVQFLVYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QAD 182
Query: 375 EQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG--LRPSDDMFKDNLN 431
           E+    G   T  Y APE  +     +   D++S G ++ E+  G  L P  D       
Sbjct: 183 EEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKR 240
Query: 432 LRNCVKSALPERAEEIRASSGST 454
           +   V +  PE   +I +    T
Sbjct: 241 IMEVVGTPSPEVLAKISSEHART 263

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G+FG V      ES    A+K+      D  K   ++ ++   +  + +++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLK-QIEHTLNEKRILQ 96
Query: 267 V----FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
                F       F+ N    +V E++A G +   +  I          G  +       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFY 146
Query: 323 AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ ++      R+  
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWX 197
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT   +APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA-VECEVTRNIRHRNL 264
            +++  +IG G+FG V++  L ES      KV         K F   E ++ R ++H N+
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ------DKRFKNRELQIMRIVKHPNV 94
Query: 265 V--KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           V  K F   +G D +   F  LV E++                 RH A     ++  L I
Sbjct: 95  VDLKAFFYSNG-DKKDEVFLNLVLEYVPE---------TVYRASRHYAKLK-QTMPMLLI 143
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY-VSDFGIARFLEAADEQTRSIG 381
            + +  +L+ L       I H D+KP N+LLD       + DFG A+ L A +     I 
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXI- 202
Query: 382 VEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
              +  Y APE   G    ++  D++S G ++ E+  G
Sbjct: 203 --CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFES---TTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           IG G FG V++GI         AVA+K   N       + F  E    R   H ++VK+ 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
               GV  +   +  ++ E    G L  ++       +  K   +L SL  +  A  ++ 
Sbjct: 75  ----GVITENPVW--IIMELCTLGELRSFL-------QVRKYSLDLASL--ILYAYQLST 119
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L YL         H D+   N+L+       + DFG++R++E +     S G +    +
Sbjct: 120 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 175
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           +APE       +S  DV+ FG+ + E+   G++P
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 209

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFES---TTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           IG G FG V++GI         AVA+K   N       + F  E    R   H ++VK+ 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
               GV  +   +  ++ E    G L  ++       +  K   +L SL  +  A  ++ 
Sbjct: 80  ----GVITENPVW--IIMELCTLGELRSFL-------QVRKYSLDLASL--ILYAYQLST 124
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L YL         H D+   N+L+       + DFG++R++E +     S G +    +
Sbjct: 125 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 180
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           +APE       +S  DV+ FG+ + E+   G++P
Sbjct: 181 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 214

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFES---TTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           IG G FG V++GI         AVA+K   N       + F  E    R   H ++VK+ 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
               GV  +   +  ++ E    G L  ++       +  K   +L SL  +  A  ++ 
Sbjct: 83  ----GVITENPVW--IIMELCTLGELRSFL-------QVRKYSLDLASL--ILYAYQLST 127
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L YL         H D+   N+L+       + DFG++R++E +     S G +    +
Sbjct: 128 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 183
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           +APE       +S  DV+ FG+ + E+   G++P
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 114/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH--AKRTYR-E 67
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++                  L+  F    SLEE+  ++ +T     H  
Sbjct: 68  LRLLKHMKHENVI-----------------GLLDVFTPARSLEEFNDVYLVT-----HLM 105
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 106 GADLNNIVKCAKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 162
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 163 LDFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 218 LFPGTDHI-DQLKL 230

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            D+G+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 167 LDYGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 222 LFPGTDHI-DQLKL 234

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           +++  L YLH   +  I + DLK  N+LLD E    ++D+G+ +  E       +    G
Sbjct: 129 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCG 183
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD 423
           T  YIAPE   G +     D ++ G+L+ EM  G  P D
Sbjct: 184 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 5/99 (5%)
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           +++  L YLH   +  I + DLK  N+LLD E    ++D+G+ +      + T +    G
Sbjct: 161 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--G 215
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD 423
           T  YIAPE   G +     D ++ G+L+ EM  G  P D
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 32/234 (13%)
Query: 196 SYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVK----VFNVLHHDASKSFAV 251
           S+ + ++    +     IG G +G V       +   VA+K     F+V+ +  +K    
Sbjct: 46  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN--AKRTLR 103
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL--VYEFMANGSLEEWMH---PITEEDK 306
           E ++ ++ +H N++ +          G +FK++  V + M    L + +H   P+T E  
Sbjct: 104 ELKILKHFKHDNIIAIKDILRPTVPYG-EFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHV 161
Query: 307 RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI 366
           R+     L  L R          LKY+H      + H DLKPSN+L+++     + DFG+
Sbjct: 162 RY----FLYQLLR---------GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGM 205
Query: 367 ARFL--EAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT 417
           AR L    A+ Q        T  Y APE  +  HE +   D++S G +  EM  
Sbjct: 206 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 56/109 (51%), Gaps = 4/109 (3%)
Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIX 60
           D+S+NN S T  P L   S+L   ++SGN LSG  S    +CT L+ L++  N F GPI 
Sbjct: 203 DVSSNNFS-TGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI- 260
Query: 61  XXXXXXXXXXXXXXXQNNLSDEIPEFLAGF-KFLQNLNLSYNNFESMLP 108
                          +N  + EIP+FL+G    L  L+LS N+F   +P
Sbjct: 261 -PPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVP 308

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFES---TTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           IG G FG V++GI         AVA+K   N       + F  E    R   H ++VK+ 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
               GV  +   +  ++ E    G L  ++       +  K   +L SL  +  A  ++ 
Sbjct: 78  ----GVITENPVW--IIMELCTLGELRSFL-------QVRKFSLDLASL--ILYAYQLST 122
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L YL         H D+   N+L+       + DFG++R++E +     S G +    +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 178
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           +APE       +S  DV+ FG+ + E+   G++P
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++   L++LH   +  I + D+K  NILLD      ++DFG+++    ADE  R+    G
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCG 222
Query: 385 TTGYIAPEY----GMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           T  Y+AP+       GH+ +   D +S G+L+ E+ TG  P
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGASP 261

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 22/222 (9%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           ++G G+FG V       +    AVK+     V+  D  +   VE  V         +   
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
            +C    FQ  D    V E++  G L   M+ I ++  R K P        +  A ++A 
Sbjct: 87  HSC----FQTMDRLYFVMEYVNGGDL---MYHI-QQVGRFKEP------HAVFYAAEIAI 132
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L +L       I + DLK  N++LD E    ++DFG+ +  E   +   +    GT  Y
Sbjct: 133 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDY 187
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 430
           IAPE           D ++FG+LL EM  G  P +   +D L
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVK-VFNVLHHDA-SKSFAVECEVTRNIRHRN---LVKV 267
           +G+G +G+V   +   +   VA+K ++     +  +K    E  + +++RH N   L+ V
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           FT    +D    DF  LV  FM     +   H    ED+               I   V 
Sbjct: 93  FTPDETLD-DFTDF-YLVMPFMGTDLGKLMKHEKLGEDR---------------IQFLVY 135
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
            +LK L       I H DLKP N+ ++++    + DFG+AR    AD +     V  T  
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMXGXVV--TRW 190
Query: 388 YIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
           Y APE  +     +   D++S G ++ EM TG
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           +++  L YLH   +  I + DLK  N+LLD E    ++D+G+ +  E       +    G
Sbjct: 114 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCG 168
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD 423
           T  YIAPE   G +     D ++ G+L+ EM  G  P D
Sbjct: 169 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 112/246 (45%), Gaps = 37/246 (15%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRN---LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHK 309
             + ++++H N   L+ VFT    ++ + ND   + +   A+      ++ I +  K   
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTHLMGAD------LNNIVKSQK--- 121
Query: 310 APGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
               L       +   +   LKY+H      I H DLKPSN+ ++++    + DFG+ R 
Sbjct: 122 ----LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRH 174
Query: 370 LEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG--LRPSDDMF 426
            +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  L P  D  
Sbjct: 175 TD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229
Query: 427 KDNLNL 432
            D L L
Sbjct: 230 -DQLKL 234

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 56/109 (51%), Gaps = 4/109 (3%)
Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIX 60
           D+S+NN S T  P L   S+L   ++SGN LSG  S    +CT L+ L++  N F GPI 
Sbjct: 206 DVSSNNFS-TGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI- 263
Query: 61  XXXXXXXXXXXXXXXQNNLSDEIPEFLAGF-KFLQNLNLSYNNFESMLP 108
                          +N  + EIP+FL+G    L  L+LS N+F   +P
Sbjct: 264 -PPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVP 311

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 37/225 (16%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           F    L+G G FG V   ++ E  T    A+K+     ++  D       E  V +N RH
Sbjct: 7   FDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH-----PITEEDKRHKAPGNLNS 316
             L  +  A     FQ +D    V E+   G L  + H       TEE  R         
Sbjct: 65  PFLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-------- 109
Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
                   ++   L+YLH      + + D+K  N++LD +    ++DFG+ +  E   + 
Sbjct: 110 -----YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG 159
Query: 377 TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
                  GT  Y+APE    ++     D +  G+++ EM  G  P
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV----ECEVTRNIRHRNLVKVF 268
           IG G FG V+K    ++   VA+K   VL  +  + F +    E ++ + ++H N+V + 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 269 TACSGVDFQGNDFKA---LVYEFMAN---GSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
             C       N  K    LV++F  +   G L   +   T           L+ +KR+  
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT-----------LSEIKRV-- 130
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD--EQTRSI 380
              +  +L  L+   +  I H D+K +N+L+  +    ++DFG+AR    A   +  R  
Sbjct: 131 ---MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 381 GVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFT 417
               T  Y  PE  +G     YG   D++  G ++ EM+T
Sbjct: 188 NRVVTLWYRPPELLLGER--DYGPPIDLWGAGCIMAEMWT 225

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           +++  L YLH   +  I + DLK  N+LLD E    ++D+G+ +  E       +    G
Sbjct: 118 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCG 172
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD 423
           T  YIAPE   G +     D ++ G+L+ EM  G  P D
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 37/225 (16%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           F    L+G G FG V   ++ E  T    A+K+     ++  D       E  V +N RH
Sbjct: 10  FDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH-----PITEEDKRHKAPGNLNS 316
             L  +  A     FQ +D    V E+   G L  + H       TEE  R         
Sbjct: 68  PFLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-------- 112
Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
                   ++   L+YLH      + + D+K  N++LD +    ++DFG+ +  E   + 
Sbjct: 113 -----YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG 162
Query: 377 TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
                  GT  Y+APE    ++     D +  G+++ EM  G  P
Sbjct: 163 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFES---TTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           IG G FG V++GI         AVA+K   N       + F  E    R   H ++VK+ 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
               GV  +   +  ++ E    G L  ++       +  K   +L SL  +  A  ++ 
Sbjct: 458 ----GVITENPVW--IIMELCTLGELRSFL-------QVRKFSLDLASL--ILYAYQLST 502
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L YL         H D+   N+L+       + DFG++R++E +     S G +    +
Sbjct: 503 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 558
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           +APE       +S  DV+ FG+ + E+   G++P
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 37/225 (16%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           F    L+G G FG V   ++ E  T    A+K+     ++  D       E  V +N RH
Sbjct: 7   FDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH-----PITEEDKRHKAPGNLNS 316
             L  +  A     FQ +D    V E+   G L  + H       TEE  R         
Sbjct: 65  PFLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-------- 109
Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
                   ++   L+YLH      + + D+K  N++LD +    ++DFG+ +  E   + 
Sbjct: 110 -----YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG 159
Query: 377 TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
                  GT  Y+APE    ++     D +  G+++ EM  G  P
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 37/225 (16%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           F    L+G G FG V   ++ E  T    A+K+     ++  D       E  V +N RH
Sbjct: 7   FDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH-----PITEEDKRHKAPGNLNS 316
             L  +  A     FQ +D    V E+   G L  + H       TEE  R         
Sbjct: 65  PFLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-------- 109
Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
                   ++   L+YLH      + + D+K  N++LD +    ++DFG+ +  E   + 
Sbjct: 110 -----YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG 159
Query: 377 TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
                  GT  Y+APE    ++     D +  G+++ EM  G  P
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 37/225 (16%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           F    L+G G FG V   ++ E  T    A+K+     ++  D       E  V +N RH
Sbjct: 7   FDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH-----PITEEDKRHKAPGNLNS 316
             L  +  A     FQ +D    V E+   G L  + H       TEE  R         
Sbjct: 65  PFLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-------- 109
Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
                   ++   L+YLH      + + D+K  N++LD +    ++DFG+ +  E   + 
Sbjct: 110 -----YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG 159
Query: 377 TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
                  GT  Y+APE    ++     D +  G+++ EM  G  P
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 32/234 (13%)
Query: 196 SYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVK----VFNVLHHDASKSFAV 251
           S+ + ++    +     IG G +G V       +   VA+K     F+V+ +  +K    
Sbjct: 45  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN--AKRTLR 102
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL--VYEFMANGSLEEWMH---PITEEDK 306
           E ++ ++ +H N++ +          G +FK++  V + M    L + +H   P+T E  
Sbjct: 103 ELKILKHFKHDNIIAIKDILRPTVPYG-EFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHV 160
Query: 307 RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI 366
           R+     L  L R          LKY+H      + H DLKPSN+L+++     + DFG+
Sbjct: 161 RY----FLYQLLR---------GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGM 204
Query: 367 ARFL--EAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT 417
           AR L    A+ Q        T  Y APE  +  HE +   D++S G +  EM  
Sbjct: 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 258

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/284 (22%), Positives = 108/284 (38%), Gaps = 41/284 (14%)
Query: 219 GSVYKGILFESTTAVAVKVFNVLHHDASKS--FAVECEVTRNIRHRNLVKVFTACSGVDF 276
           G ++KG        + VKV  V      KS  F  EC   R   H N++ V  AC     
Sbjct: 24  GELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS--- 78
Query: 277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLD 336
                  L+  +M  GSL   +H  T           ++  + +  A+D+A  + +LH  
Sbjct: 79  PPAPHPTLITHWMPYGSLYNVLHEGTN--------FVVDQSQAVKFALDMARGMAFLH-T 129
Query: 337 CQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG 396
            +P I    L   ++++D++MTA +S     +F        +S G      ++APE    
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARIS-MADVKF------SFQSPGRMYAPAWVAPEALQK 182
Query: 397 HEVSS---YGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGS 453
               +     D++SF +LL E+ T   P  D+    + ++  ++   P     I      
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSK 242
Query: 454 TQRXXXXXXXXXXXXXGVACSAEQPGERMKINDVEPRLRLIKKK 497
             +                C  E P +R K + + P L  ++ K
Sbjct: 243 LMK---------------ICMNEDPAKRPKFDMIVPILEKMQDK 271

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 37/225 (16%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           F    L+G G FG V   ++ E  T    A+K+     ++  D       E  V +N RH
Sbjct: 12  FDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH-----PITEEDKRHKAPGNLNS 316
             L  +  A     FQ +D    V E+   G L  + H       TEE  R         
Sbjct: 70  PFLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-------- 114
Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
                   ++   L+YLH      + + D+K  N++LD +    ++DFG+ +  E   + 
Sbjct: 115 -----YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG 164
Query: 377 TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
                  GT  Y+APE    ++     D +  G+++ EM  G  P
Sbjct: 165 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV----ECEVTRNIRHRNLVKVF 268
           IG G FG V+K    ++   VA+K   VL  +  + F +    E ++ + ++H N+V + 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 269 TACSGVDFQGNDFKA---LVYEFMAN---GSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
             C       N  K    LV++F  +   G L   +   T           L+ +KR+  
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT-----------LSEIKRV-- 130
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD--EQTRSI 380
              +  +L  L+   +  I H D+K +N+L+  +    ++DFG+AR    A   +  R  
Sbjct: 131 ---MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 381 GVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFT 417
               T  Y  PE  +G     YG   D++  G ++ EM+T
Sbjct: 188 NRVVTLWYRPPELLLGER--DYGPPIDLWGAGCIMAEMWT 225

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 112/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH--AKRTYR-E 91
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 92  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 129
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 130 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 186
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE     G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 187 LDFGLARHTD--DEMX---GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 242 LFPGTDHI-DQLKL 254

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + R IRH N++ +        F+      L+ E ++ G L +++     +TE++   
Sbjct: 79  EVNILREIRHPNIITLHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 133
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                L+ +              YLH      IAH DLKP NI+L D+        + DF
Sbjct: 134 FLKQILDGVH-------------YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDF 177
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GIA  +EA +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 178 GIAHKIEAGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 37/225 (16%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           F    L+G G FG V   ++ E  T    A+K+     ++  D       E  V +N RH
Sbjct: 7   FDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH-----PITEEDKRHKAPGNLNS 316
             L  +  A     FQ +D    V E+   G L  + H       TEE  R         
Sbjct: 65  PFLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-------- 109
Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
                   ++   L+YLH      + + D+K  N++LD +    ++DFG+ +  E   + 
Sbjct: 110 -----YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG 159
Query: 377 TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
                  GT  Y+APE    ++     D +  G+++ EM  G  P
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 112/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 94
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 95  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 132
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 133 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 189
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE     G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 190 LDFGLARHTD--DEMX---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 244
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 245 LFPGTDHI-DQLKL 257

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + R IRH N++ +        F+      L+ E ++ G L +++     +TE++   
Sbjct: 58  EVNILREIRHPNIITLHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 112
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                L+ +              YLH      IAH DLKP NI+L D+        + DF
Sbjct: 113 FLKQILDGVH-------------YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GIA  +EA +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 157 GIAHKIEAGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++                  L+  F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVI-----------------GLLDVFTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE     G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 167 LDFGLARHTD--DEMA---GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 222 LFPGTDHI-DQLKL 234

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++                  L+  F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVI-----------------GLLDVFTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE     G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 167 LDFGLARHTD--DEMA---GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 222 LFPGTDHI-DQLKL 234

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH--AKRTYR-E 67
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++                  L+  F    SLEE+  ++ +T     H  
Sbjct: 68  LRLLKHMKHENVI-----------------GLLDVFTPARSLEEFNDVYLVT-----HLM 105
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 106 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 162
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DFG+AR  +  DE     G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 163 LDFGLARHTD--DEMA---GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 218 LFPGTDHI-DQLKL 230

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + R IRH N++ +        F+      L+ E ++ G L +++     +TE++   
Sbjct: 65  EVNILREIRHPNIITLHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 119
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                L+ +              YLH      IAH DLKP NI+L D+        + DF
Sbjct: 120 FLKQILDGVH-------------YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDF 163
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GIA  +EA +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 164 GIAHKIEAGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 21/223 (9%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGI-LFESTTAVAVKVFNVLHHDASKSFAV--ECEVT 256
           L  A + +     IG G +G V+K   L      VA+K   V   +     +   E  V 
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 257 RNIR---HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGN 313
           R++    H N+V++F  C+           LV+E + +  L  ++  + E       PG 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-------PGV 117
Query: 314 LNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA 373
                + ++   +   L +LH      + H DLKP NIL+       ++DFG+AR     
Sbjct: 118 PTETIK-DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF- 172
Query: 374 DEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMF 416
             Q     V  T  Y APE  +    ++  D++S G +  EMF
Sbjct: 173 --QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV----ECEVTRNIRHRNLVKVF 268
           IG G FG V+K    ++   VA+K   VL  +  + F +    E ++ + ++H N+V + 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 269 TACSGVDFQGNDFKA---LVYEFMAN---GSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
             C       N  K    LV++F  +   G L   +   T           L+ +KR+  
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT-----------LSEIKRV-- 129
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD--EQTRSI 380
              +  +L  L+   +  I H D+K +N+L+  +    ++DFG+AR    A   +  R  
Sbjct: 130 ---MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 381 GVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFT 417
               T  Y  PE  +G     YG   D++  G ++ EM+T
Sbjct: 187 NRVVTLWYRPPELLLGER--DYGPPIDLWGAGCIMAEMWT 224

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 92/231 (39%), Gaps = 26/231 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           +G G FG+VY     +S   VA+KV     +           E E+  ++ H N+++++ 
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
                 F       L+ E+   G L + +      D++  A           I  ++A  
Sbjct: 91  Y-----FYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTA----------TIMEELADA 135
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           L Y H      + H D+KP N+LL  +    ++DFG +    +   +T      GT  Y+
Sbjct: 136 LMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC----GTLDYL 188
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL 440
            PE   G   +   D++  G+L  E+  G  P  +    N   R  VK  L
Sbjct: 189 PPEMIEGRMHNEKVDLWCIGVLCYELLVG-NPPFESASHNETYRRIVKVDL 238

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 213 IGAGNFGSVYKGILFES---TTAVAVKVF-NVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           IG G FG V++GI         AVA+K   N       + F  E    R   H ++VK+ 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
               GV  +   +  ++ E    G L  ++       +  K   +L SL  +  A  ++ 
Sbjct: 458 ----GVITENPVW--IIMELCTLGELRSFL-------QVRKFSLDLASL--ILYAYQLST 502
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L YL         H D+   N+L+       + DFG++R++E +     S G +    +
Sbjct: 503 ALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 558
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           +APE       +S  DV+ FG+ + E+   G++P
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 21/223 (9%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGI-LFESTTAVAVKVFNVLHHDASKSFAV--ECEVT 256
           L  A + +     IG G +G V+K   L      VA+K   V   +     +   E  V 
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 257 RNIR---HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGN 313
           R++    H N+V++F  C+           LV+E + +  L  ++  + E       PG 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-------PGV 117
Query: 314 LNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA 373
                + ++   +   L +LH      + H DLKP NIL+       ++DFG+AR     
Sbjct: 118 PTETIK-DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF- 172
Query: 374 DEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMF 416
             Q     V  T  Y APE  +    ++  D++S G +  EMF
Sbjct: 173 --QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 92/224 (41%), Gaps = 31/224 (13%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNIR 260
           K F  +  +G G F  V   +L E      +     +   A K    S   E  V R I+
Sbjct: 22  KIFEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIK 78
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+V    A   + ++  +   LV + ++ G L      I E  K      + ++L R 
Sbjct: 79  HENIV----ALEDI-YESPNHLYLVMQLVSGGEL---FDRIVE--KGFYTEKDASTLIR- 127
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQT 377
                V   + YLH   +  I H DLKP N+L    D+E    +SDFG+++     D  +
Sbjct: 128 ----QVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMS 180
Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            + G   T GY+APE       S   D +S G++   +  G  P
Sbjct: 181 TACG---TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 91/235 (38%), Gaps = 35/235 (14%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKV---FNVLHHDASKSFAVECE 254
           R L    + +    +IG G FG V       S    A+K+   F ++    S  F  E +
Sbjct: 68  RGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERD 127
Query: 255 VTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNL 314
           +        +V++F A     FQ + +  +V E+M  G L   M      +K  K     
Sbjct: 128 IMAFANSPWVVQLFCA-----FQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF---- 178
Query: 315 NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD 374
                     +V   L  +H      + H D+KP N+LLD      ++DFG    ++   
Sbjct: 179 -------YTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 228
Query: 375 EQTRSIGVEGTTGYIAPEY-----GMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
                  V GT  YI+PE      G G+    YG   D +S G+ L EM  G  P
Sbjct: 229 MVHCDTAV-GTPDYISPEVLKSQGGDGY----YGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 21/223 (9%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGI-LFESTTAVAVKVFNVLHHDASKSFAV--ECEVT 256
           L  A + +     IG G +G V+K   L      VA+K   V   +     +   E  V 
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 257 RNIR---HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGN 313
           R++    H N+V++F  C+           LV+E + +  L  ++  + E       PG 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-------PGV 117
Query: 314 LNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA 373
                + ++   +   L +LH      + H DLKP NIL+       ++DFG+AR     
Sbjct: 118 PTETIK-DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF- 172
Query: 374 DEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMF 416
             Q     V  T  Y APE  +    ++  D++S G +  EMF
Sbjct: 173 --QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 106/241 (43%), Gaps = 33/241 (13%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVK-VFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G G +G V K     S   +AVK +   ++    K   ++ +++     R +   FT  
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS----MRTVDCPFT-- 112
Query: 272 SGVDFQGNDFKA----LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
             V F G  F+     +  E M + SL+++   +   DK    P ++       IA+ + 
Sbjct: 113 --VTFYGALFREGDVWICMELM-DTSLDKFYKQVI--DKGQTIPEDILG----KIAVSIV 163
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             L++LH      + H D+KPSN+L++      + DFGI+ +L   D   ++I   G   
Sbjct: 164 KALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDSVAKTIDA-GCKP 218
Query: 388 YIAPEY------GMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP 441
           Y+APE         G+ V S  D++S GI ++E+     P D        L+  V+   P
Sbjct: 219 YMAPERINPELNQKGYSVKS--DIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 276
Query: 442 E 442
           +
Sbjct: 277 Q 277

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 38/231 (16%)
Query: 203 ATKG-----FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTR 257
           +TKG     ++ EN IG G++G V   +   +    A K       +    F  E E+ +
Sbjct: 19  STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 78
Query: 258 NIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
           ++ H N+++++       F+ N    LV E    G L E +         HK     +  
Sbjct: 79  SLDHPNIIRLYET-----FEDNTDIYLVMELCTGGELFERV--------VHKRVFRESDA 125
Query: 318 KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNIL-LDDEMTAYVS--DFGI-ARFLEAA 373
            R  I  DV   + Y H   +  +AH DLKP N L L D   + +   DFG+ ARF    
Sbjct: 126 AR--IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 180
Query: 374 DEQTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
             +T+     GT  Y++P+   G     YG   D +S G+++  +  G  P
Sbjct: 181 MMRTKV----GTPYYVSPQVLEG----LYGPECDEWSAGVMMYVLLCGYPP 223

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 38/231 (16%)
Query: 203 ATKG-----FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTR 257
           +TKG     ++ EN IG G++G V   +   +    A K       +    F  E E+ +
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61
Query: 258 NIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
           ++ H N+++++       F+ N    LV E    G L E +         HK     +  
Sbjct: 62  SLDHPNIIRLYET-----FEDNTDIYLVMELCTGGELFERV--------VHKRVFRESDA 108
Query: 318 KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNIL-LDDEMTAYVS--DFGI-ARFLEAA 373
            R  I  DV   + Y H   +  +AH DLKP N L L D   + +   DFG+ ARF    
Sbjct: 109 AR--IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163
Query: 374 DEQTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
             +T+     GT  Y++P+   G     YG   D +S G+++  +  G  P
Sbjct: 164 MMRTKV----GTPYYVSPQVLEG----LYGPECDEWSAGVMMYVLLCGYPP 206

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 112/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
             FG+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 167 LGFGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 222 LFPGTDHI-DQLKL 234

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 96/241 (39%), Gaps = 54/241 (22%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT--RNIRHRNL 264
           F    ++G G FG V K      +   A+K    + H   K   +  EV    ++ H+ +
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKK---IRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 265 VKVFTAC----------SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNL 314
           V+ + A           + V  +   F  +  E+  NG+L + +H             NL
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQM--EYCENGTLYDLIHS-----------ENL 111
Query: 315 NSLK--RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE- 371
           N  +     +   +   L Y+H      I H DLKP NI +D+     + DFG+A+ +  
Sbjct: 112 NQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 372 --------------AADEQTRSIGVEGTTGYIAPEY--GMGHEVSSYGDVYSFGILLLEM 415
                         ++D  T +I   GT  Y+A E   G GH  +   D+YS GI+  EM
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAI---GTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEM 224
Query: 416 F 416
Sbjct: 225 I 225

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 99/243 (40%), Gaps = 35/243 (14%)
Query: 189 SISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDA 245
            +   +V+YR  Y   K      +IG G+FG V K    +    VA+K+       H  A
Sbjct: 89  QVPHDHVAYR--YEVLK------VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 246 SKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEED 305
           ++   +  E  R     N + V        F+ +    + +E ++          + E  
Sbjct: 141 AEEIRI-LEHLRKQDKDNTMNVIHMLENFTFRNHI--CMTFELLSMN--------LYELI 189
Query: 306 KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA--YVSD 363
           K++K  G    L R   A  +   L  LH +    I HCDLKP NILL  +  +   V D
Sbjct: 190 KKNKFQGFSLPLVR-KFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID 245
Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG--LRP 421
           FG + +     E  R      +  Y APE  +G       D++S G +L E+ TG  L P
Sbjct: 246 FGSSCY-----EHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300
Query: 422 SDD 424
            +D
Sbjct: 301 GED 303

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 112/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            D G+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 167 LDAGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 222 LFPGTDHI-DQLKL 234

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 99/243 (40%), Gaps = 35/243 (14%)
Query: 189 SISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDA 245
            +   +V+YR  Y   K      +IG G+FG V K    +    VA+K+       H  A
Sbjct: 89  QVPHDHVAYR--YEVLK------VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 246 SKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEED 305
           ++   +  E  R     N + V        F+ +    + +E ++          + E  
Sbjct: 141 AEEIRI-LEHLRKQDKDNTMNVIHMLENFTFRNH--ICMTFELLSMN--------LYELI 189
Query: 306 KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA--YVSD 363
           K++K  G    L R   A  +   L  LH +    I HCDLKP NILL  +  +   V D
Sbjct: 190 KKNKFQGFSLPLVR-KFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID 245
Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG--LRP 421
           FG + +     E  R      +  Y APE  +G       D++S G +L E+ TG  L P
Sbjct: 246 FGSSCY-----EHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300
Query: 422 SDD 424
            +D
Sbjct: 301 GED 303

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 91/226 (40%), Gaps = 35/226 (15%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRNIRHRNLV 265
           ++    IG G +G V         T VA+K  +   H    +    E ++    RH N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
            +         + +  +A+   ++    +E  ++ +               LK   ++ D
Sbjct: 105 GIRDI-----LRASTLEAMRDVYIVQDLMETDLYKL---------------LKSQQLSND 144
Query: 326 VACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT 377
             C         LKY+H      + H DLKPSN+L++      + DFG+AR  +   + T
Sbjct: 145 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHT 201
Query: 378 RSIG-VEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
             +     T  Y APE  +  +  +   D++S G +L EM +  RP
Sbjct: 202 GFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 246

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 90/224 (40%), Gaps = 31/224 (13%)
Query: 204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRN 263
           + G+  +  IG G++    + +   +    AVKV +    D S+   +   + R  +H N
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPN 82
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEED--KRHKAPGNLNSLKRLN 321
           ++ +        +       LV E M  G L   +  I  +      +A   L+++ +  
Sbjct: 83  IITLKDV-----YDDGKHVYLVTELMRGGEL---LDKILRQKFFSEREASFVLHTIGK-- 132
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM----TAYVSDFGIARFLEAADEQT 377
                   ++YLH      + H DLKPSNIL  DE        + DFG A+ L A  E  
Sbjct: 133 -------TVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRA--ENG 180
Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             +    T  ++APE           D++S GILL  M  G  P
Sbjct: 181 LLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 34/228 (14%)
Query: 209 SENLIGAGNFGSVYKGILFESTTAVAVKVFNVL-HHDASKSFAVECEVTRNIR-HRNLVK 266
            E+++G G    V   I   ++   AVK+      H  S+ F  E E+    + HRN+++
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR-EVEMLYQCQGHRNVLE 75
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +        F+  D   LV+E M  GS+   +H      +RH      N L+   +  DV
Sbjct: 76  LIEF-----FEEEDRFYLVFEKMRGGSILSHIH-----KRRH-----FNELEASVVVQDV 120
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDE---MTAYVSDFGIARFLEAADEQTRSIGVE 383
           A  L +LH      IAH DLKP NIL +         + DFG+   ++   + +     E
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 384 -----GTTGYIAPEY--GMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
                G+  Y+APE       E S Y    D++S G++L  + +G  P
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 90/224 (40%), Gaps = 31/224 (13%)
Query: 204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRN 263
           + G+  +  IG G++    + +   +    AVKV +    D S+   +   + R  +H N
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPN 82
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEED--KRHKAPGNLNSLKRLN 321
           ++ +        +       LV E M  G L   +  I  +      +A   L+++ +  
Sbjct: 83  IITLKDV-----YDDGKHVYLVTELMRGGEL---LDKILRQKFFSEREASFVLHTIGK-- 132
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM----TAYVSDFGIARFLEAADEQT 377
                   ++YLH      + H DLKPSNIL  DE        + DFG A+ L A  E  
Sbjct: 133 -------TVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRA--ENG 180
Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             +    T  ++APE           D++S GILL  M  G  P
Sbjct: 181 LLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           ++G G+FG V K     +    AVKV N     + D S +   E E+ + + H N++K+F
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLF 87
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                   + +    +V E    G L        E  KR +     +      I   V  
Sbjct: 88  EI-----LEDSSSFYIVGELYTGGEL------FDEIIKRKR----FSEHDAARIIKQVFS 132
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
            + Y+H   +  I H DLKP NILL   + +    + DFG++   +   +    I   GT
Sbjct: 133 GITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GT 186
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             YIAPE   G       DV+S G++L  + +G  P
Sbjct: 187 AYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 106/238 (44%), Gaps = 50/238 (21%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG 418
            D G+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG
Sbjct: 167 LDRGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 112/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            DF +AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 167 LDFYLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 222 LFPGTDHI-DQLKL 234

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           ++G G+FG V K     +    AVKV N     + D S +   E E+ + + H N++K+F
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLF 87
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                   + +    +V E    G L        E  KR +     +      I   V  
Sbjct: 88  EI-----LEDSSSFYIVGELYTGGEL------FDEIIKRKR----FSEHDAARIIKQVFS 132
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
            + Y+H   +  I H DLKP NILL   + +    + DFG++   +   +    I   GT
Sbjct: 133 GITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GT 186
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             YIAPE   G       DV+S G++L  + +G  P
Sbjct: 187 AYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           ++G G+FG V K     +    AVKV N     + D S +   E E+ + + H N++K+F
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLF 87
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                   + +    +V E    G L        E  KR +     +      I   V  
Sbjct: 88  EI-----LEDSSSFYIVGELYTGGEL------FDEIIKRKR----FSEHDAARIIKQVFS 132
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
            + Y+H   +  I H DLKP NILL   + +    + DFG++   +   +    I   GT
Sbjct: 133 GITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GT 186
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             YIAPE   G       DV+S G++L  + +G  P
Sbjct: 187 AYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 62/275 (22%), Positives = 106/275 (38%), Gaps = 53/275 (19%)
Query: 184 GNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH 243
             PT S+  P+  +++       +   +LIG G++G V +         VA+K    +  
Sbjct: 36  SKPTASMPRPHSDWQI----PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE 91
Query: 244 DA--SKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPI 301
           D    K    E  +   + H ++VKV       D +  D   +V E +A+   +      
Sbjct: 92  DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE-IADSDFK------ 144
Query: 302 TEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
               K  + P  L  L    +  ++   +KY+H      I H DLKP+N L++ + +  V
Sbjct: 145 ----KLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKV 197
Query: 362 SDFGIAR-------------------------FLEAADEQTRSIGVEGTTGYIAPEYGMG 396
            DFG+AR                         F    + + +  G   T  Y APE  + 
Sbjct: 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL 257
Query: 397 HE-VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 430
            E  +   DV+S G +  E+        +M K+N+
Sbjct: 258 QENYTEAIDVWSIGCIFAELL-------NMIKENV 285

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    A      +    T  
Sbjct: 139 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMVPFVVTRY 192
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
           Y APE  +G       D++S G ++ EM  G
Sbjct: 193 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 98/243 (40%), Gaps = 35/243 (14%)
Query: 189 SISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDA 245
            +   +V+YR  Y   K      +IG G FG V K    +    VA+K+       H  A
Sbjct: 89  QVPHDHVAYR--YEVLK------VIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 246 SKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEED 305
           ++   +  E  R     N + V        F+ +    + +E ++          + E  
Sbjct: 141 AEEIRI-LEHLRKQDKDNTMNVIHMLENFTFRNHI--CMTFELLSMN--------LYELI 189
Query: 306 KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA--YVSD 363
           K++K  G    L R   A  +   L  LH +    I HCDLKP NILL  +  +   V D
Sbjct: 190 KKNKFQGFSLPLVR-KFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID 245
Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG--LRP 421
           FG + +     E  R      +  Y APE  +G       D++S G +L E+ TG  L P
Sbjct: 246 FGSSCY-----EHQRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300
Query: 422 SDD 424
            +D
Sbjct: 301 GED 303

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 109/259 (42%), Gaps = 53/259 (20%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--------VLHHDASKSFAVECEVTRNIRHRNL 264
           +G+G  G V      ++   VA+K+ +            D + +   E E+ + + H  +
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +K+        F   D+  +V E M  G L +            K  GN    KRL  A 
Sbjct: 84  IKIKNF-----FDAEDY-YIVLELMEGGELFD------------KVVGN----KRLKEAT 121
Query: 325 ------DVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADE 375
                  +   ++YLH   +  I H DLKP N+LL   +++    ++DFG ++ L    E
Sbjct: 122 CKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GE 175
Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNL 432
            +    + GT  Y+APE  +    + Y    D +S G++L    +G  P  +  +  ++L
Sbjct: 176 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE-HRTQVSL 234
Query: 433 RNCVKSA----LPERAEEI 447
           ++ + S     +PE   E+
Sbjct: 235 KDQITSGKYNFIPEVWAEV 253

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 109/259 (42%), Gaps = 53/259 (20%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--------VLHHDASKSFAVECEVTRNIRHRNL 264
           +G+G  G V      ++   VA+K+ +            D + +   E E+ + + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +K+        F   D+  +V E M  G L +            K  GN    KRL  A 
Sbjct: 78  IKIKNF-----FDAEDY-YIVLELMEGGELFD------------KVVGN----KRLKEAT 115
Query: 325 ------DVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADE 375
                  +   ++YLH   +  I H DLKP N+LL   +++    ++DFG ++ L    E
Sbjct: 116 CKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GE 169
Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNL 432
            +    + GT  Y+APE  +    + Y    D +S G++L    +G  P  +  +  ++L
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE-HRTQVSL 228
Query: 433 RNCVKSA----LPERAEEI 447
           ++ + S     +PE   E+
Sbjct: 229 KDQITSGKYNFIPEVWAEV 247

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 30/227 (13%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           + F    +IG G FG V    +  +    A+K+ N   +L    +  F  E +V  N   
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNS--LKR 319
           + +  +  A     FQ  +   LV ++   G L   +    +     K P ++    +  
Sbjct: 134 QWITALHYA-----FQDENHLYLVMDYYVGGDLLTLLSKFED-----KLPEDMARFYIGE 183
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
           + +AID    L Y+H D         +KP N+LLD      ++DFG    +        S
Sbjct: 184 MVLAIDSIHQLHYVHRD---------IKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSS 234
Query: 380 IGVEGTTGYIAPEY--GMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
           + V GT  YI+PE    M   +  YG   D +S G+ + EM  G  P
Sbjct: 235 VAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 30/227 (13%)
Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           + F    +IG G FG V    +  +    A+K+ N   +L    +  F  E +V  N   
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNS--LKR 319
           + +  +  A     FQ  +   LV ++   G L   +    +     K P ++    +  
Sbjct: 150 QWITALHYA-----FQDENHLYLVMDYYVGGDLLTLLSKFED-----KLPEDMARFYIGE 199
Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
           + +AID    L Y+H D         +KP N+LLD      ++DFG    +        S
Sbjct: 200 MVLAIDSIHQLHYVHRD---------IKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSS 250
Query: 380 IGVEGTTGYIAPEY--GMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
           + V GT  YI+PE    M   +  YG   D +S G+ + EM  G  P
Sbjct: 251 VAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 86/221 (38%), Gaps = 28/221 (12%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           F    L+G G FG V   ++ E  T    A+K+     ++  D       E  V +N RH
Sbjct: 150 FEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
                 F       FQ +D    V E+   G L             H +   + S  R  
Sbjct: 208 -----PFLTALKYSFQTHDRLCFVMEYANGGEL-----------FFHLSRERVFSEDRAR 251
Query: 322 I-AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
               ++   L YLH   +  + + DLK  N++LD +    ++DFG+ +  E   +     
Sbjct: 252 FYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMK 307
Query: 381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
              GT  Y+APE    ++     D +  G+++ EM  G  P
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 109/259 (42%), Gaps = 53/259 (20%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--------VLHHDASKSFAVECEVTRNIRHRNL 264
           +G+G  G V      ++   VA+K+ +            D + +   E E+ + + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +K+        F   D+  +V E M  G L +            K  GN    KRL  A 
Sbjct: 78  IKIKNF-----FDAEDY-YIVLELMEGGELFD------------KVVGN----KRLKEAT 115
Query: 325 ------DVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADE 375
                  +   ++YLH   +  I H DLKP N+LL   +++    ++DFG ++ L    E
Sbjct: 116 CKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GE 169
Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNL 432
            +    + GT  Y+APE  +    + Y    D +S G++L    +G  P  +  +  ++L
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE-HRTQVSL 228
Query: 433 RNCVKSA----LPERAEEI 447
           ++ + S     +PE   E+
Sbjct: 229 KDQITSGKYNFIPEVWAEV 247

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 86/221 (38%), Gaps = 28/221 (12%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           F    L+G G FG V   ++ E  T    A+K+     ++  D       E  V +N RH
Sbjct: 153 FEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
                 F       FQ +D    V E+   G L             H +   + S  R  
Sbjct: 211 -----PFLTALKYSFQTHDRLCFVMEYANGGEL-----------FFHLSRERVFSEDRAR 254
Query: 322 I-AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
               ++   L YLH   +  + + DLK  N++LD +    ++DFG+ +  E   +     
Sbjct: 255 FYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMK 310
Query: 381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
              GT  Y+APE    ++     D +  G+++ EM  G  P
Sbjct: 311 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 109/259 (42%), Gaps = 53/259 (20%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--------VLHHDASKSFAVECEVTRNIRHRNL 264
           +G+G  G V      ++   VA+K+ +            D + +   E E+ + + H  +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +K+        F   D+  +V E M  G L +            K  GN    KRL  A 
Sbjct: 77  IKIKNF-----FDAEDY-YIVLELMEGGELFD------------KVVGN----KRLKEAT 114
Query: 325 ------DVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADE 375
                  +   ++YLH   +  I H DLKP N+LL   +++    ++DFG ++ L    E
Sbjct: 115 CKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GE 168
Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNL 432
            +    + GT  Y+APE  +    + Y    D +S G++L    +G  P  +  +  ++L
Sbjct: 169 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE-HRTQVSL 227
Query: 433 RNCVKSA----LPERAEEI 447
           ++ + S     +PE   E+
Sbjct: 228 KDQITSGKYNFIPEVWAEV 246

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEV---VTRY 190
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
           Y APE  +G       D++S G ++ EM  G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 109/259 (42%), Gaps = 53/259 (20%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--------VLHHDASKSFAVECEVTRNIRHRNL 264
           +G+G  G V      ++   VA+K+ +            D + +   E E+ + + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +K+        F   D+  +V E M  G L +            K  GN    KRL  A 
Sbjct: 78  IKIKNF-----FDAEDY-YIVLELMEGGELFD------------KVVGN----KRLKEAT 115
Query: 325 ------DVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADE 375
                  +   ++YLH   +  I H DLKP N+LL   +++    ++DFG ++ L    E
Sbjct: 116 CKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GE 169
Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNL 432
            +    + GT  Y+APE  +    + Y    D +S G++L    +G  P  +  +  ++L
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE-HRTQVSL 228
Query: 433 RNCVKSA----LPERAEEI 447
           ++ + S     +PE   E+
Sbjct: 229 KDQITSGKYNFIPEVWAEV 247

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 62/128 (48%), Gaps = 13/128 (10%)
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            IA+ +   L++LH   +  + H D+KPSN+L++      + DFGI+ +L   D+  + I
Sbjct: 113 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDI 168
Query: 381 GVEGTTGYIAPEY------GMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN 434
              G   Y+APE         G+ V S  D++S GI ++E+     P D        L+ 
Sbjct: 169 DA-GCKPYMAPERINPELNQKGYSVKS--DIWSLGITMIELAILRFPYDSWGTPFQQLKQ 225
Query: 435 CVKSALPE 442
            V+   P+
Sbjct: 226 VVEEPSPQ 233

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 41/219 (18%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-ASKSFAV-ECEVTRNIRHRNLVKVFTA 270
           IG G++G V+K    ++   VA+K F     D   K  A+ E  + + ++H NLV +   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNL------NSLKRLNIAI 324
                F+      LV+E+  +  L E       +  +   P +L       +L+ +N   
Sbjct: 71  -----FRRKRRLHLVFEYCDHTVLHEL------DRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEA-ADEQTRSIGVE 383
              C+             H D+KP NIL+       + DFG AR L   +D     +   
Sbjct: 120 KHNCI-------------HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV--- 163
Query: 384 GTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGL 419
            T  Y +PE  +G   + YG   DV++ G +  E+ +G+
Sbjct: 164 ATRWYRSPELLVGD--TQYGPPVDVWAIGCVFAELLSGV 200

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 96/236 (40%), Gaps = 37/236 (15%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAV-AVKV---FNVLHHDASKSFAVEC 253
           R L    + +    +IG G FG V + +  +ST  V A+K+   F ++    S  F  E 
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 254 EVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGN 313
           ++        +V++F A     FQ + +  +V E+M  G L   M         +  P  
Sbjct: 126 DIMAFANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDLVNLM-------SNYDVP-- 171
Query: 314 LNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA 373
                R   A +V   L  +H        H D+KP N+LLD      ++DFG    +   
Sbjct: 172 -EKWARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-K 225
Query: 374 DEQTRSIGVEGTTGYIAPEY-----GMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
           +   R     GT  YI+PE      G G+    YG   D +S G+ L EM  G  P
Sbjct: 226 EGMVRCDTAVGTPDYISPEVLKSQGGDGY----YGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 112/254 (44%), Gaps = 53/254 (20%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVE 252
           + ++   + + + + +G+G +GSV      ++   VAVK  +     ++H  A +++  E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYR-E 71
Query: 253 CEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--MHPITEEDKRHKA 310
             + ++++H N++ +                    F    SLEE+  ++ +T     H  
Sbjct: 72  LRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLVT-----HLM 109
Query: 311 PGNLNSLKRLNIAID---------VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             +LN++ +     D         +   LKY+H      I H DLKPSN+ ++++    +
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 166
Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTG-- 418
            D G+AR  +  DE T   G   T  Y APE  +     +   D++S G ++ E+ TG  
Sbjct: 167 LDGGLARHTD--DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221
Query: 419 LRPSDDMFKDNLNL 432
           L P  D   D L L
Sbjct: 222 LFPGTDHI-DQLKL 234

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 89/214 (41%), Gaps = 31/214 (14%)
Query: 212 LIGAGNFGSVYKGILFE---STTAVAVKVFNV-LHHDASKSFAVECEVTRNIRHRNLVKV 267
           ++G G FG VY+G+          VAVK        D  + F  E  + +N+ H ++VK+
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI---AI 324
                 +     +   ++ E    G L             H    N NSLK L +   ++
Sbjct: 91  ------IGIIEEEPTWIIMELYPYGEL------------GHYLERNKNSLKVLTLVLYSL 132
Query: 325 DVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +   + YL  ++C     H D+   NIL+       + DFG++R++E  D    S+   
Sbjct: 133 QICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV-TR 187
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
               +++PE       ++  DV+ F + + E+ +
Sbjct: 188 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 87/221 (39%), Gaps = 28/221 (12%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           F    L+G G FG V   ++ E  T    A+K+     ++  D       E  V +N RH
Sbjct: 10  FEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
                 F       FQ +D    V E+   G L  + H   E          + S  R  
Sbjct: 68  -----PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE---------RVFSEDRAR 111
Query: 322 I-AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
               ++   L YLH   +  + + DLK  N++LD +    ++DFG+ +  E   +     
Sbjct: 112 FYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMK 167
Query: 381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
              GT  Y+APE    ++     D +  G+++ EM  G  P
Sbjct: 168 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 31/220 (14%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G  G V+  +  +    VA+K   +    + K    E ++ R + H N+VKVF    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMH----------PITEEDKRHKAPGNLNSLKRLNI 322
               Q  D    + E  +   ++E+M           P+ EE  R      L        
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRG------ 132
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE-MTAYVSDFGIARFLEAADEQTRSIG 381
                  LKY+H      + H DLKP+N+ ++ E +   + DFG+AR ++        + 
Sbjct: 133 -------LKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 382 VEG--TTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
            EG  T  Y +P   +  +  +   D+++ G +  EM TG
Sbjct: 183 -EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIRHRNL 264
           F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+            +   LV+EF+             ++ K+      L  +    I  
Sbjct: 72  VKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLPLIKS 114
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+   E 
Sbjct: 115 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEV 171
Query: 385 TT-GYIAPEYGMGHEVSSYG-DVYSFGILLLEMFT--GLRPSD 423
            T  Y APE  +G +  S   D++S G +  EM T   L P D
Sbjct: 172 VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGD 214

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 100/238 (42%), Gaps = 41/238 (17%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAV-AVKV---FNVLHHDASKSFAVEC 253
           R L    + +    +IG G FG V + +  +ST  V A+K+   F ++    S  F  E 
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 254 EVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM--HPITEEDKRHKAP 311
           ++        +V++F A     FQ + +  +V E+M  G L   M  + + E+  R    
Sbjct: 121 DIMAFANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 175
Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
                   + +A+D    + ++H D         +KP N+LLD      ++DFG    + 
Sbjct: 176 -------EVVLALDAIHSMGFIHRD---------VKPDNMLLDKSGHLKLADFGTCMKMN 219
Query: 372 AADEQTRSIGVEGTTGYIAPEY-----GMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
             +   R     GT  YI+PE      G G+    YG   D +S G+ L EM  G  P
Sbjct: 220 -KEGMVRCDTAVGTPDYISPEVLKSQGGDGY----YGRECDWWSVGVFLYEMLVGDTP 272

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVKVFTAC 271
           IG G +G VYK       T    K+      +   S  + E  + + ++H N+VK++   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV- 68
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
                       LV+E + +  L++ +             G L S+   +  + +   + 
Sbjct: 69  ----IHTKKRLVLVFEHL-DQDLKKLLDV---------CEGGLESVTAKSFLLQLLNGIA 114
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR-FLEAADEQTRSIGVEGTTGYIA 390
           Y H      + H DLKP N+L++ E    ++DFG+AR F     + T  I    T  Y A
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI---VTLWYRA 168
Query: 391 PEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
           P+  MG  + S+  D++S G +  EM  G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 87/221 (39%), Gaps = 28/221 (12%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           F    L+G G FG V   ++ E  T    A+K+     ++  D       E  V +N RH
Sbjct: 11  FEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
                 F       FQ +D    V E+   G L  + H   E          + S  R  
Sbjct: 69  -----PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE---------RVFSEDRAR 112
Query: 322 I-AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
               ++   L YLH   +  + + DLK  N++LD +    ++DFG+ +  E   +     
Sbjct: 113 FYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMK 168
Query: 381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
              GT  Y+APE    ++     D +  G+++ EM  G  P
Sbjct: 169 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
           Y APE  +G       D++S G ++ EM  G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 87/221 (39%), Gaps = 28/221 (12%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTA--VAVKVFN---VLHHDASKSFAVECEVTRNIRH 261
           F    L+G G FG V   ++ E  T    A+K+     ++  D       E  V +N RH
Sbjct: 12  FEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
                 F       FQ +D    V E+   G L  + H   E          + S  R  
Sbjct: 70  -----PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE---------RVFSEDRAR 113
Query: 322 I-AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
               ++   L YLH   +  + + DLK  N++LD +    ++DFG+ +  E   +     
Sbjct: 114 FYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMK 169
Query: 381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
              GT  Y+APE    ++     D +  G+++ EM  G  P
Sbjct: 170 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
           Y APE  +G       D++S G ++ EM  G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 96/236 (40%), Gaps = 37/236 (15%)
Query: 198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAV-AVKV---FNVLHHDASKSFAVEC 253
           R L    + +    +IG G FG V + +  +ST  V A+K+   F ++    S  F  E 
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 254 EVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGN 313
           ++        +V++F A     FQ + +  +V E+M  G L   M         +  P  
Sbjct: 126 DIMAFANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDLVNLM-------SNYDVP-- 171
Query: 314 LNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA 373
                R   A +V   L  +H        H D+KP N+LLD      ++DFG    +   
Sbjct: 172 -EKWARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-K 225
Query: 374 DEQTRSIGVEGTTGYIAPEY-----GMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
           +   R     GT  YI+PE      G G+    YG   D +S G+ L EM  G  P
Sbjct: 226 EGMVRCDTAVGTPDYISPEVLKSQGGDGY----YGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 91/195 (46%), Gaps = 33/195 (16%)
Query: 207 FSSENLIGAGNFGS-VYKGILFESTTAVAVKVFNVLHHDASKSFA-VECEVTR-NIRHRN 263
           F  ++++G G  G+ VY+G+      AV   +          SFA  E ++ R +  H N
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPN 79
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           +++ F  C+  D Q   F+ +  E  A  +L+E+   + ++D  H        L+ + + 
Sbjct: 80  VIRYF--CTEKDRQ---FQYIAIELCA-ATLQEY---VEQKDFAHLG------LEPITLL 124
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLD-----DEMTAYVSDFGIARFLEAADEQ-T 377
                 L +LH      I H DLKP NIL+       ++ A +SDFG+ + L       +
Sbjct: 125 QQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181
Query: 378 RSIGVEGTTGYIAPE 392
           R  GV GT G+IAPE
Sbjct: 182 RRSGVPGTEGWIAPE 196

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 32/219 (14%)
Query: 212 LIGAGNFGSVYKGILFE---STTAVAVKVFNV-LHHDASKSFAVECEVTRNIRHRNLVKV 267
           ++G G FG VY+G+          VAVK        D  + F  E  + +N+ H ++VK+
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI---AI 324
                 +     +   ++ E    G L             H    N NSLK L +   ++
Sbjct: 79  ------IGIIEEEPTWIIMELYPYGEL------------GHYLERNKNSLKVLTLVLYSL 120
Query: 325 DVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +   + YL  ++C     H D+   NIL+       + DFG++R++E  D    S+   
Sbjct: 121 QICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV-TR 175
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
               +++PE       ++  DV+ F + + E+ + G +P
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIRHRNL 264
           F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+            +   LV+EF+             ++ K+      L  +    I  
Sbjct: 65  VKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLPLIKS 107
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+   E 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEV 164
Query: 385 TT-GYIAPEYGMGHEVSSYG-DVYSFGILLLEMFT--GLRPSD 423
            T  Y APE  +G +  S   D++S G +  EM T   L P D
Sbjct: 165 VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
           Y APE  +G       D++S G ++ EM  G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 138 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 191
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
           Y APE  +G       D++S G ++ EM  G
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
           Y APE  +G       D++S G ++ EM  G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 95/235 (40%), Gaps = 29/235 (12%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F  E+ +G G    VY+     +    A+KV         K    E  V   + H N++K
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +        F+     +LV E +  G L + +       +R  A    +++K++  A+  
Sbjct: 113 LKEI-----FETPTEISLVLELVTGGELFDRIVEKGYYSERDAA----DAVKQILEAV-- 161
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDD---EMTAYVSDFGIARFLEAADEQTRSIGVE 383
                YLH   +  I H DLKP N+L      +    ++DFG+++ +E    Q     V 
Sbjct: 162 ----AYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE---HQVLMKTVC 211
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR---NC 435
           GT GY APE   G       D++S GI+   +  G  P  D   D    R   NC
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC 266

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 90/219 (41%), Gaps = 24/219 (10%)
Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVE-----CEVTRNIRHRNLV 265
            +IG G F  V + I  E+    AVK+ +V    +S   + E       +   ++H ++V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           ++        +  +    +V+EFM    L        E  KR  A    +     +    
Sbjct: 90  ELLET-----YSSDGMLYMVFEFMDGADL------CFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           +   L+Y H      I H D+KP N+LL   ++     + DFG+A  ++  +    + G 
Sbjct: 139 ILEALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGR 193
Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            GT  ++APE           DV+  G++L  + +G  P
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 32/219 (14%)
Query: 212 LIGAGNFGSVYKGILFE---STTAVAVKVFNV-LHHDASKSFAVECEVTRNIRHRNLVKV 267
           ++G G FG VY+G+          VAVK        D  + F  E  + +N+ H ++VK+
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI---AI 324
                 +     +   ++ E    G L             H    N NSLK L +   ++
Sbjct: 75  ------IGIIEEEPTWIIMELYPYGEL------------GHYLERNKNSLKVLTLVLYSL 116
Query: 325 DVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +   + YL  ++C     H D+   NIL+       + DFG++R++E  D    S+   
Sbjct: 117 QICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV-TR 171
Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
               +++PE       ++  DV+ F + + E+ + G +P
Sbjct: 172 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
           Y APE  +G       D++S G ++ EM  G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 6/89 (6%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  Y 
Sbjct: 139 IKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV---VTRYYR 192
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTG 418
           APE  +G       D++S G+++ EM  G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 6/89 (6%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  Y 
Sbjct: 139 IKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV---VTRYYR 192
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTG 418
           APE  +G       D++S G+++ EM  G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/75 (33%), Positives = 38/75 (50%)
Query: 343 HCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSY 402
           H DL   NILL ++    + DFG+AR +    +  R         ++APE       +  
Sbjct: 216 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 275
Query: 403 GDVYSFGILLLEMFT 417
            DV+SFG+LL E+F+
Sbjct: 276 SDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/75 (33%), Positives = 38/75 (50%)
Query: 343 HCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSY 402
           H DL   NILL ++    + DFG+AR +    +  R         ++APE       +  
Sbjct: 214 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 273
Query: 403 GDVYSFGILLLEMFT 417
            DV+SFG+LL E+F+
Sbjct: 274 SDVWSFGVLLWEIFS 288

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/75 (33%), Positives = 38/75 (50%)
Query: 343 HCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSY 402
           H DL   NILL ++    + DFG+AR +    +  R         ++APE       +  
Sbjct: 221 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 280
Query: 403 GDVYSFGILLLEMFT 417
            DV+SFG+LL E+F+
Sbjct: 281 SDVWSFGVLLWEIFS 295

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 27/222 (12%)
Query: 204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRN 263
           T G+  +  IG G++    + I   +    AVK+ +    D ++   +   + R  +H N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEI---LLRYGQHPN 77
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++ +        +    +  +V E    G L        ++  R K     +  +   + 
Sbjct: 78  IITLKDV-----YDDGKYVYVVTELXKGGEL-------LDKILRQKF---FSEREASAVL 122
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM----TAYVSDFGIARFLEAADEQTRS 379
             +   ++YLH      + H DLKPSNIL  DE     +  + DFG A+ L A +    +
Sbjct: 123 FTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXT 179
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
                T  ++APE        +  D++S G+LL    TG  P
Sbjct: 180 PCY--TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/75 (33%), Positives = 38/75 (50%)
Query: 343 HCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSY 402
           H DL   NILL ++    + DFG+AR +    +  R         ++APE       +  
Sbjct: 223 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 282
Query: 403 GDVYSFGILLLEMFT 417
            DV+SFG+LL E+F+
Sbjct: 283 SDVWSFGVLLWEIFS 297

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVKVFTAC 271
           IG G +G VYK       T    K+      +   S  + E  + + ++H N+VK++   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV- 68
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
                       LV+E + +  L++ +             G L S+   +  + +   + 
Sbjct: 69  ----IHTKKRLVLVFEHL-DQDLKKLLDV---------CEGGLESVTAKSFLLQLLNGIA 114
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR-FLEAADEQTRSIGVEGTTGYIA 390
           Y H      + H DLKP N+L++ E    ++DFG+AR F     + T  +    T  Y A
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV---VTLWYRA 168
Query: 391 PEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
           P+  MG  + S+  D++S G +  EM  G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVKVFTAC 271
           IG G +G VYK       T    K+      +   S  + E  + + ++H N+VK++   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV- 68
Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
                       LV+E + +  L++ +             G L S+   +  + +   + 
Sbjct: 69  ----IHTKKRLVLVFEHL-DQDLKKLLDV---------CEGGLESVTAKSFLLQLLNGIA 114
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR-FLEAADEQTRSIGVEGTTGYIA 390
           Y H      + H DLKP N+L++ E    ++DFG+AR F     + T  +    T  Y A
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV---VTLWYRA 168
Query: 391 PEYGMG-HEVSSYGDVYSFGILLLEMFTG 418
           P+  MG  + S+  D++S G +  EM  G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 33/213 (15%)
Query: 238 FNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVD----------FQGNDFKALVYE 287
           F  +H    K    +C V +       V+   AC+G+            +   +  +  E
Sbjct: 85  FGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 144
Query: 288 FMANGSLEEWMHPI--TEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCD 345
            +  GSL + +  +    ED+         +L  L  A++    L+YLH      I H D
Sbjct: 145 LLEGGSLGQLIKQMGCLPEDR---------ALYYLGQALEG---LEYLHTR---RILHGD 189
Query: 346 LKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSI----GVEGTTGYIAPEYGMGHEVS 400
           +K  N+LL  D   A + DFG A  L+  D   +S+     + GT  ++APE  MG    
Sbjct: 190 VKADNVLLSSDGSRAALCDFGHALCLQP-DGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 248
Query: 401 SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR 433
           +  D++S   ++L M  G  P    F+  L L+
Sbjct: 249 AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIRHRNL 264
           F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+            +   LV+EF+             ++ K+      L  +    I  
Sbjct: 65  VKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLPLIKS 107
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+   E 
Sbjct: 108 YLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEV 164
Query: 385 TT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
            T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIRHRNL 264
           F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+            +   LV+EF+             ++ K+      L  +    I  
Sbjct: 72  VKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLPLIKS 114
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+   E 
Sbjct: 115 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEV 171
Query: 385 TT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
            T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 172 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 214

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 33/213 (15%)
Query: 238 FNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVD----------FQGNDFKALVYE 287
           F  +H    K    +C V +       V+   AC+G+            +   +  +  E
Sbjct: 71  FGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130
Query: 288 FMANGSLEEWMHPI--TEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCD 345
            +  GSL + +  +    ED+         +L  L  A++    L+YLH      I H D
Sbjct: 131 LLEGGSLGQLIKQMGCLPEDR---------ALYYLGQALEG---LEYLHTR---RILHGD 175
Query: 346 LKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSI----GVEGTTGYIAPEYGMGHEVS 400
           +K  N+LL  D   A + DFG A  L+  D   +S+     + GT  ++APE  MG    
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQP-DGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 401 SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR 433
           +  D++S   ++L M  G  P    F+  L L+
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 52/108 (48%), Gaps = 17/108 (15%)
Query: 324 IDVACVLK-------YLHLDCQPPIAHCDLKPSNILLD-DEMTAYVS--DFGIARFLEAA 373
           +D A ++K       YLH   +  I H DLKP N+LL+  E  A +   DFG++   E  
Sbjct: 136 VDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192
Query: 374 DEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            +    +   GT  YIAPE  +  +     DV+S G++L  +  G  P
Sbjct: 193 KKMKERL---GTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF+             ++ K+      L  +   
Sbjct: 64  HPNIVKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLP 106
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 107 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTY 163
Query: 381 GVEGTT-GYIAPEYGMGHEVSSYG-DVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G +  S   D++S G +  EM T   L P D
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF+             ++ K+      L  +   
Sbjct: 63  HPNIVKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLP 105
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 106 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTY 162
Query: 381 GVEGTT-GYIAPEYGMGHEVSSYG-DVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G +  S   D++S G +  EM T   L P D
Sbjct: 163 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF+             ++ K+      L  +   
Sbjct: 65  HPNIVKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLP 107
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 108 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTY 164
Query: 381 GVEGTT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 165 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF+             ++ K+      L  +   
Sbjct: 64  HPNIVKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLP 106
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 107 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTY 163
Query: 381 GVEGTT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF+             ++ K+      L  +   
Sbjct: 62  HPNIVKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLP 104
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 105 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTY 161
Query: 381 GVEGTT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 162 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF+             ++ K+      L  +   
Sbjct: 61  HPNIVKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLP 103
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 104 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTY 160
Query: 381 GVEGTT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 161 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/75 (33%), Positives = 38/75 (50%)
Query: 343 HCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSY 402
           H DL   NILL +     + DFG+AR +    +  R         ++APE       S+ 
Sbjct: 222 HRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTK 281
Query: 403 GDVYSFGILLLEMFT 417
            DV+S+G+LL E+F+
Sbjct: 282 SDVWSYGVLLWEIFS 296

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF+             ++ K+      L  +   
Sbjct: 63  HPNIVKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLP 105
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 106 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTY 162
Query: 381 GVEGTT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 163 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF+             ++ K+      L  +   
Sbjct: 62  HPNIVKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLP 104
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 105 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTY 161
Query: 381 GVEGTT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 162 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIRHRNL 264
           F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+            +   LV+EF+             ++ K+      L  +    I  
Sbjct: 65  VKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLPLIKS 107
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+   E 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEV 164
Query: 385 TT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
            T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 213 IGAGNFGSVYKGILFE-------STTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV 265
           +G G F  ++KG+  E         T V +KV +  H + S+SF     +   + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             +  C    F G++   LV EF+  GSL+ ++          K    +N L +L +A  
Sbjct: 76  LNYGVC----FCGDE-NILVQEFVKFGSLDTYL---------KKNKNCINILWKLEVAKQ 121
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTA-----YVSDFGIARFLEAADEQT 377
           +A  + +L    +  + H ++   NILL   +D  T       +SD GI+  +   D   
Sbjct: 122 LAWAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 378 RSIGVEGTTGYIAPE-YGMGHEVSSYGDVYSFGILLLEMFTG 418
             I       ++ PE       ++   D +SFG  L E+ +G
Sbjct: 179 ERI------PWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIRHRNL 264
           F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+            +   LV+EF+             ++ K+      L  +    I  
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLPLIKS 106
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+   E 
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEV 163
Query: 385 TT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
            T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF+             ++ K+      L  +   
Sbjct: 61  HPNIVKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLP 103
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 104 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTY 160
Query: 381 GVEGTT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 161 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF+             ++ K+      L  +   
Sbjct: 61  HPNIVKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLP 103
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 104 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTY 160
Query: 381 GVEGTT-GYIAPEYGMGHEVSSYG-DVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G +  S   D++S G +  EM T   L P D
Sbjct: 161 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIRHRNL 264
           F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+            +   LV+EF+             ++ K+      L  +    I  
Sbjct: 65  VKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLPLIKS 107
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+   E 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEV 164
Query: 385 TT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
            T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF+             ++ K+      L  +   
Sbjct: 61  HPNIVKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLP 103
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 104 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTY 160
Query: 381 GVEGTT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 161 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIRHRNL 264
           F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+            +   LV+EF+             ++ K+      L  +    I  
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLPLIKS 106
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+   E 
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYXHEV 163
Query: 385 TT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
            T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 88/219 (40%), Gaps = 25/219 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-SFAVECEVTRNIRHRNLV 265
           +   +++G G F  V       +   VA+K       +  + S   E  V   I+H N+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
               A   + ++      L+ + ++ G L      I E+       G         +   
Sbjct: 80  ----ALDDI-YESGGHLYLIMQLVSGGEL---FDRIVEK-------GFYTERDASRLIFQ 124
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNIL---LDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           V   +KYLH      I H DLKP N+L   LD++    +SDFG+++  +     + + G 
Sbjct: 125 VLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG- 180
Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             T GY+APE       S   D +S G++   +  G  P
Sbjct: 181 --TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 33/213 (15%)
Query: 238 FNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVD----------FQGNDFKALVYE 287
           F  +H    K    +C V +       V+   AC+G+            +   +  +  E
Sbjct: 87  FGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 146
Query: 288 FMANGSLEEWMHPI--TEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCD 345
            +  GSL + +  +    ED+         +L  L  A++    L+YLH      I H D
Sbjct: 147 LLEGGSLGQLIKQMGCLPEDR---------ALYYLGQALEG---LEYLHTR---RILHGD 191
Query: 346 LKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSI----GVEGTTGYIAPEYGMGHEVS 400
           +K  N+LL  D   A + DFG A  L+  D   +S+     + GT  ++APE  MG    
Sbjct: 192 VKADNVLLSSDGSRAALCDFGHALCLQP-DGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 250
Query: 401 SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR 433
           +  D++S   ++L M  G  P    F+  L L+
Sbjct: 251 AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF+             ++ K+      L  +   
Sbjct: 62  HPNIVKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLP 104
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 105 LIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLAR---AFGVPVRTY 161
Query: 381 GVEGTT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 162 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIRHRNL 264
           F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+            +   LV+EF+             ++ K+      L  +    I  
Sbjct: 69  VKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLPLIKS 111
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+   E 
Sbjct: 112 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEV 168
Query: 385 TT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
            T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 169 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 108/259 (41%), Gaps = 53/259 (20%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--------VLHHDASKSFAVECEVTRNIRHRNL 264
           +G+G  G V      ++   VA+++ +            D + +   E E+ + + H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +K+       D+       +V E M  G L +            K  GN    KRL  A 
Sbjct: 203 IKIKNFFDAEDYY------IVLELMEGGELFD------------KVVGN----KRLKEAT 240
Query: 325 ------DVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADE 375
                  +   ++YLH   +  I H DLKP N+LL   +++    ++DFG ++ L    E
Sbjct: 241 CKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GE 294
Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNL 432
            +    + GT  Y+APE  +    + Y    D +S G++L    +G  P  +  +  ++L
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE-HRTQVSL 353
Query: 433 RNCVKSA----LPERAEEI 447
           ++ + S     +PE   E+
Sbjct: 354 KDQITSGKYNFIPEVWAEV 372

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF+             ++ K+      L  +   
Sbjct: 63  HPNIVKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLP 105
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 106 LIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLAR---AFGVPVRTY 162
Query: 381 GVEGTT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 163 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIRHRNL 264
           F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+            +   LV+EF+             ++ K+      L  +    I  
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLPLIKS 106
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+   E 
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEV 163
Query: 385 TT-GYIAPEYGMGHEVSSYG-DVYSFGILLLEMFT--GLRPSD 423
            T  Y APE  +G +  S   D++S G +  EM T   L P D
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 31/222 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNIRHR 262
           +   +++G G F  V   IL E      +     +  +A +    S   E  V   I+H 
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N+V    A   + ++      L+ + ++ G L      I E+       G         +
Sbjct: 77  NIV----ALDDI-YESGGHLYLIMQLVSGGEL---FDRIVEK-------GFYTERDASRL 121
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNIL---LDDEMTAYVSDFGIARFLEAADEQTRS 379
              V   +KYLH      I H DLKP N+L   LD++    +SDFG+++  +     + +
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA 178
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            G   T GY+APE       S   D +S G++   +  G  P
Sbjct: 179 CG---TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIRHRNL 264
           F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+            +   LV+EF+             ++ K+      L  +    I  
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLPLIKS 106
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+   E 
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYXHEV 163
Query: 385 TT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
            T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIRHRNL 264
           F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+            +   LV+EF+             ++ K+      L  +    I  
Sbjct: 66  VKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLPLIKS 108
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+   E 
Sbjct: 109 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYXHEV 165
Query: 385 TT-GYIAPEYGMGHEVSSYG-DVYSFGILLLEMFT--GLRPSD 423
            T  Y APE  +G +  S   D++S G +  EM T   L P D
Sbjct: 166 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 108/259 (41%), Gaps = 53/259 (20%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--------VLHHDASKSFAVECEVTRNIRHRNL 264
           +G+G  G V      ++   VA+++ +            D + +   E E+ + + H  +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +K+       D+       +V E M  G L +            K  GN    KRL  A 
Sbjct: 217 IKIKNFFDAEDYY------IVLELMEGGELFD------------KVVGN----KRLKEAT 254
Query: 325 ------DVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADE 375
                  +   ++YLH   +  I H DLKP N+LL   +++    ++DFG ++ L    E
Sbjct: 255 CKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GE 308
Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNL 432
            +    + GT  Y+APE  +    + Y    D +S G++L    +G  P  +  +  ++L
Sbjct: 309 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE-HRTQVSL 367
Query: 433 RNCVKSA----LPERAEEI 447
           ++ + S     +PE   E+
Sbjct: 368 KDQITSGKYNFIPEVWAEV 386

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 9/95 (9%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNIL---LDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
           +KYLH      I H DLKP N+L   LD++    +SDFG+++  +     + + G   T 
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG---TP 182
Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           GY+APE       S   D +S G++   +  G  P
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 87/223 (39%), Gaps = 25/223 (11%)
Query: 202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRH 261
           N  K F    ++G+G F  V+      +    A+K           S   E  V + I+H
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            N+V +        ++      LV + ++ G L      I E     +   +L       
Sbjct: 66  ENIVTLEDI-----YESTTHYYLVMQLVSGGEL---FDRILERGVYTEKDASL------- 110
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTR 378
           +   V   +KYLH   +  I H DLKP N+L    ++     ++DFG+++  +     T 
Sbjct: 111 VIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA 167
Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
                GT GY+APE       S   D +S G++   +  G  P
Sbjct: 168 C----GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF++             + K+      L  +   
Sbjct: 64  HPNIVKLLDVI-----HTENKLYLVFEFLSM------------DLKKFMDASALTGIPLP 106
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 107 LIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLAR---AFGVPVRTY 163
Query: 381 GVEGTT-GYIAPEYGMGHEVSSYG-DVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G +  S   D++S G +  EM T   L P D
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF++   L+++M               L  +   
Sbjct: 64  HPNIVKLLDVI-----HTENKLYLVFEFLSM-DLKDFMDA-----------SALTGIPLP 106
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 107 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTY 163
Query: 381 GVEGTT-GYIAPEYGMGHEVSSYG-DVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G +  S   D++S G +  EM T   L P D
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 88/222 (39%), Gaps = 31/222 (13%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK----SFAVECEVTRNIRHR 262
           +   +++G G F  V   IL E      +     +  +A +    S   E  V   I+H 
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N+V +        ++      L+ + ++ G L      I E+       G         +
Sbjct: 77  NIVALDDI-----YESGGHLYLIMQLVSGGEL---FDRIVEK-------GFYTERDASRL 121
Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNIL---LDDEMTAYVSDFGIARFLEAADEQTRS 379
              V   +KYLH      I H DLKP N+L   LD++    +SDFG+++  +     + +
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA 178
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            G   T GY+APE       S   D +S G++   +  G  P
Sbjct: 179 CG---TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF++             + K+      L  +   
Sbjct: 62  HPNIVKLLDVI-----HTENKLYLVFEFLSM------------DLKKFMDASALTGIPLP 104
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 105 LIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLAR---AFGVPVRTY 161
Query: 381 GVEGTT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 162 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF+ +  L+++M               L  +   
Sbjct: 61  HPNIVKLLDVI-----HTENKLYLVFEFL-HQDLKDFMDA-----------SALTGIPLP 103
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 104 LIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLAR---AFGVPVRTY 160
Query: 381 GVEGTT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 161 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 40/80 (50%), Gaps = 3/80 (3%)
Query: 343 HCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG-VEGTTGYIAPEYGMGHEVSS 401
           H D+KP NIL+  +  AY+ DFGIA      DE+   +G   GT  Y APE       + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYXAPERFSESHATY 214
Query: 402 YGDVYSFGILLLEMFTGLRP 421
             D+Y+   +L E  TG  P
Sbjct: 215 RADIYALTCVLYECLTGSPP 234

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 87/219 (39%), Gaps = 39/219 (17%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-------HRNLV 265
           +G G+F    K +  +S  A AVK+          S  +E    + I        H N+V
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII---------SKRMEANTQKEITALKLCEGHPNIV 69
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           K+        F       LV E +  G L E +     + K+H +    + + R      
Sbjct: 70  KLHEV-----FHDQLHTFLVMELLNGGELFERI-----KKKKHFSETEASYIMR-----K 114
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDE---MTAYVSDFGIARFLEAADEQTRSIGV 382
           +   + ++H      + H DLKP N+L  DE   +   + DFG AR L+  D Q      
Sbjct: 115 LVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR-LKPPDNQPLKTPC 170
Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             T  Y APE    +      D++S G++L  M +G  P
Sbjct: 171 -FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF++   L+++M               L  +   
Sbjct: 63  HPNIVKLLDVI-----HTENKLYLVFEFLSM-DLKDFMDA-----------SALTGIPLP 105
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 106 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTY 162
Query: 381 GVEGTT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 163 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 39/222 (17%)
Query: 213 IGAGNFGSVYKGILFE-------STTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV 265
           +G G F  ++KG+  E         T V +KV +  H + S+SF     +   + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             +  C        D   LV EF+  GSL+ ++          K    +N L +L +A  
Sbjct: 76  LNYGVCV-----CGDENILVQEFVKFGSLDTYL---------KKNKNCINILWKLEVAKQ 121
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTA-----YVSDFGIARFLEAADEQT 377
           +A  + +L    +  + H ++   NILL   +D  T       +SD GI+  +   D   
Sbjct: 122 LAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 378 RSIGVEGTTGYIAPE-YGMGHEVSSYGDVYSFGILLLEMFTG 418
             I       ++ PE       ++   D +SFG  L E+ +G
Sbjct: 179 ERI------PWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRN 258
           +++    +++ + IG G +G V       +   VA+K  +   H       + E ++   
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLR 81
Query: 259 IRHRNLVKVFTACSGVDFQGNDF-KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            RH N++ +           ND  +A   E M +  +   +  + E D           L
Sbjct: 82  FRHENIIGI-----------NDIIRAPTIEQMKDVYI---VQDLMETDL-------YKLL 120
Query: 318 KRLNIAIDVACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           K  +++ D  C         LKY+H      + H DLKPSN+LL+      + DFG+AR 
Sbjct: 121 KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARV 177
Query: 370 LEAADEQTRSIG-VEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            +   + T  +     T  Y APE  +  +  +   D++S G +L EM +  RP
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 230

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 39/229 (17%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V      ++    AVKV   +    ++S  +E ++ + I++ ++        
Sbjct: 43  MGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKY 101
Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
              F   D   L++E +     E     IT          N N     +I +    +LK 
Sbjct: 102 HGKFMYYDHMCLIFEPLGPSLYE----IITR--------NNYNGFHIEDIKLYCIEILKA 149
Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ---TRSIGVE------ 383
           L+   +  + H DLKP NILLDD      S   + R  +    Q   T+S G++      
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFE-KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 384 ------------GTTGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTG 418
                        T  Y APE    +G +VSS  D++SFG +L E++TG
Sbjct: 209 ATFKSDYHGSIINTRQYRAPEVILNLGWDVSS--DMWSFGCVLAELYTG 255

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA---VECEVTRN 258
           +  K FS    IG G+FG+VY      ++  VA+K  +     +++ +     E    + 
Sbjct: 51  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 110
Query: 259 IRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLK 318
           +RH N ++ +  C    +       LV E+   GS  + +       + HK P     L+
Sbjct: 111 LRHPNTIQ-YRGC----YLREHTAWLVMEYCL-GSASDLL-------EVHKKP-----LQ 152
Query: 319 RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
            + IA      L+ L       + H D+K  NILL +     + DFG A  +  A+    
Sbjct: 153 EVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV- 211
Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEM 415
                GT  ++APE  +  +   Y    DV+S GI  +E+
Sbjct: 212 -----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 59/128 (46%), Gaps = 13/128 (10%)
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            IA+ +   L++LH   +  + H D+KPSN+L++        DFGI+ +L   D+  + I
Sbjct: 140 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYL--VDDVAKDI 195
Query: 381 GVEGTTGYIAPEY------GMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN 434
              G   Y APE         G+ V S  D++S GI  +E+     P D        L+ 
Sbjct: 196 DA-GCKPYXAPERINPELNQKGYSVKS--DIWSLGITXIELAILRFPYDSWGTPFQQLKQ 252
Query: 435 CVKSALPE 442
            V+   P+
Sbjct: 253 VVEEPSPQ 260

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           Y APE  +G       D++S G ++ EM
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 34/228 (14%)
Query: 209 SENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIR-HRNLVK 266
            E+++G G    V   I   ++   AVK+      H  S+ F  E E+    + HRN+++
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR-EVEMLYQCQGHRNVLE 75
Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +        F+  D   LV+E M  GS+   +H      +RH      N L+   +  DV
Sbjct: 76  LIEF-----FEEEDRFYLVFEKMRGGSILSHIH-----KRRH-----FNELEASVVVQDV 120
Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDE---MTAYVSDFGIARFLEAADEQTRSIGVE 383
           A  L +LH      IAH DLKP NIL +         + DF +   ++   + +     E
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 384 -----GTTGYIAPEY--GMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
                G+  Y+APE       E S Y    D++S G++L  + +G  P
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 9/109 (8%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSI----GVEG 384
           L+YLH      I H D+K  N+LL  D   A + DFG A  L+  D   +S+     + G
Sbjct: 198 LEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQP-DGLGKSLLTGDYIPG 253
Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR 433
           T  ++APE  +G    +  DV+S   ++L M  G  P    F+  L L+
Sbjct: 254 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 302

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 95/241 (39%), Gaps = 54/241 (22%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT--RNIRHRNL 264
           F    ++G G FG V K      +   A+K    + H   K   +  EV    ++ H+ +
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKK---IRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 265 VKVFTAC----------SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNL 314
           V+ + A           + V  +   F  +  E+  N +L + +H             NL
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQM--EYCENRTLYDLIHS-----------ENL 111
Query: 315 NSLK--RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE- 371
           N  +     +   +   L Y+H      I H DLKP NI +D+     + DFG+A+ +  
Sbjct: 112 NQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 372 --------------AADEQTRSIGVEGTTGYIAPEY--GMGHEVSSYGDVYSFGILLLEM 415
                         ++D  T +I   GT  Y+A E   G GH  +   D+YS GI+  EM
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAI---GTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEM 224
Query: 416 F 416
Sbjct: 225 I 225

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+EF+             ++ K       L  +   
Sbjct: 64  HPNIVKLLDVI-----HTENKLYLVFEFLH------------QDLKTFMDASALTGIPLP 106
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 107 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTY 163
Query: 381 GVEGTT-GYIAPEYGMGHEVSSYG-DVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G +  S   D++S G +  EM T   L P D
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 36/223 (16%)
Query: 202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA---VECEVTRN 258
           +  K FS    IG G+FG+VY      ++  VA+K  +     +++ +     E    + 
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 259 IRHRNLVKVFTACSGVDFQGNDFKALVYEF---MANGSLEEWMHPITEEDKRHKAPGNLN 315
           +RH N ++ +  C    +       LV E+    A+  LE    P+ E +      G L 
Sbjct: 72  LRHPNTIQ-YRGC----YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ 126
Query: 316 SLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE 375
            L              YLH      + H D+K  NILL +     + DFG A  +  A+ 
Sbjct: 127 GLA-------------YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX 170
Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEM 415
                   GT  ++APE  +  +   Y    DV+S GI  +E+
Sbjct: 171 FV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           Y APE  +G       D++S G ++ EM
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRN 258
           +++    +++ + IG G +G V       +   VA+K  +   H    +    E ++   
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 259 IRHRNLVKVFTACSGVDFQGNDF-KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            RH N++ +           ND  +A   E M +  +   +  + E D           L
Sbjct: 78  FRHENIIGI-----------NDIIRAPTIEQMKDVYI---VQDLMETDL-------YKLL 116
Query: 318 KRLNIAIDVACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           K  +++ D  C         LKY+H      + H DLKPSN+LL+      + DFG+AR 
Sbjct: 117 KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARV 173
Query: 370 LEAADEQTRSIG-VEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            +   + T  +     T  Y APE  +  +  +   D++S G +L EM +  RP
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 226

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + + I+H N++ +        ++      L+ E +A G L +++     +TEE+   
Sbjct: 64  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                LN +              YLH      IAH DLKP NI+L D         + DF
Sbjct: 119 FLKQILNGVY-------------YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           G+A  ++  +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 163 GLAHKIDFGNEFK---NIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 86/219 (39%), Gaps = 35/219 (15%)
Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVF 268
            LIG G FG VY G        VA+++ ++     D  K+F  E    R  RH N+V   
Sbjct: 39  ELIGKGRFGQVYHG---RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
            AC           A++       +L    + +  +     A   L+  K   IA ++  
Sbjct: 96  GAC-----MSPPHLAIITSLCKGRTL----YSVVRD-----AKIVLDVNKTRQIAQEIVK 141
Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG---IARFLEAADEQTRSIGVEGT 385
            + YLH      I H DLK  N+  D+     ++DFG   I+  L+A   + +     G 
Sbjct: 142 GMGYLHAKG---ILHKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 386 TGYIAPEYGMGHE---------VSSYGDVYSFGILLLEM 415
             ++APE                S + DV++ G +  E+
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG-VEGTTGY 388
           LKY+H      + H DLKPSN+LL+      + DFG+AR  +   + T  +     T  Y
Sbjct: 137 LKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 389 IAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            APE  +  +  +   D++S G +L EM +  RP
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 226

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG-VEGTTGY 388
           LKY+H      + H DLKPSN+LL+      + DFG+AR  +   + T  +     T  Y
Sbjct: 141 LKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 389 IAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            APE  +  +  +   D++S G +L EM +  RP
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 230

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 175 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 228
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           Y APE  +G       D++S G ++ EM
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEM 256

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRN 258
           +++    +++ + IG G +G V       +   VA+K  +   H    +    E ++   
Sbjct: 20  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 79
Query: 259 IRHRNLVKVFTACSGVDFQGNDF-KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            RH N++ +           ND  +A   E M +  +   +  + E D           L
Sbjct: 80  FRHENIIGI-----------NDIIRAPTIEQMKDVYI---VQDLMETDL-------YKLL 118
Query: 318 KRLNIAIDVACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           K  +++ D  C         LKY+H      + H DLKPSN+LL+      + DFG+AR 
Sbjct: 119 KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 175
Query: 370 LEAADEQTRSIG-VEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            +   + T  +     T  Y APE  +  +  +   D++S G +L EM +  RP
Sbjct: 176 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 228

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG-VEGTTGY 388
           LKY+H      + H DLKPSN+LL+      + DFG+AR  +   + T  +     T  Y
Sbjct: 137 LKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 389 IAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            APE  +  +  +   D++S G +L EM +  RP
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 226

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 6/89 (6%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  Y 
Sbjct: 139 IKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV---VTRYYR 192
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTG 418
           APE  +G       D++S G ++ EM  G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRN 258
           +++    +++ + IG G +G V       +   VA+K  +   H    +    E ++   
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 259 IRHRNLVKVFTACSGVDFQGNDF-KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            RH N++ +           ND  +A   E M +  +   +  + E D           L
Sbjct: 78  FRHENIIGI-----------NDIIRAPTIEQMKDVYI---VQDLMETDL-------YKLL 116
Query: 318 KRLNIAIDVACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           K  +++ D  C         LKY+H      + H DLKPSN+LL+      + DFG+AR 
Sbjct: 117 KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 173
Query: 370 LEAADEQTRSIG-VEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            +   + T  +     T  Y APE  +  +  +   D++S G +L EM +  RP
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 226

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG-VEGTTGY 388
           LKY+H      + H DLKPSN+LL+      + DFG+AR  +   + T  +     T  Y
Sbjct: 157 LKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 213
Query: 389 IAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            APE  +  +  +   D++S G +L EM +  RP
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 246

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 175 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 228
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           Y APE  +G       D++S G ++ EM
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEM 256

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRN 258
           +++    +++ + IG G +G V       +   VA+K  +   H    +    E ++   
Sbjct: 38  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 97
Query: 259 IRHRNLVKVFTACSGVDFQGNDF-KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            RH N++ +           ND  +A   E M +  +   +  + E D           L
Sbjct: 98  FRHENIIGI-----------NDIIRAPTIEQMKDVYI---VQDLMETDL-------YKLL 136
Query: 318 KRLNIAIDVACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           K  +++ D  C         LKY+H      + H DLKPSN+LL+      + DFG+AR 
Sbjct: 137 KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 193
Query: 370 LEAADEQTRSIG-VEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            +   + T  +     T  Y APE  +  +  +   D++S G +L EM +  RP
Sbjct: 194 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 246

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRN 258
           +++    +++ + IG G +G V       +   VA+K  +   H    +    E ++   
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 81
Query: 259 IRHRNLVKVFTACSGVDFQGNDF-KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            RH N++ +           ND  +A   E M +  +   +  + E D           L
Sbjct: 82  FRHENIIGI-----------NDIIRAPTIEQMKDVYI---VQDLMETDL-------YKLL 120
Query: 318 KRLNIAIDVACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           K  +++ D  C         LKY+H      + H DLKPSN+LL+      + DFG+AR 
Sbjct: 121 KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 370 LEAADEQTRSIG-VEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            +   + T  +     T  Y APE  +  +  +   D++S G +L EM +  RP
Sbjct: 178 ADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 230

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRN 258
           +++    +++ + IG G +G V       +   VA+K  +   H    +    E ++   
Sbjct: 23  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 82
Query: 259 IRHRNLVKVFTACSGVDFQGNDF-KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            RH N++ +           ND  +A   E M +  +   +  + E D           L
Sbjct: 83  FRHENIIGI-----------NDIIRAPTIEQMKDVYI---VQDLMETDL-------YKLL 121
Query: 318 KRLNIAIDVACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           K  +++ D  C         LKY+H      + H DLKPSN+LL+      + DFG+AR 
Sbjct: 122 KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 178
Query: 370 LEAADEQTRSIG-VEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            +   + T  +     T  Y APE  +  +  +   D++S G +L EM +  RP
Sbjct: 179 ADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 231

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 136 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 189
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           Y APE  +G       D++S G ++ EM
Sbjct: 190 YRAPEVILGMGYKENVDIWSVGCIMGEM 217

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           Y APE  +G       D++S G ++ EM
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 138 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 191
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           Y APE  +G       D++S G ++ EM
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEM 219

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRN 258
           +++    +++ + IG G +G V       +   VA+K  +   H    +    E ++   
Sbjct: 26  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 85
Query: 259 IRHRNLVKVFTACSGVDFQGNDF-KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            RH N++ +           ND  +A   E M +  +   +  + E D           L
Sbjct: 86  FRHENIIGI-----------NDIIRAPTIEQMKDVYI---VQDLMETDL-------YKLL 124
Query: 318 KRLNIAIDVACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           K  +++ D  C         LKY+H      + H DLKPSN+LL+      + DFG+AR 
Sbjct: 125 KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 181
Query: 370 LEAADEQTRSIG-VEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            +   + T  +     T  Y APE  +  +  +   D++S G +L EM +  RP
Sbjct: 182 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 234

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRN 258
           +++    +++ + IG G +G V       +   VA+K  +   H    +    E ++   
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 259 IRHRNLVKVFTACSGVDFQGNDF-KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            RH N++ +           ND  +A   E M +  +   +  + E D           L
Sbjct: 78  FRHENIIGI-----------NDIIRAPTIEQMKDVYI---VQDLMETDL-------YKLL 116
Query: 318 KRLNIAIDVACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           K  +++ D  C         LKY+H      + H DLKPSN+LL+      + DFG+AR 
Sbjct: 117 KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 173
Query: 370 LEAADEQTRSIG-VEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            +   + T  +     T  Y APE  +  +  +   D++S G +L EM +  RP
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 226

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG-VEGTTGY 388
           LKY+H      + H DLKPSN+LL+      + DFG+AR  +   + T  +     T  Y
Sbjct: 141 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 389 IAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            APE  +  +  +   D++S G +L EM +  RP
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 230

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           Y APE  +G       D++S G ++ EM
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 138 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 191
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           Y APE  +G       D++S G ++ EM
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEM 219

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG-VEGTTGY 388
           LKY+H      + H DLKPSN+LL+      + DFG+AR  +   + T  +     T  Y
Sbjct: 139 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 195
Query: 389 IAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            APE  +  +  +   D++S G +L EM +  RP
Sbjct: 196 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 228

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRN 258
           +++    +++ + IG G +G V       +   VA+K  +   H    +    E ++   
Sbjct: 23  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 82
Query: 259 IRHRNLVKVFTACSGVDFQGNDF-KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            RH N++ +           ND  +A   E M +  +   +  + E D           L
Sbjct: 83  FRHENIIGI-----------NDIIRAPTIEQMKDVYI---VQDLMETDL-------YKLL 121
Query: 318 KRLNIAIDVACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           K  +++ D  C         LKY+H      + H DLKPSN+LL+      + DFG+AR 
Sbjct: 122 KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 178
Query: 370 LEAADEQTRSIG-VEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            +   + T  +     T  Y APE  +  +  +   D++S G +L EM +  RP
Sbjct: 179 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 231

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRN 258
           +++    +++ + IG G +G V       +   VA+K  +   H    +    E ++   
Sbjct: 24  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 83
Query: 259 IRHRNLVKVFTACSGVDFQGNDF-KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            RH N++ +           ND  +A   E M +  +   +  + E D           L
Sbjct: 84  FRHENIIGI-----------NDIIRAPTIEQMKDVYI---VQDLMETDL-------YKLL 122
Query: 318 KRLNIAIDVACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           K  +++ D  C         LKY+H      + H DLKPSN+LL+      + DFG+AR 
Sbjct: 123 KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 179
Query: 370 LEAADEQTRSIG-VEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            +   + T  +     T  Y APE  +  +  +   D++S G +L EM +  RP
Sbjct: 180 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 232

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRN 258
           +++    +++ + IG G +G V       +   VA+K  +   H    +    E ++   
Sbjct: 15  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 74
Query: 259 IRHRNLVKVFTACSGVDFQGNDF-KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            RH N++ +           ND  +A   E M +  +   +  + E D           L
Sbjct: 75  FRHENIIGI-----------NDIIRAPTIEQMKDVYI---VQDLMETDL-------YKLL 113
Query: 318 KRLNIAIDVACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           K  +++ D  C         LKY+H      + H DLKPSN+LL+      + DFG+AR 
Sbjct: 114 KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 170
Query: 370 LEAADEQTRSIG-VEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            +   + T  +     T  Y APE  +  +  +   D++S G +L EM +  RP
Sbjct: 171 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 223

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRN 258
           +++    +++ + IG G +G V       +   VA+K  +   H    +    E ++   
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 81
Query: 259 IRHRNLVKVFTACSGVDFQGNDF-KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            RH N++ +           ND  +A   E M +  +   +  + E D           L
Sbjct: 82  FRHENIIGI-----------NDIIRAPTIEQMKDVYI---VQDLMETDL-------YKLL 120
Query: 318 KRLNIAIDVACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           K  +++ D  C         LKY+H      + H DLKPSN+LL+      + DFG+AR 
Sbjct: 121 KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 370 LEAADEQTRSIG-VEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            +   + T  +     T  Y APE  +  +  +   D++S G +L EM +  RP
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 230

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 131 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 184
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           Y APE  +G       D++S G ++ EM
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEM 212

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG-VEGTTGY 388
           LKY+H      + H DLKPSN+LL+      + DFG+AR  +   + T  +     T  Y
Sbjct: 141 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 389 IAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            APE  +  +  +   D++S G +L EM +  RP
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 230

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 131 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 184
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           Y APE  +G       D++S G ++ EM
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEM 212

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTRN 258
           +++    +++ + IG G +G V       +   VA+K  +   H    +    E ++   
Sbjct: 16  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 75
Query: 259 IRHRNLVKVFTACSGVDFQGNDF-KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
            RH N++ +           ND  +A   E M +  +   +  + E D           L
Sbjct: 76  FRHENIIGI-----------NDIIRAPTIEQMKDVYI---VQDLMETDL-------YKLL 114
Query: 318 KRLNIAIDVACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           K  +++ D  C         LKY+H      + H DLKPSN+LL+      + DFG+AR 
Sbjct: 115 KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 171
Query: 370 LEAADEQTRSIG-VEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            +   + T  +     T  Y APE  +  +  +   D++S G +L EM +  RP
Sbjct: 172 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 224

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    A           T  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRY 190
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
           Y APE  +G   ++  D++S G ++ E+  G
Sbjct: 191 YRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 183
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           Y APE  +G       D++S G ++ EM
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEM 211

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG-VEGTTGY 388
           LKY+H      + H DLKPSN+LL+      + DFG+AR  +   + T  +     T  Y
Sbjct: 135 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 191
Query: 389 IAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            APE  +  +  +   D++S G +L EM +  RP
Sbjct: 192 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 224

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG-VEGTTGY 388
           LKY+H      + H DLKPSN+LL+      + DFG+AR  +   + T  +     T  Y
Sbjct: 139 LKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWY 195
Query: 389 IAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRP 421
            APE  +  +  +   D++S G +L EM +  RP
Sbjct: 196 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP 228

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR        T  +    T  
Sbjct: 135 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYV---VTRY 188
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
           Y APE  +G       D++S G ++ E+  G
Sbjct: 189 YRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAV-KVFNVLHHDASKSFAV-ECEVTRNIRHRNL 264
           F     IG G +G VYK     +   VA+ K+      +   S A+ E  + + + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+            +   LV+EF+             ++ K+      L  +    I  
Sbjct: 65  VKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLPLIKS 107
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+   E 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEV 164
Query: 385 TT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
            T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAV-KVFNVLHHDASKSFAV-ECEVTRNIRHRNL 264
           F     IG G +G VYK     +   VA+ K+      +   S A+ E  + + + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+            +   LV+EF+             ++ K+      L  +    I  
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLH------------QDLKKFMDASALTGIPLPLIKS 106
Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+   E 
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEV 163
Query: 385 TT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
            T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 50/108 (46%), Gaps = 7/108 (6%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEA---ADEQTRSIGVEGT 385
           L+YLH      I H D+K  N+LL  D   A + DFG A  L+      +      + GT
Sbjct: 179 LEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGT 235
Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR 433
             ++APE  +G    +  DV+S   ++L M  G  P    F+  L L+
Sbjct: 236 ETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 283

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 16/93 (17%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR-----FLEAADEQTRSIGV 382
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR     F+   +  TR    
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY--- 190
Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEM 415
                Y APE  +G       D++S G ++ EM
Sbjct: 191 -----YRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 51/108 (47%), Gaps = 17/108 (15%)
Query: 324 IDVACVLK-------YLHLDCQPPIAHCDLKPSNILLDD---EMTAYVSDFGIARFLEAA 373
           +D A ++K       YLH   +  I H DLKP N+LL+    +    + DFG++   E  
Sbjct: 104 VDAAVIMKQVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG 160
Query: 374 DEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            +    +   GT  YIAPE  +  +     DV+S G++L  +  G  P
Sbjct: 161 GKMKERL---GTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPP 204

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 51/108 (47%), Gaps = 17/108 (15%)
Query: 324 IDVACVLK-------YLHLDCQPPIAHCDLKPSNILLDD---EMTAYVSDFGIARFLEAA 373
           +D A ++K       YLH   +  I H DLKP N+LL+    +    + DFG++   E  
Sbjct: 121 VDAAVIMKQVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG 177
Query: 374 DEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            +    +   GT  YIAPE  +  +     DV+S G++L  +  G  P
Sbjct: 178 GKMKERL---GTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 62/139 (44%), Gaps = 6/139 (4%)
Query: 2   LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIXX 61
           +S N L+G + P    L+ L+  ++S N+L G  S  FGS  + +++ +  N  A  +  
Sbjct: 181 ISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 62  XXXXXXXXXXXXXXQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSV 121
                          N +   +P+ L   KFL +LN+S+NN    +P  G  +    ++ 
Sbjct: 240 VGLSKNLNGLDLR-NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 122 FGNKKLCGGIPEFQLPTCV 140
             NK LCG      LP C 
Sbjct: 299 ANNKCLCGS----PLPACT 313

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 102/241 (42%), Gaps = 32/241 (13%)
Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV---ECEVTRNIRHRNLVKV 267
            ++  G F  VY+     S    A+K   +L ++  K+ A+    C + +   H N+V+ 
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALK--RLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 268 FTACSGVDFQGNDFKA--LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
            +A S    + +  +A  L+   +  G L E++       K+ ++ G L+    L I   
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFL-------KKMESRGPLSCDTVLKIFYQ 144
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE-----AADEQTRSI 380
               ++++H   +PPI H DLK  N+LL ++ T  + DFG A  +      +   Q R++
Sbjct: 145 TCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 381 GVEGTTGYIAPEYGMGHEVSSYG--------DVYSFGILLLEMFTGLRPSDDMFKDNLNL 432
             E  T    P Y     +  Y         D+++ G +L  +     P    F+D   L
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKL 259
Query: 433 R 433
           R
Sbjct: 260 R 260

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 37/230 (16%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHD--ASKSFAVECEVTRNIRHRNLVKVFTA 270
           +G G +G VYK I   +   VA+K   + H +     +   E  + + ++HRN++++ + 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                   N    L++E+  N  L+++M    +   R         +  +N      C+ 
Sbjct: 102 -----IHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCL- 154
Query: 331 KYLHLDCQPPIAHCDLKPSNILL-----DDEMTAYVSDFGIARFLEAADEQ-TRSIGVEG 384
                       H DLKP N+LL      +     + DFG+AR       Q T  I    
Sbjct: 155 ------------HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI---I 199
Query: 385 TTGYIAPEYGMG-HEVSSYGDVYSFGILLLEM------FTGLRPSDDMFK 427
           T  Y  PE  +G    S+  D++S   +  EM      F G    D +FK
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + + I+H N++ +        ++      L+ E +A G L +++     +TEE+   
Sbjct: 64  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                LN +              YLH      IAH DLKP NI+L D         + DF
Sbjct: 119 FLKQILNGVY-------------YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           G+A  ++  +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 163 GLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 142 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 195
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           Y APE  +G       D++S G ++ EM
Sbjct: 196 YRAPEVILGMGYKENVDLWSVGCIMGEM 223

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 26/227 (11%)
Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAV-ECEVTRNIR 260
           + + F     IG G +G VYK     +   VA+K   +    +   S A+ E  + + + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+VK+            +   LV+E             + ++ K+      L  +   
Sbjct: 64  HPNIVKLLDVI-----HTENKLYLVFEH------------VDQDLKKFMDASALTGIPLP 106
Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            I   +  +L+ L       + H DLKP N+L++ E    ++DFG+AR   A     R+ 
Sbjct: 107 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTY 163
Query: 381 GVEGTT-GYIAPEYGMG-HEVSSYGDVYSFGILLLEMFT--GLRPSD 423
             E  T  Y APE  +G    S+  D++S G +  EM T   L P D
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHD--ASKSFAVECEVTRNIRHRNLVKVFTA 270
           IG G +G+V+K    E+   VA+K   +   D     S   E  + + ++H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH-- 67
Query: 271 CSGVDFQGNDFK-ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
               D   +D K  LV+EF  +  L+++              G+L+     +    +   
Sbjct: 68  ----DVLHSDKKLTLVFEF-CDQDLKKYFDSCN---------GDLDPEIVKSFLFQLLKG 113
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT-GY 388
           L + H      + H DLKP N+L++      ++DFG+AR   A     R    E  T  Y
Sbjct: 114 LGFCH---SRNVLHRDLKPQNLLINRNGELKLADFGLAR---AFGIPVRCYSAEVVTLWY 167
Query: 389 IAPEYGMGHEVSSYG-DVYSFGILLLEMFTGLRP 421
             P+   G ++ S   D++S G +  E+    RP
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  
Sbjct: 131 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 184
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEM 415
           Y APE  +G       D++S G ++ EM
Sbjct: 185 YRAPEVILGMGYKENVDLWSVGCIMGEM 212

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/236 (21%), Positives = 91/236 (38%), Gaps = 26/236 (11%)
Query: 188 PSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK 247
           P   + Y S+ + +     +     +G G +  V++ I   +   V VK+   +  +  K
Sbjct: 20  PREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIK 79
Query: 248 SFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKR 307
               E ++  N+R      + T    V    +   ALV+E + N   ++    +T+ D R
Sbjct: 80  R---EIKILENLR--GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR 134
Query: 308 HKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY-VSDFGI 366
                            ++   L Y H      I H D+KP N+++D E     + D+G+
Sbjct: 135 F-------------YMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG-DVYSFGILLLEMFTGLRP 421
           A F     E    +      G   PE  + +++  Y  D++S G +L  M     P
Sbjct: 179 AEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 16/93 (17%)
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR-----FLEAADEQTRSIGV 382
           C +K+LH      I H DLKPSNI++  + T  + DFG+AR     F+   +  TR    
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY--- 190
Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEM 415
                Y APE  +G       D++S G ++ EM
Sbjct: 191 -----YRAPEVILGMGYKENVDLWSVGCIMGEM 218

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 45/87 (51%), Gaps = 7/87 (8%)
Query: 341 IAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT-GYIAPEYGMGHEV 399
           + H DLKP N+L++ E    ++DFG+AR   A     R+   E  T  Y APE  +G + 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 400 SSYG-DVYSFGILLLEMFT--GLRPSD 423
            S   D++S G +  EM T   L P D
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + + I+H N++ +        ++      L+ E +A G L +++     +TEE+   
Sbjct: 64  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                LN +              YLH      IAH DLKP NI+L D         + DF
Sbjct: 119 FLKQILNGVY-------------YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           G+A  ++  +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 163 GLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + + I+H N++ +        ++      L+ E +A G L +++     +TEE+   
Sbjct: 64  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                LN +              YLH      IAH DLKP NI+L D         + DF
Sbjct: 119 FLKQILNGVY-------------YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           G+A  ++  +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 163 GLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + + I+H N++ +        ++      L+ E +A G L +++     +TEE+   
Sbjct: 64  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                LN +              YLH      IAH DLKP NI+L D         + DF
Sbjct: 119 FLKQILNGVY-------------YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           G+A  ++  +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 163 GLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + + I+H N++ +        ++      L+ E +A G L +++     +TEE+   
Sbjct: 64  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                LN +              YLH      IAH DLKP NI+L D         + DF
Sbjct: 119 FLKQILNGVY-------------YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           G+A  ++  +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 163 GLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + + I+H N++ +        ++      L+ E +A G L +++     +TEE+   
Sbjct: 64  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                LN +              YLH      IAH DLKP NI+L D         + DF
Sbjct: 119 FLKQILNGVY-------------YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           G+A  ++  +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 163 GLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 37/234 (15%)
Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA--SKSFAVECEVTRNIRHRNLVKV 267
           ++LIG G++G VY      +   VA+K  N +  D    K    E  +   ++   ++++
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           +      D    D   +V E +A+  L+          K  K P  L       I  ++ 
Sbjct: 91  YDLIIPDDLLKFDELYIVLE-IADSDLK----------KLFKTPIFLTEEHIKTILYNLL 139
Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG--- 384
               ++H   +  I H DLKP+N LL+ + +  V DFG+AR + +  +      +E    
Sbjct: 140 LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 385 -----------------TTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLR 420
                            T  Y APE  +  E  +   D++S G +  E+   L+
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + + I+H N++ +        ++      L+ E +A G L +++     +TEE+   
Sbjct: 64  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                LN +              YLH      IAH DLKP NI+L D         + DF
Sbjct: 119 FLKQILNGVY-------------YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           G+A  ++  +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 163 GLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + + I+H N++ +        ++      L+ E +A G L +++     +TEE+   
Sbjct: 64  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                LN +              YLH      IAH DLKP NI+L D         + DF
Sbjct: 119 FLKQILNGVY-------------YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           G+A  ++  +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 163 GLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 66/143 (46%), Gaps = 23/143 (16%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEE--WMHPITEEDKRHK 309
           E  + + + H N+VK+      +D    D   +V+E +  G + E   + P++E+  R  
Sbjct: 86  EIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFY 142
Query: 310 APGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
                          D+   ++YLH      I H D+KPSN+L+ ++    ++DFG++  
Sbjct: 143 FQ-------------DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 370 LEAADEQTRSIGVEGTTGYIAPE 392
            + +D    +    GT  ++APE
Sbjct: 187 FKGSDALLSN--TVGTPAFMAPE 207

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + + I+H N++ +        ++      L+ E +A G L +++     +TEE+   
Sbjct: 64  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                LN +              YLH      IAH DLKP NI+L D         + DF
Sbjct: 119 FLKQILNGVY-------------YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           G+A  ++  +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 163 GLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + + I+H N++ +        ++      L+ E +A G L +++     +TEE+   
Sbjct: 64  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                LN +              YLH      IAH DLKP NI+L D         + DF
Sbjct: 119 FLKQILNGVY-------------YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           G+A  ++  +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 163 GLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 29/218 (13%)
Query: 204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN--------VLHHDASKSFAVECEV 255
           ++ +S+ + +G+G FG V+  +  E    V VK            +         +E  +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 256 TRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLN 315
              + H N++KV        F+   F  LV E   +G L+  +    +   R   P    
Sbjct: 83  LSRVEHANIIKVLDI-----FENQGFFQLVMEKHGSG-LD--LFAFIDRHPRLDEPLASY 134
Query: 316 SLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE 375
             ++L  A+       YL L     I H D+K  NI++ ++ T  + DFG A +LE    
Sbjct: 135 IFRQLVSAVG------YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-- 183
Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYG-DVYSFGILL 412
                   GT  Y APE  MG+       +++S G+ L
Sbjct: 184 -KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + + I+H N++ +        ++      L+ E +A G L +++     +TEE+   
Sbjct: 63  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                LN +              YLH      IAH DLKP NI+L D         + DF
Sbjct: 118 FLKQILNGVY-------------YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           G+A  ++  +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 162 GLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + + I+H N++ +        ++      L+ E +A G L +++     +TEE+   
Sbjct: 63  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                LN +              YLH      IAH DLKP NI+L D         + DF
Sbjct: 118 FLKQILNGVY-------------YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           G+A  ++  +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 162 GLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 9/93 (9%)
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEM---TAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
           YLH   Q  I H DLKP NILL          + DFG++R +  A E      + GT  Y
Sbjct: 146 YLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEY 199
Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           +APE      +++  D+++ GI+   + T   P
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  Y 
Sbjct: 132 IKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV---VTRYYR 185
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEM 415
           APE  +G       D++S G ++ EM
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEM 211

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  Y 
Sbjct: 139 IKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV---VTRYYR 192
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEM 415
           APE  +G       D++S G ++ EM
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  Y 
Sbjct: 139 IKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV---VTRYYR 192
Query: 390 APEYGMGHEVSSYGDVYSFGILLLEM 415
           APE  +G       D++S G ++ EM
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA--SKSFAVECEVTRNIRHRN 263
            +  ++LIG G++G VY      +   VA+K  N +  D    K    E  +   ++   
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++++       D    D   +V E +A+  L+          K  K P  L       I 
Sbjct: 89  IIRLHDLIIPEDLLKFDELYIVLE-IADSDLK----------KLFKTPIFLTEQHVKTIL 137
Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR 368
            ++    K++H   +  I H DLKP+N LL+ + +  + DFG+AR
Sbjct: 138 YNLLLGEKFIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLAR 179

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 101/245 (41%), Gaps = 44/245 (17%)
Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK----VF 268
           IGAGNFG        ++   VAVK          ++   E    R++RH N+V+    + 
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRLNIAID 325
           T             A+V E+ + G L E +      +E++ R          ++L   + 
Sbjct: 86  TPTH---------LAIVMEYASGGELFERICNAGRFSEDEARF-------FFQQLISGVS 129
Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY--VSDFGIARFLEAADEQTRSIGVE 383
            A  ++         +AH DLK  N LLD        ++DFG ++   A+   ++     
Sbjct: 130 YAHAMQ---------VAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAV 177
Query: 384 GTTGYIAPEYGMGHEVS-SYGDVYSFGILLLEMFTGLRPSDDM-----FKDNLNLRNCVK 437
           GT  YIAPE  +  E      DV+S G+ L  M  G  P +D      F+  ++    V+
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 237
Query: 438 SALPE 442
            A+P+
Sbjct: 238 YAIPD 242

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 23/217 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-----RH 261
           +  ++LIG G+FG V K         VA+K+         K+F  + ++   +     +H
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQIEVRLLELMNKH 110
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
              +K +       F   +   LV+E ++       ++ +           NL       
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-----LYDLLRNTNFRGVSLNLTR----K 161
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
            A  +   L +L    +  I HCDLKP NILL +   + +    I  F  +     R   
Sbjct: 162 FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK---IVDFGSSCQLGQRIYQ 217
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
              +  Y +PE  +G       D++S G +L+EM TG
Sbjct: 218 XIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 105/269 (39%), Gaps = 67/269 (24%)
Query: 197 YRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT 256
           Y  +   +  F  E+ IG G F SVY   L  +   V  +    L H    S        
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVY---LATAQLQVGPEEKIALKHLIPTSHP------ 63
Query: 257 RNIRHRNLVKVFTACSGVD--------FQGNDFKALVYEFMANGSLEEWMHPITEEDKRH 308
             IR    ++  T   G D        F+ ND   +   ++ + S  + ++ ++ ++ R 
Sbjct: 64  --IRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVRE 121
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY-VSDFGIA 367
                  +LKR++                Q  I H D+KPSN L +  +  Y + DFG+A
Sbjct: 122 YMLNLFKALKRIH----------------QFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165
Query: 368 -----------RFLEAADEQTR------SIGVE---------GTTGYIAPEY-GMGHEVS 400
                      +F+++  +Q R      SI +          GT G+ APE        +
Sbjct: 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQT 225
Query: 401 SYGDVYSFGILLLEMFTGLRP----SDDM 425
           +  D++S G++ L + +G  P    SDD+
Sbjct: 226 TAIDMWSAGVIFLSLLSGRYPFYKASDDL 254

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 84/219 (38%), Gaps = 27/219 (12%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-----RH 261
           +  ++LIG G+FG V K         VA+K+         K+F  + ++   +     +H
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQIEVRLLELMNKH 110
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
              +K +       F   +   LV+E ++       ++ +           NL       
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-----LYDLLRNTNFRGVSLNLTR----K 161
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILL--DDEMTAYVSDFGIARFLEAADEQTRS 379
            A  +   L +L    +  I HCDLKP NILL         + DFG      +     R 
Sbjct: 162 FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRXAIKIVDFG-----SSCQLGQRI 215
Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
                +  Y +PE  +G       D++S G +L+EM TG
Sbjct: 216 YQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 23/217 (10%)
Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-----RH 261
           +  ++LIG G+FG V K         VA+K+         K+F  + ++   +     +H
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQIEVRLLELMNKH 91
Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
              +K +       F   +   LV+E ++       ++ +           NL       
Sbjct: 92  DTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-----LYDLLRNTNFRGVSLNLTR----K 142
Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
            A  +   L +L    +  I HCDLKP NILL +   + +    I  F  +     R   
Sbjct: 143 FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK---IVDFGSSCQLGQRIYQ 198
Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
              +  Y +PE  +G       D++S G +L+EM TG
Sbjct: 199 XIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 235

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 31/177 (17%)
Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRH 308
           E  + + I+H N++ +        ++      L+ E +A G L +++     +TEE+   
Sbjct: 64  EVSILKEIQHPNVITLHEV-----YENKTDVILIGELVAGGELFDFLAEKESLTEEEATE 118
Query: 309 KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----AYVSDF 364
                LN +              YLH      IAH DLKP NI+L D         + DF
Sbjct: 119 FLKQILNGVY-------------YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           G+A  ++  +E      + GT  ++APE      +    D++S G++   + +G  P
Sbjct: 163 GLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 45/94 (47%), Gaps = 10/94 (10%)
Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAY----VSDFGIARFLEAADEQTRSIGVEGTTG 387
           YLH      IAH DLKP NI+L D+        + DFG+A  +E   E      + GT  
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPE 183
Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           ++APE      +    D++S G++   + +G  P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	502
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-74
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-68
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-63
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-61
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-52
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-51
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-50
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-49
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-48
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-47
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-46
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-46
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-46
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-46
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-45
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-44
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-44
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-44
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-25
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-21
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-44
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-28
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-28
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-27
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-27
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-24
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-23
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-22
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-22
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-19
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-09
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-32
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-31
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-30
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-29
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-29
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-28
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-28
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-28
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-28
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-27
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-27
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-27
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-27
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-27
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-27
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-27
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-27
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	9e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-27
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-27
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-26
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-26
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-26
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-26
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-26
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-26
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-26
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-26
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-25
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-25
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-25
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-25
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-25
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-25
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-25
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-24
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-24
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-24
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-24
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-24
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-24
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-24
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-24
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-24
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-24
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-23
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-23
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-23
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-23
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-23
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-20
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-15
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-08
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-23
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-23
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-22
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-22
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-21
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-21
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-21
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-21
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-08
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-20
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-20
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-15
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-15
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-15
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-15
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-07
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-20
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-17
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-17
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-05
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-10
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-19
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-18
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-18
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-18
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-18
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-18
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-18
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-07
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-17
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-17
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-17
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-17
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-17
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-16
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-16
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-16
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-09
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-09
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-05
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-16
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-15
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-15
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-15
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-12
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-07
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-15
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-15
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-09
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-15
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-15
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-13
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-12
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-12
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-14
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-14
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-12
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-12
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-04
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-14
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-14
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-14
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-13
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-13
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-13
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-09
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-09
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-10
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-05
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-04
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-06
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-06
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-11
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-08
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-06
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-07
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-04
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-13
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-12
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-11
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-10
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-08
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-05
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-12
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-12
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-12
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-12
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-11
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-11
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-09
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-05
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-11
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-11
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-08
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-11
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-08
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-08
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-07
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-11
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-11
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-11
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-11
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-08
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-10
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-09
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-07
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-11
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-09
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-09
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-06
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-04
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-11
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-11
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-11
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-10
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-07
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-10
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-05
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	8e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-05
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-09
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-08
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-07
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-04
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	8e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-08
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-04
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-09
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-08
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-07
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-08
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-08
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-07
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-06
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	9e-06
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-08
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-06
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-08
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-08
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-06
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-08
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-05
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-04
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-04
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-08
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-08
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-08
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-08
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-05
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-04
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-08
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-05
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-04
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-07
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-07
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-07
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-06
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-07
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-07
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-07
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	3e-07
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	1e-06
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	3e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-07
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-05
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-05
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-04
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-04
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-04
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	5e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  236 bits (605), Expect = 3e-74
 Identities = 102/297 (34%), Positives = 152/297 (51%), Gaps = 20/297 (6%)

Query: 196 SYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS-FAVECE 254
           S R L  A+  FS++N++G G FG VYKG L    T VAVK          +  F  E E
Sbjct: 21  SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 255 VTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNL 314
           +     HRNL+++   C        + + LVY +MANGS+   +       +R ++   L
Sbjct: 80  MISMAVHRNLLRLRGFCM----TPTE-RLLVYPYMANGSVASCLR------ERPESQPPL 128

Query: 315 NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD 374
           +  KR  IA+  A  L YLH  C P I H D+K +NILLD+E  A V DFG+A+ ++   
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--Y 186

Query: 375 EQTR-SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMF---KDNL 430
           + T  +  V GT G+IAPEY    + S   DV+ +G++LLE+ TG R  D       D++
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246

Query: 431 NLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV 487
            L + VK  L E+  E        Q +   E +  + ++ + C+   P ER K+++V
Sbjct: 247 MLLDWVKGLLKEKKLEALVDV-DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  221 bits (565), Expect = 2e-68
 Identities = 87/296 (29%), Positives = 128/296 (43%), Gaps = 19/296 (6%)

Query: 194 YVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVEC 253
            V    L  AT  F  + LIG G FG VYKG+L      VA+K          + F  E 
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEI 86

Query: 254 EVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGN 313
           E     RH +LV +   C        +   L+Y++M NG+L+  ++             +
Sbjct: 87  ETLSFCRHPHLVSLIGFC-----DERNEMILIYKYMENGNLKRHLY------GSDLPTMS 135

Query: 314 LNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA 373
           ++  +RL I I  A  L YLH      I H D+K  NILLD+     ++DFGI++     
Sbjct: 136 MSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192

Query: 374 DEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMF-KDNLNL 432
           D+   S  V+GT GYI PEY +   ++   DVYSFG++L E+            ++ +NL
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252

Query: 433 RNCVKSALPER-AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV 487
                 +      E+I     +    I  E L    +  V C A    +R  + DV
Sbjct: 253 AEWAVESHNNGQLEQIVDP--NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  206 bits (526), Expect = 8e-63
 Identities = 82/238 (34%), Positives = 115/238 (48%), Gaps = 28/238 (11%)

Query: 196 SYRMLYNATKGFSSE------NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--- 246
           S+  L N T  F         N +G G FG VYKG +    T VAVK    +    +   
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVAVKKLAAMVDITTEEL 73

Query: 247 -KSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEED 305
            + F  E +V    +H NLV++    S     G+D   LVY +M NGSL + +       
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSS----DGDD-LCLVYVYMPNGSLLDRLS-----C 123

Query: 306 KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG 365
                P  L+   R  IA   A  + +LH +      H D+K +NILLD+  TA +SDFG
Sbjct: 124 LDGTPP--LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFG 178

Query: 366 IARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD 423
           +AR  E   +   +  + GTT Y+APE   G  ++   D+YSFG++LLE+ TGL   D
Sbjct: 179 LARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVD 235

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  202 bits (516), Expect = 3e-61
 Identities = 70/320 (21%), Positives = 125/320 (39%), Gaps = 35/320 (10%)

Query: 196 SYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV 255
               LY  +       +   G FG V+K  L      VAVK+F +     S     E   
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFPI-QDKQSWQNEYEVYS 71

Query: 256 TRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLN 315
              ++H N+++   A         D   L+  F   GSL +++         +     ++
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLK-------ANV----VS 119

Query: 316 SLKRLNIAIDVACVLKYLHLD-------CQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR 368
             +  +IA  +A  L YLH D        +P I+H D+K  N+LL + +TA ++DFG+A 
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179

Query: 369 FLEAADEQTRSIGVEGTTGYIAPEY---GMGHEVSSY--GDVYSFGILLLEMFTGLRPSD 423
             EA      + G  GT  Y+APE     +  +  ++   D+Y+ G++L E+ +    +D
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

Query: 424 DMFKDN-LNLRNCVKSALPERAEEIRASSGSTQRSII------LECLISICEIGVACSAE 476
               +  L     +    P   +         +R ++         +  +CE    C   
Sbjct: 240 GPVDEYMLPFEEEIGQH-PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298

Query: 477 QPGERMKINDVEPRLRLIKK 496
               R+    V  R+  +++
Sbjct: 299 DAEARLSAGCVGERITQMQR 318

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  179 bits (456), Expect = 2e-52
 Identities = 79/327 (24%), Positives = 127/327 (38%), Gaps = 48/327 (14%)

Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV--TRNIR 260
                    LIG G +G+VYKG L E    VAVKVF+  +    ++F  E  +     + 
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSLDERP--VAVKVFSFANR---QNFINEKNIYRVPLME 65

Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N+ +       V   G     LV E+  NGSL +++   T            + +   
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----------SDWVSSC 114

Query: 321 NIAIDVACVLKYLHLD------CQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL---- 370
            +A  V   L YLH +       +P I+H DL   N+L+ ++ T  +SDFG++  L    
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 371 --EAADEQTRSIGVEGTTGYIAPEYGMG-------HEVSSYGDVYSFGILLLEMF---TG 418
                +E   +I   GT  Y+APE   G              D+Y+ G++  E+F   T 
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 419 LRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILE-------CLISICEIGV 471
           L P + + +  +  +  V +  P   +     S   QR    E        + S+ E   
Sbjct: 235 LFPGESVPEYQMAFQTEVGNH-PTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 472 ACSAEQPGERMKINDVEPRLRLIKKKL 498
            C  +    R+     E R+  +    
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIW 320

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  177 bits (450), Expect = 1e-51
 Identities = 69/218 (31%), Positives = 111/218 (50%), Gaps = 19/218 (8%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKV 267
           +  IGAG+FG+V++       + VAVK+      H +    F  E  + + +RH N+V  
Sbjct: 42  KEKIGAGSFGTVHRAEWHG--SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
             A +    Q  +  ++V E+++ GSL   +H       +  A   L+  +RL++A DVA
Sbjct: 100 MGAVT----QPPNL-SIVTEYLSRGSLYRLLH-------KSGAREQLDERRRLSMAYDVA 147

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YLH +  PPI H +LK  N+L+D + T  V DFG++R    A     S    GT  
Sbjct: 148 KGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTPE 204

Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
           ++APE       +   DVYSFG++L E+ T  +P  ++
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  172 bits (439), Expect = 4e-50
 Identities = 71/291 (24%), Positives = 115/291 (39%), Gaps = 40/291 (13%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           E ++G G FG V K         VA+K          K+F VE      + H N+VK++ 
Sbjct: 13  EEVVGRGAFGVVCKAKWRAKD--VAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYG 68

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
           AC       N    LV E+   GSL   +H         +      +   ++  +  +  
Sbjct: 69  ACL------NPV-CLVMEYAEGGSLYNVLH-------GAEPLPYYTAAHAMSWCLQCSQG 114

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAY-VSDFGIARFLEAADEQTRSIGVEGTTGY 388
           + YLH      + H DLKP N+LL    T   + DFG A      D QT     +G+  +
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAW 169

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIR 448
           +APE   G   S   DV+S+GI+L E+ T  +P D++                  A  I 
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI---------------GGPAFRIM 214

Query: 449 ASSGSTQR-SIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL 498
            +  +  R  +I      I  +   C ++ P +R  + ++   +  + +  
Sbjct: 215 WAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  169 bits (430), Expect = 3e-49
 Identities = 50/221 (22%), Positives = 87/221 (39%), Gaps = 26/221 (11%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKV 267
              +   + G ++KG        + VKV  V       S+ F  EC   R   H N++ V
Sbjct: 15  LTKLNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
             AC            L+  +M  GSL   +H              ++  + +  A+D+A
Sbjct: 73  LGACQS---PPAPHPTLITHWMPYGSLYNVLH--------EGTNFVVDQSQAVKFALDMA 121

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + +LH   +P I    L   ++++D++MTA +S   +    +       S G      
Sbjct: 122 RGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPA 173

Query: 388 YIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDM 425
           ++APE        +     D++SF +LL E+ T   P  D+
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  167 bits (425), Expect = 2e-48
 Identities = 65/300 (21%), Positives = 115/300 (38%), Gaps = 51/300 (17%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-------KSFAVECEVTRNIRHR 262
           E  IG G FG V+KG L +  + VA+K   +   +         + F  E  +  N+ H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N+VK++           +   +V EF+  G L   +               +    +L +
Sbjct: 84  NIVKLYGLMH-------NPPRMVMEFVPCGDLYHRLL---------DKAHPIKWSVKLRL 127

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLD-----DEMTAYVSDFGIARFLEAADEQT 377
            +D+A  ++Y+  +  PPI H DL+  NI L        + A V+DFG+++         
Sbjct: 128 MLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVH 181

Query: 378 RSIGVEGTTGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC 435
              G+ G   ++APE         +   D YSF ++L  + TG  P D+           
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY---------- 231

Query: 436 VKSALPERAEEIRASSGSTQR-SIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI 494
                  + + I        R +I  +C   +  +   C +  P +R   + +   L  +
Sbjct: 232 ----SYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  165 bits (420), Expect = 1e-47
 Identities = 68/257 (26%), Positives = 114/257 (44%), Gaps = 30/257 (11%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           IG+G+FG+VYKG        VAVK+ NV        ++F  E  V R  RH N++     
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
            +          A+V ++    SL   +H          +       K ++IA   A  +
Sbjct: 89  STAPQL------AIVTQWCEGSSLYHHLH---------ASETKFEMKKLIDIARQTARGM 133

Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
            YLH      I H DLK +NI L ++ T  + DFG+A          +   + G+  ++A
Sbjct: 134 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190

Query: 391 PEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLN--LRNCVKSALPERAE 445
           PE     + + Y    DVY+FGI+L E+ TG  P  ++  +N +  +    + +L     
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIEMVGRGSLSPDLS 248

Query: 446 EIRASSGSTQRSIILEC 462
           ++R++     + ++ EC
Sbjct: 249 KVRSNCPKRMKRLMAEC 265

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  160 bits (408), Expect = 4e-46
 Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 34/228 (14%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS----KSFAVECEVTRNIRHRNLV 265
           E +IG G FG VY+         VAVK       +      ++   E ++   ++H N++
Sbjct: 12  EEIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
            +   C     +  +   LV EF   G L   +        +      +     +N A+ 
Sbjct: 70  ALRGVCL----KEPNL-CLVMEFARGGPLNRVLS------GKR-----IPPDILVNWAVQ 113

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY--------VSDFGIARFLEAADEQT 377
           +A  + YLH +   PI H DLK SNIL+  ++           ++DFG+AR       +T
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRT 169

Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
             +   G   ++APE       S   DV+S+G+LL E+ TG  P   +
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  160 bits (408), Expect = 9e-46
 Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 32/231 (13%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV--TRNIRHRNLVKV 267
              +G G +G V++G        VAVK+F+       KS+  E E+  T  +RH N++  
Sbjct: 13  LECVGKGRYGEVWRGSWQGEN--VAVKIFSSRD---EKSWFRETELYNTVMLRHENILGF 67

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
             +             L+  +   GSL +++               L+++  L I + +A
Sbjct: 68  IASDMTSRHSSTQL-WLITHYHEMGSLYDYLQ-------LTT----LDTVSCLRIVLSIA 115

Query: 328 CVLKYLHLD-----CQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE--QTRSI 380
             L +LH++      +P IAH DLK  NIL+       ++D G+A     +       + 
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175

Query: 381 GVEGTTGYIAPE------YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
              GT  Y+APE           +     D+++FG++L E+   +  +  +
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  161 bits (410), Expect = 1e-45
 Identities = 71/308 (23%), Positives = 113/308 (36%), Gaps = 39/308 (12%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV--TRNIRHRNLVKV 267
              IG G +G V+ G        VAVKVF         S+  E E+  T  +RH N++  
Sbjct: 42  VKQIGKGRYGEVWMGKWRGEK--VAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGF 96

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
             A             L+ ++  NGSL +++               L++   L +A    
Sbjct: 97  IAADIKGTGSWTQL-YLITDYHENGSLYDYLK-------STT----LDAKSMLKLAYSSV 144

Query: 328 CVLKYLHLD-----CQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA--DEQTRSI 380
             L +LH +      +P IAH DLK  NIL+    T  ++D G+A    +   +      
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204

Query: 381 GVEGTTGYIAPE------YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN 434
              GT  Y+ PE           +     D+YSFG++L E+         + +  L   +
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264

Query: 435 CVKSALPERAEEIRASSGSTQRSII------LECLISICEIGVACSAEQPGERMKINDVE 488
            V S  P   +          R          ECL  + ++   C A  P  R+    V+
Sbjct: 265 LVPSD-PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323

Query: 489 PRLRLIKK 496
             L  + +
Sbjct: 324 KTLAKMSE 331

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  159 bits (403), Expect = 1e-44
 Identities = 72/308 (23%), Positives = 122/308 (39%), Gaps = 39/308 (12%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV--TRNIRHRNLVKV 267
           +  IG G FG V++G        VAVK+F+       +S+  E E+  T  +RH N++  
Sbjct: 47  QESIGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGF 101

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
             A +  +        LV ++  +GSL ++++       R+     +     + +A+  A
Sbjct: 102 IAADNKDNGTWTQL-WLVSDYHEHGSLFDYLN-------RYT----VTVEGMIKLALSTA 149

Query: 328 CVLKYLHLD-----CQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA--DEQTRSI 380
             L +LH++      +P IAH DLK  NIL+    T  ++D G+A   ++A         
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209

Query: 381 GVEGTTGYIAPE-----YGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN 434
              GT  Y+APE       M H E     D+Y+ G++  E+              L   +
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269

Query: 435 CVKSALPERAEEIRASSGSTQRSII------LECLISICEIGVACSAEQPGERMKINDVE 488
            V S  P   E  +       R  I       E L  + +I   C       R+    ++
Sbjct: 270 LVPSD-PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328

Query: 489 PRLRLIKK 496
             L  + +
Sbjct: 329 KTLSQLSQ 336

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  158 bits (401), Expect = 1e-44
 Identities = 66/301 (21%), Positives = 106/301 (35%), Gaps = 43/301 (14%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
             ++G G FG   K    E+   + +K       +  ++F  E +V R + H N++K   
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
                  +       + E++  G+L   +                   +R++ A D+A  
Sbjct: 75  VLY----KDKRL-NFITEYIKGGTLRGII---------KSMDSQYPWSQRVSFAKDIASG 120

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT------------ 377
           + YLH      I H DL   N L+ +     V+DFG+AR +     Q             
Sbjct: 121 MAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177

Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK 437
           +   V G   ++APE   G       DV+SFGI+L E+   +    D             
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY------------ 225

Query: 438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK 497
             LP   +      G   R     C  S   I V C    P +R     +E  L  ++  
Sbjct: 226 --LPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283

Query: 498 L 498
           L
Sbjct: 284 L 284

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  157 bits (399), Expect = 3e-44
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 6/139 (4%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            +S N L+G + P      +L+  ++S N+L G  S  FGS  + +++ +  N  A  + 
Sbjct: 180 TISRNRLTGKI-PPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL- 237

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
             +   + L  LDL  N +   +P+ L   KFL +LN+S+NN    +P  G  +    ++
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSA 297

Query: 121 VFGNKKLCGGIPEFQLPTC 139
              NK LCG      LP C
Sbjct: 298 YANNKCLCGSP----LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  105 bits (264), Expect = 2e-25
 Identities = 30/112 (26%), Positives = 49/112 (43%), Gaps = 2/112 (1%)

Query: 1   DLSN-NNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            +   NNL G + P +  L+ L    ++   +SGAI +      +L  LD   N  +G +
Sbjct: 82  YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL 141

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFL-QNLNLSYNNFESMLPIE 110
             S+SSL  L  +    N +S  IP+    F  L  ++ +S N     +P  
Sbjct: 142 PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 91.8 bits (229), Expect = 8e-21
 Identities = 38/137 (27%), Positives = 59/137 (43%), Gaps = 5/137 (3%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSG--AISNNFGSCTSLEQLDMHG-NLFAG 57
           D  N    G L         ++  ++SG  L     I ++  +   L  L + G N   G
Sbjct: 32  DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNA 116
           PI  +++ L  L  L ++  N+S  IP+FL+  K L  L+ SYN     LP       N 
Sbjct: 92  PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151

Query: 117 SATSVFGNKKLCGGIPE 133
              +  GN ++ G IP+
Sbjct: 152 VGITFDGN-RISGAIPD 167

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  156 bits (396), Expect = 9e-44
 Identities = 51/230 (22%), Positives = 80/230 (34%), Gaps = 35/230 (15%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKV 267
             LIG G FG VY G        VA+++ ++   +    K+F  E    R  RH N+V  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
             AC           A++       +L   +           A   L+  K   IA ++ 
Sbjct: 95  MGACM----SPPHL-AIITSLCKGRTLYSVVR---------DAKIVLDVNKTRQIAQEIV 140

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS---IGVEG 384
             + YLH      I H DLK  N+  D+     ++DFG+           R        G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNG 196

Query: 385 TTGYIAPE------YGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDM 425
              ++APE           +   +    DV++ G +  E+     P    
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  146 bits (371), Expect = 9e-38
 Identities = 44/139 (31%), Positives = 65/139 (46%), Gaps = 4/139 (2%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           ++++    G  SP      S+   ++S N+LSG I    GS   L  L++  N  +G I 
Sbjct: 614 NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIP 673

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
             +  LRGL +LDLS N L   IP+ ++    L  ++LS NN    +P  G F+      
Sbjct: 674 DEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAK 733

Query: 121 VFGNKKLCGGIPEFQLPTC 139
              N  LCG    + LP C
Sbjct: 734 FLNNPGLCG----YPLPRC 748

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  118 bits (297), Expect = 3e-28
 Identities = 40/110 (36%), Positives = 54/110 (49%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            LS N LSGT+   L  LS L    +  N+L G I        +LE L +  N   G I 
Sbjct: 424 HLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP 483

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE 110
           S LS+   L  + LS N L+ EIP+++   + L  L LS N+F   +P E
Sbjct: 484 SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE 533

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  116 bits (293), Expect = 8e-28
 Identities = 38/164 (23%), Positives = 68/164 (41%), Gaps = 4/164 (2%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L  N L G +  +L+ + +L    +  N L+G I +   +CT+L  + +  N   G I 
Sbjct: 448 KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
             +  L  L +L LS N+ S  IP  L   + L  L+L+ N F   +P   +FK +   +
Sbjct: 508 KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP-AAMFKQSGKIA 566

Query: 121 VFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLL 164
                 + G    +     + K+     + L  + +    +  L
Sbjct: 567 ---ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  115 bits (290), Expect = 2e-27
 Identities = 46/137 (33%), Positives = 67/137 (48%), Gaps = 4/137 (2%)

Query: 1   DLSNNNLSGTLSPQL--VGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGP 58
           DLS+NN SG + P L     ++L    +  N  +G I     +C+ L  L +  N  +G 
Sbjct: 374 DLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGT 433

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASA 118
           I SSL SL  LR L L  N L  EIP+ L   K L+ L L +N+    +P  G+    + 
Sbjct: 434 IPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP-SGLSNCTNL 492

Query: 119 TSV-FGNKKLCGGIPEF 134
             +   N +L G IP++
Sbjct: 493 NWISLSNNRLTGEIPKW 509

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  114 bits (287), Expect = 5e-27
 Identities = 42/134 (31%), Positives = 62/134 (46%), Gaps = 2/134 (1%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L NN  +G + P L   S L   ++S N LSG I ++ GS + L  L +  N+  G I 
Sbjct: 400 YLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASAT 119
             L  ++ L  L L  N+L+ EIP  L+    L  ++LS N     +P   G  +N +  
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL 519

Query: 120 SVFGNKKLCGGIPE 133
            +  N    G IP 
Sbjct: 520 KLSNN-SFSGNIPA 532

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  106 bits (266), Expect = 2e-24
 Identities = 44/138 (31%), Positives = 65/138 (47%), Gaps = 11/138 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDMHGNLFAGPI 59
           ++S+N   G + P    L SL   +++ N  +G I +   G+C +L  LD+ GN F G +
Sbjct: 253 NISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAV 310

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIP-EFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASA 118
                S   L  L LS NN S E+P + L   + L+ L+LS+N F   LP      N SA
Sbjct: 311 PPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES--LTNLSA 368

Query: 119 T----SVFGNKKLCGGIP 132
           +     +  N    G I 
Sbjct: 369 SLLTLDLSSN-NFSGPIL 385

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  103 bits (258), Expect = 2e-23
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 8/135 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            +S N +SG +   +    +L   +VS N  S  I    G C++L+ LD+ GN  +G   
Sbjct: 184 AISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFS 240

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP--IEGIFKNASA 118
            ++S+   L++L++S N     IP      K LQ L+L+ N F   +P  + G     + 
Sbjct: 241 RAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTG 298

Query: 119 TSVFGNKKLCGGIPE 133
             + GN    G +P 
Sbjct: 299 LDLSGN-HFYGAVPP 312

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =   99 bits (250), Expect = 2e-22
 Identities = 38/140 (27%), Positives = 62/140 (44%), Gaps = 9/140 (6%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAIS--NNFGSCTSLEQLDMHGNLFAGP 58
            LSN++++G++       +SL+  ++S N LSG ++   + GSC+ L+ L++  N    P
Sbjct: 83  FLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFP 141

Query: 59  I-GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGF---KFLQNLNLSYNNFESMLPIEGIFK 114
              S    L  L VLDLS N++S               L++L +S N     + +     
Sbjct: 142 GKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV-SRCV 200

Query: 115 NASATSVFGNKKLCGGIPEF 134
           N     V  N     GIP  
Sbjct: 201 NLEFLDVSSN-NFSTGIPFL 219

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 98.4 bits (246), Expect = 6e-22
 Identities = 35/147 (23%), Positives = 62/147 (42%), Gaps = 12/147 (8%)

Query: 1   DLSNNNLS---GTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG 57
           DLS+  L+     +S  L+ L+ L    +S + ++G++S  F    SL  LD+  N  +G
Sbjct: 56  DLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSG 114

Query: 58  PI--GSSLSSLRGLRVLDLSQNNLSDEIP-EFLAGFKFLQNLNLSYNNFESMLPIEGIFK 114
           P+   +SL S  GL+ L++S N L              L+ L+LS N+      +     
Sbjct: 115 PVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG-WVL 173

Query: 115 NASATSV----FGNKKLCGGIPEFQLP 137
           +     +        K+ G +   +  
Sbjct: 174 SDGCGELKHLAISGNKISGDVDVSRCV 200

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 97.7 bits (244), Expect = 1e-21
 Identities = 44/139 (31%), Positives = 56/139 (40%), Gaps = 8/139 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDMHGNLFAGPI 59
           DLS N+  G + P     S L    +S N  SG +  +       L+ LD+  N F+G +
Sbjct: 300 DLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGEL 359

Query: 60  GSSLSSLRG-LRVLDLSQNNLSDEIPEFLAGF--KFLQNLNLSYNNFESMLPIEGIFKNA 116
             SL++L   L  LDLS NN S  I   L       LQ L L  N F   +P      N 
Sbjct: 360 PESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT--LSNC 417

Query: 117 SATSV--FGNKKLCGGIPE 133
           S           L G IP 
Sbjct: 418 SELVSLHLSFNYLSGTIPS 436

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 90.4 bits (225), Expect = 3e-19
 Identities = 21/112 (18%), Positives = 40/112 (35%), Gaps = 6/112 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNL--FAGP 58
           DL+ N  +GT+   +   S      ++ N ++G       +    ++    GNL  F G 
Sbjct: 544 DLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGI 599

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE 110
               L+ L      +++                 +  L++SYN     +P E
Sbjct: 600 RSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE 651

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 78.4 bits (194), Expect = 2e-15
 Identities = 27/99 (27%), Positives = 46/99 (46%), Gaps = 3/99 (3%)

Query: 18  LSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQN 77
           ++S+ + +   N+   A+S++  S T LE L +  +   G + S       L  LDLS+N
Sbjct: 52  VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLSRN 110

Query: 78  NLSDEIPEF--LAGFKFLQNLNLSYNNFESMLPIEGIFK 114
           +LS  +     L     L+ LN+S N  +    + G  K
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLK 149

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 20/78 (25%), Positives = 34/78 (43%), Gaps = 1/78 (1%)

Query: 40  GSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLS 99
              TS++      N+    + SSL SL GL  L LS ++++  +  F      L +L+LS
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGF-KCSASLTSLDLS 108

Query: 100 YNNFESMLPIEGIFKNAS 117
            N+    +       + S
Sbjct: 109 RNSLSGPVTTLTSLGSCS 126

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  122 bits (309), Expect = 8e-32
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 26/216 (12%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT--RNIRHRNLVKVFT 269
            IG G+F +VYKG+  E+T  VA           S+    + E    + ++H N+V+ F 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR-FY 91

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
                  +G     LV E M +G+L+ ++       KR K    +  L+       +   
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYL-------KRFKVM-KIKVLRS--WCRQILKG 141

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEM-TAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
           L++LH    PPI H DLK  NI +     +  + D G+A    A+  +     V GT  +
Sbjct: 142 LQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEF 196

Query: 389 IAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
           +APE         Y    DVY+FG+ +LEM T   P
Sbjct: 197 MAPEMYEEK----YDESVDVYAFGMCMLEMATSEYP 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  124 bits (314), Expect = 4e-31
 Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 23/219 (10%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKV 267
           ++ +G G +G VY+G+  + +  VAVK    L  D    + F  E  V + I+H NLV++
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQL 281

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C+    +   F  ++ EFM  G+L +++        R      ++++  L +A  ++
Sbjct: 282 LGVCT----REPPFY-IITEFMTYGNLLDYL--------RECNRQEVSAVVLLYMATQIS 328

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             ++YL         H +L   N L+ +     V+DFG++R +   D  T   G +    
Sbjct: 329 SAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 384

Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
           + APE    ++ S   DV++FG+LL E+ T G+ P   +
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  119 bits (301), Expect = 6e-30
 Identities = 62/220 (28%), Positives = 86/220 (39%), Gaps = 29/220 (13%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
           IG GNFG V+ G L    T VAVK     L  D    F  E  + +   H N+V++    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI--- 178

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            GV  Q      +V E +  G    ++               L     L +  D A  ++
Sbjct: 179 -GVCTQKQPI-YIVMELVQGGDFLTFL---------RTEGARLRVKTLLQMVGDAAAGME 227

Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI-- 389
           YL         H DL   N L+ ++    +SDFG++R          S G       +  
Sbjct: 228 YLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGG----LRQVPV 279

Query: 390 ---APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
              APE       SS  DV+SFGILL E F+ G  P  ++
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  118 bits (298), Expect = 3e-29
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 27/220 (12%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           E  +GAG FG V+     + T  VAVK            F  E  V + ++H  LVK+  
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA 250

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
             +           ++ EFMA GSL +++        +          K ++ +  +A  
Sbjct: 251 VVTKEPIY------IITEFMAKGSLLDFL--------KSDEGSKQPLPKLIDFSAQIAEG 296

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           + ++    Q    H DL+ +NIL+   +   ++DFG+AR +E  +E T     EG    I
Sbjct: 297 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAR---EGAKFPI 349

Query: 390 ---APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
              APE       +   DV+SFGILL+E+ T G  P   M
Sbjct: 350 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  115 bits (291), Expect = 4e-29
 Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 23/223 (10%)

Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNL 264
             ++G G FGSV +G L     ++  VAVK   + +      + F  E    ++  H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           +++   C  +  QG     ++  FM  G L  ++       +    P ++     L   +
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL----YSRLETGPKHIPLQTLLKFMV 154

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           D+A  ++YL         H DL   N +L D+MT  V+DFG+++ + + D   +     G
Sbjct: 155 DIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ-----G 206

Query: 385 TTGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
               +     A E       +S  DV++FG+ + E+ T G+ P
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  118 bits (297), Expect = 5e-29
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 25/219 (11%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS--FAVECEVTRNIRHRNLVKV 267
           E  +G G FG V+ G     TT VA+K    L         F  E +V + +RH  LV++
Sbjct: 189 EVKLGQGCFGEVWMGTW-NGTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQL 244

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           +   S           +V E+M+ GSL +++        + +    L   + +++A  +A
Sbjct: 245 YAVVSEEPIY------IVTEYMSKGSLLDFL--------KGETGKYLRLPQLVDMAAQIA 290

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + Y+    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    
Sbjct: 291 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIK 346

Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
           + APE  +    +   DV+SFGILL E+ T G  P   M
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  115 bits (291), Expect = 5e-29
 Identities = 53/230 (23%), Positives = 98/230 (42%), Gaps = 40/230 (17%)

Query: 210 ENLIGAGNFGSVYKGILF----ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNL 264
             ++G+G FG+VYKG+      +    VA+K         +      E  V  ++ + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
            ++   C     Q      L+ + M  G L +++       + HK   N+ S   LN  +
Sbjct: 80  CRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLNWCV 124

Query: 325 DVACVLKYL---HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
            +A  + YL    L       H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 125 QIAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178

Query: 382 VEGTTGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
                G +     A E  +    +   DV+S+G+ + E+ T G +P D +
Sbjct: 179 -----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  117 bits (296), Expect = 7e-29
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 27/218 (12%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-KSFAVECEVTRNIRHRNLVKVF 268
              IG G FG V  G    +   VAVK    + +DA+ ++F  E  V   +RH NLV++ 
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNK--VAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQLL 252

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                   +      +V E+MA GSL +++        R +    L     L  ++DV  
Sbjct: 253 GVIV----EEKGGLYIVTEYMAKGSLVDYL--------RSRGRSVLGGDCLLKFSLDVCE 300

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            ++YL         H DL   N+L+ ++  A VSDFG+ +   +  +  + + V+ T   
Sbjct: 301 AMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-LPVKWT--- 353

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            APE     + S+  DV+SFGILL E+++ G  P   +
Sbjct: 354 -APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  118 bits (296), Expect = 1e-28
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 25/219 (11%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS--FAVECEVTRNIRHRNLVKV 267
           E  +G G FG V+ G    +T  VA+K    L         F  E +V + +RH  LV++
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQL 327

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           +   S           +V E+M+ GSL +++        + +    L   + +++A  +A
Sbjct: 328 YAVVSEEPIY------IVTEYMSKGSLLDFL--------KGETGKYLRLPQLVDMAAQIA 373

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + Y+    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +    
Sbjct: 374 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIK 429

Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
           + APE  +    +   DV+SFGILL E+ T G  P   M
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  114 bits (287), Expect = 2e-28
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 24/222 (10%)

Query: 210 ENLIGAGNFGSVYKGILF----ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNL 264
             ++G+G FG+V+KG+           V +KV        S            ++ H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           V++   C G   Q      LV +++  GSL + +       ++H+  G L     LN  +
Sbjct: 78  VRLLGLCPGSSLQ------LVTQYLPLGSLLDHV-------RQHR--GALGPQLLLNWGV 122

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +A  + YL    +  + H +L   N+LL       V+DFG+A  L   D+Q      + 
Sbjct: 123 QIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
              ++A E     + +   DV+S+G+ + E+ T G  P   +
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  112 bits (283), Expect = 3e-28
 Identities = 56/229 (24%), Positives = 82/229 (35%), Gaps = 36/229 (15%)

Query: 210 ENLIGAGNFGSVYKGIL---FESTTAVAVKVFNV---LHHDASKSFAVECEVTRNIRHRN 263
              +G G+FG V +G        T +VAVK          +A   F  E     ++ HRN
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           L++++        +      +V E    GSL + +          K  G+         A
Sbjct: 83  LIRLYGVVLTPPMK------MVTELAPLGSLLDRLR---------KHQGHFLLGTLSRYA 127

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           + VA  + YL         H DL   N+LL       + DFG+ R L   D+        
Sbjct: 128 VQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM---- 180

Query: 384 GTTG------YIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
                     + APE       S   D + FG+ L EMFT G  P   +
Sbjct: 181 -QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  111 bits (280), Expect = 6e-28
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 37/225 (16%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
              +GAG FG V+ G      T VAVK            F  E  + + ++H+ LV+++ 
Sbjct: 18  VERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYA 75

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
             +       +   ++ E+M NGSL +++        +  +   L   K L++A  +A  
Sbjct: 76  VVTQ------EPIYIITEYMENGSLVDFL--------KTPSGIKLTINKLLDMAAQIAEG 121

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           + ++    +    H DL+ +NIL+ D ++  ++DFG+AR +E  +E T   G        
Sbjct: 122 MAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREG-----AKF 172

Query: 390 -----APE---YGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
                APE   YG     +   DV+SFGILL E+ T G  P   M
Sbjct: 173 PIKWTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIPYPGM 214

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  111 bits (280), Expect = 8e-28
 Identities = 57/222 (25%), Positives = 103/222 (46%), Gaps = 29/222 (13%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           ++ +G G +G VY+G+  + +  VAVK       +  + F  E  V + I+H NLV++  
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 76

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C+    +   F  ++ EFM  G+L +++        R      ++++  L +A  ++  
Sbjct: 77  VCT----REPPF-YIITEFMTYGNLLDYL--------RECNRQEVSAVVLLYMATQISSA 123

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           ++YL    +    H DL   N L+ +     V+DFG++R +   D  T   G        
Sbjct: 124 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAG-----AKF 174

Query: 390 -----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
                APE    ++ S   DV++FG+LL E+ T G+ P   +
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  111 bits (280), Expect = 1e-27
 Identities = 60/216 (27%), Positives = 89/216 (41%), Gaps = 28/216 (12%)

Query: 212 LIGAGNFGSVYKG---ILFESTTAVAVKVFNV-LHHDAS--KSFAVECEVTRNIRHRNLV 265
            +G G   +VY     IL      VA+K   +         K F  E   +  + H+N+V
Sbjct: 18  KLGGGGMSTVYLAEDTIL---NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
            +       +     +  LV E++   +L E+   I          G L+    +N    
Sbjct: 75  SMID--VDEE-DDCYY--LVMEYIEGPTLSEY---IESH-------GPLSVDTAINFTNQ 119

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +   +K+ H      I H D+KP NIL+D   T  + DFGIA+ L      T++  V GT
Sbjct: 120 ILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGT 175

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             Y +PE   G       D+YS GI+L EM  G  P
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  111 bits (280), Expect = 1e-27
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 29/222 (13%)

Query: 210 ENLIGAGNFGSVYKGILF----ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV 265
            + +G GNFGSV           +   VAVK       D  + F  E ++ + +    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           K      G    G     LV E++ +G L +++       +RH+    L++ + L  +  
Sbjct: 88  KYRGVSYG---PGRQSLRLVMEYLPSGCLRDFL-------QRHR--ARLDASRLLLYSSQ 135

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +   ++YL         H DL   NIL++ E    ++DFG+A+ L    +          
Sbjct: 136 ICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV----RE 188

Query: 386 TGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
            G       APE    +  S   DV+SFG++L E+FT   + 
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  111 bits (279), Expect = 2e-27
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 24/221 (10%)

Query: 213 IGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKV 267
           +G G FGSV +  L     S   VAVK+       +S  + F  E    +   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 268 FTACSGVDFQGNDFKAL-VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
                    +G     + +  FM +G L  ++       +  + P NL     +   +D+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL----ASRIGENPFNLPLQTLVRFMVDI 146

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
           AC ++YL         H DL   N +L ++MT  V+DFG++R + + D   +     G  
Sbjct: 147 ACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ-----GCA 198

Query: 387 GYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
             +     A E    +  + + DV++FG+ + E+ T G  P
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  110 bits (278), Expect = 2e-27
 Identities = 52/220 (23%), Positives = 82/220 (37%), Gaps = 32/220 (14%)

Query: 210 ENLIGAGNFGSVYKGILFESTT---AVAVKVFNV-LHHDAS--KSFAVECEVTRNIRHRN 263
             L+G G  G VY+    E T     VA+K+ +  L  D         E      ++  +
Sbjct: 39  RRLVGRGGMGDVYEA---EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           +V +     G    G  +  +    +    L   +          +  G L   + + I 
Sbjct: 96  VVPIHD--FGEI-DGQLY--VDMRLINGVDLAAML----------RRQGPLAPPRAVAIV 140

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ--TRSIG 381
             +   L   H        H D+KP NIL+  +  AY+ DFGIA    A  ++  T+   
Sbjct: 141 RQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIAS---ATTDEKLTQLGN 194

Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             GT  Y+APE       +   D+Y+   +L E  TG  P
Sbjct: 195 TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  109 bits (276), Expect = 2e-27
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 27/218 (12%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-KSFAVECEVTRNIRHRNLVKVF 268
              IG G FG V  G    +   VAVK    + +DA+ ++F  E  V   +RH NLV++ 
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNK--VAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQLL 80

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                   +      +V E+MA GSL +++        R +    L     L  ++DV  
Sbjct: 81  GVIV----EEKGGLYIVTEYMAKGSLVDYL--------RSRGRSVLGGDCLLKFSLDVCE 128

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            ++YL         H DL   N+L+ ++  A VSDFG+ +   +  +  + + V+ T   
Sbjct: 129 AMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-LPVKWT--- 181

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            APE     + S+  DV+SFGILL E+++ G  P   +
Sbjct: 182 -APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  114 bits (288), Expect = 2e-27
 Identities = 45/215 (20%), Positives = 78/215 (36%), Gaps = 31/215 (14%)

Query: 212 LIGAGNFGSVYKGI-LFESTTAVAVKVFNVLHH----DASKSFAVECEVTRNIRHRNLVK 266
            I  G  G +Y  +    +   V +K    L H    +A      E +    + H ++V+
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKG---LVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +F      D  G+    +V E++   SL+                  L   + +   +++
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------------QKLPVAEAIAYLLEI 191

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
              L YLH      + + DLKP NI+L +E    + D G    +           + GT 
Sbjct: 192 LPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGYLYGTP 241

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           G+ APE        +  D+Y+ G  L  +   L  
Sbjct: 242 GFQAPEIVRTGPTVA-TDIYTVGRTLAALTLDLPT 275

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  110 bits (276), Expect = 3e-27
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 24/215 (11%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
           ++G G +G VY G    +   +A+K         S+    E  + ++++H+N+V+     
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL--- 85

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
            G   +    K +  E +  GSL   +       +    P   N          +   LK
Sbjct: 86  -GSFSENGFIK-IFMEQVPGGSLSALL-------RSKWGPLKDNEQTIGFYTKQILEGLK 136

Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEM-TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           YLH +    I H D+K  N+L++       +SDFG ++ L   +  T +    GT  Y+A
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMA 191

Query: 391 PE----YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           PE       G+  ++  D++S G  ++EM TG  P
Sbjct: 192 PEIIDKGPRGYGKAA--DIWSLGCTIIEMATGKPP 224

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  109 bits (274), Expect = 3e-27
 Identities = 63/224 (28%), Positives = 97/224 (43%), Gaps = 35/224 (15%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKV 267
              IG+G FG V+ G    +   VA+K    +   A   + F  E EV   + H  LV++
Sbjct: 13  VQEIGSGQFGLVHLGYW-LNKDKVAIKT---IREGAMSEEDFIEEAEVMMKLSHPKLVQL 68

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           +    GV  +      LV EFM +G L +++             G   +   L + +DV 
Sbjct: 69  Y----GVCLEQAPI-CLVTEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVC 114

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YL    +  + H DL   N L+ +     VSDFG+ RF+   D+ T S G      
Sbjct: 115 EGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTG-----T 165

Query: 388 YI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
                  +PE       SS  DV+SFG+L+ E+F+ G  P ++ 
Sbjct: 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  109 bits (274), Expect = 4e-27
 Identities = 58/241 (24%), Positives = 96/241 (39%), Gaps = 33/241 (13%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F    LIG+G FG V+K           +K     +  A +    E +    + H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68

Query: 267 VFTACSGVDFQGNDFKA-----------LVYEFMANGSLEEWMHPITEEDKRHKAPGNLN 315
                 G D+                  +  EF   G+LE+W+       KR      L+
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE------KRRGEK--LD 120

Query: 316 SLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE 375
            +  L +   +   + Y+H      + + DLKPSNI L D     + DFG+   L+   +
Sbjct: 121 KVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177

Query: 376 QTRSIGVEGTTGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR 433
           +TRS    GT  Y++PE      +      D+Y+ G++L E+      + +  K   +LR
Sbjct: 178 RTRSK---GTLRYMSPEQISSQDYGKEV--DLYALGLILAELLHVCDTAFETSKFFTDLR 232

Query: 434 N 434
           +
Sbjct: 233 D 233

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  111 bits (278), Expect = 4e-27
 Identities = 23/241 (9%), Positives = 62/241 (25%), Gaps = 40/241 (16%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNV---LHHDASKSFAVECEVTRNIRHRNLVKVF 268
            +  G+   V+     E     A+KVF +         +           +   +  +  
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 269 TACSGVDFQ-----------------GNDFKA----LVYEFMANGSLEEWMHPITEEDKR 307
                +                     +D+      L+    +   LE      +  D  
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELL---FSTLDFV 184

Query: 308 HKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA 367
           +   G+   L    +   +  +   L       + H    P N+ +  +    + D    
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 368 RFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDD 424
                   +  +        Y   E+ +    +++    + +  G+ +  ++    P   
Sbjct: 242 W---KVGTRGPASS--VPVTYAPREF-LNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295

Query: 425 M 425
           +
Sbjct: 296 V 296

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  110 bits (276), Expect = 5e-27
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 37/229 (16%)

Query: 210 ENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDAS----KSFAVECEVTRNIRHR 262
           E +IG+G+ G V  G L    +    VA+K    L    +    + F  E  +     H 
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA---LKAGYTERQRRDFLSEASIMGQFDHP 110

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N++++    +    +G     +V E+M NGSL+ ++       + H   G    ++ + +
Sbjct: 111 NIIRLEGVVT----RGRLA-MIVTEYMENGSLDTFL-------RTHD--GQFTIMQLVGM 156

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
              V   ++YL         H DL   N+L+D  +   VSDFG++R LE   +   +   
Sbjct: 157 LRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT--- 210

Query: 383 EGTTGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             T G I     APE       SS  DV+SFG+++ E+   G RP  +M
Sbjct: 211 -TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  110 bits (276), Expect = 6e-27
 Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 34/224 (15%)

Query: 213 IGAGNFGSVYKGILF----ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +G+G FG+VYKG+      +    VA+K         +      E  V  ++ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C     Q      L+ + M  G L +++       + HK   N+ S   LN  + +A
Sbjct: 83  LGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLNWCVQIA 127

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G     G
Sbjct: 128 KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179

Query: 388 YI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            +     A E  +    +   DV+S+G+ + E+ T G +P D +
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  108 bits (273), Expect = 6e-27
 Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 39/229 (17%)

Query: 210 ENLIGAGNFGSVYKGIL--FESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVK 266
           +  +G GNFGSV +G+    +    VA+KV       A       E ++   + +  +V+
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +   C            LV E    G L +++          +    +       +   V
Sbjct: 75  LIGVCQAEALM------LVMEMAGGGPLHKFL-------VGKR--EEIPVSNVAELLHQV 119

Query: 327 ACVLKYL---HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           +  +KYL   +        H DL   N+LL +   A +SDFG+++ L A D    +    
Sbjct: 120 SMGMKYLEEKNF------VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA---- 169

Query: 384 GTTG------YIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             +       + APE     + SS  DV+S+G+ + E  + G +P   M
Sbjct: 170 -RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  108 bits (273), Expect = 9e-27
 Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 29/218 (13%)

Query: 210 ENLIGAGNFGSVYKGILF----ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNL 264
              +G G+FG V           +   VAVK           +    E E+ RN+ H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK    C+     G +   L+ EF+ +GSL+E++        ++K    +N  ++L  A+
Sbjct: 86  VKYKGICTE---DGGNGIKLIMEFLPSGSLKEYL-------PKNK--NKINLKQQLKYAV 133

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +   + YL         H DL   N+L++ E    + DFG+ + +E   E         
Sbjct: 134 QICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV----K 186

Query: 385 TTGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT 417
                     APE  M  +     DV+SFG+ L E+ T
Sbjct: 187 DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  113 bits (283), Expect = 9e-27
 Identities = 53/243 (21%), Positives = 93/243 (38%), Gaps = 35/243 (14%)

Query: 196 SYRMLYNATKGFSSENL-----IGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASK 247
           +Y M          E +     IG G FG V++GI         AVA+K       D+ +
Sbjct: 376 TYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR 435

Query: 248 S-FAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK 306
             F  E    R   H ++VK+    +           ++ E    G L  ++       +
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENPVW------IIMELCTLGELRSFL-------Q 482

Query: 307 RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI 366
             K   +L+    +  A  ++  L YL         H D+   N+L+       + DFG+
Sbjct: 483 VRK--FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGL 537

Query: 367 ARFLEAADEQTRSIG---VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPS 422
           +R++E +     S G   ++      APE       +S  DV+ FG+ + E+   G++P 
Sbjct: 538 SRYMEDSTYYKASKGKLPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593

Query: 423 DDM 425
             +
Sbjct: 594 QGV 596

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  108 bits (273), Expect = 9e-27
 Identities = 52/277 (18%), Positives = 105/277 (37%), Gaps = 39/277 (14%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLV 265
           F     +G G FG V++          A+K   + + + ++   + E +    + H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 266 KVFTAC----SGVDFQGNDFKALVY---EFMANGSLEEWMHPITEEDKRHKAPGNLNSLK 318
           + F A     +    Q +  K  +Y   +     +L++WM                    
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-------NGRCTIEERERSV 119

Query: 319 RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
            L+I + +A  +++LH      + H DLKPSNI    +    V DFG+   ++  +E+  
Sbjct: 120 CLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176

Query: 379 SIGVE----------GTTGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMF 426
            +             GT  Y++PE  +G  +      D++S G++L E+        +  
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV--DIFSLGLILFELLYPFSTQMERV 234

Query: 427 KDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECL 463
           +   ++RN     L  +           +  ++ + L
Sbjct: 235 RTLTDVRNLKFPPLFTQ-------KYPCEYVMVQDML 264

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  108 bits (272), Expect = 1e-26
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 47/230 (20%)

Query: 213 IGAGNFGSVYKGIL--FESTTAVAVKVF--NVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           +G+GNFG+V KG     +    VAVK+                E  V + + +  +V++ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             C    +       LV E    G L +++          +   ++     + +   V+ 
Sbjct: 85  GICEAESWM------LVMEMAELGPLNKYL----------QQNRHVKDKNIIELVHQVSM 128

Query: 329 VLKYL---HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
            +KYL   +        H DL   N+LL  +  A +SDFG+++ L A +   ++      
Sbjct: 129 GMKYLEESNF------VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA-----Q 177

Query: 386 TG------YIAPE---YGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
           T       + APE   Y    + SS  DV+SFG+L+ E F+ G +P   M
Sbjct: 178 THGKWPVKWYAPECINYY---KFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  108 bits (271), Expect = 1e-26
 Identities = 57/236 (24%), Positives = 98/236 (41%), Gaps = 46/236 (19%)

Query: 210 ENLIGAGNFGSVYKGIL-------FESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHR 262
              +G G F  ++KG+            T V +KV +  H + S+SF     +   + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           +LV  +    GV   G++   LV EF+  GSL+ ++       K++K    +N L +L +
Sbjct: 73  HLVLNY----GVCVCGDEN-ILVQEFVKFGSLDTYL-------KKNK--NCINILWKLEV 118

Query: 323 AIDVACVLKYL---HLDCQPPIAHCDLKPSNILLDDEMTAY--------VSDFGIARFLE 371
           A  +A  + +L    L       H ++   NILL  E            +SD GI+  + 
Sbjct: 119 AKQLAAAMHFLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172

Query: 372 AADEQTRSIGVEGTTGYIAPE-YGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             D     I       ++ PE       ++   D +SFG  L E+ + G +P   +
Sbjct: 173 PKDILQERI------PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  108 bits (271), Expect = 1e-26
 Identities = 50/227 (22%), Positives = 89/227 (39%), Gaps = 36/227 (15%)

Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLV 265
              IG G FG V++GI         AVA+K       D+ +  F  E    R   H ++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           K+    +           ++ E    G L  ++       +  K   +L+    +  A  
Sbjct: 80  KLIGVITENPVW------IIMELCTLGELRSFL-------QVRK--YSLDLASLILYAYQ 124

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG---V 382
           ++  L YL         H D+   N+L+       + DFG++R++E +     S G   +
Sbjct: 125 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 181

Query: 383 EGTTGYIAPE---YGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
           +      APE   +      +S  DV+ FG+ + E+   G++P   +
Sbjct: 182 KWM----APESINFRR---FTSASDVWMFGVCMWEILMHGVKPFQGV 221

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  108 bits (271), Expect = 2e-26
 Identities = 60/240 (25%), Positives = 99/240 (41%), Gaps = 33/240 (13%)

Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLV 265
             +IG G+FG VY G L          AVK  N +      S F  E  + ++  H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
            +   C     +G+    +V  +M +G L  ++              N      +   + 
Sbjct: 90  SLLGICL--RSEGSPL--VVLPYMKHGDLRNFIR---------NETHNPTVKDLIGFGLQ 136

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           VA  +KYL         H DL   N +LD++ T  V+DFG+AR +   +       V   
Sbjct: 137 VAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNK 189

Query: 386 TG------YIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS 438
           TG      ++A E     + ++  DV+SFG+LL E+ T G  P  D+  +  ++   +  
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQ 247

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  107 bits (269), Expect = 2e-26
 Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 41/227 (18%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKV 267
              +G G FG V  G        VA+K+   +   +     F  E +V  N+ H  LV++
Sbjct: 29  LKELGTGQFGVVKYGKW-RGQYDVAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQL 84

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           +    GV  +      ++ E+MANG L  ++       +  +      + + L +  DV 
Sbjct: 85  Y----GVCTKQRPI-FIITEYMANGCLLNYL-------REMR--HRFQTQQLLEMCKDVC 130

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             ++YL         H DL   N L++D+    VSDFG++R++   DE T S+G      
Sbjct: 131 EAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVG-----S 181

Query: 388 YI-----APE---YGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
                   PE   Y      SS  D+++FG+L+ E+++ G  P +  
Sbjct: 182 KFPVRWSPPEVLMYSK---FSSKSDIWAFGVLMWEIYSLGKMPYERF 225

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  107 bits (270), Expect = 2e-26
 Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 31/223 (13%)

Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLV 265
           + +IG G+FG VY G      ++    A+K  + +        F  E  + R + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
            +     G+         ++  +M +G L +++       +  +   N      ++  + 
Sbjct: 86  ALI----GIMLPPEGLPHVLLPYMCHGDLLQFI-------RSPQ--RNPTVKDLISFGLQ 132

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG- 384
           VA  ++YL    +    H DL   N +LD+  T  V+DFG+AR +   +  +        
Sbjct: 133 VARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189

Query: 385 -----TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
                T    A E    +  ++  DV+SFG+LL E+ T G  P
Sbjct: 190 LPVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  108 bits (271), Expect = 2e-26
 Identities = 59/305 (19%), Positives = 102/305 (33%), Gaps = 46/305 (15%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
              +G G F  V            A+K          +    E ++ R   H N++++  
Sbjct: 34  IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C       ++   L+  F   G+L   +      ++       L   + L + + +   
Sbjct: 94  YCLRERGAKHEAW-LLLPFFKRGTLWNEI------ERLKDKGNFLTEDQILWLLLGICRG 146

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE------ 383
           L+ +H       AH DLKP+NILL DE    + D G         E +R           
Sbjct: 147 LEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203

Query: 384 -GTTGYIAPE-------YGMGHEVSSYGDVYSFGILLLEMFTGLRP--SDDMFKDNLNLR 433
             T  Y APE         +        DV+S G +L  M  G  P        D++ L 
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERT----DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259

Query: 434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL 493
              + ++P+          S + S  L  L++      +     P +R  I  +  +L  
Sbjct: 260 VQNQLSIPQ----------SPRHSSALWQLLN------SMMTVDPHQRPHIPLLLSQLEA 303

Query: 494 IKKKL 498
           ++   
Sbjct: 304 LQPPA 308

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  107 bits (270), Expect = 3e-26
 Identities = 56/248 (22%), Positives = 81/248 (32%), Gaps = 39/248 (15%)

Query: 184 GNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH 243
                  S  Y   R      + F   + +G G++G V+K    E     AVK       
Sbjct: 36  EASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR 95

Query: 244 DASKSFAVECEVT---RNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSL----EE 296
                     EV    +  +H   V++  A     ++      L  E     SL    E 
Sbjct: 96  GPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----WEEGGILYLQTEL-CGPSLQQHCEA 149

Query: 297 WMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE 356
           W   + E                     D    L +LH      + H D+KP+NI L   
Sbjct: 150 WGASLPEAQVW-------------GYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPR 193

Query: 357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLL 413
               + DFG+   L            EG   Y+APE   G    SYG   DV+S G+ +L
Sbjct: 194 GRCKLGDFGLLVEL---GTAGAGEVQEGDPRYMAPELLQG----SYGTAADVFSLGLTIL 246

Query: 414 EMFTGLRP 421
           E+   +  
Sbjct: 247 EVACNMEL 254

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  108 bits (273), Expect = 3e-26
 Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 39/230 (16%)

Query: 210 ENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDAS----KSFAVECEVTRNIRHR 262
           + ++GAG FG V  G L    +   +VA+K    L    +    + F  E  +     H 
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKT---LKVGYTEKQRRDFLGEASIMGQFDHP 106

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N++++    +    +      +V E+M NGSL+ ++          K       ++ + +
Sbjct: 107 NIIRLEGVVT----KSKPV-MIVTEYMENGSLDSFLR---------KHDAQFTVIQLVGM 152

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
              +A  +KYL         H DL   NIL++  +   VSDFG+ R LE   E   +   
Sbjct: 153 LRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT--- 206

Query: 383 EGTTG------YIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             T G      + +PE     + +S  DV+S+GI+L E+ + G RP  +M
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  111 bits (279), Expect = 3e-26
 Identities = 52/228 (22%), Positives = 89/228 (39%), Gaps = 37/228 (16%)

Query: 210 ENLIGAGNFGSVYKGILFES--TTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVK 266
           +  +G GNFGSV +G+         VA+KV       A       E ++   + +  +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +   C            LV E    G L +++          +    +       +   V
Sbjct: 401 LIGVCQAEALM------LVMEMAGGGPLHKFL-------VGKR--EEIPVSNVAELLHQV 445

Query: 327 ACVLKYL---HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
           +  +KYL   +        H +L   N+LL +   A +SDFG+++ L A D    +    
Sbjct: 446 SMGMKYLEEKNF------VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA---- 495

Query: 384 GTTGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
            + G       APE     + SS  DV+S+G+ + E  + G +P   M
Sbjct: 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  106 bits (268), Expect = 4e-26
 Identities = 57/236 (24%), Positives = 99/236 (41%), Gaps = 43/236 (18%)

Query: 210 ENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRN 263
              +G   FG VYKG LF     E T AVA+K          +  F  E  +   ++H N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW------MHPITEEDKRHKAPGNLNSL 317
           +V +    +    +     ++++ + ++G L E+         +   D        L   
Sbjct: 74  VVCLLGVVT----KDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 318 KRLNIAIDVACVLKYL---HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD 374
             +++   +A  ++YL   H      + H DL   N+L+ D++   +SD G+ R + AAD
Sbjct: 129 DFVHLVAQIAAGMEYLSSHH------VVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182

Query: 375 EQTRSIGVEGTTGYI-----APE---YGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
                         +     APE   YG     S   D++S+G++L E+F+ GL+P
Sbjct: 183 YYKL-----LGNSLLPIRWMAPEAIMYGK---FSIDSDIWSYGVVLWEVFSYGLQP 230

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  107 bits (269), Expect = 4e-26
 Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 36/223 (16%)

Query: 212 LIGAGNFGSVYKG---ILFESTTAVAVKVFNV-LHHDAS--KSFAVECEVTRNIRHRNLV 265
           ++G G    V+             VAVKV    L  D S    F  E +    + H  +V
Sbjct: 19  ILGFGGMSEVHLARDLRDHRD---VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 266 KVFTACSGVDFQGNDFKA------LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
            V+      D  G           +V E++   +L +    +  E       G +   + 
Sbjct: 76  AVY------D-TGEAETPAGPLPYIVMEYVDGVTLRDI---VHTE-------GPMTPKRA 118

Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL-EAADEQTR 378
           + +  D    L + H   Q  I H D+KP+NI++       V DFGIAR + ++ +  T+
Sbjct: 119 IEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175

Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           +  V GT  Y++PE   G  V +  DVYS G +L E+ TG  P
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  108 bits (272), Expect = 4e-26
 Identities = 59/243 (24%), Positives = 102/243 (41%), Gaps = 39/243 (16%)

Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASKS----FAVECEVTRNIRHR 262
             +IG G+FG VY G L          AVK    L+          F  E  + ++  H 
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS---LNRITDIGEVSQFLTEGIIMKDFSHP 150

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           N++ +   C     +G+    +V  +M +G L  ++        R++   N      +  
Sbjct: 151 NVLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFI--------RNETH-NPTVKDLIGF 197

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
            + VA  +K+L         H DL   N +LD++ T  V+DFG+AR +   +  +    V
Sbjct: 198 GLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS----V 250

Query: 383 EGTTG------YIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNC 435
              TG      ++A E     + ++  DV+SFG+LL E+ T G  P  D+  +  ++   
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVY 308

Query: 436 VKS 438
           +  
Sbjct: 309 LLQ 311

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  106 bits (268), Expect = 6e-26
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 25/221 (11%)

Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVK 266
           +G G+FG VY+G+       E  T VA+K  N       +  F  E  V +     ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +    S    QG     ++ E M  G L+ ++  +      +      +  K + +A ++
Sbjct: 93  LLGVVS----QGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
           A  + YL+        H DL   N ++ ++ T  + DFG+ R +   D   +     G  
Sbjct: 148 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK-----GGK 199

Query: 387 GYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           G +     +PE       ++Y DV+SFG++L E+ T   +P
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  107 bits (269), Expect = 6e-26
 Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 35/228 (15%)

Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKV 267
           +G G FG V+          +    VAVK        A + F  E E+   ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWM-----HPITEEDKRHKAPGNLNSLKRLNI 322
           F  C+    +G     +V+E+M +G L  ++                APG L   + L +
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 323 AIDVACVLKYL---HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
           A  VA  + YL   H        H DL   N L+   +   + DFG++R + + D     
Sbjct: 164 ASQVAAGMVYLAGLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV- 216

Query: 380 IGVEGTTGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
               G    +      PE  +  + ++  DV+SFG++L E+FT G +P
Sbjct: 217 ----GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  105 bits (265), Expect = 7e-26
 Identities = 59/224 (26%), Positives = 93/224 (41%), Gaps = 35/224 (15%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKV 267
              +G+G FG V  G   +    VAVK+   +   +     F  E +    + H  LVK 
Sbjct: 13  LKELGSGQFGVVKLGKW-KGQYDVAVKM---IKEGSMSEDEFFQEAQTMMKLSHPKLVKF 68

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           +    GV  +      +V E+++NG L  ++               L   + L +  DV 
Sbjct: 69  Y----GVCSKEYPI-YIVTEYISNGCLLNYLR---------SHGKGLEPSQLLEMCYDVC 114

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + +L         H DL   N L+D ++   VSDFG+ R++   D+   S+G      
Sbjct: 115 EGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVG-----T 165

Query: 388 YI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
                  APE     + SS  DV++FGIL+ E+F+ G  P D  
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  105 bits (265), Expect = 9e-26
 Identities = 57/237 (24%), Positives = 98/237 (41%), Gaps = 30/237 (12%)

Query: 210 ENLIGAGNFGSVYKGILF----ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV 265
              +G GNFGSV           +   VAVK       +  + F  E E+ ++++H N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           K    C      G     L+ E++  GSL +++       ++HK    ++ +K L     
Sbjct: 75  KYKGVCYS---AGRRNLKLIMEYLPYGSLRDYL-------QKHK--ERIDHIKLLQYTSQ 122

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +   ++YL         H DL   NIL+++E    + DFG+ + L    E  +       
Sbjct: 123 ICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV-----K 174

Query: 386 TG------YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV 436
                   + APE     + S   DV+SFG++L E+FT +  S     + + +    
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  105 bits (264), Expect = 1e-25
 Identities = 45/229 (19%), Positives = 91/229 (39%), Gaps = 40/229 (17%)

Query: 210 ENLIGAGNFGSVYKGIL---FESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLV 265
             ++G G FG VY+G+          VAVK         +K  F  E  + +N+ H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           K+                ++ E    G L  ++       +R+K   +L  L  +  ++ 
Sbjct: 77  KLIGIIEEEPTW------IIMELYPYGELGHYL-------ERNK--NSLKVLTLVLYSLQ 121

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +   + YL         H D+   NIL+       + DFG++R++E  ++  ++      
Sbjct: 122 ICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASV---- 173

Query: 386 TGYI-----APE---YGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
              +     +PE   +      ++  DV+ F + + E+ + G +P   +
Sbjct: 174 -TRLPIKWMSPESINFRR---FTTASDVWMFAVCMWEILSFGKQPFFWL 218

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  106 bits (266), Expect = 1e-25
 Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 34/228 (14%)

Query: 210 ENLIGAGNFGSVYKGIL----FESTTAVAVKVFNVLHHDAS----KSFAVECEVTRNIRH 261
           + +IGAG FG VYKG+L     +    VA+K    L    +      F  E  +     H
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT---LKAGYTEKQRVDFLGEAGIMGQFSH 105

Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            N++++     GV  +      ++ E+M NG+L++++       +     G  + L+ + 
Sbjct: 106 HNIIRLE----GVISKYKPM-MIITEYMENGALDKFL-------REKD--GEFSVLQLVG 151

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           +   +A  +KYL         H DL   NIL++  +   VSDFG++R LE   E T +  
Sbjct: 152 MLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-- 206

Query: 382 VEGTTGYI---APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDM 425
             G    I   APE     + +S  DV+SFGI++ E+ T G RP  ++
Sbjct: 207 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  106 bits (266), Expect = 1e-25
 Identities = 66/230 (28%), Positives = 99/230 (43%), Gaps = 43/230 (18%)

Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVK 266
           +G G FG VY+G +       S   VAVK    +  +  +  F +E  +     H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C GV  Q      ++ E MA G L+ ++    E   R   P +L  L  L++A D+
Sbjct: 98  ----CIGVSLQSLPR-FILMELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 149

Query: 327 ACVLKYL---HLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTRSI 380
           AC  +YL   H        H D+   N LL        A + DFG+AR +  A    +  
Sbjct: 150 ACGCQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK-- 201

Query: 381 GVEGTTGYI-----APE---YGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
              G    +      PE    G+    +S  D +SFG+LL E+F+ G  P
Sbjct: 202 ---GGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFSLGYMP 245

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  105 bits (264), Expect = 1e-25
 Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 36/229 (15%)

Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKV 267
           +G G FG V+    +     +    VAVK        A K F  E E+  N++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEW------MHPITEEDKRHKAPGNLNSLKRLN 321
           +  C      G+    +V+E+M +G L ++         I  + +  +A G L   + L+
Sbjct: 83  YGVCG----DGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           IA  +A  + YL         H DL   N L+   +   + DFG++R + + D       
Sbjct: 138 IASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV--- 191

Query: 382 VEGTTGYI-----APE---YGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
             G    +      PE   Y      ++  DV+SFG++L E+FT G +P
Sbjct: 192 --GGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVILWEIFTYGKQP 235

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  105 bits (265), Expect = 2e-25
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 28/217 (12%)

Query: 210 ENLIGAGNFGSVYKGILF----ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV 265
              +G GNFGSV           +   VAVK       +  + F  E E+ ++++H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           K    C      G     L+ E++  GSL +++       ++HK    ++ +K L     
Sbjct: 106 KYKGVCYS---AGRRNLKLIMEYLPYGSLRDYL-------QKHK--ERIDHIKLLQYTSQ 153

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +   ++YL         H DL   NIL+++E    + DFG+ + L    E  +       
Sbjct: 154 ICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV----KE 206

Query: 386 TGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT 417
            G       APE     + S   DV+SFG++L E+FT
Sbjct: 207 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  104 bits (262), Expect = 3e-25
 Identities = 63/296 (21%), Positives = 112/296 (37%), Gaps = 31/296 (10%)

Query: 178 MCMKKRGNPTPSI----SFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAV 233
           M  + +G   P +        +   M YN    F  E  IG G F  VY+         V
Sbjct: 1   MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPV 60

Query: 234 AVKVFNVLHHDASK---SFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMA 290
           A+K   +     +K       E ++ + + H N++K + +     F  ++   +V E   
Sbjct: 61  ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS-----FIEDNELNIVLELAD 115

Query: 291 NGSLEEWMHPITEEDKRHKAPGNLNSLKR-LNIAIDVACVLKYLHLDCQPPIAHCDLKPS 349
            G L   +       K  K    L   +      + +   L+++H      + H D+KP+
Sbjct: 116 AGDLSRMI-------KHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPA 165

Query: 350 NILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFG 409
           N+ +       + D G+ RF  +      S  + GT  Y++PE    +  +   D++S G
Sbjct: 166 NVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLG 223

Query: 410 ILLLEMFTGLRPSDDMFK-DNLNLRNCVKSALPERAEEIRASSGSTQ-RSIILECL 463
            LL EM     P    F  D +NL +  K         + +   S + R ++  C+
Sbjct: 224 CLLYEMAALQSP----FYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCI 275

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  104 bits (262), Expect = 3e-25
 Identities = 53/230 (23%), Positives = 86/230 (37%), Gaps = 34/230 (14%)

Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNI-RHRNLV 265
           +GAG FG V +   +     ++   VAVK+     H   +     E +V   +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSL--------EEWMHPITEEDKRHKAPGNLNSL 317
            +  AC+     G     ++ E+   G L        + ++   T           L+  
Sbjct: 91  NLLGACT----IGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 318 KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT 377
             L+ +  VA  + +L         H DL   NILL       + DFG+AR ++      
Sbjct: 146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 378 RSIGVEGTTGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
                      +     APE       +   DV+S+GI L E+F+ G  P
Sbjct: 203 V-----KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  104 bits (261), Expect = 4e-25
 Identities = 56/280 (20%), Positives = 103/280 (36%), Gaps = 42/280 (15%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F    ++G G FG V K      +   A+K       +   +   E  +  ++ H+ +V+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVR 66

Query: 267 VFTA-----CSGVDFQGNDFKALVY---EFMANGSLEEWMHPITEEDKRHKAPGNLNSLK 318
            + A                K+ ++   E+  NG+L + +H             N    +
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH---------SENLNQQRDE 117

Query: 319 RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
              +   +   L Y+H      I H DLKP NI +D+     + DFG+A+ +  + +  +
Sbjct: 118 YWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174

Query: 379 SIGVE------------GTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSD 423
                            GT  Y+A E  +      Y    D+YS GI+  EM      S 
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATE--VLDGTGHYNEKIDMYSLGIIFFEMIYP--FST 230

Query: 424 DMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECL 463
            M  + +N+   ++S   E   +   +    ++ II   +
Sbjct: 231 GM--ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLI 268

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  105 bits (263), Expect = 4e-25
 Identities = 56/229 (24%), Positives = 93/229 (40%), Gaps = 30/229 (13%)

Query: 210 ENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNI-RHR 262
              +GAG FG V +   F     ++   VAVK+     H   K     E ++  ++ +H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH---PITEEDKRHKAPGNLNSLKR 319
           N+V +  AC+     G     ++ E+   G L  ++     + E D       +  S + 
Sbjct: 111 NIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 320 L-NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
           L + +  VA  + +L         H D+   N+LL +   A + DFG+AR +        
Sbjct: 166 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222

Query: 379 SIGVEGTTGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
                     +     APE       +   DV+S+GILL E+F+ GL P
Sbjct: 223 -----KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  104 bits (261), Expect = 5e-25
 Identities = 66/309 (21%), Positives = 113/309 (36%), Gaps = 38/309 (12%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN-VLHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           ++G G   +V++G   ++    A+KVFN +           E EV + + H+N+VK+F  
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR---LNIAIDVA 327
               +      K L+ EF   GSL   +          + P N   L     L +  DV 
Sbjct: 76  ---EEETTTRHKVLIMEFCPCGSLYTVL----------EEPSNAYGLPESEFLIVLRDVV 122

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILL----DDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
             + +L    +  I H ++KP NI+     D +    ++DFG AR LE  DEQ  S+   
Sbjct: 123 GGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-- 176

Query: 384 GTTGYIAPE-----YGMGHEVSSYG---DVYSFGILLLEMFTGLRP--SDDMFKDNLNLR 433
           GT  Y+ P+              YG   D++S G+      TG  P    +  + N  + 
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236

Query: 434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL 493
             + +  P  A      + +       + +   C +              I + +     
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGD-MPVSCSLSRGLQVLLTPVLANILEADQEKCW 295

Query: 494 IKKKLLEAP 502
              +     
Sbjct: 296 GFDQFFAET 304

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  107 bits (269), Expect = 6e-25
 Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 24/220 (10%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN-VLHHDASKSFAVECEVTRNIRHRNLVKVF-TA 270
           +G G FG V + I  ++   VA+K     L     + + +E ++ + + H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                   ND   L  E+   G L ++++       + +    L       +  D++  L
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLN-------QFENCCGLKEGPIRTLLSDISSAL 134

Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAY---VSDFGIARFLEAADEQTRSIGVEGTTG 387
           +YLH   +  I H DLKP NI+L          + D G A+ L+  +  T  +   GT  
Sbjct: 135 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTLQ 188

Query: 388 YIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDD 424
           Y+APE         Y    D +SFG L  E  TG RP   
Sbjct: 189 YLAPELLEQK---KYTVTVDYWSFGTLAFECITGFRPFLP 225

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  104 bits (262), Expect = 7e-25
 Identities = 66/230 (28%), Positives = 99/230 (43%), Gaps = 43/230 (18%)

Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVK 266
           +G G FG VY+G +       S   VAVK    +  +  +  F +E  +     H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
               C GV  Q      ++ E MA G L+ ++    E   R   P +L  L  L++A D+
Sbjct: 139 ----CIGVSLQSLPR-FILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 190

Query: 327 ACVLKYL---HLDCQPPIAHCDLKPSNILLD---DEMTAYVSDFGIARFLEAADEQTRSI 380
           AC  +YL   H        H D+   N LL        A + DFG+AR +  A    +  
Sbjct: 191 ACGCQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK-- 242

Query: 381 GVEGTTGYI-----APE---YGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
              G    +      PE    G+    +S  D +SFG+LL E+F+ G  P
Sbjct: 243 ---GGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFSLGYMP 286

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  104 bits (262), Expect = 2e-24
 Identities = 58/240 (24%), Positives = 103/240 (42%), Gaps = 35/240 (14%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLV 265
           F  ++++G G  G++    +F+    VAVK         +     E ++ R    H N++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECFSFADR---EVQLLRESDEHPNVI 81

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           + F  C+    +   F+ +  E  A  +L+E+   + ++D  H        L+ + +   
Sbjct: 82  RYF--CT---EKDRQFQYIAIELCA-ATLQEY---VEQKDFAHL------GLEPITLLQQ 126

Query: 326 VACVLKYLH-LDCQPPIAHCDLKPSNILL-----DDEMTAYVSDFGIARFLEAAD-EQTR 378
               L +LH L+    I H DLKP NIL+       ++ A +SDFG+ + L       +R
Sbjct: 127 TTSGLAHLHSLN----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182

Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFT-GLRPSDDMFKDNLNLRN 434
             GV GT G+IAPE        +     D++S G +   + + G  P     +   N+  
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  102 bits (257), Expect = 2e-24
 Identities = 58/235 (24%), Positives = 92/235 (39%), Gaps = 39/235 (16%)

Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVK 266
           +G G FG V K   F        T VAVK+       +       E  V + + H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEW--------------MHPITEEDKRHKAPG 312
           ++ ACS    Q      L+ E+   GSL  +                        H    
Sbjct: 91  LYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 313 NLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEA 372
            L     ++ A  ++  ++YL    +  + H DL   NIL+ +     +SDFG++R +  
Sbjct: 146 ALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 373 ADEQTRSIGVEGTTGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
            D   +      + G I     A E    H  ++  DV+SFG+LL E+ T G  P
Sbjct: 203 EDSYVK-----RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  104 bits (260), Expect = 2e-24
 Identities = 35/239 (14%), Positives = 74/239 (30%), Gaps = 36/239 (15%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRH------- 261
           ++G  +  +  +    E+  +  V V         +A K    E    R +R        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 262 ---------RNLVKVFTACSGVDFQGNDFKALVYEF-----MANGSLEEWMHPITEEDKR 307
                     +LVK       +  + ++    V            +L+ +   +      
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 308 HKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA 367
           HK+  +     RL + + V  +L  LH      + H  L+P +I+LD     +++ F   
Sbjct: 205 HKSLVHH---ARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258

Query: 368 RFLEAADEQTRSIGVEGTTGYIAPE--YGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
              + A   +            A        H  +      D ++ G+ +  ++    P
Sbjct: 259 V-RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  102 bits (256), Expect = 2e-24
 Identities = 52/228 (22%), Positives = 87/228 (38%), Gaps = 31/228 (13%)

Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNI-RHRNLV 265
           +G G FG V +   F      +   VAVK+       +       E ++  +I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWM------HPITEEDKRHKAPGNLNSLKR 319
            +  AC+    +      ++ EF   G+L  ++          +          L     
Sbjct: 95  NLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
           +  +  VA  +++L         H DL   NILL ++    + DFG+AR +    +  R 
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR- 206

Query: 380 IGVEGTTGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
                    +     APE       +   DV+SFG+LL E+F+ G  P
Sbjct: 207 ----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  103 bits (259), Expect = 3e-24
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 40/233 (17%)

Query: 213 IGAGNFGSVYKGILF-------ESTTAVAVKVFNVLHHDASKS----FAVECEVTRNI-R 260
           +G G FG V                T VAVK+   L  DA++        E E+ + I +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM---LKSDATEKDLSDLISEMEMMKMIGK 133

Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW------MHPITEEDKRHKAPGNL 314
           H+N++ +  AC+    Q      ++ E+ + G+L E+             +  H     L
Sbjct: 134 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 315 NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD 374
           +S   ++ A  VA  ++YL         H DL   N+L+ ++    ++DFG+AR +   D
Sbjct: 189 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245

Query: 375 EQTRSIGVEGTTGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
              +      T G +     APE       +   DV+SFG+LL E+FT G  P
Sbjct: 246 YYKK-----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  102 bits (256), Expect = 3e-24
 Identities = 64/248 (25%), Positives = 101/248 (40%), Gaps = 40/248 (16%)

Query: 210 ENLIGAGNFGSVYKGIL--FESTTAVAVKVFNVLHHDASKS----FAVECEVTRNI-RHR 262
           +++IG GNFG V K  +         A+K    +   ASK     FA E EV   +  H 
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKR---MKEYASKDDHRDFAGELEVLCKLGHHP 86

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW------MHPITEEDKRHKAPGNLNS 316
           N++ +  AC            L  E+  +G+L ++      +         +     L+S
Sbjct: 87  NIINLLGACE----HRGYL-YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141

Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
            + L+ A DVA  + YL    Q    H DL   NIL+ +   A ++DFG++R  E     
Sbjct: 142 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--- 195

Query: 377 TRSIGVEGTTGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNL 430
                V+ T G +     A E       ++  DV+S+G+LL E+ + G  P   M     
Sbjct: 196 -----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCA 248

Query: 431 NLRNCVKS 438
            L   +  
Sbjct: 249 ELYEKLPQ 256

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  103 bits (259), Expect = 3e-24
 Identities = 63/242 (26%), Positives = 99/242 (40%), Gaps = 39/242 (16%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN-VLHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           ++G G   +V++G   ++    A+KVFN +           E EV + + H+N+VK+F  
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR---LNIAIDVA 327
               +      K L+ EF   GSL   +          + P N   L     L +  DV 
Sbjct: 76  ---EEETTTRHKVLIMEFCPCGSLYTVL----------EEPSNAYGLPESEFLIVLRDVV 122

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILL----DDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
             + +L    +  I H ++KP NI+     D +    ++DFG AR LE  DEQ  S+   
Sbjct: 123 GGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-- 176

Query: 384 GTTGYIAPE-----YGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC 435
           GT  Y+ P+              YG   D++S G+      TG  P    F+     R  
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP----FRPFEGPRRN 232

Query: 436 VK 437
            +
Sbjct: 233 KE 234

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  102 bits (256), Expect = 3e-24
 Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 34/230 (14%)

Query: 213 IGAGNFGSVYKGILF-------ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNI-RHRN 263
           +G G FG V             +    VAVK+      +   S    E E+ + I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW------MHPITEEDKRHKAPGNLNSL 317
           ++ +  AC+    Q      ++ E+ + G+L E+             D        +   
Sbjct: 103 IINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 318 KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT 377
             ++    +A  ++YL         H DL   N+L+ +     ++DFG+AR +   D   
Sbjct: 158 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214

Query: 378 RSIGVEGTTGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
           +      T G +     APE       +   DV+SFG+L+ E+FT G  P
Sbjct: 215 K-----TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  102 bits (256), Expect = 4e-24
 Identities = 34/249 (13%), Positives = 79/249 (31%), Gaps = 55/249 (22%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS----------------------- 248
           ++G  +  +  +    E+  +  V V        S +                       
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 249 -----FAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITE 303
                F    ++ ++ + + +++V        +  + F   +Y  M   +L+ +   +  
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDER-DMWVLSRF--FLYPRMQ-SNLQTFGEVLLS 195

Query: 304 EDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD 363
               H    +L    RL + + V  +L  LH      + H  L+P +I+LD     +++ 
Sbjct: 196 HSSTH---KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTG 249

Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG-----------DVYSFGILL 412
           F               +    + G+  PE        SY            D ++ G+++
Sbjct: 250 FEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303

Query: 413 LEMFTGLRP 421
             ++    P
Sbjct: 304 YWIWCADLP 312

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  102 bits (255), Expect = 4e-24
 Identities = 65/308 (21%), Positives = 116/308 (37%), Gaps = 53/308 (17%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRNLVKVF 268
             ++  G F  VY+     S    A+K       + +++   E    + +  H N+V+  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 269 TACSGVDFQGNDFKALVYEFM--ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +A S    + +  +A          G L E++       K+ ++ G L+    L I    
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFL-------KKMESRGPLSCDTVLKIFYQT 145

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS------- 379
              ++++H   +PPI H DLK  N+LL ++ T  + DFG A  +    + + S       
Sbjct: 146 CRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204

Query: 380 ---IGVEGTTGYIAPE-------YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN 429
              I    T  Y  PE       + +G +     D+++ G +L  +     P    F+D 
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQ----DIWALGCILYLLCFRQHP----FEDG 256

Query: 430 LNLRNC-VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVE 488
             LR    K ++P              +  +   LI       A     P ER+ I +V 
Sbjct: 257 AKLRIVNGKYSIPP----------HDTQYTVFHSLIR------AMLQVNPEERLSIAEVV 300

Query: 489 PRLRLIKK 496
            +L+ I  
Sbjct: 301 HQLQEIAA 308

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  101 bits (254), Expect = 5e-24
 Identities = 54/320 (16%), Positives = 106/320 (33%), Gaps = 80/320 (25%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLV 265
           F     +G G FG V++          A+K   + + + ++   + E +    + H  +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 266 KVFTACSGVDFQGNDF-------------------------------------------- 281
           + F A      +                                                
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 282 -----KALVY---EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYL 333
                K  +Y   +     +L++WM        R  +  +      L+I I +A  +++L
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWM-------NRRCSLEDREHGVCLHIFIQIAEAVEFL 180

Query: 334 HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE---------- 383
           H      + H DLKPSNI    +    V DFG+   ++  +E+   +             
Sbjct: 181 H---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237

Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER 443
           GT  Y++PE   G+  S   D++S G++L E+        +  +   ++RN     L  +
Sbjct: 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQ 297

Query: 444 AEEIRASSGSTQRSIILECL 463
                      +  ++ + L
Sbjct: 298 -------KYPQEHMMVQDML 310

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  101 bits (255), Expect = 5e-24
 Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 39/238 (16%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
            +G G F   ++    ++    A K+     +L     +  ++E  + R++ H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRLNIAID 325
                  F+ NDF  +V E     SL E       +TE + R+                 
Sbjct: 108 GF-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-------------YLRQ 149

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +    +YLH   +  + H DLK  N+ L++++   + DFG+A  +E   E+ + +   GT
Sbjct: 150 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GT 204

Query: 386 TGYIAPE--YGMGH--EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA 439
             YIAPE     GH  EV    DV+S G ++  +  G  P +            +K  
Sbjct: 205 PNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPPFET--SCLKETYLRIKKN 256

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  101 bits (254), Expect = 6e-24
 Identities = 64/244 (26%), Positives = 99/244 (40%), Gaps = 57/244 (23%)

Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKS----FAVECEVTRNIRHRN 263
           IG G FG V++         E  T VAVK+   L  +AS      F  E  +     + N
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKM---LKEEASADMQADFQREAALMAEFDNPN 111

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW--------------MHPITEEDKRHK 309
           +VK+   C+     G     L++E+MA G L E+                  T       
Sbjct: 112 IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 310 APGNLNSLKRLNIAIDVACVLKYL---HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI 366
            P  L+  ++L IA  VA  + YL            H DL   N L+ + M   ++DFG+
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERK------FVHRDLATRNCLVGENMVVKIADFGL 220

Query: 367 ARFLEAADEQTRSIGVEGTTGYI-----APE---YGMGHEVSSYGDVYSFGILLLEMFT- 417
           +R + +AD              I      PE   Y      ++  DV+++G++L E+F+ 
Sbjct: 221 SRNIYSADYYKA-----DGNDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSY 272

Query: 418 GLRP 421
           GL+P
Sbjct: 273 GLQP 276

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  100 bits (252), Expect = 7e-24
 Identities = 53/215 (24%), Positives = 85/215 (39%), Gaps = 31/215 (14%)

Query: 213 IGAGNFGSVYKGIL----FESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLVKV 267
           +G G+FG V           +   VAVK          +S +  E ++ R + H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              C            LV E++  GSL +++        RH     +   + L  A  + 
Sbjct: 99  KGCCEDAGAASL---QLVMEYVPLGSLRDYL-------PRHS----IGLAQLLLFAQQIC 144

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YLH        H DL   N+LLD++    + DFG+A+ +    E  R        G
Sbjct: 145 EGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV----REDG 197

Query: 388 YI-----APEYGMGHEVSSYGDVYSFGILLLEMFT 417
                  APE    ++     DV+SFG+ L E+ T
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  101 bits (254), Expect = 8e-24
 Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 26/218 (11%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLV 265
           F   + +GAGN G V+K     S   +A K+ ++    A ++  + E +V        +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
                  G  +   +   +  E M  GSL          D+  K  G +       ++I 
Sbjct: 95  G----FYGAFYSDGEIS-ICMEHMDGGSL----------DQVLKKAGRIPEQILGKVSIA 139

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           V   L YL    +  I H D+KPSNIL++      + DFG++  L  +   +      GT
Sbjct: 140 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GT 193

Query: 386 TGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             Y++PE   G  + V S  D++S G+ L+EM  G  P
Sbjct: 194 RSYMSPERLQGTHYSVQS--DIWSMGLSLVEMAVGRYP 229

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  100 bits (251), Expect = 9e-24
 Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 39/238 (16%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
            +G G F   ++    ++    A K+     +L     +  ++E  + R++ H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRLNIAID 325
                  F+ NDF  +V E     SL E       +TE + R+                 
Sbjct: 82  GF-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-------------YLRQ 123

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +    +YLH   +  + H DLK  N+ L++++   + DFG+A  +E   E+ + +   GT
Sbjct: 124 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GT 178

Query: 386 TGYIAPE--YGMGH--EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA 439
             YIAPE     GH  EV    DV+S G ++  +  G  P +            +K  
Sbjct: 179 PNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPPFET--SCLKETYLRIKKN 230

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 47/215 (21%), Positives = 82/215 (38%), Gaps = 17/215 (7%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVFT 269
            IG G++G   K         +  K  +      +  +    E  + R ++H N+V+ + 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR-LNIAIDVAC 328
               +D        +V E+   G L   +        +          +  L +   +  
Sbjct: 73  --RIIDRTNTTLY-IVMEYCEGGDLASVI-------TKGTKERQYLDEEFVLRVMTQLTL 122

Query: 329 VLKYLH--LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
            LK  H   D    + H DLKP+N+ LD +    + DFG+AR L       ++    GT 
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTP 180

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            Y++PE       +   D++S G LL E+   + P
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  101 bits (253), Expect = 1e-23
 Identities = 55/233 (23%), Positives = 94/233 (40%), Gaps = 40/233 (17%)

Query: 213 IGAGNFGSVYKGILF-------ESTTAVAVKVFNVLHHDASKS----FAVECEVTRNI-R 260
           +G G FG V             +    VAVK+   L  DA++        E E+ + I +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW------MHPITEEDKRHKAPGNL 314
           H+N++ +  AC+    Q      ++ E+ + G+L E+             D        +
Sbjct: 146 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 315 NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD 374
                ++    +A  ++YL         H DL   N+L+ +     ++DFG+AR +   D
Sbjct: 201 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257

Query: 375 EQTRSIGVEGTTGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
              +      T G +     APE       +   DV+SFG+L+ E+FT G  P
Sbjct: 258 YYKK-----TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  100 bits (252), Expect = 1e-23
 Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 30/217 (13%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVFT 269
            IG G+FG        E      +K  N+    +   +    E  V  N++H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWM-----HPITEEDKRHKAPGNLNSLKRLNIAI 324
           +     F+ N    +V ++   G L + +         E+             + L+  +
Sbjct: 91  S-----FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED-------------QILDWFV 132

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +   LK++H      I H D+K  NI L  + T  + DFGIAR L +  E  R+    G
Sbjct: 133 QICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIG 187

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           T  Y++PE       ++  D+++ G +L E+ T    
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  102 bits (257), Expect = 2e-23
 Identities = 26/116 (22%), Positives = 48/116 (41%), Gaps = 3/116 (2%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAI-SNNFGSCTSLEQLDMHGNLFAGPI 59
           D+S+ +     +    GLSSL +  ++GN        + F    +L  LD+         
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            ++ +SL  L+VL++S NN              LQ L+ S N+  +    +   ++
Sbjct: 487 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT--SKKQELQH 540

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  100 bits (252), Expect = 9e-23
 Identities = 27/115 (23%), Positives = 45/115 (39%), Gaps = 1/115 (0%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DLS N L    S        L + ++S   +       + S + L  L + GN       
Sbjct: 34  DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLAL 93

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            + S L  L+ L   + NL+      +   K L+ LN+++N  +S   +   F N
Sbjct: 94  GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FKLPEYFSN 147

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 97.4 bits (243), Expect = 1e-21
 Identities = 28/105 (26%), Positives = 44/105 (41%), Gaps = 2/105 (1%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            ++ N+      P     L +L+  ++S   L       F S +SL+ L+M  N F    
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 510

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAG-FKFLQNLNLSYNNF 103
                 L  L+VLD S N++     + L      L  LNL+ N+F
Sbjct: 511 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 93.9 bits (234), Expect = 1e-20
 Identities = 35/118 (29%), Positives = 49/118 (41%), Gaps = 5/118 (4%)

Query: 1   DLSNNNLS--GTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGP 58
           DLS N LS  G  S    G +SL   ++S N +   +S+NF     LE LD   +     
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQM 411

Query: 59  I-GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
              S   SLR L  LD+S  +          G   L+ L ++ N+F+       IF  
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTE 468

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 86.2 bits (214), Expect = 4e-18
 Identities = 29/126 (23%), Positives = 49/126 (38%), Gaps = 7/126 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLL-SGAISNNFGSCTSLEQLDMHGNLFAGPI 59
                NL+   +  +  L +L   NV+ NL+ S  +   F + T+LE LD+  N      
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165

Query: 60  GSSLSSLRGLRV----LDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            + L  L  + +    LDLS N ++   P      + L  L L  N     +  +   + 
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVM-KTCIQG 223

Query: 116 ASATSV 121
            +   V
Sbjct: 224 LAGLEV 229

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 24/108 (22%), Positives = 35/108 (32%), Gaps = 3/108 (2%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
                N    +   L    S    ++S N L    S +F S   L+ LD+          
Sbjct: 13  QCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
            +  SL  L  L L+ N +        +G   LQ L     N  S+  
Sbjct: 70  GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 76.6 bits (189), Expect = 5e-15
 Identities = 28/111 (25%), Positives = 39/111 (35%), Gaps = 3/111 (2%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DLS   L          LSSL + N+S N      +  +    SL+ LD   N       
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535

Query: 61  SSLSSL-RGLRVLDLSQNNLSDEIP--EFLAGFKFLQNLNLSYNNFESMLP 108
             L      L  L+L+QN+ +       FL   K  + L +     E   P
Sbjct: 536 QELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 586

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 18/116 (15%), Positives = 34/116 (29%), Gaps = 8/116 (6%)

Query: 1   DLSNNNLSGTLSP-QLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            L+  +            L+++S F++    +      +F      + L++    F    
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFP 320

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
              L SL+ L        N   E+         L+ L+LS N              
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAFSEV-----DLPSLEFLDLSRNGLSFKGCCSQSDFG 371

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 20/107 (18%), Positives = 30/107 (28%), Gaps = 5/107 (4%)

Query: 2   LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLS---GAISNNFGSCTSLEQLDMHGNLFAGP 58
            +  NL       L GL +L+I       L      I + F   T++    +        
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
                S   G + L+L            L   K L   +    N  S
Sbjct: 298 --KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS 342

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  100 bits (250), Expect = 2e-23
 Identities = 35/256 (13%), Positives = 74/256 (28%), Gaps = 47/256 (18%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTA-----VAVKVFNVLHHDASKSFAVECEVTRNIR- 260
               +L+G G F  VY+    +   A       +KV          +   E  +   +  
Sbjct: 67  VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-------PANPWEFYIGTQLME 119

Query: 261 ------HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNL 314
                     +K ++A         +   LV E  + G+L   +        ++     +
Sbjct: 120 RLKPSMQHMFMKFYSA-----HLFQNGSVLVGELYSYGTLLNAI-----NLYKNTPEKVM 169

Query: 315 NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY-----------VSD 363
                ++ A+ +  +++ +H      I H D+KP N +L +                + D
Sbjct: 170 PQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226

Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            G +  ++   + T       T+G+   E             D +     +  M  G   
Sbjct: 227 LGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI--DYFGVAATVYCMLFGTYM 284

Query: 422 SDDMFKDNLNLRNCVK 437
                          +
Sbjct: 285 KVKNEGGECKPEGLFR 300

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 99.4 bits (248), Expect = 4e-23
 Identities = 50/215 (23%), Positives = 81/215 (37%), Gaps = 27/215 (12%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
             +G G+FG V++    ++    AVK   +           E      +    +V ++  
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRL--EVFRVE---ELVACAGLSSPRIVPLY-- 116

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
             G   +G     +  E +  GSL + +          K  G L   + L         L
Sbjct: 117 --GAVREGPWVN-IFMELLEGGSLGQLI----------KQMGCLPEDRALYYLGQALEGL 163

Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDE-MTAYVSDFGIARFLEA---ADEQTRSIGVEGTT 386
           +YLH      I H D+K  N+LL  +   A + DFG A  L+             + GT 
Sbjct: 164 EYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            ++APE  MG    +  D++S   ++L M  G  P
Sbjct: 221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 98.9 bits (247), Expect = 7e-23
 Identities = 50/235 (21%), Positives = 87/235 (37%), Gaps = 39/235 (16%)

Query: 213 IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNI-RHRNLV 265
           +G+G FG V     +       +  VAVK+       + +     E ++   +  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSL-------------EEWMHPITEEDKRHKAPG 312
            +  AC+           L++E+   G L             +E  +   +  +  +   
Sbjct: 113 NLLGACT----LSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 313 NLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEA 372
            L     L  A  VA  +++L         H DL   N+L+       + DFG+AR + +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 373 ADEQTRSIGVEGTTGYI-----APEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
                           +     APE       +   DV+S+GILL E+F+ G+ P
Sbjct: 225 DSNYVV-----RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 95.5 bits (238), Expect = 4e-22
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 25/225 (11%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLV 265
           +  + +IG+G    V           VA+K  N+     S      E +      H N+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             +T+     F   D   LV + ++ GS+ + +  I  + +          L    IA  
Sbjct: 77  SYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-----LDESTIATI 126

Query: 326 VACVLK---YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG- 381
           +  VL+   YLH + Q  I H D+K  NILL ++ +  ++DFG++ FL    + TR+   
Sbjct: 127 LREVLEGLEYLHKNGQ--I-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183

Query: 382 --VEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
               GT  ++APE  +  +V  Y    D++SFGI  +E+ TG  P
Sbjct: 184 KTFVGTPCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGAAP 226

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 95.9 bits (239), Expect = 5e-22
 Identities = 53/252 (21%), Positives = 91/252 (36%), Gaps = 36/252 (14%)

Query: 205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHR 262
           + +S    IG+G    V++  L E     A+K  N+   D     S+  E      ++  
Sbjct: 9   RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 263 NL--VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           +   ++++          + +  +V E   N  L  W+          K   +++  +R 
Sbjct: 68  SDKIIRLYDY-----EITDQYIYMVMEC-GNIDLNSWL----------KKKKSIDPWERK 111

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
           +   ++   +  +H   Q  I H DLKP+N L+ D M   + DFGIA  ++         
Sbjct: 112 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKD 167

Query: 381 GVEGTTGYIAPE--------YGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKDN 429
              GT  Y+ PE           G   S      DV+S G +L  M  G  P   +    
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227

Query: 430 LNLRNCVKSALP 441
             L   +     
Sbjct: 228 SKLHAIIDPNHE 239

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 95.5 bits (238), Expect = 7e-22
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 26/221 (11%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAVECEVT-RNIRHRNLVKVFTA 270
           IG G +GSV K +   S   +AVK     +     K   ++ +V  R+     +V+ + A
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                F+  D   +  E M+  S +++   +               L +  I +     L
Sbjct: 90  L----FREGDCW-ICMELMS-TSFDKFYKYVY---SVLDDVIPEEILGK--ITLATVKAL 138

Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
            +L  + +  I H D+KPSNILLD      + DFGI+  L  +  +TR     G   Y+A
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA---GCRPYMA 193

Query: 391 PE------YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
           PE         G++V S  DV+S GI L E+ TG  P    
Sbjct: 194 PERIDPSASRQGYDVRS--DVWSLGITLYELATGRFPYPKW 232

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 94.7 bits (236), Expect = 9e-22
 Identities = 50/246 (20%), Positives = 86/246 (34%), Gaps = 36/246 (14%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKV--FNVLHHDASKSFAVECEVTRNIRHRNL--VK 266
             IG+G    V++  L E     A+K        +    S+  E      ++  +   ++
Sbjct: 34  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           ++          + +  +V E   N  L  W+          K   +++  +R +   ++
Sbjct: 93  LYDY-----EITDQYIYMVMEC-GNIDLNSWL----------KKKKSIDPWERKSYWKNM 136

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
              +  +H   Q  I H DLKP+N L+ D M   + DFGIA  ++            GT 
Sbjct: 137 LEAVHTIH---QHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTV 192

Query: 387 GYIAPE--------YGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC 435
            Y+ PE           G   S      DV+S G +L  M  G  P   +      L   
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252

Query: 436 VKSALP 441
           +     
Sbjct: 253 IDPNHE 258

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 27/214 (12%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS-KSFAVECEVT-RNIRHRNLVKVFTA 270
           +G G +G V K     S   +AVK      +    K   ++ +++ R +     V     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT---- 70

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
             G  F+  D   +  E M + SL+++   + ++ +          L +  IA+ +   L
Sbjct: 71  FYGALFREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPED----ILGK--IAVSIVKAL 122

Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           ++LH      + H D+KPSN+L++      + DFGI+ +L     +       G   Y+A
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMA 177

Query: 391 PE------YGMGHEVSSYGDVYSFGILLLEMFTG 418
           PE         G+ V S  D++S GI ++E+   
Sbjct: 178 PERINPELNQKGYSVKS--DIWSLGITMIELAIL 209

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 96.0 bits (239), Expect = 1e-21
 Identities = 54/256 (21%), Positives = 100/256 (39%), Gaps = 40/256 (15%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV-TRNIRHRNLV 265
             SE ++G G+ G+V     F+    VAVK   +   D +     E ++ T +  H N++
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIALM---EIKLLTESDDHPNVI 72

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           + +  CS      + F  +  E   N +L++    +  ++   +          +++   
Sbjct: 73  RYY--CS---ETTDRFLYIALELC-NLNLQDL---VESKNVSDENLKLQKEYNPISLLRQ 123

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY-------------VSDFGIARFLEA 372
           +A  + +LH      I H DLKP NIL+                    +SDFG+ + L++
Sbjct: 124 IASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 373 ADE--QTRSIGVEGTTGYIAPEYGMGHEVSS----YG---DVYSFGILLLEMFT-GLRPS 422
                +T      GT+G+ APE                  D++S G +   + + G  P 
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 423 DDMFKDNLNLRNCVKS 438
            D +    N+   + S
Sbjct: 241 GDKYSRESNIIRGIFS 256

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 45/258 (17%), Positives = 94/258 (36%), Gaps = 40/258 (15%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT---RNIRHRN 263
           F     IG+G FGSV+K +        A+K        +        EV       +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           +V+ F+A     +  +D   +  E+   GSL + +       + ++        +  ++ 
Sbjct: 73  VVRYFSA-----WAEDDHMLIQNEYCNGGSLADAI------SENYRIMSYFKEAELKDLL 121

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG-- 381
           + V   L+Y+H      + H D+KPSNI +        +         A+++    IG  
Sbjct: 122 LQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178

Query: 382 -----------VEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP--SDDM 425
                       EG + ++A E  +  E  ++    D+++  + ++          + D 
Sbjct: 179 GHVTRISSPQVEEGDSRFLANE--VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236

Query: 426 FKDNLNLRNCVKSALPER 443
           +     +R      +P+ 
Sbjct: 237 WH---EIRQGRLPRIPQV 251

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 64/251 (25%), Positives = 108/251 (43%), Gaps = 27/251 (10%)

Query: 185 NPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD 244
           + +P+ S   +    L +    F    L+G G +G VYKG   ++    A+KV + +  D
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGD 62

Query: 245 ASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKA-LVYEFMANGSLEEWMHPIT 302
             +    E  + +    HRN+   + A    +  G D +  LV EF   GS+ + +    
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122

Query: 303 EEDKRHKAPGNLNSLKRLNIAIDVACVLK---YLHLDCQPPIAHCDLKPSNILLDDEMTA 359
                       N+LK   IA     +L+   +LH   Q  + H D+K  N+LL +    
Sbjct: 123 G-----------NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV 168

Query: 360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE--YGMGHEVSSYG---DVYSFGILLLE 414
            + DFG++  L+    +  +    GT  ++APE      +  ++Y    D++S GI  +E
Sbjct: 169 KLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

Query: 415 MFTGLRPSDDM 425
           M  G  P  DM
Sbjct: 227 MAEGAPPLCDM 237

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 48/222 (21%), Positives = 84/222 (37%), Gaps = 35/222 (15%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKV 267
             +G G FG+VY     +S   +A+KV     +           E E+  ++RH N++++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRLNIAI 324
           +       F       L+ E+   G++   +       E+                    
Sbjct: 75  YGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------------YIT 116

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++A  L Y H      + H D+KP N+LL       ++DFG +    ++          G
Sbjct: 117 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----G 169

Query: 385 TTGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD 424
           T  Y+ PE   G  H+     D++S G+L  E   G  P + 
Sbjct: 170 TLDYLPPEMIEGRMHDEKV--DLWSLGVLCYEFLVGKPPFEA 209

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 94.5 bits (235), Expect = 3e-21
 Identities = 53/248 (21%), Positives = 89/248 (35%), Gaps = 40/248 (16%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNL--VK 266
             IG+G    V++  L E     A+K  N+   D     S+  E      ++  +   ++
Sbjct: 62  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 267 VFTACSGVDFQGNDFKALVYEFM--ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           ++      D++  D    +Y  M   N  L  W+          K   +++  +R +   
Sbjct: 121 LY------DYEITDQY--IYMVMECGNIDLNSWL----------KKKKSIDPWERKSYWK 162

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           ++   +  +H   Q  I H DLKP+N L+ D M   + DFGIA  ++            G
Sbjct: 163 NMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVG 218

Query: 385 TTGYIAPE--------YGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNLR 433
              Y+ PE           G   S      DV+S G +L  M  G  P   +      L 
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278

Query: 434 NCVKSALP 441
             +     
Sbjct: 279 AIIDPNHE 286

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 94.6 bits (235), Expect = 3e-21
 Identities = 48/225 (21%), Positives = 83/225 (36%), Gaps = 33/225 (14%)

Query: 214 GAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV--ECEVTRNIRHRNLVKVFTAC 271
           G  +  +V       +   V V+  N+          +  E  V++   H N+V      
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT- 94

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
               F  ++   +V  FMA GS ++ +         H   G    +  L IA  +  VLK
Sbjct: 95  ----FIADNELWVVTSFMAYGSAKDLI-------CTHFMDG----MNELAIAYILQGVLK 139

Query: 332 ---YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE----- 383
              Y+H        H  +K S+IL+  +   Y+S       + +  ++ R +        
Sbjct: 140 ALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196

Query: 384 GTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDM 425
               +++PE  +   +  Y    D+YS GI   E+  G  P  DM
Sbjct: 197 KVLPWLSPEV-LQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 92.4 bits (230), Expect = 5e-21
 Identities = 51/226 (22%), Positives = 91/226 (40%), Gaps = 35/226 (15%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           ++    IG G  G+VY  +   +   VA++  N+      +    E  V R  ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
              +     +   D   +V E++A GSL + +                  +    IA   
Sbjct: 82  YLDS-----YLVGDELWVVMEYLAGGSLTDVVTE--------------TCMDEGQIAAVC 122

Query: 327 ACVLK---YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
              L+   +LH      + H D+K  NILL  + +  ++DFG    +     +  +  + 
Sbjct: 123 RECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MV 177

Query: 384 GTTGYIAPE----YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
           GT  ++APE       G +V    D++S GI+ +EM  G  P  + 
Sbjct: 178 GTPYWMAPEVVTRKAYGPKV----DIWSLGIMAIEMIEGEPPYLNE 219

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 92.8 bits (231), Expect = 5e-21
 Identities = 52/224 (23%), Positives = 93/224 (41%), Gaps = 31/224 (13%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
             S   IG G+ G V       S   VAVK+ ++      +    E  + R+ +H N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMH--PITEEDKRHKAPGNLNSLKRLNIAI 324
           ++ +     +   +   ++ EF+  G+L + +    + EE                 IA 
Sbjct: 107 MYKS-----YLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ----------------IAT 145

Query: 325 DVACVLK---YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
               VL+   YLH      + H D+K  +ILL  +    +SDFG    +    +  +   
Sbjct: 146 VCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS--KDVPKRKS 200

Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
           + GT  ++APE       ++  D++S GI+++EM  G  P    
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 91.4 bits (228), Expect = 7e-21
 Identities = 56/235 (23%), Positives = 98/235 (41%), Gaps = 32/235 (13%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           L+G G+F  VY+     +   VA+K+ +   +      +    E ++   ++H ++++++
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMH----PITEEDKRHKAPGNLNSLKRLNIAI 324
                  F+ +++  LV E   NG +  ++     P +E + RH                
Sbjct: 78  ----NY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH-------------FMH 119

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +   + YLH      I H DL  SN+LL   M   ++DFG+A  L+   E+  ++   G
Sbjct: 120 QIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--G 174

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA 439
           T  YI+PE           DV+S G +   +  G  P D       N  N V  A
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT--DTVKNTLNKVVLA 227

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 95.1 bits (237), Expect = 8e-21
 Identities = 30/110 (27%), Positives = 43/110 (39%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           D+  N +S         L  L + N+  N LS      F  CT+L +L +  N       
Sbjct: 55  DVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE 110
           +     + L  LDLS N LS          + LQ L LS N  +++   E
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 93.9 bits (234), Expect = 2e-20
 Identities = 31/111 (27%), Positives = 50/111 (45%), Gaps = 3/111 (2%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG-- 57
           DL  N +   L+ Q   GL ++    +S N       N+F    SL++L +         
Sbjct: 411 DLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVD 470

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
              S    LR L +LDLS NN+++   + L G + L+ L+L +NN   +  
Sbjct: 471 SSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWK 521

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 92.8 bits (231), Expect = 4e-20
 Identities = 22/108 (20%), Positives = 39/108 (36%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +L++N L    +      S L+  +V  N +S            L+ L++  N  +    
Sbjct: 31  NLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSD 90

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
            + +    L  L L  N++           K L  L+LS+N   S   
Sbjct: 91  KTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL 138

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 91.6 bits (228), Expect = 9e-20
 Identities = 31/116 (26%), Positives = 46/116 (39%), Gaps = 8/116 (6%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLS--------GAISNNFGSCTSLEQLDMHG 52
           DLSNNN++      L GL  L I ++  N L+        G         + L  L++  
Sbjct: 486 DLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLES 545

Query: 53  NLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
           N F          L  L+++DL  NNL+            L++LNL  N   S+  
Sbjct: 546 NGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 90.8 bits (226), Expect = 1e-19
 Identities = 28/120 (23%), Positives = 43/120 (35%), Gaps = 5/120 (4%)

Query: 1   DLSNNNLSGT----LSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFA 56
            LSN+  S       +   +  S L I N++ N +S   S+ F     LE LD+  N   
Sbjct: 359 SLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIG 418

Query: 57  GPI-GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
             + G     L  +  + LS N          A    LQ L L     +++      F+ 
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 90.8 bits (226), Expect = 2e-19
 Identities = 24/129 (18%), Positives = 46/129 (35%), Gaps = 9/129 (6%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DLS NNL+   +     L  L  F +  N +    S++     ++  L++  +     I 
Sbjct: 254 DLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS 313

Query: 61  ---------SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
                     S   L+ L  L++  N++         G   L+ L+LS +          
Sbjct: 314 LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNE 373

Query: 112 IFKNASATS 120
            F + + + 
Sbjct: 374 TFVSLAHSP 382

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 90.8 bits (226), Expect = 2e-19
 Identities = 28/117 (23%), Positives = 45/117 (38%), Gaps = 4/117 (3%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +L +N LS          ++L+  ++  N +    +N F    +L  LD+  N  +    
Sbjct: 79  NLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL 138

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKF--LQNLNLSYNNFESMLPIEGIFKN 115
            +   L  L+ L LS N +     E L  F    L+ L LS N  +      G F  
Sbjct: 139 GTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE--FSPGCFHA 193

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 89.7 bits (223), Expect = 3e-19
 Identities = 29/113 (25%), Positives = 48/113 (42%), Gaps = 9/113 (7%)

Query: 1   DLSNNNLS--------GTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHG 52
           DL +NNL+        G     L GLS L I N+  N         F     L+ +D+  
Sbjct: 510 DLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGL 569

Query: 53  NLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPE-FLAGFKFLQNLNLSYNNFE 104
           N       S  ++   L+ L+L +N ++    + F   F+ L  L++ +N F+
Sbjct: 570 NNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 87.0 bits (216), Expect = 3e-18
 Identities = 29/125 (23%), Positives = 48/125 (38%), Gaps = 7/125 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSC--TSLEQLDMHGNLFAGP 58
           DLS+N LS T     V L +L    +S N +    S        +SL++L++  N     
Sbjct: 127 DLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEF 186

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGF---KFLQNLNLSYNNFESMLPIEGIFKN 115
                 ++  L  L L+   L   + E L        ++NL+LS +   +       F  
Sbjct: 187 SPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT--SNTTFLG 244

Query: 116 ASATS 120
              T+
Sbjct: 245 LKWTN 249

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 86.6 bits (215), Expect = 4e-18
 Identities = 32/125 (25%), Positives = 44/125 (35%), Gaps = 12/125 (9%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSG--AISNNFGSCTSLEQLDMHGNLFAGP 58
            LS N            + SL    +    L    +  + F    +L  LD+  N  A  
Sbjct: 436 YLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI 495

Query: 59  IGSSLSSLRGLRVLDLSQNNLSD--------EIPEFLAGFKFLQNLNLSYNNFESMLPIE 110
               L  L  L +LDL  NNL+             FL G   L  LNL  N F+ +    
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI--PV 553

Query: 111 GIFKN 115
            +FK+
Sbjct: 554 EVFKD 558

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 84.7 bits (210), Expect = 2e-17
 Identities = 27/115 (23%), Positives = 47/115 (40%), Gaps = 5/115 (4%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           D S+  L+  +   L   +++++ N++ N L    + NF   + L  LD+  N  +    
Sbjct: 10  DCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEP 66

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
                L  L+VL+L  N LS    +  A    L  L+L  N+ +        F  
Sbjct: 67  ELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK--IKNNPFVK 119

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 80.4 bits (199), Expect = 4e-16
 Identities = 26/117 (22%), Positives = 48/117 (41%), Gaps = 5/117 (4%)

Query: 1   DLSNNNLSGTLSPQL---VGLSSLSIFNVSGNLLSGAISNNFGSC--TSLEQLDMHGNLF 55
            L+N  L  +L+ +L   +  +S+   ++S + LS   +  F     T+L  LD+  N  
Sbjct: 201 FLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNL 260

Query: 56  AGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGI 112
                 S + L  L    L  NN+       L G   ++ LNL  +  +  + +  +
Sbjct: 261 NVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASL 317

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 67.7 bits (166), Expect = 3e-12
 Identities = 21/104 (20%), Positives = 38/104 (36%), Gaps = 4/104 (3%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +L +N            L  L I ++  N L+   ++ F +  SL+ L++  NL      
Sbjct: 542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601

Query: 61  SSLS-SLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNF 103
                + R L  LD+  N              F+  +N ++ N 
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCTCESIAW---FVNWINETHTNI 642

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 54.2 bits (131), Expect = 6e-08
 Identities = 24/104 (23%), Positives = 38/104 (36%), Gaps = 6/104 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFG-SCTSLEQLDMHGNLFAGPI 59
           DL  NNL+   +       SL   N+  NL++      FG +  +L +LDM  N F    
Sbjct: 566 DLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEI----PEFLAGFKFLQNLNLS 99
            S    +  +     +   LS       P    G   ++  + S
Sbjct: 626 ESIAWFVNWINETHTNIPELSSHYLCNTPPHYHG-FPVRLFDTS 668

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 52/227 (22%), Positives = 89/227 (39%), Gaps = 30/227 (13%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           +     +G G FG VYK    E+    A KV      +  + + VE E+     H  +VK
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +  A     +  +    ++ EF   G+++  M  +               L    I +  
Sbjct: 81  LLGA-----YYHDGKLWIMIEFCPGGAVDAIMLELD------------RGLTEPQIQVVC 123

Query: 327 ACVLK---YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
             +L+   +LH      I H DLK  N+L+  E    ++DFG++          +     
Sbjct: 124 RQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDSFI 178

Query: 384 GTTGYIAPE--YGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDM 425
           GT  ++APE       + + Y    D++S GI L+EM     P  ++
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 37/225 (16%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAVECEVT-RNIRHRNLVKVFTA 270
           +G+G  G V+K    ++   +AVK      + + +K   ++ +V  ++     +V+    
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---- 88

Query: 271 CSGVDFQGNDFKALVYEFMANGSLE---EWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           C G      D   +  E M   + +       PI E                  + + + 
Sbjct: 89  CFGTFITNTDVF-IAMELMGTCAEKLKKRMQGPIPERILGK-------------MTVAIV 134

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             L YL       + H D+KPSNILLD+     + DFGI+  L     + RS    G   
Sbjct: 135 KALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---GCAA 189

Query: 388 YIAPE-------YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
           Y+APE           +++ +  DV+S GI L+E+ TG  P  + 
Sbjct: 190 YMAPERIDPPDPTKPDYDIRA--DVWSLGISLVELATGQFPYKNC 232

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 51/242 (21%), Positives = 90/242 (37%), Gaps = 40/242 (16%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN-----------------VLHHDASKSFAVECEV 255
           +  G F  +      +     A+K +                  +        F  E ++
Sbjct: 39  LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 256 TRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLN 315
             +I++   +       G+     D   ++YE+M N S+ ++       DK +     + 
Sbjct: 97  ITDIKNEYCLTCE----GI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151

Query: 316 SLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE 375
            +K   I   V     Y+H   +  I H D+KPSNIL+D      +SDFG + ++     
Sbjct: 152 VIKC--IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207

Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNL 432
           +       GT  ++ PE+      S  G   D++S GI L  MF  + P    F   ++L
Sbjct: 208 KG----SRGTYEFMPPEFFSNES-SYNGAKVDIWSLGICLYVMFYNVVP----FSLKISL 258

Query: 433 RN 434
             
Sbjct: 259 VE 260

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 92.6 bits (230), Expect = 6e-20
 Identities = 26/127 (20%), Positives = 43/127 (33%), Gaps = 14/127 (11%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSG---------AISNNFGSCTSLEQLDMH 51
           +L N      L   L  L  L   N++ N              ++++  +   ++   M 
Sbjct: 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG 556

Query: 52  GNLFAG-PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE 110
            N     P  +SL  +  L +LD   N +   +  F      L +L L YN  E  +P E
Sbjct: 557 YNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAF-GTNVKLTDLKLDYNQIEE-IP-E 612

Query: 111 GIFKNAS 117
                  
Sbjct: 613 DFCAFTD 619

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 82.6 bits (204), Expect = 8e-17
 Identities = 21/124 (16%), Positives = 39/124 (31%), Gaps = 9/124 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLS-------GAISNNFGSCTSLEQLDMHGN 53
            LS N +    +      S +S   +S NL++            N+ +   L  +D+  N
Sbjct: 679 TLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN 738

Query: 54  LFAG-PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGI 112
                      ++L  L  +D+S N  S   P        L+   + +        I   
Sbjct: 739 KLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQ 797

Query: 113 FKNA 116
           +   
Sbjct: 798 WPTG 801

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 80.3 bits (198), Expect = 5e-16
 Identities = 26/142 (18%), Positives = 50/142 (35%), Gaps = 18/142 (12%)

Query: 1   DLSNNNLSGTLSPQLV--GLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFA-- 56
           DL  N L+ +LS       L  LS  +VS N  S        + + L+   +     A  
Sbjct: 734 DLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEG 791

Query: 57  ----GPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGI 112
                   + +++   L  L +  N++  ++ E L     L  L+++ N   S + +  +
Sbjct: 792 NRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNIS-IDVTSV 847

Query: 113 FKNASATSVF----GNKKLCGG 130
                A          + + G 
Sbjct: 848 CPYIEAGMYVLLYDKTQDIRGC 869

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 79.1 bits (195), Expect = 1e-15
 Identities = 25/126 (19%), Positives = 42/126 (33%), Gaps = 15/126 (11%)

Query: 1   DLSNNNLSG---------TLSPQLVGLSSLSIFNVSGNLLSG-AISNNFGSCTSLEQLDM 50
           +++ N              L+        + IF +  N L     S +      L  LD 
Sbjct: 521 NIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDC 580

Query: 51  HGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIP-EFLAGFKFLQNLNLSYNNFESMLPI 109
             N        +  +   L  L L  N +  EIP +F A    ++ L  S+N  +  +P 
Sbjct: 581 VHNKVRHL--EAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPN 636

Query: 110 EGIFKN 115
               K+
Sbjct: 637 IFNAKS 642

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 77.6 bits (191), Expect = 3e-15
 Identities = 20/115 (17%), Positives = 42/115 (36%), Gaps = 6/115 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
               N ++  +S  +  L+ L I   + +  +             E  +           
Sbjct: 431 GNLTNRITF-ISKAIQRLTKLQIIYFANSPFTY-----DNIAVDWEDANSDYAKQYENEE 484

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            S S+L+ L  ++L       ++P+FL     LQ+LN++ N   S   ++  +  
Sbjct: 485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 77.2 bits (190), Expect = 4e-15
 Identities = 20/123 (16%), Positives = 35/123 (28%), Gaps = 10/123 (8%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG-PI 59
           D  +N +   L         L+   +  N +     +       +E L    N     P 
Sbjct: 579 DCVHNKVR-HL-EAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPN 636

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKF-----LQNLNLSYNNFESMLPIEGIFK 114
             +  S+  +  +D S N +  E                  + LSYN  +       +F 
Sbjct: 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK--FPTELFA 694

Query: 115 NAS 117
             S
Sbjct: 695 TGS 697

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 77.2 bits (190), Expect = 4e-15
 Identities = 19/130 (14%), Positives = 43/130 (33%), Gaps = 19/130 (14%)

Query: 1   DLSNNNLS-------GTLSPQLVGLSSLSIFNVSGNLLSGAISNN--FGSCTSLEQLDMH 51
            LSNN ++                   L+  ++  N L+  +S++    +   L  +D+ 
Sbjct: 703 ILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVS 761

Query: 52  GNLFAGPIGSSLSSLRGLRVLDLSQ------NNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
            N F+    +   +   L+   +        N +  + P  +     L  L +  N+   
Sbjct: 762 YNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK 820

Query: 106 MLPIEGIFKN 115
            +  E +   
Sbjct: 821 -VD-EKLTPQ 828

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 75.3 bits (185), Expect = 2e-14
 Identities = 21/112 (18%), Positives = 32/112 (28%), Gaps = 8/112 (7%)

Query: 1   DLSNNNLSGTLSPQL-VGLSSLSIFNVSGNLLSG-AISNNFGSCTSLEQLDMHGNLFAGP 58
            L  N +   +          +     S N L       N  S   +  +D   N     
Sbjct: 601 KLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSE 659

Query: 59  ---IGSSLSSLRG--LRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
              I  S+   +G     + LS N +     E  A    +  + LS N   S
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS 711

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 75.3 bits (185), Expect = 2e-14
 Identities = 22/111 (19%), Positives = 36/111 (32%), Gaps = 6/111 (5%)

Query: 1   DLSNNNLSG-TLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            +  NNL     S  L  +  L + +   N +   +   FG+   L  L +  N      
Sbjct: 554 YMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEEIP 611

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPE--FLAGFKFLQNLNLSYNNFESMLP 108
               +    +  L  S N L   IP          + +++ SYN   S   
Sbjct: 612 EDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGR 661

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 13/116 (11%), Positives = 36/116 (31%), Gaps = 1/116 (0%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +   +         L     ++  +++G    G + +  G  T L+ L    +       
Sbjct: 305 NKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGR 364

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPE-FLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
                     + +  ++ +     + FL   + L   +L  +       ++ I K+
Sbjct: 365 LFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 54.1 bits (130), Expect = 8e-08
 Identities = 12/108 (11%), Positives = 29/108 (26%), Gaps = 1/108 (0%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           D  N           +   + + FN   ++       +  +   +  L + G    G + 
Sbjct: 282 DGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP 340

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
            ++  L  L+VL    ++ +     F              +       
Sbjct: 341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYK 388

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 10/107 (9%), Positives = 30/107 (28%), Gaps = 1/107 (0%)

Query: 5   NNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLS 64
              +  +       +     +           NN     +    +   +++    G  L 
Sbjct: 262 KETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLD 320

Query: 65  SLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
           +   +  L L+       +P+ +     L+ L+   ++      + G
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFG 367

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 88.8 bits (221), Expect = 7e-20
 Identities = 50/224 (22%), Positives = 87/224 (38%), Gaps = 41/224 (18%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
            +G G FG+VY     ++   +A+KV     +           E E+  ++RH N+++++
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN------I 322
                  F       L+ EF   G L +                 L    R +       
Sbjct: 81  NY-----FHDRKRIYLMLEFAPRGELYKE----------------LQKHGRFDEQRSATF 119

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
             ++A  L Y H   +  + H D+KP N+L+  +    ++DFG +    +   +T     
Sbjct: 120 MEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC--- 173

Query: 383 EGTTGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD 424
            GT  Y+ PE   G  H+     D++  G+L  E   G+ P D 
Sbjct: 174 -GTLDYLPPEMIEGKTHDEKV--DLWCAGVLCYEFLVGMPPFDS 214

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 28/223 (12%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLV 265
           F+    IG G+FG V+KGI   +   VA+K+ ++   +        E  V        + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           K + +     +  +    ++ E++  GS  + + P                L    IA  
Sbjct: 84  KYYGS-----YLKDTKLWIIMEYLGGGSALDLLEP--------------GPLDETQIATI 124

Query: 326 VACVLK---YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           +  +LK   YLH +      H D+K +N+LL +     ++DFG+A  L   D Q +    
Sbjct: 125 LREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTF 179

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
            GT  ++APE        S  D++S GI  +E+  G  P  ++
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 90.9 bits (226), Expect = 1e-19
 Identities = 28/118 (23%), Positives = 46/118 (38%), Gaps = 3/118 (2%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAI-SNNFGSCTSLEQLDMHGNLFAGPI 59
           D+S  N         +GL+SL+   ++GN       SN F + T+L  LD+         
Sbjct: 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNAS 117
                +L  L++L++S NNL             L  L+ S+N  E+      +     
Sbjct: 490 WGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET--SKGILQHFPK 545

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 87.4 bits (217), Expect = 2e-18
 Identities = 26/115 (22%), Positives = 39/115 (33%), Gaps = 1/115 (0%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DLS N L    S      S L   ++S   +       +     L  L + GN       
Sbjct: 38  DLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSP 97

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            S S L  L  L   +  L+      +     L+ LN+++N   S   +   F N
Sbjct: 98  GSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSN 151

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 87.4 bits (217), Expect = 2e-18
 Identities = 21/106 (19%), Positives = 36/106 (33%), Gaps = 1/106 (0%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            ++ N+             ++L+  ++S   L       F +   L+ L+M  N      
Sbjct: 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLD 513

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
            S  + L  L  LD S N +           K L   NL+ N+   
Sbjct: 514 SSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVAC 559

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 83.5 bits (207), Expect = 4e-17
 Identities = 34/120 (28%), Positives = 50/120 (41%), Gaps = 5/120 (4%)

Query: 1   DLSNNNLS--GTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG- 57
           DLS N LS  G  S   +G +SL   ++S N     +S NF     L+ LD   +     
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRV 414

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNAS 117
              S+  SL  L  LD+S  N   +      G   L  L ++ N+F+       +F N +
Sbjct: 415 TEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL-SNVFANTT 473

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 82.0 bits (203), Expect = 9e-17
 Identities = 24/122 (19%), Positives = 44/122 (36%), Gaps = 7/122 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG-PI 59
            L+ N +         GL+SL         L+   S   G   +L++L++  N      +
Sbjct: 86  ILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKL 145

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQN----LNLSYNNFESMLPIEGIFKN 115
            +  S+L  L  +DLS N +       L   +        L++S N  + +      F+ 
Sbjct: 146 PAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQD--QAFQG 203

Query: 116 AS 117
             
Sbjct: 204 IK 205

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 76.6 bits (189), Expect = 5e-15
 Identities = 23/115 (20%), Positives = 39/115 (33%), Gaps = 5/115 (4%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
              +  LS  +   +   SS    ++S N L    S +F + + L+ LD+          
Sbjct: 17  QCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIED 73

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            +   L  L  L L+ N +    P   +G   L+NL        S+         
Sbjct: 74  KAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL--ESFPIGQ 126

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 63.5 bits (155), Expect = 8e-11
 Identities = 20/108 (18%), Positives = 36/108 (33%), Gaps = 9/108 (8%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L+  ++       +         ++    L             L+ L +  N  +    
Sbjct: 291 SLAGVSIKYL--EDVPKHFKWQSLSIIRCQLK---QFPTLDLPFLKSLTLTMNKGSIS-- 343

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKF--LQNLNLSYNNFESM 106
               +L  L  LDLS+N LS       +      L++L+LS+N    M
Sbjct: 344 FKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM 391

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 57.7 bits (140), Expect = 5e-09
 Identities = 18/123 (14%), Positives = 37/123 (30%), Gaps = 10/123 (8%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAI-SNNFGSCTSLEQLDMHGNLFAG-- 57
           D+S N +   +  Q      L    + GN  S  I      +   L    +    F    
Sbjct: 187 DMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER 245

Query: 58  ----PIGSSLSSLRGLRV--LDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
                  S +  L  + +    L+  N   +          +  ++L+  + + +  +  
Sbjct: 246 NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPK 305

Query: 112 IFK 114
            FK
Sbjct: 306 HFK 308

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 25/126 (19%), Positives = 37/126 (29%), Gaps = 12/126 (9%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIF----NVSGNLLSGAISNNFGSCTSLEQLDMHGNLFA 56
           DLS N +       L  L          ++S N +   I +       L +L + GN  +
Sbjct: 159 DLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNS 217

Query: 57  GPI-GSSLSSLRGLRVLDLSQNNLSDEI------PEFLAGFKFLQNLNLSYNNFESMLPI 109
             I  + L +L GL V  L      DE       P  + G   +                
Sbjct: 218 SNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDD 277

Query: 110 EGIFKN 115
              F  
Sbjct: 278 IVKFHC 283

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 17/100 (17%), Positives = 30/100 (30%), Gaps = 23/100 (23%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLF----- 55
           ++S+NNL    S     L SLS  + S N +  +         SL   ++  N       
Sbjct: 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE 562

Query: 56  ------------------AGPIGSSLSSLRGLRVLDLSQN 77
                                  ++   +    VLD + +
Sbjct: 563 HQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDFNNS 602

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 90.7 bits (225), Expect = 2e-19
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 22/211 (10%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V++     +    A K     H    ++   E +    +RH  LV +  A  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-- 222

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKY 332
              F+ ++   ++YEFM+ G L E    + +E         ++  + +     V   L +
Sbjct: 223 ---FEDDNEMVMIYEFMSGGELFEK---VADEH------NKMSEDEAVEYMRQVCKGLCH 270

Query: 333 LHLDCQPPIAHCDLKPSNILLDDEMTAYV--SDFGIARFLEAADEQTRSIGVEGTTGYIA 390
           +H   +    H DLKP NI+   + +  +   DFG+   L+       + G   T  + A
Sbjct: 271 MH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG---TAEFAA 324

Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           PE   G  V  Y D++S G+L   + +GL P
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 51/236 (21%), Positives = 96/236 (40%), Gaps = 43/236 (18%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--------VLHHDASKSFAVECEVTRNIRHRNL 264
           +G+G  G V      ++   VA+++ +            D + +   E E+ + + H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEW---MHPITEEDKRHKAPGNLNSLKRLN 321
           +K+        F   D+  +V E M  G L +       + E   +              
Sbjct: 203 IKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL------------- 243

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTR 378
               +   ++YLH   +  I H DLKP N+LL   +++    ++DFG ++ L    E + 
Sbjct: 244 YFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSL 297

Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP-SDDMFKDNL 430
              + GT  Y+APE  +    + Y    D +S G++L    +G  P S+   + +L
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 353

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 30/221 (13%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
            S   ++G G FG V+K     +   +A K+         +    E  V   + H NL++
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWM----HPITEEDKRHKAPGNLNSLKRLNI 322
           ++ A     F+  +   LV E++  G L + +    + +TE D                 
Sbjct: 151 LYDA-----FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL-------------F 192

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV--SDFGIARFLEAADEQTRSI 380
              +   ++++H   Q  I H DLKP NIL  +     +   DFG+AR  +  ++   + 
Sbjct: 193 MKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249

Query: 381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
              GT  ++APE      VS   D++S G++   + +GL P
Sbjct: 250 ---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 88.2 bits (219), Expect = 4e-19
 Identities = 46/215 (21%), Positives = 87/215 (40%), Gaps = 30/215 (13%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G+G FG V++ +   +      K  N  +     +   E  +   + H  L+ +  A  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116

Query: 273 GVDFQGNDFKALVYEFMANGSLEEWM----HPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
              F+      L+ EF++ G L + +    + ++E +  +                    
Sbjct: 117 ---FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN-------------YMRQACE 160

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV--SDFGIARFLEAADEQTRSIGVEGTT 386
            LK++H   +  I H D+KP NI+ + +  + V   DFG+A  L   +    +     T 
Sbjct: 161 GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATA 214

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            + APE      V  Y D+++ G+L   + +GL P
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 86.9 bits (216), Expect = 5e-19
 Identities = 55/261 (21%), Positives = 99/261 (37%), Gaps = 46/261 (17%)

Query: 184 GNPTPSISFPYVSYRMLYNATKG---FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN- 239
             P P       +        K    F    ++G G+F +V       ++   A+K+   
Sbjct: 6   AEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEK 65

Query: 240 --VLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEW 297
             ++  +       E +V   + H   VK++       FQ ++       +  NG L   
Sbjct: 66  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGEL--L 118

Query: 298 MHPITEEDKRHKAPGNLNSLKRLNI------AIDVACVLKYLH-LDCQPPIAHCDLKPSN 350
            +              +  +   +         ++   L+YLH       I H DLKP N
Sbjct: 119 KY--------------IRKIGSFDETCTRFYTAEIVSALEYLHGKG----IIHRDLKPEN 160

Query: 351 ILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE--YGMGHEVSSYGDVYSF 408
           ILL+++M   ++DFG A+ L    +Q R+    GT  Y++PE         SS  D+++ 
Sbjct: 161 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS--DLWAL 218

Query: 409 GILLLEMFTGLRPSDDMFKDN 429
           G ++ ++  GL P    F+  
Sbjct: 219 GCIIYQLVAGLPP----FRAG 235

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 89.3 bits (222), Expect = 5e-19
 Identities = 23/116 (19%), Positives = 46/116 (39%), Gaps = 2/116 (1%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +L  +      S      S L   +++   LS  + +     ++L++L +  N F     
Sbjct: 260 NLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ 318

Query: 61  SSLSSLRGLRVLDLSQNNLSDEI-PEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            S S+   L  L +  N    E+    L   + L+ L+LS+++ E+        +N
Sbjct: 319 ISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 88.5 bits (220), Expect = 9e-19
 Identities = 23/115 (20%), Positives = 43/115 (37%), Gaps = 2/115 (1%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           + S N L    +     L +L+  +++   +     + F S   L+ L +  N       
Sbjct: 39  EFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAE 98

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
           ++LS  + L+ L   Q  +S      L   K L++L L  N+  S+         
Sbjct: 99  TALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI--KLPKGFP 151

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 16/105 (15%), Positives = 30/105 (28%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DL+   +             L    ++ N L            +L+ L       +    
Sbjct: 63  DLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF 122

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
             L + + L  L L  N++S          + L+ L+   N    
Sbjct: 123 IPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 81.6 bits (202), Expect = 1e-16
 Identities = 26/119 (21%), Positives = 42/119 (35%), Gaps = 4/119 (3%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L+ N L       L G  +L         +S        +  +LE L +  N  +    
Sbjct: 87  VLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKL 146

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQN--LNLSYNNFESMLPIEGIFKNAS 117
                   L+VLD   N +     E ++  +   N  LNL+ N+   + P  G F +A 
Sbjct: 147 PKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEP--GAFDSAV 203

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 81.2 bits (201), Expect = 2e-16
 Identities = 23/118 (19%), Positives = 43/118 (36%), Gaps = 4/118 (3%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDMHGN--LFAG 57
            LS N              SL+  ++ GN     +      +  +L +LD+  +    + 
Sbjct: 307 VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSD 366

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
                L +L  L+ L+LS N       E       L+ L+L++     +   +  F+N
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL-KVKDAQSPFQN 423

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 26/107 (24%), Positives = 45/107 (42%), Gaps = 4/107 (3%)

Query: 1   DLSNNNLSGT---LSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG 57
           +L  N+        +  L  L  L I  +S   LS    + F S   +  +D+  N    
Sbjct: 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS 514

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFE 104
               +LS L+G+  L+L+ N++S  +P  L      + +NL  N  +
Sbjct: 515 SSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.4 bits (199), Expect = 3e-16
 Identities = 21/121 (17%), Positives = 43/121 (35%), Gaps = 6/121 (4%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDMHGNLFAGPI 59
           +LS N      +        L + +++   L    + + F +   L+ L++  +L     
Sbjct: 382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISS 441

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEI---PEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNA 116
                 L  L+ L+L  N+           L     L+ L LS+ +  S+   +  F + 
Sbjct: 442 EQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI--DQHAFTSL 499

Query: 117 S 117
            
Sbjct: 500 K 500

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.4 bits (199), Expect = 3e-16
 Identities = 28/120 (23%), Positives = 51/120 (42%), Gaps = 6/120 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAI---SNNFGSCTSLEQLDMHGNLFAG 57
           +LS++ L  +      GL +L   N+ GN         +N+  +   LE L +     + 
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNAS 117
               + +SL+ +  +DLS N L+    E L+  K +  LNL+ N+      +  +    S
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISI--ILPSLLPILS 547

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 75.8 bits (187), Expect = 9e-15
 Identities = 24/115 (20%), Positives = 38/115 (33%), Gaps = 5/115 (4%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +  N  L+  +   L   +S      S N+L    +  F    +L  LD+          
Sbjct: 18  NCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHE 74

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            +  S   L  L L+ N L       L+G K L++L        S+        N
Sbjct: 75  DTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSI--DFIPLHN 127

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 60.8 bits (148), Expect = 5e-10
 Identities = 15/110 (13%), Positives = 34/110 (30%), Gaps = 5/110 (4%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAI--SNNFGSCTSLEQLDMHGNLFAGP 58
           +L+ N+++  + P     +     N  G      I       +  SL             
Sbjct: 185 NLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDI 243

Query: 59  IGSSLSSLRG--LRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESM 106
             +    L    +  ++L ++   +        F  LQ L+L+  +   +
Sbjct: 244 SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL 293

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 60.4 bits (147), Expect = 7e-10
 Identities = 22/121 (18%), Positives = 43/121 (35%), Gaps = 9/121 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSI--FNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGP 58
           D  NN +       +  L   +    N++GN ++G I          + L+  G      
Sbjct: 159 DFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLV 217

Query: 59  I--GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKF--LQNLNLSYNNFESMLPIEGIFK 114
           I  G   S+++ L +      +  D  P    G     ++++NL  + F ++      F 
Sbjct: 218 IFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS--NTFH 275

Query: 115 N 115
            
Sbjct: 276 C 276

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 86.5 bits (215), Expect = 5e-19
 Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 49/222 (22%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN---------VLHHDASKSFAVECEVTRNI-RHR 262
           +G G    V + I   +    AVK+ +             +  ++   E ++ R +  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPI------TEEDKRHKAPGNLNS 316
           N++++        ++ N F  LV++ M  G L ++   +      +E++ R         
Sbjct: 85  NIIQLKDT-----YETNTFFFLVFDLMKKGELFDY---LTEKVTLSEKETRK-------- 128

Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
                I   +  V+  LH      I H DLKP NILLDD+M   ++DFG +  L+  ++ 
Sbjct: 129 -----IMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 180

Query: 377 TRSIGVEGTTGYIAPE---YGMGHEVSSYG---DVYSFGILL 412
                V GT  Y+APE     M      YG   D++S G+++
Sbjct: 181 R---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 87.8 bits (218), Expect = 9e-19
 Identities = 52/223 (23%), Positives = 84/223 (37%), Gaps = 39/223 (17%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFN--VLHHDASKSFAVECEVTRNIRHRNLVKV 267
              +G+G +G V       +    A+K+     +   ++     E  V + + H N++K+
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRLNIAI 324
           +       F+      LV E    G L + +       E D                I  
Sbjct: 102 YDF-----FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV-------------IIK 143

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTRSIG 381
            V   + YLH   +  I H DLKP N+LL   + +    + DFG++   E   +    + 
Sbjct: 144 QVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL- 199

Query: 382 VEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
             GT  YIAPE         Y    DV+S G++L  +  G  P
Sbjct: 200 --GTAYYIAPEVLRK----KYDEKCDVWSIGVILFILLAGYPP 236

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 87.8 bits (218), Expect = 1e-18
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 40/221 (18%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           +G G+FG V       +    AVKV +   V      +S   E ++ + + H N++K++ 
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRLNIAIDV 326
                 F+   +  LV E    G L + +      +E D                I   V
Sbjct: 94  F-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-------------IIRQV 135

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
              + Y+H   +  I H DLKP N+LL     +    + DFG++   EA+ +    I   
Sbjct: 136 LSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--- 189

Query: 384 GTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
           GT  YIAPE   G    +Y    DV+S G++L  + +G  P
Sbjct: 190 GTAYYIAPEVLHG----TYDEKCDVWSTGVILYILLSGCPP 226

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 54/232 (23%), Positives = 88/232 (37%), Gaps = 44/232 (18%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRN 263
           FS    IG G+FG+VY      ++  VA+K  +      ++  +    E    + +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH----PITEEDKRHKAPGNLNSLKR 319
            ++         +       LV E+   GS  + +     P+ E +              
Sbjct: 116 TIQYRGC-----YLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE-------------- 155

Query: 320 LNIAIDVACVLK---YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
             IA      L+   YLH      + H D+K  NILL +     + DFG A  +      
Sbjct: 156 --IAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------ 204

Query: 377 TRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDM 425
             +    GT  ++APE  +  +   Y    DV+S GI  +E+     P  +M
Sbjct: 205 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 48/217 (22%), Positives = 88/217 (40%), Gaps = 42/217 (19%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--------VLHHDASKSFAVECEVTRNIRHRNL 264
           +G+G  G V      ++   VA+K+ +            D + +   E E+ + + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEW---MHPITEEDKRHKAPGNLNSLKRLN 321
           +K+        F   D+  +V E M  G L +       + E   +              
Sbjct: 78  IKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL------------- 118

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTR 378
               +   ++YLH   +  I H DLKP N+LL   +++    ++DFG ++ L    E + 
Sbjct: 119 YFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSL 172

Query: 379 SIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILL 412
              + GT  Y+APE  +    + Y    D +S G++L
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 50/218 (22%), Positives = 83/218 (38%), Gaps = 47/218 (21%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +G G F  V + +   +    A  + N   L     +    E  + R ++H N+V++  +
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEW---MHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                        L+++ +  G L E        +E D  H                 + 
Sbjct: 79  -----ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH-------------CIQQIL 120

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
             + + H   Q  + H +LKP N+LL          ++DFG+A  +E   EQ    G  G
Sbjct: 121 EAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE--GEQQAWFGFAG 175

Query: 385 TTGYIAPEYGMGHEV---SSYG---DVYSFG----ILL 412
           T GY++P      EV     YG   D+++ G    ILL
Sbjct: 176 TPGYLSP------EVLRKDPYGKPVDLWACGVILYILL 207

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 35/226 (15%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           F     +G G++GSVYK I  E+   VA+K   V      +    E  + +     ++VK
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMH----PITEEDKRHKAPGNLNSLKRLNI 322
            + +     +  N    +V E+   GS+ + +      +TE++                I
Sbjct: 89  YYGS-----YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE----------------I 127

Query: 323 AIDVACVLK---YLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
           A  +   LK   YLH        H D+K  NILL+ E  A ++DFG+A  L   D   + 
Sbjct: 128 ATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDTMAKR 182

Query: 380 IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM 425
             V GT  ++APE       +   D++S GI  +EM  G  P  D+
Sbjct: 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 49/251 (19%), Positives = 84/251 (33%), Gaps = 51/251 (20%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN-----VLHHDASKSFAVECEVTRNIRHRNLVKV 267
           IG G++G V   I  ++    A+K+ N      ++    +    E  + + + H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSL-----------EEWMHPITEEDKRHKAPGNLNS 316
           +       ++   +  LV E    G L                    + +    P     
Sbjct: 94  YEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 317 LKRL-------------------NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM 357
                                  NI   +   L YLH      I H D+KP N L     
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNK 205

Query: 358 TAYV--SDFGIARFLEAADEQTRSIGVE--GTTGYIAPEYGMGHEVSSYG---DVYSFGI 410
           +  +   DFG+++     +           GT  ++APE  +     SYG   D +S G+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCDAWSAGV 264

Query: 411 LLLEMFTGLRP 421
           LL  +  G  P
Sbjct: 265 LLHLLLMGAVP 275

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 51/219 (23%), Positives = 84/219 (38%), Gaps = 47/219 (21%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
             ++G+G F  V+      +    A+K           S   E  V + I+H N+V +  
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPI------TEEDKRHKAPGNLNSLKRLNIA 323
                 ++      LV + ++ G L +    I      TE+D                + 
Sbjct: 74  I-----YESTTHYYLVMQLVSGGELFDR---ILERGVYTEKDASL-------------VI 112

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTRSI 380
             V   +KYLH   +  I H DLKP N+L    ++     ++DFG+++  +  +    + 
Sbjct: 113 QQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMSTA 167

Query: 381 GVEGTTGYIAPEYGMGHEVSSYG---DVYSFG----ILL 412
              GT GY+APE         Y    D +S G    ILL
Sbjct: 168 C--GTPGYVAPEVLAQK---PYSKAVDCWSIGVITYILL 201

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 46/216 (21%), Positives = 82/216 (37%), Gaps = 33/216 (15%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           +G G FG V++ +   S      K   V   D       E  +    RHRN++ +  +  
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHES-- 69

Query: 273 GVDFQGNDFKALVYEFMANGSL-----EEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              F+  +   +++EF++   +           + E +                    V 
Sbjct: 70  ---FESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVS-------------YVHQVC 112

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV--SDFGIARFLEAADEQTRSIGVEGT 385
             L++LH      I H D++P NI+     ++ +   +FG AR L+  D           
Sbjct: 113 EALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---A 166

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             Y APE      VS+  D++S G L+  + +G+ P
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 83.4 bits (207), Expect = 5e-18
 Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 37/219 (16%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--VLHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +G G+FG V K     +    AVKV N     +  + +   E E+ + + H N++K+F  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                 + +    +V E    G L +    I +           +      I   V   +
Sbjct: 90  -----LEDSSSFYIVGELYTGGELFDE---IIKR-------KRFSEHDAARIIKQVFSGI 134

Query: 331 KYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
            Y+H   +  I H DLKP NILL   + +    + DFG++   +   +    I   GT  
Sbjct: 135 TYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAY 188

Query: 388 YIAPE-----YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           YIAPE     Y    +     DV+S G++L  + +G  P
Sbjct: 189 YIAPEVLRGTY--DEKC----DVWSAGVILYILLSGTPP 221

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 85.9 bits (213), Expect = 7e-18
 Identities = 22/129 (17%), Positives = 41/129 (31%), Gaps = 17/129 (13%)

Query: 1   DLSNNNLSG-------TLSPQLVGLSSLSIFNVSGNLLSGAISN-NFGSCTSLEQLDMHG 52
           +L  N L+          +        L+  ++  N L+    +    +   L  +D+  
Sbjct: 463 NLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSY 522

Query: 53  NLFAGPIGSSLSSLRGLRVL------DLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESM 106
           N F+    +   +   L+        D   N    E PE +     L  L +  N+    
Sbjct: 523 NSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK- 580

Query: 107 LPIEGIFKN 115
           +  E I  N
Sbjct: 581 VN-EKITPN 588

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 19/124 (15%), Positives = 44/124 (35%), Gaps = 11/124 (8%)

Query: 1   DLSNNNL--------SGTLSPQLVGLSSLSIFNVSGN-LLSGAISNNFGSCTSLEQLDMH 51
           +++ N                       + I  +  N L +  +  +      L  L+  
Sbjct: 279 NVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECL 338

Query: 52  GNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
            N   G +  +  S   L  L+L+ N +++    F    + ++NL+ ++N  +  +P   
Sbjct: 339 YNQLEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIF 396

Query: 112 IFKN 115
             K+
Sbjct: 397 DAKS 400

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 19/130 (14%), Positives = 43/130 (33%), Gaps = 16/130 (12%)

Query: 1   DLSNNNLSGTLSPQLVG-LSSLSIFNVSGNLLSGAISNNF-------GSCTSLEQLDMHG 52
             ++N L    +      +S +S  + S N +      NF           ++  +++  
Sbjct: 383 SFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSN 442

Query: 53  NLFAGPIGSSLSSLRGLRVLDLSQNNLSD-------EIPEFLAGFKFLQNLNLSYNNFES 105
           N  +       S+   L  ++L  N L++       +  E       L +++L +N    
Sbjct: 443 NQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502

Query: 106 MLPIEGIFKN 115
            L  +     
Sbjct: 503 -LSDDFRATT 511

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 18/114 (15%), Positives = 39/114 (34%), Gaps = 10/114 (8%)

Query: 1   DLSNNNLSGTLSPQLVG-LSSLSIFNVSGNLLSG-AISNNFGSCTSLEQLDMHGNLFAG- 57
           +L+ N ++  +     G    +   + + N L       +  S + +  +D   N     
Sbjct: 359 NLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSV 417

Query: 58  ------PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
                 P+  +      +  ++LS N +S    E  +    L ++NL  N    
Sbjct: 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 80.1 bits (198), Expect = 4e-16
 Identities = 16/134 (11%), Positives = 42/134 (31%), Gaps = 20/134 (14%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            ++++    ++          +      N ++  +S      T L Q  M  + F     
Sbjct: 165 CINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI 223

Query: 61  S-------------------SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYN 101
                                  +L+ L  +++       ++P FL     +Q +N++ N
Sbjct: 224 CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283

Query: 102 NFESMLPIEGIFKN 115
              S   ++  ++ 
Sbjct: 284 RGISGEQLKDDWQA 297

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 79.3 bits (196), Expect = 8e-16
 Identities = 23/108 (21%), Positives = 35/108 (32%), Gaps = 10/108 (9%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIF------NVSGNLLSGAISNNFGSCTSLEQLDMHGNL 54
           DLS N+ S     Q +  S+L  F      +  GN            C SL QL +  N 
Sbjct: 519 DLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577

Query: 55  FAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNN 102
                     ++    VLD+  N        ++  +       L Y+ 
Sbjct: 578 IRKVNEKITPNIS---VLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 12/111 (10%), Positives = 25/111 (22%), Gaps = 6/111 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSG----AISNNFGSCTSLEQLDMHGNLFA 56
            L     SG +   +  L+ L +  +  +               +  S EQ       + 
Sbjct: 87  SLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQ 146

Query: 57  GPIGSSLSSLR--GLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
                         L    ++ +     I +          +    NN   
Sbjct: 147 KTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 11/81 (13%), Positives = 23/81 (28%), Gaps = 3/81 (3%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           D   N         +    SL+   +  N +   ++       ++  LD+  N       
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDL 604

Query: 61  SSLSSLRGLRVLDLSQNNLSD 81
           S +       +  L  +   D
Sbjct: 605 SYVCPYIEAGMYMLFYDKTQD 625

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 13/112 (11%), Positives = 37/112 (33%), Gaps = 8/112 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +  N +  G  +      +     ++ G     ++++N      +  L + G   +G + 
Sbjct: 43  NGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN----GRVTGLSLEGFGASGRVP 98

Query: 61  SSLSSLRGLRVLDLSQNNLS----DEIPEFLAGFKFLQNLNLSYNNFESMLP 108
            ++  L  L VL L  +          P+ ++     +       +++    
Sbjct: 99  DAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 51.2 bits (123), Expect = 6e-07
 Identities = 20/130 (15%), Positives = 42/130 (32%), Gaps = 6/130 (4%)

Query: 53  NLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGI 112
           +++    G SL+S   +  L L     S  +P+ +     L+ L L  +  +    +   
Sbjct: 67  DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF-G 125

Query: 113 FKNASATSVFGNKKLC-----GGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLLVLT 167
            K  SA      K+           ++      S   K   ++ P +  I     + +  
Sbjct: 126 PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185

Query: 168 LALSSLFCRL 177
             +  L   +
Sbjct: 186 TQIGQLSNNI 195

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 82.7 bits (205), Expect = 8e-18
 Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 28/216 (12%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN-VLHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
           +G+G FG V+      S     +K  N        +    E EV +++ H N++K+F   
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
               F+      +V E    G   E +  I     R      L+      +   +   L 
Sbjct: 89  ----FEDYHNMYIVMETCEGG---ELLERIVSAQARG---KALSEGYVAELMKQMMNALA 138

Query: 332 YLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
           Y H      + H DLKP NIL           + DFG+A   ++ +  T +    GT  Y
Sbjct: 139 YFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALY 192

Query: 389 IAPE---YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           +APE     +  +     D++S G+++  + TG  P
Sbjct: 193 MAPEVFKRDVTFKC----DIWSAGVVMYFLLTGCLP 224

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 84.4 bits (209), Expect = 8e-18
 Identities = 62/246 (25%), Positives = 104/246 (42%), Gaps = 33/246 (13%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           F    +IG G F  V    + ++    A+K+ N   +L       F  E +V  N   R 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           + ++  A     FQ  ++  LV E+   G L   +  +++  +R  A      + R  +A
Sbjct: 123 ITQLHFA-----FQDENYLYLVMEYYVGGDL---LTLLSKFGERIPAE-----MARFYLA 169

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++   +  +H   +    H D+KP NILLD      ++DFG    L  AD   RS+   
Sbjct: 170 -EIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR-ADGTVRSLVAV 224

Query: 384 GTTGYIAPE----YGMGHEVSSYG---DVYSFGILLLEMFTGLRP-----SDDMFKDNLN 431
           GT  Y++PE     G G    SYG   D ++ G+   EMF G  P     + + +   ++
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284

Query: 432 LRNCVK 437
            +  + 
Sbjct: 285 YKEHLS 290

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 83.1 bits (206), Expect = 9e-18
 Identities = 54/218 (24%), Positives = 86/218 (39%), Gaps = 32/218 (14%)

Query: 209 SENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRNLVKV 267
            E+++G G    V   I   ++   AVK+              E E+    + HRN++++
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                   F+  D   LV+E M  GS+                  + N L+   +  DVA
Sbjct: 77  IEF-----FEEEDRFYLVFEKMRGGSILS----------HIHKRRHFNELEASVVVQDVA 121

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTRSIGVE- 383
             L +LH      IAH DLKP NIL    +      + DF +   ++   + +     E 
Sbjct: 122 SALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 384 ----GTTGYIAPE--YGMGHEVSSYG---DVYSFGILL 412
               G+  Y+APE       E S Y    D++S G++L
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 52/225 (23%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--------VLHHDASKSFAVECEVTRNIR-HRN 263
           IG G    V + +   +    AVK+              +  ++   E  + R +  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPI------TEEDKRHKAPGNLNSL 317
           ++ +  +     ++ + F  LV++ M  G L ++   +      +E++ R          
Sbjct: 162 IITLIDS-----YESSSFMFLVFDLMRKGELFDY---LTEKVALSEKETRS--------- 204

Query: 318 KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT 377
               I   +   + +LH +    I H DLKP NILLDD M   +SDFG +  LE   E+ 
Sbjct: 205 ----IMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKL 256

Query: 378 RSIGVEGTTGYIAPE---YGMGHEVSSYG---DVYSFG----ILL 412
           R +   GT GY+APE     M      YG   D+++ G     LL
Sbjct: 257 REL-C-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 51/230 (22%), Positives = 87/230 (37%), Gaps = 50/230 (21%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-----ECEVTRNIRHRNLVKV 267
           IG G F  V + I  E+    AVK+ +V    +S   +      E  +   ++H ++V++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSL-------EEWMHPITEEDKRHKAPGNLNSLKRL 320
                   +  +    +V+EFM    L        +     +E    H            
Sbjct: 92  LET-----YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH------------ 134

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQT 377
                +   L+Y H      I H D+KP  +LL   ++     +  FG+A  L   +   
Sbjct: 135 -YMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGL 188

Query: 378 RSIGVEGTTGYIAPE------YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            + G  GT  ++APE      Y  G  V    DV+  G++L  + +G  P
Sbjct: 189 VAGGRVGTPHFMAPEVVKREPY--GKPV----DVWGCGVILFILLSGCLP 232

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 81.8 bits (203), Expect = 2e-17
 Identities = 51/218 (23%), Positives = 82/218 (37%), Gaps = 48/218 (22%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +G G F  V + +   +    A K+ N   L     +    E  + R ++H N+V++  +
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEW---MHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                 Q   F  LV++ +  G L E        +E D  H                 + 
Sbjct: 74  -----IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH-------------CIQQIL 115

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
             + Y H      I H +LKP N+LL          ++DFG+A  +    +     G  G
Sbjct: 116 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAWHGFAG 169

Query: 385 TTGYIAPE------YGMGHEVSSYGDVYSFG----ILL 412
           T GY++PE      Y     V    D+++ G    ILL
Sbjct: 170 TPGYLSPEVLKKDPYSK--PV----DIWACGVILYILL 201

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFN--VLHHDASKSFAVECEVTRNIRHRNLVKV 267
             ++G G+FG V K     +    AVKV N     +  + +   E E+ + + H N++K+
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEW---MHPITEEDKRHKAPGNLNSLKRLNIAI 324
           F        + +    +V E    G L +        +E D                I  
Sbjct: 87  FEI-----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR-------------IIK 128

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTRSIG 381
            V   + Y+H   +  I H DLKP NILL   + +    + DFG++   +   +    I 
Sbjct: 129 QVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI- 184

Query: 382 VEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
             GT  YIAPE   G    +Y    DV+S G++L  + +G  P
Sbjct: 185 --GTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPP 221

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 46/219 (21%), Positives = 86/219 (39%), Gaps = 31/219 (14%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV------LHHDASKSFAVECEVTRNIRHRNLVK 266
           +G+G F  V K     +    A K                +    E  + R + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +        ++      L+ E ++ G L ++   + ++        +L+  +  +    +
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDF---LAQK-------ESLSEEEATSFIKQI 124

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY----VSDFGIARFLEAADEQTRSIGV 382
              + YLH      IAH DLKP NI+L D+        + DFG+A  +E   E      +
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NI 178

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            GT  ++APE      +    D++S G++   + +G  P
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 51/220 (23%), Positives = 82/220 (37%), Gaps = 41/220 (18%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG G++G V   +   +    A K       +    F  E E+ +++ H N+++++    
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74

Query: 273 GVDFQGNDFKALVYEFMANGSLEEW---MHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
              F+ N    LV E    G L E         E D                I  DV   
Sbjct: 75  ---FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR-------------IMKDVLSA 118

Query: 330 LKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
           + Y H   +  +AH DLKP N L      +    + DFG+A   +        +   GT 
Sbjct: 119 VAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTP 172

Query: 387 GYIAPE-----YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            Y++P+     Y  G E     D +S G+++  +  G  P
Sbjct: 173 YYVSPQVLEGLY--GPEC----DEWSAGVMMYVLLCGYPP 206

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 83.7 bits (207), Expect = 3e-17
 Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 28/233 (12%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G FG V+   +  +    A K  N   +      +   VE ++   +  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           +V +  A     F+      LV   M  G +   ++ + E++   + P           A
Sbjct: 247 IVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-----RAIFYTA 296

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
             +   L++LH   Q  I + DLKP N+LLDD+    +SD G+A   E    QT++ G  
Sbjct: 297 -QIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYA 350

Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP---------SDDMFK 427
           GT G++APE  +G E     D ++ G+ L EM     P         + ++ +
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ 403

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 46/220 (20%), Positives = 79/220 (35%), Gaps = 35/220 (15%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT--RNIRHR-NLVKVFT 269
           +G G F  V + I   +    A K              +  E+      +    ++ +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 270 ACSGVDFQGNDFKALVYEFMANGSL-----EEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
                 ++      L+ E+ A G +      E    ++E D                +  
Sbjct: 97  V-----YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR-------------LIK 138

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY---VSDFGIARFLEAADEQTRSIG 381
            +   + YLH   Q  I H DLKP NILL          + DFG++R +  A E      
Sbjct: 139 QILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---E 192

Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           + GT  Y+APE      +++  D+++ GI+   + T   P
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 31/219 (14%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV------ECEVTRNIRHRNLVK 266
           +G+G F  V K     +    A K        AS+          E  + R + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +        ++      L+ E ++ G L ++   + ++        +L+  +  +    +
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDF---LAQK-------ESLSEEEATSFIKQI 124

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY----VSDFGIARFLEAADEQTRSIGV 382
              + YLH      IAH DLKP NI+L D+        + DFG+A  +E   E      +
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NI 178

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            GT  ++APE      +    D++S G++   + +G  P
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 51/218 (23%), Positives = 82/218 (37%), Gaps = 48/218 (22%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
           +G G F  V + +   +    A K+ N   L     +    E  + R ++H N+V++  +
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEW---MHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
                 Q   F  LV++ +  G L E        +E D  H                 + 
Sbjct: 97  -----IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH-------------CIQQIL 138

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
             + Y H      I H +LKP N+LL          ++DFG+A  +    +     G  G
Sbjct: 139 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAWHGFAG 192

Query: 385 TTGYIAPE------YGMGHEVSSYGDVYSFG----ILL 412
           T GY++PE      Y     V    D+++ G    ILL
Sbjct: 193 TPGYLSPEVLKKDPY--SKPV----DIWACGVILYILL 224

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 82.1 bits (203), Expect = 7e-17
 Identities = 55/234 (23%), Positives = 88/234 (37%), Gaps = 50/234 (21%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKV-------------FNVLHHDASKSFAVECEVT 256
              +G+G +G V         +  A+KV              N       +    E  + 
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 257 RNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGN 313
           +++ H N++K+F       F+   +  LV EF   G L E +   H   E D  +     
Sbjct: 101 KSLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN----- 150

Query: 314 LNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFL 370
                   I   +   + YLH   +  I H D+KP NILL   +  +   + DFG++ F 
Sbjct: 151 --------IMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199

Query: 371 EAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
               +    +   GT  YIAPE         Y    DV+S G+++  +  G  P
Sbjct: 200 SKDYKLRDRL---GTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPP 246

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 59/244 (24%), Positives = 92/244 (37%), Gaps = 34/244 (13%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           +    +IG G FG V       +    A+K+ +   ++    S  F  E ++        
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           +V++F A     FQ + +  +V E+M  G L   M         +  P       R   A
Sbjct: 131 VVQLFYA-----FQDDRYLYMVMEYMPGGDLVNLM-------SNYDVP---EKWARFYTA 175

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +V   L  +H        H D+KP N+LLD      ++DFG    +           V 
Sbjct: 176 -EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV- 230

Query: 384 GTTGYIAPE--YGMGHEVSSYG---DVYSFGILLLEMFTGLRP-----SDDMFKDNLNLR 433
           GT  YI+PE     G +   YG   D +S G+ L EM  G  P         +   +N +
Sbjct: 231 GTPDYISPEVLKSQGGD-GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289

Query: 434 NCVK 437
           N + 
Sbjct: 290 NSLT 293

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 81.4 bits (201), Expect = 1e-16
 Identities = 57/213 (26%), Positives = 82/213 (38%), Gaps = 22/213 (10%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           ++G G FG V    +  +    A K      +           E ++   +  R +V + 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
            A     ++  D   LV   M  G L      I          G   +      A ++ C
Sbjct: 251 YA-----YETKDALCLVLTLMNGGDL---KFHI----YHMGQAGFPEARAVFYAA-EICC 297

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L+ LH   +  I + DLKP NILLDD     +SD G+A      + QT    V GT GY
Sbjct: 298 GLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRV-GTVGY 351

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           +APE       +   D ++ G LL EM  G  P
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 31/219 (14%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN------VLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G+G F  V K     +    A K              + +    E  + R IRH N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +        F+      L+ E ++ G L ++   + E+        +L   +       +
Sbjct: 73  LHDI-----FENKTDVVLILELVSGGELFDF---LAEK-------ESLTEDEATQFLKQI 117

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY----VSDFGIARFLEAADEQTRSIGV 382
              + YLH      IAH DLKP NI+L D+        + DFGIA  +EA +E      +
Sbjct: 118 LDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK---NI 171

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            GT  ++APE      +    D++S G++   + +G  P
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 81.1 bits (200), Expect = 2e-16
 Identities = 50/240 (20%), Positives = 89/240 (37%), Gaps = 65/240 (27%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA--------------VE 252
           FS   +IG G FG                +V+     D  K +A                
Sbjct: 191 FSVHRIIGRGGFG----------------EVYGCRKADTGKMYAMKCLDKKRIKMKQGET 234

Query: 253 C--------EVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEE 304
                     +        +V +  A     F   D  + + + M  G L    + +   
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDL---HYHL--- 283

Query: 305 DKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF 364
               +      +  R   A ++   L+++H      + + DLKP+NILLD+     +SD 
Sbjct: 284 ---SQHGVFSEADMRFYAA-EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDL 336

Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPE---YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           G+A   + + ++  +    GT GY+APE    G+ ++ S+  D +S G +L ++  G  P
Sbjct: 337 GLAC--DFSKKKPHASV--GTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGHSP 390

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 47/219 (21%), Positives = 85/219 (38%), Gaps = 31/219 (14%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN------VLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G+G F  V K     +    A K              + +    E  + + I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +        ++      L+ E +A G L ++   + E+        +L   +       +
Sbjct: 79  LHEV-----YENKTDVILILELVAGGELFDF---LAEK-------ESLTEEEATEFLKQI 123

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY----VSDFGIARFLEAADEQTRSIGV 382
              + YLH      IAH DLKP NI+L D         + DFG+A  ++  +E       
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            GT  ++APE      +    D++S G++   + +G  P
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 80.2 bits (198), Expect = 3e-16
 Identities = 54/229 (23%), Positives = 91/229 (39%), Gaps = 37/229 (16%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           L+G G FG V       +    A+K+     ++  D       E  V +N RH  L  + 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK--RHKAPGNLNSLKRLNIAIDV 326
            +     FQ +D    V E+   G L      ++ E      +A        R   A ++
Sbjct: 215 YS-----FQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRA--------RFYGA-EI 257

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
              L YLH +    + + DLK  N++LD +    ++DFG+ +         ++    GT 
Sbjct: 258 VSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GTP 313

Query: 387 GYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP-----SDDMFK 427
            Y+APE    +    YG   D +  G+++ EM  G  P      + +F+
Sbjct: 314 EYLAPEVLEDN---DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 35/118 (29%), Positives = 49/118 (41%), Gaps = 5/118 (4%)

Query: 1   DLSNNNLS--GTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG- 57
           DLS N LS  G  S    G +SL   ++S N +   +S+NF     LE LD   +     
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQM 411

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
              S   SLR L  LD+S  +          G   L+ L ++ N+F+       IF  
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTE 468

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 26/106 (24%), Positives = 48/106 (45%), Gaps = 1/106 (0%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DLS   +          LS LS   ++GN +       F   +SL++L       A    
Sbjct: 58  DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117

Query: 61  SSLSSLRGLRVLDLSQNNLSD-EIPEFLAGFKFLQNLNLSYNNFES 105
             +  L+ L+ L+++ N +   ++PE+ +    L++L+LS N  +S
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 24/104 (23%), Positives = 43/104 (41%), Gaps = 1/104 (0%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDMHGNLFAGPI 59
           D+S+ +     +    GLSSL +  ++GN        + F    +L  LD+         
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNF 103
            ++ +SL  L+VL+++ N L             LQ + L  N +
Sbjct: 487 PTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 37/118 (31%), Positives = 52/118 (44%), Gaps = 6/118 (5%)

Query: 1   DLSNNNLSGTLSPQ--LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGP 58
           D  ++NL   +S     + L +L   ++S      A +  F   +SLE L M GN F   
Sbjct: 402 DFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460

Query: 59  I-GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
                 + LR L  LDLSQ  L    P        LQ LN++ N  +S +P +GIF  
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VP-DGIFDR 516

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 29/120 (24%), Positives = 46/120 (38%), Gaps = 7/120 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN-LFAGPI 59
            L+ N +         GLSSL         L+   +   G   +L++L++  N + +  +
Sbjct: 82  ILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL 141

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQN----LNLSYNNFESMLPIEGIFKN 115
               S+L  L  LDLS N +       L     +      L+LS N    + P  G FK 
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP--GAFKE 199

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 63.6 bits (155), Expect = 7e-11
 Identities = 24/115 (20%), Positives = 36/115 (31%), Gaps = 5/115 (4%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
                N    +   L    S    ++S N L    S +F S   L+ LD+          
Sbjct: 13  QCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            +  SL  L  L L+ N +        +G   LQ L     N  S+        +
Sbjct: 70  GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL--ENFPIGH 122

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 30/145 (20%), Positives = 48/145 (33%), Gaps = 29/145 (20%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLL-SGAISNNFGSCTSLEQLDMHGNLFAGPI 59
                NL+   +  +  L +L   NV+ NL+ S  +   F + T+LE LD+  N      
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165

Query: 60  GSSLSSLRG---------------------------LRVLDLSQNNLSDEIPE-FLAGFK 91
            + L  L                             L  L L  N  S  + +  + G  
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLA 225

Query: 92  FLQNLNLSYNNFESMLPIEGIFKNA 116
            L+   L    F +   +E   K+A
Sbjct: 226 GLEVHRLVLGEFRNEGNLEKFDKSA 250

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 17/81 (20%), Positives = 29/81 (35%), Gaps = 1/81 (1%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            ++ N+      P     L +L+  ++S   L       F S +SL+ L+M  N      
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVP 510

Query: 60  GSSLSSLRGLRVLDLSQNNLS 80
                 L  L+ + L  N   
Sbjct: 511 DGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 25/109 (22%), Positives = 36/109 (33%), Gaps = 11/109 (10%)

Query: 1   DLSNNNLSGTLS-PQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            L +  +          G   L + N                  SL++L    N      
Sbjct: 288 SLVSVTIERVKDFSYNFGWQHLELVNCKFGQFP------TLKLKSLKRLTFTSNKGGNAF 341

Query: 60  GSSLSSLRGLRVLDLSQNNLS--DEIPEFLAGFKFLQNLNLSYNNFESM 106
             S   L  L  LDLS+N LS      +   G   L+ L+LS+N   +M
Sbjct: 342 --SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM 388

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 18/116 (15%), Positives = 36/116 (31%), Gaps = 8/116 (6%)

Query: 1   DLSNNNLSGTLSPQL-VGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            L+  +        L   L+++S F++    +      +F      + L++    F    
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFP 320

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
              L SL+    L  + N   +     +     L+ L+LS N              
Sbjct: 321 TLKLKSLK---RLTFTSNKGGN-AFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFG 371

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 22/114 (19%), Positives = 41/114 (35%), Gaps = 9/114 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIF----NVSGNLLSGAISNNFGSCTSLEQLDMHGNLFA 56
           DLS+N +       L  L  + +     ++S N ++  I         L +L +  N  +
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDS 213

Query: 57  GPIGS-SLSSLRGLRVLDLSQNNLSDE--IPEFLAG-FKFLQNLNLSYNNFESM 106
             +    +  L GL V  L      +E  + +F     + L NL +       +
Sbjct: 214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 37/237 (15%)

Query: 194 YVSYRM---LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVK-VFNVLHH--DASK 247
           + S  +    +   K + +   IG+G  G V           VA+K +     +   A +
Sbjct: 11  FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR 70

Query: 248 SFAVECEVTRNIRHRNLVK---VFTACSGVDFQGNDFKA--LVYEFMANGSLEEWMH-PI 301
           ++  E  + + + H+N++    VFT    ++    +F+   +V E M + +L + +   +
Sbjct: 71  AYR-ELVLMKCVNHKNIIGLLNVFTPQKSLE----EFQDVYIVMELM-DANLCQVIQMEL 124

Query: 302 TEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
             E   +             +   + C +K+LH      I H DLKPSNI++  + T  +
Sbjct: 125 DHERMSY-------------LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 168

Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
            DFG+AR    +   T  +    T  Y APE  +G       D++S G ++ EM  G
Sbjct: 169 LDFGLARTAGTSFMMTPYV---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 47/214 (21%), Positives = 82/214 (38%), Gaps = 47/214 (21%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV-TRNIRHRNLVKVFTAC 271
           IG G++    + I   +    AVK+ +    D ++    E E+  R  +H N++ +    
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDV- 84

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMH---PITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
               +    +  +V E M  G L + +      +E +                +   +  
Sbjct: 85  ----YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA-------------VLFTITK 127

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILL----DDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            ++YLH      + H DLKPSNIL      +  +  + DFG A+ L A +          
Sbjct: 128 TVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM--TPCY 182

Query: 385 TTGYIAPE------YGMGHEVSSYGDVYSFGILL 412
           T  ++APE      Y          D++S G+LL
Sbjct: 183 TANFVAPEVLERQGYDA--AC----DIWSLGVLL 210

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 33/245 (13%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           F    +IG G FG V    L  +    A+K+ N   +L    +  F  E +V  N   + 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           +  +  A     FQ ++   LV ++   G L   +  +++ + R         + R  +A
Sbjct: 136 ITTLHYA-----FQDDNNLYLVMDYYVGGDL---LTLLSKFEDRLP-----EEMARFYLA 182

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA-RFLEAADEQTRSIGV 382
            ++   +  +H   Q    H D+KP NIL+D      ++DFG   + +E    Q+     
Sbjct: 183 -EMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV- 237

Query: 383 EGTTGYIAPE--YGMGHEVSSYG---DVYSFGILLLEMFTGLRP-----SDDMFKDNLNL 432
            GT  YI+PE    M      YG   D +S G+ + EM  G  P       + +   +N 
Sbjct: 238 -GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296

Query: 433 RNCVK 437
           +   +
Sbjct: 297 KERFQ 301

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.5 bits (194), Expect = 6e-16
 Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 9/99 (9%)

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +   L YL       I H D+KP NILLD+    +++DF IA  L   + Q  +  + GT
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-RETQITT--MAGT 177

Query: 386 TGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
             Y+APE     + + Y    D +S G+   E+  G RP
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 57/249 (22%), Positives = 88/249 (35%), Gaps = 50/249 (20%)

Query: 181 KKRGNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV 240
                    +   ++        +  F  E+ +G G    VY+     +    A+KV   
Sbjct: 29  SAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK- 87

Query: 241 LHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHP 300
                 K    E  V   + H N++K+        F+     +LV E +  G L +    
Sbjct: 88  -KTVDKKIVRTEIGVLLRLSHPNIIKLKEI-----FETPTEISLVLELVTGGELFDR--- 138

Query: 301 I------TEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL- 353
           I      +E D                    +   + YLH   +  I H DLKP N+L  
Sbjct: 139 IVEKGYYSERDAAD-------------AVKQILEAVAYLH---ENGIVHRDLKPENLLYA 182

Query: 354 --DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPE----YGMGHEVSSYGDVYS 407
               +    ++DFG+++ +E    Q     V GT GY APE       G EV    D++S
Sbjct: 183 TPAPDAPLKIADFGLSKIVE---HQVLMKTVCGTPGYCAPEILRGCAYGPEV----DMWS 235

Query: 408 FG----ILL 412
            G    ILL
Sbjct: 236 VGIITYILL 244

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 47/227 (20%), Positives = 80/227 (35%), Gaps = 45/227 (19%)

Query: 209 SENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV---TRNIRHRNLV 265
           S+ ++G G  G V +     +    A+K+          S     EV    +     ++V
Sbjct: 33  SKQVLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIV 85

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSL-----EEWMHPITEEDKRHKAPGNLNSLKRL 320
            +      +         ++ E M  G L     E      TE +               
Sbjct: 86  CILDVYENMHHGKRCL-LIIMECMEGGELFSRIQERGDQAFTEREAAE------------ 132

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQT 377
            I  D+   +++LH      IAH D+KP N+L    + +    ++DFG A+       QT
Sbjct: 133 -IMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT 188

Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
                  T  Y+APE         Y    D++S G+++  +  G  P
Sbjct: 189 PC----YTPYYVAPEVLGPE---KYDKSCDMWSLGVIMYILLCGFPP 228

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 44/239 (18%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT--RNIRHRNLVKVFTA 270
           IG GNF  V       +   VA+K+ +    + +    +  EV   + + H N+VK+F  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
              ++ +   +  L+ E+ + G + +++     + E++ R K                + 
Sbjct: 83  ---IETEKTLY--LIMEYASGGEVFDYLVAHGRMKEKEARSKF-------------RQIV 124

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             ++Y H      I H DLK  N+LLD +M   ++DFG +       +        G   
Sbjct: 125 SAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPP 178

Query: 388 YIAPE------YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL-NLRNCVKSA 439
           Y APE      Y  G EV    DV+S G++L  + +G  P D     NL  LR  V   
Sbjct: 179 YAAPELFQGKKY-DGPEV----DVWSLGVILYTLVSGSLPFDG---QNLKELRERVLRG 229

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 23/106 (21%), Positives = 46/106 (43%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DLS+  +    S     L  L + N++ N ++      F    +L+ L++  NL      
Sbjct: 272 DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYS 331

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESM 106
           S+   L  +  +DL +N+++    +     + LQ L+L  N   ++
Sbjct: 332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI 377

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 70.2 bits (172), Expect = 7e-13
 Identities = 25/116 (21%), Positives = 46/116 (39%), Gaps = 5/116 (4%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
                NL+    PQ   L++     +S N +    +++F     L+ L++        I 
Sbjct: 10  FYRFCNLTQV--PQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65

Query: 61  S-SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
             +  +L  LR+LDL  + +    P+   G   L  L L +      +  +G F+N
Sbjct: 66  KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 70.2 bits (172), Expect = 7e-13
 Identities = 26/114 (22%), Positives = 44/114 (38%), Gaps = 7/114 (6%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAI--SNNFGSCTSLEQLDMHGNLFAG 57
           DL ++ +   L P    GL  L    +    LS A+     F +  +L +LD+  N    
Sbjct: 79  DLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS 137

Query: 58  -PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKF--LQNLNLSYNNFESMLP 108
             +  S   L  L+ +D S N +       L   +   L   +L+ N+  S + 
Sbjct: 138 LYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVS 191

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 30/122 (24%), Positives = 47/122 (38%), Gaps = 8/122 (6%)

Query: 1   DLSNNNLSG-TLSPQLVGLSSLSIFNVSGNLLSG-AISNNFGSCTSLEQLDMHGNLFAGP 58
            LS N L    +   L+ +  L I  ++ N  S  +         SLEQL +  N+    
Sbjct: 407 HLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA 466

Query: 59  IGSSL-----SSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIF 113
             + L       L  L+VL L+ N L+   P   +    L+ L+L+ N     L    + 
Sbjct: 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV-LSHNDLP 525

Query: 114 KN 115
            N
Sbjct: 526 AN 527

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 31/147 (21%), Positives = 52/147 (35%), Gaps = 13/147 (8%)

Query: 1   DLSNNNLSGTLSPQ--LVGLSSLSIFNVSGNLLSG-AISNNFGSCTSLEQLDMHGNLFAG 57
            L    LS  +        L +L+  ++S N +    +  +FG   SL+ +D   N    
Sbjct: 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162

Query: 58  PIGSSLSSLRG--LRVLDLSQNNLSDEIPEFLAG------FKFLQNLNLSYNNFESMLPI 109
                L  L+G  L    L+ N+L   +               L+ L++S N +   +  
Sbjct: 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT- 221

Query: 110 EGIFKNASATSVFGNKKLCGGIPEFQL 136
            G F NA + S   +  L   I     
Sbjct: 222 -GNFSNAISKSQAFSLILAHHIMGAGF 247

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 27/136 (19%), Positives = 46/136 (33%), Gaps = 27/136 (19%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +LS N L    S    GL  ++  ++  N ++      F     L+ LD+  N       
Sbjct: 320 NLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL----- 374

Query: 61  SSLSSLRGLRVLDLSQNNL---------------------SDEIPEFLAGFKFLQNLNLS 99
           +++  +  +  + LS N L                     + +I  FL     LQ L L+
Sbjct: 375 TTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILN 434

Query: 100 YNNFESMLPIEGIFKN 115
            N F S    +     
Sbjct: 435 QNRFSS-CSGDQTPSE 449

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 29/135 (21%), Positives = 46/135 (34%), Gaps = 22/135 (16%)

Query: 1   DLSNNNLSGTLSPQLVGLS------SLSIFNVSGNLLSGAISNNFGSCTS---------- 44
            L+ N+L   +S              L I +VSGN  +  I+ NF +  S          
Sbjct: 180 SLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILA 239

Query: 45  --LEQLDMHGNLFAGPIGSSLSSLR--GLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSY 100
             +       +    P  ++ + L    +R LDLS   +           K L+ LNL+Y
Sbjct: 240 HHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAY 299

Query: 101 NNFESMLPIEGIFKN 115
           N    +      F  
Sbjct: 300 NKINKIAD--EAFYG 312

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 57.5 bits (139), Expect = 6e-09
 Identities = 39/188 (20%), Positives = 67/188 (35%), Gaps = 25/188 (13%)

Query: 1   DLSNNNLSGTLSPQL-----VGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLF 55
            L  N L      +L      GLS L +  ++ N L+      F   T+L  L ++ N  
Sbjct: 457 FLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516

Query: 56  AGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
                + L +   L +LD+S+N L    P+    F  L  L++++N F     +      
Sbjct: 517 TVLSHNDLPAN--LEILDISRNQLLAPNPDV---FVSLSVLDITHNKFICECELSTFINW 571

Query: 116 ASATSVFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPL--------KLVIVIDIGLLVLT 167
            + T    N  + G         CV   S    S   L        +++  +   L ++ 
Sbjct: 572 LNHT----NVTIAG---PPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVC 624

Query: 168 LALSSLFC 175
               +LF 
Sbjct: 625 TVTLTLFL 632

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 59/251 (23%), Positives = 100/251 (39%), Gaps = 57/251 (22%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN--VLHHDASKSFAVECEVT--RNIRHRNLVKV 267
           L+G G++G V + +  E+    AVK+     L    +    V+ E+   R +RH+N++++
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 268 FTACSGVDFQGNDFKALVYEFM--ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
                  D   N+ K  +Y  M      ++E +  + E              KR  +   
Sbjct: 72  V------DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--------------KRFPV--C 109

Query: 326 VACV--------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE-- 375
            A          L+YLH      I H D+KP N+LL    T  +S  G+A  L       
Sbjct: 110 QAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166

Query: 376 --QTRSIGVEGTTGYIAPEYGMGHEVSSYG----DVYSFGILLLEMFTGLRPSDDMFKDN 429
             +T      G+  +  PE   G +  ++     D++S G+ L  + TGL P +    DN
Sbjct: 167 TCRTSQ----GSPAFQPPEIANGLD--TFSGFKVDIWSAGVTLYNITTGLYPFEG---DN 217

Query: 430 L-NLRNCVKSA 439
           +  L   +   
Sbjct: 218 IYKLFENIGKG 228

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 57/280 (20%), Positives = 98/280 (35%), Gaps = 68/280 (24%)

Query: 207 FSSENL-----IGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDAS-KSFAVECEV 255
           F  + L     +G G FG V +   F      +   VAVK+       +  ++   E ++
Sbjct: 19  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78

Query: 256 TRNI-RHRNLVKVFTACSGVDF------------------------------------QG 278
             +I  H N+V +  AC+                                        QG
Sbjct: 79  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQG 138

Query: 279 NDFKALVYEFMANGS---------------LEEWMHPITEEDKRHKAPGNLNSLKRL-NI 322
            D+   +   +                    E+ +  + EE+       +  +L+ L   
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICY 198

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           +  VA  +++L         H DL   NILL ++    + DFG+AR +    +  R    
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP 421
                ++APE       +   DV+SFG+LL E+F+ G  P
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 74.3 bits (183), Expect = 8e-15
 Identities = 25/115 (21%), Positives = 49/115 (42%), Gaps = 9/115 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            +++++L   L+       ++   ++SGN LS   + +    T LE L++  N+      
Sbjct: 16  KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET-- 73

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
             L SL  LR LDL+ N + +     L     ++ L+ + NN    +      + 
Sbjct: 74  LDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISR-VSCS-RGQG 121

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 2/88 (2%)

Query: 18  LSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQN 77
            +   I  V+ + L  A+++   S  ++++LD+ GN  +    + L+    L +L+LS N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 78  NLSDEIPEFLAGFKFLQNLNLSYNNFES 105
            L  E  +       L+ L+L+ N  + 
Sbjct: 69  VLY-ETLDL-ESLSTLRTLDLNNNYVQE 94

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 23/116 (19%), Positives = 45/116 (38%), Gaps = 13/116 (11%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +LS+N L    +  L  LS+L   +++ N +            S+E L    N     I 
Sbjct: 64  NLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN----IS 112

Query: 61  S-SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
             S S  +G + + L+ N ++            +Q L+L  N  ++ +    +  +
Sbjct: 113 RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELAAS 167

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 27/125 (21%), Positives = 45/125 (36%), Gaps = 5/125 (4%)

Query: 1   DLSNNNLSGTLSPQLVG-LSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
           DL  N +      +L     +L   N+  N +   +         L+ LD+  N  A  +
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-M 206

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASAT 119
           G    S  G+  + L  N L   I + L   + L++ +L  N F      +   KN    
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265

Query: 120 SVFGN 124
           +V   
Sbjct: 266 TVAKQ 270

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 59.2 bits (144), Expect = 8e-10
 Identities = 22/78 (28%), Positives = 31/78 (39%)

Query: 34  AISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFL 93
           AI     +    +   +  +     + S   S   ++ LDLS N LS      LA F  L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 94  QNLNLSYNNFESMLPIEG 111
           + LNLS N     L +E 
Sbjct: 61  ELLNLSSNVLYETLDLES 78

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 32/223 (14%)

Query: 204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVK-VFNVLHH--DASKSFAVECEVTRNIR 260
            K + +   IG+G  G V           VA+K +     +   A +++  E  + + + 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 119

Query: 261 HRNLVK---VFTACSGVDFQGNDFKA--LVYEFMANGSLEEWMHPITEEDKRHKAPGNLN 315
           H+N++    VFT    ++    +F+   LV E M     +  +  + + +        L+
Sbjct: 120 HKNIISLLNVFTPQKTLE----EFQDVYLVMELM-----DANLCQVIQME--------LD 162

Query: 316 SLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE 375
             +   +   + C +K+LH      I H DLKPSNI++  + T  + DFG+AR    +  
Sbjct: 163 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 219

Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
            T  +    T  Y APE  +G       D++S G ++ EM   
Sbjct: 220 MTPYV---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 25/115 (21%), Positives = 49/115 (42%), Gaps = 9/115 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            +++++L   L+       ++   ++SGN LS   + +    T LE L++  N+      
Sbjct: 16  KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET-- 73

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
             L SL  LR LDL+ N + +     L     ++ L+ + NN    +      + 
Sbjct: 74  LDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISR-VS-CSRGQG 121

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 2/88 (2%)

Query: 18  LSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQN 77
            +   I  V+ + L  A+++   S  ++++LD+ GN  +    + L+    L +L+LS N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 78  NLSDEIPEFLAGFKFLQNLNLSYNNFES 105
            L  E  +       L+ L+L+ N  + 
Sbjct: 69  VLY-ETLDL-ESLSTLRTLDLNNNYVQE 94

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 22/115 (19%), Positives = 45/115 (39%), Gaps = 11/115 (9%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +LS+N L    +  L  LS+L   +++ N +            S+E L    N  +    
Sbjct: 64  NLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR--- 113

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            S S  +G + + L+ N ++            +Q L+L  N  ++ +    +  +
Sbjct: 114 VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELAAS 167

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 27/125 (21%), Positives = 45/125 (36%), Gaps = 5/125 (4%)

Query: 1   DLSNNNLSGTLSPQLVG-LSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
           DL  N +      +L     +L   N+  N +   +         L+ LD+  N  A  +
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-M 206

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASAT 119
           G    S  G+  + L  N L   I + L   + L++ +L  N F      +   KN    
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265

Query: 120 SVFGN 124
           +V   
Sbjct: 266 TVAKQ 270

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 59.9 bits (145), Expect = 9e-10
 Identities = 22/78 (28%), Positives = 31/78 (39%)

Query: 34  AISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFL 93
           AI     +    +   +  +     + S   S   ++ LDLS N LS      LA F  L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 94  QNLNLSYNNFESMLPIEG 111
           + LNLS N     L +E 
Sbjct: 61  ELLNLSSNVLYETLDLES 78

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 7/113 (6%), Positives = 27/113 (23%), Gaps = 6/113 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQ-----LDMHGNLF 55
            ++   +           +  ++ +          +       +L++     L   G+  
Sbjct: 266 TVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET 325

Query: 56  AGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
              +     +    R +D  +      I +     +    L       +  + 
Sbjct: 326 ER-LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 53/244 (21%), Positives = 90/244 (36%), Gaps = 52/244 (21%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN------------------------VLHHDASK 247
            IG G++G V         T  A+KV +                                
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 248 SFAVECEVT--RNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH--PITE 303
              V  E+   + + H N+VK+      +D    D   +V+E +  G + E     P++E
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE 136

Query: 304 EDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD 363
           +  R                 D+   ++YLH      I H D+KPSN+L+ ++    ++D
Sbjct: 137 DQARF-------------YFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIAD 180

Query: 364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLR 420
           FG++   + +D    +    GT  ++APE          G   DV++ G+ L     G  
Sbjct: 181 FGVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

Query: 421 PSDD 424
           P  D
Sbjct: 239 PFMD 242

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 56/235 (23%), Positives = 89/235 (37%), Gaps = 51/235 (21%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN--VLHHDASKSFAVECEVTRNI------RHRNL 264
           +G+G FG V+  +  E    V VK      +  D         +VT  I       H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGS-----LEEWMHP-ITEEDKRHKAPGNLNSLK 318
           +KV        F+   F  LV E   +G      ++   HP + E    +         +
Sbjct: 92  IKVLDI-----FENQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYI-------FR 137

Query: 319 RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
           +L  A+       YL       I H D+K  NI++ ++ T  + DFG A +LE       
Sbjct: 138 QLVSAVG------YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188

Query: 379 SIGVEGTTGYIAPE------YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFK 427
                GT  Y APE      Y  G E+    +++S G+ L  +     P  ++ +
Sbjct: 189 FC---GTIEYCAPEVLMGNPYR-GPEL----EMWSLGVTLYTLVFEENPFCELEE 235

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 73.7 bits (182), Expect = 2e-14
 Identities = 33/111 (29%), Positives = 52/111 (46%), Gaps = 6/111 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            + NN ++  LSP L  LS L+   +  N +S  I+      T L+ L++  N  +    
Sbjct: 227 KIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-INA-VKDLTKLKMLNVGSNQISDI-- 280

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
           S L++L  L  L L+ N L +E  E + G   L  L LS N+   + P+  
Sbjct: 281 SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLAS 331

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 71.0 bits (175), Expect = 1e-13
 Identities = 24/102 (23%), Positives = 45/102 (44%), Gaps = 6/102 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           ++  N +S  ++  +  L+ L + NV  N +S  IS    + + L  L ++ N       
Sbjct: 249 EIGTNQIS-DINA-VKDLTKLKMLNVGSNQISD-ISV-LNNLSQLNSLFLNNNQLGNEDM 304

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNN 102
             +  L  L  L LSQN+++D  P  LA    + + + +   
Sbjct: 305 EVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 69.9 bits (172), Expect = 3e-13
 Identities = 22/111 (19%), Positives = 50/111 (45%), Gaps = 7/111 (6%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +L+ N ++  +SP L  L  L+   +  N ++    +   + T+L +L ++ +  +    
Sbjct: 72  NLNGNQITD-ISP-LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDI-- 125

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
           S L++L  +  L+L  N+        L+    L  L ++ +  + + PI  
Sbjct: 126 SPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTPIAN 175

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 68.3 bits (168), Expect = 9e-13
 Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 7/111 (6%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +L  N+    LSP L  ++ L+   V+ + +         + T L  L ++ N       
Sbjct: 138 NLGANHNLSDLSP-LSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDI-- 192

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
           S L+SL  L       N ++D  P  +A    L +L +  N    + P+  
Sbjct: 193 SPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLAN 241

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 58.7 bits (143), Expect = 1e-09
 Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 4/80 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           ++ +N +S  +S  L  LS L+   ++ N L        G  T+L  L +  N       
Sbjct: 271 NVGSNQISD-ISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI-- 326

Query: 61  SSLSSLRGLRVLDLSQNNLS 80
             L+SL  +   D +   + 
Sbjct: 327 RPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 58.3 bits (142), Expect = 2e-09
 Identities = 18/111 (16%), Positives = 39/111 (35%), Gaps = 8/111 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
                 ++  + P    L+      +    ++  +        S+ +L + G   A    
Sbjct: 6   ATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVV--TQEELESITKLVVAGEKVASI-- 59

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
             +  L  L  L+L+ N ++D  P  L+    L NL +  N    +  ++ 
Sbjct: 60  QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQN 108

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 52/226 (23%), Positives = 87/226 (38%), Gaps = 43/226 (19%)

Query: 208 SSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT--RNIR-HRNL 264
             +  +G G+F    K +  +S  A AVK+              + E+T  +    H N+
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKII-----SKRMEANTQKEITALKLCEGHPNI 68

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+        F       LV E +  G L E          R K   + +  +   I  
Sbjct: 69  VKLHEV-----FHDQLHTFLVMELLNGGELFE----------RIKKKKHFSETEASYIMR 113

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTRSIG 381
            +   + ++H      + H DLKP N+L    +D +   + DFG AR     ++  ++  
Sbjct: 114 KLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170

Query: 382 VEGTTGYIAPEYGMGHEV---SSYG---DVYSFGILLLEMFTGLRP 421
              T  Y AP      E+   + Y    D++S G++L  M +G  P
Sbjct: 171 --FTLHYAAP------ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 26/117 (22%), Positives = 48/117 (41%), Gaps = 5/117 (4%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGN-LLSGAISNNFGSCTSLEQLDMHGNLFAGP 58
           D+S+ +           GLSSL +  ++GN      + + F    +L  LD+        
Sbjct: 132 DISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 190

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
             ++ +SL  L+VL++S NN              LQ L+ S N+  +    +   ++
Sbjct: 191 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SK-KQELQH 245

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 35/118 (29%), Positives = 50/118 (42%), Gaps = 5/118 (4%)

Query: 1   DLSNNNLS--GTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN-LFAG 57
            LS+N LS  G  S    G +SL   ++S N +   +S+NF     LE LD   + L   
Sbjct: 58  SLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQM 116

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
              S   SLR L  LD+S  +          G   L+ L ++ N+F+       IF  
Sbjct: 117 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTE 173

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 23/120 (19%), Positives = 43/120 (35%), Gaps = 13/120 (10%)

Query: 1   DLSNNNLS---GTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN-LFA 56
             ++  L+     +      L       +  N L       F   T L +L +  N L  
Sbjct: 13  RCNSKGLTSVPTGIPSSATRL------ELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66

Query: 57  GPIGS-SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
               S S      L+ LDLS N +   +     G + L++L+  ++N +  +    +F +
Sbjct: 67  KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLS 124

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 49/243 (20%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
            +G G FG V  G    +   VAVK+ N   +   D       E +  +  RH +++K++
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 269 TACSGVDFQGNDFKA-LVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRLNIAI 324
                           +V E+++ G L +++     + E + R          +++  A+
Sbjct: 78  ------QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRL-------FQQILSAV 124

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE-QTRSIGVE 383
           D      Y H   +  + H DLKP N+LLD  M A ++DFG++  +   +  +T      
Sbjct: 125 D------YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---- 171

Query: 384 GTTGYIAPE------YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL-NLRNCV 436
           G+  Y APE      Y  G EV    D++S G++L  +  G  P DD   +++  L   +
Sbjct: 172 GSPNYAAPEVISGRLYA-GPEV----DIWSCGVILYALLCGTLPFDD---EHVPTLFKKI 223

Query: 437 KSA 439
           +  
Sbjct: 224 RGG 226

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 46/229 (20%), Positives = 79/229 (34%), Gaps = 50/229 (21%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV---TRNIRHRNLVK 266
             ++G G  G V +     +    A+K+                EV    R  +  ++V+
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVR 119

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSL-----EEWMHPITEEDKRHKAPGNLNSLKRLN 321
           +        + G     +V E +  G L     +      TE +                
Sbjct: 120 IVDVYEN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE------------- 165

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIARFLEAADEQTR 378
           I   +   ++YLH      IAH D+KP N+L           ++DFG A+   + +  T 
Sbjct: 166 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT- 221

Query: 379 SIGVEGTTGYIAPEYGMGHEV---SSYG---DVYSFGILLLEMFTGLRP 421
                 T  Y+AP      EV     Y    D++S G+++  +  G  P
Sbjct: 222 --TPCYTPYYVAP------EVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 71.8 bits (177), Expect = 3e-14
 Identities = 59/237 (24%), Positives = 96/237 (40%), Gaps = 36/237 (15%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTA 270
            +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+VK +  
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY-- 71

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
             G   +GN    L  E+ + G L + +     + E D +           +L   +   
Sbjct: 72  --GHRREGNIQ-YLFLEYCSGGELFDRIEPDIGMPEPDAQRF-------FHQLMAGVV-- 119

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
               YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  
Sbjct: 120 ----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 388 YIAPE------YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS 438
           Y+APE      +     V    DV+S GI+L  M  G  P D          +  + 
Sbjct: 173 YVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 52/249 (20%), Positives = 102/249 (40%), Gaps = 50/249 (20%)

Query: 195 VSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVE 252
           +  R++YN +  F  ++L+G G +G V       +   VA+K          A ++   E
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-E 59

Query: 253 CEVTRNIRHRNLVK---VFTACSGVDFQGNDFKALVYEFMANGSLEEWMH------PITE 303
            ++ ++ +H N++    +    S  +F  N+   ++ E M     +  +H       +++
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENF--NEV-YIIQELM-----QTDLHRVISTQMLSD 111

Query: 304 EDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD 363
           +  ++                     +K LH      + H DLKPSN+L++      V D
Sbjct: 112 DHIQY-------------FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCD 155

Query: 364 FGIARFLEAADEQTRSIGVEGT--TGYI------APEYGMGHEVSSYG---DVYSFGILL 412
           FG+AR ++ +         + +    ++      APE  +    + Y    DV+S G +L
Sbjct: 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS--AKYSRAMDVWSCGCIL 213

Query: 413 LEMFTGLRP 421
            E+F   RP
Sbjct: 214 AELFLR-RP 221

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 71.9 bits (177), Expect = 8e-14
 Identities = 53/249 (21%), Positives = 85/249 (34%), Gaps = 65/249 (26%)

Query: 201 YNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV----ECEVT 256
                 F  E + G G FG+V  G    +  +VA+K   V+       F        +  
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK--KVIQD---PRFRNRELQIMQDL 73

Query: 257 RNIRHRNLVK---VFTACSGVDFQGND-FKALVYEFMANGSLEEWMHPITEEDKRHKAPG 312
             + H N+V+    F      D    D +  +V E++      + +H             
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDR--RDIYLNVVMEYV-----PDTLHRC----------- 115

Query: 313 NLNSLKRLNIAIDVACV----------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAY-V 361
              +  R  +A     +          +  LHL     + H D+KP N+L+++      +
Sbjct: 116 -CRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKL 173

Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYI------APEYGMGHEVSSYG---DVYSFGILL 412
            DFG A+ L            E    YI      APE   G+    Y    D++S G + 
Sbjct: 174 CDFGSAKKLSP---------SEPNVAYICSRYYRAPELIFGN--QHYTTAVDIWSVGCIF 222

Query: 413 LEMFTGLRP 421
            EM  G  P
Sbjct: 223 AEMMLG-EP 230

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.5 bits (176), Expect = 9e-14
 Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 38/229 (16%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           L+G G FG V       +    A+K+     ++  D       E  V +N RH  L  + 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK--RHKAPGNLNSLKRLNIAIDV 326
            A     FQ +D    V E+   G L      ++ E      +A        R   A ++
Sbjct: 72  YA-----FQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERA--------RFYGA-EI 114

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
              L+YLH      + + D+K  N++LD +    ++DFG+ +   +     ++    GT 
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GTP 169

Query: 387 GYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP-----SDDMFK 427
            Y+APE    +    YG   D +  G+++ EM  G  P      + +F+
Sbjct: 170 EYLAPEVLEDN---DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 27/280 (9%), Positives = 61/280 (21%), Gaps = 76/280 (27%)

Query: 212 LIGAGNFGSVYKGILFESTT--AVAVKVFNVLHHDASKS------FAVECEVTRNIRHRN 263
             G       ++    ++     VA+     +                       I    
Sbjct: 38  FHGGVPPLQFWQA--LDTALDRQVALTF---VDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 264 LVKVFTACSGVDF-QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           + +V       D         +V E++  GSL+E                + + +  +  
Sbjct: 93  VARVL------DVVHTRAGGLVVAEWIRGGSLQEVAD------------TSPSPVGAIRA 134

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
              +A      H   +  +A     PS + +  +    ++           D   +    
Sbjct: 135 MQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATM-----PDANPQD--- 183

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN-LNLRNCVKSALP 441
                                D+   G  L  +     P  +    + L       +  P
Sbjct: 184 ---------------------DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222

Query: 442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGER 481
               +I         ++    +               G R
Sbjct: 223 IEPADIDRDIPFQISAVAARSV-----------QGDGGIR 251

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 30/115 (26%), Positives = 49/115 (42%), Gaps = 6/115 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L +NNL+ T    L+    L   ++S N L   + + F     LE+L +  N     + 
Sbjct: 232 KLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LN 288

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
                +  L+VLDLS N+L   +      F  L+NL L +N+  + L +      
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LKL-STHHT 340

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 68.9 bits (169), Expect = 7e-13
 Identities = 30/128 (23%), Positives = 55/128 (42%), Gaps = 6/128 (4%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DLS N L   +    V +  L    +S N L  A++       +L+ LD+  N     + 
Sbjct: 254 DLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VE 311

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
            +      L  L L  N++   +   L+    L+NL LS+N+++    +  +F+N +  +
Sbjct: 312 RNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDC-NSLRALFRNVARPA 367

Query: 121 VFGNKKLC 128
           V    + C
Sbjct: 368 VDDADQHC 375

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 20/105 (19%), Positives = 44/105 (41%), Gaps = 6/105 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           D S+N+++  +   +     L+I  +  N L+   +    +   L ++D+  N     + 
Sbjct: 211 DASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMY 265

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
                ++ L  L +S N L   +  +      L+ L+LS+N+   
Sbjct: 266 HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH 309

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 19/114 (16%), Positives = 38/114 (33%), Gaps = 2/114 (1%)

Query: 2   LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGS 61
           +           + + L++  I     + +    +    S   +E L+++          
Sbjct: 28  IDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTY 87

Query: 62  SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
           + +    ++ L +  N +    P        L  L L  N+  S LP  GIF N
Sbjct: 88  AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LP-RGIFHN 139

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 62.8 bits (153), Expect = 8e-11
 Identities = 19/116 (16%), Positives = 39/116 (33%), Gaps = 4/116 (3%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
           +L++  +   +         ++    +  N +     + F +   L  L +  N  +   
Sbjct: 75  NLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLP 133

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
                +   L  L +S NNL     +       LQNL LS N     + +  +  +
Sbjct: 134 RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDL-SLIPS 187

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 22/115 (19%), Positives = 41/115 (35%), Gaps = 13/115 (11%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           ++S N LS      L    ++   + S N ++  +         L  L +  N       
Sbjct: 192 NVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT-- 241

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
           + L +  GL  +DLS N L   +       + L+ L +S N   +   +    + 
Sbjct: 242 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA---LNLYGQP 293

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 27/117 (23%), Positives = 50/117 (42%), Gaps = 14/117 (11%)

Query: 1   DLSNNNLSGTLSPQL-VGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            L  N+LS +L   +      L+  ++S N L     + F + TSL+ L +  N     +
Sbjct: 123 VLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN----RL 177

Query: 60  GS-SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
               LS +  L   ++S N LS      LA    ++ L+ S+N+  +++    +   
Sbjct: 178 THVDLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSI-NVVR-GPVNVE 227

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 15/106 (14%), Positives = 36/106 (33%), Gaps = 5/106 (4%)

Query: 13  PQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVL 72
                   + I   + ++  G       +  + + +    +       + L S R + +L
Sbjct: 18  QYDCVFYDVHIDMQTQDVYFG---FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 74

Query: 73  DLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASA 118
           +L+   + +      A    +Q L + +N     LP   +F+N   
Sbjct: 75  NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI-RYLP-PHVFQNVPL 118

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 12/83 (14%), Positives = 26/83 (31%), Gaps = 2/83 (2%)

Query: 35  ISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQ 94
           I +N         + +         G    +L   +++    + +       L  F+ ++
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 95  NLNLSYNNFESMLPIEGIFKNAS 117
            LNL+    E  +     F  A 
Sbjct: 73  LLNLNDLQIEE-ID-TYAFAYAH 93

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 60/237 (25%), Positives = 96/237 (40%), Gaps = 36/237 (15%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN-VLHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
            +G G +G V   +   +  AVAVK+ +     D  ++   E  + + + H N+VK +  
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY-- 71

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHP---ITEEDKRHKAPGNLNSLKRLNIAIDVA 327
             G   +GN    L  E+ + G L + + P   + E D +           +L   +   
Sbjct: 72  --GHRREGNIQ-YLFLEYCSGGELFDRIEPDIGMPEPDAQRF-------FHQLMAGVV-- 119

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
               YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT  
Sbjct: 120 ----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 388 YIAPE------YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS 438
           Y+APE      +     V    DV+S GI+L  M  G  P D          +  + 
Sbjct: 173 YVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 55/316 (17%), Positives = 114/316 (36%), Gaps = 52/316 (16%)

Query: 180 MKKRGNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVK-VF 238
           M    + +      Y       +    +  ++LIG G++G VY      +   VA+K V 
Sbjct: 1   MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60

Query: 239 NVLHH--DASKSFAVECEVTRNIRHRNLVK---VFTACSGVDFQGNDFKALVYEFMANGS 293
            +     D  +    E  +   ++   +++   +      + F  ++   +V E      
Sbjct: 61  RMFEDLIDCKRILR-EITILNRLKSDYIIRLYDLIIPDDLLKF--DEL-YIVLEIA---- 112

Query: 294 LEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL 353
            +  +  +       K P  L       I  ++     ++H   +  I H DLKP+N LL
Sbjct: 113 -DSDLKKLF------KTPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLL 162

Query: 354 DDEMTAYVSDFGIARFLEAADEQTRSIGVEGT--------------TGYI------APEY 393
           + + +  V DFG+AR + +  +      +E                T ++      APE 
Sbjct: 163 NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL 222

Query: 394 GMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNL---RNCVKSALPERAEEI 447
            +     +Y    D++S G +  E+   L+   +   +   L    +C   +    ++++
Sbjct: 223 ILLQ--ENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKV 280

Query: 448 RASSGSTQRSIILECL 463
              S   Q +II   +
Sbjct: 281 HEKSNRDQLNIIFNII 296

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 27/120 (22%), Positives = 47/120 (39%), Gaps = 8/120 (6%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNN---FGSCTSLEQLDMHGNLFA- 56
            + N+ +          L SL   ++S NL+      N    G+  SL+ L +  N    
Sbjct: 316 TVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS 375

Query: 57  -GPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
               G  L +L+ L  LD+S+N     +P+     + ++ LNLS      +     I + 
Sbjct: 376 MQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKT--CIPQT 432

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 22/118 (18%), Positives = 42/118 (35%), Gaps = 3/118 (2%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           D + +          V   ++   ++    L   +S  +     ++++ +  +       
Sbjct: 268 DFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPC 327

Query: 61  SSLSSLRGLRVLDLSQNNLSDEI---PEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
           S    L+ L  LDLS+N + +E          +  LQ L LS N+  SM     I   
Sbjct: 328 SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 28/118 (23%), Positives = 49/118 (41%), Gaps = 6/118 (5%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG-P 58
            L ++ ++ T+       L SL   ++S N LS   S+ FG  +SL+ L++ GN +    
Sbjct: 56  ILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLG 114

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPE-FLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
           + S   +L  L+ L +       EI     AG   L  L +   +  +        K+
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS--QSLKS 170

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 26/115 (22%), Positives = 53/115 (46%), Gaps = 4/115 (3%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           D  + + + ++   L   +++   ++S N ++     +  +C +L+ L +  +      G
Sbjct: 11  DGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            +  SL  L  LDLS N+LS     +      L+ LNL  N +++ L +  +F N
Sbjct: 68  DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT-LGVTSLFPN 121

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 29/137 (21%), Positives = 43/137 (31%), Gaps = 24/137 (17%)

Query: 1   DLSNNNLSGTLSPQLV---GLSSLSIFNVSGNLLS--GAISNNFGSCTSLEQLDMHGNLF 55
           DLS N +               SL    +S N L           +  +L  LD+  N F
Sbjct: 340 DLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399

Query: 56  AGPIGSSLSSLRGLRVLDLSQNNLSD-----------------EIPEFLAGFKFLQNLNL 98
             P+  S      +R L+LS   +                    +  F      LQ L +
Sbjct: 400 -HPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYI 458

Query: 99  SYNNFESMLPIEGIFKN 115
           S N  ++ LP   +F  
Sbjct: 459 SRNKLKT-LPDASLFPV 474

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 18/110 (16%), Positives = 34/110 (30%), Gaps = 1/110 (0%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            + N      +      GL+SL+   +    L    S +  S   +  L +H +  A  +
Sbjct: 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLL 188

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPI 109
                 L  +R L+L   NL+      L   +    +         +   
Sbjct: 189 EIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 27/115 (23%), Positives = 46/115 (40%), Gaps = 12/115 (10%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           D+S N     +         +   N+S   +            +LE LD+  N     + 
Sbjct: 393 DISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR---VVKTCIPQTLEVLDVSNN----NLD 444

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
           S    L  L+ L +S+N L   +P+  + F  L  + +S N  +S +P +GIF  
Sbjct: 445 SFSLFLPRLQELYISRNKLKT-LPDA-SLFPVLLVMKISRNQLKS-VP-DGIFDR 495

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 12/112 (10%), Positives = 33/112 (29%)

Query: 5   NNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLS 64
             +      +    +   + + + +              ++ +L +        + +  S
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307

Query: 65  SLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNA 116
            L  ++ + +  + +      F    K L+ L+LS N            K A
Sbjct: 308 LLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 12/129 (9%), Positives = 35/129 (27%), Gaps = 7/129 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNL---FAG 57
           ++   +L    S  L  +  +    +  +  +  +       +S+  L++       F  
Sbjct: 154 EIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQF 213

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSD----EIPEFLAGFKFLQNLNLSYNNFESMLPIEGIF 113
                      ++ L    + L+D    E+ + L     L  +         +       
Sbjct: 214 SPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSE 273

Query: 114 KNASATSVF 122
            +  +    
Sbjct: 274 SDVVSELGK 282

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 56/250 (22%), Positives = 100/250 (40%), Gaps = 64/250 (25%)

Query: 194 YVSYRM---LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVK-VFNVLHH--DASK 247
           +    +    +   K + S   +G+G +GSV   I   S   VA+K +         A +
Sbjct: 10  FYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR 69

Query: 248 SFAVECEVTRNIRHRNLVK---VFTACSGVDFQGNDFKA--LVYEFMANGSLEEWMH--- 299
           ++  E  + ++++H N++    VFT  S +     +F    LV  FM     +  +    
Sbjct: 70  AYR-ELLLLKHMQHENVIGLLDVFTPASSLR----NFYDFYLVMPFM-----QTDLQKIM 119

Query: 300 --PITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM 357
               +EE  ++             +   +   LKY+H      + H DLKP N+ ++++ 
Sbjct: 120 GLKFSEEKIQY-------------LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDC 163

Query: 358 TAYVSDFGIARFLEAADEQTRSIGVEGTTGYI------APEYGMGHEVSSYG---DVYSF 408
              + DFG+AR  +              TGY+      APE  +      Y    D++S 
Sbjct: 164 ELKILDFGLARHAD-----------AEMTGYVVTRWYRAPEVILSW--MHYNQTVDIWSV 210

Query: 409 GILLLEMFTG 418
           G ++ EM TG
Sbjct: 211 GCIMAEMLTG 220

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 46/229 (20%), Positives = 95/229 (41%), Gaps = 45/229 (19%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVF--NVLHHDASKSFAVECEVTRNIR--------H 261
            +G G+F +V+      + T VA+K+   + ++ +A++    E ++ + +          
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADNTKEDS 82

Query: 262 RNLVKVFTACSGVDFQGNDFK--ALVYEFMANGSLEEWMHPITEEDKRHKAPG-NLNSLK 318
                +       + +G +     +V+E +   +L   +       K+++  G  L  +K
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALI-------KKYEHRGIPLIYVK 134

Query: 319 RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY------VSDFGIARFLE- 371
           +  I+  +   L Y+H  C   I H D+KP N+L++   +        ++D G A + + 
Sbjct: 135 Q--ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190

Query: 372 --AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
                 QTR         Y +PE  +G       D++S   L+ E+ TG
Sbjct: 191 HYTNSIQTRE--------YRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 67.7 bits (166), Expect = 3e-13
 Identities = 26/111 (23%), Positives = 50/111 (45%), Gaps = 3/111 (2%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            ++N + +   +P + GLS+L    + G  ++     N    TSL  LD+  +     I 
Sbjct: 72  TINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
           + +++L  +  +DLS N    +I   L     L++LN+ ++       IE 
Sbjct: 130 TKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIED 179

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 66.9 bits (164), Expect = 5e-13
 Identities = 19/105 (18%), Positives = 41/105 (39%), Gaps = 3/105 (2%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            +   +++    P L GL+SL++ ++S +    +I     +   +  +D+  N     I 
Sbjct: 94  RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI- 152

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
             L +L  L+ L++  + + D     +  F  L  L         
Sbjct: 153 MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 66.5 bits (163), Expect = 6e-13
 Identities = 22/102 (21%), Positives = 45/102 (44%), Gaps = 4/102 (3%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L+N N++  L+  +    ++    ++    +    N     ++LE+L + G        
Sbjct: 50  TLANINVT-DLTG-IEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKI 105

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNN 102
            +LS L  L +LD+S +   D I   +     + +++LSYN 
Sbjct: 106 PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 46.5 bits (111), Expect = 4e-06
 Identities = 10/84 (11%), Positives = 30/84 (35%), Gaps = 7/84 (8%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           D+S++    ++  ++  L  ++  ++S N     I     +   L+ L++  +     + 
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFD----GVH 172

Query: 61  --SSLSSLRGLRVLDLSQNNLSDE 82
               +     L  L      +  +
Sbjct: 173 DYRGIEDFPKLNQLYAFSQTIGGK 196

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 46/235 (19%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           F     +G G+FG V      ES    A+K+ +   V+     +    E  + + +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN-- 321
           LVK+  +     F+ N    +V E++A G +  + H              L  + R +  
Sbjct: 103 LVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSH--------------LRRIGRFSEP 141

Query: 322 ----IAIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
                A  +    +YLH LD    + + DLKP N+L+D +    V+DFG A+ +     +
Sbjct: 142 HARFYAAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGR 194

Query: 377 TRSIGVEGTTGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTGLRP--SDDMFK 427
           T ++   GT   +APE     G+  +   D ++ G+L+ EM  G  P  +D   +
Sbjct: 195 TWTLC--GTPEALAPEIILSKGYNKAV--DWWALGVLIYEMAAGYPPFFADQPIQ 245

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 69.5 bits (171), Expect = 4e-13
 Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 48/235 (20%)

Query: 212 LIGAGNFGSVY---KGILFESTTAVAVKVF---NVLHHDASKSFAVECEVTRNI----RH 261
           ++G G+FG V+   K    ++    A+KV     +   D      V  ++ R+I     H
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR-----VRTKMERDILVEVNH 85

Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK--RHKAPGNLNSLKR 319
             +VK+  A     FQ      L+ +F+  G L      +++E                +
Sbjct: 86  PFIVKLHYA-----FQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDV--------K 129

Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             +A ++A  L +LH      I + DLKP NILLD+E    ++DFG+++     +++  S
Sbjct: 130 FYLA-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185

Query: 380 IGVEGTTGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTGLRP-----SDDMFK 427
               GT  Y+APE     GH  S+  D +SFG+L+ EM TG  P       +   
Sbjct: 186 FC--GTVEYMAPEVVNRRGHTQSA--DWWSFGVLMFEMLTGTLPFQGKDRKETMT 236

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 70.4 bits (173), Expect = 4e-13
 Identities = 30/111 (27%), Positives = 49/111 (44%), Gaps = 8/111 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DL+NN +S      L GL+ L+   +  N +S    +     T+L  L+++ N       
Sbjct: 249 DLANNQISN--LAPLSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDI-- 302

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
           S +S+L+ L  L L  NN+SD  P  ++    LQ L    N    +  +  
Sbjct: 303 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLAN 351

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 69.6 bits (171), Expect = 6e-13
 Identities = 34/111 (30%), Positives = 56/111 (50%), Gaps = 8/111 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           D+S+N +S  +S  L  L++L     + N +S       G  T+L++L ++GN       
Sbjct: 183 DISSNKVSD-ISV-LAKLTNLESLIATNNQISDIT--PLGILTNLDELSLNGNQLKDI-- 236

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
            +L+SL  L  LDL+ N +S+  P  L+G   L  L L  N   ++ P+ G
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAG 285

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 8/111 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
                 +  ++   +  L++L+  N S N L+        + T L  + M+ N  A    
Sbjct: 52  QADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADI-- 105

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
           + L++L  L  L L  N ++D  P  L     L  L LS N    +  + G
Sbjct: 106 TPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSG 154

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 26/130 (20%), Positives = 54/130 (41%), Gaps = 25/130 (19%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            ++NN ++  ++P L  L++L+   +  N ++    +   + T+L +L++  N  +    
Sbjct: 96  LMNNNQIAD-ITP-LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISDISA 151

Query: 61  -------------------SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYN 101
                                L++L  L  LD+S N +SD     LA    L++L  + N
Sbjct: 152 LSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNN 209

Query: 102 NFESMLPIEG 111
               + P+  
Sbjct: 210 QISDITPLGI 219

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 21/117 (17%), Positives = 44/117 (37%), Gaps = 9/117 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L  NN+S  +SP +  L+ L       N +S    ++  + T++  L    N  +    
Sbjct: 315 TLYFNNISD-ISP-VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDL-- 368

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNAS 117
           + L++L  +  L L+    ++    +      +   N   N   +++    I    S
Sbjct: 369 TPLANLTRITQLGLNDQAWTNAPVNY---KANVSIPNTVKNVTGALIAPATISDGGS 422

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 60.4 bits (147), Expect = 6e-10
 Identities = 14/111 (12%), Positives = 34/111 (30%), Gaps = 7/111 (6%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            ++ +     +      L+      +    ++  +S        +  L            
Sbjct: 7   TITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI-- 61

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
             +  L  L  ++ S N L+D  P  L     L ++ ++ N    + P+  
Sbjct: 62  DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLAN 110

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 16/103 (15%), Positives = 34/103 (33%), Gaps = 5/103 (4%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
              +N +S  L+P L  L+ ++   ++    + A  N   + +    +         P  
Sbjct: 359 SAGHNQISD-LTP-LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAP-- 414

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNF 103
           +++S        D++ N  S    E    F     +      F
Sbjct: 415 ATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTF 456

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 27/113 (23%), Positives = 42/113 (37%), Gaps = 11/113 (9%)

Query: 1   DLSNNNLSGTL----SPQLVGLSSLSIFNVSGNL---LSGAISNNFGSCTSLEQLDMHGN 53
           DLS+N   G      +   +   +L +  +        SG  S    +   L+ LD+  N
Sbjct: 179 DLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHN 238

Query: 54  LFAG-PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
                    S      L  L+LS   L  ++P+ L     L  L+LSYN  + 
Sbjct: 239 SLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR 288

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 20/122 (16%), Positives = 37/122 (30%), Gaps = 11/122 (9%)

Query: 1   DLSNNNLSGTLSP----QLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFA 56
           +L N + +   +     Q      L + +++                +L  LD+  N   
Sbjct: 127 NLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPEL 186

Query: 57  GPIG-------SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPI 109
           G  G           +L+ L + +      S       A    LQ L+LS+N+       
Sbjct: 187 GERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246

Query: 110 EG 111
             
Sbjct: 247 PS 248

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 27/115 (23%), Positives = 39/115 (33%), Gaps = 10/115 (8%)

Query: 1   DLSNNNLSGTLSPQLV-----GLSSLSIFNVSGNLLSGAISNNFG-SCTSLEQLDMHGNL 54
            L N  ++GT  P L+      L+ L++ NVS       ++         L+ L +    
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160

Query: 55  FAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLA----GFKFLQNLNLSYNNFES 105
                   +     L  LDLS N    E     A     F  LQ L L     E+
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 20/119 (16%), Positives = 39/119 (32%), Gaps = 9/119 (7%)

Query: 1   DLSNNNLSGTLSPQLV---GLSSLSIFNVSGNLLSGAISNNFGSCT--SLEQLDMHGNLF 55
            +    +   +    +   G+S L    +    ++G         T   L  L++    +
Sbjct: 74  TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133

Query: 56  AGPIGSSLS----SLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE 110
           A               GL+VL ++Q +  +   E +  F  L  L+LS N       + 
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 20/82 (24%), Positives = 26/82 (31%), Gaps = 6/82 (7%)

Query: 1   DLSNNNLSGTLSPQL-VGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
           DLS+N+L            S L+  N+S   L             L  LD+  N      
Sbjct: 234 DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP---AKLSVLDLSYNRLDR-- 288

Query: 60  GSSLSSLRGLRVLDLSQNNLSD 81
             S   L  +  L L  N   D
Sbjct: 289 NPSPDELPQVGNLSLKGNPFLD 310

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 50/246 (20%), Positives = 94/246 (38%), Gaps = 52/246 (21%)

Query: 193 PYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFA 250
           P +    +++    +++ + IG G +G V       +   VA+K  +   H     ++  
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 74

Query: 251 VECEVTRNIRHRNLVK---VFTACSGVDFQGNDFKALVYEFMANGSLEEWMH------PI 301
            E ++    RH N++    +  A +       D   +V + M     E  ++       +
Sbjct: 75  -EIKILLRFRHENIIGINDIIRAPTIEQM--KDV-YIVQDLM-----ETDLYKLLKTQHL 125

Query: 302 TEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
           + +   +                 +   LKY+H      + H DLKPSN+LL+      +
Sbjct: 126 SNDHICY-------------FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKI 169

Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYI------APEYGMGHEVSSYG---DVYSFGILL 412
            DFG+AR  +   + T  +     T Y+      APE  +      Y    D++S G +L
Sbjct: 170 CDFGLARVADPDHDHTGFL-----TEYVATRWYRAPEIMLNS--KGYTKSIDIWSVGCIL 222

Query: 413 LEMFTG 418
            EM + 
Sbjct: 223 AEMLSN 228

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 69.1 bits (170), Expect = 5e-13
 Identities = 54/232 (23%), Positives = 91/232 (39%), Gaps = 40/232 (17%)

Query: 212 LIGAGNFGSVY---KGILFESTTAVAVKVFN----VLHHDASKSFAVECEVTRNIRHRNL 264
           ++G G +G V+   K     +    A+KV      V +   +     E  +   ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK--RHKAPGNLNSLKRLNI 322
           V +  A     FQ      L+ E+++ G L      +  E       A           +
Sbjct: 84  VDLIYA-----FQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTA--------CFYL 127

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           A +++  L +LH   Q  I + DLKP NI+L+ +    ++DFG+ +        T +   
Sbjct: 128 A-EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC- 182

Query: 383 EGTTGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTGLRP-----SDDMFK 427
            GT  Y+APE     GH  +   D +S G L+ +M TG  P           
Sbjct: 183 -GTIEYMAPEILMRSGHNRAV--DWWSLGALMYDMLTGAPPFTGENRKKTID 231

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 70.3 bits (172), Expect = 5e-13
 Identities = 29/106 (27%), Positives = 48/106 (45%), Gaps = 4/106 (3%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L +NNL+ T    L+    L   ++S N L   + + F     LE+L +  N     + 
Sbjct: 238 KLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LN 294

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESM 106
                +  L+VLDLS N+L   +      F  L+NL L +N+  ++
Sbjct: 295 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL 339

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 69.6 bits (170), Expect = 1e-12
 Identities = 30/129 (23%), Positives = 55/129 (42%), Gaps = 8/129 (6%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
           DLS N L   +     V +  L    +S N L  A++       +L+ LD+  N     +
Sbjct: 260 DLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-V 316

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASAT 119
             +      L  L L  N++   +   L+    L+NL LS+N+++    +  +F+N +  
Sbjct: 317 ERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDC-NSLRALFRNVARP 372

Query: 120 SVFGNKKLC 128
           +V    + C
Sbjct: 373 AVDDADQHC 381

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 20/105 (19%), Positives = 44/105 (41%), Gaps = 6/105 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           D S+N+++  +   +     L+I  +  N L+   +    +   L ++D+  N     + 
Sbjct: 217 DASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMY 271

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
                ++ L  L +S N L   +  +      L+ L+LS+N+   
Sbjct: 272 HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH 315

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 64.2 bits (156), Expect = 5e-11
 Identities = 19/114 (16%), Positives = 38/114 (33%), Gaps = 2/114 (1%)

Query: 2   LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGS 61
           +           + + L++  I     + +    +    S   +E L+++          
Sbjct: 34  IDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTY 93

Query: 62  SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
           + +    ++ L +  N +    P        L  L L  N+  S LP  GIF N
Sbjct: 94  AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LP-RGIFHN 145

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 19/116 (16%), Positives = 39/116 (33%), Gaps = 4/116 (3%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
           +L++  +   +         ++    +  N +     + F +   L  L +  N  +   
Sbjct: 81  NLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLP 139

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
                +   L  L +S NNL     +       LQNL LS N     + +  +  +
Sbjct: 140 RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDL-SLIPS 193

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 60.3 bits (146), Expect = 8e-10
 Identities = 27/117 (23%), Positives = 50/117 (42%), Gaps = 14/117 (11%)

Query: 1   DLSNNNLSGTLSPQL-VGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            L  N+LS +L   +      L+  ++S N L     + F + TSL+ L +  N     +
Sbjct: 129 VLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN----RL 183

Query: 60  GS-SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
               LS +  L   ++S N LS      LA    ++ L+ S+N+  +++    +   
Sbjct: 184 THVDLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSI-NVVR-GPVNVE 233

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 22/115 (19%), Positives = 41/115 (35%), Gaps = 13/115 (11%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           ++S N LS      L    ++   + S N ++  +         L  L +  N       
Sbjct: 198 NVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTDT-- 247

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
           + L +  GL  +DLS N L   +       + L+ L +S N   +   +    + 
Sbjct: 248 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA---LNLYGQP 299

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 15/106 (14%), Positives = 36/106 (33%), Gaps = 5/106 (4%)

Query: 13  PQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVL 72
                   + I   + ++  G       +  + + +    +       + L S R + +L
Sbjct: 24  QYDCVFYDVHIDMQTQDVYFG---FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 80

Query: 73  DLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASA 118
           +L+   + +      A    +Q L + +N     LP   +F+N   
Sbjct: 81  NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI-RYLP-PHVFQNVPL 124

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 12/83 (14%), Positives = 26/83 (31%), Gaps = 2/83 (2%)

Query: 35  ISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQ 94
           I +N         + +         G    +L   +++    + +       L  F+ ++
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78

Query: 95  NLNLSYNNFESMLPIEGIFKNAS 117
            LNL+    E  +     F  A 
Sbjct: 79  LLNLNDLQIEE-ID-TYAFAYAH 99

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 68.8 bits (169), Expect = 7e-13
 Identities = 52/250 (20%), Positives = 94/250 (37%), Gaps = 47/250 (18%)

Query: 194 YVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVEC 253
           Y S+ + +     +     +G G +  V++ I   +   V VK+   +     K    E 
Sbjct: 25  YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EI 81

Query: 254 EVTRNIR-HRNLVKVFTACSGVDFQGNDFK-ALVYEFMANGSLEEWMHPITEEDKRH--- 308
           ++  N+R   N++ +      +         ALV+E + N   ++    +T+ D R    
Sbjct: 82  KILENLRGGPNIITLAD----IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY 137

Query: 309 ---KAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE-MTAYVSDF 364
              KA                   L Y H      I H D+KP N+++D E     + D+
Sbjct: 138 EILKA-------------------LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDW 175

Query: 365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSD 423
           G+A F     E    +    +  +  PE  + +++  Y  D++S G +L  M     P  
Sbjct: 176 GLAEFYHPGQEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP-- 230

Query: 424 DMF--KDNLN 431
             F   DN +
Sbjct: 231 -FFHGHDNYD 239

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 68.1 bits (167), Expect = 9e-13
 Identities = 55/229 (24%), Positives = 80/229 (34%), Gaps = 41/229 (17%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN----VLHHDASKSFAVECEV------TRNIRH 261
           L+G G FG+V+ G        VA+KV      +     S S     EV           H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 262 RNLVKVFTACSGVDFQGNDFKA-LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
             ++++       D+        LV E       ++    ITE+       G L      
Sbjct: 98  PGVIRLL------DWFETQEGFMLVLERPLPA--QDLFDYITEK-------GPLGEGPSR 142

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM-TAYVSDFGIARFLEAADEQTRS 379
                V   +++ H      + H D+K  NIL+D     A + DFG    L         
Sbjct: 143 CFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD 199

Query: 380 IGVEGTTGYIAPEYGMGHEVSSYG----DVYSFGILLLEMFTGLRPSDD 424
               GT  Y  PE+   H+   Y      V+S GILL +M  G  P + 
Sbjct: 200 ----GTRVYSPPEWISRHQ---YHALPATVWSLGILLYDMVCGDIPFER 241

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 69.0 bits (169), Expect = 9e-13
 Identities = 62/229 (27%), Positives = 97/229 (42%), Gaps = 43/229 (18%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLV 265
           ++   +IG G+FG VY+  L +S   VA+K   VL     K F   E ++ R + H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQD---KRFKNRELQIMRKLDHCNIV 110

Query: 266 K---VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
           +    F   S  + +   +  LV +++      E ++ +     R K    +  +K    
Sbjct: 111 RLRYFFY--SSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVK--LY 161

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY-VSDFGIARFLEAADEQTRSIG 381
              +   L Y+H      I H D+KP N+LLD +     + DFG A+ L           
Sbjct: 162 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-------- 210

Query: 382 VEGTTGYI------APEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
            E    YI      APE   G   + Y    DV+S G +L E+  G +P
Sbjct: 211 -EPNVSYICSRYYRAPELIFG--ATDYTSSIDVWSAGCVLAELLLG-QP 255

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 69.0 bits (169), Expect = 9e-13
 Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 47/242 (19%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
            +G G FG V  G    +   VAVK+ N   +   D       E +  +  RH +++K++
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRLNIAID 325
                          +V E+++ G L +++     + E++ R          +++   +D
Sbjct: 83  QV-----ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRL-------FQQILSGVD 130

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE-QTRSIGVEG 384
                 Y H   +  + H DLKP N+LLD  M A ++DFG++  +   +  +T      G
Sbjct: 131 ------YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----G 177

Query: 385 TTGYIAPE------YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL-NLRNCVK 437
           +  Y APE      Y  G EV    D++S G++L  +  G  P DD   D++  L   + 
Sbjct: 178 SPNYAAPEVISGRLYA-GPEV----DIWSSGVILYALLCGTLPFDD---DHVPTLFKKIC 229

Query: 438 SA 439
             
Sbjct: 230 DG 231

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 39/230 (16%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEV-TRNIRHRNLVKV 267
           ++G G+FG V       +    AVK+     V+  D  +   VE  V     +   L ++
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK--RHKAPGNLNSLKRLNIAID 325
            +      FQ  D    V E++  G L   M+ I +  +     A            A +
Sbjct: 408 HSC-----FQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHA--------VFYAA-E 450

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +A  L +L       I + DLK  N++LD E    ++DFG+ +        T++    GT
Sbjct: 451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC--GT 505

Query: 386 TGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP-----SDDMFK 427
             YIAPE         YG   D ++FG+LL EM  G  P      D++F+
Sbjct: 506 PDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 56/250 (22%), Positives = 101/250 (40%), Gaps = 50/250 (20%)

Query: 186 PTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVK-VFNVLHH- 243
           P  S  +     +  +     +     +G+G +G+V   +   +   VA+K ++      
Sbjct: 6   PARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE 65

Query: 244 -DASKSFAVECEVTRNIRHRNLVK---VFTACSGVDFQGNDFKA--LVYEFMANGSLEEW 297
             A +++  E  + +++RH N++    VFT    +D    DF    LV  FM        
Sbjct: 66  LFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLD----DFTDFYLVMPFM-----GTD 115

Query: 298 MH------PITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNI 351
           +        + E+  +              +   +   L+Y+H      I H DLKP N+
Sbjct: 116 LGKLMKHEKLGEDRIQF-------------LVYQMLKGLRYIH---AAGIIHRDLKPGNL 159

Query: 352 LLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSF 408
            ++++    + DFG+AR  +A  E T  +    T  Y APE  +      Y    D++S 
Sbjct: 160 AVNEDCELKILDFGLAR--QADSEMTGYV---VTRWYRAPEVILNW--MRYTQTVDIWSV 212

Query: 409 GILLLEMFTG 418
           G ++ EM TG
Sbjct: 213 GCIMAEMITG 222

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 54/245 (22%), Positives = 104/245 (42%), Gaps = 53/245 (21%)

Query: 194 YVSYRM---LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVK-VFNVLHH--DASK 247
           +    +   ++   + + + + +G+G +GSV      ++   VAVK +         A +
Sbjct: 15  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 74

Query: 248 SFAVECEVTRNIRHRNLVK---VFTACSGVDFQGNDFKA--LVYEFMANGSLEEWMH--- 299
           ++  E  + ++++H N++    VFT    ++    +F    LV   M        ++   
Sbjct: 75  TYR-ELRLLKHMKHENVIGLLDVFTPARSLE----EFNDVYLVTHLM-----GADLNNIV 124

Query: 300 ---PITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE 356
               +T++  +              +   +   LKY+H      I H DLKPSN+ ++++
Sbjct: 125 KCQKLTDDHVQF-------------LIYQILRGLKYIH---SADIIHRDLKPSNLAVNED 168

Query: 357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLL 413
               + DFG+AR    ADE T  +    T  Y APE  +      Y    D++S G ++ 
Sbjct: 169 CELKILDFGLAR--HTADEMTGYV---ATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMA 221

Query: 414 EMFTG 418
           E+ TG
Sbjct: 222 ELLTG 226

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 65/243 (26%), Positives = 107/243 (44%), Gaps = 50/243 (20%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
            +G G+FG V     +++   VA+K  +   +   D       E    + +RH +++K++
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 269 TACSGVDFQGNDFKA-LVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRLNIAI 324
                 D         +V E+ A G L +++     +TE++ R          +++  AI
Sbjct: 76  ------DVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRF-------FQQIICAI 121

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE-QTRSIGVE 383
           +      Y H   +  I H DLKP N+LLDD +   ++DFG++  +   +  +T      
Sbjct: 122 E------YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---- 168

Query: 384 GTTGYIAPE------YGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL-NLRNCV 436
           G+  Y APE      Y  G EV    DV+S GI+L  M  G  P DD   + + NL   V
Sbjct: 169 GSPNYAAPEVINGKLYA-GPEV----DVWSCGIVLYVMLVGRLPFDD---EFIPNLFKKV 220

Query: 437 KSA 439
            S 
Sbjct: 221 NSC 223

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 37/229 (16%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEV-TRNIRHRNLVKV 267
           +IG G+FG V            AVKV     +L     K    E  V  +N++H  LV +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK--RHKAPGNLNSLKRLNIAID 325
             +     FQ  D    V +++  G L    + +  E      +A        R   A +
Sbjct: 105 HFS-----FQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRA--------RFYAA-E 147

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +A  L YLH      I + DLKP NILLD +    ++DFG+ +     +  T +    GT
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC--GT 202

Query: 386 TGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTGLRP-----SDDMFK 427
             Y+APE  +   ++ +   D +  G +L EM  GL P     + +M+ 
Sbjct: 203 PEYLAPEVLHKQPYDRTV--DWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 33/227 (14%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEV-TRNIRHRNLVKV 267
           ++G G+FG V+     ++    A+K      VL  D  +   VE  V +    H  L  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK--RHKAPGNLNSLKRLNIAID 325
           F       FQ  +    V E++  G L   M+ I    K    +A            A +
Sbjct: 84  FCT-----FQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRA--------TFYAA-E 126

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +   L++LH      I + DLK  NILLD +    ++DFG+ +     D +T +    GT
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GT 181

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP-----SDDMFK 427
             YIAPE  +G + +   D +SFG+LL EM  G  P      +++F 
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 21/116 (18%), Positives = 45/116 (38%), Gaps = 4/116 (3%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
           ++ +N+L   +S +   GL+SL    +    L+   +        L  L +         
Sbjct: 134 EVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIR 192

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
             S   L  L+VL++S     D +         L +L++++ N  + +P     ++
Sbjct: 193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VP-YLAVRH 246

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 67.0 bits (164), Expect = 5e-12
 Identities = 22/117 (18%), Positives = 46/117 (39%), Gaps = 6/117 (5%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            L   NL+ ++  + L  L  L +  +    ++     +F     L+ L++    +   +
Sbjct: 158 TLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTM 216

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEF-LAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
             +      L  L ++  NL+  +P   +    +L+ LNLSYN   S +    +   
Sbjct: 217 TPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPI-STIE-GSMLHE 270

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 66.3 bits (162), Expect = 8e-12
 Identities = 25/107 (23%), Positives = 42/107 (39%), Gaps = 4/107 (3%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
           +L+ N +S  + P     L +L    +  N L       F   ++L +LD+  N     +
Sbjct: 62  ELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILL 120

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPE-FLAGFKFLQNLNLSYNNFES 105
                 L  L+ L++  N+L   I     +G   L+ L L   N  S
Sbjct: 121 DYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTS 166

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 25/115 (21%), Positives = 49/115 (42%), Gaps = 2/115 (1%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           ++S+     T++P  +   +L+  +++   L+            L  L++  N  +   G
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEG 265

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
           S L  L  L+ + L    L+   P    G  +L+ LN+S N   + L  E +F +
Sbjct: 266 SMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT-LE-ESVFHS 318

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 59.7 bits (145), Expect = 8e-10
 Identities = 23/104 (22%), Positives = 41/104 (39%), Gaps = 2/104 (1%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            +++ NL+  +    +  L  L   N+S N +S    +       L+++ + G   A   
Sbjct: 230 SITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVE 288

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNF 103
             +   L  LRVL++S N L+            L+ L L  N  
Sbjct: 289 PYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 21/118 (17%), Positives = 44/118 (37%), Gaps = 5/118 (4%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
                     +   +   +   + ++  N +     + F S   LE+L+++ N+ +    
Sbjct: 17  LCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEP 73

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASA 118
            + ++L  LR L L  N L         G   L  L++S N    +L    +F++   
Sbjct: 74  GAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLD--YMFQDLYN 129

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 44.7 bits (106), Expect = 5e-05
 Identities = 22/81 (27%), Positives = 31/81 (38%), Gaps = 2/81 (2%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
           +LS N +S T+    L  L  L    + G  L+      F     L  L++ GN      
Sbjct: 254 NLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLE 312

Query: 60  GSSLSSLRGLRVLDLSQNNLS 80
            S   S+  L  L L  N L+
Sbjct: 313 ESVFHSVGNLETLILDSNPLA 333

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 66.5 bits (163), Expect = 5e-12
 Identities = 57/246 (23%), Positives = 92/246 (37%), Gaps = 71/246 (28%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA--------------VECEVT- 256
           ++G G+FG                KV         + +A              VEC +  
Sbjct: 27  VLGKGSFG----------------KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE 70

Query: 257 RNI-----RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK--RHK 309
           + +     +   L ++ +      FQ  D    V E++  G L   M+ I +  +     
Sbjct: 71  KRVLALPGKPPFLTQLHSC-----FQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPH 122

Query: 310 APGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           A            A ++A  L +L       I + DLK  N++LD E    ++DFG+ + 
Sbjct: 123 A--------VFYAA-EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170

Query: 370 LEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP----- 421
                  T++    GT  YIAPE         YG   D ++FG+LL EM  G  P     
Sbjct: 171 NIWDGVTTKTFC--GTPDYIAPEIIAYQ---PYGKSVDWWAFGVLLYEMLAGQAPFEGED 225

Query: 422 SDDMFK 427
            D++F+
Sbjct: 226 EDELFQ 231

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 47/226 (20%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVF--NVLHHDASKSFAVECEVTRNIRHR------ 262
           +LIG G+FG V K         VA+K+        + ++   +E  +   +         
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ---IEVRLLELMNKHDTEMKY 116

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG-NLNSLKRLN 321
            +V +        F   +   LV+E ++  +L + +       +     G +LN  ++  
Sbjct: 117 YIVHLKRH-----FMFRNHLCLVFEMLSY-NLYDLL-------RNTNFRGVSLNLTRK-- 161

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY--VSDFGIARFLEAADE---- 375
            A  +   L +L    +  I HCDLKP NILL +   +   + DFG +       +    
Sbjct: 162 FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQRIYQ 217

Query: 376 --QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGL 419
             Q+R         Y +PE  +G       D++S G +L+EM TG 
Sbjct: 218 YIQSRF--------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 49/225 (21%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVF--NVLHHDASKSFAVECEVTRNIRHR------N 263
           +IG G+FG V K    +    VA+K+       H  +     E  +  ++R +      N
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA---EEIRILEHLRKQDKDNTMN 160

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG-NLNSLKRLNI 322
           ++ +        F+ +    + +E ++  +L E +       K++K  G +L  +++   
Sbjct: 161 VIHMLEN---FTFRNHIC--MTFELLSM-NLYELI-------KKNKFQGFSLPLVRK--F 205

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY--VSDFGIARFLEAADE----- 375
           A  +   L  LH   +  I HCDLKP NILL  +  +   V DFG + +     +     
Sbjct: 206 AHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE---HQRVYTY 259

Query: 376 -QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGL 419
            Q+R         Y APE  +G       D++S G +L E+ TG 
Sbjct: 260 IQSRF--------YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 50/231 (21%), Positives = 80/231 (34%), Gaps = 47/231 (20%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN------VLHHDASKSFAVECEVTRNIRHR--N 263
           L+G+G FGSVY GI       VA+K                    +E  + + +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 264 LVKVFTACSGVDFQGNDFKA-LVYEFMAN-GSLEEWMH---PITEEDKRHKAPGNLNSLK 318
           ++++       D+        L+ E       L +++     + EE  R           
Sbjct: 110 VIRLL------DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS---------- 153

Query: 319 RLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQT 377
                  V   +++ H      + H D+K  NIL+D +     + DFG    L+      
Sbjct: 154 ---FFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD 207

Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYG----DVYSFGILLLEMFTGLRPSDD 424
                 GT  Y  PE+   H    Y      V+S GILL +M  G  P + 
Sbjct: 208 FD----GTRVYSPPEWIRYHR---YHGRSAAVWSLGILLYDMVCGDIPFEH 251

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 65.7 bits (161), Expect = 7e-12
 Identities = 64/246 (26%), Positives = 92/246 (37%), Gaps = 71/246 (28%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA--------------VECEVT- 256
           ++G G+FG                KV      +    +A              VEC +T 
Sbjct: 30  VLGKGSFG----------------KVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE 73

Query: 257 RNI-----RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK--RHK 309
           + I      H  L ++F       FQ  D    V EF+  G L   M  I +  +    +
Sbjct: 74  KRILSLARNHPFLTQLFCC-----FQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEAR 125

Query: 310 APGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF 369
           A        R   A ++   L +LH      I + DLK  N+LLD E    ++DFG+ + 
Sbjct: 126 A--------RFYAA-EIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173

Query: 370 LEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP----- 421
                  T +    GT  YIAPE         YG   D ++ G+LL EM  G  P     
Sbjct: 174 GICNGVTTATFC--GTPDYIAPEILQE---MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228

Query: 422 SDDMFK 427
            DD+F+
Sbjct: 229 EDDLFE 234

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 65.4 bits (160), Expect = 8e-12
 Identities = 22/110 (20%), Positives = 37/110 (33%), Gaps = 2/110 (1%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L    +  +L   +  L +L    +  + LS A+         LE+LD+ G        
Sbjct: 189 RLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYP 246

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE 110
                   L+ L L   +    +P  +     L+ L+L      S LP  
Sbjct: 247 PIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 65.4 bits (160), Expect = 9e-12
 Identities = 20/119 (16%), Positives = 41/119 (34%), Gaps = 11/119 (9%)

Query: 1   DLSNNNLSGTL---------SPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMH 51
            +        L         S +  GL +L    +    +  ++  +  +  +L+ L + 
Sbjct: 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIR 214

Query: 52  GNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE 110
            +  +  +G ++  L  L  LDL         P    G   L+ L L   +    LP++
Sbjct: 215 NSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD 272

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 29/117 (24%), Positives = 43/117 (36%), Gaps = 13/117 (11%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +L +  L      Q   LS L    +    L   + +       LE L +  N     + 
Sbjct: 87  ELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LP 143

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKF---------LQNLNLSYNNFESMLP 108
           +S++SL  LR L +       E+PE LA             LQ+L L +    S LP
Sbjct: 144 ASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LP 199

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 23/110 (20%), Positives = 39/110 (35%), Gaps = 6/110 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHG--NLFAGP 58
            + N+ LS  L P +  L  L   ++ G          FG    L++L +    NL   P
Sbjct: 212 KIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP 270

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
               +  L  L  LDL        +P  +A       + +   + ++ L 
Sbjct: 271 --LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQLD 317

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 16/112 (14%), Positives = 36/112 (32%), Gaps = 6/112 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSS--LSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGP 58
             +   L    +  L   +        +    L     +     + L+ + +        
Sbjct: 62  TRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME- 118

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE 110
           +  ++    GL  L L++N L   +P  +A    L+ L++      + LP  
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEP 169

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 44.2 bits (105), Expect = 6e-05
 Identities = 19/91 (20%), Positives = 29/91 (31%), Gaps = 5/91 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSG-NLLSGAISNNFGSCTSLEQLDMHGN--LFAG 57
           DL          P   G + L    +   + L   +  +    T LE+LD+ G   L   
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRL 293

Query: 58  PIG-SSLSSLRGLRVLDLSQNNLSDEIPEFL 87
           P   + L +   + V    Q  L    P   
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 65.4 bits (160), Expect = 9e-12
 Identities = 51/231 (22%), Positives = 96/231 (41%), Gaps = 51/231 (22%)

Query: 212 LIGAGNFGSVY---KGILFESTTAVAVKVF---NVLHHDASKSFAVECEVT-RNI----- 259
           ++G G +G V+   K    ++    A+KV     ++    +     E   T R +     
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT----TEHTRTERQVLEHIR 116

Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK--RHKAPGNLNSL 317
           +   LV +  A     FQ      L+ +++  G L      +++ ++   H+        
Sbjct: 117 QSPFLVTLHYA-----FQTETKLHLILDYINGGEL---FTHLSQRERFTEHEV------- 161

Query: 318 KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIA-RFLEAADEQ 376
            ++ +  ++   L++LH   +  I + D+K  NILLD      ++DFG++  F+    E+
Sbjct: 162 -QIYVG-EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216

Query: 377 TRSIGVEGTTGYIAPE------YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
                  GT  Y+AP+       G    V    D +S G+L+ E+ TG  P
Sbjct: 217 AYDFC--GTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 50/282 (17%), Positives = 102/282 (36%), Gaps = 54/282 (19%)

Query: 181 KKRGNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVK-VFN 239
           +++ + +   +         +     +   +LIG G++G V +         VA+K +  
Sbjct: 29  QRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR 88

Query: 240 VLHH--DASKSFAVECEVTRNIRHRNLVK---VFTACSGVDFQGNDFKALVYEFMANGSL 294
           V     D  +    E  +   + H ++VK   +        F  ++   +V E       
Sbjct: 89  VFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIVIPKDVEKF--DEL-YVVLEIA----- 139

Query: 295 EEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD 354
           +     +       + P  L  L    +  ++   +KY+H      I H DLKP+N L++
Sbjct: 140 DSDFKKLF------RTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVN 190

Query: 355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGT-------------------TGYI------ 389
            + +  V DFG+AR ++  +     + +                      TG++      
Sbjct: 191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR 250

Query: 390 APEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKD 428
           APE  +     +Y    DV+S G +  E+   ++ +     D
Sbjct: 251 APELILLQ--ENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 64.9 bits (159), Expect = 1e-11
 Identities = 57/251 (22%), Positives = 90/251 (35%), Gaps = 78/251 (31%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFA--------------VE 252
           F     +G G+FG                +V  +      + +A              VE
Sbjct: 8   FQILRTLGTGSFG----------------RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVE 51

Query: 253 C-----EVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKR 307
                  +   + H  +++++       FQ      ++ +++  G L  +          
Sbjct: 52  HTNDERLMLSIVTHPFIIRMWGT-----FQDAQQIFMIMDYIEGGEL--FSL-------- 96

Query: 308 HKAPGNLNSLKRLNI------AIDVACVLKYLH-LDCQPPIAHCDLKPSNILLDDEMTAY 360
                 L   +R         A +V   L+YLH  D    I + DLKP NILLD      
Sbjct: 97  ------LRKSQRFPNPVAKFYAAEVCLALEYLHSKD----IIYRDLKPENILLDKNGHIK 146

Query: 361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTG 418
           ++DFG A+      + T ++   GT  YIAPE      +  S   D +SFGIL+ EM  G
Sbjct: 147 ITDFGFAK---YVPDVTYTLC--GTPDYIAPEVVSTKPYNKSI--DWWSFGILIYEMLAG 199

Query: 419 LRP--SDDMFK 427
             P    +  K
Sbjct: 200 YTPFYDSNTMK 210

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 26/105 (24%), Positives = 52/105 (49%), Gaps = 4/105 (3%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            +++ N++ T+   L    SL+  ++ GN ++   + +     +L +L +  N  +    
Sbjct: 177 RIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN 233

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
            SL++   LR L L+ N L  ++P  LA  K++Q + L  NN  +
Sbjct: 234 GSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 17/112 (15%), Positives = 32/112 (28%), Gaps = 15/112 (13%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN------ 53
            LS N++S  +    L     L   +++ N L   +         ++ + +H N      
Sbjct: 222 GLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIG 279

Query: 54  --LFAGPIGSSLSSLRGLRVLDLSQNNLS-DEIPEFL-AGFKFLQNLNLSYN 101
              F  P     +       + L  N +   EI             + L   
Sbjct: 280 SNDFCPP--GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 56.5 bits (137), Expect = 6e-09
 Identities = 30/117 (25%), Positives = 47/117 (40%), Gaps = 8/117 (6%)

Query: 1   DLSNNNL-SGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGP 58
           +L  N L S  +      G+  LS   ++   ++  I    G   SL +L + GN     
Sbjct: 151 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKV 207

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
             +SL  L  L  L LS N++S      LA    L+ L+L+ N       + G   +
Sbjct: 208 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK---VPGGLAD 261

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 56.5 bits (137), Expect = 6e-09
 Identities = 23/117 (19%), Positives = 40/117 (34%), Gaps = 7/117 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DL NN ++         L +L    +  N +S      F     LE+L +  N       
Sbjct: 58  DLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL----- 112

Query: 61  SSLSS--LRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
             L     + L+ L + +N ++        G   +  + L  N  +S     G F+ 
Sbjct: 113 KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 21/109 (19%), Positives = 45/109 (41%), Gaps = 9/109 (8%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            L  N ++  +    L GL++L+   +S N +S   + +  +   L +L ++ N     +
Sbjct: 198 HLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-V 255

Query: 60  GSSLSSLRGLRVLDLSQNNLSD------EIPEFLAGFKFLQNLNLSYNN 102
              L+  + ++V+ L  NN+S         P +         ++L  N 
Sbjct: 256 PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 304

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 26/118 (22%), Positives = 44/118 (37%), Gaps = 14/118 (11%)

Query: 1   DLSNNNLS---GTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG 57
             S+  L      L P    L      ++  N ++     +F +  +L  L +  N  + 
Sbjct: 37  QCSDLGLEKVPKDLPPDTALL------DLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
               + + L  L  L LS+N L  E+PE +   K LQ L +  N    +     +F  
Sbjct: 91  ISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRK--SVFNG 143

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 27/105 (25%), Positives = 41/105 (39%), Gaps = 4/105 (3%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            +S   L+  +   L    +L+  ++  N +      +    + L +L +  N       
Sbjct: 178 RISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIEN 234

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
            SLS L  LR L L  N LS  +P  L   K LQ + L  NN   
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK 278

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 23/118 (19%), Positives = 39/118 (33%), Gaps = 9/118 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDMHGNLFAGPI 59
           DL NN++S        GL  L    +  N +S  I    F     L++L +  N      
Sbjct: 60  DLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHL---- 114

Query: 60  GSSLSS--LRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
              +       L  L +  N +        +G + +  + +  N  E+     G F  
Sbjct: 115 -VEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 25/116 (21%), Positives = 44/116 (37%), Gaps = 9/116 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN-LFAGPI 59
            +S N+L   + P L   SSL    +  N +       F    ++  ++M GN L     
Sbjct: 108 YISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGF 164

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
                    L  L +S+  L+  IP+ L   + L  L+L +N  ++ +        
Sbjct: 165 EPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQA-IE-LEDLLR 215

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 50.0 bits (120), Expect = 9e-07
 Identities = 29/118 (24%), Positives = 47/118 (39%), Gaps = 14/118 (11%)

Query: 1   DLSNNNLS---GTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG 57
             S+  L      +SP    L      ++  N +S    ++F     L  L +  N  + 
Sbjct: 39  QCSDLGLKAVPKEISPDTTLL------DLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
               + S LR L+ L +S+N+L  EIP  L     L  L +  N     +P +G+F  
Sbjct: 93  IHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRI-RKVP-KGVFSG 145

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 50/228 (21%), Positives = 83/228 (36%), Gaps = 41/228 (17%)

Query: 213 IGAGNFGSVYKGILFESTTA--VAVKVFNVLHHDASKSFAVECEVT--RNIRHRNLVKVF 268
           +G G +G VYK    +       A+K           S +   E+   R ++H N++ + 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACREIALLRELKHPNVISLQ 84

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                     +    L++++  +  L   +         H+A        +L     V  
Sbjct: 85  KVFLS---HADRKVWLLFDYAEH-DLWHIIK-------FHRASKANKKPVQLPRG-MVKS 132

Query: 329 VLK-------YLHLDCQPPIAHCDLKPSNILLDDEMTAY----VSDFGIAR-FLEAADEQ 376
           +L        YLH +    + H DLKP+NIL+  E        ++D G AR F       
Sbjct: 133 LLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189

Query: 377 TRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
                V  T  Y APE  +G     Y    D+++ G +  E+ T   P
Sbjct: 190 ADLDPVVVTFWYRAPELLLGAR--HYTKAIDIWAIGCIFAELLTS-EP 234

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 59/224 (26%), Positives = 86/224 (38%), Gaps = 41/224 (18%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT--RNIRHRNLVKVFT 269
            IG+GNFG         +   VAVK              V+ E+   R++RH N+V+   
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN---VQREIINHRSLRHPNIVRFKE 83

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRLNIAIDV 326
                        A++ E+ + G L E +      +E++ R          ++L   +  
Sbjct: 84  V-----ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFF-------FQQLLSGVS- 130

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY--VSDFGIARFLEAADEQTRSIGVEG 384
                Y H      I H DLK  N LLD        + DFG ++       Q +S    G
Sbjct: 131 -----YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKS--TVG 179

Query: 385 TTGYIAPEYGMGHEVSSYG----DVYSFGILLLEMFTGLRPSDD 424
           T  YIAPE  +  E   Y     DV+S G+ L  M  G  P +D
Sbjct: 180 TPAYIAPEVLLRQE---YDGKIADVWSCGVTLYVMLVGAYPFED 220

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 58/219 (26%), Positives = 89/219 (40%), Gaps = 34/219 (15%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEV-TRNIRHRNLVKV 267
           +IG G++  V    L ++    A+KV     V   +       E  V  +   H  LV +
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK--RHKAPGNLNSLKRLNIAID 325
            +      FQ       V E++  G L   M  +  + K     A        R   A +
Sbjct: 76  HSC-----FQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHA--------RFYSA-E 118

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           ++  L YLH   +  I + DLK  N+LLD E    ++D+G+ +      + T +    GT
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GT 173

Query: 386 TGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
             YIAPE   G     YG   D ++ G+L+ EM  G  P
Sbjct: 174 PNYIAPEILRGE---DYGFSVDWWALGVLMFEMMAGRSP 209

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 31/116 (26%), Positives = 45/116 (38%), Gaps = 5/116 (4%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
           DL        +S     GL +L   N+    +   +  N      LE+L+M GN F    
Sbjct: 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DM-PNLTPLVGLEELEMSGNHFPEIR 234

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
             S   L  L+ L +  + +S        G   L  LNL++NN  S LP   +F  
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS-LP-HDLFTP 288

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 62.8 bits (153), Expect = 9e-11
 Identities = 25/103 (24%), Positives = 45/103 (43%), Gaps = 2/103 (1%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +L   N+     P L  L  L    +SGN        +F   +SL++L +  +  +    
Sbjct: 202 NLGMCNI--KDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIER 259

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNF 103
           ++   L  L  L+L+ NNLS    +     ++L  L+L +N +
Sbjct: 260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 23/115 (20%), Positives = 36/115 (31%), Gaps = 1/115 (0%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +L  NN+    +     L  L +  +  N +       F    SL  L++  N       
Sbjct: 81  NLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPS 140

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            +   L  LR L L  N +             L  L+L        +  EG F+ 
Sbjct: 141 GAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYIS-EGAFEG 194

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 54.0 bits (130), Expect = 7e-08
 Identities = 23/118 (19%), Positives = 36/118 (30%), Gaps = 11/118 (9%)

Query: 1   DLSNNNLS---GTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG 57
             +   LS     +      L      N+  N +    ++ F     LE L +  N    
Sbjct: 60  VCTRRGLSEVPQGIPSNTRYL------NLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ 113

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
               + + L  L  L+L  N L+            L+ L L  N  ES+      F  
Sbjct: 114 IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPS--YAFNR 169

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 48/260 (18%), Positives = 90/260 (34%), Gaps = 63/260 (24%)

Query: 202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVK-VFNVLHHDASKSFAV-ECEVTRNI 259
            ++K +S    +G G+FG V +    ES    A+K V           +   E ++ + +
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD------PRYKNRELDIMKVL 57

Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
            H N++K+        F     +        +   +         +       N +  K 
Sbjct: 58  DHVNIIKLVDY-----FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112

Query: 320 LNIAI-----DVACVLKYLHLDCQP-PIAHC----------------------DLKPSNI 351
           LN+ +      +  VLK      +  P+                         D+KP N+
Sbjct: 113 LNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNL 172

Query: 352 LLDDEMTAY-VSDFGIARFLEAADEQTRSIGVEGTTGYI------APEYGMGHEVSSYG- 403
           L++ +     + DFG A+ L  ++          +  YI      APE  +G   + Y  
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEP---------SVAYICSRFYRAPELMLG--ATEYTP 221

Query: 404 --DVYSFGILLLEMFTGLRP 421
             D++S G +  E+  G +P
Sbjct: 222 SIDLWSIGCVFGELILG-KP 240

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 45/240 (18%), Positives = 87/240 (36%), Gaps = 54/240 (22%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVK--VFNVLHHDASKSFAVECEVTRNIRHRNL 264
           +     +G G  G V+  +  +    VA+K  V          +   E ++ R + H N+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ-SVKHALR-EIKIIRRLDHDNI 70

Query: 265 VK---VFTACSGVDFQG----NDFKA--LVYEFMANGSLEEWMH------PITEEDKRHK 309
           VK   +                +  +  +V E+M     E  +       P+ EE  R  
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARL- 124

Query: 310 APGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE-MTAYVSDFGIAR 368
                           +   LKY+H      + H DLKP+N+ ++ E +   + DFG+AR
Sbjct: 125 ------------FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169

Query: 369 FLEAADEQTRSIGVEGTTGYI------APEYGMG-HEVSSYGDVYSFGILLLEMFTGLRP 421
            ++        +     +  +      +P   +  +  +   D+++ G +  EM TG + 
Sbjct: 170 IMDPHYSHKGHL-----SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KT 223

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 30/117 (25%), Positives = 43/117 (36%), Gaps = 6/117 (5%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDMHGNLFAGP 58
            L    L   L P    GL++L    +  N L  A+ ++ F    +L  L +HGN  +  
Sbjct: 111 HLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSV 168

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
              +   L  L  L L QN ++   P        L  L L  NN  + LP       
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA-LP-TEALAP 223

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 32/104 (30%), Positives = 44/104 (42%), Gaps = 2/104 (1%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            L +N L   L       L +L+   + GN +S      F    SL++L +H N  A   
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNF 103
             +   L  L  L L  NNLS    E LA  + LQ L L+ N +
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 29/117 (24%), Positives = 47/117 (40%), Gaps = 5/117 (4%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L  N +S   +       +L+I  +  N+L+   +  F     LEQLD+  N     + 
Sbjct: 38  FLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD 97

Query: 61  SS-LSSLRGLRVLDLSQNNLSDEIPE-FLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            +    L  L  L L +  L  E+      G   LQ L L  N  ++ LP +  F++
Sbjct: 98  PATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LP-DDTFRD 151

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 25/119 (21%), Positives = 43/119 (36%), Gaps = 12/119 (10%)

Query: 1   DLSNNNLS---GTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG 57
                 L      +      +       + GN +S   + +F +C +L  L +H N+ A 
Sbjct: 17  SCPQQGLQAVPVGIPAASQRI------FLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIP-EFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
              ++ + L  L  LDLS N     +      G   L  L+L     +  L   G+F+ 
Sbjct: 71  IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LG-PGLFRG 127

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 64.4 bits (156), Expect = 4e-11
 Identities = 34/114 (29%), Positives = 46/114 (40%), Gaps = 8/114 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L  N +   LS  L  L  L   ++  N +S  I+        LE L +  N       
Sbjct: 93  FLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDI-- 146

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFK 114
           + LS L  L  L L  N +SD     LAG   LQNL LS N+   +  + G+  
Sbjct: 147 TVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHISDLRALAGLKN 198

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 30/107 (28%), Positives = 46/107 (42%), Gaps = 12/107 (11%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L +N +S  ++  LV L  L    +  N ++  I+      T L+ L +  N     I 
Sbjct: 115 SLEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITV-LSRLTKLDTLSLEDN----QIS 166

Query: 61  --SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
               L+ L  L+ L LS+N++SD     LAG K L  L L      +
Sbjct: 167 DIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLN 211

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 57.4 bits (138), Expect = 6e-09
 Identities = 19/113 (16%), Positives = 50/113 (44%), Gaps = 12/113 (10%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +L   +++  ++     L+S+     + + +  ++        ++ +L ++GN     + 
Sbjct: 27  NLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNK----LT 78

Query: 61  --SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
               L++L+ L  L L +N + D +   L   K L++L+L +N    +  +  
Sbjct: 79  DIKPLTNLKNLGWLFLDENKIKD-L-SSLKDLKKLKSLSLEHNGISDINGLVH 129

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 47.8 bits (113), Expect = 6e-06
 Identities = 5/74 (6%), Positives = 24/74 (32%), Gaps = 4/74 (5%)

Query: 38  NFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLN 97
              +     + ++           + + L  +  +  + +++   + + +     +  L 
Sbjct: 16  PDDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVTKLF 71

Query: 98  LSYNNFESMLPIEG 111
           L+ N    + P+  
Sbjct: 72  LNGNKLTDIKPLTN 85

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 4/51 (7%), Positives = 19/51 (37%), Gaps = 2/51 (3%)

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
               +       +L + +++D +         +  +  + ++ +S+  I+ 
Sbjct: 15  FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQY 63

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVF---NVLHHDASKSFAVECEV-TRNIRHRNLVKV 267
           +IG G++  V    L ++    A++V     V   +       E  V  +   H  LV +
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK--RHKAPGNLNSLKRLNIAID 325
            +      FQ       V E++  G L   M  +  + K     A        R   A +
Sbjct: 119 HSC-----FQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHA--------RFYSA-E 161

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           ++  L YLH   +  I + DLK  N+LLD E    ++D+G+ +      + T +    GT
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GT 216

Query: 386 TGYIAPE--YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
             YIAPE   G  +  S   D ++ G+L+ EM  G  P
Sbjct: 217 PNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGRSP 252

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 63.4 bits (155), Expect = 4e-11
 Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 42/227 (18%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV----ECEVTRNIRHRNLVKVF 268
           IG G FG V+K    ++   VA+K   VL  +  + F +    E ++ + ++H N+V + 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 82

Query: 269 TACSGVDFQGNDFKA---LVYEFMAN---GSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
             C       N  K    LV++F  +   G L   +   T  + +         ++ L  
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR-------VMQMLLN 135

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
                  L Y+H +    I H D+K +N+L+  +    ++DFG+AR          S   
Sbjct: 136 G------LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF---SLAKNSQPN 183

Query: 383 EGTTG-----YIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
             T       Y  PE  +G     YG   D++  G ++ EM+T   P
Sbjct: 184 RYTNRVVTLWYRPPELLLGER--DYGPPIDLWGAGCIMAEMWTR-SP 227

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 63/266 (23%), Positives = 101/266 (37%), Gaps = 64/266 (24%)

Query: 180 MKKRGNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN 239
           +    +P   I       +        +++  +IG G+FG V++  L E +  VA+K   
Sbjct: 15  LNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVE-SDEVAIK--K 71

Query: 240 VLHHDASKSFAVECEVTRNIRHRNLVK---VFTACSGVDFQGNDFKALVYEFMANGSLEE 296
           VL     K+   E ++ R ++H N+V     F   S  D +   F  LV E++       
Sbjct: 72  VLQDKRFKN--RELQIMRIVKHPNVVDLKAFFY--SNGDKKDEVFLNLVLEYV------- 120

Query: 297 WMHPITEED-KRHKAPGNLNSLKRLNIAIDVACV----------LKYLHLDCQPPIAHCD 345
                  E   R           +L   + +  +          L Y+H      I H D
Sbjct: 121 ------PETVYRA-----SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRD 166

Query: 346 LKPSNILLDDEMTAY-VSDFGIARFLEAADEQTRSIGVEGTTGYI------APEYGMGHE 398
           +KP N+LLD       + DFG A+ L         I  E    YI      APE   G  
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKIL---------IAGEPNVSYICSRYYRAPELIFG-- 215

Query: 399 VSSYG---DVYSFGILLLEMFTGLRP 421
            ++Y    D++S G ++ E+  G +P
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQG-QP 240

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 51/239 (21%), Positives = 86/239 (35%), Gaps = 45/239 (18%)

Query: 200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVK-VFNVL-HHDASKSFAVECEVTR 257
           L+     ++ +  I +G++G+V  G+       VA+K VFN +         +      R
Sbjct: 17  LHAMQSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75

Query: 258 NIR---------HRNLVK---VFTACSGVDFQGNDFKALVYEFMA---NGSLEEWMHPIT 302
            +R         H N++    +F          +    LV E M       + +    I+
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAM--HKL-YLVTELMRTDLAQVIHDQRIVIS 132

Query: 303 EEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS 362
            +  ++                 +   L  LH   +  + H DL P NILL D     + 
Sbjct: 133 PQHIQY-------------FMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITIC 176

Query: 363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTG 418
           DF +AR   A   +T  +       Y APE  M      +    D++S G ++ EMF  
Sbjct: 177 DFNLAREDTADANKTHYV---THRWYRAPELVMQF--KGFTKLVDMWSAGCVMAEMFNR 230

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 63.2 bits (154), Expect = 7e-11
 Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 5/116 (4%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
           DL        +S     GLS+L   N++   L      N      L++LD+ GN  +   
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIR 223

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
             S   L  L+ L + Q+ +           + L  +NL++NN  ++LP   +F  
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL-TLLP-HDLFTP 277

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 25/103 (24%), Positives = 47/103 (45%), Gaps = 2/103 (1%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +L+  NL     P L  L  L   ++SGN LS     +F     L++L M  +       
Sbjct: 191 NLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIER 248

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNF 103
           ++  +L+ L  ++L+ NNL+    +       L+ ++L +N +
Sbjct: 249 NAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 25/116 (21%), Positives = 40/116 (34%), Gaps = 3/116 (2%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +L  N +          L  L I  +S N +       F    +L  L++  N       
Sbjct: 70  NLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPN 129

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFL-AGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            +   L  L+ L L  N +   IP +       L+ L+L      S +  EG F+ 
Sbjct: 130 GAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYIS-EGAFEG 183

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 26/118 (22%), Positives = 37/118 (31%), Gaps = 11/118 (9%)

Query: 1   DLSNNNLS---GTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG 57
                NL      +S     L      N+  N +     N+F     LE L +  N    
Sbjct: 49  ICVRKNLREVPDGISTNTRLL------NLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT 102

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
               + + L  L  L+L  N L+            L+ L L  N  ES +P    F  
Sbjct: 103 IEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES-IP-SYAFNR 158

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 61.9 bits (151), Expect = 8e-11
 Identities = 33/166 (19%), Positives = 55/166 (33%), Gaps = 35/166 (21%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV---TRNIRHRNLVKVFT 269
           +G G  G V +     +    A+K+                EV    R  +  ++V++  
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD 78

Query: 270 ACSGVDFQGNDFKALVYEFMANGSL-----EEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
                 + G     +V E +  G L     +      TE +                I  
Sbjct: 79  VYEN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE-------------IMK 124

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIA 367
            +   ++YLH      IAH D+KP N+L           ++DFG A
Sbjct: 125 SIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 62/253 (24%), Positives = 101/253 (39%), Gaps = 72/253 (28%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVK-VFNVLHH--DASKSFAVECEVTRNIR--- 260
           +     +G G +G V+K I   +   VAVK +F+   +  DA ++F       R I    
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-------REIMILT 63

Query: 261 ----HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH------PITEEDKRHKA 310
               H N+V +       +    D   LV+++M     E  +H       +    K++  
Sbjct: 64  ELSGHENIVNLLNVLRADND--RDV-YLVFDYM-----ETDLHAVIRANILEPVHKQY-- 113

Query: 311 PGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL 370
                      +   +  V+KYLH      + H D+KPSNILL+ E    V+DFG++R  
Sbjct: 114 -----------VVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159

Query: 371 EAADEQTRSIGVEGT-------------TGYI------APEYGMGHEVSSYG---DVYSF 408
                 T +I +                T Y+      APE  +G   + Y    D++S 
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS--TKYTKGIDMWSL 217

Query: 409 GILLLEMFTGLRP 421
           G +L E+  G +P
Sbjct: 218 GCILGEILCG-KP 229

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 59.9 bits (146), Expect = 4e-10
 Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 42/221 (19%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAV-ECEVTRNIRHRNLVKVFT 269
           IG G++G V+K    ++   VA+K F +   D    K  A+ E  + + ++H NLV +  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
                 F+      LV+E+  + ++   +        R++     + +K  +I       
Sbjct: 70  V-----FRRKRRLHLVFEYC-DHTVLHEL-------DRYQRGVPEHLVK--SITWQTLQA 114

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           + + H   +    H D+KP NIL+       + DFG AR L        +   +     +
Sbjct: 115 VNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLL--------TGPSDYYDDEV 163

Query: 390 ------APEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
                 +PE  +G     YG   DV++ G +  E+ +G  P
Sbjct: 164 ATRWYRSPELLVGDT--QYGPPVDVWAIGCVFAELLSG-VP 201

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 60.8 bits (148), Expect = 5e-10
 Identities = 23/105 (21%), Positives = 39/105 (37%), Gaps = 14/105 (13%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
             S N+L+  L      L SL + N +   LS            LE L +  N       
Sbjct: 97  VASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLEKL-- 146

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
             L +   L+++D+  N+L  ++P+       L+ +    N  E 
Sbjct: 147 PELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLEE 187

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 60.0 bits (146), Expect = 7e-10
 Identities = 24/105 (22%), Positives = 34/105 (32%), Gaps = 12/105 (11%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
              NN L   L P+L  L  L+      N L            SLE +    N+      
Sbjct: 179 AAGNNQLE-EL-PELQNLPFLTAIYADNNSLK----KLPDLPLSLESIVAGNNILEEL-- 230

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
             L +L  L  +    N L   +P+       L+ LN+  N    
Sbjct: 231 PELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDNYLTD 271

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 56.9 bits (138), Expect = 6e-09
 Identities = 26/105 (24%), Positives = 41/105 (39%), Gaps = 12/105 (11%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            +SNN L   L P+L   S L I +V  N L   + +   S   LE +    N       
Sbjct: 137 GVSNNQLE-KL-PELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLEEL-- 188

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
             L +L  L  +    N+L  ++P+       L+++    N  E 
Sbjct: 189 PELQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNILEE 229

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 20/122 (16%), Positives = 39/122 (31%), Gaps = 21/122 (17%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGS-------------CTSLEQ 47
              ++NL+  +  +   + S + +  + +          G                   +
Sbjct: 17  LRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHE 75

Query: 48  LDMHGNLFAGPIGSSL-SSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESM 106
           L+++         SSL      L  L  S N+L+ E+PE     K L   N +      +
Sbjct: 76  LELNNLGL-----SSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDL 129

Query: 107 LP 108
            P
Sbjct: 130 PP 131

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 28/124 (22%), Positives = 46/124 (37%), Gaps = 25/124 (20%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAI--------SNN-----FGSCTSLEQ 47
           ++ +N L+  L      L+ L +     + LS           S+N          SLE+
Sbjct: 263 NVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEE 321

Query: 48  LDMHGNLFAGPIGSSL-SSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESM 106
           L++  N         L +    L  L  S N+L+ E+PE       L+ L++ YN     
Sbjct: 322 LNVSNNKL-----IELPALPPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLRE- 371

Query: 107 LPIE 110
            P  
Sbjct: 372 FPDI 375

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 51.5 bits (124), Expect = 4e-07
 Identities = 21/110 (19%), Positives = 38/110 (34%), Gaps = 17/110 (15%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
             S N+L+  +      L  L   +V  N L     +   S   +E L M+ +L   P  
Sbjct: 343 IASFNHLA-EVPELPQNLKQL---HVEYNPLR-EFPDIPES---VEDLRMNSHLAEVP-- 392

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE 110
                 + L+ L +  N L  E P+       +++L ++           
Sbjct: 393 ---ELPQNLKQLHVETNPLR-EFPDIPES---VEDLRMNSERVVDPYEFA 435

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 23/123 (18%), Positives = 39/123 (31%), Gaps = 31/123 (25%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           + S+N +  +L      L  L   NVS N L   +         LE+L    N       
Sbjct: 303 NASSNEIR-SLCDLPPSLEEL---NVSNNKLI-ELPA---LPPRLERLIASFNHL----- 349

Query: 61  SSL-SSLRGLRVLDLSQNNLSDEIPEFLAGFKF----------------LQNLNLSYNNF 103
           + +    + L+ L +  N L  E P+     +                 L+ L++  N  
Sbjct: 350 AEVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPL 408

Query: 104 ESM 106
              
Sbjct: 409 REF 411

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 60.5 bits (146), Expect = 7e-10
 Identities = 25/104 (24%), Positives = 42/104 (40%), Gaps = 10/104 (9%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L++ +L+  L   L  L  ++  ++S N L  A+     +   LE L    N     + 
Sbjct: 447 HLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDN----ALE 499

Query: 61  S--SLSSLRGLRVLDLSQNNLSD-EIPEFLAGFKFLQNLNLSYN 101
           +   +++L  L+ L L  N L      + L     L  LNL  N
Sbjct: 500 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 57.1 bits (137), Expect = 8e-09
 Identities = 25/97 (25%), Positives = 38/97 (39%), Gaps = 4/97 (4%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG-PI 59
           DLS+N L   L P L  L  L +   S N L   +     +   L++L +  N       
Sbjct: 469 DLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAA 525

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNL 96
              L S   L +L+L  N+L  E        + L ++
Sbjct: 526 IQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 49.8 bits (118), Expect = 1e-06
 Identities = 20/92 (21%), Positives = 39/92 (42%), Gaps = 5/92 (5%)

Query: 23  IFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDE 82
           + +++   L+  + +       +  LD+  N     +  +L++LR L VL  S N L + 
Sbjct: 445 VLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN- 500

Query: 83  IPEFLAGFKFLQNLNLSYNNFESMLPIEGIFK 114
           +   +A    LQ L L  N  +    I+ +  
Sbjct: 501 VDG-VANLPRLQELLLCNNRLQQSAAIQPLVS 531

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 47.8 bits (113), Expect = 6e-06
 Identities = 17/69 (24%), Positives = 26/69 (37%), Gaps = 3/69 (4%)

Query: 42  CTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYN 101
              +  L +            L  L  +  LDLS N L   +P  LA  + L+ L  S N
Sbjct: 440 YADVRVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDN 496

Query: 102 NFESMLPIE 110
             E++  + 
Sbjct: 497 ALENVDGVA 505

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 60.3 bits (146), Expect = 7e-10
 Identities = 27/111 (24%), Positives = 46/111 (41%), Gaps = 3/111 (2%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFA--GP 58
           + + +            +S     + S NLL+  +  N G  T LE L +  N       
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSK 365

Query: 59  IGSSLSSLRGLRVLDLSQNNL-SDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
           I    + ++ L+ LD+SQN++  DE     +  K L +LN+S N     + 
Sbjct: 366 IAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 33/119 (27%), Positives = 51/119 (42%), Gaps = 10/119 (8%)

Query: 1   DLSNNNLSGTLSPQ---LVGLSSLSIFNVSGN-LLSGAISNNFGSCTSLEQLDMHGNLFA 56
            L  N L   LS        + SL   ++S N +       +     SL  L+M  N+  
Sbjct: 354 ILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412

Query: 57  GPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
             I   L     ++VLDL  N +   IP+ +   + LQ LN++ N  +S +P +GIF  
Sbjct: 413 DTIFRCLPPR--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VP-DGIFDR 466

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 23/121 (19%), Positives = 41/121 (33%), Gaps = 7/121 (5%)

Query: 1   DLSNNNLSG-----TLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN-L 54
            +SN  L G             L +LSI  V  ++     S  +   +++   +   +  
Sbjct: 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT 312

Query: 55  FAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFK 114
               +    S +     LD S N L+D + E       L+ L L  N  + +  I  +  
Sbjct: 313 RMVHMLCP-SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTT 371

Query: 115 N 115
            
Sbjct: 372 Q 372

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 35/116 (30%), Positives = 52/116 (44%), Gaps = 9/116 (7%)

Query: 1   DLSNNNLSGTLSPQLVGL-SSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
           D S N L     P+   L    +I N+S N +S   +++  S + L  L +  N      
Sbjct: 6   DRSKNGL--IHVPK--DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            S     + L  LDLS N L  +I         L++L+LS+N F++ LPI   F N
Sbjct: 62  ISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDA-LPICKEFGN 113

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 27/134 (20%), Positives = 49/134 (36%), Gaps = 22/134 (16%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLS----GA-----------ISNN------F 39
           ++S N +S   +  ++ LS L I  +S N +                  +S+N       
Sbjct: 27  NISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISC 86

Query: 40  GSCTSLEQLDMHGNLFAG-PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNL 98
               +L+ LD+  N F   PI     ++  L+ L LS  +L       +A     + L +
Sbjct: 87  HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146

Query: 99  SYNNFESMLPIEGI 112
               +      EG+
Sbjct: 147 LGETYGEKEDPEGL 160

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 26/106 (24%), Positives = 46/106 (43%), Gaps = 8/106 (7%)

Query: 1   DLSNNNLSGTLSPQL-VGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN-LFAGP 58
           D+S N++S            SL   N+S N+L+  I         ++ LD+H N + + P
Sbjct: 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIKSIP 437

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPE-FLAGFKFLQNLNLSYNNF 103
               +  L  L+ L+++ N L   +P+        LQ + L  N +
Sbjct: 438 KQ--VVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 44.1 bits (104), Expect = 7e-05
 Identities = 24/111 (21%), Positives = 40/111 (36%), Gaps = 6/111 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLL-SGAISNNFGSCTSLEQLDMHGNLFAGPI 59
           DLS+N L   +S       +L   ++S N   +  I   FG+ + L+ L +         
Sbjct: 75  DLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSS 131

Query: 60  GSSLSSLRGLRV-LDLSQNNLSDEIPEFLAGFKFLQN-LNLSYNNFESMLP 108
              ++ L   +V L L +     E PE L  F      +    N     + 
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFIL 182

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 59/232 (25%), Positives = 87/232 (37%), Gaps = 60/232 (25%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAV-ECEVTRNIRHRNLVKV 267
            L+G G++G V K    ++   VA+K F +   D    K  A+ E ++ + +RH NLV +
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRHENLVNL 89

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEED-KRHKAPGNLNSLKRLNIAIDV 326
                    +      LV+EF+             +              L+     +D 
Sbjct: 90  LEV-----CKKKKRWYLVFEFV-------------DHTILDD--------LELFPNGLDY 123

Query: 327 ACVLKYLHLDCQPPIAHC--------DLKPSNILLDDEMTAYVSDFGIARFLEAADEQTR 378
             V KYL       I  C        D+KP NIL+       + DFG AR L        
Sbjct: 124 QVVQKYLFQIIN-GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL-------- 174

Query: 379 SIGVEGTTGYI------APEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
           +   E     +      APE  +G     YG   DV++ G L+ EMF G  P
Sbjct: 175 AAPGEVYDDEVATRWYRAPELLVGDV--KYGKAVDVWAIGCLVTEMFMG-EP 223

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 57.5 bits (140), Expect = 2e-09
 Identities = 49/232 (21%), Positives = 91/232 (39%), Gaps = 51/232 (21%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK----SFAV-ECEVTRNIRH 261
           +     IG G +G+V+K    E+   VA+K    +  D       S A+ E  + + ++H
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKR---VRLDDDDEGVPSSALREICLLKELKH 60

Query: 262 RNLVKVFTACSGVD-FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           +N+V++       D    +    LV+EF  +  L+++               +   +K  
Sbjct: 61  KNIVRLH------DVLHSDKKLTLVFEFC-DQDLKKYF-------DSCNGDLDPEIVKSF 106

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
              +     L + H      + H DLKP N+L++      +++FG+A          R+ 
Sbjct: 107 LFQLLKG--LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLA----------RAF 151

Query: 381 GVEG--------TTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
           G+          T  Y  P+   G +   Y    D++S G +  E+    RP
Sbjct: 152 GIPVRCYSAEVVTLWYRPPDVLFGAK--LYSTSIDMWSAGCIFAELANAGRP 201

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 34/120 (28%), Positives = 47/120 (39%), Gaps = 8/120 (6%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDMHGN-LFAG 57
           DLS N+++  L+      L  L    V        I NN F   +SL  L +  N     
Sbjct: 36  DLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQL 94

Query: 58  PIGSSLSSLRGLRVLDLSQNNL-SDEIPE-FLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
             G+  + L  L VL L+Q NL    +   F      L+ L L  NN + + P    F N
Sbjct: 95  ETGA-FNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP-ASFFLN 152

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 30/117 (25%), Positives = 50/117 (42%), Gaps = 6/117 (5%)

Query: 1   DLSNNNLSGTLSPQL-VGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
           DLS + +   L   +    + L    ++ N ++    N F   T L +L++  N      
Sbjct: 281 DLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSID 339

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPE-FLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
                +L  L VLDLS N++   + +    G   L+ L L  N  +S +P +GIF  
Sbjct: 340 SRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKS-VP-DGIFDR 393

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 28/105 (26%), Positives = 41/105 (39%), Gaps = 4/105 (3%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            L+ N ++  +      GL+ L   N+S N L    S  F +   LE LD+  N      
Sbjct: 305 TLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALG 363

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPE-FLAGFKFLQNLNLSYNNF 103
             S   L  L+ L L  N L   +P+        LQ + L  N +
Sbjct: 364 DQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 31/112 (27%), Positives = 44/112 (39%), Gaps = 7/112 (6%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLL-SGAISNN-FGSCTSLEQLDMHGN-LFA 56
            L  N     L      GL++L +  ++   L    +S N F   TSLE L +  N +  
Sbjct: 85  KLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK 143

Query: 57  GPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGF--KFLQNLNLSYNNFESM 106
               S   ++R   VLDL+ N +     E L  F  K    L LS    + M
Sbjct: 144 IQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDM 195

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 18/98 (18%), Positives = 35/98 (35%), Gaps = 1/98 (1%)

Query: 19  SSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGS-SLSSLRGLRVLDLSQN 77
           + ++  ++S N ++     +F     L+ L +        I + +   L  L +L L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 78  NLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
                      G   L+ L L+  N +  +     FK 
Sbjct: 90  QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 20/133 (15%), Positives = 46/133 (34%), Gaps = 17/133 (12%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQL------------ 48
           D++   L           +S++  ++SGN    +++  F    +  ++            
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253

Query: 49  -DMHGNLFAGPIGSSLSSLR--GLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
                  F  P   +   L   G++  DLS++ +   +    + F  L+ L L+ N    
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK 313

Query: 106 MLPIEGIFKNASA 118
            +  +  F   + 
Sbjct: 314 -ID-DNAFWGLTH 324

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 57.2 bits (139), Expect = 3e-09
 Identities = 59/220 (26%), Positives = 87/220 (39%), Gaps = 31/220 (14%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVEC----EVT-----RNIRH 261
             IG G +G+VYK     S   VA+K    + +       +      EV          H
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVR-VPNGGGGGGGLPISTVREVALLRRLEAFEH 73

Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            N+V++   C+           LV+E +    L  ++      DK         ++K L 
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL------DKAPPPGLPAETIKDLM 126

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
                   L +LH +C   I H DLKP NIL+    T  ++DFG+AR        T  + 
Sbjct: 127 RQFLRG--LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV- 180

Query: 382 VEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTG 418
           V  T  Y APE  +    S+Y    D++S G +  EMF  
Sbjct: 181 V--TLWYRAPEVLLQ---STYATPVDMWSVGCIFAEMFRR 215

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 53/242 (21%), Positives = 91/242 (37%), Gaps = 67/242 (27%)

Query: 212 LIGAGNFGSVYKGI-LFESTTAVAVKVF-NVLH-HDASKSFAVECEVTRNIRHR------ 262
            +G G FG V + +      + VA+K+  NV    +A++   +E  V + I+ +      
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR---LEINVLKKIKEKDKENKF 82

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG-NLNSLKRLN 321
             V +       +F G+    + +E +   +  E++       K +      L  ++   
Sbjct: 83  LCVLMSDW---FNFHGHMC--IAFELLGK-NTFEFL-------KENNFQPYPLPHVRH-- 127

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY-------------------VS 362
           +A  +   L++LH + Q  + H DLKP NIL  +                        V+
Sbjct: 128 MAYQLCHALRFLH-ENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184

Query: 363 DFGIARFLEAADE------QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMF 416
           DFG A F     E       TR         Y  PE  +    +   DV+S G +L E +
Sbjct: 185 DFGSATF---DHEHHTTIVATRH--------YRPPEVILELGWAQPCDVWSIGCILFEYY 233

Query: 417 TG 418
            G
Sbjct: 234 RG 235

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.5 bits (134), Expect = 4e-09
 Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 12/105 (11%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            LS NN+   +S  L G+ +L I ++  NL+   I N      +LE+L +  N     I 
Sbjct: 54  ALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQ----IA 106

Query: 61  --SSLSSLRGLRVLDLSQNNLSD--EIPEFLAGFKFLQNLNLSYN 101
             S +  L  LRVL +S N +++  EI + LA    L++L L+ N
Sbjct: 107 SLSGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.4 bits (126), Expect = 4e-08
 Identities = 22/79 (27%), Positives = 34/79 (43%), Gaps = 7/79 (8%)

Query: 35  ISNNFGSCTSLEQLDMHGNLFAGPIG--SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKF 92
           +     +  + + L +  N     I   SSLS +  LR+L L +N +   I    A    
Sbjct: 40  MDATLSTLKACKHLALSTNN----IEKISSLSGMENLRILSLGRNLIKK-IENLDAVADT 94

Query: 93  LQNLNLSYNNFESMLPIEG 111
           L+ L +SYN   S+  IE 
Sbjct: 95  LEELWISYNQIASLSGIEK 113

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 45.8 bits (109), Expect = 8e-06
 Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 6/88 (6%)

Query: 29  NLLSGAISNNFGSCTSLEQLDMHGNLFA-GPIGSSLSSLRGLRVLDLSQNNLSDEIPEFL 87
           + +           T  E++++HG +     + ++LS+L+  + L LS NN+  +I   L
Sbjct: 9   DAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSL 66

Query: 88  AGFKFLQNLNLSYNNFESMLPIEGIFKN 115
           +G + L+ L+L  N  +    IE +   
Sbjct: 67  SGMENLRILSLGRNLIKK---IENLDAV 91

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 20/110 (18%), Positives = 38/110 (34%), Gaps = 6/110 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
                 +   +   L  L +     +S N +   IS+      +L  L +  NL    I 
Sbjct: 31  HGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIKK-IE 86

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE 110
           +  +    L  L +S N ++      +     L+ L +S N   +   I+
Sbjct: 87  NLDAVADTLEELWISYNQIAS--LSGIEKLVNLRVLYMSNNKITNWGEID 134

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 26/113 (23%), Positives = 45/113 (39%), Gaps = 12/113 (10%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +LS N L   +S  + GL S+   +++   ++          ++L+ L +  N     I 
Sbjct: 91  ELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLN----QIT 142

Query: 61  --SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
             S L+ L  L+ L +    +SD  P  LA    L  L    N    + P+  
Sbjct: 143 NISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISPLAS 193

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 21/111 (18%), Positives = 47/111 (42%), Gaps = 8/111 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
               +N++ T++     L  ++  +  G  ++  I        +L  L++  N       
Sbjct: 25  AAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDL-- 78

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
           + L +L  +  L+LS N L +     +AG + ++ L+L+      + P+ G
Sbjct: 79  APLKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTPLAG 127

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 53.2 bits (128), Expect = 6e-08
 Identities = 23/115 (20%), Positives = 46/115 (40%), Gaps = 9/115 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            + N  +S  L+P L  LS L+      N +S  IS    S  +L ++ +  N  +    
Sbjct: 157 SIGNAQVS-DLTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDV-- 210

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
           S L++   L ++ L+   ++++   +      L   N+      + +    I  N
Sbjct: 211 SPLANTSNLFIVTLTNQTITNQPVFY---NNNLVVPNVVKGPSGAPIAPATISDN 262

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 11/79 (13%), Positives = 26/79 (32%), Gaps = 6/79 (7%)

Query: 35  ISNNFG--SCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKF 92
           I+  F   +  +  ++    +        + + L G+  L      ++    E +     
Sbjct: 9   INVIFPDPALANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVTT--IEGVQYLNN 64

Query: 93  LQNLNLSYNNFESMLPIEG 111
           L  L L  N    + P++ 
Sbjct: 65  LIGLELKDNQITDLAPLKN 83

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 56.0 bits (136), Expect = 8e-09
 Identities = 60/260 (23%), Positives = 100/260 (38%), Gaps = 60/260 (23%)

Query: 180 MKKRGNPTPSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTA-VAVKVF 238
           M    + +      Y    M     + +     +G G +G VYK    +S    VA+K  
Sbjct: 1   MHHHHHHSSGRENLYFQGLM-----EKYQKLEKVGEGTYGVVYKAK--DSQGRIVALKR- 52

Query: 239 NVLHHDASK----SFAV-ECEVTRNIRHRNLVKVFTACSGVD-FQGNDFKALVYEFMANG 292
             +  DA      S A+ E  + + + H N+V +       D         LV+EFM   
Sbjct: 53  --IRLDAEDEGIPSTAIREISLLKELHHPNIVSLI------DVIHSERCLTLVFEFMEK- 103

Query: 293 SLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNIL 352
            L++ +         +K     + +K     +     + + H      I H DLKP N+L
Sbjct: 104 DLKKVL-------DENKTGLQDSQIKIYLYQLLRG--VAHCHQHR---ILHRDLKPQNLL 151

Query: 353 LDDEMTAYVSDFGIARFLEAADEQTRSIGVEG--------TTGYIAPEYGMGHEVSSYG- 403
           ++ +    ++DFG+A          R+ G+          T  Y AP+  MG +   Y  
Sbjct: 152 INSDGALKLADFGLA----------RAFGIPVRSYTHEVVTLWYRAPDVLMGSK--KYST 199

Query: 404 --DVYSFGILLLEMFTGLRP 421
             D++S G +  EM TG +P
Sbjct: 200 SVDIWSIGCIFAEMITG-KP 218

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 40/222 (18%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLVKVFTAC 271
           +G G + +VYKG+   +   VA+K   +   + + S A+ E  + + ++H N+V+++   
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWM-HPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                +      LV+EFM +  L+++M         R      +           +   L
Sbjct: 73  HT---ENKLT--LVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYF-----QWQLLQGL 121

Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG------ 384
            + H +    I H DLKP N+L++      + DFG+A          R+ G+        
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLA----------RAFGIPVNTFSSE 168

Query: 385 --TTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
             T  Y AP+  MG    +Y    D++S G +L EM TG +P
Sbjct: 169 VVTLWYRAPDVLMGSR--TYSTSIDIWSCGCILAEMITG-KP 207

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 55.3 bits (134), Expect = 1e-08
 Identities = 54/232 (23%), Positives = 88/232 (37%), Gaps = 52/232 (22%)

Query: 211 NLIGAGNFGSVYKGILFEST-TAVAVKVFNVLHHDASK----SFAVECEVT-----RNIR 260
             IG G +G V+K    ++    VA+K    +     +       +  EV          
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKR---VRVQTGEEGMPLSTIR-EVAVLRHLETFE 72

Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG-NLNSLKR 319
           H N+V++F  C+           LV+E + +  L  ++        +   PG    ++K 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-------DKVPEPGVPTETIKD 124

Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
           +     +   L +LH      + H DLKP NIL+       ++DFG+A          R 
Sbjct: 125 M--MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA----------RI 169

Query: 380 IGVEG-------TTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
              +        T  Y APE  +    SSY    D++S G +  EMF   +P
Sbjct: 170 YSFQMALTSVVVTLWYRAPEVLLQ---SSYATPVDLWSVGCIFAEMFRR-KP 217

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 35/174 (20%), Positives = 70/174 (40%), Gaps = 33/174 (18%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS---------KSFAVECEVTRNIRHR 262
            IG+G FG +Y           A  V  V + +           +  A +  + + I  +
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 263 NLVKV----FTACSGVDFQGNDFKALVYEFMANG-SLEEWMHPITEEDKRHKAPGNLNSL 317
            L  +    F      +F+G  ++ +V E +  G  L++    I+ ++            
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK----ISGQNGTF-------KK 150

Query: 318 KR-LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD--DEMTAYVSDFGIAR 368
              L + I +  VL+Y+H +      H D+K +N+LL   +    Y++D+G++ 
Sbjct: 151 STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 18/105 (17%), Positives = 42/105 (40%), Gaps = 11/105 (10%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           D  N++++  ++  +  L+ L+    + N ++   + +    T+L  L    N       
Sbjct: 48  DCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT---TLDLSQNTNLTYLACDSNKLTNL-- 100

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
             ++ L  L  L+   N L+ ++   ++    L  LN + N    
Sbjct: 101 -DVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLTE 141

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 15/128 (11%), Positives = 31/128 (24%), Gaps = 14/128 (10%)

Query: 2   LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGS 61
                        +   + L + +     ++     +      L  L ++         +
Sbjct: 280 FQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTEL-----T 331

Query: 62  SL--SSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASAT 119
            L  S    L+ L     ++ D     +     L N   +     +M        N S T
Sbjct: 332 ELDVSHNTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTITMPKE--TLTNNSLT 387

Query: 120 SVFGNKKL 127
                  L
Sbjct: 388 IAVSPDLL 395

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 53.5 bits (129), Expect = 8e-08
 Identities = 23/109 (21%), Positives = 33/109 (30%), Gaps = 12/109 (11%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +   NN++      L     L+  + S N L+     +    T L   D   N       
Sbjct: 197 NCDTNNIT---KLDLNQNIQLTFLDCSSNKLT---EIDVTPLTQLTYFDCSVNPLTELDV 250

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPI 109
           S+LS    L  L   Q +L  EI   L     L             L +
Sbjct: 251 STLSK---LTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELDV 293

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 19/111 (17%), Positives = 38/111 (34%), Gaps = 12/111 (10%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           + + N L+      +   + L+  +   N     +  +    T L  LD   N       
Sbjct: 133 NCARNTLT---EIDVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKI---TE 184

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
             +S  + L  L+   NN++ ++   L     L  L+ S N     + +  
Sbjct: 185 LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE-IDVTP 231

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 17/106 (16%), Positives = 33/106 (31%), Gaps = 13/106 (12%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           D S+N L+  +   +  L+ L+ F+ S N L+     +  + + L  L          + 
Sbjct: 218 DCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQT----DLL 267

Query: 61  S-SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
              L+    L            E+   +     L  L+        
Sbjct: 268 EIDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITE 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 21/123 (17%), Positives = 45/123 (36%), Gaps = 11/123 (8%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           ++  ++L       L  + ++S   +        +       +S+E L++          
Sbjct: 180 EIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHF 239

Query: 61  SSLSS--------LRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGI 112
           S LS+            R + ++  +L  ++ + L     L  L  S N  +S +P +GI
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VP-DGI 296

Query: 113 FKN 115
           F  
Sbjct: 297 FDR 299

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 30/118 (25%), Positives = 46/118 (38%), Gaps = 6/118 (5%)

Query: 1   DLSNNNLSGTLSPQL-VGLSSLSIFNVSGNLLSG-AISNNFGSCTSLEQLDMHGNLFAGP 58
           DLS N LS  LS      LSSL+  N+ GN       ++ F   T L+ L +        
Sbjct: 106 DLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK 164

Query: 59  IGS-SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
           I     + L  L  L++  ++L    P+ L   + + +L L       +L  E     
Sbjct: 165 IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH-ILLL-EIFVDV 220

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 28/118 (23%), Positives = 47/118 (39%), Gaps = 6/118 (5%)

Query: 1   DLSNNNLSGTLSP-QLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
           DLSNN ++  +S   L    +L    ++ N ++    ++F S  SLE LD+  N  +   
Sbjct: 58  DLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLS 116

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPE--FLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            S    L  L  L+L  N     + E    +    LQ L +   +  + +     F  
Sbjct: 117 SSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQ-RKDFAG 172

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 18/111 (16%), Positives = 34/111 (30%), Gaps = 9/111 (8%)

Query: 1   DLSNNNLS--------GTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHG 52
            L               T S + + L    +     + LS   +N+     +   + +  
Sbjct: 204 ILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263

Query: 53  NLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNF 103
                 +   L+ + GL  L+ S+N L             LQ + L  N +
Sbjct: 264 ESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 29/109 (26%), Positives = 45/109 (41%), Gaps = 18/109 (16%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L+  NLS +L   L     +++  ++ N L  ++     S   LE LD   N       
Sbjct: 65  QLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPAS---LEYLDACDNRL----- 112

Query: 61  SSL-SSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
           S+L      L+ LD+  N L+  +PE  A    L+ +N   N     LP
Sbjct: 113 STLPELPASLKHLDVDNNQLT-MLPELPAL---LEYINADNNQLTM-LP 156

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 25/108 (23%), Positives = 37/108 (34%), Gaps = 12/108 (11%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN-LFAGP- 58
           +  NN L+  L      L  L   +V  N L+           SLE LD+  N L + P 
Sbjct: 146 NADNNQLT-MLPELPTSLEVL---SVRNNQLTFLPE----LPESLEALDVSTNLLESLPA 197

Query: 59  -IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
               +  S          +N ++  IPE +        + L  N   S
Sbjct: 198 VPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 25/114 (21%), Positives = 43/114 (37%), Gaps = 19/114 (16%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISN-NFGSCTSLEQLDMHGNLFAGPI 59
           +   N +SGT +             + G   + A+S           +L ++        
Sbjct: 16  NSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRL------ 69

Query: 60  GSSLSSL-----RGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
             +LSSL       + VL+++QN L   +PE  A    L+ L+   N   + LP
Sbjct: 70  --NLSSLPDNLPPQITVLEITQNALI-SLPELPAS---LEYLDACDNRLST-LP 116

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 24/108 (22%), Positives = 37/108 (34%), Gaps = 10/108 (9%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQ----LDMHGNLFA 56
            + NN L+  L      L +L   +VS NLL  ++          E+         N   
Sbjct: 166 SVRNNQLT-FLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT 220

Query: 57  GPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFE 104
             I  ++ SL     + L  N LS  I E L+      + +     F 
Sbjct: 221 H-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 17/83 (20%), Positives = 28/83 (33%), Gaps = 10/83 (12%)

Query: 35  ISNNFGSCTSLEQLDMHGNLFAGP--IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKF 92
           I+NNF    SL Q   +  +        S+        +   ++N     + E L     
Sbjct: 7   INNNF----SLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQ 60

Query: 93  LQNLNLSYNNFESMLPIEGIFKN 115
              L L+  N  S LP + +   
Sbjct: 61  FSELQLNRLNLSS-LP-DNLPPQ 81

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 58/246 (23%), Positives = 91/246 (36%), Gaps = 71/246 (28%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVF-NVLH-HDASKSFAVECEVTRNIRHR-----NL 264
            +G G FG V      ++    AVKV  N+     ++K   +E ++ + I++      N+
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAK---IEADILKKIQNDDINNNNI 98

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPG-NLNSLKRLNIA 323
           VK         +  +    L++E +   SL E +        R+   G ++  +K     
Sbjct: 99  VKYHGK---FMYYDHMC--LIFEPLGP-SLYEII-------TRNNYNGFHIEDIKL--YC 143

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS--------------------- 362
           I++   L YL       + H DLKP NILLDD                            
Sbjct: 144 IEILKALNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200

Query: 363 ----DFGIARFLEAADE------QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILL 412
               DFG A F     +       TR         Y APE  +        D++SFG +L
Sbjct: 201 IKLIDFGCATF---KSDYHGSIINTRQ--------YRAPEVILNLGWDVSSDMWSFGCVL 249

Query: 413 LEMFTG 418
            E++TG
Sbjct: 250 AELYTG 255

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 54.9 bits (133), Expect = 2e-08
 Identities = 50/228 (21%), Positives = 97/228 (42%), Gaps = 45/228 (19%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV-ECEVTRNIRHRNLV 265
           +   + +G G + +VYKG    +   VA+K   + H + +   A+ E  + ++++H N+V
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63

Query: 266 KVFTACSGVD-FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
            +       D         LV+E++ +  L++++              N++++K     +
Sbjct: 64  TLH------DIIHTEKSLTLVFEYL-DKDLKQYL-------DDCGNIINMHNVKLFLFQL 109

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
                L Y H   +  + H DLKP N+L+++     ++DFG+A          R+  +  
Sbjct: 110 LRG--LAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLA----------RAKSIPT 154

Query: 385 --------TTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
                   T  Y  P+  +G     Y    D++  G +  EM TG RP
Sbjct: 155 KTYDNEVVTLWYRPPDILLGST--DYSTQIDMWGVGCIFYEMATG-RP 199

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 28/122 (22%), Positives = 54/122 (44%), Gaps = 15/122 (12%)

Query: 1   DLSNNNLSGTLSPQL-VGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
           DLS   +  T+       LS LS   ++GN +       F   +SL++L           
Sbjct: 58  DLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL---- 112

Query: 60  GSSLSS-----LRGLRVLDLSQNNLSD-EIPEFLAGFKFLQNLNLSYNNFESMLPIEGIF 113
            +SL +     L+ L+ L+++ N +   ++PE+ +    L++L+LS N  +S +      
Sbjct: 113 -ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IY-CTDL 169

Query: 114 KN 115
           + 
Sbjct: 170 RV 171

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 33/121 (27%), Positives = 51/121 (42%), Gaps = 10/121 (8%)

Query: 1   DLSNNNLSGTLSPQL-VGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDMHGN-LFAG 57
                NL+ +L       L +L   NV+ NL+        F + T+LE LD+  N + + 
Sbjct: 106 VAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164

Query: 58  PIG--SSLSSLRGLRV-LDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFK 114
                  L  +  L + LDLS N ++  I         L+ L L  N  +S +P +GIF 
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKS-VP-DGIFD 221

Query: 115 N 115
            
Sbjct: 222 R 222

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 21/74 (28%), Positives = 29/74 (39%), Gaps = 4/74 (5%)

Query: 43  TSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPE-FLAGFKFLQNLNLSYN 101
            S + LD+  N        S  S   L+VLDLS+  +   I +        L  L L+ N
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGN 86

Query: 102 NFESMLPIEGIFKN 115
             +S L   G F  
Sbjct: 87  PIQS-LA-LGAFSG 98

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 53/241 (21%), Positives = 90/241 (37%), Gaps = 65/241 (26%)

Query: 212 LIGAGNFGSVYKGI-LFESTTAVAVKVF-NVL-HHDASKSFAVECEVTRNIRHR------ 262
            +G G FG V + I        VAVK+  NV  + +A++    E +V  ++         
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAAR---SEIQVLEHLNTTDPNSTF 77

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
             V++       +  G+    +V+E +   S  +++       +    P  L+ +++  +
Sbjct: 78  RCVQMLEW---FEHHGHIC--IVFELLGL-STYDFI------KENGFLPFRLDHIRK--M 123

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS-------------------D 363
           A  +   + +LH   +  + H DLKP NIL                             D
Sbjct: 124 AYQICKSVNFLH-SNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180

Query: 364 FGIARFLEAADE------QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
           FG A +    DE       TR         Y APE  +    S   DV+S G +L+E + 
Sbjct: 181 FGSATY---DDEHHSTLVSTRH--------YRAPEVILALGWSQPCDVWSIGCILIEYYL 229

Query: 418 G 418
           G
Sbjct: 230 G 230

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 35/124 (28%), Positives = 57/124 (45%), Gaps = 7/124 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDMHGNLFAGPI 59
           DLS+N L  +L      L +L++ +VS N L+ ++          L++L + GN      
Sbjct: 83  DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLP 140

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFL-AGFKFLQNLNLSYNNFESMLPIEGIFKNASA 118
              L+    L  L L+ NNL+ E+P  L  G + L  L L  N+  + +P +G F +   
Sbjct: 141 PGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IP-KGFFGSHLL 197

Query: 119 TSVF 122
              F
Sbjct: 198 PFAF 201

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 32/114 (28%), Positives = 45/114 (39%), Gaps = 10/114 (8%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN-LFAGPI 59
           +    NL+  L P L      +I ++S NLL           T L QL++    L    +
Sbjct: 16  NCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV 72

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIF 113
             +L     L  LDLS N L   +P        L  L++S+N   S LP  G  
Sbjct: 73  DGTLPV---LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LP-LGAL 120

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 25/135 (18%), Positives = 42/135 (31%), Gaps = 9/135 (6%)

Query: 1   DLSNNNLSGTLSPQL-VGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDMHGN-LFAG 57
            +S +     L       LS ++   +        I  +       L+ L +    L   
Sbjct: 61  YVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMF 120

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIPE--FLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
           P  + + S     +L+++ N     IP   F         L L  N F S +     F  
Sbjct: 121 PDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQ-GYAFNG 178

Query: 116 ASATSVF--GNKKLC 128
               +V+   NK L 
Sbjct: 179 TKLDAVYLNKNKYLT 193

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 19/121 (15%), Positives = 40/121 (33%), Gaps = 10/121 (8%)

Query: 1   DLSNNNLSGTLSPQ--LVGLSSLSIFNVSGNLLSGAISNN-FGSCTS-LEQLDMHGNLFA 56
            + N  L         +       I  ++ N    +I  N F    +    L ++ N F 
Sbjct: 111 GIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169

Query: 57  GPIGSSLSSLRGLRVLDLSQNNLSDEIPE--FLAGFKFLQNLNLSYNNFESMLPIEGIFK 114
             +     +   L  + L++N     I +  F   +     L++S  +  + LP     +
Sbjct: 170 S-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LP-SKGLE 226

Query: 115 N 115
           +
Sbjct: 227 H 227

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 6/74 (8%), Positives = 22/74 (29%), Gaps = 2/74 (2%)

Query: 43  TSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFL-AGFKFLQNLNLSYN 101
            S + L +           + S+L  +  + +S +    ++          + ++ +   
Sbjct: 31  PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90

Query: 102 NFESMLPIEGIFKN 115
              + +      K 
Sbjct: 91  RNLTYID-PDALKE 103

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 40.4 bits (95), Expect = 7e-04
 Identities = 19/112 (16%), Positives = 46/112 (41%), Gaps = 22/112 (19%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIF-NVSGNLLSGAISNNFGSCTSLEQLDMHGN----- 53
           ++++N    ++      GL + ++   +  N  + ++     + T L+ + ++ N     
Sbjct: 136 EITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTV 194

Query: 54  ----LFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYN 101
                F G     + S  G  +LD+SQ +++  +P    G + L+ L     
Sbjct: 195 IDKDAFGG-----VYS--GPSLLDVSQTSVT-ALPS--KGLEHLKELIARNT 236

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 26/129 (20%), Positives = 41/129 (31%), Gaps = 26/129 (20%)

Query: 1   DLSNNNLSGT----LSPQLVGLSSLSIFNVSGN-------------LLSGAISNNFGSCT 43
            LS+N    T    L   L   + L    +  N             L   A++    +  
Sbjct: 100 RLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAP 159

Query: 44  SLEQLDMHGNLF----AGPIGSSLSSLRGLRVLDLSQNNLSDE-----IPEFLAGFKFLQ 94
            L  +    N            +  S R L  + + QN +  E     + E LA  + L+
Sbjct: 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219

Query: 95  NLNLSYNNF 103
            L+L  N F
Sbjct: 220 VLDLQDNTF 228

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 24/122 (19%), Positives = 38/122 (31%), Gaps = 19/122 (15%)

Query: 1   DLSNNNLSG----TLSPQLVGLSSLSIFNVSGNLL-----SGAISNNFGSCTSLEQLDMH 51
               N L        +        L    +  N +        +      C  L+ LD+ 
Sbjct: 165 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 224

Query: 52  GNLF----AGPIGSSLSSLRGLRVLDLSQNNLSDE----IPEFLAGFKF--LQNLNLSYN 101
            N F    +  +  +L S   LR L L+   LS      + +  +  +   LQ L L YN
Sbjct: 225 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYN 284

Query: 102 NF 103
             
Sbjct: 285 EI 286

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 24/123 (19%), Positives = 42/123 (34%), Gaps = 20/123 (16%)

Query: 1   DLSNNNL-----SGTLSPQLVGLSSLSIFNVSGNLLSG----AISNNFGSCTSLEQLDMH 51
            +  N +        L   L     L + ++  N  +     A++    S  +L +L ++
Sbjct: 193 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 252

Query: 52  GNLF----AGPIGSSLSSL--RGLRVLDLSQNNLSDEIPEFLA-----GFKFLQNLNLSY 100
             L     A  +  + S L   GL+ L L  N +  +    L          L  L L+ 
Sbjct: 253 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 312

Query: 101 NNF 103
           N F
Sbjct: 313 NRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 23/136 (16%), Positives = 36/136 (26%), Gaps = 31/136 (22%)

Query: 1   DLSNNNLSGT----LSPQLVGLSSLSIFNVSGNLLS----------GAISNNFGSCTSLE 46
            LS N +       LS  +     L I   S                 +      C  L 
Sbjct: 38  VLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLH 97

Query: 47  QLDMHGNLF----AGPIGSSLSSLRGLRVLDLSQNNLSDE-------------IPEFLAG 89
            + +  N F      P+   LS    L  L L  N L  +             + +    
Sbjct: 98  TVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKN 157

Query: 90  FKFLQNLNLSYNNFES 105
              L+++    N  E+
Sbjct: 158 APPLRSIICGRNRLEN 173

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 14/102 (13%), Positives = 36/102 (35%), Gaps = 18/102 (17%)

Query: 20  SLSIFNVSGNLLSG----AISNNFGSCTSLEQLDMHGNLF----AGPIGSSLSSLRGLRV 71
           S+   ++  + ++     ++        S++++ + GN      A  +  +++S + L +
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 72  LDLSQNNLSDEIPEFLAGFKF----------LQNLNLSYNNF 103
            + S         E     +           L  + LS N F
Sbjct: 65  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF 106

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 24/113 (21%), Positives = 48/113 (42%), Gaps = 12/113 (10%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
             +N+++  ++   +  L +++   ++GN L+  I     +  +L  L +  N     + 
Sbjct: 52  IANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDEN----KVK 103

Query: 61  --SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
             SSL  L+ L+ L L  N +SD     L     L++L L  N    +  +  
Sbjct: 104 DLSSLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITDITVLSR 154

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 26/122 (21%), Positives = 45/122 (36%), Gaps = 13/122 (10%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L NN ++  ++  L  L+ L   ++  N +S  I       T L+ L +  N     I 
Sbjct: 140 YLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKN----HIS 191

Query: 61  --SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASA 118
              +L+ L+ L VL+L      ++          L   N   N   S++  E I  +   
Sbjct: 192 DLRALAGLKNLDVLELFSQECLNKPINHQ---SNLVVPNTVKNTDGSLVTPEIISDDGDY 248

Query: 119 TS 120
             
Sbjct: 249 EK 250

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 5/74 (6%), Positives = 25/74 (33%), Gaps = 4/74 (5%)

Query: 38  NFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLN 97
           +  +     + ++           + + L  +  +  + +++   + + +     +  L 
Sbjct: 19  SDDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVTKLF 74

Query: 98  LSYNNFESMLPIEG 111
           L+ N    + P+  
Sbjct: 75  LNGNKLTDIKPLAN 88

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 30/111 (27%), Positives = 48/111 (43%), Gaps = 19/111 (17%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
              NN L+ +L     GL  L   +VS N L+ ++         L +L  + N       
Sbjct: 167 WAYNNQLT-SLPMLPSGLQEL---SVSDNQLA-SLPTLPSE---LYKLWAYNNRL----- 213

Query: 61  SSL-SSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE 110
           +SL +   GL+ L +S N L+  +P   +    L+ L +S N   S LP+ 
Sbjct: 214 TSLPALPSGLKELIVSGNRLT-SLPVLPSE---LKELMVSGNRLTS-LPML 259

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 34/137 (24%), Positives = 48/137 (35%), Gaps = 35/137 (25%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAIS---------NNFGS----CTSLEQ 47
           ++S N L+ +L     GL  LSIF+     L    S         N   S       L++
Sbjct: 87  EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQE 145

Query: 48  LDMHGNLFAG--PIGSSLSSLR--------------GLRVLDLSQNNLSDEIPEFLAGFK 91
           L +  N  A    + S L  L               GL+ L +S N L+  +P   +   
Sbjct: 146 LSVSDNQLASLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLA-SLPTLPSE-- 202

Query: 92  FLQNLNLSYNNFESMLP 108
            L  L    N   S LP
Sbjct: 203 -LYKLWAYNNRLTS-LP 217

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 54.1 bits (130), Expect = 7e-08
 Identities = 19/108 (17%), Positives = 36/108 (33%), Gaps = 16/108 (14%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           ++  + L+ TL   L   + ++   +  N L+ ++         L  L++ GN     + 
Sbjct: 46  NVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPE---LRTLEVSGNQLTS-LP 97

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
                L  L +      +L             L  L +  N   S LP
Sbjct: 98  VLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLTS-LP 137

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 21/106 (19%), Positives = 38/106 (35%), Gaps = 12/106 (11%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            +S N L+ +L      L  L    VSGN L+ ++       + L  L ++ N     + 
Sbjct: 227 IVSGNRLT-SLPVLPSELKEL---MVSGNRLT-SLPM---LPSGLLSLSVYRNQLTR-LP 277

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESM 106
            SL  L     ++L  N LS+   +     + + +           
Sbjct: 278 ESLIHLSSETTVNLEGNPLSERTLQA---LREITSAPGYSGPIIRF 320

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 16/100 (16%), Positives = 32/100 (32%), Gaps = 5/100 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            +S N L+ +L     GL SL   +V  N L+  +  +    +S   +++ GN  +    
Sbjct: 247 MVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL 301

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSY 100
            +L  +                        + L      +
Sbjct: 302 QALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW 341

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 28/117 (23%), Positives = 45/117 (38%), Gaps = 13/117 (11%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L NN L       L+ L +L I ++  N L  +I    G  + LE LD+HGN     I 
Sbjct: 112 FLDNNELR-DTDS-LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGN----EIT 163

Query: 61  --SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
               L+ L+ +  +DL+     +E  ++      L   N   +     +    I   
Sbjct: 164 NTGGLTRLKKVNWIDLTGQKCVNEPVKYQ---PELYITNTVKDPDGRWISPYYISNG 217

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 22/113 (19%), Positives = 42/113 (37%), Gaps = 13/113 (11%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           +L   +++  L      LS +  FN   + +  +++      T+L++L +  N     I 
Sbjct: 25  NLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHN----QIS 76

Query: 61  --SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
             S L  L  L  L +++N L +     +     L  L L  N       +  
Sbjct: 77  DLSPLKDLTKLEELSVNRNRLKN--LNGIPSAC-LSRLFLDNNELRDTDSLIH 126

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 11/71 (15%), Positives = 27/71 (38%), Gaps = 4/71 (5%)

Query: 41  SCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSY 100
              +  + ++           S   L G++  +   +N+       +  F  L+ L+LS+
Sbjct: 17  GLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHLSH 72

Query: 101 NNFESMLPIEG 111
           N    + P++ 
Sbjct: 73  NQISDLSPLKD 83

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 51.6 bits (124), Expect = 7e-08
 Identities = 18/119 (15%), Positives = 37/119 (31%), Gaps = 9/119 (7%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L+   +    + Q          ++ G  +   I N   +    + +D   N     I 
Sbjct: 3   KLTAELI--EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE----IR 55

Query: 61  S--SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNAS 117
                  LR L+ L ++ N +             L  L L+ N+   +  ++ +    S
Sbjct: 56  KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS 114

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.7 bits (101), Expect = 7e-05
 Identities = 17/83 (20%), Positives = 32/83 (38%), Gaps = 3/83 (3%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           D S+N +   L      L  L    V+ N +         +   L +L +  N       
Sbjct: 48  DFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGD 105

Query: 61  -SSLSSLRGLRVLDLSQNNLSDE 82
              L+SL+ L  L + +N ++++
Sbjct: 106 LDPLASLKSLTYLCILRNPVTNK 128

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 53.4 bits (129), Expect = 7e-08
 Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 69/236 (29%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK----SFAV-ECEVTRNIRHRNLVKV 267
           +G G F +VYK     +   VA+K   + H   +K      A+ E ++ + + H N++ +
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEED-KRHKAPGNLNSLKRLNIAIDV 326
             A     F      +LV++FM             E D +          +K  ++ +  
Sbjct: 78  LDA-----FGHKSNISLVFDFM-------------ETDLEVI--------IKDNSLVLTP 111

Query: 327 ACV----------LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
           + +          L+YLH      I H DLKP+N+LLD+     ++DFG+A         
Sbjct: 112 SHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA--------- 159

Query: 377 TRSIGVEG--------TTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
            +S G           T  Y APE   G     YG   D+++ G +L E+     P
Sbjct: 160 -KSFGSPNRAYTHQVVTRWYRAPELLFGAR--MYGVGVDMWAVGCILAELLLR-VP 211

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 33/119 (27%), Positives = 52/119 (43%), Gaps = 10/119 (8%)

Query: 1   DLSNNNLSGTLSP---QLVGLSSLSIFNVSGNLL-SGAISNNFGSCTSLEQLDMHGNLFA 56
            L  N L             +SSL   +VS N L S A         S+  L++  N+  
Sbjct: 383 ILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441

Query: 57  GPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
           G +   L     ++VLDL  N +   IP+ +   + LQ LN++ N  +S +P +G+F  
Sbjct: 442 GSVFRCLPPK--VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VP-DGVFDR 495

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 23/98 (23%), Positives = 40/98 (40%), Gaps = 6/98 (6%)

Query: 19  SSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN-LFAGPIGSSLSSLRGLRVLDLSQN 77
                 ++S N +S     +    + L  L +  N + +          + L  LD+S N
Sbjct: 52  PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHV-FLFNQDLEYLDVSHN 110

Query: 78  NLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            L   I         L++L+LS+N+F+  LP+   F N
Sbjct: 111 RLQ-NIS--CCPMASLRHLDLSFNDFDV-LPVCKEFGN 144

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 47.6 bits (113), Expect = 8e-06
 Identities = 19/124 (15%), Positives = 42/124 (33%), Gaps = 13/124 (10%)

Query: 1   DLSNNNLSG-----TLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN-- 53
           ++ N  ++        +     L SL I +V   +   +    +     +    +  +  
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341

Query: 54  --LFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
             +      S          L+ +QN  +D + +  +  K LQ L L  N  ++   +  
Sbjct: 342 PFIHMVCPPS----PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVAL 397

Query: 112 IFKN 115
           + KN
Sbjct: 398 MTKN 401

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 26/131 (19%), Positives = 42/131 (32%), Gaps = 27/131 (20%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLS----GA-----------ISNN------ 38
            LS N++S  L    +  LS L +  +S N +                  +S+N      
Sbjct: 58  SLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNIS 116

Query: 39  FGSCTSLEQLDMHGNLFAG-PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLN 97
                SL  LD+  N F   P+     +L  L  L LS      ++   L     L    
Sbjct: 117 CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLD--LLPVAHLHLSC 173

Query: 98  LSYNNFESMLP 108
           +  +     + 
Sbjct: 174 ILLDLVSYHIK 184

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 26/107 (24%), Positives = 53/107 (49%), Gaps = 10/107 (9%)

Query: 1   DLSNNNLSGTLSPQLVGL-SSLSIFNVSGNLLSGAISNNFGSCT-SLEQLDMHGN-LFAG 57
           D+S N+L+     +      S+ + N+S N+L+G++   F      ++ LD+H N + + 
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIMSI 465

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIPE-FLAGFKFLQNLNLSYNNF 103
           P    ++ L+ L+ L+++ N L   +P+        LQ + L  N +
Sbjct: 466 PKD--VTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPW 509

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 45/249 (18%), Positives = 86/249 (34%), Gaps = 45/249 (18%)

Query: 212 LIGAGNFGSVYKGILFEST-TAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
            IG G FG +Y   +  S            +    +     E +  +       ++ +  
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 271 CSGV--------------DFQGNDFKALVYEFMANG-SLEEWMHPITEEDKRHKAPGNLN 315
              +              D  G  ++ ++ +    G  L         +           
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDL---------QKIYEANAKRF- 149

Query: 316 SLKR-LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD--DEMTAYVSDFGIA-RFLE 371
           S K  L +++ +  +L+Y+H        H D+K SN+LL+  +    Y+ D+G+A R+  
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY-- 204

Query: 372 AADEQTRS-------IGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD 424
              E              +GT  + + +   G   S  GD+   G  +++  TG  P +D
Sbjct: 205 -CPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263

Query: 425 MFKDNLNLR 433
             KD   +R
Sbjct: 264 NLKDPKYVR 272

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 22/124 (17%), Positives = 39/124 (31%), Gaps = 24/124 (19%)

Query: 1   DLSNNNLSGT----LSPQLVGLSSLSIFNVSGN--------LLSGAISNNFGSCTSLEQL 48
            + + + +       S  L     L    +S N         L   +       + L  L
Sbjct: 319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQP---GSVLRVL 375

Query: 49  DMHGNLF----AGPIGSSLSSLRGLRVLDLSQNNLSDE-IPEFLAGFK----FLQNLNLS 99
            +            + ++L +   LR LDLS N L D  I + +   +     L+ L L 
Sbjct: 376 WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLY 435

Query: 100 YNNF 103
              +
Sbjct: 436 DIYW 439

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 25/121 (20%), Positives = 44/121 (36%), Gaps = 18/121 (14%)

Query: 1   DLSNNNLSGT----LSPQLVGLSSLSIFNVSGNLLSG----AISNNFGSC-TSLEQLDMH 51
            L +  L+      +S  L    +L+  N+  N L       +     +    +++L + 
Sbjct: 34  RLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 93

Query: 52  GNLF----AGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGF-----KFLQNLNLSYNN 102
                    G + S+L +L  L+ L LS N L D   + L          L+ L L Y +
Sbjct: 94  NCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCS 153

Query: 103 F 103
            
Sbjct: 154 L 154

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 22/125 (17%), Positives = 38/125 (30%), Gaps = 26/125 (20%)

Query: 1   DLSNNNLS---------GTLSPQLVGLSSLSIFNVSGNLLS----GAISNNFGSCTSLEQ 47
            LS+N L          G L PQ      L    +    LS      +++   +    ++
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQ----CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKE 174

Query: 48  LDMHGNLF----AGPIGSSLSSLR-GLRVLDLSQNNLSDE----IPEFLAGFKFLQNLNL 98
           L +  N         +   L      L  L L    ++ +    +   +A    L+ L L
Sbjct: 175 LTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELAL 234

Query: 99  SYNNF 103
             N  
Sbjct: 235 GSNKL 239

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 28/124 (22%), Positives = 45/124 (36%), Gaps = 24/124 (19%)

Query: 1   DLSNNNLSGT----LSPQLVGLSSLSIFNVSGN--------LLSGAISNNFGSCTSLEQL 48
            L N  L+G     LS  L  L +L   ++S N        LL   + +       LE+L
Sbjct: 91  SLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDP---QCRLEKL 147

Query: 49  DMHGNLF----AGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLA-GFKF----LQNLNLS 99
            +           P+ S L +    + L +S N++++     L  G K     L+ L L 
Sbjct: 148 QLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLE 207

Query: 100 YNNF 103
               
Sbjct: 208 SCGV 211

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 21/126 (16%), Positives = 42/126 (33%), Gaps = 26/126 (20%)

Query: 1   DLSNNNLSGT----LSPQL-VGLSSLSIFNVSGNLLS----GAISNNFGSCTSLEQLDMH 51
            +SNN+++      L   L      L    +    ++      +     S  SL +L + 
Sbjct: 176 TVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALG 235

Query: 52  GNLFAGPIGSS---------LSSLRGLRVLDLSQNNLSDE----IPEFLAGFKFLQNLNL 98
            N     +G           L     LR L + +  ++ +    +   L   + L+ L+L
Sbjct: 236 SN----KLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSL 291

Query: 99  SYNNFE 104
           + N   
Sbjct: 292 AGNELG 297

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 48.8 bits (117), Expect = 3e-06
 Identities = 25/122 (20%), Positives = 38/122 (31%), Gaps = 18/122 (14%)

Query: 1   DLSNNNLSGT----LSPQLV-GLSSLSIFNVSGNLLSG----AISNNFGSCTSLEQLDMH 51
            L+ N L       L   L+     L    V     +       S+       L +L + 
Sbjct: 290 SLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQIS 349

Query: 52  GNLF----AGPIGSSL-SSLRGLRVLDLSQNNLSDE----IPEFLAGFKFLQNLNLSYNN 102
            N         +   L      LRVL L+  ++SD     +   L     L+ L+LS N 
Sbjct: 350 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 409

Query: 103 FE 104
             
Sbjct: 410 LG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 48.0 bits (115), Expect = 4e-06
 Identities = 21/124 (16%), Positives = 39/124 (31%), Gaps = 24/124 (19%)

Query: 1   DLSNNNLS----GTLSPQLVGLSSLSIFNVSGN--------LLSGAISNNFGSCTSLEQL 48
            L +  ++      L   +   +SL    +  N         L   + +     + L  L
Sbjct: 205 KLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLH---PSSRLRTL 261

Query: 49  DMHGNLF----AGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLA-GFKF----LQNLNLS 99
            +          G +   L +   L+ L L+ N L DE    L          L++L + 
Sbjct: 262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321

Query: 100 YNNF 103
             +F
Sbjct: 322 SCSF 325

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 27/106 (25%), Positives = 41/106 (38%), Gaps = 5/106 (4%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN-LFAGP 58
           DLS+N+L  TL       L +L +  +  N +     N F     L++L +  N +   P
Sbjct: 94  DLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152

Query: 59  IG--SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNN 102
           +      + L  L +LDLS N L       L          L  +N
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 40.6 bits (95), Expect = 8e-04
 Identities = 26/116 (22%), Positives = 40/116 (34%), Gaps = 27/116 (23%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN-LFAGPI 59
           DLS+NNLS  L  +                            T+L  L +  N L     
Sbjct: 45  DLSHNNLS-RLRAEWT----------------------PTRLTNLHSLLLSHNHLNFISS 81

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKN 115
            +    +  LR LDLS N+L        +  + L+ L L  N+    +     F++
Sbjct: 82  EA-FVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VD-RNAFED 134

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 27/181 (14%), Positives = 61/181 (33%), Gaps = 40/181 (22%)

Query: 210 ENLIGAGNFGSVYKGILFESTTA--------VAVKV----------FNVLHHDASKSFAV 251
           ++     N G +Y+     + T          ++K+           N     A      
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANG-SLEEWMHPITEEDKRHKA 310
           + +   +     +        GV    + ++ LV   +  G SL         +     +
Sbjct: 107 KWKKLYSTPLLAIPTCM--GFGV--HQDKYRFLVLPSL--GRSL---------QSALDVS 151

Query: 311 PGNLNSLKR-LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL--DDEMTAYVSDFGIA 367
           P ++ S +  L +A  +   L++LH +      H ++   NI +  +D+    ++ +G A
Sbjct: 152 PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208

Query: 368 R 368
            
Sbjct: 209 F 209

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 51.0 bits (123), Expect = 3e-07
 Identities = 51/227 (22%), Positives = 89/227 (39%), Gaps = 55/227 (24%)

Query: 213 IGAGNFGSVYKGILFESTTA-VAVKVFNVLHHDASK----SFAV-ECEVTRNIRHRNLVK 266
           IG G +G VYK     +     A+K    +  +       S  + E  + + ++H N+VK
Sbjct: 10  IGEGTYGVVYKAQ--NNYGETFALK---KIRLEKEDEGIPSTTIREISILKELKHSNIVK 64

Query: 267 VFTACSGVD-FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           ++      D         LV+E + +  L++ +          +      + K   + + 
Sbjct: 65  LY------DVIHTKKRLVLVFEHL-DQDLKKLL-------DVCEGGLESVTAKSFLLQLL 110

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG- 384
               + Y H      + H DLKP N+L++ E    ++DFG+A          R+ G+   
Sbjct: 111 NG--IAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA----------RAFGIPVR 155

Query: 385 -------TTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
                  T  Y AP+  MG +   Y    D++S G +  EM  G  P
Sbjct: 156 KYTHEIVTLWYRAPDVLMGSK--KYSTTIDIWSVGCIFAEMVNG-TP 199

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 23/120 (19%), Positives = 41/120 (34%), Gaps = 20/120 (16%)

Query: 1   DLSNNNLSG----TLSPQLVGLSSL-----SIFNVSGNLLSGAISNNFGSCTSLEQLDMH 51
           +L++  L      TL P  +    L     S+   +   L   + ++      +  L + 
Sbjct: 107 NLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHD---QCQITTLRLS 163

Query: 52  GNLF----AGPIGSSLSSLRGLRVLDLSQNNLSDE----IPEFLAGFKFLQNLNLSYNNF 103
            N         +   L+    +  L L    L DE    +   L   + LQ LN++YN  
Sbjct: 164 NNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGA 223

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 21/120 (17%), Positives = 39/120 (32%), Gaps = 17/120 (14%)

Query: 1   DLSNNNLSGT----LSPQL-VGLSSLSIFNVSGNLLSG----AISNNFGSCTSLEQLDMH 51
            L  N+L       L   L      ++   +S N L+      +       TS+  L + 
Sbjct: 132 GLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLL 191

Query: 52  GNLF----AGPIGSSLSSLRGLRVLDLSQNNLSDE----IPEFLAGFKFLQNLNLSYNNF 103
                      + + L   R L+ L+++ N   D     +         L+ L+L +N  
Sbjct: 192 HTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 22/118 (18%), Positives = 42/118 (35%), Gaps = 16/118 (13%)

Query: 1   DLSNNNLSGT----LSPQLVGLSSLSIFNVSGNLLS----GAISNNFGSCTSLEQLDMHG 52
            LSNN L+      L   L G +S++  ++    L       ++        L++L++  
Sbjct: 161 RLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAY 220

Query: 53  NLF----AGPIGSSLSSLRGLRVLDLSQNNLSDE----IPEFLAGFKFLQNLNLSYNN 102
           N      A  +  +      L +L L  N LS E    + +     +    + +S   
Sbjct: 221 NGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTE 278

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.5 bits (116), Expect = 4e-07
 Identities = 21/80 (26%), Positives = 31/80 (38%), Gaps = 6/80 (7%)

Query: 33  GAISNNFGSCTSLEQLDMHGNLFAGPIGS--SLSSLRGLRVLDLSQNNLSDEIPEFLAGF 90
           G +         LE L          + S  +L  L  L+ L+LS N +S  +       
Sbjct: 32  GKLEGLTDEFEELEFLSTINVG----LTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKC 87

Query: 91  KFLQNLNLSYNNFESMLPIE 110
             L +LNLS N  + +  IE
Sbjct: 88  PNLTHLNLSGNKIKDLSTIE 107

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.8 bits (109), Expect = 4e-06
 Identities = 20/83 (24%), Positives = 35/83 (42%), Gaps = 3/83 (3%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
              N  L+ +++  L  L+ L    +S N +SG +      C +L  L++ GN       
Sbjct: 48  STINVGLT-SIA-NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLST 105

Query: 61  -SSLSSLRGLRVLDLSQNNLSDE 82
              L  L  L+ LDL    +++ 
Sbjct: 106 IEPLKKLENLKSLDLFNCEVTNL 128

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 48.6 bits (116), Expect = 5e-07
 Identities = 20/80 (25%), Positives = 33/80 (41%), Gaps = 6/80 (7%)

Query: 33  GAISNNFGSCTSLEQLDMHGNLFAGPIGS--SLSSLRGLRVLDLSQNNLSDEIPEFLAGF 90
           G I        +LE L +        + S  +L  L  L+ L+LS+N +   +       
Sbjct: 39  GKIEGLTAEFVNLEFLSLINVG----LISVSNLPKLPKLKKLELSENRIFGGLDMLAEKL 94

Query: 91  KFLQNLNLSYNNFESMLPIE 110
             L +LNLS N  + +  +E
Sbjct: 95  PNLTHLNLSGNKLKDISTLE 114

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.1 bits (107), Expect = 9e-06
 Identities = 20/83 (24%), Positives = 32/83 (38%), Gaps = 3/83 (3%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L N  L  ++S  L  L  L    +S N + G +        +L  L++ GN       
Sbjct: 55  SLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDIST 112

Query: 61  -SSLSSLRGLRVLDLSQNNLSDE 82
              L  L  L+ LDL    +++ 
Sbjct: 113 LEPLKKLECLKSLDLFNCEVTNL 135

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 50.1 bits (120), Expect = 7e-07
 Identities = 41/172 (23%), Positives = 63/172 (36%), Gaps = 48/172 (27%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV------K 266
           IG+G+FG +Y G    +   VA+K                 E     +H  L       K
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIK----------------LE-CVKTKHPQLHIESKIYK 59

Query: 267 VFTACSGV----DF-QGNDFKALVYEFMANG-SLEEWMHPITEEDKRHKAPGNLNSLKR- 319
           +     G+          D+  +V E +  G SLE         D  +       SLK  
Sbjct: 60  MMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLE---------DLFNFCSRKF-SLKTV 107

Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIAR 368
           L +A  +   ++Y+H        H D+KP N L+         Y+ DFG+A+
Sbjct: 108 LLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 49.9 bits (120), Expect = 8e-07
 Identities = 48/239 (20%), Positives = 85/239 (35%), Gaps = 74/239 (30%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK----SFAV-ECEVTRNIRHRNLVKV 267
           +G G +G VYK I   +   VA+K    +  +  +      A+ E  + + ++HRN++++
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKR---IRLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98

Query: 268 FTACSGVD-FQGNDFKALVYEFMANGSLEEWMHPITEED-KRHKAPGNLNSLKRLNIAID 325
                       N    L++E+              E D K++     ++    +++   
Sbjct: 99  K------SVIHHNHRLHLIFEYA-------------ENDLKKY-----MDKNPDVSMR-V 133

Query: 326 VACVLK-------YLHLDCQPPIAHCDLKPSNILLDDEMTAY-----VSDFGIARFLEAA 373
           +   L        + H        H DLKP N+LL     +      + DFG+AR     
Sbjct: 134 IKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA---- 186

Query: 374 DEQTRSIGVEG--------TTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP 421
                  G+          T  Y  PE  +G     Y    D++S   +  EM     P
Sbjct: 187 ------FGIPIRQFTHEIITLWYRPPEILLGSR--HYSTSVDIWSIACIWAEMLMK-TP 236

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 51/263 (19%), Positives = 89/263 (33%), Gaps = 75/263 (28%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-----HRNLVKV 267
           +G G+F +V+     +    VA+KV     H    +   E  + +++R       N   V
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103

Query: 268 FTACSGVDFQGNDFK--ALVYEFMANGSLEEWMHPITEEDKRHKAPG-NLNSLKRLNIAI 324
                     G +     +V+E + +  L +W+        +    G  L  +K+  I  
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWI-------IKSNYQGLPLPCVKK--IIQ 153

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILL------------------------------- 353
            V   L YLH  C+  I H D+KP NILL                               
Sbjct: 154 QVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 354 ------------------DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM 395
                              +++   ++D G A ++      T  I    T  Y + E  +
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH--KHFTEDI---QTRQYRSLEVLI 266

Query: 396 GHEVSSYGDVYSFGILLLEMFTG 418
           G   ++  D++S   +  E+ TG
Sbjct: 267 GSGYNTPADIWSTACMAFELATG 289

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 50.0 bits (118), Expect = 1e-06
 Identities = 21/116 (18%), Positives = 40/116 (34%), Gaps = 13/116 (11%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNF------GSCTSLEQLDMHGNL 54
            L ++ +   L   L  L  L ++    +       N F          +L+ L +    
Sbjct: 204 GLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263

Query: 55  FAGPIGSSLSS---LRGLRVLDLSQNNLSDE----IPEFLAGFKFLQNLNLSYNNF 103
               +         L  L  +D+S   L+DE    + + +   K L+ +N+ YN  
Sbjct: 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 42.6 bits (99), Expect = 2e-04
 Identities = 17/98 (17%), Positives = 37/98 (37%), Gaps = 12/98 (12%)

Query: 7   LSGTLSPQL--VGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLF----AGPIG 60
            S    P L  +G+      NV   +   +          LE +D+   +     A  + 
Sbjct: 246 FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP-----QLETMDISAGVLTDEGARLLL 300

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLA-GFKFLQNLN 97
             +  ++ L+ +++  N LSDE+ + L        +++
Sbjct: 301 DHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 48/229 (20%), Positives = 81/229 (35%), Gaps = 55/229 (24%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV------K 266
           IG G+FG +++G    +   VA+K                 E  R      L       K
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIK----------------FE-PRRSDAPQLRDEYRTYK 60

Query: 267 VFTACSGV----DF-QGNDFKALVYEFMANG-SLEEWMHPITEEDKRHKAPGNLNSLKR- 319
           +   C+G+     F Q      LV + +  G SL         ED          S+K  
Sbjct: 61  LLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSL---------EDLLDLCGRKF-SVKTV 108

Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA-----YVSDFGIA-RFLEAA 373
              A  +   ++ +H      + + D+KP N L+    +      YV DFG+   + +  
Sbjct: 109 AMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165

Query: 374 DEQ----TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
            +Q         + GT  Y++    +G E S   D+ + G + +    G
Sbjct: 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 38/168 (22%), Positives = 62/168 (36%), Gaps = 38/168 (22%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACS 272
           IG GNFG +  G    +   VA+K+       +           +        K   +  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAP--------QLHLEYRFYKQLGSGD 65

Query: 273 GV----DF-QGNDFKALVYEFMANG-SLEEWMHPITEEDKRHKAPGNLNSLKR-LNIAID 325
           G+     F     + A+V E +  G SLE         D          SLK  L IAI 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL--GPSLE---------DLFDLCDRTF-SLKTVLMIAIQ 113

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILL-----DDEMTAYVSDFGIAR 368
           +   ++Y+H      + + D+KP N L+       +   ++ DF +A+
Sbjct: 114 LISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 52/226 (23%), Positives = 86/226 (38%), Gaps = 51/226 (22%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNL---VKVFT 269
           IG+G+FG +Y G   ++   VA+K                 E     +H  L    K++ 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIK----------------LE-NVKTKHPQLLYESKIYR 57

Query: 270 ACSGVDF--------QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR-L 320
              G              D+  LV + +   SLE         D  +     L SLK  L
Sbjct: 58  ILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE---------DLFNFCSRKL-SLKTVL 106

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAYVSDFGIA-RFLEAADEQ 376
            +A  +   ++++H        H D+KP N L+         Y+ DFG+A ++ + +  Q
Sbjct: 107 MLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163

Query: 377 ----TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG 418
                 +  + GT  Y +    +G E S   D+ S G +L+    G
Sbjct: 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 47.2 bits (111), Expect = 7e-06
 Identities = 32/197 (16%), Positives = 56/197 (28%), Gaps = 35/197 (17%)

Query: 203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKV--------FNVLHHDASKSFAVECE 254
            T+       IG G FG V++ I     T VA+K+         N  H    +    E  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 255 VTRNIRH-----RNLVKVFTACSGVDF-QGNDFKALVYEFMA----NGSLEEWMHPITE- 303
           +++ +        N  + F   + V   QG+    L+  +       GS  +      + 
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 304 ------------EDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNI 351
                        D         +     +I   +   L       +    H DL   N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNV 193

Query: 352 LLDDEMTAYVSDFGIAR 368
           LL       +      +
Sbjct: 194 LLKKTSLKKLHYTLNGK 210

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 45.8 bits (109), Expect = 8e-06
 Identities = 28/104 (26%), Positives = 47/104 (45%), Gaps = 5/104 (4%)

Query: 1   DLSNNNLSGTLSPQL-VGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN-LFAGP 58
           DLSNN +S  L+P    GL SL+   + GN ++    + F    SL+ L ++ N +    
Sbjct: 62  DLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLR 120

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNN 102
           + +    L  L +L L  N L        +  + +Q ++L   N
Sbjct: 121 VDA-FQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHL-AQN 162

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 24/104 (23%), Positives = 39/104 (37%), Gaps = 5/104 (4%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN-LFAGP 58
           + SNN ++  +      G S ++   ++ N L       F    SL+ L +  N +    
Sbjct: 63  NFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVG 121

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNN 102
              S   L  +R+L L  N ++   P        L  LNL   N
Sbjct: 122 ND-SFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNL-LAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 22/118 (18%), Positives = 41/118 (34%), Gaps = 7/118 (5%)

Query: 1   DLSNNNLSGTLSPQLV--GLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGP 58
            L+NN  +  L    +   L  L   N S N ++      F   + + ++ +  N     
Sbjct: 38  RLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENV 96

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPEFL-AGFKFLQNLNLSYNNFESMLPIEGIFKN 115
                  L  L+ L L  N ++  +      G   ++ L+L  N   + +   G F  
Sbjct: 97  QHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITT-VA-PGAFDT 151

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 17/119 (14%), Positives = 35/119 (29%), Gaps = 7/119 (5%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDM-HGNLFAG 57
                 L   +      G   L    +S N +   I  + F +   L ++ +   N    
Sbjct: 36  RFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY 94

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIPEFL-AGFKFLQNLNLSYNNFESMLPIEGIFKN 115
               +  +L  L+ L +S   +   +P+           L++  N     +     F  
Sbjct: 95  INPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIE-RNSFVG 151

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 17/102 (16%), Positives = 31/102 (30%), Gaps = 6/102 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDMHGNLFAGPI 59
            L+ N +    +    G     +     N L   + N+ F   +    LD+         
Sbjct: 160 WLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLP 218

Query: 60  GSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYN 101
              L +L+ LR           ++P        L   +L+Y 
Sbjct: 219 SYGLENLKKLRARSTYNLK---KLPTL-EKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 28/120 (23%), Positives = 43/120 (35%), Gaps = 5/120 (4%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI 59
            +   N    ++P+    L +L    +S   +      +         LD+  N+    I
Sbjct: 85  RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI 144

Query: 60  GS-SLSSLRG-LRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNAS 117
              S   L     +L L++N +  EI         L  LNLS NN    LP   +F  AS
Sbjct: 145 ERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELP-NDVFHGAS 202

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 23/114 (20%), Positives = 41/114 (35%), Gaps = 6/114 (5%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSS-LSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGP 58
           D+ +N    T+     VGLS    I  ++ N +    ++ F      E      N     
Sbjct: 134 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEEL 193

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLN-LSYNNFESMLPIEG 111
                    G  +LD+S+  +   +P    G + L+ L   S  N + +  +E 
Sbjct: 194 PNDVFHGASGPVILDISRTRIH-SLPS--YGLENLKKLRARSTYNLKKLPTLEK 244

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.7 bits (105), Expect = 4e-05
 Identities = 17/92 (18%), Positives = 26/92 (28%), Gaps = 2/92 (2%)

Query: 13  PQLVGLSSLSIFNVSGNLLSGAISNN-FGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRV 71
             L G  +L+   +        +          L  L +  +        +      L  
Sbjct: 25  HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84

Query: 72  LDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNF 103
           L+LS N L   +         LQ L LS N  
Sbjct: 85  LNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.8 bits (100), Expect = 2e-04
 Identities = 21/94 (22%), Positives = 34/94 (36%), Gaps = 5/94 (5%)

Query: 38  NFGSCTSLEQLDMHGNLFAGPIGS-SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNL 96
           +     +L +L +        +    L  L  LR L + ++ L    P+       L  L
Sbjct: 26  HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85

Query: 97  NLSYNNFESMLPIEGIFKNASATSVF--GNKKLC 128
           NLS+N  ES+       +  S   +   GN   C
Sbjct: 86  NLSFNALESLSW--KTVQGLSLQELVLSGNPLHC 117

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 25/123 (20%), Positives = 45/123 (36%), Gaps = 20/123 (16%)

Query: 1   DLSNNNLSGT----LSPQLVGL-SSLSIFNVSGNLLSG----AISNNFGSC-TSLEQLDM 50
           DL  N+ S             L +S++  N+ GN L       +     +   ++  L++
Sbjct: 115 DLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNL 174

Query: 51  HGNLF----AGPIGSSLSSL-RGLRVLDLSQNNLSDE----IPEFLAGFK-FLQNLNLSY 100
            GN         +   L+S+   +  LDLS N L  +    +    +     + +LNL  
Sbjct: 175 RGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCL 234

Query: 101 NNF 103
           N  
Sbjct: 235 NCL 237

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 27/125 (21%), Positives = 49/125 (39%), Gaps = 19/125 (15%)

Query: 1   DLSNNNLSGT----LSPQLVGL-SSLSIFNVSGNLLS----GAISNNFGSC-TSLEQLDM 50
           +L  N+L       L   L  + ++++  N+ GN L+      ++    S   S+  LD+
Sbjct: 144 NLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDL 203

Query: 51  HGNLF----AGPIGSSLSSL-RGLRVLDLSQNNLSDE----IPEFLAGFKFLQNLNLSYN 101
             NL        +    SS+   +  L+L  N L       +       K LQ + L Y+
Sbjct: 204 SANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYD 263

Query: 102 NFESM 106
             ++M
Sbjct: 264 IVKNM 268

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 28/123 (22%), Positives = 49/123 (39%), Gaps = 20/123 (16%)

Query: 1   DLSNNNLSGT----LSPQLVGL-SSLSIFNVSGNLLSGAISNNFGS-----CTSLEQLDM 50
           DLS NNL       L        +S++  N+SGN L    S+           ++  L++
Sbjct: 28  DLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNL 87

Query: 51  HGNLF----AGPIGSSLSSL-RGLRVLDLSQNNLSDEIPEFLAGF-----KFLQNLNLSY 100
            GN      +  +  +L+++   + VLDL  N+ S +               + +LNL  
Sbjct: 88  SGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRG 147

Query: 101 NNF 103
           N+ 
Sbjct: 148 NDL 150

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 16/123 (13%), Positives = 41/123 (33%), Gaps = 23/123 (18%)

Query: 1   DLSNNNLSGTLSPQLVGL-----SSLSIFNVSGNLLSG----AISNNFGSCTSLEQLDMH 51
           DLS N L      +L  +     + +   N+  N L G     +     S   L+ + + 
Sbjct: 202 DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLD 261

Query: 52  GNLF-------AGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLA------GFKFLQNLNL 98
            ++           +G++  +++ + ++D +   +       ++        K     +L
Sbjct: 262 YDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGK-ADVPSL 320

Query: 99  SYN 101
              
Sbjct: 321 LNQ 323

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 36/117 (30%), Positives = 52/117 (44%), Gaps = 10/117 (8%)

Query: 1   DLSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG-P 58
           DL +N LS +L  +    L+ L +  ++ N L    +  F    +LE L +  N     P
Sbjct: 43  DLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALP 101

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPE--FLAGFKFLQNLNLSYNNFESMLPIEGIF 113
           IG     L  L  L L +N L   +P   F      L  L+L YN  +S LP +G+F
Sbjct: 102 IG-VFDQLVNLAELRLDRNQLK-SLPPRVF-DSLTKLTYLSLGYNELQS-LP-KGVF 153

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 17/90 (18%), Positives = 28/90 (31%), Gaps = 1/90 (1%)

Query: 13  PQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVL 72
           PQL  L +          +   +S     C  L  L    +     + +  S    L  L
Sbjct: 235 PQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTL 294

Query: 73  DLSQNNLSDE-IPEFLAGFKFLQNLNLSYN 101
           +LS   +    + + L     LQ L +   
Sbjct: 295 NLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.8 bits (97), Expect = 6e-04
 Identities = 58/461 (12%), Positives = 120/461 (26%), Gaps = 164/461 (35%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
                ++        V   +    +V  ++    +S         E++D   ++      
Sbjct: 15  QYQYKDILSVFEDAFV--DNFDCKDVQ-DMPKSILSK--------EEID---HIIMSK-- 58

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
            ++S     R+     +   + + +F+        L ++Y    S +  E   + +  T 
Sbjct: 59  DAVSGTL--RLFWTLLSKQEEMVQKFVEEV-----LRINYKFLMSPIKTEQR-QPSMMTR 110

Query: 121 VFGNK--KLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLLVLTLALSSLFCRLM 178
           ++  +  +L      F         +K N S L            L L  AL  L     
Sbjct: 111 MYIEQRDRLYNDNQVF---------AKYNVSRLQP---------YLKLRQALLEL----- 147

Query: 179 CMKKRGNPTPSISFPYVSYRMLYNATKGF----------SSENLIGAGNFGSVYKGILFE 228
                  P  ++    +   +      G            S  +    +F   +  +   
Sbjct: 148 ------RPAKNV----LIDGV-----LGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNC 192

Query: 229 STTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEF 288
           ++    +++   L +    ++    + + NI+ R                +  +A +   
Sbjct: 193 NSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI---------------HSIQAELRRL 237

Query: 289 MANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV--ACVLKYLHLDCQPPIAHCDL 346
           +                K ++     N L  L    +V  A      +L C+        
Sbjct: 238 LK--------------SKPYE-----NCLLVLL---NVQNAKAWNAFNLSCK-------- 267

Query: 347 KPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVY 406
               ILL    T       +  FL AA     S               + H   +     
Sbjct: 268 ----ILL---TT---RFKQVTDFLSAATTTHIS---------------LDHHSMTLTPDE 302

Query: 407 SFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEI 447
              +LL   +   RP D                LP      
Sbjct: 303 VKSLLLK--YLDCRPQD----------------LPREVLTT 325

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.0 bits (95), Expect = 8e-04
 Identities = 51/308 (16%), Positives = 88/308 (28%), Gaps = 107/308 (34%)

Query: 222 YKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF---- 276
           YK IL     A  V  F+     D  KS   + E+       +++    A SG       
Sbjct: 18  YKDILSVFEDAF-VDNFDCKDVQDMPKSILSKEEI------DHIIMSKDAVSGTLRLFWT 70

Query: 277 ---QGNDFKALVYEFMANGSLE---EW-MHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
              +  +   +V +F+    L    ++ M PI  E ++      +   +R  +  D    
Sbjct: 71  LLSKQEE---MVQKFV-EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVF 126

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
            KY ++    P     L+    LL+      V                    +       
Sbjct: 127 AKY-NVSRLQPYL--KLR--QALLELRPAKNV-------------------LI------- 155

Query: 390 APEYGMGHEVSSYGDVYSFG--ILLLEMFTGLRPSD--DMFKDN---LNLRNCVKSALPE 442
               G+       G     G   + L++                   LNL+NC       
Sbjct: 156 ---DGVL------G----SGKTWVALDV---CLSYKVQCKMDFKIFWLNLKNC------N 193

Query: 443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK-----INDVEPRLR-LIKK 496
             E +            LE L  +    +  +     +        I+ ++  LR L+K 
Sbjct: 194 SPETV------------LEMLQKLLYQ-IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS 240

Query: 497 K-----LL 499
           K     LL
Sbjct: 241 KPYENCLL 248

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	502
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.81
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.76
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.76
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.74
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.74
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.74
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.73
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.72
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.72
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.71
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.71
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.7
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.7
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.69
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.69
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.69
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.67
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.66
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.66
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.66
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.66
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.66
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.66
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.65
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.65
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.65
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.65
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.64
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.63
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.62
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.62
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.62
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.62
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.62
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.61
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.61
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.6
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.6
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.6
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.6
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.59
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.58
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.58
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.58
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.58
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.57
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.57
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.57
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.57
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.56
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.56
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.56
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.56
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.55
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.55
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.55
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.55
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.53
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.53
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.53
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.53
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.52
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.52
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.52
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.52
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.52
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.51
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.51
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.51
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.51
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.51
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.51
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.51
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.51
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.51
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.5
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.5
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.5
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.5
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.5
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.5
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.5
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.5
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.49
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.49
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.49
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.49
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.48
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.48
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.48
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.48
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.48
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.47
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.47
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.47
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.46
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.46
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.46
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.46
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.45
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.45
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.44
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.44
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.44
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.44
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.42
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.41
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.41
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.4
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.39
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.39
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.38
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.37
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.36
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.32
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.31
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.3
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.3
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.27
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.24
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.23
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.23
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.22
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.22
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.22
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.2
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.2
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.19
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.16
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.16
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.13
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.12
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.96
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.87
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.87
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.85
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.76
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.74
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.57
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.54
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.52
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.52
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.47
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.44
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.4
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.37
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.3
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.22
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.22
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.08
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.05
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.96
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	97.95
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	97.94
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.83
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.82
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.81
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.72
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.69
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.52
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.52
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.49
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.45
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.24
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.2
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	97.13
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	97.08
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.0
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.97
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.93
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	96.89
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	96.85
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	96.8
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.73
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	96.68
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	96.68
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.64
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.54
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.49
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.42
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.26
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.03
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.03
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.97
3mes_A	424	Choline kinase; malaria, structural genomics, stru	92.14
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.29
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.84

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-57  Score=438.54  Aligned_cols=265  Identities=26%  Similarity=0.393  Sum_probs=206.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .+++...++||+|+||+||+|++.   ..||||+++....  ...+.|.+|++++++++|||||+++|+|..      +.
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence            356777889999999999999653   3599999875432  334679999999999999999999998732      35


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++|||||++|+|.++++.         ....++|.+++.|+.|+|.||+|||   +++|+||||||+|||+++++.+||
T Consensus       106 ~~iVmEy~~gGsL~~~l~~---------~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki  173 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHV---------QETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKI  173 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHT---------SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEE
T ss_pred             EEEEEEcCCCCCHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEE
Confidence            7999999999999999953         3456999999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCC---CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG---HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +|||+|+...............||+.|||||++.+   +.|+.++|||||||++|||+||+.||....... .+...+..
T Consensus       174 ~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~  252 (307)
T 3omv_A          174 GDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGR  252 (307)
T ss_dssp             CCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHT
T ss_pred             eeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhc
Confidence            99999987654443334455789999999999864   468999999999999999999999997632111 11111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE  500 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~  500 (502)
                      ..       ..+...   ....+++..+.+|+.+||+.||++||||+||++.|+.++..+++
T Consensus       253 ~~-------~~p~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          253 GY-------ASPDLS---KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             TC-------CCCCST---TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             CC-------CCCCcc---cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence            11       111111   11235667888999999999999999999999999999876654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.8e-58  Score=441.71  Aligned_cols=270  Identities=24%  Similarity=0.413  Sum_probs=215.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      ++|...+.||+|+||+||+|++.     .++..||||+++.......++|.+|++++++++|||||+++|+|..     +
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----G   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----C
Confidence            46777889999999999999764     3578999999987655667889999999999999999999999753     3


Q ss_pred             cceeEEeeeccCCChhhhccCCchhh---hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEED---KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE  356 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~  356 (502)
                      +..++|||||++|+|.++++......   ........++|.+++.|+.|+|+||+|||   +++|+||||||+|||++.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCC
Confidence            47899999999999999996432111   01133567999999999999999999999   8999999999999999999


Q ss_pred             CcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHH
Q 046112          357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~  435 (502)
                      +.+||+|||+|+.....+.........||+.|||||++.+..++.++|||||||++|||+| |+.||.....  ..+...
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~  242 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIEC  242 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH
Confidence            9999999999987655544444445678999999999999999999999999999999999 9999976321  112222


Q ss_pred             HHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      +....           ..   +.+..++..+.+|+.+||+.||++||||+||++.|+++.+.-
T Consensus       243 i~~~~-----------~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          243 ITQGR-----------VL---QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             HHHTC-----------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHcCC-----------CC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            21110           00   112245677889999999999999999999999999987653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.6e-57  Score=443.41  Aligned_cols=269  Identities=25%  Similarity=0.411  Sum_probs=206.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      ++|...++||+|+||+||+|++.     .+++.||||+++.......++|.+|++++++++|||||+++|+|..     .
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----G  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence            45667789999999999999764     3588999999986655566789999999999999999999999753     3


Q ss_pred             cceeEEeeeccCCChhhhccCCchhh-----hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEED-----KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                      +..++|||||++|+|.++++......     .......+++|.+++.|+.|+|+||+|||   +++|+||||||+|||++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEEC
Confidence            47899999999999999996532111     01123467999999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchH
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLR  433 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~  433 (502)
                      +++.+||+|||+|+.+...+.........||+.|||||++.+..++.++|||||||++|||+| |+.||......  ...
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~  270 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAI  270 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHH
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHH
Confidence            999999999999997765544444455779999999999999999999999999999999999 99999763211  122


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ..+....           .   .+.+..++..+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus       271 ~~i~~g~-----------~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          271 DCITQGR-----------E---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHHTC-----------C---CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHcCC-----------C---CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            2111110           0   011224567788999999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6e-57  Score=435.27  Aligned_cols=264  Identities=24%  Similarity=0.387  Sum_probs=210.0

Q ss_pred             CCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          207 FSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      +...+.||+|+||+||+|.+.     .+++.||||+++.... ...++|.+|+.++++++|||||+++|+|..     ++
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-----~~  102 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-----DQ  102 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-----CC
Confidence            445678999999999999763     3678999999975433 345789999999999999999999999753     34


Q ss_pred             ceeEEeeeccCCChhhhccCCchhh------hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          281 FKALVYEFMANGSLEEWMHPITEED------KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                      ..++|||||++|||.++|+......      ........++|.+++.|+.|||+||+|||   +.+|+||||||+|||++
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEEC
Confidence            7899999999999999996422110      00122356999999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchH
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLR  433 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~  433 (502)
                      +++.+||+|||+|+.+...+.........||+.|||||++.++.++.++|||||||++|||+| |+.||.+...  .++.
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~  257 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVV  257 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHH
Confidence            999999999999997765554444456779999999999999999999999999999999999 8999976322  1222


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      +.+...           ..   .+.+.+|+..+.+|+.+||+.||++||||+||++.|+.+
T Consensus       258 ~~i~~~-----------~~---~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          258 EMIRNR-----------QV---LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHTT-----------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHcC-----------CC---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            222111           00   111235677889999999999999999999999998753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.2e-54  Score=418.20  Aligned_cols=273  Identities=23%  Similarity=0.301  Sum_probs=201.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|...+.||+|+||+||+|++  +|+.||||+++... .....+..|+..+.+++|||||+++++|...+ ......+|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEE
Confidence            3466778999999999999977  68999999987432 11222344566667899999999999985422 12236799


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceeecCCCCCeeeCCCCcE
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLD-----CQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      |||||++|+|.++++.           ..++|..+++++.|+|.||+|||..     ..++|+||||||+|||+|.++.+
T Consensus        79 V~Ey~~~gsL~~~l~~-----------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~  147 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             EEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             EecCCCCCcHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence            9999999999999953           3489999999999999999999943     13499999999999999999999


Q ss_pred             EEeeeccceeccccccc--ceecccccccccccCcccCCC------ccCccccchhHHHHHHHHHhCCCCCcccccccc-
Q 046112          360 YVSDFGIARFLEAADEQ--TRSIGVEGTTGYIAPEYGMGH------EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL-  430 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~-  430 (502)
                      ||+|||+|+........  .......||+.|||||++.+.      .++.++|||||||++|||+||+.|+........ 
T Consensus       148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p  227 (303)
T 3hmm_A          148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence            99999999877544322  122346799999999998764      578899999999999999999887754221111 


Q ss_pred             ---------chHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          431 ---------NLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       431 ---------~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                               ...+......    ....++..+.... ..+++..+.+|+.+||+.||++||||+||++.|+++.++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~----~~~~rp~~p~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          228 YYDLVPSDPSVEEMRKVVC----EQKLRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHT----TSCCCCCCCGGGG-SSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chhcccccchHHHHHHHHh----cccCCCCCCcccc-chHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                     1111111111    0111111111111 236778899999999999999999999999999998765

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.5e-55  Score=430.26  Aligned_cols=277  Identities=21%  Similarity=0.290  Sum_probs=218.8

Q ss_pred             HhccCCCCCCcccccCCceEEEEEEcC-----CCeEEEEEEecccCc-chhHHHHHHHHHHhcCCC-Cccceeeeccccc
Q 046112          202 NATKGFSSENLIGAGNFGSVYKGILFE-----STTAVAVKVFNVLHH-DASKSFAVECEVTRNIRH-RNLVKVFTACSGV  274 (502)
Q Consensus       202 ~~t~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~  274 (502)
                      ...++|...+.||+|+||+||+|.+..     .++.||||+++.... ...+.|.+|++++.+++| ||||+++|+|.. 
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~-  139 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-  139 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe-
Confidence            345678889999999999999998754     347899999975433 335679999999999965 899999999743 


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhhh------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEEDK------RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKP  348 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~  348 (502)
                         .+...++|||||++|+|.++++.......      .......+++.+++.++.|||+||+|||   +++|+||||||
T Consensus       140 ---~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~  213 (353)
T 4ase_A          140 ---PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA  213 (353)
T ss_dssp             ---TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             ---cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCc
Confidence               33468999999999999999964221100      0112456899999999999999999999   89999999999


Q ss_pred             CCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccc
Q 046112          349 SNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFK  427 (502)
Q Consensus       349 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~  427 (502)
                      +|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+...
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999997765555455556779999999999999999999999999999999998 9999976322


Q ss_pred             cccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 046112          428 DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE  500 (502)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~  500 (502)
                      .. .+...+.....              ...+..++..+.+++.+||+.||++||||+|+++.|+.+.+...+
T Consensus       294 ~~-~~~~~i~~g~~--------------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~  351 (353)
T 4ase_A          294 DE-EFCRRLKEGTR--------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ  351 (353)
T ss_dssp             SH-HHHHHHHHTCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC-
T ss_pred             HH-HHHHHHHcCCC--------------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhC
Confidence            11 12222221110              011123456788999999999999999999999999998775443

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.9e-54  Score=421.21  Aligned_cols=250  Identities=22%  Similarity=0.294  Sum_probs=206.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      +.|+..+.||+|+||+||+|.+..+|+.||||+++.......+.+.+|++++++++|||||++++++     ..++..+|
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence            4588889999999999999999999999999999765555567789999999999999999999995     44558999


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      |||||++|+|.+++..           ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus       149 vmEy~~gg~L~~~l~~-----------~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DF  214 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDF  214 (346)
T ss_dssp             EECCCTTEEHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEeCCCCCcHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecC
Confidence            9999999999999842           34899999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      |+|+.+.....  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+..  .......+....+.  
T Consensus       215 Gla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~--  288 (346)
T 4fih_A          215 GFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPP--  288 (346)
T ss_dssp             TTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSSCC--
T ss_pred             cCceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCC--
Confidence            99987654322  2345789999999999999999999999999999999999999997521  11122222111110  


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                            ....    .......+.+++.+||+.||++|||++|+++
T Consensus       289 ------~~~~----~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          289 ------RLKN----LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ------CCSC----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CCCc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  1111    1233456779999999999999999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.5e-55  Score=424.68  Aligned_cols=251  Identities=22%  Similarity=0.299  Sum_probs=200.2

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|...+.||+|+||+||+|++..+|+.||||+++...  ....+.+.+|++++++++|||||++++++     ..++..
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECCEE
Confidence            57889999999999999999999999999999997543  23346799999999999999999999984     445689


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++|||||++|+|.+++..        .....+++.+...++.|++.||+|||   +++|+||||||+|||++.++.+||+
T Consensus        99 yiVmEy~~gg~L~~~i~~--------~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~  167 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINA--------QKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLG  167 (350)
T ss_dssp             EEEEECCTTCBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEEC
T ss_pred             EEEEeCCCCCcHHHHHHH--------cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEc
Confidence            999999999999999853        33455789999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      |||+|+.+.....  ......||+.|||||++.+..|+.++|||||||++|||+||+.||....     ..+........
T Consensus       168 DFGla~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~~  240 (350)
T 4b9d_A          168 DFGIARVLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNLVLKIISG  240 (350)
T ss_dssp             STTEESCCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHT
T ss_pred             ccccceeecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHcC
Confidence            9999987654322  2234679999999999999999999999999999999999999997621     11111111111


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                              ....   ....+...+.+|+.+||++||++|||++|+++
T Consensus       241 --------~~~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          241 --------SFPP---VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             --------CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------CCCC---CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    0000   01133456779999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.9e-54  Score=419.92  Aligned_cols=257  Identities=21%  Similarity=0.268  Sum_probs=206.2

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      +.|...++||+|+||.||+|++..+|+.||||+++....     ..+|+.++++++|||||++++++     ..++..+|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~i  127 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAV-----REGPWVNI  127 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence            456677889999999999999999999999999975322     24699999999999999999985     34558999


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC-cEEEee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM-TAYVSD  363 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~-~~kl~D  363 (502)
                      |||||++|+|.++++.          .+.+++.++..++.|++.||+|||   +++|+||||||+|||++.++ .+||+|
T Consensus       128 vmEy~~gg~L~~~l~~----------~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~D  194 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQ----------MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCD  194 (336)
T ss_dssp             EECCCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECC
T ss_pred             EEeccCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEee
Confidence            9999999999999942          245899999999999999999999   99999999999999999887 699999


Q ss_pred             eccceeccccccc---ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          364 FGIARFLEAADEQ---TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       364 fg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      ||+|+.+......   .......||+.|||||++.+..|+.++|||||||++|||+||+.||....... -+........
T Consensus       195 FGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~  273 (336)
T 4g3f_A          195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASEPP  273 (336)
T ss_dssp             CTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHSCC
T ss_pred             CCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcCCC
Confidence            9999977544321   12234679999999999999999999999999999999999999997643222 1111111110


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      +             ...+...+...+.+++.+||++||++|||+.|+++.|....++.
T Consensus       274 ~-------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          274 P-------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             G-------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             C-------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence            0             00112244567789999999999999999999999998887654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.8e-55  Score=420.74  Aligned_cols=249  Identities=21%  Similarity=0.354  Sum_probs=206.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||+||+|++..+++.||||+++..   .....+.+.+|++++++++|||||+++++     +..++.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEeCCE
Confidence            5689999999999999999999999999999999642   23345679999999999999999999998     455668


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          .+.+++.....++.|++.||+|||   +++|+||||||+|||++.++.+||
T Consensus       107 ~yivmEy~~gG~L~~~i~~----------~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl  173 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRK----------IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI  173 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEE
Confidence            9999999999999999842          246899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+|+.+............+||+.|||||++.+..|+.++||||+||++|||+||+.||....  ...+...+...  
T Consensus       174 ~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~--  249 (311)
T 4aw0_A          174 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EGLIFAKIIKL--  249 (311)
T ss_dssp             CCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHT--
T ss_pred             EEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcC--
Confidence            99999998765544444556789999999999999999999999999999999999999997521  11111111110  


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVE  488 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~  488 (502)
                       .        .    +++......+.+++.+|+++||++|||++|+.
T Consensus       250 -~--------~----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          250 -E--------Y----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -C--------C----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -C--------C----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence             0        0    00112234567899999999999999999874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.5e-53  Score=406.90  Aligned_cols=249  Identities=26%  Similarity=0.371  Sum_probs=195.6

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEE
Q 046112          208 SSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       208 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      ...++||+|+||+||+|.+..++..||+|++....  ....+.|.+|++++++++|||||++++++... ...+...++|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEEE
Confidence            44567999999999999999999999999986432  23346799999999999999999999986432 1234568999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeecCCCCCeeeCC-CCcEEEe
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPP--IAHCDLKPSNILLDD-EMTAYVS  362 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--i~H~dlk~~NIll~~-~~~~kl~  362 (502)
                      ||||++|+|.++++.          ...+++..+..++.|++.||+|||   +++  |+||||||+|||++. ++.+||+
T Consensus       108 mEy~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~  174 (290)
T 3fpq_A          108 TELMTSGTLKTYLKR----------FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             EECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred             EeCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEE
Confidence            999999999999942          245899999999999999999999   766  999999999999984 7999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      |||+|+....    .......||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.... ..+...+..... 
T Consensus       175 DFGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~~i~~~~~-  247 (290)
T 3fpq_A          175 DLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIYRRVTSGVK-  247 (290)
T ss_dssp             CTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHHHHHTTTCC-
T ss_pred             eCcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-HHHHHHHHcCCC-
Confidence            9999975432    12235679999999998865 6999999999999999999999999752111 111111111100 


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                       .           ..+...+...+.+++.+||+.||++|||++|+++
T Consensus       248 -~-----------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          248 -P-----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -C-----------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -C-----------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0           0011122345779999999999999999999875

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.8e-53  Score=422.06  Aligned_cols=250  Identities=22%  Similarity=0.294  Sum_probs=207.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      +.|+..+.||+|+||.||+|++..+|+.||||+++.......+.+.+|++++++++|||||++++++     ..++..||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EECCEEEE
Confidence            4688899999999999999999999999999999866555567799999999999999999999995     34558999


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      |||||++|+|.+++..           ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus       226 VmEy~~gG~L~~~i~~-----------~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DF  291 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDF  291 (423)
T ss_dssp             EEECCTTEEHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCC
T ss_pred             EEeCCCCCcHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecC
Confidence            9999999999999842           34899999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      |+|+.+.....  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+..  .......+....+.  
T Consensus       292 Gla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~--  365 (423)
T 4fie_A          292 GFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPP--  365 (423)
T ss_dssp             TTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCC--
T ss_pred             ccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCC--
Confidence            99987654322  2345689999999999999999999999999999999999999997521  11122222211110  


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                            ....    ...+...+.+|+.+||+.||++|||++|+++
T Consensus       366 ------~~~~----~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          366 ------RLKN----LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             ------CCSC----TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CCcc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  1111    1123456779999999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.1e-53  Score=402.26  Aligned_cols=246  Identities=22%  Similarity=0.318  Sum_probs=188.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|+..+.||+|+||+||+|.+..+|+.||||+++...   ....+.+.+|++++++++|||||++++++     ..++.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence            58999999999999999999998999999999986432   23346799999999999999999999984     45568


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+ +|+|.+++..          ...+++.+...++.|++.||+|||   +++|+||||||+|||++.++.+||
T Consensus        88 ~~ivmEy~-~g~L~~~l~~----------~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl  153 (275)
T 3hyh_A           88 IIMVIEYA-GNELFDYIVQ----------RDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKI  153 (275)
T ss_dssp             EEEEEECC-CEEHHHHHHH----------SCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEE
T ss_pred             EEEEEeCC-CCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEE
Confidence            99999999 7899998842          356999999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCcc-CccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEV-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      +|||+|+......   ......||+.|||||.+.+..+ +.++||||+||++|||+||+.||.+..  ...+.+.+....
T Consensus       154 ~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--~~~~~~~i~~~~  228 (275)
T 3hyh_A          154 ADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--IPVLFKNISNGV  228 (275)
T ss_dssp             CCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTC
T ss_pred             eecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCC
Confidence            9999998654322   2234679999999999998876 578999999999999999999997621  111111111111


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..               ++......+.+++.+|++.||++|||++|+++
T Consensus       229 ~~---------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 YT---------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CC---------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CC---------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            00               01123455678999999999999999999976

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.4e-53  Score=407.37  Aligned_cols=243  Identities=23%  Similarity=0.283  Sum_probs=189.8

Q ss_pred             cCCCCCCcccccCCceEEEEEEc---CCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      ++|...+.||+|+||+||+|+..   .+++.||||+++...  ......+.+|++++++++|||||++++++     ..+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence            57899999999999999999764   467899999987432  22345688999999999999999999984     445


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +..++|||||++|+|.+++..          ...+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~----------~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~v  165 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSK----------EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHI  165 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCE
T ss_pred             CEEEEEEEcCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCE
Confidence            689999999999999999842          346899999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||+|+.......  ......||+.|||||.+.+..++.++||||+||++|||+||+.||.....  ..+...+...
T Consensus       166 Kl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~  241 (304)
T 3ubd_A          166 KLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--KETMTMILKA  241 (304)
T ss_dssp             EEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC
T ss_pred             EecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--HHHHHHHHcC
Confidence            9999999986543322  23456799999999999999999999999999999999999999976211  1111111111


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKI  484 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~  484 (502)
                                 ..    .++..+...+.+++.+||++||++|||+
T Consensus       242 -----------~~----~~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          242 -----------KL----GMPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             -----------CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             -----------CC----CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence                       00    0111234567799999999999999985

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.3e-51  Score=395.18  Aligned_cols=256  Identities=21%  Similarity=0.344  Sum_probs=189.6

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeeccccccc-------C
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-------Q  277 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------~  277 (502)
                      +|+..+.||+|+||+||+|++..+|+.||||+++....+ ..+.+.+|++++++++|||||++++++...+.       .
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            578889999999999999999999999999999754433 34678999999999999999999998643221       1


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                      .....++|||||++|+|.+++...       ......++..+..++.|++.||+|||   +++|+||||||+|||++.++
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~  155 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGR-------CTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDD  155 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTC-------CSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhc-------CCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCC
Confidence            123478999999999999999641       11233566778899999999999999   89999999999999999999


Q ss_pred             cEEEeeeccceeccccccc----------ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccc
Q 046112          358 TAYVSDFGIARFLEAADEQ----------TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFK  427 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~  427 (502)
                      .+||+|||+|+.+......          ......+||+.|||||++.+..|+.++|||||||++|||++   ||.....
T Consensus       156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~  232 (299)
T 4g31_A          156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME  232 (299)
T ss_dssp             CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH
Confidence            9999999999876543221          12344679999999999999999999999999999999996   7754211


Q ss_pred             cccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          428 DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .    ....        ..+....   .++...+......+++.+||+.||++|||+.|+++
T Consensus       233 ~----~~~~--------~~~~~~~---~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          233 R----VRTL--------TDVRNLK---FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             H----HHHH--------HHHHTTC---CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H----HHHH--------HHHhcCC---CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0    0000        0011111   11222344455678999999999999999999976

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.6e-49  Score=391.88  Aligned_cols=269  Identities=19%  Similarity=0.203  Sum_probs=202.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccc-cCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVD-FQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~  281 (502)
                      ++|...+.||+|+||+||+|++..+|+.||||+++....  ...+.+.+|+++|+.++|||||++++++.... +.....
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            578899999999999999999999999999999975432  23467889999999999999999999865422 334567


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .|+|||||+ |+|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus       134 ~~ivmE~~~-g~L~~~i~----------~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki  199 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH----------SSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKI  199 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT----------SSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEeCCC-CCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEE
Confidence            899999995 78999984          3456999999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccc--cceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          362 SDFGIARFLEAADE--QTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +|||+|+.+.....  .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+...  ......+..
T Consensus       200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~--~~~l~~I~~  277 (398)
T 4b99_A          200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY--VHQLQLIMM  277 (398)
T ss_dssp             CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--HHHHHHHHH
T ss_pred             eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH--HHHHHHHHH
Confidence            99999987644322  2234567899999999998875 468999999999999999999999975211  111111111


Q ss_pred             hcccchhh------------hcccCCCCc----chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 ALPERAEE------------IRASSGSTQ----RSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~~~~~~~------------~~d~~~~~~----~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ....-...            .........    ..........+.+|+.+|++.||++|||++|+++
T Consensus       278 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          278 VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11000000            000000000    0001122346778999999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2e-47  Score=377.66  Aligned_cols=201  Identities=23%  Similarity=0.317  Sum_probs=168.7

Q ss_pred             HhccCCCCCCcccccCCceEEEEEEc---CCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeecccccccC
Q 046112          202 NATKGFSSENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       202 ~~t~~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  277 (502)
                      ...+.|.+.+.||+|+||+||+|++.   .+++.||||++...  .....+.+|+++++.+ +|||||++++++     .
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~   90 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCF-----R   90 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----E
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEE-----E
Confidence            34678999999999999999999764   46789999988643  2346688999999988 699999999984     4


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC-
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE-  356 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~-  356 (502)
                      .++..++||||+++|+|.+++.             .+++.+...++.|++.||+|||   +.+|+||||||+|||++.+ 
T Consensus        91 ~~~~~~lvmE~~~g~~L~~~~~-------------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~  154 (361)
T 4f9c_A           91 KNDHVVIAMPYLEHESFLDILN-------------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRL  154 (361)
T ss_dssp             ETTEEEEEEECCCCCCHHHHHT-------------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTT
T ss_pred             ECCEEEEEEeCCCcccHHHHHc-------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCC
Confidence            5568999999999999999883             2788899999999999999999   8999999999999999876 


Q ss_pred             CcEEEeeeccceecccccc--------------------------cceecccccccccccCcccCCC-ccCccccchhHH
Q 046112          357 MTAYVSDFGIARFLEAADE--------------------------QTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFG  409 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~G  409 (502)
                      +.+||+|||+|+.......                          .......+||++|||||++.+. .++.++||||+|
T Consensus       155 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG  234 (361)
T 4f9c_A          155 KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAG  234 (361)
T ss_dssp             TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHH
T ss_pred             CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhH
Confidence            7999999999986543211                          0112345799999999998875 589999999999


Q ss_pred             HHHHHHHhCCCCCccc
Q 046112          410 ILLLEMFTGLRPSDDM  425 (502)
Q Consensus       410 v~l~el~tg~~p~~~~  425 (502)
                      |++|||+||+.||...
T Consensus       235 ~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          235 VIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             HHHHHHHHTCSSSSCC
T ss_pred             HHHHHHHHCCCCCCCC
Confidence            9999999999999653

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.5e-46  Score=368.03  Aligned_cols=283  Identities=31%  Similarity=0.434  Sum_probs=228.4

Q ss_pred             HHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCC
Q 046112          199 MLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       199 ~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      ++..++++|...+.||+|+||.||+|.+ .+++.||||++........+.+.+|+++++.++||||++++++|.     .
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~  106 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-----E  106 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-----C
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----C
Confidence            4455788999999999999999999964 578999999987665566778999999999999999999999964     3


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      .+..++||||+++|+|.+++....      .....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~  177 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSD------LPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFV  177 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSC------CCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccC------CCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCC
Confidence            457899999999999999986411      22346899999999999999999999   899999999999999999999


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccccc-ccchHHHHH
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD-NLNLRNCVK  437 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~-~~~~~~~~~  437 (502)
                      +||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ......|..
T Consensus       178 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~  257 (321)
T 2qkw_B          178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV  257 (321)
T ss_dssp             EEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH
T ss_pred             EEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh
Confidence            9999999998654433333333456899999999998889999999999999999999999999764332 233444433


Q ss_pred             hhcc-cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          438 SALP-ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       438 ~~~~-~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      .... .....+.++....  ....+++..+.+++.+|++.||++|||++|+++.|+.+.+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          258 ESHNNGQLEQIVDPNLAD--KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             HHHTTTCCCSSSSSSCTT--CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             hccccccHHHhcChhhcc--ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            2222 1233333333222  223578889999999999999999999999999999887643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.3e-47  Score=397.39  Aligned_cols=253  Identities=23%  Similarity=0.317  Sum_probs=206.3

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++........+.+.+|+++|+.++|||||+++++     +......+
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-----~~~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEE-----EECSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEE
Confidence            3578999999999999999999999999999999976555556778999999999999999999998     45566899


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC--CcEEE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE--MTAYV  361 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~--~~~kl  361 (502)
                      +|||||++|+|.+++.         .....+++.++..++.|++.||+|||   +.+|+||||||+|||++.+  +.+||
T Consensus       231 iv~E~~~gg~L~~~i~---------~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl  298 (573)
T 3uto_A          231 MIYEFMSGGELFEKVA---------DEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKL  298 (573)
T ss_dssp             EEEECCCCCBHHHHHT---------CTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred             EEEeecCCCcHHHHHH---------HhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEE
Confidence            9999999999999984         23356899999999999999999999   8999999999999999854  89999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+|+.+.....   .....||+.|||||++.+..|+.++||||+||++|||++|+.||.+...  ......+.....
T Consensus       299 ~DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--~~~~~~i~~~~~  373 (573)
T 3uto_A          299 IDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKSCDW  373 (573)
T ss_dssp             CCCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHTTCC
T ss_pred             eeccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHhCCC
Confidence            99999997754332   2345799999999999999999999999999999999999999976321  111111111100


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .    +       ...........+.+|+.+||+.||.+|||++|+++
T Consensus       374 ~----~-------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          374 N----M-------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             C----C-------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C----C-------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0    0       00011123445678999999999999999999876

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5e-46  Score=365.11  Aligned_cols=288  Identities=35%  Similarity=0.506  Sum_probs=233.1

Q ss_pred             CCCccCHHHHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeee
Q 046112          191 SFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFT  269 (502)
Q Consensus       191 ~~~~~~~~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~  269 (502)
                      ....+++.++..++++|...+.||+|+||.||+|. ..+++.||||+++.... .....+.+|+++++.++||||+++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEEC-CSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEE-ecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            45678899999999999999999999999999995 45789999999875432 23347899999999999999999999


Q ss_pred             cccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCC
Q 046112          270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPS  349 (502)
Q Consensus       270 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~  349 (502)
                      +|.     ..+..++||||+++|+|.+++...      ......+++..+..++.|++.||+|||..+.++|+||||||+
T Consensus        95 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~  163 (326)
T 3uim_A           95 FCM-----TPTERLLVYPYMANGSVASCLRER------PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA  163 (326)
T ss_dssp             EEC-----CSSCCEEEEECCTTCBHHHHHHCC------STTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred             EEe-----cCCceEEEEEeccCCCHHHHHHhc------cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence            964     344789999999999999999641      133456999999999999999999999444449999999999


Q ss_pred             CeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccc---c
Q 046112          350 NILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM---F  426 (502)
Q Consensus       350 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~---~  426 (502)
                      |||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||+..   .
T Consensus       164 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  242 (326)
T 3uim_A          164 NILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN  242 (326)
T ss_dssp             GEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred             hEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence            99999999999999999987654332 2234456999999999998889999999999999999999999999742   2


Q ss_pred             ccccchHHHHHhhccc-chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 046112          427 KDNLNLRNCVKSALPE-RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL  493 (502)
Q Consensus       427 ~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~  493 (502)
                      ........|+...... ....+.+.....  ....++...+.+++.+|++.||.+|||++||++.|+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          243 DDDVMLLDWVKGLLKEKKLEALVDVDLQG--NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TSCSBHHHHHTTTTSSCCSTTSSCTTCTT--SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             ccchhHHHHHHHHhhchhhhhhcChhhcc--ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            2334566666655543 334444433332  2245778899999999999999999999999999974

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=365.90  Aligned_cols=266  Identities=24%  Similarity=0.374  Sum_probs=214.5

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|+||+||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++.     .+...+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCeeE
Confidence            356788899999999999999998999999999987655556678999999999999999999999964     345789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++|+|.+++..         ....+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        84 lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D  151 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKS---------MDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVAD  151 (310)
T ss_dssp             EEEECCTTCBHHHHHHH---------CCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECC
T ss_pred             EEEEecCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEee
Confidence            99999999999999852         2456899999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccc------------eecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccc
Q 046112          364 FGIARFLEAADEQT------------RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN  431 (502)
Q Consensus       364 fg~a~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~  431 (502)
                      ||+++.........            ......||+.|+|||.+.+..++.++||||||+++|||++|..|+.........
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~  231 (310)
T 3s95_A          152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD  231 (310)
T ss_dssp             CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred             cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence            99998765433211            112457999999999999999999999999999999999999998753322211


Q ss_pred             hHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 046112          432 LRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE  500 (502)
Q Consensus       432 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~  500 (502)
                      .....        ....+...      ...++..+.+++.+|++.||++|||++|+++.|+.+++....
T Consensus       232 ~~~~~--------~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          232 FGLNV--------RGFLDRYC------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             SSBCH--------HHHHHHTC------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             Hhhhh--------hccccccC------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence            11000        00000000      112345677999999999999999999999999999887654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.3e-47  Score=392.47  Aligned_cols=248  Identities=21%  Similarity=0.275  Sum_probs=195.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHH---HHHHHHHhcCCCCccceeeecccccccCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSF---AVECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      ++|...++||+|+||.||+|+...+|+.||||+++...   ......+   ..++.+++.++|||||+++++     +..
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~-----f~~  263 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FHT  263 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EEC
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE-----EEE
Confidence            57889999999999999999999999999999986421   1222223   334677788899999999998     455


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      .+..|+|||||+||+|.+++..          .+.+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~----------~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~  330 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQ----------HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGH  330 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSC
T ss_pred             CCEEEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCC
Confidence            6689999999999999999842          346899999999999999999999   999999999999999999999


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHH
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  437 (502)
                      +||+|||+|+.+....    ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||.......  ..+..+
T Consensus       331 vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~~  404 (689)
T 3v5w_A          331 VRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDR  404 (689)
T ss_dssp             EEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHHH
T ss_pred             EEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH
Confidence            9999999998765332    234679999999999975 579999999999999999999999997632211  111111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK-----INDVE  488 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt-----~~ev~  488 (502)
                      .....        ...    ++......+.+|+.+|+++||.+|++     ++|+.
T Consensus       405 ~i~~~--------~~~----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          405 MTLTM--------AVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             HHHHC--------CCC----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             hhcCC--------CCC----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            11100        000    01123445679999999999999998     56654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.7e-44  Score=351.17  Aligned_cols=284  Identities=32%  Similarity=0.466  Sum_probs=226.7

Q ss_pred             CCCccCHHHHHHhccCCCCC------CcccccCCceEEEEEEcCCCeEEEEEEecccC----cchhHHHHHHHHHHhcCC
Q 046112          191 SFPYVSYRMLYNATKGFSSE------NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH----HDASKSFAVECEVTRNIR  260 (502)
Q Consensus       191 ~~~~~~~~~l~~~t~~~~~~------~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~  260 (502)
                      ....+++.++..++++|...      +.||+|+||.||+|..  +++.||||++....    ....+.+.+|++++++++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            45678999999999999887      8999999999999965  68899999986432    233567999999999999


Q ss_pred             CCccceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 046112          261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPP  340 (502)
Q Consensus       261 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~  340 (502)
                      ||||+++++++.     ..+..++||||+++|+|.+++...       .....+++..++.++.|++.||+|||   +.+
T Consensus        89 h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~  153 (307)
T 2nru_A           89 HENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDRLSCL-------DGTPPLSWHMRCKIAQGAANGINFLH---ENH  153 (307)
T ss_dssp             CTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHTG-------GGCCCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             CCCeEEEEEEEe-----cCCceEEEEEecCCCcHHHHHHhc-------cCCCCCCHHHHHHHHHHHHHHHHHHh---cCC
Confidence            999999999954     345789999999999999998531       22356899999999999999999999   899


Q ss_pred             ceeecCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCC
Q 046112          341 IAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLR  420 (502)
Q Consensus       341 i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~  420 (502)
                      |+||||||+||+++.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.
T Consensus       154 i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~  232 (307)
T 2nru_A          154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLP  232 (307)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCC
T ss_pred             eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCC
Confidence            99999999999999999999999999987654433333344678999999998765 58999999999999999999999


Q ss_pred             CCccccccccchHHHHHhhc--ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          421 PSDDMFKDNLNLRNCVKSAL--PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       421 p~~~~~~~~~~~~~~~~~~~--~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                      ||+...... ....+.....  ........+.....   ....+...+.+++.+|++.||.+|||+.++++.|+++..
T Consensus       233 p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          233 AVDEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             SBCTTBSSS-BTTHHHHHHHTTSCCHHHHSCSSCSC---CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             CcccCcchH-HHHHHHHHhhhhhhhhhhhccccccc---cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            997643221 2222222111  11233333333322   234678889999999999999999999999999998854

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.6e-46  Score=362.76  Aligned_cols=276  Identities=24%  Similarity=0.326  Sum_probs=210.5

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...++||+|+||+||+|++  .++.||||+++... .....+..|+.++++++||||+++++++.... ......+
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~   98 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW   98 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred             hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence            45788899999999999999976  47999999986532 22345667889999999999999999975422 1133579


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC----------CceeecCCCCCeee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQP----------PIAHCDLKPSNILL  353 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~----------~i~H~dlk~~NIll  353 (502)
                      +||||+++|+|.++++.           ..+++..+..++.|++.||+|||   +.          +|+||||||+|||+
T Consensus        99 lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill  164 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKA-----------NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLL  164 (322)
T ss_dssp             EEEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEE
T ss_pred             EEEecCCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEE
Confidence            99999999999999852           24899999999999999999999   77          99999999999999


Q ss_pred             CCCCcEEEeeeccceecccccccceecccccccccccCcccCC-----CccCccccchhHHHHHHHHHhCCCCCcccccc
Q 046112          354 DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-----HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD  428 (502)
Q Consensus       354 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~  428 (502)
                      +.++.+||+|||+++.+.............||+.|+|||.+.+     ..++.++|||||||++|||+||+.||......
T Consensus       165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~  244 (322)
T 3soc_A          165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE  244 (322)
T ss_dssp             CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred             CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence            9999999999999987765444333445679999999999886     46778899999999999999999999764322


Q ss_pred             cc-chHHHHHhhcc-cchhh-hc----ccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          429 NL-NLRNCVKSALP-ERAEE-IR----ASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       429 ~~-~~~~~~~~~~~-~~~~~-~~----d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      .. .+......... ..... ..    .+...... ....++..+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYW-QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGG-GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hccchhhhhccCCchhhhhhhhhcccCCCCccccc-cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            11 11111000000 00000 00    01111100 11256677999999999999999999999999999998753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.5e-46  Score=363.62  Aligned_cols=275  Identities=24%  Similarity=0.352  Sum_probs=208.2

Q ss_pred             cCCCCCCcccccCCceEEEEE----EcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGI----LFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ++|...+.||+|+||+||+|+    ...+++.||||+++.......+.+.+|++++++++||||++++++|...   +..
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~   86 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR   86 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---HHT
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CCC
Confidence            567888999999999999997    4568899999999865555567899999999999999999999986432   233


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~k  154 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQK---------HKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVK  154 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHH---------CGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEE
T ss_pred             ceEEEEEeCCCCCHHHHHHh---------cccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEE
Confidence            57899999999999999853         2234899999999999999999999   89999999999999999999999


Q ss_pred             Eeeeccceeccccccc-ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||+||..|+.....+   ........
T Consensus       155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~  231 (295)
T 3ugc_A          155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGND  231 (295)
T ss_dssp             ECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTT
T ss_pred             EccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCc
Confidence            9999999876544321 2223445778899999999999999999999999999999999998653211   00000000


Q ss_pred             ccc-----chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          440 LPE-----RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       440 ~~~-----~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      ...     ...+......  .......++..+.+++.+||+.||++|||++|+++.|+++++.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          232 KQGQMIVFHLIELLKNNG--RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             CCTHHHHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             cccchhHHHHHHHHhccC--cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            000     0000000000  011122456778899999999999999999999999999988654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.9e-45  Score=363.45  Aligned_cols=273  Identities=21%  Similarity=0.318  Sum_probs=213.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEc-------CCCeEEEEEEecccCc-chhHHHHHHHHHHhcC-CCCccceeeeccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILF-------ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNI-RHRNLVKVFTACSGV  274 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  274 (502)
                      .++|...+.||+|+||.||+|.+.       .++..||||+++.... ...+.+.+|+++++++ +||||++++++|.  
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence            357888899999999999999764       3567899999975432 2346789999999999 8999999999964  


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhh------hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEED------KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKP  348 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~  348 (502)
                         ..+..++||||+++|+|.+++.......      ........+++..++.++.|++.||+|||   +.+|+||||||
T Consensus       158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp  231 (370)
T 2psq_A          158 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAA  231 (370)
T ss_dssp             ---SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCG
T ss_pred             ---cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccch
Confidence               3457899999999999999986421100      00112346899999999999999999999   89999999999


Q ss_pred             CCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccc
Q 046112          349 SNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFK  427 (502)
Q Consensus       349 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~  427 (502)
                      +|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999999999987655443333344567889999999999999999999999999999999 9999976321


Q ss_pred             cccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 046112          428 DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE  500 (502)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~  500 (502)
                        ..+...+.....              ......+...+.+++.+||+.||++|||+.|+++.|+.+.....+
T Consensus       312 --~~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~  368 (370)
T 2psq_A          312 --EELFKLLKEGHR--------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  368 (370)
T ss_dssp             --GGHHHHHHTTCC--------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             --HHHHHHHhcCCC--------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence              112221111110              001123456788999999999999999999999999999876543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.4e-45  Score=352.90  Aligned_cols=251  Identities=21%  Similarity=0.277  Sum_probs=205.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|+||+||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++.     ..+..+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE-----ECCEEE
Confidence            457999999999999999999988999999999997665556678999999999999999999999854     344789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++|+|.+++..           ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        94 lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~D  159 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTD  159 (297)
T ss_dssp             EEEECCTTCBHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred             EEEECCCCCCHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEee
Confidence            99999999999999842           24889999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||++........  ......||+.|+|||.+.+..++.++|||||||++|||+||+.||....... ..........+  
T Consensus       160 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~--  234 (297)
T 3fxz_A          160 FGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTP--  234 (297)
T ss_dssp             CTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSC--
T ss_pred             CCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC--
Confidence            999987654332  2234679999999999999999999999999999999999999997532111 11111111100  


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                             ...    ........+.+++.+|++.||++|||++|+++
T Consensus       235 -------~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          235 -------ELQ----NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -------CCS----CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------CCC----CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                   000    01234556789999999999999999999975

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.8e-46  Score=371.88  Aligned_cols=262  Identities=26%  Similarity=0.354  Sum_probs=210.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||+++.... .....|.+|++++++++||||++++++|.     ..+..
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~  187 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPI  187 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSSSC
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCCCc
Confidence            4577888999999999999999888999999999875432 23356889999999999999999999964     34478


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++|+|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus       188 ~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~  255 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRT---------EGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKIS  255 (377)
T ss_dssp             EEEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEEC
Confidence            999999999999999852         1234889999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||+| |+.||......  ...+.+.....
T Consensus       256 DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~  333 (377)
T 3cbl_A          256 DFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEKGGR  333 (377)
T ss_dssp             CGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHTTCC
T ss_pred             cCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC
Confidence            9999986543222111122335778999999998899999999999999999998 99999763211  11111111100


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                                    ......++..+.+++.+||+.||++|||++++++.|++++++.
T Consensus       334 --------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~  376 (377)
T 3cbl_A          334 --------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH  376 (377)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence                          0011234567889999999999999999999999999998764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=359.95  Aligned_cols=262  Identities=23%  Similarity=0.398  Sum_probs=207.3

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCC---CeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFES---TTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ++|...+.||+|+||.||+|.+..+   +..||||+++... ....+.+.+|++++++++||||+++++++.     ...
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~  123 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT-----RGR  123 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----GGG
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence            4677789999999999999988754   4469999997543 234567999999999999999999999963     345


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.+++..         ....+++..++.++.+++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~k  191 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRT---------HDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCK  191 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHT---------TTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred             ccEEEeeCCCCCcHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEE
Confidence            78999999999999999852         3356899999999999999999999   89999999999999999999999


Q ss_pred             Eeeeccceecccccc-cceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHh
Q 046112          361 VSDFGIARFLEAADE-QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  438 (502)
                      |+|||+++....... ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......  .....+..
T Consensus       192 l~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~  269 (325)
T 3kul_A          192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSVEE  269 (325)
T ss_dssp             ECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHT
T ss_pred             ECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHc
Confidence            999999987654432 222234456889999999998899999999999999999999 99999763211  11111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      ...              ......++..+.+++.+||..||++|||+.|+++.|+.+.+...
T Consensus       270 ~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          270 GYR--------------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             TCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             CCC--------------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            100              00112345678899999999999999999999999999876543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.1e-45  Score=354.97  Aligned_cols=263  Identities=28%  Similarity=0.390  Sum_probs=199.1

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ..++|...+.||+|+||+||+|++  .++.||||++.....  ...+.+.+|++++++++||||+++++++.     ...
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~  107 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT-----QPP  107 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----STT
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECC
Confidence            345788889999999999999976  688999999875432  23467899999999999999999999953     344


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeecCCCCCeeeCCCCc
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPP--IAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--i~H~dlk~~NIll~~~~~  358 (502)
                      ..++||||+++|+|.+++....       ....+++..++.++.|++.||+|||   +.+  |+||||||+||+++.++.
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~  177 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSG-------AREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYT  177 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTT-------HHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCC
T ss_pred             ceEEEEecCCCCcHHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCc
Confidence            7899999999999999986411       1123889999999999999999999   888  999999999999999999


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +||+|||+++......  .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......  .....+..
T Consensus       178 ~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~~~  253 (309)
T 3p86_A          178 VKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAVGF  253 (309)
T ss_dssp             EEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHHHH
T ss_pred             EEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh
Confidence            9999999997543322  1223456899999999999999999999999999999999999999763211  11111110


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      ...         .    ......+...+.+++.+||+.||++|||++|+++.|+.+.+...
T Consensus       254 ~~~---------~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          254 KCK---------R----LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             SCC---------C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             cCC---------C----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            000         0    00112344568899999999999999999999999999876543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.9e-44  Score=351.59  Aligned_cols=262  Identities=21%  Similarity=0.259  Sum_probs=211.4

Q ss_pred             CccCHHHHHHhccC----------CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCC
Q 046112          193 PYVSYRMLYNATKG----------FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHR  262 (502)
Q Consensus       193 ~~~~~~~l~~~t~~----------~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  262 (502)
                      +.++++++..+++.          |...+.||+|+||.||+|....+|+.||||+++.......+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45778888777764          55667899999999999988889999999999866556667899999999999999


Q ss_pred             ccceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 046112          263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIA  342 (502)
Q Consensus       263 niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~  342 (502)
                      ||+++++++..     .+..++||||+++|+|.+++..           ..+++..+..++.|++.||+|||   +.+|+
T Consensus       103 niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-----------~~l~~~~~~~i~~qi~~~L~~LH---~~~iv  163 (321)
T 2c30_A          103 NVVEMYKSYLV-----GEELWVLMEFLQGGALTDIVSQ-----------VRLNEEQIATVCEAVLQALAYLH---AQGVI  163 (321)
T ss_dssp             TBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             CcceEEEEEEE-----CCEEEEEEecCCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            99999998643     4478999999999999999842           35899999999999999999999   89999


Q ss_pred             eecCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCC
Q 046112          343 HCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPS  422 (502)
Q Consensus       343 H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~  422 (502)
                      ||||||+||+++.++.+||+|||+++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus       164 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf  241 (321)
T 2c30_A          164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY  241 (321)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999987654322  223467999999999999999999999999999999999999999


Q ss_pred             ccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          423 DDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .....  ......+.....        +....    .......+.+++.+|++.||++|||++|+++
T Consensus       242 ~~~~~--~~~~~~~~~~~~--------~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          242 FSDSP--VQAMKRLRDSPP--------PKLKN----SHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             TTSCH--HHHHHHHHHSSC--------CCCTT----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCH--HHHHHHHhcCCC--------CCcCc----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            75211  111111111110        01111    1123456779999999999999999999986

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.4e-45  Score=359.86  Aligned_cols=249  Identities=22%  Similarity=0.325  Sum_probs=202.0

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ..++|...+.||+|+||.||+|.+..+|+.||||++....  ....+.+.+|+++++.++||||+++++++.     ..+
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~   87 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TEK   87 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECC
Confidence            3568899999999999999999998999999999987542  233467889999999999999999999953     445


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~k  154 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVA----------HGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIK  154 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred             EEEEEEECCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEE
Confidence            88999999999999999842          245889999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccC-ccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVS-SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++......   ......||+.|+|||.+.+..++ .++||||+||++|||++|+.||+...     ..+.....
T Consensus       155 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i  226 (328)
T 3fe3_A          155 IADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRERV  226 (328)
T ss_dssp             ECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHH
T ss_pred             EeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHH
Confidence            99999997654332   22346799999999999888775 78999999999999999999997631     11111111


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...        ...    .+......+.+++.+|++.||.+|||++|+++
T Consensus       227 ~~~--------~~~----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          227 LRG--------KYR----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HHC--------CCC----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             HhC--------CCC----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            100        000    01123445678999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.4e-44  Score=347.84  Aligned_cols=269  Identities=24%  Similarity=0.373  Sum_probs=206.9

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhc--CCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRN--IRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||+||+|.+  +++.||||+++..   ....+..|.+++..  ++||||+++++++... ......
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence            46789999999999999999976  7899999998642   34556667777665  7999999999986442 233456


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceeecCCCCCeeeCCC
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLD-----CQPPIAHCDLKPSNILLDDE  356 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~i~H~dlk~~NIll~~~  356 (502)
                      .++||||+++|+|.++++.           ..+++..++.++.|++.||+|||..     ++.+|+||||||+|||++.+
T Consensus        81 ~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~  149 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL-----------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN  149 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT-----------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred             eEEehhhccCCCHHHHHhh-----------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC
Confidence            8999999999999999842           3589999999999999999999943     26799999999999999999


Q ss_pred             CcEEEeeeccceecccccccc--eecccccccccccCcccCCC------ccCccccchhHHHHHHHHHhC----------
Q 046112          357 MTAYVSDFGIARFLEAADEQT--RSIGVEGTTGYIAPEYGMGH------EVSSYGDVYSFGILLLEMFTG----------  418 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDvws~Gv~l~el~tg----------  418 (502)
                      +.+||+|||+++.........  ......||+.|+|||.+.+.      .++.++|||||||++|||+||          
T Consensus       150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~  229 (301)
T 3q4u_A          150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY  229 (301)
T ss_dssp             SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence            999999999998765443221  12335799999999998876      566899999999999999999          


Q ss_pred             CCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          419 LRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       419 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      +.||.....................    ..+..+ .......++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       230 ~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          230 KPPFYDVVPNDPSFEDMRKVVCVDQ----QRPNIP-NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCC-GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccccCCCCcchhhhhHHHhccC----CCCCCC-hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            7887654333333322222111110    000111 1112235778899999999999999999999999999876

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.2e-44  Score=361.39  Aligned_cols=262  Identities=24%  Similarity=0.416  Sum_probs=198.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEc---CCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .++|...+.||+|+||.||+|+..   .++..||||+++.... ...+.|.+|++++++++||||++++++|.     ..
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~  118 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KS  118 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eC
Confidence            357889999999999999999765   4677899999875432 33467999999999999999999999964     34


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++||||+++|+|.++++.         ....+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  186 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRK---------HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVC  186 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHT---------TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCE
T ss_pred             CceEEEEeCCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCE
Confidence            578999999999999999853         2346899999999999999999999   8899999999999999999999


Q ss_pred             EEeeeccceeccccccc-ceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHH
Q 046112          360 YVSDFGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  437 (502)
                      ||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  .....+.
T Consensus       187 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~~~i~  264 (373)
T 2qol_A          187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVD  264 (373)
T ss_dssp             EECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHHHHHH
T ss_pred             EECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence            99999999876543321 11223345788999999999999999999999999999998 99999753211  1111111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      ....       .       .....++..+.+++.+||+.||++||++.|+++.|+.+.+..
T Consensus       265 ~~~~-------~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          265 EGYR-------L-------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             TTEE-------C-------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             cCCC-------C-------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            1100       0       001234567889999999999999999999999999987653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.6e-45  Score=361.59  Aligned_cols=281  Identities=21%  Similarity=0.268  Sum_probs=217.2

Q ss_pred             CHHHHHHhccCCCCCCcccccCCceEEEEE-----EcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcC-CCCccceee
Q 046112          196 SYRMLYNATKGFSSENLIGAGNFGSVYKGI-----LFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNI-RHRNLVKVF  268 (502)
Q Consensus       196 ~~~~l~~~t~~~~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~  268 (502)
                      .........++|...+.||+|+||.||+|.     ...+++.||||+++.... ...+.+.+|++++.++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            344455567889999999999999999998     445679999999975433 2346799999999999 799999999


Q ss_pred             ecccccccCCCcceeEEeeeccCCChhhhccCCchhhh------------------------------------------
Q 046112          269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK------------------------------------------  306 (502)
Q Consensus       269 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------------------  306 (502)
                      ++|..    .+...++||||+++|+|.++++.......                                          
T Consensus        93 ~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           93 GACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             EEECS----TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeec----CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            98743    33458999999999999999965321000                                          


Q ss_pred             --------------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceeccc
Q 046112          307 --------------RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEA  372 (502)
Q Consensus       307 --------------~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~  372 (502)
                                    .......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                          0001223899999999999999999999   89999999999999999999999999999987654


Q ss_pred             ccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccchhhhcccC
Q 046112          373 ADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAEEIRASS  451 (502)
Q Consensus       373 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  451 (502)
                      ...........||+.|+|||++.+..++.++|||||||++|||+| |+.||....... .....+......         
T Consensus       246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~---------  315 (359)
T 3vhe_A          246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRM---------  315 (359)
T ss_dssp             CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHHTCCC---------
T ss_pred             cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHHHHHcCCCC---------
Confidence            444344445678999999999999999999999999999999998 999997632221 111111111100         


Q ss_pred             CCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          452 GSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       452 ~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                        ..   ...+...+.+++.+|++.||++|||++|+++.|+.+.+..
T Consensus       316 --~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          316 --RA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             --CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --CC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence              00   1123456789999999999999999999999999998764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.1e-44  Score=354.83  Aligned_cols=254  Identities=23%  Similarity=0.315  Sum_probs=203.7

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||+++.... ...+.+.+|+.+++.++||||+++++++.     ..+..
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeE
Confidence            3578899999999999999999988999999999864332 23466889999999999999999999853     44588


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++|+|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus        81 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~  147 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKIS  147 (323)
T ss_dssp             EEEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEcCCCCcHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEE
Confidence            99999999999999984          2345899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCcc-CccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEV-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||+++.+.............||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.........+..+......
T Consensus       148 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  227 (323)
T 3tki_A          148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY  227 (323)
T ss_dssp             CCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT
T ss_pred             EeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc
Confidence            9999987654443333345679999999999988775 778999999999999999999997643322222222211110


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .          .    ........+.+++.+|++.||++|||++|+++
T Consensus       228 ~----------~----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          228 L----------N----PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             S----------T----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C----------C----ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0          0    01123456678999999999999999999875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-45  Score=363.35  Aligned_cols=267  Identities=26%  Similarity=0.364  Sum_probs=209.2

Q ss_pred             cCCCCCCcccccCCceEEEEEE-----cCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGIL-----FESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      ++|...+.||+|+||.||+|.+     ..++..||||+++... ......+.+|+.++++++||||+++++++.     .
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~  145 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-----Q  145 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-----c
Confidence            5678889999999999999984     4567899999986432 334567889999999999999999999953     3


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC-
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM-  357 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~-  357 (502)
                      ....++||||+++|+|.+++....   ........+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++ 
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~  219 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGP  219 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHS---CCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSST
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhc---cccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCC
Confidence            447799999999999999985311   11123456899999999999999999999   89999999999999999554 


Q ss_pred             --cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHH
Q 046112          358 --TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRN  434 (502)
Q Consensus       358 --~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~  434 (502)
                        .+||+|||+++.+.............+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.....  .....
T Consensus       220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~  297 (367)
T 3l9p_A          220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLE  297 (367)
T ss_dssp             TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHH
T ss_pred             CceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH
Confidence              599999999986654433333344567999999999998999999999999999999998 9999976321  11111


Q ss_pred             HHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          435 CVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       435 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      .+.....           .   .....++..+.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus       298 ~i~~~~~-----------~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          298 FVTSGGR-----------M---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HHHTTCC-----------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHcCCC-----------C---CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            1111100           0   001234556889999999999999999999999999887643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1e-44  Score=355.89  Aligned_cols=259  Identities=22%  Similarity=0.384  Sum_probs=201.2

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeE----EEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTA----VAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      ++|...+.||+|+||+||+|.+..+++.    ||+|.++... ....+.+.+|+.++++++||||++++++|..      
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------   88 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   88 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES------
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec------
Confidence            4688889999999999999988777665    4777775332 2345789999999999999999999999743      


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++|+||+++|+|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~  156 (327)
T 3poz_A           89 STVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHV  156 (327)
T ss_dssp             SSEEEEEECCTTCBHHHHHHH---------STTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEE
T ss_pred             CCeEEEEEecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCE
Confidence            247899999999999999852         2356899999999999999999999   8899999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  438 (502)
                      ||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |+.||+.....  .+...+..
T Consensus       157 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~  234 (327)
T 3poz_A          157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEK  234 (327)
T ss_dssp             EECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT
T ss_pred             EEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHc
Confidence            9999999987655444333345567889999999999999999999999999999999 99999763221  12222211


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ....          .    ....+...+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       235 ~~~~----------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          235 GERL----------P----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             TCCC----------C----CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCC----------C----CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            1100          0    0113455688999999999999999999999999988654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.1e-44  Score=357.00  Aligned_cols=277  Identities=18%  Similarity=0.221  Sum_probs=211.2

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCC-----CeEEEEEEecccCcch-----------hHHHHHHHHHHhcCCCCccce
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFES-----TTAVAVKVFNVLHHDA-----------SKSFAVECEVTRNIRHRNLVK  266 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~  266 (502)
                      ..++|...+.||+|+||.||+|.+..+     ++.||||++.......           ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            345889999999999999999987654     5789999986543211           122344556677889999999


Q ss_pred             eeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecC
Q 046112          267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDL  346 (502)
Q Consensus       267 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dl  346 (502)
                      +++++.... .+....++||||+ +|+|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||
T Consensus       113 ~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~---------~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDl  178 (364)
T 3op5_A          113 YWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEA---------NAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDI  178 (364)
T ss_dssp             EEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHH---------TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred             EEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecC
Confidence            999875421 2234689999999 9999999852         2356999999999999999999999   889999999


Q ss_pred             CCCCeeeC--CCCcEEEeeeccceecccccccc-----eecccccccccccCcccCCCccCccccchhHHHHHHHHHhCC
Q 046112          347 KPSNILLD--DEMTAYVSDFGIARFLEAADEQT-----RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGL  419 (502)
Q Consensus       347 k~~NIll~--~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~  419 (502)
                      ||+|||++  .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus       179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~  258 (364)
T 3op5_A          179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH  258 (364)
T ss_dssp             CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred             CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999  88999999999998775443211     113355999999999999999999999999999999999999


Q ss_pred             CCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          420 RPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       420 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      .||.....+. ................+.+.....     ..++..+.+++..||+.||++||+++++++.|+++.++..
T Consensus       259 ~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  332 (364)
T 3op5_A          259 LPWEDNLKDP-KYVRDSKIRYRENIASLMDKCFPA-----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG  332 (364)
T ss_dssp             CTTGGGTTCH-HHHHHHHHHHHHCHHHHHHHHSCT-----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CCccccccCH-HHHHHHHHHhhhhHHHHHHHhccc-----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            9998633222 222222222222333333322211     1235678899999999999999999999999999887653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.3e-44  Score=353.55  Aligned_cols=252  Identities=19%  Similarity=0.262  Sum_probs=203.6

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc------hhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD------ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      .+.|...+.||+|+||.||+|.+..+|+.||+|+++.....      ..+.+.+|++++++++||||+++++++     .
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~   85 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----E   85 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----E
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----E
Confidence            45788999999999999999999999999999998754321      246789999999999999999999985     3


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                      .....++||||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~----------~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~  152 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLA----------QKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKN  152 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHT----------TCSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTT
T ss_pred             eCCEEEEEEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCC
Confidence            4558999999999999999984          2356899999999999999999999   89999999999999998877


Q ss_pred             ----cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchH
Q 046112          358 ----TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR  433 (502)
Q Consensus       358 ----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~  433 (502)
                          .+||+|||+++.+....   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......  ...
T Consensus       153 ~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--~~~  227 (361)
T 2yab_A          153 IPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETL  227 (361)
T ss_dssp             SSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHH
T ss_pred             CCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHH
Confidence                79999999998765432   223456999999999999999999999999999999999999999762111  111


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..+...           ...............+.+++.+|+..||++|||+.|+++
T Consensus       228 ~~i~~~-----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          228 ANITAV-----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHTT-----------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhc-----------CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111110           000011111233456779999999999999999999874

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.5e-44  Score=349.35  Aligned_cols=261  Identities=24%  Similarity=0.388  Sum_probs=203.3

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .++|...+.||+|+||.||+|.+..++..||+|++.....   ...+.+.+|+.++++++||||+++++++     ..++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence            3578889999999999999999989999999999864322   2346789999999999999999999985     3455


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~k  151 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIES----------HGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLK  151 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEE
T ss_pred             eEEEEEeCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence            88999999999999999842          245899999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||........ .........
T Consensus       152 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~~  229 (294)
T 4eqm_A          152 IFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-AIKHIQDSV  229 (294)
T ss_dssp             ECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-HHHHHSSCC
T ss_pred             EEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhhccC
Confidence            999999986543321 222345689999999999999999999999999999999999999976321110 011111111


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-KINDVEPRLRLIK  495 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-t~~ev~~~L~~i~  495 (502)
                      +...           .....+.+..+.+++.+|++.||++|| +++++.+.|+.+.
T Consensus       230 ~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          230 PNVT-----------TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             CCHH-----------HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             CCcc-----------hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            1100           011123456788999999999999999 8999998887653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.6e-44  Score=353.55  Aligned_cols=248  Identities=21%  Similarity=0.246  Sum_probs=200.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||+|+...+++.||+|+++..   .......+.+|+++++.++||||+++++++     ...+.
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~~   79 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCCE
Confidence            5788889999999999999999889999999998643   223456788999999999999999999985     44558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        80 ~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL  146 (337)
T 1o6l_A           80 LCFVMEYANGGELFFHLSR----------ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKI  146 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEE
Confidence            9999999999999998842          245889999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+++......  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  ..+.+.+..   
T Consensus       147 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~---  219 (337)
T 1o6l_A          147 TDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM---  219 (337)
T ss_dssp             CCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH---
T ss_pred             eeccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HHHHHHHHc---
Confidence            9999997543222  122346789999999999999999999999999999999999999975211  111111110   


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~  489 (502)
                      .        ...    +.......+.+++.+|++.||++||     +++|+++
T Consensus       220 ~--------~~~----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          220 E--------EIR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             C--------CCC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C--------CCC----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            0        000    0112345677999999999999999     8888865

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-44  Score=348.87  Aligned_cols=253  Identities=21%  Similarity=0.283  Sum_probs=204.7

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|+||.||+|.+..+++.||+|+++... .....+.+|+++++.++||||+++++++.     ..+..+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEE
Confidence            467888999999999999999999999999999987532 33566889999999999999999999853     345899


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC--CCcEEE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD--EMTAYV  361 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~--~~~~kl  361 (502)
                      +||||+++|+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.  ++.+||
T Consensus        78 lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl  145 (321)
T 1tki_A           78 MIFEFISGLDIFERINT---------SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKI  145 (321)
T ss_dssp             EEECCCCCCBHHHHHTS---------SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred             EEEEeCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEE
Confidence            99999999999999852         3346899999999999999999999   899999999999999987  789999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+++.+.....   .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......  .....+.... 
T Consensus       146 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~-  219 (321)
T 1tki_A          146 IEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNAE-  219 (321)
T ss_dssp             CCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTC-
T ss_pred             EECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHcCC-
Confidence            99999987654332   23456899999999999988999999999999999999999999763211  1111111110 


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                                .........+.+..+.+++.+|+..||++|||+.|+++.
T Consensus       220 ----------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          220 ----------YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ----------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----------CCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                      000011112335567899999999999999999999873

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-44  Score=355.79  Aligned_cols=273  Identities=24%  Similarity=0.393  Sum_probs=211.0

Q ss_pred             hccCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeeccccccc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDF  276 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  276 (502)
                      ..++|...+.||+|+||.||+|.+.     .+++.||||+++.... ...+.+.+|++++++++||||++++++|.    
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----  120 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA----  120 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc----
Confidence            4578999999999999999999876     3558999999975432 33567999999999999999999999964    


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhh--------------hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEED--------------KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIA  342 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~  342 (502)
                       ..+..++||||+++|+|.+++.......              ........+++.+++.++.|++.||+|||   +.+|+
T Consensus       121 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~iv  196 (343)
T 1luf_A          121 -VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV  196 (343)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             -cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence             3457899999999999999986421100              00011367999999999999999999999   89999


Q ss_pred             eecCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCC
Q 046112          343 HCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP  421 (502)
Q Consensus       343 H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p  421 (502)
                      ||||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.|
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            999999999999999999999999987654433333345668899999999998899999999999999999999 9999


Q ss_pred             CccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          422 SDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      |......  .....+..           ......   ...++..+.+++.+||+.||++|||+.++++.|+++.++..
T Consensus       277 ~~~~~~~--~~~~~~~~-----------~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          277 YYGMAHE--EVIYYVRD-----------GNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             TTTSCHH--HHHHHHHT-----------TCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             CCCCChH--HHHHHHhC-----------CCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            9763211  11111111           000001   12345678899999999999999999999999999876654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8e-44  Score=364.45  Aligned_cols=254  Identities=26%  Similarity=0.369  Sum_probs=206.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|+||.||+|.+  .++.||||+++...  ..+.|.+|++++++++||||++++++|..    .....+
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~~  263 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY  263 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSCEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCceE
Confidence            45677889999999999999976  47899999997543  45789999999999999999999998742    334689


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++|+|.+++..        .....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus       264 iv~e~~~~g~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~D  332 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSD  332 (450)
T ss_dssp             EEEECCTTCBHHHHHHH--------HCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEecCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEee
Confidence            99999999999999953        22344789999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+++......     ....++..|+|||.+.+..++.++|||||||++|||+| |+.||......  .....+..... 
T Consensus       333 fG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~-  404 (450)
T 1k9a_A          333 FGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYK-  404 (450)
T ss_dssp             CTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHHHHTTCC-
T ss_pred             CCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC-
Confidence            99998543221     12356889999999999999999999999999999998 99999764221  12221111110 


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                                   ......++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       405 -------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          405 -------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                         011124567788999999999999999999999999998765

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.5e-43  Score=341.03  Aligned_cols=254  Identities=24%  Similarity=0.383  Sum_probs=202.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcch-------hHHHHHHHHHHhcCCCCccceeeeccccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-------SKSFAVECEVTRNIRHRNLVKVFTACSGVDF  276 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  276 (502)
                      .++|...+.||+|+||+||+|.+..+++.||+|++.......       .+.+.+|++++++++||||+++++++..   
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   94 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN---   94 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---
Confidence            357888899999999999999998999999999986433221       1678999999999999999999998632   


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeecCCCCCeeeC
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPP--IAHCDLKPSNILLD  354 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--i~H~dlk~~NIll~  354 (502)
                          ..++||||+++|+|.+++.         .....+++..++.++.|++.||+|||   +.+  |+||||||+||+++
T Consensus        95 ----~~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~  158 (287)
T 4f0f_A           95 ----PPRMVMEFVPCGDLYHRLL---------DKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQ  158 (287)
T ss_dssp             ----TTEEEEECCTTCBHHHHHH---------CTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEES
T ss_pred             ----CCeEEEEecCCCCHHHHHh---------cccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEe
Confidence                2369999999999998884         23456899999999999999999999   888  99999999999998


Q ss_pred             CCCc-----EEEeeeccceecccccccceecccccccccccCcccC--CCccCccccchhHHHHHHHHHhCCCCCccccc
Q 046112          355 DEMT-----AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM--GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFK  427 (502)
Q Consensus       355 ~~~~-----~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~  427 (502)
                      .++.     +||+|||+++....     ......||+.|+|||.+.  ...++.++|||||||++|||++|+.||.....
T Consensus       159 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  233 (287)
T 4f0f_A          159 SLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY  233 (287)
T ss_dssp             CCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             ccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence            8776     99999999974432     123456899999999984  45688999999999999999999999976332


Q ss_pred             cccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          428 DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      ..............             .......++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       234 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          234 GKIKFINMIREEGL-------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CHHHHHHHHHHSCC-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             cHHHHHHHHhccCC-------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            22211211111100             0011123456788999999999999999999999999753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.4e-44  Score=341.42  Aligned_cols=257  Identities=26%  Similarity=0.409  Sum_probs=207.3

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|...+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|++++++++||||+++++++.     .....++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   82 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICL   82 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEEE
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceEE
Confidence            56788899999999999999764 677899999875432 3567999999999999999999999953     3457899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++|+|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        83 v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Df  150 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDF  150 (269)
T ss_dssp             EEECCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCT
T ss_pred             EEEeCCCCcHHHHHHh---------cCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccc
Confidence            9999999999999852         3456899999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |+++...... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+.....  
T Consensus       151 g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~~--  225 (269)
T 4hcu_A          151 GMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFR--  225 (269)
T ss_dssp             TGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC--
T ss_pred             cccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCcc--
Confidence            9998654332 122234557888999999998899999999999999999999 99999763211  11111111100  


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                            ..   .+   ......+.+++.+|++.||++|||++|+++.|+++.+.
T Consensus       226 ------~~---~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          226 ------LY---KP---RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             ------CC---CC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ------CC---CC---CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence                  00   00   12245678999999999999999999999999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=344.30  Aligned_cols=274  Identities=20%  Similarity=0.265  Sum_probs=212.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|...+.||+|+||+||+|.+..+++.||||+++... ....+.+.+|++++++++||||+++++++..   ......+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~   85 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHKV   85 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceEE
Confidence            46888899999999999999998889999999987533 2345678899999999999999999998642   2334679


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee----CCCCcE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL----DDEMTA  359 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll----~~~~~~  359 (502)
                      +||||+++|+|.+++...       .....+++..+..++.|++.||+|||   +.+|+||||||+|||+    +.++.+
T Consensus        86 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~  155 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEP-------SNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVY  155 (319)
T ss_dssp             EEEECCTTCBHHHHHHSG-------GGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEE
T ss_pred             EEEeCCCCCCHHHHHHHh-------ccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceE
Confidence            999999999999999641       12334899999999999999999999   8999999999999999    888899


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccC--------CCccCccccchhHHHHHHHHHhCCCCCcccccccc-
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM--------GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL-  430 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~-  430 (502)
                      ||+|||+++.......   .....||+.|+|||.+.        +..++.++|||||||++|||+||+.||........ 
T Consensus       156 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  232 (319)
T 4euu_A          156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (319)
T ss_dssp             EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred             EEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence            9999999987654332   23456899999999876        57899999999999999999999999975322111 


Q ss_pred             -c-hHHHHHhhcccchhhhc---------ccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          431 -N-LRNCVKSALPERAEEIR---------ASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       431 -~-~~~~~~~~~~~~~~~~~---------d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                       . +..............+.         .................+.+++.+|++.||++|||++|+++...+.
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence             1 11112211111111110         1111222233467788899999999999999999999999987754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=355.92  Aligned_cols=273  Identities=23%  Similarity=0.342  Sum_probs=214.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcC-------CCeEEEEEEecccCc-chhHHHHHHHHHHhcC-CCCccceeeeccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFE-------STTAVAVKVFNVLHH-DASKSFAVECEVTRNI-RHRNLVKVFTACSGV  274 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  274 (502)
                      .++|...+.||+|+||.||+|.+..       .+..||||+++.... ...+.+.+|+++++++ +||||++++++|.  
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--  145 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--  145 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec--
Confidence            4578888999999999999998643       446899999875432 2346789999999999 8999999999964  


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhh------hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEED------KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKP  348 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~  348 (502)
                         ..+..++||||+++|+|.+++.......      ........+++..++.++.|++.||+|||   +.+|+||||||
T Consensus       146 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp  219 (382)
T 3tt0_A          146 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAA  219 (382)
T ss_dssp             ---SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred             ---cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCc
Confidence               3457899999999999999986421100      00112356999999999999999999999   89999999999


Q ss_pred             CCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccc
Q 046112          349 SNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFK  427 (502)
Q Consensus       349 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~  427 (502)
                      +|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987655443334445567899999999999999999999999999999999 9999975321


Q ss_pred             cccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 046112          428 DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE  500 (502)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~  500 (502)
                        ..+...+.....           ...   ...+...+.+++.+||+.||++|||++|+++.|+++......
T Consensus       300 --~~~~~~~~~~~~-----------~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          300 --EELFKLLKEGHR-----------MDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             --HHHHHHHHTTCC-----------CCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             --HHHHHHHHcCCC-----------CCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence              111111111110           000   113455688999999999999999999999999999876543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.5e-44  Score=351.51  Aligned_cols=247  Identities=23%  Similarity=0.368  Sum_probs=199.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||+++..   .......+.+|+++++.++||||+++++++.     ...
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TPT   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence            35788899999999999999999899999999998642   1223467899999999999999999999954     345


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+ +|+|.+++..          ...+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.+|
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~----------~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~k  148 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVE----------KKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVK  148 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEE
T ss_pred             EEEEEEECC-CCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEE
Confidence            789999999 7899988842          245899999999999999999999   88999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCcc-CccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEV-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||++........   .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||++......         
T Consensus       149 l~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------  216 (336)
T 3h4j_B          149 IADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------  216 (336)
T ss_dssp             ECCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------
T ss_pred             EEEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------
Confidence            999999986544322   234568999999999998876 6899999999999999999999976321110         


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                          ...+    ..............+.+++.+|++.||.+|||++|+++
T Consensus       217 ----~~~i----~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          217 ----FKKV----NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ----BCCC----CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ----HHHH----HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                0000    00011111123456779999999999999999999975

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.3e-44  Score=349.73  Aligned_cols=272  Identities=22%  Similarity=0.357  Sum_probs=195.1

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCe---EEEEEEeccc--CcchhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTT---AVAVKVFNVL--HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      ..++|...+.||+|+||.||+|.+..++.   .||||+++..  .....+.+.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            45678999999999999999998766554   8999998754  334457899999999999999999999986443211


Q ss_pred             C-CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC
Q 046112          278 G-NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE  356 (502)
Q Consensus       278 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~  356 (502)
                      + ....++||||+++|+|.+++....    .......+++..+..++.|++.||+|||   +.+|+||||||+|||++.+
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASR----IGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAED  173 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHH----C---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTT
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhh----ccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCC
Confidence            1 112389999999999999985311    1122346899999999999999999999   8999999999999999999


Q ss_pred             CcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHH
Q 046112          357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~  435 (502)
                      +.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......  .....
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~  251 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYNY  251 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHHH
Confidence            9999999999987655443333344567889999999999999999999999999999999 99999763221  11111


Q ss_pred             HHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      +....           ..   .....++..+.+++.+|++.||++|||+.++++.|+++.+.
T Consensus       252 ~~~~~-----------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          252 LIGGN-----------RL---KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             HHTTC-----------CC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HhcCC-----------CC---CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            11110           00   00113445688999999999999999999999999998764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=347.59  Aligned_cols=251  Identities=22%  Similarity=0.287  Sum_probs=202.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc------hhHHHHHHHHHHhcCCCCccceeeecccccccCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD------ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      +.|...+.||+|+||.||+|.+..++..||+|+++.....      ..+.+.+|++++++++||||+++++++.     .
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~   85 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----N   85 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence            4578889999999999999999889999999998753221      3567999999999999999999999853     4


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC-
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM-  357 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~-  357 (502)
                      ....++||||+++|+|.+++..          ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++ 
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~  152 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAE----------KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV  152 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTT----------SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSS
T ss_pred             CCEEEEEEEcCCCCCHHHHHHh----------cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCC
Confidence            4588999999999999999842          356899999999999999999999   89999999999999999887 


Q ss_pred             ---cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHH
Q 046112          358 ---TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN  434 (502)
Q Consensus       358 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~  434 (502)
                         .+||+|||+++.......   .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......  ....
T Consensus       153 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~  227 (326)
T 2y0a_A          153 PKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLA  227 (326)
T ss_dssp             SSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHH
T ss_pred             CCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHH
Confidence               899999999987643322   23456899999999999999999999999999999999999999752111  1111


Q ss_pred             HHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          435 CVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       435 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .+......           ........+...+.+++.+|++.||++|||++|+++
T Consensus       228 ~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          228 NVSAVNYE-----------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHTCCC-----------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhcCCC-----------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111000           001111233456789999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.8e-43  Score=344.89  Aligned_cols=275  Identities=23%  Similarity=0.367  Sum_probs=202.4

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcC---CCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFE---STTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      ..++|...+.||+|+||.||+|....   ++..||+|+++....  ...+.+.+|++++++++||||+++++++......
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            45678888999999999999997764   456899999875432  2346789999999999999999999997654333


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                      .....++||||+++|+|.+++....    .......+++..++.++.|++.||.|||   +.+|+||||||+||+++.++
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSR----LETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTT----BTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTS
T ss_pred             CCcccEEEEecccCCCHHHHHHHhh----hhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCC
Confidence            3335699999999999999984211    1133466999999999999999999999   89999999999999999999


Q ss_pred             cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHH
Q 046112          358 TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~  436 (502)
                      .+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~  262 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYL  262 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHH
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHH
Confidence            999999999987654433333334557889999999999999999999999999999999 89998763221  111111


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE  500 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~  500 (502)
                      .....           .   .....++..+.+++.+|++.||.+|||+.++++.|+.+.+++++
T Consensus       263 ~~~~~-----------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~  312 (313)
T 3brb_A          263 LHGHR-----------L---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD  312 (313)
T ss_dssp             HTTCC-----------C---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             HcCCC-----------C---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence            11100           0   01123456788999999999999999999999999999887654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3e-43  Score=340.68  Aligned_cols=265  Identities=16%  Similarity=0.226  Sum_probs=211.6

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||++....  ..+.+.+|+.+++.+ +|+|++++++++     ......
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~   81 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN   81 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCcee
Confidence            357889999999999999999988999999999986432  345688899999999 799999999985     344578


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc----
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----  358 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~----  358 (502)
                      ++||||+ +++|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.    
T Consensus        82 ~lv~e~~-~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~  148 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDL---------CGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNAN  148 (298)
T ss_dssp             EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTT
T ss_pred             EEEEEec-CCCHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCC
Confidence            9999999 9999999852         2345899999999999999999999   999999999999999987776    


Q ss_pred             -EEEeeeccceeccccccc-----ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccc-cc
Q 046112          359 -AYVSDFGIARFLEAADEQ-----TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN-LN  431 (502)
Q Consensus       359 -~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~-~~  431 (502)
                       +||+|||+++........     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ..
T Consensus       149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  228 (298)
T 1csn_A          149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ  228 (298)
T ss_dssp             CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred             eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH
Confidence             999999999877544321     12345679999999999999999999999999999999999999997632211 11


Q ss_pred             hHHHH-HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          432 LRNCV-KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       432 ~~~~~-~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      ....+ ..........           ....++..+.+++.+|++.||++|||++++++.|+++.++..
T Consensus       229 ~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          229 KYERIGEKKQSTPLRE-----------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HHHHHHHHHHHSCHHH-----------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHhhccCccHHH-----------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            11111 1111001100           111345678899999999999999999999999999988754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7.5e-44  Score=368.74  Aligned_cols=258  Identities=23%  Similarity=0.401  Sum_probs=210.8

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ...+|...+.||+|+||.||+|.+..++..||||+++... ...+.|.+|++++++++||||++++++|..     ....
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~  291 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF  291 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSC
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcE
Confidence            3456778889999999999999988889999999997543 346789999999999999999999999643     3478


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++|+|.+++..        .....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus       292 ~lv~E~~~~g~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~  360 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRE--------CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVA  360 (495)
T ss_dssp             EEEEECCTTCBHHHHHHH--------SCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEEC
T ss_pred             EEEEEccCCCCHHHHHHh--------cCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEe
Confidence            999999999999999853        23456899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||+++...... ........+++.|+|||.+.+..++.++|||||||++|||+| |+.||......  ...+.+.....
T Consensus       361 DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~  437 (495)
T 1opk_A          361 DFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYR  437 (495)
T ss_dssp             CTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCC
T ss_pred             ecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC
Confidence            999998764322 222234556789999999998999999999999999999999 99999763221  22222211110


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                                    ......++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       438 --------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          438 --------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence                          001124456788999999999999999999999999865

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.3e-43  Score=345.96  Aligned_cols=270  Identities=24%  Similarity=0.370  Sum_probs=211.5

Q ss_pred             ccCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      .++|...+.||+|+||.||+|.+.     .++..||||+++.... ...+.+.+|++++++++||||+++++++.     
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----   96 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS-----   96 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe-----
Confidence            457888899999999999999773     4568999999875432 33467899999999999999999999853     


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhh--------------hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEED--------------KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAH  343 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H  343 (502)
                      .....++||||+++|+|.+++.......              ........+++.+++.++.|++.||+|||   +.+|+|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH  173 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVH  173 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcc
Confidence            3457899999999999999986421100              00011244889999999999999999999   899999


Q ss_pred             ecCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCC
Q 046112          344 CDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPS  422 (502)
Q Consensus       344 ~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~  422 (502)
                      |||||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |+.||
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987655443333344567889999999998899999999999999999999 99999


Q ss_pred             ccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          423 DDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ......  .....+.....           ..   ....++..+.+++.+|++.||++|||+.|+++.|+++.++
T Consensus       254 ~~~~~~--~~~~~~~~~~~-----------~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          254 PGIPPE--RLFNLLKTGHR-----------ME---RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             TTCCGG--GHHHHHHTTCC-----------CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCHH--HHHHHhhcCCc-----------CC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            763221  12222211110           00   0113456788999999999999999999999999998764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=343.51  Aligned_cols=258  Identities=26%  Similarity=0.387  Sum_probs=199.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|...+.||+|+||.||+|.+  .++.||||++...  ...+.+.+|++++++++||||+++++++.       +..++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~l   76 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVCL   76 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTEE
T ss_pred             hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcEE
Confidence            4678889999999999999976  5788999998642  34577999999999999999999999864       24789


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc-EEEee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT-AYVSD  363 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~-~kl~D  363 (502)
                      ||||+++|+|.++++..       .....+++..++.++.|+++||+|||.....+|+||||||+||+++.++. +||+|
T Consensus        77 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~D  149 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGA-------EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD  149 (307)
T ss_dssp             EEECCTTCBHHHHHHCS-------SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECC
T ss_pred             EEEcCCCCCHHHHHhcc-------CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcc
Confidence            99999999999998641       12234788999999999999999999332289999999999999998886 79999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||++.......     ....||+.|+|||.+.+..++.++||||||+++|||+||+.||+.................   
T Consensus       150 fg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---  221 (307)
T 2eva_A          150 FGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---  221 (307)
T ss_dssp             CCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC---
T ss_pred             ccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC---
Confidence            99997553321     2345899999999999999999999999999999999999999753222111111111000   


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                              .   ......++..+.+++.+|++.||++|||++|+++.|+.+.+.+.
T Consensus       222 --------~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          222 --------R---PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             --------C---CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             --------C---CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence                    0   00112334567899999999999999999999999999877654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3e-43  Score=345.97  Aligned_cols=265  Identities=17%  Similarity=0.248  Sum_probs=209.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||++....  ..+.+..|+++++++ +||||+++++++.     .....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~~~~~   80 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGP-----CGKYN   80 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEE-----ETTEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEe-----cCCcc
Confidence            357888999999999999999988999999999987532  234688999999999 9999999999853     34578


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc----
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT----  358 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~----  358 (502)
                      ++||||+ +++|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.    
T Consensus        81 ~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~  147 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDL---------CDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQ  147 (330)
T ss_dssp             EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTT
T ss_pred             EEEEEeC-CCCHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCc
Confidence            9999999 9999999852         2356899999999999999999999   889999999999999998887    


Q ss_pred             -EEEeeeccceecccccccc-----eecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccch
Q 046112          359 -AYVSDFGIARFLEAADEQT-----RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL  432 (502)
Q Consensus       359 -~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~  432 (502)
                       +||+|||+++.+.......     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....+  ..
T Consensus       148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~~  225 (330)
T 2izr_A          148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--TL  225 (330)
T ss_dssp             SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--SH
T ss_pred             eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc--cH
Confidence             9999999998765433211     124567999999999999999999999999999999999999999864222  11


Q ss_pred             HHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          433 RNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       433 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      .+............   +    .......++ .+.+++..|++.||.+||+++++.+.|+++.++.
T Consensus       226 ~~~~~~i~~~~~~~---~----~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          226 KERYQKIGDTKRAT---P----IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HHHHHHHHHHHHHS---C----HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHhhhccC---C----HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            11111110000000   0    000001134 7889999999999999999999999999887764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.4e-44  Score=343.61  Aligned_cols=261  Identities=26%  Similarity=0.388  Sum_probs=194.3

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||+||+|.+.   ..||||+++....  ...+.+.+|++++++++||||+++++++.      ...
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~   93 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQ   93 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------CCc
Confidence            457888999999999999999642   3599999875432  23467899999999999999999999742      235


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++++|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||
T Consensus        94 ~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl  161 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHA---------SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKI  161 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTT---------C---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEE
T ss_pred             cEEEEEecCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEE
Confidence            7899999999999999852         3456899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccC---CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM---GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +|||+++...............||+.|+|||.+.   +..++.++||||||+++|||++|+.||....... .....+..
T Consensus       162 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~  240 (289)
T 3og7_A          162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMVGR  240 (289)
T ss_dssp             CCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHHHH
T ss_pred             ccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHhcc
Confidence            9999998655433333334466899999999986   5678899999999999999999999997632211 12222111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                      ...       .+....   ....++..+.+++.+|++.||++|||+.|+++.|+++.+
T Consensus       241 ~~~-------~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          241 GSL-------SPDLSK---VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             TSC-------CCCTTS---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ccc-------Ccchhh---ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            110       001111   112445678899999999999999999999999988753

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=348.42  Aligned_cols=278  Identities=24%  Similarity=0.314  Sum_probs=203.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHH--HhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV--TRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||.||+|+.  +++.||||+++..   ....+..|.++  +..++||||+++++++......+...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            45788899999999999999966  7899999998743   23445555555  45689999999998665444555567


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC---------CceeecCCCCCee
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQP---------PIAHCDLKPSNIL  352 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~---------~i~H~dlk~~NIl  352 (502)
                      .++||||+++|+|.+++..           ...++..+..++.|++.||+|||   +.         +|+||||||+|||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nil  152 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSL-----------HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVL  152 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEE
T ss_pred             EEEEEecCCCCcHHHHHhh-----------cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEE
Confidence            8899999999999999842           23478899999999999999999   77         9999999999999


Q ss_pred             eCCCCcEEEeeeccceecccccc------cceecccccccccccCcccCC-------CccCccccchhHHHHHHHHHhCC
Q 046112          353 LDDEMTAYVSDFGIARFLEAADE------QTRSIGVEGTTGYIAPEYGMG-------HEVSSYGDVYSFGILLLEMFTGL  419 (502)
Q Consensus       353 l~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvws~Gv~l~el~tg~  419 (502)
                      ++.++.+||+|||+++.+.....      ........||+.|+|||.+.+       ..++.++|||||||++|||++|.
T Consensus       153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~  232 (336)
T 3g2f_A          153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC  232 (336)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence            99999999999999987653321      122234569999999999887       46778999999999999999998


Q ss_pred             CCCccccccccchHHHH--Hhhccc--chhhh-----cccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          420 RPSDDMFKDNLNLRNCV--KSALPE--RAEEI-----RASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       420 ~p~~~~~~~~~~~~~~~--~~~~~~--~~~~~-----~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      .|+............+.  ....+.  .....     ..+..+........+...+.+++.+||+.||++|||++|+++.
T Consensus       233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~  312 (336)
T 3g2f_A          233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER  312 (336)
T ss_dssp             GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence            77643221110000000  000000  00000     0011111111123467789999999999999999999999999


Q ss_pred             HHHHHHHHhh
Q 046112          491 LRLIKKKLLE  500 (502)
Q Consensus       491 L~~i~~~~~~  500 (502)
                      |+++.+.+.+
T Consensus       313 L~~ll~~~~~  322 (336)
T 3g2f_A          313 MAELMMIWER  322 (336)
T ss_dssp             HHHHHHCCCC
T ss_pred             HHHHHHHHHh
Confidence            9999876654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.2e-44  Score=350.60  Aligned_cols=259  Identities=21%  Similarity=0.338  Sum_probs=203.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeE----EEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTA----VAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      ++|...+.||+|+||.||+|.+..++..    ||+|.+.... ......+.+|+.++++++||||++++++|.      +
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~   86 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------G   86 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------B
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------C
Confidence            4677889999999999999988777765    7777765332 233456788999999999999999999863      2


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++|+||+++|+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~  154 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQ---------HRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQV  154 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHS---------SGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCE
T ss_pred             CccEEEEEeCCCCCHHHHHHH---------ccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeE
Confidence            368899999999999999853         2345888899999999999999999   8899999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  438 (502)
                      ||+|||+++.+.............+|..|+|||.+.+..++.++|||||||++|||+| |+.||.....  ......+..
T Consensus       155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~  232 (325)
T 3kex_A          155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLEK  232 (325)
T ss_dssp             EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--THHHHHHHT
T ss_pred             EECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH--HHHHHHHHc
Confidence            9999999987765444333445668889999999998899999999999999999999 9999976321  112222211


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ....        .   .   ...+...+.+++.+||+.||.+|||++|+++.|+.+.+.
T Consensus       233 ~~~~--------~---~---~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          233 GERL--------A---Q---PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             TCBC--------C---C---CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CCCC--------C---C---CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            1100        0   0   012234567899999999999999999999999988643

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.3e-44  Score=340.66  Aligned_cols=258  Identities=26%  Similarity=0.370  Sum_probs=206.5

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|+||.||+|.+ .++..||+|+++.... ..+++.+|++++.+++||||+++++++.     .....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKW-KGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYPIY   79 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEE
T ss_pred             hhheeeeeeeccCCCceEEEEEe-cCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCceE
Confidence            45788889999999999999965 5677899999875432 3567999999999999999999999953     445789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++|+|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        80 lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~D  147 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRS---------HGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSD  147 (268)
T ss_dssp             EEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECC
T ss_pred             EEEEccCCCcHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEcc
Confidence            99999999999999852         1234889999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||++........ .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+......  ....+....  
T Consensus       148 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~--  222 (268)
T 3sxs_A          148 FGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--VVLKVSQGH--  222 (268)
T ss_dssp             TTCEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHTTC--
T ss_pred             Cccceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--HHHHHHcCC--
Confidence            999987654332 22234556788999999998899999999999999999999 999997632211  111111000  


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                               ....+   ..+...+.+++.+|++.||++|||+.|+++.|+.++++
T Consensus       223 ---------~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          223 ---------RLYRP---HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ---------CCCCC---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ---------CCCCC---CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                     00000   11244678999999999999999999999999988654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=353.33  Aligned_cols=262  Identities=24%  Similarity=0.394  Sum_probs=196.9

Q ss_pred             CCCCCcccccCCceEEEEEEcCC---CeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          207 FSSENLIGAGNFGSVYKGILFES---TTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      |...+.||+|+||.||+|.+..+   +..||||.++... ....+.|.+|+.++++++||||++++++|.    ..++..
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~----~~~~~~  166 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSP  166 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC----CCSSCC
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE----cCCCCe
Confidence            45567899999999999976533   3468999987533 234577999999999999999999999863    334567


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++|+|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus       167 ~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~  234 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVA  234 (373)
T ss_dssp             EEEEECCTTCBHHHHHHC---------TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEEEECCCCCCHHHHHhh---------cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEe
Confidence            899999999999999852         3355789999999999999999999   8999999999999999999999999


Q ss_pred             eeccceeccccccc--ceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhh
Q 046112          363 DFGIARFLEAADEQ--TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       363 Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |||+++.+......  .......+|+.|+|||.+.+..++.++|||||||++|||+| |..||......  .....+...
T Consensus       235 DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~~~  312 (373)
T 3c1x_A          235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQG  312 (373)
T ss_dssp             CC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHHTT
T ss_pred             eccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHHcC
Confidence            99999866443221  12234567889999999999999999999999999999999 67777653221  122211111


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE  500 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~  500 (502)
                      ..           ...   ...++..+.+++.+||+.||++|||++|+++.|+.+...+..
T Consensus       313 ~~-----------~~~---p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          313 RR-----------LLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             CC-----------CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             CC-----------CCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence            00           000   113456788999999999999999999999999999877653

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-43  Score=352.43  Aligned_cols=253  Identities=20%  Similarity=0.272  Sum_probs=204.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|+||.||+|.+..+++.||+|++..........+.+|+++++.++||||+++++++.     .....+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence            457889999999999999999998999999999987654445567899999999999999999999853     455899


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC--CCcEEE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD--EMTAYV  361 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~--~~~~kl  361 (502)
                      +||||+++|+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.  ++.+||
T Consensus       125 lv~E~~~gg~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL  192 (387)
T 1kob_A          125 LILEFLSGGELFDRIAA---------EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKI  192 (387)
T ss_dssp             EEEECCCCCBHHHHTTC---------TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEE
T ss_pred             EEEEcCCCCcHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEE
Confidence            99999999999999852         2346899999999999999999999   899999999999999974  578999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ......+.....
T Consensus       193 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~~~~~  267 (387)
T 1kob_A          193 IDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDW  267 (387)
T ss_dssp             CCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHHCCC
T ss_pred             EecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC
Confidence            99999987654322   2234689999999999999999999999999999999999999976311  111111111100


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .    .       ...........+.+++.+|++.||++|||+.|+++
T Consensus       268 ~----~-------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          268 E----F-------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             C----C-------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             C----C-------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            0    0       00001133456789999999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-43  Score=349.80  Aligned_cols=275  Identities=22%  Similarity=0.314  Sum_probs=208.8

Q ss_pred             hccCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccC-cchhHHHHHHHHHHhcC-CCCccceeeecccccc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLH-HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVD  275 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  275 (502)
                      ..++|...+.||+|+||.||+|.+.     .++..||||+++... ....+.+.+|+++++++ +||||+++++++.   
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---  119 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT---  119 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---
Confidence            3467888899999999999999863     466789999987432 23457799999999999 8999999999964   


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhh-------------hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEED-------------KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIA  342 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~  342 (502)
                        ..+..++||||+++|+|.+++.......             ........+++..++.++.|++.||+|||   +.+|+
T Consensus       120 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iv  194 (344)
T 1rjb_A          120 --LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCV  194 (344)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             --eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence              3457899999999999999996421100             00011245899999999999999999999   89999


Q ss_pred             eecCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCC
Q 046112          343 HCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRP  421 (502)
Q Consensus       343 H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p  421 (502)
                      ||||||+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||+| |+.|
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999987655444334445567889999999988899999999999999999998 9999


Q ss_pred             CccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 046112          422 SDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE  500 (502)
Q Consensus       422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~  500 (502)
                      |...... ......+......           ..   ...++..+.+++.+||+.||.+|||+.|+++.|+.+.+...+
T Consensus       275 ~~~~~~~-~~~~~~~~~~~~~-----------~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          275 YPGIPVD-ANFYKLIQNGFKM-----------DQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             STTCCCS-HHHHHHHHTTCCC-----------CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             cccCCcH-HHHHHHHhcCCCC-----------CC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence            9763221 1122222111100           00   112356688999999999999999999999999988765443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.2e-43  Score=339.18  Aligned_cols=252  Identities=22%  Similarity=0.292  Sum_probs=196.6

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--------------------------chhHHHHHHHHHHh
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--------------------------DASKSFAVECEVTR  257 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  257 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4678899999999999999999989999999999864321                          11356889999999


Q ss_pred             cCCCCccceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 046112          258 NIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDC  337 (502)
Q Consensus       258 ~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~  337 (502)
                      +++||||+++++++..   ......++||||+++|+|.+++.           ...+++..+..++.|++.||+|||   
T Consensus        92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH---  154 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPT-----------LKPLSEDQARFYFQDLIKGIEYLH---  154 (298)
T ss_dssp             TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSC-----------SSCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred             hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHH---
Confidence            9999999999998643   23457899999999999988653           246899999999999999999999   


Q ss_pred             CCCceeecCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCc---cCccccchhHHHHHHH
Q 046112          338 QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE---VSSYGDVYSFGILLLE  414 (502)
Q Consensus       338 ~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDvws~Gv~l~e  414 (502)
                      +.+|+||||||+|||++.++.+||+|||+++.......  ......||+.|+|||.+.+..   ++.++|||||||++||
T Consensus       155 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~  232 (298)
T 2zv2_A          155 YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC  232 (298)
T ss_dssp             HTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred             HCCeeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence            88999999999999999999999999999987654322  223457999999999988765   4788999999999999


Q ss_pred             HHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          415 MFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       415 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      |++|+.||.....  ..+...+.....    .     .+..    ......+.+++.+|++.||++|||+.|+++
T Consensus       233 l~~g~~pf~~~~~--~~~~~~~~~~~~----~-----~~~~----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          233 FVFGQCPFMDERI--MCLHSKIKSQAL----E-----FPDQ----PDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHSSCSSCCSSH--HHHHHHHHHCCC----C-----CCSS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHCCCCCCCccH--HHHHHHHhcccC----C-----CCCc----cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            9999999975211  111111111100    0     0001    123456789999999999999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.9e-43  Score=344.56  Aligned_cols=273  Identities=22%  Similarity=0.298  Sum_probs=213.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEE-----cCCCeEEEEEEecccCc-chhHHHHHHHHHHhcC-CCCccceeeeccccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGIL-----FESTTAVAVKVFNVLHH-DASKSFAVECEVTRNI-RHRNLVKVFTACSGVDF  276 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  276 (502)
                      .++|...+.||+|+||.||+|.+     ..+++.||||+++.... ...+.+.+|+++++++ +||||+++++++.    
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~----   97 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----   97 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe----
Confidence            45788889999999999999974     35778999999975433 2346789999999999 9999999999964    


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhh--------hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCC
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEED--------KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKP  348 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~  348 (502)
                       ..+..++||||+++|+|.+++.......        ........+++..++.++.|++.||+|||   +.+|+||||||
T Consensus        98 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp  173 (313)
T 1t46_A           98 -IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAA  173 (313)
T ss_dssp             -SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             -cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCcc
Confidence             3447899999999999999985321100        00011235899999999999999999999   89999999999


Q ss_pred             CCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccc
Q 046112          349 SNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFK  427 (502)
Q Consensus       349 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~  427 (502)
                      +||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            999999999999999999987765444333344567889999999988899999999999999999999 9999976322


Q ss_pred             cccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          428 DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      .. .....+......        ..      ...++..+.+++.+|++.||.+|||+.|+++.|+++.++..
T Consensus       254 ~~-~~~~~~~~~~~~--------~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          254 DS-KFYKMIKEGFRM--------LS------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             SH-HHHHHHHHTCCC--------CC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             hh-HHHHHhccCCCC--------CC------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            11 122222111110        00      11234567899999999999999999999999999887654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=358.28  Aligned_cols=253  Identities=19%  Similarity=0.275  Sum_probs=201.5

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||.||+|.+..+|+.+|+|++.....  ...+.+.+|+++++.++||||+++++++     ...+.
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~   84 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH   84 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCE
Confidence            4578889999999999999999999999999999875432  2346688999999999999999999985     44558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC---CCCc
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMT  358 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~---~~~~  358 (502)
                      .++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++   .++.
T Consensus        85 ~~lv~E~~~gg~L~~~i~~----------~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~  151 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVA----------REYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAA  151 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHH----------CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCC
T ss_pred             EEEEEEeCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCc
Confidence            8999999999999998842          345899999999999999999999   89999999999999998   5678


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +||+|||+++.......  ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.....  ......+..
T Consensus       152 vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~  227 (444)
T 3soa_A          152 VKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQQIKA  227 (444)
T ss_dssp             EEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHH
T ss_pred             EEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHh
Confidence            99999999986654322  22356799999999999999999999999999999999999999965211  111111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ....    ...+.       .......+.+++.+|++.||++|||+.|+++
T Consensus       228 ~~~~----~~~~~-------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          228 GAYD----FPSPE-------WDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             TCCC----CCTTT-------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCC----CCccc-------cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1100    00000       1123456779999999999999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=355.54  Aligned_cols=244  Identities=24%  Similarity=0.283  Sum_probs=193.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  279 (502)
                      .++|...+.||+|+||.||+|++..+++.||||+++..   .......+..|..++..+ +||||+++++++     ...
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QTP   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----EeC
Confidence            46889999999999999999999999999999998743   223345678899999988 699999999984     445


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +..++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~i  163 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQK----------SRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHC  163 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCE
Confidence            589999999999999999842          245899999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .+...+...
T Consensus       164 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~~  239 (353)
T 3txo_A          164 KLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAILND  239 (353)
T ss_dssp             EECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC
T ss_pred             EEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--HHHHHHHcC
Confidence            999999997543222  2233467999999999999889999999999999999999999999763211  111111110


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKI  484 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~  484 (502)
                                 ...    +.......+.+++.+|+++||++||++
T Consensus       240 -----------~~~----~p~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          240 -----------EVV----YPTWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             -----------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             -----------CCC----CCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence                       000    011233457789999999999999998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.8e-43  Score=339.49  Aligned_cols=262  Identities=20%  Similarity=0.351  Sum_probs=198.6

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcC---CCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFE---STTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .++|...+.||+|+||.||+|.+..   .+..||+|+++.... ...+.+.+|+.++++++||||+++++++.      +
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~   87 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------c
Confidence            4577888999999999999998754   356799999875432 33467899999999999999999999852      2


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +..++||||+++|+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  155 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQV---------RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCV  155 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHH---------TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEE
T ss_pred             CccEEEEecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCE
Confidence            367899999999999999852         2345899999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  438 (502)
                      ||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+..
T Consensus       156 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~~  232 (281)
T 1mp8_A          156 KLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIEN  232 (281)
T ss_dssp             EECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT
T ss_pred             EECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHHc
Confidence            99999999876543221 1223456789999999988899999999999999999997 99999763221  11111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE  500 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~  500 (502)
                      ..           ..   .....++..+.+++.+|++.||++|||+.|+++.|+++.++...
T Consensus       233 ~~-----------~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  280 (281)
T 1mp8_A          233 GE-----------RL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA  280 (281)
T ss_dssp             TC-----------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             CC-----------CC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhcc
Confidence            10           00   01123456788999999999999999999999999999876543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.7e-43  Score=345.30  Aligned_cols=257  Identities=21%  Similarity=0.320  Sum_probs=199.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeeccccccc-------
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-------  276 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  276 (502)
                      ++|...+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++.....       
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            467888999999999999999988999999999875433 345779999999999999999999998643210       


Q ss_pred             ---------------------------------------------CCCcceeEEeeeccCCChhhhccCCchhhhccCCC
Q 046112          277 ---------------------------------------------QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAP  311 (502)
Q Consensus       277 ---------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~  311 (502)
                                                                   ......++||||+++|+|.+++...       ...
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~  158 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-------CSL  158 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC-------CSG
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc-------cCc
Confidence                                                         1122478999999999999998642       222


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceeccccccc----------ceecc
Q 046112          312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ----------TRSIG  381 (502)
Q Consensus       312 ~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~  381 (502)
                      ...++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........          .....
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG  235 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred             cchhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccc
Confidence            34567788999999999999999   899999999999999999999999999999877544221          12234


Q ss_pred             cccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHH
Q 046112          382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILE  461 (502)
Q Consensus       382 ~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  461 (502)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|..|+....    ......           ...   ..+.....
T Consensus       236 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----~~~~~~-----------~~~---~~~~~~~~  297 (332)
T 3qd2_B          236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----RIITDV-----------RNL---KFPLLFTQ  297 (332)
T ss_dssp             CC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----HHHHHH-----------HTT---CCCHHHHH
T ss_pred             cCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----HHHHHh-----------hcc---CCCccccc
Confidence            569999999999999999999999999999999999987754311    000000           000   11112234


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          462 CLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       462 ~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ....+.+++.+|++.||++|||++|+++
T Consensus       298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          298 KYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             CChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            5566789999999999999999999985

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-43  Score=344.44  Aligned_cols=245  Identities=23%  Similarity=0.289  Sum_probs=199.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||+|+...+|+.||+|+++...   ....+.+.+|..+++.++||||+++++++     .....
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   80 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ   80 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCCE
Confidence            56888899999999999999998899999999986431   23346688899999999999999999985     34558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        81 ~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL  147 (318)
T 1fot_A           81 IFMIMDYIEGGELFSLLRK----------SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKI  147 (318)
T ss_dssp             EEEEECCCCSCBHHHHHHH----------TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEeCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEE
Confidence            9999999999999999842          345889999999999999999999   999999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+++.....     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     ........ 
T Consensus       148 ~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~-  216 (318)
T 1fot_A          148 TDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEKIL-  216 (318)
T ss_dssp             CCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHH-
T ss_pred             eecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHH-
Confidence            999999865432     2345789999999999999999999999999999999999999975211     11111111 


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~  489 (502)
                             .....    +.......+.+++.+|++.||++||     +++|+.+
T Consensus       217 -------~~~~~----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          217 -------NAELR----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -------HCCCC----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -------hCCCC----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                   00000    0112234677999999999999999     7888764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-42  Score=340.10  Aligned_cols=272  Identities=25%  Similarity=0.339  Sum_probs=203.9

Q ss_pred             HhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC--CCCccceeeecccccccCCC
Q 046112          202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI--RHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       202 ~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~~~~  279 (502)
                      ...++|...+.||+|+||.||+|++  .++.||||++...   ....+..|.+++...  +||||+++++++.... ...
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~  107 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSW  107 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCC
Confidence            3456899999999999999999976  4899999998642   234455566666554  8999999999864321 112


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--------CceeecCCCCCe
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQP--------PIAHCDLKPSNI  351 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~--------~i~H~dlk~~NI  351 (502)
                      ...++||||+++|+|.++++.           ..+++..++.++.|++.||+|||   +.        +|+||||||+||
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Ni  173 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKS-----------TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNI  173 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGE
T ss_pred             CceEEEEeccCCCcHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHE
Confidence            578999999999999999842           24889999999999999999999   66        999999999999


Q ss_pred             eeCCCCcEEEeeeccceecccccccc--eecccccccccccCcccCCCccCcc------ccchhHHHHHHHHHhC-----
Q 046112          352 LLDDEMTAYVSDFGIARFLEAADEQT--RSIGVEGTTGYIAPEYGMGHEVSSY------GDVYSFGILLLEMFTG-----  418 (502)
Q Consensus       352 ll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------sDvws~Gv~l~el~tg-----  418 (502)
                      |++.++.+||+|||+++.+.......  ......||+.|+|||.+.+...+.+      +|||||||++|||+||     
T Consensus       174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~  253 (337)
T 3mdy_A          174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG  253 (337)
T ss_dssp             EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccc
Confidence            99999999999999998665433221  1224579999999999988766665      9999999999999999     


Q ss_pred             -----CCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 046112          419 -----LRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL  493 (502)
Q Consensus       419 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~  493 (502)
                           +.||.....................    ..+...... ...+++..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          254 IVEEYQLPYHDLVPSDPSYEDMREIVCIKK----LRPSFPNRW-SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             BCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGG-GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccccccHhhhcCCCCchhhhHHHHhhhc----cCccccccc-hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence                 5666543332222222211111110    001111110 123778889999999999999999999999999999


Q ss_pred             HHHHH
Q 046112          494 IKKKL  498 (502)
Q Consensus       494 i~~~~  498 (502)
                      +.+..
T Consensus       329 l~~~~  333 (337)
T 3mdy_A          329 MSESQ  333 (337)
T ss_dssp             HHHTT
T ss_pred             HHhhc
Confidence            98764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=346.42  Aligned_cols=260  Identities=22%  Similarity=0.373  Sum_probs=200.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEE----EEEEeccc-CcchhHHHHHHHHHHhcCCCCccceeeecccccccCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAV----AVKVFNVL-HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      .++|...+.||+|+||.||+|.+..+++.+    |+|.+... .....+.+.+|+.++++++||||++++++|..     
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence            357888999999999999999887777654    66666432 23456789999999999999999999998643     


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                       ...++|+||+++|+|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.
T Consensus        89 -~~~~~v~~~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~  155 (327)
T 3lzb_A           89 -STVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH  155 (327)
T ss_dssp             -SSEEEEECCCSSCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTE
T ss_pred             -CCceEEEEecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCC
Confidence             247899999999999999852         2356899999999999999999999   899999999999999999999


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHH
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  437 (502)
                      +||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......  .+...+.
T Consensus       156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~  233 (327)
T 3lzb_A          156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILE  233 (327)
T ss_dssp             EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHH
T ss_pred             EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHH
Confidence            99999999987655444333344567889999999999999999999999999999999 99999763221  1222221


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ....          ..    ....+...+.+++.+||+.||.+|||+.|+++.|+.+.+.
T Consensus       234 ~~~~----------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          234 KGER----------LP----QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             TTCC----------CC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             cCCC----------CC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            1110          00    0112345678999999999999999999999999998753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.8e-43  Score=338.44  Aligned_cols=265  Identities=18%  Similarity=0.254  Sum_probs=199.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|...+.||+|+||+||+|.+..+++.||||+++....  .....+.+|++++++++||||+++++++.     .+...
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence            468888999999999999999999999999999875432  23467889999999999999999999953     34588


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++ ++.+.+.         .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus        77 ~lv~e~~~~-~l~~~~~---------~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~  143 (292)
T 3o0g_A           77 TLVFEFCDQ-DLKKYFD---------SCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLA  143 (292)
T ss_dssp             EEEEECCSE-EHHHHHH---------HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCC-CHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEe
Confidence            999999975 5555542         22356899999999999999999999   8899999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCc-cCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||+++.......  ......||+.|+|||.+.+.. ++.++|||||||++|||++|..|+.........+....+....
T Consensus       144 Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~  221 (292)
T 3o0g_A          144 NFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT  221 (292)
T ss_dssp             CCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ecccceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence            9999987643322  223456899999999988765 8999999999999999999988864422222122222111110


Q ss_pred             cch------hhhccc-------CCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERA------EEIRAS-------SGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~------~~~~d~-------~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...      ....+.       ...............+.+++.+|++.||++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            000      000000       000011111234556779999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.5e-43  Score=338.71  Aligned_cols=258  Identities=24%  Similarity=0.392  Sum_probs=204.7

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|+||.||+|.+ .++..||+|+++.... ..+++.+|++++.+++||||+++++++.     .....+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   95 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIF   95 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEE-TTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEE-cCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCCCeE
Confidence            45778889999999999999965 5778899999975432 3577999999999999999999999953     445789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++|+|.+++..         ....+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        96 lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~D  163 (283)
T 3gen_A           96 IITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSD  163 (283)
T ss_dssp             EEECCCTTCBHHHHHHC---------GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECS
T ss_pred             EEEeccCCCcHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcc
Confidence            99999999999999853         2345899999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+++...... ........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......  .....+..... 
T Consensus       164 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~-  239 (283)
T 3gen_A          164 FGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLR-  239 (283)
T ss_dssp             TTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCC-
T ss_pred             ccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHhcccC-
Confidence            99998654332 122234557889999999998899999999999999999998 99999763211  11111111100 


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                             ..   .+   ..+...+.+++.+|++.||++|||++|+++.|+++.++
T Consensus       240 -------~~---~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          240 -------LY---RP---HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             -------CC---CC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CC---CC---CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                   00   00   12245678999999999999999999999999998765

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.7e-43  Score=350.59  Aligned_cols=255  Identities=20%  Similarity=0.257  Sum_probs=201.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-----cchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-----HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      +.|...+.||+|+||.||+|.+..+++.||||+++...     ....+.+.+|+++++.++||||+++++++.     ..
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~   98 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----SD   98 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence            46888899999999999999998999999999986321     123577999999999999999999999853     34


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc-
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT-  358 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~-  358 (502)
                      +..++||||+++|+|.+++...      ......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++. 
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~  169 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKR------ADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENS  169 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTT
T ss_pred             CEEEEEEeCCCCCCHHHHHHHh------cccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCC
Confidence            5889999999999998887431      122345889999999999999999999   899999999999999986654 


Q ss_pred             --EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          359 --AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       359 --~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                        +||+|||+++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  ..+....
T Consensus       170 ~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~  245 (351)
T 3c0i_A          170 APVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGII  245 (351)
T ss_dssp             CCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHH
T ss_pred             CcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHH
Confidence              99999999987654322  22345799999999999999999999999999999999999999976311  0111111


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ....            .............+.+++.+|++.||++|||+.|+++
T Consensus       246 ~~~~------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          246 KGKY------------KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HTCC------------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCC------------CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1110            0011111123456789999999999999999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=348.64  Aligned_cols=252  Identities=23%  Similarity=0.292  Sum_probs=187.9

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ..++|...+.||+|+||.||+|.+..+++.||||+++...  ..+.+.+|++++++++||||+++++++.     .....
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~  123 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEI  123 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeE
Confidence            4567889999999999999999998889999999987532  3466889999999999999999999964     34578


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC---CCcE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD---EMTA  359 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~---~~~~  359 (502)
                      ++||||+++|+|.+++..          ...+++.++..++.|++.||.|||   +.+|+||||||+|||++.   ++.+
T Consensus       124 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~  190 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVE----------KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPL  190 (349)
T ss_dssp             EEEECCCCSCBHHHHHTT----------CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCE
T ss_pred             EEEEEeCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCE
Confidence            999999999999999842          345899999999999999999999   889999999999999975   8899


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+.......
T Consensus       191 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~  267 (349)
T 2w4o_A          191 KIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE  267 (349)
T ss_dssp             EECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC
T ss_pred             EEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC
Confidence            999999998654322   12345689999999999999999999999999999999999999975322111111111110


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .     ...       .....+....+.+++.+|++.||++|||+.|+++
T Consensus       268 ~-----~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          268 Y-----YFI-------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             C-----CCC-------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C-----ccC-------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0     000       0011233456789999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7e-44  Score=349.86  Aligned_cols=275  Identities=24%  Similarity=0.349  Sum_probs=212.3

Q ss_pred             cCCCCCCcccccCCceEEEEEE----cCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGIL----FESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ++|...+.||+|+||.||+|.+    ..+++.||||++........+.+.+|++++++++||||+++++++..   .+..
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~  117 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR  117 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-------
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---cCCC
Confidence            4577889999999999999973    56799999999986655556789999999999999999999998643   2234


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.+++..         ....+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k  185 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQK---------HKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVK  185 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHH---------STTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEE
T ss_pred             ceEEEEECCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEE
Confidence            67899999999999999852         2345899999999999999999999   89999999999999999999999


Q ss_pred             Eeeeccceecccccccc-eecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQT-RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++......... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+.....+   +.......
T Consensus       186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~  262 (326)
T 2w1i_A          186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGND  262 (326)
T ss_dssp             ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTT
T ss_pred             EecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccc
Confidence            99999998765443221 122345778899999999888999999999999999999999998642110   00000000


Q ss_pred             cc-----cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          440 LP-----ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       440 ~~-----~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      ..     ....+......  .......++..+.+++.+||+.||++|||+.|+++.|+++++++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          263 KQGQMIVFHLIELLKNNG--RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             CCTHHHHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             cchhhhHHHHHHHhhcCC--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            00     00001111000  001112455678899999999999999999999999999998864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=351.60  Aligned_cols=248  Identities=23%  Similarity=0.276  Sum_probs=195.2

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeee
Q 046112          209 SENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEF  288 (502)
Q Consensus       209 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  288 (502)
                      ..+.||+|+||.||+|....+|+.||+|+++.......+.+.+|++++++++||||+++++++.     ..+..++||||
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~E~  167 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVMEY  167 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEEC
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEeC
Confidence            3568999999999999998999999999998655555678999999999999999999999964     34578999999


Q ss_pred             ccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee--CCCCcEEEeeecc
Q 046112          289 MANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL--DDEMTAYVSDFGI  366 (502)
Q Consensus       289 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll--~~~~~~kl~Dfg~  366 (502)
                      +++|+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||+  +.++.+||+|||+
T Consensus       168 ~~~~~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~  235 (373)
T 2x4f_A          168 VDGGELFDRIID---------ESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGL  235 (373)
T ss_dssp             CTTCEEHHHHHH---------TGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSS
T ss_pred             CCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCC
Confidence            999999998842         2245889999999999999999999   8999999999999999  6778999999999


Q ss_pred             ceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhh
Q 046112          367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       367 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      ++.+.....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.........     
T Consensus       236 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~-----  306 (373)
T 2x4f_A          236 ARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWD-----  306 (373)
T ss_dssp             CEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCC-----
T ss_pred             ceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCC-----
Confidence            987654332   22346899999999999999999999999999999999999999763211 111111111110     


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                             ............+.+++.+|++.||.+|||++|+++
T Consensus       307 -------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          307 -------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             -------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   000001133456789999999999999999999987

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5e-44  Score=351.10  Aligned_cols=276  Identities=24%  Similarity=0.344  Sum_probs=210.8

Q ss_pred             cCCCCCCcccccCCceEEEEE----EcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGI----LFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ++|...+.||+|+||.||+|.    ...++..||||++........+.+.+|++++++++||||+++++++..   ....
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGRQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSSC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCCc
Confidence            467888999999999999997    356889999999986655556779999999999999999999998642   2345


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~k  167 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQR---------HRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVK  167 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred             eEEEEEeecCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEE
Confidence            78999999999999999852         1234899999999999999999999   89999999999999999999999


Q ss_pred             Eeeeccceeccccccc-ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||++|+.||.....+......+. ..
T Consensus       168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~  246 (327)
T 3lxl_A          168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE-RD  246 (327)
T ss_dssp             ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----
T ss_pred             EcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc-cc
Confidence            9999999876544322 222345688899999999998999999999999999999999999865321110000000 00


Q ss_pred             cc--cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          440 LP--ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       440 ~~--~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      .+  ...........  .......++..+.+++.+|++.||++|||++|+++.|+.+....
T Consensus       247 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          247 VPALSRLLELLEEGQ--RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             CCHHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             cccHHHHHHHhhccc--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            00  00000000000  01111245667889999999999999999999999999876544

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3e-43  Score=349.92  Aligned_cols=253  Identities=20%  Similarity=0.301  Sum_probs=202.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||.||+|.+..++..||+|+++....  ...+.+.+|++++++++||||+++++++.     ..+.
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~  102 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF  102 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence            4578889999999999999999988999999999875432  23467889999999999999999999853     4458


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC---Cc
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE---MT  358 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~---~~  358 (502)
                      .++||||+++|+|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.+   +.
T Consensus       103 ~~lv~e~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~  169 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAA  169 (362)
T ss_dssp             EEEEECCCCSCBHHHHHT----------TCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCC
T ss_pred             EEEEEecCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCC
Confidence            899999999999999884          2356899999999999999999999   8999999999999999865   45


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +||+|||+++.......   .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  ..+...+..
T Consensus       170 ~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~  244 (362)
T 2bdw_A          170 VKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKA  244 (362)
T ss_dssp             EEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH
T ss_pred             EEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHh
Confidence            99999999986653322   2346799999999999999999999999999999999999999975211  111111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ......           ......+...+.+++.+|++.||++|||+.|+++.
T Consensus       245 ~~~~~~-----------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          245 GAYDYP-----------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             TCCCCC-----------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCCCCC-----------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            110000           00012334567899999999999999999998753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.1e-43  Score=347.78  Aligned_cols=274  Identities=20%  Similarity=0.304  Sum_probs=213.5

Q ss_pred             HHHHHhccCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecc
Q 046112          198 RMLYNATKGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTAC  271 (502)
Q Consensus       198 ~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~  271 (502)
                      ++.....++|...+.||+|+||.||+|.+.     .+++.||||+++.... .....+.+|+++++.++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344456678999999999999999999765     3578899999875432 2345688999999999999999999995


Q ss_pred             cccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCe
Q 046112          272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNI  351 (502)
Q Consensus       272 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NI  351 (502)
                      .     .....++||||+++|+|.+++...............+++..++.++.|++.||+|||   +.+|+||||||+||
T Consensus        98 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NI  169 (322)
T 1p4o_A           98 S-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNC  169 (322)
T ss_dssp             C-----SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGE
T ss_pred             c-----cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceE
Confidence            3     345789999999999999999653322222233456789999999999999999999   88999999999999


Q ss_pred             eeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCcccccccc
Q 046112          352 LLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNL  430 (502)
Q Consensus       352 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~  430 (502)
                      +++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......  
T Consensus       170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--  247 (322)
T 1p4o_A          170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--  247 (322)
T ss_dssp             EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--
T ss_pred             EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--
Confidence            999999999999999986654433222334457889999999998899999999999999999999 89998763211  


Q ss_pred             chHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          431 NLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                      .....+..   .        .....   ...++..+.+++.+|++.||++|||+.|+++.|+++.
T Consensus       248 ~~~~~~~~---~--------~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          248 QVLRFVME---G--------GLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             HHHHHHHT---T--------CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHHHHHc---C--------CcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            11111111   0        00000   1134556889999999999999999999999997653

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-43  Score=347.32  Aligned_cols=276  Identities=22%  Similarity=0.305  Sum_probs=209.9

Q ss_pred             CCCCCcccccCCceEEEEEE----cCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          207 FSSENLIGAGNFGSVYKGIL----FESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      |...+.||+|+||+||++.+    ..+++.||||+++.... ...+.+.+|++++++++||||+++++++..   .+...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---AGAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---TTTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---CCCce
Confidence            37789999999999988754    34789999999975432 335678999999999999999999998743   22457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..           ..+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.+||
T Consensus       110 ~~lv~e~~~~~~L~~~l~~-----------~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl  175 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPR-----------HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKI  175 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGG-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEecccCCcHHHHHhh-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEE
Confidence            8999999999999999853           23899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceeccccccc-ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          362 SDFGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      +|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||+||+.||............+.....
T Consensus       176 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~  255 (318)
T 3lxp_A          176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM  255 (318)
T ss_dssp             CCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH
T ss_pred             CCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch
Confidence            999999877544321 2223456788999999999989999999999999999999999998753221100000000000


Q ss_pred             c-cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhhC
Q 046112          441 P-ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEA  501 (502)
Q Consensus       441 ~-~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~~  501 (502)
                      . ............  ......++..+.+++.+||+.||++|||++|+++.|+.+.+++..+
T Consensus       256 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          256 TVLRLTELLERGER--LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             HHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             hHHHHHHHHhcccC--CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence            0 001111111110  1111244567889999999999999999999999999999988765

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.7e-43  Score=354.17  Aligned_cols=250  Identities=23%  Similarity=0.279  Sum_probs=196.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcC-CCCccceeeecccccccCCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  279 (502)
                      .++|...++||+|+||.||+|+...+++.||+|+++...   ......+..|..++.++ +||||+++++++     ...
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~  125 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE  125 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----ECS
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EEC
Confidence            357888999999999999999999999999999987532   22335678899998876 899999999984     445


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +..++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~i  192 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQR----------QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHI  192 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCE
Confidence            589999999999999998842          245899999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccc---cchHHHH
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN---LNLRNCV  436 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~---~~~~~~~  436 (502)
                      ||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .......
T Consensus       193 kL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~  270 (396)
T 4dc2_A          193 KLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL  270 (396)
T ss_dssp             EECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH
T ss_pred             EEeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH
Confidence            999999997533222  22345679999999999999999999999999999999999999996422111   1111111


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKI  484 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~  484 (502)
                      ...+..       ...    .++......+.+++.+|++.||++||++
T Consensus       271 ~~~i~~-------~~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          271 FQVILE-------KQI----RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHHHH-------CCC----CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             HHHHhc-------ccc----CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            111100       000    0111234567799999999999999996

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.7e-43  Score=338.38  Aligned_cols=264  Identities=24%  Similarity=0.389  Sum_probs=205.2

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCC---CeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFES---TTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .+|...+.||+|+||+||+|.+..+   ...||+|.++.... ...+.+.+|++++++++||||++++++|.    ..+.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~  100 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEG  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSS
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----cCCC
Confidence            3577789999999999999976433   34689999875332 34467899999999999999999999863    3445


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~k  168 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVK  168 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHC---------TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEE
T ss_pred             ceEEEEeCCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEE
Confidence            78899999999999999852         3456889999999999999999999   89999999999999999999999


Q ss_pred             Eeeeccceecccccc--cceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHH
Q 046112          361 VSDFGIARFLEAADE--QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  437 (502)
                      |+|||+++.......  ........+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......  .......
T Consensus       169 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~~  246 (298)
T 3f66_A          169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL  246 (298)
T ss_dssp             ECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHHH
T ss_pred             ECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHh
Confidence            999999987654332  122344567889999999998899999999999999999999 55566542211  1111111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE  500 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~  500 (502)
                      .....           ..+   ..++..+.+++.+|++.||++|||++|+++.|+++.+.+..
T Consensus       247 ~~~~~-----------~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          247 QGRRL-----------LQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             TTCCC-----------CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             cCCCC-----------CCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            11100           000   12345688999999999999999999999999999887654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.6e-44  Score=365.19  Aligned_cols=259  Identities=25%  Similarity=0.388  Sum_probs=208.1

Q ss_pred             HhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       202 ~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ...++|...+.||+|+||.||+|.+ .++..||||+++... ...+.|.+|++++++++||||+++++++.      .+.
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~  256 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEP  256 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEE-TTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred             echHHeEEEEEcccCCceEEEEEEE-CCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCc
Confidence            3456788889999999999999966 467889999997543 34678999999999999999999999863      236


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.++++.        .....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus       257 ~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl  325 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKS--------DEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKI  325 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHS--------HHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEE
T ss_pred             cEEEEeecCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEE
Confidence            8999999999999999964        11234788899999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      +|||+++....... .......+|..|+|||.+....++.++|||||||++|||+| |+.||......  .....+....
T Consensus       326 ~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~  402 (454)
T 1qcf_A          326 ADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGY  402 (454)
T ss_dssp             CSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHHTC
T ss_pred             eeCCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC
Confidence            99999986643221 11233456789999999998899999999999999999999 99999763211  1111111111


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                      .          .    .....++..+.+++.+||+.||++|||++++++.|+.+..
T Consensus       403 ~----------~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          403 R----------M----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             C----------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             C----------C----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            0          0    0012456678899999999999999999999999988754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7.7e-44  Score=351.16  Aligned_cols=250  Identities=24%  Similarity=0.316  Sum_probs=199.9

Q ss_pred             HhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcC-CCCccceeeecccccccC
Q 046112          202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       202 ~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  277 (502)
                      ...++|...+.||+|+||.||+|++..+++.||+|+++...   ......+..|..++..+ +||||+++++++     .
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~   88 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----Q   88 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----E
Confidence            34578999999999999999999998999999999987431   23346678899998876 899999999985     4


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                      ..+..++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++
T Consensus        89 ~~~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g  155 (345)
T 1xjd_A           89 TKENLFFVMEYLNGGDLMYHIQS----------CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDG  155 (345)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTS
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCC
Confidence            45589999999999999999842          245889999999999999999999   89999999999999999999


Q ss_pred             cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHH
Q 046112          358 TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  437 (502)
                      .+||+|||+++......  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  ..+...+.
T Consensus       156 ~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~  231 (345)
T 1xjd_A          156 HIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIR  231 (345)
T ss_dssp             CEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH
T ss_pred             CEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHH
Confidence            99999999997543222  123456799999999999999999999999999999999999999975311  11111111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKIN-DVE  488 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~-ev~  488 (502)
                      ...         ...      .......+.+++.+|++.||++||++. |+.
T Consensus       232 ~~~---------~~~------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          232 MDN---------PFY------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HCC---------CCC------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             hCC---------CCC------CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            110         000      112345677999999999999999997 654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.4e-43  Score=337.90  Aligned_cols=262  Identities=23%  Similarity=0.391  Sum_probs=213.9

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ..++|...+.||+|+||.||+|.+..++..||+|+++.. ....+.+.+|++++++++||||+++++++.     .....
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   84 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF   84 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCE
Confidence            456788889999999999999999888999999998753 334577999999999999999999999953     34578


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++|+|.+++..        .....+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~  153 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRE--------CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVA  153 (288)
T ss_dssp             EEEEECCTTEEHHHHHHH--------CCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEEEEcCCCCcHHHHHHh--------cccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEc
Confidence            999999999999999853        33456899999999999999999999   8899999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....  ....+.+.....
T Consensus       154 Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--~~~~~~~~~~~~  230 (288)
T 3kfa_A          154 DFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKDYR  230 (288)
T ss_dssp             CCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCC
T ss_pred             cCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhccCC
Confidence            999998665332 223344557889999999998899999999999999999999 9999976321  112222111110


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      .           .   ....++..+.+++.+|++.||.+|||+.|+++.|+.+..+.
T Consensus       231 ~-----------~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          231 M-----------E---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             C-----------C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             C-----------C---CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            0           0   01133567889999999999999999999999999887654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.1e-42  Score=336.31  Aligned_cols=267  Identities=19%  Similarity=0.289  Sum_probs=209.3

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ..++|...+.||+|+||.||+|.+..+++.||||++....  ....+..|+++++.++|++++..+.+|.    ...+..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~   80 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYN   80 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETTEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeec----CCCCce
Confidence            4578999999999999999999988999999999876432  2345888999999999999888887763    344578


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee---CCCCcE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTA  359 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll---~~~~~~  359 (502)
                      ++||||+ +|+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||+   +.++.+
T Consensus        81 ~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~  147 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNF---------CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLV  147 (296)
T ss_dssp             EEEEECC-CCBHHHHHHH---------TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCE
T ss_pred             EEEEEcc-CCCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeE
Confidence            9999999 9999999852         2345899999999999999999999   8999999999999999   788999


Q ss_pred             EEeeeccceeccccccc-----ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccc-cc-h
Q 046112          360 YVSDFGIARFLEAADEQ-----TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN-LN-L  432 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~-~~-~  432 (502)
                      ||+|||+++........     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .. +
T Consensus       148 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  227 (296)
T 4hgt_A          148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY  227 (296)
T ss_dssp             EECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred             EEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh
Confidence            99999999876544321     12234678999999999999999999999999999999999999997643221 11 1


Q ss_pred             HHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          433 RNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       433 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      ...............           ...++..+.+++.+|++.||++|||++++++.|+++.++..
T Consensus       228 ~~~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          228 ERISEKKMSTPIEVL-----------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHHHHHHHSCHHHH-----------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             hhhhcccccchhhhh-----------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            111111111100000           01234678899999999999999999999999999987754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.1e-42  Score=332.82  Aligned_cols=254  Identities=23%  Similarity=0.324  Sum_probs=204.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|+.+++.++||||+++++++.     ..+..
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence            356888899999999999999988899999999987432 334577899999999999999999999853     34578


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++|+||+++++|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        81 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~  147 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEP----------DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKIS  147 (276)
T ss_dssp             EEEEECCTTEEGGGGSBT----------TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEecCCCcHHHHHhh----------ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEe
Confidence            999999999999999842          345899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCcc-CccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEV-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||++................||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+........+..+......
T Consensus       148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  227 (276)
T 2yex_A          148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY  227 (276)
T ss_dssp             CCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT
T ss_pred             eCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc
Confidence            9999987654333223345678999999999988765 778999999999999999999997643322222222211100


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                                ...    .......+.+++.+|++.||++|||++|+++
T Consensus       228 ----------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 ----------LNP----WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ----------STT----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----------cCc----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                      000    1123456778999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.3e-42  Score=335.92  Aligned_cols=266  Identities=19%  Similarity=0.290  Sum_probs=212.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||++....  ..+.+.+|+++++.++|++++..+.++.    ......+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEE----EETTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCcccccc----CCCCceE
Confidence            468899999999999999999988999999999986533  2356899999999999999888877763    3345789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee---CCCCcEE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAY  360 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll---~~~~~~k  360 (502)
                      +||||+ +++|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||+   +.++.+|
T Consensus        82 lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~k  148 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNF---------CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVY  148 (296)
T ss_dssp             EEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEE
T ss_pred             EEEEec-CCCHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEE
Confidence            999999 9999999852         2346899999999999999999999   8999999999999999   4889999


Q ss_pred             Eeeeccceeccccccc-----ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccc-cc-hH
Q 046112          361 VSDFGIARFLEAADEQ-----TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN-LN-LR  433 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~-~~-~~  433 (502)
                      |+|||+++........     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .. +.
T Consensus       149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  228 (296)
T 3uzp_A          149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE  228 (296)
T ss_dssp             ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred             EeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh
Confidence            9999999876544321     11234678999999999999999999999999999999999999998632211 11 11


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      .............           ....++..+.+++.+||+.||++|||++++++.|+.+.++..
T Consensus       229 ~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          229 RISEKKMSTPIEV-----------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHHHHHHSCHHH-----------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             hhcccccCCchHH-----------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence            2111111111100           011234678899999999999999999999999999987654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.9e-43  Score=343.98  Aligned_cols=272  Identities=21%  Similarity=0.328  Sum_probs=210.3

Q ss_pred             ccCCCCCCcccccCCceEEEEEEc-------CCCeEEEEEEecccCc-chhHHHHHHHHHHhcC-CCCccceeeeccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILF-------ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNI-RHRNLVKVFTACSGV  274 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  274 (502)
                      .++|...+.||+|+||.||+|.+.       .++..||||+++.... ...+.+.+|+++++++ +||||++++++|.  
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc--
Confidence            457888899999999999999865       4577899999875432 3346789999999999 8999999999964  


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhhh------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEEDK------RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKP  348 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~  348 (502)
                         ..+..++||||+++|+|.+++........      .......+++..++.++.|++.||+|||   +.+|+||||||
T Consensus       112 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp  185 (334)
T 2pvf_A          112 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAA  185 (334)
T ss_dssp             ---SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred             ---cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCcc
Confidence               34578999999999999999964221000      0011245899999999999999999999   89999999999


Q ss_pred             CCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccc
Q 046112          349 SNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFK  427 (502)
Q Consensus       349 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~  427 (502)
                      +||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            999999999999999999987655443333344567889999999988899999999999999999999 9999976321


Q ss_pred             cccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          428 DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      .  .+...+.....           ..   ....+...+.+++.+||+.||.+|||+.|+++.|+++.....
T Consensus       266 ~--~~~~~~~~~~~-----------~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          266 E--ELFKLLKEGHR-----------MD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             H--HHHHHHHHTCC-----------CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             H--HHHHHHhcCCC-----------CC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            1  11111111110           00   011345568899999999999999999999999999977543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-42  Score=335.93  Aligned_cols=263  Identities=22%  Similarity=0.346  Sum_probs=206.1

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCe---EEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTT---AVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      |...++||+|+||+||+|.+..++.   .||+|+++.... ...+.+.+|++++++++||||+++++++..    .+...
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~   98 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP----PEGLP   98 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSSCC
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec----CCCCc
Confidence            4456889999999999998655444   799999875433 334678999999999999999999998632    23345


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++|+||+.+|+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        99 ~~v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~  166 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRS---------PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVA  166 (298)
T ss_dssp             EEEECCCTTCBHHHHHHC---------TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEecccCCCHHHHHhc---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeC
Confidence            899999999999999852         3456889999999999999999999   8899999999999999999999999


Q ss_pred             eeccceecccccc--cceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          363 DFGIARFLEAADE--QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       363 Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |||+++.......  ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+..... .......+....
T Consensus       167 Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~  245 (298)
T 3pls_A          167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQGR  245 (298)
T ss_dssp             CTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHHTTC
T ss_pred             cCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhhcCC
Confidence            9999986644332  1222345678999999999999999999999999999999996655433211 112222221111


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE  500 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~  500 (502)
                      ..           ..   ...++..+.+++.+|++.||.+|||++++++.|+++.+++..
T Consensus       246 ~~-----------~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          246 RL-----------PQ---PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             CC-----------CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             CC-----------CC---CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            00           00   112345678999999999999999999999999999887654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.3e-43  Score=335.41  Aligned_cols=255  Identities=23%  Similarity=0.338  Sum_probs=202.7

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||.||+|.+  .++.||||+++...  ....+.+.+|++++++++||||+++++++...   ....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence            35788889999999999999977  58899999987543  23346799999999999999999999997432   2357


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeecCCCCCeeeCCCCcE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPP--IAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--i~H~dlk~~NIll~~~~~~  359 (502)
                      .++||||+++|+|.+++..        .....+++..++.++.|++.||+|||   +.+  |+||||||+||+++.++.+
T Consensus        84 ~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~  152 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHE--------GTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTA  152 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHS--------CSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCE
T ss_pred             eEeeecccCCCcHHHHHhh--------cccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcce
Confidence            8999999999999999964        33346899999999999999999999   777  9999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCc---cccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSS---YGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                      +|+|||++.....       ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||........ .....
T Consensus       153 ~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~  224 (271)
T 3kmu_A          153 RISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVA  224 (271)
T ss_dssp             EEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHHHH
T ss_pred             eEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHHHH
Confidence            9999998754221       2345799999999988766554   79999999999999999999976321110 01110


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                      ....        .+      .....++..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       225 ~~~~--------~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          225 LEGL--------RP------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HSCC--------CC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             hcCC--------CC------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            0000        00      0111345568899999999999999999999999998864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.3e-43  Score=344.06  Aligned_cols=270  Identities=23%  Similarity=0.330  Sum_probs=206.1

Q ss_pred             cCCCCCCcccccCCceEEEEE----EcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGI----LFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      ..|...+.||+|+||.||+|.    ...+++.||||+++... ....+.+.+|++++++++||||+++++++..   .+.
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence            347778999999999999997    45689999999987433 2345779999999999999999999998653   223


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++||||+++|+|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~  165 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPK---------NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQV  165 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHH---------HTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred             ceEEEEEEeCCCCcHHHHHHh---------ccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCE
Confidence            468999999999999999842         2345899999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceeccccccc-ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      ||+|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||+||+.|+.......   ......
T Consensus       166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~  242 (302)
T 4e5w_A          166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF---LKMIGP  242 (302)
T ss_dssp             EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHHCS
T ss_pred             EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHH---hhccCC
Confidence            99999999877544332 22334568889999999999999999999999999999999999875421100   000000


Q ss_pred             hccc----c-hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          439 ALPE----R-AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       439 ~~~~----~-~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                      ....    . ...+....   .......++..+.+++.+||+.||.+|||++|+++.|+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          243 THGQMTVTRLVNTLKEGK---RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             CCGGGHHHHHHHHHHTTC---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccccCHHHHHHHHhccC---CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0000    0 00000000   00111234567889999999999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.5e-43  Score=343.16  Aligned_cols=282  Identities=21%  Similarity=0.267  Sum_probs=216.3

Q ss_pred             HHHHHHhccCCCCCCcccccCCceEEEEEE-----cCCCeEEEEEEecccCc-chhHHHHHHHHHHhcC-CCCccceeee
Q 046112          197 YRMLYNATKGFSSENLIGAGNFGSVYKGIL-----FESTTAVAVKVFNVLHH-DASKSFAVECEVTRNI-RHRNLVKVFT  269 (502)
Q Consensus       197 ~~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~  269 (502)
                      ........++|...+.||+|+||.||+|.+     ..+++.||||+++.... ...+.+.+|++++.++ +||||+++++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            334444567899999999999999999974     35678999999875433 2346789999999999 7999999999


Q ss_pred             cccccccCCCcceeEEeeeccCCChhhhccCCchhhhc------cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 046112          270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKR------HKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAH  343 (502)
Q Consensus       270 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H  343 (502)
                      ++..    .+...++||||+++|+|.+++.........      ......+++..+..++.|++.||.|||   +.+|+|
T Consensus        99 ~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H  171 (316)
T 2xir_A           99 ACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIH  171 (316)
T ss_dssp             EECC----TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred             EEec----CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence            8642    234589999999999999999642210000      001233889999999999999999999   899999


Q ss_pred             ecCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCC
Q 046112          344 CDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPS  422 (502)
Q Consensus       344 ~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~  422 (502)
                      |||||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||
T Consensus       172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~  251 (316)
T 2xir_A          172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  251 (316)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987655443334445667899999999998899999999999999999998 99999


Q ss_pred             ccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 046112          423 DDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE  500 (502)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~  500 (502)
                      ....... .....+......           ..   ...+...+.+++.+||+.||.+|||+.|+++.|+.+.+...+
T Consensus       252 ~~~~~~~-~~~~~~~~~~~~-----------~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  314 (316)
T 2xir_A          252 PGVKIDE-EFCRRLKEGTRM-----------RA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ  314 (316)
T ss_dssp             TTCCCSH-HHHHHHHHTCCC-----------CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             cccchhH-HHHHHhccCccC-----------CC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcc
Confidence            7632221 111111111100           00   112345678999999999999999999999999999876543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.5e-43  Score=345.93  Aligned_cols=274  Identities=23%  Similarity=0.337  Sum_probs=213.0

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCC-----eEEEEEEecccCc-chhHHHHHHHHHHhcC-CCCccceeeecccccc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFEST-----TAVAVKVFNVLHH-DASKSFAVECEVTRNI-RHRNLVKVFTACSGVD  275 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  275 (502)
                      ..++|...+.||+|+||.||+|.+...+     ..||+|+++.... ...+.+.+|+++++++ +||||++++++|.   
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---  120 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT---  120 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---
Confidence            4567888899999999999999876555     4799999875432 3456789999999999 8999999999964   


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhhhc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCe
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEEDKR----HKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNI  351 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NI  351 (502)
                        ..+..++||||+++|+|.+++.........    ......+++..++.++.|++.||+|||   +.+|+||||||+||
T Consensus       121 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NI  195 (333)
T 2i1m_A          121 --HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNV  195 (333)
T ss_dssp             --SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGC
T ss_pred             --cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceE
Confidence              344789999999999999998542111000    001346899999999999999999999   88999999999999


Q ss_pred             eeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCcccccccc
Q 046112          352 LLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNL  430 (502)
Q Consensus       352 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~  430 (502)
                      |++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |+.||....... 
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-  274 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-  274 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-
Confidence            999999999999999987655443333344567889999999988899999999999999999999 999997632211 


Q ss_pred             chHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          431 NLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      .....+......        .   .   ...++..+.+++.+||+.||.+|||+.|+++.|+.+.++..
T Consensus       275 ~~~~~~~~~~~~--------~---~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  329 (333)
T 2i1m_A          275 KFYKLVKDGYQM--------A---Q---PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR  329 (333)
T ss_dssp             HHHHHHHHTCCC--------C---C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCC--------C---C---CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence            122222211110        0   0   01234567899999999999999999999999999877654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3e-43  Score=348.02  Aligned_cols=245  Identities=21%  Similarity=0.273  Sum_probs=200.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||+|++..+|+.||+|+++...   ....+.+.+|+++++.++||||+++++++     .....
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~  115 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCCE
Confidence            57888999999999999999998899999999986432   23346788999999999999999999984     44558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus       116 ~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL  182 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRR----------IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQV  182 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEE
Confidence            9999999999999999842          245899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+++.....     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  ......+...  
T Consensus       183 ~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~--  253 (350)
T 1rdq_E          183 TDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVSG--  253 (350)
T ss_dssp             CCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC--
T ss_pred             cccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--HHHHHHHHcC--
Confidence            999999866432     2345689999999999999999999999999999999999999975211  1111111110  


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK-----INDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt-----~~ev~~  489 (502)
                               ...    +.......+.+++.+|++.||++||+     ++|+.+
T Consensus       254 ---------~~~----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          254 ---------KVR----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---------CCC----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---------CCC----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                     000    01123456779999999999999998     777754

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.2e-43  Score=342.22  Aligned_cols=270  Identities=21%  Similarity=0.223  Sum_probs=210.6

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|+||.||++....+++.||||++........+.+.+|+++++.++||||+++++++... .......+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCceeE
Confidence            35788899999999999999998899999999998765555567899999999999999999999987421 12344788


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +|+||+++|+|.+++....      .....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus       107 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~d  177 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLK------DKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMD  177 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHH------TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEeCCCCcHHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEe
Confidence            9999999999999985311      23466899999999999999999999   88999999999999999999999999


Q ss_pred             eccceeccccccc-------ceecccccccccccCcccCCCc---cCccccchhHHHHHHHHHhCCCCCccccccccchH
Q 046112          364 FGIARFLEAADEQ-------TRSIGVEGTTGYIAPEYGMGHE---VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR  433 (502)
Q Consensus       364 fg~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~  433 (502)
                      ||++.........       .......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||+..........
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  257 (317)
T 2buj_A          178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA  257 (317)
T ss_dssp             CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred             cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence            9998765432111       0112345799999999987653   78999999999999999999999976433332222


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ........          ...    ...+...+.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus       258 ~~~~~~~~----------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          258 LAVQNQLS----------IPQ----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HHHHCC------------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             HHhhccCC----------CCc----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            22211100          000    012345688999999999999999999999999887543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=9.8e-43  Score=338.90  Aligned_cols=271  Identities=23%  Similarity=0.255  Sum_probs=202.0

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-----chhHHHHHHHHHHhcCC---CCccceeeeccccc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-----DASKSFAVECEVTRNIR---HRNLVKVFTACSGV  274 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  274 (502)
                      .+++|...+.||+|+||+||+|++..+++.||||+++....     .....+.+|++++++++   ||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            36789999999999999999999888999999999864321     12356778888877664   99999999997543


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                      ........++||||+. |+|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+|||++
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~  154 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDK--------APPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVT  154 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHT--------CCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEc
Confidence            3233336789999996 699999854        33345899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHH
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN  434 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~  434 (502)
                      .++.+||+|||+++......   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .+..
T Consensus       155 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~  230 (308)
T 3g33_A          155 SGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGK  230 (308)
T ss_dssp             TTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHH
T ss_pred             CCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence            99999999999997654322   2234568999999999999999999999999999999999999997632211 1111


Q ss_pred             HHHhhcccchhhh----------cccC-CCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          435 CVKSALPERAEEI----------RASS-GSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       435 ~~~~~~~~~~~~~----------~d~~-~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ............+          .... .........+....+.+++.+|++.||++|||+.|+++
T Consensus       231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1111100000000          0000 00001111234567789999999999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2e-42  Score=338.06  Aligned_cols=270  Identities=21%  Similarity=0.270  Sum_probs=189.3

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .++|...+.||+|+||.||+|.+..+++.||+|+++.... ...+.+.+|++++++++||||+++++++.     .++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----TENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECCeE
Confidence            4678999999999999999998888999999999875432 33467889999999999999999999953     44588


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||++ |+|.+++...    ........+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus        79 ~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~  150 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSR----TVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLG  150 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHH----HSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEecC-CCHHHHHHhc----cccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEEC
Confidence            99999997 6999988531    11133456899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc-
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL-  440 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-  440 (502)
                      |||+++.......  ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+.......- 
T Consensus       151 Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~  227 (317)
T 2pmi_A          151 DFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGT  227 (317)
T ss_dssp             CCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCS
T ss_pred             cCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCC
Confidence            9999987643221  1234568999999999876 468999999999999999999999997632211 1111111100 


Q ss_pred             -ccc----hhhh--cccCCCC-----c-----chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 -PER----AEEI--RASSGST-----Q-----RSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 -~~~----~~~~--~d~~~~~-----~-----~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                       ...    ....  ..+....     .     ..........+.+++.+|++.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence             000    0000  0000000     0     0000123456889999999999999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.1e-43  Score=346.47  Aligned_cols=270  Identities=19%  Similarity=0.261  Sum_probs=201.3

Q ss_pred             cCCCCCCcccccCCceEEEEEEcC---CCeEEEEEEecccCcc-----------hhHHHHHHHHHHhcCCCCccceeeec
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFE---STTAVAVKVFNVLHHD-----------ASKSFAVECEVTRNIRHRNLVKVFTA  270 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~  270 (502)
                      ++|...+.||+|+||.||+|.+..   ++..||||++......           ....+.+|+..+..++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            578889999999999999998876   7889999998754321           12346678888999999999999998


Q ss_pred             ccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCC
Q 046112          271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSN  350 (502)
Q Consensus       271 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~N  350 (502)
                      +... +.+....++||||+ +++|.+++..          ...+++..++.++.|++.||+|||   +.+|+||||||+|
T Consensus       117 ~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N  181 (345)
T 2v62_A          117 GLTE-FKGRSYRFMVMERL-GIDLQKISGQ----------NGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAAN  181 (345)
T ss_dssp             EEEE-SSSCEEEEEEEECE-EEEHHHHCBG----------GGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred             cccc-cCCCcEEEEEEecc-CCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHH
Confidence            7542 23456889999999 9999999853          226899999999999999999999   8899999999999


Q ss_pred             eeeCCCC--cEEEeeeccceeccccccc-----ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCc
Q 046112          351 ILLDDEM--TAYVSDFGIARFLEAADEQ-----TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD  423 (502)
Q Consensus       351 Ill~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~  423 (502)
                      ||++.++  .+||+|||+++.+......     .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.
T Consensus       182 Ill~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~  261 (345)
T 2v62_A          182 LLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE  261 (345)
T ss_dssp             EEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred             EEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9998877  9999999999877543321     11134578999999999999999999999999999999999999997


Q ss_pred             cccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          424 DMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                      .......................+.... .     ...++..+.+++.+||+.||++|||++++++.|+.+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          262 QNLKDPVAVQTAKTNLLDELPQSVLKWA-P-----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             GGTTCHHHHHHHHHHHHHTTTHHHHHHS-C-----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             ccccccHHHHHHHHhhcccccHHHHhhc-c-----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            5332222222111111111111110000 0     0023457889999999999999999999999997653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-43  Score=344.20  Aligned_cols=262  Identities=26%  Similarity=0.432  Sum_probs=199.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCC----CeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFES----TTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      ++|...+.||+|+||.||+|.+..+    +..||||+++.... .....+.+|++++++++||||+++++++.     ..
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~  118 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY  118 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----cC
Confidence            3566678999999999999987644    34699999875432 23457899999999999999999999953     34


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +..++||||+++|+|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~  186 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLRE---------KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVC  186 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHH---------TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCE
T ss_pred             CCcEEEEeCCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcE
Confidence            578999999999999999852         2356899999999999999999999   8899999999999999999999


Q ss_pred             EEeeeccceeccccccc-ceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHH
Q 046112          360 YVSDFGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  437 (502)
                      ||+|||+++........ .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......  .....+.
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~  264 (333)
T 1mqb_A          187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAIN  264 (333)
T ss_dssp             EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHH
T ss_pred             EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHH
Confidence            99999999876543221 12223456789999999999999999999999999999999 99999753211  1111111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      ...          ...    ....++..+.+++.+||+.||++||++.++++.|+++.+...
T Consensus       265 ~~~----------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          265 DGF----------RLP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             TTC----------CCC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             CCC----------cCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            110          000    011345668899999999999999999999999999876543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.8e-43  Score=349.12  Aligned_cols=249  Identities=22%  Similarity=0.303  Sum_probs=199.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||+|.+..+++.||+|+++..   .....+.+.+|+++++.++||||+++++++     .....
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~   89 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEED   89 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCCE
Confidence            5688889999999999999999999999999998642   223456788999999999999999999985     34458


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL  156 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQ----------QNVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHI  156 (384)
T ss_dssp             EEEEECCCTTEEHHHHHH----------TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEE
Confidence            999999999999999984          2356899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCC---CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG---HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +|||+++.+....   ......||+.|+|||++..   ..++.++|||||||++|||++|+.||......  ...+....
T Consensus       157 ~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~~  231 (384)
T 4fr4_A          157 TDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIVHT  231 (384)
T ss_dssp             CCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHHHHHH
T ss_pred             eccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHHHHHH
Confidence            9999998764332   2245679999999999874   45899999999999999999999999753221  11111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC-HHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK-INDVE  488 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt-~~ev~  488 (502)
                      ....        ..    .+.......+.+++.+|++.||.+||+ ++++.
T Consensus       232 ~~~~--------~~----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          232 FETT--------VV----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             HHHC--------CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             Hhhc--------cc----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence            1000        00    001123456789999999999999998 66654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.3e-43  Score=339.70  Aligned_cols=269  Identities=19%  Similarity=0.283  Sum_probs=200.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .++|...+.||+|+||.||+|....+++.||||+++...   ......+.+|++++++++||||+++++++..     .+
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~  105 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DN  105 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CC
Confidence            357888999999999999999988899999999987432   2334678899999999999999999998643     44


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.+++....      .....+++..++.++.+++.||.|||   +.+|+||||||+||+++.++.+|
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~k  176 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFK------KQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVK  176 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEE
T ss_pred             cEEEEEecCCCCCHHHHHHHhc------ccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEE
Confidence            7899999999999999985311      23456899999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||+++.......  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.........+...+... 
T Consensus       177 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-  253 (310)
T 2wqm_A          177 LGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-  253 (310)
T ss_dssp             ECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT-
T ss_pred             EEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc-
Confidence            999999976543322  12245689999999999999999999999999999999999999975322111111111110 


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhhC
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEA  501 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~~  501 (502)
                        .        .....  ...+...+.+++.+||+.||++|||+.++++.|++++.....+
T Consensus       254 --~--------~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          254 --D--------YPPLP--SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             --C--------SCCCC--TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             --c--------CCCCc--ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence              0        00000  0123456789999999999999999999999999998876654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=350.11  Aligned_cols=277  Identities=20%  Similarity=0.263  Sum_probs=214.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|...++||+|+||+||+|.+..+++.||||+++... ....+.+.+|++++++++||||+++++++..   ......+
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~~~   85 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHKV   85 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCeeE
Confidence            46888899999999999999998899999999987533 2335678899999999999999999998642   2234679


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee----CCCCcE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL----DDEMTA  359 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll----~~~~~~  359 (502)
                      +||||+++|+|.+++...       .....+++..++.++.|++.||+|||   +.+|+||||||+|||+    +.++.+
T Consensus        86 lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~  155 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEP-------SNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVY  155 (396)
T ss_dssp             EEECCCTTEEHHHHTTSG-------GGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEE
T ss_pred             EEEecCCCCCHHHHHHhh-------hcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeE
Confidence            999999999999999641       12234899999999999999999999   8999999999999999    788889


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCC--------CccCccccchhHHHHHHHHHhCCCCCccccccccc
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG--------HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN  431 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~  431 (502)
                      ||+|||+++.......   .....||+.|+|||++.+        ..++.++|||||||++|||+||+.||.........
T Consensus       156 kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~  232 (396)
T 4eut_A          156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (396)
T ss_dssp             EECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred             EEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence            9999999987654322   234568999999998765        56888999999999999999999999753222111


Q ss_pred             ---hHHHHHhhcccchhhh---------cccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          432 ---LRNCVKSALPERAEEI---------RASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       432 ---~~~~~~~~~~~~~~~~---------~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                         +..............+         +....+............+.+++.+|++.||++||++.|+++.++.+.++
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence               1111111111111100         01111222233467788899999999999999999999999999887654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.2e-42  Score=336.82  Aligned_cols=265  Identities=22%  Similarity=0.268  Sum_probs=198.5

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ..++|...+.||+|+||+||+|.+ .+++.||+|+++....  .....+.+|++++++++||||+++++++.     ...
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~   92 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SER   92 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSS
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCC
Confidence            346788999999999999999976 5689999999874322  23467889999999999999999999953     445


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||++ |+|.+++.         .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus        93 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~k  159 (311)
T 3niz_A           93 CLTLVFEFME-KDLKKVLD---------ENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALK  159 (311)
T ss_dssp             CEEEEEECCS-EEHHHHHH---------TCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred             EEEEEEcCCC-CCHHHHHH---------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEE
Confidence            8899999997 58888774         23355899999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++.......  ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+.......
T Consensus       160 l~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~  236 (311)
T 3niz_A          160 LADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSIL  236 (311)
T ss_dssp             ECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHH
T ss_pred             EccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHH
Confidence            999999987643322  2234568999999999876 568999999999999999999999997643222 122211111


Q ss_pred             cccchhh---------hcccCCC-----CcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAEE---------IRASSGS-----TQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~~---------~~d~~~~-----~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .......         .......     ............+.+++.+|++.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          237 GTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1000000         0000000     000111123456789999999999999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.7e-43  Score=335.34  Aligned_cols=250  Identities=22%  Similarity=0.365  Sum_probs=181.3

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|++++++++||||+++++++.     ..+
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCC
Confidence            457888999999999999999988899999999986432   122467899999999999999999999953     345


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++++|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~k  152 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKN---------RVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIK  152 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHT---------CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEE
T ss_pred             eEEEEEecCCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEE
Confidence            78999999999999999852         2356899999999999999999999   88999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||++........  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......     ......
T Consensus       153 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~  225 (278)
T 3cok_A          153 IADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----TLNKVV  225 (278)
T ss_dssp             ECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CC
T ss_pred             EEeecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----HHHHHh
Confidence            999999986643322  1223568999999999999899999999999999999999999997532111     000000


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                              ....    .........+.+++.+|++.||++|||++++++
T Consensus       226 --------~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          226 --------LADY----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             --------SSCC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --------hccc----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                    0000    001123456779999999999999999999976

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7.8e-43  Score=342.04  Aligned_cols=249  Identities=22%  Similarity=0.272  Sum_probs=179.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-CCccceeeecccccccCCCcceeEEeee
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDFKALVYEF  288 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~  288 (502)
                      .+.||+|+||.||+|.+..+++.||||+++..   ....+.+|+.++..+. ||||+++++++.     .....++||||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~lv~e~   87 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTFLVMEL   87 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEEEECC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEEEEEEc
Confidence            57899999999999999889999999998642   3567889999999997 999999999953     44588999999


Q ss_pred             ccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC---cEEEeeec
Q 046112          289 MANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM---TAYVSDFG  365 (502)
Q Consensus       289 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~---~~kl~Dfg  365 (502)
                      +++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++   .+||+|||
T Consensus        88 ~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg  154 (325)
T 3kn6_A           88 LNGGELFERIKK----------KKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFG  154 (325)
T ss_dssp             CCSCBHHHHHHH----------CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred             cCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence            999999999842          356899999999999999999999   89999999999999997665   89999999


Q ss_pred             cceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccc--cchHHHHHhhcccc
Q 046112          366 IARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN--LNLRNCVKSALPER  443 (502)
Q Consensus       366 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~  443 (502)
                      +++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......  ....+....     
T Consensus       155 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----  227 (325)
T 3kn6_A          155 FARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-----  227 (325)
T ss_dssp             TCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-----
T ss_pred             cceecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-----
Confidence            9986543322  2234568999999999999999999999999999999999999997632211  111111111     


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                         +..................+.+++.+|++.||++|||++|+++
T Consensus       228 ---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          228 ---IKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             ---HTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ---HHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence               1111111111112344567889999999999999999998863

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.5e-43  Score=350.67  Aligned_cols=270  Identities=19%  Similarity=0.212  Sum_probs=203.0

Q ss_pred             ccCCCCCCccccc--CCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          204 TKGFSSENLIGAG--NFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       204 t~~~~~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .++|...+.||+|  +||.||+|++..+++.||||+++...  ....+.+.+|+++++.++||||+++++++.     ..
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~   98 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----AD   98 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----EC
Confidence            4578899999999  99999999998899999999987543  233467888999999999999999999954     34


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +..++||||+++|+|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~  167 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICT--------HFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKV  167 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHH--------TCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCE
T ss_pred             CEEEEEEEccCCCCHHHHHhh--------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence            588999999999999999853        33456899999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceeccccccc-----ceecccccccccccCcccCC--CccCccccchhHHHHHHHHHhCCCCCccccccccch
Q 046112          360 YVSDFGIARFLEAADEQ-----TRSIGVEGTTGYIAPEYGMG--HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL  432 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~  432 (502)
                      ||+|||.+.........     .......||+.|+|||.+.+  ..++.++|||||||++|||++|+.||.+..... .+
T Consensus       168 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~  246 (389)
T 3gni_B          168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-ML  246 (389)
T ss_dssp             EECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT-HH
T ss_pred             EEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH-HH
Confidence            99999998765432211     11123468999999999987  679999999999999999999999997632211 11


Q ss_pred             HHHHHhhcccchh-------hh-------------ccc----------CCCCcchhhHHHHHHHHHHHhhcccCCCCCCC
Q 046112          433 RNCVKSALPERAE-------EI-------------RAS----------SGSTQRSIILECLISICEIGVACSAEQPGERM  482 (502)
Q Consensus       433 ~~~~~~~~~~~~~-------~~-------------~d~----------~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP  482 (502)
                      ........+....       ..             .+.          ...............+.+++.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp  326 (389)
T 3gni_B          247 LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP  326 (389)
T ss_dssp             HHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSC
T ss_pred             HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCC
Confidence            1111111110000       00             000          00000011223456788999999999999999


Q ss_pred             CHHHHHHH
Q 046112          483 KINDVEPR  490 (502)
Q Consensus       483 t~~ev~~~  490 (502)
                      |++|+++.
T Consensus       327 ta~ell~h  334 (389)
T 3gni_B          327 SASTLLNH  334 (389)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.3e-43  Score=356.86  Aligned_cols=248  Identities=24%  Similarity=0.332  Sum_probs=201.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .++|...+.||+|+||.||+|.+..+|+.||||+++...   .+....+.+|+++++.++||||+++++++.     ..+
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~~   89 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TPS   89 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECC
Confidence            357888899999999999999998899999999986432   223467899999999999999999999853     345


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus        90 ~~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vk  156 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYIC----------KNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAK  156 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTT----------SSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEE
T ss_pred             EEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeE
Confidence            8899999999999999984          2356899999999999999999999   99999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCcc-CccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEV-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++.......   .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||++...  ..+...+.. 
T Consensus       157 L~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~-  230 (476)
T 2y94_A          157 IADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--PTLFKKICD-  230 (476)
T ss_dssp             ECCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--HHHHHHHHT-
T ss_pred             EEeccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--HHHHHHHhc-
Confidence            999999987654321   234568999999999988765 6899999999999999999999976311  111111111 


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                                .....    .......+.+++.+|++.||++|||++|+++
T Consensus       231 ----------~~~~~----p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          231 ----------GIFYT----PQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ----------TCCCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----------CCcCC----CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                      10000    0122345779999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.9e-43  Score=333.45  Aligned_cols=251  Identities=25%  Similarity=0.372  Sum_probs=190.6

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc----chhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH----DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .++|...+.||+|+||.||+|.+  .++.||||+++....    ...+.+.+|+++++.++||||+++++++.     ..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KE   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC
T ss_pred             hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cC
Confidence            35788889999999999999976  488999999864322    22467899999999999999999999964     34


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---ceeecCCCCCeeeCC-
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPP---IAHCDLKPSNILLDD-  355 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~---i~H~dlk~~NIll~~-  355 (502)
                      +..++||||+++++|.+++..           ..+++..+..++.|++.||+|||   +.+   |+||||||+||+++. 
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~  144 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLSG-----------KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQK  144 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTS-----------SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSC
T ss_pred             CceEEEEEcCCCCCHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecc
Confidence            478999999999999999842           35889999999999999999999   666   999999999999986 


Q ss_pred             -------CCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccccc
Q 046112          356 -------EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD  428 (502)
Q Consensus       356 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~  428 (502)
                             ++.+||+|||+++.......    ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus       145 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  220 (271)
T 3dtc_A          145 VENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL  220 (271)
T ss_dssp             CSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred             cccccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                   77899999999986543322    2356899999999999889999999999999999999999999763211


Q ss_pred             ccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          429 NLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      .  ...   ......        .  .......++..+.+++.+|++.||++|||+.|+++.|++|
T Consensus       221 ~--~~~---~~~~~~--------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          221 A--VAY---GVAMNK--------L--ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             H--HHH---HHHTSC--------C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             H--HHH---hhhcCC--------C--CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1  000   000000        0  0001123456788999999999999999999999999764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.1e-42  Score=352.87  Aligned_cols=262  Identities=21%  Similarity=0.233  Sum_probs=204.5

Q ss_pred             HHHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeeccccc
Q 046112          198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGV  274 (502)
Q Consensus       198 ~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  274 (502)
                      .++...+++|...++||+|+||+||+|++..+++.||+|+++...   ......+.+|..++..++||||++++++|.  
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~--  144 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ--  144 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE--
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--
Confidence            344456789999999999999999999998899999999986421   122344889999999999999999999853  


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                         ..+..++||||+++|+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||++
T Consensus       145 ---~~~~~~lV~Ey~~gg~L~~~l~~---------~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~  209 (437)
T 4aw2_A          145 ---DDNNLYLVMDYYVGGDLLTLLSK---------FEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMD  209 (437)
T ss_dssp             ---CSSEEEEEECCCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred             ---eCCEEEEEEecCCCCcHHHHHHH---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEc
Confidence               45589999999999999999852         2456899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccC-----CCccCccccchhHHHHHHHHHhCCCCCccccccc
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM-----GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN  429 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~  429 (502)
                      .++.+||+|||+++....... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.......
T Consensus       210 ~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~  288 (437)
T 4aw2_A          210 MNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  288 (437)
T ss_dssp             TTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             CCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH
Confidence            999999999999986644322 2223467999999999987     5679999999999999999999999997521111


Q ss_pred             cchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 046112          430 LNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGE--RMKINDVEP  489 (502)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~--RPt~~ev~~  489 (502)
                       .+.......     ..+.   .+..   .......+.+++.+|++.+|++  ||+++|+++
T Consensus       289 -~~~~i~~~~-----~~~~---~p~~---~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          289 -TYGKIMNHK-----ERFQ---FPTQ---VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             -HHHHHHTHH-----HHCC---CCSS---CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             -HHHhhhhcc-----cccc---CCcc---cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence             111111100     0000   0000   0112345678999999888888  999999865

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.2e-43  Score=345.86  Aligned_cols=264  Identities=23%  Similarity=0.340  Sum_probs=195.9

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc---hhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD---ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .++|...+.||+|+||.||+|++..+++.||||+++.....   ....+.+|++++++++||||+++++++.... ....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence            45788899999999999999999899999999999754322   2357889999999999999999999864322 1122


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.++++.          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~k  156 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHT----------EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVK  156 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEE
T ss_pred             ccEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEE
Confidence            45899999999999999842          245899999999999999999999   89999999999999999999999


Q ss_pred             Eeeeccceecccccc-cceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADE-QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++.+..... ........||+.|+|||.+.+..++.++|||||||++|||+||+.||........ ........
T Consensus       157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~  235 (311)
T 3ork_A          157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVRED  235 (311)
T ss_dssp             ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCC
T ss_pred             EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhcCC
Confidence            999999987654332 1223345689999999999999999999999999999999999999976321110 01111100


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHH-HHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV-EPRLRLI  494 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev-~~~L~~i  494 (502)
                      .            .........++..+.+++.+|++.||++||++.++ ...+.++
T Consensus       236 ~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          236 P------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             C------------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             C------------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            0            00000011235567899999999999999965554 4455444

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.3e-43  Score=347.79  Aligned_cols=244  Identities=23%  Similarity=0.266  Sum_probs=196.6

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  279 (502)
                      .++|...+.||+|+||.||+|+...+++.||+|+++..   .......+..|..++..+ +||||+++++++     ...
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~   93 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM   93 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----ECS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----EcC
Confidence            46788999999999999999999888999999998743   223346688899999988 799999999984     445


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +..++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus        94 ~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~v  160 (353)
T 2i0e_A           94 DRLYFVMEYVNGGDLMYHIQQ----------VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHI  160 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcE
Confidence            589999999999999999842          235889999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||+++......  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  ..+.+.+...
T Consensus       161 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~  236 (353)
T 2i0e_A          161 KIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIMEH  236 (353)
T ss_dssp             EECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC
T ss_pred             EEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--HHHHHHHHhC
Confidence            999999997543222  123356799999999999999999999999999999999999999975211  1111111110


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKI  484 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~  484 (502)
                                 ...    +.......+.+++.+|++.||++||++
T Consensus       237 -----------~~~----~p~~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          237 -----------NVA----YPKSMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             -----------CCC----CCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             -----------CCC----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                       000    011234567799999999999999964

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-42  Score=356.78  Aligned_cols=201  Identities=25%  Similarity=0.365  Sum_probs=158.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||+||+|.+..+++.||||++.....  ...+.+.+|+++++.++||||+++++++..........
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            4689999999999999999999989999999999864322  23467899999999999999999999986554455568


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+ +|+|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus       132 ~~lv~e~~-~~~L~~~~~----------~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl  197 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFR----------TPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKV  197 (458)
T ss_dssp             EEEEECCC-SEEHHHHHH----------SSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEecc-ccchhhhcc----------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEee
Confidence            99999998 578998884          2356899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceeccccccc-------------------------ceecccccccccccCccc-CCCccCccccchhHHHHHHHH
Q 046112          362 SDFGIARFLEAADEQ-------------------------TRSIGVEGTTGYIAPEYG-MGHEVSSYGDVYSFGILLLEM  415 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDvws~Gv~l~el  415 (502)
                      +|||+++........                         .......||++|+|||++ ....++.++|||||||++|||
T Consensus       198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el  277 (458)
T 3rp9_A          198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL  277 (458)
T ss_dssp             CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred             cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence            999999876432210                         123456789999999976 556799999999999999999


Q ss_pred             HhC
Q 046112          416 FTG  418 (502)
Q Consensus       416 ~tg  418 (502)
                      +||
T Consensus       278 ltg  280 (458)
T 3rp9_A          278 LNM  280 (458)
T ss_dssp             HTT
T ss_pred             HHh
Confidence            994

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.7e-43  Score=345.45  Aligned_cols=249  Identities=23%  Similarity=0.275  Sum_probs=196.2

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ++|...+.||+|+||.||+|++..+++.||+|+++...   ....+.+..|..++.++ +||||+++++++     ....
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~~   83 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTES   83 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeCC
Confidence            56888899999999999999998999999999997542   22345678899999887 899999999985     3455


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~k  150 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQR----------QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIK  150 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEE
Confidence            89999999999999999842          245899999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccccccc---chHHHHH
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL---NLRNCVK  437 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~---~~~~~~~  437 (502)
                      |+|||+++......  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........   .......
T Consensus       151 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  228 (345)
T 3a8x_A          151 LTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF  228 (345)
T ss_dssp             ECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH
T ss_pred             EEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH
Confidence            99999997543222  123356799999999999999999999999999999999999999965211110   0111111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKI  484 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~  484 (502)
                      ..+.       .....    +.......+.+++.+|++.||++||++
T Consensus       229 ~~i~-------~~~~~----~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          229 QVIL-------EKQIR----IPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HHHH-------HCCCC----CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             HHHH-------cCCCC----CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            1110       00000    111234567799999999999999996

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=367.76  Aligned_cols=254  Identities=24%  Similarity=0.351  Sum_probs=201.3

Q ss_pred             cccccCCceEEEEEEc--CCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEeee
Q 046112          212 LIGAGNFGSVYKGILF--ESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEF  288 (502)
Q Consensus       212 ~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  288 (502)
                      .||+|+||.||+|.+.  .++..||||+++... ....++|.+|++++++++||||++++++|..      +..++||||
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~~lv~E~  416 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEM  416 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSEEEEEEC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCeEEEEEe
Confidence            6999999999999765  356789999997543 3346789999999999999999999999742      358999999


Q ss_pred             ccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccce
Q 046112          289 MANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR  368 (502)
Q Consensus       289 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~  368 (502)
                      +++|+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       417 ~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~  484 (613)
T 2ozo_A          417 AGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSK  484 (613)
T ss_dssp             CTTCBHHHHHTT---------CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred             CCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence            999999999852         3456899999999999999999999   8999999999999999999999999999998


Q ss_pred             ecccccc-cceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccchhh
Q 046112          369 FLEAADE-QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAEE  446 (502)
Q Consensus       369 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  446 (502)
                      .+..... ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||......  .....+.....     
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~-----  557 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKR-----  557 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHTTCC-----
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCC-----
Confidence            7644332 111223345789999999998999999999999999999998 99999763221  12222211110     


Q ss_pred             hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       447 ~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                               ......++..+.+++.+||+.||++||++.++++.|+.+.....
T Consensus       558 ---------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~  601 (613)
T 2ozo_A          558 ---------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  601 (613)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred             ---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence                     01112456778899999999999999999999999999876654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.8e-43  Score=344.76  Aligned_cols=269  Identities=19%  Similarity=0.270  Sum_probs=201.8

Q ss_pred             HHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc-----CcchhHHHHHHHHHHhcCCCCccceeeeccccc
Q 046112          200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL-----HHDASKSFAVECEVTRNIRHRNLVKVFTACSGV  274 (502)
Q Consensus       200 l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  274 (502)
                      +....++|...+.||+|+||.||+|.+..++..||+|+++..     .....+.+.+|++++++++||||+++++++.  
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--   98 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE--   98 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc--
Confidence            445567899999999999999999999899999999998643     2344578999999999999999999999963  


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhhh------------------------------ccCCCCCCCHHHHHHHHH
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEEDK------------------------------RHKAPGNLNSLKRLNIAI  324 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------~~~~~~~l~~~~~~~i~~  324 (502)
                         ..+..++||||+++|+|.+++........                              .......+++..+..++.
T Consensus        99 ---~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A           99 ---DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             ---CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             ---cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence               34588999999999999999853111100                              001122245677888999


Q ss_pred             HHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC--cEEEeeeccceecccccc--cceecccccccccccCcccCC--Cc
Q 046112          325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM--TAYVSDFGIARFLEAADE--QTRSIGVEGTTGYIAPEYGMG--HE  398 (502)
Q Consensus       325 ~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~  398 (502)
                      |++.||+|||   +.+|+||||||+||+++.++  .+||+|||+++.+.....  ........||+.|+|||.+.+  ..
T Consensus       176 qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  252 (345)
T 3hko_A          176 QIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES  252 (345)
T ss_dssp             HHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred             HHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence            9999999999   88999999999999998776  899999999987654322  112345679999999999875  67


Q ss_pred             cCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCC
Q 046112          399 VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQP  478 (502)
Q Consensus       399 ~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP  478 (502)
                      ++.++|||||||++|||++|+.||....... ..........            .............+.+++.+|++.||
T Consensus       253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-TISQVLNKKL------------CFENPNYNVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC------------CTTSGGGGGSCHHHHHHHHHHSCSCT
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHhccc------------ccCCcccccCCHHHHHHHHHHcCCCh
Confidence            8999999999999999999999997632211 1111111110            00011111235567899999999999


Q ss_pred             CCCCCHHHHHH
Q 046112          479 GERMKINDVEP  489 (502)
Q Consensus       479 ~~RPt~~ev~~  489 (502)
                      .+|||+.|+++
T Consensus       320 ~~Rps~~~~l~  330 (345)
T 3hko_A          320 DERFDAMRALQ  330 (345)
T ss_dssp             TTSCCHHHHHH
T ss_pred             hHCCCHHHHhc
Confidence            99999999976

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.1e-43  Score=331.80  Aligned_cols=257  Identities=26%  Similarity=0.400  Sum_probs=206.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|...+.||+|+||.||+|.+. ++..||+|+++.... ..+.+.+|++++++++||||+++++++.     ..+..++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   80 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICL   80 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCEE
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeEE
Confidence            56788899999999999999764 678899999875433 3467999999999999999999999964     3457899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++++|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        81 v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~df  148 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDF  148 (267)
T ss_dssp             EECCCTTCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCT
T ss_pred             EEeCCCCCcHHHHHhh---------CcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccc
Confidence            9999999999999852         2346889999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |+++...... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+.....  
T Consensus       149 g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~i~~~~~--  223 (267)
T 3t9t_A          149 GMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFR--  223 (267)
T ss_dssp             TGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC--
T ss_pred             cccccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHHHHhcCCc--
Confidence            9997654322 122234557889999999988889999999999999999999 89998763111  11111111100  


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                               ...+   ..+...+.+++.+|++.||++|||++|+++.|+++.++
T Consensus       224 ---------~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          224 ---------LYKP---RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             ---------CCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ---------CCCC---ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                     0000   12345678999999999999999999999999999764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.9e-43  Score=360.52  Aligned_cols=258  Identities=27%  Similarity=0.426  Sum_probs=201.4

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ..++|...+.||+|+||.||+|.+. ++..||||+++... ...+.|.+|++++++++||||+++++++..      +..
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~  253 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  253 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cce
Confidence            4456778889999999999999764 56779999997543 335789999999999999999999998642      367


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++|+|.+++..        .....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus       254 ~iv~e~~~~gsL~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~  322 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVA  322 (452)
T ss_dssp             EEEECCCTTCBHHHHHSH--------HHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEEehhhcCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEEC
Confidence            999999999999999953        12245889999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||+++...... ........+|..|+|||.+.+..++.++|||||||++|||+| |+.||......  .....+.....
T Consensus       323 DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~  399 (452)
T 1fmk_A          323 DFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYR  399 (452)
T ss_dssp             CCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC
T ss_pred             CCccceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC
Confidence            999998765322 122234457889999999998899999999999999999999 99999763211  11111111100


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                                    ......++..+.+++.+||+.||++|||++++++.|+.+..
T Consensus       400 --------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          400 --------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             --------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence                          00112456678899999999999999999999999987654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.9e-42  Score=338.88  Aligned_cols=252  Identities=20%  Similarity=0.261  Sum_probs=202.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc------hhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD------ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      .++|...+.||+|+||.||+|.+..+++.||+|+++.....      ..+.+.+|++++++++||||+++++++.     
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----   85 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE-----   85 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence            34688889999999999999999889999999998753321      3567999999999999999999999853     


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                      .....++||||+++++|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~  152 (321)
T 2a2a_A           86 NRTDVVLILELVSGGELFDFLAQ----------KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKN  152 (321)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHT----------CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTT
T ss_pred             cCCEEEEEEEcCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCC
Confidence            44588999999999999999842          345889999999999999999999   89999999999999999888


Q ss_pred             ----cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchH
Q 046112          358 ----TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR  433 (502)
Q Consensus       358 ----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~  433 (502)
                          .+||+|||++........   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......  ...
T Consensus       153 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~  227 (321)
T 2a2a_A          153 IPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETL  227 (321)
T ss_dssp             SSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHH
T ss_pred             CCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHH
Confidence                799999999987654322   23456899999999999999999999999999999999999999753211  111


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..+.....           .............+.+++.+|++.||++|||++|+++
T Consensus       228 ~~i~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          228 ANITSVSY-----------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHHTTCC-----------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHHhccc-----------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11111100           0001111233456789999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.2e-44  Score=343.57  Aligned_cols=253  Identities=22%  Similarity=0.319  Sum_probs=199.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCC-------eEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeeccccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFEST-------TAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF  276 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  276 (502)
                      .++|...+.||+|+||+||+|.+..++       ..||+|+++.......+.+.+|++++++++||||+++++++.    
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----   82 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV----   82 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC----
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE----
Confidence            356788899999999999999887655       579999997665566688999999999999999999999964    


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE  356 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~  356 (502)
                       ..+..++||||+++|+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.+
T Consensus        83 -~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  149 (289)
T 4fvq_A           83 -CGDENILVQEFVKFGSLDTYLKK---------NKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIRE  149 (289)
T ss_dssp             -CTTCCEEEEECCTTCBHHHHHHH---------TGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEEC
T ss_pred             -eCCCCEEEEECCCCCCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecC
Confidence             34478999999999999999853         2234889999999999999999999   8999999999999999988


Q ss_pred             Cc--------EEEeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccc
Q 046112          357 MT--------AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFK  427 (502)
Q Consensus       357 ~~--------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~  427 (502)
                      +.        +||+|||++......      ....+|+.|+|||.+.+ ..++.++|||||||++|||++|..|+.....
T Consensus       150 ~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~  223 (289)
T 4fvq_A          150 EDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD  223 (289)
T ss_dssp             CBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             CcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence            87        999999998654322      12347889999999987 7799999999999999999996544433111


Q ss_pred             cccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          428 DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                      .. .........     .     ...      ......+.+++.+||+.||++|||++|+++.|+++..
T Consensus       224 ~~-~~~~~~~~~-----~-----~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          224 SQ-RKLQFYEDR-----H-----QLP------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HH-HHHHHHHTT-----C-----CCC------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             hH-HHHHHhhcc-----C-----CCC------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            11 111111100     0     000      0112346789999999999999999999999987754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.4e-42  Score=332.42  Aligned_cols=251  Identities=20%  Similarity=0.268  Sum_probs=202.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|+||.||+|.+..++..||+|++........+.+.+|++++++++||||+++++++.     .....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence            456888899999999999999998899999999987655556788999999999999999999999953     445789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee---CCCCcEE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAY  360 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll---~~~~~~k  360 (502)
                      +||||+++++|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+|
T Consensus        83 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~  149 (277)
T 3f3z_A           83 LVMELCTGGELFERVVH----------KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLK  149 (277)
T ss_dssp             EEEECCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEE
T ss_pred             EEEeccCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEE
Confidence            99999999999998842          245889999999999999999999   8999999999999999   7889999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||++........   .....||+.|+|||.+.+. ++.++||||||+++|||++|+.||......  .....+....
T Consensus       150 l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~  223 (277)
T 3f3z_A          150 LIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EVMLKIREGT  223 (277)
T ss_dssp             ECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC
T ss_pred             EEecccceeccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCC
Confidence            999999987654322   2345689999999988664 899999999999999999999999763211  1111111110


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .           .........+...+.+++.+|++.||++|||+.|+++
T Consensus       224 ~-----------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          224 F-----------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             C-----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             C-----------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0           0000001133567889999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.1e-42  Score=337.00  Aligned_cols=277  Identities=23%  Similarity=0.337  Sum_probs=212.2

Q ss_pred             HHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhc--CCCCccceeeecccccccC
Q 046112          200 LYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRN--IRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       200 l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~  277 (502)
                      -....++|...+.||+|+||.||+|.+  +++.||||+++..   ....+..|.+++..  ++||||+++++++.... .
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~  110 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-G  110 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-S
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-C
Confidence            344567899999999999999999976  5899999998642   34667888888877  78999999999864321 1


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceeecCCCCCee
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDC-----QPPIAHCDLKPSNIL  352 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~i~H~dlk~~NIl  352 (502)
                      .....++||||+++|+|.+++..           ..+++..++.++.|++.||+|||...     +.+|+||||||+|||
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIl  179 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL  179 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEE
T ss_pred             ccceeEEEEeecCCCcHHHHHhc-----------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEE
Confidence            11368999999999999999842           24889999999999999999999421     578999999999999


Q ss_pred             eCCCCcEEEeeeccceecccccccc--eecccccccccccCcccCCC------ccCccccchhHHHHHHHHHhC------
Q 046112          353 LDDEMTAYVSDFGIARFLEAADEQT--RSIGVEGTTGYIAPEYGMGH------EVSSYGDVYSFGILLLEMFTG------  418 (502)
Q Consensus       353 l~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDvws~Gv~l~el~tg------  418 (502)
                      ++.++.+||+|||+++.........  ......||+.|+|||.+.+.      .++.++|||||||++|||+||      
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            9999999999999998765443211  22345789999999998775      345789999999999999999      


Q ss_pred             ----CCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          419 ----LRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       419 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                          +.||............+........    ..+...... ...++...+.+++.+||+.||++|||++|+++.|+++
T Consensus       260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGG-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccccCccccCcCcccHHHHHHHHHHHH----hCCCCcccc-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence                6787654333333333322221110    011111110 1236778899999999999999999999999999999


Q ss_pred             HHHH
Q 046112          495 KKKL  498 (502)
Q Consensus       495 ~~~~  498 (502)
                      .++.
T Consensus       335 ~~~~  338 (342)
T 1b6c_B          335 SQQE  338 (342)
T ss_dssp             HHTT
T ss_pred             HHHh
Confidence            8764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.5e-42  Score=340.78  Aligned_cols=259  Identities=15%  Similarity=0.128  Sum_probs=205.0

Q ss_pred             hccCCCCCCcccccCCceEEEE-----EEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC---CCccceeeeccccc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKG-----ILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR---HRNLVKVFTACSGV  274 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  274 (502)
                      ..++|...+.||+|+||+||+|     ....+++.||||+++..   ...++..|++++.+++   |+|++++++++.  
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~--  137 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL--  137 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE--
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee--
Confidence            4567888899999999999999     35678899999998743   3567788888888876   999999999864  


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                         ..+..++||||+++|+|.++++...     ......+++..++.++.|++.||+|||   +.+|+||||||+|||++
T Consensus       138 ---~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~  206 (365)
T 3e7e_A          138 ---FQNGSVLVGELYSYGTLLNAINLYK-----NTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILG  206 (365)
T ss_dssp             ---CSSCEEEEECCCCSCBHHHHHHHHH-----TSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEEC
T ss_pred             ---cCCCcEEEEeccCCCcHHHHHHHhh-----cccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEec
Confidence               3447899999999999999995311     123466999999999999999999999   89999999999999999


Q ss_pred             C-----------CCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCc
Q 046112          355 D-----------EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD  423 (502)
Q Consensus       355 ~-----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~  423 (502)
                      .           ++.+||+|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  286 (365)
T 3e7e_A          207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV  286 (365)
T ss_dssp             GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred             ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence            8           89999999999987654444444556789999999999999999999999999999999999999986


Q ss_pred             cccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCC-CCHHHHHHHHHHHHHHH
Q 046112          424 DMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGER-MKINDVEPRLRLIKKKL  498 (502)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~R-Pt~~ev~~~L~~i~~~~  498 (502)
                      ........            .    ........     ....+.+++..|++.+|.+| |+++++.+.|+.+..+.
T Consensus       287 ~~~~~~~~------------~----~~~~~~~~-----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          287 KNEGGECK------------P----EGLFRRLP-----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             EEETTEEE------------E----CSCCTTCS-----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cCCCCcee------------e----chhccccC-----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence            53221100            0    00011111     13455688889999999988 57888988888876654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.6e-42  Score=349.93  Aligned_cols=253  Identities=20%  Similarity=0.295  Sum_probs=193.6

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--------cchhHHHHHHHHHHhcCCCCccceeeeccccc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--------HDASKSFAVECEVTRNIRHRNLVKVFTACSGV  274 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  274 (502)
                      ..++|...+.||+|+||.||+|.+..+++.||||++....        ......+.+|++++++++||||+++++++.  
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--  210 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--  210 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE--
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence            4578999999999999999999999999999999986431        111235889999999999999999999852  


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                          .+..++||||+++|+|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+|||++
T Consensus       211 ----~~~~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~  273 (419)
T 3i6u_A          211 ----AEDYYIVLELMEGGELFDKVV----------GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLS  273 (419)
T ss_dssp             ----SSEEEEEEECCTTCBGGGGTS----------SSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEES
T ss_pred             ----cCceEEEEEcCCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEe
Confidence                235789999999999999884          3356899999999999999999999   88999999999999997


Q ss_pred             CC---CcEEEeeeccceecccccccceecccccccccccCcccCC---CccCccccchhHHHHHHHHHhCCCCCcccccc
Q 046112          355 DE---MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG---HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD  428 (502)
Q Consensus       355 ~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~  428 (502)
                      .+   ..+||+|||+++......   ......||+.|+|||++.+   ..++.++|||||||++|||+||+.||..... 
T Consensus       274 ~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-  349 (419)
T 3i6u_A          274 SQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-  349 (419)
T ss_dssp             SSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS-
T ss_pred             cCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc-
Confidence            54   459999999998664322   2234568999999999864   5788999999999999999999999976322 


Q ss_pred             ccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          429 NLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...+...+......           ............+.+++.+|++.||++|||++|+++
T Consensus       350 ~~~~~~~i~~~~~~-----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          350 QVSLKDQITSGKYN-----------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             SCCHHHHHHTTCCC-----------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHhcCCCC-----------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            12222222221111           111111234567889999999999999999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.8e-43  Score=361.77  Aligned_cols=249  Identities=20%  Similarity=0.234  Sum_probs=192.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||+++..   .......+.+|+.+++.++||||+++++++.     ..+
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THD  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ETT
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eCC
Confidence            35788899999999999999999999999999998743   2233456788999999999999999999864     344


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceeecCCCCCeeeCCCCcE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ-PPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ..++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   + .+|+||||||+|||++.++.+
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~  288 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSR----------ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHI  288 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCE
T ss_pred             EEEEEEeeCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCE
Confidence            78999999999999998842          245899999999999999999999   7 899999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .+...+.. 
T Consensus       289 kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~-  363 (446)
T 4ejn_A          289 KITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILM-  363 (446)
T ss_dssp             EECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-
T ss_pred             EEccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHHh-
Confidence            999999997543222  2223467999999999999999999999999999999999999999753111  11111111 


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEP  489 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~  489 (502)
                        .        ...    +.......+.+++.+|++.||.+||     +++|+++
T Consensus       364 --~--------~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          364 --E--------EIR----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             --C--------CCC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --C--------CCC----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence              0        000    0112345677999999999999999     9999875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.1e-42  Score=339.66  Aligned_cols=267  Identities=21%  Similarity=0.267  Sum_probs=195.7

Q ss_pred             cCCCC-CCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcce
Q 046112          205 KGFSS-ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      +.|.+ .+.||+|+||.||+|.+..+++.||||+++.........+.+|++++.++ +||||+++++++.     ..+..
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~~~   86 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EEDRF   86 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCCEE
Confidence            45666 47899999999999988889999999999766555567899999999885 7999999999953     34589


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc---E
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT---A  359 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~---~  359 (502)
                      ++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.   +
T Consensus        87 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~  153 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHK----------RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPV  153 (316)
T ss_dssp             EEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSE
T ss_pred             EEEEEcCCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCce
Confidence            999999999999999842          245889999999999999999999   889999999999999998776   9


Q ss_pred             EEeeeccceecccccc-----cceecccccccccccCcccCC-----CccCccccchhHHHHHHHHHhCCCCCccccccc
Q 046112          360 YVSDFGIARFLEAADE-----QTRSIGVEGTTGYIAPEYGMG-----HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN  429 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~  429 (502)
                      ||+|||++........     ........||+.|+|||.+.+     ..++.++|||||||++|||++|+.||.......
T Consensus       154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  233 (316)
T 2ac3_A          154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD  233 (316)
T ss_dssp             EECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC
T ss_pred             EEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc
Confidence            9999999976543221     111223568999999999875     568999999999999999999999997643221


Q ss_pred             cchHHHH--HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          430 LNLRNCV--KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       430 ~~~~~~~--~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..+....  ..........+..................+.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          234 CGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             SCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            1100000  00000000011111110000001123556889999999999999999999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=7.3e-43  Score=334.84  Aligned_cols=249  Identities=20%  Similarity=0.293  Sum_probs=198.7

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      +.++|...+.||+|+||.||+|.+..++..||+|++....   ......+.+|++++++++||||+++++++.     ..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   81 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DA   81 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cC
Confidence            3467888999999999999999999999999999985421   223467889999999999999999999953     34


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~  148 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQK----------LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGEL  148 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCE
T ss_pred             CEEEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCE
Confidence            578999999999999999842          245889999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||++.......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......  .....+...
T Consensus       149 ~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~  222 (279)
T 3fdn_A          149 KIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRISRV  222 (279)
T ss_dssp             EECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHT
T ss_pred             EEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHHHHHHhC
Confidence            999999986543221    23456899999999999999999999999999999999999999752111  111111110


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      .         ...      .......+.+++.+|++.||++|||+.|+++.
T Consensus       223 ~---------~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          223 E---------FTF------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             C---------CCC------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             C---------CCC------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0         000      11234567799999999999999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.2e-43  Score=355.23  Aligned_cols=258  Identities=21%  Similarity=0.246  Sum_probs=203.1

Q ss_pred             HHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccc
Q 046112          199 MLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVD  275 (502)
Q Consensus       199 ~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  275 (502)
                      ++....++|...++||+|+||.||+|++..+++.||+|+++..   .......+.+|+.+++.++||||+++++++    
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~----  138 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF----  138 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE----
Confidence            4445567899999999999999999999999999999998642   122334588999999999999999999985    


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD  355 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~  355 (502)
                       ......++||||+++|+|.++++.           ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.
T Consensus       139 -~~~~~~~lV~E~~~gg~L~~~l~~-----------~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~  203 (410)
T 3v8s_A          139 -QDDRYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDK  203 (410)
T ss_dssp             -ECSSEEEEEECCCTTEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECT
T ss_pred             -EECCEEEEEEeCCCCCcHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECC
Confidence             345589999999999999998842           24889999999999999999999   899999999999999999


Q ss_pred             CCcEEEeeeccceecccccccceecccccccccccCcccCCCc----cCccccchhHHHHHHHHHhCCCCCccccccccc
Q 046112          356 EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE----VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN  431 (502)
Q Consensus       356 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~  431 (502)
                      ++.+||+|||+++....... .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||...... ..
T Consensus       204 ~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~  281 (410)
T 3v8s_A          204 SGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GT  281 (410)
T ss_dssp             TSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-HH
T ss_pred             CCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-hH
Confidence            99999999999987654322 2233567999999999987655    889999999999999999999999752111 01


Q ss_pred             hHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 046112          432 LRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGE--RMKINDVEP  489 (502)
Q Consensus       432 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~--RPt~~ev~~  489 (502)
                      +.......     ..+.   .+...    .....+.+++.+|++.+|.+  ||+++|+.+
T Consensus       282 ~~~i~~~~-----~~~~---~p~~~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          282 YSKIMNHK-----NSLT---FPDDN----DISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHHHTHH-----HHCC---CCTTC----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HHHHHhcc-----cccc---CCCcc----cccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            11111110     0000   01001    22345678999999999998  999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.6e-43  Score=336.04  Aligned_cols=255  Identities=26%  Similarity=0.367  Sum_probs=198.3

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|+||.||+|.+  .++.||||+++..  ...+.+.+|++++++++||||+++++++.    ......+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEE----cCCCceE
Confidence            35788889999999999999976  5889999998743  34577999999999999999999999863    2334689


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++|+|.+++..        .....+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        92 lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~D  160 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSD  160 (278)
T ss_dssp             EEECCCTTEEHHHHHHH--------HHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred             EEEecCCCCCHHHHHHh--------cccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEee
Confidence            99999999999999853        11123788899999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||++.......     ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||......  .....+....  
T Consensus       161 fg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~--  231 (278)
T 1byg_A          161 FGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGY--  231 (278)
T ss_dssp             CCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTC--
T ss_pred             ccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCC--
Confidence            99997554321     12346889999999988899999999999999999998 99999763211  1111111100  


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                               .   ......++..+.+++.+|++.||++|||+.|+++.|+.++...
T Consensus       232 ---------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          232 ---------K---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             ---------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ---------C---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence                     0   0011234567889999999999999999999999999998753

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.3e-43  Score=345.96  Aligned_cols=272  Identities=14%  Similarity=0.169  Sum_probs=206.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcC--------CCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccc---
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFE--------STTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSG---  273 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---  273 (502)
                      ++|...+.||+|+||.||+|.+..        .++.||||+++..     +.+.+|++++++++||||+++++....   
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578889999999999999998876        4889999998643     468899999999999999985432111   


Q ss_pred             --------cccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeec
Q 046112          274 --------VDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCD  345 (502)
Q Consensus       274 --------~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~d  345 (502)
                              .....+...++||||+ +|+|.+++..        .....+++..++.++.|++.||+|||   +.+|+|||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--------~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~D  184 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDV--------SPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGN  184 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHH--------SGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSC
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHh--------CCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCC
Confidence                    0012346789999999 9999999953        22356899999999999999999999   88999999


Q ss_pred             CCCCCeeeCCCC--cEEEeeeccceecccccccc-----eecccccccccccCcccCCCccCccccchhHHHHHHHHHhC
Q 046112          346 LKPSNILLDDEM--TAYVSDFGIARFLEAADEQT-----RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG  418 (502)
Q Consensus       346 lk~~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg  418 (502)
                      |||+|||++.++  .+||+|||+++.+.......     ......||+.|+|||.+.+..++.++|||||||++|||++|
T Consensus       185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  264 (352)
T 2jii_A          185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG  264 (352)
T ss_dssp             CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             CCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence            999999999998  99999999998765433211     12345789999999999999999999999999999999999


Q ss_pred             CCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          419 LRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       419 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      +.||.........+....... ......+.+....     ....+..+.+++.+|++.||++|||++++++.|+++.++.
T Consensus       265 ~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          265 FLPWTNCLPNTEDIMKQKQKF-VDKPGPFVGPCGH-----WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             CCTTGGGTTCHHHHHHHHHHH-HHSCCCEECTTSC-----EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CCCcccCCcCHHHHHHHHHhc-cCChhhhhhhccc-----cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            999987432222222221111 1111111111100     0122456789999999999999999999999999998775


Q ss_pred             h
Q 046112          499 L  499 (502)
Q Consensus       499 ~  499 (502)
                      .
T Consensus       339 ~  339 (352)
T 2jii_A          339 R  339 (352)
T ss_dssp             T
T ss_pred             C
Confidence            4

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-42  Score=333.48  Aligned_cols=262  Identities=23%  Similarity=0.342  Sum_probs=208.3

Q ss_pred             cCCCCCC-cccccCCceEEEEEEc--CCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          205 KGFSSEN-LIGAGNFGSVYKGILF--ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~-~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ++|...+ .||+|+||.||+|.+.  .++..||||+++.... ...+.+.+|++++++++||||+++++++.      .+
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------CC
Confidence            3455555 8999999999999753  4678899999976432 34567899999999999999999999862      23


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++++|.+++..         ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+|
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~k  150 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAK  150 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTT---------CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEE
T ss_pred             CcEEEEEeCCCCCHHHHHHh---------CCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEE
Confidence            58999999999999999852         3456899999999999999999999   89999999999999999999999


Q ss_pred             Eeeeccceeccccccc-ceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHh
Q 046112          361 VSDFGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  438 (502)
                      |+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....  ......+..
T Consensus       151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~i~~  228 (287)
T 1u59_A          151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQ  228 (287)
T ss_dssp             ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHT
T ss_pred             ECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHhc
Confidence            9999999877543321 12233456899999999988889999999999999999999 9999976321  112221111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE  500 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~  500 (502)
                      ...              ......++..+.+++.+||+.||++||++.|+++.|+.+..+...
T Consensus       229 ~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          229 GKR--------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             TCC--------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             CCc--------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence            100              001123456788999999999999999999999999999776543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.1e-43  Score=342.69  Aligned_cols=249  Identities=20%  Similarity=0.265  Sum_probs=189.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEc---CCCeEEEEEEecccC----cchhHHHHHHHHHHhcCCCCccceeeeccccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLH----HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF  276 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  276 (502)
                      .++|...+.||+|+||.||+++..   .+++.||+|+++...    ......+.+|+++++.++||||+++++++.    
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----   91 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ----   91 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE----
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE----
Confidence            457888999999999999999774   688999999987532    223456788999999999999999999853    


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE  356 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~  356 (502)
                       ..+..++||||+++|+|.+++..          ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.+
T Consensus        92 -~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~  157 (327)
T 3a62_A           92 -TGGKLYLILEYLSGGELFMQLER----------EGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQ  157 (327)
T ss_dssp             -CSSCEEEEEECCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTT
T ss_pred             -cCCEEEEEEeCCCCCcHHHHHHh----------CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCC
Confidence             44588999999999999999842          235788999999999999999999   8899999999999999999


Q ss_pred             CcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                      +.+||+|||+++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......     +..
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~  230 (327)
T 3a62_A          158 GHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-----KTI  230 (327)
T ss_dssp             SCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHH
T ss_pred             CcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-----HHH
Confidence            9999999999975432221  223457899999999999999999999999999999999999999763211     111


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEP  489 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~  489 (502)
                      ......        ...    +.......+.+++.+|++.||++||     ++.|+++
T Consensus       231 ~~i~~~--------~~~----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          231 DKILKC--------KLN----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHHHT--------CCC----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHHhC--------CCC----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            111000        000    0112345677999999999999999     6667654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.1e-42  Score=336.69  Aligned_cols=260  Identities=20%  Similarity=0.260  Sum_probs=197.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc---hhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD---ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .++|...+.||+|+||.||+|.+..+++.||+|+++.....   ..+.+.+|++++++++||||+++++++.     .++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE-----IDG  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETT
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-----eCC
Confidence            46889999999999999999998889999999998754222   2367889999999999999999999853     345


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++|+||+++++|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~k  174 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRR----------QGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAY  174 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred             eEEEEEEecCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEE
Confidence            78999999999999999842          245899999999999999999999   88999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||++........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......  .+...+....
T Consensus       175 l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~  251 (309)
T 2h34_A          175 LVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAI  251 (309)
T ss_dssp             ECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCC
T ss_pred             EecCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCC
Confidence            999999976543321 1223456899999999999999999999999999999999999999763211  1111111111


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-KINDVEPRLRLIKK  496 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-t~~ev~~~L~~i~~  496 (502)
                      +.            .......++..+.+++.+|++.||++|| +++++++.|+.+..
T Consensus       252 ~~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          252 PR------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             CC------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             CC------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence            00            0011123345678999999999999999 99999999987643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-42  Score=334.07  Aligned_cols=261  Identities=19%  Similarity=0.314  Sum_probs=204.2

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcC---CCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFE---STTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      ..++|...+.||+|+||.||+|.+..   .+..||+|+++... ....+.+.+|++++++++||||+++++++..     
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----   84 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-----   84 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence            34678889999999999999997653   34569999987542 2345779999999999999999999998532     


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                       +..++||||+++++|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.
T Consensus        85 -~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~  151 (281)
T 3cc6_A           85 -EPTWIIMELYPYGELGHYLER---------NKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPEC  151 (281)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHH---------HTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTE
T ss_pred             -CCCEEEEecCCCCCHHHHHHh---------ccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCc
Confidence             246899999999999999852         2345889999999999999999999   899999999999999999999


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHH
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  437 (502)
                      +||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......  .....+.
T Consensus       152 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~  228 (281)
T 3cc6_A          152 VKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLE  228 (281)
T ss_dssp             EEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHH
T ss_pred             EEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHh
Confidence            999999999866543221 1233457889999999988899999999999999999998 99999753221  1222111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      ....          .. .   ...+...+.+++.+|++.||++|||+.|+++.|+.+.+..
T Consensus       229 ~~~~----------~~-~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          229 KGDR----------LP-K---PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             HTCC----------CC-C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCCC----------CC-C---CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence            1100          00 0   1123456889999999999999999999999999987654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.2e-42  Score=333.10  Aligned_cols=263  Identities=21%  Similarity=0.292  Sum_probs=195.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|...+.||+|+||+||+|++ .+++.||+|+++....  ...+.+.+|++++++++||||+++++++.     ..+..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence            4678889999999999999977 6789999999865432  23467889999999999999999999953     34588


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++ +|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        76 ~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~  142 (288)
T 1ob3_A           76 VLVFEHLDQ-DLKKLLDV---------CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIA  142 (288)
T ss_dssp             EEEEECCSE-EHHHHHHT---------STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEecCC-CHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEe
Confidence            999999975 89888752         2356899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||+++.......  ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+....+..-.
T Consensus       143 Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~  219 (288)
T 1ob3_A          143 DFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGT  219 (288)
T ss_dssp             CTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCC
T ss_pred             ECccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCC
Confidence            9999976543221  1234568999999999876 458999999999999999999999997632211 11111111000


Q ss_pred             ---c-ch--hh--hcccCCCC-----cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ---E-RA--EE--IRASSGST-----QRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ---~-~~--~~--~~d~~~~~-----~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                         . +.  .+  ..++....     ...........+.+++.+|++.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               0 00  00  00000000     00111123456789999999999999999999875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.2e-42  Score=342.49  Aligned_cols=254  Identities=24%  Similarity=0.305  Sum_probs=192.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|+||+||++++..+++.||||++.... ...+.+.+|+.+++.++||||+++++++.     .....+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~   92 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLA   92 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEE
Confidence            467889999999999999999998899999999987533 23467889999999999999999999954     345789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc--EEE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT--AYV  361 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~--~kl  361 (502)
                      +||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.  +||
T Consensus        93 lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl  159 (361)
T 3uc3_A           93 IIMEYASGGELYERICN----------AGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKI  159 (361)
T ss_dssp             EEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred             EEEEeCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEE
Confidence            99999999999999842          235899999999999999999999   899999999999999987765  999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCcc-ccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSY-GDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      +|||+++......   ......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||...... ..+........
T Consensus       160 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~~~~  235 (361)
T 3uc3_A          160 CDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-RDYRKTIQRIL  235 (361)
T ss_dssp             CCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C-CCHHHHHHHHH
T ss_pred             eecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-HHHHHHHHHHh
Confidence            9999997433221   2234568999999999988887766 89999999999999999999763221 22222222211


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ....      ..+..    ......+.+++.+|++.||++|||+.|+++.
T Consensus       236 ~~~~------~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          236 SVKY------SIPDD----IRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             TTCC------CCCTT----SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cCCC------CCCCc----CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            1100      00000    0123567799999999999999999999863

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.9e-43  Score=342.69  Aligned_cols=243  Identities=21%  Similarity=0.306  Sum_probs=199.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--------chhHHHHHHHHHHhcCCCCccceeeecccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--------DASKSFAVECEVTRNIRHRNLVKVFTACSGVD  275 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  275 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||+++....        .....+.+|++++++++||||+++++++    
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~----   98 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF----   98 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence            4578889999999999999999999999999999875421        1234677899999999999999999995    


Q ss_pred             cCCCcceeEEeeeccCC-ChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          276 FQGNDFKALVYEFMANG-SLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                       ...+..++||||+.+| +|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++
T Consensus        99 -~~~~~~~lv~e~~~~g~~l~~~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~  164 (335)
T 3dls_A           99 -ENQGFFQLVMEKHGSGLDLFAFIDR----------HPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIA  164 (335)
T ss_dssp             -ECSSEEEEEEECCTTSCBHHHHHHT----------CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred             -eeCCEEEEEEEeCCCCccHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEc
Confidence             3455889999999777 99999842          345899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCCCcc-CccccchhHHHHHHHHHhCCCCCccccccccchH
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEV-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR  433 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~  433 (502)
                      .++.+||+|||+++.......   .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.......    
T Consensus       165 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----  237 (335)
T 3dls_A          165 EDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV----  237 (335)
T ss_dssp             TTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----
T ss_pred             CCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----
Confidence            999999999999987654332   223568999999999988876 789999999999999999999997521100    


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                                     .......    ..+...+.+++.+|++.||++|||++|+++.
T Consensus       238 ---------------~~~~~~~----~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 ---------------EAAIHPP----YLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ---------------TTCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ---------------hhccCCC----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                           0000000    1124567899999999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.9e-42  Score=349.97  Aligned_cols=266  Identities=20%  Similarity=0.184  Sum_probs=197.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc--CcchhHHHHHHHHHHhcCCCCccceeeeccccccc-CCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL--HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-QGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~  280 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+++++.++||||+++++++..... ....
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            56889999999999999999999999999999998753  22345678899999999999999999998754321 2335


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||++++ |.+.+.            ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus       141 ~~~lv~E~~~~~-l~~~~~------------~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~k  204 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK  204 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEE
T ss_pred             eEEEEEeCCCCC-HHHHHh------------hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEE
Confidence            679999999764 665552            23889999999999999999999   88999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||+++......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ..+...++..-
T Consensus       205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~lg  280 (464)
T 3ttj_A          205 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLG  280 (464)
T ss_dssp             ECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC
T ss_pred             EEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcC
Confidence            99999998654322   223467899999999999999999999999999999999999999763211 11111111000


Q ss_pred             c---c-------chhhhc----------------ccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 P---E-------RAEEIR----------------ASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~---~-------~~~~~~----------------d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .   +       ......                +................+.+|+.+|++.||++|||++|+++
T Consensus       281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             SCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0   0       000000                00011111112233567889999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1e-42  Score=341.72  Aligned_cols=268  Identities=26%  Similarity=0.359  Sum_probs=203.5

Q ss_pred             ccCCCCCCcccccCCceEEEEE-----EcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGI-----LFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      .++|...+.||+|+||.||+|.     ...++..||||++.... ......+.+|+.++++++||||+++++++.     
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----  103 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-----  103 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc-----
Confidence            4678899999999999999997     44577899999986432 334567899999999999999999999954     


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC--
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD--  355 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~--  355 (502)
                      .....++||||+++|+|.+++.....   .......+++..++.++.|++.||.|||   +.+|+||||||+|||++.  
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~  177 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRP---RPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPG  177 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSC---CSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSS
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcc---cccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCC
Confidence            34478999999999999999964111   1122356899999999999999999999   899999999999999984  


Q ss_pred             -CCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchH
Q 046112          356 -EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLR  433 (502)
Q Consensus       356 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~  433 (502)
                       +..+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....  ....
T Consensus       178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~  255 (327)
T 2yfx_A          178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVL  255 (327)
T ss_dssp             TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHH
T ss_pred             CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHH
Confidence             45699999999976544333333334567899999999988899999999999999999998 9999875321  1111


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      ..+.....           .   .....+...+.+++.+||+.||.+|||+.|+++.|+.+....
T Consensus       256 ~~~~~~~~-----------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          256 EFVTSGGR-----------M---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HHHHTTCC-----------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHhcCCC-----------C---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            11111100           0   001134556889999999999999999999999999887643

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7e-43  Score=337.09  Aligned_cols=261  Identities=25%  Similarity=0.364  Sum_probs=204.9

Q ss_pred             hccCCCCCC-cccccCCceEEEEEE--cCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          203 ATKGFSSEN-LIGAGNFGSVYKGIL--FESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       203 ~t~~~~~~~-~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      ..++|...+ .||+|+||.||+|.+  ...++.||||+++....  ...+.+.+|+++++.++||||+++++++.     
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   88 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----   88 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-----
Confidence            345677777 999999999999954  45678999999875432  23567999999999999999999999862     


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                       .+..++||||+++++|.+++..          ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++
T Consensus        89 -~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~  154 (291)
T 1xbb_A           89 -AESWMLVMEMAELGPLNKYLQQ----------NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQH  154 (291)
T ss_dssp             -SSSEEEEEECCTTEEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETT
T ss_pred             -CCCcEEEEEeCCCCCHHHHHHh----------CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCC
Confidence             2367899999999999999842          245889999999999999999999   88999999999999999999


Q ss_pred             cEEEeeeccceeccccccc-ceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHH
Q 046112          358 TAYVSDFGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~  435 (502)
                      .+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......  .....
T Consensus       155 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~  232 (291)
T 1xbb_A          155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAM  232 (291)
T ss_dssp             EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH
T ss_pred             cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH
Confidence            9999999999876544322 11223446789999999988889999999999999999999 99999763221  11111


Q ss_pred             HHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      +.....              ......++..+.+++.+||+.||++|||+.++++.|+.+-...
T Consensus       233 ~~~~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          233 LEKGER--------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             HHTTCC--------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HHcCCC--------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            111100              0011234567889999999999999999999999999886654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=341.35  Aligned_cols=266  Identities=21%  Similarity=0.253  Sum_probs=192.9

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-CCccceeeecccccc---cCCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRNLVKVFTACSGVD---FQGN  279 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~---~~~~  279 (502)
                      ..+|...+.||+|+||.||+|++..+++.||||++........+.+.+|+.++.++. ||||+++++++....   ....
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            347888899999999999999998899999999986655555677899999999996 999999999873211   1344


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeecCCCCCeeeCCCC
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPP--IAHCDLKPSNILLDDEM  357 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--i~H~dlk~~NIll~~~~  357 (502)
                      ...++|+||+. |+|.+++...       .....+++..++.++.|++.||+|||   +.+  |+||||||+|||++.++
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKM-------ESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHH-------HTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTS
T ss_pred             ceEEEEEEecC-CCHHHHHHHh-------hccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCC
Confidence            56889999995 8999988421       22346899999999999999999999   777  99999999999999999


Q ss_pred             cEEEeeeccceecccccccc----------eecccccccccccCccc---CCCccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          358 TAYVSDFGIARFLEAADEQT----------RSIGVEGTTGYIAPEYG---MGHEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      .+||+|||+++.........          ......||+.|+|||.+   .+..++.++|||||||++|||+||+.||..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            99999999998765432211          11234589999999998   567789999999999999999999999975


Q ss_pred             ccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          425 MFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      ....     .........       +..       ..+...+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus       256 ~~~~-----~~~~~~~~~-------~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          256 GAKL-----RIVNGKYSI-------PPH-------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             ---------------CCC-------CTT-------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             hhHH-----HhhcCcccC-------Ccc-------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            2111     111111000       000       0112346789999999999999999999999999977543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-42  Score=346.61  Aligned_cols=268  Identities=22%  Similarity=0.305  Sum_probs=191.9

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc--CcchhHHHHHHHHHHhcCC-CCccceeeecccccccCCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL--HHDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~  279 (502)
                      ..++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++..+. ||||+++++++..   .+.
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~   83 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DND   83 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTS
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CCC
Confidence            456899999999999999999999999999999998643  2233466788999999997 9999999998642   233


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++||||++ |+|.+++..           ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~  148 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRA-----------NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHV  148 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH-----------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCE
T ss_pred             CEEEEEecccC-cCHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCE
Confidence            46899999997 689888742           35889999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceeccccc-------------------ccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCC
Q 046112          360 YVSDFGIARFLEAAD-------------------EQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGL  419 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~  419 (502)
                      ||+|||+|+.+....                   .........||+.|+|||.+.+ ..++.++|||||||++|||++|+
T Consensus       149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~  228 (388)
T 3oz6_A          149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK  228 (388)
T ss_dssp             EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCC
Confidence            999999998764311                   1112344679999999999876 67899999999999999999999


Q ss_pred             CCCccccccccchHHHHHhhccc-chhhhc---------------------ccCCCCcchh----------hHHHHHHHH
Q 046112          420 RPSDDMFKDNLNLRNCVKSALPE-RAEEIR---------------------ASSGSTQRSI----------ILECLISIC  467 (502)
Q Consensus       420 ~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~---------------------d~~~~~~~~~----------~~~~~~~l~  467 (502)
                      .||...... ..+.... ..... ....+.                     ..........          ...+...+.
T Consensus       229 ~pf~~~~~~-~~~~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (388)
T 3oz6_A          229 PIFPGSSTM-NQLERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL  306 (388)
T ss_dssp             CSCCCSSHH-HHHHHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHH
T ss_pred             CCCCCCCHH-HHHHHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHH
Confidence            999763211 1111111 11100 000000                     0000000000          002345678


Q ss_pred             HHHhhcccCCCCCCCCHHHHHHH
Q 046112          468 EIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       468 ~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      +++.+|++.||++|||++|+++.
T Consensus       307 dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          307 DLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHhhccCcccCCCHHHHhCC
Confidence            99999999999999999998753

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.4e-42  Score=331.20  Aligned_cols=260  Identities=25%  Similarity=0.397  Sum_probs=207.3

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|+||.||+|.. .++..||||+++... ...+.+.+|++++++++||||+++++++.      .+..+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~   83 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIY   83 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCE
T ss_pred             HHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc------CCCcE
Confidence            35678889999999999999965 567889999987543 33578999999999999999999999853      23578


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++++|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        84 ~v~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~D  152 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKT--------PSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIAD  152 (279)
T ss_dssp             EEEECCTTCBHHHHTTS--------HHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECC
T ss_pred             EEEecCCCCCHHHHHhc--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECC
Confidence            99999999999999853        11125889999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+..... 
T Consensus       153 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~-  228 (279)
T 1qpc_A          153 FGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYR-  228 (279)
T ss_dssp             CTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC-
T ss_pred             CcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcccC-
Confidence            999987654322 22234556889999999988889999999999999999999 99998753211  11111111100 


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                             ..   .   ...++..+.+++.+|++.||++|||+.++++.|+.+.....
T Consensus       229 -------~~---~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          229 -------MV---R---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             -------CC---C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             -------CC---C---cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence                   00   0   11334578899999999999999999999999999876643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.2e-42  Score=342.82  Aligned_cols=269  Identities=22%  Similarity=0.259  Sum_probs=204.0

Q ss_pred             CHHHHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-----CCccceeeec
Q 046112          196 SYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-----HRNLVKVFTA  270 (502)
Q Consensus       196 ~~~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~  270 (502)
                      ++.+-....++|...++||+|+||+||+|++..+++.||||+++.. ......+..|+++++.++     ||||++++++
T Consensus        26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~  104 (360)
T 3llt_A           26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK  104 (360)
T ss_dssp             CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred             eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence            3333444567899999999999999999999899999999998642 233466788999999886     9999999998


Q ss_pred             ccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCC
Q 046112          271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSN  350 (502)
Q Consensus       271 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~N  350 (502)
                      +.     ..+..++||||+ +++|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+|
T Consensus       105 ~~-----~~~~~~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~N  167 (360)
T 3llt_A          105 FM-----YYDHMCLIFEPL-GPSLYEIITR--------NNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPEN  167 (360)
T ss_dssp             EE-----ETTEEEEEECCC-CCBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred             ee-----ECCeeEEEEcCC-CCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCccc
Confidence            54     344889999999 9999999853        33345899999999999999999999   8999999999999


Q ss_pred             eeeCC-------------------------CCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccc
Q 046112          351 ILLDD-------------------------EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDV  405 (502)
Q Consensus       351 Ill~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv  405 (502)
                      ||++.                         ++.+||+|||+++......     ....||+.|+|||++.+..++.++||
T Consensus       168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di  242 (360)
T 3llt_A          168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDM  242 (360)
T ss_dssp             EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHH
T ss_pred             EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccch
Confidence            99986                         7899999999998644322     24568999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchh------------hhcccC-----CCCc-------------
Q 046112          406 YSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAE------------EIRASS-----GSTQ-------------  455 (502)
Q Consensus       406 ws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------~~~d~~-----~~~~-------------  455 (502)
                      |||||++|||+||+.||......  .....+.........            ...+..     .+..             
T Consensus       243 wslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  320 (360)
T 3llt_A          243 WSFGCVLAELYTGSLLFRTHEHM--EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC  320 (360)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTC
T ss_pred             HHHHHHHHHHHHCCCCCCCCcHH--HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhc
Confidence            99999999999999999753211  111111111110000            000000     0000             


Q ss_pred             -chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          456 -RSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       456 -~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                       ..........+.+++.+|++.||++|||++|+++
T Consensus       321 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence             0000111256779999999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=333.51  Aligned_cols=255  Identities=21%  Similarity=0.326  Sum_probs=200.7

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC----cchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH----HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .++|...+.||+|+||.||+|.+..++..||+|+++...    ......+.+|++++++++||||+++++++..   ...
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence            468999999999999999999988899999999986432    2345679999999999999999999998632   334


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++||||++++ |.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~  148 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDS--------VPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTL  148 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHH--------STTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred             CeEEEEehhccCC-HHHHHHh--------CcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcE
Confidence            5789999999876 7776642        23456899999999999999999999   8899999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCc--cCccccchhHHHHHHHHHhCCCCCccccccccchHHHHH
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE--VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  437 (502)
                      ||+|||++................||+.|+|||.+.+..  ++.++||||||+++|||++|+.||.....  ....+.+.
T Consensus       149 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~  226 (305)
T 2wtk_C          149 KISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--YKLFENIG  226 (305)
T ss_dssp             EECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHH
T ss_pred             EeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHHh
Confidence            999999998765443333344567899999999987643  47899999999999999999999975211  11111111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ..           ..    ....++...+.+++.+|++.||.+|||++|+++.
T Consensus       227 ~~-----------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          227 KG-----------SY----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HC-----------CC----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             cC-----------CC----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            10           00    0011334567799999999999999999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.6e-42  Score=345.88  Aligned_cols=255  Identities=18%  Similarity=0.266  Sum_probs=192.4

Q ss_pred             cCCCCC-CcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHh-cCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSE-NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTR-NIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|... ++||+|+||+||+|.+..+++.||||+++.     ...+.+|++++. ..+||||+++++++... ..+....
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcEE
Confidence            455554 689999999999999989999999999863     346778888874 55899999999986431 2334578


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC---CCcE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD---EMTA  359 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~---~~~~  359 (502)
                      ++||||+++|+|.+++..        .....+++..+..++.|++.||.|||   +.+|+||||||+|||++.   ++.+
T Consensus       135 ~lv~E~~~gg~L~~~l~~--------~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~  203 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQD--------RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAIL  203 (400)
T ss_dssp             EEEEECCCSEEHHHHHHC--------C---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCE
T ss_pred             EEEEEeCCCCcHHHHHHH--------hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccE
Confidence            999999999999999954        23346899999999999999999999   899999999999999997   7899


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccccccc--chHHHHH
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL--NLRNCVK  437 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~--~~~~~~~  437 (502)
                      ||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  .....+.
T Consensus       204 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~  280 (400)
T 1nxk_A          204 KLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR  280 (400)
T ss_dssp             EECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred             EEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence            999999998654322   22345689999999999999999999999999999999999999976322211  1111111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      .....    +..+.       ...+...+.+++.+||+.||++|||+.|+++.
T Consensus       281 ~~~~~----~~~~~-------~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          281 MGQYE----FPNPE-------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             HTCCC----CCTTT-------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCccc----CCCcc-------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11000    00000       11334567899999999999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.8e-42  Score=331.58  Aligned_cols=252  Identities=20%  Similarity=0.310  Sum_probs=201.5

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|++++++++||||+++++++.     ....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCE
Confidence            467889999999999999999998999999999986533  223467889999999999999999999853     4457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc---
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT---  358 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~---  358 (502)
                      .++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   
T Consensus        80 ~~~v~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~  146 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVA----------REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAA  146 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCC
T ss_pred             EEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCc
Confidence            8999999999999988742          245899999999999999999999   899999999999999986655   


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +||+|||++........   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......  .....+..
T Consensus       147 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~  221 (284)
T 3kk8_A          147 VKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKA  221 (284)
T ss_dssp             EEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred             EEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHHHh
Confidence            99999999976653322   23456899999999999999999999999999999999999999753211  11111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .....    ..+.       .......+.+++.+|++.||++|||++|+++
T Consensus       222 ~~~~~----~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          222 GAYDY----PSPE-------WDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             TCCCC----CTTT-------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccC----Cchh-------hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            11000    0000       1123456789999999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.9e-43  Score=348.96  Aligned_cols=248  Identities=24%  Similarity=0.273  Sum_probs=189.7

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHH-HhcCCCCccceeeecccccccCCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEV-TRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .++|...+.||+|+||.||+|++..+++.||+|+++...   ......+..|..+ ++.++||||+++++++     ...
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~~  111 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTA  111 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----ECS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EeC
Confidence            357888999999999999999999999999999987542   2223456667776 5778999999999985     445


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +..++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~i  178 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQR----------ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHI  178 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCE
Confidence            589999999999999999842          245788899999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||+++......  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     .+.....
T Consensus       179 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~i  251 (373)
T 2r5t_A          179 VLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNI  251 (373)
T ss_dssp             EECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----HHHHHHH
T ss_pred             EEeeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHH
Confidence            999999997533221  223456799999999999999999999999999999999999999975211     1111111


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVE  488 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~  488 (502)
                      .        .......    ......+.+++.+|++.||.+||++.+..
T Consensus       252 ~--------~~~~~~~----~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          252 L--------NKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             H--------HSCCCCC----SSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             H--------hcccCCC----CCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            1        0000000    12244577899999999999999986443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.3e-42  Score=368.82  Aligned_cols=254  Identities=24%  Similarity=0.372  Sum_probs=200.1

Q ss_pred             CcccccCCceEEEEEEc--CCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILF--ESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      +.||+|+||.||+|.+.  ..++.||||+++....  ...+++.+|++++++++|||||+++++|..      +..++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence            47999999999999543  5678999999975432  235789999999999999999999998632      3578999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       449 E~~~~g~L~~~l~~----------~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGl  515 (635)
T 4fl3_A          449 EMAELGPLNKYLQQ----------NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL  515 (635)
T ss_dssp             ECCTTEEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred             EccCCCCHHHHHhh----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCC
Confidence            99999999999842          345899999999999999999999   89999999999999999999999999999


Q ss_pred             ceecccccc-cceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccch
Q 046112          367 ARFLEAADE-QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       367 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      ++.+..... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  ...+.+.....   
T Consensus       516 a~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~---  590 (635)
T 4fl3_A          516 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGER---  590 (635)
T ss_dssp             HHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC---
T ss_pred             ccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC---
Confidence            987654332 122233456889999999999999999999999999999998 99999763221  11111111100   


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                                 ......++..+.+++.+||+.||++|||+++|++.|+.+..++.
T Consensus       591 -----------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~  634 (635)
T 4fl3_A          591 -----------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  634 (635)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence                       01112456778899999999999999999999999999877653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=336.77  Aligned_cols=245  Identities=21%  Similarity=0.232  Sum_probs=190.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc--hhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD--ASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...++||+|+||+||+|.+..+++.||||++......  ....+..|+..+.++ +||||++++++|.     ..+.
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence            4688889999999999999999889999999998643322  223445555555544 8999999999964     3458


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+ +++|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus       132 ~~lv~e~~-~~~L~~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl  198 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEA---------WGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKL  198 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHH---------HCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEE
T ss_pred             EEEEEecc-CCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEE
Confidence            89999999 7799988742         2346999999999999999999999   889999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+++......   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+....    .......... 
T Consensus       199 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~~~~~~~-  269 (311)
T 3p1a_A          199 GDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GWQQLRQGYL-  269 (311)
T ss_dssp             CCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHHHHTTTCC-
T ss_pred             ccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHhccCC-
Confidence            9999998664332   2234568999999999876 79999999999999999999977654411    1111111000 


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                                   ...........+.+++.+|++.||++|||++|+++
T Consensus       270 -------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 -------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                         01111234567889999999999999999999875

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=342.05  Aligned_cols=252  Identities=20%  Similarity=0.315  Sum_probs=190.7

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCC--CccceeeecccccccCCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRH--RNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~  279 (502)
                      .++|...+.||+|+||.||++.+ .+++.||||+++....  ...+.+.+|++++.+++|  |||+++++++.     ..
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~   81 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD   81 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence            35688899999999999999965 6789999999875432  234678999999999986  99999999954     34


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      ...++||| +.+|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++ ++.+
T Consensus        82 ~~~~lv~e-~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~  146 (343)
T 3dbq_A           82 QYIYMVME-CGNIDLNSWLKK----------KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGML  146 (343)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHH----------SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEE
T ss_pred             CEEEEEEe-CCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcE
Confidence            58899999 568899999842          346899999999999999999999   88999999999999997 5789


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCC-----------CccCccccchhHHHHHHHHHhCCCCCcccccc
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-----------HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD  428 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~  428 (502)
                      ||+|||+++...............||+.|+|||++.+           ..++.++|||||||++|||++|+.||......
T Consensus       147 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  226 (343)
T 3dbq_A          147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  226 (343)
T ss_dssp             EECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             EEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH
Confidence            9999999987655443333345679999999999754           67899999999999999999999999763221


Q ss_pred             ccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          429 NLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ...+...            .++.....  +.......+.+++.+||+.||.+|||+.|+++.
T Consensus       227 ~~~~~~~------------~~~~~~~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          227 ISKLHAI------------IDPNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHHHHH------------HCTTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHH------------hcCCcccC--CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            1111111            11111000  001123457799999999999999999999764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.8e-42  Score=329.19  Aligned_cols=259  Identities=22%  Similarity=0.294  Sum_probs=203.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc------chhHHHHHHHHHHhcCCCCccceeeecccccccCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH------DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      ++|...+.||+|+||.||+|.+..+++.||+|+++....      ...+.+.+|++++++++||||+++++++.     .
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence            457888999999999999999988999999999874321      13577999999999999999999999854     3


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC-
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM-  357 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~-  357 (502)
                      ....++||||+++++|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++ 
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~  146 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAE----------KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNV  146 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSS
T ss_pred             CCeEEEEEeecCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCC
Confidence            4578999999999999999842          245899999999999999999999   89999999999999998877 


Q ss_pred             ---cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHH
Q 046112          358 ---TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN  434 (502)
Q Consensus       358 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~  434 (502)
                         .+||+|||++........   .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||......  ....
T Consensus       147 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~  221 (283)
T 3bhy_A          147 PNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETLT  221 (283)
T ss_dssp             SSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH
T ss_pred             CCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHHH
Confidence               899999999986643322   23456899999999999999999999999999999999999999763211  1111


Q ss_pred             HHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HHHHHHHH
Q 046112          435 CVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP--RLRLIKKK  497 (502)
Q Consensus       435 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~--~L~~i~~~  497 (502)
                      .+....           ..............+.+++.+|++.||++|||+.|+++  .++.++++
T Consensus       222 ~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          222 NISAVN-----------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             HHHTTC-----------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             HhHhcc-----------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence            111000           00011111233556789999999999999999999997  45555443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=347.30  Aligned_cols=261  Identities=21%  Similarity=0.244  Sum_probs=202.2

Q ss_pred             HHHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeeccccc
Q 046112          198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGV  274 (502)
Q Consensus       198 ~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  274 (502)
                      ++.....++|...+.||+|+||.||+|+...+++.||+|+++...   ......+.+|.+++..++||||+++++++   
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~---  130 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF---  130 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE---
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE---
Confidence            344445688999999999999999999998899999999986421   12234588999999999999999999985   


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                        ...+..++||||+++|+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||++
T Consensus       131 --~~~~~~~lVmE~~~gg~L~~~l~~---------~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld  196 (412)
T 2vd5_A          131 --QDENYLYLVMEYYVGGDLLTLLSK---------FGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLD  196 (412)
T ss_dssp             --ECSSEEEEEECCCCSCBHHHHHHH---------HSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred             --eeCCEEEEEEcCCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeec
Confidence              445589999999999999999852         1235899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccC-------CCccCccccchhHHHHHHHHHhCCCCCccccc
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM-------GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFK  427 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~  427 (502)
                      .++.+||+|||+++....... .......||+.|+|||++.       ...++.++|||||||++|||++|+.||.....
T Consensus       197 ~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~  275 (412)
T 2vd5_A          197 RCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST  275 (412)
T ss_dssp             TTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             CCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence            999999999999987654322 2223467999999999987       46789999999999999999999999976311


Q ss_pred             cccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCC---CCHHHHHH
Q 046112          428 DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGER---MKINDVEP  489 (502)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~R---Pt~~ev~~  489 (502)
                      .. .+...+...     .....+.      ........+.+++.+|++ +|++|   |+++|+.+
T Consensus       276 ~~-~~~~i~~~~-----~~~~~p~------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          276 AE-TYGKIVHYK-----EHLSLPL------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HH-HHHHHHTHH-----HHCCCC----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HH-HHHHHHhcc-----cCcCCCc------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            11 111111100     0000000      011234567799999999 99998   58888754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.9e-43  Score=349.29  Aligned_cols=261  Identities=16%  Similarity=0.167  Sum_probs=193.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHH---HHHhcCCCCccceeeecccccc--
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVEC---EVTRNIRHRNLVKVFTACSGVD--  275 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~--  275 (502)
                      .++|...+.||+|+||.||+|.+..+|+.||||+++..   .....+.+.+|+   +.+++++||||+++++.+....  
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35677789999999999999988888999999998742   233457789999   5566668999999985442100  


Q ss_pred             cCC------------Cc-----ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 046112          276 FQG------------ND-----FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ  338 (502)
Q Consensus       276 ~~~------------~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~  338 (502)
                      +..            ++     ..++||||+ +|+|.+++.....   .......+++..++.++.|++.||+|||   +
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~---~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~  224 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS---HSSTHKSLVHHARLQLTLQVIRLLASLH---H  224 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHH---TTTTTHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccc---cccccccccHHHHHHHHHHHHHHHHHHH---h
Confidence            111            11     378999999 6899999853110   0011233556888999999999999999   8


Q ss_pred             CCceeecCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCC-----------ccCccccchh
Q 046112          339 PPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-----------EVSSYGDVYS  407 (502)
Q Consensus       339 ~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDvws  407 (502)
                      .+|+||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++||||
T Consensus       225 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS  298 (377)
T 3byv_A          225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA  298 (377)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred             CCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence            8999999999999999999999999999985332     2234567 999999999887           8999999999


Q ss_pred             HHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 046112          408 FGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV  487 (502)
Q Consensus       408 ~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev  487 (502)
                      |||++|||+||+.||.......             ....+.. ..       ..++..+.+++.+||+.||++|||+.|+
T Consensus       299 lG~il~elltg~~Pf~~~~~~~-------------~~~~~~~-~~-------~~~~~~~~~li~~~L~~dp~~Rpt~~e~  357 (377)
T 3byv_A          299 LGLVIYWIWCADLPITKDAALG-------------GSEWIFR-SC-------KNIPQPVRALLEGFLRYPKEDRLLPLQA  357 (377)
T ss_dssp             HHHHHHHHHHSSCCC------C-------------CSGGGGS-SC-------CCCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred             HHHHHHHHHHCCCCCccccccc-------------chhhhhh-hc-------cCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence            9999999999999997532111             0001110 00       1224567799999999999999999999


Q ss_pred             HH--HHHHHHHHH
Q 046112          488 EP--RLRLIKKKL  498 (502)
Q Consensus       488 ~~--~L~~i~~~~  498 (502)
                      ++  .++.+.+..
T Consensus       358 l~hp~f~~~~~~~  370 (377)
T 3byv_A          358 METPEYEQLRTEL  370 (377)
T ss_dssp             HTSHHHHHHHHHH
T ss_pred             hhChHHHHHHHHH
Confidence            86  566665554

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-41  Score=334.27  Aligned_cols=260  Identities=18%  Similarity=0.215  Sum_probs=200.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-CCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|...+.||+|+||+||+|.+..+++.||||+++.   ...+.+.+|++++++++ ||||+++++++..   ......+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~~  109 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA  109 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCceE
Confidence            578889999999999999999989999999999874   23577999999999997 9999999998643   2245789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC-cEEEe
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM-TAYVS  362 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~-~~kl~  362 (502)
                      +||||+++++|.+++..             +++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+
T Consensus       110 lv~e~~~~~~l~~~~~~-------------~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~  173 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQT-------------LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLI  173 (330)
T ss_dssp             EEEECCCCCCHHHHGGG-------------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEeccCchhHHHHHHh-------------CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEE
Confidence            99999999999998742             788899999999999999999   89999999999999999776 89999


Q ss_pred             eeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||+++.......   .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.........+.......-.
T Consensus       174 Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~  250 (330)
T 3nsz_A          174 DWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  250 (330)
T ss_dssp             CCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred             eCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCC
Confidence            9999987654332   234568999999999887 678999999999999999999999995432222112211111111


Q ss_pred             cchhhhccc---------------CCCC------cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRAS---------------SGST------QRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~---------------~~~~------~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ....+..+.               ....      ...........+.+++.+|++.||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             chhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111000000               0000      00001124567889999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.8e-42  Score=331.44  Aligned_cols=256  Identities=22%  Similarity=0.335  Sum_probs=205.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeeccccccc--------
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF--------  276 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  276 (502)
                      .+|...+.||+|+||.||+|.+..+++.||+|+++...    ..+.+|++++++++||||+++++++...++        
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            46788899999999999999988899999999987532    457789999999999999999998643211        


Q ss_pred             ---CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee
Q 046112          277 ---QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL  353 (502)
Q Consensus       277 ---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll  353 (502)
                         ......++||||+++|+|.+++..        .....+++..++.++.|++.||.|||   +.+|+||||||+||++
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  155 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEK--------RRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFL  155 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHH--------GGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEE
Confidence               123467899999999999999853        22356899999999999999999999   8899999999999999


Q ss_pred             CCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchH
Q 046112          354 DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR  433 (502)
Q Consensus       354 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~  433 (502)
                      +.++.+||+|||++........   .....||+.|+|||.+.+..++.++||||||+++|||++|..|+....    ...
T Consensus       156 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~  228 (284)
T 2a19_B          156 VDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----KFF  228 (284)
T ss_dssp             EETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----HHH
T ss_pred             cCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----HHH
Confidence            9999999999999987654322   234568999999999999999999999999999999999998875411    011


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      .   .        +.......      .....+.+++.+|++.||++|||+.|+++.|..+++...
T Consensus       229 ~---~--------~~~~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          229 T---D--------LRDGIISD------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             H---H--------HHTTCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             H---H--------hhcccccc------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            1   0        00111111      123456789999999999999999999999998876543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.7e-42  Score=333.52  Aligned_cols=250  Identities=22%  Similarity=0.277  Sum_probs=201.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .++|...+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.     ..+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCC
Confidence            356888899999999999999998899999999986432   233467889999999999999999999954     345


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++++|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~k  155 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKR----------RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVK  155 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred             EEEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEE
Confidence            78999999999999998742          245889999999999999999999   88999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||+++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......     +......
T Consensus       156 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~  228 (294)
T 2rku_A          156 IGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLRIK  228 (294)
T ss_dssp             ECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHH
T ss_pred             EEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHh
Confidence            999999987643322  123456899999999999999999999999999999999999999763211     1111000


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                              .....    ........+.+++.+|++.||++|||++|+++.
T Consensus       229 --------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          229 --------KNEYS----IPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             --------TTCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             --------hccCC----CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                    00000    011223467789999999999999999999863

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.2e-42  Score=334.86  Aligned_cols=263  Identities=20%  Similarity=0.277  Sum_probs=196.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc--hhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD--ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|...+.||+|+||+||+|.+..+++.||||++......  ..+.+.+|++++++++||||+++++++.     ..+..
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence            5788899999999999999999889999999998654332  2466889999999999999999999964     34578


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++++|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        78 ~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~  144 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDR----------YQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLC  144 (311)
T ss_dssp             EEEEECCSEEHHHHHHH----------TSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEEeCCCchHHHHHh----------hhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEe
Confidence            99999999999998873          2345899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||+++.......  ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||.......  ....+.....
T Consensus       145 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~  220 (311)
T 4agu_A          145 DFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD--QLYLIRKTLG  220 (311)
T ss_dssp             CCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHC
T ss_pred             eCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhc
Confidence            9999987653322  1234568999999999876 678999999999999999999999997632211  1111111110


Q ss_pred             c----c---------hhhhcccCCCCcch---hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 E----R---------AEEIRASSGSTQRS---IILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~----~---------~~~~~d~~~~~~~~---~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .    .         ......+.......   ........+.+++.+|++.||++|||++|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          221 DLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             SCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0    0         00000000000000   01134556789999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.5e-41  Score=346.92  Aligned_cols=265  Identities=19%  Similarity=0.289  Sum_probs=208.3

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...++||+|+||.||+|.+..+++.||||+++....  ..++..|+++++.++|++.+..+.++    ....+..+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~----~~~~~~~~   79 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWF----GVEGDYNV   79 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEE----EEETTEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEE----EeeCCEEE
Confidence            4678999999999999999999889999999998765332  34588999999999886555555443    22345789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee---CCCCcEE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAY  360 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll---~~~~~~k  360 (502)
                      +||||+ +++|.+++..         ....+++..++.|+.|++.||+|||   +.+|+||||||+|||+   +.++.+|
T Consensus        80 lvme~~-g~sL~~ll~~---------~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vk  146 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNF---------CSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVY  146 (483)
T ss_dssp             EEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEE
T ss_pred             EEEECC-CCCHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEE
Confidence            999999 9999999852         2346899999999999999999999   8999999999999999   6889999


Q ss_pred             Eeeeccceeccccccc-----ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccccccc--chH
Q 046112          361 VSDFGIARFLEAADEQ-----TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL--NLR  433 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~--~~~  433 (502)
                      |+|||+++.+......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........  .+.
T Consensus       147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~  226 (483)
T 3sv0_A          147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE  226 (483)
T ss_dssp             ECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHH
T ss_pred             EEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHH
Confidence            9999999877544321     122356799999999999999999999999999999999999999986432211  111


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      .............+           ...++..+.+++..||+.||++||++++|++.|+.+....
T Consensus       227 ~i~~~~~~~~~~~l-----------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          227 KISEKKVATSIEAL-----------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHHHHHHSCHHHH-----------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHhhccccccHHHH-----------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            11111111111111           1233567889999999999999999999999999986643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.8e-42  Score=344.72  Aligned_cols=251  Identities=20%  Similarity=0.312  Sum_probs=190.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCC--CCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIR--HRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~  280 (502)
                      .+|...+.||+|+||.||+|.+. .++.||||+++...  ....+.+.+|++++.+++  ||||+++++++..     .+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred             CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence            34888899999999999999664 58999999987543  233467899999999996  5999999998543     44


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||| +.+++|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++ ++.+|
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~k  194 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKK----------KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLK  194 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHH----------CSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEE
T ss_pred             EEEEEEe-cCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEE
Confidence            7899999 568999999842          236888999999999999999999   89999999999999996 57999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCC-----------CccCccccchhHHHHHHHHHhCCCCCccccccc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-----------HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN  429 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~  429 (502)
                      |+|||+++.+.............||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......
T Consensus       195 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~  274 (390)
T 2zmd_A          195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI  274 (390)
T ss_dssp             ECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred             EEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH
Confidence            999999987654433333345679999999999865           468999999999999999999999997532211


Q ss_pred             cchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          430 LNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ..+..            +.+......  +.......+.+++.+||+.||++|||+.|+++.
T Consensus       275 ~~~~~------------~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          275 SKLHA------------IIDPNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHHH------------HHCTTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHH------------HhCccccCC--CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            11111            111111000  000113457799999999999999999999753

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.2e-42  Score=348.24  Aligned_cols=206  Identities=23%  Similarity=0.334  Sum_probs=170.5

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||+++....  ...+.+.+|+++++.++||||+++++++..........
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            4688999999999999999999999999999999975322  23467899999999999999999999976544344467


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+. |+|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus       105 ~~lv~e~~~-~~L~~~~~----------~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL  170 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFK----------TPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKV  170 (432)
T ss_dssp             EEEEEECCS-EEHHHHHH----------SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEecCC-cCHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEE
Confidence            899999986 69999984          2356899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceeccccccc--------------------ceecccccccccccCccc-CCCccCccccchhHHHHHHHHHhCCC
Q 046112          362 SDFGIARFLEAADEQ--------------------TRSIGVEGTTGYIAPEYG-MGHEVSSYGDVYSFGILLLEMFTGLR  420 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDvws~Gv~l~el~tg~~  420 (502)
                      +|||+++........                    .......||++|+|||.+ ....++.++||||+||++|||++|..
T Consensus       171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~  250 (432)
T 3n9x_A          171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ  250 (432)
T ss_dssp             CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred             ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence            999999876543221                    123567799999999985 56679999999999999999998766


Q ss_pred             CCc
Q 046112          421 PSD  423 (502)
Q Consensus       421 p~~  423 (502)
                      ||.
T Consensus       251 p~~  253 (432)
T 3n9x_A          251 SHI  253 (432)
T ss_dssp             TTC
T ss_pred             ccc
Confidence            553

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.6e-42  Score=358.37  Aligned_cols=254  Identities=24%  Similarity=0.318  Sum_probs=203.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .++|...+.||+|+||.||+|+...+|+.||+|+++..   .......+.+|+++++.++||||+++++++     ...+
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~  257 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKD  257 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeCC
Confidence            45688889999999999999999889999999998642   123346688999999999999999999985     3455


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~--------~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vK  326 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYH--------MGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIR  326 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHS--------SSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeE
Confidence            89999999999999999853        33345899999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||+++.+.....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... ...+
T Consensus       327 L~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i-~~~i  401 (576)
T 2acx_A          327 ISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEV-ERLV  401 (576)
T ss_dssp             ECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHH-HHHH
T ss_pred             EEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHH-HHHh
Confidence            999999987653322   234579999999999999999999999999999999999999997632211 11111 1111


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~  489 (502)
                      .....     ..      .......+.+++.+|++.||++||     +++|+++
T Consensus       402 ~~~~~-----~~------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          402 KEVPE-----EY------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHCCC-----CC------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             hcccc-----cC------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            00000     00      112345677999999999999999     6787764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.2e-42  Score=338.25  Aligned_cols=268  Identities=25%  Similarity=0.347  Sum_probs=205.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEE--EEEEeccc-CcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAV--AVKVFNVL-HHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ++|...+.||+|+||.||+|.+..++..+  |+|.++.. .....+.+.+|+++++++ +||||+++++++.     ..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~   99 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG   99 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----eCC
Confidence            56888899999999999999988888755  99988743 233456789999999999 8999999999953     345


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhh------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDK------RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                      ..++||||+++|+|.+++........      .......+++..++.++.|++.||+|||   +.+|+||||||+||+++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG  176 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEc
Confidence            78999999999999999964221000      0022356899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchH
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLR  433 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~  433 (502)
                      .++.+||+|||+++......   ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||.....     .
T Consensus       177 ~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~  248 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----A  248 (327)
T ss_dssp             GGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H
T ss_pred             CCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----H
Confidence            99999999999997433221   1123456889999999988889999999999999999998 9999976321     1


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      +.........     ...      ....+...+.+++.+|++.||.+|||++|+++.|+++.++..
T Consensus       249 ~~~~~~~~~~-----~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          249 ELYEKLPQGY-----RLE------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             HHHHHGGGTC-----CCC------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             HHHHHhhcCC-----CCC------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            1111111000     000      011334568899999999999999999999999999877543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.4e-42  Score=340.45  Aligned_cols=247  Identities=23%  Similarity=0.270  Sum_probs=196.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc---hhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD---ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      +.|...+.||+|+||+||+|.+..+++.||||++......   ..+.+.+|++++++++||||+++++++.     ..+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCe
Confidence            3477888999999999999998899999999998754322   2356889999999999999999999864     3458


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+. |+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus       129 ~~lv~e~~~-g~l~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL  195 (348)
T 1u5q_A          129 AWLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKL  195 (348)
T ss_dssp             EEEEEECCS-EEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEE
T ss_pred             EEEEEecCC-CCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEE
Confidence            899999997 788887742         2356899999999999999999999   889999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccC---CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM---GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +|||+++.....      ....||+.|+|||.+.   ...++.++|||||||++|||++|+.||....... .+......
T Consensus       196 ~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~  268 (348)
T 1u5q_A          196 GDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQN  268 (348)
T ss_dssp             CCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHS
T ss_pred             eeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhc
Confidence            999999765432      2356899999999874   5678999999999999999999999987532111 11111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ..+         ...     ...+...+.+++.+||+.||++|||++++++.
T Consensus       269 ~~~---------~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          269 ESP---------ALQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CCC---------CCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCC---------CCC-----CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000         000     01234557799999999999999999998753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.7e-41  Score=338.11  Aligned_cols=270  Identities=19%  Similarity=0.252  Sum_probs=205.0

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ..++|...+.||+|+||.||+|.+..++..||||++..... ...+.+.+|++++++++||||+++++++..........
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            34678999999999999999999988999999999875332 23467889999999999999999999976544444567


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++|+||+. |+|.+++..           ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus       105 ~~iv~e~~~-~~L~~~l~~-----------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl  169 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKT-----------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKI  169 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEcccC-cCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEE
Confidence            899999996 699988742           34899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccc-eecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          362 SDFGIARFLEAADEQT-RSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      +|||+++......... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+.... ..
T Consensus       170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~-~~  247 (364)
T 3qyz_A          170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHIL-GI  247 (364)
T ss_dssp             CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHH-HH
T ss_pred             EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHH-HH
Confidence            9999998765443221 1234579999999998665 458999999999999999999999997632211 111111 11


Q ss_pred             ccc-chh---------------hhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPE-RAE---------------EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~-~~~---------------~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ... ...               ....................+.+++.+|++.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            100 000               00000000001111123456789999999999999999999975

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.1e-42  Score=329.81  Aligned_cols=246  Identities=20%  Similarity=0.310  Sum_probs=200.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||+|.+..++..||+|++....   ......+.+|++++++++||||+++++++.     ..+.
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   88 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DRKR   88 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cCCE
Confidence            57888899999999999999998899999999986421   223467899999999999999999999953     3458


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl  155 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQK----------HGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKI  155 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEE
T ss_pred             EEEEEEeCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEE
Confidence            8999999999999999842          235889999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||++.......    .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......     ....... 
T Consensus       156 ~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~-  225 (284)
T 2vgo_A          156 ADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHRRIV-  225 (284)
T ss_dssp             CCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHH-
T ss_pred             ecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHHHHh-
Confidence            9999997554321    23456899999999999999999999999999999999999999753211     1111100 


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                             .....    +.......+.+++.+|++.||.+|||++|+++
T Consensus       226 -------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          226 -------NVDLK----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -------TTCCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------ccccC----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                   00000    01123456779999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.8e-41  Score=327.10  Aligned_cols=250  Identities=25%  Similarity=0.355  Sum_probs=196.6

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      |...+.||+|+||+||+|.+..++..||+|++....  ....+.+.+|++++++++||||+++++++... ..+....++
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~l  106 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceEEE
Confidence            556678999999999999999999999999987432  23456789999999999999999999986432 234557899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeecCCCCCeeeC-CCCcEEE
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPP--IAHCDLKPSNILLD-DEMTAYV  361 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--i~H~dlk~~NIll~-~~~~~kl  361 (502)
                      ||||+++|+|.+++..          ...+++..+..++.+++.||.|||   +.+  |+||||||+||+++ .++.+||
T Consensus       107 v~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl  173 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKR----------FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKI  173 (290)
T ss_dssp             EEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred             EEEecCCCCHHHHHHH----------ccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEE
Confidence            9999999999999842          245889999999999999999999   777  99999999999998 7899999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||++.......    .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......    .........
T Consensus       174 ~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~  244 (290)
T 1t4h_A          174 GDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVTS  244 (290)
T ss_dssp             CCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHTT
T ss_pred             eeCCCcccccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH----HHHHHHHhc
Confidence            9999996543221    234568999999998764 5899999999999999999999999763221    111111111


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ....          ..........+.+++.+|++.||.+|||++|+++
T Consensus       245 ~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          245 GVKP----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TCCC----------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCc----------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1000          0011122346789999999999999999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.9e-42  Score=333.35  Aligned_cols=251  Identities=22%  Similarity=0.300  Sum_probs=199.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|+||.||+|.+..+++.||+|+++.........+.+|++++++++||||+++++++.     .....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence            356888899999999999999998899999999998654444567899999999999999999999853     445889


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee---CCCCcEE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAY  360 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll---~~~~~~k  360 (502)
                      +||||+++|+|.+++..          ...+++..+..++.|++.||.|||   +.+|+||||||+||++   +.++.+|
T Consensus        83 lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~k  149 (304)
T 2jam_A           83 LVMQLVSGGELFDRILE----------RGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIM  149 (304)
T ss_dssp             EEECCCCSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEE
T ss_pred             EEEEcCCCccHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEE
Confidence            99999999999998842          235889999999999999999999   8899999999999999   7889999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||+++......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....  ..+...+....
T Consensus       150 l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~  223 (304)
T 2jam_A          150 ITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEKIKEGY  223 (304)
T ss_dssp             BCSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHCC
T ss_pred             EccCCcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCC
Confidence            99999997543221    1234589999999999999999999999999999999999999976321  11111111111


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..    .       ...........+.+++.+|++.||++|||++|+++
T Consensus       224 ~~----~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          224 YE----F-------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             CC----C-------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CC----C-------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00    0       00111233456789999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-42  Score=330.37  Aligned_cols=253  Identities=22%  Similarity=0.282  Sum_probs=195.3

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|...+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|++++++++||||+++++++.     .....+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   96 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNMY   96 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeEE
Confidence            46788899999999999999998999999999987543 234578999999999999999999999953     445789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee---CCCCcEE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMTAY  360 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll---~~~~~~k  360 (502)
                      +||||+++|+|.+++....      .....+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+|
T Consensus        97 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~k  167 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQ------ARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIK  167 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHH------HHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEE
T ss_pred             EEEEeCCCCcHHHHHHhhh------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEE
Confidence            9999999999999885311      12356899999999999999999999   8999999999999999   4568899


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||+++.......   .....||+.|+|||.+. ..++.++||||||+++|||++|+.||.......  .........
T Consensus       168 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~  241 (285)
T 3is5_A          168 IIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQKATYKE  241 (285)
T ss_dssp             ECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCC
T ss_pred             EEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhhhccCC
Confidence            999999976543322   23456899999999875 568999999999999999999999997632111  111111110


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      +.         .....   ......+.+++.+|++.||++|||++|+++
T Consensus       242 ~~---------~~~~~---~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          242 PN---------YAVEC---RPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CC---------CCC-----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cc---------ccccc---CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00         00000   012345778999999999999999999975

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.7e-42  Score=339.83  Aligned_cols=249  Identities=22%  Similarity=0.284  Sum_probs=201.6

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .++|...+.||+|+||.||++.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.     ..+
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence            357888999999999999999998899999999986432   233467889999999999999999999954     345


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++++|.+++..          ...+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~----------~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~k  181 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKR----------RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVK  181 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEE
T ss_pred             eEEEEEecCCCCCHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEE
Confidence            88999999999999998742          245899999999999999999999   88999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||+++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......  ....+... 
T Consensus       182 l~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~-  256 (335)
T 2owb_A          182 IGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TYLRIKKN-  256 (335)
T ss_dssp             ECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHHT-
T ss_pred             EeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHHhcC-
Confidence            999999987643322  1234568999999999999999999999999999999999999997632111  11101000 


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                                ...    ....+...+.+++.+|++.||++|||++|+++
T Consensus       257 ----------~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          257 ----------EYS----IPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ----------CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ----------CCC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      000    00122345778999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=338.75  Aligned_cols=263  Identities=20%  Similarity=0.260  Sum_probs=192.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|...+.||+|+||+||+|.+..+++.||||+++..... ....+.+|++++++++||||+++++++.     .....+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence            4688889999999999999999889999999998743322 1224567999999999999999999953     345789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||++ |+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        77 lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~D  143 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLDD---------CGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLAD  143 (324)
T ss_dssp             EEEECCS-EEHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECS
T ss_pred             EEecccc-cCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEcc
Confidence            9999997 689888742         2345889999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+++.......  ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......  .....+......
T Consensus       144 fg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~  219 (324)
T 3mtl_A          144 FGLARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE--EQLHFIFRILGT  219 (324)
T ss_dssp             SSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCC
T ss_pred             CcccccccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCC
Confidence            999986543221  2234568999999999876 56899999999999999999999999763211  111111111110


Q ss_pred             chh----hhc------c---cC--CCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 RAE----EIR------A---SS--GSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ~~~----~~~------d---~~--~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...    ...      .   +.  ..............+.+++.+|++.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            000    000      0   00  00000111123456789999999999999999999975

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=327.20  Aligned_cols=253  Identities=23%  Similarity=0.315  Sum_probs=196.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEE
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      +|....+||+|+||.||+|.+..++..||||.++.......+.+.+|+.+++.++||||+++++++.     ..+..++|
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv   97 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIKIF   97 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEEEE
Confidence            4455569999999999999998999999999998665555678999999999999999999999864     34478999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC-CCcEEEeee
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD-EMTAYVSDF  364 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~-~~~~kl~Df  364 (502)
                      |||+++++|.+++..       ......+++..+..++.|++.||+|||   +.+|+||||||+||+++. ++.+||+||
T Consensus        98 ~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Df  167 (295)
T 2clq_A           98 MEQVPGGSLSALLRS-------KWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDF  167 (295)
T ss_dssp             EECCSEEEHHHHHHH-------TTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCT
T ss_pred             EEeCCCCCHHHHHHh-------hccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeec
Confidence            999999999999853       122345678889999999999999999   889999999999999987 899999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCc--cCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE--VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      |+++.......  ......||+.|+|||.+.+..  ++.++||||||+++|||++|+.||............   .....
T Consensus       168 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~  242 (295)
T 2clq_A          168 GTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK---VGMFK  242 (295)
T ss_dssp             TTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH---HHHHC
T ss_pred             ccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh---hcccc
Confidence            99986643221  123456899999999987643  789999999999999999999999753221111110   00000


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                           ..+.      ....+...+.+++.+|++.||++|||++|+++
T Consensus       243 -----~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          243 -----VHPE------IPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -----CCCC------CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -----cccc------ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 0001      11133456789999999999999999999975

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=363.12  Aligned_cols=257  Identities=27%  Similarity=0.427  Sum_probs=205.7

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ..++|...+.||+|+||.||+|.+. .+..||||+++... ...+.|.+|++++++++||||++++++|..      +..
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~  336 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  336 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             chhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccc
Confidence            3456778889999999999999764 56779999997543 335789999999999999999999998642      368


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++|+|.+++..        .....+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus       337 ~lv~e~~~~gsL~~~l~~--------~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~  405 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVA  405 (535)
T ss_dssp             EEEECCCTTEEHHHHHSH--------HHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             eEeeehhcCCcHHHHHhh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEc
Confidence            999999999999999953        12245889999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||+++.+.... ........++..|+|||.+....++.++|||||||++|||+| |+.||......  .....+.....
T Consensus       406 DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~  482 (535)
T 2h8h_A          406 DFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYR  482 (535)
T ss_dssp             CTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHHHHHTTCC
T ss_pred             ccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC
Confidence            999998664322 111233456889999999998899999999999999999999 99999763221  11111111100


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                                    ......++..+.+++.+||+.||++|||+++|++.|+.+.
T Consensus       483 --------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          483 --------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                          0011245567889999999999999999999999998764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.7e-42  Score=335.41  Aligned_cols=258  Identities=19%  Similarity=0.221  Sum_probs=200.3

Q ss_pred             HHHhccCCCCC-CcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCC-CCccceeeecccccc
Q 046112          200 LYNATKGFSSE-NLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIR-HRNLVKVFTACSGVD  275 (502)
Q Consensus       200 l~~~t~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  275 (502)
                      .....+.|... +.||+|+||.||+|.+..+++.||+|+++...  ......+.+|+.++..++ ||||+++++++    
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~----   98 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY----   98 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE----
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE----
Confidence            33445556665 78999999999999998899999999987532  233577899999999995 69999999995    


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD  355 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~  355 (502)
                       ......++||||+++|+|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.
T Consensus        99 -~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~  166 (327)
T 3lm5_A           99 -ENTSEIILILEYAAGGEIFSLCLP--------ELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSS  166 (327)
T ss_dssp             -ECSSEEEEEEECCTTEEGGGGGSS--------CC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESC
T ss_pred             -EeCCeEEEEEEecCCCcHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEec
Confidence             345578999999999999999853        33466899999999999999999999   899999999999999998


Q ss_pred             ---CCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccch
Q 046112          356 ---EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL  432 (502)
Q Consensus       356 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~  432 (502)
                         ++.+||+|||+++.......   .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......  .
T Consensus       167 ~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~  241 (327)
T 3lm5_A          167 IYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--T  241 (327)
T ss_dssp             BTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H
T ss_pred             CCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--H
Confidence               78999999999987643322   234568999999999999999999999999999999999999997632111  1


Q ss_pred             HHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          433 RNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       433 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...+......           ........+...+.+++.+|++.||++|||++|+++
T Consensus       242 ~~~i~~~~~~-----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          242 YLNISQVNVD-----------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHHHTCCC-----------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHhcccc-----------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            1111111000           001111234556789999999999999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.6e-42  Score=338.52  Aligned_cols=252  Identities=22%  Similarity=0.287  Sum_probs=196.5

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||+++....    ...+|++++.++ +||||+++++++     ......
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~   91 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVY-----DDGKYV   91 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEE
Confidence            4578889999999999999999989999999999975432    245688888877 799999999985     445589


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC----Cc
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE----MT  358 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~----~~  358 (502)
                      ++||||+++|+|.+++..          ...+++..+..++.+++.||+|||   +.+|+||||||+|||+.++    +.
T Consensus        92 ~lv~E~~~gg~L~~~i~~----------~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~  158 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILR----------QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPES  158 (342)
T ss_dssp             EEEECCCCSCBHHHHHHT----------CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGG
T ss_pred             EEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCe
Confidence            999999999999999842          345899999999999999999999   8999999999999998543    35


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +||+|||+++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....+  ...+....
T Consensus       159 ~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~  234 (342)
T 2qr7_A          159 IRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILAR  234 (342)
T ss_dssp             EEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHH
T ss_pred             EEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHH
Confidence            99999999987654322  223456899999999998888999999999999999999999999753211  11111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ....        ...............+.+++.+|++.||++|||+.|+++
T Consensus       235 i~~~--------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          235 IGSG--------KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHC--------CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HccC--------CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1100        000000011123456779999999999999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9.8e-42  Score=353.24  Aligned_cols=252  Identities=23%  Similarity=0.314  Sum_probs=200.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||+|++..+|+.||+|+++...   ......+..|++++++++||||+++++++     .....
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~~  259 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETKTD  259 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeCCE
Confidence            56888899999999999999998899999999986432   23346788999999999999999999984     44558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++....      .....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~------~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL  330 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVD------EDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRI  330 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSS------TTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEEeccCCCHHHHHHHhh------cccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEE
Confidence            999999999999999985411      22456899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+++.+.....  ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ....+.......
T Consensus       331 ~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~~~~~~i~~  407 (543)
T 3c4z_A          331 SDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLE  407 (543)
T ss_dssp             CCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHHHHHHHHHH
T ss_pred             eecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHHHHHHHHhh
Confidence            99999987654322  223457999999999999999999999999999999999999999763211 111111111110


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKIN  485 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~  485 (502)
                      .        ...    +.......+.+++.+|++.||++||++.
T Consensus       408 ~--------~~~----~p~~~s~~~~~li~~lL~~dP~~R~~~~  439 (543)
T 3c4z_A          408 Q--------AVT----YPDKFSPASKDFCEALLQKDPEKRLGFR  439 (543)
T ss_dssp             C--------CCC----CCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred             c--------ccC----CCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence            0        000    0112345677899999999999999763

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-41  Score=334.91  Aligned_cols=264  Identities=20%  Similarity=0.240  Sum_probs=195.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccc-cCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVD-FQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~  280 (502)
                      .++|...+.||+|+||.||+|.+..+|+.||||++.....  ...+.+.+|+++++.++||||+++++++.... .....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            4678889999999999999999989999999999864322  23467889999999999999999999875422 11224


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+ +++|.+++..           ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~k  168 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-----------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELK  168 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred             eEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEE
Confidence            569999999 8899998842           35889999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++.....     .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+..... .
T Consensus       169 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~-~  241 (367)
T 1cm8_A          169 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMK-V  241 (367)
T ss_dssp             ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH-H
T ss_pred             EEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-h
Confidence            9999999865432     234568999999999877 67999999999999999999999999753211 01111111 0


Q ss_pred             cccchhhh------------c----ccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAEEI------------R----ASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~~~------------~----d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ......++            .    .................+.+++.+|++.||++|||++|+++
T Consensus       242 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          242 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            00000000            0    00000111111233556789999999999999999999976

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-41  Score=363.51  Aligned_cols=245  Identities=24%  Similarity=0.276  Sum_probs=198.5

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcC-CCCccceeeecccccccCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  278 (502)
                      ..++|...++||+|+||.||+|++..+++.||||+++..   .......+..|..++..+ +||+|++++++     +..
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----~~~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQT  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----CBC
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----EEe
Confidence            346788899999999999999999999999999998742   233456788899999987 79999999988     445


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      .+..++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~  480 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQ----------VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGH  480 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSC
T ss_pred             CCEEEEEEeCcCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCc
Confidence            5689999999999999999852          245899999999999999999999   899999999999999999999


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ..+.+   .
T Consensus       481 ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~~~~~---~  553 (674)
T 3pfq_A          481 IKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQ---S  553 (674)
T ss_dssp             EEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH---H
T ss_pred             EEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--HHHHH---H
Confidence            99999999986433222  23456799999999999999999999999999999999999999976311  11111   1


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKI  484 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~  484 (502)
                      ...        ...    .+.......+.+|+.+|++.||++||++
T Consensus       554 i~~--------~~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          554 IME--------HNV----AYPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             HHS--------SCC----CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             HHh--------CCC----CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence            111        100    0111234567799999999999999997

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.3e-41  Score=327.29  Aligned_cols=250  Identities=23%  Similarity=0.343  Sum_probs=203.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .+.|...+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|+.++++++||||+++++++.     .....
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   95 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKL   95 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeE
Confidence            356888899999999999999988899999999987543 334578999999999999999999999864     34478


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++++|.+++..           ..+++..+..++.+++.||.|||   +.+|+||||||+||+++.++.+||+
T Consensus        96 ~lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~  161 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLA  161 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEEeCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEe
Confidence            999999999999999842           45899999999999999999999   8899999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      |||++........  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......  .....+....+ 
T Consensus       162 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~-  236 (303)
T 3a7i_A          162 DFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNP-  236 (303)
T ss_dssp             CCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCC-
T ss_pred             ecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCC-
Confidence            9999987654322  223456899999999999999999999999999999999999999753211  11111111100 


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                             +..      ...+...+.+++.+|++.||++|||+.|+++.
T Consensus       237 -------~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          237 -------PTL------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             -------CCC------CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             -------CCC------ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                   001      11234567899999999999999999999874

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.1e-42  Score=327.31  Aligned_cols=249  Identities=23%  Similarity=0.347  Sum_probs=192.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||+++...   ....+.+.+|+++++.++||||+++++++.     ..+
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TPT   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence            357888999999999999999988899999999986431   233467899999999999999999999853     345


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++++|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~  151 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICK----------HGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAK  151 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEE
T ss_pred             eEEEEEeccCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEE
Confidence            88999999999999999842          235889999999999999999999   88999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCcc-CccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEV-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||++........   .....+|+.|+|||.+.+..+ +.++||||||+++|||++|+.||+....  ....+.+...
T Consensus       152 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~  226 (276)
T 2h6d_A          152 IADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PTLFKKIRGG  226 (276)
T ss_dssp             ECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC
T ss_pred             EeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHhhcC
Confidence            999999976543221   223468999999999988765 6899999999999999999999976311  1111111111


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ...         .      .......+.+++.+|++.||++|||+.|+++.
T Consensus       227 ~~~---------~------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          227 VFY---------I------PEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CCC---------C------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ccc---------C------chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            000         0      11224567799999999999999999999863

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.2e-42  Score=330.30  Aligned_cols=258  Identities=21%  Similarity=0.268  Sum_probs=202.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|++++++++||||+++++++..   .....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence            457888999999999999999998899999999987543  2334678999999999999999999998632   23457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----ceeecCCCCCeeeCCC
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPP-----IAHCDLKPSNILLDDE  356 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-----i~H~dlk~~NIll~~~  356 (502)
                      .++||||+++|+|.+++....      .....+++..++.++.|++.||+|||   +.+     |+||||||+||+++.+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~  152 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGT------KERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGK  152 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSS
T ss_pred             EEEEEeCCCCCCHHHHHHhhc------ccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCC
Confidence            899999999999999985311      23455899999999999999999999   666     9999999999999999


Q ss_pred             CcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                      +.+||+|||+++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....  ..+...+
T Consensus       153 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i  228 (279)
T 2w5a_A          153 QNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKI  228 (279)
T ss_dssp             SCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH
T ss_pred             CCEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHH
Confidence            9999999999976543221  11234689999999999998999999999999999999999999976321  1111111


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL  491 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L  491 (502)
                      ....           ....   ...+...+.+++.+||+.||++|||++|+++.+
T Consensus       229 ~~~~-----------~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          229 REGK-----------FRRI---PYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHTC-----------CCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             hhcc-----------cccC---CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            1110           0000   113345678999999999999999999998754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-41  Score=334.66  Aligned_cols=267  Identities=21%  Similarity=0.248  Sum_probs=195.7

Q ss_pred             HhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc-----hhHHHHHHHHHHhcCCCCccceeeeccccccc
Q 046112          202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-----ASKSFAVECEVTRNIRHRNLVKVFTACSGVDF  276 (502)
Q Consensus       202 ~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  276 (502)
                      ...++|...+.||+|+||.||+|.+..+|+.||||+++.....     ..+.+.+|++++++++||||+++++++.    
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----   82 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG----   82 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe----
Confidence            3457899999999999999999998888999999998743221     1346889999999999999999999853    


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE  356 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~  356 (502)
                       .....++||||+++ +|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.+
T Consensus        83 -~~~~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~  148 (346)
T 1ua2_A           83 -HKSNISLVFDFMET-DLEVIIKD---------NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDEN  148 (346)
T ss_dssp             -CTTCCEEEEECCSE-EHHHHHTT---------CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred             -eCCceEEEEEcCCC-CHHHHHHh---------cCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCC
Confidence             44578999999975 88888752         3345888899999999999999999   8999999999999999999


Q ss_pred             CcEEEeeeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHH
Q 046112          357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  435 (502)
                      +.+||+|||+++.......  ......||+.|+|||.+.+. .++.++|||||||++|||++|..||...... ..+...
T Consensus       149 ~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i  225 (346)
T 1ua2_A          149 GVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRI  225 (346)
T ss_dssp             CCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH
T ss_pred             CCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHH
Confidence            9999999999986643321  22345689999999998764 5899999999999999999999998763211 112222


Q ss_pred             HHhhcccchhhhccc----------CCCCc--chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          436 VKSALPERAEEIRAS----------SGSTQ--RSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~----------~~~~~--~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...........+.+.          .....  ..........+.+++.+|++.||++|||++|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            111110000000000          00000  0011233467889999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.4e-41  Score=334.25  Aligned_cols=265  Identities=24%  Similarity=0.308  Sum_probs=197.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc--hhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD--ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||++......  ..+.+.+|++++++++||||+++++++.     ....
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~   98 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKKR   98 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCCE
Confidence            35788889999999999999999889999999998654332  2456789999999999999999999964     3457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++++|.++..          ....+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.+||
T Consensus        99 ~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl  165 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLEL----------FPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKL  165 (331)
T ss_dssp             EEEEEECCSEEHHHHHHH----------STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEecCCcchHHHHHh----------hccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEE
Confidence            899999999999988763          2345899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      +|||+++.......  ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... .+........
T Consensus       166 ~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~  242 (331)
T 4aaa_A          166 CDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLG  242 (331)
T ss_dssp             CCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred             EeCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhC
Confidence            99999976543322  12345689999999998875 78999999999999999999999997632211 1111111000


Q ss_pred             ---cc---------chhhhcccCCCCcc---hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 ---PE---------RAEEIRASSGSTQR---SIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ---~~---------~~~~~~d~~~~~~~---~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                         +.         .......+......   .....+...+.+++.+|++.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             SCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               00         00000001111000   011134567889999999999999999999885

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.3e-42  Score=335.88  Aligned_cols=265  Identities=19%  Similarity=0.240  Sum_probs=191.3

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc--hhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD--ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ..++|...+.||+|+||+||+|.+..+++.||||+++.....  ..+.+.+|++++++++||||+++++++.     .+.
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~  106 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HNH  106 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ETT
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cCC
Confidence            456889999999999999999999999999999998754322  2456789999999999999999999953     445


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee-----CC
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL-----DD  355 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll-----~~  355 (502)
                      ..++||||++ |+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||+     +.
T Consensus       107 ~~~lv~e~~~-~~L~~~~~~----------~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~  172 (329)
T 3gbz_A          107 RLHLIFEYAE-NDLKKYMDK----------NPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASE  172 (329)
T ss_dssp             EEEEEEECCS-EEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----
T ss_pred             EEEEEEecCC-CCHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCc
Confidence            8899999997 599998842          245899999999999999999999   8999999999999999     45


Q ss_pred             CCcEEEeeeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHH
Q 046112          356 EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN  434 (502)
Q Consensus       356 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~  434 (502)
                      ++.+||+|||+++.......  ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+..
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~  249 (329)
T 3gbz_A          173 TPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFK  249 (329)
T ss_dssp             CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH
T ss_pred             cceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHH
Confidence            56699999999976543221  22345679999999998874 4899999999999999999999999763221 11111


Q ss_pred             HHHhh-ccc--ch---hhhc--ccCCCC-----cc-hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          435 CVKSA-LPE--RA---EEIR--ASSGST-----QR-SIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       435 ~~~~~-~~~--~~---~~~~--d~~~~~-----~~-~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..... .+.  ..   ....  ......     .. .........+.+++.+|++.||++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          250 IFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            11111 000  00   0000  000000     00 001113456789999999999999999999875

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.9e-41  Score=336.14  Aligned_cols=275  Identities=20%  Similarity=0.207  Sum_probs=199.6

Q ss_pred             HHHHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc-----------hhHHHHHHHHHHhcCCCCccc
Q 046112          197 YRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-----------ASKSFAVECEVTRNIRHRNLV  265 (502)
Q Consensus       197 ~~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv  265 (502)
                      ..++....++|...+.||+|+||.||+|.+ .++..||||++......           ..+.+.+|++++++++||||+
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEEC-TTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEEC-CCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            456777889999999999999999999966 45999999998643221           126789999999999999999


Q ss_pred             eeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeec
Q 046112          266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCD  345 (502)
Q Consensus       266 ~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~d  345 (502)
                      ++++++...........++||||++ |+|.+++.         .....+++..+..++.|++.||+|||   +.+|+|||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~D  159 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH---------DQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRD  159 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH---------CTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH---------hcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecC
Confidence            9999875433344557899999997 68888874         23456899999999999999999999   88999999


Q ss_pred             CCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          346 LKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       346 lk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      |||+||+++.++.+||+|||+++......   ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  236 (362)
T 3pg1_A          160 LHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG  236 (362)
T ss_dssp             CCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999997543322   2234568999999998877 6789999999999999999999999976


Q ss_pred             ccccccchHHHHHhhcccc-----------hhhhcccCCC-----CcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 046112          425 MFKDNLNLRNCVKSALPER-----------AEEIRASSGS-----TQRSIILECLISICEIGVACSAEQPGERMKINDVE  488 (502)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~-----------~~~~~d~~~~-----~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~  488 (502)
                      ..... .+...+.......           ..........     ............+.+++.+|++.||++|||+.|++
T Consensus       237 ~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  315 (362)
T 3pg1_A          237 STFYN-QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL  315 (362)
T ss_dssp             SSHHH-HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCHHH-HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence            32111 1111111000000           0000000000     00111123345688999999999999999999997


Q ss_pred             H
Q 046112          489 P  489 (502)
Q Consensus       489 ~  489 (502)
                      +
T Consensus       316 ~  316 (362)
T 3pg1_A          316 R  316 (362)
T ss_dssp             T
T ss_pred             c
Confidence            5

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1e-41  Score=330.73  Aligned_cols=270  Identities=22%  Similarity=0.309  Sum_probs=184.8

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ..++|...+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++++++||||+++++++.     ..+.
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   87 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VKDE   87 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE-----SSSC
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ecCC
Confidence            4568999999999999999999888889999999986432 233567889999999999999999999854     3447


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++......  .......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAK--GEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHT--TTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEE
T ss_pred             cEEEehhccCCchHHHHHHHhhc--cccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEE
Confidence            89999999999999998532111  1123456899999999999999999999   889999999999999999999999


Q ss_pred             eeeccceecccccc---cceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHH
Q 046112          362 SDFGIARFLEAADE---QTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  437 (502)
                      +|||++........   ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .......
T Consensus       163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~  241 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK-VLMLTLQ  241 (303)
T ss_dssp             CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHT
T ss_pred             EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-HHHHHhc
Confidence            99999976543321   111234568999999999876 568999999999999999999999997632211 1111111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...+.......+...      ...+...+.+++.+|++.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          242 NDPPSLETGVQDKEM------LKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SSCCCTTC-----CC------CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cCCCccccccccchh------hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            111110111111111      1123456789999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.8e-41  Score=334.40  Aligned_cols=269  Identities=19%  Similarity=0.219  Sum_probs=201.9

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcch-----------------hHHHHHHHHHHhcCCCCccce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-----------------SKSFAVECEVTRNIRHRNLVK  266 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~  266 (502)
                      .++|...+.||+|+||.||+|.+  +++.||||++.......                 .+.+.+|++++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46788999999999999999977  89999999986432111                 178999999999999999999


Q ss_pred             eeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceeec
Q 046112          267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ-PPIAHCD  345 (502)
Q Consensus       267 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~i~H~d  345 (502)
                      +++++.     ..+..++||||+++|+|.+++......  .......+++..+..++.|++.||+|||   + .+|+|||
T Consensus       108 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l--~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~d  177 (348)
T 2pml_X          108 CEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVL--DKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRD  177 (348)
T ss_dssp             CSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESS--CSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCC
T ss_pred             EEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhh--hhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecC
Confidence            999954     345889999999999999993211000  0123567999999999999999999999   7 8999999


Q ss_pred             CCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCC-ccCc-cccchhHHHHHHHHHhCCCCCc
Q 046112          346 LKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSS-YGDVYSFGILLLEMFTGLRPSD  423 (502)
Q Consensus       346 lk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDvws~Gv~l~el~tg~~p~~  423 (502)
                      |||+||+++.++.+||+|||++......    ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||.
T Consensus       178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  253 (348)
T 2pml_X          178 VKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS  253 (348)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999865433    23446689999999999887 6766 9999999999999999999997


Q ss_pred             cccccccchHHHHHhhcccchh---hhcccCCCC-cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          424 DMFKDNLNLRNCVKSALPERAE---EIRASSGST-QRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~---~~~d~~~~~-~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..... ......+.........   ......... ...........+.+++.+|++.||++|||++|+++
T Consensus       254 ~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          254 LKISL-VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             CSSCS-HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCcH-HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            63221 1222222111111000   000000000 00001234567889999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.2e-41  Score=337.02  Aligned_cols=254  Identities=21%  Similarity=0.331  Sum_probs=200.2

Q ss_pred             HhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc--------hhHHHHHHHHHHhcC-CCCccceeeeccc
Q 046112          202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD--------ASKSFAVECEVTRNI-RHRNLVKVFTACS  272 (502)
Q Consensus       202 ~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~~~~~  272 (502)
                      ...++|...+.||+|+||.||+|.+..+|+.||||+++.....        ..+.+.+|++++.++ +||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            3456788899999999999999988888999999998754311        135678899999999 7999999999853


Q ss_pred             ccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCee
Q 046112          273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNIL  352 (502)
Q Consensus       273 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIl  352 (502)
                           .....++||||+++|+|.+++..          ...+++..+..++.|++.||.|||   +.+|+||||||+|||
T Consensus       171 -----~~~~~~lv~e~~~g~~L~~~l~~----------~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl  232 (365)
T 2y7j_A          171 -----SSSFMFLVFDLMRKGELFDYLTE----------KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENIL  232 (365)
T ss_dssp             -----BSSEEEEEECCCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred             -----eCCEEEEEEEeCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence                 34588999999999999999842          245899999999999999999999   889999999999999


Q ss_pred             eCCCCcEEEeeeccceecccccccceecccccccccccCcccCC------CccCccccchhHHHHHHHHHhCCCCCcccc
Q 046112          353 LDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG------HEVSSYGDVYSFGILLLEMFTGLRPSDDMF  426 (502)
Q Consensus       353 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvws~Gv~l~el~tg~~p~~~~~  426 (502)
                      ++.++.+||+|||++..+.....   .....||+.|+|||++.+      ..++.++|||||||++|||++|+.||....
T Consensus       233 ~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  309 (365)
T 2y7j_A          233 LDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR  309 (365)
T ss_dssp             ECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence            99999999999999987654322   234678999999998753      358899999999999999999999996521


Q ss_pred             ccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          427 KDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .  ......+.....           .........+...+.+++.+|++.||++|||+.|+++
T Consensus       310 ~--~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          310 Q--ILMLRMIMEGQY-----------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             H--HHHHHHHHHTCC-----------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             H--HHHHHHHHhCCC-----------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1  111111111100           0000001123456789999999999999999999975

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.9e-41  Score=332.53  Aligned_cols=271  Identities=18%  Similarity=0.230  Sum_probs=200.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeeccccccc---CC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF---QG  278 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~  278 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||++....  ......+.+|+++++.++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            357888999999999999999998999999999986433  2234678899999999999999999998754321   11


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      ....++||||+++ +|.+.+.         .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~---------~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~  162 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLS---------NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGV  162 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHH---------CTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSC
T ss_pred             CceEEEEEeccCC-CHHHHHh---------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCC
Confidence            4468999999974 7777764         23345899999999999999999999   899999999999999999999


Q ss_pred             EEEeeeccceecccccc--cceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHH
Q 046112          359 AYVSDFGIARFLEAADE--QTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  435 (502)
                      +||+|||+++.+.....  ........||+.|+|||.+.+ ..++.++|||||||++|||+||+.||......  .....
T Consensus       163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~  240 (351)
T 3mi9_A          163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLAL  240 (351)
T ss_dssp             EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH
T ss_pred             EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHH
Confidence            99999999987653322  222345678999999998876 45899999999999999999999999763221  11111


Q ss_pred             HHhhcccchhh----h-----ccc---CCCCcchhhHH-----HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          436 VKSALPERAEE----I-----RAS---SGSTQRSIILE-----CLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       436 ~~~~~~~~~~~----~-----~d~---~~~~~~~~~~~-----~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      +.........+    .     .+.   ...........     ....+.+++.+|++.||++|||++|+++
T Consensus       241 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            11111100000    0     000   00001111111     1345789999999999999999999875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.5e-41  Score=329.53  Aligned_cols=254  Identities=22%  Similarity=0.263  Sum_probs=197.4

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+++++.++||||+++++++.     ..+..
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   91 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-----HDGKL   91 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CC-CE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----eCCeE
Confidence            3467888999999999999999998889999999987665556688999999999999999999999864     34478


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++++|.+++..         ....+++..+..++.+++.||.|||   +.+|+||||||+||+++.++.+||+
T Consensus        92 ~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~  159 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLE---------LDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLA  159 (302)
T ss_dssp             EEEEECCTTEEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEEeCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEE
Confidence            999999999999998742         2345899999999999999999999   8899999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCccc-----CCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHH
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYG-----MGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  437 (502)
                      |||++.......  .......||+.|+|||.+     .+..++.++||||||+++|||++|+.||....... .......
T Consensus       160 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~  236 (302)
T 2j7t_A          160 DFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAK  236 (302)
T ss_dssp             CCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH
T ss_pred             ECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhc
Confidence            999976432211  112335689999999987     46678999999999999999999999997632111 1111111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...+         ..    .....+...+.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~---------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          237 SDPP---------TL----LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             SCCC---------CC----SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cCCc---------cc----CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1000         00    001233456789999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.5e-41  Score=331.07  Aligned_cols=252  Identities=20%  Similarity=0.297  Sum_probs=196.5

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--------chhHHHHHHHHHHhcCCCCccceeeecccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--------DASKSFAVECEVTRNIRHRNLVKVFTACSGVD  275 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  275 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||++.....        .....+.+|++++++++||||+++++++..  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence            4578889999999999999999989999999999864321        122458899999999999999999998532  


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD  355 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~  355 (502)
                          +..++||||+++|+|.+++.          ....+++.....++.|++.||.|||   +.+|+||||||+||+++.
T Consensus        87 ----~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~  149 (322)
T 2ycf_A           87 ----EDYYIVLELMEGGELFDKVV----------GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSS  149 (322)
T ss_dssp             ----SSEEEEEECCTTEETHHHHS----------TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESS
T ss_pred             ----CceEEEEecCCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEec
Confidence                24799999999999999884          2356899999999999999999999   899999999999999987


Q ss_pred             CCc---EEEeeeccceecccccccceecccccccccccCcccC---CCccCccccchhHHHHHHHHHhCCCCCccccccc
Q 046112          356 EMT---AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM---GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN  429 (502)
Q Consensus       356 ~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~  429 (502)
                      ++.   +||+|||+++.......   .....||+.|+|||.+.   ...++.++|||||||++|||++|+.||...... 
T Consensus       150 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-  225 (322)
T 2ycf_A          150 QEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-  225 (322)
T ss_dssp             SSSSCCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-
T ss_pred             CCCCCeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-
Confidence            654   99999999987643221   12346899999999863   567899999999999999999999999763222 


Q ss_pred             cchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          430 LNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..+...+.......           ...........+.+++.+|++.||++|||++|+++
T Consensus       226 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          226 VSLKDQITSGKYNF-----------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             SCHHHHHHHTCCCC-----------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHhCcccc-----------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            12222222111110           11111234567889999999999999999999984

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.5e-41  Score=326.75  Aligned_cols=247  Identities=18%  Similarity=0.226  Sum_probs=196.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .++|...+.||+|+||.||+|.+..+++.||+|+++...  ......+.+|+..+..+ +||||+++++++.     ..+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~~~   84 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----EDD   84 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----ETT
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCC
Confidence            457888999999999999999998899999999987532  33456788899999998 9999999999853     345


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC-----
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD-----  355 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~-----  355 (502)
                      ..++||||+++|+|.+++....      .....+++..+..++.|++.||+|||   +.+|+||||||+||+++.     
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~  155 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENY------RIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPN  155 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHH------HHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC------
T ss_pred             eEEEEEEecCCCcHHHHHHhhc------ccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCc
Confidence            8899999999999999985311      12356899999999999999999999   899999999999999984     


Q ss_pred             --------------CCcEEEeeeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCC
Q 046112          356 --------------EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLR  420 (502)
Q Consensus       356 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~  420 (502)
                                    ...+||+|||.+.......      ...||+.|+|||.+.+. .++.++|||||||++|||++|..
T Consensus       156 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~  229 (289)
T 1x8b_A          156 AASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP  229 (289)
T ss_dssp             --------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred             ccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence                          4489999999998664322      23489999999998876 56789999999999999999998


Q ss_pred             CCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          421 PSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       421 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      |+...    ...........            ...   ...+...+.+++.+|++.||++|||+.|+++
T Consensus       230 ~~~~~----~~~~~~~~~~~------------~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          230 LPRNG----DQWHEIRQGRL------------PRI---PQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             CCSSS----HHHHHHHTTCC------------CCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCcch----hHHHHHHcCCC------------CCC---CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            76431    11111111111            001   1123456789999999999999999999975

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-41  Score=338.92  Aligned_cols=277  Identities=17%  Similarity=0.206  Sum_probs=200.7

Q ss_pred             HHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeeccccccc----
Q 046112          201 YNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF----  276 (502)
Q Consensus       201 ~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  276 (502)
                      ....++|...+.||+|+||.||+|.+..+|+.||||++....    ....+|+++++.++||||+++++++.....    
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            345678999999999999999999999999999999986432    223479999999999999999998743221    


Q ss_pred             -----------------------------CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHH
Q 046112          277 -----------------------------QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA  327 (502)
Q Consensus       277 -----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia  327 (502)
                                                   ......++||||++ |+|.+.+....      .....+++..+..++.|++
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI------RSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHH------HTTCCCCHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH------hcCCCCCHHHHHHHHHHHH
Confidence                                         23345889999997 68887774311      2345689999999999999


Q ss_pred             HHHHHHHhCCCCCceeecCCCCCeeeC-CCCcEEEeeeccceecccccccceecccccccccccCcccCCC-ccCccccc
Q 046112          328 CVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDV  405 (502)
Q Consensus       328 ~~l~~LH~~~~~~i~H~dlk~~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv  405 (502)
                      .||+|||   +.+|+||||||+|||++ .++.+||+|||+++.+.....   .....+|+.|+|||.+.+. .++.++||
T Consensus       152 ~aL~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di  225 (383)
T 3eb0_A          152 RAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDL  225 (383)
T ss_dssp             HHHHHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred             HHHHHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhh
Confidence            9999999   99999999999999997 688999999999987644332   2345689999999998775 48999999


Q ss_pred             hhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhc----------ccCCCC---cchhhHHHHHHHHHHHhh
Q 046112          406 YSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIR----------ASSGST---QRSIILECLISICEIGVA  472 (502)
Q Consensus       406 ws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------d~~~~~---~~~~~~~~~~~l~~l~~~  472 (502)
                      ||+||++|||++|+.||...... ..+...+...-......+.          -+....   ...+....+..+.+++.+
T Consensus       226 wslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  304 (383)
T 3eb0_A          226 WSIGCVFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ  304 (383)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred             hhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH
Confidence            99999999999999999763211 1122222111110000000          000000   000111245568899999


Q ss_pred             cccCCCCCCCCHHHHHH--HHHHHH
Q 046112          473 CSAEQPGERMKINDVEP--RLRLIK  495 (502)
Q Consensus       473 c~~~dP~~RPt~~ev~~--~L~~i~  495 (502)
                      |++.||++|||+.|+++  .++.++
T Consensus       305 ~L~~dP~~R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          305 ILRYEPDLRINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             HCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred             HccCChhhCCCHHHHhcCHHHHHHH
Confidence            99999999999999984  344443

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.1e-41  Score=335.03  Aligned_cols=264  Identities=19%  Similarity=0.244  Sum_probs=185.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeeccccc-ccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGV-DFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~~  280 (502)
                      .++|...+.||+|+||.||+|.+..+|+.||||++....  ....+.+.+|+++++.++||||+++++++... ......
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468899999999999999999999999999999986432  22346788999999999999999999986432 112235


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++|+||+ +++|.+++..           ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~k  172 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK  172 (367)
T ss_dssp             CCEEEEECC-CEECC----------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred             eEEEEeccc-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEE
Confidence            679999999 7899888742           45899999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++.....     .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||.....  ......+...
T Consensus       173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~  245 (367)
T 2fst_X          173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRL  245 (367)
T ss_dssp             ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHH
T ss_pred             Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHH
Confidence            9999999865422     234568999999999877 6789999999999999999999999976321  1111111111


Q ss_pred             cccchhh------------hcccCC--C--CcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAEE------------IRASSG--S--TQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~~------------~~d~~~--~--~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ......+            ......  .  ............+.+|+.+|++.||++|||+.|+++
T Consensus       246 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          246 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            1100000            000000  0  000011123456789999999999999999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.8e-42  Score=328.70  Aligned_cols=254  Identities=20%  Similarity=0.228  Sum_probs=186.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc-h-hHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-A-SKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||+||+|.+..+++.||||+++..... . .+.+.++...++.++||||+++++++.     ..+.
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~~   80 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REGD   80 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccCC
Confidence            46788899999999999999999899999999998754222 2 233445555688899999999999964     3457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceeecCCCCCeeeCCCCcEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQP-PIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~i~H~dlk~~NIll~~~~~~k  360 (502)
                      .++||||++ |+|.+++....      .....+++..+..++.|++.||+|||   +. +|+||||||+||+++.++.+|
T Consensus        81 ~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~k  150 (290)
T 3fme_A           81 VWICMELMD-TSLDKFYKQVI------DKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVK  150 (290)
T ss_dssp             EEEEEECCS-EEHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEE
T ss_pred             EEEEEehhc-cchHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEE
Confidence            899999997 58888774311      23456899999999999999999999   76 999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCccc----CCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYG----MGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                      |+|||+++.......   .....||+.|+|||.+    .+..++.++|||||||++|||+||+.||+........+....
T Consensus       151 l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  227 (290)
T 3fme_A          151 MCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV  227 (290)
T ss_dssp             BCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH
T ss_pred             EeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh
Confidence            999999986644322   1234689999999995    566789999999999999999999999975322211122211


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ....+..           .   .......+.+++.+|++.||++|||++|+++
T Consensus       228 ~~~~~~~-----------~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          228 EEPSPQL-----------P---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HSCCCCC-----------C---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ccCCCCc-----------c---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1111100           0   0123456789999999999999999999987

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.8e-41  Score=350.03  Aligned_cols=251  Identities=20%  Similarity=0.267  Sum_probs=195.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      +.|...+.||+|+||+||+|.+..++..||+|+++...  ......+.+|+.+++.++||||+++++++.     .....
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~  111 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRNY  111 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCEE
Confidence            46888899999999999999998899999999987542  334577899999999999999999999963     44578


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC---CCcE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD---EMTA  359 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~---~~~~  359 (502)
                      ++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.   ++.+
T Consensus       112 ~lv~e~~~~g~L~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~  178 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIH----------RMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALI  178 (494)
T ss_dssp             EEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCE
T ss_pred             EEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcE
Confidence            999999999999988742          245889999999999999999999   899999999999999976   4559


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||+++.......   .....||+.|+|||++. ..++.++||||+||++|||++|+.||......  .+...+...
T Consensus       179 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~  252 (494)
T 3lij_A          179 KIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKVEKG  252 (494)
T ss_dssp             EECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHT
T ss_pred             EEEECCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC
Confidence            9999999987654322   23456999999999876 46999999999999999999999999763211  111111111


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ...    .       ...........+.+++.+|++.||.+|||+.|+++.
T Consensus       253 ~~~----~-------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          253 KYT----F-------DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CCC----C-------CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CCC----C-------CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            100    0       000011234567799999999999999999999853

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5e-41  Score=328.33  Aligned_cols=269  Identities=19%  Similarity=0.271  Sum_probs=196.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccc--------
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVD--------  275 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  275 (502)
                      .++|...+.||+|+||.||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++....        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            357888999999999999999998889999999987665555678999999999999999999998863211        


Q ss_pred             -cCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          276 -FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       276 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                       .......++||||++ |+|.+++..           ..+++..+..++.|++.||+|||   +.+|+||||||+||+++
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~  154 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ-----------GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFIN  154 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc-----------CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEc
Confidence             133457899999997 699998842           45889999999999999999999   89999999999999997


Q ss_pred             -CCCcEEEeeeccceecccccc-cceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccc
Q 046112          355 -DEMTAYVSDFGIARFLEAADE-QTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN  431 (502)
Q Consensus       355 -~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~  431 (502)
                       +++.+||+|||+++....... ........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......  .
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~  232 (320)
T 2i6l_A          155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--E  232 (320)
T ss_dssp             TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--H
T ss_pred             CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--H
Confidence             567999999999987643322 112233457899999998765 67899999999999999999999999763211  1


Q ss_pred             hHHHHHhhccc----chhhhcc-----------cCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          432 LRNCVKSALPE----RAEEIRA-----------SSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       432 ~~~~~~~~~~~----~~~~~~d-----------~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ....+....+.    ...++..           ............+...+.+++.+|++.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          233 QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            11111111110    0000000           0000000111234567889999999999999999999976

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.5e-42  Score=341.98  Aligned_cols=267  Identities=9%  Similarity=-0.007  Sum_probs=183.7

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHH---HHHhcCCCCccceeeeccc----c
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVEC---EVTRNIRHRNLVKVFTACS----G  273 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~----~  273 (502)
                      ..+|...+.||+|+||.||+|.+..+++.||||+++....   ...+.+.+|+   +.++. +||||++++..+.    .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            3457888999999999999999988999999999986442   2345577784   45555 7999888553221    0


Q ss_pred             cccCC---------------CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHH------HHHHHHHHHHHHH
Q 046112          274 VDFQG---------------NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR------LNIAIDVACVLKY  332 (502)
Q Consensus       274 ~~~~~---------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~------~~i~~~ia~~l~~  332 (502)
                      ....+               ....++||||++ |+|.+++...         ...+.+..+      ..++.|++.||+|
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---------~~~~~~~~~~~~~vk~~i~~qi~~aL~~  209 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---------DFVYVFRGDEGILALHILTAQLIRLAAN  209 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---------HHSCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---------ccccchhhhhhhhhHHHHHHHHHHHHHH
Confidence            00000               134799999998 9999999531         112344455      7888999999999


Q ss_pred             HHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCC--CccCccccchhHHH
Q 046112          333 LHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG--HEVSSYGDVYSFGI  410 (502)
Q Consensus       333 LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvws~Gv  410 (502)
                      ||   +.+|+||||||+|||++.++.+||+|||+++......     ....+|+.|+|||.+.+  ..++.++|||||||
T Consensus       210 LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~  281 (371)
T 3q60_A          210 LQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGL  281 (371)
T ss_dssp             HH---HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred             HH---HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence            99   8999999999999999999999999999998654221     13456799999999987  77999999999999


Q ss_pred             HHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH-
Q 046112          411 LLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP-  489 (502)
Q Consensus       411 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~-  489 (502)
                      ++|||+||+.||..........  +..    .........  .........++..+.+++.+||+.||++|||+.|+++ 
T Consensus       282 il~elltg~~Pf~~~~~~~~~~--~~~----~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          282 SIYRVWCLFLPFGLVTPGIKGS--WKR----PSLRVPGTD--SLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             HHHHHHHSSCSTTBCCTTCTTC--CCB----CCTTSCCCC--SCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             HHHHHHhCCCCCCCcCcccccc--hhh----hhhhhcccc--ccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            9999999999998642221100  000    000000000  0000001134567789999999999999999999974 


Q ss_pred             -HHHHHHHH
Q 046112          490 -RLRLIKKK  497 (502)
Q Consensus       490 -~L~~i~~~  497 (502)
                       .++.+...
T Consensus       354 p~f~~~~~~  362 (371)
T 3q60_A          354 PEFLQLQNE  362 (371)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence             44444443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.9e-41  Score=337.30  Aligned_cols=260  Identities=23%  Similarity=0.289  Sum_probs=200.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|...+.||+|+||.||+|.+..++..||+|+++.... ...+.+.+|++++++++||||+++++++.     .++..+
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~  107 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEIS  107 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECCEEE
Confidence            568888999999999999999988999999999875432 33467899999999999999999999854     345789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceeecCCCCCeeeCCCCcEEEe
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQP-PIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      +||||+++|+|.+++..          ...+++..+..++.+++.||+|||   +. +|+||||||+|||++.++.+||+
T Consensus       108 lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~  174 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKK----------AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLC  174 (360)
T ss_dssp             EEECCCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEECCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEE
Confidence            99999999999999842          235889999999999999999999   65 89999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc-
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP-  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-  441 (502)
                      |||++......    ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........  ......... 
T Consensus       175 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~  248 (360)
T 3eqc_A          175 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEG  248 (360)
T ss_dssp             CCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH--HHHHC-----
T ss_pred             ECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcccccc
Confidence            99999755322    12345689999999999999999999999999999999999999975322111  000000000 


Q ss_pred             --------------------------c----chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          442 --------------------------E----RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       442 --------------------------~----~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                                                .    ....+.........  .......+.+++.+|++.||++|||++|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             -------------------------CCCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCC--cccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                                      0    00000000000000  01234568899999999999999999999863

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.3e-41  Score=348.82  Aligned_cols=252  Identities=22%  Similarity=0.293  Sum_probs=198.9

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc--CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL--HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||+||+|.+..+++.||||+++..  .......+.+|++++++++||||+++++++.     ....
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~   95 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS   95 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCCE
Confidence            35688899999999999999999889999999998632  2234577899999999999999999999953     4458


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC---CCCc
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMT  358 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~---~~~~  358 (502)
                      .++||||+++|+|.+++..          ...+++..+..++.|++.||.|||   +.+|+||||||+|||++   .++.
T Consensus        96 ~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~  162 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIK----------RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCD  162 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCC
T ss_pred             EEEEEEcCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCC
Confidence            8999999999999998842          245899999999999999999999   89999999999999995   5568


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +||+|||+++......   ......||+.|+|||.+.+ .++.++||||+||++|||++|+.||.....  ......+..
T Consensus       163 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~  236 (486)
T 3mwu_A          163 IKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVET  236 (486)
T ss_dssp             EEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH
T ss_pred             EEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHh
Confidence            9999999997654322   2234579999999999876 599999999999999999999999976311  111111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ..           .....+........+.+++.+|++.||.+|||+.|+++.
T Consensus       237 ~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          237 GK-----------YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             TC-----------CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CC-----------CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            10           000001112334567799999999999999999999863

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.4e-41  Score=335.52  Aligned_cols=270  Identities=20%  Similarity=0.247  Sum_probs=202.5

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ..++|...+.||+|+||.||+|.+..+|+.||||+++.... .....+.+|++++++++||||+++++++....+.....
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            35688899999999999999999988999999999874332 23456889999999999999999999876544555568


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+. |+|.+++..           ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        89 ~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl  153 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST-----------QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKV  153 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEE
T ss_pred             EEEEEeccC-ccHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEE
Confidence            899999996 689988742           35899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccc--------eecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccch
Q 046112          362 SDFGIARFLEAADEQT--------RSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL  432 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~  432 (502)
                      +|||+++.........        ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......  .
T Consensus       154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~  231 (353)
T 2b9h_A          154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH--Q  231 (353)
T ss_dssp             CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H
T ss_pred             EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH--H
Confidence            9999998765332111        1223568999999998654 678999999999999999999999997632111  0


Q ss_pred             HHHHHhhccc-------------chhhhcccC----CCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          433 RNCVKSALPE-------------RAEEIRASS----GSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       433 ~~~~~~~~~~-------------~~~~~~d~~----~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...+......             ...+.....    ..........+...+.+++.+|++.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1101000000             000000000    00000111234567789999999999999999999976

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.6e-41  Score=327.32  Aligned_cols=252  Identities=24%  Similarity=0.286  Sum_probs=197.8

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ..++|...+.||+|+||.||+|.+..+|+.||+|++...  ...+.+.+|++++++++||||+++++++.     .....
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   99 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYF-----KNTDL   99 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEE
Confidence            346788899999999999999999888999999998753  23567899999999999999999999864     34478


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++|+|.+++..         ....+++..+..++.+++.||.|||   +.+|+||||||+||+++.++.+||+
T Consensus       100 ~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~  167 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRL---------RNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLA  167 (314)
T ss_dssp             EEEEECCTTEEHHHHHHH---------HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             EEEeecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEe
Confidence            999999999999999841         2356899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      |||++........  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......  .......... 
T Consensus       168 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~-  242 (314)
T 3com_A          168 DFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPP-  242 (314)
T ss_dssp             CCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCC-
T ss_pred             ecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCC-
Confidence            9999986643322  2234568999999999999999999999999999999999999997632110  0000000000 


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                             +...    ........+.+++.+|++.||.+|||+.++++
T Consensus       243 -------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          243 -------PTFR----KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -------CCCS----SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -------cccC----CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                   0000    01123456789999999999999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.3e-41  Score=342.78  Aligned_cols=199  Identities=24%  Similarity=0.316  Sum_probs=169.5

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC------CCCccceeeecccccccC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI------RHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  277 (502)
                      ..+|...+.||+|+||.||+|.+..+++.||||+++.. ......+.+|+++++.+      +|+||+++++++.     
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~-----  169 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT-----  169 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE-----
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc-----
Confidence            45688899999999999999999899999999998743 22345677888887776      5779999999854     


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                      .....++||||+. ++|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~  237 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKK--------NKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQG  237 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTT
T ss_pred             cCCeEEEEEeccC-CCHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCC
Confidence            3458899999995 799998853        33355899999999999999999999   88999999999999999988


Q ss_pred             c--EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccc
Q 046112          358 T--AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM  425 (502)
Q Consensus       358 ~--~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~  425 (502)
                      .  +||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       238 ~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          238 RSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             SCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            7  999999999754322     22456899999999999999999999999999999999999999763

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.8e-41  Score=350.88  Aligned_cols=250  Identities=23%  Similarity=0.322  Sum_probs=200.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||+|.+..+++.||||++....   ......+.+|++++++++||||+++++++.     ....
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~  100 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DKGY  100 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCCE
Confidence            46888899999999999999998899999999986432   234577999999999999999999999953     4558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee---CCCCc
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---DDEMT  358 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll---~~~~~  358 (502)
                      .++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||+   +.++.
T Consensus       101 ~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~  167 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIIS----------RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDAN  167 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHT----------CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCC
T ss_pred             EEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCc
Confidence            8999999999999998842          355899999999999999999999   8999999999999999   56789


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +||+|||+++.+.....   .....||+.|+|||.+.+ .++.++||||+||++|||++|+.||.....  ......+..
T Consensus       168 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~  241 (484)
T 3nyv_A          168 IRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKKVEK  241 (484)
T ss_dssp             EEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH
T ss_pred             EEEEeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHc
Confidence            99999999986644322   234568999999999876 699999999999999999999999976321  111111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..           .....+........+.+++.+|++.||.+|||+.|+++
T Consensus       242 ~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          242 GK-----------YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CC-----------CCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC-----------CCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            10           00000111233556779999999999999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.7e-42  Score=334.56  Aligned_cols=267  Identities=23%  Similarity=0.296  Sum_probs=199.6

Q ss_pred             ccCHHHHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeeccc
Q 046112          194 YVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACS  272 (502)
Q Consensus       194 ~~~~~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  272 (502)
                      .+++..+....++|...+.||+|+||.||+|.+..+++.||||++.... .....+.+|+++++++ +||||+++++++.
T Consensus        13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            3344445556788999999999999999999998899999999987543 3457789999999998 7999999999875


Q ss_pred             ccccC-CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCe
Q 046112          273 GVDFQ-GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNI  351 (502)
Q Consensus       273 ~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NI  351 (502)
                      ..... .....++||||+++|+|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+||
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NI  160 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKN--------TKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNV  160 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHH--------SGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGE
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHh--------cccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHE
Confidence            42211 14578999999999999999853        22346889999999999999999999   88999999999999


Q ss_pred             eeCCCCcEEEeeeccceecccccccceecccccccccccCcccC-----CCccCccccchhHHHHHHHHHhCCCCCcccc
Q 046112          352 LLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM-----GHEVSSYGDVYSFGILLLEMFTGLRPSDDMF  426 (502)
Q Consensus       352 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~  426 (502)
                      +++.++.+||+|||++........  ......||+.|+|||.+.     +..++.++|||||||++|||++|+.||....
T Consensus       161 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          161 LLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             EECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             EEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            999999999999999976543221  123456899999999987     5678999999999999999999999997532


Q ss_pred             ccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          427 KDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ... ..........         +...     ...+...+.+++.+||..||.+|||++++++
T Consensus       239 ~~~-~~~~~~~~~~---------~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          239 PMR-ALFLIPRNPA---------PRLK-----SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHH-HHHHHHHSCC---------CCCS-----CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHH-HHHHhhcCcc---------ccCC-----ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            111 0111000000         0000     0122456789999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.3e-42  Score=330.23  Aligned_cols=261  Identities=25%  Similarity=0.313  Sum_probs=195.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcC-CC--eEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFE-ST--TAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      .++|...+.||+|+||+||+|.+.. ++  ..||||+++..   .....+.+.+|++++++++||||+++++++..    
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   92 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----   92 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence            3578888999999999999997543 33  36899998743   22345778999999999999999999998642    


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                        ...++|+||+++|+|.+++..         ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++
T Consensus        93 --~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~  158 (291)
T 1u46_A           93 --PPMKMVTELAPLGSLLDRLRK---------HQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRD  158 (291)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHH---------HGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETT
T ss_pred             --CCceeeEecccCCCHHHHHHh---------ccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCC
Confidence              237899999999999999852         1234889999999999999999999   88999999999999999999


Q ss_pred             cEEEeeeccceeccccccc-ceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHH
Q 046112          358 TAYVSDFGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~  435 (502)
                      .+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......     +.
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~  233 (291)
T 1u46_A          159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QI  233 (291)
T ss_dssp             EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HH
T ss_pred             CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----HH
Confidence            9999999999876544322 12234557889999999988889999999999999999999 99999763211     11


Q ss_pred             HHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      .........      ...    ....++..+.+++.+|++.||++|||+.++++.|+++...
T Consensus       234 ~~~~~~~~~------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          234 LHKIDKEGE------RLP----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             HHHHHTSCC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             HHHHHccCC------CCC----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            111110000      000    0123456788999999999999999999999999987654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.5e-40  Score=331.88  Aligned_cols=266  Identities=19%  Similarity=0.185  Sum_probs=193.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccc-cCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVD-FQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~  280 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||++....  ....+.+.+|+.+++.++||||+++++++.... .....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467889999999999999999998899999999987532  233467889999999999999999999865322 12234


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||++ |+|.+++.            ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus       104 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~k  167 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK  167 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred             ceEEEEEcCC-CCHHHHHh------------hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEE
Confidence            7899999996 57887763            23788999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||+++......   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+........
T Consensus       168 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~  243 (371)
T 2xrw_A          168 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLG  243 (371)
T ss_dssp             ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHC-CC
T ss_pred             EEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence            99999998654321   223456899999999999999999999999999999999999999763211 01111110000


Q ss_pred             ----------ccc---------------hhhh-cccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 ----------PER---------------AEEI-RASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ----------~~~---------------~~~~-~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                                ...               .... .+...+............+.+++.+|++.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                      000               0000 000011111122344678899999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.7e-41  Score=349.18  Aligned_cols=252  Identities=21%  Similarity=0.278  Sum_probs=198.4

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-------------chhHHHHHHHHHHhcCCCCccceeee
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-------------DASKSFAVECEVTRNIRHRNLVKVFT  269 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  269 (502)
                      ..++|...+.||+|+||+||+|.+..++..||||+++....             ...+.+.+|++++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            35678999999999999999999999999999999874321             23467889999999999999999999


Q ss_pred             cccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCC
Q 046112          270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPS  349 (502)
Q Consensus       270 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~  349 (502)
                      ++.     .....++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+
T Consensus       114 ~~~-----~~~~~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~  175 (504)
T 3q5i_A          114 VFE-----DKKYFYLVTEFYEGGELFEQIIN----------RHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPE  175 (504)
T ss_dssp             EEE-----CSSEEEEEEECCTTCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred             EEE-----cCCEEEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHH
Confidence            953     45588999999999999998842          245899999999999999999999   899999999999


Q ss_pred             CeeeCCCC---cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccc
Q 046112          350 NILLDDEM---TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMF  426 (502)
Q Consensus       350 NIll~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~  426 (502)
                      |||++.++   .+||+|||+++......   ......||+.|+|||.+. +.++.++||||+||++|+|++|+.||....
T Consensus       176 Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  251 (504)
T 3q5i_A          176 NILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN  251 (504)
T ss_dssp             GEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99998775   69999999998765432   223456999999999987 469999999999999999999999997632


Q ss_pred             ccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          427 KDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..  .+...+....           ..............+.+++.+|++.||.+|||++|+++
T Consensus       252 ~~--~~~~~i~~~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          252 DQ--DIIKKVEKGK-----------YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HH--HHHHHHHHCC-----------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HH--HHHHHHHcCC-----------CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11  1111111110           00000111123456789999999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-42  Score=340.37  Aligned_cols=255  Identities=20%  Similarity=0.282  Sum_probs=197.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEc---CCCeEEEEEEecccC----cchhHHHHHHHHHHhcC-CCCccceeeecccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLH----HDASKSFAVECEVTRNI-RHRNLVKVFTACSGVD  275 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  275 (502)
                      .++|...+.||+|+||.||+|+..   .+++.||||+++...    ......+.+|+++++.+ +||||+++++++.   
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---  129 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---  129 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe---
Confidence            357888999999999999999874   578999999986432    12345677899999999 6999999999853   


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD  355 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~  355 (502)
                        .....++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.
T Consensus       130 --~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~  194 (355)
T 1vzo_A          130 --TETKLHLILDYINGGELFTHLSQ----------RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDS  194 (355)
T ss_dssp             --ETTEEEEEECCCCSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred             --eCceEEEEeecCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECC
Confidence              34578999999999999999842          235889999999999999999999   889999999999999999


Q ss_pred             CCcEEEeeeccceecccccccceecccccccccccCcccCC--CccCccccchhHHHHHHHHHhCCCCCccccccccchH
Q 046112          356 EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG--HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR  433 (502)
Q Consensus       356 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~  433 (502)
                      ++.+||+|||+++.+...... ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||...... ....
T Consensus       195 ~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~  272 (355)
T 1vzo_A          195 NGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQA  272 (355)
T ss_dssp             TSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCHH
T ss_pred             CCcEEEeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc-chHH
Confidence            999999999999876433222 2234579999999999886  35789999999999999999999999753221 1122


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEPR  490 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~~  490 (502)
                      .........        .    ..+..+....+.+++.+|++.||++||     |++|+++.
T Consensus       273 ~~~~~~~~~--------~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          273 EISRRILKS--------E----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HHHHHHHHC--------C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HHHHHHhcc--------C----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            221111100        0    001123345677999999999999999     89998764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.5e-41  Score=338.89  Aligned_cols=267  Identities=18%  Similarity=0.208  Sum_probs=201.6

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC--------CCccceeeecccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR--------HRNLVKVFTACSGVD  275 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~~~  275 (502)
                      .++|...+.||+|+||+||+|.+..+++.||||+++.. ....+.+.+|+++++.++        |+||+++++++....
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            35788899999999999999999899999999998743 233567889999999885        788999999864211


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceeecCCCCCeeeC
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQP-PIAHCDLKPSNILLD  354 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~i~H~dlk~~NIll~  354 (502)
                       ......++||||+ +|+|.+++..        .....+++..+..++.|++.||+|||   +. +|+||||||+|||++
T Consensus       115 -~~~~~~~lv~e~~-~~~l~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~  181 (397)
T 1wak_A          115 -VNGTHICMVFEVL-GHHLLKWIIK--------SNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLS  181 (397)
T ss_dssp             -TTEEEEEEEECCC-CCBHHHHHHH--------TTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEEC
T ss_pred             -CCCceEEEEEecc-CccHHHHHHh--------cccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEe
Confidence             2345789999999 6677666632        23356899999999999999999999   77 999999999999999


Q ss_pred             CCC-------------------------------------------------cEEEeeeccceecccccccceecccccc
Q 046112          355 DEM-------------------------------------------------TAYVSDFGIARFLEAADEQTRSIGVEGT  385 (502)
Q Consensus       355 ~~~-------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt  385 (502)
                      .++                                                 .+||+|||+++.....     .....||
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt  256 (397)
T 1wak_A          182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQT  256 (397)
T ss_dssp             CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSC
T ss_pred             ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCC
Confidence            775                                                 8999999999876432     2345689


Q ss_pred             cccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccc----hHHHHHhhcccch----------hhhcccC
Q 046112          386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN----LRNCVKSALPERA----------EEIRASS  451 (502)
Q Consensus       386 ~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~----------~~~~d~~  451 (502)
                      +.|+|||++.+..++.++|||||||++|||+||+.||.........    .............          ..+....
T Consensus       257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  336 (397)
T 1wak_A          257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK  336 (397)
T ss_dssp             GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred             CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence            9999999999999999999999999999999999999753222110    0111111000000          0000000


Q ss_pred             C--C---------------CcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          452 G--S---------------TQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       452 ~--~---------------~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .  .               .......++...+.+++.+||+.||++|||++|+++
T Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            0  0               011123566788999999999999999999999975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6e-41  Score=324.58  Aligned_cols=252  Identities=23%  Similarity=0.311  Sum_probs=200.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc---------chhHHHHHHHHHHhcCC-CCccceeeecccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH---------DASKSFAVECEVTRNIR-HRNLVKVFTACSG  273 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  273 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||+++....         ...+.+.+|+++++++. ||||+++++++. 
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-   94 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-   94 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec-
Confidence            4688899999999999999999988999999999875431         12356788999999996 999999999853 


Q ss_pred             cccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee
Q 046112          274 VDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL  353 (502)
Q Consensus       274 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll  353 (502)
                          .....++||||+++++|.+++..          ...+++..+..++.|++.||.|||   +.+|+||||||+||++
T Consensus        95 ----~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~  157 (298)
T 1phk_A           95 ----TNTFFFLVFDLMKKGELFDYLTE----------KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILL  157 (298)
T ss_dssp             ----CSSEEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             ----cCCeEEEEEeccCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEE
Confidence                44588999999999999999842          245899999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeeeccceecccccccceecccccccccccCcccC------CCccCccccchhHHHHHHHHHhCCCCCccccc
Q 046112          354 DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM------GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFK  427 (502)
Q Consensus       354 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~  427 (502)
                      +.++.+||+|||++........   .....+|+.|+|||.+.      ...++.++||||||+++|||++|+.||.....
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  234 (298)
T 1phk_A          158 DDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ  234 (298)
T ss_dssp             CTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH
Confidence            9999999999999987654322   23456899999999874      45688999999999999999999999965211


Q ss_pred             cccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          428 DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .  .....+....           ...........+..+.+++.+|++.||++|||+.|+++
T Consensus       235 ~--~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          235 M--LMLRMIMSGN-----------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             H--HHHHHHHHTC-----------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             H--HHHHHHhcCC-----------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1  1111111110           00000111234566889999999999999999999875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.2e-40  Score=326.83  Aligned_cols=271  Identities=21%  Similarity=0.268  Sum_probs=202.5

Q ss_pred             hccCCCCCCcccccCCceEEEEEEc-CCCeEEEEEEecccCc--chhHHHHHHHHHHhcC---CCCccceeeeccccccc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILF-ESTTAVAVKVFNVLHH--DASKSFAVECEVTRNI---RHRNLVKVFTACSGVDF  276 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~  276 (502)
                      +.++|...+.||+|+||.||+|.+. .+++.||+|+++....  .....+.+|+.+++.+   +||||++++++|.....
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999885 6789999999864322  2234567777777665   89999999998753222


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE  356 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~  356 (502)
                      ......++||||++ |+|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+||+++.+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~  156 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDK--------VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSS  156 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHH--------SCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred             CCCceEEEEEecCC-CCHHHHHHh--------cccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCC
Confidence            34557899999997 699999853        23345899999999999999999999   8999999999999999999


Q ss_pred             CcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                      +.+||+|||+++......   ......||..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+....
T Consensus       157 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~  232 (326)
T 1blx_A          157 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKIL  232 (326)
T ss_dssp             CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHH
T ss_pred             CCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHH
Confidence            999999999998654322   123456899999999999999999999999999999999999999763221 1111111


Q ss_pred             Hhhccc----chhh-------hcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          437 KSALPE----RAEE-------IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       437 ~~~~~~----~~~~-------~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ......    +...       +..........+.......+.+++.+|++.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            111000    0000       0000000111112234566789999999999999999999984

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1e-40  Score=338.38  Aligned_cols=267  Identities=21%  Similarity=0.246  Sum_probs=195.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeeccccccc-CCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-QGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~  283 (502)
                      .+|...+.||+|+||.||+|.+..+++.||||++....    ....+|++++++++||||+++++++..... ......+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            36788899999999999999998899999999986432    223479999999999999999998754221 1223467


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC-CcEEEe
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE-MTAYVS  362 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~-~~~kl~  362 (502)
                      +||||+++ +|.+.+....      .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+
T Consensus       130 lv~e~~~~-~l~~~~~~~~------~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~  199 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYS------RAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLC  199 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             eehhcccc-cHHHHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEec
Confidence            99999975 6666553211      23456899999999999999999999   8999999999999999955 678999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||+++.+.....   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+.+.++..-.
T Consensus       200 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~  275 (420)
T 1j1b_A          200 DFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGT  275 (420)
T ss_dssp             CCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCS
T ss_pred             cchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCC
Confidence            9999987643322   2345689999999998764 799999999999999999999999976321 1122222221110


Q ss_pred             c---chhhh-------cccCCCCcc---hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 E---RAEEI-------RASSGSTQR---SIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~---~~~~~-------~d~~~~~~~---~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .   ....+       ..+......   .+.......+.+|+.+|++.||++|||+.|+++
T Consensus       276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            0   00000       000000000   001123467889999999999999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.3e-40  Score=354.58  Aligned_cols=259  Identities=20%  Similarity=0.357  Sum_probs=202.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcC---CCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFE---STTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ++|...+.||+|+||.||+|.+..   .+..||||.++.... ...+.+.+|+.++++++||||+++++++.      ++
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~~  463 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------EN  463 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------SS
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------cC
Confidence            445667789999999999998754   356799999875433 23467899999999999999999999863      23


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vk  531 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQV---------RKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVK  531 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHH---------TTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEE
T ss_pred             ceEEEEEcCCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEE
Confidence            57999999999999999852         2345899999999999999999999   88999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......  .....+...
T Consensus       532 L~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~~  608 (656)
T 2j0j_A          532 LGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENG  608 (656)
T ss_dssp             ECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHHT
T ss_pred             EEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcC
Confidence            9999999876443221 2223456789999999988899999999999999999997 99999763211  111111111


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      .           .   ......++..+.+++.+||..||++|||+.|+++.|+++.++.
T Consensus       609 ~-----------~---~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          609 E-----------R---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             C-----------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             C-----------C---CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            0           0   0011234567889999999999999999999999999997654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=325.56  Aligned_cols=261  Identities=23%  Similarity=0.299  Sum_probs=195.4

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ..++|...+.||+|+||.||+|.+..   .||+|+++...  ....+.+.+|+.++++++||||+++++++..     .+
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~  102 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----PP  102 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-----SS
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence            45688899999999999999997633   48999987532  2234567889999999999999999999643     44


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++++|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+||+++ ++.+|
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~  169 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRD---------AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVV  169 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTS---------SCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCE
T ss_pred             ceEEEeecccCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEE
Confidence            78999999999999999853         2346899999999999999999999   88999999999999998 67999


Q ss_pred             Eeeeccceecccccc---cceecccccccccccCcccCC---------CccCccccchhHHHHHHHHHhCCCCCcccccc
Q 046112          361 VSDFGIARFLEAADE---QTRSIGVEGTTGYIAPEYGMG---------HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD  428 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~  428 (502)
                      |+|||+++.......   ........||+.|+|||.+..         ..++.++||||||+++|||++|+.||.....+
T Consensus       170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  249 (319)
T 2y4i_B          170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE  249 (319)
T ss_dssp             ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH
T ss_pred             EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999876532221   122234568999999998874         45789999999999999999999999763211


Q ss_pred             ccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          429 NLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      .  ....+....        .+....     ..++..+.+++.+||..||++|||+.++++.|+.+.++..
T Consensus       250 ~--~~~~~~~~~--------~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          250 A--IIWQMGTGM--------KPNLSQ-----IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             H--HHHHHHTTC--------CCCCCC-----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             H--HHHHhccCC--------CCCCCc-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence            1  111111100        000000     0123457799999999999999999999999998876643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.4e-40  Score=326.03  Aligned_cols=261  Identities=18%  Similarity=0.224  Sum_probs=198.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEE-cCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCc------cceeeeccccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGIL-FESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRN------LVKVFTACSGVDF  276 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  276 (502)
                      .++|...+.||+|+||.||+|.+ ..+++.||||+++.. ....+.+.+|+++++.++|++      ++++++++     
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~-----   86 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF-----   86 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE-----
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc-----
Confidence            35788899999999999999987 567899999998743 233467889999999887665      89999885     


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC-
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD-  355 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~-  355 (502)
                      ...+..++||||+ +++|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+|||++. 
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~  154 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKE--------NGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQS  154 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCC
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHh--------cCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEecc
Confidence            3345889999999 8999999853        33346889999999999999999999   899999999999999987 


Q ss_pred             ------------------CCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh
Q 046112          356 ------------------EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT  417 (502)
Q Consensus       356 ------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t  417 (502)
                                        ++.+||+|||+++.....     .....||+.|+|||.+.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  229 (339)
T 1z57_A          155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL  229 (339)
T ss_dssp             CEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred             ccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence                              678999999999864332     124568999999999999999999999999999999999


Q ss_pred             CCCCCccccccccchHHHHHhhcccchhhhcc-----------------------------cCCCCcchhhHHHHHHHHH
Q 046112          418 GLRPSDDMFKDNLNLRNCVKSALPERAEEIRA-----------------------------SSGSTQRSIILECLISICE  468 (502)
Q Consensus       418 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d-----------------------------~~~~~~~~~~~~~~~~l~~  468 (502)
                      |+.||.......  ....+..........+..                             ............+...+.+
T Consensus       230 g~~pf~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  307 (339)
T 1z57_A          230 GFTVFPTHDSKE--HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD  307 (339)
T ss_dssp             SSCSCCCSCHHH--HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred             CCCCCCCCChHH--HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHH
Confidence            999997532111  111111111000000000                             0000000011245678899


Q ss_pred             HHhhcccCCCCCCCCHHHHHH
Q 046112          469 IGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       469 l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ++.+|++.||++|||++|+++
T Consensus       308 li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          308 LIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHhCcCcccccCHHHHhc
Confidence            999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.8e-40  Score=327.69  Aligned_cols=264  Identities=21%  Similarity=0.245  Sum_probs=196.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeeccccccc-CCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-QGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~  280 (502)
                      .++|...+.||+|+||.||+|.+..+|+.||||+++....  ...+.+.+|+.+++.++||||+++++++..... ....
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            4678889999999999999999999999999999875432  234678899999999999999999998754321 1111


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+. |+|.+++.            ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus       121 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~k  184 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG------------MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELK  184 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEE
T ss_pred             eEEEEEcccc-ccHHHHhh------------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEE
Confidence            3489999997 68888763            23889999999999999999999   88999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++.....     .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+.......
T Consensus       185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~  258 (371)
T 4exu_A          185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVT  258 (371)
T ss_dssp             ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred             EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHh
Confidence            9999999755432     234568999999999887 789999999999999999999999997632111 111111100


Q ss_pred             ccc---c--------h----hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPE---R--------A----EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~---~--------~----~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      -..   .        .    ..+..............+...+.+++.+|++.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            000   0        0    000000000111111233567889999999999999999999975

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.8e-41  Score=324.24  Aligned_cols=258  Identities=21%  Similarity=0.276  Sum_probs=192.3

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccc--------
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVD--------  275 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  275 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||+++.. ....+.+.+|++++++++||||+++++++....        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            35688889999999999999998889999999998643 233567899999999999999999999864311        


Q ss_pred             cCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC
Q 046112          276 FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD  355 (502)
Q Consensus       276 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~  355 (502)
                      .......++||||+++|+|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~  151 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS---------ENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDE  151 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH---------SCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECT
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc---------cccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcC
Confidence            1234578999999999999999852         2244678899999999999999999   889999999999999999


Q ss_pred             CCcEEEeeeccceecccccc------------cceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCC
Q 046112          356 EMTAYVSDFGIARFLEAADE------------QTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPS  422 (502)
Q Consensus       356 ~~~~kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~  422 (502)
                      ++.+||+|||+++.......            ........||+.|+|||.+.+. .++.++|||||||++|||++   ||
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~  228 (303)
T 1zy4_A          152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF  228 (303)
T ss_dssp             TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred             CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence            99999999999986543211            1122345689999999998764 78999999999999999998   55


Q ss_pred             ccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          423 DDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...... ......+....           ..........++..+.+++.+|++.||.+|||+.|+++
T Consensus       229 ~~~~~~-~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          229 STGMER-VNILKKLRSVS-----------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             SSHHHH-HHHHHHHHSTT-----------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCchhH-HHHHHhccccc-----------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            431111 11111111100           00001111234556789999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.7e-40  Score=327.12  Aligned_cols=279  Identities=19%  Similarity=0.195  Sum_probs=192.9

Q ss_pred             HHHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeeccccccc-
Q 046112          198 RMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-  276 (502)
Q Consensus       198 ~~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  276 (502)
                      .......++|...+.||+|+||.||+|.+..+++.||||++.... .....+..|++.++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            345567789999999999999999999998899999999886432 223456778888899999999999999754321 


Q ss_pred             -CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC
Q 046112          277 -QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD  355 (502)
Q Consensus       277 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~  355 (502)
                       ......++||||+++ +|.+.+..      .......+++..+..++.|++.||.|||. ++.+|+||||||+|||++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRN------YYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNE  166 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHH------HHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEET
T ss_pred             cccceeEEEEeecccc-cHHHHHHH------HhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeC
Confidence             122247899999976 55444321      01344568899999999999999999993 3679999999999999996


Q ss_pred             -CCcEEEeeeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchH
Q 046112          356 -EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR  433 (502)
Q Consensus       356 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~  433 (502)
                       ++.+||+|||+++.......   .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+.
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~  242 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLH  242 (360)
T ss_dssp             TTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH
T ss_pred             CCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHH
Confidence             89999999999986654322   2345689999999998765 4899999999999999999999999763211 1122


Q ss_pred             HHHHhhccc---chhh---------hcccCCCC----cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          434 NCVKSALPE---RAEE---------IRASSGST----QRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       434 ~~~~~~~~~---~~~~---------~~d~~~~~----~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...+.....   ....         ..+.....    .......+...+.+++.+|++.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            222111100   0000         00000000    00001124667889999999999999999999975

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.1e-40  Score=333.14  Aligned_cols=266  Identities=17%  Similarity=0.208  Sum_probs=200.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-----------CCccceeeeccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-----------HRNLVKVFTACS  272 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  272 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||+++.. ......+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            35788899999999999999998899999999998742 223467888999998886           899999999864


Q ss_pred             ccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceeecCCCCCe
Q 046112          273 GVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQP-PIAHCDLKPSNI  351 (502)
Q Consensus       273 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~i~H~dlk~~NI  351 (502)
                      ... ......++||||+ +++|.+++..        .....+++..+..++.|++.||+|||   +. +|+||||||+||
T Consensus        97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NI  163 (373)
T 1q8y_A           97 HKG-PNGVHVVMVFEVL-GENLLALIKK--------YEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENV  163 (373)
T ss_dssp             EEE-TTEEEEEEEECCC-CEEHHHHHHH--------TTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGE
T ss_pred             ccC-CCCceEEEEEecC-CCCHHHHHHH--------hhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHe
Confidence            321 2233788999999 9999999853        23345899999999999999999999   77 999999999999


Q ss_pred             eeC------CCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccc
Q 046112          352 LLD------DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDM  425 (502)
Q Consensus       352 ll~------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~  425 (502)
                      |++      ..+.+||+|||+++.....     .....||+.|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus       164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  238 (373)
T 1q8y_A          164 LMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  238 (373)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            994      4558999999999866432     22346899999999999999999999999999999999999999753


Q ss_pred             cccc-----cchHHHHHhhcccchhh----------hcccC-----------------CCCcchhhHHHHHHHHHHHhhc
Q 046112          426 FKDN-----LNLRNCVKSALPERAEE----------IRASS-----------------GSTQRSIILECLISICEIGVAC  473 (502)
Q Consensus       426 ~~~~-----~~~~~~~~~~~~~~~~~----------~~d~~-----------------~~~~~~~~~~~~~~l~~l~~~c  473 (502)
                      ....     ..+.+... ........          +....                 ......+...+...+.+++.+|
T Consensus       239 ~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  317 (373)
T 1q8y_A          239 EGHSYTKDDDHIAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM  317 (373)
T ss_dssp             ------CHHHHHHHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred             cccccCChHHHHHHHHH-hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHH
Confidence            2111     11111111 00000000          00000                 0001122356778899999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 046112          474 SAEQPGERMKINDVEP  489 (502)
Q Consensus       474 ~~~dP~~RPt~~ev~~  489 (502)
                      ++.||++|||++|+++
T Consensus       318 L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          318 LQLDPRKRADAGGLVN  333 (373)
T ss_dssp             GCSSTTTCBCHHHHHT
T ss_pred             hccCccccCCHHHHhh
Confidence            9999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=8.3e-40  Score=327.95  Aligned_cols=201  Identities=24%  Similarity=0.294  Sum_probs=168.2

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-CC-----ccceeeeccccccc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HR-----NLVKVFTACSGVDF  276 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~  276 (502)
                      ..++|...+.||+|+||+||+|.+..+++.||||+++.. .....++..|+.+++.++ |+     +++++.+++.    
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~----  126 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM----  126 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE----
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec----
Confidence            457889999999999999999999889999999998743 223456778888888775 44     4888888853    


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC--
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD--  354 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~--  354 (502)
                       ..+..++||||++ |+|.+++..        .....+++..+..++.|++.||.|||.+ +.+|+||||||+|||++  
T Consensus       127 -~~~~~~lv~e~~~-~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~  195 (382)
T 2vx3_A          127 -FRNHLCLVFEMLS-YNLYDLLRN--------TNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNP  195 (382)
T ss_dssp             -ETTEEEEEEECCC-CBHHHHHHH--------TTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESST
T ss_pred             -cCCceEEEEecCC-CCHHHHHhh--------cCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecC
Confidence             3458899999995 699999853        3335589999999999999999999932 46899999999999994  


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      .++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       196 ~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          196 KRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             TSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            5788999999999876432     2345689999999999999999999999999999999999999976

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.5e-40  Score=325.83  Aligned_cols=257  Identities=18%  Similarity=0.229  Sum_probs=174.0

Q ss_pred             ccCCCCC-CcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSE-NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .++|... ++||+|+||.||+|.+..+++.||||++...    .....+....++.++||||+++++++.... .+....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceE
Confidence            4577774 4699999999999999889999999998642    222233333466779999999999864321 224468


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC---CCcE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD---EMTA  359 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~---~~~~  359 (502)
                      ++||||+++|+|.+++..        .....+++.++..++.|++.||+|||   +.+|+||||||+||+++.   ++.+
T Consensus       102 ~lv~e~~~gg~L~~~l~~--------~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~  170 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQE--------RGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVL  170 (336)
T ss_dssp             EEEEECCTTEEHHHHHHT--------C-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCE
T ss_pred             EEEEeccCCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceE
Confidence            999999999999999964        33356999999999999999999999   889999999999999976   4569


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||+++......    .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||.........  ......
T Consensus       171 kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~  244 (336)
T 3fhr_A          171 KLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--PGMKRR  244 (336)
T ss_dssp             EECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred             EEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--hhHHHh
Confidence            999999998654322    22356799999999999999999999999999999999999999763222110  000000


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .........       ......+...+.+++.+|++.||.+|||++|+++
T Consensus       245 ~~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          245 IRLGQYGFP-------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ------CCC-------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhccccccC-------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000000000       0001133556789999999999999999999987

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.6e-40  Score=331.29  Aligned_cols=208  Identities=22%  Similarity=0.284  Sum_probs=154.1

Q ss_pred             CCC-CCcccccCCceEEEEEEc--CCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          207 FSS-ENLIGAGNFGSVYKGILF--ESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       207 ~~~-~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      |.. +++||+|+||+||+|++.  .+++.||||+++..  .....+.+|++++++++||||+++++++..   ......+
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~~~   96 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLS---HADRKVW   96 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCeEE
Confidence            444 568999999999999865  46889999998743  234578899999999999999999998632   3355789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee----CCCCcE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL----DDEMTA  359 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll----~~~~~~  359 (502)
                      +||||+. |+|.+++....... .......+++..+..++.|++.||+|||   +.+|+||||||+|||+    +.++.+
T Consensus        97 lv~e~~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           97 LLFDYAE-HDLWHIIKFHRASK-ANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEECCS-EEHHHHHHHHHHHC--------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEeCCC-CCHHHHHHHhcccc-ccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            9999996 58888774211110 1122345899999999999999999999   8999999999999999    778999


Q ss_pred             EEeeeccceecccccc-cceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          360 YVSDFGIARFLEAADE-QTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      ||+|||+++....... ........||+.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  238 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  238 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence            9999999987654322 1223456789999999998874 589999999999999999999999965

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=322.79  Aligned_cols=264  Identities=21%  Similarity=0.253  Sum_probs=195.7

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeeccccccc-CCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-QGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~  280 (502)
                      .++|...+.||+|+||.||+|.+..+|+.||||++.....  ...+.+.+|+.+++.++||||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            4678889999999999999999989999999999875332  234678899999999999999999998643221 1112


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+. |+|.+++.            ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus       103 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~k  166 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG------------LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELK  166 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEE
T ss_pred             eEEEEecccc-CCHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEE
Confidence            4589999997 68887763            23889999999999999999999   88999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|||+++.....     .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+....+..
T Consensus       167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~  240 (353)
T 3coi_A          167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVT  240 (353)
T ss_dssp             ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHH
T ss_pred             EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence            9999999754322     234568999999999877 678999999999999999999999997632111 111111100


Q ss_pred             c-c-c-ch------------hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 L-P-E-RA------------EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~-~-~-~~------------~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      - + . ..            ..+..................+.+++.+|++.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0 0 0 00            000000000111111234567889999999999999999999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.3e-40  Score=317.74  Aligned_cols=251  Identities=22%  Similarity=0.285  Sum_probs=198.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||.||+|.+..+++.||+|++....  ......+.+|++++++++||||+++++++.     ....
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   95 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS   95 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCe
Confidence            457888999999999999999988899999999986432  234577899999999999999999999853     3457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC---Cc
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE---MT  358 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~---~~  358 (502)
                      .++|+||+++++|.+++..          ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.+   +.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~  162 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIK----------RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCD  162 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             EEEEEEccCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCccc
Confidence            8999999999999988742          235889999999999999999999   8899999999999999754   47


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +||+|||++........   .....+|+.|+|||.+.+ .++.++||||||+++|||++|+.||......  .....+..
T Consensus       163 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~  236 (287)
T 2wei_A          163 IKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVET  236 (287)
T ss_dssp             EEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred             EEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHc
Confidence            99999999976543321   123457899999998876 4899999999999999999999999763211  11111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..           .....+........+.+++.+|++.||++|||+.|+++
T Consensus       237 ~~-----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          237 GK-----------YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CC-----------CCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC-----------CCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            10           00000001133456789999999999999999999987

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.9e-40  Score=322.59  Aligned_cols=258  Identities=23%  Similarity=0.251  Sum_probs=177.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHH-HHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECE-VTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||+++.... ....++..|+. +++.++||||+++++++.     ..+.
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REGD   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSSE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCCc
Confidence            3578888999999999999999988999999999875432 23345556665 778889999999999964     3457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceeecCCCCCeeeCCCCcEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQP-PIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~i~H~dlk~~NIll~~~~~~k  360 (502)
                      .++||||+++ +|.+++...     .......+++..+..++.+++.||.|||   +. +|+||||||+||+++.++.+|
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~-----~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~k  166 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYV-----YSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIK  166 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHH-----HHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEE
T ss_pred             eEEEEeecCC-ChHHHHHHH-----HhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEE
Confidence            8999999974 888776421     1123466899999999999999999999   77 999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCccc----CCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHH
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYG----MGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  436 (502)
                      |+|||+++.......   .....||+.|+|||.+    .+..++.++|||||||++|||++|+.||.......    +..
T Consensus       167 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~  239 (327)
T 3aln_A          167 LCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----DQL  239 (327)
T ss_dssp             ECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------
T ss_pred             EccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----HHH
Confidence            999999976643321   1234689999999998    45678999999999999999999999997532111    000


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..........+...       ....+...+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          240 TQVVKGDPPQLSNS-------EEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCSCCCCCCCC-------SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHhcCCCCCCCCc-------ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            00000000000000       00123456889999999999999999999976

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.3e-39  Score=323.12  Aligned_cols=261  Identities=18%  Similarity=0.241  Sum_probs=196.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCC-eEEEEEEecccCcchhHHHHHHHHHHhcCCCCc------cceeeeccccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFEST-TAVAVKVFNVLHHDASKSFAVECEVTRNIRHRN------LVKVFTACSGVDF  276 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  276 (502)
                      .++|...+.||+|+||.||+|.+..++ ..||+|+++.. ....+.+.+|++++++++|++      ++.+.+++     
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-----   91 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-----   91 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-----
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-----
Confidence            357888999999999999999887666 79999998743 233567888999999998766      78887774     


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee---
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL---  353 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll---  353 (502)
                      ......++||||+ +++|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+|||+   
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~--------~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~  159 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKE--------NNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNS  159 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCC
T ss_pred             eeCCeEEEEEecc-CCChHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecc
Confidence            3345889999999 6777777642        33356899999999999999999999   8999999999999999   


Q ss_pred             ----------------CCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh
Q 046112          354 ----------------DDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT  417 (502)
Q Consensus       354 ----------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t  417 (502)
                                      +.++.+||+|||+++.....     .....||+.|+|||.+.+..++.++|||||||++|||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  234 (355)
T 2eu9_A          160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR  234 (355)
T ss_dssp             CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence                            56789999999999864332     134568999999999999999999999999999999999


Q ss_pred             CCCCCccccccccchHHHHHhhcccchhhhc----------------ccC-------------CCCcchhhHHHHHHHHH
Q 046112          418 GLRPSDDMFKDNLNLRNCVKSALPERAEEIR----------------ASS-------------GSTQRSIILECLISICE  468 (502)
Q Consensus       418 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------d~~-------------~~~~~~~~~~~~~~l~~  468 (502)
                      |+.||.......  ....+..........+.                +..             ..........+...+.+
T Consensus       235 g~~pf~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  312 (355)
T 2eu9_A          235 GFTLFQTHENRE--HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD  312 (355)
T ss_dssp             SSCSCCCSSHHH--HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred             CCCCCCCCCHHH--HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHH
Confidence            999997632211  11111111110000000                000             00000001234567889


Q ss_pred             HHhhcccCCCCCCCCHHHHHH
Q 046112          469 IGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       469 l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ++.+|++.||++|||++|+++
T Consensus       313 li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          313 LMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHhcCChhhCcCHHHHhc
Confidence            999999999999999999974

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4e-40  Score=321.22  Aligned_cols=253  Identities=21%  Similarity=0.319  Sum_probs=190.2

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCC--CCccceeeecccccccCC
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIR--HRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~  278 (502)
                      ..++|...+.||+|+||.||++.+ .+++.||||+++....  ...+.+.+|++++.+++  ||||+++++++.     .
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~   99 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----T   99 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----C
T ss_pred             ccceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----c
Confidence            456788899999999999999966 5688999999875432  33467899999999997  599999999854     3


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      ....++||| +.+++|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+||++++ +.
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~  164 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKK----------KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GM  164 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHH----------CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TE
T ss_pred             CCEEEEEEe-cCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-Ce
Confidence            447899999 668999999842          246889999999999999999999   889999999999999965 89


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCC-----------CccCccccchhHHHHHHHHHhCCCCCccccc
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-----------HEVSSYGDVYSFGILLLEMFTGLRPSDDMFK  427 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~  427 (502)
                      +||+|||+++...............||+.|+|||.+.+           ..++.++||||||+++|||++|+.||.....
T Consensus       165 ~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (313)
T 3cek_A          165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN  244 (313)
T ss_dssp             EEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             EEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence            99999999987654433222334568999999999875           4788899999999999999999999976322


Q ss_pred             cccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          428 DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ....+....            +.....  .+...+...+.+++.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~~------------~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          245 QISKLHAII------------DPNHEI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHHHHHHHH------------CTTSCC--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHH------------hccccc--CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            111111111            111000  0001123467799999999999999999999863

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.6e-40  Score=330.89  Aligned_cols=266  Identities=21%  Similarity=0.220  Sum_probs=191.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeeccccccc-CCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-QGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~  283 (502)
                      .+|...+.||+|+||+||+|++..++. ||+|++....    ....+|+++++.++||||+++++++..... ......+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            468888999999999999998766555 8888765322    122469999999999999999998754321 2233478


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC-CCCcEEEe
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVS  362 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~-~~~~~kl~  362 (502)
                      +||||++++.+....+.       ......+++..+..++.|++.||+|||   +.+|+||||||+|||++ .++.+||+
T Consensus       115 lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~  184 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHY-------AKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLI  184 (394)
T ss_dssp             EEEECCSEEHHHHHHHH-------HHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             EEeeccCccHHHHHHHH-------HhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEe
Confidence            99999976544333210       123456899999999999999999999   89999999999999999 79999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||+++.......   .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+...++..-.
T Consensus       185 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~  260 (394)
T 4e7w_A          185 DFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGT  260 (394)
T ss_dssp             CCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCC
T ss_pred             eCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence            9999987643322   2345689999999998765 5899999999999999999999999763211 112222211100


Q ss_pred             cc---hhh----hcccCCCCc--c----hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ER---AEE----IRASSGSTQ--R----SIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~---~~~----~~d~~~~~~--~----~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..   ...    ......+..  .    .+.......+.+++.+|++.||.+|||+.|+++
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            00   000    000000000  0    001124567889999999999999999999875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3e-39  Score=338.68  Aligned_cols=274  Identities=22%  Similarity=0.270  Sum_probs=203.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccc-cCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVD-FQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~  281 (502)
                      .++|...+.||+|+||.||+|.+..+|+.||||+++... ....+.+.+|++++++++||||+++++++.... ...+..
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999888899999999987542 233567899999999999999999999865422 223567


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc---
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT---  358 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~---  358 (502)
                      .++||||+++|+|.+++...       .....+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.   
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~-------~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~  162 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQF-------ENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLI  162 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSS-------SCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCE
T ss_pred             EEEEEEeCCCCCHHHHHHhc-------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCcee
Confidence            89999999999999998641       22345888899999999999999999   899999999999999987664   


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +||+|||+++.......   .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....    ...|...
T Consensus       163 vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~  235 (676)
T 3qa8_A          163 HKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGK  235 (676)
T ss_dssp             EEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTT
T ss_pred             EEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhh
Confidence            99999999987644322   2345789999999999999999999999999999999999999965211    1111111


Q ss_pred             hcccch-----hhh------cccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHH-----HHHHHHHH
Q 046112          439 ALPERA-----EEI------RASSGSTQRSIILECLISICEIGVACSAEQPGERMKIND-----VEPRLRLI  494 (502)
Q Consensus       439 ~~~~~~-----~~~------~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~e-----v~~~L~~i  494 (502)
                      ......     ...      .....+............+.+++.+|+..||++|||+.|     ..+.+..+
T Consensus       236 i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i  307 (676)
T 3qa8_A          236 VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI  307 (676)
T ss_dssp             CC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred             hhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence            100000     000      000111111223346778899999999999999999988     44555444

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.7e-40  Score=321.12  Aligned_cols=242  Identities=21%  Similarity=0.304  Sum_probs=196.0

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc------hhHHHHHHHHHHhcCC--CCccceeeeccccc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD------ASKSFAVECEVTRNIR--HRNLVKVFTACSGV  274 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~  274 (502)
                      ..++|...+.||+|+||.||+|.+..+++.||||+++.....      ....+..|+.++++++  |+||+++++++.  
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~--  118 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--  118 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe--
Confidence            456789999999999999999999899999999998753221      2245778999999996  599999999953  


Q ss_pred             ccCCCcceeEEeeeccC-CChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeee
Q 046112          275 DFQGNDFKALVYEFMAN-GSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILL  353 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll  353 (502)
                         ..+..++|+||+.+ ++|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||+
T Consensus       119 ---~~~~~~lv~e~~~~~~~L~~~l~~----------~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll  182 (320)
T 3a99_A          119 ---RPDSFVLILERPEPVQDLFDFITE----------RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILI  182 (320)
T ss_dssp             ---CSSEEEEEEECCSSEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred             ---cCCcEEEEEEcCCCCccHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEE
Confidence               44578999999976 899999842          245889999999999999999999   8999999999999999


Q ss_pred             C-CCCcEEEeeeccceecccccccceecccccccccccCcccCCCcc-CccccchhHHHHHHHHHhCCCCCccccccccc
Q 046112          354 D-DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEV-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN  431 (502)
Q Consensus       354 ~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~  431 (502)
                      + +++.+||+|||+++......    .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....     
T Consensus       183 ~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----  253 (320)
T 3a99_A          183 DLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----  253 (320)
T ss_dssp             ETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----
T ss_pred             eCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----
Confidence            9 78999999999998765322    224568999999999877665 678999999999999999999997521     


Q ss_pred             hHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          432 LRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       432 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                        .......          ...      ..+...+.+++.+||+.||++|||++|+++
T Consensus       254 --~~~~~~~----------~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          254 --EIIRGQV----------FFR------QRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             --HHHHCCC----------CCS------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --hhhcccc----------ccc------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              1111000          000      122456779999999999999999999976

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2e-39  Score=330.27  Aligned_cols=255  Identities=20%  Similarity=0.271  Sum_probs=182.3

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcceeEE
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      |...++||+|+||+||.+ ...+|+.||||++...   ..+.+.+|++++.++ +||||+++++++     ......++|
T Consensus        17 ~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv   87 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIA   87 (434)
T ss_dssp             EEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred             eeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEE
Confidence            445678999999999876 4567999999998642   345678899999876 899999999884     345588999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC---------
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE---------  356 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~---------  356 (502)
                      |||+. |+|.+++.......   ......++..++.++.|++.||+|||   +.+|+||||||+|||++.+         
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~  160 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSD---ENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQT  160 (434)
T ss_dssp             ECCCS-EEHHHHHHTC---------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred             EecCC-CCHHHHHhccCCCc---hhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCccccccccc
Confidence            99995 79999996421110   00011233356789999999999999   8999999999999999653         


Q ss_pred             ----CcEEEeeeccceeccccccc--ceecccccccccccCcccCC-------CccCccccchhHHHHHHHHHh-CCCCC
Q 046112          357 ----MTAYVSDFGIARFLEAADEQ--TRSIGVEGTTGYIAPEYGMG-------HEVSSYGDVYSFGILLLEMFT-GLRPS  422 (502)
Q Consensus       357 ----~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvws~Gv~l~el~t-g~~p~  422 (502)
                          +.+||+|||+++.+......  .......||+.|+|||++.+       ..++.++|||||||++|||+| |+.||
T Consensus       161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence                58999999999877543321  12234579999999999875       678999999999999999999 99999


Q ss_pred             ccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          423 DDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .+.....   ..........       +.....  ........+.+++.+|++.||.+|||+.|+++
T Consensus       241 ~~~~~~~---~~i~~~~~~~-------~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          241 GDKYSRE---SNIIRGIFSL-------DEMKCL--HDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             CSTTTHH---HHHHHTCCCC-------CCCTTC--CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCchhhH---HHHhcCCCCc-------cccccc--ccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            7632211   1111111100       000000  12356678889999999999999999999975

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-40  Score=321.97  Aligned_cols=242  Identities=22%  Similarity=0.316  Sum_probs=190.1

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc------hhHHHHHHHHHHhcC----CCCccceeeeccc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD------ASKSFAVECEVTRNI----RHRNLVKVFTACS  272 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~~~  272 (502)
                      ..++|...+.||+|+||.||+|.+..+++.||||+++.....      ....+..|+.++.++    +||||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            456899999999999999999988889999999998643221      223456788888888    8999999999853


Q ss_pred             ccccCCCcceeEEeee-ccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCe
Q 046112          273 GVDFQGNDFKALVYEF-MANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNI  351 (502)
Q Consensus       273 ~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NI  351 (502)
                           ..+..++|+|| +.+++|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+||
T Consensus       109 -----~~~~~~~v~e~~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Ni  170 (312)
T 2iwi_A          109 -----TQEGFMLVLERPLPAQDLFDYITE----------KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENI  170 (312)
T ss_dssp             ---------CEEEEECCSSEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGE
T ss_pred             -----cCCeEEEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhE
Confidence                 34578999999 789999999842          235899999999999999999999   88999999999999


Q ss_pred             eeC-CCCcEEEeeeccceecccccccceecccccccccccCcccCCCccC-ccccchhHHHHHHHHHhCCCCCccccccc
Q 046112          352 LLD-DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVS-SYGDVYSFGILLLEMFTGLRPSDDMFKDN  429 (502)
Q Consensus       352 ll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvws~Gv~l~el~tg~~p~~~~~~~~  429 (502)
                      +++ .++.+||+|||+++......    .....||..|+|||.+.+..+. .++||||||+++|||++|+.||....   
T Consensus       171 l~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---  243 (312)
T 2iwi_A          171 LIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---  243 (312)
T ss_dssp             EEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---
T ss_pred             EEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---
Confidence            999 88999999999998765432    2345689999999998776664 58999999999999999999997521   


Q ss_pred             cchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          430 LNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                          +.....            ..    +...+...+.+++.+|++.||++|||++|+++
T Consensus       244 ----~~~~~~------------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          244 ----EILEAE------------LH----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ----HHHHTC------------CC----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----HHhhhc------------cC----CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                111000            00    01123456779999999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=316.18  Aligned_cols=252  Identities=22%  Similarity=0.257  Sum_probs=177.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc-h-hHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-A-SKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||.||+|.+..+++.||||+++..... . .+.+.++..+++.++||||+++++++.     ..+.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNTD   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCCc
Confidence            35678889999999999999999889999999998754322 2 233445556788889999999999964     3458


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceeecCCCCCeeeCCCCcEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQP-PIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~i~H~dlk~~NIll~~~~~~k  360 (502)
                      .++||||+ ++.+..+..         .....+++..+..++.+++.||.|||   +. +|+||||||+||+++.++.+|
T Consensus        99 ~~lv~e~~-~~~~~~l~~---------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~k  165 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKK---------RMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIK  165 (318)
T ss_dssp             EEEEECCC-SEEHHHHHH---------HHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEecc-CCcHHHHHH---------HhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEE
Confidence            89999999 455554432         12356899999999999999999999   74 999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccC-----CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHH
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGM-----GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  435 (502)
                      |+|||++........   .....+|+.|+|||.+.     ...++.++|||||||++|||++|+.||.........+...
T Consensus       166 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  242 (318)
T 2dyl_A          166 LCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV  242 (318)
T ss_dssp             ECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             EEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence            999999976543222   22346899999999984     4578899999999999999999999997632211111111


Q ss_pred             HHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       436 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .....         +.....    ..+...+.+++.+||+.||.+|||++|+++
T Consensus       243 ~~~~~---------~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          243 LQEEP---------PLLPGH----MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHSCC---------CCCCSS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             hccCC---------CCCCcc----CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            11110         000100    123456779999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-39  Score=326.44  Aligned_cols=250  Identities=24%  Similarity=0.298  Sum_probs=181.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ..+|...++||+|+||+||.. ...+++.||||++....   ...+.+|+++++.+ +||||+++++++     ......
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~   93 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQ   93 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEE
T ss_pred             cEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEE
Confidence            345788899999999996544 34578999999986432   23357899999999 799999999885     344578


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC-----CC
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD-----EM  357 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~-----~~  357 (502)
                      ++||||+. |+|.+++..         ......+..+..++.|++.||+|||   +.+|+||||||+|||++.     ..
T Consensus        94 ~lv~E~~~-g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~  160 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQ---------KDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKI  160 (432)
T ss_dssp             EEEEECCS-EEHHHHHHS---------SSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBC
T ss_pred             EEEEECCC-CCHHHHHHh---------cCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCce
Confidence            99999995 699999853         2223444456789999999999999   899999999999999943     34


Q ss_pred             cEEEeeeccceecccccc-cceecccccccccccCcccC---CCccCccccchhHHHHHHHHHh-CCCCCccccccccch
Q 046112          358 TAYVSDFGIARFLEAADE-QTRSIGVEGTTGYIAPEYGM---GHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNL  432 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~  432 (502)
                      .+||+|||+++....... ........||+.|+|||++.   ...++.++|||||||++|||+| |+.||.......   
T Consensus       161 ~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~---  237 (432)
T 3p23_A          161 KAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---  237 (432)
T ss_dssp             CEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---
T ss_pred             eEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---
Confidence            688999999987654322 22334567999999999988   4567889999999999999999 999986521111   


Q ss_pred             HHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          433 RNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       433 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..   ...........        .........+.+++.+|++.||.+|||++|+++
T Consensus       238 ~~---~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          238 AN---ILLGACSLDCL--------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HH---HHTTCCCCTTS--------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HH---HHhccCCcccc--------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            11   11100000000        001133455779999999999999999999983

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.1e-39  Score=325.15  Aligned_cols=253  Identities=15%  Similarity=0.136  Sum_probs=184.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHHHHhcCCC-Cccceeeec---------
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECEVTRNIRH-RNLVKVFTA---------  270 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~~~---------  270 (502)
                      +.+|...++||+|+||+||+|.+..+|+.||||+++....   ...+.+.+|+.+++.++| +|...+..+         
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3456778899999999999999999999999999873322   235779999999999987 332222111         


Q ss_pred             c------------cccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 046112          271 C------------SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ  338 (502)
Q Consensus       271 ~------------~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~  338 (502)
                      +            ...........+++|+++ +++|.+++......   ......+++..++.++.|++.||+|||   +
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH---~  229 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH---SSTHKSLVHHARLQLTLQVIRLLASLH---H  229 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHH---TTTSHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcc---cccCCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence            0            000000012345666654 78999988421110   123445788899999999999999999   8


Q ss_pred             CCceeecCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCccc----------CCCccCccccchhH
Q 046112          339 PPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYG----------MGHEVSSYGDVYSF  408 (502)
Q Consensus       339 ~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDvws~  408 (502)
                      .+|+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||
T Consensus       230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl  303 (413)
T 3dzo_A          230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL  303 (413)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred             CCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence            99999999999999999999999999999865432     234567 999999998          66678999999999


Q ss_pred             HHHHHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 046112          409 GILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVE  488 (502)
Q Consensus       409 Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~  488 (502)
                      ||++|||+||+.||........             ...+.    ....    ..+..+.+++.+||+.||++|||+.|++
T Consensus       304 Gvil~elltg~~Pf~~~~~~~~-------------~~~~~----~~~~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          304 GLAIYWIWCADLPNTDDAALGG-------------SEWIF----RSCK----NIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHHHHSSCCCCTTGGGSC-------------SGGGG----SSCC----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHHHHCCCCCCCcchhhh-------------HHHHH----hhcc----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            9999999999999976322110             00111    1111    1235678999999999999999988876


Q ss_pred             HH
Q 046112          489 PR  490 (502)
Q Consensus       489 ~~  490 (502)
                      +.
T Consensus       363 ~~  364 (413)
T 3dzo_A          363 ET  364 (413)
T ss_dssp             TS
T ss_pred             hC
Confidence            53

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-38  Score=340.52  Aligned_cols=248  Identities=21%  Similarity=0.305  Sum_probs=196.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcC-CCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFE-STTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|.+.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|++++++++||||+++++++...+..+...
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3678999999999999999998865 789999999864332 33457889999999999999999999975433222223


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++++|.+++.            ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.+ .+||
T Consensus       159 ~~lv~E~~~g~~L~~~~~------------~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl  222 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG------------QKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKL  222 (681)
T ss_dssp             EEEEEECCCCEECC----------------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEE
T ss_pred             eEEEEEeCCCCcHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEE
Confidence            699999999999988763            15899999999999999999999   8999999999999999986 9999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+++.....      ....||+.|+|||++.+. ++.++|||||||++|||++|..||........          +
T Consensus       223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~  285 (681)
T 2pzi_A          223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------P  285 (681)
T ss_dssp             CCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------C
T ss_pred             EecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------c
Confidence            999999866432      345689999999988765 48899999999999999999988765321110          0


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-KINDVEPRLRLIKKK  497 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-t~~ev~~~L~~i~~~  497 (502)
                                  .. .........+.+++.+|++.||++|| +++++...|..+.++
T Consensus       286 ------------~~-~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          286 ------------ED-DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             ------------TT-CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             ------------cc-ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence                        00 01123446788999999999999999 577777777766544

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.4e-38  Score=303.14  Aligned_cols=234  Identities=12%  Similarity=0.064  Sum_probs=182.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc---hhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD---ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||+|.+..+++.||||+++.....   ..+.+.+|+.++.+++||||+++++++.     ..+.
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~~  105 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----TRAG  105 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----ECCc
Confidence            5788899999999999999999888999999999754322   2367899999999999999999999853     3457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++++|.+++..            .....+...++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus       106 ~~lv~e~~~g~~L~~~l~~------------~~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl  170 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADT------------SPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVL  170 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTT------------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEE
T ss_pred             EEEEEEecCCCCHHHHHhc------------CCChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEE
Confidence            8999999999999999842            1345578899999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +++|                      |++|       ++.++|||||||++|||+||+.||........ +.        
T Consensus       171 ~~~~----------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-~~--------  212 (286)
T 3uqc_A          171 AYPA----------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-LA--------  212 (286)
T ss_dssp             CSCC----------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-SE--------
T ss_pred             Eecc----------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-hH--------
Confidence            7443                      3333       68899999999999999999999986322110 00        


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      . ..................++..+.+++.+||+.||++| |+.|+++.|+++....
T Consensus       213 ~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          213 P-AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             E-CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             H-HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            0 00000000000001112345678899999999999999 9999999999886543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.1e-37  Score=301.85  Aligned_cols=235  Identities=19%  Similarity=0.296  Sum_probs=180.0

Q ss_pred             cCCCCC-CcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHH-hcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSE-NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVT-RNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|... +.||+|+||.||+|.+..+++.||+|+++.     ...+.+|++++ +..+||||+++++++... .......
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCceE
Confidence            456665 779999999999999989999999999863     35677888887 666999999999986431 1235578


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC---CCcE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD---EMTA  359 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~---~~~~  359 (502)
                      ++||||+++|+|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++.+
T Consensus        91 ~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~  159 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQD--------RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAIL  159 (299)
T ss_dssp             EEEECCCCSCBHHHHHHH--------CTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCE
T ss_pred             EEEEeecCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcE
Confidence            999999999999999853        33356899999999999999999999   899999999999999998   7899


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||++....                        +..++.++|||||||++|||+||+.||........         
T Consensus       160 kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---------  206 (299)
T 3m2w_A          160 KLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---------  206 (299)
T ss_dssp             EECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------------
T ss_pred             EEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh---------
Confidence            999999986432                        23567899999999999999999999975321110         


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .......+..............+...+.+++.+|++.||++|||++|+++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          207 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             -CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            00000000000001111111234567889999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1e-36  Score=300.18  Aligned_cols=248  Identities=16%  Similarity=0.152  Sum_probs=182.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--------chhHHHHHHHHHHhcCC---------CCccce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--------DASKSFAVECEVTRNIR---------HRNLVK  266 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~niv~  266 (502)
                      .++|...+.||+|+||+||+|++  +|+.||||+++....        ...+.+.+|+++++.++         |||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            35678889999999999999977  789999999975421        22377889999988886         555555


Q ss_pred             eeec-----------------cccc--------ccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHH
Q 046112          267 VFTA-----------------CSGV--------DFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN  321 (502)
Q Consensus       267 l~~~-----------------~~~~--------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~  321 (502)
                      +.+.                 +...        ++......++||||+++|++.+.+..           ..+++..+..
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----------~~~~~~~~~~  165 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----------KLSSLATAKS  165 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----------TCCCHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----------cCCCHHHHHH
Confidence            5543                 2210        01125689999999999987776631           4478999999


Q ss_pred             HHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC--------------------cEEEeeeccceecccccccceecc
Q 046112          322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM--------------------TAYVSDFGIARFLEAADEQTRSIG  381 (502)
Q Consensus       322 i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~  381 (502)
                      ++.|++.||+|||+  +.+|+||||||+|||++.++                    .+||+|||+|+.....       .
T Consensus       166 i~~qi~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~  236 (336)
T 2vuw_A          166 ILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------I  236 (336)
T ss_dssp             HHHHHHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------E
T ss_pred             HHHHHHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------c
Confidence            99999999999993  36899999999999999887                    9999999999866432       2


Q ss_pred             cccccccccCcccCCCccCccccchhHHHH-HHHHHhCCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhH
Q 046112          382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGIL-LLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIIL  460 (502)
Q Consensus       382 ~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  460 (502)
                      ..||+.|+|||.+.+.. +.++||||+|++ .+++++|..||...        .|..... +..................
T Consensus       237 ~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~-~~~~~~~~~~~~~~~~~~~  306 (336)
T 2vuw_A          237 VVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLT-DKMLKQMTFKTKCNTPAMK  306 (336)
T ss_dssp             EECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHH-HHHHHTCCCSSCCCSHHHH
T ss_pred             EEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHH-HhhhhhhccCcccchhhhh
Confidence            36899999999998766 899999998777 77889999998541        1111000 0000000001111222345


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 046112          461 ECLISICEIGVACSAEQPGERMKINDVE  488 (502)
Q Consensus       461 ~~~~~l~~l~~~c~~~dP~~RPt~~ev~  488 (502)
                      .....+.+++.+|++.|     |++|++
T Consensus       307 ~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          307 QIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hcCHHHHHHHHHHhccC-----CHHHHH
Confidence            67888999999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=1.6e-30  Score=271.96  Aligned_cols=185  Identities=14%  Similarity=0.009  Sum_probs=128.4

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEecccCc----------chhHHHHHHHHHHhcC-CCCccceeeecccccccCCCcc
Q 046112          213 IGAGNFGSVYKGILFESTTAVAVKVFNVLHH----------DASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       213 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .+.|++|.+..++....|+.++||++.....          ...++|.+|+++|+++ .|+||++++++     ++.+..
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed~~~  316 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-----GENAQS  316 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-----EECSSE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEECCE
Confidence            4566677666666666788899999864321          1235699999999999 69999999999     556678


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .||||||++||+|.+++..          .+.++..   +|+.||+.||+|+|   +.+|+||||||+|||++.++.+||
T Consensus       317 ~yLVMEyv~G~~L~d~i~~----------~~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL  380 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAA----------GEEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARL  380 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHT----------TCCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHHh----------CCCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEE
Confidence            9999999999999999953          2345543   58899999999999   999999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCC
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP  421 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p  421 (502)
                      +|||+|+.......  ......||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       381 ~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          381 IDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CCCTTEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             eecccCeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            99999986654322  2345679999999999876 467789999999998888766544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=2.2e-27  Score=246.95  Aligned_cols=186  Identities=17%  Similarity=0.180  Sum_probs=143.1

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--c------hhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          208 SSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--D------ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       208 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      ...++||+|+||.||+|..  .+..+++|+......  .      ..+.+.+|++++++++||||+++..++.     ..
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-----~~  411 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-----DL  411 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-----ET
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-----eC
Confidence            4467999999999999943  677889988643211  1      1245899999999999999996555543     23


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +..++||||+++|+|.+++..                  +..++.|++.||.|||   +.+|+||||||+|||++.  .+
T Consensus       412 ~~~~lVmE~~~ggsL~~~l~~------------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~  468 (540)
T 3en9_A          412 DNKRIMMSYINGKLAKDVIED------------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DL  468 (540)
T ss_dssp             TTTEEEEECCCSEEHHHHSTT------------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SE
T ss_pred             CccEEEEECCCCCCHHHHHHH------------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eE
Confidence            356999999999999999842                  4589999999999999   899999999999999999  99


Q ss_pred             EEeeeccceecccccccc-----eecccccccccccCcccCC--CccCccccchhHHHHHHHHHhCCCCCc
Q 046112          360 YVSDFGIARFLEAADEQT-----RSIGVEGTTGYIAPEYGMG--HEVSSYGDVYSFGILLLEMFTGLRPSD  423 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~sDvws~Gv~l~el~tg~~p~~  423 (502)
                      ||+|||+++.........     ......||+.|||||++..  ..|+..+|+|+..+-.++-+.++.+|.
T Consensus       469 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          469 YIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             EECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             EEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            999999999876543211     1235679999999999887  668888999999999999888877764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=5.9e-24  Score=202.97  Aligned_cols=149  Identities=18%  Similarity=0.112  Sum_probs=117.8

Q ss_pred             HhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc------------------chhHHHHHHHHHHhcCCCCc
Q 046112          202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH------------------DASKSFAVECEVTRNIRHRN  263 (502)
Q Consensus       202 ~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~n  263 (502)
                      .....|...+.||+|+||.||+|.+ .+|+.||||+++....                  .....+.+|++++++++  |
T Consensus        87 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~  163 (282)
T 1zar_A           87 RSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G  163 (282)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred             hCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence            3444566779999999999999988 8899999999864321                  12456889999999998  4


Q ss_pred             cceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 046112          264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAH  343 (502)
Q Consensus       264 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H  343 (502)
                       +++.+++.      .+..++||||+++|+|.+ +..                .....++.|++.||.|||   +.+|+|
T Consensus       164 -~~v~~~~~------~~~~~lvmE~~~g~~L~~-l~~----------------~~~~~i~~qi~~~l~~lH---~~giiH  216 (282)
T 1zar_A          164 -LAVPKVYA------WEGNAVLMELIDAKELYR-VRV----------------ENPDEVLDMILEEVAKFY---HRGIVH  216 (282)
T ss_dssp             -SSSCCEEE------EETTEEEEECCCCEEGGG-CCC----------------SCHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred             -CCcCeEEe------ccceEEEEEecCCCcHHH-cch----------------hhHHHHHHHHHHHHHHHH---HCCCEe
Confidence             56665431      135699999999999998 421                123469999999999999   899999


Q ss_pred             ecCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCC
Q 046112          344 CDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG  396 (502)
Q Consensus       344 ~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  396 (502)
                      |||||+|||++ ++.+||+|||+|+.               +..|+|||++..
T Consensus       217 rDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          217 GDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             SCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             CCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            99999999999 99999999999973               334788887643

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.81  E-value=3.4e-20  Score=201.92  Aligned_cols=138  Identities=32%  Similarity=0.541  Sum_probs=129.9

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +++.|.++|.+|..+.++++|+.|+|++|+|+|.+|..|++|++|+.|+|++|+|+|.+|..|+++++|+.|||++|+++
T Consensus       614 ~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~  693 (768)
T 3rgz_A          614 NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLD  693 (768)
T ss_dssp             CTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCE
T ss_pred             ccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCccc
Confidence            35678999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCccccCCCCCcCCcccccc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIPEFQLPTCVSK  142 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~g~~p~~~~~~~~~~  142 (502)
                      |.+|..+.+++.|+.|++++|+|+|.+|..+.+..+....+.||+.+||.+    ++.|...
T Consensus       694 g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~----l~~C~~~  751 (768)
T 3rgz_A          694 GRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP----LPRCDPS  751 (768)
T ss_dssp             ECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT----SCCCCSC
T ss_pred             CcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC----CcCCCCC
Confidence            999999999999999999999999999998889999999999999999963    3478644

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=1.6e-19  Score=170.16  Aligned_cols=139  Identities=22%  Similarity=0.234  Sum_probs=105.3

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeE--EEEEEecccCcc------------------------hhHHHHHHHHHHhcCC
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTA--VAVKVFNVLHHD------------------------ASKSFAVECEVTRNIR  260 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  260 (502)
                      |...+.||+|+||.||+|.+..+|+.  ||||+++.....                        ....+.+|+..+.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999987678888  999987542111                        0136788999999998


Q ss_pred             CCcc--ceeeecccccccCCCcceeEEeeeccC-C----ChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 046112          261 HRNL--VKVFTACSGVDFQGNDFKALVYEFMAN-G----SLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYL  333 (502)
Q Consensus       261 h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L  333 (502)
                      |+++  ..++++         ...++||||+.+ |    +|.++...             .++.....++.|++.||.||
T Consensus       129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~-------------~~~~~~~~i~~qi~~~l~~l  186 (258)
T 1zth_A          129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE-------------LKELDVEGIFNDVVENVKRL  186 (258)
T ss_dssp             HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG-------------GGGSCHHHHHHHHHHHHHHH
T ss_pred             hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc-------------cChHHHHHHHHHHHHHHHHH
Confidence            8764  233321         256899999942 4    56555321             12345678999999999999


Q ss_pred             HhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceecc
Q 046112          334 HLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE  371 (502)
Q Consensus       334 H~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~  371 (502)
                      |.  +.+|+||||||+|||++.  .++|+|||+|....
T Consensus       187 H~--~~givHrDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          187 YQ--EAELVHADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             HH--TSCEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             HH--HCCEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence            94  468999999999999998  99999999997543

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.76  E-value=2.9e-18  Score=157.49  Aligned_cols=129  Identities=19%  Similarity=0.194  Sum_probs=109.8

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +|++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|+.|+|++|+|+
T Consensus        38 ~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~  117 (220)
T 2v9t_B           38 RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN  117 (220)
T ss_dssp             ECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             ECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCC
Confidence            47888888666667888999999999999999888889999999999999999999866666888999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcc-hhhcccccceeecCCccccC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPI-EGIFKNASATSVFGNKKLCG  129 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~~l~g  129 (502)
                      +..|..|..+++|+.|+|++|+|+++++. ...+..+..+.+.+|+..|.
T Consensus       118 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  167 (220)
T 2v9t_B          118 CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD  167 (220)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             EeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence            87788899999999999999999988875 34567788888888877663

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.76  E-value=1.9e-20  Score=192.90  Aligned_cols=118  Identities=22%  Similarity=0.126  Sum_probs=68.5

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcC-CCCCCCEEEccCcccC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLS-SLRGLRVLDLSQNNLS   80 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~   80 (502)
                      |++|+|++..+.   .+++|+.|+|++|.|++..|..|+.+++|+.|+|++|+|++.+|..+. .+++|+.|+|++|.|+
T Consensus       106 L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~  182 (487)
T 3oja_A          106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY  182 (487)
T ss_dssp             CCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred             CcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence            455555533332   345566666666666666666666666666666666666665555554 5666666666666666


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGN  124 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n  124 (502)
                      +. |. +..+++|+.|+|++|+|+++++....++++..+.+++|
T Consensus       183 ~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N  224 (487)
T 3oja_A          183 DV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNN  224 (487)
T ss_dssp             EE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTS
T ss_pred             cc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCC
Confidence            33 22 23456666666666666666655555555666666555

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.74  E-value=4.8e-18  Score=156.02  Aligned_cols=129  Identities=18%  Similarity=0.232  Sum_probs=101.7

Q ss_pred             CCCCCcccccccc-ccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSP-QLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~-~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      +|++|+|++..|. .|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|
T Consensus        38 ~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  117 (220)
T 2v70_A           38 RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI  117 (220)
T ss_dssp             ECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCC
T ss_pred             EcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcC
Confidence            4678888855443 467888888888888888877777888888888888888888887777788888888888888888


Q ss_pred             CCCChhhhcCcCCCceeeCCCCccccCCcc-hhhcccccceeecCCccccC
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYNNFESMLPI-EGIFKNASATSVFGNKKLCG  129 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~~l~g  129 (502)
                      ++..|..|..+++|+.|+|++|+|++.+|. ...+.++..+.+.+|+.-|.
T Consensus       118 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  168 (220)
T 2v70_A          118 TCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN  168 (220)
T ss_dssp             CCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred             CeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence            877788888888888888888888888553 35567778888888866553

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.74  E-value=9.8e-18  Score=154.95  Aligned_cols=128  Identities=23%  Similarity=0.258  Sum_probs=99.9

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+
T Consensus        46 ~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~  125 (229)
T 3e6j_A           46 YLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT  125 (229)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             EcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc
Confidence            47788888777777888888888888888887665566788888888888888888766666788888888888888888


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCccccC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNKKLCG  129 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~l~g  129 (502)
                       .+|..+..+++|+.|+|++|+|+++++.. ..+..+..+.+.+|+..|.
T Consensus       126 -~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  174 (229)
T 3e6j_A          126 -ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE  174 (229)
T ss_dssp             -SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred             -ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence             67888888888888888888888877643 4566777788888865543

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.74  E-value=2e-18  Score=167.55  Aligned_cols=128  Identities=31%  Similarity=0.534  Sum_probs=104.1

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +|++|++++.+|..+..++ |+.|+|++|++++.+|..|..+++|+.|+|++|++++.+|. +..+++|+.|+|++|+|+
T Consensus       180 ~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~  257 (313)
T 1ogq_A          180 TISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIY  257 (313)
T ss_dssp             ECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCE
T ss_pred             ECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCccc
Confidence            3566666666666666665 77777777777777777788888888888888888875554 778889999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCccccCC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGG  130 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~g~  130 (502)
                      +.+|..+..+++|+.|+|++|+|+|.+|....++.+..+.+.+|+.+||.
T Consensus       258 ~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~  307 (313)
T 1ogq_A          258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             ECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred             CcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCC
Confidence            88999999999999999999999988887778888999999999999985

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.73  E-value=7.2e-18  Score=151.35  Aligned_cols=125  Identities=18%  Similarity=0.289  Sum_probs=90.1

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCc-cCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISN-NFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      |+++|+|+ .+|..+..  +|+.|+|++|+|++..+. .|+.+++|++|+|++|+|++..|..|..+++|+.|+|++|+|
T Consensus        14 ~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l   90 (192)
T 1w8a_A           14 DCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI   90 (192)
T ss_dssp             ECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCC
T ss_pred             EcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcC
Confidence            46777776 67765543  777788888877755554 377777888888888888777677777777888888888887


Q ss_pred             CCCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCcccc
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNKKLC  128 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~l~  128 (502)
                      ++..|..|.++++|+.|+|++|+|++.+|.. ..++++..+.+.+|+.-|
T Consensus        91 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  140 (192)
T 1w8a_A           91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             CccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence            7666666777777888888888877775543 456667777777776544

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.72  E-value=3.7e-17  Score=153.33  Aligned_cols=125  Identities=23%  Similarity=0.236  Sum_probs=109.1

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+
T Consensus        41 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  120 (251)
T 3m19_A           41 DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK  120 (251)
T ss_dssp             ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             EccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCC
Confidence            57899999777778999999999999999999888888999999999999999999877788899999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcc-hhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPI-EGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~  125 (502)
                      +..+..|..+++|+.|+|++|+|+++++. ...++++..+.+.+|.
T Consensus       121 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  166 (251)
T 3m19_A          121 SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQ  166 (251)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCc
Confidence            66666678899999999999999988874 4567888888888884

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.72  E-value=3.2e-17  Score=147.13  Aligned_cols=125  Identities=22%  Similarity=0.259  Sum_probs=113.0

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      |+++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+
T Consensus        16 ~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~   91 (193)
T 2wfh_A           16 RCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR   91 (193)
T ss_dssp             ECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             EcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccC
Confidence            47889999 8887664  68999999999999 88899999999999999999999988889999999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCccccC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNKKLCG  129 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~l~g  129 (502)
                      +..|..|..+++|+.|+|++|+|+++++.. ..+..+..+.+.+|+..|.
T Consensus        92 ~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           92 CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             BCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             EeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            877788999999999999999999988864 5678899999999987764

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.71  E-value=2.9e-17  Score=147.42  Aligned_cols=130  Identities=23%  Similarity=0.299  Sum_probs=109.9

Q ss_pred             CCCCCcccccccc-ccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSP-QLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~-~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      +|++|+|++..+. .+.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|
T Consensus        35 ~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  114 (192)
T 1w8a_A           35 LLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQI  114 (192)
T ss_dssp             ECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCC
T ss_pred             ECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcC
Confidence            5889999955554 388999999999999999999999999999999999999999998888899999999999999999


Q ss_pred             CCCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCccccCC
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGG  130 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~g~  130 (502)
                      ++..|..|..+++|+.|+|++|.+++..+..+....+....+.++...|+.
T Consensus       115 ~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~  165 (192)
T 1w8a_A          115 SCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA  165 (192)
T ss_dssp             CEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred             CeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCC
Confidence            998899999999999999999999987665433333333344455555554

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.71  E-value=6.8e-17  Score=146.94  Aligned_cols=128  Identities=23%  Similarity=0.240  Sum_probs=102.1

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..+..+.++++|+.|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+|+
T Consensus        34 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  113 (208)
T 2o6s_A           34 DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ  113 (208)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             EcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCc
Confidence            47888888555556778888888899888888766666888888888999888888866666888888888998888888


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCcccc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNKKLC  128 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~l~  128 (502)
                      +..+..|..+++|+.|++++|+|++.++.. ..+.++..+.+.+|+..|
T Consensus       114 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  162 (208)
T 2o6s_A          114 SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC  162 (208)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred             ccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence            665666788888888888888888877753 556778888888886543

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.70  E-value=7.1e-17  Score=154.69  Aligned_cols=121  Identities=23%  Similarity=0.198  Sum_probs=69.1

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      |++|+|+ .+|.. +.+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++
T Consensus        62 L~~n~l~-~~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~  138 (290)
T 1p9a_G           62 LDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT  138 (290)
T ss_dssp             CTTSCCC-EEECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred             CCCCccC-cccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc
Confidence            5566666 33322 55666666666666665 555556666666666666666665444556666666666666666664


Q ss_pred             CChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCc
Q 046112           82 EIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNK  125 (502)
Q Consensus        82 ~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~  125 (502)
                      ..+..|..+++|+.|+|++|+|+++++.. ..+.++..+.+.+|.
T Consensus       139 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~  183 (290)
T 1p9a_G          139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS  183 (290)
T ss_dssp             CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCc
Confidence            44444555666666666666666555543 234555555555553

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.70  E-value=7.8e-17  Score=151.13  Aligned_cols=121  Identities=17%  Similarity=0.174  Sum_probs=80.1

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      |++++.++ .+|..+.  ++|+.|+|++|++++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|+
T Consensus        20 ~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~   96 (251)
T 3m19_A           20 DCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA   96 (251)
T ss_dssp             ECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC
T ss_pred             ecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCccc
Confidence            35566666 5665554  46677777777777666666777777777777777777666666677777777777777776


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGN  124 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n  124 (502)
                      +..|..|..+++|+.|+|++|+|+++++.. ..+..+..+.+.+|
T Consensus        97 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  141 (251)
T 3m19_A           97 SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTN  141 (251)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCC
Confidence            555556666777777777777777666653 34566666666666

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.69  E-value=3.2e-17  Score=178.51  Aligned_cols=91  Identities=30%  Similarity=0.447  Sum_probs=61.5

Q ss_pred             CCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCceeeCCCCccccCCcch-hhccccccee
Q 046112           42 CTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATS  120 (502)
Q Consensus        42 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~  120 (502)
                      +++|+.|||++|+++|.+|..|+++++|+.|+|++|+|+|.+|..|+++++|+.|+|++|+++|.+|.. ..++.+..+.
T Consensus       631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~  710 (768)
T 3rgz_A          631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID  710 (768)
T ss_dssp             SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred             cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence            455666777777777777777777777777777777777777777777777777777777777666544 4455666666


Q ss_pred             ecCCccccCCCCC
Q 046112          121 VFGNKKLCGGIPE  133 (502)
Q Consensus       121 ~~~n~~l~g~~p~  133 (502)
                      +++| .+.|.+|+
T Consensus       711 ls~N-~l~g~iP~  722 (768)
T 3rgz_A          711 LSNN-NLSGPIPE  722 (768)
T ss_dssp             CCSS-EEEEECCS
T ss_pred             CcCC-cccccCCC
Confidence            6666 45565553

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.69  E-value=5.4e-17  Score=148.92  Aligned_cols=110  Identities=23%  Similarity=0.282  Sum_probs=102.6

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|+
T Consensus        63 ~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  142 (220)
T 2v70_A           63 NFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT  142 (220)
T ss_dssp             ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCC
T ss_pred             ECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCC
Confidence            58999999777778999999999999999999888888999999999999999999988999999999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE  110 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~  110 (502)
                      +..|..|..+++|+.|+|++|.+++..+..
T Consensus       143 ~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~  172 (220)
T 2v70_A          143 TVAPGAFDTLHSLSTLNLLANPFNCNCYLA  172 (220)
T ss_dssp             CBCTTTTTTCTTCCEEECCSCCEECSGGGH
T ss_pred             EECHHHhcCCCCCCEEEecCcCCcCCCchH
Confidence            877999999999999999999998766543

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.69  E-value=1.8e-16  Score=150.52  Aligned_cols=123  Identities=23%  Similarity=0.322  Sum_probs=83.5

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|++++ + +.+.++++|+.|+|++|.+++..+..|+.+++|++|+|++|++++..|..|..+++|+.|+|++|.|+
T Consensus        69 ~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  146 (272)
T 3rfs_A           69 ALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ  146 (272)
T ss_dssp             ECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             ECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccC
Confidence            466777763 3 35667777777777777777666666677777777777777777655566677777777777777777


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~  125 (502)
                      +..|..+..+++|+.|++++|+|++.++.. ..++++..+.+.+|.
T Consensus       147 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~  192 (272)
T 3rfs_A          147 SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ  192 (272)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence            555555667777777777777777666654 445666666666663

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.67  E-value=6.9e-17  Score=138.63  Aligned_cols=106  Identities=21%  Similarity=0.228  Sum_probs=69.1

Q ss_pred             CCCCCccc-cccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLS-GTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~-~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      +|++|+++ +.+|..+..+++|+.|+|++|.+++.  ..++.+++|++|+|++|++++.+|..+..+++|+.|+|++|.+
T Consensus        23 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i  100 (149)
T 2je0_A           23 VLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI  100 (149)
T ss_dssp             ECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCC
T ss_pred             EccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcC
Confidence            35666666 56666666666677777777766644  5566666777777777776665666666666677777777766


Q ss_pred             CCC-ChhhhcCcCCCceeeCCCCccccCCc
Q 046112           80 SDE-IPEFLAGFKFLQNLNLSYNNFESMLP  108 (502)
Q Consensus        80 ~~~-~p~~~~~~~~L~~l~l~~N~l~~~~~  108 (502)
                      ++. .|..+..+++|+.|++++|++++.++
T Consensus       101 ~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  130 (149)
T 2je0_A          101 KDLSTIEPLKKLENLKSLDLFNCEVTNLND  130 (149)
T ss_dssp             CSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred             CChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence            642 23566666667777777776666655

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.67  E-value=3.9e-16  Score=138.06  Aligned_cols=125  Identities=18%  Similarity=0.200  Sum_probs=108.1

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ++++|+++ .+|..+  .++|+.|+|++|++++..+..|+.+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+
T Consensus        13 ~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~   89 (177)
T 2o6r_A           13 RCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ   89 (177)
T ss_dssp             ECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             EecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCcc
Confidence            46788888 677654  379999999999999877778899999999999999999877777899999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCcccc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNKKLC  128 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~l~  128 (502)
                      +..+..+..+++|+.|++++|+|+++++.. ..++++..+.+.+|+..|
T Consensus        90 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  138 (177)
T 2o6r_A           90 SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  138 (177)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             ccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence            766677899999999999999999988865 457888999999996544

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.66  E-value=4.1e-17  Score=158.25  Aligned_cols=125  Identities=27%  Similarity=0.388  Sum_probs=112.1

Q ss_pred             CCCCCcccc--ccccccCCCCCCCEEeccC-CcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCc
Q 046112            1 DLSNNNLSG--TLSPQLVGLSSLSIFNVSG-NLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQN   77 (502)
Q Consensus         1 dl~~n~l~~--~~p~~~~~l~~L~~l~l~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N   77 (502)
                      ||++|+|+|  .+|+.+.++++|+.|+|++ |.+++.+|..|+++++|++|+|++|++++.+|..|..+++|+.|+|++|
T Consensus        56 ~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N  135 (313)
T 1ogq_A           56 DLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN  135 (313)
T ss_dssp             EEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSS
T ss_pred             ECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCC
Confidence            478899998  8999999999999999995 9999999999999999999999999999889999999999999999999


Q ss_pred             ccCCCChhhhcCcCCCceeeCCCCccccCCc-chhhcc-cccceeecCCc
Q 046112           78 NLSDEIPEFLAGFKFLQNLNLSYNNFESMLP-IEGIFK-NASATSVFGNK  125 (502)
Q Consensus        78 ~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~-~~~~~~-~~~~~~~~~n~  125 (502)
                      .|++.+|..+..+++|+.|++++|+|++..| ....+. .+..+.+.+|.
T Consensus       136 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~  185 (313)
T 1ogq_A          136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR  185 (313)
T ss_dssp             EEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSE
T ss_pred             ccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCe
Confidence            9999999999999999999999999996555 445555 77888888874

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.66  E-value=2e-16  Score=141.96  Aligned_cols=107  Identities=21%  Similarity=0.246  Sum_probs=98.6

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|.|+
T Consensus        37 ~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~  115 (193)
T 2wfh_A           37 YLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS  115 (193)
T ss_dssp             ECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             ECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCC
Confidence            58899999 88899999999999999999999888889999999999999999999988889999999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLP  108 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~  108 (502)
                      +..+..|..+++|+.|+|++|.+...-.
T Consensus       116 ~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A          116 VVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             BCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             eeChhhhhcCccccEEEeCCCCeecCCc
Confidence            6555678999999999999999976443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.66  E-value=9.4e-17  Score=140.76  Aligned_cols=122  Identities=20%  Similarity=0.252  Sum_probs=94.6

Q ss_pred             CCCCCccc-cccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLS-GTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~-~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      +|++|+++ +.+|..+..+++|+.|+|++|.|++.  ..|..+++|++|+|++|++++.+|..+..+++|+.|+|++|.|
T Consensus        30 ~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  107 (168)
T 2ell_A           30 VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL  107 (168)
T ss_dssp             ECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSC
T ss_pred             ECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCcc
Confidence            46788887 77777778888888888888888855  6788888888888888888877777777788888888888888


Q ss_pred             CCCCh--hhhcCcCCCceeeCCCCccccCCc----chhhcccccceeecCCc
Q 046112           80 SDEIP--EFLAGFKFLQNLNLSYNNFESMLP----IEGIFKNASATSVFGNK  125 (502)
Q Consensus        80 ~~~~p--~~~~~~~~L~~l~l~~N~l~~~~~----~~~~~~~~~~~~~~~n~  125 (502)
                      ++ +|  ..+..+++|+.|++++|++++.++    ....++++..+.+.+|.
T Consensus       108 ~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~  158 (168)
T 2ell_A          108 KD-ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRE  158 (168)
T ss_dssp             CS-SGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETT
T ss_pred             Cc-chhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCC
Confidence            74 43  677888888888888888888776    44556677777776664

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.66  E-value=5.7e-16  Score=143.03  Aligned_cols=122  Identities=17%  Similarity=0.196  Sum_probs=110.4

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      |.++++++ .+|..+.  ++|+.|+|++|+|++..|..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|+|+
T Consensus        25 ~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~  101 (229)
T 3e6j_A           25 DCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT  101 (229)
T ss_dssp             ECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             EccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCC
Confidence            46778888 8887664  89999999999999999999999999999999999999866677899999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      +..+..|..+++|+.|+|++|+|+.++.....+.++..+.+.+|.
T Consensus       102 ~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~  146 (229)
T 3e6j_A          102 VLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQ  146 (229)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSC
T ss_pred             ccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCc
Confidence            766677899999999999999999988888888999999999884

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.66  E-value=4.4e-16  Score=136.72  Aligned_cols=106  Identities=19%  Similarity=0.239  Sum_probs=96.3

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      |+++|+|+ .+|..+.  ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|+
T Consensus        15 ~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~   91 (170)
T 3g39_A           15 DCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLK   91 (170)
T ss_dssp             ECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             EeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccC
Confidence            57899999 7887764  89999999999999988999999999999999999999977778899999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPI  109 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~  109 (502)
                      +..|..|..+++|+.|+|++|.++...+.
T Consensus        92 ~~~~~~~~~l~~L~~L~L~~N~~~c~c~~  120 (170)
T 3g39_A           92 SIPRGAFDNLKSLTHIWLLNNPWDCACSD  120 (170)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred             EeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence            76666799999999999999999887653

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.66  E-value=6.6e-16  Score=146.41  Aligned_cols=125  Identities=19%  Similarity=0.180  Sum_probs=102.1

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +|++|+|+...+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|.|+
T Consensus        67 ~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  146 (270)
T 2o6q_A           67 YLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ  146 (270)
T ss_dssp             ECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             ECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC
Confidence            47888888444444678899999999999999777777888999999999999999877778888999999999999998


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~  125 (502)
                      +..+..|..+++|+.|+|++|+|+++++.. ..++.+..+.+.+|.
T Consensus       147 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  192 (270)
T 2o6q_A          147 SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ  192 (270)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCc
Confidence            655556888899999999999998887753 456778888888874

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.65  E-value=4.9e-17  Score=159.19  Aligned_cols=145  Identities=13%  Similarity=0.138  Sum_probs=97.2

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--------------chhHHHHHHHHHHhcCCCCccceeeeccc
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--------------DASKSFAVECEVTRNIRHRNLVKVFTACS  272 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~  272 (502)
                      |.+.+.||+|+||.||+|.. .+|+.||||+++....              ........+.++.+...|+|++++.....
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            77889999999999999965 6799999998753210              01112222222222223444444432211


Q ss_pred             cccc-CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCe
Q 046112          273 GVDF-QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNI  351 (502)
Q Consensus       273 ~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NI  351 (502)
                      .... -.....++||||+++++|..+...              +  ....++.|++.+|.|||   +.+||||||||.||
T Consensus       176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~--------------~--~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NI  236 (397)
T 4gyi_A          176 PVPEPIAQSRHTIVMSLVDALPMRQVSSV--------------P--DPASLYADLIALILRLA---KHGLIHGDFNEFNI  236 (397)
T ss_dssp             SCCCEEEEETTEEEEECCSCEEGGGCCCC--------------S--CHHHHHHHHHHHHHHHH---HTTEECSCCSTTSE
T ss_pred             CCCeeeeccCceEEEEecCCccHhhhccc--------------H--HHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHE
Confidence            1000 001134799999999888765421              1  23467899999999999   88999999999999


Q ss_pred             eeCCCC----------cEEEeeeccceecc
Q 046112          352 LLDDEM----------TAYVSDFGIARFLE  371 (502)
Q Consensus       352 ll~~~~----------~~kl~Dfg~a~~~~  371 (502)
                      |+++++          .+.|+||+.+....
T Consensus       237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          237 LIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             EEeCCCCcccccccccceEEEEeCCcccCC
Confidence            998776          38999999886544

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.65  E-value=4e-16  Score=137.48  Aligned_cols=107  Identities=18%  Similarity=0.190  Sum_probs=95.7

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      |+++|+|+ .+|..+.  ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|+
T Consensus        18 ~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~   94 (174)
T 2r9u_A           18 NCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLK   94 (174)
T ss_dssp             ECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             EeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccc
Confidence            57899998 8888775  89999999999999998999999999999999999999966667899999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE  110 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~  110 (502)
                      +..+..|..+++|+.|+|++|.|...++..
T Consensus        95 ~l~~~~~~~l~~L~~L~L~~N~~~c~~~~~  124 (174)
T 2r9u_A           95 SIPRGAFDNLKSLTHIYLYNNPWDCECRDI  124 (174)
T ss_dssp             CCCTTTTTTCTTCSEEECCSSCBCTTBGGG
T ss_pred             eeCHHHhccccCCCEEEeCCCCcccccccH
Confidence            655556999999999999999999877643

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.65  E-value=3e-16  Score=155.35  Aligned_cols=125  Identities=26%  Similarity=0.186  Sum_probs=102.4

Q ss_pred             CCCCCccccccccccC-CCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSPQLV-GLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~-~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      ||++|+|++..+..+. ++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|
T Consensus        45 ~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i  124 (361)
T 2xot_A           45 DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI  124 (361)
T ss_dssp             ECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             ECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcc
Confidence            5788888866666666 888899999999999877777888899999999999998887777788889999999999998


Q ss_pred             CCCChhhhcCcCCCceeeCCCCccccCCcch----hhcccccceeecCCc
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYNNFESMLPIE----GIFKNASATSVFGNK  125 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~----~~~~~~~~~~~~~n~  125 (502)
                      ++..|..|.++++|+.|+|++|+|+++++..    ..+..+..+.+++|.
T Consensus       125 ~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~  174 (361)
T 2xot_A          125 VVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNK  174 (361)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSC
T ss_pred             cEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCC
Confidence            8767788888889999999999998887765    346777778888774

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.65  E-value=3.8e-16  Score=149.27  Aligned_cols=125  Identities=22%  Similarity=0.221  Sum_probs=89.3

Q ss_pred             CCCCCc-cccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNN-LSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~-l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      ||++|+ ++...|..+..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..+..|+.+++|+.|+|++|+|
T Consensus        86 ~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  165 (285)
T 1ozn_A           86 DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI  165 (285)
T ss_dssp             ECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             eCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcc
Confidence            466776 6644466677777888888888887777677777778888888888877775556677777777888877777


Q ss_pred             CCCChhhhcCcCCCceeeCCCCccccCCcc-hhhcccccceeecCCc
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYNNFESMLPI-EGIFKNASATSVFGNK  125 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~  125 (502)
                      ++..+..|..+++|+.|++++|++++..+. ...++.+..+.+.+|.
T Consensus       166 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  212 (285)
T 1ozn_A          166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN  212 (285)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             cccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCc
Confidence            754445677777777777777777776443 3455667777777663

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.64  E-value=7.9e-16  Score=141.15  Aligned_cols=122  Identities=20%  Similarity=0.272  Sum_probs=108.6

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      |+++|+++ .+|..+.  ++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|.|+
T Consensus        17 ~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~   93 (220)
T 2v9t_B           17 DCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT   93 (220)
T ss_dssp             ECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC
T ss_pred             EcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC
Confidence            46788898 7887765  78999999999999888889999999999999999999988999999999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~  125 (502)
                      +..+..|..+++|+.|+|++|+|+++++.. ..+.++..+.+.+|.
T Consensus        94 ~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  139 (220)
T 2v9t_B           94 ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNK  139 (220)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCc
Confidence            655556789999999999999999997654 567788999998885

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.63  E-value=4.9e-16  Score=158.75  Aligned_cols=129  Identities=22%  Similarity=0.242  Sum_probs=117.7

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|++++.+|..+.++++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..|..+++|+.|+|++|+++
T Consensus       281 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  360 (455)
T 3v47_A          281 DLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR  360 (455)
T ss_dssp             ECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCC
T ss_pred             EecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCccc
Confidence            57889999888989999999999999999999888999999999999999999999988899999999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCccccC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNKKLCG  129 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~l~g  129 (502)
                      +..|..|..+++|+.|++++|+|++.++.. ..++.+..+.+.+|+.-|.
T Consensus       361 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  410 (455)
T 3v47_A          361 ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  410 (455)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             ccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccC
Confidence            888999999999999999999999988765 5678899999999976554

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.62  E-value=2.2e-15  Score=142.92  Aligned_cols=124  Identities=21%  Similarity=0.190  Sum_probs=58.5

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      |++|+|++..+..+.++++|+.|+|++|++++..+..|+.+++|++|+|++|++++..|..|+.+++|+.|+|++|+|++
T Consensus        92 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  171 (272)
T 3rfs_A           92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS  171 (272)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence            44445543333334445555555555555554444444455555555555555554434444445555555555555544


Q ss_pred             CChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCc
Q 046112           82 EIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNK  125 (502)
Q Consensus        82 ~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~  125 (502)
                      ..|..|..+++|+.|++++|+|++.++.. ..++++..+.+.+|+
T Consensus       172 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  216 (272)
T 3rfs_A          172 LPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP  216 (272)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCC
Confidence            33334444455555555555555444432 334444444444443

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.62  E-value=7.2e-16  Score=164.05  Aligned_cols=125  Identities=22%  Similarity=0.197  Sum_probs=108.5

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..|.+|.++++|+.|+|++|+|++..|+.|.+|++|++|+|++|+|++..|..|.+|++|+.|+|++|+|+
T Consensus        58 dLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~  137 (635)
T 4g8a_A           58 DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA  137 (635)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCC
T ss_pred             EeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCC
Confidence            68999999666678999999999999999999888888999999999999999999866778999999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCC--cchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESML--PIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~--~~~~~~~~~~~~~~~~n~  125 (502)
                      +..+..|+++++|+.|+|++|+|++..  .....+..+..+.+.+|.
T Consensus       138 ~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~  184 (635)
T 4g8a_A          138 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK  184 (635)
T ss_dssp             CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred             CCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcc
Confidence            765667999999999999999998753  334567788888888884

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.62  E-value=1.5e-15  Score=134.25  Aligned_cols=110  Identities=22%  Similarity=0.250  Sum_probs=97.8

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +|++|+|++..+..+.++++|+.|+|++|+|++..+..|+.+++|++|+|++|+|++..+..|..+++|+.|+|++|.|+
T Consensus        34 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  113 (177)
T 2o6r_A           34 ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLK  113 (177)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             EeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcce
Confidence            58899999666666899999999999999999777777999999999999999999977777899999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE  110 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~  110 (502)
                      +..+..+..+++|+.|++++|.+++..+..
T Consensus       114 ~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l  143 (177)
T 2o6r_A          114 SVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  143 (177)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCBCCCHHHH
T ss_pred             EeCHHHhcCCcccCEEEecCCCeeccCccH
Confidence            655556788999999999999999877643

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.62  E-value=3.3e-16  Score=152.83  Aligned_cols=122  Identities=23%  Similarity=0.299  Sum_probs=80.2

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|+ .+|+.++++++|+.|+|++|.++ .+|..|+.+++|++|+|++|+++ .+|..++.+++|+.|+|++|++.
T Consensus        87 ~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~  163 (328)
T 4fcg_A           87 ELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL  163 (328)
T ss_dssp             EEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTC
T ss_pred             EccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCc
Confidence            35666666 66666666777777777777776 66666677777777777777766 36666666677777777766666


Q ss_pred             CCChhhhcC---------cCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAG---------FKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~---------~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      +.+|..+..         +++|+.|++++|+|+.++.....++++..+.+.+|.
T Consensus       164 ~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~  217 (328)
T 4fcg_A          164 TELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSP  217 (328)
T ss_dssp             CCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSC
T ss_pred             cccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCC
Confidence            666665543         666666666666666555555555666666666653

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.62  E-value=2.7e-15  Score=142.18  Aligned_cols=123  Identities=23%  Similarity=0.267  Sum_probs=65.1

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      |++|+|++..+..|.++++|+.|+|++|+|+...+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+++
T Consensus        44 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  123 (270)
T 2o6q_A           44 LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS  123 (270)
T ss_dssp             CCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCC
T ss_pred             CcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCe
Confidence            45555553333345555555555555555554434444555555555555555555444445555555555555555554


Q ss_pred             CChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCC
Q 046112           82 EIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGN  124 (502)
Q Consensus        82 ~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n  124 (502)
                      ..|..|..+++|+.|+|++|+|++.++.. ..++++..+.+.+|
T Consensus       124 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  167 (270)
T 2o6q_A          124 LPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNN  167 (270)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             eCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCC
Confidence            44444555555555555555555555432 33445555555554

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.61  E-value=1.5e-15  Score=150.39  Aligned_cols=128  Identities=23%  Similarity=0.222  Sum_probs=109.5

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|+
T Consensus        70 ~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  149 (361)
T 2xot_A           70 LLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS  149 (361)
T ss_dssp             ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             ECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC
Confidence            58999999777778999999999999999999888888999999999999999999988999999999999999999999


Q ss_pred             CCChhh-h---cCcCCCceeeCCCCccccCCcch-hhccc--ccceeecCCccccC
Q 046112           81 DEIPEF-L---AGFKFLQNLNLSYNNFESMLPIE-GIFKN--ASATSVFGNKKLCG  129 (502)
Q Consensus        81 ~~~p~~-~---~~~~~L~~l~l~~N~l~~~~~~~-~~~~~--~~~~~~~~n~~l~g  129 (502)
                      + +|.. |   ..+++|+.|+|++|+|+++++.. ..+..  +..+.+.+|+..|.
T Consensus       150 ~-l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~  204 (361)
T 2xot_A          150 R-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECD  204 (361)
T ss_dssp             S-CCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred             e-eCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCC
Confidence            5 5554 4   57999999999999999988644 23333  36688889987664

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.61  E-value=3.2e-15  Score=142.85  Aligned_cols=125  Identities=23%  Similarity=0.268  Sum_probs=99.7

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCc-cCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNL-FAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      +|++|+|++..+..|.++++|+.|+|++|.+++..|..|.++++|++|+|++|. ++...|..|..+++|+.|+|++|.+
T Consensus        38 ~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l  117 (285)
T 1ozn_A           38 FLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL  117 (285)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred             EeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcC
Confidence            467888886556678888888888888888887778888888888888888886 7776677888888888888888888


Q ss_pred             CCCChhhhcCcCCCceeeCCCCccccCCcc-hhhcccccceeecCCc
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYNNFESMLPI-EGIFKNASATSVFGNK  125 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~  125 (502)
                      ++..|..+.++++|+.|++++|++++.++. ...++++..+.+.+|.
T Consensus       118 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  164 (285)
T 1ozn_A          118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR  164 (285)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCc
Confidence            876677788888888888888888887765 3456777778777774

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.60  E-value=2.6e-15  Score=142.73  Aligned_cols=124  Identities=22%  Similarity=0.193  Sum_probs=83.9

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..+..|.++++|+.|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|+.|++++|.++
T Consensus        34 ~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  113 (276)
T 2z62_A           34 DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA  113 (276)
T ss_dssp             ECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred             ECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCcc
Confidence            46677777555556777777777777777777666666777777777777777777666666777777777777777777


Q ss_pred             CCChhhhcCcCCCceeeCCCCcccc--CCcchhhcccccceeecCC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFES--MLPIEGIFKNASATSVFGN  124 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~--~~~~~~~~~~~~~~~~~~n  124 (502)
                      +..+..+..+++|+.|++++|++++  .+.....++++..+.+++|
T Consensus       114 ~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N  159 (276)
T 2z62_A          114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN  159 (276)
T ss_dssp             CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred             ccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCC
Confidence            5444466777777777777777766  2344455566666666666

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.60  E-value=4.1e-15  Score=142.37  Aligned_cols=122  Identities=25%  Similarity=0.229  Sum_probs=94.8

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..|..|.++++|+.|+|++|.|++. +.. +.+++|++|+|++|+|+. +|..+..+++|+.|+|++|+|+
T Consensus        37 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~l~~N~l~  113 (290)
T 1p9a_G           37 HLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT  113 (290)
T ss_dssp             ECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCC
T ss_pred             EcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCCEEECCCCcCCc-CchhhccCCCCCEEECCCCcCc
Confidence            4778888877777788888888888888888844 332 778888888888888875 7777888888888888888888


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~  125 (502)
                      +..|..|.++++|+.|+|++|+|++.++.. ..+.++..+.+.+|.
T Consensus       114 ~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G          114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             ccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            655677888888888888888888877654 356677777777774

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.60  E-value=2.4e-15  Score=145.22  Aligned_cols=125  Identities=29%  Similarity=0.334  Sum_probs=104.6

Q ss_pred             CCCCCccccccc-cccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCC-CCCCCcCCCCCCCEEEccCcc
Q 046112            1 DLSNNNLSGTLS-PQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG-PIGSSLSSLRGLRVLDLSQNN   78 (502)
Q Consensus         1 dl~~n~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~ls~N~   78 (502)
                      ||++|++++..+ ..+.++++|+.|+|++|.+++..|..|..+++|++|+|++|++++ .+|..+..+++|+.|+|++|.
T Consensus       107 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~  186 (306)
T 2z66_A          107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ  186 (306)
T ss_dssp             ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred             ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCC
Confidence            478888884443 468888999999999999998888888999999999999999887 578889999999999999999


Q ss_pred             cCCCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCc
Q 046112           79 LSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNK  125 (502)
Q Consensus        79 l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~  125 (502)
                      +++..|..+..+++|+.|++++|++++.++.. ..++++..+.+.+|.
T Consensus       187 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  234 (306)
T 2z66_A          187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH  234 (306)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSC
T ss_pred             cCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCC
Confidence            98777888888999999999999998877643 456778888888884

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.60  E-value=1.5e-15  Score=160.90  Aligned_cols=128  Identities=24%  Similarity=0.292  Sum_probs=72.2

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCC-cCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSG-AISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      |++|++++..|..+.++++|+.|+|++|++++ .+|..|+.+++|++|+|++|++++..|..|..+++|+.|+|++|+++
T Consensus       431 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  510 (606)
T 3vq2_A          431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL  510 (606)
T ss_dssp             CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             CcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCC
Confidence            45555555555555555555555555555554 24555555666666666666665555555555666666666666665


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcc-cccceeecCCccccC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFK-NASATSVFGNKKLCG  129 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~-~~~~~~~~~n~~l~g  129 (502)
                      +..|..|.++++|+.|++++|+|+.+++....+. .+..+.+.+|+..|.
T Consensus       511 ~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~  560 (606)
T 3vq2_A          511 FLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACI  560 (606)
T ss_dssp             CEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCS
T ss_pred             CcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccC
Confidence            5555555556666666666666655554443443 355555556555443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.59  E-value=2.3e-15  Score=135.54  Aligned_cols=120  Identities=18%  Similarity=0.250  Sum_probs=101.7

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +|++|+|+ .+| .+..+++|+.|+|++|.++ . +..+..+++|++|++++|++++..|..|+.+++|+.|+|++|.++
T Consensus        50 ~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~  125 (197)
T 4ezg_A           50 TLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD  125 (197)
T ss_dssp             EEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCB
T ss_pred             eccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccC
Confidence            46788888 677 6888999999999999776 3 347888999999999999999878888999999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCc-cccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNN-FESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~-l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      +..|..+..+++|+.|++++|+ ++..+ ....++++..+.+.+|.
T Consensus       126 ~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~  170 (197)
T 4ezg_A          126 DSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDG  170 (197)
T ss_dssp             GGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBC
T ss_pred             cHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCC
Confidence            8788899999999999999998 66654 56677888888888874

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.58  E-value=3.3e-15  Score=156.08  Aligned_cols=105  Identities=25%  Similarity=0.276  Sum_probs=80.2

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|+ .+|. ++++++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .|+.+++|+.|+|++|+|+
T Consensus       447 ~Ls~n~l~-~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~  521 (567)
T 1dce_A          447 HLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQ  521 (567)
T ss_dssp             ECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCC
T ss_pred             EecCCCCC-CCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCC
Confidence            46777777 3665 777788888888888887 777778888888888888888877 56 6777888888888888887


Q ss_pred             CCC-hhhhcCcCCCceeeCCCCccccCCcch
Q 046112           81 DEI-PEFLAGFKFLQNLNLSYNNFESMLPIE  110 (502)
Q Consensus        81 ~~~-p~~~~~~~~L~~l~l~~N~l~~~~~~~  110 (502)
                      +.. |..|..+++|+.|+|++|+|++.++..
T Consensus       522 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  552 (567)
T 1dce_A          522 QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ  552 (567)
T ss_dssp             SSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred             CCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence            655 777777888888888888887777644

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.58  E-value=2.4e-15  Score=146.76  Aligned_cols=124  Identities=16%  Similarity=0.201  Sum_probs=106.4

Q ss_pred             CCCCCccccccccccCC---------CCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCE
Q 046112            1 DLSNNNLSGTLSPQLVG---------LSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRV   71 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~---------l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   71 (502)
                      ||++|++.+.+|..+..         +++|+.|+|++|+|+ .+|..|+.+++|++|+|++|++++ +|..+..+++|+.
T Consensus       156 ~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~  233 (328)
T 4fcg_A          156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEE  233 (328)
T ss_dssp             EEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCE
T ss_pred             ECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCE
Confidence            46777788888887764         899999999999999 888889999999999999999997 7778999999999


Q ss_pred             EEccCcccCCCChhhhcCcCCCceeeCCCCccccCCcc-hhhcccccceeecCCcc
Q 046112           72 LDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPI-EGIFKNASATSVFGNKK  126 (502)
Q Consensus        72 L~ls~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~~  126 (502)
                      |+|++|.+.+.+|..+..+++|+.|+|++|++.+..|. ...++++..+.+.+|+.
T Consensus       234 L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~  289 (328)
T 4fcg_A          234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN  289 (328)
T ss_dssp             EECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTT
T ss_pred             EECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCc
Confidence            99999999989999999999999999999888776664 46678888888888864

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.58  E-value=7.7e-16  Score=163.89  Aligned_cols=120  Identities=14%  Similarity=0.232  Sum_probs=74.2

Q ss_pred             CCccccccccccCCCCCCCEEeccCCcCCCc-----------------CCccCC--CCCCCCEEECcCCccCCCCCCCcC
Q 046112            4 NNNLSGTLSPQLVGLSSLSIFNVSGNLLSGA-----------------ISNNFG--SCTSLEQLDMHGNLFAGPIGSSLS   64 (502)
Q Consensus         4 ~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~-----------------~~~~~~--~l~~L~~L~l~~N~l~~~~p~~~~   64 (502)
                      +|+|+| +|+.++++++|+.|+|++|+|+|.                 +|..++  ++++|++|+|++|++.+.+|..|+
T Consensus       192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~  270 (636)
T 4eco_A          192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK  270 (636)
T ss_dssp             SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred             cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence            455555 666666666666666666666654                 666666  666666666666666666666666


Q ss_pred             CCCCCCEEEccCcc-cCC-CChhhhcCc------CCCceeeCCCCccccCCc--chhhcccccceeecCC
Q 046112           65 SLRGLRVLDLSQNN-LSD-EIPEFLAGF------KFLQNLNLSYNNFESMLP--IEGIFKNASATSVFGN  124 (502)
Q Consensus        65 ~l~~L~~L~ls~N~-l~~-~~p~~~~~~------~~L~~l~l~~N~l~~~~~--~~~~~~~~~~~~~~~n  124 (502)
                      ++++|+.|+|++|+ ++| .+|..+.++      ++|+.|++++|+++.+|.  ....++++..+.+.+|
T Consensus       271 ~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~~N  340 (636)
T 4eco_A          271 ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYN  340 (636)
T ss_dssp             TCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECCSC
T ss_pred             cCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCcCC
Confidence            66666666666665 665 566666554      666666666666665444  4455556666666555

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.58  E-value=9.4e-15  Score=132.69  Aligned_cols=125  Identities=25%  Similarity=0.256  Sum_probs=104.6

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.|+
T Consensus        58 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  137 (208)
T 2o6s_A           58 YLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK  137 (208)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             ECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc
Confidence            58899999555556789999999999999999777777999999999999999999977777999999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCccccCCCC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIP  132 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~g~~p  132 (502)
                      +..+..+..+++|+.|++++|.+.+..+      .+..+....| .+.|..|
T Consensus       138 ~~~~~~~~~l~~L~~L~l~~N~~~~~~~------~l~~L~~~~n-~~~g~ip  182 (208)
T 2o6s_A          138 SVPDGVFDRLTSLQYIWLHDNPWDCTCP------GIRYLSEWIN-KHSGVVR  182 (208)
T ss_dssp             CCCTTTTTTCTTCCEEECCSCCBCCCTT------TTHHHHHHHH-HCTTTBB
T ss_pred             eeCHHHhccCCCccEEEecCCCeecCCC------CHHHHHHHHH-hCCceee
Confidence            7666678999999999999999987655      3344444444 4556554

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.57  E-value=8e-15  Score=139.36  Aligned_cols=125  Identities=22%  Similarity=0.323  Sum_probs=108.1

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..+..+.++++|+.|+|++|++++..+..|.++++|++|++++|++++..+..++.+++|+.|+|++|.++
T Consensus        58 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  137 (276)
T 2z62_A           58 DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ  137 (276)
T ss_dssp             ECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCC
T ss_pred             ECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccc
Confidence            58899999767778999999999999999999888889999999999999999999977778999999999999999998


Q ss_pred             C-CChhhhcCcCCCceeeCCCCccccCCcch-hhccccc----ceeecCCc
Q 046112           81 D-EIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNAS----ATSVFGNK  125 (502)
Q Consensus        81 ~-~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~----~~~~~~n~  125 (502)
                      + .+|..+.++++|+.|++++|++++.++.. ..+..+.    .+.+++|.
T Consensus       138 ~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             CCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             eecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            6 36999999999999999999999987643 3344444    45566663

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.57  E-value=3.3e-15  Score=131.91  Aligned_cols=119  Identities=18%  Similarity=0.118  Sum_probs=70.4

Q ss_pred             CCCCCccccccccccCCCC-CCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSPQLVGLS-SLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~-~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      +|++|+|+ .+|. +..+. +|+.|+|++|.|++.  ..|+.+++|++|+|++|+|++..|..+..+++|+.|+|++|.|
T Consensus        25 ~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i  100 (176)
T 1a9n_A           25 DLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL  100 (176)
T ss_dssp             ECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCC
T ss_pred             EeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcC
Confidence            35666666 4433 44433 666666666666643  4566666666666666666653333336666666666666666


Q ss_pred             CCCChh--hhcCcCCCceeeCCCCccccCCcc----hhhcccccceeecCC
Q 046112           80 SDEIPE--FLAGFKFLQNLNLSYNNFESMLPI----EGIFKNASATSVFGN  124 (502)
Q Consensus        80 ~~~~p~--~~~~~~~L~~l~l~~N~l~~~~~~----~~~~~~~~~~~~~~n  124 (502)
                      + .+|.  .+..+++|+.|++++|+++..++.    ...++.+..+.+.+|
T Consensus       101 ~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n  150 (176)
T 1a9n_A          101 V-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKV  150 (176)
T ss_dssp             C-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEEC
T ss_pred             C-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcC
Confidence            5 4554  566666666666666666665543    344555555555544

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.57  E-value=5.6e-15  Score=150.90  Aligned_cols=125  Identities=25%  Similarity=0.237  Sum_probs=112.3

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcC-CccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAI-SNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      ||++|+|++..|..|+++++|+.|+|++|.+.+.+ |..|.++++|++|+|++|++++..|..|+++++|+.|+|++|.+
T Consensus        36 ~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l  115 (455)
T 3v47_A           36 DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNL  115 (455)
T ss_dssp             ECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             EecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCC
Confidence            68999999888889999999999999999998666 56799999999999999999998899999999999999999999


Q ss_pred             CCCChhh--hcCcCCCceeeCCCCccccCCcc--hhhcccccceeecCCc
Q 046112           80 SDEIPEF--LAGFKFLQNLNLSYNNFESMLPI--EGIFKNASATSVFGNK  125 (502)
Q Consensus        80 ~~~~p~~--~~~~~~L~~l~l~~N~l~~~~~~--~~~~~~~~~~~~~~n~  125 (502)
                      ++.+|..  |..+++|+.|+|++|++++..|.  ...++++..+.+.+|.
T Consensus       116 ~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~  165 (455)
T 3v47_A          116 DGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK  165 (455)
T ss_dssp             BTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred             CccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence            9866665  89999999999999999998765  4577889999998885

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.57  E-value=7.9e-15  Score=155.44  Aligned_cols=125  Identities=21%  Similarity=0.130  Sum_probs=101.3

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|++++..|..|.++++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|.++
T Consensus        38 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~  117 (606)
T 3vq2_A           38 DLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA  117 (606)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCC
T ss_pred             ECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccc
Confidence            57888888766668888888888888888888777888888888888888888888877888888888888888888888


Q ss_pred             CCChhhhcCcCCCceeeCCCCcccc--CCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFES--MLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~--~~~~~~~~~~~~~~~~~~n~  125 (502)
                      +..|..+.++++|+.|++++|++++  +|.....++++..+.+.+|.
T Consensus       118 ~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~  164 (606)
T 3vq2_A          118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY  164 (606)
T ss_dssp             CSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC
T ss_pred             cccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc
Confidence            6666778888888888888888875  35556667788888887774

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.56  E-value=1e-15  Score=166.49  Aligned_cols=71  Identities=25%  Similarity=0.336  Sum_probs=35.3

Q ss_pred             CCccCCCCCCCCEEECcCCccCC-----------------CCCCCcC--CCCCCCEEEccCcccCCCChhhhcCcCCCce
Q 046112           35 ISNNFGSCTSLEQLDMHGNLFAG-----------------PIGSSLS--SLRGLRVLDLSQNNLSDEIPEFLAGFKFLQN   95 (502)
Q Consensus        35 ~~~~~~~l~~L~~L~l~~N~l~~-----------------~~p~~~~--~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~   95 (502)
                      +|..|++|++|++|+|++|+|++                 .+|..++  ++++|+.|+|++|.+.+.+|..|.++++|+.
T Consensus       440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~  519 (876)
T 4ecn_A          440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS  519 (876)
T ss_dssp             ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred             hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence            44444555555555555555554                 2444444  4555555555555554455555555555555


Q ss_pred             eeCCCCc-ccc
Q 046112           96 LNLSYNN-FES  105 (502)
Q Consensus        96 l~l~~N~-l~~  105 (502)
                      |+|++|+ |+|
T Consensus       520 L~Ls~N~~lsg  530 (876)
T 4ecn_A          520 LNIACNRGISA  530 (876)
T ss_dssp             EECTTCTTSCH
T ss_pred             EECcCCCCccc
Confidence            5555554 444

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.56  E-value=6.6e-15  Score=156.63  Aligned_cols=129  Identities=23%  Similarity=0.267  Sum_probs=115.6

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCC-CcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLS-GAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      |+++|++++..|..+..+++|+.|+|++|++. +.+|..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|
T Consensus       451 ~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l  530 (635)
T 4g8a_A          451 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF  530 (635)
T ss_dssp             ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             cccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcC
Confidence            47889999888888899999999999999854 56888999999999999999999998899999999999999999999


Q ss_pred             CCCChhhhcCcCCCceeeCCCCccccCCcchh-hc-ccccceeecCCccccC
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG-IF-KNASATSVFGNKKLCG  129 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~-~~-~~~~~~~~~~n~~l~g  129 (502)
                      ++..|..|..+++|+.|+|++|+|++.+|... .+ ..+..+.+.+|+..|.
T Consensus       531 ~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          531 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  582 (635)
T ss_dssp             CBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred             CCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence            98888899999999999999999999988653 33 5788999999998875

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.56  E-value=2.7e-15  Score=159.72  Aligned_cols=125  Identities=18%  Similarity=0.228  Sum_probs=115.5

Q ss_pred             CCCCCccccc-----------------cccccC--CCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCc-cCC-CC
Q 046112            1 DLSNNNLSGT-----------------LSPQLV--GLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNL-FAG-PI   59 (502)
Q Consensus         1 dl~~n~l~~~-----------------~p~~~~--~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~-~~   59 (502)
                      ||++|+|+|.                 +|+.++  ++++|+.|+|++|++.|.+|..|+++++|++|+|++|+ ++| .+
T Consensus       212 ~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~l  291 (636)
T 4eco_A          212 YMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL  291 (636)
T ss_dssp             EEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHH
T ss_pred             ECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccc
Confidence            5789999985                 999999  99999999999999999999999999999999999998 998 89


Q ss_pred             CCCcCCC------CCCCEEEccCcccCCCChh--hhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCcc
Q 046112           60 GSSLSSL------RGLRVLDLSQNNLSDEIPE--FLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKK  126 (502)
Q Consensus        60 p~~~~~l------~~L~~L~ls~N~l~~~~p~--~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~  126 (502)
                      |..++.+      ++|+.|+|++|+++ .+|.  .+.++++|+.|++++|+++|.+|....++++..+.+.+|..
T Consensus       292 p~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N~l  365 (636)
T 4eco_A          292 KDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQI  365 (636)
T ss_dssp             HHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSSEE
T ss_pred             hHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCCcc
Confidence            9998887      99999999999999 8998  99999999999999999997666667778899999998853

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.56  E-value=7.7e-15  Score=141.69  Aligned_cols=124  Identities=23%  Similarity=0.303  Sum_probs=108.4

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCC-ccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAIS-NNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      ||++|+++ .+|..+..+++|+.|+|++|++++..+ ..+..+++|++|++++|++++..|..+..+++|+.|+|++|.+
T Consensus        84 ~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  162 (306)
T 2z66_A           84 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF  162 (306)
T ss_dssp             ECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEE
T ss_pred             ECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcc
Confidence            57899998 678889999999999999999996655 5799999999999999999998888899999999999999999


Q ss_pred             CC-CChhhhcCcCCCceeeCCCCccccCCcc-hhhcccccceeecCCc
Q 046112           80 SD-EIPEFLAGFKFLQNLNLSYNNFESMLPI-EGIFKNASATSVFGNK  125 (502)
Q Consensus        80 ~~-~~p~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~  125 (502)
                      ++ .+|..+..+++|+.|++++|++++.++. ...++++..+.+.+|.
T Consensus       163 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~  210 (306)
T 2z66_A          163 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN  210 (306)
T ss_dssp             GGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             ccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCc
Confidence            86 5788899999999999999999988654 4567788888888885

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.55  E-value=7.8e-15  Score=132.06  Aligned_cols=120  Identities=21%  Similarity=0.286  Sum_probs=94.6

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcc-c
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNN-L   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~-l   79 (502)
                      +|++|.++ . ++.+..+++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..++.+++|+.|+|++|. +
T Consensus        72 ~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i  149 (197)
T 4ezg_A           72 TINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI  149 (197)
T ss_dssp             EEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBC
T ss_pred             EccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCc
Confidence            35667665 3 3468888888888888888887778888888888888888888888777888888888888888887 5


Q ss_pred             CCCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      + .+| .+..+++|+.|++++|++++.+ ....++++..+.+.+|+
T Consensus       150 ~-~~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          150 T-DIM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             C-CCG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC-
T ss_pred             c-ccH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCcc
Confidence            5 566 6888888888888888888865 45567778888888775

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.55  E-value=8.9e-15  Score=150.38  Aligned_cols=125  Identities=15%  Similarity=0.179  Sum_probs=103.9

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..|..|.++++|+.|+|++|.+++..|..|+++++|++|+|++|++++..+..|.++++|+.|+|++|+++
T Consensus        38 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~  117 (477)
T 2id5_A           38 DLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV  117 (477)
T ss_dssp             ECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCC
T ss_pred             ECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccc
Confidence            57888888777778888999999999999998888888999999999999999988866667888889999999999988


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcc-hhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPI-EGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~  125 (502)
                      +..|..|.++++|+.|++++|++++..+. ...+.++..+.+.+|.
T Consensus       118 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  163 (477)
T 2id5_A          118 ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCN  163 (477)
T ss_dssp             EECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCC
T ss_pred             cCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCc
Confidence            77788888888888888888888877653 3456677778777774

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.55  E-value=9.3e-15  Score=154.88  Aligned_cols=125  Identities=20%  Similarity=0.141  Sum_probs=111.0

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+.+++|+.|+|++|.++
T Consensus        39 ~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~  118 (606)
T 3t6q_A           39 EFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS  118 (606)
T ss_dssp             ECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCS
T ss_pred             EccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcc
Confidence            68999999777889999999999999999999888999999999999999999999988999999999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCC-cchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESML-PIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~-~~~~~~~~~~~~~~~~n~  125 (502)
                      +..|..+.++++|++|++++|++++.. +....++++..+.+.+|.
T Consensus       119 ~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  164 (606)
T 3t6q_A          119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA  164 (606)
T ss_dssp             CGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSC
T ss_pred             cCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCc
Confidence            766788999999999999999999853 444457788888888874

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.55  E-value=1.4e-15  Score=163.70  Aligned_cols=106  Identities=22%  Similarity=0.267  Sum_probs=65.3

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|. .+|..++++++|+.|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+|..|+.|++|+.|+|++|.|+
T Consensus       230 ~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~  306 (727)
T 4b8c_D          230 DLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT  306 (727)
T ss_dssp             ECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC
T ss_pred             ECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC
Confidence            35566665 55555556666666666666666 56666666666666666666666 35666666666666666666665


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE  110 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~  110 (502)
                       .+|..|.++++|+.|+|++|+|++.+|..
T Consensus       307 -~lp~~~~~l~~L~~L~L~~N~l~~~~p~~  335 (727)
T 4b8c_D          307 -TLPWEFGNLCNLQFLGVEGNPLEKQFLKI  335 (727)
T ss_dssp             -CCCSSTTSCTTCCCEECTTSCCCSHHHHH
T ss_pred             -ccChhhhcCCCccEEeCCCCccCCCChHH
Confidence             55655666666666666666666655544

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.53  E-value=3.1e-14  Score=150.44  Aligned_cols=110  Identities=18%  Similarity=0.135  Sum_probs=55.0

Q ss_pred             cCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCc
Q 046112           15 LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQ   94 (502)
Q Consensus        15 ~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~   94 (502)
                      +.++++|+.|+|++|.|++..|..|+.+++|++|+|++|.|++..|..|+.+++|+.|+|++|.|++..+..|.++++|+
T Consensus        71 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~  150 (597)
T 3oja_B           71 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT  150 (597)
T ss_dssp             HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             HccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCC
Confidence            34455555555555555544444555555555555555555554444455555555555555555532223344555555


Q ss_pred             eeeCCCCccccCCcc-hhhcccccceeecCC
Q 046112           95 NLNLSYNNFESMLPI-EGIFKNASATSVFGN  124 (502)
Q Consensus        95 ~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n  124 (502)
                      .|+|++|+|++.++. ...++++..+.+.+|
T Consensus       151 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  181 (597)
T 3oja_B          151 TLSMSNNNLERIEDDTFQATTSLQNLQLSSN  181 (597)
T ss_dssp             EEECCSSCCCBCCTTTTTTCTTCCEEECTTS
T ss_pred             EEEeeCCcCCCCChhhhhcCCcCcEEECcCC
Confidence            555555555554443 233444444554444

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.53  E-value=4.7e-15  Score=161.35  Aligned_cols=121  Identities=16%  Similarity=0.187  Sum_probs=110.5

Q ss_pred             CCccccccccccCCCCCCCEEeccCCcCCC-----------------cCCccCC--CCCCCCEEECcCCccCCCCCCCcC
Q 046112            4 NNNLSGTLSPQLVGLSSLSIFNVSGNLLSG-----------------AISNNFG--SCTSLEQLDMHGNLFAGPIGSSLS   64 (502)
Q Consensus         4 ~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~-----------------~~~~~~~--~l~~L~~L~l~~N~l~~~~p~~~~   64 (502)
                      +|+|+| +|+.|+++++|+.|+|++|+|+|                 .+|..++  +|++|++|+|++|++.+.+|..|+
T Consensus       434 ~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~  512 (876)
T 4ecn_A          434 TNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY  512 (876)
T ss_dssp             SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGG
T ss_pred             cCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHh
Confidence            588997 99999999999999999999998                 3999988  999999999999999999999999


Q ss_pred             CCCCCCEEEccCcc-cCC-CChhhhcCcC-------CCceeeCCCCccccCCc--chhhcccccceeecCCc
Q 046112           65 SLRGLRVLDLSQNN-LSD-EIPEFLAGFK-------FLQNLNLSYNNFESMLP--IEGIFKNASATSVFGNK  125 (502)
Q Consensus        65 ~l~~L~~L~ls~N~-l~~-~~p~~~~~~~-------~L~~l~l~~N~l~~~~~--~~~~~~~~~~~~~~~n~  125 (502)
                      ++++|+.|+|++|+ |+| .+|..+.+++       +|+.|+|++|+|+.+|+  ....++++..+.+.+|.
T Consensus       513 ~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L~Ls~N~  584 (876)
T 4ecn_A          513 DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNK  584 (876)
T ss_dssp             GCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEEECTTSC
T ss_pred             CCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEEECCCCC
Confidence            99999999999998 998 8998888776       99999999999997776  67788889999998885

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.53  E-value=2.7e-15  Score=145.32  Aligned_cols=102  Identities=25%  Similarity=0.241  Sum_probs=51.9

Q ss_pred             CCCCcccccccccc--CCCCCCCEEeccCCcCCCcCCccCCCC-----CCCCEEECcCCccCCCCCCCcCCCCCCCEEEc
Q 046112            2 LSNNNLSGTLSPQL--VGLSSLSIFNVSGNLLSGAISNNFGSC-----TSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDL   74 (502)
Q Consensus         2 l~~n~l~~~~p~~~--~~l~~L~~l~l~~N~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   74 (502)
                      |++|+|++.+|..+  ..+++|+.|+|++|++++. |..++.+     ++|++|+|++|++++..|..|+.+++|+.|+|
T Consensus       102 L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  180 (312)
T 1wwl_A          102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL  180 (312)
T ss_dssp             EEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEEC
T ss_pred             ccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEEC
Confidence            44455555555543  4555555555555555544 4444444     55555555555555544455555555555555


Q ss_pred             cCcccCCC--Chhhh--cCcCCCceeeCCCCccc
Q 046112           75 SQNNLSDE--IPEFL--AGFKFLQNLNLSYNNFE  104 (502)
Q Consensus        75 s~N~l~~~--~p~~~--~~~~~L~~l~l~~N~l~  104 (502)
                      ++|++.+.  +|..+  ..+++|+.|++++|+|+
T Consensus       181 s~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  214 (312)
T 1wwl_A          181 SDNPELGERGLISALCPLKFPTLQVLALRNAGME  214 (312)
T ss_dssp             CSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred             CCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence            55555433  22233  45555555555555555

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.53  E-value=1.6e-14  Score=142.15  Aligned_cols=105  Identities=20%  Similarity=0.166  Sum_probs=90.8

Q ss_pred             CCCCC-ccccccccccCCCCCCCEEeccC-CcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcc
Q 046112            1 DLSNN-NLSGTLSPQLVGLSSLSIFNVSG-NLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNN   78 (502)
Q Consensus         1 dl~~n-~l~~~~p~~~~~l~~L~~l~l~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~   78 (502)
                      |++++ +|+ .+|. |..+++|+.|+|++ |+|++..+..|++|++|+.|+|++|+|++..|..|.+|++|+.|||++|+
T Consensus        14 ~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~   91 (347)
T 2ifg_A           14 RCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA   91 (347)
T ss_dssp             ECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred             EcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence            35666 898 6888 99999999999996 99998888899999999999999999999888899999999999999999


Q ss_pred             cCCCChhhhcCcCCCceeeCCCCccccCCc
Q 046112           79 LSDEIPEFLAGFKFLQNLNLSYNNFESMLP  108 (502)
Q Consensus        79 l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~  108 (502)
                      |++..|..|..++ |+.|+|++|+|.....
T Consensus        92 l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~  120 (347)
T 2ifg_A           92 LESLSWKTVQGLS-LQELVLSGNPLHCSCA  120 (347)
T ss_dssp             CSCCCSTTTCSCC-CCEEECCSSCCCCCGG
T ss_pred             cceeCHHHcccCC-ceEEEeeCCCccCCCc
Confidence            9965455555555 9999999999986543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.52  E-value=5.3e-14  Score=123.32  Aligned_cols=107  Identities=21%  Similarity=0.202  Sum_probs=95.5

Q ss_pred             CCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCceeeCC
Q 046112           20 SLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLS   99 (502)
Q Consensus        20 ~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l~   99 (502)
                      ..+.|++++|+|+ .+|..+.  ++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|+
T Consensus        10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            3589999999999 6887764  899999999999999889999999999999999999997666678999999999999


Q ss_pred             CCccccCCcc-hhhcccccceeecCCccccC
Q 046112          100 YNNFESMLPI-EGIFKNASATSVFGNKKLCG  129 (502)
Q Consensus       100 ~N~l~~~~~~-~~~~~~~~~~~~~~n~~l~g  129 (502)
                      +|+|+++++. ...+.++..+.+.+|+.-|.
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             CCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            9999999886 46778899999999976554

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.52  E-value=2.6e-14  Score=122.45  Aligned_cols=107  Identities=20%  Similarity=0.201  Sum_probs=97.7

Q ss_pred             CCCCCCEEeccCCcCC-CcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCce
Q 046112           17 GLSSLSIFNVSGNLLS-GAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQN   95 (502)
Q Consensus        17 ~l~~L~~l~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~   95 (502)
                      ..++|+.|+|++|.++ +.+|..+..+++|++|++++|++++.  ..++.+++|+.|+|++|.+++.+|..+..+++|+.
T Consensus        15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~   92 (149)
T 2je0_A           15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH   92 (149)
T ss_dssp             CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred             CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence            3478999999999999 89999999999999999999999985  88999999999999999999879999999999999


Q ss_pred             eeCCCCccccCC--cchhhcccccceeecCCc
Q 046112           96 LNLSYNNFESML--PIEGIFKNASATSVFGNK  125 (502)
Q Consensus        96 l~l~~N~l~~~~--~~~~~~~~~~~~~~~~n~  125 (502)
                      |++++|++++.+  .....++++..+.+.+|+
T Consensus        93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~  124 (149)
T 2je0_A           93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCE  124 (149)
T ss_dssp             EECTTSCCCSHHHHGGGGGCTTCCEEECTTCG
T ss_pred             EECCCCcCCChHHHHHHhhCCCCCEEeCcCCc
Confidence            999999999865  556778889999999884

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.52  E-value=2.5e-14  Score=151.53  Aligned_cols=106  Identities=26%  Similarity=0.333  Sum_probs=50.5

Q ss_pred             CCCCccccccccc-cCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCC---CCCCCcCCCCCCCEEEccCc
Q 046112            2 LSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG---PIGSSLSSLRGLRVLDLSQN   77 (502)
Q Consensus         2 l~~n~l~~~~p~~-~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~---~~p~~~~~l~~L~~L~ls~N   77 (502)
                      |++|++++..|+. +.++++|+.|+|++|.+++..|..|+.+++|++|+|++|++++   ..+..+..+++|+.|+|++|
T Consensus       407 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n  486 (606)
T 3t6q_A          407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC  486 (606)
T ss_dssp             CTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTS
T ss_pred             CCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCC
Confidence            4455555443332 4445555555555555554444445555555555555555443   11233444444444444444


Q ss_pred             ccCCCChhhhcCcCCCceeeCCCCccccCC
Q 046112           78 NLSDEIPEFLAGFKFLQNLNLSYNNFESML  107 (502)
Q Consensus        78 ~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~  107 (502)
                      ++++..|..|..+++|+.|+|++|++++.+
T Consensus       487 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  516 (606)
T 3t6q_A          487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSS  516 (606)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCGGG
T ss_pred             ccCccChhhhccccCCCEEECCCCccCcCC
Confidence            444444444444444444444444444443

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.52  E-value=3.2e-14  Score=145.19  Aligned_cols=125  Identities=18%  Similarity=0.126  Sum_probs=83.2

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|.|+
T Consensus        81 ~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  160 (452)
T 3zyi_A           81 NLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE  160 (452)
T ss_dssp             ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCC
T ss_pred             ECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcc
Confidence            46777777666667777777777777777777666677777777777777777777655566777777777777777777


Q ss_pred             CCChhhhcCcCCCceeeCCC-CccccCCcc-hhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSY-NNFESMLPI-EGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~-N~l~~~~~~-~~~~~~~~~~~~~~n~  125 (502)
                      +..+..|.++++|+.|++++ |.++.+++. ...+.++..+.+.+|.
T Consensus       161 ~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~  207 (452)
T 3zyi_A          161 SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN  207 (452)
T ss_dssp             EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             eeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCc
Confidence            54444666666777777766 344444432 2345556666666653

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.52  E-value=2.4e-14  Score=147.16  Aligned_cols=125  Identities=18%  Similarity=0.181  Sum_probs=111.9

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|.++
T Consensus        62 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~  141 (477)
T 2id5_A           62 ELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV  141 (477)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCC
T ss_pred             ECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccc
Confidence            58899999888999999999999999999999776677999999999999999999988999999999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcc-hhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPI-EGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~  125 (502)
                      +..|..|.++++|+.|++++|++++.++. ...+.++..+.+.+|.
T Consensus       142 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~  187 (477)
T 2id5_A          142 YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLN  187 (477)
T ss_dssp             EECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCC
T ss_pred             eeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCc
Confidence            87888999999999999999999988865 3556778888888775

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.51  E-value=6.8e-14  Score=123.12  Aligned_cols=106  Identities=17%  Similarity=0.189  Sum_probs=94.4

Q ss_pred             CCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCceeeCCC
Q 046112           21 LSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSY  100 (502)
Q Consensus        21 L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l~~  100 (502)
                      -+.+++++|+|+ .+|..+.  ++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            478999999998 7888775  8999999999999998899999999999999999999965555678999999999999


Q ss_pred             CccccCCcc-hhhcccccceeecCCccccC
Q 046112          101 NNFESMLPI-EGIFKNASATSVFGNKKLCG  129 (502)
Q Consensus       101 N~l~~~~~~-~~~~~~~~~~~~~~n~~l~g  129 (502)
                      |+|+++++. ...+.++..+.+.+|+.-|.
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence            999999886 56688999999999976554

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.51  E-value=4.1e-14  Score=138.09  Aligned_cols=122  Identities=25%  Similarity=0.285  Sum_probs=75.0

Q ss_pred             CCCCCccc--cccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcc
Q 046112            1 DLSNNNLS--GTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNN   78 (502)
Q Consensus         1 dl~~n~l~--~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~   78 (502)
                      ||++|+++  +..+..+.++++|+.|+|++|+++ .+|..+.  ++|++|+|++|++++..|..|..+++|+.|+|++|.
T Consensus       151 ~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~  227 (330)
T 1xku_A          151 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS  227 (330)
T ss_dssp             ECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSC
T ss_pred             ECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCc
Confidence            35667775  355666667777777777777666 3444433  566666666666666555666666666666666666


Q ss_pred             cCCCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           79 LSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        79 l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      +++..|..+..+++|+.|++++|+|+.++.....++.+..+.+.+|+
T Consensus       228 l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~  274 (330)
T 1xku_A          228 ISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN  274 (330)
T ss_dssp             CCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSC
T ss_pred             CceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCc
Confidence            66544555666666666666666666555555555556666666553

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.51  E-value=4.1e-14  Score=139.53  Aligned_cols=125  Identities=22%  Similarity=0.243  Sum_probs=106.7

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      |+++|+++ .+|..+.  ++|+.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|+++
T Consensus        37 ~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  113 (353)
T 2z80_A           37 KGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS  113 (353)
T ss_dssp             ECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             eCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCC
Confidence            46788888 7887665  48999999999999777778999999999999999999977888999999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCc--chhhcccccceeecCCcccc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLP--IEGIFKNASATSVFGNKKLC  128 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~--~~~~~~~~~~~~~~~n~~l~  128 (502)
                      +..+..|.++++|+.|++++|+++++++  ....++++..+.+.+|+.+.
T Consensus       114 ~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~  163 (353)
T 2z80_A          114 NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT  163 (353)
T ss_dssp             SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC
T ss_pred             cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcccc
Confidence            6555568999999999999999998877  45667888999998885443

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.51  E-value=3.4e-14  Score=138.81  Aligned_cols=122  Identities=25%  Similarity=0.242  Sum_probs=74.2

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      |++|+++ .+|..+.  ++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|+ 
T Consensus       179 l~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-  254 (332)
T 2ft3_A          179 ISEAKLT-GIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-  254 (332)
T ss_dssp             CCSSBCS-SCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-
T ss_pred             CcCCCCC-ccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-
Confidence            4444444 2443332  46666666666666665566666677777777777776655556666667777777777766 


Q ss_pred             CChhhhcCcCCCceeeCCCCccccCCcchhh-------cccccceeecCCccc
Q 046112           82 EIPEFLAGFKFLQNLNLSYNNFESMLPIEGI-------FKNASATSVFGNKKL  127 (502)
Q Consensus        82 ~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~-------~~~~~~~~~~~n~~l  127 (502)
                      .+|..+..+++|+.|++++|+|++.++....       ...+..+.+.+|+..
T Consensus       255 ~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~  307 (332)
T 2ft3_A          255 RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP  307 (332)
T ss_dssp             BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred             ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccc
Confidence            5666666666677777777776666543321       233455666666543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.51  E-value=7.4e-14  Score=139.64  Aligned_cols=122  Identities=19%  Similarity=0.218  Sum_probs=76.7

Q ss_pred             CCCCccccccccc-cCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            2 LSNNNLSGTLSPQ-LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         2 l~~n~l~~~~p~~-~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +++|.++ .+|+. +.++++|+.|+|++|.+++..+..|+.+++|++|+|++|++++..|..|+.+++|+.|+|++|.++
T Consensus        52 l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  130 (390)
T 3o6n_A           52 FKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS  130 (390)
T ss_dssp             EESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             ecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC
Confidence            4455665 34443 456666777777777766555566666777777777777776655666666677777777777766


Q ss_pred             CCChh-hhcCcCCCceeeCCCCccccCCcc-hhhcccccceeecCCc
Q 046112           81 DEIPE-FLAGFKFLQNLNLSYNNFESMLPI-EGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~-~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~  125 (502)
                      . +|. .|.++++|+.|++++|++++.++. ...++++..+.+.+|.
T Consensus       131 ~-l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~  176 (390)
T 3o6n_A          131 S-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR  176 (390)
T ss_dssp             C-CCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSC
T ss_pred             c-CCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCc
Confidence            3 443 346666677777777776666554 2345566666666653

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.51  E-value=4e-14  Score=148.77  Aligned_cols=125  Identities=22%  Similarity=0.200  Sum_probs=100.5

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..+..|.++++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..|+.+++|+.|+|++|.++
T Consensus        34 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  113 (570)
T 2z63_A           34 DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA  113 (570)
T ss_dssp             ECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred             EccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccc
Confidence            57888888766777888888888888888888777778888888888888888888877788888888888888888888


Q ss_pred             CCChhhhcCcCCCceeeCCCCcccc--CCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFES--MLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~--~~~~~~~~~~~~~~~~~~n~  125 (502)
                      +..+..+.++++|+.|++++|++++  .|.....++++..+.+.+|.
T Consensus       114 ~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~  160 (570)
T 2z63_A          114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK  160 (570)
T ss_dssp             CSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSC
T ss_pred             cCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCc
Confidence            5444468888888888888888876  34555667778888887774

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.51  E-value=3.2e-14  Score=149.56  Aligned_cols=128  Identities=27%  Similarity=0.317  Sum_probs=84.3

Q ss_pred             CCCCCccccccc-cccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccC-CCCCCCcCCCCCCCEEEccCcc
Q 046112            1 DLSNNNLSGTLS-PQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFA-GPIGSSLSSLRGLRVLDLSQNN   78 (502)
Q Consensus         1 dl~~n~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~ls~N~   78 (502)
                      ||++|++++..| ..+.++++|+.|+|++|.+++..|..|.++++|++|+|++|+++ +.+|..+..+++|+.|+|++|+
T Consensus       402 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~  481 (570)
T 2z63_A          402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ  481 (570)
T ss_dssp             ECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred             EccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCc
Confidence            355666664444 34566667777777777776666666777777777777777766 4566677777777777777777


Q ss_pred             cCCCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCcccc
Q 046112           79 LSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNKKLC  128 (502)
Q Consensus        79 l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~l~  128 (502)
                      +++..|..|..+++|+.|++++|++++.++.. ..++.+..+.+.+|+..|
T Consensus       482 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~  532 (570)
T 2z63_A          482 LEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  532 (570)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             cccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccC
Confidence            77655667777777777777777777766543 445666666666665443

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.51  E-value=2.1e-14  Score=154.67  Aligned_cols=113  Identities=24%  Similarity=0.212  Sum_probs=100.6

Q ss_pred             ccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcC
Q 046112           10 TLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAG   89 (502)
Q Consensus        10 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~   89 (502)
                      ..|..+..+++|+.|+|++|+|. .+|..+..|++|++|+|++|+|+ .+|..|++|++|+.|+|++|.|+ .+|..|.+
T Consensus       215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~  291 (727)
T 4b8c_D          215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGS  291 (727)
T ss_dssp             -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGG
T ss_pred             cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcC
Confidence            45777899999999999999999 88888889999999999999999 59999999999999999999999 88999999


Q ss_pred             cCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           90 FKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        90 ~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      +++|+.|+|++|+|+.+|.....+.++..+.+.+|+
T Consensus       292 l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~  327 (727)
T 4b8c_D          292 CFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNP  327 (727)
T ss_dssp             GTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSC
T ss_pred             CCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCc
Confidence            999999999999999988888888999999999985

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.51  E-value=4.5e-14  Score=143.54  Aligned_cols=122  Identities=23%  Similarity=0.203  Sum_probs=58.0

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCC-cCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGN-LLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      ||++|+|++..+..|.++++|+.|+|++| .++...+..|.++++|++|+|++|+++. +| .+..+++|+.|+|++|.|
T Consensus       142 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l  219 (440)
T 3zyj_A          142 WLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHL  219 (440)
T ss_dssp             ECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCC
T ss_pred             eCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCcc
Confidence            35666666444444555555555555552 2322222235555555555555555543 33 244445555555555555


Q ss_pred             CCCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCC
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGN  124 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n  124 (502)
                      ++..|..|.++++|+.|+|++|+|++.++.. ..++++..+.+.+|
T Consensus       220 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  265 (440)
T 3zyj_A          220 SAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN  265 (440)
T ss_dssp             CEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTS
T ss_pred             CccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCC
Confidence            4444444444445555555555444443322 22334444444444

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.50  E-value=1.2e-14  Score=141.23  Aligned_cols=119  Identities=23%  Similarity=0.148  Sum_probs=70.5

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcC-CCCCCCEEEccCcccC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLS-SLRGLRVLDLSQNNLS   80 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~   80 (502)
                      |++|+|++..+.   .+++|+.|+|++|++++..|..++.+++|++|+|++|++++..|..+. .+++|+.|+|++|.|+
T Consensus       106 l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~  182 (317)
T 3o53_A          106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY  182 (317)
T ss_dssp             CCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred             CCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc
Confidence            455555533322   245566666666666665565666666666666666666665555543 5666666666666666


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      + +|. ...+++|+.|+|++|+|+++++....++++..+.+.+|.
T Consensus       183 ~-~~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~  225 (317)
T 3o53_A          183 D-VKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNK  225 (317)
T ss_dssp             E-EEC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSC
T ss_pred             c-ccc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCc
Confidence            3 332 223566666666666666666655555666666666663

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.50  E-value=5.8e-14  Score=150.87  Aligned_cols=129  Identities=26%  Similarity=0.263  Sum_probs=80.2

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCC--------ccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEE
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAIS--------NNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVL   72 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~--------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   72 (502)
                      ||++|+|++..|..+.++++|+.|+|++|++++..+        ..|.++++|++|+|++|+++...+..|..+++|+.|
T Consensus       486 ~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L  565 (680)
T 1ziw_A          486 DLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKII  565 (680)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             ECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCccee
Confidence            355666664444445666666666666666654311        125666666666666666665333456777777777


Q ss_pred             EccCcccCCCChhhhcCcCCCceeeCCCCccccCCcchh--hcccccceeecCCccccC
Q 046112           73 DLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG--IFKNASATSVFGNKKLCG  129 (502)
Q Consensus        73 ~ls~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~--~~~~~~~~~~~~n~~l~g  129 (502)
                      +|++|+|++..+..|.++++|+.|+|++|+|++.++...  .+.++..+.+.+|+..|.
T Consensus       566 ~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~  624 (680)
T 1ziw_A          566 DLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT  624 (680)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred             ECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence            777777775444456667777777777777777666543  456677777777776665

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.50  E-value=2.6e-14  Score=157.10  Aligned_cols=125  Identities=21%  Similarity=0.182  Sum_probs=87.4

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcC-CccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAI-SNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      ||++|+|++..|..|.++++|+.|+|++|.+.+.+ |..|++|++|++|+|++|++++..|..|+++++|+.|+|++|.+
T Consensus        30 dLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l  109 (844)
T 3j0a_A           30 LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGL  109 (844)
T ss_dssp             EEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCC
T ss_pred             ECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCC
Confidence            56777777666777777777777777777655555 56677777777777777777776677777777777777777777


Q ss_pred             CCCChhh--hcCcCCCceeeCCCCccccCCc--chhhcccccceeecCCc
Q 046112           80 SDEIPEF--LAGFKFLQNLNLSYNNFESMLP--IEGIFKNASATSVFGNK  125 (502)
Q Consensus        80 ~~~~p~~--~~~~~~L~~l~l~~N~l~~~~~--~~~~~~~~~~~~~~~n~  125 (502)
                      ++.+|..  |.++++|+.|+|++|++++..+  ....++++..+.+.+|.
T Consensus       110 ~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~  159 (844)
T 3j0a_A          110 SDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ  159 (844)
T ss_dssp             SSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSC
T ss_pred             CcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCc
Confidence            7655554  6777777777777777776543  23556666666666653

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.50  E-value=6.8e-15  Score=142.52  Aligned_cols=124  Identities=19%  Similarity=0.224  Sum_probs=107.3

Q ss_pred             CCCCCccc-cccccccC-------CCCCCCEEeccCCcCCCcCCccC--CCCCCCCEEECcCCccCCCCCCCcCCC----
Q 046112            1 DLSNNNLS-GTLSPQLV-------GLSSLSIFNVSGNLLSGAISNNF--GSCTSLEQLDMHGNLFAGPIGSSLSSL----   66 (502)
Q Consensus         1 dl~~n~l~-~~~p~~~~-------~l~~L~~l~l~~N~l~~~~~~~~--~~l~~L~~L~l~~N~l~~~~p~~~~~l----   66 (502)
                      ||++|+++ +.+|..+.       ++++|++|+|++|++++.+|..+  +.+++|++|+|++|++++. |..++.+    
T Consensus        69 ~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~  147 (312)
T 1wwl_A           69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWL  147 (312)
T ss_dssp             CCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTC
T ss_pred             ccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhh
Confidence            57889994 56777766       79999999999999999999987  8999999999999999996 8888887    


Q ss_pred             -CCCCEEEccCcccCCCChhhhcCcCCCceeeCCCCccccC---Ccch--hhcccccceeecCCc
Q 046112           67 -RGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESM---LPIE--GIFKNASATSVFGNK  125 (502)
Q Consensus        67 -~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~---~~~~--~~~~~~~~~~~~~n~  125 (502)
                       ++|+.|+|++|+|++..|..|.++++|+.|++++|++++.   ++..  ..++++..+.+.+|.
T Consensus       148 ~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~  212 (312)
T 1wwl_A          148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG  212 (312)
T ss_dssp             CTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSC
T ss_pred             cCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCc
Confidence             9999999999999987779999999999999999998774   2233  456778888888874

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.50  E-value=1e-14  Score=135.52  Aligned_cols=122  Identities=18%  Similarity=0.193  Sum_probs=77.9

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCc-CCCcCCccCCCCCCCCEEECcC-CccCCCCCCCcCCCCCCCEEEccCcc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNL-LSGAISNNFGSCTSLEQLDMHG-NLFAGPIGSSLSSLRGLRVLDLSQNN   78 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~-l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~ls~N~   78 (502)
                      ||++|+|++..+..|.++++|+.|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|..+++|+.|+|++|.
T Consensus        37 ~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~  116 (239)
T 2xwt_C           37 KLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTG  116 (239)
T ss_dssp             EEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEEC
T ss_pred             EEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCC
Confidence            355666764444466667777777777775 6655555667777777777776 77776555666677777777777777


Q ss_pred             cCCCChhhhcCcCCCc---eeeCCCC-ccccCCcch-hhccccc-ceeecCC
Q 046112           79 LSDEIPEFLAGFKFLQ---NLNLSYN-NFESMLPIE-GIFKNAS-ATSVFGN  124 (502)
Q Consensus        79 l~~~~p~~~~~~~~L~---~l~l~~N-~l~~~~~~~-~~~~~~~-~~~~~~n  124 (502)
                      +++ +|. +..+++|+   .|++++| +++++++.. ..+..+. .+.+.+|
T Consensus       117 l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n  166 (239)
T 2xwt_C          117 LKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN  166 (239)
T ss_dssp             CCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSC
T ss_pred             Ccc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCC
Confidence            764 555 66666666   6777777 666666542 3445555 5666555

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.50  E-value=5.1e-14  Score=123.18  Aligned_cols=108  Identities=19%  Similarity=0.181  Sum_probs=98.2

Q ss_pred             CCCCCCCEEeccCCcCC-CcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCc
Q 046112           16 VGLSSLSIFNVSGNLLS-GAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQ   94 (502)
Q Consensus        16 ~~l~~L~~l~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~   94 (502)
                      ...++|+.|+|++|+++ +.+|..+..+++|++|+|++|++++.  ..+..+++|+.|+|++|.+++.+|..+..+++|+
T Consensus        21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   98 (168)
T 2ell_A           21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT   98 (168)
T ss_dssp             SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred             CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence            34588999999999998 89999999999999999999999985  8899999999999999999987899888899999


Q ss_pred             eeeCCCCccccCC--cchhhcccccceeecCCc
Q 046112           95 NLNLSYNNFESML--PIEGIFKNASATSVFGNK  125 (502)
Q Consensus        95 ~l~l~~N~l~~~~--~~~~~~~~~~~~~~~~n~  125 (502)
                      .|++++|+|++.+  +....++.+..+.+.+|+
T Consensus        99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~  131 (168)
T 2ell_A           99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCE  131 (168)
T ss_dssp             EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSG
T ss_pred             EEeccCCccCcchhHHHHhcCCCCCEEEeeCCc
Confidence            9999999999976  455677889999999885

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.50  E-value=4.5e-14  Score=146.73  Aligned_cols=123  Identities=26%  Similarity=0.226  Sum_probs=106.8

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCC--cCCccCCCCCCCCEEECcCCccCCCCCC-CcCCCCCCCEEEccCc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSG--AISNNFGSCTSLEQLDMHGNLFAGPIGS-SLSSLRGLRVLDLSQN   77 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~ls~N   77 (502)
                      ||++|++++.+|..+.++++|+.|+|++|++++  .+|..|+.+++|++|+|++|++++.+|. .+..+++|+.|+|++|
T Consensus       330 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N  409 (520)
T 2z7x_B          330 DFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN  409 (520)
T ss_dssp             ECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSS
T ss_pred             EeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCC
Confidence            588999998889999999999999999999996  5677899999999999999999985665 4888899999999999


Q ss_pred             ccCCCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           78 NLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        78 ~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      ++++.+|..+.  ++|+.|++++|+|+.+++....++.+..+.+.+|.
T Consensus       410 ~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~  455 (520)
T 2z7x_B          410 ILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQ  455 (520)
T ss_dssp             CCCGGGGGSCC--TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred             CCCcchhhhhc--ccCCEEECCCCcccccchhhhcCCCCCEEECCCCc
Confidence            99887777664  68899999999999888777778888888888884

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.50  E-value=5.7e-14  Score=142.84  Aligned_cols=125  Identities=16%  Similarity=0.112  Sum_probs=87.3

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..+..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|.|+
T Consensus        70 ~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~  149 (440)
T 3zyj_A           70 NLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE  149 (440)
T ss_dssp             ECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCC
T ss_pred             EccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCccc
Confidence            46777777666677777788888888888877766677777888888888888777755566777778888888888777


Q ss_pred             CCChhhhcCcCCCceeeCCCC-ccccCCcc-hhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYN-NFESMLPI-EGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N-~l~~~~~~-~~~~~~~~~~~~~~n~  125 (502)
                      +..+..|.++++|+.|++++| .++.+++. ...+.++..+.+.+|.
T Consensus       150 ~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~  196 (440)
T 3zyj_A          150 SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCN  196 (440)
T ss_dssp             EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSC
T ss_pred             ccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCc
Confidence            554556777777777777763 34444432 2345566666666663

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.49  E-value=2.1e-14  Score=150.19  Aligned_cols=122  Identities=20%  Similarity=0.271  Sum_probs=89.3

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      |+++|+++ .+|+.+.  ++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..|+.+++|+.|+|++|.++
T Consensus        11 ~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~   87 (549)
T 2z81_A           11 DGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS   87 (549)
T ss_dssp             ECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred             ECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccC
Confidence            45667777 6776554  67778888888877777777777888888888888877766677777788888888888877


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccC--CcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESM--LPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~--~~~~~~~~~~~~~~~~~n~  125 (502)
                      +..|..|.++++|+.|++++|++++.  ++....++++..+.+.+|.
T Consensus        88 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~  134 (549)
T 2z81_A           88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE  134 (549)
T ss_dssp             SCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS
T ss_pred             ccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCc
Confidence            66666677777788888888877753  3445566677777777764

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.49  E-value=7.1e-14  Score=146.22  Aligned_cols=125  Identities=19%  Similarity=0.216  Sum_probs=111.7

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+.+++|+.|+|++|.++
T Consensus        32 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  111 (549)
T 2z81_A           32 DLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ  111 (549)
T ss_dssp             ECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCS
T ss_pred             ECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCccc
Confidence            68999999888889999999999999999999988899999999999999999999977777999999999999999999


Q ss_pred             C-CChhhhcCcCCCceeeCCCCc-cccCCc-chhhcccccceeecCCc
Q 046112           81 D-EIPEFLAGFKFLQNLNLSYNN-FESMLP-IEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~-~~p~~~~~~~~L~~l~l~~N~-l~~~~~-~~~~~~~~~~~~~~~n~  125 (502)
                      + .+|..+.++++|+.|++++|+ ++..++ ....++++..+.+.+|.
T Consensus       112 ~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~  159 (549)
T 2z81_A          112 TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS  159 (549)
T ss_dssp             SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred             ccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCc
Confidence            6 467889999999999999998 555543 34667788888888885

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.49  E-value=4.8e-14  Score=149.05  Aligned_cols=123  Identities=17%  Similarity=0.109  Sum_probs=110.8

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..|..|+++++|+.|+|++|.|++..|..|+++++|++|+|++|.|++..+..|+.+++|+.|+|++|.|+
T Consensus        81 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~  160 (597)
T 3oja_B           81 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE  160 (597)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             ECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCC
Confidence            58899999877789999999999999999999988889999999999999999999866666899999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      +..|..|..+++|+.|++++|+|++.+.  ..++.+..+.+.+|.
T Consensus       161 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~l~~L~~L~l~~n~  203 (597)
T 3oja_B          161 RIEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNL  203 (597)
T ss_dssp             BCCTTTTTTCTTCCEEECTTSCCSBCCG--GGCTTCSEEECCSSC
T ss_pred             CCChhhhhcCCcCcEEECcCCCCCCcCh--hhhhhhhhhhcccCc
Confidence            8888899999999999999999999753  446778888877774

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.49  E-value=4.8e-14  Score=151.50  Aligned_cols=124  Identities=19%  Similarity=0.144  Sum_probs=84.9

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..|+++++|+.|+|++|+++
T Consensus        31 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~  110 (680)
T 1ziw_A           31 NLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQ  110 (680)
T ss_dssp             ECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC
T ss_pred             ECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccC
Confidence            46777777555556777777777777777777776777777777777777777777644446777777777777777777


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGN  124 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n  124 (502)
                      +..|..|.++++|+.|++++|++++.++.. ..++++..+.+.+|
T Consensus       111 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  155 (680)
T 1ziw_A          111 KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN  155 (680)
T ss_dssp             CCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSS
T ss_pred             ccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCC
Confidence            555566777777777777777777665543 34556666666665

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.48  E-value=8.1e-14  Score=146.28  Aligned_cols=123  Identities=20%  Similarity=0.177  Sum_probs=104.1

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCC--cCCccCCCCCCCCEEECcCCccCCCCCC-CcCCCCCCCEEEccCc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSG--AISNNFGSCTSLEQLDMHGNLFAGPIGS-SLSSLRGLRVLDLSQN   77 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~ls~N   77 (502)
                      ||++|++++.+|..+.++++|+.|+|++|++++  .+|..|+++++|++|+|++|++++.+|. .+..+++|+.|+|++|
T Consensus       359 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n  438 (562)
T 3a79_B          359 NFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN  438 (562)
T ss_dssp             ECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSS
T ss_pred             ECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCC
Confidence            588999998889999999999999999999996  3456799999999999999999985554 5888899999999999


Q ss_pred             ccCCCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           78 NLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        78 ~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      +|++.+|..+.  ++|+.|++++|+|+.+++....++.+..+.+.+|.
T Consensus       439 ~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~  484 (562)
T 3a79_B          439 MLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQ  484 (562)
T ss_dssp             CCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSC
T ss_pred             CCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCC
Confidence            99877776554  68889999999998888777777888888888875

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.48  E-value=4.6e-14  Score=146.67  Aligned_cols=109  Identities=26%  Similarity=0.248  Sum_probs=72.5

Q ss_pred             CCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCC--CCCCCcCCCCCCCEEEccCcccCCCChhh-hcCcCC
Q 046112           16 VGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAG--PIGSSLSSLRGLRVLDLSQNNLSDEIPEF-LAGFKF   92 (502)
Q Consensus        16 ~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~   92 (502)
                      ..+++|+.|+|++|++++.+|..++.+++|++|+|++|++++  .+|..+..+++|+.|+|++|.+++.+|.. +..+++
T Consensus       321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  400 (520)
T 2z7x_B          321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS  400 (520)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred             hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence            466777777777777776677777777777777777777775  34556677777777777777777546553 666677


Q ss_pred             CceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           93 LQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        93 L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      |+.|++++|++++..+.... ..+..+.+++|.
T Consensus       401 L~~L~Ls~N~l~~~~~~~l~-~~L~~L~Ls~N~  432 (520)
T 2z7x_B          401 LLSLNMSSNILTDTIFRCLP-PRIKVLDLHSNK  432 (520)
T ss_dssp             CCEEECCSSCCCGGGGGSCC-TTCCEEECCSSC
T ss_pred             CCEEECcCCCCCcchhhhhc-ccCCEEECCCCc
Confidence            77777777777655443221 456666666663

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.48  E-value=1.7e-14  Score=134.08  Aligned_cols=126  Identities=17%  Similarity=0.110  Sum_probs=106.8

Q ss_pred             CCCCCc-cccccccccCCCCCCCEEeccC-CcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCC---EEEcc
Q 046112            1 DLSNNN-LSGTLSPQLVGLSSLSIFNVSG-NLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLR---VLDLS   75 (502)
Q Consensus         1 dl~~n~-l~~~~p~~~~~l~~L~~l~l~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~---~L~ls   75 (502)
                      ||++|+ +++..+..|.++++|++|+|++ |+|++..+..|.++++|++|++++|++++ +|. |..+++|+   .|+++
T Consensus        61 ~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~  138 (239)
T 2xwt_C           61 YVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEIT  138 (239)
T ss_dssp             EEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEE
T ss_pred             eCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECC
Confidence            467886 8855556789999999999999 99997777889999999999999999998 776 88889998   99999


Q ss_pred             Cc-ccCCCChhhhcCcCCCc-eeeCCCCccccCCcchhhcccccceeecCCcccc
Q 046112           76 QN-NLSDEIPEFLAGFKFLQ-NLNLSYNNFESMLPIEGIFKNASATSVFGNKKLC  128 (502)
Q Consensus        76 ~N-~l~~~~p~~~~~~~~L~-~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~  128 (502)
                      +| .+++..+..|.++++|+ .|++++|+++.+++.......+..+.+.+|..+.
T Consensus       139 ~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~  193 (239)
T 2xwt_C          139 DNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLT  193 (239)
T ss_dssp             SCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCC
T ss_pred             CCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcc
Confidence            99 99865566789999999 9999999999887766555778888888885343

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.48  E-value=9.8e-14  Score=141.58  Aligned_cols=124  Identities=22%  Similarity=0.218  Sum_probs=106.9

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|...
T Consensus       105 ~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l  184 (452)
T 3zyi_A          105 QLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKL  184 (452)
T ss_dssp             ECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTC
T ss_pred             ECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCc
Confidence            58999999888889999999999999999999777778999999999999999999877778999999999999984433


Q ss_pred             CCCh-hhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIP-EFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p-~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      +.+| ..|.++++|+.|+|++|+|++.+ ....+.++..+.+++|.
T Consensus       185 ~~i~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~l~~L~~L~Ls~N~  229 (452)
T 3zyi_A          185 EYISEGAFEGLFNLKYLNLGMCNIKDMP-NLTPLVGLEELEMSGNH  229 (452)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSCCSSCC-CCTTCTTCCEEECTTSC
T ss_pred             cccChhhccCCCCCCEEECCCCcccccc-cccccccccEEECcCCc
Confidence            3555 46889999999999999999875 45667788888888884

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.48  E-value=3.4e-14  Score=140.11  Aligned_cols=124  Identities=22%  Similarity=0.229  Sum_probs=107.8

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++..+..+.++++|+.|+|++|++++..|..|+++++|++|+|++|++++..+..|..+++|+.|+|++|.++
T Consensus        58 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  137 (353)
T 2z80_A           58 DLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK  137 (353)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS
T ss_pred             ECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc
Confidence            58999999666668999999999999999999888889999999999999999999855555999999999999999999


Q ss_pred             CCChh--hhcCcCCCceeeCCCC-ccccCCcc-hhhcccccceeecCCc
Q 046112           81 DEIPE--FLAGFKFLQNLNLSYN-NFESMLPI-EGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~--~~~~~~~L~~l~l~~N-~l~~~~~~-~~~~~~~~~~~~~~n~  125 (502)
                       .+|.  .+..+++|+.|++++| .+++.++. ...++.+..+.+.+|.
T Consensus       138 -~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~  185 (353)
T 2z80_A          138 -TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD  185 (353)
T ss_dssp             -SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred             -ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence             5665  7899999999999999 57777654 4567788888888885

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.47  E-value=2.5e-13  Score=132.51  Aligned_cols=120  Identities=18%  Similarity=0.231  Sum_probs=59.1

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      |++|+|++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|+++. +|..+.  ++|+.|++++|.+++
T Consensus        59 L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~--~~L~~L~l~~n~l~~  135 (330)
T 1xku_A           59 LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMP--KTLQELRVHENEITK  135 (330)
T ss_dssp             CCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSCC--TTCCEEECCSSCCCB
T ss_pred             CCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCc-cChhhc--ccccEEECCCCcccc
Confidence            45555553333345555555555555555554445555555555555555555553 444333  455555555555554


Q ss_pred             CChhhhcCcCCCceeeCCCCcccc--CCc-chhhcccccceeecCC
Q 046112           82 EIPEFLAGFKFLQNLNLSYNNFES--MLP-IEGIFKNASATSVFGN  124 (502)
Q Consensus        82 ~~p~~~~~~~~L~~l~l~~N~l~~--~~~-~~~~~~~~~~~~~~~n  124 (502)
                      ..+..|.++++|+.|++++|+++.  ..+ ....++++..+.+.+|
T Consensus       136 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n  181 (330)
T 1xku_A          136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT  181 (330)
T ss_dssp             BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred             cCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCC
Confidence            444445555555555555555532  221 2233344444444444

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.47  E-value=1.5e-13  Score=134.31  Aligned_cols=125  Identities=18%  Similarity=0.185  Sum_probs=76.3

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCC--CcCCccCCCC--------------------CCCCEEECcCCccCCC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLS--GAISNNFGSC--------------------TSLEQLDMHGNLFAGP   58 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~--~~~~~~~~~l--------------------~~L~~L~l~~N~l~~~   58 (502)
                      +|++|+|++..+..+.++++|+.|+|++|.++  +..|..|..+                    ++|++|+|++|++++.
T Consensus       129 ~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~  208 (332)
T 2ft3_A          129 RIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAI  208 (332)
T ss_dssp             ECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCC
T ss_pred             ECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCcc
Confidence            35666666444445677777777777777775  3555555544                    3455555555555554


Q ss_pred             CCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           59 IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        59 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      .|..|..+++|+.|+|++|.+++..|..+..+++|+.|++++|+|+.+++....++.+..+.+.+|+
T Consensus       209 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~  275 (332)
T 2ft3_A          209 ELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNN  275 (332)
T ss_dssp             CTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSSC
T ss_pred             CHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCCC
Confidence            4556666666666666666666555556666666666666666666655555555666666666653

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.47  E-value=1.2e-13  Score=144.98  Aligned_cols=119  Identities=23%  Similarity=0.241  Sum_probs=71.5

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      |+++|+|+ .+|..+.  ++|+.|+|++|.+++..|..|+++++|++|+|++|++++..|..|..+++|+.|||++|+|+
T Consensus        37 ~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  113 (562)
T 3a79_B           37 DYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ  113 (562)
T ss_dssp             ECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred             EcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC
Confidence            45666666 4555443  56666666666666555556666666666666666666655666666666666666666666


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCC--cchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESML--PIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~--~~~~~~~~~~~~~~~~n~  125 (502)
                       .+|..  .+++|+.|++++|+|++.+  .....++++..+.+.+|.
T Consensus       114 -~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~  157 (562)
T 3a79_B          114 -NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAK  157 (562)
T ss_dssp             -EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSB
T ss_pred             -ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCc
Confidence             45554  5666666666666666543  234455556666665553

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.46  E-value=2.4e-13  Score=128.06  Aligned_cols=115  Identities=24%  Similarity=0.337  Sum_probs=83.4

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|+ .+| .+..+++|+.|+|++|+|++..+  +..+++|++|+|++|++++ +|.. .. ++|+.|+|++|+|+
T Consensus        47 ~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~  119 (263)
T 1xeu_A           47 NGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELR  119 (263)
T ss_dssp             ECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCS
T ss_pred             ECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccCCccC
Confidence            46777777 565 67778888888888888885444  7888888888888888877 4432 22 77888888888887


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      + +| .+..+++|+.|++++|+|++.+ ....++++..+.+.+|.
T Consensus       120 ~-~~-~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~L~~L~L~~N~  161 (263)
T 1xeu_A          120 D-TD-SLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNE  161 (263)
T ss_dssp             B-SG-GGTTCTTCCEEECTTSCCCBCG-GGGGCTTCCEEECTTSC
T ss_pred             C-Ch-hhcCcccccEEECCCCcCCCCh-HHccCCCCCEEECCCCc
Confidence            4 44 4777788888888888887764 45556677777777764

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.46  E-value=9.2e-14  Score=138.93  Aligned_cols=123  Identities=17%  Similarity=0.108  Sum_probs=105.9

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|++++..|..|.++++|+.|+|++|++++..|..|+++++|++|+|++|+++...+..|..+++|+.|+|++|.++
T Consensus        75 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~  154 (390)
T 3o6n_A           75 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE  154 (390)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             ECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccC
Confidence            57899999766778999999999999999999888888999999999999999999754555789999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      +..|..|..+++|+.|++++|++++..  ...++.+..+.+.+|.
T Consensus       155 ~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L~~L~l~~n~  197 (390)
T 3o6n_A          155 RIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNL  197 (390)
T ss_dssp             BCCTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTCSEEECCSSC
T ss_pred             ccChhhccCCCCCCEEECCCCcCCccc--cccccccceeeccccc
Confidence            777888999999999999999998874  3456777778777774

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.46  E-value=2.2e-13  Score=130.34  Aligned_cols=116  Identities=22%  Similarity=0.301  Sum_probs=83.5

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ++++|.++ .+| .+..+++|+.|+|++|++++..+  +..+++|++|+|++|++++ +| .+..+++|+.|+|++|.++
T Consensus        52 ~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~  125 (291)
T 1h6t_A           52 IANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS  125 (291)
T ss_dssp             ECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC
T ss_pred             EccCCCcc-cCh-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCC
Confidence            36677777 444 47777888888888888875444  7778888888888888776 33 3777788888888888877


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      + + ..+..+++|+.|++++|++++. +....++++..+.+++|.
T Consensus       126 ~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~  167 (291)
T 1h6t_A          126 D-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQ  167 (291)
T ss_dssp             C-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSC
T ss_pred             C-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCc
Confidence            4 3 3577777788888888887776 445566777777777763

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.46  E-value=1.3e-15  Score=137.37  Aligned_cols=121  Identities=20%  Similarity=0.205  Sum_probs=105.9

Q ss_pred             CCCCCcccccccc------ccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEc
Q 046112            1 DLSNNNLSGTLSP------QLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDL   74 (502)
Q Consensus         1 dl~~n~l~~~~p~------~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   74 (502)
                      +|++|.++|.+|.      .+..+++|+.|+|++|++++ +| .+..+++|++|+|++|+++. +|..+..+++|+.|+|
T Consensus        24 ~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~-l~~~~~~~~~L~~L~L  100 (198)
T 1ds9_A           24 EAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWI  100 (198)
T ss_dssp             TCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECS-CSSHHHHHHHCSEEEE
T ss_pred             chheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccc-ccchhhcCCcCCEEEC
Confidence            5778888888877      89999999999999999996 77 89999999999999999995 8888888899999999


Q ss_pred             cCcccCCCChhhhcCcCCCceeeCCCCccccCCc--chhhcccccceeecCCcc
Q 046112           75 SQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP--IEGIFKNASATSVFGNKK  126 (502)
Q Consensus        75 s~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~--~~~~~~~~~~~~~~~n~~  126 (502)
                      ++|+|++ +| .+..+++|+.|++++|+|++.++  ....++++..+.+.+|+.
T Consensus       101 ~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l  152 (198)
T 1ds9_A          101 SYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL  152 (198)
T ss_dssp             EEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHH
T ss_pred             cCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcc
Confidence            9999995 66 68899999999999999998654  456678888999988853

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.45  E-value=3.7e-14  Score=137.16  Aligned_cols=125  Identities=18%  Similarity=0.115  Sum_probs=99.5

Q ss_pred             CCCCCcccccccccc--CCCCCCCEEeccCCcCCCcCC----ccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEc
Q 046112            1 DLSNNNLSGTLSPQL--VGLSSLSIFNVSGNLLSGAIS----NNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDL   74 (502)
Q Consensus         1 dl~~n~l~~~~p~~~--~~l~~L~~l~l~~N~l~~~~~----~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   74 (502)
                      ||++|++++..|..+  .++++|++|+|++|++++..+    ..+..+++|++|+|++|++++..|..|+.+++|+.|||
T Consensus        97 ~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  176 (310)
T 4glp_A           97 TLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDL  176 (310)
T ss_dssp             EEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEEC
T ss_pred             EeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEEC
Confidence            467889988888887  889999999999999997655    44567899999999999998888888999999999999


Q ss_pred             cCcccCCC--Ch--hhhcCcCCCceeeCCCCccccCCcc----hhhcccccceeecCCc
Q 046112           75 SQNNLSDE--IP--EFLAGFKFLQNLNLSYNNFESMLPI----EGIFKNASATSVFGNK  125 (502)
Q Consensus        75 s~N~l~~~--~p--~~~~~~~~L~~l~l~~N~l~~~~~~----~~~~~~~~~~~~~~n~  125 (502)
                      ++|++.+.  ++  ..+..+++|+.|+|++|+|+..++.    ...+..+..+.+++|.
T Consensus       177 s~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~  235 (310)
T 4glp_A          177 SDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNS  235 (310)
T ss_dssp             CSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSC
T ss_pred             CCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCC
Confidence            99988642  32  2346788899999999998765543    2345778888888885

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.45  E-value=3.1e-13  Score=127.37  Aligned_cols=117  Identities=28%  Similarity=0.342  Sum_probs=100.8

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++ +|+ +.++++|+.|+|++|+|++ +|.. .. ++|+.|+|++|++++ +| .+..+++|+.|+|++|+|+
T Consensus        69 ~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~  141 (263)
T 1xeu_A           69 HLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLK  141 (263)
T ss_dssp             ECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCC
T ss_pred             ECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCC
Confidence            589999994 555 9999999999999999995 5543 33 999999999999998 44 5999999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCccc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKL  127 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l  127 (502)
                      + +| .+..+++|+.|++++|+|++. +....++++..+.+.+|+..
T Consensus       142 ~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~  185 (263)
T 1xeu_A          142 S-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCV  185 (263)
T ss_dssp             B-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEE
T ss_pred             C-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCccc
Confidence            5 55 689999999999999999998 55667788999999998643

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.44  E-value=2.3e-14  Score=138.64  Aligned_cols=124  Identities=15%  Similarity=0.091  Sum_probs=92.4

Q ss_pred             CCCCCccccccc----cccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCC--C--CCCcCCCCCCCEE
Q 046112            1 DLSNNNLSGTLS----PQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGP--I--GSSLSSLRGLRVL   72 (502)
Q Consensus         1 dl~~n~l~~~~p----~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~--p~~~~~l~~L~~L   72 (502)
                      ||++|++++..|    ..+..+++|+.|+|++|++++..|..|+.+++|++|+|++|++.+.  +  +..+..+++|+.|
T Consensus       123 ~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L  202 (310)
T 4glp_A          123 RLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNL  202 (310)
T ss_dssp             EEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSC
T ss_pred             EeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEE
Confidence            467888886554    3456788899999999999888888888899999999999987652  2  2334678888888


Q ss_pred             EccCcccCCCChh----hhcCcCCCceeeCCCCccccC-Ccchhhc---ccccceeecCCc
Q 046112           73 DLSQNNLSDEIPE----FLAGFKFLQNLNLSYNNFESM-LPIEGIF---KNASATSVFGNK  125 (502)
Q Consensus        73 ~ls~N~l~~~~p~----~~~~~~~L~~l~l~~N~l~~~-~~~~~~~---~~~~~~~~~~n~  125 (502)
                      +|++|+++ .+|.    .+..+++|+.|+|++|+|++. |+....+   +++..+.+++|.
T Consensus       203 ~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~  262 (310)
T 4glp_A          203 ALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAG  262 (310)
T ss_dssp             BCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSC
T ss_pred             ECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCC
Confidence            88888887 4444    256778888888888888887 3444444   477778887774

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.44  E-value=5.2e-14  Score=144.75  Aligned_cols=127  Identities=19%  Similarity=0.157  Sum_probs=104.3

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCC-CCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFG-SCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      +|++|+|++..|..++++++|+.|+|++|.|++.+|..|. .+++|+.|+|++|.|++. |. +..+++|+.|+|++|.|
T Consensus       126 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l  203 (487)
T 3oja_A          126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKL  203 (487)
T ss_dssp             ECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCC
T ss_pred             ECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCC
Confidence            4788899887788888889999999999999988888876 789999999999998875 33 34588899999999999


Q ss_pred             CCCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCccccCC
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGG  130 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~g~  130 (502)
                      ++ +|+.+..+++|+.|+|++|+|+++|+....++.+..+.+.+|+..|+.
T Consensus       204 ~~-~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~  253 (487)
T 3oja_A          204 AF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGT  253 (487)
T ss_dssp             CE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHHH
T ss_pred             CC-CCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCcc
Confidence            85 555688888999999999999888777667778888888888776653

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.44  E-value=2.5e-13  Score=130.01  Aligned_cols=116  Identities=23%  Similarity=0.330  Sum_probs=93.6

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++ +++ +.++++|+.|+|++|++++ +| .+..+++|++|+|++|++++.  ..+..+++|+.|+|++|+++
T Consensus        74 ~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~  147 (291)
T 1h6t_A           74 FLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT  147 (291)
T ss_dssp             ECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCC
T ss_pred             EccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCC
Confidence            578888884 444 8889999999999999885 44 388889999999999988873  46888888999999999888


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      + + ..+..+++|+.|++++|+|++.++ ...++++..+.+.+|.
T Consensus       148 ~-~-~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~  189 (291)
T 1h6t_A          148 D-I-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNH  189 (291)
T ss_dssp             C-C-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred             c-c-hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCc
Confidence            5 3 568888888888888888888776 6667778888888774

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.44  E-value=4.1e-13  Score=129.67  Aligned_cols=116  Identities=21%  Similarity=0.357  Sum_probs=89.9

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +|++|+++ .+| .+..+++|+.|+|++|++++..+  +..+++|++|+|++|++++ +| .+..+++|+.|+|++|.++
T Consensus        47 ~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~  120 (308)
T 1h6u_A           47 SAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQIT  120 (308)
T ss_dssp             ECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCC
T ss_pred             EeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCC
Confidence            46778887 555 57888888888888888885444  8888888888888888887 33 6888888888888888888


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      + +|. +..+++|+.|++++|++++.++ ...++++..+.+.+|.
T Consensus       121 ~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~  162 (308)
T 1h6u_A          121 D-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQ  162 (308)
T ss_dssp             C-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSC
T ss_pred             C-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCc
Confidence            5 554 7888888888888888888766 5566777778877773

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.44  E-value=2.6e-13  Score=131.04  Aligned_cols=116  Identities=22%  Similarity=0.357  Sum_probs=88.7

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|+ .+| .+..+++|+.|+|++|++++ ++. +..+++|++|+|++|++++.. . +..+++|+.|+|++|.++
T Consensus        91 ~L~~n~l~-~~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~-~-l~~l~~L~~L~l~~n~l~  164 (308)
T 1h6u_A           91 ELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNIS-P-LAGLTNLQYLSIGNAQVS  164 (308)
T ss_dssp             ECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCG-G-GGGCTTCCEEECCSSCCC
T ss_pred             EccCCcCC-Cch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCc-c-ccCCCCccEEEccCCcCC
Confidence            47788888 344 68888888888888888885 343 888888888888888888743 3 778888888888888888


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      + +|. +..+++|+.|++++|++++.++ ...++.+..+.+.+|.
T Consensus       165 ~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~  206 (308)
T 1h6u_A          165 D-LTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQ  206 (308)
T ss_dssp             C-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSC
T ss_pred             C-Chh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCc
Confidence            4 444 7788888888888888887765 5556777777777774

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.42  E-value=4.8e-13  Score=131.37  Aligned_cols=116  Identities=18%  Similarity=0.267  Sum_probs=73.7

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      +++|++++..+  +..+++|+.|+|++|++++..+  +..+++|++|++++|++++.  +.+..+++|+.|++++|.+++
T Consensus       206 l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~  279 (347)
T 4fmz_A          206 AYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD  279 (347)
T ss_dssp             CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC
T ss_pred             cccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC
Confidence            55666663322  6667777777777777774333  66677777777777777652  346666777777777777764


Q ss_pred             CChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCc
Q 046112           82 EIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNK  125 (502)
Q Consensus        82 ~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~  125 (502)
                       +| .+..+++|+.|++++|++++.++.. ..++++..+.+.+|+
T Consensus       280 -~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~  322 (347)
T 4fmz_A          280 -IS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH  322 (347)
T ss_dssp             -CG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSS
T ss_pred             -Ch-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCc
Confidence             33 4666677777777777776655443 445666666666664

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.41  E-value=3.7e-13  Score=132.26  Aligned_cols=106  Identities=21%  Similarity=0.189  Sum_probs=95.0

Q ss_pred             CEEeccCC-cCCCcCCccCCCCCCCCEEECcC-CccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCceeeCC
Q 046112           22 SIFNVSGN-LLSGAISNNFGSCTSLEQLDMHG-NLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLS   99 (502)
Q Consensus        22 ~~l~l~~N-~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l~   99 (502)
                      ..+++++| +|+ .+|. |..+++|+.|+|++ |+|++..|..|..|++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            45799998 999 6888 99999999999996 99999777899999999999999999998888899999999999999


Q ss_pred             CCccccCCcchhhcccccceeecCCccccC
Q 046112          100 YNNFESMLPIEGIFKNASATSVFGNKKLCG  129 (502)
Q Consensus       100 ~N~l~~~~~~~~~~~~~~~~~~~~n~~l~g  129 (502)
                      +|+|+++++.......+..+.+.+|+.-|.
T Consensus        89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~  118 (347)
T 2ifg_A           89 FNALESLSWKTVQGLSLQELVLSGNPLHCS  118 (347)
T ss_dssp             SSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred             CCccceeCHHHcccCCceEEEeeCCCccCC
Confidence            999999998776655688899998876553

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.41  E-value=3.8e-13  Score=118.58  Aligned_cols=110  Identities=16%  Similarity=0.187  Sum_probs=93.4

Q ss_pred             cccCCCCCCCEEeccCCcCCCcCCccCCCCC-CCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcC
Q 046112           13 PQLVGLSSLSIFNVSGNLLSGAISNNFGSCT-SLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFK   91 (502)
Q Consensus        13 ~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~   91 (502)
                      +.+.++.+|+.|+|++|+++ .+|. +..+. +|++|+|++|+|++.  ..|..+++|+.|+|++|.|++..|..+..++
T Consensus        13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~   88 (176)
T 1a9n_A           13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP   88 (176)
T ss_dssp             CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred             HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence            45778999999999999999 4565 55544 999999999999984  7899999999999999999954445569999


Q ss_pred             CCceeeCCCCccccCCc--chhhcccccceeecCCcc
Q 046112           92 FLQNLNLSYNNFESMLP--IEGIFKNASATSVFGNKK  126 (502)
Q Consensus        92 ~L~~l~l~~N~l~~~~~--~~~~~~~~~~~~~~~n~~  126 (502)
                      +|+.|++++|+|+..++  ....++++..+.+.+|+.
T Consensus        89 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i  125 (176)
T 1a9n_A           89 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV  125 (176)
T ss_dssp             TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGG
T ss_pred             CCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCC
Confidence            99999999999988776  556778889999999863

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.40  E-value=7.7e-13  Score=139.01  Aligned_cols=115  Identities=23%  Similarity=0.318  Sum_probs=69.6

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++.. + +.++++|+.|+|++|+|++ +| .|..|++|+.|+|++|+|++ + ..+..|++|+.|+|++|.|+
T Consensus        71 ~Ls~N~l~~~~-~-l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~  144 (605)
T 1m9s_A           71 FLNGNKLTDIK-P-LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKIT  144 (605)
T ss_dssp             ECTTSCCCCCG-G-GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCC
T ss_pred             EeeCCCCCCCh-h-hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccC
Confidence            46667776433 2 6666667777777776663 33 46666666666666666665 2 34666666666666666666


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGN  124 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n  124 (502)
                      +.  ..+..+++|+.|+|++|+|++.++ ...+.++..|.+++|
T Consensus       145 ~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N  185 (605)
T 1m9s_A          145 DI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKN  185 (605)
T ss_dssp             CC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred             Cc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCC
Confidence            42  455666666666666666666555 444555555555555

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.39  E-value=9.7e-13  Score=138.26  Aligned_cols=114  Identities=22%  Similarity=0.306  Sum_probs=63.1

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      |++|.|+ .+| .+..|++|+.|+|++|+|++..|  +..|++|+.|+|++|+|++ +| .+..+++|+.|+|++|.|++
T Consensus        50 l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~  123 (605)
T 1m9s_A           50 ANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD  123 (605)
T ss_dssp             CTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC
T ss_pred             CcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC
Confidence            4555555 333 35556666666666666664333  5556666666666666654 22 45556666666666666653


Q ss_pred             CChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCC
Q 046112           82 EIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGN  124 (502)
Q Consensus        82 ~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n  124 (502)
                       +| .+..+++|+.|+|++|+|+++ +....+.++..|.+++|
T Consensus       124 -l~-~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N  163 (605)
T 1m9s_A          124 -IN-GLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDN  163 (605)
T ss_dssp             -CG-GGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSS
T ss_pred             -Cc-cccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCC
Confidence             32 355556666666666666554 33444555555555555

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.39  E-value=6.4e-13  Score=146.07  Aligned_cols=121  Identities=21%  Similarity=0.235  Sum_probs=100.9

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|.+++..|..+.++++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|++|.++
T Consensus       272 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~  351 (844)
T 3j0a_A          272 DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA  351 (844)
T ss_dssp             ECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCC
T ss_pred             ECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCC
Confidence            47788888777888888999999999999999888888999999999999999998877888999999999999999998


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      +..+..|..+++|+.|+|++|++++++.    ++.+..+.+.+|+
T Consensus       352 ~~~~~~~~~l~~L~~L~Ls~N~l~~i~~----~~~L~~L~l~~N~  392 (844)
T 3j0a_A          352 IIQDQTFKFLEKLQTLDLRDNALTTIHF----IPSIPDIFLSGNK  392 (844)
T ss_dssp             CCCSSCSCSCCCCCEEEEETCCSCCCSS----CCSCSEEEEESCC
T ss_pred             ccChhhhcCCCCCCEEECCCCCCCcccC----CCCcchhccCCCC
Confidence            7667778888999999999998887654    4556666666654

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.38  E-value=3e-13  Score=131.18  Aligned_cols=126  Identities=19%  Similarity=0.163  Sum_probs=93.0

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccC-CCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNF-GSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      +|++|++++..|..+..+++|+.|+|++|++++..+..+ ..+++|++|+|++|++++. |. ...+++|+.|+|++|+|
T Consensus       126 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l  203 (317)
T 3o53_A          126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKL  203 (317)
T ss_dssp             ECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCC
T ss_pred             ECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcC
Confidence            467788886666677778888888888888887666665 3678888888888888774 33 33477888888888888


Q ss_pred             CCCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCccccC
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCG  129 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~g  129 (502)
                      + .+|..+..+++|+.|++++|+|+++++....++.+..+.+.+|+..|+
T Consensus       204 ~-~l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~  252 (317)
T 3o53_A          204 A-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG  252 (317)
T ss_dssp             C-EECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHH
T ss_pred             C-cchhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCc
Confidence            7 455567788888888888888887776666667777777777765544

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.37  E-value=1.1e-12  Score=136.87  Aligned_cols=105  Identities=22%  Similarity=0.301  Sum_probs=95.4

Q ss_pred             CCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCceeeCC
Q 046112           20 SLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLS   99 (502)
Q Consensus        20 ~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l~   99 (502)
                      .|+.|+|++|+|++ +|. |+.|++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|.|++ +| .+.++++|+.|+|+
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls  516 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC  516 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence            58999999999996 676 999999999999999999 589999999999999999999995 78 89999999999999


Q ss_pred             CCccccC--CcchhhcccccceeecCCccccCC
Q 046112          100 YNNFESM--LPIEGIFKNASATSVFGNKKLCGG  130 (502)
Q Consensus       100 ~N~l~~~--~~~~~~~~~~~~~~~~~n~~l~g~  130 (502)
                      +|+|++.  |.....++++..+.+.+|+ +++.
T Consensus       517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~-l~~~  548 (567)
T 1dce_A          517 NNRLQQSAAIQPLVSCPRLVLLNLQGNS-LCQE  548 (567)
T ss_dssp             SSCCCSSSTTGGGGGCTTCCEEECTTSG-GGGS
T ss_pred             CCCCCCCCCcHHHhcCCCCCEEEecCCc-CCCC
Confidence            9999999  5666788999999999985 4543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.36  E-value=1.7e-12  Score=135.04  Aligned_cols=92  Identities=30%  Similarity=0.382  Sum_probs=56.5

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++ +|. +.+  +|+.|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|+.|+|++|+|+
T Consensus       106 ~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~  173 (571)
T 3cvr_A          106 DACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLT  173 (571)
T ss_dssp             ECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS
T ss_pred             EccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCC
Confidence            466677764 655 544  66777777777664 554   46666666666666665 444   3456666666666666


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLP  108 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~  108 (502)
                      + +|. |.  ++|+.|+|++|+|+.+++
T Consensus       174 ~-lp~-l~--~~L~~L~Ls~N~L~~lp~  197 (571)
T 3cvr_A          174 F-LPE-LP--ESLEALDVSTNLLESLPA  197 (571)
T ss_dssp             C-CCC-CC--TTCCEEECCSSCCSSCCC
T ss_pred             C-cch-hh--CCCCEEECcCCCCCchhh
Confidence            4 555 43  566666666666665554

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.32  E-value=3.3e-12  Score=130.79  Aligned_cols=116  Identities=28%  Similarity=0.343  Sum_probs=81.0

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|++++..|  +..+++|+.|+|++|.+++..+  +..+++|+.|+|++|++++..|  +..+++|+.|+|++|+++
T Consensus       249 ~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~  322 (466)
T 1o6v_A          249 DLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNIS  322 (466)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCS
T ss_pred             ECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCC
Confidence            467777774443  7777888888888888875443  7777778888888877777433  677777777777777777


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      +..|  +..+++|+.|++++|++++. +....++++..+.+.+|+
T Consensus       323 ~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~  364 (466)
T 1o6v_A          323 DISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQ  364 (466)
T ss_dssp             CCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSC
T ss_pred             Cchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCc
Confidence            6544  66777777777777777776 344556666666666663

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.32  E-value=4.9e-12  Score=129.46  Aligned_cols=116  Identities=26%  Similarity=0.409  Sum_probs=99.2

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +|++|++++ + +.+..+++|+.|+|++|.+++..|  +..+++|+.|++++|++++..|  +..+++|+.|+|++|+++
T Consensus       227 ~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~  300 (466)
T 1o6v_A          227 SLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE  300 (466)
T ss_dssp             ECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCS
T ss_pred             ECCCCCccc-c-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCccc
Confidence            478899884 4 368889999999999999997655  8999999999999999998443  889999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      +..|  +..+++|+.|++++|++++.++ ...++++..+.+.+|.
T Consensus       301 ~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~  342 (466)
T 1o6v_A          301 DISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNK  342 (466)
T ss_dssp             CCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSC
T ss_pred             Cchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCc
Confidence            6443  8899999999999999999877 5677888889998884

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.31  E-value=6.5e-12  Score=128.00  Aligned_cols=113  Identities=19%  Similarity=0.258  Sum_probs=94.8

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++ +| .+..+++|+.|+|++|+|++. |  ++.+++|++|+|++|+|++ +|  ++.+++|+.|+|++|+++
T Consensus        48 ~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~  119 (457)
T 3bz5_A           48 DCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLT  119 (457)
T ss_dssp             ECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCS
T ss_pred             EccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCC
Confidence            578899995 45 688999999999999999964 4  8899999999999999998 44  889999999999999998


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCcc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKK  126 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~  126 (502)
                      + +|  +..+++|+.|++++|+|++++  ...++.+..+.+.+|..
T Consensus       120 ~-l~--~~~l~~L~~L~l~~N~l~~l~--l~~l~~L~~L~l~~n~~  160 (457)
T 3bz5_A          120 K-LD--VSQNPLLTYLNCARNTLTEID--VSHNTQLTELDCHLNKK  160 (457)
T ss_dssp             C-CC--CTTCTTCCEEECTTSCCSCCC--CTTCTTCCEEECTTCSC
T ss_pred             e-ec--CCCCCcCCEEECCCCccceec--cccCCcCCEEECCCCCc
Confidence            6 55  888999999999999999863  45667777788777753

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.30  E-value=2e-14  Score=129.47  Aligned_cols=103  Identities=30%  Similarity=0.387  Sum_probs=92.8

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++ +| .+.++++|+.|+|++|+|+ .+|..+..+++|++|+|++|++++ +| .+..+++|+.|+|++|+|+
T Consensus        54 ~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~  128 (198)
T 1ds9_A           54 ALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKIT  128 (198)
T ss_dssp             ECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECC
T ss_pred             ECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCC
Confidence            588999995 77 8999999999999999999 788888889999999999999998 56 6899999999999999999


Q ss_pred             CCCh--hhhcCcCCCceeeCCCCccccCCcc
Q 046112           81 DEIP--EFLAGFKFLQNLNLSYNNFESMLPI  109 (502)
Q Consensus        81 ~~~p--~~~~~~~~L~~l~l~~N~l~~~~~~  109 (502)
                      + +|  ..+..+++|+.|++++|++++.+|.
T Consensus       129 ~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~  158 (198)
T 1ds9_A          129 N-WGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             C-HHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred             c-hhHHHHHhcCCCCCEEEecCCcccccccc
Confidence            4 44  4789999999999999999987664

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.30  E-value=7.6e-12  Score=130.14  Aligned_cols=106  Identities=26%  Similarity=0.357  Sum_probs=55.3

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++ +|..+.  ++|+.|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. +..  +|+.|+|++|+|+
T Consensus        65 ~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~  133 (571)
T 3cvr_A           65 QLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLT  133 (571)
T ss_dssp             ECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCS
T ss_pred             EeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCC
Confidence            356666663 555442  55666666666666 444   335556666666666655 444 443  5555555555555


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGN  124 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n  124 (502)
                      + +|.   .+++|+.|+|++|+|+++++   .++++..+.+++|
T Consensus       134 ~-lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N  170 (571)
T 3cvr_A          134 M-LPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNN  170 (571)
T ss_dssp             C-CCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSS
T ss_pred             C-CCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCC
Confidence            3 444   34455555555555555333   2334444444444

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.27  E-value=1.1e-12  Score=129.57  Aligned_cols=125  Identities=21%  Similarity=0.195  Sum_probs=105.6

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCC----ccCCCCC-CCCEEECcCCccCCCCCCCcCCC-----CCCC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAIS----NNFGSCT-SLEQLDMHGNLFAGPIGSSLSSL-----RGLR   70 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~----~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l-----~~L~   70 (502)
                      +|++|+++|.+|..+...++|+.|+|++|.|++..+    ..|..++ +|++|+|++|++++..+..+..+     ++|+
T Consensus         4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~   83 (362)
T 3goz_A            4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT   83 (362)
T ss_dssp             ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred             ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence            478999999998877777889999999999997776    7788899 99999999999999778778776     9999


Q ss_pred             EEEccCcccCCCChhhhcC----c-CCCceeeCCCCccccCCcchhh------cccccceeecCCc
Q 046112           71 VLDLSQNNLSDEIPEFLAG----F-KFLQNLNLSYNNFESMLPIEGI------FKNASATSVFGNK  125 (502)
Q Consensus        71 ~L~ls~N~l~~~~p~~~~~----~-~~L~~l~l~~N~l~~~~~~~~~------~~~~~~~~~~~n~  125 (502)
                      .|+|++|.+++..+..+..    + ++|+.|+|++|+|++..+....      ...+..+.+++|.
T Consensus        84 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~  149 (362)
T 3goz_A           84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGND  149 (362)
T ss_dssp             EEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSC
T ss_pred             EEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCc
Confidence            9999999999877775544    4 8999999999999988764421      2478888888884

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.26  E-value=7.4e-12  Score=117.84  Aligned_cols=147  Identities=14%  Similarity=0.059  Sum_probs=108.9

Q ss_pred             HHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-CCccceeeecccccccCCC
Q 046112          201 YNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       201 ~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~  279 (502)
                      .....+|.....++.|+.+.||++..  .+..+++|+...........+.+|+++++.+. +..+.++++++.     ..
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~   82 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HD   82 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ET
T ss_pred             HHHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cC
Confidence            34456787777888888999999953  46789999986432223346889999998884 567778887743     23


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLD-----------------------  336 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----------------------  336 (502)
                      ...++||||++|.+|.+.+..               ......++.+++++++.||..                       
T Consensus        83 ~~~~lv~e~i~G~~l~~~~~~---------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~  147 (263)
T 3tm0_A           83 GWSNLLMSEADGVLCSEEYED---------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN  147 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHCCT---------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred             CceEEEEEecCCeehhhccCC---------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHh
Confidence            478899999999999876411               112346788999999999961                       


Q ss_pred             ---------------------------------CCCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          337 ---------------------------------CQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       337 ---------------------------------~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                                                       ....++|+|++|.||+++++..+.|.||+.+..
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                             014589999999999998766677999998753

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.24  E-value=4.2e-13  Score=131.14  Aligned_cols=124  Identities=18%  Similarity=0.309  Sum_probs=101.0

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCc-CCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCc-c
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGA-ISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQN-N   78 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N-~   78 (502)
                      +|++|.+++..+ .+.++++|+.|+|++|.+++. +|..+..+++|++|+|++|++++..|..++.+++|+.|+|++| .
T Consensus        76 ~l~~n~l~~~~~-~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~  154 (336)
T 2ast_B           76 RCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG  154 (336)
T ss_dssp             ECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBS
T ss_pred             EcCCccccccch-hhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCC
Confidence            467888886554 467889999999999998865 7888888999999999999988878888888999999999998 6


Q ss_pred             cCC-CChhhhcCcCCCceeeCCCC-cccc--CCcchhhcc-cccceeecCCc
Q 046112           79 LSD-EIPEFLAGFKFLQNLNLSYN-NFES--MLPIEGIFK-NASATSVFGNK  125 (502)
Q Consensus        79 l~~-~~p~~~~~~~~L~~l~l~~N-~l~~--~~~~~~~~~-~~~~~~~~~n~  125 (502)
                      +++ .+|..+.++++|+.|++++| ++++  .+.....++ ++..+.+.+|.
T Consensus       155 l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~  206 (336)
T 2ast_B          155 FSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR  206 (336)
T ss_dssp             CCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred             CCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCc
Confidence            775 37777888999999999999 8875  344445667 88888888885

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.23  E-value=8.7e-13  Score=131.63  Aligned_cols=87  Identities=24%  Similarity=0.314  Sum_probs=41.5

Q ss_pred             CCCCEEeccCCcCC-CcCC---ccCCCCCCCCEEECcCCccC--C---CCCCCcCCCCCCCEEEccCcccC----CCChh
Q 046112           19 SSLSIFNVSGNLLS-GAIS---NNFGSCTSLEQLDMHGNLFA--G---PIGSSLSSLRGLRVLDLSQNNLS----DEIPE   85 (502)
Q Consensus        19 ~~L~~l~l~~N~l~-~~~~---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~L~ls~N~l~----~~~p~   85 (502)
                      ++|+.|+|++|+|+ +.+|   ..+..+++|++|+|++|+++  |   ..|..+..+++|+.|+|++|.|+    +.+|.
T Consensus       159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~  238 (386)
T 2ca6_A          159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI  238 (386)
T ss_dssp             CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred             CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence            45555555555554 2333   23444455555555555544  1   22334444555555555555553    33444


Q ss_pred             hhcCcCCCceeeCCCCcccc
Q 046112           86 FLAGFKFLQNLNLSYNNFES  105 (502)
Q Consensus        86 ~~~~~~~L~~l~l~~N~l~~  105 (502)
                      .+..+++|+.|+|++|+|++
T Consensus       239 ~l~~~~~L~~L~L~~n~i~~  258 (386)
T 2ca6_A          239 ALKSWPNLRELGLNDCLLSA  258 (386)
T ss_dssp             HGGGCTTCCEEECTTCCCCH
T ss_pred             HHccCCCcCEEECCCCCCch
Confidence            45555555555555555543

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.23  E-value=7e-12  Score=123.27  Aligned_cols=123  Identities=16%  Similarity=0.118  Sum_probs=98.1

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCC-CCcCCCCCCCE-EEccCccc
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG-SSLSSLRGLRV-LDLSQNNL   79 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~-L~ls~N~l   79 (502)
                      .++|+|+ .+|..+  .++|++|+|++|+|+...+..|.+|++|++|+|++|++.+.+| ..|.++++|.. +++++|+|
T Consensus        16 C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l   92 (350)
T 4ay9_X           16 CQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL   92 (350)
T ss_dssp             EESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTC
T ss_pred             ecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcc
Confidence            3578888 888876  3689999999999996555679999999999999999877565 56899998775 66778999


Q ss_pred             CCCChhhhcCcCCCceeeCCCCccccCCcchh-hcccccceeecCCccc
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYNNFESMLPIEG-IFKNASATSVFGNKKL  127 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~-~~~~~~~~~~~~n~~l  127 (502)
                      +...|..|..+++|+.|++++|+|++.++... ....+..+.+.+++.+
T Consensus        93 ~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i  141 (350)
T 4ay9_X           93 LYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI  141 (350)
T ss_dssp             CEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTC
T ss_pred             cccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccc
Confidence            97668889999999999999999998887542 2334455666565443

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.22  E-value=4.5e-11  Score=117.25  Aligned_cols=117  Identities=26%  Similarity=0.327  Sum_probs=88.4

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ++++|.++ .+| .+..+++|+.|+|++|++++. |. +..+++|++|+|++|+++. +| .+..+++|+.|+|++|.++
T Consensus        50 ~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~~n~i~  123 (347)
T 4fmz_A           50 VVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLNEDNIS  123 (347)
T ss_dssp             ECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECTTSCCC
T ss_pred             EEeCCccc-cch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECcCCccc
Confidence            36777777 554 477888888888888888844 43 8888888888888888886 43 5888888888888888888


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      + +|. +..+++|+.|++++|.....++....++.+..+.+.+|.
T Consensus       124 ~-~~~-~~~l~~L~~L~l~~n~~~~~~~~~~~l~~L~~L~l~~~~  166 (347)
T 4fmz_A          124 D-ISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESK  166 (347)
T ss_dssp             C-CGG-GTTCTTCCEEECTTCTTCCCCGGGTTCTTCCEEECCSSC
T ss_pred             C-chh-hccCCceeEEECCCCCCcccccchhhCCCCcEEEecCCC
Confidence            4 454 778888888888888665556656667777777777764

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.22  E-value=1.2e-12  Score=127.81  Aligned_cols=124  Identities=20%  Similarity=0.194  Sum_probs=104.4

Q ss_pred             CCCCCccccccccccCCC--CCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCC-CCCCcCCCCCCCEEEccCc
Q 046112            1 DLSNNNLSGTLSPQLVGL--SSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGP-IGSSLSSLRGLRVLDLSQN   77 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l--~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~ls~N   77 (502)
                      ||++|.+.   |..+..+  ++++.|++++|.+++..+. +..+++|++|+|++|.+++. +|..+..+++|+.|+|++|
T Consensus        53 ~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~  128 (336)
T 2ast_B           53 DLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL  128 (336)
T ss_dssp             ECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred             ccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCc
Confidence            46677766   4556666  8999999999999977666 66799999999999999876 7888999999999999999


Q ss_pred             ccCCCChhhhcCcCCCceeeCCCC-cccc--CCcchhhcccccceeecCCcccc
Q 046112           78 NLSDEIPEFLAGFKFLQNLNLSYN-NFES--MLPIEGIFKNASATSVFGNKKLC  128 (502)
Q Consensus        78 ~l~~~~p~~~~~~~~L~~l~l~~N-~l~~--~~~~~~~~~~~~~~~~~~n~~l~  128 (502)
                      .+++..|..+..+++|+.|++++| .+++  .+.....++++..+.+.+|..+.
T Consensus       129 ~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~  182 (336)
T 2ast_B          129 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFT  182 (336)
T ss_dssp             BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCC
T ss_pred             ccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcC
Confidence            999888999999999999999999 7875  44445678889999999985554

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.22  E-value=2.9e-11  Score=123.19  Aligned_cols=107  Identities=19%  Similarity=0.201  Sum_probs=88.2

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +|++|+..+.+  .+..+++|+.|+|++|+|++ +|  ++.+++|+.|++++|++++.   .++.+++|+.|+|++|+|+
T Consensus       154 ~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~  225 (457)
T 3bz5_A          154 DCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT  225 (457)
T ss_dssp             ECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCS
T ss_pred             ECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccc
Confidence            46778666566  48889999999999999996 55  88999999999999999984   4889999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhccccccee
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS  120 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~  120 (502)
                      + +|  +..+++|+.|++++|+|++.++.  .+..+..+.
T Consensus       226 ~-ip--~~~l~~L~~L~l~~N~l~~~~~~--~l~~L~~L~  260 (457)
T 3bz5_A          226 E-ID--VTPLTQLTYFDCSVNPLTELDVS--TLSKLTTLH  260 (457)
T ss_dssp             C-CC--CTTCTTCSEEECCSSCCSCCCCT--TCTTCCEEE
T ss_pred             c-cC--ccccCCCCEEEeeCCcCCCcCHH--HCCCCCEEe
Confidence            6 67  88999999999999999998743  344444333

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.20  E-value=1.2e-11  Score=121.68  Aligned_cols=108  Identities=14%  Similarity=0.070  Sum_probs=85.6

Q ss_pred             CCCCCccccccc-cccCCCCCCCEEeccCCcCCCcCCc-cCCCCCCCCE-EECcCCccCCCCCCCcCCCCCCCEEEccCc
Q 046112            1 DLSNNNLSGTLS-PQLVGLSSLSIFNVSGNLLSGAISN-NFGSCTSLEQ-LDMHGNLFAGPIGSSLSSLRGLRVLDLSQN   77 (502)
Q Consensus         1 dl~~n~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~l~~L~~-L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N   77 (502)
                      ||++|+|+ .+| ..|.++++|+.|+|++|++.+.+|. .|.+|++|++ +++++|+|+...|..|..+++|+.|++++|
T Consensus        36 ~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n  114 (350)
T 4ay9_X           36 RFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT  114 (350)
T ss_dssp             EEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEE
T ss_pred             EccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccccccc
Confidence            57899999 555 5689999999999999999877764 5899999876 577789999988899999999999999999


Q ss_pred             ccCCCChhhhcCcCCCceeeCCC-CccccCCcc
Q 046112           78 NLSDEIPEFLAGFKFLQNLNLSY-NNFESMLPI  109 (502)
Q Consensus        78 ~l~~~~p~~~~~~~~L~~l~l~~-N~l~~~~~~  109 (502)
                      +|++..+..+.....+..+++++ |+++.+++.
T Consensus       115 ~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~  147 (350)
T 4ay9_X          115 GIKHLPDVHKIHSLQKVLLDIQDNINIHTIERN  147 (350)
T ss_dssp             CCSSCCCCTTCCBSSCEEEEEESCTTCCEECTT
T ss_pred             ccccCCchhhcccchhhhhhhcccccccccccc
Confidence            99965555555555666666643 456555543

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.20  E-value=5.3e-11  Score=121.12  Aligned_cols=95  Identities=18%  Similarity=0.280  Sum_probs=69.5

Q ss_pred             CCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCceeeC
Q 046112           19 SSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNL   98 (502)
Q Consensus        19 ~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l   98 (502)
                      ++|++|+|++|++++ +| .|+++++|++|++++|++++ +|..+   ++|+.|++++|++++ +| .+.++++|+.|++
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l  202 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA  202 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence            578888888888885 66 58888888888888888876 66543   478888888888875 66 5777888888888


Q ss_pred             CCCccccCCcchhhcccccceeecCC
Q 046112           99 SYNNFESMLPIEGIFKNASATSVFGN  124 (502)
Q Consensus        99 ~~N~l~~~~~~~~~~~~~~~~~~~~n  124 (502)
                      ++|++++++...   ..+..+.+.+|
T Consensus       203 ~~N~l~~l~~~~---~~L~~L~l~~n  225 (454)
T 1jl5_A          203 DNNSLKKLPDLP---LSLESIVAGNN  225 (454)
T ss_dssp             CSSCCSSCCCCC---TTCCEEECCSS
T ss_pred             CCCcCCcCCCCc---CcccEEECcCC
Confidence            888887755432   35666666666

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.19  E-value=8.1e-11  Score=123.87  Aligned_cols=51  Identities=29%  Similarity=0.309  Sum_probs=31.0

Q ss_pred             CCCCEEEccCcccCCCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCC
Q 046112           67 RGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGN  124 (502)
Q Consensus        67 ~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n  124 (502)
                      ++|+.|+|++|+|++ +|   ..+++|+.|+|++|+|+++++   .+.++..+.+.+|
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N  271 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRN  271 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSS
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCC
Confidence            556666666666663 55   344566666666666666554   3455666666665

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.16  E-value=1.1e-10  Score=118.75  Aligned_cols=110  Identities=23%  Similarity=0.226  Sum_probs=84.6

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|++++ +|+.   +++|+.|+|++|++++ +|..   .++|++|++++|++++ +| .|+++++|+.|++++|+++
T Consensus        97 ~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~  166 (454)
T 1jl5_A           97 VASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK  166 (454)
T ss_dssp             ECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCS
T ss_pred             EccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCc
Confidence            466777774 6543   3678888888888884 3321   2689999999999987 77 5899999999999999998


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      + +|..+   .+|+.|++++|++++++ ....++.+..+.+.+|.
T Consensus       167 ~-lp~~~---~~L~~L~L~~n~l~~l~-~~~~l~~L~~L~l~~N~  206 (454)
T 1jl5_A          167 K-LPDLP---PSLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNS  206 (454)
T ss_dssp             C-CCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSC
T ss_pred             c-cCCCc---ccccEEECcCCcCCcCc-cccCCCCCCEEECCCCc
Confidence            5 67543   47899999999998865 56677888888888874

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.16  E-value=4.3e-12  Score=125.45  Aligned_cols=125  Identities=25%  Similarity=0.291  Sum_probs=99.7

Q ss_pred             CCCCCccccccc----cccCCCC-CCCEEeccCCcCCCcCCccCCCC-----CCCCEEECcCCccCCCCCCCcCC----C
Q 046112            1 DLSNNNLSGTLS----PQLVGLS-SLSIFNVSGNLLSGAISNNFGSC-----TSLEQLDMHGNLFAGPIGSSLSS----L   66 (502)
Q Consensus         1 dl~~n~l~~~~p----~~~~~l~-~L~~l~l~~N~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~----l   66 (502)
                      ||++|+|++..+    ..+.+++ +|++|+|++|+|++..+..|..+     ++|++|+|++|++++..+..+..    +
T Consensus        28 ~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~  107 (362)
T 3goz_A           28 DLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAI  107 (362)
T ss_dssp             ECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTS
T ss_pred             EccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhC
Confidence            689999996655    6788888 89999999999998888878775     99999999999999866664444    4


Q ss_pred             -CCCCEEEccCcccCCCChhhhcC-----cCCCceeeCCCCccccCCcch-----hhc-ccccceeecCCc
Q 046112           67 -RGLRVLDLSQNNLSDEIPEFLAG-----FKFLQNLNLSYNNFESMLPIE-----GIF-KNASATSVFGNK  125 (502)
Q Consensus        67 -~~L~~L~ls~N~l~~~~p~~~~~-----~~~L~~l~l~~N~l~~~~~~~-----~~~-~~~~~~~~~~n~  125 (502)
                       ++|+.|+|++|.|++..+..+..     .++|+.|+|++|+|++.....     ... ..+..+.+.+|.
T Consensus       108 ~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~  178 (362)
T 3goz_A          108 PFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN  178 (362)
T ss_dssp             CTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSC
T ss_pred             CCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCC
Confidence             89999999999999776665543     368999999999998644322     123 378888888884

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.13  E-value=5.2e-11  Score=111.71  Aligned_cols=137  Identities=14%  Similarity=0.036  Sum_probs=93.4

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCc--cceeeecccccccCCCccee
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRN--LVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++....+.+.|..+.||++ ...+|..+++|+....   ....+..|+++++.+.+.+  +.+++++..     .++..+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~-~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~~   91 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRL-SAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDW   91 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEE-ECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEE
T ss_pred             CCceEecccCCCCceEEEE-ecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCCE
Confidence            3443333345666999999 4466788999987543   2355788999998886544  344666532     234679


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDC--------------------------  337 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------  337 (502)
                      +||||++|.+|.  ...             .   ....++.++++.++.||...                          
T Consensus        92 ~v~e~i~G~~l~--~~~-------------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SSH-------------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLV  153 (264)
T ss_dssp             EEEECCSSEETT--TSC-------------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCC
T ss_pred             EEEEecCCcccC--cCc-------------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCc
Confidence            999999998884  211             0   12256667777777777321                          


Q ss_pred             -----------------------------CCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          338 -----------------------------QPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       338 -----------------------------~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                                                   ...++|+|++|.||+++++..+.|.|||.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          154 DQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                         12399999999999998876677999998853

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.12  E-value=1.5e-10  Score=121.78  Aligned_cols=107  Identities=21%  Similarity=0.247  Sum_probs=80.9

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|.   .+++|++|+|++|+|++ +|.   .+++|+.|+|++|.|+
T Consensus        46 ~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~  114 (622)
T 3g06_A           46 NVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLT  114 (622)
T ss_dssp             ECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCC
T ss_pred             EecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCC
Confidence            57888888 7887765  78888999998888 5665   57888888888888886 665   5678888888888888


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      + +|.   .+++|+.|++++|+|+++++.   ++++..+.+++|.
T Consensus       115 ~-l~~---~l~~L~~L~L~~N~l~~lp~~---l~~L~~L~Ls~N~  152 (622)
T 3g06_A          115 H-LPA---LPSGLCKLWIFGNQLTSLPVL---PPGLQELSVSDNQ  152 (622)
T ss_dssp             C-CCC---CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSC
T ss_pred             C-CCC---CCCCcCEEECCCCCCCcCCCC---CCCCCEEECcCCc
Confidence            4 555   456777888888888776653   3566677776663

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.12  E-value=9.1e-12  Score=124.18  Aligned_cols=116  Identities=20%  Similarity=0.201  Sum_probs=78.8

Q ss_pred             ccccccCCCCCCCEEeccCCcCCCc----CCccCCCCCCCCEEECcCC---ccCCCCCCCc-------CCCCCCCEEEcc
Q 046112           10 TLSPQLVGLSSLSIFNVSGNLLSGA----ISNNFGSCTSLEQLDMHGN---LFAGPIGSSL-------SSLRGLRVLDLS   75 (502)
Q Consensus        10 ~~p~~~~~l~~L~~l~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N---~l~~~~p~~~-------~~l~~L~~L~ls   75 (502)
                      .++..+..+++|+.|+|++|++++.    ++..|..+++|++|+|++|   ++++.+|..+       ..+++|+.|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            3556666777788888888887755    3344667888888888775   4444555554       577788888888


Q ss_pred             CcccCC----CChhhhcCcCCCceeeCCCCccccCCcch-----hhc---------ccccceeecCCc
Q 046112           76 QNNLSD----EIPEFLAGFKFLQNLNLSYNNFESMLPIE-----GIF---------KNASATSVFGNK  125 (502)
Q Consensus        76 ~N~l~~----~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-----~~~---------~~~~~~~~~~n~  125 (502)
                      +|.|++    .+|..+..+++|+.|+|++|.|++..+..     ..+         +++..+.+.+|.
T Consensus       103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~  170 (386)
T 2ca6_A          103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR  170 (386)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred             CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC
Confidence            888876    36777777888888888888876443221     111         567777777764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.98  E-value=1.6e-09  Score=106.67  Aligned_cols=145  Identities=13%  Similarity=0.163  Sum_probs=103.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEec--ccC-cchhHHHHHHHHHHhcCC--CCccceeeecccccccCCCcceeE
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFN--VLH-HDASKSFAVECEVTRNIR--HRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      .+.++.|.++.||+...  .+..+++|+..  ... ......+.+|+.+++.+.  +..+.+++.+|....  .....++
T Consensus        43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~~  118 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAFY  118 (359)
T ss_dssp             EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCEE
T ss_pred             EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeEE
Confidence            46789999999999854  34577888765  221 122346788999998886  455778887764321  1135789


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDC---------------------------  337 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------  337 (502)
                      ||||+++.++.+..            ...++..++..++.++++.|+.||...                           
T Consensus       119 vme~v~G~~l~~~~------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQY  186 (359)
T ss_dssp             EEECCCCBCCCCTT------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHH
T ss_pred             EEEecCCeecCCCc------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHH
Confidence            99999998775421            123677888899999999999999520                           


Q ss_pred             ----------------------------CCCceeecCCCCCeeeCCCCc--EEEeeeccceec
Q 046112          338 ----------------------------QPPIAHCDLKPSNILLDDEMT--AYVSDFGIARFL  370 (502)
Q Consensus       338 ----------------------------~~~i~H~dlk~~NIll~~~~~--~kl~Dfg~a~~~  370 (502)
                                                  ...++|+|+++.||+++.++.  +.|.||+.+..-
T Consensus       187 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          187 KLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                        256999999999999997753  689999998754

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.96  E-value=1.9e-11  Score=124.74  Aligned_cols=125  Identities=19%  Similarity=0.133  Sum_probs=88.8

Q ss_pred             CCCCCcccccc----ccc-cCCCCCCCEEeccCCcCCCc----CCccCCCCCCCCEEECcCCccCCCCCCCcCC-----C
Q 046112            1 DLSNNNLSGTL----SPQ-LVGLSSLSIFNVSGNLLSGA----ISNNFGSCTSLEQLDMHGNLFAGPIGSSLSS-----L   66 (502)
Q Consensus         1 dl~~n~l~~~~----p~~-~~~l~~L~~l~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l   66 (502)
                      ||++|++++.-    ++. +..+++|+.|+|++|++++.    ++..+..+++|++|+|++|.+++..+..+..     .
T Consensus       233 ~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~  312 (461)
T 1z7x_W          233 ALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG  312 (461)
T ss_dssp             ECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTT
T ss_pred             eccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCC
Confidence            47788887432    222 33588899999999988854    6777778889999999999887543333332     2


Q ss_pred             CCCCEEEccCcccCCC----ChhhhcCcCCCceeeCCCCccccCCcch-hh-----cccccceeecCCc
Q 046112           67 RGLRVLDLSQNNLSDE----IPEFLAGFKFLQNLNLSYNNFESMLPIE-GI-----FKNASATSVFGNK  125 (502)
Q Consensus        67 ~~L~~L~ls~N~l~~~----~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~-----~~~~~~~~~~~n~  125 (502)
                      ++|+.|+|++|.+++.    +|..+..+++|+.|++++|++++..+.. ..     .+.+..+.+.+|.
T Consensus       313 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~  381 (461)
T 1z7x_W          313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD  381 (461)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred             ccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence            6888888888888865    5667777888888888888887654322 11     3467778877774

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.87  E-value=1.2e-10  Score=118.91  Aligned_cols=125  Identities=18%  Similarity=0.177  Sum_probs=93.3

Q ss_pred             CCCCCccccccccccC-CCC----CCCEEeccCCcCCC----cCCccCCCCCCCCEEECcCCccCCCCCCCcC-----CC
Q 046112            1 DLSNNNLSGTLSPQLV-GLS----SLSIFNVSGNLLSG----AISNNFGSCTSLEQLDMHGNLFAGPIGSSLS-----SL   66 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~-~l~----~L~~l~l~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~l   66 (502)
                      ||++|+++...+..+. .+.    +|++|+|++|+++.    .+|..+..+++|++|+|++|.+++..+..+.     .+
T Consensus        62 ~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~  141 (461)
T 1z7x_W           62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ  141 (461)
T ss_dssp             ECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred             eCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCC
Confidence            5788998855444443 344    79999999999994    5688899999999999999998764333332     35


Q ss_pred             CCCCEEEccCcccCCC----ChhhhcCcCCCceeeCCCCccccCCcchh------hcccccceeecCCc
Q 046112           67 RGLRVLDLSQNNLSDE----IPEFLAGFKFLQNLNLSYNNFESMLPIEG------IFKNASATSVFGNK  125 (502)
Q Consensus        67 ~~L~~L~ls~N~l~~~----~p~~~~~~~~L~~l~l~~N~l~~~~~~~~------~~~~~~~~~~~~n~  125 (502)
                      ++|+.|+|++|.+++.    ++..+..+++|+.|++++|+++.......      ....+..+.+.+|.
T Consensus       142 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~  210 (461)
T 1z7x_W          142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCG  210 (461)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSC
T ss_pred             CcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCC
Confidence            6899999999999864    46677788999999999999876433221      13477888888874

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.87  E-value=6e-10  Score=103.80  Aligned_cols=66  Identities=26%  Similarity=0.307  Sum_probs=38.7

Q ss_pred             CCCCCCCEEECcCCccCC--CCCCCcCCCCCCCEEEccCcccCCCChhhhcCcC--CCceeeCCCCccccCC
Q 046112           40 GSCTSLEQLDMHGNLFAG--PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFK--FLQNLNLSYNNFESML  107 (502)
Q Consensus        40 ~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~--~L~~l~l~~N~l~~~~  107 (502)
                      .++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.+++..
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~  236 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTF  236 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGC
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcccc
Confidence            345666666666666666  3344555666666666666666642  2233333  6666666666666543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.85  E-value=7e-10  Score=106.65  Aligned_cols=191  Identities=17%  Similarity=0.119  Sum_probs=117.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-CCc--cceeeecccccccCCCcceeEEe
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRN--LVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      .+.++.|.+..||+..     ..+++|+....  .....+.+|.++++.+. +..  +.+++..+..  .......++||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceEEE
Confidence            4568999999999872     35778875422  23567889999998773 322  3334433211  11112347899


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLD------------------------------  336 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------  336 (502)
                      ||++|.+|.+...            ..++..++..++.++++.++.||..                              
T Consensus        96 ~~i~G~~l~~~~~------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (304)
T 3sg8_A           96 TKIKGVPLTPLLL------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR  163 (304)
T ss_dssp             ECCCCEECCHHHH------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred             cccCCeECCcccc------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence            9999988764321            1255666677777777777777741                              


Q ss_pred             -------------------------CCCCceeecCCCCCeeeCC--CCcEEEeeeccceecccccccceeccc---c---
Q 046112          337 -------------------------CQPPIAHCDLKPSNILLDD--EMTAYVSDFGIARFLEAADEQTRSIGV---E---  383 (502)
Q Consensus       337 -------------------------~~~~i~H~dlk~~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~---~---  383 (502)
                                               ....++|+|++|.||++++  +..+.|.||+.+....+..........   .   
T Consensus       164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~  243 (304)
T 3sg8_A          164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGME  243 (304)
T ss_dssp             TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHH
T ss_pred             cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHH
Confidence                                     1245899999999999998  556889999998754322110000000   0   


Q ss_pred             ------ccccccc-CcccCCCccCccccchhHHHHHHHHHhCCCCCc
Q 046112          384 ------GTTGYIA-PEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD  423 (502)
Q Consensus       384 ------gt~~y~a-PE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~  423 (502)
                            ...++.. |+...  ......+.|++|.++|++.+|..+|.
T Consensus       244 ~~~~~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          244 FVSKILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence                  0001111 22111  11223689999999999999987764

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.76  E-value=2.6e-10  Score=112.69  Aligned_cols=86  Identities=21%  Similarity=0.165  Sum_probs=39.6

Q ss_pred             CCCCEEeccCCcCCCcCCccC-CCCCCCCEEECcCCccCCCCCCCc-----CCCCCCCEEEccCcccCC----CChhhhc
Q 046112           19 SSLSIFNVSGNLLSGAISNNF-GSCTSLEQLDMHGNLFAGPIGSSL-----SSLRGLRVLDLSQNNLSD----EIPEFLA   88 (502)
Q Consensus        19 ~~L~~l~l~~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~~~-----~~l~~L~~L~ls~N~l~~----~~p~~~~   88 (502)
                      ++|+.|+|++|.|+......+ ..+++|+.|+|++|+|+......+     ...++|+.|+|++|.|++    .++..+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            456666666665553222222 224455555555555543222222     123455555555555542    1233334


Q ss_pred             CcCCCceeeCCCCccc
Q 046112           89 GFKFLQNLNLSYNNFE  104 (502)
Q Consensus        89 ~~~~L~~l~l~~N~l~  104 (502)
                      .+++|+.|+|++|+|+
T Consensus       181 ~~~~L~~L~Ls~N~l~  196 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLG  196 (372)
T ss_dssp             TCSSCCEEECTTSSCH
T ss_pred             cCCCcCEEeCCCCCCC
Confidence            4555555555555554

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.74  E-value=7.3e-10  Score=109.44  Aligned_cols=125  Identities=17%  Similarity=0.192  Sum_probs=90.7

Q ss_pred             CCCCCccccccccccC-CCCCCCEEeccCCcCCCcCCccC-----CCCCCCCEEECcCCccCC----CCCCCcCCCCCCC
Q 046112            1 DLSNNNLSGTLSPQLV-GLSSLSIFNVSGNLLSGAISNNF-----GSCTSLEQLDMHGNLFAG----PIGSSLSSLRGLR   70 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~-~l~~L~~l~l~~N~l~~~~~~~~-----~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~   70 (502)
                      ||++|.|+..-...+. .+++|+.|+|++|.|+......+     ...++|++|+|++|.|+.    .++..+..+++|+
T Consensus       107 ~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~  186 (372)
T 3un9_A          107 NLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVT  186 (372)
T ss_dssp             ECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCC
T ss_pred             EecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcC
Confidence            5788888744333333 35688999999999985444444     346889999999999865    2445557788999


Q ss_pred             EEEccCcccCCC----ChhhhcCcCCCceeeCCCCccccCCcc-----hhhcccccceeecCCc
Q 046112           71 VLDLSQNNLSDE----IPEFLAGFKFLQNLNLSYNNFESMLPI-----EGIFKNASATSVFGNK  125 (502)
Q Consensus        71 ~L~ls~N~l~~~----~p~~~~~~~~L~~l~l~~N~l~~~~~~-----~~~~~~~~~~~~~~n~  125 (502)
                      .|||++|.|++.    ++..+...++|+.|+|++|.|+.....     ....+.+..+.+++|+
T Consensus       187 ~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~  250 (372)
T 3un9_A          187 HLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNE  250 (372)
T ss_dssp             EEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSS
T ss_pred             EEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCC
Confidence            999999998753    356677788999999999998753321     1234678888888885

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.57  E-value=3.3e-09  Score=98.84  Aligned_cols=80  Identities=25%  Similarity=0.320  Sum_probs=64.9

Q ss_pred             CCCCCCCEEeccCCcCCC--cCCccCCCCCCCCEEECcCCccCCCCCCCcCCCC--CCCEEEccCcccCCCCh-------
Q 046112           16 VGLSSLSIFNVSGNLLSG--AISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLR--GLRVLDLSQNNLSDEIP-------   84 (502)
Q Consensus        16 ~~l~~L~~l~l~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--~L~~L~ls~N~l~~~~p-------   84 (502)
                      .++++|++|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..++  +|+.|+|++|.+++.+|       
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~  244 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS  244 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence            468899999999999997  4567778899999999999999984  3455555  89999999999997666       


Q ss_pred             hhhcCcCCCceee
Q 046112           85 EFLAGFKFLQNLN   97 (502)
Q Consensus        85 ~~~~~~~~L~~l~   97 (502)
                      ..+..+++|+.||
T Consensus       245 ~il~~~P~L~~LD  257 (267)
T 3rw6_A          245 AIRERFPKLLRLD  257 (267)
T ss_dssp             HHHHHCTTCCEES
T ss_pred             HHHHHCcccCeEC
Confidence            2466788888776

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.54  E-value=8.7e-08  Score=93.01  Aligned_cols=101  Identities=11%  Similarity=-0.005  Sum_probs=85.2

Q ss_pred             CCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCC-EEEccCcccCCCChhhhcCcCCCce
Q 046112           17 GLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLR-VLDLSQNNLSDEIPEFLAGFKFLQN   95 (502)
Q Consensus        17 ~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~-~L~ls~N~l~~~~p~~~~~~~~L~~   95 (502)
                      .+++|+.|+|++|+++...+..|.+|++|+.|+|.+| ++.+.+.+|.++++|+ .|+|.+ .++..-+..|.+|++|+.
T Consensus       224 ~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~  301 (329)
T 3sb4_A          224 YMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY  301 (329)
T ss_dssp             HCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred             hcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence            3789999999999999666677999999999999998 8887788899999999 999999 777455689999999999


Q ss_pred             eeCCCCccccCCcchh-hcccccce
Q 046112           96 LNLSYNNFESMLPIEG-IFKNASAT  119 (502)
Q Consensus        96 l~l~~N~l~~~~~~~~-~~~~~~~~  119 (502)
                      ++++.|+++.+.+..+ .+.++..+
T Consensus       302 l~l~~n~i~~I~~~aF~~~~~L~~l  326 (329)
T 3sb4_A          302 VLATGDKITTLGDELFGNGVPSKLI  326 (329)
T ss_dssp             EEECSSCCCEECTTTTCTTCCCCEE
T ss_pred             EEeCCCccCccchhhhcCCcchhhh
Confidence            9999999998887553 33444443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.52  E-value=1.3e-07  Score=91.75  Aligned_cols=81  Identities=15%  Similarity=0.044  Sum_probs=44.8

Q ss_pred             CCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCc-eeeCCCCccccCCcch-hhcccccce
Q 046112           42 CTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQ-NLNLSYNNFESMLPIE-GIFKNASAT  119 (502)
Q Consensus        42 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~-~l~l~~N~l~~~~~~~-~~~~~~~~~  119 (502)
                      +++|+.|+|++|+++...+.+|.++++|+.|+|++| ++..-+..|.+|++|+ .+++++ +++.+.+.. ..+.++..+
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            566666666666666544555666666666666665 4433344566666666 666655 555544333 233445555


Q ss_pred             eecCC
Q 046112          120 SVFGN  124 (502)
Q Consensus       120 ~~~~n  124 (502)
                      .+.+|
T Consensus       303 ~l~~n  307 (329)
T 3sb4_A          303 LATGD  307 (329)
T ss_dssp             EECSS
T ss_pred             EeCCC
Confidence            54444

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.52  E-value=9.9e-09  Score=90.81  Aligned_cols=115  Identities=13%  Similarity=0.095  Sum_probs=86.0

Q ss_pred             cccccCCCCCCCEEeccCC-cCCCc----CCccCCCCCCCCEEECcCCccCCC----CCCCcCCCCCCCEEEccCcccCC
Q 046112           11 LSPQLVGLSSLSIFNVSGN-LLSGA----ISNNFGSCTSLEQLDMHGNLFAGP----IGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus        11 ~p~~~~~l~~L~~l~l~~N-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      +...+...++|++|+|++| .|...    +...+...++|++|+|++|+|...    +...+...++|+.|+|++|.|++
T Consensus        28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~  107 (185)
T 1io0_A           28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG  107 (185)
T ss_dssp             HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence            3445677899999999999 88732    455667789999999999998752    34456666899999999999985


Q ss_pred             C----ChhhhcCcCCCceeeC--CCCccccCC-----cchhhcccccceeecCCc
Q 046112           82 E----IPEFLAGFKFLQNLNL--SYNNFESML-----PIEGIFKNASATSVFGNK  125 (502)
Q Consensus        82 ~----~p~~~~~~~~L~~l~l--~~N~l~~~~-----~~~~~~~~~~~~~~~~n~  125 (502)
                      .    +...+...+.|+.|+|  ++|.|+..-     ........+..+.+.+|.
T Consensus       108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~  162 (185)
T 1io0_A          108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  162 (185)
T ss_dssp             HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCC
Confidence            3    4567777889999999  889987532     112234667788887774

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.44  E-value=2.3e-08  Score=88.37  Aligned_cols=104  Identities=17%  Similarity=0.276  Sum_probs=66.2

Q ss_pred             CCCCC-cccc----ccccccCCCCCCCEEeccCCcCCCc----CCccCCCCCCCCEEECcCCccCCC----CCCCcCCCC
Q 046112            1 DLSNN-NLSG----TLSPQLVGLSSLSIFNVSGNLLSGA----ISNNFGSCTSLEQLDMHGNLFAGP----IGSSLSSLR   67 (502)
Q Consensus         1 dl~~n-~l~~----~~p~~~~~l~~L~~l~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~   67 (502)
                      ||++| .|..    .+...+...++|++|+|++|.|+..    +...+...++|++|+|++|+|+..    +...+...+
T Consensus        42 ~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~  121 (185)
T 1io0_A           42 NLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNT  121 (185)
T ss_dssp             ECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCS
T ss_pred             EecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCC
Confidence            35666 6652    2344556667777777777777632    333445567777777777777652    345566667


Q ss_pred             CCCEEEc--cCcccCCC----ChhhhcCcCCCceeeCCCCccc
Q 046112           68 GLRVLDL--SQNNLSDE----IPEFLAGFKFLQNLNLSYNNFE  104 (502)
Q Consensus        68 ~L~~L~l--s~N~l~~~----~p~~~~~~~~L~~l~l~~N~l~  104 (502)
                      +|+.|+|  ++|.|...    +...+...+.|+.|+|++|.+.
T Consensus       122 ~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          122 SLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             SCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             CceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            7777777  66777643    3344555577777777777764

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.37  E-value=6.8e-08  Score=101.63  Aligned_cols=84  Identities=14%  Similarity=0.126  Sum_probs=60.8

Q ss_pred             CCCCCCCEEeccCCcCCCc----CCccCCCCCCCCEEECcCCccCC----CCCCCcCCCCCCCEEEccCcccCCCChhhh
Q 046112           16 VGLSSLSIFNVSGNLLSGA----ISNNFGSCTSLEQLDMHGNLFAG----PIGSSLSSLRGLRVLDLSQNNLSDEIPEFL   87 (502)
Q Consensus        16 ~~l~~L~~l~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~   87 (502)
                      .++++|+.|+|++|.+++.    ++..+..+++|++|+|++|.+++    .++..+.++++|+.|+|++|.+.+ +|..+
T Consensus       161 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~  239 (592)
T 3ogk_B          161 THCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFF  239 (592)
T ss_dssp             HHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHH
T ss_pred             hhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHH
Confidence            4678888888888887755    34445667888888888888863    344445667888888888888874 77777


Q ss_pred             cCcCCCceeeCCC
Q 046112           88 AGFKFLQNLNLSY  100 (502)
Q Consensus        88 ~~~~~L~~l~l~~  100 (502)
                      .++++|+.|+++.
T Consensus       240 ~~~~~L~~L~l~~  252 (592)
T 3ogk_B          240 KAAANLEEFCGGS  252 (592)
T ss_dssp             HHCTTCCEEEECB
T ss_pred             hhhhHHHhhcccc
Confidence            7777777777764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.30  E-value=1.8e-06  Score=81.09  Aligned_cols=136  Identities=15%  Similarity=0.071  Sum_probs=91.8

Q ss_pred             cccccCCc-eEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-CCccceeeecccccccCCCcceeEEeeec
Q 046112          212 LIGAGNFG-SVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDFKALVYEFM  289 (502)
Q Consensus       212 ~lG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~  289 (502)
                      .+..|..| .||+.....++..+++|+-..   .....+..|...++.+. +-.+-++++++.     ..+..++|||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~lvme~l  102 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAWLLTTAI  102 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEEEECC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEEEEEEee
Confidence            45556555 689986666777889998643   23566888999888774 223555666643     234679999999


Q ss_pred             cCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------
Q 046112          290 ANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLD---------------------------------  336 (502)
Q Consensus       290 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------------------------------  336 (502)
                      ++.++.+....              .......++.+++..|+.||..                                 
T Consensus       103 ~G~~~~~~~~~--------------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (272)
T 4gkh_A          103 PGKTAFQVLEE--------------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFD  168 (272)
T ss_dssp             CSEEHHHHHHH--------------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCC
T ss_pred             CCccccccccC--------------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcc
Confidence            99887765421              0112334555666666666631                                 


Q ss_pred             ----------------------CCCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          337 ----------------------CQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       337 ----------------------~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                                            ....++|+|+.+.||++++++.+-|.||+.+..
T Consensus       169 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          169 DERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             GGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                  012379999999999999887778999998863

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.22  E-value=4.1e-07  Score=95.65  Aligned_cols=124  Identities=15%  Similarity=0.027  Sum_probs=76.5

Q ss_pred             CCCCCccccc----cccccCCCCCCCEEeccCCcCC----CcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEE
Q 046112            1 DLSNNNLSGT----LSPQLVGLSSLSIFNVSGNLLS----GAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVL   72 (502)
Q Consensus         1 dl~~n~l~~~----~p~~~~~l~~L~~l~l~~N~l~----~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   72 (502)
                      ||++|.+++.    ++..+.++++|+.|+|++|.++    +.++..+.++++|+.|+|++|.+.+ +|..+..+++|+.|
T Consensus       170 ~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L  248 (592)
T 3ogk_B          170 LMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEF  248 (592)
T ss_dssp             ECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEE
T ss_pred             ECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhh
Confidence            4778887644    4444567888999999999887    3444456678899999999888876 66666677777777


Q ss_pred             EccCcccC---CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           73 DLSQNNLS---DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        73 ~ls~N~l~---~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      +++++...   +..+..+..+++|+.|+++++.....+.....++++..+.+.+|.
T Consensus       249 ~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~  304 (592)
T 3ogk_B          249 CGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYAL  304 (592)
T ss_dssp             EECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCC
T ss_pred             cccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcEEecCCCc
Confidence            77643222   122234444555555555554433333333444455555555543

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.22  E-value=3.6e-06  Score=80.57  Aligned_cols=137  Identities=15%  Similarity=0.122  Sum_probs=86.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCC---ccceeeecccccccCCCcceeEEe
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHR---NLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      .+.++.|....||+.     +..+++|+-..  ......+..|.++++.+.+.   .+.+++.++.    ...+..++||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~   92 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGY   92 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEE
Confidence            346788888899987     35577887421  22346788999999988653   2444555432    1234568999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLD------------------------------  336 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------  336 (502)
                      ||++|.++.+..-            ..++..++..++.++++.|+.||..                              
T Consensus        93 e~i~G~~l~~~~~------------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~  160 (306)
T 3tdw_A           93 RKVQGQILGEDGM------------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV  160 (306)
T ss_dssp             ECCCSEECHHHHH------------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred             eccCCeECchhhh------------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence            9999988765210            0122233333333444444333321                              


Q ss_pred             ---------------------------CCCCceeecCCCCCeeeCC---CCc-EEEeeecccee
Q 046112          337 ---------------------------CQPPIAHCDLKPSNILLDD---EMT-AYVSDFGIARF  369 (502)
Q Consensus       337 ---------------------------~~~~i~H~dlk~~NIll~~---~~~-~kl~Dfg~a~~  369 (502)
                                                 ....++|+|+++.||+++.   ++. +.|.||+.+..
T Consensus       161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                       2446799999999999987   455 48999998864

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.07  E-value=8.8e-08  Score=100.75  Aligned_cols=123  Identities=13%  Similarity=0.118  Sum_probs=74.0

Q ss_pred             CCCccccccccccC-CCCCCCEEeccCCcCCCcCCccCC-CCCCCCEEECc--C----CccCCC-----CCCCcCCCCCC
Q 046112            3 SNNNLSGTLSPQLV-GLSSLSIFNVSGNLLSGAISNNFG-SCTSLEQLDMH--G----NLFAGP-----IGSSLSSLRGL   69 (502)
Q Consensus         3 ~~n~l~~~~p~~~~-~l~~L~~l~l~~N~l~~~~~~~~~-~l~~L~~L~l~--~----N~l~~~-----~p~~~~~l~~L   69 (502)
                      +.|.+++.....+. ++++|+.|.++.|.+++..+..+. .+++|+.|+|+  +    |+++..     ++..+..+++|
T Consensus       355 ~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L  434 (594)
T 2p1m_B          355 PNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDL  434 (594)
T ss_dssp             CSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTC
T ss_pred             cCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCc
Confidence            34455533223333 377788888888888765555554 47788888887  3    555531     11124556777


Q ss_pred             CEEEccCcccCCCChhhhcC-cCCCceeeCCCCccccCCcch--hhcccccceeecCCcc
Q 046112           70 RVLDLSQNNLSDEIPEFLAG-FKFLQNLNLSYNNFESMLPIE--GIFKNASATSVFGNKK  126 (502)
Q Consensus        70 ~~L~ls~N~l~~~~p~~~~~-~~~L~~l~l~~N~l~~~~~~~--~~~~~~~~~~~~~n~~  126 (502)
                      +.|+|++ .+++..+..+.. +++|+.|+|++|.+++.....  ..++++..+.+.+|+.
T Consensus       435 ~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~  493 (594)
T 2p1m_B          435 RRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF  493 (594)
T ss_dssp             CEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred             cEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence            7777766 565555555554 677777777777775432211  3356677777777753

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.05  E-value=4.1e-07  Score=95.63  Aligned_cols=86  Identities=17%  Similarity=0.249  Sum_probs=51.4

Q ss_pred             CCCCCCEEeccCCcCCCcCCccCC-CCCCCCEEECcCC-ccCCC-CCCCcCCCCCCCEEEccCcccCCCChhhhc----C
Q 046112           17 GLSSLSIFNVSGNLLSGAISNNFG-SCTSLEQLDMHGN-LFAGP-IGSSLSSLRGLRVLDLSQNNLSDEIPEFLA----G   89 (502)
Q Consensus        17 ~l~~L~~l~l~~N~l~~~~~~~~~-~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~----~   89 (502)
                      .+++|+.|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|+.|+|++|.+++..+.++.    .
T Consensus       103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~  182 (594)
T 2p1m_B          103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT  182 (594)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred             hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence            456677777777776655555554 4667777777666 34331 333334566777777777766654444333    4


Q ss_pred             cCCCceeeCCCCc
Q 046112           90 FKFLQNLNLSYNN  102 (502)
Q Consensus        90 ~~~L~~l~l~~N~  102 (502)
                      +++|+.|++++|.
T Consensus       183 ~~~L~~L~l~~~~  195 (594)
T 2p1m_B          183 YTSLVSLNISCLA  195 (594)
T ss_dssp             CCCCCEEECTTCC
T ss_pred             CCcCcEEEecccC
Confidence            4566667766665

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.96  E-value=1.6e-05  Score=77.76  Aligned_cols=84  Identities=8%  Similarity=-0.017  Sum_probs=52.7

Q ss_pred             Ccc-cccCCceEEEEEEc---C---CCeEEEEEEecccC---cchhHHHHHHHHHHhcCCC---CccceeeecccccccC
Q 046112          211 NLI-GAGNFGSVYKGILF---E---STTAVAVKVFNVLH---HDASKSFAVECEVTRNIRH---RNLVKVFTACSGVDFQ  277 (502)
Q Consensus       211 ~~l-G~G~~g~Vy~~~~~---~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~  277 (502)
                      +.| +.|....+|+....   +   ++..+++|+.....   ......+..|+.+++.+..   -.+.+++.++..... 
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~-  104 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV-  104 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT-
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc-
Confidence            567 78888999988542   1   26678888764322   1012457788888877742   245666766432211 


Q ss_pred             CCcceeEEeeeccCCChhh
Q 046112          278 GNDFKALVYEFMANGSLEE  296 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~  296 (502)
                       ....++||||++|.++.+
T Consensus       105 -~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 -LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             -TSSCEEEEECCCCBCCCB
T ss_pred             -cCCceEEEEecCCCChhh
Confidence             124579999999887764

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=97.95  E-value=1.7e-05  Score=78.78  Aligned_cols=109  Identities=15%  Similarity=0.133  Sum_probs=78.7

Q ss_pred             cccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccC-----CCCCCCcCCCCCCCEEEccCcccCCCChhhh
Q 046112           13 PQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFA-----GPIGSSLSSLRGLRVLDLSQNNLSDEIPEFL   87 (502)
Q Consensus        13 ~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~   87 (502)
                      .+|.+ .+|+.+.| .|.++..-+..|.+|++|+.+++.+|.+.     ...+.+|.+|++|+.++|.+ .++..-...|
T Consensus       243 ~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF  319 (401)
T 4fdw_A          243 EAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLL  319 (401)
T ss_dssp             TTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTT
T ss_pred             ccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhh
Confidence            34555 78888888 45566566777888999999998888775     44567788888999999884 4664445688


Q ss_pred             cCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           88 AGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        88 ~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      .+|.+|+.+.|.+| ++.+....+...++..+.+.+|.
T Consensus       320 ~~c~~L~~l~lp~~-l~~I~~~aF~~~~L~~l~l~~n~  356 (401)
T 4fdw_A          320 GGNRKVTQLTIPAN-VTQINFSAFNNTGIKEVKVEGTT  356 (401)
T ss_dssp             TTCCSCCEEEECTT-CCEECTTSSSSSCCCEEEECCSS
T ss_pred             cCCCCccEEEECcc-ccEEcHHhCCCCCCCEEEEcCCC
Confidence            88888999888655 66655544332377777777774

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=97.94  E-value=2.1e-05  Score=78.14  Aligned_cols=91  Identities=9%  Similarity=0.077  Sum_probs=51.1

Q ss_pred             ccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccC---------------
Q 046112           12 SPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQ---------------   76 (502)
Q Consensus        12 p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~---------------   76 (502)
                      +.+|.+|++|+.++|++|+++......|. +++|+.+.|..| ++..-..+|.++++|+.|+|.+               
T Consensus       173 ~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~l~~I~~~aF~~~~L  250 (401)
T 4fdw_A          173 EDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPENVSTIGQEAFRESGI  250 (401)
T ss_dssp             SSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTTCCEECTTTTTTCCC
T ss_pred             HHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCCccCccccccccCCc
Confidence            34566777777777777766633333333 345555555422 4433334444444444444433               


Q ss_pred             ------cccCCCChhhhcCcCCCceeeCCCCccc
Q 046112           77 ------NNLSDEIPEFLAGFKFLQNLNLSYNNFE  104 (502)
Q Consensus        77 ------N~l~~~~p~~~~~~~~L~~l~l~~N~l~  104 (502)
                            |.++..-+..|.+|++|+.+.+.+|.+.
T Consensus       251 ~~i~lp~~i~~I~~~aF~~c~~L~~l~l~~~~~~  284 (401)
T 4fdw_A          251 TTVKLPNGVTNIASRAFYYCPELAEVTTYGSTFN  284 (401)
T ss_dssp             SEEEEETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred             cEEEeCCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence                  2343223557777888888888777765

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.83  E-value=1.6e-06  Score=84.75  Aligned_cols=109  Identities=12%  Similarity=0.103  Sum_probs=75.7

Q ss_pred             CCCCCCEEeccCCcCCCcCCccCC--CCCCCCEEECcC--CccCCC-----CCCCc--CCCCCCCEEEccCcccCCCChh
Q 046112           17 GLSSLSIFNVSGNLLSGAISNNFG--SCTSLEQLDMHG--NLFAGP-----IGSSL--SSLRGLRVLDLSQNNLSDEIPE   85 (502)
Q Consensus        17 ~l~~L~~l~l~~N~l~~~~~~~~~--~l~~L~~L~l~~--N~l~~~-----~p~~~--~~l~~L~~L~ls~N~l~~~~p~   85 (502)
                      .+++|+.|+|..|.++......++  .+++|+.|+|+.  |...+.     +...+  ..+++|+.|+|++|.+.+..+.
T Consensus       191 ~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~  270 (362)
T 2ra8_A          191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVE  270 (362)
T ss_dssp             BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHH
T ss_pred             cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHH
Confidence            378999999999988754434443  789999999863  332221     11122  2478999999999999865555


Q ss_pred             hhc---CcCCCceeeCCCCccccC-----CcchhhcccccceeecCCc
Q 046112           86 FLA---GFKFLQNLNLSYNNFESM-----LPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        86 ~~~---~~~~L~~l~l~~N~l~~~-----~~~~~~~~~~~~~~~~~n~  125 (502)
                      .+.   .+++|+.|+|+.|+|++.     ......++++..+.+.+|.
T Consensus       271 ~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~  318 (362)
T 2ra8_A          271 MFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY  318 (362)
T ss_dssp             HHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBB
T ss_pred             HHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCc
Confidence            554   478999999999998763     2222346778888887773

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.82  E-value=4.5e-05  Score=75.76  Aligned_cols=76  Identities=20%  Similarity=0.154  Sum_probs=47.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccCc-------chhHHHHHHHHHHhcCCC--Cccc-eeeecccccccCCC
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-------DASKSFAVECEVTRNIRH--RNLV-KVFTACSGVDFQGN  279 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~~~~~~~  279 (502)
                      .+.+|.|.++.||++....+++.++||.......       .....+..|.++++.+..  +..+ +++.+.       .
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence            4578999999999996555678899997542211       123456778888877642  3333 444331       1


Q ss_pred             cceeEEeeeccCC
Q 046112          280 DFKALVYEFMANG  292 (502)
Q Consensus       280 ~~~~lv~e~~~~g  292 (502)
                      +..++||||+++.
T Consensus       108 ~~~~lvmE~l~g~  120 (397)
T 2olc_A          108 EMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CccEEEEEeCCCc
Confidence            2457999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.81  E-value=8e-05  Score=72.15  Aligned_cols=31  Identities=26%  Similarity=0.451  Sum_probs=28.3

Q ss_pred             CCCceeecCCCCCeeeCCCCcEEEeeeccce
Q 046112          338 QPPIAHCDLKPSNILLDDEMTAYVSDFGIAR  368 (502)
Q Consensus       338 ~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~  368 (502)
                      ...++|+|+.+.||+++.++.+.|.||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            5789999999999999888899999999875

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.72  E-value=5.4e-06  Score=71.54  Aligned_cols=92  Identities=14%  Similarity=0.117  Sum_probs=63.2

Q ss_pred             cccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCc-cCCCCCCCcCCC----CCCCEEEccCc-ccCCCCh
Q 046112           11 LSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNL-FAGPIGSSLSSL----RGLRVLDLSQN-NLSDEIP   84 (502)
Q Consensus        11 ~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~L~ls~N-~l~~~~p   84 (502)
                      +|.....--+|+.|||+++.++..--..+.++++|+.|+|+++. ++..-=..++.+    ++|+.|+|+++ ++++.-=
T Consensus        53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl  132 (176)
T 3e4g_A           53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI  132 (176)
T ss_dssp             SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred             CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence            44433233468899999988885544567888999999998884 654222234443    36889999886 4775444


Q ss_pred             hhhcCcCCCceeeCCCCc
Q 046112           85 EFLAGFKFLQNLNLSYNN  102 (502)
Q Consensus        85 ~~~~~~~~L~~l~l~~N~  102 (502)
                      ..+.++++|+.|+|+++.
T Consensus       133 ~~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A          133 IALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             HHGGGCTTCCEEEEESCT
T ss_pred             HHHhcCCCCCEEECCCCC
Confidence            567788888888888774

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.69  E-value=1.2e-05  Score=78.65  Aligned_cols=112  Identities=15%  Similarity=0.180  Sum_probs=75.3

Q ss_pred             cccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcC--CCCCCCEEEccC--cccCCC----
Q 046112           11 LSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLS--SLRGLRVLDLSQ--NNLSDE----   82 (502)
Q Consensus        11 ~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~ls~--N~l~~~----   82 (502)
                      ++.-+..+++|+.|+|++|.-. .++. +. +++|+.|+|..|.++......+.  .+++|+.|+|+.  |...+.    
T Consensus       164 L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~  240 (362)
T 2ra8_A          164 LSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMN  240 (362)
T ss_dssp             CHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGG
T ss_pred             HHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHH
Confidence            4444567899999999998412 2333 43 89999999999987653323343  689999999963  332221    


Q ss_pred             -Chhhh--cCcCCCceeeCCCCccccCCcc----hhhcccccceeecCCc
Q 046112           83 -IPEFL--AGFKFLQNLNLSYNNFESMLPI----EGIFKNASATSVFGNK  125 (502)
Q Consensus        83 -~p~~~--~~~~~L~~l~l~~N~l~~~~~~----~~~~~~~~~~~~~~n~  125 (502)
                       +...+  ..+++|+.|+|++|.++.....    ...++++..+.++.|.
T Consensus       241 ~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~  290 (362)
T 2ra8_A          241 VFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGV  290 (362)
T ss_dssp             GTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSC
T ss_pred             HHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCC
Confidence             11223  2578999999999998753221    1246788889987774

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.52  E-value=0.00022  Score=67.37  Aligned_cols=78  Identities=13%  Similarity=0.020  Sum_probs=54.2

Q ss_pred             CCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCC---ccceeeecccccccCCCccee
Q 046112          207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHR---NLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       207 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ....+.+|.|..+.||+. ...+|+.+.+|+-..........|..|+..|+.+.-.   .+.+++++.         ..+
T Consensus        17 v~~v~~~g~G~~~~vyrv-~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~~   86 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRV-ELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DRT   86 (288)
T ss_dssp             EEEEEEEEEETTEEEEEE-EETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TTE
T ss_pred             eEEEEecCCCCCeEEEEE-EECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cce
Confidence            344567899999999999 4578899999986543333345688899988877422   334444431         347


Q ss_pred             EEeeeccCCCh
Q 046112          284 LVYEFMANGSL  294 (502)
Q Consensus       284 lv~e~~~~gsL  294 (502)
                      +||||++.+..
T Consensus        87 lv~e~l~~~~~   97 (288)
T 3f7w_A           87 LAMEWVDERPP   97 (288)
T ss_dssp             EEEECCCCCCC
T ss_pred             EEEEeecccCC
Confidence            89999987654

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.52  E-value=0.00018  Score=58.99  Aligned_cols=55  Identities=20%  Similarity=0.283  Sum_probs=25.1

Q ss_pred             EEeccCCcCC-CcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112           23 IFNVSGNLLS-GAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus        23 ~l~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      .++.+++.|+ ..+|..+.  ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            4555555554 23333221  2345555555555543344444445555555554443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.49  E-value=0.00019  Score=58.89  Aligned_cols=57  Identities=19%  Similarity=0.247  Sum_probs=47.8

Q ss_pred             CEEECcCCccC-CCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCceeeCCCCccc
Q 046112           46 EQLDMHGNLFA-GPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFE  104 (502)
Q Consensus        46 ~~L~l~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l~~N~l~  104 (502)
                      ..++.++++|+ ..+|..+.  ++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            48899999998 23887765  58999999999999544567889999999999999875

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.45  E-value=0.0001  Score=73.76  Aligned_cols=80  Identities=9%  Similarity=0.022  Sum_probs=50.6

Q ss_pred             CCCceeecCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCC---ccCccccchhHHHHHHH
Q 046112          338 QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH---EVSSYGDVYSFGILLLE  414 (502)
Q Consensus       338 ~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDvws~Gv~l~e  414 (502)
                      ...++|+|+++.|||++.++ +++.||+.+..-.+.-...... ..-...|++|+.....   ......++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            67899999999999998876 9999999987543221111100 0012346676655321   12233556678888888


Q ss_pred             HHhCC
Q 046112          415 MFTGL  419 (502)
Q Consensus       415 l~tg~  419 (502)
                      .++++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.24  E-value=0.00084  Score=63.97  Aligned_cols=75  Identities=13%  Similarity=0.116  Sum_probs=54.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC---CCccceeeecccccccCCCcceeEEe
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR---HRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      .+.|+.|.+..+|+...  ++..+++|+....   ....+..|...++.+.   ...+.+++.++..     .+..++||
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvm  110 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLL  110 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEE
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEE
Confidence            46789999999999853  5667888986532   3566888988888774   3556777766432     24689999


Q ss_pred             eeccCCCh
Q 046112          287 EFMANGSL  294 (502)
Q Consensus       287 e~~~~gsL  294 (502)
                      ||+++..+
T Consensus       111 e~l~G~~~  118 (312)
T 3jr1_A          111 EALNKSKN  118 (312)
T ss_dssp             ECCCCCCC
T ss_pred             EeccCCCC
Confidence            99998865

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.20  E-value=6.4e-05  Score=66.08  Aligned_cols=87  Identities=13%  Similarity=0.142  Sum_probs=65.7

Q ss_pred             cCCCCCCCEEeccCC-cCCC----cCCccCCCCCCCCEEECcCCccCCC----CCCCcCCCCCCCEEEccCcccCCCC--
Q 046112           15 LVGLSSLSIFNVSGN-LLSG----AISNNFGSCTSLEQLDMHGNLFAGP----IGSSLSSLRGLRVLDLSQNNLSDEI--   83 (502)
Q Consensus        15 ~~~l~~L~~l~l~~N-~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~--   83 (502)
                      +.+-+.|++|+|++| +|..    .+...+..-+.|+.|+|++|+|...    +...+..-+.|+.|+|++|.|++.-  
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~  116 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA  116 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence            455678999999996 7763    2455677789999999999999752    3344446689999999999998542  


Q ss_pred             --hhhhcCcCCCceeeCCCC
Q 046112           84 --PEFLAGFKFLQNLNLSYN  101 (502)
Q Consensus        84 --p~~~~~~~~L~~l~l~~N  101 (502)
                        -..+..-+.|+.|+|++|
T Consensus       117 ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          117 RLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHHHHTTTTCCCSEEECCCC
T ss_pred             HHHHHHhhCCceeEEECCCC
Confidence              234555677999999865

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=97.13  E-value=0.001  Score=65.80  Aligned_cols=109  Identities=11%  Similarity=0.227  Sum_probs=75.0

Q ss_pred             cccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCC
Q 046112           13 PQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKF   92 (502)
Q Consensus        13 ~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~   92 (502)
                      .+|.++.+|+.+.+..+..+ .-...|.++++|+.+.+. +.++.....+|.++.+|+.++|.+| ++..-..+|.+|.+
T Consensus       259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~  335 (394)
T 4gt6_A          259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQ  335 (394)
T ss_dssp             TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred             ceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCC
Confidence            45677888888888776554 556668888888888885 4566555667888888888888765 44233567888888


Q ss_pred             CceeeCCCCccccCCcch-hhcccccceeecCCc
Q 046112           93 LQNLNLSYNNFESMLPIE-GIFKNASATSVFGNK  125 (502)
Q Consensus        93 L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~  125 (502)
                      |+.+.+..+ ++.+.... ..+.++..+.+.+|.
T Consensus       336 L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~  368 (394)
T 4gt6_A          336 LERIAIPSS-VTKIPESAFSNCTALNNIEYSGSR  368 (394)
T ss_dssp             CCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred             CCEEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence            888888654 66555443 344667777776664

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=97.08  E-value=0.0019  Score=63.85  Aligned_cols=88  Identities=13%  Similarity=0.219  Sum_probs=68.3

Q ss_pred             cccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCC
Q 046112           13 PQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKF   92 (502)
Q Consensus        13 ~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~   92 (502)
                      .+|.++++|+.+.+. +.++..-...|.++++|+.++|..| ++..-..+|.++.+|+.+.|..| ++..-..+|.+|.+
T Consensus       282 ~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~  358 (394)
T 4gt6_A          282 GAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTA  358 (394)
T ss_dssp             TTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTT
T ss_pred             cccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCC
Confidence            356788899999996 5566455667999999999999765 66655678999999999999765 65344578899999


Q ss_pred             CceeeCCCCcc
Q 046112           93 LQNLNLSYNNF  103 (502)
Q Consensus        93 L~~l~l~~N~l  103 (502)
                      |+.+++.+|..
T Consensus       359 L~~i~~~~~~~  369 (394)
T 4gt6_A          359 LNNIEYSGSRS  369 (394)
T ss_dssp             CCEEEESSCHH
T ss_pred             CCEEEECCcee
Confidence            99999888764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.00  E-value=0.0015  Score=61.87  Aligned_cols=31  Identities=23%  Similarity=0.398  Sum_probs=26.1

Q ss_pred             CCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          338 QPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       338 ~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                      ...++|+|+.+.||+ ..++.+.+.||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            445899999999999 5667789999998864

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.97  E-value=0.0022  Score=61.31  Aligned_cols=171  Identities=14%  Similarity=0.098  Sum_probs=87.1

Q ss_pred             CccCHHHHHHhccCCCCC-----CcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCc--cc
Q 046112          193 PYVSYRMLYNATKGFSSE-----NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRN--LV  265 (502)
Q Consensus       193 ~~~~~~~l~~~t~~~~~~-----~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv  265 (502)
                      ..++.+++......|...     +.|+.|....+|+... .+| .+++|+....  .....+..|..++..+....  +.
T Consensus         5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEE-SSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEe-CCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCC
Confidence            345556666655556542     3466688889999854 344 5778887642  12345666777776664222  23


Q ss_pred             eeeecccccc-cCCCcceeEEeeeccCCChhhh--------------ccCCchhhhccCCCCCC---CHHHHHH------
Q 046112          266 KVFTACSGVD-FQGNDFKALVYEFMANGSLEEW--------------MHPITEEDKRHKAPGNL---NSLKRLN------  321 (502)
Q Consensus       266 ~l~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~~~~~~~~~~~~l---~~~~~~~------  321 (502)
                      +++....+.. ....+..+++++|++|..+...              +|.... ..........   .|.....      
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~-~~~~~~~~~~~~~~w~~~~~~~~~~~  159 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASE-GFEIKRPNALSVDGWKVLWDKSEERA  159 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTT-TCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhc-cCCCcccCccChHHHHHHHHHHHHHH
Confidence            3332211100 0112356899999988654220              111000 0000000001   1222110      


Q ss_pred             ------HHHHHHHHHHHHHhC----CCCCceeecCCCCCeeeCCCCcEEEeeeccce
Q 046112          322 ------IAIDVACVLKYLHLD----CQPPIAHCDLKPSNILLDDEMTAYVSDFGIAR  368 (502)
Q Consensus       322 ------i~~~ia~~l~~LH~~----~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~  368 (502)
                            +...+...++++...    ....++|+|+.+.||+++++..+.|.||+.+.
T Consensus       160 ~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          160 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                  001134445555421    23578999999999999987666899999875

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.93  E-value=0.00021  Score=62.78  Aligned_cols=87  Identities=13%  Similarity=0.113  Sum_probs=58.2

Q ss_pred             cCCCCCCCCEEECcCC-ccCC----CCCCCcCCCCCCCEEEccCcccCCC----ChhhhcCcCCCceeeCCCCccccCCc
Q 046112           38 NFGSCTSLEQLDMHGN-LFAG----PIGSSLSSLRGLRVLDLSQNNLSDE----IPEFLAGFKFLQNLNLSYNNFESMLP  108 (502)
Q Consensus        38 ~~~~l~~L~~L~l~~N-~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~~~~L~~l~l~~N~l~~~~~  108 (502)
                      .+.+-+.|+.|+|++| +|..    .+-..+..-+.|+.|+|++|.|.+.    +...+..-+.|+.|+|+.|+|+..-.
T Consensus        36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga  115 (197)
T 1pgv_A           36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL  115 (197)
T ss_dssp             HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred             HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence            3456688999999986 7653    2344566668899999999999743    33455566789999999999864211


Q ss_pred             c-----hhhcccccceeecCC
Q 046112          109 I-----EGIFKNASATSVFGN  124 (502)
Q Consensus       109 ~-----~~~~~~~~~~~~~~n  124 (502)
                      .     ......+..+.+.+|
T Consensus       116 ~ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          116 ARLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHHHHHTTTTCCCSEEECCCC
T ss_pred             HHHHHHHhhCCceeEEECCCC
Confidence            1     112345666766644

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=96.89  E-value=0.0021  Score=63.14  Aligned_cols=93  Identities=14%  Similarity=0.174  Sum_probs=60.8

Q ss_pred             cccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCC
Q 046112           13 PQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKF   92 (502)
Q Consensus        13 ~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~   92 (502)
                      ..+.++..|+.+.+..+ ++..-...|.++.+|+.+.+..+ +.......|..+++|+.+++.+|.++..-+..|.+|.+
T Consensus       234 ~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~  311 (379)
T 4h09_A          234 GAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVK  311 (379)
T ss_dssp             TTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTT
T ss_pred             ccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCC
Confidence            34566777888887765 55455556777777777777543 44444556777777777777777776333457777777


Q ss_pred             CceeeCCCCccccCCc
Q 046112           93 LQNLNLSYNNFESMLP  108 (502)
Q Consensus        93 L~~l~l~~N~l~~~~~  108 (502)
                      |+.+.|.++ ++.+..
T Consensus       312 L~~i~lp~~-l~~I~~  326 (379)
T 4h09_A          312 LSSVTLPTA-LKTIQV  326 (379)
T ss_dssp             CCEEECCTT-CCEECT
T ss_pred             CCEEEcCcc-ccEEHH
Confidence            777777644 444433

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=96.85  E-value=7.9e-05  Score=64.24  Aligned_cols=81  Identities=12%  Similarity=0.124  Sum_probs=59.5

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCc-CCCcCCccCCCC----CCCCEEECcCCc-cCCCCCCCcCCCCCCCEEEc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNL-LSGAISNNFGSC----TSLEQLDMHGNL-FAGPIGSSLSSLRGLRVLDL   74 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~-l~~~~~~~~~~l----~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~l   74 (502)
                      ||+++.|+..--..+.++++|+.|+|+++. ++..--..++.+    ++|++|+|+++. +|..-=..++.+++|+.|+|
T Consensus        67 DLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L  146 (176)
T 3e4g_A           67 DATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFL  146 (176)
T ss_dssp             EEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCCEEEE
T ss_pred             eCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCCEEEC
Confidence            567777764333457899999999999985 774433445654    479999999984 77633345778999999999


Q ss_pred             cCcc-cCC
Q 046112           75 SQNN-LSD   81 (502)
Q Consensus        75 s~N~-l~~   81 (502)
                      ++.. +++
T Consensus       147 ~~c~~Itd  154 (176)
T 3e4g_A          147 SDLPGVKE  154 (176)
T ss_dssp             ESCTTCCC
T ss_pred             CCCCCCCc
Confidence            9874 653

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=96.80  E-value=0.0014  Score=64.80  Aligned_cols=103  Identities=15%  Similarity=0.128  Sum_probs=53.2

Q ss_pred             ccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCC
Q 046112           14 QLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFL   93 (502)
Q Consensus        14 ~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L   93 (502)
                      .+..+..|+.+.+..+.+.   ...|..+.+|+.+.+.+| ++..-..+|.++++|+.++|.++ ++..-..+|.+|.+|
T Consensus       271 ~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L  345 (394)
T 4fs7_A          271 LFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSL  345 (394)
T ss_dssp             TTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTC
T ss_pred             ccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCC
Confidence            4555566666666554322   234556666666666543 44434455666666666666543 442224456666666


Q ss_pred             ceeeCCCCccccCCcch-hhcccccceeec
Q 046112           94 QNLNLSYNNFESMLPIE-GIFKNASATSVF  122 (502)
Q Consensus        94 ~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~  122 (502)
                      +.+.+..| ++.+.... ..+.++..+.+.
T Consensus       346 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp  374 (394)
T 4fs7_A          346 SNINFPLS-LRKIGANAFQGCINLKKVELP  374 (394)
T ss_dssp             CEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred             CEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence            66666554 44443322 223444444443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.73  E-value=0.0091  Score=57.12  Aligned_cols=171  Identities=13%  Similarity=0.098  Sum_probs=87.4

Q ss_pred             CCccCHHHHHHhccCCCC-----CCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCc--c
Q 046112          192 FPYVSYRMLYNATKGFSS-----ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRN--L  264 (502)
Q Consensus       192 ~~~~~~~~l~~~t~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--i  264 (502)
                      +..++.+.+......|..     ...++ |....||+. ...+|+.+++|+..... .....+..|..++..+....  +
T Consensus         8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v-~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~v   84 (328)
T 1zyl_A            8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQF-QDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPV   84 (328)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEE-CCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSB
T ss_pred             CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEE-EcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCee
Confidence            344455555444433322     23466 788899988 33556678999876321 13456677888777664222  3


Q ss_pred             ceeeecccccc-cCCCcceeEEeeeccCCChhh-----h---------ccCCchhhhccCCCCCCCHHHH----------
Q 046112          265 VKVFTACSGVD-FQGNDFKALVYEFMANGSLEE-----W---------MHPITEEDKRHKAPGNLNSLKR----------  319 (502)
Q Consensus       265 v~l~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~-----~---------l~~~~~~~~~~~~~~~l~~~~~----------  319 (502)
                      .+++.. .+.. ....+..+++++|++|.++..     +         +|...... .......+++...          
T Consensus        85 p~~~~~-~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~  162 (328)
T 1zyl_A           85 AAPVAF-NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQ-LFIHRPTIGLNEYLIEPRKLFED  162 (328)
T ss_dssp             CCCCCB-TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSS-CCSSSCBCSHHHHTHHHHHHHHT
T ss_pred             cceeec-CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccC-CCccCCCCCHHHHHhhHHHHHhh
Confidence            334332 1110 011335678999998755421     0         11100000 0000111222111          


Q ss_pred             ---------HHHHHHHHHHHHHHHh----CCCCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          320 ---------LNIAIDVACVLKYLHL----DCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       320 ---------~~i~~~ia~~l~~LH~----~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                               ..+...+...++.+..    .....++|+|+++.||+++ + .+.|.||+.+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          163 ATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             cCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                     0001111122223221    1245689999999999999 4 899999998753

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=96.68  E-value=0.0021  Score=63.46  Aligned_cols=86  Identities=20%  Similarity=0.187  Sum_probs=71.1

Q ss_pred             cccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCC
Q 046112           13 PQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKF   92 (502)
Q Consensus        13 ~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~   92 (502)
                      ..+..+.+|+.+.+..+ ++..-...|.++++|+.++|.++ ++..-..+|.++++|+.++|..| ++..-..+|.+|.+
T Consensus       291 ~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~  367 (394)
T 4fs7_A          291 KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCIN  367 (394)
T ss_dssp             TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTT
T ss_pred             ccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCC
Confidence            35778999999999876 66466677999999999999754 77666788999999999999887 66344678999999


Q ss_pred             CceeeCCCC
Q 046112           93 LQNLNLSYN  101 (502)
Q Consensus        93 L~~l~l~~N  101 (502)
                      |+.+++..|
T Consensus       368 L~~i~lp~~  376 (394)
T 4fs7_A          368 LKKVELPKR  376 (394)
T ss_dssp             CCEEEEEGG
T ss_pred             CCEEEECCC
Confidence            999999765

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=96.68  E-value=0.0048  Score=60.50  Aligned_cols=91  Identities=12%  Similarity=0.155  Sum_probs=45.1

Q ss_pred             cCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCc
Q 046112           15 LVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQ   94 (502)
Q Consensus        15 ~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~   94 (502)
                      +..+.+|+.+.+..+ +.......|.++.+|+.+.+..+ ++..-..+|.++.+|+.+.+..+ +...-...|.++.+|+
T Consensus       213 f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~  289 (379)
T 4h09_A          213 FSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLT  289 (379)
T ss_dssp             TTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCC
T ss_pred             cccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccc
Confidence            444555555555444 22233444555555665555444 44333445555555555555433 3212233455555566


Q ss_pred             eeeCCCCccccCCc
Q 046112           95 NLNLSYNNFESMLP  108 (502)
Q Consensus        95 ~l~l~~N~l~~~~~  108 (502)
                      .+.+.+|.++.+.+
T Consensus       290 ~i~l~~~~i~~I~~  303 (379)
T 4h09_A          290 KVVMDNSAIETLEP  303 (379)
T ss_dssp             EEEECCTTCCEECT
T ss_pred             cccccccccceehh
Confidence            55555555554443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.64  E-value=0.0072  Score=60.76  Aligned_cols=75  Identities=13%  Similarity=0.173  Sum_probs=45.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCcc-ceeeecccccccCCCcceeEEeee
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNL-VKVFTACSGVDFQGNDFKALVYEF  288 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~  288 (502)
                      .+.|+.|-...+|+......+..+++|+....... .-+-..|..+++.+...++ .++++.+     .    -..|+||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~-----~----~G~v~e~  182 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF-----T----NGRIEEF  182 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE-----T----TEEEEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe-----C----CeEEEEe
Confidence            35678888899999965333578889987432111 1112578888887765444 3455542     1    1369999


Q ss_pred             ccCCCh
Q 046112          289 MANGSL  294 (502)
Q Consensus       289 ~~~gsL  294 (502)
                      +++.+|
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            987655

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.54  E-value=0.0034  Score=62.79  Aligned_cols=74  Identities=16%  Similarity=0.223  Sum_probs=47.2

Q ss_pred             CCcccccCCceEEEEEEcC-------CCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCcc-ceeeecccccccCCCcc
Q 046112          210 ENLIGAGNFGSVYKGILFE-------STTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNL-VKVFTACSGVDFQGNDF  281 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~  281 (502)
                      .+.|+.|....+|+.....       .+..+++|+....  .....+..|..+++.+...++ .++++.+     .    
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~----  146 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIF-----S----  146 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----T----
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----C----
Confidence            3567888889999996532       2568889987431  112456678888887753333 4455542     1    


Q ss_pred             eeEEeeeccCCCh
Q 046112          282 KALVYEFMANGSL  294 (502)
Q Consensus       282 ~~lv~e~~~~gsL  294 (502)
                      -.+|+||+++.+|
T Consensus       147 ~g~v~e~l~G~~l  159 (429)
T 1nw1_A          147 GGRLEEYIPSRPL  159 (429)
T ss_dssp             TEEEECCCCEEEC
T ss_pred             CCEEEEEeCCccc
Confidence            1389999986554

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.49  E-value=0.0056  Score=54.11  Aligned_cols=102  Identities=14%  Similarity=0.097  Sum_probs=65.4

Q ss_pred             ChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeeccceeccc
Q 046112          293 SLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEA  372 (502)
Q Consensus       293 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~  372 (502)
                      ||.+.|.         ....++++.+++.++.|.+.+|.-+-.  ...-..+=+.|..|++..+|.|...+ +.+.    
T Consensus        34 SL~eIL~---------~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----   97 (229)
T 2yle_A           34 SLEEILR---------LYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----   97 (229)
T ss_dssp             EHHHHHH---------HHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C-------
T ss_pred             cHHHHHH---------HcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc----
Confidence            6888875         446789999999999999999877621  11101233456889999999888764 1110    


Q ss_pred             ccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCC
Q 046112          373 ADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP  421 (502)
Q Consensus       373 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p  421 (502)
                                .....+.|||... ...+.+.-|||+|+++|.-+--..|
T Consensus        98 ----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                      0123466888764 3557888999999999998874444

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.42  E-value=0.019  Score=54.99  Aligned_cols=33  Identities=27%  Similarity=0.250  Sum_probs=28.4

Q ss_pred             CCCceeecCCCCCeeeCCC----CcEEEeeeccceec
Q 046112          338 QPPIAHCDLKPSNILLDDE----MTAYVSDFGIARFL  370 (502)
Q Consensus       338 ~~~i~H~dlk~~NIll~~~----~~~kl~Dfg~a~~~  370 (502)
                      ...++|||+.+.||+++.+    ..+.|.||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4679999999999999875    68999999988643

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.26  E-value=0.039  Score=53.09  Aligned_cols=33  Identities=21%  Similarity=0.469  Sum_probs=28.7

Q ss_pred             CCCceeecCCCCCeeeCCCCcEEEeeeccceec
Q 046112          338 QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL  370 (502)
Q Consensus       338 ~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~  370 (502)
                      ...++|+|+.+.||++++++.+.|.||+.+...
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            357899999999999998888999999887643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.03  E-value=0.0082  Score=58.74  Aligned_cols=149  Identities=12%  Similarity=0.185  Sum_probs=79.6

Q ss_pred             CcccccCCceEEEEEEcC-------CCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCcc-ceeeecccccccCCCcce
Q 046112          211 NLIGAGNFGSVYKGILFE-------STTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNL-VKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~  282 (502)
                      +.+..|-...+|+.....       ++..+.+|+.... ........+|..+++.+.-..+ .++++++     .+    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----
Confidence            567778888999985432       3468889986432 1234556789888877742222 4455543     11    


Q ss_pred             eEEeeeccCCChhhh-ccC----------Cch-hhhccCCCCCCC--HHHHHHHHHHHH-------------------HH
Q 046112          283 ALVYEFMANGSLEEW-MHP----------ITE-EDKRHKAPGNLN--SLKRLNIAIDVA-------------------CV  329 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~-l~~----------~~~-~~~~~~~~~~l~--~~~~~~i~~~ia-------------------~~  329 (502)
                      .+|+||++|.+|..- +..          ... ............  |.+..++..++.                   ..
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            399999998665421 100          000 000000111122  333334443322                   12


Q ss_pred             HHHHH----h-CCCCCceeecCCCCCeeeCCC----CcEEEeeecccee
Q 046112          330 LKYLH----L-DCQPPIAHCDLKPSNILLDDE----MTAYVSDFGIARF  369 (502)
Q Consensus       330 l~~LH----~-~~~~~i~H~dlk~~NIll~~~----~~~kl~Dfg~a~~  369 (502)
                      +.+|.    . .....++|+|+.+.||+++.+    +.+.+.||..+..
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            23332    1 123468999999999999876    7899999998863

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.03  E-value=0.0083  Score=58.59  Aligned_cols=31  Identities=26%  Similarity=0.391  Sum_probs=25.6

Q ss_pred             CCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          338 QPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       338 ~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                      ...++|+|+.+.|||++++. +.+.||..+..
T Consensus       211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             CEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             CeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            34689999999999998665 89999998863

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=92.14  E-value=0.28  Score=48.58  Aligned_cols=30  Identities=23%  Similarity=0.364  Sum_probs=26.7

Q ss_pred             CCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          339 PPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       339 ~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                      ..++|+|+.+.||+ +.++.+.+.||..|..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            46899999999999 7888999999998864

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=89.29  E-value=0.1  Score=51.40  Aligned_cols=30  Identities=27%  Similarity=0.474  Sum_probs=25.4

Q ss_pred             CceeecCCCCCeee------CCCCcEEEeeecccee
Q 046112          340 PIAHCDLKPSNILL------DDEMTAYVSDFGIARF  369 (502)
Q Consensus       340 ~i~H~dlk~~NIll------~~~~~~kl~Dfg~a~~  369 (502)
                      .++|+|+.+.||++      +++..+.+.||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4567899999999864

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.84  E-value=0.13  Score=51.79  Aligned_cols=60  Identities=8%  Similarity=0.059  Sum_probs=17.0

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEE------EEeccc--CcchhHHHHHHHHHHhcCCCCccceeeecc
Q 046112          209 SENLIGAGNFGSVYKGILFESTTAVAV------KVFNVL--HHDASKSFAVECEVTRNIRHRNLVKVFTAC  271 (502)
Q Consensus       209 ~~~~lG~G~~g~Vy~~~~~~~~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  271 (502)
                      ..+.+|   ||.||+|.+.....+|||      |..+..  ..+....|.+|..++..++|||+++.+++.
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            456676   999999987655567888      655432  122335688899999999999999998764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	502
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-49
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-49
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-49
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-48
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-48
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-48
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-47
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-46
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-46
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-46
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-45
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-44
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-44
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-44
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-43
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-43
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-43
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-43
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-43
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-42
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-42
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-42
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-42
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-42
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-41
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-39
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-39
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-39
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-37
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-36
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-35
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-34
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-34
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-34
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-33
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-33
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-33
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-32
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-30
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-30
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-30
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-30
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-29
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-29
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-28
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-27
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-26
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-26
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-25
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-13
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-09
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.001
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-07
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-06
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-06
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-05
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	0.004
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.004
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	4e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.003
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.004
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 8e-59
 Identities = 72/294 (24%), Positives = 123/294 (41%), Gaps = 37/294 (12%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKV 267
              IG+G+FG+VYKG        VAVK+ NV        ++F  E  V R  RH N++  
Sbjct: 13  GQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
               +          A+V ++    SL   +H                 +K ++IA   A
Sbjct: 70  MGYSTA------PQLAIVTQWCEGSSLYHHLH---------IIETKFEMIKLIDIARQTA 114

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
             + YLH      I H DLK +NI L +++T  + DFG+A          +   + G+  
Sbjct: 115 QGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171

Query: 388 YIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA 444
           ++APE     + + Y    DVY+FGI+L E+ TG  P  ++   +  +    +  L    
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL 231

Query: 445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL 498
            ++R++     + ++ ECL            ++  ER     +   + L+ + L
Sbjct: 232 SKVRSNCPKAMKRLMAECL-----------KKKRDERPLFPQILASIELLARSL 274

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 2e-49
 Identities = 55/285 (19%), Positives = 97/285 (34%), Gaps = 31/285 (10%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNL 264
           +     IG G++G   K         +  K  +      +  +    E  + R ++H N+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           V+ +        + N    +V E+   G L   +       K  K    L+    L +  
Sbjct: 66  VRYYDRIID---RTNTTLYIVMEYCEGGDLASVIT------KGTKERQYLDEEFVLRVMT 116

Query: 325 DVACVLKYLHL--DCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
            +   LK  H   D    + H DLKP+N+ LD +    + DFG+AR L    + + +   
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAF 174

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE 442
            GT  Y++PE       +   D++S G LL E+   + P     +  L      +     
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREGKFRR 233

Query: 443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV 487
                          II   L             +   R  + ++
Sbjct: 234 IPYRYSDEL----NEIITRML-----------NLKDYHRPSVEEI 263

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  169 bits (429), Expect = 3e-49
 Identities = 72/324 (22%), Positives = 129/324 (39%), Gaps = 54/324 (16%)

Query: 196 SYRMLYNATKGFSSE---------NLIGAGNFGSVYKGILFEST---TAVAVKVFN-VLH 242
           ++     A + F+ E          +IGAG FG V  G L         VA+K       
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 243 HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPIT 302
               + F  E  +     H N++ +           +    ++ EFM NGSL+ ++    
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLR--- 119

Query: 303 EEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS 362
                 +  G    ++ + +   +A  +KYL         H DL   NIL++  +   VS
Sbjct: 120 ------QNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVS 170

Query: 363 DFGIARFLE---AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-G 418
           DFG++RFLE   +    T ++G +    + APE     + +S  DV+S+GI++ E+ + G
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230

Query: 419 LRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQP 478
            RP  DM   N ++ N ++                      ++C  ++ ++ + C  +  
Sbjct: 231 ERPYWDM--TNQDVINAIEQDYR--------------LPPPMDCPSALHQLMLDCWQKDR 274

Query: 479 GERMKINDVEPRLRLIKKKLLEAP 502
             R K   +   L     K++  P
Sbjct: 275 NHRPKFGQIVNTL----DKMIRNP 294

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 7e-49
 Identities = 65/281 (23%), Positives = 120/281 (42%), Gaps = 35/281 (12%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
             +GAG FG V+ G      T VAVK        +  +F  E  + + ++H+ LV+++  
Sbjct: 19  ERLGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
            +       +   ++ E+M NGSL +++           +   L   K L++A  +A  +
Sbjct: 77  VT------QEPIYIITEYMENGSLVDFLK--------TPSGIKLTINKLLDMAAQIAEGM 122

Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
            ++    +    H DL+ +NIL+ D ++  ++DFG+AR +E  +   R  G +    + A
Sbjct: 123 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTA 178

Query: 391 PEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRAS 450
           PE       +   DV+SFGILL E+ T  R       +   ++N  +     R +     
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD----- 233

Query: 451 SGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL 491
                      C   + ++   C  E+P +R   + +   L
Sbjct: 234 ----------NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 2e-48
 Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 34/281 (12%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKV 267
           +  IG G+F +VYKG+  E+T  VA        L     + F  E E+ + ++H N+V+ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 268 FTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVA 327
           + +      +G     LV E M +G+L+ ++               +      +    + 
Sbjct: 74  YDSWES-TVKGKKCIVLVTELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQIL 122

Query: 328 CVLKYLHLDCQPPIAHCDLKPSNILLDDE-MTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
             L++LH    PPI H DLK  NI +     +  + D G+A         + +  V GT 
Sbjct: 123 KGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTP 177

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE 446
            ++APE     +     DVY+FG+ +LEM T   P  +        R       P   ++
Sbjct: 178 EFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236

Query: 447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV 487
           +        + II  C+            +   ER  I D+
Sbjct: 237 VAIPEV---KEIIEGCI-----------RQNKDERYSIKDL 263

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 7e-48
 Identities = 72/285 (25%), Positives = 125/285 (43%), Gaps = 35/285 (12%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
              E  +G G FG V+ G     TT VA+K        + ++F  E +V + +RH  LV+
Sbjct: 19  LRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           ++   S       +   +V E+M+ GSL +++    E  K  + P      + +++A  +
Sbjct: 77  LYAVVS------EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLP------QLVDMAAQI 122

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
           A  + Y+    +    H DL+ +NIL+ + +   V+DFG+AR +E  +E T   G +   
Sbjct: 123 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPI 178

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE 446
            + APE  +    +   DV+SFGILL E+ T  R        N  + + V+         
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRMPCPP 237

Query: 447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL 491
                         EC  S+ ++   C  ++P ER     ++  L
Sbjct: 238 --------------ECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 9e-48
 Identities = 62/297 (20%), Positives = 104/297 (35%), Gaps = 24/297 (8%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAVECEVTRNIRHRNLV 265
           F   + +GAGN G V+K     S   +A K+ ++ +          E +V        +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             + A        +   ++  E M  GSL++ +             G +       ++I 
Sbjct: 68  GFYGAF-----YSDGEISICMEHMDGGSLDQVLK----------KAGRIPEQILGKVSIA 112

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           V   L YL       I H D+KPSNIL++      + DFG++  L      + +    GT
Sbjct: 113 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGT 166

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP--SDDMFKDNLNLRNCVKSALPER 443
             Y++PE   G   S   D++S G+ L+EM  G  P    D  +  L     V+    E 
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226

Query: 444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE 500
               R          +           +     +P  ++         +    K L 
Sbjct: 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 4e-47
 Identities = 64/305 (20%), Positives = 116/305 (38%), Gaps = 33/305 (10%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           +  IG G FG V++G        VAVK+F+    + S     E   T  +RH N++    
Sbjct: 8   QESIGKGRFGEVWRGKW--RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIA 64

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
           A +  +        LV ++  +GSL ++++              +     + +A+  A  
Sbjct: 65  ADNKDNGTWTQL-WLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASG 112

Query: 330 LKYLHLDC-----QPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE--QTRSIGV 382
           L +LH++      +P IAH DLK  NIL+    T  ++D G+A   ++A +         
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172

Query: 383 EGTTGYIAPEY------GMGHEVSSYGDVYSFGILLLEMFTGLRPS-----DDMFKDNLN 431
            GT  Y+APE           E     D+Y+ G++  E+              +   +L 
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232

Query: 432 LRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL 491
             +     + +   E +       R    E L  + +I   C       R+    ++  L
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

Query: 492 RLIKK 496
             + +
Sbjct: 293 SQLSQ 297

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 8e-47
 Identities = 61/295 (20%), Positives = 107/295 (36%), Gaps = 39/295 (13%)

Query: 213 IGAGNFGSVYKGILFESTT--AVAVKVFNV-LHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           +G GNFGSV +G+         VA+KV         ++    E ++   + +  +V++  
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C            LV E    G L +++               +       +   V+  
Sbjct: 77  VCQAEAL------MLVMEMAGGGPLHKFLV---------GKREEIPVSNVAELLHQVSMG 121

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ-TRSIGVEGTTGY 388
           +KYL    +    H DL   N+LL +   A +SDFG+++ L A D   T     +    +
Sbjct: 122 MKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERAEEI 447
            APE     + SS  DV+S+G+ + E  + G +P   M    + +    +    E   E 
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQGKRMECPPEC 237

Query: 448 RASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEAP 502
                    +++ +C              +  +R     VE R+R     L    
Sbjct: 238 PPEL----YALMSDCW-----------IYKWEDRPDFLTVEQRMRACYYSLASKV 277

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (406), Expect = 5e-46
 Identities = 63/314 (20%), Positives = 113/314 (35%), Gaps = 47/314 (14%)

Query: 207 FSSENLIGAGNFGSVYKGIL-----FESTTAVAVKVFNV-LHHDASKSFAVECEVTRNIR 260
                 IG G FG V++        +E  T VAVK+       D    F  E  +     
Sbjct: 15  IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74

Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH--------------PITEEDK 306
           + N+VK+   C            L++E+MA G L E++                 T    
Sbjct: 75  NPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129

Query: 307 RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI 366
               P  L+  ++L IA  VA  + YL    +    H DL   N L+ + M   ++DFG+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGL 186

Query: 367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMF 426
           +R + +AD             ++ PE    +  ++  DV+++G++L E+F+         
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246

Query: 427 KDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKIND 486
                +       +    E                C + +  +   C ++ P +R     
Sbjct: 247 AHEEVIYYVRDGNILACPE---------------NCPLELYNLMRLCWSKLPADRPSFCS 291

Query: 487 VEPRLRLIKKKLLE 500
           +   L    +++ E
Sbjct: 292 IHRIL----QRMCE 301

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 5e-46
 Identities = 63/290 (21%), Positives = 105/290 (36%), Gaps = 39/290 (13%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
                 IG G FG V  G        VAVK     +   +++F  E  V   +RH NLV+
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQ 64

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +         +      +V E+MA GSL +++          +    L     L  ++DV
Sbjct: 65  LLGVI----VEEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDV 112

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
              ++YL         H DL   N+L+ ++  A VSDFG+ +   +  +       +   
Sbjct: 113 CEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPV 164

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE 446
            + APE     + S+  DV+SFGILL E+++  R           +    K    +  + 
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 224

Query: 447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK 496
              +       ++  C                  R     +  +L  IK 
Sbjct: 225 CPPAV----YEVMKNCW-----------HLDAAMRPSFLQLREQLEHIKT 259

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 6e-46
 Identities = 59/296 (19%), Positives = 107/296 (36%), Gaps = 37/296 (12%)

Query: 210 ENLIGAGNFGSVYKGILFEST---TAVAVKVFN-VLHHDASKSFAVECEVTRNIRHRNLV 265
             +IG G+FG VY G L ++       AVK  N +        F  E  + ++  H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
            +   C     +      +V  +M +G L  ++              N      +   + 
Sbjct: 92  SLLGIC----LRSEGSPLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQ 138

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ--TRSIGVE 383
           VA   K +         H DL   N +LD++ T  V+DFG+AR +   +        G +
Sbjct: 139 VA---KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195

Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER 443
               ++A E     + ++  DV+SFG+LL E+ T   P              ++     +
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 255

Query: 444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL 499
            E                C   + E+ + C   +   R   +++  R+  I    +
Sbjct: 256 PE---------------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 6e-46
 Identities = 70/302 (23%), Positives = 127/302 (42%), Gaps = 42/302 (13%)

Query: 207 FSSENLIGAGNFGSVYKGILFEST----TAVAVKVFNVLHHDASK-SFAVECEVTRNIRH 261
            + + +IGAG FG VYKG+L  S+      VA+K     + +  +  F  E  +     H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            N++++                ++ E+M NG+L++++          +  G  + L+ + 
Sbjct: 69  HNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLR---------EKDGEFSVLQLVG 114

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI- 380
           +   +A  +KYL         H DL   NIL++  +   VSDFG++R LE   E T +  
Sbjct: 115 MLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171

Query: 381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL 440
           G +    + APE     + +S  DV+SFGI++ E+ T          ++  ++       
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 231

Query: 441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE 500
                              ++C  +I ++ + C  ++   R K  D+   L     KL+ 
Sbjct: 232 LP---------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL----DKLIR 272

Query: 501 AP 502
           AP
Sbjct: 273 AP 274

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 5e-45
 Identities = 66/282 (23%), Positives = 108/282 (38%), Gaps = 38/282 (13%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTA 270
             +G G FG VYK    E++   A KV +    +  + + VE ++  +  H N+VK+  A
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 271 CSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVL 330
                    +   ++ EF A G+++  M          +    L   +   +       L
Sbjct: 78  F-----YYENNLWILIEFCAGGAVDAVM---------LELERPLTESQIQVVCKQTLDAL 123

Query: 331 KYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIA 390
            YLH      I H DLK  NIL   +    ++DFG++       ++  S    GT  ++A
Sbjct: 124 NYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMA 178

Query: 391 PEYGMGHEVSSYG-----DVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAE 445
           PE  M             DV+S GI L+EM     P  ++    + L    KS  P  A+
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPPTLAQ 237

Query: 446 EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV 487
             R SS    +  + +CL            +    R   + +
Sbjct: 238 PSRWSSNF--KDFLKKCL-----------EKNVDARWTTSQL 266

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-44
 Identities = 67/295 (22%), Positives = 119/295 (40%), Gaps = 39/295 (13%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
            +    IG+G FG V+ G    +   VA+K        + + F  E EV   + H  LV+
Sbjct: 7   LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           ++  C            LV+EFM +G L +++             G   +   L + +DV
Sbjct: 65  LYGVC-----LEQAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDV 110

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
              + YL    +  + H DL   N L+ +     VSDFG+ RF+   D+ T S G +   
Sbjct: 111 CEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPV 166

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE 446
            + +PE       SS  DV+SFG+L+ E+F+  +   +  + N  +   + +        
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRLYKPR 225

Query: 447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEA 501
           +                  + +I   C  E+P +R   + +  +L     ++ E+
Sbjct: 226 L--------------ASTHVYQIMNHCWKERPEDRPAFSRLLRQL----AEIAES 262

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  155 bits (392), Expect = 4e-44
 Identities = 61/291 (20%), Positives = 116/291 (39%), Gaps = 33/291 (11%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
            + ++ +G G +G VY+G+  + +  VAVK          + F  E  V + I+H NLV+
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQ 77

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           +   C            ++ EFM  G+L +++               ++++  L +A  +
Sbjct: 78  LLGVC-----TREPPFYIITEFMTYGNLLDYLR--------ECNRQEVSAVVLLYMATQI 124

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
           +  ++YL    +    H DL   N L+ +     V+DFG++R +   D  T   G +   
Sbjct: 125 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPI 180

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE 446
            + APE    ++ S   DV++FG+LL E+ T          D   +   ++        E
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRMERPE 239

Query: 447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK 497
                          C   + E+  AC    P +R    ++      + ++
Sbjct: 240 --------------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 7e-44
 Identities = 63/289 (21%), Positives = 109/289 (37%), Gaps = 41/289 (14%)

Query: 210 ENLIGAGNFGSVYKGILFESTT--AVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLV 265
           +  +G+GNFG+V KG          VAVK+     +D +       E  V + + +  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           ++   C        +   LV E    G L +++              ++     + +   
Sbjct: 72  RMIGICE------AESWMLVMEMAELGPLNKYLQQ----------NRHVKDKNIIELVHQ 115

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA-DEQTRSIGVEG 384
           V+  +KYL    +    H DL   N+LL  +  A +SDFG+++ L A  +        + 
Sbjct: 116 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER 443
              + APE    ++ SS  DV+SFG+L+ E F+ G +P   M      +   ++      
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGERMG 230

Query: 444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR 492
                             C   + ++   C       R     VE RLR
Sbjct: 231 CPA--------------GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (390), Expect = 1e-43
 Identities = 55/266 (20%), Positives = 95/266 (35%), Gaps = 34/266 (12%)

Query: 204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIR 260
            K FS    IG G+FG+VY      ++  VA+K  +      ++  +    E    + +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
           H N ++                 LV E+    + +                  L  ++  
Sbjct: 74  HPNTIQYRGCY-----LREHTAWLVMEYCLGSASDLL----------EVHKKPLQEVEIA 118

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
            +       L YLH      + H D+K  NILL +     + DFG A  +        + 
Sbjct: 119 AVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APAN 169

Query: 381 GVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK 437
              GT  ++APE  +  +   Y    DV+S GI  +E+     P  +M   +  L +  +
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQ 228

Query: 438 SALPERAEEIRASSGSTQRSIILECL 463
           +  P       +      R+ +  CL
Sbjct: 229 NESPALQSGHWSEYF---RNFVDSCL 251

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-43
 Identities = 62/281 (22%), Positives = 111/281 (39%), Gaps = 35/281 (12%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
            +    +G G FG V  G        VA+K+       +   F  E +V  N+ H  LV+
Sbjct: 6   LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           ++  C            ++ E+MANG L  ++                 + + L +  DV
Sbjct: 64  LYGVC-----TKQRPIFIITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCKDV 109

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTT 386
              ++YL         H DL   N L++D+    VSDFG++R++   DE T S+G +   
Sbjct: 110 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPV 165

Query: 387 GYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEE 446
            +  PE  M  + SS  D+++FG+L+ E+++  +   + F ++    +  +     R   
Sbjct: 166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH- 224

Query: 447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV 487
                              +  I  +C  E+  ER     +
Sbjct: 225 --------------LASEKVYTIMYSCWHEKADERPTFKIL 251

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 2e-43
 Identities = 52/249 (20%), Positives = 98/249 (39%), Gaps = 26/249 (10%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           F    ++G G+F +V       ++   A+K+     ++  +       E +V   + H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
            VK++       FQ ++       +  NG L +++  I              S       
Sbjct: 70  FVKLYFT-----FQDDEKLYFGLSYAKNGELLKYIRKI-------------GSFDETCTR 111

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
              A ++  L       I H DLKP NILL+++M   ++DFG A+ L    +Q R+    
Sbjct: 112 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 171

Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLNLRNCVKS 438
           GT  Y++PE           D+++ G ++ ++  GL P        +F+  + L      
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 231

Query: 439 ALPERAEEI 447
               +A ++
Sbjct: 232 KFFPKARDL 240

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-43
 Identities = 62/283 (21%), Positives = 108/283 (38%), Gaps = 34/283 (12%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLV 265
           +     +G G +G V   +   +  AVAVK+ ++    D  ++   E  + + + H N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           K +        +  + + L  E+ + G L + + P             +           
Sbjct: 67  KFYGHR-----REGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPDAQRFFHQ 111

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +   + YLH      I H D+KP N+LLD+     +SDFG+A      + +     + GT
Sbjct: 112 LMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

Query: 386 TGYIAPEYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA 444
             Y+APE     E  +   DV+S GI+L  M  G     D   D+    +  K       
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKKTYLN 227

Query: 445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV 487
              +  S     +++ + L            E P  R+ I D+
Sbjct: 228 PWKKIDSAP--LALLHKIL-----------VENPSARITIPDI 257

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 4e-43
 Identities = 67/320 (20%), Positives = 123/320 (38%), Gaps = 44/320 (13%)

Query: 188 PSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTT--AVAVKVFN-VLHHD 244
           P+I +P + +            +++IG GNFG V K  + +       A+K        D
Sbjct: 1   PTI-YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD 52

Query: 245 ASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH--PI 301
             + FA E EV   +  H N++ +  AC     +   +  L  E+  +G+L +++    +
Sbjct: 53  DHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRV 107

Query: 302 TEEDKR----HKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM 357
            E D      +     L+S + L+ A DVA  + YL    Q    H DL   NIL+ +  
Sbjct: 108 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENY 164

Query: 358 TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT 417
            A ++DFG++R     +   +         ++A E       ++  DV+S+G+LL E+ +
Sbjct: 165 VAKIADFGLSRG---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221

Query: 418 GLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQ 477
                              +    E+                  C   + ++   C  E+
Sbjct: 222 LGGTPYCGMTCAELYEKLPQGYRLEKPL---------------NCDDEVYDLMRQCWREK 266

Query: 478 PGERMKINDVEPRLRLIKKK 497
           P ER     +   L  + ++
Sbjct: 267 PYERPSFAQILVSLNRMLEE 286

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 5e-43
 Identities = 61/309 (19%), Positives = 106/309 (34%), Gaps = 40/309 (12%)

Query: 207 FSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHDAS-KSFAVECEVTRNI- 259
            S    +GAG FG V +   +     ++   VAVK+     H    ++   E +V   + 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH--------PITEEDKRHKAP 311
            H N+V +  AC            ++ E+   G L  ++           T         
Sbjct: 85  NHMNIVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
             L+    L+ +  VA  + +L         H DL   NILL       + DFG+AR ++
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196

Query: 372 AADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN 431
                           ++APE       +   DV+S+GI L E+F+           +  
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

Query: 432 LRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRL 491
               +K      + E                   + +I   C    P +R     +   +
Sbjct: 257 FYKMIKEGFRMLSPE--------------HAPAEMYDIMKTCWDADPLKRPTFKQI---V 299

Query: 492 RLIKKKLLE 500
           +LI+K++ E
Sbjct: 300 QLIEKQISE 308

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 1e-42
 Identities = 50/249 (20%), Positives = 92/249 (36%), Gaps = 30/249 (12%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           F     +G G FG+VY     +S   +A+KV     +           E E+  ++RH N
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           +++++               L+ E+   G++   +                +  +     
Sbjct: 68  ILRLYGYF-----HDATRVYLILEYAPLGTVYRELQK----------LSKFDEQRTATYI 112

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            ++A  L Y H      + H D+KP N+LL       ++DFG +         +R   + 
Sbjct: 113 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC 165

Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSD-----DMFKDNLNLRNCVKS 438
           GT  Y+ PE   G       D++S G+L  E   G  P +     + +K    +      
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 225

Query: 439 ALPERAEEI 447
            + E A ++
Sbjct: 226 FVTEGARDL 234

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 1e-42
 Identities = 54/305 (17%), Positives = 100/305 (32%), Gaps = 42/305 (13%)

Query: 207 FSSENLIGAGNFGSVYKGILFEST-----TAVAVKVFNV-LHHDASKSFAVECEVTRNI- 259
                ++G+G FG V     +  +       VAVK+          ++   E ++   + 
Sbjct: 39  LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98

Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH-------------PITEEDK 306
            H N+V +  AC       +    L++E+   G L  ++                 +  +
Sbjct: 99  SHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 307 RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI 366
             +    L     L  A  VA  +++L         H DL   N+L+       + DFG+
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGL 210

Query: 367 ARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMF 426
           AR + +               ++APE       +   DV+S+GILL E+F+         
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 427 KDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKIND 486
             + N    +++                           I  I  +C A    +R    +
Sbjct: 271 PVDANFYKLIQNGFKMDQPF--------------YATEEIYIIMQSCWAFDSRKRPSFPN 316

Query: 487 VEPRL 491
           +   L
Sbjct: 317 LTSFL 321

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 2e-42
 Identities = 58/286 (20%), Positives = 108/286 (37%), Gaps = 35/286 (12%)

Query: 202 NATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRH 261
           +  K ++    IG G  G+VY  +   +   VA++  N+      +    E  V R  ++
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76

Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            N+V    +         D   +V E++A GSL + +     ++ +              
Sbjct: 77  PNIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-----------IAA 120

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
           +  +    L++LH      + H D+K  NILL  + +  ++DFG    +    EQ++   
Sbjct: 121 VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRST 175

Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP 441
           + GT  ++APE           D++S GI+ +EM  G  P  +       L     +  P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP 234

Query: 442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV 487
           E     + S+    R  +  CL                +R    ++
Sbjct: 235 ELQNPEKLSAIF--RDFLNRCL-----------DMDVEKRGSAKEL 267

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 2e-42
 Identities = 58/311 (18%), Positives = 113/311 (36%), Gaps = 35/311 (11%)

Query: 194 YVSYRMLYNATK------GFSSENLIGAGNFGSVYKGIL-----FESTTAVAVKVFN-VL 241
           Y S   +Y   +        +    +G G+FG VY+G+       E  T VA+K  N   
Sbjct: 3   YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 62

Query: 242 HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPI 301
                  F  E  V +     ++V++                ++ E M  G L+ ++  +
Sbjct: 63  SMRERIEFLNEASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSL 117

Query: 302 TEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV 361
                 +      +  K + +A ++A  + YL         H DL   N ++ ++ T  +
Sbjct: 118 RPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKI 174

Query: 362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
            DFG+ R +   D   +         +++PE       ++Y DV+SFG++L E+ T    
Sbjct: 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234

Query: 422 SDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGER 481
                 +   LR  ++  L ++ +                C   + E+   C    P  R
Sbjct: 235 PYQGLSNEQVLRFVMEGGLLDKPD---------------NCPDMLFELMRMCWQYNPKMR 279

Query: 482 MKINDVEPRLR 492
               ++   ++
Sbjct: 280 PSFLEIISSIK 290

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  150 bits (380), Expect = 9e-42
 Identities = 57/254 (22%), Positives = 99/254 (38%), Gaps = 24/254 (9%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
            +G G FG V++     +    A K     H    ++   E +    +RH  LV +  A 
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA- 91

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
               F+ ++   ++YEFM+ G L E +               ++  + +     V   L 
Sbjct: 92  ----FEDDNEMVMIYEFMSGGELFEKV---------ADEHNKMSEDEAVEYMRQVCKGLC 138

Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYV--SDFGIARFLEAADEQTRSIGVEGTTGYI 389
           ++H   +    H DLKP NI+   + +  +   DFG+   L   D +       GT  + 
Sbjct: 139 HMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFA 192

Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRA 449
           APE   G  V  Y D++S G+L   + +GL P     +++      VKS      +   +
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG--ENDDETLRNVKSCDWNMDDSAFS 250

Query: 450 SSGSTQRSIILECL 463
                 +  I + L
Sbjct: 251 GISEDGKDFIRKLL 264

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 1e-41
 Identities = 56/295 (18%), Positives = 108/295 (36%), Gaps = 38/295 (12%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKV-----FNVLHHDASKSFAVECEVTRNIRH 261
           F    ++G+G FG+VYKG+       V + V            A+K    E  V  ++ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLN 321
            ++ ++   C            L+ + M  G L +++          +   N+ S   LN
Sbjct: 71  PHVCRLLGICL------TSTVQLITQLMPFGCLLDYVR---------EHKDNIGSQYLLN 115

Query: 322 IAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIG 381
             + +A  + YL       + H DL   N+L+       ++DFG+A+ L A +++  + G
Sbjct: 116 WCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172

Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP 441
            +    ++A E  +    +   DV+S+G+ + E+ T      D    +       K    
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 232

Query: 442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK 496
            +                  C I +  I V C       R K  ++      + +
Sbjct: 233 PQPP---------------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-41
 Identities = 56/292 (19%), Positives = 104/292 (35%), Gaps = 38/292 (13%)

Query: 210 ENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLHHDASKS-FAVECEVTRNIRHRNLV 265
              IG G FG V++GI         AVA+K       D+ +  F  E    R   H ++V
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           K+    +       +   ++ E    G L  ++              +L+    +  A  
Sbjct: 72  KLIGVIT------ENPVWIIMELCTLGELRSFLQ---------VRKYSLDLASLILYAYQ 116

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           ++  L YL         H D+   N+L+       + DFG++R++E +     S G    
Sbjct: 117 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK-LP 172

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAE 445
             ++APE       +S  DV+ FG+ + E+           K+N  +             
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 232

Query: 446 EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK 497
               +      S++ +C            A  P  R +  +++ +L  I ++
Sbjct: 233 NCPPTL----YSLMTKCW-----------AYDPSRRPRFTELKAQLSTILEE 269

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  147 bits (371), Expect = 2e-40
 Identities = 57/278 (20%), Positives = 106/278 (38%), Gaps = 35/278 (12%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
            +G+G FG V++ +   +      K  N  +     +   E  +   + H  L+ +  A 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 94

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
               F+      L+ EF++ G L + +               ++  + +N        LK
Sbjct: 95  ----FEDKYEMVLILEFLSGGELFDRI---------AAEDYKMSEAEVINYMRQACEGLK 141

Query: 332 YLHLDCQPPIAHCDLKPSNILLD--DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
           ++H   +  I H D+KP NI+ +     +  + DFG+A  L   +          T  + 
Sbjct: 142 HMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFA 195

Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRA 449
           APE      V  Y D+++ G+L   + +GL P      D+L     VK    E  E+  +
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--DDLETLQNVKRCDWEFDEDAFS 253

Query: 450 SSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV 487
           S     +  I   L            ++P +R+ ++D 
Sbjct: 254 SVSPEAKDFIKNLL-----------QKEPRKRLTVHDA 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  142 bits (359), Expect = 1e-39
 Identities = 59/258 (22%), Positives = 104/258 (40%), Gaps = 20/258 (7%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVK 266
             ++G G    V+          VAVKV              F  E +    + H  +V 
Sbjct: 12  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           V+      +        +V E++   +L + +H            G +   + + +  D 
Sbjct: 72  VYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHT----------EGPMTPKRAIEVIADA 120

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL-EAADEQTRSIGVEGT 385
              L +     Q  I H D+KP+NI++       V DFGIAR + ++ +  T++  V GT
Sbjct: 121 CQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAE 445
             Y++PE   G  V +  DVYS G +L E+ TG  P       ++  ++  +  +P  A 
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237

Query: 446 EIRASSGSTQRSIILECL 463
               S+     +++L+ L
Sbjct: 238 HEGLSADL--DAVVLKAL 253

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 3e-39
 Identities = 60/304 (19%), Positives = 106/304 (34%), Gaps = 36/304 (11%)

Query: 210 ENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNV-LHHDASKSFAVECEVTRNIRHRN 263
              +G G FG V +   F      +   VAVK+      H   ++   E ++  +I H  
Sbjct: 18  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 77

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMH------PITEEDKRHKAPGNLNSL 317
            V       G   +      ++ EF   G+L  ++          +          L   
Sbjct: 78  NVVNLL---GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134

Query: 318 KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQT 377
             +  +  VA  +++L         H DL   NILL ++    + DFG+AR +    +  
Sbjct: 135 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 378 RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK 437
           R         ++APE       +   DV+SFG+LL E+F+         K +      +K
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

Query: 438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK 497
                RA +                   + +  + C   +P +R   +++   L      
Sbjct: 252 EGTRMRAPD--------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL----GN 293

Query: 498 LLEA 501
           LL+A
Sbjct: 294 LLQA 297

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 4e-39
 Identities = 68/296 (22%), Positives = 103/296 (34%), Gaps = 46/296 (15%)

Query: 213 IGAGNFGSVYKGILFEST---TAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVK 266
           +G G+FG V +G     +    +VAVK      +   +A   F  E     ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 267 VFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDV 326
           ++               +V E    GSL + +          K  G+         A+ V
Sbjct: 76  LYGVVL------TPPMKMVTELAPLGSLLDRLR---------KHQGHFLLGTLSRYAVQV 120

Query: 327 ACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFL-EAADEQTRSIGVEGT 385
           A  + YL         H DL   N+LL       + DFG+ R L +  D        +  
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 386 TGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAE 445
             + APE       S   D + FG+ L EMFT  +        +  L    K        
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237

Query: 446 EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEA 501
           E              +C   I  + V C A +P +R       P    ++  LLEA
Sbjct: 238 E--------------DCPQDIYNVMVQCWAHKPEDR-------PTFVALRDFLLEA 272

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 8e-37
 Identities = 59/300 (19%), Positives = 106/300 (35%), Gaps = 38/300 (12%)

Query: 210 ENLIGAGNFGSVYKGIL-------FESTTAVAVKVFNV-LHHDASKSFAVECEVTRNI-R 260
              +G G FG V                T VAVK+               E E+ + I +
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77

Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHP------ITEEDKRHKAPGNL 314
           H+N++ +  AC       +    ++ E+ + G+L E++            +  H     L
Sbjct: 78  HKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 315 NSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAAD 374
           +S   ++ A  VA  ++YL         H DL   N+L+ ++    ++DFG+AR +   D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 375 EQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN 434
              ++        ++APE       +   DV+SFG+LL E+FT               + 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

Query: 435 CVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI 494
             +    ++                  C   +  +   C    P +R     +   L  I
Sbjct: 250 LKEGHRMDKPS---------------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-36
 Identities = 51/254 (20%), Positives = 98/254 (38%), Gaps = 25/254 (9%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTAC 271
            +G G FG V++ +   S      K    +          E  +    RHRN++ +  + 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES- 69

Query: 272 SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLK 331
               F+  +   +++EF++   + E ++          +   LN  + ++    V   L+
Sbjct: 70  ----FESMEELVMIFEFISGLDIFERIN---------TSAFELNEREIVSYVHQVCEALQ 116

Query: 332 YLHLDCQPPIAHCDLKPSNILLDDEMTAYV--SDFGIARFLEAADEQTRSIGVEGTTGYI 389
           +LH      I H D++P NI+     ++ +   +FG AR L+  D       +     Y 
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYY 170

Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIRA 449
           APE      VS+  D++S G L+  + +G+ P     + N  +   + +A     EE   
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA--ETNQQIIENIMNAEYTFDEEAFK 228

Query: 450 SSGSTQRSIILECL 463
                    +   L
Sbjct: 229 EISIEAMDFVDRLL 242

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (333), Expect = 2e-35
 Identities = 50/292 (17%), Positives = 92/292 (31%), Gaps = 32/292 (10%)

Query: 197 YRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNV-LHHDASKSFAVECEV 255
           ++   +    +   +++G G F  V       +   VA+K            S   E  V
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 256 TRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLN 315
              I+H N+V +        ++      L+ + ++ G L + +             G   
Sbjct: 61  LHKIKHPNIVALDDI-----YESGGHLYLIMQLVSGGELFDRI----------VEKGFYT 105

Query: 316 SLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE 375
                 +   V   +KYLH                  LD++    +SDFG+++     D 
Sbjct: 106 ERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DP 162

Query: 376 QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC 435
            +      GT GY+APE       S   D +S G++   +  G  P  D   ++  L   
Sbjct: 163 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE--NDAKLFEQ 220

Query: 436 VKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV 487
           +  A  E           + +  I   +            + P +R      
Sbjct: 221 ILKAEYEFDSPYWDDISDSAKDFIRHLM-----------EKDPEKRFTCEQA 261

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 2e-35
 Identities = 60/261 (22%), Positives = 105/261 (40%), Gaps = 30/261 (11%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEV-TRNIRHR 262
           F    ++G G+FG V+     ++    A+K      VL  D  +   VE  V +    H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 263 NLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNI 322
            L  +F        Q  +    V E++  G L   +           +    +  +    
Sbjct: 64  FLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRATFY 108

Query: 323 AIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGV 382
           A ++   L++L       I + DLK  NILLD +    ++DFG+ +     D +T +   
Sbjct: 109 AAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-- 163

Query: 383 EGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE 442
            GT  YIAPE  +G + +   D +SFG+LL EM  G  P     +D   L + ++   P 
Sbjct: 164 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG--QDEEELFHSIRMDNPF 221

Query: 443 RAEEIRASSGSTQRSIILECL 463
               +   +    + ++++  
Sbjct: 222 YPRWLEKEA----KDLLVKLF 238

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  130 bits (328), Expect = 4e-35
 Identities = 60/297 (20%), Positives = 114/297 (38%), Gaps = 50/297 (16%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS---------KSFAVECEVTR 257
           +  + ++G G    V + I   +    AVK+ +V    +          ++   E ++ R
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 258 NIR-HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNS 316
            +  H N++++        ++ N F  LV++ M  G L +++               L+ 
Sbjct: 65  KVSGHPNIIQLKD-----TYETNTFFFLVFDLMKKGELFDYLT----------EKVTLSE 109

Query: 317 LKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ 376
            +   I   +  V+  LH   +  I H DLKP NILLDD+M   ++DFG +  L   D  
Sbjct: 110 KETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPG 163

Query: 377 TRSIGVEGTTGYIAPEYGMGHEVSSYG------DVYSFGILLLEMFTGLRPSDDMFKDNL 430
            +   V GT  Y+APE        ++       D++S G+++  +  G  P     +  +
Sbjct: 164 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH--RKQM 221

Query: 431 NLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV 487
            +   + S   +           T + ++   L             QP +R    + 
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFL-----------VVQPQKRYTAEEA 267

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-34
 Identities = 59/300 (19%), Positives = 105/300 (35%), Gaps = 53/300 (17%)

Query: 207 FSSENL---------IGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS------KSFAV 251
           F  EN+         +G+G F  V K     +    A K        +S      +    
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 252 ECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAP 311
           E  + + I+H N++ +        ++      L+ E +A G L +++             
Sbjct: 63  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLA------------ 105

Query: 312 GNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA----YVSDFGIA 367
               SL        +  +L  ++      IAH DLKP NI+L D         + DFG+A
Sbjct: 106 -EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164

Query: 368 RFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFK 427
             +   D       + GT  ++APE      +    D++S G++   + +G  P      
Sbjct: 165 HKI---DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-- 219

Query: 428 DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV 487
                   V +   E  +E  +++ +  +  I   L            + P +RM I D 
Sbjct: 220 TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLL-----------VKDPKKRMTIQDS 268

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (324), Expect = 2e-34
 Identities = 47/264 (17%), Positives = 88/264 (33%), Gaps = 29/264 (10%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
              IG+G+FG +Y G    +   VA+K+  V          +E ++ + ++    +    
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIR 69

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
            C        D+  +V E +     + +                 +    L +A  +   
Sbjct: 70  WC----GAEGDYNVMVMELLGPSLEDLFNFC----------SRKFSLKTVLLLADQMISR 115

Query: 330 LKYLHLDCQPPIAHCDLKPSNIL---LDDEMTAYVSDFGIARFLEAADEQT-----RSIG 381
           ++Y+H        H D+KP N L          Y+ DFG+A+    A          +  
Sbjct: 116 IEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172

Query: 382 VEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL--NLRNCVKSA 439
           + GT  Y +    +G E S   D+ S G +L+    G  P   +             +  
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232

Query: 440 LPERAEEIRASSGSTQRSIILECL 463
           +    E +     S   + +  C 
Sbjct: 233 MSTPIEVLCKGYPSEFATYLNFCR 256

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  129 bits (325), Expect = 6e-34
 Identities = 56/265 (21%), Positives = 95/265 (35%), Gaps = 34/265 (12%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH------HDASKSFAVECEVTRNIR 260
           FS   +IG G FG VY     ++    A+K  +            + +  +   +     
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
              +V +  A     F   D  + + + M  G L   +             G  +     
Sbjct: 66  CPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLS----------QHGVFSEADMR 110

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
             A ++   L+++H      + + DLKP+NILLD+     +SD G+A        + +  
Sbjct: 111 FYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPH 163

Query: 381 GVEGTTGYIAPEYGM-GHEVSSYGDVYSFGILLLEMFTGLRPSDDM-FKDNLNLRNCVKS 438
              GT GY+APE    G    S  D +S G +L ++  G  P      KD   +     +
Sbjct: 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223

Query: 439 ALPERAEEIRASSGSTQRSIILECL 463
              E  +          RS++   L
Sbjct: 224 MAVELPDSFSPEL----RSLLEGLL 244

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  128 bits (322), Expect = 6e-34
 Identities = 55/260 (21%), Positives = 94/260 (36%), Gaps = 32/260 (12%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           F     +G G+FG V+      +    A+KV     V+     +    E  +   + H  
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           +++++        Q      ++ +++  G L   +                        A
Sbjct: 66  IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK----------FYA 110

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVE 383
            +V   L+YLH      I + DLKP NILLD      ++DFG A+++   D         
Sbjct: 111 AEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVTYTLC--- 162

Query: 384 GTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER 443
           GT  YIAPE       +   D +SFGIL+ EM  G  P  D   + +     + +A    
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--NTMKTYEKILNAELRF 220

Query: 444 AEEIRASSGSTQRSIILECL 463
                       + ++   +
Sbjct: 221 PPFFNEDV----KDLLSRLI 236

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 2e-33
 Identities = 46/281 (16%), Positives = 93/281 (33%), Gaps = 31/281 (11%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEV-TRNIRHRNLVKVF 268
             ++G G  G V +     +    A+K+              E E+  R  +  ++V++ 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIV 71

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                + + G     +V E +  G L   +          +        +   I   +  
Sbjct: 72  DVYENL-YAGRKCLLIVMECLDGGELFSRIQ--------DRGDQAFTEREASEIMKSIGE 122

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            ++YLH      IAH D+KP N+L   +    +       F +             T  Y
Sbjct: 123 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 179

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP--SDDMFKDNLNLRNCVKSALPERAEE 446
           +APE     +     D++S G+++  +  G  P  S+     +  ++  ++    E    
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239

Query: 447 IRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDV 487
             +      + +I   L             +P +RM I + 
Sbjct: 240 EWSEVSEEVKMLIRNLL-----------KTEPTQRMTITEF 269

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 2e-33
 Identities = 67/297 (22%), Positives = 111/297 (37%), Gaps = 33/297 (11%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVK 266
           ++   +IG G+FG VY+  L +S   VA+K          +    E ++ R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77

Query: 267 VFTAC-SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
           +     S  + +   +  LV +++         H         +A   L  +        
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-------YSRAKQTLPVIYVKLYMYQ 130

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
           +   L Y+H      I H D+KP N+LLD D     + DFG A+ L   +     I    
Sbjct: 131 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---C 184

Query: 385 TTGYIAPEYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER 443
           +  Y APE   G    +   DV+S G +L E+  G       F  +  +         ++
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGV---------DQ 231

Query: 444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE 500
             EI    G+  R  I E   +  E         P  ++      P    +  +LLE
Sbjct: 232 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLE 288

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 5e-33
 Identities = 59/300 (19%), Positives = 105/300 (35%), Gaps = 30/300 (10%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK-----SFAVECEVTRNIRHRNLV 265
           + +G G F +VYK     +   VA+K   + H   +K     +   E ++ + + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 266 KVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
            +  A            +LV++FM                  H             I   
Sbjct: 64  GLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSLVLTPSH-------------IKAY 105

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGT 385
           +   L+ L    Q  I H DLKP+N+LLD+     ++DFG+A+                T
Sbjct: 106 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVT 163

Query: 386 TGYIAPEYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA 444
             Y APE   G  +   G D+++ G +L E+   +         +L+    +   L    
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG--DSDLDQLTRIFETLGTPT 221

Query: 445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM--KINDVEPRLRLIKKKLLEAP 502
           EE      S    +  +    I    +  +A      +   +    P  R+   + L+  
Sbjct: 222 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 281

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-32
 Identities = 48/226 (21%), Positives = 86/226 (38%), Gaps = 18/226 (7%)

Query: 199 MLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDA-SKSFAVECEVTR 257
            +++    +++ + IG G +G V       +   VA+K  +   H    +    E ++  
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 258 NIRHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSL 317
             RH N++ +         +      LV   M    L + +              +L++ 
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKT-----------QHLSND 109

Query: 318 KRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAA-DEQ 376
                   +   LKY+H      + H DLKPSN+LL+      + DFG+AR  +   D  
Sbjct: 110 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166

Query: 377 TRSIGVEGTTGYIAPEYGMGHEVSSY-GDVYSFGILLLEMFTGLRP 421
                   T  Y APE  +  +  +   D++S G +L EM +    
Sbjct: 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 2e-32
 Identities = 57/298 (19%), Positives = 97/298 (32%), Gaps = 22/298 (7%)

Query: 211 NLIGAGNFGSVYKGILFEST-TAVAVKVFNVLHHDASKSFAVECEVT-----RNIRHRNL 264
             IG G +G V+K    ++    VA+K   V   +     +   EV          H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           V++F  C+           LV+E +                        + +    ++  
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---------VPEPGVPTETIKDMMF 123

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +   L +LH      + H DLKP NIL+       ++DFG+AR        T  +    
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---V 177

Query: 385 TTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA 444
           T  Y APE  +    ++  D++S G +  EMF           D   L   +        
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS-SDVDQLGKILDVIGLPGE 236

Query: 445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLEAP 502
           E+        +++   +    I +             +K     P  R+     L  P
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 294

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  119 bits (299), Expect = 1e-30
 Identities = 49/237 (20%), Positives = 92/237 (38%), Gaps = 28/237 (11%)

Query: 188 PSISFPYVSYRMLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASK 247
           P   + Y S+ + +     +     +G G +  V++ I   +   V VK   +L     K
Sbjct: 18  PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK---ILKPVKKK 74

Query: 248 SFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDK 306
               E ++  N+R   N++ +           +   ALV+E + N   ++    +T+ D 
Sbjct: 75  KIKREIKILENLRGGPNIITLADIV---KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI 131

Query: 307 RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE-MTAYVSDFG 365
           R                 ++   L Y H      I H D+KP N+++D E     + D+G
Sbjct: 132 RF-------------YMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG 175

Query: 366 IARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYG-DVYSFGILLLEMFTGLRP 421
           +A F     E    +    +  +  PE  + +++  Y  D++S G +L  M     P
Sbjct: 176 LAEFYHPGQEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 2e-30
 Identities = 53/252 (21%), Positives = 89/252 (35%), Gaps = 34/252 (13%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRN 263
           F    L+G G FG V       +    A+K+     ++  D       E  V +N RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWM---HPITEEDKRHKAPGNLNSLKRL 320
           L  +  A      Q +D    V E+   G L   +      TEE  R             
Sbjct: 67  LTALKYAF-----QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG---------- 111

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSI 380
                 A ++  L       + + D+K  N++LD +    ++DFG+ +      +     
Sbjct: 112 ------AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMK 163

Query: 381 GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLNLRNC 435
              GT  Y+APE    ++     D +  G+++ EM  G  P      + +F+  L     
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223

Query: 436 VKSALPERAEEI 447
               L   A+ +
Sbjct: 224 FPRTLSPEAKSL 235

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  116 bits (292), Expect = 4e-30
 Identities = 40/266 (15%), Positives = 79/266 (29%), Gaps = 31/266 (11%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
              IG G+FG +++G    +   VA+K         +     E    + +     +    
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVY 67

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
                  Q      LV + +            + ED         +       A  +   
Sbjct: 68  YF----GQEGLHNVLVIDLL----------GPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 113

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMT-----AYVSDFGIARFLEAADEQTRSI---- 380
           ++ +H   +  + + D+KP N L+    +      YV DFG+ +F      +        
Sbjct: 114 VQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170

Query: 381 -GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN--LRNCVK 437
             + GT  Y++    +G E S   D+ + G + +    G  P   +             +
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230

Query: 438 SALPERAEEIRASSGSTQRSIILECL 463
                   E+ A         +    
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMHYAR 256

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 5e-30
 Identities = 46/219 (21%), Positives = 84/219 (38%), Gaps = 21/219 (9%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNV--LHHDASKSFAVECEVTRNIRHRNLVKVF 268
             IG G FG V+K    ++   VA+K   +         +   E ++ + ++H N+V + 
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 269 TACSGVDFQGNDFKA---LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAID 325
             C       N  K    LV++F  +       + + +                  I   
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-------------IKRV 122

Query: 326 VACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADE--QTRSIGVE 383
           +  +L  L+   +  I H D+K +N+L+  +    ++DFG+AR    A      R     
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 384 GTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRP 421
            T  Y  PE  +G  +     D++  G ++ EM+T    
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 3e-29
 Identities = 47/218 (21%), Positives = 75/218 (34%), Gaps = 22/218 (10%)

Query: 207 FSSENLIGAGNFGSVYKGILFESTTAVAVKVFN--VLHHDASKSFAVECEVTRNIRHRNL 264
           F     IG G +G VYK     +   VA+K             +   E  + + + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 265 VKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAI 324
           VK+            +   LV+EF+     +              A   +      +   
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLHQDLKKFM---------DASALTGIPLPLIKSYLF 109

Query: 325 DVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEG 384
            +   L +        + H DLKP N+L++ E    ++DFG+AR                
Sbjct: 110 QLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--V 164

Query: 385 TTGYIAPE-YGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           T  Y APE        S+  D++S G +  EM T    
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 5e-29
 Identities = 49/242 (20%), Positives = 78/242 (32%), Gaps = 34/242 (14%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR--------HRN 263
           L+G+G FGSVY GI       VA+K                  V   +            
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 264 LVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIA 323
           ++++         +  D   L+ E                        G L      +  
Sbjct: 71  VIRLLDWF-----ERPDSFVLILERPEPVQDLFD---------FITERGALQEELARSFF 116

Query: 324 IDVACVLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGV 382
             V   +++        + H D+K  NIL+D +     + DFG    L+           
Sbjct: 117 WQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----F 169

Query: 383 EGTTGYIAPEYGMGHEVSSYG-DVYSFGILLLEMFTGLRP---SDDMFKDNLNLRNCVKS 438
           +GT  Y  PE+   H        V+S GILL +M  G  P    +++ +  +  R  V S
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 229

Query: 439 AL 440
             
Sbjct: 230 EC 231

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-28
 Identities = 44/213 (20%), Positives = 80/213 (37%), Gaps = 21/213 (9%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVF 268
             IG G +G+V+K    E+   VA+K   +   D     S   E  + + ++H+N+V++ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                     +    LV+EF      + +     + D                +   +  
Sbjct: 68  DV-----LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI-------------VKSFLFQ 109

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
           +LK L       + H DLKP N+L++      +++FG+AR       +  S  V      
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYR 168

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
                      S+  D++S G +  E+    RP
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  109 bits (273), Expect = 1e-27
 Identities = 49/214 (22%), Positives = 81/214 (37%), Gaps = 24/214 (11%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDAS--KSFAVECEVTRNIRHRNLVKVF 268
             IG G +G VYK          A+K   +   D     +   E  + + ++H N+VK++
Sbjct: 8   EKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                          LV+E +     +                G L S+   +  + +  
Sbjct: 67  DVI-----HTKKRLVLVFEHLDQDLKKLL----------DVCEGGLESVTAKSFLLQLLN 111

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            + Y H      + H DLKP N+L++ E    ++DFG+AR         +      T  Y
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWY 166

Query: 389 IAPEYGMGHEVSSYG-DVYSFGILLLEMFTGLRP 421
            AP+  MG +  S   D++S G +  EM  G   
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  109 bits (273), Expect = 5e-27
 Identities = 50/238 (21%), Positives = 91/238 (38%), Gaps = 28/238 (11%)

Query: 213 IGAGNFGSVYKGILFESTTAVAVKVFN---VLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
           +G G+FG V      ES    A+K+ +   V+     +    E  + + +    LVK+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACV 329
           +      + N    +V E++A G +   +             G  +       A  +   
Sbjct: 109 SF-----KDNSNLYMVMEYVAGGEMFSHLR----------RIGRFSEPHARFYAAQIVLT 153

Query: 330 LKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYI 389
            +YLH      + + DLKP N+L+D +    V+DFG A+       + R+  + GT   +
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEAL 205

Query: 390 APEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEI 447
           APE  +    +   D ++ G+L+ EM  G  P        + +   + S         
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSGKVRFPSHF 261

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  108 bits (270), Expect = 1e-26
 Identities = 38/214 (17%), Positives = 76/214 (35%), Gaps = 5/214 (2%)

Query: 210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
              +G G+F +V+      + T VA+K+        +++   E ++ + +   +  K  +
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDS 76

Query: 270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL-NIAIDVAC 328
             +    +  D          +  +   +          K       L  +  I+  +  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLD-DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTG 387
            L Y+H   +  I H D+KP N+L++  +    +    IA    A            T  
Sbjct: 137 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 388 YIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRP 421
           Y +PE  +G       D++S   L+ E+ TG   
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 2e-26
 Identities = 55/251 (21%), Positives = 93/251 (37%), Gaps = 24/251 (9%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN--VLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
            IG+G  G V           VA+K  +    +   +K    E  + + + H+N++ +  
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 270 ACSGVD-FQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
             +     +      LV E M     +     +  E   +             +   + C
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-------------LLYQMLC 130

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            +K+LH      I H DLKPSNI++  + T  + DFG+AR    +   T  +    T  Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYY 184

Query: 389 IAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEIR 448
            APE  +G       D++S G ++ EM           +D ++  N V   L     E  
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF--PGRDYIDQWNKVIEQLGTPCPEFM 242

Query: 449 ASSGSTQRSII 459
                T R+ +
Sbjct: 243 KKLQPTVRNYV 253

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 2e-26
 Identities = 57/269 (21%), Positives = 102/269 (37%), Gaps = 35/269 (13%)

Query: 207 FSSENLIGAGNFGSVYKG---ILFESTTAVAVKVFN----VLHHDASKSFAVECEVTRNI 259
           F    ++G G +G V+        ++    A+KV      V     ++    E +V  +I
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 260 RHRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKR 319
           R    +          FQ      L+ +++  G L   +                     
Sbjct: 86  RQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLS-------------QRERFTE 128

Query: 320 LNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRS 379
             + I V  ++  L    +  I + D+K  NILLD      ++DFG+++    ADE  R+
Sbjct: 129 HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERA 187

Query: 380 IGVEGTTGYIAPEYGMGHEVSSYG---DVYSFGILLLEMFTGLRP--SDDMFKDNLNLRN 434
               GT  Y+AP+   G + S +    D +S G+L+ E+ TG  P   D        +  
Sbjct: 188 YDFCGTIEYMAPDIVRGGD-SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 246

Query: 435 CVKSALPERAEEIRASSGSTQRSIILECL 463
            +  + P   +E+ A +    + +I   L
Sbjct: 247 RILKSEPPYPQEMSALA----KDLIQRLL 271

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 2e-25
 Identities = 48/262 (18%), Positives = 97/262 (37%), Gaps = 24/262 (9%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFN--VLHHDASKSFAVECEVTRNIRHRNLVKVF 268
           + +G+G +GSV      ++   VAVK  +        +K    E  + ++++H N++ + 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 269 TACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
              +            +   +    L   +               L       +   +  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----------CQKLTDDHVQFLIYQILR 132

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            LKY+H      I H DLKPSN+ ++++    + DFG+AR  +         G   T  Y
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWY 184

Query: 389 IAPEYGMGHEVSSYG-DVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERAEEI 447
            APE  +     +   D++S G ++ E+ TG         D+++    +   +     E+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHIDQLKLILRLVGTPGAEL 242

Query: 448 RASSGSTQRSIILECLISICEI 469
                S      ++ L  + ++
Sbjct: 243 LKKISSESARNYIQSLTQMPKM 264

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 4e-25
 Identities = 46/214 (21%), Positives = 82/214 (38%), Gaps = 24/214 (11%)

Query: 212 LIGAGNFGSVYKGILFESTTAVAVKVFN--VLHHDASKSFAVECEVTRNIRHRNLVKVFT 269
            +G+G +G+V   +   +   VA+K           +K    E  + +++RH N++ +  
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 270 AC-SGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVAC 328
                          LV  FM     +   H              L   +   +   +  
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKH------------EKLGEDRIQFLVYQMLK 132

Query: 329 VLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGY 388
            L+Y+H      I H DLKP N+ ++++    + DFG+AR  +     +   G   T  Y
Sbjct: 133 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-----SEMTGYVVTRWY 184

Query: 389 IAPEYGMGHEVSSYG-DVYSFGILLLEMFTGLRP 421
            APE  +     +   D++S G ++ EM TG   
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 74.0 bits (181), Expect = 5e-16
 Identities = 25/171 (14%), Positives = 47/171 (27%), Gaps = 33/171 (19%)

Query: 211 NLIGAGNFGSVYKGILFESTTAVAVKVFNV----------LHHDASKSFAVECEVTRNIR 260
            L+G G   +V+     E      VK   V                  F+V    +    
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 261 HRNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRL 320
            R L K+            +  A++ E +    L        +E                
Sbjct: 65  FRALQKLQGLAV-PKVYAWEGNAVLMELIDAKELYRVRVENPDE---------------- 107

Query: 321 NIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGIARFLE 371
            +   +   +   +      I H DL   N+L+ +    ++ DF  +  + 
Sbjct: 108 -VLDMILEEVAKFY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVG 153

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 69.3 bits (168), Expect = 2e-13
 Identities = 22/84 (26%), Positives = 35/84 (41%), Gaps = 6/84 (7%)

Query: 18  LSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQN 77
           L +L+   +  N +S        S T L++L    N  +    SSL++L  +  L    N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHN 361

Query: 78  NLSDEIPEFLAGFKFLQNLNLSYN 101
            +SD  P  LA    +  L L+  
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 58.1 bits (139), Expect = 1e-09
 Identities = 27/132 (20%), Positives = 49/132 (37%), Gaps = 26/132 (19%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAIS--------------------NNFG 40
           DL+NN +S      L GL+ L+   +  N +S                        +   
Sbjct: 247 DLANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS 304

Query: 41  SCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSY 100
           +  +L  L ++ N  +      +SSL  L+ L  + N +SD     LA    +  L+  +
Sbjct: 305 NLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360

Query: 101 NNFESMLPIEGI 112
           N    + P+  +
Sbjct: 361 NQISDLTPLANL 372

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 2e-06
 Identities = 25/89 (28%), Positives = 42/89 (47%), Gaps = 6/89 (6%)

Query: 24  FNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEI 83
              + N +S          T+L++L ++GN        +L+SL  L  LDL+ N +S+  
Sbjct: 202 LIATNNQISDITPLGI--LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA 257

Query: 84  PEFLAGFKFLQNLNLSYNNFESMLPIEGI 112
           P  L+G   L  L L  N   ++ P+ G+
Sbjct: 258 P--LSGLTKLTELKLGANQISNISPLAGL 284

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.8 bits (89), Expect = 0.001
 Identities = 9/53 (16%), Positives = 20/53 (37%), Gaps = 2/53 (3%)

Query: 62  SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFK 114
           S + L  +  L   +  +     + +     L  +N S N    + P++ + K
Sbjct: 39  SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITPLKNLTK 89

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 66.7 bits (161), Expect = 1e-12
 Identities = 23/67 (34%), Positives = 33/67 (49%), Gaps = 4/67 (5%)

Query: 73  DLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIP 132
           DL  N +   +P+ L   KFL +LN+S+NN    +P  G  +    ++   NK LCG   
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG--- 306

Query: 133 EFQLPTC 139
              LP C
Sbjct: 307 -SPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 56.7 bits (135), Expect = 2e-09
 Identities = 18/68 (26%), Positives = 29/68 (42%), Gaps = 1/68 (1%)

Query: 42  CTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYN 101
             +L  LD+  N   G +   L+ L+ L  L++S NNL  EIP+     +       + N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANN 301

Query: 102 NFESMLPI 109
                 P+
Sbjct: 302 KCLCGSPL 309

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 54.8 bits (130), Expect = 8e-09
 Identities = 19/53 (35%), Positives = 22/53 (41%), Gaps = 1/53 (1%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN 53
           DL NN + GTL   L  L  L   NVS N L G I    G+    +      N
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN 301

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 51.3 bits (121), Expect = 1e-07
 Identities = 11/61 (18%), Positives = 22/61 (36%), Gaps = 1/61 (1%)

Query: 19  SSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNN 78
            +L+  ++  N + G +         L  L++  N   G I     +L+   V   + N 
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNK 302

Query: 79  L 79
            
Sbjct: 303 C 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 38.6 bits (88), Expect = 0.001
 Identities = 30/111 (27%), Positives = 42/111 (37%), Gaps = 3/111 (2%)

Query: 1   DLSNNNLSG--TLSPQLVGLSSLSIFNVSGNL-LSGAISNNFGSCTSLEQLDMHGNLFAG 57
           DLS  NL     +   L  L  L+   + G   L G I       T L  L +     +G
Sbjct: 56  DLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG 115

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
            I   LS ++ L  LD S N LS  +P  ++    L  +    N     +P
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 52.4 bits (125), Expect = 4e-09
 Identities = 25/112 (22%), Positives = 41/112 (36%), Gaps = 6/112 (5%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L++ +L  T+   L  L  ++  ++S N L         +   LE L    N       
Sbjct: 4   HLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV-- 58

Query: 61  SSLSSLRGLRVLDLSQNNLSD-EIPEFLAGFKFLQNLNLSYNNFESMLPIEG 111
             +++L  L+ L L  N L      + L     L  LNL  N+      I+ 
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 110

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.8 bits (87), Expect = 5e-04
 Identities = 11/39 (28%), Positives = 21/39 (53%), Gaps = 2/39 (5%)

Query: 70  RVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
           RVL L+  +L+  +   L     + +L+LS+N   ++ P
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP 37

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.3 bits (123), Expect = 7e-08
 Identities = 12/92 (13%), Positives = 27/92 (29%), Gaps = 5/92 (5%)

Query: 20  SLSIFNVSGNLLSGA-ISNNFGSCTSLEQLDMHGNLF----AGPIGSSLSSLRGLRVLDL 74
            +   ++    LS A  +         + + +            I S+L     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 75  SQNNLSDEIPEFLAGFKFLQNLNLSYNNFESM 106
             N L D     +       +  +   + ++ 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 3e-07
 Identities = 16/75 (21%), Positives = 24/75 (32%), Gaps = 9/75 (12%)

Query: 38  NFGSCTSLEQLDMHGNLF----AGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGF--- 90
                + L  L +            + ++L +   LR LDLS N L D     L      
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423

Query: 91  --KFLQNLNLSYNNF 103
               L+ L L    +
Sbjct: 424 PGCLLEQLVLYDIYW 438

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 2e-06
 Identities = 15/82 (18%), Positives = 29/82 (35%), Gaps = 9/82 (10%)

Query: 19  SSLSIFNVSGNLLSG----AISNNFGSCTSLEQLDMHGNLFAGPIGSSLSS-----LRGL 69
           S L +  ++   +S     +++    +  SL +LD+  N         L          L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 70  RVLDLSQNNLSDEIPEFLAGFK 91
             L L     S+E+ + L   +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALE 450

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.7 bits (114), Expect = 9e-07
 Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 10/88 (11%)

Query: 29  NLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSL-SSLRGLRVLDLSQNNLSDEIPEFL 87
           N  S  I +      SLE+L++  N         L +    L  L  S N+L+ E+PE  
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKL-----IELPALPPRLERLIASFNHLA-EVPELP 323

Query: 88  AGFKFLQNLNLSYNNFESMLPIEGIFKN 115
                L+ L++ YN       I    ++
Sbjct: 324 QN---LKQLHVEYNPLREFPDIPESVED 348

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.4 bits (108), Expect = 4e-06
 Identities = 20/99 (20%), Positives = 34/99 (34%), Gaps = 14/99 (14%)

Query: 2   LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGS 61
              N  S  +        SL   NVS N L   +         LE+L    N       +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL-----A 317

Query: 62  SL-SSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLS 99
            +    + L+ L +  N L  E P+       +++L ++
Sbjct: 318 EVPELPQNLKQLHVEYNPLR-EFPDIPES---VEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.2 bits (92), Expect = 4e-04
 Identities = 11/39 (28%), Positives = 17/39 (43%), Gaps = 4/39 (10%)

Query: 67  RGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFES 105
           R    L+L+   LS  +PE       L++L  S N+   
Sbjct: 38  RQAHELELNNLGLS-SLPELPPH---LESLVASCNSLTE 72

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.3 bits (87), Expect = 0.002
 Identities = 14/60 (23%), Positives = 23/60 (38%), Gaps = 7/60 (11%)

Query: 66  LRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK 125
              L  L++S N L  E+P        L+ L  S+N+      +  + +N     V  N 
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE---VPELPQNLKQLHVEYNP 335

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 48.1 bits (113), Expect = 1e-06
 Identities = 16/66 (24%), Positives = 23/66 (34%)

Query: 43  TSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNN 102
                LD+  N           +L+ L  L L  N +S   P   A    L+ L LS N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 103 FESMLP 108
            + +  
Sbjct: 91  LKELPE 96

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 45.4 bits (106), Expect = 8e-06
 Identities = 32/202 (15%), Positives = 56/202 (27%), Gaps = 5/202 (2%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DL NN ++         L +L    +  N +S      F     LE+L +  N       
Sbjct: 37  DLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPE 96

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
               +L+ LRV +     +   +   L     ++       +           K  S   
Sbjct: 97  KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 156

Query: 121 VFGNKKLCGGIPEFQLPTCVSKKSKRNRSTLPLKLVIVIDIGLLVLTLALSSLFCRLMCM 180
           +         IP+   P+        N+ T      +    GL  L     S        
Sbjct: 157 IADTN--ITTIPQGLPPSLTELHLDGNKITKVDAASL---KGLNNLAKLGLSFNSISAVD 211

Query: 181 KKRGNPTPSISFPYVSYRMLYN 202
                 TP +   +++   L  
Sbjct: 212 NGSLANTPHLRELHLNNNKLVK 233

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 40.0 bits (92), Expect = 4e-04
 Identities = 28/122 (22%), Positives = 45/122 (36%), Gaps = 3/122 (2%)

Query: 4   NNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSL 63
               SG  +    G+  LS   ++   ++   +   G   SL +L + GN       +SL
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASL 191

Query: 64  SSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFG 123
             L  L  L LS N++S      LA    L+ L+L+ N    +       K      +  
Sbjct: 192 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHN 251

Query: 124 NK 125
           N 
Sbjct: 252 NN 253

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 37.7 bits (86), Expect = 0.002
 Identities = 22/134 (16%), Positives = 37/134 (27%), Gaps = 5/134 (3%)

Query: 3   SNNNLSGTLSPQLVGLSSLSIFNVSG--NLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
             N ++        GL+ + +  +       SG  +  F     L  + +          
Sbjct: 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ 167

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATS 120
               SL     L L  N ++      L G   L  L LS+N+  ++              
Sbjct: 168 GLPPSLT---ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 224

Query: 121 VFGNKKLCGGIPEF 134
              N KL       
Sbjct: 225 HLNNNKLVKVPGGL 238

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 3e-06
 Identities = 16/63 (25%), Positives = 24/63 (38%), Gaps = 4/63 (6%)

Query: 37  NNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNL 96
               + + L  L    N  +      L+SL  L  + L  N +SD  P  LA    L  +
Sbjct: 167 TPLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222

Query: 97  NLS 99
            L+
Sbjct: 223 TLT 225

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.0 bits (107), Expect = 5e-06
 Identities = 18/104 (17%), Positives = 36/104 (34%), Gaps = 4/104 (3%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L  N ++         L  L    +  N LS   +       +L+ L ++ N +     
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC- 241

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFE 104
            +      L+    S + +   +P+ LAG        L+ N+ +
Sbjct: 242 RARPLWAWLQKFRGSSSEVPCSLPQRLAGRDL---KRLAANDLQ 282

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.0 bits (102), Expect = 2e-05
 Identities = 32/134 (23%), Positives = 48/134 (35%)

Query: 2   LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGS 61
           L +N L          L +L+   + GN +S      F    SL++L +H N  A     
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195

Query: 62  SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSV 121
           +   L  L  L L  NNLS    E LA  + LQ L L+ N +        ++        
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRG 255

Query: 122 FGNKKLCGGIPEFQ 135
             ++  C       
Sbjct: 256 SSSEVPCSLPQRLA 269

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (84), Expect = 0.004
 Identities = 26/109 (23%), Positives = 42/109 (38%), Gaps = 1/109 (0%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
            L  N +S   +       +L+I  +  N+L+   +  F     LEQLD+  N     + 
Sbjct: 38  FLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD 97

Query: 61  S-SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
             +   L  L  L L +  L +  P    G   LQ L L  N  +++  
Sbjct: 98  PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD 146

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.5 bits (103), Expect = 2e-05
 Identities = 12/75 (16%), Positives = 24/75 (32%), Gaps = 4/75 (5%)

Query: 58  PIGSSLSSLRGLRVLDLSQNNLSDE----IPEFLAGFKFLQNLNLSYNNFESMLPIEGIF 113
            + + L     ++ + LS N +  E    + E +A  K L+    S      +       
Sbjct: 22  SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81

Query: 114 KNASATSVFGNKKLC 128
                 ++    KL 
Sbjct: 82  LRLLLQALLKCPKLH 96

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 4e-04
 Identities = 12/91 (13%), Positives = 32/91 (35%), Gaps = 5/91 (5%)

Query: 20  SLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLF----AGPIGSSLSSLRGLRVLDLS 75
           SL +  ++      ++        S++++ + GN      A  +  +++S + L + + S
Sbjct: 9   SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67

Query: 76  QNNLSDEIPEFLAGFKFLQNLNLSYNNFESM 106
                    E     + L    L      ++
Sbjct: 68  DIFTGRVKDEIPEALRLLLQALLKCPKLHTV 98

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.1 bits (89), Expect = 9e-04
 Identities = 12/49 (24%), Positives = 16/49 (32%), Gaps = 5/49 (10%)

Query: 62  SLSSLRGLRVLDLSQNNLSDEIPEFLA-----GFKFLQNLNLSYNNFES 105
           S     GL+ L L  N +  +    L          L  L L+ N F  
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.2 bits (84), Expect = 0.004
 Identities = 10/67 (14%), Positives = 20/67 (29%), Gaps = 5/67 (7%)

Query: 38  NFGSCTSLEQLDMHGNLFAGPIGSSLSS-----LRGLRVLDLSQNNLSDEIPEFLAGFKF 92
           +      L+ L +  N        +L +     +  L  L+L+ N  S+E        + 
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327

Query: 93  LQNLNLS 99
                  
Sbjct: 328 FSTRGRG 334

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (100), Expect = 4e-05
 Identities = 17/109 (15%), Positives = 35/109 (32%), Gaps = 27/109 (24%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG 60
           DL+  NL   ++ +L+    ++                              +    P+ 
Sbjct: 6   DLTGKNLHPDVTGRLLSQGVIA-------------------------FRCPRSFMDQPLA 40

Query: 61  SSLSSLRGLRVLDLSQNNLSDE-IPEFLAGFKFLQNLNLSYNNFESMLP 108
              S  R ++ +DLS + +    +   L+    LQNL+L        + 
Sbjct: 41  EHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIV 88

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 2e-04
 Identities = 11/69 (15%), Positives = 20/69 (28%), Gaps = 2/69 (2%)

Query: 42  CTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYN 101
               E      N              G  +LD+S+  +       L   K L+  +    
Sbjct: 176 TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--Y 233

Query: 102 NFESMLPIE 110
           N + +  +E
Sbjct: 234 NLKKLPTLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.001
 Identities = 10/50 (20%), Positives = 18/50 (36%), Gaps = 3/50 (6%)

Query: 35  ISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIP 84
            ++ F   +    LD+            L +L+ LR       NL  ++P
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP 239

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (90), Expect = 3e-04
 Identities = 21/110 (19%), Positives = 37/110 (33%), Gaps = 7/110 (6%)

Query: 1   DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN--LFAGP 58
           DL          P LV  +   + N   ++ +  +     +   L  L++  N       
Sbjct: 28  DLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDD 82

Query: 59  IGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLP 108
           + S +     L++L+LS N L  E          L+ L L  N+      
Sbjct: 83  MSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (89), Expect = 4e-04
 Identities = 8/43 (18%), Positives = 14/43 (32%), Gaps = 1/43 (2%)

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNF 103
           +  ++    R LDL    +   I    A       ++ S N  
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.0 bits (84), Expect = 0.003
 Identities = 13/73 (17%), Positives = 24/73 (32%), Gaps = 13/73 (17%)

Query: 39  FGSCTSLEQLDMHGNLFAGPIGSSLSSL-----RGLRVLDLSQNNLSDEIPEFLAGFKFL 93
                S  +++            +L++L     +   +L LS+N L       L  +  L
Sbjct: 6   VSKVASHLEVNCDKR--------NLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRL 57

Query: 94  QNLNLSYNNFESM 106
             LNL       +
Sbjct: 58  TQLNLDRAELTKL 70

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.0 bits (84), Expect = 0.004
 Identities = 14/54 (25%), Positives = 20/54 (37%), Gaps = 1/54 (1%)

Query: 50  MHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNF 103
           +  N         L+ L  L  L L +N+L   IP+   G   L    L  N +
Sbjct: 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.5 bits (83), Expect = 0.004
 Identities = 16/39 (41%), Positives = 21/39 (53%), Gaps = 2/39 (5%)

Query: 61  SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLS 99
             L+ L  L+ L LS+N++SD     LAG K L  L L 
Sbjct: 172 VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	502
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.7
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.68
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.68
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.65
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.6
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.59
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.55
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.54
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.53
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.49
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.48
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.46
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.46
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.4
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.4
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.3
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.28
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.26
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.23
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.22
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.21
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.19
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.18
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.05
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.03
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.02
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.9
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.79
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.77
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.55
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.51
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.5
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.35
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.29
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.17
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.09
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.07
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.94
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.88
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.7
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.67
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.58
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.43
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.94
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.84
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.74
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.98
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.9

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=417.41  Aligned_cols=264  Identities=27%  Similarity=0.399  Sum_probs=205.9

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|...+.||+|+||+||+|+..   ..||||+++...  ....+.|.+|++++++++|||||+++++|..      +.
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence            467889999999999999999642   359999987442  3445789999999999999999999998632      35


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.++++.         ....+++.+++.++.|+|+||+|||   +++|+||||||+|||++.++.+||
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl  145 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHI---------IETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKI  145 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHT---------SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEE
T ss_pred             EEEEEecCCCCCHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEE
Confidence            7999999999999999853         3356899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCC---CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG---HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +|||+|+...............||+.|||||++.+   ..++.++|||||||++|||+||+.||.+..... .+...+..
T Consensus       146 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~~~  224 (276)
T d1uwha_         146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGR  224 (276)
T ss_dssp             CCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHH
T ss_pred             ccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHHhc
Confidence            99999987665444444456779999999999864   358999999999999999999999997632211 11121211


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      ...       .+   .......+++..+.+++.+||+.||++||||+|+++.|+.+++.++
T Consensus       225 ~~~-------~p---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         225 GYL-------SP---DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             TSC-------CC---CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CCC-------CC---cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            110       00   0111123456778899999999999999999999999999988654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3e-54  Score=414.16  Aligned_cols=270  Identities=25%  Similarity=0.425  Sum_probs=201.5

Q ss_pred             cCHHHHHHhccC---------CCCCCcccccCCceEEEEEEcCCCe---EEEEEEecccCc-chhHHHHHHHHHHhcCCC
Q 046112          195 VSYRMLYNATKG---------FSSENLIGAGNFGSVYKGILFESTT---AVAVKVFNVLHH-DASKSFAVECEVTRNIRH  261 (502)
Q Consensus       195 ~~~~~l~~~t~~---------~~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h  261 (502)
                      +++++...++.+         |...++||+|+||+||+|.+..+++   .||||.+..... ...+.|.+|++++++++|
T Consensus         7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H   86 (299)
T d1jpaa_           7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH   86 (299)
T ss_dssp             GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence            345555555544         4456789999999999998765553   689998865433 345679999999999999


Q ss_pred             CccceeeecccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 046112          262 RNLVKVFTACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPI  341 (502)
Q Consensus       262 ~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i  341 (502)
                      ||||+++|+|..     ++..++|||||++|+|.+++.         .....+++.+++.++.|+|+||+|||   +++|
T Consensus        87 pnIv~l~g~~~~-----~~~~~iv~Ey~~~g~L~~~~~---------~~~~~l~~~~~~~i~~qia~gl~yLH---~~~i  149 (299)
T d1jpaa_          87 PNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLR---------QNDGQFTVIQLVGMLRGIAAGMKYLA---DMNY  149 (299)
T ss_dssp             TTBCCEEEEECS-----SSSCEEEEECCTTEEHHHHHH---------TTTTCSCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             CCCccEEEEEee-----CCEEEEEEEecCCCcceeeec---------cccCCCCHHHHHHHHHHHHHHHHHHh---hCCC
Confidence            999999999643     347899999999999999875         23456999999999999999999999   8999


Q ss_pred             eeecCCCCCeeeCCCCcEEEeeeccceeccccccc---ceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-
Q 046112          342 AHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQ---TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-  417 (502)
Q Consensus       342 ~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-  417 (502)
                      +||||||+|||++.++.+||+|||+|+.+......   .......||+.|||||.+.++.++.++|||||||++|||+| 
T Consensus       150 iHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~  229 (299)
T d1jpaa_         150 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY  229 (299)
T ss_dssp             CCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             ccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhC
Confidence            99999999999999999999999999877544332   22234567999999999999999999999999999999998 


Q ss_pred             CCCCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          418 GLRPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       418 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      |+.||.+...  ..+...+.....              .+...+++..+.+++.+||+.||++||||+||++.|+++.+.
T Consensus       230 g~~Pf~~~~~--~~~~~~i~~~~~--------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         230 GERPYWDMTN--QDVINAIEQDYR--------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             SCCTTTTCCH--HHHHHHHHTTCC--------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCCCCCH--HHHHHHHHcCCC--------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            8999976321  112222211110              111224566788999999999999999999999999988653

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-54  Score=406.11  Aligned_cols=253  Identities=23%  Similarity=0.320  Sum_probs=203.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|+..+.||+|+||+||+|++..+|+.||||+++... .+..+.+.+|++++++++|||||++++++     ..++..+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~~~   79 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQY   79 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCceeE
Confidence            57888999999999999999999999999999987543 23345689999999999999999999995     3455899


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++|+|.+++.          ....+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|
T Consensus        80 ivmEy~~gg~L~~~l~----------~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~D  146 (271)
T d1nvra_          80 LFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISD  146 (271)
T ss_dssp             EEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECC
T ss_pred             EEEeccCCCcHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEcc
Confidence            9999999999999984          2356899999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCcc-CccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEV-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+|+...............||+.|||||++.+..+ +.++||||+||++|||+||+.||+........+..+.......
T Consensus       147 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~  226 (271)
T d1nvra_         147 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL  226 (271)
T ss_dssp             CTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS
T ss_pred             chhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Confidence            999998765544444456789999999999988876 5779999999999999999999976332221121111110000


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                                ..    .......+.+++.+|++.||++|||++|+++
T Consensus       227 ----------~~----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 ----------NP----WKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ----------TT----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----------Cc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                      00    1123455678999999999999999999864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=403.12  Aligned_cols=257  Identities=26%  Similarity=0.388  Sum_probs=198.3

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|+..+.||+|+||+||+|.+ .++..||||+++... ...++|.+|++++++++|||||+++|+|..     ++..++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~l   77 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL   77 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEE-TTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEE-CCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceEE
Confidence            5678889999999999999976 467889999997543 345789999999999999999999999743     347899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++|+|.+++.         .....+++..++.++.|+|.||+|||   +.+|+||||||+|||+|.++.+||+||
T Consensus        78 v~E~~~~g~L~~~l~---------~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DF  145 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDF  145 (263)
T ss_dssp             EEECCTTCBHHHHHH---------TTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSC
T ss_pred             EEEecCCCcHHHHhh---------ccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEeccc
Confidence            999999999999985         33456899999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhC-CCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTG-LRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |+++........ ......||+.|+|||++.+..++.++|||||||++|||+|+ ++||...  ....+.+.+...... 
T Consensus       146 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~~-  221 (263)
T d1sm2a_         146 GMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRL-  221 (263)
T ss_dssp             C-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHHHTCCC-
T ss_pred             chheeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHHHHhcCCC-
Confidence            999876543322 22346789999999999999999999999999999999995 5555431  111122222211100 


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                                ..   +..++..+.+++.+||+.||++||||+|+++.|++|++.
T Consensus       222 ----------~~---p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         222 ----------YK---PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             ----------CC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------CC---ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence                      00   123456788999999999999999999999999999764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.9e-54  Score=409.67  Aligned_cols=260  Identities=22%  Similarity=0.358  Sum_probs=211.9

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ..++|...+.||+|+||+||+|.+..+++.||||+++... ...++|.+|++++++++|||||+++++|.     .++..
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~   88 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF   88 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSC
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEe-----eCCee
Confidence            3457888899999999999999998899999999987543 34578999999999999999999999964     34578


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+++|+|.+++..        .....+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+
T Consensus        89 ~iv~E~~~~g~l~~~l~~--------~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~  157 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRE--------CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVA  157 (287)
T ss_dssp             EEEEECCTTCBHHHHHHH--------SCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEEeecccCcchHHHhhh--------ccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEc
Confidence            999999999999999853        34567899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      |||+|+...... ........||+.|+|||++.+..++.++|||||||++|||++|..|+..... ...+.+.+..... 
T Consensus       158 DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~i~~~~~-  234 (287)
T d1opja_         158 DFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYR-  234 (287)
T ss_dssp             CCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTCC-
T ss_pred             cccceeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHHHHhcCCC-
Confidence            999998665432 2333455689999999999999999999999999999999997777643211 1112222221110 


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                                   .+....++..+.+++.+||+.||++||||+|+++.|+.+.
T Consensus       235 -------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         235 -------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                         0111234567889999999999999999999999998763

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-53  Score=400.41  Aligned_cols=246  Identities=20%  Similarity=0.302  Sum_probs=202.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||+||+|++..+++.||+|++...   .....+.+.+|++++++++|||||++++++     ..++.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence            4688889999999999999999999999999998632   223456789999999999999999999995     34558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        81 ~~ivmEy~~~g~L~~~l~~----------~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl  147 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQK----------LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKI  147 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEeecCCCcHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEee
Confidence            9999999999999999842          245899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+|+......    .....||+.|||||.+.+..++.++|||||||++|||+||+.||+....  ......+...  
T Consensus       148 ~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~--  219 (263)
T d2j4za1         148 ADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QETYKRISRV--  219 (263)
T ss_dssp             CCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHTT--
T ss_pred             cccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--HHHHHHHHcC--
Confidence            9999997654322    2346799999999999999999999999999999999999999975211  1111111110  


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                               .    ..++..++..+.+++.+|++.||++|||++|+++
T Consensus       220 ---------~----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         220 ---------E----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---------C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------C----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                     0    0011123456778999999999999999999976

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-53  Score=401.16  Aligned_cols=262  Identities=23%  Similarity=0.351  Sum_probs=209.7

Q ss_pred             cCCCCCCc-ccccCCceEEEEEEc--CCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          205 KGFSSENL-IGAGNFGSVYKGILF--ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~-lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ++|...+. ||+|+||+||+|.+.  .++..||||+++.... ...++|.+|++++++++|||||+++|+|..      +
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence            34555564 999999999999764  3456899999975433 345779999999999999999999998732      2


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.+++.         .....+++.+++.++.|+|.||+|||   +++|+||||||+|||++.++.+|
T Consensus        82 ~~~lvmE~~~~g~L~~~l~---------~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~K  149 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLV---------GKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAK  149 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHT---------TCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEE
T ss_pred             eEEEEEEeCCCCcHHHHhh---------ccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCcee
Confidence            5799999999999999874         33456999999999999999999999   89999999999999999999999


Q ss_pred             Eeeeccceeccccccc-ceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHh
Q 046112          361 VSDFGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  438 (502)
                      |+|||+|+.+...... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+...  ......+..
T Consensus       150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i~~  227 (285)
T d1u59a_         150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQ  227 (285)
T ss_dssp             ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHT
T ss_pred             eccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHc
Confidence            9999999987654332 22234568999999999999999999999999999999998 9999986321  122222221


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE  500 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~  500 (502)
                      ...              .+.+..++..+.+|+.+||+.||++||||.+|.+.|+.+-..+.+
T Consensus       228 ~~~--------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~  275 (285)
T d1u59a_         228 GKR--------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  275 (285)
T ss_dssp             TCC--------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             CCC--------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence            110              111224566788999999999999999999999999887655543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=400.16  Aligned_cols=262  Identities=25%  Similarity=0.413  Sum_probs=200.5

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCC----eEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccccccCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFEST----TAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      .++|+..++||+|+||+||+|.+..++    ..||||+++..... ...+|.+|++++++++|||||+++|+|..     
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-----   80 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----   80 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-----
Confidence            356788899999999999999876544    57999998754333 34578999999999999999999999643     


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      .+..++||||+.+|++.+++.         .....+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.
T Consensus        81 ~~~~~~v~e~~~~~~l~~~~~---------~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~  148 (283)
T d1mqba_          81 YKPMMIITEYMENGALDKFLR---------EKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLV  148 (283)
T ss_dssp             SSSEEEEEECCTTEEHHHHHH---------HTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCC
T ss_pred             CCceEEEEEecccCcchhhhh---------cccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCe
Confidence            347899999999999998874         23456999999999999999999999   899999999999999999999


Q ss_pred             EEEeeeccceeccccccc-ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHH
Q 046112          359 AYVSDFGIARFLEAADEQ-TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  437 (502)
                      +||+|||+|+.+...... .......||+.|+|||++.++.++.++|||||||++|||+||..|+...... ......+.
T Consensus       149 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~  227 (283)
T d1mqba_         149 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAIN  227 (283)
T ss_dssp             EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHH
T ss_pred             EEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHh
Confidence            999999999876544332 2234466899999999999999999999999999999999976665432111 11222221


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ....              .+...+++..+.+|+.+||+.||++||||+||++.|+++.+.
T Consensus       228 ~~~~--------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         228 DGFR--------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             TTCC--------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ccCC--------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            1110              111124566788999999999999999999999999988753

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-53  Score=399.86  Aligned_cols=258  Identities=24%  Similarity=0.382  Sum_probs=205.9

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|+||+||+|.+ .+++.||||+++... ...+.|.+|++++++++|||||+++|+|..      +..+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~   83 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY   83 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeE
Confidence            35677889999999999999975 567899999997543 345789999999999999999999998632      3578


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++|+|.+++..        .....+++.+++.|+.|+++||+|||   +++|+||||||+|||+++++.+||+|
T Consensus        84 iv~Ey~~~g~L~~~~~~--------~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~D  152 (272)
T d1qpca_          84 IITEYMENGSLVDFLKT--------PSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIAD  152 (272)
T ss_dssp             EEEECCTTCBHHHHTTS--------HHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECC
T ss_pred             EEEEeCCCCcHHHHHhh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeecc
Confidence            99999999999998754        22235899999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||+|+.+..... .......||+.|+|||++.++.++.++|||||||++|||+||..|+...... ......+.....  
T Consensus       153 FGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~~i~~~~~--  228 (272)
T d1qpca_         153 FGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLERGYR--  228 (272)
T ss_dssp             CTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCC--
T ss_pred             ccceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCC--
Confidence            999997754332 2234567899999999999999999999999999999999966554432111 111221111110  


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                               ...   +..++..+.+++.+||+.||++||||+||++.|+.+-.
T Consensus       229 ---------~~~---p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         229 ---------MVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             ---------CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCC---cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence                     000   12345568899999999999999999999999987643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=398.86  Aligned_cols=250  Identities=21%  Similarity=0.282  Sum_probs=205.8

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|+..+.||+|+||+||+|.+..+|+.||||+++.......+.+.+|++++++++|||||++++++.     .++..++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE-----ECCEEEE
Confidence            46999999999999999999998999999999998655555678999999999999999999999953     4458999


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++|+|.+++..           ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus        95 vmEy~~gg~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DF  160 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF  160 (293)
T ss_dssp             EEECCTTCBHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEecCCCcHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccc
Confidence            9999999999988642           35899999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccch
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      |+|+.+.....  ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.+..... .+........+.  
T Consensus       161 G~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~--  235 (293)
T d1yhwa1         161 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE--  235 (293)
T ss_dssp             TTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC--
T ss_pred             hhheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCC--
Confidence            99987654322  2345679999999999999999999999999999999999999997532111 111111111100  


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                             .    .....+...+.+++.+||+.||++|||++|+++
T Consensus       236 -------~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         236 -------L----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -------C----SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -------C----CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   0    011233556779999999999999999999874

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=403.45  Aligned_cols=251  Identities=20%  Similarity=0.350  Sum_probs=201.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|+..+.||+|+||+||+|++..+++.||||+++..   .....+.+.+|++++++++||||+++++++     ..++.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence            5789999999999999999999899999999998642   223456799999999999999999999984     44568


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          .+.+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||
T Consensus        83 ~~ivmEy~~gg~L~~~~~~----------~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl  149 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRK----------IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI  149 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEE
T ss_pred             EEEEEEccCCCCHHHhhhc----------cCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEe
Confidence            9999999999999998742          346899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||....  ...+.+.+   ..
T Consensus       150 ~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~~~~~~~i---~~  224 (288)
T d1uu3a_         150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EYLIFQKI---IK  224 (288)
T ss_dssp             CCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH---HT
T ss_pred             cccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--HHHHHHHH---Hc
Confidence            99999998765544444456789999999999999999999999999999999999999997521  11111111   10


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                      ..            .+++......+.+++.+|++.||++|||++|+.+.
T Consensus       225 ~~------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         225 LE------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             TC------------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             CC------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            00            00111234557799999999999999999997543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-53  Score=398.96  Aligned_cols=258  Identities=21%  Similarity=0.265  Sum_probs=192.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|+..+.||+|+||+||+|++..+|+.||||+++....  ...+.+.+|++++++++|||||++++++..   ..+...
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCEE
Confidence            578899999999999999999999999999999875432  234668899999999999999999998642   224467


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceeecCCCCCeeeCCCCcEE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDC--QPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ++||||+++|+|.+++....      .....+++..++.++.|++.||.|||...  ..+|+||||||+|||++.++.+|
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~------~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGT------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHH------HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence            99999999999999985311      23456999999999999999999999421  23599999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||+|+.+.....  ......||+.|||||.+.+..++.++|||||||++|||+||+.||.....  ..+...+... 
T Consensus       155 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~i~~~-  229 (269)
T d2java1         155 LGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREG-  229 (269)
T ss_dssp             ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHT-
T ss_pred             EeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHHHHHcC-
Confidence            999999987654322  22356799999999999999999999999999999999999999976321  1111111111 


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                                .....   ...++..+.+++.+||+.||++|||++|+++
T Consensus       230 ----------~~~~~---~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         230 ----------KFRRI---PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ----------CCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----------CCCCC---CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                      00101   1123456789999999999999999999874

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-52  Score=388.19  Aligned_cols=254  Identities=24%  Similarity=0.391  Sum_probs=208.6

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|+..+.||+|+||+||+|++ .++..||||+++.... ..++|.+|++++++++||||++++|+|..     ++..+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~~~   75 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIF   75 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSSEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEee-----CCceE
Confidence            36899999999999999999986 5788999999986443 35789999999999999999999999643     44789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++|+|.+++..         ....+++..+.+++.|+++||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        76 iv~Ey~~~g~l~~~~~~---------~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~D  143 (258)
T d1k2pa_          76 IITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSD  143 (258)
T ss_dssp             EEEECCTTEEHHHHHHS---------GGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEccCCCcHHHhhhc---------cccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECc
Confidence            99999999999999742         3356889999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+++.+..... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......  .....+..... 
T Consensus       144 fG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~i~~~~~-  219 (258)
T d1k2pa_         144 FGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLR-  219 (258)
T ss_dssp             CSSCCBCSSSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCC-
T ss_pred             chhheeccCCCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHHHHhCCC-
Confidence            999987654432 23345678999999999999999999999999999999998 89999764221  11111111100 


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRL  493 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~  493 (502)
                                ...   +..++..+.+++.+||+.||++|||++|+++.|.+
T Consensus       220 ----------~~~---p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         220 ----------LYR---PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ----------CCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ----------CCC---cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                      001   12345678899999999999999999999998854

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-52  Score=393.66  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=200.1

Q ss_pred             CcccccCCceEEEEEEcC--CCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEEe
Q 046112          211 NLIGAGNFGSVYKGILFE--STTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALVY  286 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  286 (502)
                      ++||+|+||+||+|.+..  .++.||||+++...  ....++|.+|++++++++|||||+++|+|..      +..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence            479999999999997643  45789999987432  2234679999999999999999999998732      2568999


Q ss_pred             eeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeecc
Q 046112          287 EFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFGI  366 (502)
Q Consensus       287 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg~  366 (502)
                      ||+++|+|.++++.          ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        87 E~~~~g~L~~~l~~----------~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGl  153 (277)
T d1xbba_          87 EMAELGPLNKYLQQ----------NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL  153 (277)
T ss_dssp             ECCTTEEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             EcCCCCcHHHHHhh----------ccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhh
Confidence            99999999999842          345899999999999999999999   89999999999999999999999999999


Q ss_pred             ceeccccccc-ceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccch
Q 046112          367 ARFLEAADEQ-TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPERA  444 (502)
Q Consensus       367 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  444 (502)
                      |+.+...... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+...  ......+....    
T Consensus       154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~i~~~~----  227 (277)
T d1xbba_         154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGE----  227 (277)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTC----
T ss_pred             hhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHHHHHcCC----
Confidence            9877544332 22344678999999999999999999999999999999998 8999976321  11222221110    


Q ss_pred             hhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          445 EEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       445 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                                ..+.+..++..+.+|+.+||+.||++|||+++|.+.|+..-.+
T Consensus       228 ----------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         228 ----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                      0111124566788999999999999999999999988876443

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=398.04  Aligned_cols=252  Identities=24%  Similarity=0.292  Sum_probs=204.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      +.|+..+.||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++|||||++++++.     .++..++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEE
Confidence            45788899999999999999999999999999998666566678999999999999999999999953     4458899


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++|+|.+++..         ....+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+||
T Consensus        87 vmEy~~~g~L~~~~~~---------~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DF  154 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLE---------LERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADF  154 (288)
T ss_dssp             EEECCTTEEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEec
Confidence            9999999999998742         2346899999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccC-----CCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGM-----GHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |+|+.......  ......||+.|+|||++.     ...++.++|||||||++|||+||+.||.+..... .+.......
T Consensus       155 G~a~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~  231 (288)
T d2jfla1         155 GVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSE  231 (288)
T ss_dssp             TTCEECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSC
T ss_pred             hhhhccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCC
Confidence            99986543321  223467999999999874     4568999999999999999999999997632211 111111111


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .+         ..    .....++..+.+++.+||+.||++|||++|+++
T Consensus       232 ~~---------~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         232 PP---------TL----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CC---------CC----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CC---------CC----CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10         00    011234556789999999999999999999976

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=401.57  Aligned_cols=265  Identities=22%  Similarity=0.329  Sum_probs=206.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCC-----eEEEEEEeccc-CcchhHHHHHHHHHHhcC-CCCccceeeecccccccC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFEST-----TAVAVKVFNVL-HHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  277 (502)
                      ++|...++||+|+||+||+|++...+     ..||||++... .......+.+|+.++.++ +|||||+++++|.     
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~-----  111 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT-----  111 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe-----
Confidence            56788899999999999999876543     37999998643 233456789999999998 8999999999964     


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhh-------------hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceee
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEED-------------KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHC  344 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~  344 (502)
                      ..+..++||||+++|+|.++++......             ........+++..++.++.|++.||+|||   +.+|+||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHR  188 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR  188 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence            3457899999999999999996421100             00012346899999999999999999999   8999999


Q ss_pred             cCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCc
Q 046112          345 DLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSD  423 (502)
Q Consensus       345 dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~  423 (502)
                      ||||+|||++.++.+||+|||+|+...............||+.|||||.+.++.++.++|||||||++|||+| |+.||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987766555444456678999999999999999999999999999999998 899997


Q ss_pred             cccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 046112          424 DMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLR  492 (502)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~  492 (502)
                      +.... ..+...+.....              .+.+..++..+.+|+.+||+.||++|||++||++.|.
T Consensus       269 ~~~~~-~~~~~~~~~~~~--------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         269 GIPVD-ANFYKLIQNGFK--------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TCCCS-HHHHHHHHTTCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHH-HHHHHHHhcCCC--------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            63221 122222222111              0111234567889999999999999999999999885

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=388.79  Aligned_cols=249  Identities=26%  Similarity=0.370  Sum_probs=195.8

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEE
Q 046112          208 SSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       208 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      ...++||+|+||+||+|.+..++..||+|++....  ....+.|.+|++++++++|||||++++++... ..++...++|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEE
Confidence            44568999999999999999999999999986432  23346789999999999999999999986432 2334578999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeecCCCCCeeeC-CCCcEEEe
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPP--IAHCDLKPSNILLD-DEMTAYVS  362 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--i~H~dlk~~NIll~-~~~~~kl~  362 (502)
                      |||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+  |+||||||+|||++ +++.+||+
T Consensus        91 mE~~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~  157 (270)
T d1t4ha_          91 TELMTSGTLKTYLKR----------FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIG  157 (270)
T ss_dssp             EECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             EeCCCCCcHHHHHhc----------cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence            999999999999842          245889999999999999999999   766  99999999999996 57899999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      |||+|+.....    ......||+.|||||.+.+ .++.++|||||||++|||+||+.||....... .+...+..... 
T Consensus       158 DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~~~~i~~~~~-  230 (270)
T d1t4ha_         158 DLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSGVK-  230 (270)
T ss_dssp             CTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTTCC-
T ss_pred             ecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HHHHHHHcCCC-
Confidence            99999754322    2235679999999998865 69999999999999999999999997532111 11111111110 


Q ss_pred             chhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 RAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                       .           ..+...+...+.+++.+||+.||++|||++|+++
T Consensus       231 -~-----------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 -P-----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -C-----------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -C-----------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence             0           0111123445779999999999999999999875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-52  Score=390.08  Aligned_cols=253  Identities=26%  Similarity=0.373  Sum_probs=199.2

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|...+.||+|+||.||+|.+  .|+.||||+++..  ...++|.+|++++++++||||++++|+|.    ...+..++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~l   78 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI   78 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEE----ecCCcEEE
Confidence            4567788999999999999977  5789999999753  34578999999999999999999999874    23346799


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+++|+|.++++.        .....++|..++.++.|++.||+|||   +.+|+||||||+|||++.++.+|++||
T Consensus        79 v~ey~~~g~L~~~l~~--------~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~df  147 (262)
T d1byga_          79 VTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDF  147 (262)
T ss_dssp             EECCCTTEEHHHHHHH--------HHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             EEeccCCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeeccc
Confidence            9999999999999853        11234889999999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |+++......     ....+|..|+|||++.++.++.++|||||||++|||+| |+.||....  ..++...+....   
T Consensus       148 g~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--~~~~~~~i~~~~---  217 (262)
T d1byga_         148 GLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGY---  217 (262)
T ss_dssp             CC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGGHHHHHTTTC---
T ss_pred             ccceecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCC---
Confidence            9998654322     23457889999999999999999999999999999998 788876532  222333332211   


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                                 ..++...++..+.+++.+||+.||++||||.|+++.|++++..
T Consensus       218 -----------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         218 -----------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence                       1111223456788999999999999999999999999999764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.3e-52  Score=397.99  Aligned_cols=272  Identities=23%  Similarity=0.367  Sum_probs=211.6

Q ss_pred             HHHhccCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccc
Q 046112          200 LYNATKGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSG  273 (502)
Q Consensus       200 l~~~t~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~  273 (502)
                      ++...++|...+.||+|+||+||+|++.     .+++.||||+++..... ..++|.+|++++++++||||++++++|..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            4445678999999999999999999864     35689999998754333 35679999999999999999999999743


Q ss_pred             cccCCCcceeEEeeeccCCChhhhccCCchhh--------------hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 046112          274 VDFQGNDFKALVYEFMANGSLEEWMHPITEED--------------KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQP  339 (502)
Q Consensus       274 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~  339 (502)
                           ....++||||+++|+|.++++......              ........+++..++.++.|++.||+|||   +.
T Consensus        88 -----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~  159 (301)
T d1lufa_          88 -----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ER  159 (301)
T ss_dssp             -----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred             -----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cC
Confidence                 347899999999999999985321100              01122345899999999999999999999   89


Q ss_pred             CceeecCCCCCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCC
Q 046112          340 PIAHCDLKPSNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGL  419 (502)
Q Consensus       340 ~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~  419 (502)
                      +|+||||||+|||+|.++.+||+|||+|+.+.............||+.|+|||.+.+..++.++|||||||++|||++|.
T Consensus       160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence            99999999999999999999999999998765554444445567899999999999999999999999999999999986


Q ss_pred             -CCCccccccccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          420 -RPSDDMFKDNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       420 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                       .||......  .....+...           ....   .+..++..+.+|+.+||+.||++||||.||+++|++|.
T Consensus       240 ~~p~~~~~~~--e~~~~v~~~-----------~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         240 LQPYYGMAHE--EVIYYVRDG-----------NILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CCTTTTSCHH--HHHHHHHTT-----------CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCCHH--HHHHHHHcC-----------CCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence             566653111  112212111           1111   11244567889999999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-51  Score=396.52  Aligned_cols=259  Identities=22%  Similarity=0.384  Sum_probs=204.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCe----EEEEEEeccc-CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTT----AVAVKVFNVL-HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .+|+..++||+|+||+||+|.+..+|+    .||+|+++.. .....++|.+|++++++++|||||+++|+|..      
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------   82 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   82 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            468889999999999999998877765    5888887643 33446789999999999999999999999753      


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +..++++||+.+|+|.+++.         .....+++..++.++.|+|.||+|||   +++|+||||||+|||++.++.+
T Consensus        83 ~~~~~v~e~~~~~~l~~~~~---------~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~  150 (317)
T d1xkka_          83 STVQLITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHV  150 (317)
T ss_dssp             SSEEEEEECCTTCBHHHHHH---------HTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEE
T ss_pred             CCeeEEEEeccCCccccccc---------ccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCe
Confidence            24678999999999998874         23456899999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  438 (502)
                      ||+|||+|+...............||+.|+|||.+.++.++.++|||||||++|||+| |+.||+....  ..+...+..
T Consensus       151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~~  228 (317)
T d1xkka_         151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEK  228 (317)
T ss_dssp             EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHHH
T ss_pred             EeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHc
Confidence            9999999987765544444445678999999999999999999999999999999999 8899876322  122222222


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ...              .+.+..++..+.+++.+||+.||++|||+.|+++.|..+.+.
T Consensus       229 ~~~--------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         229 GER--------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             TCC--------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCC--------------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            110              011123456788999999999999999999999999888654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-51  Score=394.18  Aligned_cols=252  Identities=21%  Similarity=0.277  Sum_probs=188.6

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC-cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH-HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .+.|...+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++|||||++++++     ..++..
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            456888999999999999999998999999999987543 22345688999999999999999999984     445689


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC---CCCcE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTA  359 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~---~~~~~  359 (502)
                      ++||||+++|+|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+|||++   +++.+
T Consensus        83 ~lvmE~~~gg~L~~~l~----------~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~v  149 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIV----------EKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKI  149 (307)
T ss_dssp             EEEECCCCSCBHHHHHH----------TCSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCE
T ss_pred             EEEEeccCCCcHHHhhh----------cccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceE
Confidence            99999999999999984          2456999999999999999999999   89999999999999994   57899


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ||+|||+|+......   ......||+.|||||.+.+..++.++|||||||++|||+||+.||.+....  .....+...
T Consensus       150 kl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~~~  224 (307)
T d1a06a_         150 MISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFEQILKA  224 (307)
T ss_dssp             EECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHTT
T ss_pred             EEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHhcc
Confidence            999999998654332   223467999999999999999999999999999999999999999763211  111111111


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .           .....+.....+..+.+++.+|++.||++|||++|+++
T Consensus       225 ~-----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         225 E-----------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             C-----------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C-----------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            0           00000111233456789999999999999999999986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=397.42  Aligned_cols=199  Identities=27%  Similarity=0.363  Sum_probs=174.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .++|+..+.||+|+||+||+|++..+|+.||+|+++.... .....+.+|++++++++|||||++++++.     .++..
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence            5678999999999999999999999999999999875432 33467899999999999999999999954     44589


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceeecCCCCCeeeCCCCcEEE
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQ-PPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      ++||||+++|+|.+++..          ...+++..+..++.|++.||.|||   + .+|+||||||+|||++.++.+||
T Consensus        80 ~iVmEy~~gg~L~~~l~~----------~~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl  146 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKK----------AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKL  146 (322)
T ss_dssp             EEEEECCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEcCCCCcHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEE
Confidence            999999999999999842          245899999999999999999999   6 48999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDD  424 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~  424 (502)
                      +|||+|+.+....    .....||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       147 ~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         147 CDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             CCCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             eeCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9999998654322    2346799999999999999999999999999999999999999975

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=390.51  Aligned_cols=260  Identities=23%  Similarity=0.387  Sum_probs=206.0

Q ss_pred             CCcccccCCceEEEEEEcCCC---eEEEEEEeccc-CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeEE
Q 046112          210 ENLIGAGNFGSVYKGILFEST---TAVAVKVFNVL-HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKALV  285 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  285 (502)
                      .++||+|+||+||+|.+..++   ..||||+++.. .....++|.+|++++++++||||++++|+|..    .+...++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCceEEE
Confidence            468999999999999875533   46899998743 33345789999999999999999999999743    33468999


Q ss_pred             eeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeeec
Q 046112          286 YEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDFG  365 (502)
Q Consensus       286 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg  365 (502)
                      ||||++|+|.++++         .....+++..++.++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||
T Consensus       108 ~E~~~~g~l~~~~~---------~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG  175 (311)
T d1r0pa_         108 LPYMKHGDLRNFIR---------NETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFG  175 (311)
T ss_dssp             EECCTTCBHHHHHH---------CTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred             EEEeecCchhhhhc---------cccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEeccc
Confidence            99999999999985         34456788899999999999999999   8999999999999999999999999999


Q ss_pred             cceeccccccc--ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          366 IARFLEAADEQ--TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       366 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      +++........  .......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .++..++.....  
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~~g~~--  252 (311)
T d1r0pa_         176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRR--  252 (311)
T ss_dssp             GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCC--
T ss_pred             chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCC--
Confidence            99876544332  2233467899999999999999999999999999999999988887653221 122222211110  


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLLE  500 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~~  500 (502)
                               ...   +..++..+.+++.+||+.||++||||.||++.|+++.+.+..
T Consensus       253 ---------~~~---p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         253 ---------LLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             ---------CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             ---------CCC---cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence                     001   113456788999999999999999999999999999887544

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1e-50  Score=397.20  Aligned_cols=253  Identities=23%  Similarity=0.299  Sum_probs=205.9

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      -++|.+.+.||+|+||.||+|++..+|+.||||++........+.+.+|++++++++|||||++++++     ..++..+
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            35799999999999999999999999999999999766555567789999999999999999999985     3456899


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC--CCCcEEE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD--DEMTAYV  361 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~--~~~~~kl  361 (502)
                      +|||||++|+|.+++..         ....+++..+..++.|++.||+|||   +.+|+||||||+|||++  .++.+||
T Consensus       100 ivmE~~~gg~L~~~l~~---------~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL  167 (350)
T d1koaa2         100 MIYEFMSGGELFEKVAD---------EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKL  167 (350)
T ss_dssp             EEECCCCSCBHHHHHTC---------TTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEE
T ss_pred             EEEEcCCCCCHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEE
Confidence            99999999999999842         3456999999999999999999999   89999999999999996  4678999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+|+.+.....   .....||+.|||||++.+..++.++|||||||++|||+||+.||.....  ......+.....
T Consensus       168 ~DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~  242 (350)
T d1koaa2         168 IDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKSCDW  242 (350)
T ss_dssp             CCCTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCC
T ss_pred             eecchheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC
Confidence            99999987654322   2346789999999999999999999999999999999999999975311  111111111100


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .           ............+.+++.+|++.||++|||++|+++
T Consensus       243 ~-----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         243 N-----------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             C-----------SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             C-----------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0           001111123456779999999999999999999976

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=387.51  Aligned_cols=276  Identities=24%  Similarity=0.303  Sum_probs=203.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHH--HHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAV--ECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|...+.||+|+||.||+|+.  +|+.||||+++..   ..+++..  |+..+.+++|||||+++++|.... ......
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEE
Confidence            3566678999999999999976  6899999998643   2334444  455566789999999999986432 223468


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceeecCCCCCeeeCCCC
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLD-----CQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~i~H~dlk~~NIll~~~~  357 (502)
                      ++|||||++|+|.++++.           ..++|..++.++.++|.||+|||..     .+++|+||||||+|||++.++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~-----------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~  145 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  145 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred             EEEEecccCCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence            899999999999999953           2489999999999999999999942     146999999999999999999


Q ss_pred             cEEEeeeccceecccccc--cceecccccccccccCcccCCC------ccCccccchhHHHHHHHHHhCCCCCccccccc
Q 046112          358 TAYVSDFGIARFLEAADE--QTRSIGVEGTTGYIAPEYGMGH------EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDN  429 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~  429 (502)
                      .+||+|||+++.......  ........||+.|+|||++.+.      .++.++|||||||++|||+||..|+.......
T Consensus       146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~  225 (303)
T d1vjya_         146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  225 (303)
T ss_dssp             CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred             CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence            999999999987755432  2223457799999999998764      36789999999999999999998875422211


Q ss_pred             cchHHHHHhhcc-c-chhhh----cccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          430 LNLRNCVKSALP-E-RAEEI----RASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       430 ~~~~~~~~~~~~-~-~~~~~----~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      ....+....... . .....    .++..+... ...+++..+.+++.+||+.||++|||+.||++.|+++.++-
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cchhhcccccchHHHHHHHHhccccCCCCCccc-CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            111110000000 0 00011    111111111 12356778999999999999999999999999999998764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2e-50  Score=395.38  Aligned_cols=253  Identities=20%  Similarity=0.256  Sum_probs=205.9

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|...+.||+|+||.||+|.+..+|+.||||+++.........+.+|++++++++|||||++++++     ..+...+
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            35788999999999999999999999999999999865545566788999999999999999999984     4556899


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC--CCCcEEE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD--DEMTAYV  361 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~--~~~~~kl  361 (502)
                      +||||+++|+|.+++.         .....+++.++..++.|++.||+|||   +.+|+||||||+|||++  .++.+||
T Consensus       103 ivmE~~~gg~L~~~~~---------~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL  170 (352)
T d1koba_         103 LILEFLSGGELFDRIA---------AEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKI  170 (352)
T ss_dssp             EEEECCCCCBHHHHTT---------CTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEE
T ss_pred             EEEEcCCCChHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEE
Confidence            9999999999998874         23456999999999999999999999   89999999999999998  6789999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+|+.+.....   .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+....  .....+.....
T Consensus       171 ~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~~  245 (352)
T d1koba_         171 IDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKRCDW  245 (352)
T ss_dssp             CCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHCCC
T ss_pred             eecccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC
Confidence            99999987754322   23456899999999999999999999999999999999999999763111  11111111100


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...           ..........+.+++.+|++.||.+|||++|+++
T Consensus       246 ~~~-----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         246 EFD-----------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             CCC-----------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCC-----------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000           0001123456779999999999999999999975

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-51  Score=388.08  Aligned_cols=257  Identities=26%  Similarity=0.397  Sum_probs=199.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|+..+.||+|+||.||+|.+. ++..||||+++... ...+.|.+|+.++++++|||||+++|+|..      +..+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~   87 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY   87 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeE
Confidence            357888999999999999999764 55679999997543 345789999999999999999999998632      2578


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEee
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSD  363 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~D  363 (502)
                      +||||+++|+|.+++..        .....++|.+++.++.|++.||+|||   +.+|+||||||+|||+|.++.+||+|
T Consensus        88 lv~Ey~~~g~l~~~~~~--------~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~D  156 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVAD  156 (285)
T ss_dssp             EEECCCTTCBHHHHHSH--------HHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             EEEEecCCCchhhhhhh--------cccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcc
Confidence            99999999999998853        22345899999999999999999999   89999999999999999999999999


Q ss_pred             eccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      ||+|+.+..... .......||+.|+|||++.++.++.++|||||||++|||+||..|+...... ......+.....  
T Consensus       157 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~~~--  232 (285)
T d1fmka3         157 FGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYR--  232 (285)
T ss_dssp             CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCC--
T ss_pred             cchhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCC--
Confidence            999987654332 2234467899999999999999999999999999999999976665442211 112222221110  


Q ss_pred             hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHH
Q 046112          444 AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIK  495 (502)
Q Consensus       444 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~  495 (502)
                                  .+...+++..+.+++.+||+.||++||||++|++.|+...
T Consensus       233 ------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         233 ------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ------------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence                        0112245567889999999999999999999998887643

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=388.79  Aligned_cols=272  Identities=21%  Similarity=0.281  Sum_probs=202.3

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcC-----CCeEEEEEEecccCc-chhHHHHHHHHHHhcC-CCCccceeeeccccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFE-----STTAVAVKVFNVLHH-DASKSFAVECEVTRNI-RHRNLVKVFTACSGVDF  276 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  276 (502)
                      .++|...+.||+|+||.||+|.+..     +++.||||+++.... ...+.+..|...+.++ +|+||+.+++++.    
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~----   87 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT----   87 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec----
Confidence            3578889999999999999998653     457899999875332 3356678888887776 6899999999863    


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhh------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCC
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDK------RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSN  350 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~N  350 (502)
                      ..+...++|||||++|+|.++++.......      .......+++.+++.++.|+++||+|||   +++|+||||||+|
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~N  164 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN  164 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccc
Confidence            334568999999999999999964221100      0012345899999999999999999999   8999999999999


Q ss_pred             eeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCC-CCCccccccc
Q 046112          351 ILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGL-RPSDDMFKDN  429 (502)
Q Consensus       351 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~-~p~~~~~~~~  429 (502)
                      ||++.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||. .||..... .
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-~  243 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-D  243 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-S
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH-H
Confidence            999999999999999998766555444445677999999999999999999999999999999999974 56764221 1


Q ss_pred             cchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          430 LNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ..+...+......              +....++..+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus       244 ~~~~~~~~~~~~~--------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         244 EEFCRRLKEGTRM--------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             HHHHHHHHHTCCC--------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCC--------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            1222222221110              01123455688999999999999999999999999998754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=383.77  Aligned_cols=261  Identities=21%  Similarity=0.357  Sum_probs=199.8

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCC---CeEEEEEEecccCcc-hhHHHHHHHHHHhcCCCCccceeeecccccccCCC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFES---TTAVAVKVFNVLHHD-ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  279 (502)
                      .++|...+.||+|+||.||+|.+..+   +..||||.++....+ ..+.|.+|++++++++|||||+++++|.      +
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------c
Confidence            35788889999999999999987543   467899988654333 3467999999999999999999999863      2


Q ss_pred             cceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcE
Q 046112          280 DFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTA  359 (502)
Q Consensus       280 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~  359 (502)
                      +..++||||+++|+|.+++.         .....+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~---------~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~  147 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQ---------VRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCV  147 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHH---------HTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEE
T ss_pred             CeEEEEEEeccCCcHHhhhh---------ccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcE
Confidence            36899999999999999874         23456899999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHHHh
Q 046112          360 YVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       360 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  438 (502)
                      ||+|||+|+....... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......  .....+..
T Consensus       148 Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~  224 (273)
T d1mp8a_         148 KLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIEN  224 (273)
T ss_dssp             EECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT
T ss_pred             EEccchhheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHHc
Confidence            9999999987654332 22334568999999999999999999999999999999998 89998763221  22222211


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHh
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKLL  499 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~~  499 (502)
                      ...              .+....++..+.+++.+||+.||++|||++||++.|+++.++-.
T Consensus       225 ~~~--------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k  271 (273)
T d1mp8a_         225 GER--------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  271 (273)
T ss_dssp             TCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCC--------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence            110              01122455678899999999999999999999999999977643

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-50  Score=389.88  Aligned_cols=245  Identities=22%  Similarity=0.247  Sum_probs=197.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc---hhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD---ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      .|+..+.||+|+||+||+|++..+++.||||+++.....   ..+.+.+|++++++++|||||++++++.     .++..
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECCEE
Confidence            488889999999999999999999999999998754322   2356889999999999999999999954     34589


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++|||||++|+|..++.          ....+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus        91 ~iv~E~~~~g~l~~~~~----------~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~  157 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEV----------HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLG  157 (309)
T ss_dssp             EEEEECCSEEHHHHHHH----------HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEEC
T ss_pred             EEEEEecCCCchHHHHH----------hCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEe
Confidence            99999999999976652          2356899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCC---CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG---HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      |||+|+.....      ....||+.|||||++.+   +.++.++|||||||++|||++|+.||.+..... .+.......
T Consensus       158 DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~  230 (309)
T d1u5ra_         158 DFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNE  230 (309)
T ss_dssp             CCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSC
T ss_pred             ecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCC
Confidence            99999865332      24569999999999864   468999999999999999999999997532111 111111111


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .+         ...     ...++..+.+++.+||+.||++|||++|+++
T Consensus       231 ~~---------~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         231 SP---------ALQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CC---------CCS-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC---------CCC-----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            00         000     0123456779999999999999999999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-50  Score=384.79  Aligned_cols=252  Identities=21%  Similarity=0.283  Sum_probs=203.6

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc------chhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH------DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      .+.|...+.||+|+||+||+|++..+|+.||||+++....      ...+.+.+|++++++++|||||++++++     .
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~   83 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E   83 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            4578999999999999999999989999999999864321      2346799999999999999999999995     4


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                      ..+..++|||||++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~----------~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~  150 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAE----------KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRN  150 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSS
T ss_pred             ECCEEEEEEEcCCCccccchhcc----------ccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCC
Confidence            45689999999999999999842          246899999999999999999999   89999999999999998776


Q ss_pred             ----cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchH
Q 046112          358 ----TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR  433 (502)
Q Consensus       358 ----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~  433 (502)
                          .+|++|||+|+.......   .....||+.|+|||.+.+..++.++|||||||++|||+||+.||.+....  ...
T Consensus       151 ~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~  225 (293)
T d1jksa_         151 VPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETL  225 (293)
T ss_dssp             SSSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH
T ss_pred             CcccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--HHH
Confidence                599999999987654322   23457899999999999999999999999999999999999999763111  111


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..+...           ...........++..+.+++.+||+.||++|||++|+++
T Consensus       226 ~~i~~~-----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         226 ANVSAV-----------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHTT-----------CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHhc-----------CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111111           000111111234556779999999999999999999975

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.7e-50  Score=381.08  Aligned_cols=265  Identities=23%  Similarity=0.342  Sum_probs=202.7

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc---chhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH---DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .++|.+.+.||+|+||+||+|++..+|+.||||+++....   .....|.+|+++++.++||||+++++++...+ ....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence            4578999999999999999999999999999999975432   23457899999999999999999999864322 2233


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.+++.          ....+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.++
T Consensus        85 ~~~lvmE~~~g~~L~~~~~----------~~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~  151 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVH----------TEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVK  151 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEE
T ss_pred             eEEEEEECCCCCEehhhhc----------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccce
Confidence            5789999999999998873          2346899999999999999999999   89999999999999999999999


Q ss_pred             Eeeeccceecccccc-cceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADE-QTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ++|||.+........ ........||+.|+|||.+.+..++.++|||||||++|||+||+.||.....     .+.....
T Consensus       152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~~  226 (277)
T d1o6ya_         152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAYQH  226 (277)
T ss_dssp             ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHH
T ss_pred             eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-----HHHHHHH
Confidence            999999876544332 2233456799999999999999999999999999999999999999975211     1111111


Q ss_pred             cccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHHHHHH
Q 046112          440 LPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-KINDVEPRLRLIK  495 (502)
Q Consensus       440 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-t~~ev~~~L~~i~  495 (502)
                      +.....      .  ......+.+..+.+++.+|+++||.+|| |++++...|.++.
T Consensus       227 ~~~~~~------~--~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         227 VREDPI------P--PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHCCCC------C--GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HhcCCC------C--CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            111000      0  0000113345678999999999999999 8999999988775

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-50  Score=386.75  Aligned_cols=269  Identities=20%  Similarity=0.306  Sum_probs=213.4

Q ss_pred             ccCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  277 (502)
                      .++|...+.||+|+||+||+|.+.     .+++.||||+++.... .....|.+|++++++++|||||+++++|..    
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----   94 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ----   94 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec----
Confidence            457778899999999999999764     2457899999975432 334568999999999999999999999643    


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                       ++..++||||+++|+|.++++..............+++..+.+++.|+|+||.|||   +.+|+||||||+|||++.++
T Consensus        95 -~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          95 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred             -CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCc
Confidence             44789999999999999998654333333344556899999999999999999999   89999999999999999999


Q ss_pred             cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCC-CCCccccccccchHHHH
Q 046112          358 TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGL-RPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~-~p~~~~~~~~~~~~~~~  436 (502)
                      ++||+|||+|+.+.............||+.|+|||.+.+..++.++|||||||++|||+||. .||...     ...+..
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~~~~~~  245 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVL  245 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHH
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----CHHHHH
Confidence            99999999998776655444445567899999999999999999999999999999999985 666542     111111


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                      ...        .+.....   ....++..+.+++.+||+.||++||||+||++.|++..+
T Consensus       246 ~~i--------~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         246 RFV--------MEGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHH--------HTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHH--------HhCCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            111        1111111   112445678899999999999999999999999876543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-50  Score=388.73  Aligned_cols=248  Identities=21%  Similarity=0.243  Sum_probs=202.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|...+.||+|+||.||+|++..+|+.||||+++..   .....+.+.+|++++++++||||+++++++     ...+.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccccc
Confidence            5788999999999999999999999999999998743   223456788999999999999999999984     45568


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|.+++..          ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        80 ~~iv~ey~~gg~L~~~~~~----------~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl  146 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSR----------ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKI  146 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred             cccceeccCCCchhhhhhc----------ccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEE
Confidence            9999999999999999842          345888999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+|+.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....  ..+.+....   
T Consensus       147 ~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~~~~~~i~~---  219 (337)
T d1o6la_         147 TDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM---  219 (337)
T ss_dssp             CCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH---
T ss_pred             eecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--HHHHHHHhc---
Confidence            99999986543322  23356799999999999999999999999999999999999999976321  111111111   


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK-----INDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt-----~~ev~~  489 (502)
                      ..        .    .++......+.+++.+|+++||++||+     ++|+++
T Consensus       220 ~~--------~----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         220 EE--------I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CC--------C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CC--------C----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            00        0    011123445678999999999999995     777765

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=381.07  Aligned_cols=257  Identities=25%  Similarity=0.329  Sum_probs=195.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCC---CeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFES---TTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      ++|+..+.||+|+||.||+|+....   ...||||+++..   .....++|.+|++++++++|||||+++|+|..     
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            5688889999999999999976432   347899998643   22334689999999999999999999999742     


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                       +..++||||+++|++.+++..         ....+++..++.++.|+|.||.|||   +++|+||||||+|||++.++.
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~  149 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRK---------HQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDL  149 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHH---------HGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTE
T ss_pred             -cchheeeeeecCcchhhhhhc---------ccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccc
Confidence             256899999999999988742         2345899999999999999999999   899999999999999999999


Q ss_pred             EEEeeeccceecccccccc-eecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccccccchHHHH
Q 046112          359 AYVSDFGIARFLEAADEQT-RSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLRNCV  436 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~  436 (502)
                      +||+|||+++.+....... ......||..|+|||.+.+..++.++|||||||++|||+| |+.||......  .....+
T Consensus       150 vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i  227 (273)
T d1u46a_         150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKI  227 (273)
T ss_dssp             EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHH
T ss_pred             eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHH
Confidence            9999999999875544322 2334567889999999999999999999999999999998 89999753211  111111


Q ss_pred             HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHH
Q 046112          437 KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLI  494 (502)
Q Consensus       437 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i  494 (502)
                      .   ...          ...+....++..+.+|+.+||+.||++||||+||.+.|++.
T Consensus       228 ~---~~~----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         228 D---KEG----------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             H---TSC----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H---hCC----------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1   110          00011123456788999999999999999999999988764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.7e-50  Score=385.21  Aligned_cols=245  Identities=23%  Similarity=0.290  Sum_probs=200.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|.+.+.||+|+||+||+|++..+|+.||||+++..   .....+.+.+|+.++++++|||||++++++     ..++.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence            4688899999999999999999999999999998642   223456789999999999999999999995     44568


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+++|+|..++.          ....+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||
T Consensus        79 ~~ivmE~~~gg~l~~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL  145 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLR----------KSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKI  145 (316)
T ss_dssp             EEEEECCCCSCBHHHHHH----------HTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEE
T ss_pred             eeeEeeecCCcccccccc----------ccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEE
Confidence            999999999999999873          3455788888999999999999999   999999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+|+......     ....||+.|||||++.+..++.++||||+||++|||+||+.||.....     .+.......
T Consensus       146 ~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~i~~  215 (316)
T d1fota_         146 TDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEKILN  215 (316)
T ss_dssp             CCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHH
T ss_pred             ecCccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----HHHHHHHHc
Confidence            9999998765332     346799999999999999999999999999999999999999976211     111111110


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~  489 (502)
                              ....    +.......+.+++.+|++.||.+||     |++|+++
T Consensus       216 --------~~~~----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         216 --------AELR----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             --------CCCC----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --------CCCC----CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                    0000    0112234577899999999999996     8888875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-49  Score=381.25  Aligned_cols=267  Identities=25%  Similarity=0.342  Sum_probs=206.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCe--EEEEEEeccc-CcchhHHHHHHHHHHhcC-CCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTT--AVAVKVFNVL-HHDASKSFAVECEVTRNI-RHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ++|+..++||+|+||+||+|.+..++.  .||||+++.. ..+..+.|.+|+++++++ +|||||+++|+|..     ++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----CC
Confidence            567888999999999999998877776  4677877533 233456799999999998 79999999999743     44


Q ss_pred             ceeEEeeeccCCChhhhccCCchh------hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          281 FKALVYEFMANGSLEEWMHPITEE------DKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                      ..++||||+++|+|.++++.....      .........+++..+++++.|+|.||.|||   +.+|+||||||+|||++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEc
Confidence            889999999999999999653211      111234567999999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCC-CCccccccccchH
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLR-PSDDMFKDNLNLR  433 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~-p~~~~~~~~~~~~  433 (502)
                      .++.+||+|||+|+.......   .....||..|+|||.+.++.++.++|||||||++|||++|.. ||....  ...+.
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~~  236 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELY  236 (309)
T ss_dssp             GGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHH
T ss_pred             CCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHHHH
Confidence            999999999999986543322   223468999999999999999999999999999999999764 565421  11122


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      ..+....              ..+....++..+.+++.+||+.||++||||+||++.|+++.++.
T Consensus       237 ~~i~~~~--------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         237 EKLPQGY--------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             HHGGGTC--------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHHhcC--------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            2111110              01111234567889999999999999999999999999987653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-49  Score=381.40  Aligned_cols=272  Identities=20%  Similarity=0.270  Sum_probs=213.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccCcc-hhHHHHHHHHHHhcC-CCCccceeeeccccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILF-----ESTTAVAVKVFNVLHHD-ASKSFAVECEVTRNI-RHRNLVKVFTACSGVDF  276 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  276 (502)
                      .++|...++||+|+||.||+|++.     ..++.||||+++..... ....|.+|+.+++++ +|||||+++++|..   
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~---   98 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI---   98 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee---
Confidence            457788899999999999999753     56789999999754432 345789999999998 69999999999743   


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhh--------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCC
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDK--------RHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKP  348 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~  348 (502)
                        ....++||||+++|+|.++++.......        .......+++..+..++.|++.||+|||   +++|+||||||
T Consensus        99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp  173 (311)
T d1t46a_          99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAA  173 (311)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccc
Confidence              3478999999999999999864221110        1123346899999999999999999999   89999999999


Q ss_pred             CCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccccc
Q 046112          349 SNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD  428 (502)
Q Consensus       349 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~  428 (502)
                      +||+++.++.+|++|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|+..|+......
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999999876555445555678999999999999999999999999999999999954444332222


Q ss_pred             ccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          429 NLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      ...+...+....+..           .   ...++..+.+|+.+||+.||++||||+|+++.|+++.++
T Consensus       254 ~~~~~~~i~~~~~~~-----------~---~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         254 DSKFYKMIKEGFRML-----------S---PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             SHHHHHHHHHTCCCC-----------C---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCC-----------C---cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            223333333322110           0   112345688999999999999999999999999887654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-49  Score=377.80  Aligned_cols=269  Identities=23%  Similarity=0.353  Sum_probs=207.1

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCC-------CeEEEEEEecccCc-chhHHHHHHHHHHhcC-CCCccceeeeccccc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFES-------TTAVAVKVFNVLHH-DASKSFAVECEVTRNI-RHRNLVKVFTACSGV  274 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  274 (502)
                      .++|...+.||+|+||.||+|+....       +..||||+++.... ....++.+|...+.++ +|||||+++++|.. 
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence            35677889999999999999976543       35799999976443 3347788899998888 89999999999743 


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhh------hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEED------KRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKP  348 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~  348 (502)
                          +...++||||+++|+|.+++.......      ........+++.+++.++.|++.||+|||   +.+|+||||||
T Consensus        91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp  163 (299)
T d1fgka_          91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAA  163 (299)
T ss_dssp             ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecc
Confidence                447899999999999999996422110      11123456899999999999999999999   89999999999


Q ss_pred             CCeeeCCCCcEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHh-CCCCCccccc
Q 046112          349 SNILLDDEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFT-GLRPSDDMFK  427 (502)
Q Consensus       349 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~t-g~~p~~~~~~  427 (502)
                      +|||++.++.+||+|||+++...............+|+.|+|||.+.++.++.++|||||||++|||+| |+.||.+...
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            999999999999999999998766555555556778999999999999999999999999999999998 7888865322


Q ss_pred             cccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 046112          428 DNLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKK  496 (502)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~  496 (502)
                      .  .....+.....              .+.+..++..+.+++.+||+.||.+|||+.||++.|++|..
T Consensus       244 ~--~~~~~i~~~~~--------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         244 E--ELFKLLKEGHR--------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             H--HHHHHHHTTCC--------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H--HHHHHHHcCCC--------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            1  12222211110              00111334568899999999999999999999999998864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=377.08  Aligned_cols=252  Identities=21%  Similarity=0.289  Sum_probs=203.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCccee
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      .++|.+.+.||+|+||+||+|.+..+++.||||+++.... ....+.+|++++++++|||||++++++     ..++..+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESF-----ESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence            4678899999999999999999999999999999976432 345688999999999999999999984     4556899


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC--CCcEEE
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD--EMTAYV  361 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~--~~~~kl  361 (502)
                      +|||||++|+|.+++..         ....+++.++..++.|++.||+|||   +.+|+||||||+|||++.  ...+||
T Consensus        78 lvmE~~~gg~L~~~i~~---------~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl  145 (321)
T d1tkia_          78 MIFEFISGLDIFERINT---------SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKI  145 (321)
T ss_dssp             EEECCCCCCBHHHHHTS---------SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred             EEEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEE
Confidence            99999999999999852         2346899999999999999999999   899999999999999985  458999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+++.......   .....+|+.|+|||...+..++.++||||+||++|||++|+.||......  .....+...  
T Consensus       146 ~DFG~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~~i~~~--  218 (321)
T d1tkia_         146 IEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNA--  218 (321)
T ss_dssp             CCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHT--
T ss_pred             cccchhhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC--
Confidence            99999987644322   23356899999999999999999999999999999999999999763211  111111111  


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                               ...............+.+++.+|+..||++|||++|+++
T Consensus       219 ---------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         219 ---------EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---------CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---------CCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     000001111123456779999999999999999999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.3e-49  Score=384.66  Aligned_cols=245  Identities=21%  Similarity=0.268  Sum_probs=201.1

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      ++|.+.+.||+|+||.||+|++..+|+.||||+++..   .....+.+.+|+++++.++|||||++++++     .....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccccc
Confidence            4788999999999999999999999999999998632   223346789999999999999999999984     44558


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+.+|+|.+++..          ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||
T Consensus       116 ~~~v~e~~~~g~l~~~l~~----------~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL  182 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRR----------IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQV  182 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred             cccccccccccchhhhHhh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEe
Confidence            8999999999999999842          245899999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+|+.+....     ....||+.|||||++.+..++.++|||||||++|||+||+.||....  .......+.... 
T Consensus       183 ~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~~~~-  254 (350)
T d1rdqe_         183 TDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSGK-  254 (350)
T ss_dssp             CCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCC-
T ss_pred             eeceeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHHHHHHHhcCC-
Confidence            9999998764322     34569999999999999999999999999999999999999997521  111111111110 


Q ss_pred             cchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 046112          442 ERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERM-----KINDVEP  489 (502)
Q Consensus       442 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RP-----t~~ev~~  489 (502)
                                ..    ........+.+++.+|++.||.+|+     |++|+++
T Consensus       255 ----------~~----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 ----------VR----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----------CC----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----------CC----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                      00    0112345677999999999999994     8998875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-48  Score=370.08  Aligned_cols=251  Identities=23%  Similarity=0.329  Sum_probs=201.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcc---------hhHHHHHHHHHHhcCC-CCccceeeeccccc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD---------ASKSFAVECEVTRNIR-HRNLVKVFTACSGV  274 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  274 (502)
                      ++|+..+.||+|+||+||+|++..+++.||||+++.....         ..+.+.+|+.++++++ ||||+++++++   
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---   79 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY---   79 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence            5788899999999999999999999999999998753221         1245889999999997 99999999994   


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                        ..++..++||||+++|+|.+++..          ...+++.++..++.|++.||+|||   +.+|+||||||+|||++
T Consensus        80 --~~~~~~~ivmE~~~~g~L~~~l~~----------~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~  144 (277)
T d1phka_          80 --ETNTFFFLVFDLMKKGELFDYLTE----------KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLD  144 (277)
T ss_dssp             --ECSSEEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred             --ccCcceEEEEEcCCCchHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEc
Confidence              456689999999999999999842          346899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeeccceecccccccceecccccccccccCcccCC------CccCccccchhHHHHHHHHHhCCCCCcccccc
Q 046112          355 DEMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG------HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD  428 (502)
Q Consensus       355 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~  428 (502)
                      .++.+||+|||+++.+.....   .....||+.|+|||.+.+      ..++.++||||+||++|||+||+.||......
T Consensus       145 ~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~  221 (277)
T d1phka_         145 DDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM  221 (277)
T ss_dssp             TTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             CCCCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH
Confidence            999999999999987654322   234679999999998753      35788999999999999999999999763211


Q ss_pred             ccchHHHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          429 NLNLRNCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      . .......... .    .       ........+.++.+++.+|++.||++|||++|+++
T Consensus       222 ~-~~~~i~~~~~-~----~-------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         222 L-MLRMIMSGNY-Q----F-------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             H-HHHHHHHTCC-C----C-------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             H-HHHHHHhCCC-C----C-------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1 1111111110 0    0       00011234556789999999999999999999865

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=378.67  Aligned_cols=257  Identities=18%  Similarity=0.247  Sum_probs=200.2

Q ss_pred             ccCCCCCC-cccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhc-CCCCccceeeecccccccCCCcc
Q 046112          204 TKGFSSEN-LIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRN-IRHRNLVKVFTACSGVDFQGNDF  281 (502)
Q Consensus       204 t~~~~~~~-~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~~~  281 (502)
                      .++|.+.+ .||+|+||+||+|++..+++.||||+++.     ...+.+|++++.+ .+|||||++++++... ...+..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence            35787664 69999999999999999999999999863     3567889998665 5899999999985321 133457


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC---CCc
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD---EMT  358 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~---~~~  358 (502)
                      .++|||||++|+|.+++..        .....+++.++..++.|++.||+|||   +.+|+||||||+|||++.   ++.
T Consensus        84 ~~ivmEy~~gg~L~~~i~~--------~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~  152 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQD--------RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAI  152 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHS--------CSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCC
T ss_pred             EEEEEECCCCCcHHHHHHh--------cCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccc
Confidence            8999999999999999953        33456999999999999999999999   899999999999999985   567


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHh
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKS  438 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  438 (502)
                      +||+|||+|+.......   .....||+.|||||++.+..++.++|||||||++|||+||+.||.+....  ........
T Consensus       153 ~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~--~~~~~~~~  227 (335)
T d2ozaa1         153 LKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKT  227 (335)
T ss_dssp             EEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------
T ss_pred             ccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH--HHHHHHHH
Confidence            99999999987654332   23467999999999999999999999999999999999999999763211  11111111


Q ss_pred             hcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          439 ALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       439 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .+..       ................+.+++.+|++.||++|||+.|+++
T Consensus       228 ~i~~-------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         228 RIRM-------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CCCS-------CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhc-------CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1110       0001111112345667889999999999999999999976

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=381.56  Aligned_cols=247  Identities=24%  Similarity=0.333  Sum_probs=198.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc---CcchhHHHHHHHHHHh-cCCCCccceeeecccccccCCCc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL---HHDASKSFAVECEVTR-NIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      ++|...+.||+|+||+||+|++..+++.||||+++..   .....+.+..|..++. .++|||||++++++     ..++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence            5788899999999999999999999999999998642   1233455667777655 68999999999994     4456


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+++|+|.++++.          ...+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus        77 ~~yivmEy~~~g~L~~~i~~----------~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~k  143 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQS----------CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIK  143 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEE
T ss_pred             ceeEEEeecCCCcHHHHhhc----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCcee
Confidence            89999999999999999842          245788999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |+|||+++......  .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.+...  ..+...+....
T Consensus       144 l~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~  219 (320)
T d1xjda_         144 IADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDN  219 (320)
T ss_dssp             ECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC
T ss_pred             ccccchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHcCC
Confidence            99999998654332  223346799999999999999999999999999999999999999976311  11111111110


Q ss_pred             ccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 046112          441 PERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKIN-DVE  488 (502)
Q Consensus       441 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~-ev~  488 (502)
                               +      .++..+...+.+++.+|++.||++|||+. |+.
T Consensus       220 ---------~------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         220 ---------P------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             ---------C------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ---------C------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence                     0      01112345678999999999999999995 675

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.1e-48  Score=383.07  Aligned_cols=249  Identities=21%  Similarity=0.265  Sum_probs=195.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC---cchhHHHH---HHHHHHhcCCCCccceeeecccccccCC
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH---HDASKSFA---VECEVTRNIRHRNLVKVFTACSGVDFQG  278 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~  278 (502)
                      ++|.+.+.||+|+||.||+|++..+|+.||||+++...   ......+.   .|+++++.++|||||++++++     ..
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~~   78 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HT   78 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----EC
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----EE
Confidence            57889999999999999999999999999999986321   11223333   447778888999999999984     44


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      .+..++||||+++|+|.+++..          ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~----------~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~  145 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQ----------HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGH  145 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSC
T ss_pred             CCEEEEEEEecCCCcHHHHHHh----------cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCc
Confidence            5589999999999999999842          345788999999999999999999   899999999999999999999


Q ss_pred             EEEeeeccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHH
Q 046112          359 AYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  437 (502)
                      +||+|||+|+.+....    .....||+.|+|||++.. ..++.++|||||||++|||+||+.||......  ......+
T Consensus       146 iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~  219 (364)
T d1omwa3         146 VRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDR  219 (364)
T ss_dssp             EEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHHHHH
T ss_pred             EEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH
Confidence            9999999998765432    234579999999999875 56899999999999999999999999763221  1222111


Q ss_pred             hhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 046112          438 SALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK-----INDVEP  489 (502)
Q Consensus       438 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt-----~~ev~~  489 (502)
                      ..... .           ..........+.+++.+||+.||++|||     ++|+++
T Consensus       220 ~~~~~-~-----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         220 MTLTM-A-----------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HSSSC-C-----------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             hcccC-C-----------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            11110 0           0011123456779999999999999999     577654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-48  Score=370.16  Aligned_cols=259  Identities=20%  Similarity=0.218  Sum_probs=193.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccCcc-----hhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHD-----ASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      .++||+|+||+||+|++..+|+.||||+++.....     ..+.+.+|++++++++|||||++++++     ..++..++
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~i   77 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNISL   77 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCEE
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCceee
Confidence            46899999999999998899999999998643221     135688999999999999999999995     44558999


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEeee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVSDF  364 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df  364 (502)
                      ||||+.++++..+.          .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus        78 vmE~~~~~~~~~~~----------~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DF  144 (299)
T d1ua2a_          78 VFDFMETDLEVIIK----------DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADF  144 (299)
T ss_dssp             EEECCSEEHHHHHT----------TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             hhhhhcchHHhhhh----------hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccC
Confidence            99999988877665          33456888899999999999999999   899999999999999999999999999


Q ss_pred             ccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcccc
Q 046112          365 GIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPER  443 (502)
Q Consensus       365 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  443 (502)
                      |+|+.......  ......||+.|+|||.+... .++.++|||||||++|||+||+.||...... ..+....+......
T Consensus       145 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~~~~~  221 (299)
T d1ua2a_         145 GLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPT  221 (299)
T ss_dssp             GGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCC
T ss_pred             ccccccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHHHHHhcCCCC
Confidence            99986544322  22345789999999988754 5799999999999999999999999753211 11111111110000


Q ss_pred             hhhhccc-------CCCCcc-----hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          444 AEEIRAS-------SGSTQR-----SIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       444 ~~~~~d~-------~~~~~~-----~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ...+.+.       ......     .........+.+++.+|++.||++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         222 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0000000       000000     001122456789999999999999999999875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=366.31  Aligned_cols=266  Identities=21%  Similarity=0.248  Sum_probs=198.2

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|...+.||+|+||+||+|.+..+|+.||||+++...  ....+.+.+|++++++++|||||++++++     ..++..
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence            57888999999999999999999999999999986432  22357799999999999999999999995     445589


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++||||+.++ +.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus        77 ~iv~e~~~~~-~~~~~~~--------~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~  144 (298)
T d1gz8a_          77 YLVFEFLHQD-LKKFMDA--------SALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLA  144 (298)
T ss_dssp             EEEEECCSEE-HHHHHHH--------TTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEeecCCc-hhhhhhh--------hcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceec
Confidence            9999999654 4444321        34566999999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCc-cCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||+|+......  .......||+.|+|||...... ++.++||||+||++|||++|+.||......+ .+.........
T Consensus       145 DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~  221 (298)
T d1gz8a_         145 DFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGT  221 (298)
T ss_dssp             STTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCC
T ss_pred             cCCcceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCC
Confidence            999998654322  2233457999999999877665 5789999999999999999999997532111 11111111100


Q ss_pred             --cc----hhhhccc--CCC--Cc---chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 046112          442 --ER----AEEIRAS--SGS--TQ---RSIILECLISICEIGVACSAEQPGERMKINDVEPR  490 (502)
Q Consensus       442 --~~----~~~~~d~--~~~--~~---~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~  490 (502)
                        +.    .....+.  ...  ..   ..........+.+++.+|++.||++|||++|+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence              00    0000000  000  00   00111223567789999999999999999999863

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-47  Score=365.80  Aligned_cols=270  Identities=21%  Similarity=0.248  Sum_probs=201.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCC-CeEEEEEEecccC--cchhHHHHHHHHHHhcC---CCCccceeeecccccccC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFES-TTAVAVKVFNVLH--HDASKSFAVECEVTRNI---RHRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~  277 (502)
                      .++|.+.+.||+|+||+||+|++..+ ++.||||+++...  ......+.+|+++++.+   +||||+++++++......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999988654 6789999986432  22234566777776655   899999999987654445


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM  357 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~  357 (502)
                      .....++++||+++|++.....         .....+++.....++.|++.||+|||   +.+|+||||||+|||++.++
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~  153 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK---------VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSG  153 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH---------SCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred             cCceEEEEEEeccCCchhhhhh---------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCC
Confidence            5668899999998887765432         34566889999999999999999999   89999999999999999999


Q ss_pred             cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHH
Q 046112          358 TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK  437 (502)
Q Consensus       358 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  437 (502)
                      .+||+|||+++......   ......||+.|+|||++.+..++.++||||+||++|||+||+.||...... ..+.....
T Consensus       154 ~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~  229 (305)
T d1blxa_         154 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILD  229 (305)
T ss_dssp             CEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH
T ss_pred             Ceeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Confidence            99999999998654332   223567999999999999999999999999999999999999999763211 11111111


Q ss_pred             hhcccchh-----------hhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          438 SALPERAE-----------EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       438 ~~~~~~~~-----------~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ........           ............+.......+.+|+.+|++.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11000000           00000011111112233456778999999999999999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-47  Score=360.81  Aligned_cols=240  Identities=22%  Similarity=0.302  Sum_probs=192.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc------chhHHHHHHHHHHhcCC--CCccceeeeccccccc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH------DASKSFAVECEVTRNIR--HRNLVKVFTACSGVDF  276 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  276 (502)
                      ++|.+.+.||+|+||+||+|++..+|+.||||+++....      .....+.+|+.++++++  |||||++++++     
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~-----   78 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF-----   78 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-----
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE-----
Confidence            578889999999999999999999999999999864321      11234678999999986  89999999984     


Q ss_pred             CCCcceeEEeeeccC-CChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC
Q 046112          277 QGNDFKALVYEFMAN-GSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD  355 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~  355 (502)
                      ...+..++||||+.+ +++.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.
T Consensus        79 ~~~~~~~lv~e~~~~~~~l~~~~~----------~~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~  145 (273)
T d1xwsa_          79 ERPDSFVLILERPEPVQDLFDFIT----------ERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDL  145 (273)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEET
T ss_pred             eeCCeEEEEEEeccCcchHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEec
Confidence            445688999999976 57777763          2346899999999999999999999   899999999999999985


Q ss_pred             -CCcEEEeeeccceecccccccceecccccccccccCcccCCCcc-CccccchhHHHHHHHHHhCCCCCccccccccchH
Q 046112          356 -EMTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEV-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLR  433 (502)
Q Consensus       356 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~  433 (502)
                       ++.+||+|||+|+.....    ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||....       
T Consensus       146 ~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------  214 (273)
T d1xwsa_         146 NRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------  214 (273)
T ss_dssp             TTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------
T ss_pred             CCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------
Confidence             579999999999865432    2234679999999999887765 567899999999999999999997521       


Q ss_pred             HHHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          434 NCVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       434 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      +..+...          ..+      ...+..+.+++.+|++.||++|||++|+++
T Consensus       215 ~i~~~~~----------~~~------~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         215 EIIRGQV----------FFR------QRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHHCCC----------CCS------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHhhccc----------CCC------CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1111100          000      112345778999999999999999999976

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.8e-46  Score=357.34  Aligned_cols=263  Identities=21%  Similarity=0.272  Sum_probs=196.3

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccC--cchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLH--HDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|...++||+|+||+||+|++ .+|+.||||+++...  ....+.+.+|+.++++++||||+++++++     ..++..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred             CCceeccEEecCCCcEEEEEEe-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCce
Confidence            5788899999999999999977 578999999987543  22357899999999999999999999985     445689


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++++||+.++.+..+.          .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++
T Consensus        76 ~i~~e~~~~~~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~  142 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLD----------VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIA  142 (286)
T ss_dssp             EEEEECCSEEHHHHHH----------TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEeehhhhHHHHH----------hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEec
Confidence            9999999887777665          33467999999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||.|........  ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+ .+.........
T Consensus       143 DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~  219 (286)
T d1ob3a_         143 DFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGT  219 (286)
T ss_dssp             CTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCC
T ss_pred             ccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCC
Confidence            9999986543322  22345689999999998764 56899999999999999999999997632211 11111111100


Q ss_pred             cc------hhhhc--ccCC-----CCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ER------AEEIR--ASSG-----STQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ~~------~~~~~--d~~~-----~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ..      .....  +...     .............+.+++.+|++.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00      00000  0000     0011111223456779999999999999999999874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-45  Score=353.71  Aligned_cols=263  Identities=19%  Similarity=0.302  Sum_probs=203.5

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeecccccccCCCcceeE
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFKAL  284 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  284 (502)
                      ++|+..+.||+|+||+||+|.+..+|+.||||+++...  ..+++..|+++++.++|+|++..+..|.    ...+..++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEEE
Confidence            46889999999999999999999999999999987543  2346888999999999888777776653    34557889


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC---CCCcEEE
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD---DEMTAYV  361 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~---~~~~~kl  361 (502)
                      ||||+ +|++.+.+.         .....+++..+..++.|++.||+|||   +.+|+||||||+|||++   .+..+||
T Consensus        81 vme~~-~~~l~~~~~---------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl  147 (299)
T d1ckia_          81 VMELL-GPSLEDLFN---------FCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYI  147 (299)
T ss_dssp             EEECC-CCBHHHHHH---------HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEE
T ss_pred             EEEEc-CCchhhhhh---------hccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeee
Confidence            99999 566666553         23456899999999999999999999   89999999999999875   4567999


Q ss_pred             eeeccceeccccccc-----ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccc--hHH
Q 046112          362 SDFGIARFLEAADEQ-----TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN--LRN  434 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~--~~~  434 (502)
                      +|||+|+.+......     .......||+.|||||.+.+..++.++|||||||++|||+||+.||.........  ...
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~  227 (299)
T d1ckia_         148 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  227 (299)
T ss_dssp             CCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH
T ss_pred             eccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH
Confidence            999999987654321     2234567999999999999999999999999999999999999999764322211  111


Q ss_pred             HHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 046112          435 CVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKK  497 (502)
Q Consensus       435 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~  497 (502)
                      +...........           ....++.++.+++..|++.+|++||+++++.+.|+.+..+
T Consensus       228 ~~~~~~~~~~~~-----------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         228 ISEKKMSTPIEV-----------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHHHHHHSCHHH-----------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhcccCCCChhH-----------hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            111111100000           1123456788999999999999999999999999887543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-45  Score=359.75  Aligned_cols=270  Identities=18%  Similarity=0.223  Sum_probs=198.0

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc-chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH-DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      +++|...+.||+|+||+||+|.+..+|+.||||+++.... ...+.+.+|++++++++||||+++++++....+..... 
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~-   85 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD-   85 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC-
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce-
Confidence            4578899999999999999999989999999999975432 33467899999999999999999999976544333334 


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      +++++|+.+|+|.+++..           ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus        86 ~~l~~~~~~g~L~~~l~~-----------~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~  151 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT-----------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKIC  151 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEeecCCchhhhhhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEc
Confidence            445566779999999842           35899999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccc-cceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhc
Q 046112          363 DFGIARFLEAADE-QTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSAL  440 (502)
Q Consensus       363 Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  440 (502)
                      |||+|+....... ........||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+. .........
T Consensus       152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~~  230 (345)
T d1pmea_         152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILG  230 (345)
T ss_dssp             CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHC
T ss_pred             ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhhcc
Confidence            9999987654433 222345679999999999855 4578899999999999999999999975321111 111000000


Q ss_pred             ccchh-----------hhcccC-CCCcch---hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          441 PERAE-----------EIRASS-GSTQRS---IILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       441 ~~~~~-----------~~~d~~-~~~~~~---~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .....           ...... ......   ........+.+++.+|++.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000           000000 000000   01112245779999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-45  Score=354.92  Aligned_cols=271  Identities=18%  Similarity=0.202  Sum_probs=198.2

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEeccc--CcchhHHHHHHHHHHhcCCCCccceeeeccccccc---CC
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVL--HHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF---QG  278 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~  278 (502)
                      .++|.+.+.||+|+||+||+|++..+|+.||||++...  .....+++.+|++++++++|||++++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            46788999999999999999999999999999998643  23345778999999999999999999998744221   22


Q ss_pred             CcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCc
Q 046112          279 NDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMT  358 (502)
Q Consensus       279 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~  358 (502)
                      ....++||||+.++.+....          .....++......++.|++.||.|||   +.+|+||||||+|||++.++.
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~----------~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~  155 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS----------NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGV  155 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT----------CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSC
T ss_pred             CceEEEEEeccCCCccchhh----------hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCc
Confidence            34688999999888776554          33456888999999999999999999   899999999999999999999


Q ss_pred             EEEeeeccceecccccc--cceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHH
Q 046112          359 AYVSDFGIARFLEAADE--QTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNC  435 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  435 (502)
                      +||+|||+++.+.....  ........||+.|+|||.+.+. .++.++||||+||++|||++|+.||......  .....
T Consensus       156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~--~~~~~  233 (318)
T d3blha1         156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLAL  233 (318)
T ss_dssp             EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH
T ss_pred             EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH--HHHHH
Confidence            99999999987654332  2223345799999999998765 6899999999999999999999999753211  11111


Q ss_pred             HHhhccc----chhhh--------cccCCCCcchhh-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          436 VKSALPE----RAEEI--------RASSGSTQRSII-----LECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       436 ~~~~~~~----~~~~~--------~d~~~~~~~~~~-----~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      +......    .....        ............     ......+.+|+.+|++.||++|||++|+++
T Consensus       234 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            1111111    00000        000000011100     112335678999999999999999999975

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.7e-45  Score=347.90  Aligned_cols=263  Identities=16%  Similarity=0.231  Sum_probs=206.7

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCC-CccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRH-RNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|.+.+.||+|+||+||+|++..+|+.||||+++...  ....+.+|++.++.++| +|++.+++++     ..+...+
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~   77 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNV   77 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCccE
Confidence            57889999999999999999999999999999986432  23457888999999875 8999998884     3455789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCC-----CCc
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDD-----EMT  358 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~-----~~~  358 (502)
                      +||||+ +|+|.+++.         .....+++.++..++.|++.||+|||   +.+|+||||||+|||++.     ++.
T Consensus        78 ~vme~~-~~~l~~~~~---------~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~  144 (293)
T d1csna_          78 LVIDLL-GPSLEDLLD---------LCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANM  144 (293)
T ss_dssp             EEEECC-CCBHHHHHH---------HTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTC
T ss_pred             EEEEec-CCCHHHHHH---------hhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCc
Confidence            999998 789999874         23346899999999999999999999   999999999999999974     578


Q ss_pred             EEEeeeccceeccccccc-----ceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccccccc-ch
Q 046112          359 AYVSDFGIARFLEAADEQ-----TRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL-NL  432 (502)
Q Consensus       359 ~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~-~~  432 (502)
                      +||+|||+|+.+......     .......||+.|||||.+.+..++.++|||||||++|||+||+.||........ ..
T Consensus       145 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~  224 (293)
T d1csna_         145 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK  224 (293)
T ss_dssp             EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred             eEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH
Confidence            999999999987543321     123456799999999999999999999999999999999999999975322211 11


Q ss_pred             HHHH-HhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 046112          433 RNCV-KSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEPRLRLIKKKL  498 (502)
Q Consensus       433 ~~~~-~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~~L~~i~~~~  498 (502)
                      ...+ .........+           ....++.++.+++..|+..+|++||+++.+.+.|+++.++.
T Consensus       225 ~~~i~~~~~~~~~~~-----------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         225 YERIGEKKQSTPLRE-----------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHHHHHHHHSCHHH-----------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHhccCCCChHH-----------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            1111 1110000111           11134567889999999999999999999999998887654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-44  Score=352.74  Aligned_cols=265  Identities=20%  Similarity=0.239  Sum_probs=193.9

Q ss_pred             ccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeeccccccc-CCCc
Q 046112          204 TKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-QGND  280 (502)
Q Consensus       204 t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~  280 (502)
                      .++|.+.+.||+|+||+||+|.+..+|+.||||+++....  ...+.+.+|+++++.++|||||++++++...+. ....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            4678889999999999999999999999999999975322  234678899999999999999999999754321 2334


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..++||||+ +++|..+.+           ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~k  161 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK-----------HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELK  161 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred             eEEEEEecc-cccHHHHHH-----------hccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccc
Confidence            679999999 667777653           145899999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ++|||+|+.....     .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...... ..+.......
T Consensus       162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~  235 (346)
T d1cm8a_         162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVT  235 (346)
T ss_dssp             ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred             cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhcc
Confidence            9999999866432     2346789999999998764 5789999999999999999999999763211 1111111110


Q ss_pred             c--ccch---------h----hhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 L--PERA---------E----EIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~--~~~~---------~----~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      .  +...         .    ....................+.+|+.+|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0  0000         0    00000000001111123345678999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-45  Score=357.20  Aligned_cols=266  Identities=21%  Similarity=0.235  Sum_probs=194.0

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccceeeeccccccc-CCCcceeE
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-QGNDFKAL  284 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~l  284 (502)
                      +|+..++||+|+||+||+|++..+|+.||||+++....    ...+|++++++++||||+++++++..... .+....++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            57778899999999999999999999999999875432    23479999999999999999998754321 23446789


Q ss_pred             EeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC-cEEEee
Q 046112          285 VYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM-TAYVSD  363 (502)
Q Consensus       285 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~-~~kl~D  363 (502)
                      ||||+++|.+....+.       ......+++.++..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|
T Consensus        97 v~Ey~~~~~~~~l~~~-------~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~D  166 (350)
T d1q5ka_          97 VLDYVPETVYRVARHY-------SRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCD  166 (350)
T ss_dssp             EEECCSEEHHHHHHHH-------HHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECC
T ss_pred             EEeccCCccHHHHHhh-------hhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEec
Confidence            9999986644433321       123456999999999999999999999   99999999999999999775 899999


Q ss_pred             eccceecccccccceecccccccccccCcccCC-CccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhccc
Q 046112          364 FGIARFLEAADEQTRSIGVEGTTGYIAPEYGMG-HEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALPE  442 (502)
Q Consensus       364 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  442 (502)
                      ||+++.+.....   .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+....+..-..
T Consensus       167 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~  242 (350)
T d1q5ka_         167 FGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTP  242 (350)
T ss_dssp             CTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCC
T ss_pred             ccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence            999987654332   234578999999998765 57899999999999999999999999753211 1111111110000


Q ss_pred             ---chhh----hcccCCCC---c---chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          443 ---RAEE----IRASSGST---Q---RSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       443 ---~~~~----~~d~~~~~---~---~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                         ....    ..+.....   .   ..........+.+|+.+|++.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0000    00000000   0   0001123456778999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-44  Score=345.24  Aligned_cols=265  Identities=18%  Similarity=0.237  Sum_probs=201.4

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCcce
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGNDFK  282 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  282 (502)
                      ++|...+.||+|+||+||+|++..+++.||||+++....  .....+.+|+.+++.++||||+++++++.     .....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence            468889999999999999999999999999999875432  33578899999999999999999999954     44588


Q ss_pred             eEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEEe
Q 046112          283 ALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYVS  362 (502)
Q Consensus       283 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl~  362 (502)
                      ++|+|++.+++|..++.          ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus        77 ~iv~~~~~~~~l~~~~~----------~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~  143 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDS----------CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLA  143 (292)
T ss_dssp             EEEEECCSEEHHHHHHH----------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             eEEeeeccccccccccc----------cccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeee
Confidence            99999999999888773          3456789999999999999999999   8999999999999999999999999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCCc-cCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHE-VSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      |||.|+........  .....++..|+|||.+.... ++.++||||+||++|||++|+.||.........+.........
T Consensus       144 DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  221 (292)
T d1unla_         144 NFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT  221 (292)
T ss_dssp             CCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ecchhhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCC
Confidence            99999876543322  23345788899999887665 6899999999999999999999975422211111111111100


Q ss_pred             --c-c---hhhhccc-------CCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 --E-R---AEEIRAS-------SGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 --~-~---~~~~~d~-------~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                        . .   .....+.       ...............+.+++.+|++.||.+|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0 0   0000000       000111111233456778999999999999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.1e-44  Score=350.00  Aligned_cols=260  Identities=18%  Similarity=0.229  Sum_probs=196.9

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-CCccceeeecccccccCCCccee
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQGNDFKA  283 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~  283 (502)
                      ++|.+.++||+|+||+||+|++..+++.||||+++..   ..+++.+|+++++.++ ||||+++++++..   ......+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCcee
Confidence            5788899999999999999999999999999998743   3567899999999995 9999999998642   2345789


Q ss_pred             EEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCC-cEEEe
Q 046112          284 LVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEM-TAYVS  362 (502)
Q Consensus       284 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~-~~kl~  362 (502)
                      +||||+++|+|..+.             ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+
T Consensus       109 ~v~e~~~~~~L~~~~-------------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~  172 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY-------------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLI  172 (328)
T ss_dssp             EEEECCCSCBGGGTT-------------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEeecCCCcHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeec
Confidence            999999999997764             24889999999999999999999   99999999999999998654 69999


Q ss_pred             eeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHH----
Q 046112          363 DFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVK----  437 (502)
Q Consensus       363 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~----  437 (502)
                      |||+|+.......   .....+|+.|+|||.+.+. .++.++||||+||+++|+++|+.||...............    
T Consensus       173 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~  249 (328)
T d3bqca1         173 DWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  249 (328)
T ss_dssp             CGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred             ccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCC
Confidence            9999987654322   2345689999999998765 4799999999999999999999998653221111111100    


Q ss_pred             --------hhccc---chhhhcccCCCC------cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          438 --------SALPE---RAEEIRASSGST------QRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       438 --------~~~~~---~~~~~~d~~~~~------~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                              .....   ............      ..........++.+|+.+|++.||++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    00000   000000000000      00001223456789999999999999999999975

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=348.24  Aligned_cols=265  Identities=20%  Similarity=0.174  Sum_probs=192.6

Q ss_pred             cCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeeccccccc-CCCcc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDF-QGNDF  281 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~  281 (502)
                      ++|.+.++||+|+||+||+|++..+|+.||||+++....  ...+.+.+|+.++++++||||+++++++..... +....
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            678899999999999999999999999999999975432  234568899999999999999999998754322 34568


Q ss_pred             eeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEEE
Q 046112          282 KALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAYV  361 (502)
Q Consensus       282 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~kl  361 (502)
                      .++||||+.++.+. .+.            ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+|+
T Consensus        97 ~~iv~Ey~~~~l~~-~~~------------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl  160 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEE
T ss_pred             eEEEEeccchHHHH-hhh------------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceee
Confidence            89999999765554 332            24788999999999999999999   899999999999999999999999


Q ss_pred             eeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhhcc
Q 046112          362 SDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSALP  441 (502)
Q Consensus       362 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  441 (502)
                      +|||+++......   ......+|+.|+|||.+.+..++.++||||+||+++||++|+.||...... ............
T Consensus       161 ~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~~  236 (355)
T d2b1pa1         161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGT  236 (355)
T ss_dssp             CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCC
T ss_pred             echhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhccC
Confidence            9999987654322   223456899999999999999999999999999999999999999642111 011111100000


Q ss_pred             ----------cc----------------hhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          442 ----------ER----------------AEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       442 ----------~~----------------~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                                ..                ...+.+................+.+++.+|+..||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                      00                0001111111122223455677889999999999999999999974

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-45  Score=352.36  Aligned_cols=253  Identities=21%  Similarity=0.300  Sum_probs=197.0

Q ss_pred             cCCCCCCcccccCCceEEEEEEc---CCCeEEEEEEecccC----cchhHHHHHHHHHHhcCCC-Cccceeeeccccccc
Q 046112          205 KGFSSENLIGAGNFGSVYKGILF---ESTTAVAVKVFNVLH----HDASKSFAVECEVTRNIRH-RNLVKVFTACSGVDF  276 (502)
Q Consensus       205 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  276 (502)
                      ++|...+.||+|+||+||+|+..   .+|+.||||+++...    ....+.+.+|++++++++| |||+++++++     
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~-----   98 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----   98 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-----
Confidence            56889999999999999999763   468999999986421    2234668899999999977 8999999884     


Q ss_pred             CCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCC
Q 046112          277 QGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDE  356 (502)
Q Consensus       277 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~  356 (502)
                      ......+++|||+.+|+|.+++..          ...+.+.....++.|++.||+|||   +.+|+||||||+|||++.+
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~----------~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~  165 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQ----------RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSN  165 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred             ccCCceeeeeecccccHHHHHHHh----------cccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCC
Confidence            445589999999999999999842          234678888999999999999999   8999999999999999999


Q ss_pred             CcEEEeeeccceecccccccceecccccccccccCcccCCC--ccCccccchhHHHHHHHHHhCCCCCccccccccchHH
Q 046112          357 MTAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH--EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRN  434 (502)
Q Consensus       357 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~  434 (502)
                      +.+||+|||+++.+...... ......|++.|+|||.+.+.  .++.++||||+||++|||+||+.||....... ....
T Consensus       166 ~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-~~~~  243 (322)
T d1vzoa_         166 GHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAE  243 (322)
T ss_dssp             SCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHH
T ss_pred             CCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence            99999999999876543332 22346789999999998764  47889999999999999999999997643222 1222


Q ss_pred             HHHhhcccchhhhcccCCCCcchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 046112          435 CVKSALPERAEEIRASSGSTQRSIILECLISICEIGVACSAEQPGERMK-----INDVEP  489 (502)
Q Consensus       435 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~c~~~dP~~RPt-----~~ev~~  489 (502)
                      .........            ..+..++...+.+++.+|+++||++|||     ++|+++
T Consensus       244 i~~~~~~~~------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         244 ISRRILKSE------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHHHHCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HHHhcccCC------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            111111100            0111234567889999999999999995     778765

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-43  Score=348.19  Aligned_cols=266  Identities=17%  Similarity=0.223  Sum_probs=197.1

Q ss_pred             hccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc--chhHHHHHHHHHHhcCCCCccceeeecccccccCCCc
Q 046112          203 ATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH--DASKSFAVECEVTRNIRHRNLVKVFTACSGVDFQGND  280 (502)
Q Consensus       203 ~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  280 (502)
                      .+++|...+.||+|+||+||+|++..+|+.||||+++....  ...+.+.+|+++++.++|||+|++++++.......+.
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            35689999999999999999999999999999999975432  2345788999999999999999999986543323344


Q ss_pred             ceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeCCCCcEE
Q 046112          281 FKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLDDEMTAY  360 (502)
Q Consensus       281 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~~~~~~k  360 (502)
                      ..+++++|+.+|+|.+++..           ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~-----------~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~k  161 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK  161 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred             ceEEEEEeecCCchhhhccc-----------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCcccccccccccc
Confidence            55677888899999999842           35899999999999999999999   89999999999999999999999


Q ss_pred             EeeeccceecccccccceecccccccccccCcccCCC-ccCccccchhHHHHHHHHHhCCCCCccccccccchHHHHHhh
Q 046112          361 VSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGH-EVSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLRNCVKSA  439 (502)
Q Consensus       361 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  439 (502)
                      ++|||++......     .....||+.|+|||...+. .++.++||||+||++|||++|+.||......  .....+...
T Consensus       162 l~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~--~~~~~i~~~  234 (348)
T d2gfsa1         162 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRL  234 (348)
T ss_dssp             ECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHH
T ss_pred             ccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHHh
Confidence            9999999755332     2345689999999986665 4688999999999999999999999752111  111111111


Q ss_pred             cccchh------------hhcccCCC-Ccc---hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 046112          440 LPERAE------------EIRASSGS-TQR---SIILECLISICEIGVACSAEQPGERMKINDVEP  489 (502)
Q Consensus       440 ~~~~~~------------~~~d~~~~-~~~---~~~~~~~~~l~~l~~~c~~~dP~~RPt~~ev~~  489 (502)
                      ......            ........ ...   .........+.+|+.+|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            000000            00000000 000   001123456778999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.6e-39  Score=316.30  Aligned_cols=266  Identities=17%  Similarity=0.189  Sum_probs=189.5

Q ss_pred             CCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-----------CCccceeeeccccc
Q 046112          206 GFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-----------HRNLVKVFTACSGV  274 (502)
Q Consensus       206 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~  274 (502)
                      +|.+.++||+|+||+||+|++..+|+.||||+++... ...+.+.+|+++++.++           |+||+++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~-   91 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH-   91 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE-
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee-
Confidence            4888999999999999999999999999999997532 23456788999888775           5778888887542 


Q ss_pred             ccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCCCeeeC
Q 046112          275 DFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPSNILLD  354 (502)
Q Consensus       275 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~NIll~  354 (502)
                        ......+++++++..+.......       .......+++..+..++.|++.||+|||+  ..+|+||||||+|||++
T Consensus        92 --~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~  160 (362)
T d1q8ya_          92 --KGPNGVHVVMVFEVLGENLLALI-------KKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLME  160 (362)
T ss_dssp             --EETTEEEEEEEECCCCEEHHHHH-------HHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEE
T ss_pred             --ccccceeeeeeeccccccccccc-------ccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeee
Confidence              22345566777665554332221       12445678889999999999999999993  37899999999999998


Q ss_pred             CCC------cEEEeeeccceecccccccceecccccccccccCcccCCCccCccccchhHHHHHHHHHhCCCCCcccccc
Q 046112          355 DEM------TAYVSDFGIARFLEAADEQTRSIGVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLLEMFTGLRPSDDMFKD  428 (502)
Q Consensus       355 ~~~------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~el~tg~~p~~~~~~~  428 (502)
                      .++      .++++|||.+......     .....||+.|+|||.+....++.++||||+||+++||++|+.||......
T Consensus       161 ~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~  235 (362)
T d1q8ya_         161 IVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH  235 (362)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccc
Confidence            654      4999999999755332     23456899999999999999999999999999999999999999753211


Q ss_pred             c-----cchHHHHHh--hccc-------chhhhccc-----CC------------CCcchhhHHHHHHHHHHHhhcccCC
Q 046112          429 N-----LNLRNCVKS--ALPE-------RAEEIRAS-----SG------------STQRSIILECLISICEIGVACSAEQ  477 (502)
Q Consensus       429 ~-----~~~~~~~~~--~~~~-------~~~~~~d~-----~~------------~~~~~~~~~~~~~l~~l~~~c~~~d  477 (502)
                      .     ..+...+..  ..+.       ......+.     ..            .............+.+++.+|++.|
T Consensus       236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d  315 (362)
T d1q8ya_         236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD  315 (362)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred             cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence            0     011111110  0000       00000000     00            0011223466778999999999999


Q ss_pred             CCCCCCHHHHHH
Q 046112          478 PGERMKINDVEP  489 (502)
Q Consensus       478 P~~RPt~~ev~~  489 (502)
                      |++|||++|+++
T Consensus       316 P~~Rpta~e~L~  327 (362)
T d1q8ya_         316 PRKRADAGGLVN  327 (362)
T ss_dssp             TTTCBCHHHHHT
T ss_pred             hhHCcCHHHHhc
Confidence            999999999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=9.1e-24  Score=187.72  Aligned_cols=169  Identities=18%  Similarity=0.148  Sum_probs=119.0

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccCc------------------chhHHHHHHHHHHhcCCCCccceeee
Q 046112          208 SSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHH------------------DASKSFAVECEVTRNIRHRNLVKVFT  269 (502)
Q Consensus       208 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~  269 (502)
                      .++++||+|+||+||+|.+ .+|+.||||+++....                  ........|...+.++.|.+++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            3568999999999999966 5789999998753210                  01133456888899999999988876


Q ss_pred             cccccccCCCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeecCCCC
Q 046112          270 ACSGVDFQGNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDCQPPIAHCDLKPS  349 (502)
Q Consensus       270 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~dlk~~  349 (502)
                      +.         ..+++|||++++.+.++                 +......++.|++.+++|||   +.+|+||||||+
T Consensus        82 ~~---------~~~lvme~~~~~~~~~l-----------------~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~  132 (191)
T d1zara2          82 WE---------GNAVLMELIDAKELYRV-----------------RVENPDEVLDMILEEVAKFY---HRGIVHGDLSQY  132 (191)
T ss_dssp             EE---------TTEEEEECCCCEEGGGC-----------------CCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTT
T ss_pred             ec---------CCEEEEEeeccccccch-----------------hhHHHHHHHHHHHHHHHHHh---hCCEEEccCChh
Confidence            52         24799999987655432                 22335678999999999999   899999999999


Q ss_pred             CeeeCCCCcEEEeeeccceecccccccceec-ccccccccccCcccCCCccCccccchhHHHHHH
Q 046112          350 NILLDDEMTAYVSDFGIARFLEAADEQTRSI-GVEGTTGYIAPEYGMGHEVSSYGDVYSFGILLL  413 (502)
Q Consensus       350 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~~sDvws~Gv~l~  413 (502)
                      |||++++ .++|+|||.|.....+....... .+...     .|. ..+.|+.++||||..--++
T Consensus       133 NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~~-----~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         133 NVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNI-----ITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             SEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHHHH-----HHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             heeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHHHH-----HHH-HcCCCCCcccHHHHHHHHh
Confidence            9999965 58999999997654332111000 00000     011 1356889999999765443

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.70  E-value=2.3e-17  Score=145.85  Aligned_cols=126  Identities=17%  Similarity=0.284  Sum_probs=110.9

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcC-CccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAI-SNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      |.++|+|+ .+|..+.  +++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..|..+++|+.|+|++|+|
T Consensus        14 ~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l   90 (192)
T d1w8aa_          14 DCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI   90 (192)
T ss_dssp             ECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCC
T ss_pred             EEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccc
Confidence            46889999 8898774  68999999999998655 56689999999999999999999999999999999999999999


Q ss_pred             CCCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCccccC
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNKKLCG  129 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~l~g  129 (502)
                      ++..|..|.++++|+.|+|++|+|+++++.. ..+.++..+.+.+|+..|.
T Consensus        91 ~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~  141 (192)
T d1w8aa_          91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             cccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence            9766778999999999999999999998875 4577888999999976543

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.68  E-value=2e-17  Score=158.10  Aligned_cols=132  Identities=31%  Similarity=0.527  Sum_probs=106.1

Q ss_pred             CCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCC
Q 046112            3 SNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDE   82 (502)
Q Consensus         3 ~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~   82 (502)
                      ++|+++|..|..+.++..+ .+++++|.+.|.+|..+..+++|+.|++++|.+++.+ ..++.+++|+.|+|++|+|+|.
T Consensus       182 ~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~  259 (313)
T d1ogqa_         182 SRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGT  259 (313)
T ss_dssp             CSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEEC
T ss_pred             ccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc-cccccccccccccCccCeeccc
Confidence            3444444444444443322 4555556666666777788999999999999999854 5688999999999999999999


Q ss_pred             ChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCccccCCCCCcCCcccc
Q 046112           83 IPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCGGIPEFQLPTCV  140 (502)
Q Consensus        83 ~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~g~~p~~~~~~~~  140 (502)
                      +|..|.++++|+.|+|++|+|+|.+|..+.+..+..+.+.+|+.+||.+    +|+|+
T Consensus       260 iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p----lp~c~  313 (313)
T d1ogqa_         260 LPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP----LPACT  313 (313)
T ss_dssp             CCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT----SSCCC
T ss_pred             CChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC----CCCCC
Confidence            9999999999999999999999988888888999999999999999963    57774

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.68  E-value=3.8e-17  Score=144.49  Aligned_cols=129  Identities=22%  Similarity=0.294  Sum_probs=110.1

Q ss_pred             CCCCCcccccc-ccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTL-SPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      ||++|+|++.+ +..|.++++|+.|+|++|++.+..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|
T Consensus        35 ~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l  114 (192)
T d1w8aa_          35 LLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQI  114 (192)
T ss_dssp             ECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCC
T ss_pred             EeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccc
Confidence            68999998655 45578999999999999999999999999999999999999999998888999999999999999999


Q ss_pred             CCCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCccccC
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCG  129 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~g  129 (502)
                      ++..|..|..+++|++|+|++|.+....+..+....+....+..|...|+
T Consensus       115 ~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~  164 (192)
T d1w8aa_         115 SCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG  164 (192)
T ss_dssp             CEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred             cccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeC
Confidence            97777889999999999999999988766554444444455555554454

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.65  E-value=2.4e-16  Score=128.30  Aligned_cols=103  Identities=24%  Similarity=0.270  Sum_probs=89.3

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|+ .++ .+.++++|++|+|++|+|+ .+|..|+.+++|+.|++++|+|++ +| .+..+++|+.|++++|+|+
T Consensus         4 ~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~   78 (124)
T d1dcea3           4 HLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQ   78 (124)
T ss_dssp             ECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCC
T ss_pred             EcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccC
Confidence            68999999 665 5899999999999999999 678889999999999999999997 55 4899999999999999998


Q ss_pred             CCC-hhhhcCcCCCceeeCCCCccccCCc
Q 046112           81 DEI-PEFLAGFKFLQNLNLSYNNFESMLP  108 (502)
Q Consensus        81 ~~~-p~~~~~~~~L~~l~l~~N~l~~~~~  108 (502)
                      ... ...+..+++|+.|++++|+++....
T Consensus        79 ~~~~~~~l~~~~~L~~L~l~~N~i~~~~~  107 (124)
T d1dcea3          79 QSAAIQPLVSCPRLVLLNLQGNSLCQEEG  107 (124)
T ss_dssp             SSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             CCCCchhhcCCCCCCEEECCCCcCCcCcc
Confidence            432 2578899999999999999987653

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=2.5e-15  Score=139.84  Aligned_cols=116  Identities=23%  Similarity=0.200  Sum_probs=65.9

Q ss_pred             ccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCC
Q 046112           14 QLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFL   93 (502)
Q Consensus        14 ~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L   93 (502)
                      .+.++++|+.|+|++|.+.+..+..+..+.+|+.|++++|.++...+..+..+++|+.|++++|+|++..+..|..+++|
T Consensus        95 ~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L  174 (266)
T d1p9ag_          95 LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL  174 (266)
T ss_dssp             CTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTC
T ss_pred             ccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcccccccccc
Confidence            33344444444444444443333444444444555555555555444555566666666666666665555556666666


Q ss_pred             ceeeCCCCccccCCcchhhcccccceeecCCccccC
Q 046112           94 QNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLCG  129 (502)
Q Consensus        94 ~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~g  129 (502)
                      +.|+|++|+|+.+|+.......+..+.+.||+..|.
T Consensus       175 ~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~Cd  210 (266)
T d1p9ag_         175 DTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN  210 (266)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             ceeecccCCCcccChhHCCCCCCCEEEecCCCCCCC
Confidence            677777666666666555566666666666665553

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.59  E-value=2.3e-16  Score=150.64  Aligned_cols=130  Identities=27%  Similarity=0.395  Sum_probs=110.4

Q ss_pred             CCCCCcccc--ccccccCCCCCCCEEeccC-CcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCc
Q 046112            1 DLSNNNLSG--TLSPQLVGLSSLSIFNVSG-NLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQN   77 (502)
Q Consensus         1 dl~~n~l~~--~~p~~~~~l~~L~~l~l~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N   77 (502)
                      ||++|+++|  .+|+++++|++|++|+|++ |+++|.+|..|++|++|++|+|++|+|.+..|..+..+.+|+.+++++|
T Consensus        56 ~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N  135 (313)
T d1ogqa_          56 DLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN  135 (313)
T ss_dssp             EEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSS
T ss_pred             ECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccc
Confidence            578899987  5889999999999999997 8999999999999999999999999999988899999999999999999


Q ss_pred             ccCCCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCccccCC
Q 046112           78 NLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNKKLCGG  130 (502)
Q Consensus        78 ~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~l~g~  130 (502)
                      .+.+.+|..+.+++.|+.+++++|.+++.+|.. ..+..+.......++.+.+.
T Consensus       136 ~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~  189 (313)
T d1ogqa_         136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK  189 (313)
T ss_dssp             EEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEE
T ss_pred             cccccCchhhccCcccceeecccccccccccccccccccccccccccccccccc
Confidence            999999999999999999999999999876644 44455433333333355543

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=4e-15  Score=127.00  Aligned_cols=109  Identities=16%  Similarity=0.161  Sum_probs=80.2

Q ss_pred             ccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCC
Q 046112           14 QLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFL   93 (502)
Q Consensus        14 ~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L   93 (502)
                      .+.++.+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+. + +.|..+++|+.|+|++|+|+...+..+..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCcccccccccc
Confidence            4667778888888888888 556666778888888888888876 4 347788888888888888874334445678888


Q ss_pred             ceeeCCCCccccCCc--chhhcccccceeecCCc
Q 046112           94 QNLNLSYNNFESMLP--IEGIFKNASATSVFGNK  125 (502)
Q Consensus        94 ~~l~l~~N~l~~~~~--~~~~~~~~~~~~~~~n~  125 (502)
                      +.|++++|+|+....  ....++++..+.+.+|+
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~  123 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNP  123 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSG
T ss_pred             ccceeccccccccccccccccccccchhhcCCCc
Confidence            888888888876543  33456677777777775

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.54  E-value=1.2e-14  Score=117.98  Aligned_cols=99  Identities=21%  Similarity=0.261  Sum_probs=87.6

Q ss_pred             CEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCceeeCCCC
Q 046112           22 SIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYN  101 (502)
Q Consensus        22 ~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l~~N  101 (502)
                      +.|+|++|+|+ .++ .++.+++|++|++++|+|+. +|..++.+++|+.|++++|.|+ .+| .+.++++|+.|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence            57999999999 666 48999999999999999997 7888999999999999999999 566 4899999999999999


Q ss_pred             ccccCCc--chhhcccccceeecCCc
Q 046112          102 NFESMLP--IEGIFKNASATSVFGNK  125 (502)
Q Consensus       102 ~l~~~~~--~~~~~~~~~~~~~~~n~  125 (502)
                      +|+..+.  ....++++..+.+.+|+
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~  101 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNS  101 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCc
Confidence            9998764  34567788899999986

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=1.3e-14  Score=136.14  Aligned_cols=127  Identities=21%  Similarity=0.252  Sum_probs=75.1

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      |++|.+....+..+..+.+|+.+++++|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|++++|++++
T Consensus       112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~  191 (284)
T d1ozna_         112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (284)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence            45555553344445555666666666666665555556666666666666666666555566666666666666666665


Q ss_pred             CChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCcccc
Q 046112           82 EIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNKKLC  128 (502)
Q Consensus        82 ~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~l~  128 (502)
                      ..|..|..+++|+.|++++|++++.++.. .....+..+.+.+|+.-|
T Consensus       192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             cChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence            55666666666666666666666655543 344555666666665443

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.49  E-value=1.6e-14  Score=135.57  Aligned_cols=128  Identities=25%  Similarity=0.226  Sum_probs=108.5

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ++++|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|++++|++++..|..|..+++|+.||+++|++.
T Consensus       135 ~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~  214 (284)
T d1ozna_         135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS  214 (284)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             hhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccc
Confidence            57899999666677889999999999999999888899999999999999999999988999999999999999999999


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCcccc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLC  128 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~  128 (502)
                      +..|..|.++++|+.|++++|.+...-+..+....+.......++..|
T Consensus       215 ~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C  262 (284)
T d1ozna_         215 ALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC  262 (284)
T ss_dssp             CCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBE
T ss_pred             cccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEe
Confidence            888899999999999999999998765544333334444444444444

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=2e-14  Score=122.66  Aligned_cols=104  Identities=21%  Similarity=0.194  Sum_probs=91.1

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|+ .+|..+..+++|+.|+|++|+|+ .++ .|..+++|++|++++|+++...+..+..+++|+.|+|++|+|+
T Consensus        24 ~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~  100 (162)
T d1a9na_          24 DLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV  100 (162)
T ss_dssp             ECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC
T ss_pred             ECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc
Confidence            68999999 67776788999999999999999 554 5899999999999999999855555678999999999999998


Q ss_pred             CCCh--hhhcCcCCCceeeCCCCccccCCc
Q 046112           81 DEIP--EFLAGFKFLQNLNLSYNNFESMLP  108 (502)
Q Consensus        81 ~~~p--~~~~~~~~L~~l~l~~N~l~~~~~  108 (502)
                       .++  ..+..+++|+.|++++|.++..+.
T Consensus       101 -~~~~l~~l~~l~~L~~L~l~~N~i~~~~~  129 (162)
T d1a9na_         101 -ELGDLDPLASLKSLTYLCILRNPVTNKKH  129 (162)
T ss_dssp             -CGGGGGGGGGCTTCCEEECCSSGGGGSTT
T ss_pred             -ccccccccccccccchhhcCCCccccccc
Confidence             455  478899999999999999988764

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=6.3e-14  Score=118.64  Aligned_cols=101  Identities=18%  Similarity=0.077  Sum_probs=72.0

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCC-cCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGN-LLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ++++++. ..|..+..+++|+.|+|++| .|+...+..|.++++|+.|+|++|+|+...|.+|..+++|+.|+|++|+|+
T Consensus        15 c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~   93 (156)
T d2ifga3          15 CTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE   93 (156)
T ss_dssp             CCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred             ecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc
Confidence            3555665 56677777778888888665 477555566778888888888888887766777777888888888888887


Q ss_pred             CCChhhhcCcCCCceeeCCCCccc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFE  104 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~  104 (502)
                       .+|........|+.|+|++|.|.
T Consensus        94 -~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          94 -SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             -CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             -ccChhhhccccccccccCCCccc
Confidence             55554444446778888888774

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=1.2e-13  Score=128.25  Aligned_cols=119  Identities=25%  Similarity=0.299  Sum_probs=85.2

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      |.++++|+ .+|+.+.  ++|+.|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.+++|+.|+|++|+++
T Consensus        16 ~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~   90 (266)
T d1p9ag_          16 NCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ   90 (266)
T ss_dssp             ECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS
T ss_pred             EccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccccccc
Confidence            35677777 6776654  467888888888886666678888888888888888875 43 3567788888888888887


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcch-hhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIE-GIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~  125 (502)
                       .+|..+..+++|+.|++++|.+.+.++.. .....+..+.+.+|.
T Consensus        91 -~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~  135 (266)
T d1p9ag_          91 -SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE  135 (266)
T ss_dssp             -SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred             -ccccccccccccccccccccccceeeccccccccccccccccccc
Confidence             45667777888888888888877766544 334556666666663

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.40  E-value=4.6e-13  Score=113.19  Aligned_cols=112  Identities=19%  Similarity=0.108  Sum_probs=98.7

Q ss_pred             CCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCC-ccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCce
Q 046112           17 GLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGN-LFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQN   95 (502)
Q Consensus        17 ~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~   95 (502)
                      .+...+.++.+++.+. ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+...|..|..+++|+.
T Consensus         6 ~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~   84 (156)
T d2ifga3           6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR   84 (156)
T ss_dssp             CCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred             CcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence            4455678999999999 77888999999999999876 588866788999999999999999999766888999999999


Q ss_pred             eeCCCCccccCCcchhhcccccceeecCCccccC
Q 046112           96 LNLSYNNFESMLPIEGIFKNASATSVFGNKKLCG  129 (502)
Q Consensus        96 l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~g  129 (502)
                      |+|++|+|+.+++.......+..+.+.+|+.-|.
T Consensus        85 L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~  118 (156)
T d2ifga3          85 LNLSFNALESLSWKTVQGLSLQELVLSGNPLHCS  118 (156)
T ss_dssp             EECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred             eeccCCCCcccChhhhccccccccccCCCcccCC
Confidence            9999999999998887777888999999987654

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.40  E-value=3.5e-13  Score=127.60  Aligned_cols=124  Identities=24%  Similarity=0.298  Sum_probs=104.0

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      +++|+++ .+|..+  +++|+.|++++|..++..+..|.+++.+++|++++|++++..|..+.++++|+.|+|++|+|+ 
T Consensus       157 l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-  232 (305)
T d1xkua_         157 IADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-  232 (305)
T ss_dssp             CCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-
T ss_pred             cccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-
Confidence            5677777 566543  678999999999999999999999999999999999999988889999999999999999998 


Q ss_pred             CChhhhcCcCCCceeeCCCCccccCCcchh-------hcccccceeecCCccccC
Q 046112           82 EIPEFLAGFKFLQNLNLSYNNFESMLPIEG-------IFKNASATSVFGNKKLCG  129 (502)
Q Consensus        82 ~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~-------~~~~~~~~~~~~n~~l~g  129 (502)
                      .+|.+|.++++|+.|+|++|+|+.+.....       ....+..+.+.+|+.-++
T Consensus       233 ~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~  287 (305)
T d1xkua_         233 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW  287 (305)
T ss_dssp             SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred             ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence            788899999999999999999998765332       345577788888875444

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.30  E-value=6.8e-12  Score=110.68  Aligned_cols=115  Identities=23%  Similarity=0.279  Sum_probs=73.0

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ++++|.++ .++ .+..+++|++|+|++|+|++..|  |+++++|++|++++|.+.. +| .+.++++|+.|++++|.+.
T Consensus        46 ~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~  119 (199)
T d2omxa2          46 QADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQIT  119 (199)
T ss_dssp             ECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCC
T ss_pred             ECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccccccccccc
Confidence            35666666 443 46677777777777777775433  7777777777777777765 33 3666677777777777666


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGN  124 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n  124 (502)
                      . + ..+..+++|+.|++++|+++.++ .......+..+.+.+|
T Consensus       120 ~-~-~~~~~l~~L~~L~l~~n~l~~~~-~l~~~~~L~~L~l~~n  160 (199)
T d2omxa2         120 D-I-DPLKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLNFSSN  160 (199)
T ss_dssp             C-C-GGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSS
T ss_pred             c-c-cccchhhhhHHhhhhhhhhcccc-cccccccccccccccc
Confidence            3 2 23556666777777777666543 2344555555655555

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.28  E-value=4.9e-14  Score=124.43  Aligned_cols=111  Identities=19%  Similarity=0.176  Sum_probs=94.1

Q ss_pred             ccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcC
Q 046112           10 TLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAG   89 (502)
Q Consensus        10 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~   89 (502)
                      .+|..++.+++|+.|+|++|+|+ .++ .|.+|++|+.|+|++|+|+. +|..+..+++|+.|++++|+|+ .++ .+..
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~  113 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA-SLS-GIEK  113 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECC-CHH-HHHH
T ss_pred             hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhccccccc-cccccccccccccccccccccc-ccc-cccc
Confidence            34567888999999999999999 555 58999999999999999986 6766666778999999999998 454 5888


Q ss_pred             cCCCceeeCCCCccccCCc--chhhcccccceeecCCc
Q 046112           90 FKFLQNLNLSYNNFESMLP--IEGIFKNASATSVFGNK  125 (502)
Q Consensus        90 ~~~L~~l~l~~N~l~~~~~--~~~~~~~~~~~~~~~n~  125 (502)
                      +++|+.|++++|+|+....  ....++++..+.+.+|+
T Consensus       114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~  151 (198)
T d1m9la_         114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP  151 (198)
T ss_dssp             HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSH
T ss_pred             cccccccccccchhccccccccccCCCccceeecCCCc
Confidence            9999999999999988653  34567889999999996

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.26  E-value=7.6e-12  Score=118.17  Aligned_cols=102  Identities=21%  Similarity=0.293  Sum_probs=91.8

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +|++|.+++..+..+.+++.++.|++++|.+++..+..|.++++|++|+|++|+|+. +|.+|..+++|+.|+|++|+|+
T Consensus       177 ~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~  255 (305)
T d1xkua_         177 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS  255 (305)
T ss_dssp             ECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCC
T ss_pred             ECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccc-cccccccccCCCEEECCCCccC
Confidence            478899998888999999999999999999998889999999999999999999996 7899999999999999999999


Q ss_pred             CCChh-------hhcCcCCCceeeCCCCccc
Q 046112           81 DEIPE-------FLAGFKFLQNLNLSYNNFE  104 (502)
Q Consensus        81 ~~~p~-------~~~~~~~L~~l~l~~N~l~  104 (502)
                       .++.       .+..+.+|+.|+|++|.++
T Consensus       256 -~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         256 -AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             -CCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred             -ccChhhccCcchhcccCCCCEEECCCCcCc
Confidence             4543       2345788999999999986

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.23  E-value=1.1e-11  Score=120.77  Aligned_cols=117  Identities=25%  Similarity=0.286  Sum_probs=69.9

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCC--------------------CC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI--------------------GS   61 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~--------------------p~   61 (502)
                      |++|+++ .+| .+..+++|+.|++++|.+++..+  ++.+++|++|++++|++++..                    +.
T Consensus       226 l~~n~l~-~~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~  301 (384)
T d2omza2         226 LNGNQLK-DIG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDIS  301 (384)
T ss_dssp             CCSSCCC-CCG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCG
T ss_pred             CCCCCCC-Ccc-hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCcccccccccccccccccccccc
Confidence            4455555 222 34555555555555555554322  445555555555555544321                    12


Q ss_pred             CcCCCCCCCEEEccCcccCCCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           62 SLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        62 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      .+..+++++.|++++|++++. + .+..+++|+.|++++|+|++++ ....++++..+.+.+|+
T Consensus       302 ~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~l~-~l~~l~~L~~L~l~~N~  362 (384)
T d2omza2         302 PISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSDVS-SLANLTNINWLSAGHNQ  362 (384)
T ss_dssp             GGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSC
T ss_pred             ccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCCCh-hHcCCCCCCEEECCCCc
Confidence            355667778888888888753 3 2677778888888888877754 35556777777777663

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.22  E-value=2.6e-11  Score=106.86  Aligned_cols=101  Identities=19%  Similarity=0.239  Sum_probs=52.5

Q ss_pred             CCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCcee
Q 046112           17 GLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNL   96 (502)
Q Consensus        17 ~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l   96 (502)
                      .+.+|+.|++++|.++ .++ .+..+++|++|+|++|++++. ++ ++++++|+.|++++|.+. .+| .+.+++.|+.|
T Consensus        38 ~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L  111 (199)
T d2omxa2          38 DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGL  111 (199)
T ss_dssp             HHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEE
T ss_pred             HhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCc-cc-ccCCcccccccccccccc-ccc-ccccccccccc
Confidence            3455555566555555 222 255555556666655555552 22 555555566666555555 333 25555555555


Q ss_pred             eCCCCccccCCcchhhcccccceeecCC
Q 046112           97 NLSYNNFESMLPIEGIFKNASATSVFGN  124 (502)
Q Consensus        97 ~l~~N~l~~~~~~~~~~~~~~~~~~~~n  124 (502)
                      ++++|.+....+ ...++.+..+.+.+|
T Consensus       112 ~l~~~~~~~~~~-~~~l~~L~~L~l~~n  138 (199)
T d2omxa2         112 TLFNNQITDIDP-LKNLTNLNRLELSSN  138 (199)
T ss_dssp             ECCSSCCCCCGG-GTTCTTCSEEECCSS
T ss_pred             cccccccccccc-cchhhhhHHhhhhhh
Confidence            555555554332 233445555555554

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.21  E-value=3e-11  Score=107.36  Aligned_cols=115  Identities=21%  Similarity=0.287  Sum_probs=75.7

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ++++|.++ .++ .+..+++|++|+|++|+|++. + .++.|++|+.|++++|+|++ +| .+..+++|+.|++++|.+.
T Consensus        52 ~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~  125 (210)
T d1h6ta2          52 IANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS  125 (210)
T ss_dssp             ECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC
T ss_pred             ECcCCCCC-Cch-hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-ccccccccccccccccccc
Confidence            35667766 343 367777888888888887753 3 26777888888888888776 44 4777777888888777776


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCC
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGN  124 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n  124 (502)
                       .++ .+..++.|+.+++++|++++.. ....++.+..+.+.+|
T Consensus       126 -~~~-~l~~l~~l~~l~~~~n~l~~~~-~~~~l~~L~~l~l~~n  166 (210)
T d1h6ta2         126 -DIN-GLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDN  166 (210)
T ss_dssp             -CCG-GGGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSS
T ss_pred             -ccc-cccccccccccccccccccccc-cccccccccccccccc
Confidence             333 4666666667777766666543 2334555666666655

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.19  E-value=1.4e-13  Score=121.48  Aligned_cols=103  Identities=30%  Similarity=0.387  Sum_probs=89.3

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|+ .++ .+.++++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++. ++ .+..+++|+.|+|++|+|+
T Consensus        54 ~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~  128 (198)
T d1m9la_          54 ALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKIT  128 (198)
T ss_dssp             ECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEESEEECC
T ss_pred             ECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccccccchhc
Confidence            58899999 665 5899999999999999998 677767777899999999999997 43 4888999999999999998


Q ss_pred             CCCh--hhhcCcCCCceeeCCCCccccCCcc
Q 046112           81 DEIP--EFLAGFKFLQNLNLSYNNFESMLPI  109 (502)
Q Consensus        81 ~~~p--~~~~~~~~L~~l~l~~N~l~~~~~~  109 (502)
                       .++  ..+..+++|+.|++++|+++...+.
T Consensus       129 -~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~  158 (198)
T d1m9la_         129 -NWGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             -CHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred             -cccccccccCCCccceeecCCCccccCccc
Confidence             455  4789999999999999999876554

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.18  E-value=5.1e-11  Score=105.85  Aligned_cols=116  Identities=22%  Similarity=0.308  Sum_probs=98.5

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|++ ++ .++++++|+.|++++|+|++ +| .+..+++|+.|++++|.+.. + ..+..+++|+.+++++|.++
T Consensus        74 ~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~  147 (210)
T d1h6ta2          74 FLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKIT  147 (210)
T ss_dssp             ECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCC
T ss_pred             eCCCccccC-cc-ccccCccccccccccccccc-cc-cccccccccccccccccccc-c-cccccccccccccccccccc
Confidence            588999994 54 47899999999999999994 55 58999999999999999875 3 46888999999999999998


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      +  +..+..+++|+.+++++|+++++++ ...++++..+.+++|.
T Consensus       148 ~--~~~~~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~~L~Ls~N~  189 (210)
T d1h6ta2         148 D--ITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNH  189 (210)
T ss_dssp             C--CGGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred             c--ccccccccccccccccccccccccc-ccCCCCCCEEECCCCC
Confidence            4  3457789999999999999998765 5567888999998884

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.05  E-value=3.7e-10  Score=101.44  Aligned_cols=73  Identities=16%  Similarity=0.374  Sum_probs=45.7

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      +++|+|+ .++ .+.++++|+.|+|++|++++..|  +..+++|++|++++|.++. ++ .+..+++|+.+++++|.+.
T Consensus        48 l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~  120 (227)
T d1h6ua2          48 AFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQIT  120 (227)
T ss_dssp             CTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCC
T ss_pred             CCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-cc-ccccccccccccccccccc
Confidence            5677777 453 57777888888888887775433  6666677777776666654 22 3455555555555555444

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.03  E-value=3.5e-10  Score=109.79  Aligned_cols=116  Identities=28%  Similarity=0.374  Sum_probs=67.4

Q ss_pred             CCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCC
Q 046112            2 LSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSD   81 (502)
Q Consensus         2 l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~   81 (502)
                      +++|.+++..|  +...++|+.|++++|+++. ++ .+..+++|+.|++++|++++..  .++.+++|+.|++++|.+++
T Consensus       204 l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~  277 (384)
T d2omza2         204 ATNNQISDITP--LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISN  277 (384)
T ss_dssp             CCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCC
T ss_pred             ccCCccCCCCc--ccccCCCCEEECCCCCCCC-cc-hhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCC
Confidence            45566663332  3455666666777666663 22 4566666667777666666532  25566666666666666653


Q ss_pred             CCh--------------------hhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCC
Q 046112           82 EIP--------------------EFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGN  124 (502)
Q Consensus        82 ~~p--------------------~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n  124 (502)
                      ..|                    ..+..++.++.|++++|+|+++++ ...++++..+.+.+|
T Consensus       278 ~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~-l~~l~~L~~L~L~~n  339 (384)
T d2omza2         278 ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANN  339 (384)
T ss_dssp             CGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSS
T ss_pred             CCccccccccccccccccccccccccchhcccCeEECCCCCCCCCcc-cccCCCCCEEECCCC
Confidence            221                    123445566666666666666543 444566666666666

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.02  E-value=5e-10  Score=100.55  Aligned_cols=120  Identities=23%  Similarity=0.342  Sum_probs=91.7

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCC--------------------
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIG--------------------   60 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p--------------------   60 (502)
                      ||++|++++..|  +..+++|+.+++++|.++ .++ .+..+++|+.|++++|...+..+                    
T Consensus        69 ~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  144 (227)
T d1h6ua2          69 ELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNI  144 (227)
T ss_dssp             ECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCC
T ss_pred             ecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhchhhhhchh
Confidence            578888884333  788889999999988887 444 47788888888888877654221                    


Q ss_pred             CCcCCCCCCCEEEccCcccCCCChhhhcCcCCCceeeCCCCccccCCcchhhcccccceeecCCcccc
Q 046112           61 SSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNLSYNNFESMLPIEGIFKNASATSVFGNKKLC  128 (502)
Q Consensus        61 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~l~  128 (502)
                      ..+..+++|+.|++++|.+++. + .+.++++|+.|+|++|+++++++ ...++++..+.+.+|+ +.
T Consensus       145 ~~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~~L~Ls~N~-lt  208 (227)
T d1h6ua2         145 SPLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQ-IS  208 (227)
T ss_dssp             GGGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSC-CC
T ss_pred             hhhccccccccccccccccccc-h-hhcccccceecccCCCccCCChh-hcCCCCCCEEECcCCc-CC
Confidence            2356678899999999999843 3 38889999999999999998654 5667889999998884 44

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.90  E-value=7.9e-10  Score=100.21  Aligned_cols=103  Identities=18%  Similarity=0.202  Sum_probs=86.8

Q ss_pred             CCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCC-CCCcCCCCCCCEEEcc-CcccC
Q 046112            3 SNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPI-GSSLSSLRGLRVLDLS-QNNLS   80 (502)
Q Consensus         3 ~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~ls-~N~l~   80 (502)
                      +++.++ .+|+.+.  +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|..++.++.|++. .|.+.
T Consensus        16 ~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~   92 (242)
T d1xwdc1          16 QESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL   92 (242)
T ss_dssp             ESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCC
T ss_pred             eCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccc
Confidence            455677 7887664  58999999999999666667999999999999999988754 5578999999999986 47888


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLP  108 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~  108 (502)
                      ...+..|.++++|+.+++++|+++..++
T Consensus        93 ~~~~~~~~~l~~L~~l~l~~~~l~~~~~  120 (242)
T d1xwdc1          93 YINPEAFQNLPNLQYLLISNTGIKHLPD  120 (242)
T ss_dssp             EECTTSEECCTTCCEEEEESCCCCSCCC
T ss_pred             ccccccccccccccccccchhhhccccc
Confidence            7777889999999999999999987655

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.79  E-value=2.9e-09  Score=96.31  Aligned_cols=110  Identities=13%  Similarity=0.096  Sum_probs=85.4

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCC-ccCCCCCCCCEEECc-CCccCCCCCCCcCCCCCCCEEEccCcc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAIS-NNFGSCTSLEQLDMH-GNLFAGPIGSSLSSLRGLRVLDLSQNN   78 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~~~l~~L~~L~l~-~N~l~~~~p~~~~~l~~L~~L~ls~N~   78 (502)
                      ||++|+|+...+..|.++++|++|+|++|.+...++ ..|.+++++++|++. .|++....+..|..+++|+.|++++|.
T Consensus        35 ~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~  114 (242)
T d1xwdc1          35 RFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTG  114 (242)
T ss_dssp             EEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCC
T ss_pred             ECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchhh
Confidence            578999994444468999999999999999986554 468999999999876 478888788889999999999999999


Q ss_pred             cCCCCh-hhhcCcCCCceeeCCCCccccCCcch
Q 046112           79 LSDEIP-EFLAGFKFLQNLNLSYNNFESMLPIE  110 (502)
Q Consensus        79 l~~~~p-~~~~~~~~L~~l~l~~N~l~~~~~~~  110 (502)
                      +....+ ..+..+..+..+..+++++..+.+..
T Consensus       115 l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~  147 (242)
T d1xwdc1         115 IKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS  147 (242)
T ss_dssp             CCSCCCCTTTCBSSCEEEEEESCTTCCEECTTS
T ss_pred             hcccccccccccccccccccccccccccccccc
Confidence            974322 23445566666666777777665543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.77  E-value=1e-08  Score=97.72  Aligned_cols=95  Identities=26%  Similarity=0.354  Sum_probs=63.9

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccC
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLS   80 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~   80 (502)
                      ||++|+|+ .+|+.   +++|++|+|++|+|+ .+|..+   .+|+.|++++|+++. ++. +  .+.|+.|+|++|.+.
T Consensus        44 dLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~-l--p~~L~~L~L~~n~l~  111 (353)
T d1jl5a_          44 ELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSD-L--PPLLEYLGVSNNQLE  111 (353)
T ss_dssp             ECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCS-C--CTTCCEEECCSSCCS
T ss_pred             EeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhh-h--ccccccccccccccc
Confidence            56777777 66642   456777777777777 666543   467777777777765 332 1  135777788877777


Q ss_pred             CCChhhhcCcCCCceeeCCCCccccCCcc
Q 046112           81 DEIPEFLAGFKFLQNLNLSYNNFESMLPI  109 (502)
Q Consensus        81 ~~~p~~~~~~~~L~~l~l~~N~l~~~~~~  109 (502)
                       .+|. +..++.|+.|++++|.++..+..
T Consensus       112 -~lp~-~~~l~~L~~L~l~~~~~~~~~~~  138 (353)
T d1jl5a_         112 -KLPE-LQNSSFLKIIDVDNNSLKKLPDL  138 (353)
T ss_dssp             -SCCC-CTTCTTCCEEECCSSCCSCCCCC
T ss_pred             -cccc-hhhhccceeeccccccccccccc
Confidence             5664 56677777777777777766543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.55  E-value=2.4e-09  Score=90.47  Aligned_cols=72  Identities=21%  Similarity=0.135  Sum_probs=48.6

Q ss_pred             CccCCCCCCCCEEECcCCccCCC--CCCCcCCCCCCCEEEccCcccCCCChh-hhcCcCCCceeeCCCCccccCCc
Q 046112           36 SNNFGSCTSLEQLDMHGNLFAGP--IGSSLSSLRGLRVLDLSQNNLSDEIPE-FLAGFKFLQNLNLSYNNFESMLP  108 (502)
Q Consensus        36 ~~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~~L~~l~l~~N~l~~~~~  108 (502)
                      +..+..+++|++|+|++|+|+..  ++..+..+++|+.|||++|.|+. ++. .+.....|+.|++++|.++....
T Consensus        58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~  132 (162)
T d1koha1          58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFR  132 (162)
T ss_dssp             HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred             HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCcc
Confidence            33345677888888888888763  23446667888888888888874 443 33344567888888888876554

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.51  E-value=1.5e-07  Score=89.42  Aligned_cols=94  Identities=19%  Similarity=0.159  Sum_probs=76.8

Q ss_pred             CCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChhhhcCcCCCceeeC
Q 046112           19 SSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPEFLAGFKFLQNLNL   98 (502)
Q Consensus        19 ~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~L~~l~l   98 (502)
                      .+|+.|+|++|.|+ .+|+.   +++|++|+|++|+|+. +|..+   .+|+.|++++|.++ .++..   .+.|++|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~-lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcc-cccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence            46999999999999 68864   5789999999999996 78764   58999999999998 56542   246999999


Q ss_pred             CCCccccCCcchhhcccccceeecCCc
Q 046112           99 SYNNFESMLPIEGIFKNASATSVFGNK  125 (502)
Q Consensus        99 ~~N~l~~~~~~~~~~~~~~~~~~~~n~  125 (502)
                      ++|.|+.++. ...+..+..+.+.+|.
T Consensus       106 ~~n~l~~lp~-~~~l~~L~~L~l~~~~  131 (353)
T d1jl5a_         106 SNNQLEKLPE-LQNSSFLKIIDVDNNS  131 (353)
T ss_dssp             CSSCCSSCCC-CTTCTTCCEEECCSSC
T ss_pred             cccccccccc-hhhhccceeecccccc
Confidence            9999998765 4567788888887764

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.50  E-value=1.9e-09  Score=91.12  Aligned_cols=83  Identities=24%  Similarity=0.186  Sum_probs=64.9

Q ss_pred             cCCCCCCCEEeccCCcCCCcC--CccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccCcccCCCChh-------
Q 046112           15 LVGLSSLSIFNVSGNLLSGAI--SNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQNNLSDEIPE-------   85 (502)
Q Consensus        15 ~~~l~~L~~l~l~~N~l~~~~--~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-------   85 (502)
                      +..+++|+.|+|++|+|+..-  +..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|.++.....       
T Consensus        61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~  140 (162)
T d1koha1          61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA  140 (162)
T ss_dssp             HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred             HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence            346889999999999999542  45577899999999999999984332333456799999999999865442       


Q ss_pred             hhcCcCCCceee
Q 046112           86 FLAGFKFLQNLN   97 (502)
Q Consensus        86 ~~~~~~~L~~l~   97 (502)
                      .+..+|+|+.||
T Consensus       141 i~~~~P~L~~LD  152 (162)
T d1koha1         141 IRERFPKLLRLD  152 (162)
T ss_dssp             HHTTSTTCCEET
T ss_pred             HHHHCCCCCEEC
Confidence            356789998876

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.35  E-value=5.2e-07  Score=82.08  Aligned_cols=149  Identities=15%  Similarity=0.074  Sum_probs=92.7

Q ss_pred             HHHHhccCCCCCCcccccCCceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCC-CCccceeeecccccccC
Q 046112          199 MLYNATKGFSSENLIGAGNFGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIR-HRNLVKVFTACSGVDFQ  277 (502)
Q Consensus       199 ~l~~~t~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  277 (502)
                      ++...-..|...+..+.++.+.||+..  .++..+.+|+...........+.+|...+..+. +-.+-+++.++     .
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~   80 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----R   80 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----E
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----e
Confidence            444445566555544445557899874  355667788876544334455777888776653 22244455442     2


Q ss_pred             CCcceeEEeeeccCCChhhhccCCchhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------
Q 046112          278 GNDFKALVYEFMANGSLEEWMHPITEEDKRHKAPGNLNSLKRLNIAIDVACVLKYLHLDC--------------------  337 (502)
Q Consensus       278 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------  337 (502)
                      .++..++||+++++.++.+....               ......++.++++.++.||...                    
T Consensus        81 ~~~~~~lv~~~l~G~~~~~~~~~---------------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~  145 (263)
T d1j7la_          81 HDGWSNLLMSEADGVLCSEEYED---------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYL  145 (263)
T ss_dssp             ETTEEEEEEECCSSEEHHHHTTT---------------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHH
T ss_pred             cCCceEEEEEecccccccccccc---------------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHH
Confidence            23467899999999888655421               0012234455555555555210                    


Q ss_pred             ------------------------------------CCCceeecCCCCCeeeCCCCcEEEeeecccee
Q 046112          338 ------------------------------------QPPIAHCDLKPSNILLDDEMTAYVSDFGIARF  369 (502)
Q Consensus       338 ------------------------------------~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~~  369 (502)
                                                          ...++|+|+.|.||+++++..+-|.||+.+..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         146 LNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                                12379999999999999877777999998863

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.29  E-value=2.4e-08  Score=98.63  Aligned_cols=105  Identities=21%  Similarity=0.241  Sum_probs=79.1

Q ss_pred             CCCCCccccc-cccccCCCCCCCEEeccCCcCCC----cCCccCCCCCCCCEEECcCCccCC----CCCCCcCC-CCCCC
Q 046112            1 DLSNNNLSGT-LSPQLVGLSSLSIFNVSGNLLSG----AISNNFGSCTSLEQLDMHGNLFAG----PIGSSLSS-LRGLR   70 (502)
Q Consensus         1 dl~~n~l~~~-~p~~~~~l~~L~~l~l~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~-l~~L~   70 (502)
                      ||+.|++++. +..-+..+++|++|+|++|.|+.    .++..+..+++|++|||++|+|+.    .+...+.. ..+|+
T Consensus         8 d~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~   87 (460)
T d1z7xw1           8 DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQ   87 (460)
T ss_dssp             EEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCC
T ss_pred             EeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCC
Confidence            5778888742 23335567899999999999882    345567789999999999999863    12333332 35799


Q ss_pred             EEEccCcccCCC----ChhhhcCcCCCceeeCCCCcccc
Q 046112           71 VLDLSQNNLSDE----IPEFLAGFKFLQNLNLSYNNFES  105 (502)
Q Consensus        71 ~L~ls~N~l~~~----~p~~~~~~~~L~~l~l~~N~l~~  105 (502)
                      .|+|++|.+++.    ++..+..+++|+.|++++|.++.
T Consensus        88 ~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          88 KLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             EEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             EEECCCCCccccccccccchhhccccccccccccccchh
Confidence            999999999753    45677889999999999999875

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.17  E-value=1e-07  Score=90.72  Aligned_cols=112  Identities=22%  Similarity=0.244  Sum_probs=65.1

Q ss_pred             ccCCCCCCCEEeccCCcCCCc-----CCccCCCCCCCCEEECcCCccCCC----CCCCcCCCCCCCEEEccCcccCCCCh
Q 046112           14 QLVGLSSLSIFNVSGNLLSGA-----ISNNFGSCTSLEQLDMHGNLFAGP----IGSSLSSLRGLRVLDLSQNNLSDEIP   84 (502)
Q Consensus        14 ~~~~l~~L~~l~l~~N~l~~~-----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p   84 (502)
                      .+...+.|+.|+|++|+++..     +...+..+++|+.|+|++|.++..    +...+..+++|+.|+|++|.|++.-.
T Consensus       181 ~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~  260 (344)
T d2ca6a1         181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA  260 (344)
T ss_dssp             HHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHH
T ss_pred             hhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhh
Confidence            345566777777777777621     334466677777777777776532    33445666777777777777764322


Q ss_pred             h----hhcC--cCCCceeeCCCCccccCC-----cch-hhcccccceeecCCc
Q 046112           85 E----FLAG--FKFLQNLNLSYNNFESML-----PIE-GIFKNASATSVFGNK  125 (502)
Q Consensus        85 ~----~~~~--~~~L~~l~l~~N~l~~~~-----~~~-~~~~~~~~~~~~~n~  125 (502)
                      .    .+..  .+.|+.|++++|+|+..-     ... ...+.+..+.+.+|.
T Consensus       261 ~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~  313 (344)
T d2ca6a1         261 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR  313 (344)
T ss_dssp             HHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred             HHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCc
Confidence            2    2222  245777777777765321     111 123456666666663

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.09  E-value=2.3e-07  Score=88.26  Aligned_cols=107  Identities=19%  Similarity=0.251  Sum_probs=79.9

Q ss_pred             CCCCCccccc-----cccccCCCCCCCEEeccCCcCCCc----CCccCCCCCCCCEEECcCCccCCCCCC----CcCC--
Q 046112            1 DLSNNNLSGT-----LSPQLVGLSSLSIFNVSGNLLSGA----ISNNFGSCTSLEQLDMHGNLFAGPIGS----SLSS--   65 (502)
Q Consensus         1 dl~~n~l~~~-----~p~~~~~l~~L~~l~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~p~----~~~~--   65 (502)
                      +|++|+|+..     +...+..+++|+.|+|++|.++..    +...+..+++|++|+|++|.|++.-..    .+..  
T Consensus       192 ~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~  271 (344)
T d2ca6a1         192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE  271 (344)
T ss_dssp             ECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCS
T ss_pred             ccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhcc
Confidence            4678888632     345577889999999999998733    455678899999999999999763222    2222  


Q ss_pred             CCCCCEEEccCcccCCC----Chhhhc-CcCCCceeeCCCCccccCC
Q 046112           66 LRGLRVLDLSQNNLSDE----IPEFLA-GFKFLQNLNLSYNNFESML  107 (502)
Q Consensus        66 l~~L~~L~ls~N~l~~~----~p~~~~-~~~~L~~l~l~~N~l~~~~  107 (502)
                      .++|+.|||++|+|+..    +...+. +++.|+.|+|++|++....
T Consensus       272 ~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~~  318 (344)
T d2ca6a1         272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED  318 (344)
T ss_dssp             SCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             CCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCcc
Confidence            36799999999999743    334443 5789999999999997543

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.07  E-value=1.5e-07  Score=87.00  Aligned_cols=86  Identities=22%  Similarity=0.382  Sum_probs=57.0

Q ss_pred             CCCCCCCEEeccCCcCCCc-CCccCCCCCCCCEEECcCCccCCCCCCCcCCCCCCCEEEccC-cccCCC-ChhhhcCcCC
Q 046112           16 VGLSSLSIFNVSGNLLSGA-ISNNFGSCTSLEQLDMHGNLFAGPIGSSLSSLRGLRVLDLSQ-NNLSDE-IPEFLAGFKF   92 (502)
Q Consensus        16 ~~l~~L~~l~l~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~-~p~~~~~~~~   92 (502)
                      ....+|++|+|+++.++.. ++..+..+++|++|+|++|.++...+..++.+++|+.|+|++ +.+++. +......+++
T Consensus        43 ~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~  122 (284)
T d2astb2          43 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR  122 (284)
T ss_dssp             CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT
T ss_pred             ccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHh
Confidence            3455777777777777633 344467777777777777777766666677777777777777 355531 2333456777


Q ss_pred             CceeeCCCC
Q 046112           93 LQNLNLSYN  101 (502)
Q Consensus        93 L~~l~l~~N  101 (502)
                      |++|+++++
T Consensus       123 L~~L~ls~c  131 (284)
T d2astb2         123 LDELNLSWC  131 (284)
T ss_dssp             CCEEECCCC
T ss_pred             ccccccccc
Confidence            777777764

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.94  E-value=9e-07  Score=81.57  Aligned_cols=124  Identities=20%  Similarity=0.220  Sum_probs=88.8

Q ss_pred             CCCCCccccccccccCCCCCCCEEeccCCcCCCcCCccCCCCCCCCEEECcCCccCCC-CCCCcCCCCCCCEEEccCccc
Q 046112            1 DLSNNNLSGTLSPQLVGLSSLSIFNVSGNLLSGAISNNFGSCTSLEQLDMHGNLFAGP-IGSSLSSLRGLRVLDLSQNNL   79 (502)
Q Consensus         1 dl~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~ls~N~l   79 (502)
                      ||+++.+.......+.. ..+..+.++.+.+...+. ......+|++|||++|.++.. ++..+..+++|+.|+|++|.+
T Consensus         6 DLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l   83 (284)
T d2astb2           6 DLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL   83 (284)
T ss_dssp             ECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBC
T ss_pred             ECCCCCCCchHHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCC
Confidence            67777776333332222 245677788777764333 345667999999999998753 455678899999999999999


Q ss_pred             CCCChhhhcCcCCCceeeCCCC-cccc--CCcchhhcccccceeecCCcc
Q 046112           80 SDEIPEFLAGFKFLQNLNLSYN-NFES--MLPIEGIFKNASATSVFGNKK  126 (502)
Q Consensus        80 ~~~~p~~~~~~~~L~~l~l~~N-~l~~--~~~~~~~~~~~~~~~~~~n~~  126 (502)
                      ++..+..+..+++|+.|+++++ .++.  .......+++++.+.+++...
T Consensus        84 ~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~  133 (284)
T d2astb2          84 SDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD  133 (284)
T ss_dssp             CHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTT
T ss_pred             CcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccc
Confidence            9888899999999999999985 5653  222234467788888876543

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.88  E-value=5.3e-07  Score=88.62  Aligned_cols=105  Identities=23%  Similarity=0.231  Sum_probs=76.3

Q ss_pred             CCCCCcccccc----ccccC-CCCCCCEEeccCCcCCCcCCc----cCCCCCCCCEEECcCCccCCC----CCCCcC-CC
Q 046112            1 DLSNNNLSGTL----SPQLV-GLSSLSIFNVSGNLLSGAISN----NFGSCTSLEQLDMHGNLFAGP----IGSSLS-SL   66 (502)
Q Consensus         1 dl~~n~l~~~~----p~~~~-~l~~L~~l~l~~N~l~~~~~~----~~~~l~~L~~L~l~~N~l~~~----~p~~~~-~l   66 (502)
                      ++++|.++..-    ...+. ....|+.+++++|.++.....    .+...++|++|+|++|+|+..    ++..+. ..
T Consensus       289 ~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~  368 (460)
T d1z7xw1         289 SLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPG  368 (460)
T ss_dssp             ECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred             ccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhccc
Confidence            36677776322    22222 346899999999999855333    344567899999999998752    333443 45


Q ss_pred             CCCCEEEccCcccCCC----ChhhhcCcCCCceeeCCCCcccc
Q 046112           67 RGLRVLDLSQNNLSDE----IPEFLAGFKFLQNLNLSYNNFES  105 (502)
Q Consensus        67 ~~L~~L~ls~N~l~~~----~p~~~~~~~~L~~l~l~~N~l~~  105 (502)
                      +.|+.|+|++|.|++.    ++..+..+++|++|+|++|+|+.
T Consensus       369 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~  411 (460)
T d1z7xw1         369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD  411 (460)
T ss_dssp             CCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             CCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence            7899999999999742    55667788999999999999975

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.70  E-value=4.6e-06  Score=70.02  Aligned_cols=91  Identities=12%  Similarity=0.139  Sum_probs=68.4

Q ss_pred             CCCCCCCEEeccCC-cCCCc----CCccCCCCCCCCEEECcCCccCCC----CCCCcCCCCCCCEEEccCcccCCCC---
Q 046112           16 VGLSSLSIFNVSGN-LLSGA----ISNNFGSCTSLEQLDMHGNLFAGP----IGSSLSSLRGLRVLDLSQNNLSDEI---   83 (502)
Q Consensus        16 ~~l~~L~~l~l~~N-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~---   83 (502)
                      .+.++|++|+|+++ .++..    +-..+...+.|++|+|++|.++..    +...+...++|+.|+|++|.|++.-   
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            45688999999974 56622    344577889999999999998742    3344556789999999999998532   


Q ss_pred             -hhhhcCcCCCceeeCCCCccccC
Q 046112           84 -PEFLAGFKFLQNLNLSYNNFESM  106 (502)
Q Consensus        84 -p~~~~~~~~L~~l~l~~N~l~~~  106 (502)
                       -..+...++|+.|++++|.+..+
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~~~  115 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQSVL  115 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCCC
T ss_pred             HHHHHHhCCcCCEEECCCCcCCCc
Confidence             23566778899999999976653

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.67  E-value=0.00012  Score=65.42  Aligned_cols=76  Identities=12%  Similarity=-0.015  Sum_probs=47.6

Q ss_pred             cccccCC-ceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCC--ccceeeecccccccCCCcceeEEeee
Q 046112          212 LIGAGNF-GSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHR--NLVKVFTACSGVDFQGNDFKALVYEF  288 (502)
Q Consensus       212 ~lG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~~~~~~lv~e~  288 (502)
                      .+..|.. +.||+. ...++..+++|.-...   ....+..|...++.+...  .+.+++.++.     .++..++||+|
T Consensus        17 ~~~~G~s~~~v~r~-~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~   87 (255)
T d1nd4a_          17 QQTIGCSDAAVFRL-SAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGE   87 (255)
T ss_dssp             ECSCTTSSCEEEEE-ECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEEC
T ss_pred             EcCCcccCCeEEEE-EeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEe
Confidence            3445543 678998 4566777888876533   234567788877766432  3444555432     23467899999


Q ss_pred             ccCCChhh
Q 046112          289 MANGSLEE  296 (502)
Q Consensus       289 ~~~gsL~~  296 (502)
                      +++.++.+
T Consensus        88 i~G~~~~~   95 (255)
T d1nd4a_          88 VPGQDLLS   95 (255)
T ss_dssp             CSSEETTT
T ss_pred             eecccccc
Confidence            98876543

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.58  E-value=1.1e-05  Score=67.64  Aligned_cols=41  Identities=20%  Similarity=0.288  Sum_probs=17.1

Q ss_pred             CCCCCCCEEEccCcccCCC----ChhhhcCcCCCceeeCCCCccc
Q 046112           64 SSLRGLRVLDLSQNNLSDE----IPEFLAGFKFLQNLNLSYNNFE  104 (502)
Q Consensus        64 ~~l~~L~~L~ls~N~l~~~----~p~~~~~~~~L~~l~l~~N~l~  104 (502)
                      ...++|+.|+|++|.+...    +...+...+.|+.|+|++|.|+
T Consensus        41 ~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~   85 (167)
T d1pgva_          41 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT   85 (167)
T ss_dssp             TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             hhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence            3334444445444444321    1122333344444444444443

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.43  E-value=0.00011  Score=70.27  Aligned_cols=77  Identities=17%  Similarity=0.100  Sum_probs=46.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecc----cC---cchhHHHHHHHHHHhcCC---CCccceeeecccccccCCC
Q 046112          210 ENLIGAGNFGSVYKGILFESTTAVAVKVFNV----LH---HDASKSFAVECEVTRNIR---HRNLVKVFTACSGVDFQGN  279 (502)
Q Consensus       210 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~----~~---~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~  279 (502)
                      .+.||.|....||+.....+++.++||.-..    ..   .........|.+.++.+.   ...+.+++.++       .
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------C
Confidence            3468999999999997666678899996321    11   112234556887776552   23455555542       2


Q ss_pred             cceeEEeeeccCCC
Q 046112          280 DFKALVYEFMANGS  293 (502)
Q Consensus       280 ~~~~lv~e~~~~gs  293 (502)
                      +..++|||++++..
T Consensus       104 ~~~~lvmE~L~~~~  117 (392)
T d2pula1         104 EMAVTVMEDLSHLK  117 (392)
T ss_dssp             TTTEEEECCCTTSE
T ss_pred             CCCEEEEeccCCcc
Confidence            24579999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.94  E-value=0.0021  Score=59.41  Aligned_cols=74  Identities=11%  Similarity=0.057  Sum_probs=45.7

Q ss_pred             CceEEEEEEcCCCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCc--cceeeecccccccCCCcceeEEeeeccCCC
Q 046112          218 FGSVYKGILFESTTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRN--LVKVFTACSGVDFQGNDFKALVYEFMANGS  293 (502)
Q Consensus       218 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~gs  293 (502)
                      --.||++ ..++|..+++|+.+... ....++..|.+.+..+....  ++..+....+.........+.++++++|..
T Consensus        35 EN~vy~v-~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          35 ENRVYQF-QDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SSEEEEE-CCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             cceeEEE-EcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            3579999 55788999999976432 23566888888877764221  222222222222334556788999987643

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.84  E-value=6e-05  Score=62.82  Aligned_cols=111  Identities=13%  Similarity=0.086  Sum_probs=75.2

Q ss_pred             ccCCCCCCCEEeccC-CcCCCc----CCccCCCCCCCCEEECcCCccCCC----CCCCcCCCCCCCEEEccCcccCCC--
Q 046112           14 QLVGLSSLSIFNVSG-NLLSGA----ISNNFGSCTSLEQLDMHGNLFAGP----IGSSLSSLRGLRVLDLSQNNLSDE--   82 (502)
Q Consensus        14 ~~~~l~~L~~l~l~~-N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~--   82 (502)
                      -..+.++|+.|+|++ |.++..    +-..+...++|++|+|++|.++..    +-..+...++|+.|++++|.+...  
T Consensus        12 ~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~   91 (166)
T d1io0a_          12 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI   91 (166)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhH
Confidence            345678999999998 567622    334566889999999999998753    333456678999999999998743  


Q ss_pred             --ChhhhcCcCCCceeeC--CCCccccCC-----cchhhcccccceeecCC
Q 046112           83 --IPEFLAGFKFLQNLNL--SYNNFESML-----PIEGIFKNASATSVFGN  124 (502)
Q Consensus        83 --~p~~~~~~~~L~~l~l--~~N~l~~~~-----~~~~~~~~~~~~~~~~n  124 (502)
                        +-..+...++|+.++|  ++|++...-     ......+++..+.+..+
T Consensus        92 ~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~  142 (166)
T d1io0a_          92 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT  142 (166)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred             HHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence              2246667788887554  677774311     11224455666665444

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.74  E-value=0.00014  Score=60.48  Aligned_cols=88  Identities=18%  Similarity=0.306  Sum_probs=37.3

Q ss_pred             cCCCCCCCEEeccCCcCCCc----CCccCCCCCCCCEEECcCCccCCC----CCCCcCCCCCCCEEEc--cCcccCC---
Q 046112           15 LVGLSSLSIFNVSGNLLSGA----ISNNFGSCTSLEQLDMHGNLFAGP----IGSSLSSLRGLRVLDL--SQNNLSD---   81 (502)
Q Consensus        15 ~~~l~~L~~l~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l--s~N~l~~---   81 (502)
                      +...++|+.|+|++|.++..    +...+...++|+.|++++|.++..    +-..+...++|+.++|  ++|.+..   
T Consensus        42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~  121 (166)
T d1io0a_          42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE  121 (166)
T ss_dssp             HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH
T ss_pred             HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHH
Confidence            33445555555555554422    112233345555555555554321    2233344445544333  3344432   


Q ss_pred             -CChhhhcCcCCCceeeCCCCc
Q 046112           82 -EIPEFLAGFKFLQNLNLSYNN  102 (502)
Q Consensus        82 -~~p~~~~~~~~L~~l~l~~N~  102 (502)
                       .+...+...+.|+.|+++.|.
T Consensus       122 ~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_         122 MEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHHHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHHHhCCCcCEEeCcCCC
Confidence             122333444555555554443

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.98  E-value=0.046  Score=49.56  Aligned_cols=31  Identities=23%  Similarity=0.275  Sum_probs=27.8

Q ss_pred             CCCceeecCCCCCeeeCCCCcEEEeeeccce
Q 046112          338 QPPIAHCDLKPSNILLDDEMTAYVSDFGIAR  368 (502)
Q Consensus       338 ~~~i~H~dlk~~NIll~~~~~~kl~Dfg~a~  368 (502)
                      ..+++|+|+.+.||+++.+...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            5679999999999999988777899999885

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.90  E-value=0.0073  Score=57.25  Aligned_cols=73  Identities=18%  Similarity=0.246  Sum_probs=46.3

Q ss_pred             CcccccCCceEEEEEEcC-------CCeEEEEEEecccCcchhHHHHHHHHHHhcCCCCccc-eeeecccccccCCCcce
Q 046112          211 NLIGAGNFGSVYKGILFE-------STTAVAVKVFNVLHHDASKSFAVECEVTRNIRHRNLV-KVFTACSGVDFQGNDFK  282 (502)
Q Consensus       211 ~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~~~~  282 (502)
                      +.|+.|-.-.+|+....+       ..+.|.+++...  ....-...+|..+++.+.-.+++ ++++++.         -
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~---------~  116 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFS---------G  116 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET---------T
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC---------C
Confidence            567778888999986542       235677777652  22233456788888777533443 5666531         2


Q ss_pred             eEEeeeccCCCh
Q 046112          283 ALVYEFMANGSL  294 (502)
Q Consensus       283 ~lv~e~~~~gsL  294 (502)
                      ++|+||+++.++
T Consensus       117 g~I~efi~g~~l  128 (395)
T d1nw1a_         117 GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEECCCCEEEC
T ss_pred             ceEEEEeccccC
Confidence            689999987544